data_2kj3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kj3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 112.21 0.448 . . . . 73.439999999999998 112.21 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 9.2 t30 -104.39 120.56 41.49 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.055 -1.461 . . . . 75.439999999999998 107.055 167.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 42.5 m -121.59 146.18 47.23 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 120.838 0.352 . . . . 75.120000000000005 111.359 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 264' ' ' VAL . . . -138.66 144.58 39.72 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.548 -1.279 . . . . 72.420000000000002 107.548 175.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -97.71 -60.01 1.65 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.127 0.489 . . . . 72.420000000000002 110.176 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.95 139.45 50.05 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.892 -0.594 . . . . 74.120000000000005 110.812 -175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 25.6 mt -136.15 131.82 49.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.002 -1.11 . . . . 60.43 108.002 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -129.09 116.52 19.4 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.666 -0.865 . . . . 74.400000000000006 108.666 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.404 HG23 ' HB ' ' A' ' 239' ' ' VAL . 12.4 p -119.57 127.42 52.96 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.171 -0.677 . . . . 71.030000000000001 109.171 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -135.86 144.24 45.51 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 116.592 -0.276 . . . . 73.329999999999998 111.063 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.545 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 41.6 mt-10 62.34 88.88 0.09 Allowed 'General case' 0 C--O 1.215 -0.715 0 O-C-N 124.908 1.38 . . . . 71.310000000000002 113.181 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.545 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.0 OUTLIER 59.45 21.72 10.17 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.868 0.867 . . . . 72.109999999999999 112.131 174.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.08 142.13 28.08 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.725 -0.472 . . . . 73.120000000000005 109.725 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -125.03 137.17 54.23 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.592 -0.521 . . . . 75.150000000000006 109.592 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 4.3 p -129.98 132.77 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 123.996 0.81 . . . . 75.329999999999998 111.285 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.461 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 57.9 tp60 -111.95 117.0 31.51 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 107.885 -1.154 . . . . 74.439999999999998 107.885 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.73 118.5 35.77 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.767 -0.827 . . . . 72.329999999999998 108.767 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.507 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 132.87 -114.23 1.38 Allowed Glycine 0 N--CA 1.439 -1.167 0 C-N-CA 120.679 -0.772 . . . . 73.120000000000005 113.203 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -145.4 139.19 26.76 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.452 -0.944 . . . . 75.430000000000007 108.452 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 t -123.57 114.56 42.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.965 -1.124 . . . . 75.329999999999998 107.965 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 80.4 t -111.13 119.79 60.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 109.367 -0.605 . . . . 75.099999999999994 109.367 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 28.5 m -88.44 158.01 18.49 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.211 -1.774 . . . . 64.439999999999998 106.211 172.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.42 87.58 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.392 0.515 . . . . 72.219999999999999 112.392 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.66 98.91 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.145 1.165 . . . . 73.409999999999997 114.145 -175.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 120.877 0.37 . . . . 74.129999999999995 110.883 -175.843 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.425 -1.686 0 CA-C-O 121.566 0.698 . . . . 70.129999999999995 111.767 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.609 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 7.9 t30 -126.57 143.13 51.31 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.238 -1.023 . . . . 65.319999999999993 108.238 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.6 m -138.36 125.6 21.63 Favored 'General case' 0 C--N 1.29 -1.984 0 O-C-N 121.718 -0.614 . . . . 60.130000000000003 109.721 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.6 p -126.89 145.94 33.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.244 -0.65 . . . . 63.240000000000002 109.244 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 59.9 mt-10 -87.14 -79.11 0.28 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 119.755 -0.778 . . . . 73.420000000000002 110.364 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.2 t -116.65 132.02 56.8 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.641 0.734 . . . . 65.129999999999995 111.46 -174.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.88 124.77 47.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.151 -0.931 . . . . 65.340000000000003 110.405 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 4.0 p -127.25 129.06 70.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 116.056 -0.52 . . . . 74.340000000000003 111.421 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.418 ' HA2' ' HG1' ' B' ' 233' ' ' THR . . . -123.09 131.06 8.04 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 109.469 -1.453 . . . . 61.329999999999998 109.469 175.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -134.19 120.67 20.34 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 120.142 -0.623 . . . . 72.409999999999997 111.583 -175.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.56 83.77 1.61 Allowed Glycine 0 C--N 1.306 -1.124 0 C-N-CA 120.33 -0.938 . . . . 54.130000000000003 112.974 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 55.19 28.26 10.84 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.68 1.592 . . . . 73.310000000000002 112.424 173.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 17.7 m -82.67 151.51 26.24 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.893 0.701 . . . . 72.129999999999995 112.893 -170.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -113.09 127.71 56.28 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.361 -0.836 . . . . 71.219999999999999 108.931 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.4 p -137.03 123.54 28.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.362 0.601 . . . . 73.0 110.572 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.461 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.1 tt -117.3 124.27 48.58 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.654 -1.239 . . . . 73.049999999999997 107.654 175.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.46 HG23 HD11 ' B' ' 241' ' ' LEU . 72.4 mt -113.17 103.7 15.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.14 -1.059 . . . . 70.109999999999999 108.14 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 141.65 -151.13 22.5 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 111.433 -0.667 . . . . 60.420000000000002 111.433 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -111.76 131.88 55.02 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 122.216 -0.579 . . . . 74.200000000000003 109.775 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 8.1 tp10 -113.97 118.57 34.53 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 124.401 1.08 . . . . 71.129999999999995 108.153 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -108.74 124.56 50.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.075 -1.083 . . . . 72.420000000000002 108.075 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.13 -52.71 0.64 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 111.323 -0.711 . . . . 71.239999999999995 111.323 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 88.13 18.37 55.87 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.335 -1.106 . . . . 61.020000000000003 110.335 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -122.35 -2.35 9.03 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.598 -0.519 . . . . 72.140000000000001 109.598 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -78.56 -75.69 0.97 Allowed Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.269 -0.967 . . . . 73.340000000000003 113.507 -174.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.416 ' CB ' HD13 ' A' ' 276' ' ' LEU . 59.6 t80 -79.59 -35.02 40.29 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.797 -0.361 . . . . 63.140000000000001 111.634 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 30.0 p90 . . . . . 0 C--N 1.298 -1.65 0 N-CA-C 108.857 -0.794 . . . . 72.239999999999995 108.857 178.798 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 . . . . . 0 CA--C 1.511 -0.55 0 CA-C-O 121.267 0.556 . . . . 71.319999999999993 112.238 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.609 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 9.1 t30 -110.54 133.73 53.03 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.484 -2.043 . . . . 71.209999999999994 105.484 171.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 50.8 m -133.89 149.57 51.32 Favored 'General case' 0 C--N 1.281 -2.404 0 O-C-N 121.197 -0.939 . . . . 74.519999999999996 111.769 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.643 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -135.99 146.29 47.05 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.929 -1.137 . . . . 70.439999999999998 107.929 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 3.5 tmtm? -101.88 -57.93 1.98 Allowed 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.917 -0.771 . . . . 75.549999999999997 108.917 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -135.26 139.21 44.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.255 -0.43 . . . . 74.120000000000005 109.998 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 21.8 mt -135.9 127.62 44.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.254 -1.017 . . . . 73.549999999999997 108.254 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 38.1 ttm180 -125.95 115.61 20.2 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.636 -0.876 . . . . 73.010000000000005 108.636 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' THR . . . . . 0.418 ' HG1' ' HA2' ' A' ' 269' ' ' GLY . 81.7 p -110.75 126.49 54.64 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.173 -1.417 . . . . 64.430000000000007 107.173 176.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -133.29 138.86 46.6 Favored 'General case' 0 CA--C 1.493 -1.239 0 C-N-CA 120.34 -0.544 . . . . 73.340000000000003 109.753 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . 0.627 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 43.1 mt-10 64.37 97.93 0.04 OUTLIER 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.758 1.392 . . . . 74.030000000000001 114.758 171.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.627 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.0 OUTLIER 57.71 29.25 17.04 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.57 0.748 . . . . 72.099999999999994 109.95 174.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.55 140.14 30.81 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-O 122.022 0.915 . . . . 75.530000000000001 110.984 -175.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.81 134.27 51.74 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 105.863 -1.903 . . . . 74.109999999999999 105.863 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.6 p -134.06 134.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.895 0.855 . . . . 74.129999999999995 111.097 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.537 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 35.4 tp60 -110.64 121.0 44.25 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 114.16 -1.382 . . . . 73.219999999999999 107.271 172.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . 0.46 HD11 HG23 ' A' ' 277' ' ' ILE . 2.9 tm? -117.24 118.76 33.19 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 107.072 -1.455 . . . . 70.140000000000001 107.072 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.508 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 127.6 -109.51 1.06 Allowed Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.472 -0.871 . . . . 71.340000000000003 112.42 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . 0.577 ' OD1' HG23 ' B' ' 245' ' ' VAL . 24.1 t-20 -144.4 146.58 32.59 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 122.286 -0.538 . . . . 72.150000000000006 110.699 -176.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.537 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 25.0 t -133.06 120.42 40.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.175 -1.046 . . . . 74.209999999999994 108.175 172.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . 0.577 HG23 ' OD1' ' B' ' 243' ' ' ASN . 88.6 t -115.57 119.37 61.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.65 -0.5 . . . . 70.209999999999994 109.65 176.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 24.8 m -79.02 157.44 28.08 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 106.003 -1.851 . . . . 74.019999999999996 106.003 174.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.11 -46.36 81.36 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.99 0.9 . . . . 63.439999999999998 112.201 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.29 74.33 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 113.831 -1.531 . . . . 72.049999999999997 113.576 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' C' ' 247' ' ' ALA . . . -70.48 -46.43 63.77 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.543 0.942 . . . . 71.430000000000007 113.543 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 44.2 tp . . . . . 0 C--N 1.313 -1.017 0 C-N-CA 119.967 -0.693 . . . . 75.329999999999998 110.518 -175.556 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 24.6 p . . . . . 0 N--CA 1.428 -1.566 0 CA-C-O 120.953 0.406 . . . . 74.140000000000001 110.507 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 261' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 7.4 t -94.33 127.69 40.37 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-O 121.429 0.633 . . . . 52.109999999999999 110.857 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . 0.52 ' HB3' ' OD1' ' B' ' 226' ' ' ASN . 54.5 t30 -126.66 143.56 51.19 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.127 -1.064 . . . . 74.510000000000005 108.127 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 263' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' C' ' 227' ' ' SER . 24.3 m -141.97 126.31 17.63 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 122.019 -0.426 . . . . 74.040000000000006 110.074 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.7 p -120.16 152.28 22.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 109.09 -0.708 . . . . 73.519999999999996 109.09 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.461 ' HA ' ' CB ' ' B' ' 229' ' ' LYS . 27.8 mt-10 -92.8 -86.42 0.25 Allowed 'General case' 0 N--CA 1.404 -2.768 0 C-N-CA 119.455 -0.898 . . . . 64.200000000000003 111.151 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 11.3 t -109.42 130.13 55.51 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.604 -0.839 . . . . 71.140000000000001 111.745 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.5 p -132.29 124.48 52.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.114 -0.948 . . . . 75.140000000000001 110.54 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 7.7 p -127.1 134.52 65.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 116.078 -0.51 . . . . 73.299999999999997 111.718 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . 0.432 ' HA2' ' HG1' ' C' ' 233' ' ' THR . . . -114.78 132.28 10.32 Favored Glycine 0 CA--C 1.479 -2.208 0 N-CA-C 110.062 -1.215 . . . . 72.120000000000005 110.062 176.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -133.59 116.66 16.15 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 120.778 0.323 . . . . 74.439999999999998 111.281 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.69 86.31 0.57 Allowed Glycine 0 C--O 1.25 1.123 0 C-N-CA 120.583 -0.818 . . . . 73.010000000000005 114.094 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 61.59 31.08 18.86 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.284 1.034 . . . . 73.019999999999996 111.961 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 24.5 m -83.25 145.64 29.01 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.575 0.702 . . . . 74.299999999999997 112.12 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . 0.462 ' NH2' ' HA ' ' B' ' 287' ' ' TRP . 39.6 mtp180 -115.14 125.93 54.03 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.236 -2.135 . . . . 75.030000000000001 105.236 173.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 1.6 p -135.84 127.09 44.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-O 120.958 0.408 . . . . 74.120000000000005 110.498 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . 0.434 HD12 ' CB ' ' B' ' 286' ' ' PHE . 5.5 tt -120.15 121.76 39.5 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.361 -1.348 . . . . 74.400000000000006 107.361 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . 0.449 HG21 HD12 ' C' ' 241' ' ' LEU . 36.7 mt -113.06 103.72 15.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 N-CA-C 106.767 -1.568 . . . . 63.340000000000003 106.767 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 145.11 -147.54 18.76 Favored Glycine 0 N--CA 1.416 -2.637 0 C-N-CA 120.917 -0.658 . . . . 73.409999999999997 111.783 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -115.01 128.71 56.43 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 120.937 -0.305 . . . . 74.319999999999993 111.392 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . 0.528 ' HG2' ' CZ2' ' B' ' 287' ' ' TRP . 9.7 tp10 -112.46 121.47 44.92 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.921 -1.14 . . . . 75.340000000000003 107.921 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . 0.463 ' CD2' ' HB ' ' C' ' 245' ' ' VAL . 86.7 m-85 -111.53 124.03 51.45 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.378 -0.971 . . . . 73.230000000000004 108.378 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.29 -61.59 0.31 Allowed Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 111.014 -0.834 . . . . 74.319999999999993 111.014 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . 0.42 ' C ' ' HD2' ' B' ' 284' ' ' LYS . . . 94.53 26.02 14.44 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.314 -0.715 . . . . 74.450000000000003 111.314 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . 0.42 ' HD2' ' C ' ' B' ' 283' ' ' GLY . 3.2 mptp? -134.09 2.57 3.35 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 110.39 -0.226 . . . . 73.129999999999995 110.39 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -78.53 -66.76 1.69 Allowed Glycine 0 N--CA 1.417 -2.633 0 C-N-CA 119.952 -1.118 . . . . 74.319999999999993 112.371 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.434 ' CB ' HD12 ' B' ' 276' ' ' LEU . 75.9 t80 -87.67 -37.84 16.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.914 0.709 . . . . 74.019999999999996 112.914 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.528 ' CZ2' ' HG2' ' B' ' 280' ' ' GLU . 20.8 p90 . . . . . 0 C--N 1.312 -1.064 0 N-CA-C 112.86 0.689 . . . . 74.120000000000005 112.86 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' B' ' 261' ' ' THR . 14.9 ptt180 . . . . . 0 N--CA 1.437 -1.109 0 CA-C-O 121.464 0.65 . . . . 74.230000000000004 111.102 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 7.4 t30 -108.85 141.55 40.73 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.017 -2.216 . . . . 55.030000000000001 105.017 169.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 227' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' B' ' 263' ' ' SER . 54.0 m -139.8 139.48 36.41 Favored 'General case' 0 C--N 1.278 -2.542 0 O-C-N 121.818 -0.551 . . . . 62.109999999999999 110.889 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -127.45 143.19 51.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.782 -1.192 . . . . 65.150000000000006 107.782 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 9.3 tmtt? -102.77 -53.1 2.93 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.588 -0.523 . . . . 74.120000000000005 109.588 -174.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.21 137.96 43.14 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.248 -0.649 . . . . 64.200000000000003 109.248 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 33.5 mt -136.67 130.31 46.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.01 -1.107 . . . . 75.420000000000002 108.01 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -133.6 119.1 19.0 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.43 -0.952 . . . . 73.099999999999994 108.43 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 233' ' ' THR . . . . . 0.451 HG23 ' CG1' ' C' ' 239' ' ' VAL . 45.0 p -110.49 126.41 54.33 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.19 -1.411 . . . . 73.140000000000001 107.19 174.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -127.91 139.22 52.73 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 110.05 -0.352 . . . . 63.240000000000002 110.05 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . 0.596 ' C ' ' HD3' ' C' ' 236' ' ' ARG . 62.5 mt-10 63.13 93.43 0.05 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.664 1.227 . . . . 74.140000000000001 114.218 170.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.596 ' HD3' ' C ' ' C' ' 235' ' ' GLU . 0.7 OUTLIER 56.37 26.91 11.22 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 123.889 0.875 . . . . 74.439999999999998 111.387 172.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.5 148.46 24.91 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.751 -0.659 . . . . 64.430000000000007 110.576 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -124.66 134.22 52.96 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.17 -1.418 . . . . 72.140000000000001 107.17 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 4.7 p -135.96 135.14 50.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.622 0.725 . . . . 72.239999999999995 111.188 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . 0.488 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 36.4 tp60 -114.37 115.17 26.91 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-N 114.28 -1.327 . . . . 75.5 108.152 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.469 HD11 ' ND2' ' B' ' 262' ' ' ASN . 3.0 tm? -111.85 117.79 33.76 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 105.596 -2.002 . . . . 73.319999999999993 105.596 176.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.533 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 138.65 -130.62 4.99 Favored Glycine 0 CA--C 1.485 -1.837 0 C-N-CA 119.577 -1.297 . . . . 72.150000000000006 111.724 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -141.06 131.26 24.88 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 120.956 0.408 . . . . 71.420000000000002 109.911 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . 0.488 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 21.4 t -114.52 129.87 69.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.668 -0.864 . . . . 73.310000000000002 108.668 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . 0.463 ' HB ' ' CD2' ' B' ' 281' ' ' TYR . 95.8 t -122.11 118.53 55.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 109.195 -0.668 . . . . 73.349999999999994 109.195 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 21.4 m -79.43 159.42 27.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.949 -1.871 . . . . 75.319999999999993 105.949 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' B' ' 249' ' ' ALA . . . -62.63 -47.63 82.92 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-O 122.08 0.943 . . . . 74.530000000000001 110.772 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.88 -34.76 65.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 113.718 -1.583 . . . . 74.140000000000001 112.806 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.023 0 N-CA-C 113.74 1.015 . . . . 72.510000000000005 113.74 -174.028 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 15.4 t . . . . . 0 CA--C 1.56 1.342 0 CA-C-O 121.889 0.852 . . . . 75.099999999999994 110.169 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 9.0 t30 -127.77 126.7 42.25 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.808 -0.558 . . . . 73.420000000000002 111.661 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 68.4 m -121.43 134.39 55.09 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 122.126 -0.359 . . . . 73.530000000000001 110.731 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -128.32 150.55 34.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.166 -1.05 . . . . 65.340000000000003 108.166 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' C' ' 229' ' ' LYS . 49.1 mt-10 -91.11 -88.49 0.18 Allowed 'General case' 0 N--CA 1.419 -1.978 0 C-N-CA 119.374 -0.931 . . . . 73.010000000000005 111.045 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 5.8 t -107.78 132.65 53.17 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.652 -0.819 . . . . 72.329999999999998 111.914 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.02 131.34 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.162 -0.926 . . . . 73.400000000000006 109.119 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.79 135.76 62.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 116.104 -0.498 . . . . 74.530000000000001 110.652 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.04 9.86 Favored Glycine 0 CA--C 1.474 -2.511 0 N-CA-C 109.086 -1.605 . . . . 73.510000000000005 109.086 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -134.03 116.27 15.3 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 110.227 -0.286 . . . . 72.239999999999995 110.227 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.57 83.48 0.73 Allowed Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.513 -0.851 . . . . 75.129999999999995 114.217 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 60.44 33.88 20.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.409 1.084 . . . . 75.030000000000001 112.319 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 10.7 m -83.72 145.18 28.88 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.925 0.713 . . . . 71.430000000000007 112.925 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -105.87 128.13 53.56 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.486 -1.301 . . . . 74.439999999999998 107.486 168.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 7.5 p -139.22 127.59 27.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 120.974 0.416 . . . . 75.129999999999995 111.226 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.495 HD13 ' CB ' ' C' ' 286' ' ' PHE . 7.2 tt -117.19 120.35 38.02 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.41 -0.959 . . . . 74.310000000000002 108.41 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 28.2 mt -113.26 103.6 15.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 106.991 -1.485 . . . . 72.120000000000005 106.991 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 144.85 -146.04 16.02 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.764 -0.935 . . . . 52.140000000000001 110.764 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -115.45 133.25 56.21 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 110.1 -0.333 . . . . 74.140000000000001 110.1 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -113.35 118.21 33.93 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.869 -1.159 . . . . 75.409999999999997 107.869 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -108.86 124.94 51.42 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.325 0.583 . . . . 73.120000000000005 109.861 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 106.08 -38.59 3.23 Favored Glycine 0 N--CA 1.417 -2.602 0 CA-C-N 115.089 -0.96 . . . . 63.100000000000001 110.957 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 72.76 35.06 58.92 Favored Glycine 0 CA--C 1.489 -1.569 0 N-CA-C 109.507 -1.437 . . . . 73.230000000000004 109.507 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -146.88 -7.3 0.49 Allowed 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 114.851 -0.675 . . . . 74.049999999999997 109.906 -173.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . 0.407 ' HA3' ' CG1' ' C' ' 244' ' ' VAL . . . -76.45 -70.15 1.31 Allowed Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 120.789 -0.719 . . . . 72.150000000000006 112.843 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . 0.495 ' CB ' HD13 ' C' ' 276' ' ' LEU . 70.9 t80 -77.07 -51.16 11.53 Favored 'General case' 0 CA--C 1.49 -1.355 0 C-N-CA 120.411 -0.516 . . . . 75.319999999999993 110.097 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . 0.317 28.5 p90 . . . . . 0 N--CA 1.412 -2.348 0 C-N-CA 118.504 -1.278 . . . . 75.549999999999997 112.2 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 261' ' ' THR . 37.4 ttm180 . . . . . 0 CA--C 1.507 -0.693 0 N-CA-C 110.235 -0.283 . . . . 74.239999999999995 110.235 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.53 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 34.1 t-20 -116.88 149.23 40.43 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.527 -0.916 . . . . 73.540000000000006 108.527 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.3 m -137.09 137.52 39.39 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.97 -0.752 . . . . 72.519999999999996 108.97 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.401 ' HB2' HG21 ' A' ' 277' ' ' ILE . . . -137.17 132.06 33.42 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 110.109 -0.33 . . . . 70.420000000000002 110.109 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 5.2 tmmm? -90.87 -55.06 3.7 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.122 -0.49 . . . . 74.299999999999997 110.971 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -131.59 139.4 49.17 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.972 -0.381 . . . . 74.450000000000003 109.972 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 68.0 mt -137.29 121.03 22.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.546 -0.909 . . . . 74.239999999999995 108.546 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -131.27 129.21 41.25 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.325 0.583 . . . . 72.349999999999994 112.011 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 27.2 p -132.32 128.49 37.85 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.415 -0.811 . . . . 74.5 109.029 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -121.48 147.99 45.04 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 111.841 0.311 . . . . 72.530000000000001 111.841 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 67.07 -87.23 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.729 1.212 . . . . 73.310000000000002 113.859 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 25.0 mtm-85 -116.31 3.02 13.33 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.191 0.596 . . . . 74.329999999999998 110.487 -175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -69.64 136.71 51.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.308 -0.86 . . . . 75.450000000000003 111.33 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -125.45 135.38 52.28 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.36 -0.978 . . . . 74.200000000000003 108.36 -177.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.9 p -129.68 146.03 34.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.573 0.701 . . . . 64.519999999999996 110.809 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.48 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 6.1 tp-100 -123.72 130.01 51.98 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 107.929 -1.137 . . . . 75.329999999999998 107.929 174.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -123.32 118.68 28.08 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.469 -0.937 . . . . 74.040000000000006 108.469 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.513 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 130.27 -114.12 1.58 Allowed Glycine 0 N--CA 1.433 -1.566 0 CA-C-N 115.825 -0.625 . . . . 75.219999999999999 111.618 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -145.19 138.75 26.75 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 122.437 -0.449 . . . . 74.450000000000003 111.375 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 85.5 t -122.45 114.08 41.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.806 -1.553 . . . . 74.340000000000003 106.806 174.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.78 114.35 41.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 C-N-CA 120.334 -0.546 . . . . 75.349999999999994 110.607 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 22.8 m -79.92 158.9 26.54 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.826 -1.176 . . . . 74.230000000000004 107.826 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.97 -41.49 95.41 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.054 0.455 . . . . 52.420000000000002 111.368 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -35.9 67.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.408 -1.269 . . . . 72.299999999999997 113.895 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.51 0 C-N-CA 122.766 0.426 . . . . 74.319999999999993 112.126 -176.119 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 225' ' ' ARG . 29.3 m . . . . . 0 N--CA 1.419 -1.985 0 N-CA-C 108.177 -1.046 . . . . 72.430000000000007 108.177 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 226' ' ' ASN . 38.9 t-20 -126.15 136.77 53.27 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.14 -1.43 . . . . 71.450000000000003 107.14 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.6 m -138.15 134.53 34.69 Favored 'General case' 0 C--N 1.285 -2.21 0 O-C-N 122.077 -0.389 . . . . 75.129999999999995 110.289 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 13.1 p -128.43 141.88 45.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.211 0.529 . . . . 75.010000000000005 111.118 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.596 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 6.4 mm-40 -78.58 -72.18 0.39 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.652 -0.703 . . . . 73.219999999999999 110.961 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -128.8 127.84 42.76 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.854 -0.738 . . . . 62.310000000000002 112.713 -175.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 35.5 m -119.97 126.9 75.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.975 -0.557 . . . . 73.510000000000005 110.07 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.55 136.88 59.53 Favored 'Isoleucine or valine' 0 C--O 1.257 1.473 0 CA-C-O 121.358 0.599 . . . . 73.310000000000002 112.115 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.09 131.34 8.38 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.725 -1.35 . . . . 72.120000000000005 109.725 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -124.24 117.57 24.88 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.412 0.625 . . . . 75.129999999999995 111.536 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.24 -118.87 5.41 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.106 -1.198 . . . . 74.329999999999998 110.106 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -102.63 90.66 3.9 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.449 -1.315 . . . . 62.219999999999999 107.449 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 31.5 m -130.7 145.35 51.91 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.607 -1.179 . . . . 71.120000000000005 108.643 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . 0.433 ' HB2' ' HG3' ' B' ' 238' ' ' ARG . 94.0 mtt180 -130.45 127.51 39.39 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.445 -1.302 . . . . 74.120000000000005 108.225 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.5 p -132.76 130.38 59.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.961 0.886 . . . . 71.420000000000002 111.327 -173.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.48 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.6 tt -117.51 126.13 52.06 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.972 -1.122 . . . . 74.340000000000003 107.972 176.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.401 HG21 ' HB2' ' A' ' 228' ' ' ALA . 34.6 mm -112.68 103.51 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 107.075 -1.454 . . . . 75.430000000000007 107.075 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.616 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 150.44 -141.17 8.5 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.881 -1.152 . . . . 73.519999999999996 112.85 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -113.02 134.14 54.65 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.798 -1.186 . . . . 74.450000000000003 107.798 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.4 OUTLIER -129.74 120.36 24.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.966 0.889 . . . . 73.5 109.104 176.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -113.97 124.65 52.67 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.858 -1.064 . . . . 73.010000000000005 108.951 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 129.72 -42.6 1.4 Allowed Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.841 -0.695 . . . . 74.0 112.407 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' B' ' 286' ' ' PHE . . . 100.61 -15.95 58.12 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.81 -0.916 . . . . 54.509999999999998 110.81 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.07 83.96 2.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.002 -0.74 . . . . 74.239999999999995 109.002 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -84.88 -121.75 1.02 Allowed Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.653 -0.703 . . . . 73.430000000000007 112.312 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -87.98 15.89 6.69 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.104 0.478 . . . . 75.010000000000005 110.223 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . 0.442 ' CH2' ' HB2' ' A' ' 276' ' ' LEU . 78.0 m95 . . . . . 0 C--N 1.316 -0.866 0 N-CA-C 114.686 1.365 . . . . 74.420000000000002 114.686 -170.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . 0.447 ' HD2' ' HB ' ' A' ' 261' ' ' THR . 8.1 tpt180 . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 107.524 -1.287 . . . . 74.409999999999997 107.524 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.506 HD22 HG22 ' B' ' 277' ' ' ILE . 7.3 t30 -120.95 144.56 48.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 120.747 0.308 . . . . 72.019999999999996 111.79 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' B' ' 263' ' ' SER . 50.5 m -136.33 136.96 40.14 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.179 -0.674 . . . . 70.420000000000002 109.179 173.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.03 142.94 49.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.537 -0.542 . . . . 72.299999999999997 109.537 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 2.3 tmmm? -100.69 -64.1 1.07 Allowed 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 120.393 -0.523 . . . . 74.129999999999995 110.267 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -127.85 138.33 52.66 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 108.959 -0.756 . . . . 73.430000000000007 108.959 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 16.9 mt -135.57 119.91 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.095 -0.705 . . . . 73.010000000000005 109.095 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -123.23 115.71 22.18 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.873 0.368 . . . . 74.129999999999995 110.651 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' B' ' 237' ' ' ALA . 52.6 p -111.69 127.66 55.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.625 -1.25 . . . . 73.099999999999994 107.625 175.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -130.18 149.68 51.77 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.457 -0.497 . . . . 73.450000000000003 111.028 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . 0.251 33.5 mt-10 75.87 -74.16 0.08 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 115.733 1.753 . . . . 64.129999999999995 115.733 170.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.26 24.72 2.3 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.334 -0.987 . . . . 75.209999999999994 108.334 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . 0.439 ' C ' ' HD2' ' B' ' 238' ' ' ARG . . . -84.91 142.93 29.34 Favored 'General case' 0 C--O 1.275 2.444 0 CA-C-O 122.954 1.359 . . . . 75.340000000000003 113.895 -172.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' B' ' 237' ' ' ALA . 3.7 mpt_? -125.93 135.21 51.61 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.487 -1.233 . . . . 73.430000000000007 110.845 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 14.1 p -134.29 143.4 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.201 1.001 . . . . 74.129999999999995 110.51 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.541 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 4.8 tp-100 -121.12 125.17 46.56 Favored 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 114.108 -1.405 . . . . 65.239999999999995 107.857 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -119.16 117.04 27.6 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.176 -1.787 . . . . 74.120000000000005 106.176 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 139.05 -121.33 2.08 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 110.487 -1.045 . . . . 73.430000000000007 110.487 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -145.34 139.1 26.79 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.932 0.366 . . . . 73.129999999999995 110.853 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 280' ' ' GLU . 44.8 t -122.41 122.61 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 107.989 -1.115 . . . . 73.409999999999997 107.989 175.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . 0.506 HG22 ' O ' ' B' ' 250' ' ' LEU . 7.0 p -123.67 125.67 71.68 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 C-N-CA 120.052 -0.659 . . . . 75.420000000000002 110.89 175.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 2.1 m -81.88 160.82 23.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.393 -1.336 . . . . 74.450000000000003 107.393 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.94 79.97 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 120.986 0.422 . . . . 74.519999999999996 111.636 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.33 -52.28 64.0 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.698 -1.137 . . . . 72.030000000000001 112.566 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.16 -46.42 34.38 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.707 -0.397 . . . . 75.299999999999997 110.414 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . 0.506 ' O ' HG22 ' B' ' 245' ' ' VAL . 52.1 tp . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 124.916 1.286 . . . . 75.310000000000002 113.138 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 86.1 m . . . . . 0 N--CA 1.431 -1.397 0 N-CA-C 108.92 -0.771 . . . . 73.219999999999999 108.92 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 261' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 29.1 m -126.58 112.88 16.03 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.92 -0.77 . . . . 70.510000000000005 108.92 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -121.05 138.18 54.3 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.936 -1.135 . . . . 71.230000000000004 107.936 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 263' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' C' ' 227' ' ' SER . 43.6 m -138.6 138.88 38.31 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 120.739 0.304 . . . . 71.140000000000001 110.219 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 12.5 p -128.51 150.33 34.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 120.87 0.367 . . . . 64.409999999999997 110.527 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 44.0 mm-40 -86.01 -76.21 0.35 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.834 -0.621 . . . . 71.109999999999999 110.691 174.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 27.8 m -128.81 127.87 42.8 Favored 'General case' 0 C--O 1.249 1.034 0 C-N-CA 119.931 -0.707 . . . . 74.219999999999999 112.454 -176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.46 129.31 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.696 -0.684 . . . . 64.420000000000002 109.265 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 8.8 p -127.58 128.87 70.11 Favored 'Isoleucine or valine' 0 C--O 1.266 1.922 0 CA-C-O 121.716 0.769 . . . . 70.340000000000003 112.237 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.91 132.82 10.93 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 110.46 -1.056 . . . . 61.109999999999999 110.46 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -124.09 121.29 34.77 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 122.472 0.309 . . . . 72.439999999999998 111.127 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.24 -130.0 9.42 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.65 -1.38 . . . . 61.43 109.65 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.93 98.4 11.35 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.653 -1.98 . . . . 74.340000000000003 105.653 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.4 t -130.03 143.03 50.57 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.989 -1.005 . . . . 72.349999999999994 108.764 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . 0.468 ' HB2' ' HG3' ' C' ' 238' ' ' ARG . 76.3 mtt180 -131.3 127.05 36.91 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 118.565 -1.254 . . . . 73.329999999999998 108.376 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.0 p -135.9 132.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 115.094 -0.957 . . . . 73.219999999999999 110.918 -175.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . 0.502 ' HB3' ' OE1' ' C' ' 240' ' ' GLN . 5.9 tt -119.96 125.41 48.34 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 107.546 -1.279 . . . . 74.200000000000003 107.546 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . 0.506 HG22 HD22 ' B' ' 226' ' ' ASN . 30.0 mm -112.54 103.56 15.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 N-CA-C 106.772 -1.566 . . . . 74.25 106.772 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.563 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 147.21 -143.77 11.73 Favored Glycine 0 N--CA 1.427 -1.951 0 C-N-CA 120.422 -0.894 . . . . 51.549999999999997 113.829 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -108.76 132.25 54.15 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.721 -0.844 . . . . 62.0 108.721 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' C' ' 244' ' ' VAL . 0.0 OUTLIER -127.8 122.49 32.85 Favored 'General case' 0 C--O 1.265 1.88 0 CA-C-O 122.324 1.059 . . . . 73.299999999999997 108.593 177.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -120.52 124.11 44.57 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.407 -1.27 . . . . 72.329999999999998 107.7 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 128.94 -40.05 1.76 Allowed Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.333 -0.937 . . . . 73.420000000000002 111.524 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' C' ' 286' ' ' PHE . . . 97.01 -16.54 60.77 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 110.576 -1.01 . . . . 72.530000000000001 110.576 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.29 77.56 1.68 Allowed 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.208 -0.496 . . . . 75.040000000000006 110.577 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -76.3 -128.86 0.3 Allowed Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 115.013 -0.994 . . . . 70.120000000000005 112.007 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 5.0 p90 -81.99 13.55 3.29 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.484 0.659 . . . . 73.530000000000001 111.391 -175.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.496 ' CH2' ' HB2' ' B' ' 276' ' ' LEU . 39.9 m95 . . . . . 0 C--N 1.315 -0.92 0 CA-C-N 116.037 -0.528 . . . . 75.230000000000004 109.647 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' C' ' 261' ' ' THR . 28.4 ttt180 . . . . . 0 N--CA 1.42 -1.931 0 N-CA-C 109.023 -0.732 . . . . 74.099999999999994 109.023 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . 0.489 HD22 HG22 ' C' ' 277' ' ' ILE . 7.2 t30 -118.78 148.97 42.26 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 116.182 -0.463 . . . . 65.129999999999995 110.475 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 227' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' C' ' 263' ' ' SER . 31.9 m -136.68 136.53 39.15 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.195 -1.039 . . . . 74.310000000000002 108.195 172.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.7 138.23 49.91 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.469 -0.567 . . . . 75.430000000000007 109.469 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 2.9 tmmm? -93.38 -64.22 1.12 Allowed 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.556 -0.458 . . . . 74.120000000000005 110.943 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -127.37 137.79 52.85 Favored 'General case' 0 C--O 1.253 1.243 0 C-N-CA 120.1 -0.64 . . . . 63.539999999999999 109.682 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 31.3 mt -133.95 118.94 30.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.889 -0.782 . . . . 64.519999999999996 108.889 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -118.99 122.38 42.07 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.792 -0.448 . . . . 73.200000000000003 109.792 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 31.7 p -122.24 127.9 50.49 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.865 -0.791 . . . . 75.530000000000001 108.865 176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -129.35 150.28 50.78 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 120.985 0.421 . . . . 73.129999999999995 111.596 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 74.42 -73.05 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.951 1.834 . . . . 71.510000000000005 115.951 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -139.53 29.81 2.15 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 107.498 -1.297 . . . . 70.439999999999998 107.498 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -91.3 137.6 32.24 Favored 'General case' 0 C--O 1.277 2.524 0 CA-C-O 122.571 1.177 . . . . 54.310000000000002 113.102 -173.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.468 ' HG3' ' HB2' ' B' ' 274' ' ' ARG . 2.9 mpt_? -125.7 134.71 51.72 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.891 -1.504 . . . . 75.409999999999997 109.426 176.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 8.5 p -133.42 139.4 49.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.832 0.825 . . . . 75.430000000000007 110.887 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . 0.598 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 49.0 tp60 -114.85 118.89 34.79 Favored 'General case' 0 N--CA 1.401 -2.91 0 CA-C-N 114.228 -1.351 . . . . 73.030000000000001 108.425 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.74 118.77 36.52 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 105.416 -2.068 . . . . 72.209999999999994 105.416 175.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 135.97 -120.0 2.15 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.898 -1.281 . . . . 74.450000000000003 109.898 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 7.8 p30 -144.75 144.25 31.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 116.542 0.171 . . . . 75.319999999999993 111.156 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . 0.598 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 48.9 t -124.08 114.64 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.595 0 N-CA-C 107.075 -1.454 . . . . 70.510000000000005 107.075 172.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.87 129.17 74.47 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 C-N-CA 119.298 -0.961 . . . . 74.439999999999998 111.098 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.5 m -88.91 159.2 17.79 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.219 -1.4 . . . . 74.25 107.219 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.79 94.37 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.726 0.774 . . . . 73.340000000000003 110.702 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.98 -34.27 63.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.111 -1.404 . . . . 64.209999999999994 112.464 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.017 0 N-CA-C 113.297 0.851 . . . . 73.420000000000002 113.297 -175.326 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 261' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 21.8 m . . . . . 0 N--CA 1.425 -1.702 0 N-CA-C 109.275 -0.639 . . . . 73.140000000000001 109.275 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -111.04 141.12 44.95 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.207 -1.034 . . . . 62.210000000000001 108.207 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 263' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' C' ' 227' ' ' SER . 21.7 m -140.01 140.25 36.19 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 122.035 -0.416 . . . . 75.040000000000006 110.163 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.18 142.87 42.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 121.195 -0.202 . . . . 71.0 111.086 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 9.7 mm-40 -80.91 -52.73 7.14 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 111.798 0.295 . . . . 73.230000000000004 111.798 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 37.5 m -150.18 133.05 16.03 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.162 -0.615 . . . . 71.530000000000001 111.063 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 17.1 m -126.05 135.08 64.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 109.178 -0.675 . . . . 75.150000000000006 109.178 171.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.08 129.15 71.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 109.746 -0.464 . . . . 72.129999999999995 109.746 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.65 132.8 11.25 Favored Glycine 0 N--CA 1.428 -1.884 0 N-CA-C 108.37 -1.892 . . . . 74.120000000000005 108.37 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -128.24 117.05 20.82 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 120.925 0.393 . . . . 71.519999999999996 110.094 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.85 -136.23 17.2 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 109.811 -1.316 . . . . 55.310000000000002 109.811 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.3 96.52 6.66 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.342 -1.355 . . . . 74.040000000000006 107.342 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 273' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 51.0 m -134.99 145.04 47.72 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 115.254 -0.884 . . . . 62.119999999999997 109.502 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -135.21 126.59 28.46 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 107.05 -1.463 . . . . 73.519999999999996 107.05 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 6.2 p -139.33 139.65 38.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.874 -0.603 . . . . 75.209999999999994 110.301 -176.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 7.0 tt -123.2 122.35 38.19 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 107.71 -1.218 . . . . 72.209999999999994 107.71 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . 0.489 HG22 HD22 ' C' ' 226' ' ' ASN . 42.8 mm -110.65 103.79 16.04 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.843 0 N-CA-C 106.791 -1.559 . . . . 74.420000000000002 106.791 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.06 -133.67 5.05 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 119.918 -1.134 . . . . 71.409999999999997 113.548 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 17.9 m120 -115.07 134.07 55.49 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 120.816 0.341 . . . . 72.140000000000001 110.201 -177.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.64 119.58 19.58 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.61 -1.256 . . . . 75.540000000000006 107.61 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -119.17 124.91 47.95 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.488 -0.931 . . . . 74.109999999999999 108.488 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.2 -36.91 1.95 Allowed Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.195 -0.762 . . . . 43.140000000000001 111.195 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 100.03 -27.29 20.98 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.264 -1.134 . . . . 72.140000000000001 110.264 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -132.84 87.34 2.4 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.845 -1.169 . . . . 74.420000000000002 107.845 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' C' ' 287' ' ' TRP . . . -84.44 -130.31 2.0 Allowed Glycine 0 C--N 1.308 -0.991 0 C-N-CA 120.944 -0.646 . . . . 75.25 112.291 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' B' ' 283' ' ' GLY . 1.4 p90 -73.67 18.32 0.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.336 0.589 . . . . 65.109999999999999 112.007 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . 0.407 ' H ' ' C ' ' C' ' 285' ' ' GLY . 53.3 m95 . . . . . 0 C--O 1.244 0.768 0 O-C-N 121.407 -0.808 . . . . 74.450000000000003 110.304 -175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 . . . . . 0 CA--C 1.508 -0.66 0 CA-C-O 120.591 0.234 . . . . 75.129999999999995 110.637 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.485 ' ND2' ' HA2' ' A' ' 278' ' ' GLY . 8.7 p30 -104.3 141.0 37.07 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.132 -1.433 . . . . 71.140000000000001 107.132 172.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.6 m -121.52 137.1 54.87 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.982 -0.377 . . . . 74.329999999999998 109.982 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.74 119.65 32.35 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.075 -1.454 . . . . 62.009999999999998 107.075 176.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -88.69 -41.31 12.67 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 116.206 -0.452 . . . . 73.319999999999993 110.807 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -140.71 138.99 34.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.915 0.388 . . . . 65.140000000000001 110.352 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.6 mt -131.41 121.85 49.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 107.673 -1.232 . . . . 74.400000000000006 107.673 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 60.4 ttt180 -132.58 115.1 15.03 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.493 0.663 . . . . 73.349999999999994 109.369 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.403 HG22 ' HB ' ' A' ' 239' ' ' VAL . 22.6 p -125.88 128.77 48.11 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.988 -1.116 . . . . 73.329999999999998 107.988 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -125.47 162.14 25.54 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.679 -0.808 . . . . 71.420000000000002 111.469 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 65.27 -84.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.122 1.369 . . . . 62.420000000000002 113.979 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -140.2 26.14 2.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.126 -0.943 . . . . 73.150000000000006 109.011 -168.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.67 151.62 30.41 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.832 -1.076 . . . . 75.209999999999994 109.763 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -124.11 135.43 53.52 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.241 -1.763 . . . . 73.230000000000004 106.241 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.5 p -135.87 139.59 45.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.038 0.447 . . . . 75.140000000000001 110.175 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -129.89 130.85 45.69 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.438 -0.949 . . . . 70.129999999999995 108.438 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -120.81 120.57 35.96 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.751 -1.203 . . . . 65.400000000000006 107.751 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.53 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 137.17 -140.09 11.09 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 120.22 -0.991 . . . . 61.210000000000001 112.127 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -123.85 128.32 49.32 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.906 -0.775 . . . . 73.439999999999998 108.906 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.4 118.71 57.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 107.897 -1.149 . . . . 74.209999999999994 107.897 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.39 112.75 41.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.835 -0.802 . . . . 74.5 108.835 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 29.6 m -101.53 159.6 15.15 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 108.128 -1.064 . . . . 73.430000000000007 108.128 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.59 74.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.637 0.977 . . . . 72.439999999999998 113.637 -175.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.02 -49.46 71.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 113.377 0.88 . . . . 70.430000000000007 113.377 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' B' ' 247' ' ' ALA . . . . . . . . 0 CA--C 1.502 -0.874 0 N-CA-C 113.686 0.995 . . . . 53.119999999999997 113.686 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.416 -2.13 0 N-CA-C 108.465 -0.939 . . . . 71.030000000000001 108.465 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -95.57 144.16 26.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.721 -0.672 . . . . 73.209999999999994 109.195 -176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' B' ' 227' ' ' SER . 20.3 m -140.42 123.24 16.41 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.484 -0.562 . . . . 63.039999999999999 109.484 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.9 p -128.51 140.14 50.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.418 0.152 . . . . 75.340000000000003 110.985 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.642 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 62.6 mm-40 -77.73 -78.4 0.14 Allowed 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 116.384 -0.371 . . . . 71.040000000000006 110.273 176.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.1 t -124.42 130.82 53.17 Favored 'General case' 0 C--O 1.261 1.672 0 N-CA-C 112.986 0.735 . . . . 74.019999999999996 112.986 -174.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.49 HG12 HD11 ' B' ' 231' ' ' ILE . 17.0 m -118.09 125.35 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 115.109 -0.951 . . . . 73.200000000000003 109.167 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 5.1 p -127.4 125.91 66.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.17 0.509 . . . . 74.299999999999997 111.99 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.85 133.03 11.07 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.561 -0.745 . . . . 54.210000000000001 111.498 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -123.66 141.51 51.95 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.27 0.628 . . . . 71.239999999999995 110.437 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.41 -127.58 29.35 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.919 -0.658 . . . . 71.340000000000003 111.938 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.419 ' HB3' ' NH1' ' A' ' 274' ' ' ARG . 60.9 mm-40 -93.35 57.55 2.67 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.817 0.847 . . . . 73.099999999999994 110.407 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 70.7 m -88.74 145.09 25.83 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 120.115 -0.634 . . . . 75.140000000000001 111.969 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . 0.419 ' NH1' ' HB3' ' A' ' 272' ' ' GLU . 10.4 mpt_? -121.47 127.69 51.34 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.193 -1.41 . . . . 75.519999999999996 107.193 173.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.1 p -136.0 123.57 34.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-O 121.536 0.684 . . . . 74.299999999999997 110.852 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.432 ' HG ' HE22 ' B' ' 240' ' ' GLN . 13.3 tp -121.97 124.3 43.7 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.542 0.687 . . . . 71.319999999999993 110.256 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.411 HG23 ' HB3' ' B' ' 241' ' ' LEU . 2.9 pt -112.7 104.55 17.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.402 -1.272 . . . . 73.439999999999998 110.056 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 146.0 -148.91 20.95 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 115.53 -0.759 . . . . 74.540000000000006 111.731 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 7.0 m-20 -101.94 149.58 24.07 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 122.752 -0.263 . . . . 74.129999999999995 110.709 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.1 125.94 24.09 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.776 -1.935 . . . . 72.299999999999997 105.776 175.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -109.29 122.81 48.15 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.493 -1.299 . . . . 72.140000000000001 107.493 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 134.11 -53.03 0.8 Allowed Glycine 0 C--N 1.283 -2.373 0 N-CA-C 108.939 -1.664 . . . . 63.32 108.939 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 103.32 -7.67 51.67 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.931 -1.268 . . . . 73.099999999999994 109.931 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -160.07 53.23 0.34 Allowed 'General case' 0 C--O 1.253 1.252 0 CA-C-N 114.755 -0.722 . . . . 75.329999999999998 111.15 -175.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -95.22 -57.87 1.19 Allowed Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.57 -0.741 . . . . 62.240000000000002 113.99 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -78.66 -2.03 37.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.363 1.078 . . . . 73.409999999999997 110.788 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . 0.444 ' CZ2' ' HD1' ' B' ' 286' ' ' PHE . 36.9 p90 . . . . . 0 C--N 1.292 -1.935 0 N-CA-C 105.162 -2.162 . . . . 61.439999999999998 105.162 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.492 -1.28 0 CA-C-O 120.839 0.352 . . . . 72.129999999999995 111.326 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' B' ' 262' ' ' ASN . 20.1 p-10 -116.67 140.29 49.57 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.381 -0.97 . . . . 75.109999999999999 108.381 174.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 263' ' ' SER . 18.2 m -121.48 136.5 54.95 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 109.526 -0.546 . . . . 64.400000000000006 109.526 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -120.8 131.53 54.51 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 106.989 -1.486 . . . . 74.219999999999999 106.989 175.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.642 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 1.4 tmtp? -93.31 -62.3 1.4 Allowed 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.121 -0.696 . . . . 72.340000000000003 109.121 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -127.95 137.36 52.23 Favored 'General case' 0 C--N 1.3 -1.543 0 N-CA-C 109.575 -0.528 . . . . 63.100000000000001 109.575 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . 0.49 HD11 HG12 ' A' ' 267' ' ' VAL . 18.7 mt -133.8 122.36 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 108.523 -0.917 . . . . 74.25 108.523 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 38.9 ttp180 -123.54 115.68 21.92 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.904 -0.776 . . . . 73.310000000000002 108.904 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 70.6 p -109.24 127.75 54.5 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 105.831 -1.915 . . . . 74.140000000000001 105.831 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.55 161.67 26.65 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.207 -0.597 . . . . 72.519999999999996 111.48 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 67.52 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.251 -1.34 . . . . 72.099999999999994 113.41 172.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.06 18.3 2.28 Favored 'General case' 0 C--O 1.195 -1.783 0 N-CA-C 108.248 -1.019 . . . . 74.540000000000006 108.248 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -68.69 149.17 49.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.903 0.859 . . . . 74.409999999999997 113.016 -172.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -125.54 135.35 52.16 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.149 -0.932 . . . . 74.219999999999999 108.628 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 8.4 p -132.38 138.7 51.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.665 0.745 . . . . 72.409999999999997 110.763 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.514 ' CG ' HD12 ' B' ' 276' ' ' LEU . 52.5 tp60 -117.5 125.83 51.55 Favored 'General case' 0 N--CA 1.401 -2.887 0 CA-C-N 114.495 -1.229 . . . . 64.450000000000003 108.398 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . 0.452 ' HA ' HG13 ' B' ' 277' ' ' ILE . 2.4 tm? -118.15 119.14 33.82 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.9 -1.889 . . . . 74.5 105.9 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.652 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 136.12 -147.01 19.0 Favored Glycine 0 C--N 1.278 -2.646 0 C-N-CA 119.721 -1.228 . . . . 73.319999999999993 110.875 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 86.2 m-20 -124.93 129.13 49.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.157 0.503 . . . . 73.450000000000003 110.017 -174.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 93.7 t -111.04 129.26 66.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.758 -0.83 . . . . 75.510000000000005 108.758 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 61.1 t -118.4 111.79 35.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.229 -1.026 . . . . 71.450000000000003 108.229 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 28.2 m -96.67 161.1 14.03 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.785 -0.821 . . . . 72.450000000000003 108.785 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.442 ' HB3' ' HA ' ' A' ' 249' ' ' ALA . . . -63.69 -33.95 76.77 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.273 0.629 . . . . 73.530000000000001 112.331 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.53 -37.16 67.58 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 115.222 1.564 . . . . 55.549999999999997 115.222 -173.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.44 ' HB2' ' N ' ' B' ' 282' ' ' GLY . . . -74.78 -37.79 62.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.148 0.796 . . . . 72.299999999999997 113.148 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 108.864 -0.791 . . . . 74.030000000000001 108.864 -167.978 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 67.3 m . . . . . 0 C--O 1.244 0.775 0 CA-C-O 121.454 0.645 . . . . 72.530000000000001 110.459 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 261' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 63.4 m -105.28 108.5 20.05 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.982 -0.747 . . . . 74.439999999999998 108.982 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' B' ' 226' ' ' ASN . 15.8 m120 -100.98 138.61 37.8 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.109 -0.7 . . . . 62.329999999999998 109.109 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 263' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' C' ' 227' ' ' SER . 4.1 p -143.28 123.94 14.11 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 122.259 -0.276 . . . . 75.200000000000003 110.899 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 7.1 p -124.88 142.3 42.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 110.263 -0.273 . . . . 74.239999999999995 110.263 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 43.2 mm-40 -82.47 -78.81 0.2 Allowed 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 123.202 0.314 . . . . 65.140000000000001 110.282 175.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 10.2 t -120.86 130.43 53.93 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.992 -1.083 . . . . 71.230000000000004 112.54 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . 0.421 ' HB ' HD13 ' C' ' 231' ' ' ILE . 1.5 p -125.05 124.8 68.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.711 -1.131 . . . . 64.230000000000004 110.182 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 14.8 p -127.01 140.57 48.71 Favored 'Isoleucine or valine' 0 C--O 1.267 2.013 0 CA-C-O 121.782 0.801 . . . . 75.099999999999994 111.395 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.78 133.08 9.53 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 110.609 -0.996 . . . . 74.010000000000005 110.609 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -127.59 116.51 20.45 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.154 0.582 . . . . 74.319999999999993 110.515 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.62 -131.03 10.57 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.126 -1.035 . . . . 71.140000000000001 110.87 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 67.5 mm-40 -91.85 52.1 1.95 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.324 0.583 . . . . 72.420000000000002 109.511 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 33.3 m -82.9 145.59 29.33 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.499 0.666 . . . . 72.409999999999997 111.558 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -132.4 126.35 32.94 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.754 -1.112 . . . . 75.310000000000002 108.724 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 0.8 OUTLIER -135.92 127.07 43.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.245 -0.889 . . . . 75.209999999999994 111.076 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . 0.514 HD12 ' CG ' ' B' ' 240' ' ' GLN . 11.9 tp -122.43 121.87 37.64 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.154 0.978 . . . . 74.129999999999995 110.523 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . 0.498 HG23 ' HB3' ' C' ' 241' ' ' LEU . 4.6 pt -112.62 104.33 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-N 114.175 -1.375 . . . . 74.150000000000006 109.131 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.652 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 160.7 -148.83 17.44 Favored Glycine 0 N--CA 1.42 -2.418 0 C-N-CA 120.887 -0.673 . . . . 71.519999999999996 111.691 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 54.7 t30 -120.63 130.01 53.97 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.161 -1.052 . . . . 71.129999999999995 108.161 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . 0.403 ' HG3' ' CH2' ' B' ' 287' ' ' TRP . 0.3 OUTLIER -117.96 130.52 56.26 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.038 -1.097 . . . . 74.540000000000006 108.038 -174.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -108.32 122.93 47.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.304 0.574 . . . . 74.109999999999999 109.991 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . 0.44 ' N ' ' HB2' ' B' ' 249' ' ' ALA . . . 129.05 -53.23 0.81 Allowed Glycine 0 N--CA 1.421 -2.31 0 N-CA-C 109.378 -1.489 . . . . 72.420000000000002 109.378 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 105.95 -7.77 41.75 Favored Glycine 0 N--CA 1.434 -1.459 0 C-N-CA 120.742 -0.742 . . . . 54.130000000000003 111.84 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . 0.545 ' HA ' ' NE1' ' B' ' 287' ' ' TRP . 11.0 ptmm? -155.95 36.73 0.35 Allowed 'General case' 0 C--O 1.251 1.183 0 N-CA-C 111.774 0.287 . . . . 75.340000000000003 111.774 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -74.43 -76.03 0.75 Allowed Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.252 -0.975 . . . . 70.319999999999993 112.809 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.444 ' HD1' ' CZ2' ' A' ' 287' ' ' TRP . 75.3 t80 -56.36 -26.48 52.95 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.987 0.898 . . . . 75.030000000000001 111.419 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.545 ' NE1' ' HA ' ' B' ' 284' ' ' LYS . 26.8 p90 . . . . . 0 C--N 1.301 -1.5 0 CA-C-N 115.383 -0.826 . . . . 75.219999999999999 109.426 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' B' ' 261' ' ' THR . 1.5 ptp180 . . . . . 0 N--CA 1.429 -1.479 0 CA-C-O 121.968 0.89 . . . . 74.019999999999996 112.814 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -116.46 115.02 25.03 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 106.695 -1.594 . . . . 72.129999999999995 106.695 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 227' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' B' ' 263' ' ' SER . 8.3 p -121.13 136.6 54.95 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 122.025 0.917 . . . . 74.540000000000006 112.402 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -121.2 135.83 55.08 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.358 -1.292 . . . . 74.019999999999996 107.639 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 1.1 tmtp? -93.62 -55.7 3.17 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 109.486 -0.561 . . . . 74.200000000000003 109.486 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -131.45 138.52 49.07 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.773 0.321 . . . . 75.420000000000002 110.403 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . 0.421 HD13 ' HB ' ' B' ' 267' ' ' VAL . 28.3 mt -131.35 117.83 37.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 107.95 -1.13 . . . . 75.230000000000004 107.95 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 11.4 ttp180 -122.94 114.92 21.09 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.612 -0.514 . . . . 73.420000000000002 109.612 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 40.7 p -113.18 127.8 56.29 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.094 -1.076 . . . . 72.439999999999998 108.094 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -128.18 165.79 19.77 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.913 -0.715 . . . . 74.319999999999993 110.714 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 43.9 mt-10 68.52 -84.7 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 114.791 -1.095 . . . . 63.049999999999997 112.836 175.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.499 ' O ' ' HD2' ' C' ' 238' ' ' ARG . 0.3 OUTLIER -141.25 21.5 2.24 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 108.155 -1.054 . . . . 73.129999999999995 108.155 178.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -68.42 148.32 50.81 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.623 0.725 . . . . 73.430000000000007 112.174 -173.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' C' ' 236' ' ' ARG . 3.4 mpt_? -124.27 135.18 53.21 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.318 -1.364 . . . . 75.109999999999999 107.318 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.2 141.16 45.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.318 0.58 . . . . 74.239999999999995 111.183 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -122.82 123.3 40.7 Favored 'General case' 0 N--CA 1.408 -2.539 0 CA-C-N 114.545 -1.207 . . . . 71.340000000000003 108.808 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.498 ' HB3' HG23 ' B' ' 277' ' ' ILE . 2.1 tm? -120.48 119.16 32.2 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.586 -1.264 . . . . 72.030000000000001 107.586 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.525 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 134.7 -125.43 3.77 Favored Glycine 0 N--CA 1.411 -3.005 0 N-CA-C 110.158 -1.177 . . . . 71.209999999999994 110.158 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 92.7 m-20 -130.22 150.59 51.41 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 120.909 0.385 . . . . 72.239999999999995 110.49 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 83.1 t -128.8 118.38 46.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.449 -1.315 . . . . 74.519999999999996 107.449 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 47.5 t -114.56 112.3 39.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.784 -0.821 . . . . 74.230000000000004 108.784 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 15.4 m -100.37 160.91 13.96 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 115.561 -0.745 . . . . 62.520000000000003 109.503 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.06 -32.21 72.71 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.773 0.796 . . . . 75.049999999999997 110.508 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.97 -42.13 72.02 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.062 -1.427 . . . . 61.210000000000001 112.367 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . 0.468 ' HB1' ' N ' ' C' ' 282' ' ' GLY . . . . . . . . 0 CA--C 1.507 -0.698 0 CA-C-O 121.009 0.433 . . . . 71.0 110.014 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 107.182 -1.414 . . . . 75.340000000000003 107.182 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -119.57 135.83 54.62 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.778 -0.453 . . . . 71.439999999999998 109.778 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 20.8 m -142.47 125.38 16.13 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.194 -0.669 . . . . 71.099999999999994 109.194 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.1 p -128.16 143.59 40.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 110.195 -0.298 . . . . 74.230000000000004 110.195 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.575 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 64.2 mm-40 -76.44 -69.74 0.49 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.531 -0.304 . . . . 74.299999999999997 110.762 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 8.8 t -136.95 133.91 36.16 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 119.004 -1.078 . . . . 64.150000000000006 112.061 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.98 133.49 65.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.503 -0.925 . . . . 72.209999999999994 108.503 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 11.6 p -127.32 138.99 53.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 116.387 -0.369 . . . . 65.310000000000002 110.256 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.92 132.98 9.95 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.685 -0.966 . . . . 64.219999999999999 110.685 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -132.85 129.74 38.85 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 123.66 0.784 . . . . 75.109999999999999 109.951 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.85 -122.32 9.09 Favored Glycine 0 C--N 1.304 -1.198 0 C-N-CA 121.051 -0.595 . . . . 71.299999999999997 112.043 -176.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -96.79 51.89 1.16 Allowed 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.511 0.724 . . . . 64.349999999999994 110.463 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 56.3 m -83.67 144.36 29.45 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.778 0.799 . . . . 72.329999999999998 112.179 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . 0.453 ' HB3' ' CE2' ' C' ' 286' ' ' PHE . 7.6 mpt_? -127.64 127.72 44.27 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.369 -2.085 . . . . 75.030000000000001 105.369 172.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 3.4 p -138.53 124.03 23.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.099 0.476 . . . . 75.519999999999996 111.309 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 20.1 tp -113.41 120.12 39.96 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.728 0.775 . . . . 74.120000000000005 110.479 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.9 pt -112.51 103.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 N-CA-C 107.769 -1.197 . . . . 74.439999999999998 107.769 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 152.1 -161.14 29.23 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.073 -1.06 . . . . 73.319999999999993 111.812 -176.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -109.0 136.07 49.14 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.319 -0.623 . . . . 75.049999999999997 109.319 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.95 144.64 45.32 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.204 -1.406 . . . . 74.510000000000005 107.204 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -124.06 122.9 39.12 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.33 -0.618 . . . . 73.230000000000004 109.33 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . 0.468 ' N ' ' HB1' ' C' ' 249' ' ' ALA . . . 127.14 -48.33 0.97 Allowed Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 108.738 -1.745 . . . . 54.340000000000003 108.738 -174.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 103.04 -8.01 53.26 Favored Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.907 -0.877 . . . . 54.350000000000001 110.907 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . 0.562 ' HA ' ' NE1' ' C' ' 287' ' ' TRP . 17.3 ptmt -154.46 36.2 0.42 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.25 0.62 . . . . 72.450000000000003 110.761 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -70.23 -78.0 0.42 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.359 -0.924 . . . . 73.239999999999995 112.423 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . 0.537 ' HD1' ' CZ2' ' B' ' 287' ' ' TRP . 67.5 t80 -53.79 -19.64 4.59 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.583 1.153 . . . . 74.129999999999995 112.658 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . 0.562 ' NE1' ' HA ' ' C' ' 284' ' ' LYS . 23.8 p90 . . . . . 0 C--N 1.315 -0.894 0 CA-C-O 121.527 0.68 . . . . 74.129999999999995 111.679 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 . . . . . 0 N--CA 1.441 -0.885 0 CA-C-O 121.175 0.512 . . . . 73.409999999999997 110.868 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -92.71 126.18 37.67 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.929 -1.508 . . . . 64.299999999999997 106.929 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 14.1 m -121.84 136.81 54.94 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.216 0.531 . . . . 73.219999999999999 110.23 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.81 124.06 16.63 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.897 -1.149 . . . . 73.420000000000002 107.897 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 265' ' ' GLU . 4.8 mmmm -76.76 -64.29 1.16 Allowed 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 114.431 1.271 . . . . 73.409999999999997 114.431 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -127.74 140.08 52.28 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.058 -1.057 . . . . 73.519999999999996 110.999 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 30.1 mm -121.15 118.21 55.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.902 -0.777 . . . . 75.329999999999998 108.902 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 80.2 mtt180 -124.76 116.74 22.79 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.921 0.391 . . . . 74.230000000000004 111.046 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 27.3 p -120.44 126.76 51.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.135 -0.691 . . . . 72.099999999999994 109.135 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 270' ' ' LYS . 47.4 mt-10 -139.94 139.47 36.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.596 -0.52 . . . . 64.530000000000001 109.596 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 51.71 97.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.824 1.25 . . . . 74.319999999999993 114.229 174.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? 64.59 20.94 12.31 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.373 1.069 . . . . 75.519999999999996 110.985 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.1 129.4 45.36 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.368 0.604 . . . . 72.140000000000001 110.292 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.85 140.15 52.2 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.455 -0.793 . . . . 74.409999999999997 109.343 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.9 p -129.35 146.72 33.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 121.001 0.429 . . . . 55.340000000000003 111.165 -174.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -119.15 124.1 45.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.089 -1.449 . . . . 75.519999999999996 107.089 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -118.58 122.76 43.39 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.686 -0.487 . . . . 74.310000000000002 109.686 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.473 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 120.45 -156.85 15.92 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.906 -0.664 . . . . 74.409999999999997 112.453 175.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -102.23 132.87 47.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.104 -0.702 . . . . 72.430000000000007 109.104 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.444 HG11 ' HA3' ' A' ' 285' ' ' GLY . 15.7 t -116.33 122.11 69.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.76 -0.83 . . . . 73.519999999999996 108.76 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 48.5 t -113.11 112.69 41.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.19 -1.041 . . . . 75.109999999999999 108.19 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 54.3 m -89.44 160.73 16.64 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.243 -0.435 . . . . 70.430000000000007 109.972 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.14 -37.2 86.26 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.33 0.652 . . . . 74.219999999999999 110.9 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.36 -35.04 64.81 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.238 1.015 . . . . 73.329999999999998 113.589 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.51 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 112.79 0.663 . . . . 61.140000000000001 112.79 -175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.5 m . . . . . 0 N--CA 1.407 -2.583 0 N-CA-C 107.455 -1.313 . . . . 75.140000000000001 107.455 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -96.07 142.77 27.88 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.323 -0.991 . . . . 74.430000000000007 108.323 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.5 m -139.72 123.63 17.61 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.724 -0.391 . . . . 71.230000000000004 111.21 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 12.3 p -128.85 144.9 36.68 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.685 -0.487 . . . . 74.340000000000003 109.685 173.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.516 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 4.2 tp10 -84.34 -75.85 0.33 Allowed 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 109.572 -0.529 . . . . 73.120000000000005 109.572 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 14.6 m -123.28 134.5 54.07 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.227 -0.921 . . . . 71.140000000000001 111.3 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 32.5 m -119.3 124.33 72.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 107.972 -1.121 . . . . 74.109999999999999 107.972 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 10.4 p -127.6 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 110.221 -0.288 . . . . 74.549999999999997 110.221 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -134.19 131.48 5.98 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 119.969 -1.11 . . . . 72.430000000000007 111.94 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 234' ' ' GLU . 27.5 ttmt -135.77 144.87 46.03 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.867 0.692 . . . . 73.340000000000003 112.867 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.72 -54.37 1.43 Allowed Glycine 0 CA--C 1.5 -0.906 0 N-CA-C 111.827 -0.509 . . . . 65.420000000000002 111.827 173.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.531 ' HB3' ' H ' ' B' ' 236' ' ' ARG . 23.1 tt0 -176.76 102.98 0.06 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 105.485 -2.043 . . . . 61.310000000000002 105.485 174.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 59.8 m -135.05 145.18 47.75 Favored 'General case' 0 C--N 1.281 -2.41 0 C-N-CA 119.923 -0.711 . . . . 74.310000000000002 110.795 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -126.7 126.22 43.14 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 104.713 -2.329 . . . . 75.310000000000002 104.713 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 1.6 p -135.75 123.99 37.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 CA-C-O 121.06 0.457 . . . . 75.310000000000002 110.763 -176.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 6.7 tt -111.52 121.21 44.56 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.963 -1.125 . . . . 73.420000000000002 107.963 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 43.5 mm -112.1 104.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 107.967 -1.123 . . . . 75.109999999999999 107.967 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.509 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 149.99 -128.87 2.81 Favored Glycine 0 N--CA 1.427 -1.936 0 C-N-CA 119.241 -1.457 . . . . 60.0 113.627 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -128.71 128.88 44.93 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.205 -1.035 . . . . 75.230000000000004 108.205 -175.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -112.93 118.7 35.59 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.741 -0.837 . . . . 75.239999999999995 108.741 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 90.2 m-85 -114.79 123.85 50.27 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.969 -0.752 . . . . 74.340000000000003 108.969 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.43 ' CA ' ' HB1' ' A' ' 249' ' ' ALA . . . 105.94 -47.12 1.09 Allowed Glycine 0 C--N 1.297 -1.611 0 N-CA-C 110.905 -0.878 . . . . 62.240000000000002 110.905 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.498 ' HA2' ' H ' ' B' ' 286' ' ' PHE . . . 89.98 47.28 3.94 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.931 -0.652 . . . . 72.310000000000002 113.155 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -174.78 30.87 0.01 OUTLIER 'General case' 0 C--O 1.247 0.933 0 CA-C-O 122.151 0.977 . . . . 74.420000000000002 109.372 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.444 ' HA3' HG11 ' A' ' 244' ' ' VAL . . . -86.73 128.08 8.73 Favored Glycine 0 N--CA 1.411 -3.007 0 C-N-CA 120.351 -0.928 . . . . 73.230000000000004 112.161 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 27.0 t80 73.86 -51.69 0.69 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.917 1.287 . . . . 75.230000000000004 112.396 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.309 -1.154 0 N-CA-C 112.988 0.736 . . . . 73.25 112.988 -172.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 . . . . . 0 N--CA 1.429 -1.503 0 CA-C-O 121.306 0.574 . . . . 75.430000000000007 109.798 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -112.67 130.52 56.02 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 105.191 -2.152 . . . . 74.519999999999996 105.191 171.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 14.5 m -132.53 135.81 46.22 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 118.356 -1.338 . . . . 62.420000000000002 110.977 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.92 134.5 42.71 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 107.178 -1.416 . . . . 71.409999999999997 107.178 175.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' B' ' 265' ' ' GLU . 24.6 mmtp -80.17 -71.23 0.47 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.659 -0.416 . . . . 75.209999999999994 112.058 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -127.11 138.59 53.21 Favored 'General case' 0 N--CA 1.414 -2.274 0 C-N-CA 118.555 -1.258 . . . . 72.310000000000002 109.597 -173.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 31.1 mm -123.41 116.98 50.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.791 -1.189 . . . . 72.450000000000003 107.791 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -117.4 115.23 24.8 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 120.299 -0.561 . . . . 75.310000000000002 109.52 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' THR . . . . . 0.581 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 40.8 p -110.8 126.43 54.62 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.206 -1.405 . . . . 75.010000000000005 107.206 176.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 51.0 mt-10 -143.43 138.83 29.6 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 109.811 -0.44 . . . . 73.349999999999994 109.811 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 56.49 98.22 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.868 0 O-C-N 125.292 1.62 . . . . 73.530000000000001 113.041 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.531 ' H ' ' HB3' ' A' ' 272' ' ' GLU . 1.1 mpt_? 60.89 35.66 19.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.857 0.863 . . . . 75.319999999999993 109.718 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -103.76 138.88 39.75 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.586 0.707 . . . . 72.209999999999994 111.106 -175.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 1.4 mpt_? -133.84 136.35 44.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.978 -1.119 . . . . 71.230000000000004 107.978 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 5.7 p -137.37 137.66 45.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-O 121.578 0.704 . . . . 73.150000000000006 112.059 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -110.64 117.65 34.06 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.113 -1.44 . . . . 71.150000000000006 107.113 175.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.33 127.4 53.15 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.085 -0.709 . . . . 72.319999999999993 109.085 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 122.7 -121.3 4.59 Favored Glycine 0 CA--C 1.473 -2.542 0 N-CA-C 109.636 -1.385 . . . . 62.420000000000002 109.636 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 33.8 p30 -144.1 154.77 43.55 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 119.739 -0.784 . . . . 54.229999999999997 111.41 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.513 ' CG1' ' HA3' ' B' ' 285' ' ' GLY . 65.6 t -123.49 130.37 74.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.176 -0.92 . . . . 75.510000000000005 109.69 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 57.8 t -122.66 111.58 30.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.643 -1.243 . . . . 74.400000000000006 107.643 171.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' THR . . . . . 0.446 ' HB ' ' HA3' ' B' ' 282' ' ' GLY . 16.8 m -88.02 160.72 17.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.548 -0.908 . . . . 75.109999999999999 108.548 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.4 -43.85 96.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 122.056 0.932 . . . . 74.510000000000005 110.532 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.51 -35.63 65.83 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.65 -1.614 . . . . 74.439999999999998 112.282 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.419 ' HB2' ' CA ' ' B' ' 282' ' ' GLY . . . -63.52 -25.54 68.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.07 0.767 . . . . 71.439999999999998 113.07 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 tt . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 121.269 0.557 . . . . 75.340000000000003 110.215 -177.321 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.41 -2.434 0 N-CA-C 108.324 -0.991 . . . . 73.409999999999997 108.324 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 62.8 m -90.29 112.96 24.7 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.665 -0.865 . . . . 74.200000000000003 108.665 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -96.47 128.62 43.56 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-N 114.891 -1.05 . . . . 71.209999999999994 109.899 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 14.5 m -121.49 121.13 36.83 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.194 -1.039 . . . . 74.5 108.194 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.8 p -129.61 145.82 35.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.302 -0.999 . . . . 73.230000000000004 108.302 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 20.5 tt0 -93.0 -75.44 0.49 Allowed 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 119.03 -1.068 . . . . 74.409999999999997 112.033 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 266' ' ' THR . . . . . 0.406 ' HG1' ' HG2' ' B' ' 265' ' ' GLU . 32.8 m -124.95 134.54 52.59 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.806 -1.158 . . . . 73.019999999999996 111.478 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 10.0 m -118.4 134.33 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 108.018 -1.104 . . . . 71.129999999999995 108.018 173.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 85.1 t -123.97 128.49 74.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 115.636 -0.711 . . . . 72.400000000000006 110.036 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . 0.452 ' HA2' ' HG1' ' C' ' 233' ' ' THR . . . -115.22 131.69 9.89 Favored Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 110.293 -1.123 . . . . 71.439999999999998 110.293 174.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.441 ' HB3' ' HG2' ' C' ' 234' ' ' GLU . 2.2 tpmt? -135.53 137.85 42.47 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 122.943 0.497 . . . . 75.140000000000001 111.073 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.29 -52.74 4.54 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 114.746 0.658 . . . . 64.010000000000005 114.746 169.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . 0.592 ' HB3' ' H ' ' C' ' 236' ' ' ARG . 1.6 tm-20 -177.4 105.28 0.05 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 103.156 -2.905 . . . . 75.140000000000001 103.156 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 273' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 44.4 m -145.24 144.95 31.09 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-O 121.07 0.462 . . . . 71.219999999999999 110.764 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 60.4 mtt180 -135.68 127.28 28.89 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 106.373 -1.714 . . . . 75.099999999999994 106.373 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.2 p -132.68 129.61 58.64 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.824 0 O-C-N 123.695 0.622 . . . . 75.329999999999998 110.364 -175.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 6.6 tt -110.59 115.75 30.14 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.976 -1.12 . . . . 75.109999999999999 107.976 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . 0.411 HG21 HD13 ' C' ' 241' ' ' LEU . 37.2 mm -106.9 103.82 16.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.031 -1.1 . . . . 71.030000000000001 108.031 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 144.04 -140.39 9.39 Favored Glycine 0 N--CA 1.424 -2.167 0 C-N-CA 119.53 -1.319 . . . . 72.319999999999993 113.285 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -111.76 129.48 56.11 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.55 -0.537 . . . . 74.540000000000006 109.55 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' C' ' 244' ' ' VAL . 8.0 tp10 -114.5 118.28 33.33 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.345 -0.983 . . . . 74.349999999999994 108.345 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.22 124.52 49.27 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 109.227 -0.657 . . . . 74.439999999999998 109.227 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . 0.446 ' HA3' ' HB ' ' B' ' 246' ' ' THR . . . 103.99 -46.86 1.14 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 110.139 -1.185 . . . . 73.239999999999995 110.139 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . 0.557 ' O ' ' HE2' ' B' ' 284' ' ' LYS . . . 95.5 37.31 5.09 Favored Glycine 0 N--CA 1.411 -3.016 0 C-N-CA 120.899 -0.667 . . . . 74.349999999999994 112.748 176.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . 0.557 ' HE2' ' O ' ' B' ' 283' ' ' GLY . 9.9 tppt? -161.64 35.24 0.13 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 119.21 -0.996 . . . . 74.25 112.34 -175.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . 0.513 ' HA3' ' CG1' ' B' ' 244' ' ' VAL . . . -89.61 144.78 17.99 Favored Glycine 0 CA--C 1.488 -1.595 0 C-N-CA 119.28 -1.438 . . . . 72.25 113.572 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.498 ' H ' ' HA2' ' A' ' 283' ' ' GLY . 0.2 OUTLIER 68.78 -71.31 0.12 Allowed 'General case' 0 C--O 1.245 0.854 0 C-N-CA 124.872 1.269 . . . . 74.0 110.18 178.669 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.755 0 CA-C-N 115.047 -0.979 . . . . 74.549999999999997 112.973 -173.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 109.802 -0.444 . . . . 73.129999999999995 109.802 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -114.93 124.55 51.97 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.933 -1.506 . . . . 74.400000000000006 106.933 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 23.6 m -121.93 136.68 54.94 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 121.185 0.517 . . . . 72.329999999999998 110.35 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -139.51 129.72 25.29 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 107.878 -1.156 . . . . 74.25 107.878 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' C' ' 265' ' ' GLU . 17.5 mmtp -78.46 -71.46 0.43 Allowed 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.266 0.555 . . . . 74.219999999999999 112.361 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -127.69 138.92 52.96 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.203 -0.908 . . . . 70.430000000000007 108.833 -170.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 23.5 mm -129.34 117.83 44.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.564 -1.272 . . . . 71.420000000000002 107.564 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 78.5 mtt180 -122.08 115.56 22.69 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.201 0.524 . . . . 72.230000000000004 109.612 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 233' ' ' THR . . . . . 0.452 ' HG1' ' HA2' ' B' ' 269' ' ' GLY . 20.0 p -110.21 126.46 54.15 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 106.843 -1.54 . . . . 74.319999999999993 106.843 177.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' B' ' 270' ' ' LYS . 48.0 mt-10 -137.59 138.38 39.48 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 108.74 -0.837 . . . . 74.209999999999994 108.74 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 50.65 92.01 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.661 1.356 . . . . 72.450000000000003 114.661 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.592 ' H ' ' HB3' ' B' ' 272' ' ' GLU . 3.5 mpt_? 66.85 34.59 5.36 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.23 1.412 . . . . 73.409999999999997 109.952 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . 0.59 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -104.44 128.85 52.42 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.23 -0.895 . . . . 65.420000000000002 110.661 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.0 OUTLIER -124.98 135.3 52.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.504 -0.924 . . . . 75.129999999999995 108.504 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.6 p -139.65 142.68 32.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.862 0.839 . . . . 64.420000000000002 112.212 -176.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -110.92 130.19 55.66 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.152 -1.425 . . . . 64.549999999999997 107.152 175.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' C' ' 277' ' ' ILE . 2.8 tm? -130.13 128.79 42.52 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.008 -0.738 . . . . 74.239999999999995 109.008 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 122.25 -121.9 4.87 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 109.919 -1.273 . . . . 72.450000000000003 109.919 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -139.39 153.28 47.6 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 120.508 -0.477 . . . . 73.329999999999998 111.087 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . 0.458 HG12 ' HA3' ' C' ' 285' ' ' GLY . 63.8 t -127.58 124.23 63.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.663 -0.699 . . . . 73.140000000000001 109.61 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 59.2 t -122.15 110.76 28.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.429 -1.322 . . . . 71.439999999999998 107.429 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 246' ' ' THR . . . . . 0.409 ' HB ' ' HA3' ' C' ' 282' ' ' GLY . 37.7 m -87.78 161.92 17.31 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.154 -0.684 . . . . 72.400000000000006 109.154 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.93 -39.18 74.0 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.509 0.723 . . . . 72.140000000000001 110.83 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.41 -34.5 64.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.642 -1.617 . . . . 75.239999999999995 113.381 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.327 0 N-CA-C 112.255 0.465 . . . . 74.140000000000001 112.255 -175.445 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.433 -1.295 0 CA-C-O 121.976 0.894 . . . . 73.129999999999995 109.516 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -119.9 144.12 47.59 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.058 -1.428 . . . . 71.129999999999995 109.135 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -142.08 131.16 23.24 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 110.182 -0.303 . . . . 74.040000000000006 110.182 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 12.2 p -128.98 145.43 35.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.451 -0.944 . . . . 75.209999999999994 108.451 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' C' ' 229' ' ' LYS . 7.0 tp10 -79.76 -81.49 0.12 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 109.135 -0.691 . . . . 61.119999999999997 109.135 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 90.0 m -131.72 137.01 48.06 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.397 -0.815 . . . . 73.120000000000005 110.825 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.06 130.71 74.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.962 -0.755 . . . . 73.329999999999998 108.962 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.4 p -127.56 137.38 57.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 116.635 -0.257 . . . . 71.299999999999997 110.473 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.93 132.88 9.65 Favored Glycine 0 CA--C 1.483 -1.934 0 N-CA-C 110.352 -1.099 . . . . 70.219999999999999 110.352 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -134.6 147.73 50.28 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.145 -0.687 . . . . 74.519999999999996 109.145 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.26 -60.86 4.7 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 112.293 -0.323 . . . . 73.109999999999999 112.293 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . 0.4 ' HA ' ' HB2' ' C' ' 236' ' ' ARG . 36.4 tt0 -173.18 130.79 0.48 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.914 -2.254 . . . . 74.109999999999999 104.914 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 273' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 17.8 t -156.11 148.08 23.18 Favored 'General case' 0 N--CA 1.413 -2.324 0 C-N-CA 120.074 -0.65 . . . . 55.43 109.926 -176.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 46.2 mtm180 -138.12 125.43 21.76 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.212 -1.773 . . . . 74.140000000000001 106.212 172.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 5.1 p -139.57 135.44 39.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 123.548 0.53 . . . . 70.200000000000003 110.693 -176.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 7.0 tt -115.93 111.58 20.61 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.912 -0.773 . . . . 73.219999999999999 108.912 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 47.7 mm -102.28 104.21 16.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.871 -1.159 . . . . 73.510000000000005 107.871 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 147.84 -144.39 12.34 Favored Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.009 -1.636 . . . . 55.140000000000001 109.009 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -127.96 150.61 49.82 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 120.869 0.366 . . . . 73.200000000000003 110.405 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . 0.405 ' HA ' ' HB ' ' C' ' 244' ' ' VAL . 6.2 tp10 -126.64 118.14 24.19 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.618 -0.719 . . . . 74.420000000000002 109.801 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -109.18 124.12 50.32 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.913 -0.773 . . . . 73.450000000000003 108.913 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . 0.409 ' HA3' ' HB ' ' C' ' 246' ' ' THR . . . 102.94 -53.17 0.76 Allowed Glycine 0 N--CA 1.434 -1.497 0 N-CA-C 110.502 -1.039 . . . . 73.439999999999998 110.502 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 95.14 54.64 1.46 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.416 -0.897 . . . . 74.439999999999998 113.207 176.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -164.2 21.65 0.07 Allowed 'General case' 0 C--O 1.238 0.47 0 C-N-CA 119.903 -0.719 . . . . 74.420000000000002 110.947 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . 0.458 ' HA3' HG12 ' C' ' 244' ' ' VAL . . . -74.92 138.75 24.14 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 115.011 0.764 . . . . 65.340000000000003 115.011 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 67.43 -79.37 0.04 OUTLIER 'General case' 0 C--O 1.252 1.196 0 C-N-CA 124.786 1.234 . . . . 74.239999999999995 110.934 174.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 17.7 p90 . . . . . 0 N--CA 1.427 -1.623 0 C-N-CA 121.078 -0.249 . . . . 73.219999999999999 111.273 -177.221 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 23.1 ptt-85 . . . . . 0 N--CA 1.425 -1.681 0 N-CA-C 107.919 -1.141 . . . . 74.030000000000001 107.919 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.549 ' OD1' ' HA2' ' B' ' 242' ' ' GLY . 41.4 m-80 -109.96 135.32 50.99 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.094 -1.076 . . . . 74.310000000000002 108.094 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.9 m -121.55 136.5 54.95 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.578 0.704 . . . . 73.040000000000006 110.874 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.68 127.99 47.12 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.137 -1.431 . . . . 53.109999999999999 107.137 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -78.88 -60.42 2.39 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.913 -0.773 . . . . 74.420000000000002 108.913 -177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -137.5 139.3 40.46 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.538 0.685 . . . . 75.430000000000007 110.831 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 67.3 mt -128.78 122.47 57.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.257 -1.016 . . . . 74.299999999999997 108.257 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 7.1 tmm_? -130.69 115.01 16.1 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.721 0.772 . . . . 74.049999999999997 111.329 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.562 ' CG2' HG11 ' A' ' 239' ' ' VAL . 6.8 p -111.99 137.06 50.52 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.226 -0.897 . . . . 74.409999999999997 109.75 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -133.97 147.17 51.0 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 116.066 -0.516 . . . . 75.010000000000005 110.989 -174.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 73.38 -79.0 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.589 1.156 . . . . 73.510000000000005 112.727 170.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -136.16 15.81 3.25 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.09 0.947 . . . . 75.349999999999994 109.077 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.08 133.37 34.23 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.65 -1.159 . . . . 64.530000000000001 109.791 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -132.11 144.02 50.42 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.621 0.724 . . . . 74.310000000000002 112.006 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.562 HG11 ' CG2' ' A' ' 233' ' ' THR . 15.4 m -123.69 150.4 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 CA-C-N 114.832 -1.076 . . . . 72.230000000000004 111.804 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -116.85 120.83 39.7 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-N 114.259 -1.337 . . . . 75.120000000000005 108.148 175.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -111.26 118.2 35.26 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.049 -1.834 . . . . 75.439999999999998 106.049 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.02 -155.71 21.13 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 119.828 -1.177 . . . . 44.350000000000001 112.892 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -110.83 128.58 55.82 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.136 0.574 . . . . 71.109999999999999 110.658 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.408 ' CG1' ' HA3' ' A' ' 285' ' ' GLY . 48.6 t -116.34 115.05 47.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.369 -0.974 . . . . 74.409999999999997 108.369 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 281' ' ' TYR . 7.3 p -114.42 124.82 71.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.277 0.56 . . . . 73.5 112.46 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 23.8 p -117.24 166.59 12.09 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 116.001 -0.545 . . . . 71.209999999999994 111.366 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.74 74.13 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.536 0.734 . . . . 71.430000000000007 112.757 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.37 66.29 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.634 0.975 . . . . 73.420000000000002 113.634 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.642 ' HB2' ' N ' ' A' ' 282' ' ' GLY . . . . . . . . 0 CA--C 1.503 -0.854 0 N-CA-C 112.536 0.569 . . . . 73.319999999999993 112.536 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 10.6 t . . . . . 0 N--CA 1.427 -1.595 0 CA-C-O 121.292 0.568 . . . . 74.109999999999999 109.617 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -126.33 142.2 51.62 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.12 -0.696 . . . . 74.109999999999999 109.12 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.7 t -127.69 130.71 49.34 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 108.721 -0.844 . . . . 74.230000000000004 108.721 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.02 139.73 51.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.967 -0.383 . . . . 73.349999999999994 109.967 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 15.3 mt-10 -79.1 -70.64 0.49 Allowed 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 119.823 -0.751 . . . . 71.439999999999998 111.525 176.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 13.6 m -119.44 126.86 52.33 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.889 -0.724 . . . . 64.519999999999996 111.949 -174.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.39 122.26 67.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 N-CA-C 109.118 -0.697 . . . . 72.340000000000003 109.118 171.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 35.7 m -124.56 146.67 29.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.643 0.735 . . . . 72.239999999999995 112.593 -177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.73 133.28 7.78 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.14 -0.936 . . . . 61.439999999999998 111.002 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.27 116.0 17.75 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.074 -1.084 . . . . 74.140000000000001 108.074 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.16 -136.84 13.02 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.147 -1.581 . . . . 75.25 109.147 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -99.24 53.22 0.96 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.942 0.877 . . . . 73.019999999999996 109.701 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 7.1 m -83.02 148.22 27.69 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.167 -0.924 . . . . 74.140000000000001 111.209 -174.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 45.8 mtm180 -130.02 128.19 41.48 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.287 -0.415 . . . . 75.310000000000002 109.946 175.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.462 ' HB ' HG12 ' A' ' 239' ' ' VAL . 17.9 t -130.46 140.42 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 N-CA-C 108.095 -1.076 . . . . 61.340000000000003 108.095 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.43 HD11 ' HB3' ' A' ' 286' ' ' PHE . 5.5 tt -126.17 121.1 31.83 Favored 'General case' 0 C--N 1.275 -2.655 0 C-N-CA 118.913 -1.115 . . . . 74.329999999999998 108.426 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 3.5 mp -107.92 104.61 17.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 106.316 -1.735 . . . . 74.519999999999996 106.316 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.13 -134.77 5.37 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.435 -1.066 . . . . 62.109999999999999 110.435 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 45.2 t-20 -130.15 134.58 47.42 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 117.103 0.451 . . . . 72.5 111.396 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 287' ' ' TRP . 10.3 tp10 -111.23 122.85 48.93 Favored 'General case' 0 C--O 1.269 2.084 0 N-CA-C 106.746 -1.576 . . . . 74.219999999999999 106.746 174.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . 0.462 ' HB2' ' HA ' ' A' ' 245' ' ' VAL . 12.0 m-85 -109.24 122.81 48.14 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.751 -1.944 . . . . 73.140000000000001 105.751 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.642 ' N ' ' HB2' ' A' ' 249' ' ' ALA . . . 103.86 -51.85 0.79 Allowed Glycine 0 C--N 1.297 -1.617 0 C-N-CA 120.445 -0.883 . . . . 74.140000000000001 112.999 177.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.41 30.54 18.88 Favored Glycine 0 CA--C 1.498 -0.986 0 N-CA-C 109.9 -1.28 . . . . 60.520000000000003 109.9 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -129.81 -8.98 4.47 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.465 -0.867 . . . . 73.209999999999994 111.456 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.408 ' HA3' ' CG1' ' A' ' 244' ' ' VAL . . . -86.61 -80.27 1.19 Allowed Glycine 0 CA--C 1.487 -1.661 0 C-N-CA 119.386 -1.388 . . . . 72.25 112.415 -175.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.43 ' HB3' HD11 ' A' ' 276' ' ' LEU . 75.6 t80 -99.98 -22.74 15.14 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.504 -1.295 . . . . 75.450000000000003 107.504 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . 0.56 ' HA ' ' CE3' ' A' ' 287' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.41 -2.469 0 N-CA-C 115.741 1.756 . . . . 74.310000000000002 115.741 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 261' ' ' THR . 30.3 ptt85 . . . . . 0 N--CA 1.422 -1.847 0 CA-C-O 121.025 0.441 . . . . 70.230000000000004 110.859 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.483 ' OD1' ' HA2' ' C' ' 242' ' ' GLY . 51.1 m-80 -108.18 148.52 29.78 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.919 -1.141 . . . . 75.409999999999997 107.919 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 31.2 m -135.95 137.44 41.3 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.572 0.701 . . . . 71.329999999999998 111.163 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.51 129.85 51.37 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.631 -1.168 . . . . 74.120000000000005 108.449 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 5.3 tmtt? -78.55 -66.49 0.85 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.384 -0.826 . . . . 73.0 108.816 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -134.82 139.05 44.78 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 116.524 -0.307 . . . . 73.409999999999997 110.347 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 10.8 mt -132.23 117.72 33.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.241 -1.022 . . . . 65.530000000000001 108.241 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . 0.423 ' HB3' HG13 ' B' ' 268' ' ' VAL . 25.8 ttt180 -113.64 122.46 47.25 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.938 -0.574 . . . . 74.319999999999993 110.735 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 76.0 p -110.7 132.16 54.44 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.945 -1.131 . . . . 75.450000000000003 107.945 175.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -133.72 150.83 51.51 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.353 -0.539 . . . . 73.439999999999998 109.778 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 70.13 -95.19 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 124.556 1.142 . . . . 73.209999999999994 113.455 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.04 31.13 4.95 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.425 -1.324 . . . . 75.209999999999994 107.425 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -76.24 137.25 39.84 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.29 -0.868 . . . . 74.329999999999998 110.701 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 1.7 mpp_? -125.34 134.35 52.24 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.031 -0.986 . . . . 65.400000000000006 108.514 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.431 HG11 ' HB ' ' B' ' 275' ' ' VAL . 19.6 m -135.58 140.83 43.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.8 0.809 . . . . 74.230000000000004 111.265 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.437 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 38.8 tp60 -105.15 135.79 45.84 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 114.211 -1.359 . . . . 70.340000000000003 108.463 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -125.97 117.02 22.39 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 104.911 -2.255 . . . . 75.010000000000005 104.911 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.561 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 125.19 -146.12 16.0 Favored Glycine 0 N--CA 1.42 -2.407 0 C-N-CA 119.549 -1.31 . . . . 63.450000000000003 111.844 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 0.7 OUTLIER -113.81 146.17 40.34 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.442 -0.577 . . . . 74.430000000000007 109.442 -176.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.437 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 59.2 t -126.78 122.48 60.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.015 -1.476 . . . . 71.310000000000002 107.015 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.53 126.0 72.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.369 -1.333 . . . . 75.319999999999993 113.49 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 24.4 p -120.28 163.13 18.27 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.947 -0.569 . . . . 75.340000000000003 112.034 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.64 -31.82 58.06 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.723 1.209 . . . . 75.420000000000002 112.201 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.36 70.17 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.885 0.698 . . . . 75.430000000000007 112.885 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.48 ' HB3' ' N ' ' B' ' 282' ' ' GLY . . . -75.01 -44.37 48.44 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.484 -0.486 . . . . 72.340000000000003 109.988 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 63.8 tp . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 125.131 1.372 . . . . 70.310000000000002 110.36 -176.502 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.437 -1.082 0 N-CA-C 109.136 -0.69 . . . . 75.430000000000007 109.136 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 10.2 t -123.53 134.54 53.85 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 121.558 0.694 . . . . 75.099999999999994 110.182 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -125.16 138.15 54.15 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.582 -0.896 . . . . 71.530000000000001 108.582 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 263' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' C' ' 227' ' ' SER . 41.8 m -130.33 132.51 45.88 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.691 -0.485 . . . . 74.099999999999994 109.691 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 7.3 p -125.68 142.35 42.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 116.123 -0.489 . . . . 70.329999999999998 110.923 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 10.4 mm-40 -82.68 -69.02 0.66 Allowed 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 123.793 0.683 . . . . 75.109999999999999 109.703 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.5 m -126.06 127.21 45.48 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 119.572 -0.851 . . . . 73.510000000000005 112.252 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 48.0 t -118.66 120.76 65.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.359 -1.348 . . . . 74.150000000000006 107.359 176.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' B' ' 232' ' ' ARG . 27.4 m -125.6 137.46 57.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.69 0.757 . . . . 71.439999999999998 112.152 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.71 133.65 11.01 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 110.279 -1.128 . . . . 72.430000000000007 110.279 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -132.08 115.88 16.34 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.359 0.599 . . . . 75.040000000000006 109.566 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.75 -132.28 10.95 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 119.996 -1.097 . . . . 44.409999999999997 111.178 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -96.14 48.28 1.1 Allowed 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.746 0.818 . . . . 72.329999999999998 110.437 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 15.5 m -81.46 150.27 28.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.156 -0.929 . . . . 72.329999999999998 112.93 -171.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 49.2 mtm180 -133.26 128.09 35.09 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.887 -0.597 . . . . 75.140000000000001 110.016 173.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.431 ' HB ' HG11 ' B' ' 239' ' ' VAL . 22.0 t -131.83 138.69 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.778 0 N-CA-C 108.366 -0.976 . . . . 71.400000000000006 108.366 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 5.9 tt -120.99 116.32 24.86 Favored 'General case' 0 C--N 1.277 -2.561 0 C-N-CA 118.849 -1.14 . . . . 74.129999999999995 108.148 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . 0.428 ' HA ' ' HB3' ' C' ' 241' ' ' LEU . 4.0 mp -106.31 103.5 15.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 106.313 -1.736 . . . . 74.209999999999994 106.313 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 149.67 -135.02 5.13 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.729 -0.748 . . . . 74.420000000000002 112.501 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 48.5 t-20 -128.72 130.0 46.53 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.201 -0.666 . . . . 72.219999999999999 109.201 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -111.35 118.67 36.47 Favored 'General case' 0 C--O 1.268 2.034 0 N-CA-C 106.992 -1.484 . . . . 74.519999999999996 106.992 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -105.04 122.31 45.6 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 106.919 -1.511 . . . . 72.409999999999997 106.919 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . 0.48 ' N ' ' HB3' ' B' ' 249' ' ' ALA . . . 101.09 -52.29 0.91 Allowed Glycine 0 C--N 1.297 -1.638 0 C-N-CA 120.37 -0.919 . . . . 74.439999999999998 112.524 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.58 32.75 12.58 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.962 -1.113 . . . . 74.150000000000006 111.39 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -136.68 2.09 2.63 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.569 0.581 . . . . 72.239999999999995 112.569 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . 0.427 ' HA3' ' CG1' ' B' ' 244' ' ' VAL . . . -86.15 -77.86 1.21 Allowed Glycine 0 CA--C 1.487 -1.707 0 C-N-CA 118.712 -1.708 . . . . 70.239999999999995 110.739 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -97.01 -21.29 17.5 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.545 -1.28 . . . . 73.530000000000001 107.545 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.508 ' HA ' ' CE3' ' B' ' 287' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.418 -2.05 0 CA-C-N 114.309 -1.314 . . . . 72.239999999999995 114.374 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 . . . . . 0 N--CA 1.412 -2.365 0 N-CA-C 109.715 -0.476 . . . . 75.310000000000002 109.715 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -102.22 142.18 33.88 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 106.64 -1.615 . . . . 75.420000000000002 106.64 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 227' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' B' ' 263' ' ' SER . 55.5 m -136.98 137.91 39.99 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.382 0.611 . . . . 71.450000000000003 111.19 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.19 130.23 50.55 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.417 -0.81 . . . . 71.329999999999998 109.262 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -84.07 -61.58 1.78 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.578 -0.527 . . . . 74.049999999999997 109.578 -177.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -129.14 138.18 51.63 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 122.152 -0.342 . . . . 70.540000000000006 110.538 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 18.4 mt -136.04 117.32 19.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 107.614 -1.254 . . . . 74.540000000000006 107.614 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -119.4 126.0 50.33 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.481 0.658 . . . . 73.019999999999996 110.82 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 24.5 p -110.17 135.44 50.95 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.431 -0.951 . . . . 62.450000000000003 108.431 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -134.89 149.83 50.35 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.757 -0.831 . . . . 63.530000000000001 108.757 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 64.58 -99.02 0.07 Allowed 'General case' 0 C--O 1.203 -1.372 0 C-N-CA 124.556 1.142 . . . . 65.329999999999998 113.698 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.498 ' HD3' ' N ' ' C' ' 236' ' ' ARG . 0.2 OUTLIER -122.62 35.52 4.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 108.221 -1.029 . . . . 74.510000000000005 108.221 -177.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -81.3 134.38 35.58 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 114.563 -1.198 . . . . 72.519999999999996 110.659 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 2.0 mpp_? -125.33 133.88 52.43 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.616 -1.174 . . . . 70.319999999999993 107.942 176.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.427 HG23 HG11 ' B' ' 275' ' ' VAL . 29.4 m -134.67 141.26 43.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.649 0.738 . . . . 73.030000000000001 110.922 177.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . 0.419 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 45.1 tp60 -104.79 136.05 45.03 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 114.648 -1.16 . . . . 75.519999999999996 108.495 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.428 ' HB3' ' HA ' ' B' ' 277' ' ' ILE . 1.6 tm? -126.42 116.96 21.97 Favored 'General case' 0 N--CA 1.402 -2.848 0 N-CA-C 104.864 -2.273 . . . . 74.109999999999999 104.864 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.492 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 121.66 -131.42 8.52 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 119.618 -1.277 . . . . 75.540000000000006 113.31 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 13.1 m120 -122.23 139.7 53.46 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.884 -0.413 . . . . 73.099999999999994 109.884 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 48.4 t -126.34 117.46 48.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 106.545 -1.65 . . . . 74.239999999999995 106.545 172.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.03 127.85 74.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.797 -1.161 . . . . 71.439999999999998 113.104 -175.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 20.2 p -114.0 162.63 16.18 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.093 -0.503 . . . . 63.130000000000003 111.185 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.33 -32.04 69.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.445 0.698 . . . . 71.129999999999995 110.836 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.32 -33.61 59.26 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.505 1.122 . . . . 72.430000000000007 112.533 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.654 0 N-CA-C 112.244 0.461 . . . . 73.329999999999998 112.244 -179.566 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.415 -2.203 0 CA-C-O 121.592 0.71 . . . . 71.310000000000002 109.34 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -114.68 125.63 53.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.749 -0.66 . . . . 71.219999999999999 109.513 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 263' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' C' ' 227' ' ' SER . 28.5 t -117.78 135.37 54.1 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 108.179 -1.045 . . . . 74.209999999999994 108.179 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.0 141.44 42.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 116.402 -0.363 . . . . 73.230000000000004 110.333 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -78.42 -66.45 0.85 Allowed 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 122.493 0.317 . . . . 73.340000000000003 111.047 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.8 m -129.03 132.37 47.48 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 120.523 -0.471 . . . . 75.340000000000003 111.441 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.75 123.95 72.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.074 -1.454 . . . . 65.030000000000001 107.074 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 20.1 m -124.99 143.59 38.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.3 0.571 . . . . 70.109999999999999 112.338 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.2 133.78 9.16 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.331 -1.108 . . . . 74.209999999999994 110.331 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -133.84 125.09 27.66 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 123.643 0.777 . . . . 73.209999999999994 109.708 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.24 -136.99 21.32 Favored Glycine 0 CA--C 1.506 -0.512 0 N-CA-C 110.108 -1.197 . . . . 63.329999999999998 110.108 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -81.26 98.12 7.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.528 -0.916 . . . . 74.099999999999994 108.528 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 50.5 m -120.35 149.94 41.53 Favored 'General case' 0 C--N 1.278 -2.5 0 C-N-CA 120.121 -0.632 . . . . 72.439999999999998 110.845 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 75.6 mtm180 -140.1 127.49 21.36 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.022 -1.103 . . . . 71.420000000000002 108.022 174.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 7.8 t -135.29 140.06 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.678 0 N-CA-C 107.561 -1.274 . . . . 64.129999999999995 107.561 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 7.0 tt -120.65 111.74 18.01 Favored 'General case' 0 N--CA 1.403 -2.789 0 C-N-CA 118.894 -1.122 . . . . 71.310000000000002 108.871 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.66 103.18 14.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 105.272 -2.122 . . . . 74.519999999999996 105.272 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 149.11 -140.32 8.09 Favored Glycine 0 CA--C 1.492 -1.401 0 C-N-CA 120.286 -0.959 . . . . 64.150000000000006 111.852 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -128.45 133.89 48.63 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.417 -0.586 . . . . 72.310000000000002 109.417 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . 0.464 ' HG2' ' HB2' ' C' ' 287' ' ' TRP . 10.2 tp10 -111.75 118.72 36.37 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.351 -1.351 . . . . 74.319999999999993 107.351 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -105.31 123.58 48.1 Favored 'General case' 0 C--O 1.253 1.282 0 N-CA-C 107.713 -1.218 . . . . 73.430000000000007 107.713 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.35 -42.03 2.04 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.958 -0.857 . . . . 74.040000000000006 110.958 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 73.06 43.4 40.36 Favored Glycine 0 CA--C 1.482 -1.996 0 N-CA-C 109.219 -1.552 . . . . 75.329999999999998 109.219 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -151.46 6.23 0.47 Allowed 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.236 -0.482 . . . . 73.510000000000005 110.027 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -92.01 -80.6 1.43 Allowed Glycine 0 CA--C 1.491 -1.442 0 C-N-CA 119.943 -1.122 . . . . 33.229999999999997 110.693 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -95.42 -27.7 15.29 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.136 -1.061 . . . . 74.510000000000005 108.136 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . 0.5 ' HA ' ' CE3' ' C' ' 287' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.168 0 CA-C-N 114.61 -1.177 . . . . 74.010000000000005 112.984 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 17.0 ptt85 . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 121.776 0.798 . . . . 74.129999999999995 112.588 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -98.41 147.55 24.6 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.714 -1.958 . . . . 73.209999999999994 105.714 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.5 m -121.8 136.37 54.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.531 0.681 . . . . 73.420000000000002 111.28 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.4 129.17 37.0 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.481 -1.303 . . . . 71.519999999999996 107.481 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -89.08 -43.93 10.72 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.292 -0.633 . . . . 74.120000000000005 109.292 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -139.86 138.93 36.13 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.693 0.283 . . . . 74.409999999999997 110.267 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 56.2 mt -137.09 123.48 28.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 106.497 -1.668 . . . . 73.409999999999997 106.497 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 60.4 ttt-85 -128.88 115.27 17.61 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.201 -1.037 . . . . 71.540000000000006 108.201 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 30.9 p -120.5 128.41 53.11 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.982 -0.448 . . . . 52.219999999999999 110.789 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -127.78 140.34 52.11 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 110.083 -0.34 . . . . 72.439999999999998 110.083 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.41 ' C ' ' HD2' ' A' ' 236' ' ' ARG . 40.1 mt-10 59.87 105.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.529 1.677 . . . . 74.200000000000003 115.529 169.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 272' ' ' GLU . 1.2 mpt_? 53.0 24.15 3.28 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.071 1.348 . . . . 72.319999999999993 111.526 176.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.97 151.67 23.07 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 120.981 0.42 . . . . 72.200000000000003 110.553 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.32 135.55 38.99 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.649 -0.705 . . . . 74.420000000000002 109.241 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 3.2 p -133.11 140.17 47.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.863 -0.608 . . . . 70.340000000000003 110.526 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -116.32 124.42 50.08 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.63 -1.248 . . . . 75.340000000000003 107.63 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tt -119.07 117.47 28.83 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 105.527 -2.027 . . . . 75.140000000000001 105.527 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.58 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 131.32 -162.28 23.65 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 109.662 -1.375 . . . . 71.230000000000004 109.662 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -117.43 134.74 54.49 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 109.172 -0.677 . . . . 71.409999999999997 109.172 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 30.8 t -107.0 121.61 60.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.29 -1.004 . . . . 74.439999999999998 108.29 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 56.2 t -113.58 114.95 48.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.502 -0.925 . . . . 72.230000000000004 108.502 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.3 m -96.96 160.37 14.39 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.259 -1.015 . . . . 74.349999999999994 108.259 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.19 75.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.176 0.59 . . . . 74.219999999999999 111.067 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.38 66.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.353 1.061 . . . . 72.430000000000007 113.399 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.862 0 CA-C-O 120.854 0.359 . . . . 63.25 110.954 -179.746 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.213 -0.827 0 N-CA-C 110.135 -0.32 . . . . 74.109999999999999 110.135 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -126.25 150.2 48.57 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 104.953 -2.239 . . . . 72.530000000000001 104.953 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 26.7 m -134.93 123.77 23.91 Favored 'General case' 0 C--O 1.263 1.797 0 N-CA-C 114.494 1.294 . . . . 74.140000000000001 114.494 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -121.76 134.5 64.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 CA-C-N 115.108 -0.951 . . . . 72.349999999999994 110.616 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -77.35 -73.19 0.31 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.611 -0.722 . . . . 73.209999999999994 110.804 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 32.3 m -126.12 126.82 44.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 120.882 -0.327 . . . . 73.099999999999994 110.227 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.4 p -129.64 120.85 51.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.848 0.832 . . . . 74.099999999999994 110.874 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 44.7 t -118.71 135.28 59.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.073 -0.967 . . . . 75.25 110.892 -175.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.455 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -121.37 131.12 8.45 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 108.411 -1.875 . . . . 71.120000000000005 108.411 172.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.428 ' HB3' ' HG2' ' B' ' 234' ' ' GLU . 7.1 tmtm? -134.91 115.02 13.12 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.437 -0.579 . . . . 72.510000000000005 109.437 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.37 82.71 0.68 Allowed Glycine 0 C--O 1.216 -0.977 0 C-N-CA 120.672 -0.775 . . . . 64.400000000000006 114.309 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 236' ' ' ARG . 41.5 mt-10 63.62 24.32 13.91 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.438 1.095 . . . . 71.049999999999997 112.414 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 48.8 m -82.46 145.12 30.0 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 121.715 0.769 . . . . 75.439999999999998 111.491 -176.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -109.09 127.86 54.5 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 106.42 -1.696 . . . . 75.439999999999998 106.42 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.4 p -129.23 123.55 58.48 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.665 0 N-CA-C 108.94 -0.763 . . . . 74.010000000000005 108.94 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.432 HD12 HE22 ' B' ' 240' ' ' GLN . 4.5 tt -113.53 120.21 40.2 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 107.88 -1.155 . . . . 74.430000000000007 107.88 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 41.7 mm -112.45 103.49 15.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.716 -1.216 . . . . 73.310000000000002 107.716 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.634 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 147.15 -145.06 13.38 Favored Glycine 0 C--N 1.301 -1.381 0 N-CA-C 110.452 -1.059 . . . . 65.310000000000002 110.452 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -127.53 143.3 51.2 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.628 -0.879 . . . . 74.329999999999998 108.628 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.75 120.23 37.94 Favored 'General case' 0 C--O 1.259 1.605 0 N-CA-C 106.849 -1.537 . . . . 73.239999999999995 106.849 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -107.12 123.11 47.77 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 106.854 -1.536 . . . . 75.450000000000003 106.854 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 98.96 -48.08 1.33 Allowed Glycine 0 C--N 1.295 -1.701 0 C-N-CA 120.54 -0.838 . . . . 72.530000000000001 111.356 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 82.93 15.04 73.72 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.829 -0.7 . . . . 63.219999999999999 113.036 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -127.47 5.91 6.27 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.264 -0.551 . . . . 74.349999999999994 111.755 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -85.71 -54.79 2.69 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 110.173 -1.171 . . . . 73.510000000000005 110.173 -178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -111.86 -30.68 7.2 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.143 -0.529 . . . . 72.340000000000003 109.674 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' B' ' 238' ' ' ARG 0.283 11.3 t-105 . . . . . 0 N--CA 1.413 -2.285 0 C-N-CA 118.441 -1.304 . . . . 74.010000000000005 113.684 -173.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . 0.653 ' O ' ' HA ' ' B' ' 261' ' ' THR . 8.7 ptm180 . . . . . 0 N--CA 1.425 -1.724 0 CA-C-O 121.711 0.767 . . . . 75.030000000000001 110.621 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -103.69 149.11 25.27 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 104.576 -2.379 . . . . 71.409999999999997 104.576 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 23.9 m -125.75 134.74 51.65 Favored 'General case' 0 N--CA 1.411 -2.386 0 C-N-CA 119.252 -0.979 . . . . 74.439999999999998 110.497 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.24 121.74 25.3 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.156 -1.384 . . . . 75.349999999999994 110.331 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -76.1 -67.14 0.71 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.156 -0.929 . . . . 72.319999999999993 112.164 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -127.16 137.07 52.87 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 118.327 -1.349 . . . . 74.230000000000004 108.752 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . 0.413 HG23 HG21 ' B' ' 239' ' ' VAL . 43.3 mt -131.93 117.68 34.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.35 -1.352 . . . . 65.219999999999999 107.35 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -126.09 115.15 19.38 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.226 -0.657 . . . . 70.299999999999997 109.226 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' THR . . . . . 0.455 ' OG1' ' HA2' ' A' ' 269' ' ' GLY . 71.2 p -112.66 127.24 56.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.844 -1.169 . . . . 63.409999999999997 107.844 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' B' ' 270' ' ' LYS . 52.2 mt-10 -131.44 139.89 49.49 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 122.072 -0.392 . . . . 73.420000000000002 111.1 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . 0.528 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 28.9 mt-10 60.56 93.62 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 O-C-N 124.711 1.257 . . . . 73.310000000000002 114.037 171.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.528 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 1.4 mpt_? 63.0 15.6 8.56 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 125.036 1.335 . . . . 73.239999999999995 111.06 175.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -78.15 156.57 29.82 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.197 0.522 . . . . 75.340000000000003 111.071 -176.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.464 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -139.75 135.15 32.8 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.362 -0.607 . . . . 73.530000000000001 109.362 177.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.4 p -133.32 142.45 41.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.632 0.73 . . . . 73.510000000000005 111.381 -178.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.68 ' HB2' ' CE2' ' B' ' 286' ' ' PHE . 5.8 tp-100 -109.35 131.99 54.55 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.382 -1.34 . . . . 65.129999999999995 107.382 173.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -129.72 115.58 17.53 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 104.801 -2.296 . . . . 75.040000000000006 104.801 171.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 135.96 -136.32 8.36 Favored Glycine 0 N--CA 1.417 -2.578 0 N-CA-C 109.057 -1.617 . . . . 61.240000000000002 109.057 -175.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -142.3 148.71 38.47 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 117.575 0.688 . . . . 74.239999999999995 109.682 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 17.2 t -114.8 124.11 71.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.538 -1.282 . . . . 72.219999999999999 107.538 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.15 113.37 38.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 120.178 -0.609 . . . . 74.030000000000001 109.494 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' THR . . . . . 0.409 HG22 ' HB2' ' B' ' 284' ' ' LYS . 7.4 m -95.09 159.5 14.99 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.353 -1.351 . . . . 74.120000000000005 107.353 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.15 -32.13 73.58 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.941 0.876 . . . . 72.430000000000007 110.241 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.89 -44.47 74.13 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.383 -1.735 . . . . 73.140000000000001 113.366 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -75.74 -47.7 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.273 -0.571 . . . . 71.030000000000001 111.16 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 N--CA 1.467 0.423 0 C-N-CA 123.929 0.892 . . . . 71.140000000000001 109.296 -175.448 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 3.7 m . . . . . 0 CA--C 1.506 -0.719 0 N-CA-C 108.44 -0.948 . . . . 72.510000000000005 108.44 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 261' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' B' ' 225' ' ' ARG . 25.3 m -132.96 135.18 45.36 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.639 -1.615 . . . . 65.340000000000003 106.639 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -126.67 146.05 50.34 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.192 -1.781 . . . . 73.209999999999994 106.192 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 263' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' C' ' 227' ' ' SER . 40.5 m -125.6 123.51 39.18 Favored 'General case' 0 C--O 1.256 1.434 0 C-N-CA 118.536 -1.266 . . . . 74.409999999999997 114.043 -170.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.3 p -128.63 137.31 57.67 Favored 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 120.088 -0.645 . . . . 75.239999999999995 111.212 172.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.555 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 10.4 tp10 -86.34 -63.36 1.33 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.025 -0.534 . . . . 73.439999999999998 110.01 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 25.1 m -137.15 127.56 26.58 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.346 -0.847 . . . . 75.040000000000006 112.408 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.56 128.41 75.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 115.882 -0.599 . . . . 71.209999999999994 109.815 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.41 130.63 74.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.61 -0.723 . . . . 65.549999999999997 109.98 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.44 132.95 9.28 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 110.585 -1.006 . . . . 70.519999999999996 110.585 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.465 ' HD2' ' HB2' ' B' ' 234' ' ' GLU . 31.2 mmmt -132.91 115.64 15.49 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 123.218 0.607 . . . . 74.109999999999999 111.108 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.61 80.67 0.61 Allowed Glycine 0 C--N 1.304 -1.196 0 C-N-CA 120.445 -0.883 . . . . 51.420000000000002 114.589 172.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 63.7 28.64 14.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.159 0.984 . . . . 63.450000000000003 112.509 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 273' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 50.1 m -81.97 145.19 30.41 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.351 0.596 . . . . 73.239999999999995 111.175 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . 0.411 ' HD3' ' HB3' ' C' ' 238' ' ' ARG . 6.1 mpt_? -109.5 128.72 55.38 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 106.849 -1.537 . . . . 73.049999999999997 106.849 174.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.4 p -130.96 123.06 53.32 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 N-CA-C 108.17 -1.048 . . . . 74.400000000000006 108.17 172.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . 0.44 HD12 ' CD1' ' B' ' 286' ' ' PHE . 6.1 tt -114.08 116.79 29.7 Favored 'General case' 0 C--N 1.277 -2.571 0 C-N-CA 119.36 -0.936 . . . . 74.230000000000004 108.599 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 34.0 mm -106.46 102.54 14.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 106.834 -1.543 . . . . 71.209999999999994 106.834 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 146.82 -164.36 28.53 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 110.856 -0.897 . . . . 62.130000000000003 110.856 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -109.54 139.66 44.28 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.159 -0.682 . . . . 72.140000000000001 109.159 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.95 118.89 36.73 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.256 -1.757 . . . . 74.120000000000005 106.256 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -105.91 122.95 47.17 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.891 -1.151 . . . . 73.439999999999998 107.891 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.44 -46.47 1.28 Allowed Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.669 -0.696 . . . . 73.549999999999997 111.682 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 74.59 29.25 61.86 Favored Glycine 0 CA--C 1.506 -0.486 0 N-CA-C 111.555 -0.618 . . . . 52.439999999999998 111.555 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . 0.409 ' HB2' HG22 ' B' ' 246' ' ' THR . 73.1 mmtt -137.25 11.41 3.03 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.528 -0.336 . . . . 72.319999999999993 110.624 -177.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -103.78 -47.05 1.31 Allowed Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 119.729 -1.224 . . . . 75.319999999999993 110.686 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' B' ' 240' ' ' GLN . 6.3 t80 -110.03 -42.11 4.29 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.996 0.427 . . . . 75.409999999999997 110.39 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.514 ' CZ2' ' HB2' ' C' ' 238' ' ' ARG . 11.2 t-105 . . . . . 0 N--CA 1.427 -1.586 0 N-CA-C 115.483 1.661 . . . . 75.150000000000006 115.483 -165.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 . . . . . 0 N--CA 1.433 -1.316 0 CA-C-O 122.614 1.197 . . . . 74.310000000000002 114.115 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -116.25 147.41 41.51 Favored 'General case' 0 N--CA 1.399 -2.985 0 N-CA-C 105.26 -2.126 . . . . 75.25 105.26 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 227' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' C' ' 263' ' ' SER . 24.1 m -130.03 136.55 49.52 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 121.269 0.557 . . . . 72.319999999999993 110.117 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . 0.4 ' HB1' HG21 ' C' ' 277' ' ' ILE . . . -130.41 134.37 47.08 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 109.198 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -85.95 -61.32 1.78 Allowed 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 115.266 -0.879 . . . . 73.540000000000006 109.193 -178.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -129.56 137.97 51.05 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.953 -0.699 . . . . 71.239999999999995 110.345 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 34.5 mt -135.18 119.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.879 -0.785 . . . . 74.420000000000002 108.879 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -125.56 115.92 20.94 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.998 0.428 . . . . 75.209999999999994 110.078 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 38.9 p -112.61 127.5 56.11 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.452 -0.944 . . . . 74.129999999999995 108.452 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -131.55 139.43 49.23 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.437 -0.505 . . . . 72.120000000000005 110.691 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . 0.454 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 38.2 mt-10 62.81 92.16 0.06 Allowed 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 124.926 1.391 . . . . 74.230000000000004 114.133 170.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.454 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 2.8 mpt_? 63.55 12.04 6.14 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.859 1.264 . . . . 74.239999999999995 111.21 175.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -77.97 149.01 34.18 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.204 0.526 . . . . 62.509999999999998 111.64 -174.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.514 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.0 OUTLIER -133.65 134.96 43.8 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.943 -0.572 . . . . 72.329999999999998 111.511 176.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.6 p -132.97 137.86 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 115.276 -0.875 . . . . 72.099999999999994 111.534 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -106.03 129.79 54.07 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 114.127 -1.397 . . . . 74.150000000000006 107.863 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -125.15 116.32 21.85 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.069 -1.826 . . . . 71.129999999999995 106.069 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.632 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 126.98 -148.18 17.21 Favored Glycine 0 C--N 1.284 -2.348 0 N-CA-C 108.278 -1.929 . . . . 65.409999999999997 108.278 -176.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -126.96 150.16 49.51 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 118.336 1.068 . . . . 72.409999999999997 110.621 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.78 126.56 74.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.614 -1.254 . . . . 74.420000000000002 107.614 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 65.4 t -122.52 118.59 55.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 120.439 -0.504 . . . . 74.340000000000003 109.98 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 9.4 m -95.27 159.42 15.02 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 108.114 -1.069 . . . . 71.409999999999997 108.114 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -64.05 -33.76 76.48 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.354 0.597 . . . . 63.240000000000002 110.776 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.14 -47.76 74.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.405 -1.271 . . . . 72.120000000000005 111.464 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.515 0 CA-C-O 120.941 0.4 . . . . 74.219999999999999 111.367 177.155 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.415 -2.195 0 N-CA-C 109.584 -0.524 . . . . 75.319999999999993 109.584 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -112.51 124.48 52.61 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.064 -1.828 . . . . 71.129999999999995 106.064 173.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 263' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' C' ' 227' ' ' SER . 10.7 p -130.37 144.79 51.6 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 113.735 1.013 . . . . 75.409999999999997 113.735 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 10.0 p -128.51 149.58 33.43 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.494 -0.775 . . . . 65.140000000000001 110.296 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -81.03 -68.28 0.7 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.626 0.25 . . . . 74.099999999999994 111.284 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 61.8 m -138.59 127.6 23.94 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 120.367 -0.533 . . . . 75.120000000000005 110.646 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.1 m -118.68 134.6 61.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.466 -0.568 . . . . 64.049999999999997 109.466 172.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 13.6 m -127.1 135.53 63.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-N 115.634 -0.712 . . . . 74.510000000000005 110.485 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.15 132.35 9.08 Favored Glycine 0 CA--C 1.47 -2.739 0 N-CA-C 109.089 -1.604 . . . . 44.299999999999997 109.089 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -134.4 115.21 13.75 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.603 -0.888 . . . . 75.120000000000005 108.603 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.39 91.61 0.19 Allowed Glycine 0 C--O 1.242 0.653 0 C-N-CA 121.139 -0.553 . . . . 71.150000000000006 113.427 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 56.5 29.65 15.77 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.638 1.175 . . . . 72.519999999999996 112.158 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 23.2 m -82.8 145.24 29.62 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 119.561 -0.856 . . . . 63.200000000000003 111.547 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -118.72 127.65 53.76 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 107.908 -1.145 . . . . 71.409999999999997 107.908 177.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 4.0 p -138.25 128.5 35.06 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-N 115.592 -0.731 . . . . 74.349999999999994 109.292 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.7 tt -116.62 115.3 25.45 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.485 -0.931 . . . . 72.420000000000002 108.485 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . 0.4 HG21 ' HB1' ' C' ' 228' ' ' ALA . 43.1 mm -105.9 102.97 14.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 106.509 -1.663 . . . . 74.409999999999997 106.509 178.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 141.42 -163.2 26.84 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 111.028 -0.829 . . . . 62.409999999999997 111.028 -174.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -114.08 135.87 53.55 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.818 -0.808 . . . . 75.239999999999995 108.818 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.69 118.68 36.31 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.169 -1.789 . . . . 75.310000000000002 106.169 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -105.26 123.39 47.76 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 109.097 -0.705 . . . . 75.239999999999995 109.097 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.19 -43.65 1.66 Allowed Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 109.957 -1.257 . . . . 64.430000000000007 109.957 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 80.1 21.68 64.84 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.359 -0.697 . . . . 70.409999999999997 111.359 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' C' ' 287' ' ' TRP . 33.3 mttm -145.68 20.5 1.49 Allowed 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 113.987 1.106 . . . . 73.409999999999997 113.987 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -94.58 -45.5 3.18 Favored Glycine 0 N--CA 1.427 -1.922 0 N-CA-C 107.794 -2.123 . . . . 72.329999999999998 107.794 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.53 -50.91 3.11 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.578 -1.267 . . . . 74.25 107.578 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' C' ' 284' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.308 -1.204 0 CA-C-N 115.268 -0.878 . . . . 73.219999999999999 112.097 -169.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 . . . . . 0 N--CA 1.426 -1.674 0 CA-C-O 121.695 0.759 . . . . 75.310000000000002 112.053 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -110.28 134.96 51.74 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.301 -1.318 . . . . 74.219999999999999 108.677 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.6 m -126.19 136.71 53.17 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 109.326 -0.62 . . . . 74.099999999999994 109.326 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.18 132.19 27.83 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.453 -1.684 . . . . 73.349999999999994 106.453 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.17 -56.85 2.5 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.873 -0.731 . . . . 74.310000000000002 111.656 -174.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.81 139.57 52.57 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.129 -0.693 . . . . 64.019999999999996 109.129 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.2 mm -131.92 118.72 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.884 -0.784 . . . . 73.209999999999994 108.884 -174.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -120.56 127.01 51.75 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.846 -0.428 . . . . 74.349999999999994 109.846 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 45.1 p -133.46 128.64 35.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.684 -0.487 . . . . 65.230000000000004 109.684 -176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -142.8 139.71 31.07 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 121.059 -0.256 . . . . 74.319999999999993 110.773 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.6 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 38.7 mt-10 64.18 95.64 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 114.748 1.388 . . . . 63.0 114.748 170.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.6 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.1 mpp_? 60.31 26.85 16.37 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.674 1.19 . . . . 74.340000000000003 110.435 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -92.35 125.95 37.23 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 115.252 -0.886 . . . . 75.140000000000001 110.614 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.448 ' HD3' ' HG2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -128.05 134.94 49.25 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.621 -0.881 . . . . 74.400000000000006 108.621 176.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.487 HG11 ' HB ' ' A' ' 275' ' ' VAL . 33.1 m -134.32 150.12 30.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 116.116 -0.493 . . . . 72.540000000000006 110.711 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.598 HE21 ' HG ' ' A' ' 276' ' ' LEU . 0.9 OUTLIER -123.14 125.34 44.96 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.336 -1.357 . . . . 75.340000000000003 107.336 178.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -116.12 117.75 30.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.65 -1.241 . . . . 75.230000000000004 107.65 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.45 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 126.59 -159.57 20.86 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 111.337 -0.705 . . . . 73.140000000000001 111.337 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 279' ' ' ASN . 39.3 t30 -107.0 137.86 44.27 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 122.935 0.494 . . . . 75.319999999999993 110.383 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 99.9 t -113.27 114.33 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.249 -0.649 . . . . 73.030000000000001 109.249 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.441 ' HA ' ' HB3' ' A' ' 281' ' ' TYR . 27.4 m -99.32 118.39 45.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 119.844 -0.742 . . . . 74.230000000000004 110.711 176.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 17.6 m -102.0 158.95 15.78 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.562 -0.533 . . . . 73.150000000000006 109.562 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.79 -35.27 80.24 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.639 0.977 . . . . 71.329999999999998 113.639 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -39.03 68.01 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.476 1.288 . . . . 74.329999999999998 114.476 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.423 ' HB3' ' HA2' ' A' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.318 -0.763 0 N-CA-C 112.217 0.451 . . . . 74.420000000000002 112.217 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.408 -2.54 0 N-CA-C 106.204 -1.776 . . . . 74.349999999999994 106.204 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 17.2 m120 -104.91 130.8 53.0 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.797 -0.816 . . . . 74.319999999999993 108.797 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 59.5 m -138.96 123.43 18.34 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.53 -0.545 . . . . 70.230000000000004 109.53 174.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 12.7 p -128.19 149.18 32.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.844 -1.169 . . . . 73.129999999999995 107.844 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 32.1 tt0 -92.91 -67.6 0.85 Allowed 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 120.005 -0.678 . . . . 73.420000000000002 110.339 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 20.7 m -123.74 133.08 53.91 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.235 -0.586 . . . . 74.439999999999998 111.429 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.84 131.71 72.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 108.492 -0.929 . . . . 72.319999999999993 108.492 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 6.4 p -127.26 131.51 70.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 110.207 -0.294 . . . . 72.239999999999995 110.207 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.461 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -122.71 131.49 8.31 Favored Glycine 0 CA--C 1.485 -1.837 0 C-N-CA 120.34 -0.933 . . . . 71.239999999999995 111.347 176.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -134.41 115.84 14.48 Favored 'General case' 0 N--CA 1.428 -1.531 0 O-C-N 123.679 0.282 . . . . 74.540000000000006 110.828 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.63 99.7 0.49 Allowed Glycine 0 C--O 1.245 0.801 0 C-N-CA 120.717 -0.754 . . . . 73.25 113.878 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 60.55 24.18 13.87 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.432 1.093 . . . . 73.209999999999994 110.597 175.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 18.9 m -82.57 144.63 30.22 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.987 0.899 . . . . 74.239999999999995 112.784 -169.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . 0.448 ' HG2' ' HD3' ' A' ' 238' ' ' ARG . 82.9 mtt180 -135.31 126.21 27.57 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.124 -1.436 . . . . 75.239999999999995 107.124 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.487 ' HB ' HG11 ' A' ' 239' ' ' VAL . 46.4 t -136.19 133.67 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.989 0 N-CA-C 109.691 -0.485 . . . . 71.140000000000001 109.691 -176.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.598 ' HG ' HE21 ' A' ' 240' ' ' GLN . 6.3 tt -119.45 117.98 29.89 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.507 -1.277 . . . . 74.340000000000003 108.849 171.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 2.7 pt -112.54 104.38 16.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-O 121.622 0.725 . . . . 74.430000000000007 109.508 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.673 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 148.21 -133.45 4.62 Favored Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 115.843 -0.617 . . . . 63.539999999999999 111.568 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 243' ' ' ASN . 14.3 m120 -128.29 153.5 46.92 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.507 -0.923 . . . . 74.109999999999999 108.507 -176.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.17 143.45 34.25 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.945 0.878 . . . . 73.540000000000006 110.475 170.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . 0.441 ' HB3' ' HA ' ' A' ' 245' ' ' VAL 0.252 5.3 t80 -119.45 124.63 46.98 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 105.801 -1.926 . . . . 74.319999999999993 105.801 -175.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 249' ' ' ALA . . . 144.2 -52.13 0.62 Allowed Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.003 -1.094 . . . . 72.129999999999995 112.974 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 119.87 -34.74 4.08 Favored Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 108.816 -1.714 . . . . 40.130000000000003 108.816 -175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -135.89 87.47 2.31 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.609 -1.626 . . . . 72.099999999999994 106.609 170.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -95.97 -132.81 7.26 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.812 -0.915 . . . . 63.119999999999997 110.812 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 26.0 t80 52.07 -130.1 2.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 107.819 -1.178 . . . . 75.310000000000002 107.819 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 . . . . . 0 C--N 1.299 -1.627 0 N-CA-C 107.318 -1.364 . . . . 70.25 107.318 172.693 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 . . . . . 0 CA--C 1.502 -0.891 0 N-CA-C 112.255 0.465 . . . . 75.129999999999995 112.255 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 6.9 t30 -118.58 113.39 21.18 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.654 -0.869 . . . . 74.409999999999997 108.654 169.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 46.7 m -121.26 136.61 54.94 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-O 121.725 0.774 . . . . 63.439999999999998 110.124 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.21 147.58 52.0 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.999 -1.482 . . . . 55.539999999999999 106.999 178.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.522 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 10.0 tmtt? -104.51 -67.76 0.89 Allowed 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.677 -0.809 . . . . 75.420000000000002 109.299 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -128.01 138.7 52.69 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.435 -0.58 . . . . 73.400000000000006 109.435 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . 0.417 HD11 ' HB3' ' B' ' 228' ' ' ALA . 39.9 mm -128.88 117.57 44.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.637 -0.875 . . . . 75.409999999999997 108.637 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -114.31 114.51 26.02 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.895 -0.78 . . . . 72.420000000000002 108.895 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' THR . . . . . 0.461 ' OG1' ' HA2' ' A' ' 269' ' ' GLY . 78.2 p -111.53 127.24 55.65 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 107.664 -1.235 . . . . 71.329999999999998 107.664 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -139.34 138.93 37.07 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 120.842 -0.343 . . . . 73.129999999999995 111.019 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . 0.627 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 44.5 mt-10 57.99 98.4 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 125.098 1.499 . . . . 73.209999999999994 114.908 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.627 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.2 OUTLIER 60.75 26.21 16.02 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.859 -1.064 . . . . 71.219999999999999 110.198 174.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -91.35 136.03 33.4 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.121 -0.945 . . . . 63.439999999999998 111.882 -175.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 3.5 mpt_? -125.94 134.41 51.55 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.711 -1.218 . . . . 74.230000000000004 107.711 176.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 19.7 m -138.97 147.41 24.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.234 0.54 . . . . 73.140000000000001 110.945 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -122.06 127.93 50.78 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.66 -1.608 . . . . 74.219999999999999 106.66 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' B' ' 277' ' ' ILE . 2.3 tm? -122.5 117.67 26.49 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.892 -1.522 . . . . 73.510000000000005 106.892 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.673 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 136.92 -126.39 3.7 Favored Glycine 0 N--CA 1.428 -1.861 0 C-N-CA 120.804 -0.713 . . . . 71.340000000000003 111.761 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . 0.552 ' HA ' ' O ' ' B' ' 279' ' ' ASN . 43.9 t30 -142.78 134.86 27.23 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 110.286 -0.264 . . . . 73.430000000000007 110.286 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.445 HG11 ' H ' ' B' ' 286' ' ' PHE . 68.7 t -114.94 114.91 47.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 109.539 -0.541 . . . . 74.310000000000002 109.539 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . 0.441 ' HA ' ' HB3' ' B' ' 281' ' ' TYR . 28.5 m -104.15 112.72 38.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.69 -0.804 . . . . 64.209999999999994 111.192 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 42.0 m -81.72 158.19 24.29 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 121.047 0.451 . . . . 75.010000000000005 110.914 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.23 93.24 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.322 1.049 . . . . 73.519999999999996 112.342 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.31 -44.29 75.65 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.068 -1.424 . . . . 73.129999999999995 114.065 -173.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.495 ' HB3' ' HA2' ' B' ' 282' ' ' GLY . . . -74.95 -25.76 59.12 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 120.9 0.381 . . . . 62.530000000000001 110.744 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 CA--C 1.515 -0.389 0 C-N-CA 125.186 1.395 . . . . 74.230000000000004 109.458 -171.155 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 16.7 m . . . . . 0 CA--C 1.541 0.614 0 CA-C-O 121.936 0.874 . . . . 74.140000000000001 111.254 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 33.9 m -124.11 108.91 12.83 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 115.039 -0.982 . . . . 71.219999999999999 108.565 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -108.49 132.59 53.66 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 109.65 -0.5 . . . . 63.409999999999997 109.65 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 37.3 t -142.19 123.86 15.06 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.418 -0.586 . . . . 75.239999999999995 109.418 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.9 p -123.7 148.64 27.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.535 -0.913 . . . . 73.329999999999998 108.535 177.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.522 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 37.4 tt0 -89.21 -72.79 0.53 Allowed 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 119.576 -0.85 . . . . 73.430000000000007 110.529 175.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 25.1 m -127.81 133.97 49.44 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.917 -1.114 . . . . 73.329999999999998 112.471 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.82 135.27 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.793 -1.188 . . . . 72.530000000000001 107.793 173.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 5.3 p -127.48 125.43 65.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 121.024 0.44 . . . . 74.209999999999994 110.677 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . 0.447 ' HA2' ' HG1' ' C' ' 233' ' ' THR . . . -114.57 132.52 10.5 Favored Glycine 0 CA--C 1.476 -2.406 0 N-CA-C 111.137 -0.785 . . . . 60.43 111.137 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.437 ' HB3' ' HG2' ' C' ' 234' ' ' GLU . 40.6 tptt -134.12 115.83 14.7 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 109.987 -0.375 . . . . 75.420000000000002 109.987 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.97 99.74 0.06 OUTLIER Glycine 0 CA--C 1.527 0.782 0 N-CA-C 114.159 0.424 . . . . 64.340000000000003 114.159 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 63.91 26.83 14.33 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.161 0.984 . . . . 74.540000000000006 112.421 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 273' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 37.4 m -83.41 144.79 29.38 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.444 -0.902 . . . . 71.549999999999997 113.066 -171.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 4.8 mtt-85 -135.55 127.23 29.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.001 -1.111 . . . . 75.239999999999995 108.001 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 55.6 t -136.49 138.44 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.594 0 N-CA-C 109.165 -0.68 . . . . 75.010000000000005 109.165 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 6.1 tt -123.44 120.88 34.25 Favored 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 119.095 -1.042 . . . . 72.340000000000003 108.434 169.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' B' ' 241' ' ' LEU . 1.5 pt -112.43 104.28 16.79 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 C-N-CA 123.991 0.916 . . . . 74.310000000000002 109.502 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.496 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 145.45 -133.63 5.14 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.804 -0.635 . . . . 64.319999999999993 111.699 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' B' ' 243' ' ' ASN . 12.5 m120 -127.28 152.29 47.63 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-O 121.218 0.532 . . . . 70.5 109.978 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -137.68 150.01 47.0 Favored 'General case' 0 N--CA 1.409 -2.52 0 N-CA-C 107.962 -1.125 . . . . 72.140000000000001 107.962 170.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . 0.441 ' HB3' ' HA ' ' B' ' 245' ' ' VAL . 11.2 t80 -125.51 124.34 41.12 Favored 'General case' 0 N--CA 1.395 -3.175 0 N-CA-C 107.623 -1.251 . . . . 64.409999999999997 107.623 -174.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' B' ' 249' ' ' ALA . . . 143.6 -48.03 0.77 Allowed Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.653 -0.784 . . . . 75.209999999999994 111.747 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 111.59 -23.72 17.03 Favored Glycine 0 C--O 1.206 -1.62 0 N-CA-C 108.578 -1.809 . . . . 60.409999999999997 108.578 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -141.92 81.88 1.78 Allowed 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 106.886 -1.524 . . . . 75.409999999999997 106.886 173.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -103.88 -159.93 24.61 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.492 -1.443 . . . . 74.540000000000006 109.492 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.445 ' H ' HG11 ' B' ' 244' ' ' VAL . 71.3 t80 63.3 -175.04 0.15 Allowed 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 122.912 0.485 . . . . 73.0 110.54 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 . . . . . 0 C--N 1.303 -1.44 0 O-C-N 120.528 -1.357 . . . . 74.200000000000003 112.292 -174.072 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 N--CA 1.432 -1.351 0 N-CA-C 113.707 1.003 . . . . 75.329999999999998 113.707 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -117.24 120.58 38.68 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.03 -1.441 . . . . 74.239999999999995 108.706 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 227' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' C' ' 263' ' ' SER . 42.7 m -121.17 137.08 54.84 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.706 -0.479 . . . . 74.200000000000003 109.706 177.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -133.3 144.38 49.66 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.458 -0.942 . . . . 72.420000000000002 108.458 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -58.78 1.82 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.544 -0.862 . . . . 74.120000000000005 110.883 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' C' ' 266' ' ' THR . 1.2 m-20 -127.23 139.47 52.9 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.295 0.569 . . . . 75.150000000000006 110.734 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 32.6 mm -128.87 118.05 46.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 106.454 -1.684 . . . . 74.099999999999994 106.454 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -118.91 115.1 23.67 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.841 -0.429 . . . . 72.150000000000006 109.841 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 233' ' ' THR . . . . . 0.447 ' HG1' ' HA2' ' B' ' 269' ' ' GLY . 80.5 p -112.19 127.4 55.93 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 108.326 -0.99 . . . . 73.230000000000004 108.326 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' B' ' 270' ' ' LYS . 43.8 mt-10 -138.9 139.34 38.02 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 121.119 -0.232 . . . . 71.510000000000005 110.41 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . 0.552 ' HB3' ' NH1' ' C' ' 236' ' ' ARG . 49.2 mt-10 56.76 95.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 115.539 1.681 . . . . 73.340000000000003 115.539 174.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.552 ' NH1' ' HB3' ' C' ' 235' ' ' GLU . 0.5 OUTLIER 61.06 24.14 14.26 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.164 0.986 . . . . 70.25 111.712 175.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -91.8 139.57 30.54 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.958 0.885 . . . . 75.5 112.774 -175.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 8.8 mpt_? -125.65 135.45 52.16 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.17 -1.377 . . . . 72.109999999999999 108.309 177.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 30.5 m -138.13 147.34 25.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.313 0.578 . . . . 71.019999999999996 110.66 172.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -121.1 129.53 53.35 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.089 -1.819 . . . . 75.349999999999994 106.089 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' C' ' 277' ' ' ILE . 2.8 tm? -122.0 118.58 29.16 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 106.162 -1.792 . . . . 74.200000000000003 106.162 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 135.54 -127.77 4.42 Favored Glycine 0 N--CA 1.416 -2.7 0 C-N-CA 120.179 -1.01 . . . . 53.240000000000002 111.421 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 45.9 t30 -144.34 130.36 19.47 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.525 0.202 . . . . 74.230000000000004 110.783 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 85.2 t -110.92 117.88 56.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 123.713 0.805 . . . . 73.310000000000002 109.258 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 18.3 m -107.82 119.26 57.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 120.147 -0.621 . . . . 74.239999999999995 110.479 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 29.7 m -84.6 158.66 20.82 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 120.943 -0.303 . . . . 73.319999999999993 111.223 -176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.15 -47.83 78.4 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 122.159 0.98 . . . . 71.040000000000006 110.871 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.38 -35.98 65.87 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.265 -1.789 . . . . 72.109999999999999 112.807 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . 0.427 ' HB1' ' HA2' ' C' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.31 -1.126 0 CA-C-N 116.166 -0.47 . . . . 64.450000000000003 111.967 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.435 -1.175 0 CA-C-O 120.899 0.38 . . . . 73.239999999999995 110.048 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -123.71 136.02 54.21 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 120.989 0.423 . . . . 71.230000000000004 109.862 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 263' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' C' ' 227' ' ' SER . 33.2 m -142.83 130.41 21.3 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.133 -0.692 . . . . 73.329999999999998 109.133 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.38 153.42 34.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.507 -0.553 . . . . 62.450000000000003 109.507 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -85.35 -74.76 0.39 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.477 -0.564 . . . . 75.430000000000007 109.477 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 266' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 60.4 m -138.41 134.11 33.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.687 -0.633 . . . . 72.349999999999994 110.693 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.54 136.04 57.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 108.374 -0.973 . . . . 73.349999999999994 108.374 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.18 137.16 58.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 116.514 -0.312 . . . . 71.319999999999993 110.308 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.48 133.02 7.51 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 110.933 -0.867 . . . . 71.219999999999999 110.933 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -133.91 115.03 13.95 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.847 -0.797 . . . . 73.129999999999995 108.847 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 74.47 108.75 0.08 OUTLIER Glycine 0 CA--C 1.527 0.834 0 O-C-N 123.843 0.714 . . . . 74.019999999999996 114.42 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 58.64 20.32 7.61 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 123.716 0.807 . . . . 72.519999999999996 112.282 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 273' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 24.4 m -83.76 144.2 29.48 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-O 121.233 0.539 . . . . 72.310000000000002 110.504 -173.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 0.0 OUTLIER -150.32 128.34 11.87 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.907 -0.588 . . . . 73.230000000000004 109.677 174.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 10.1 t -136.75 140.93 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 O-C-N 123.78 0.675 . . . . 71.129999999999995 109.232 -173.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.9 tt -112.03 116.67 30.93 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 107.939 -1.134 . . . . 73.430000000000007 107.939 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 3.2 mp -101.27 104.45 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 106.555 -1.646 . . . . 71.030000000000001 106.555 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . 0.428 ' C ' HD21 ' C' ' 279' ' ' ASN . . . 138.13 -128.48 4.22 Favored Glycine 0 N--CA 1.409 -3.152 0 C-N-CA 119.446 -1.359 . . . . 32.039999999999999 112.092 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 1.0 OUTLIER -128.04 138.96 52.77 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.057 0.456 . . . . 73.420000000000002 111.822 -173.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -126.62 145.79 50.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.325 -1.361 . . . . 72.230000000000004 107.325 168.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -125.85 123.35 38.49 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 108.305 -0.998 . . . . 75.120000000000005 108.305 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . 0.427 ' HA2' ' HB1' ' C' ' 249' ' ' ALA . . . 134.03 9.77 1.87 Allowed Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.59 -0.732 . . . . 72.230000000000004 113.989 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 80.99 -47.93 3.66 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-N 117.92 0.86 . . . . 55.43 111.771 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -136.65 96.61 3.37 Favored 'General case' 0 N--CA 1.413 -2.302 0 N-CA-C 107.473 -1.306 . . . . 73.409999999999997 107.473 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -110.06 -159.74 17.73 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 108.666 -1.773 . . . . 74.129999999999995 108.666 173.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 60.6 t80 73.87 169.97 0.3 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.803 0.841 . . . . 75.310000000000002 110.993 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 5.5 m0 . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 116.81 2.152 . . . . 74.319999999999993 116.81 -167.631 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.492 -1.267 0 N-CA-C 108.43 -0.952 . . . . 75.319999999999993 108.43 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -86.34 133.89 33.77 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.479 -1.304 . . . . 73.340000000000003 107.479 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 32.9 m -133.63 141.79 47.79 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.318 0.58 . . . . 75.299999999999997 112.386 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.34 137.88 37.79 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.003 -1.851 . . . . 74.099999999999994 106.003 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.41 -48.04 10.06 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.684 -0.858 . . . . 74.040000000000006 108.684 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -140.15 140.64 36.0 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 119.76 -0.776 . . . . 71.019999999999996 111.646 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 62.6 mt -126.49 117.17 47.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 106.806 -1.553 . . . . 73.519999999999996 106.806 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -118.92 115.96 25.47 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.619 -0.833 . . . . 73.409999999999997 110.127 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.1 t -113.11 128.69 56.56 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.602 -0.726 . . . . 65.519999999999996 109.276 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.4 ' HG2' ' HG3' ' A' ' 235' ' ' GLU . 40.3 tt0 -150.23 139.81 21.58 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 108.435 -0.95 . . . . 73.540000000000006 108.435 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.4 ' HG3' ' HG2' ' A' ' 234' ' ' GLU . 43.9 mt-10 65.6 89.14 0.1 Allowed 'General case' 0 C--O 1.22 -0.48 0 O-C-N 124.409 1.068 . . . . 73.409999999999997 113.075 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 271' ' ' GLY . 36.2 mtt85 66.33 -4.82 0.65 Allowed 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 124.448 1.099 . . . . 74.200000000000003 113.136 171.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -70.61 143.44 51.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 123.352 0.661 . . . . 75.019999999999996 111.2 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -126.37 135.81 51.92 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.979 -1.119 . . . . 73.510000000000005 107.979 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.73 150.82 34.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 120.844 0.354 . . . . 74.439999999999998 111.666 -175.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -134.05 134.55 42.5 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.137 -0.938 . . . . 75.129999999999995 108.831 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -128.14 119.28 24.97 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.583 -1.266 . . . . 74.310000000000002 107.583 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.491 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 132.35 -115.67 1.67 Allowed Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 119.991 -1.1 . . . . 74.120000000000005 112.689 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -143.51 135.86 27.05 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.301 -0.629 . . . . 70.019999999999996 109.301 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 99.0 t -116.94 120.63 65.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.46 -1.311 . . . . 74.340000000000003 107.46 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.73 117.19 51.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 108.996 -0.742 . . . . 73.099999999999994 108.996 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 90.5 m -77.48 159.72 29.17 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.064 -0.717 . . . . 75.019999999999996 109.064 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.38 -38.83 91.1 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.538 0.735 . . . . 64.310000000000002 112.122 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.13 -33.74 72.57 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.861 0.864 . . . . 72.120000000000005 111.551 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.542 0 CA-C-N 115.642 -0.708 . . . . 74.0 112.223 -176.638 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.1 m . . . . . 0 N--CA 1.424 -1.756 0 N-CA-C 106.701 -1.592 . . . . 75.140000000000001 106.701 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -121.15 141.43 50.83 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.213 -1.032 . . . . 73.329999999999998 108.213 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.7 p -136.23 123.4 21.71 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.056 -0.52 . . . . 74.430000000000007 111.588 -172.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 13.4 p -129.0 148.28 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 108.917 -0.772 . . . . 72.439999999999998 108.917 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 34.5 tt0 -85.89 -69.16 0.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.686 -0.487 . . . . 74.230000000000004 109.686 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 28.6 m -126.09 128.06 46.77 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.315 -0.554 . . . . 72.400000000000006 111.404 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 36.0 m -119.77 125.67 74.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.049 0 N-CA-C 109.101 -0.704 . . . . 72.439999999999998 109.101 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.14 134.9 64.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 116.078 -0.51 . . . . 73.230000000000004 112.063 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -123.96 132.27 8.31 Favored Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 111.298 -0.721 . . . . 74.420000000000002 111.298 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 26.3 mmmt -133.76 147.6 51.31 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.117 0.967 . . . . 73.120000000000005 112.175 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' A' ' 236' ' ' ARG . . . 84.53 -57.82 5.01 Favored Glycine 0 CA--C 1.502 -0.732 0 CA-C-N 115.981 -0.554 . . . . 75.530000000000001 112.453 174.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 179.6 121.3 0.06 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 103.468 -2.79 . . . . 63.509999999999998 103.468 176.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 68.6 m -151.28 155.88 39.67 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.902 0.382 . . . . 52.210000000000001 110.685 -175.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' B' ' 238' ' ' ARG . 2.2 mpt_? -127.75 127.92 44.45 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.206 -1.776 . . . . 75.319999999999993 106.206 174.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 33.5 t -129.1 129.79 67.92 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 109.583 -0.525 . . . . 74.530000000000001 109.583 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.492 ' HB3' ' OE1' ' B' ' 240' ' ' GLN . 4.8 tt -125.32 118.94 27.04 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.197 -1.038 . . . . 72.140000000000001 108.197 172.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 43.5 mm -107.99 104.86 17.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.957 -1.127 . . . . 72.540000000000006 107.957 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 144.77 -140.04 8.91 Favored Glycine 0 N--CA 1.419 -2.464 0 C-N-CA 120.66 -0.781 . . . . 74.400000000000006 111.794 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -115.18 140.36 49.14 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 109.72 -0.474 . . . . 73.230000000000004 109.72 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.43 129.52 53.93 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.193 -2.151 . . . . 72.200000000000003 105.193 174.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 2.0 t80 -127.49 122.81 34.4 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 107.228 -1.397 . . . . 72.319999999999993 107.228 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.72 -52.95 0.63 Allowed Glycine 0 N--CA 1.412 -2.93 0 N-CA-C 108.624 -1.79 . . . . 61.25 108.624 -175.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 139.02 -57.84 0.62 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 111.17 -0.772 . . . . 74.040000000000006 111.17 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.541 ' HA ' ' NE1' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -132.18 35.2 3.72 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.948 0.88 . . . . 74.040000000000006 110.617 -176.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -57.29 -31.26 62.29 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 116.002 1.161 . . . . 70.019999999999996 116.002 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.443 ' CB ' HD13 ' A' ' 276' ' ' LEU . 71.0 t80 -114.72 0.22 13.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.908 0.861 . . . . 72.530000000000001 110.535 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . 0.541 ' NE1' ' HA ' ' A' ' 284' ' ' LYS . 10.5 p90 . . . . . 0 C--N 1.305 -1.347 0 CA-C-O 121.888 0.852 . . . . 73.340000000000003 111.291 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 N--CA 1.435 -1.18 0 CA-C-O 121.019 0.438 . . . . 74.150000000000006 110.077 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -94.03 129.86 40.39 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 103.865 -2.643 . . . . 63.119999999999997 103.865 167.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 23.9 m -131.69 137.08 48.14 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.104 -1.038 . . . . 72.530000000000001 111.63 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -132.2 135.82 46.6 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.611 -1.255 . . . . 74.450000000000003 107.611 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 0.1 OUTLIER -82.77 -61.47 1.86 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.747 -0.835 . . . . 72.329999999999998 108.747 -178.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -134.24 139.46 45.78 Favored 'General case' 0 C--O 1.254 1.318 0 C-N-CA 120.036 -0.666 . . . . 75.540000000000006 109.409 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 10.9 mt -128.43 116.77 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.199 -1.408 . . . . 75.340000000000003 107.199 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -113.3 118.83 35.71 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.216 -0.447 . . . . 75.519999999999996 110.286 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' THR . . . . . 0.463 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 0.0 OUTLIER -110.82 128.65 55.85 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 108.713 -0.847 . . . . 75.219999999999999 108.713 175.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 33.9 tt0 -147.46 138.88 23.84 Favored 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 108.543 -0.91 . . . . 74.030000000000001 108.543 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . 0.539 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 52.5 mt-10 65.09 94.85 0.06 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 124.675 1.235 . . . . 60.549999999999997 113.273 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.539 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 58.6 15.78 3.88 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 125.459 1.503 . . . . 70.540000000000006 112.711 171.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -92.33 149.05 21.66 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 121.526 0.679 . . . . 74.400000000000006 111.911 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.443 ' CZ ' ' HG3' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -129.45 135.75 49.05 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 115.612 -0.722 . . . . 72.549999999999997 110.183 175.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.461 HG12 ' HB ' ' B' ' 275' ' ' VAL . 30.4 m -125.87 136.8 59.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 124.089 0.868 . . . . 74.230000000000004 109.987 -177.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.492 ' OE1' ' HB3' ' A' ' 276' ' ' LEU . 38.8 tp60 -115.92 132.94 56.5 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.866 -1.061 . . . . 74.150000000000006 108.693 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.28 118.36 24.94 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.348 -1.353 . . . . 75.0 107.348 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 134.04 -114.12 1.28 Allowed Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 120.044 -1.074 . . . . 72.349999999999994 111.924 177.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -144.31 140.32 29.08 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.796 -0.446 . . . . 75.400000000000006 109.796 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.487 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 97.7 t -122.11 114.87 44.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.239 -1.393 . . . . 72.010000000000005 107.239 175.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . 0.442 ' CG2' ' HB2' ' B' ' 250' ' ' LEU . 4.2 p -122.13 118.5 55.66 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-O 121.21 0.529 . . . . 74.230000000000004 109.803 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 28.7 m -71.09 158.85 35.76 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 109.05 -0.722 . . . . 72.140000000000001 109.05 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.98 -47.41 80.47 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.038 0.923 . . . . 71.319999999999993 111.291 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.77 79.17 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.896 -1.502 . . . . 64.200000000000003 111.847 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.494 ' HA ' ' CB ' ' C' ' 247' ' ' ALA . . . -67.88 -40.31 83.55 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.506 0.928 . . . . 72.25 113.506 -173.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . 0.442 ' HB2' ' CG2' ' B' ' 245' ' ' VAL . 26.6 tp . . . . . 0 C--N 1.31 -1.126 0 C-N-CA 120.043 -0.663 . . . . 71.340000000000003 111.93 -173.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.435 -1.176 0 CA-C-O 121.212 0.529 . . . . 71.200000000000003 111.379 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 53.9 m -106.11 108.16 19.53 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 107.459 -1.312 . . . . 64.409999999999997 107.459 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -124.65 131.83 53.45 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.641 -1.244 . . . . 64.409999999999997 107.641 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 15.7 m -121.54 123.79 42.85 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.835 -0.62 . . . . 72.049999999999997 110.521 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 8.4 p -126.29 149.86 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 108.024 -1.102 . . . . 75.200000000000003 108.024 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 12.8 tt0 -93.95 -77.94 0.44 Allowed 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.97 -0.752 . . . . 75.420000000000002 108.97 175.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 28.8 m -113.26 127.54 56.19 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 120.25 -0.58 . . . . 72.219999999999999 110.854 -175.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.83 120.68 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-O 121.695 0.759 . . . . 72.409999999999997 109.512 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.92 141.55 45.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.623 -0.717 . . . . 72.120000000000005 112.199 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.72 132.41 7.92 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.982 -0.847 . . . . 61.420000000000002 110.982 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 25.4 mmmt -133.87 148.83 51.3 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 124.205 1.002 . . . . 74.209999999999994 112.541 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . 0.455 ' O ' ' HD3' ' B' ' 236' ' ' ARG . . . 85.57 -57.99 4.88 Favored Glycine 0 CA--C 1.499 -0.945 0 C-N-CA 121.362 -0.447 . . . . 71.349999999999994 112.954 174.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 176.24 114.17 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 103.279 -2.86 . . . . 75.219999999999999 103.279 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 273' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 67.1 m -146.79 160.22 42.53 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.734 0.778 . . . . 72.540000000000006 112.448 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . 0.478 ' HD3' ' HB3' ' C' ' 238' ' ' ARG . 0.7 OUTLIER -129.48 127.58 41.14 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 105.799 -1.926 . . . . 71.340000000000003 105.799 176.354 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.461 ' HB ' HG12 ' B' ' 239' ' ' VAL . 41.5 t -132.02 126.31 56.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.658 -0.497 . . . . 74.530000000000001 109.658 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . 0.481 ' HB3' ' OE1' ' C' ' 240' ' ' GLN . 4.7 tt -121.78 118.7 29.69 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.752 -1.179 . . . . 74.310000000000002 108.029 173.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 44.6 mm -108.18 104.23 16.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 106.952 -1.499 . . . . 75.319999999999993 106.952 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 146.36 -158.02 27.57 Favored Glycine 0 CA--C 1.476 -2.39 0 C-N-CA 120.358 -0.925 . . . . 61.130000000000003 113.204 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -96.38 138.86 33.35 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.293 -0.632 . . . . 73.030000000000001 109.293 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -121.32 126.8 50.37 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 105.801 -1.925 . . . . 74.420000000000002 105.801 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . 0.537 ' CD1' HG13 ' C' ' 245' ' ' VAL . 1.3 t80 -123.63 123.56 40.83 Favored 'General case' 0 N--CA 1.405 -2.716 0 N-CA-C 107.304 -1.369 . . . . 74.140000000000001 107.304 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.59 -43.98 1.01 Allowed Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 108.809 -1.716 . . . . 72.129999999999995 108.809 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.24 -29.0 8.26 Favored Glycine 0 N--CA 1.423 -2.215 0 N-CA-C 111.678 -0.569 . . . . 61.100000000000001 111.678 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . 0.543 ' HA ' ' CD1' ' B' ' 287' ' ' TRP . 42.6 pttt -149.04 19.84 0.98 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.679 -0.409 . . . . 73.299999999999997 111.974 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -53.97 -43.49 71.96 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.117 -0.563 . . . . 75.319999999999993 114.226 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.479 ' CB ' HD12 ' B' ' 276' ' ' LEU . 62.1 t80 -97.69 -1.09 44.31 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.685 0.755 . . . . 73.450000000000003 111.202 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.543 ' CD1' ' HA ' ' B' ' 284' ' ' LYS . 13.6 p90 . . . . . 0 C--N 1.315 -0.893 0 CA-C-O 121.329 0.585 . . . . 75.430000000000007 110.926 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 . . . . . 0 N--CA 1.433 -1.289 0 N-CA-C 107.955 -1.128 . . . . 73.400000000000006 107.955 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -93.29 133.2 36.76 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.569 -1.271 . . . . 73.310000000000002 107.569 172.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 48.8 m -140.67 141.8 34.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.549 0.944 . . . . 65.349999999999994 113.549 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -137.37 133.03 34.38 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.222 -1.029 . . . . 75.209999999999994 108.222 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -76.67 -57.98 3.54 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.24 -0.652 . . . . 70.120000000000005 109.24 -178.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.14 140.0 41.56 Favored 'General case' 0 C--O 1.265 1.881 0 C-N-CA 120.041 -0.663 . . . . 74.400000000000006 110.84 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.22 116.97 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 107.898 -1.149 . . . . 72.200000000000003 107.898 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 38.1 ttt180 -118.02 118.1 31.02 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.263 0.554 . . . . 75.319999999999993 110.625 177.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 233' ' ' THR . . . . . 0.459 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 0.0 OUTLIER -110.53 129.88 55.69 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 108.707 -0.849 . . . . 65.219999999999999 108.707 175.389 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 33.6 tt0 -144.13 138.56 28.28 Favored 'General case' 0 N--CA 1.415 -2.204 0 C-N-CA 120.317 -0.553 . . . . 73.340000000000003 109.515 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . 0.559 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 51.0 mt-10 59.72 97.76 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.617 1.167 . . . . 74.120000000000005 114.018 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.559 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 0.2 OUTLIER 61.87 13.59 5.63 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.426 1.49 . . . . 73.340000000000003 112.333 172.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . 0.4 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -94.38 151.46 19.38 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.443 0.64 . . . . 74.219999999999999 111.964 -174.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.478 ' HB3' ' HD3' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -132.91 135.47 45.58 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-N 115.44 -0.8 . . . . 73.319999999999993 110.823 178.191 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.422 HG12 ' HB ' ' C' ' 275' ' ' VAL . 33.1 m -127.85 138.32 55.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.228 -0.897 . . . . 73.329999999999998 110.234 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . 0.481 ' OE1' ' HB3' ' B' ' 276' ' ' LEU . 38.4 tp60 -116.19 133.35 56.12 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.799 -1.091 . . . . 71.319999999999993 108.873 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.27 118.41 24.17 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.802 -1.555 . . . . 74.129999999999995 106.802 175.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.458 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 133.68 -117.94 1.98 Allowed Glycine 0 N--CA 1.422 -2.269 0 C-N-CA 119.918 -1.134 . . . . 75.319999999999993 111.007 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -144.67 140.01 28.36 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 123.582 0.224 . . . . 70.530000000000001 111.066 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . 0.472 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 86.2 t -121.58 116.19 48.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 108.408 -0.96 . . . . 64.329999999999998 108.408 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . 0.537 HG13 ' CD1' ' B' ' 281' ' ' TYR . 2.7 p -122.62 123.48 68.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 109.46 -0.571 . . . . 74.109999999999999 109.46 176.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 24.9 m -77.84 159.29 29.06 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 109.561 -0.533 . . . . 74.099999999999994 109.561 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . 0.494 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.96 -46.53 81.18 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.308 1.052 . . . . 65.409999999999997 110.739 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.81 67.85 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.215 -1.811 . . . . 75.400000000000006 112.245 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . 0.418 ' HB1' ' HA2' ' C' ' 282' ' ' GLY . . . . . . . . 0 C--O 1.244 0.791 0 N-CA-C 113.085 0.772 . . . . 73.409999999999997 113.085 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 55.9 m . . . . . 0 N--CA 1.428 -1.561 0 N-CA-C 108.654 -0.869 . . . . 72.540000000000006 108.654 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -119.45 131.93 55.71 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.867 -0.606 . . . . 75.209999999999994 109.39 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 14.9 m -117.76 122.98 44.88 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.439 0.638 . . . . 63.0 110.014 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.25 129.86 65.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.163 -0.926 . . . . 73.400000000000006 111.79 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -72.49 -75.68 0.13 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.488 -0.93 . . . . 71.140000000000001 108.488 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 86.9 m -148.94 136.56 20.42 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.22 -0.925 . . . . 73.540000000000006 110.006 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 15.9 m -124.05 129.96 73.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 116.012 -0.54 . . . . 71.209999999999994 109.758 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 31.0 m -123.66 140.02 48.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 120.926 0.393 . . . . 71.310000000000002 110.602 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.31 132.58 9.64 Favored Glycine 0 C--N 1.299 -1.495 0 N-CA-C 110.879 -0.888 . . . . 65.439999999999998 110.879 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -134.54 128.92 34.25 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 123.432 0.693 . . . . 74.349999999999994 111.624 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 64.23 56.28 18.87 Favored Glycine 0 C--N 1.318 -0.462 0 O-C-N 123.553 0.533 . . . . 75.549999999999997 113.046 175.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 71.48 102.85 0.07 Allowed 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.467 1.507 . . . . 71.310000000000002 109.601 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.1 m -139.4 148.79 43.3 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.935 -1.029 . . . . 75.439999999999998 108.771 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -121.54 126.34 48.94 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.067 -1.827 . . . . 73.219999999999999 106.067 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . 0.422 ' HB ' HG12 ' C' ' 239' ' ' VAL . 31.0 t -138.13 128.79 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 110.042 -0.355 . . . . 75.010000000000005 110.042 -175.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.72 117.91 25.27 Favored 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 107.97 -1.122 . . . . 72.25 107.97 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 50.1 mm -109.34 104.43 17.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.059 -1.089 . . . . 73.430000000000007 108.059 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 146.06 -154.85 26.21 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 120.565 -0.826 . . . . 64.540000000000006 111.978 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.41 128.17 44.67 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.7 -0.482 . . . . 74.299999999999997 109.7 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -111.93 125.46 54.08 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.876 -1.527 . . . . 75.519999999999996 106.876 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -130.18 123.9 31.34 Favored 'General case' 0 N--CA 1.404 -2.765 0 CA-C-O 121.663 0.744 . . . . 64.319999999999993 109.432 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . 0.418 ' HA2' ' HB1' ' C' ' 249' ' ' ALA . . . 151.58 -46.92 0.59 Allowed Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 108.873 -1.691 . . . . 50.439999999999998 108.873 -176.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 128.4 -25.02 4.88 Favored Glycine 0 CA--C 1.481 -2.077 0 C-N-CA 120.07 -1.062 . . . . 63.130000000000003 111.255 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' C' ' 287' ' ' TRP . 56.3 pttt -151.93 -62.09 0.17 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.177 -0.511 . . . . 74.420000000000002 110.486 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . 0.432 ' H ' ' HG3' ' C' ' 284' ' ' LYS . . . 50.5 -86.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.114 0 N-CA-C 115.503 0.961 . . . . 75.219999999999999 115.503 176.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . 0.427 ' HA ' ' NE1' ' B' ' 287' ' ' TRP . 42.6 t80 -65.79 -29.72 70.25 Favored 'General case' 0 C--O 1.255 1.379 0 C-N-CA 125.192 1.397 . . . . 74.120000000000005 110.62 -176.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . 0.577 ' O ' ' HB2' ' C' ' 284' ' ' LYS . 20.1 p90 . . . . . 0 C--N 1.303 -1.416 0 CA-C-N 115.669 -0.696 . . . . 73.209999999999994 109.884 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 . . . . . 0 N--CA 1.434 -1.231 0 N-CA-C 108.569 -0.901 . . . . 75.510000000000005 108.569 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.434 ' OD1' ' HB3' ' A' ' 262' ' ' ASN . 62.9 t30 -99.01 136.9 38.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.757 -1.201 . . . . 71.109999999999999 107.757 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 43.4 m -126.59 136.87 53.1 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.854 0.835 . . . . 75.340000000000003 112.478 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.72 138.93 46.08 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.208 -1.775 . . . . 73.450000000000003 106.208 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -92.75 -60.91 1.7 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.359 -0.978 . . . . 75.310000000000002 108.359 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -129.78 140.55 51.03 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.49 0.662 . . . . 73.409999999999997 110.921 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 70.7 mt -125.43 123.26 64.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.408 -1.33 . . . . 74.219999999999999 107.408 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 57.1 ttt180 -130.01 115.89 17.78 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.491 -0.484 . . . . 74.420000000000002 109.975 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.413 HG23 HG23 ' A' ' 239' ' ' VAL . 31.4 p -126.65 128.58 46.98 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.045 0.45 . . . . 75.150000000000006 110.064 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -131.8 143.31 50.12 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 109.649 -0.5 . . . . 75.299999999999997 109.649 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.517 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 41.2 mt-10 66.11 96.88 0.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.275 1.583 . . . . 73.310000000000002 115.275 172.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.517 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.1 mpt_? 60.93 11.78 3.5 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 124.961 1.304 . . . . 74.450000000000003 111.926 175.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -88.37 140.72 29.18 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 110.096 -0.335 . . . . 63.140000000000001 110.096 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.05 142.21 51.62 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.051 -0.522 . . . . 73.140000000000001 110.601 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.413 HG23 HG23 ' A' ' 233' ' ' THR . 12.6 t -122.27 149.58 25.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 O-C-N 123.396 0.435 . . . . 73.329999999999998 110.928 -170.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -138.0 120.63 16.21 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.423 -0.955 . . . . 74.010000000000005 108.423 168.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -117.64 122.55 43.88 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.106 -1.072 . . . . 72.25 108.106 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.77 -114.08 1.11 Allowed Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.008 -1.091 . . . . 74.340000000000003 112.599 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -145.48 133.99 22.01 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.883 -0.414 . . . . 73.310000000000002 109.883 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 92.3 t -107.51 115.47 48.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.947 -0.76 . . . . 64.329999999999998 108.947 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.5 112.24 39.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.75 -0.833 . . . . 65.040000000000006 108.75 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 24.6 m -91.11 159.3 16.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.516 -0.92 . . . . 73.239999999999995 108.516 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.57 -33.72 76.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.062 0.764 . . . . 73.239999999999995 113.062 -176.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.78 -39.98 94.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.087 0.773 . . . . 75.530000000000001 113.087 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.451 ' HA ' ' HB1' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.321 -0.639 0 N-CA-C 111.418 0.155 . . . . 64.510000000000005 111.418 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.405 -2.723 0 N-CA-C 108.417 -0.957 . . . . 64.019999999999996 108.417 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.434 ' HB3' ' OD1' ' A' ' 226' ' ' ASN . 45.3 t-20 -126.38 146.83 49.9 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.7 -1.963 . . . . 75.200000000000003 105.7 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 29.6 m -142.22 125.12 16.09 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 121.122 0.487 . . . . 75.340000000000003 110.501 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 14.7 p -128.18 150.51 33.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.677 -1.231 . . . . 62.119999999999997 107.677 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . 0.351 9.1 pt-20 -98.81 -50.66 4.14 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 117.794 -1.562 . . . . 74.409999999999997 113.298 174.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 61.8 m -127.19 126.97 43.76 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 117.958 -1.497 . . . . 74.510000000000005 112.439 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.75 126.83 75.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.687 -0.857 . . . . 74.230000000000004 108.687 173.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 7.9 p -127.76 133.65 67.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-O 121.005 0.431 . . . . 71.230000000000004 111.6 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -126.26 133.11 8.04 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 111.355 -0.698 . . . . 52.240000000000002 111.355 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.462 ' HB2' ' HG2' ' B' ' 234' ' ' GLU . 29.6 mmmt -130.04 116.65 18.85 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 122.587 0.355 . . . . 75.140000000000001 111.25 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.2 100.76 0.24 Allowed Glycine 0 C--N 1.308 -0.992 0 N-CA-C 115.361 0.905 . . . . 74.010000000000005 115.361 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 61.57 20.82 11.59 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.601 0.761 . . . . 75.310000000000002 112.855 169.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 19.4 m -92.79 145.18 24.6 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.464 0.65 . . . . 61.229999999999997 112.264 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . 0.442 ' O ' HG21 ' B' ' 239' ' ' VAL . 66.0 mtt180 -108.3 127.17 53.63 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.147 -2.168 . . . . 74.540000000000006 105.147 173.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 6.1 t -121.45 123.22 69.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 120.179 -0.608 . . . . 72.409999999999997 109.37 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.611 ' HG ' ' OE1' ' B' ' 240' ' ' GLN . 26.8 tp -120.24 120.3 35.72 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.028 -1.069 . . . . 74.140000000000001 111.344 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.71 104.79 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 107.627 -1.249 . . . . 61.409999999999997 107.627 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.461 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 158.28 -145.2 11.35 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.227 -0.987 . . . . 74.349999999999994 111.858 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 45.4 t-20 -120.13 146.85 45.57 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 106.047 -1.834 . . . . 62.219999999999999 106.047 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -123.22 117.45 25.35 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.163 -1.051 . . . . 75.200000000000003 108.163 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -109.71 124.41 51.17 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.8 -1.185 . . . . 74.140000000000001 107.8 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 146.18 -46.55 0.75 Allowed Glycine 0 CA--C 1.473 -2.555 0 N-CA-C 109.896 -1.282 . . . . 53.210000000000001 109.896 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.537 ' O ' ' HG2' ' A' ' 284' ' ' LYS . . . 103.36 72.57 0.92 Allowed Glycine 0 N--CA 1.417 -2.575 0 N-CA-C 109.451 -1.46 . . . . 73.310000000000002 109.451 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 283' ' ' GLY . 4.6 ptpp? 82.09 19.4 0.33 Allowed 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 127.706 2.402 . . . . 74.010000000000005 111.419 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -47.82 -38.22 15.94 Favored Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.267 1.267 . . . . 73.510000000000005 116.267 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.448 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 80.1 t80 -83.56 -3.13 57.4 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 117.378 0.589 . . . . 73.349999999999994 112.453 -175.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . 0.448 ' CE3' ' HB3' ' A' ' 286' ' ' PHE . 32.8 p90 . . . . . 0 N--CA 1.478 0.941 0 O-C-N 121.473 -0.767 . . . . 74.299999999999997 111.592 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 . . . . . 0 N--CA 1.423 -1.813 0 CA-C-O 121.153 0.501 . . . . 72.120000000000005 110.086 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -98.08 136.7 37.94 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 104.536 -2.394 . . . . 74.219999999999999 104.536 171.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 20.1 m -131.85 136.39 47.43 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 120.109 -0.636 . . . . 72.200000000000003 111.255 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -129.2 134.84 48.18 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.689 -1.226 . . . . 64.319999999999993 107.689 175.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -65.98 0.95 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.017 -0.734 . . . . 74.340000000000003 109.017 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -128.46 140.07 52.01 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-O 121.022 0.439 . . . . 73.129999999999995 109.988 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 27.7 mt -124.72 122.64 64.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.245 -1.391 . . . . 74.400000000000006 107.245 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 22.1 ttt180 -122.84 114.55 20.65 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.746 -0.835 . . . . 73.120000000000005 108.746 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' THR . . . . . 0.478 HG21 ' CG2' ' B' ' 239' ' ' VAL . 72.4 p -117.88 127.2 53.63 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.021 -1.103 . . . . 74.340000000000003 108.021 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 270' ' ' LYS . 34.0 mt-10 -137.61 139.79 40.55 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.201 -0.599 . . . . 73.129999999999995 110.322 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . 0.497 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 46.8 mt-10 67.5 96.71 0.06 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.542 1.312 . . . . 74.400000000000006 114.542 173.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.497 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.0 OUTLIER 58.14 27.98 15.78 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.474 1.11 . . . . 73.209999999999994 110.897 175.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . 0.415 ' CB ' ' HB ' ' B' ' 233' ' ' THR . . . -84.77 150.89 24.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.163 0.506 . . . . 74.299999999999997 110.6 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.441 ' HD3' ' HG2' ' B' ' 274' ' ' ARG . 4.4 mpt_? -125.66 134.5 51.83 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.647 -1.983 . . . . 75.400000000000006 105.647 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.478 ' CG2' HG21 ' B' ' 233' ' ' THR . 2.4 t -125.41 139.67 50.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 123.404 0.44 . . . . 74.349999999999994 110.02 -172.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.611 ' OE1' ' HG ' ' A' ' 276' ' ' LEU . 24.5 tp60 -138.48 114.84 10.38 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.864 0.728 . . . . 73.349999999999994 109.8 170.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.0 118.73 34.24 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.431 -1.322 . . . . 65.230000000000004 107.431 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 141.19 -114.06 0.9 Allowed Glycine 0 N--CA 1.422 -2.268 0 C-N-CA 120.276 -0.964 . . . . 53.520000000000003 111.07 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 55.0 t30 -145.46 149.54 34.87 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.981 -0.748 . . . . 74.25 108.981 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 98.1 t -121.61 122.66 67.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.429 -0.952 . . . . 74.200000000000003 108.429 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 48.7 t -122.19 111.84 32.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.975 -0.75 . . . . 73.519999999999996 108.975 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 23.8 m -83.15 159.28 22.08 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.195 -1.039 . . . . 75.129999999999995 108.195 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' A' ' 249' ' ' ALA . . . -64.6 -42.48 95.53 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 123.207 1.48 . . . . 74.319999999999993 109.749 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.68 -34.01 61.67 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 111.762 -2.472 . . . . 74.129999999999995 112.827 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.452 ' HA ' ' HB1' ' C' ' 247' ' ' ALA . . . -62.9 -26.81 68.97 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.678 0.791 . . . . 65.530000000000001 112.482 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 1.2 tm? . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.981 0.896 . . . . 74.319999999999993 108.867 -177.322 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 108.338 -0.986 . . . . 62.43 108.338 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -91.55 127.93 37.18 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 121.799 0.809 . . . . 73.439999999999998 110.405 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -126.82 142.23 51.6 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.946 -1.872 . . . . 74.299999999999997 105.946 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 47.4 m -139.64 133.01 30.05 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 118.313 0.506 . . . . 73.239999999999995 111.655 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.1 p -128.22 144.17 38.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 116.056 -0.52 . . . . 74.209999999999994 110.658 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 38.2 mm-40 -81.05 -63.73 1.34 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.193 0.521 . . . . 75.439999999999998 110.801 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 38.2 m -137.59 127.13 25.08 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 118.138 -1.425 . . . . 75.450000000000003 111.915 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.05 121.13 66.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.891 -1.05 . . . . 72.129999999999995 108.704 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 5.4 p -127.38 138.79 53.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.721 -0.672 . . . . 74.120000000000005 112.266 -176.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.7 133.97 8.81 Favored Glycine 0 CA--C 1.485 -1.8 0 CA-C-N 115.793 -0.64 . . . . 64.329999999999998 112.134 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.437 ' HB2' ' HG2' ' C' ' 234' ' ' GLU . 30.9 mmmt -128.96 115.95 18.6 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 123.748 0.322 . . . . 74.329999999999998 110.689 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 81.58 93.31 0.51 Allowed Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.46 -0.876 . . . . 74.230000000000004 114.626 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 64.01 17.25 10.49 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.341 1.056 . . . . 75.400000000000006 111.89 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 273' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 19.8 m -82.88 145.19 29.58 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.743 0.783 . . . . 63.25 111.383 -172.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . 0.49 ' HB3' ' CE1' ' B' ' 286' ' ' PHE . 51.1 mtm180 -116.84 127.44 54.3 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 108.739 -0.837 . . . . 73.439999999999998 108.739 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.432 HG13 ' CG1' ' C' ' 239' ' ' VAL . 29.2 m -120.64 123.58 70.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-O 121.394 0.616 . . . . 75.109999999999999 110.547 -176.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . 0.562 ' HG ' ' OE1' ' C' ' 240' ' ' GLN . 26.4 tp -115.06 114.78 25.81 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.989 -0.745 . . . . 74.430000000000007 108.989 173.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . 0.446 HG22 HD11 ' C' ' 241' ' ' LEU . 3.4 mp -112.78 103.63 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.609 0 N-CA-C 106.025 -1.843 . . . . 73.239999999999995 106.025 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.433 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 161.3 -150.83 20.86 Favored Glycine 0 N--CA 1.416 -2.662 0 C-N-CA 119.798 -1.192 . . . . 72.140000000000001 112.835 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -113.77 151.81 31.47 Favored 'General case' 0 C--N 1.273 -2.753 0 N-CA-C 104.791 -2.3 . . . . 63.43 104.791 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -130.06 118.87 22.2 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.94 -1.133 . . . . 72.219999999999999 107.94 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -113.1 124.28 52.21 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.911 0.862 . . . . 75.340000000000003 110.927 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.01 -47.32 0.94 Allowed Glycine 0 N--CA 1.417 -2.619 0 CA-C-N 114.37 -1.286 . . . . 74.439999999999998 110.442 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' B' ' 284' ' ' LYS . . . 108.25 90.92 2.15 Favored Glycine 0 N--CA 1.414 -2.79 0 N-CA-C 108.363 -1.895 . . . . 72.140000000000001 108.363 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' B' ' 287' ' ' TRP . 50.0 mtmt 90.95 -59.45 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 126.408 1.883 . . . . 75.049999999999997 109.681 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 49.87 -84.27 0.01 OUTLIER Glycine 0 N--CA 1.478 1.459 0 O-C-N 124.279 0.987 . . . . 73.310000000000002 115.101 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.49 ' CE1' ' HB3' ' B' ' 274' ' ' ARG . 1.3 t80 -52.0 -45.95 64.72 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.466 1.906 . . . . 75.519999999999996 109.908 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.572 ' O ' ' HB3' ' B' ' 284' ' ' LYS . 48.9 p90 . . . . . 0 C--O 1.201 -1.484 0 N-CA-C 106.741 -1.578 . . . . 73.439999999999998 106.741 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' C' ' 261' ' ' THR . 4.9 ptp180 . . . . . 0 N--CA 1.43 -1.431 0 CA-C-O 121.085 0.469 . . . . 74.340000000000003 110.731 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -109.98 140.74 43.65 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.248 -2.131 . . . . 74.209999999999994 105.248 173.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 227' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' C' ' 263' ' ' SER . 45.0 m -139.74 137.95 35.53 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.892 -0.505 . . . . 75.340000000000003 111.399 -176.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.65 128.92 45.09 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.421 -0.955 . . . . 74.209999999999994 108.421 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 27.9 tptp -75.31 -62.17 1.65 Allowed 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.395 -0.594 . . . . 73.140000000000001 109.395 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . 0.411 ' O ' ' HA ' ' C' ' 266' ' ' THR . 16.5 m-20 -134.85 139.86 45.38 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.066 0.46 . . . . 73.549999999999997 110.719 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . 0.451 HG23 HG23 ' C' ' 239' ' ' VAL . 35.6 mt -127.53 123.52 61.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 106.96 -1.496 . . . . 65.430000000000007 106.96 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 31.6 ttt180 -126.9 114.98 18.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.755 -0.832 . . . . 73.230000000000004 108.755 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 39.4 p -110.62 127.36 55.22 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.71 -1.219 . . . . 64.540000000000006 107.71 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . 0.437 ' HG2' ' HB2' ' B' ' 270' ' ' LYS . 40.5 mt-10 -135.07 139.62 44.89 Favored 'General case' 0 N--CA 1.42 -1.943 0 C-N-CA 120.396 -0.522 . . . . 75.209999999999994 110.31 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 64.43 101.29 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 O-C-N 124.621 1.201 . . . . 73.400000000000006 114.117 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 59.6 13.88 3.63 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.669 1.188 . . . . 75.340000000000003 111.27 173.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.38 151.58 22.97 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.619 0.6 . . . . 73.430000000000007 112.619 -172.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.05 135.24 41.15 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.02 -1.474 . . . . 74.530000000000001 107.02 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.451 HG23 HG23 ' C' ' 231' ' ' ILE . 6.9 p -132.38 146.08 33.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.058 0.456 . . . . 70.400000000000006 111.437 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . 0.562 ' OE1' ' HG ' ' B' ' 276' ' ' LEU . 23.2 tp60 -124.6 120.16 31.12 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.67 -1.15 . . . . 72.540000000000006 108.829 172.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.446 HD11 HG22 ' B' ' 277' ' ' ILE . 3.4 tm? -113.66 117.78 32.54 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.966 -1.494 . . . . 71.040000000000006 106.966 177.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 139.14 -114.36 1.01 Allowed Glycine 0 N--CA 1.424 -2.116 0 C-N-CA 119.972 -1.109 . . . . 62.350000000000001 112.02 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -145.39 143.79 30.29 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.571 -0.529 . . . . 73.239999999999995 109.571 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 69.5 t -117.44 118.43 58.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.432 -0.581 . . . . 74.340000000000003 109.432 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 47.9 t -121.8 111.99 33.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.452 -0.573 . . . . 74.340000000000003 109.452 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 31.4 m -78.07 159.47 28.68 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.239 -1.023 . . . . 63.340000000000003 108.239 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' B' ' 249' ' ' ALA . . . -63.46 -43.38 97.53 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.482 1.134 . . . . 72.420000000000002 109.48 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.29 65.6 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.891 -1.959 . . . . 74.099999999999994 112.776 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.643 0 N-CA-C 111.995 0.368 . . . . 73.409999999999997 111.995 -176.409 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 261' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 39.2 m . . . . . 0 N--CA 1.413 -2.31 0 N-CA-C 108.173 -1.047 . . . . 72.25 108.173 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -124.26 127.85 48.29 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.733 -0.84 . . . . 73.510000000000005 108.733 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 263' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' C' ' 227' ' ' SER . 41.4 m -133.43 136.22 45.08 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 110.069 -0.345 . . . . 51.530000000000001 110.069 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.22 153.5 37.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.295 -0.632 . . . . 72.349999999999994 109.295 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.581 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 35.2 mm-40 -81.13 -88.5 0.08 Allowed 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 110.197 -0.297 . . . . 75.230000000000004 110.197 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 266' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 51.4 m -121.85 131.33 53.98 Favored 'General case' 0 N--CA 1.417 -2.09 0 C-N-CA 119.581 -0.848 . . . . 72.299999999999997 111.061 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 26.2 m -117.87 132.53 67.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.33 -0.989 . . . . 71.439999999999998 108.33 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.8 p -127.38 139.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.4 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.99 133.66 9.47 Favored Glycine 0 CA--C 1.476 -2.362 0 N-CA-C 110.155 -1.178 . . . . 75.310000000000002 110.155 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -131.36 115.55 16.39 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 111.988 0.366 . . . . 74.329999999999998 111.988 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 70.05 97.39 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.859 -1.064 . . . . 73.319999999999993 114.415 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 68.09 21.66 8.64 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.782 0.833 . . . . 52.240000000000002 111.955 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.5 m -83.77 144.7 29.14 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.027 0.751 . . . . 73.540000000000006 113.027 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -110.07 128.36 55.39 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.207 -1.775 . . . . 74.430000000000007 106.207 171.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 1.5 t -128.08 123.9 61.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 119.726 -0.79 . . . . 70.120000000000005 109.199 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 30.8 tp -117.62 117.96 30.82 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.902 -0.719 . . . . 74.540000000000006 110.3 174.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' C' ' 228' ' ' ALA . 3.7 mp -112.48 103.47 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.893 0 N-CA-C 105.902 -1.888 . . . . 75.510000000000005 105.902 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.35 -168.24 30.27 Favored Glycine 0 CA--C 1.478 -2.223 0 C-N-CA 120.546 -0.835 . . . . 74.420000000000002 111.456 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -96.7 156.8 16.19 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.46 -0.941 . . . . 74.120000000000005 108.46 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -129.12 121.3 27.5 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.944 -1.132 . . . . 74.430000000000007 107.944 -175.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -116.54 125.12 51.44 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.945 0.403 . . . . 72.239999999999995 110.078 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.47 -37.74 1.84 Allowed Glycine 0 N--CA 1.437 -1.3 0 N-CA-C 111.668 -0.573 . . . . 73.140000000000001 111.668 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 104.4 103.04 2.8 Favored Glycine 0 CA--C 1.48 -2.137 0 N-CA-C 107.304 -2.319 . . . . 45.119999999999997 107.304 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 75.07 -57.78 0.59 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.785 1.234 . . . . 73.129999999999995 109.169 -172.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 57.63 -86.22 0.01 OUTLIER Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.307 0.956 . . . . 61.140000000000001 113.961 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . 0.559 ' HB3' ' CE3' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -56.67 -39.57 73.99 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.023 1.729 . . . . 73.040000000000006 110.642 -178.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . 0.559 ' CE3' ' HB3' ' C' ' 286' ' ' PHE . 24.6 p90 . . . . . 0 C--N 1.306 -1.296 0 CA-C-O 121.067 0.46 . . . . 73.049999999999997 111.622 -171.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 109.948 -0.39 . . . . 74.549999999999997 109.948 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 48.1 t-20 -116.75 123.97 48.48 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.644 -1.614 . . . . 71.150000000000006 106.644 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.1 m -121.65 137.42 54.75 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 120.342 -0.543 . . . . 74.120000000000005 111.239 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.4 134.06 46.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.052 -0.722 . . . . 73.299999999999997 109.052 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -91.49 -46.87 7.74 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.643 -0.253 . . . . 71.329999999999998 110.836 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -136.9 139.71 41.8 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.372 -0.603 . . . . 75.219999999999999 109.372 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 66.1 mt -137.28 119.34 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.388 -1.338 . . . . 75.239999999999995 107.388 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -134.22 122.81 23.3 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.909 0.385 . . . . 74.549999999999997 110.834 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 33.4 p -129.43 128.65 43.39 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.053 -0.351 . . . . 73.219999999999999 110.053 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.67 166.16 17.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.141 0.496 . . . . 74.409999999999997 111.91 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 64.9 -85.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.73 1.612 . . . . 72.140000000000001 113.961 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -130.65 11.7 5.28 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 109.373 -0.602 . . . . 74.219999999999999 109.373 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -73.14 134.25 44.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.495 -0.775 . . . . 71.299999999999997 110.563 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.1 145.25 50.56 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.839 -0.8 . . . . 72.040000000000006 108.839 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.7 p -132.3 141.8 44.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.719 0.771 . . . . 52.25 111.438 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -105.14 128.25 53.29 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.678 -1.23 . . . . 75.040000000000006 107.678 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -122.32 117.85 27.07 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.281 -1.377 . . . . 71.299999999999997 107.281 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 113.25 -159.79 13.48 Favored Glycine 0 C--N 1.306 -1.113 0 C-N-CA 121.23 -0.51 . . . . 61.43 111.925 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -98.78 137.39 37.44 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 122.628 0.371 . . . . 73.549999999999997 110.916 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 61.7 t -114.73 116.32 52.21 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 N-CA-C 107.22 -1.4 . . . . 74.329999999999998 107.22 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.2 p -122.44 114.37 42.23 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 N-CA-C 108.46 -0.941 . . . . 75.349999999999994 108.46 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 15.0 m -84.22 157.18 21.69 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 118.406 -1.318 . . . . 71.510000000000005 110.045 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.01 -47.09 72.51 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.41 0.624 . . . . 73.439999999999998 111.552 176.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.38 -34.42 68.85 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.561 1.545 . . . . 72.140000000000001 112.649 -175.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.458 ' HB1' ' HA3' ' A' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.31 -1.121 0 C-N-CA 124.145 0.978 . . . . 72.430000000000007 111.548 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.406 -2.639 0 N-CA-C 106.044 -1.836 . . . . 75.409999999999997 106.044 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 38.3 t-20 -126.38 140.35 52.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.911 -0.716 . . . . 73.409999999999997 109.151 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.9 m -133.76 123.1 24.31 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 120.809 -0.356 . . . . 63.039999999999999 110.392 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 8.7 p -128.92 145.1 36.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 110.128 -0.323 . . . . 75.329999999999998 110.128 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 76.9 mm-40 -85.38 -79.09 0.24 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 121.0 -0.28 . . . . 74.420000000000002 110.747 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 25.9 m -116.29 127.65 54.89 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.182 0.438 . . . . 74.140000000000001 112.182 -172.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.421 HG21 HD12 ' A' ' 277' ' ' ILE . 17.4 m -120.69 132.78 69.34 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.276 0.56 . . . . 64.230000000000004 109.583 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.98 131.81 69.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 116.358 -0.383 . . . . 73.409999999999997 111.637 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.86 131.06 7.65 Favored Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 109.3 -1.52 . . . . 34.140000000000001 109.3 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -134.17 140.55 46.6 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.6 -0.518 . . . . 75.129999999999995 109.6 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 81.56 -136.71 16.41 Favored Glycine 0 CA--C 1.487 -1.672 0 N-CA-C 107.78 -2.128 . . . . 73.230000000000004 107.78 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -101.36 85.41 2.79 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 118.443 1.122 . . . . 73.519999999999996 109.356 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' SER . . . . . 0.581 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 21.6 m -104.39 144.98 30.92 Favored 'General case' 0 N--CA 1.408 -2.562 0 CA-C-N 114.923 -1.035 . . . . 71.439999999999998 108.934 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . 0.517 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 98.8 mtt180 -122.73 125.93 46.51 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 106.138 -1.801 . . . . 72.129999999999995 106.138 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 26.9 t -131.62 131.63 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 N-CA-C 108.973 -0.751 . . . . 71.129999999999995 108.973 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 5.4 tt -125.88 114.77 18.97 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 118.429 -1.308 . . . . 75.420000000000002 108.444 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.421 HD12 HG21 ' A' ' 267' ' ' VAL . 68.5 mt -111.02 104.33 16.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.098 -0.704 . . . . 72.239999999999995 109.098 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.512 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 144.27 -143.93 12.76 Favored Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 110.969 -0.852 . . . . 73.420000000000002 110.969 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -124.29 143.53 50.5 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.213 -1.032 . . . . 73.140000000000001 108.213 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.96 130.01 46.17 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.502 0.668 . . . . 72.239999999999995 109.314 174.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -113.55 121.56 44.58 Favored 'General case' 0 N--CA 1.409 -2.493 0 N-CA-C 107.383 -1.34 . . . . 72.019999999999996 107.383 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.458 ' HA3' ' HB1' ' A' ' 249' ' ' ALA . . . 62.81 24.82 66.95 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.407 -1.269 . . . . 75.450000000000003 113.903 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -86.69 -47.63 4.76 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.037 -1.225 . . . . 71.219999999999999 110.037 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.432 ' HB2' ' NZ ' ' A' ' 284' ' ' LYS . 0.1 OUTLIER 68.28 23.51 7.72 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.043 1.337 . . . . 74.299999999999997 110.03 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 287' ' ' TRP . . . 115.02 92.91 1.88 Allowed Glycine 0 N--CA 1.407 -3.249 0 C-N-CA 120.129 -1.034 . . . . 55.439999999999998 110.768 -176.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -73.1 33.78 0.07 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-O 122.54 1.162 . . . . 75.239999999999995 109.398 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . 0.517 ' CE3' ' HB3' ' A' ' 274' ' ' ARG . 2.5 m95 . . . . . 0 N--CA 1.432 -1.337 0 CA-C-N 115.407 -0.815 . . . . 73.400000000000006 111.979 -174.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 . . . . . 0 N--CA 1.424 -1.73 0 N-CA-C 109.637 -0.505 . . . . 73.430000000000007 109.637 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 39.1 t-20 -118.06 141.7 48.19 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.545 -1.28 . . . . 74.299999999999997 107.545 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 52.5 m -133.81 137.38 45.05 Favored 'General case' 0 C--N 1.275 -2.663 0 O-C-N 122.075 -0.39 . . . . 72.400000000000006 110.172 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -127.72 160.77 30.67 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.21 -1.404 . . . . 73.099999999999994 107.21 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.578 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 4.6 tmmm? -121.67 -54.63 1.95 Allowed 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 119.599 -0.841 . . . . 74.340000000000003 109.045 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -131.76 138.03 48.43 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.81 -1.552 . . . . 74.150000000000006 106.81 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' B' ' 267' ' ' VAL . 12.5 mt -133.85 120.04 34.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 106.795 -1.557 . . . . 70.109999999999999 106.795 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . 0.604 ' NH1' ' HB2' ' B' ' 232' ' ' ARG . 0.0 OUTLIER -115.39 119.9 37.8 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 109.191 -0.67 . . . . 75.310000000000002 109.191 -176.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 38.4 p -121.88 129.16 52.36 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.613 -1.254 . . . . 74.5 107.613 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -144.69 150.51 37.45 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 120.12 -0.632 . . . . 71.129999999999995 110.398 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 77.82 -79.19 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 125.798 1.639 . . . . 75.099999999999994 113.021 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -140.57 27.1 2.08 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.569 -0.9 . . . . 65.219999999999999 108.569 -172.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -86.71 143.65 27.47 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 112.9 0.704 . . . . 64.010000000000005 112.9 -173.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -124.4 136.46 54.08 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.311 -1.366 . . . . 73.200000000000003 107.311 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.5 p -134.14 136.14 53.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.996 0.903 . . . . 74.019999999999996 111.396 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.427 ' HB2' ' CE2' ' B' ' 286' ' ' PHE . 44.1 tp60 -104.57 130.99 52.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 106.884 -1.524 . . . . 64.409999999999997 106.884 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -130.27 116.28 18.14 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 106.561 -1.644 . . . . 74.109999999999999 106.561 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 123.05 -129.39 7.41 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.634 -0.793 . . . . 53.049999999999997 112.05 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -132.53 137.38 47.13 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.17 0.485 . . . . 75.349999999999994 109.862 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 54.4 t -114.63 114.87 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.595 -1.261 . . . . 73.150000000000006 107.595 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 3.6 p -122.42 114.3 41.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 C-N-CA 119.492 -0.883 . . . . 63.130000000000003 110.165 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 42.3 m -80.34 155.0 27.42 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 117.419 -1.713 . . . . 74.200000000000003 109.92 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.56 66.03 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.254 1.026 . . . . 74.409999999999997 111.249 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.31 -35.13 67.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.195 -1.82 . . . . 64.120000000000005 112.246 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' B' ' 250' ' ' LEU . . . -60.56 -47.03 88.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.989 -0.55 . . . . 54.340000000000003 110.381 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 18.1 tp . . . . . 0 CA--C 1.517 -0.309 0 N-CA-C 105.316 -2.105 . . . . 73.230000000000004 105.316 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.428 -1.556 0 CA-C-O 121.915 0.864 . . . . 74.299999999999997 110.171 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 261' ' ' THR . . . . . 0.405 HG21 ' CB ' ' C' ' 225' ' ' ARG . 5.1 t -115.82 120.51 39.49 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 105.687 -1.968 . . . . 72.510000000000005 105.687 171.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' B' ' 226' ' ' ASN . 37.0 t-20 -126.39 138.35 53.54 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.072 -0.651 . . . . 65.420000000000002 109.268 -172.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 263' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' C' ' 227' ' ' SER . 51.9 m -142.08 129.54 21.29 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.152 0.501 . . . . 71.439999999999998 111.336 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 14.1 p -121.11 153.16 24.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.831 -0.803 . . . . 75.129999999999995 108.831 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 75.8 mm-40 -91.94 -78.34 0.41 Allowed 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 109.583 -0.525 . . . . 63.210000000000001 109.583 171.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.6 m -114.35 127.97 56.12 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.944 -0.473 . . . . 74.430000000000007 111.192 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' B' ' 231' ' ' ILE . 1.4 p -131.27 120.74 47.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 109.162 -0.681 . . . . 75.400000000000006 109.162 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 5.4 m -124.76 148.33 29.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 121.246 0.546 . . . . 74.340000000000003 111.301 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -137.34 132.43 5.95 Favored Glycine 0 N--CA 1.415 -2.755 0 N-CA-C 109.489 -1.444 . . . . 75.439999999999998 109.489 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -132.51 116.19 16.44 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.524 0.678 . . . . 73.010000000000005 110.057 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 104.08 -139.19 14.45 Favored Glycine 0 CA--C 1.471 -2.715 0 N-CA-C 109.213 -1.555 . . . . 73.25 109.213 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' C' ' 235' ' ' GLU . 11.1 tp10 -86.42 80.65 8.6 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.133 -1.432 . . . . 74.430000000000007 107.133 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 273' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 20.6 m -113.96 144.29 43.32 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.429 -1.26 . . . . 63.219999999999999 109.061 -177.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . 0.507 ' HB3' ' CE3' ' B' ' 287' ' ' TRP . 76.3 mtt180 -134.4 127.35 31.41 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.013 -1.106 . . . . 73.420000000000002 108.013 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 10.9 t -131.2 137.77 54.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 116.101 -0.5 . . . . 73.010000000000005 109.714 -173.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 4.5 tt -126.56 113.87 17.35 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 106.872 -1.529 . . . . 74.230000000000004 106.872 173.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . 0.411 HG22 HD12 ' C' ' 241' ' ' LEU . 58.2 mt -112.72 103.19 15.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.509 -0.923 . . . . 74.0 108.509 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 140.98 -146.11 17.18 Favored Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 111.141 -0.784 . . . . 70.409999999999997 111.141 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 5.5 m-20 -123.58 138.24 54.59 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.316 -0.624 . . . . 73.530000000000001 109.316 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.81 137.85 54.29 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.075 -0.713 . . . . 72.420000000000002 109.075 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 87.4 t80 -124.03 121.92 36.52 Favored 'General case' 0 C--O 1.271 2.226 0 N-CA-C 108.493 -0.929 . . . . 74.120000000000005 108.493 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' B' ' 249' ' ' ALA . . . 81.65 -1.17 86.82 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 114.311 -1.313 . . . . 74.019999999999996 113.979 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -71.33 -60.11 4.58 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.922 -0.871 . . . . 75.519999999999996 110.922 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm 74.24 21.64 2.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.283 1.433 . . . . 74.340000000000003 109.1 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.9 90.07 0.83 Allowed Glycine 0 N--CA 1.409 -3.109 0 N-CA-C 109.48 -1.448 . . . . 75.439999999999998 109.48 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' B' ' 240' ' ' GLN . 44.5 t80 -72.73 40.54 0.09 Allowed 'General case' 0 CA--C 1.573 1.857 0 C-N-CA 124.689 1.195 . . . . 73.219999999999999 110.118 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.507 ' CE3' ' HB3' ' B' ' 274' ' ' ARG . 8.0 m95 . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 108.347 -0.982 . . . . 73.400000000000006 108.347 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' C' ' 261' ' ' THR . 26.8 ptt180 . . . . . 0 N--CA 1.42 -1.964 0 CA-C-O 120.702 0.287 . . . . 75.200000000000003 110.553 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 37.9 t-20 -117.81 136.96 53.07 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.877 -1.527 . . . . 71.319999999999993 106.877 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 227' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' B' ' 263' ' ' SER . 32.8 m -134.34 137.28 44.04 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-O 121.041 0.448 . . . . 73.299999999999997 110.622 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -125.18 150.75 46.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.52 -0.919 . . . . 72.120000000000005 108.52 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 1.0 OUTLIER -108.26 -54.21 2.53 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 109.131 -0.692 . . . . 73.030000000000001 109.131 -177.05 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . 0.407 ' CG ' HH21 ' C' ' 232' ' ' ARG . 11.8 t70 -132.8 137.62 46.85 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.495 -1.298 . . . . 63.219999999999999 107.495 176.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 19.1 mt -137.25 120.48 21.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.454 -2.054 . . . . 74.030000000000001 105.454 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.407 HH21 ' CG ' ' C' ' 230' ' ' ASP . 19.0 ptp180 -126.11 120.4 30.06 Favored 'General case' 0 C--N 1.274 -2.678 0 C-N-CA 119.815 -0.754 . . . . 71.420000000000002 111.42 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 233' ' ' THR . . . . . 0.426 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 33.0 p -111.0 134.76 52.35 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.892 -1.049 . . . . 55.350000000000001 108.854 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -144.93 148.03 33.39 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.561 -0.456 . . . . 65.439999999999998 110.062 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' B' ' 272' ' ' GLU . 64.7 mt-10 73.93 -74.02 0.09 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.231 1.567 . . . . 72.239999999999995 115.231 176.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -136.48 17.0 3.14 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.206 -0.665 . . . . 74.200000000000003 109.206 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -78.71 131.11 36.48 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.998 0.904 . . . . 72.439999999999998 113.293 -173.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.504 ' HB3' ' HB2' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -128.5 135.74 49.84 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 114.887 -1.051 . . . . 74.209999999999994 111.157 174.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.407 HG22 ' HB ' ' C' ' 275' ' ' VAL . 7.2 p -130.99 142.59 43.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.375 -0.829 . . . . 74.140000000000001 111.529 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -104.7 132.25 51.17 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 114.363 -1.29 . . . . 75.430000000000007 107.698 171.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' C' ' 277' ' ' ILE . 2.7 tm? -130.13 116.03 17.89 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 105.303 -2.11 . . . . 72.409999999999997 105.303 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 129.63 -132.4 7.06 Favored Glycine 0 C--N 1.3 -1.462 0 C-N-CA 120.147 -1.025 . . . . 63.229999999999997 111.416 -178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 44.2 t30 -137.2 135.56 37.39 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.047 0.451 . . . . 73.439999999999998 110.492 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.07 117.46 51.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.283 0 N-CA-C 107.863 -1.162 . . . . 71.099999999999994 107.863 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 2.8 p -123.56 112.83 34.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 118.691 0.678 . . . . 72.099999999999994 110.455 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.4 m -81.98 156.05 24.89 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 117.444 -1.702 . . . . 73.209999999999994 110.298 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.64 -48.79 65.71 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.744 0.783 . . . . 73.040000000000006 112.042 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.17 75.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.116 -1.402 . . . . 71.430000000000007 112.253 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.157 0 CA-C-N 115.929 -0.578 . . . . 71.010000000000005 111.561 -179.293 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 261' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 10.5 t . . . . . 0 N--CA 1.422 -1.826 0 N-CA-C 108.334 -0.987 . . . . 62.229999999999997 108.334 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -123.7 137.1 54.77 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.876 -1.157 . . . . 72.409999999999997 107.876 -176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 32.2 t -142.2 125.72 16.75 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.272 -0.64 . . . . 75.129999999999995 109.272 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.15 147.0 32.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.161 -0.681 . . . . 71.549999999999997 109.161 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 27.0 mm-40 -90.03 -76.04 0.44 Allowed 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 110.18 -0.304 . . . . 72.299999999999997 110.18 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 11.2 m -114.31 127.85 56.07 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.211 -0.996 . . . . 74.530000000000001 111.707 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 1.3 p -128.52 122.46 57.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.511 0.672 . . . . 74.319999999999993 110.028 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.7 133.73 68.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.547 -0.751 . . . . 75.109999999999999 112.13 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.34 130.57 6.64 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 108.404 -1.878 . . . . 64.409999999999997 108.404 170.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -134.41 116.51 15.26 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.667 -1.234 . . . . 74.430000000000007 107.667 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.9 -139.81 14.7 Favored Glycine 0 C--N 1.291 -1.939 0 N-CA-C 109.685 -1.366 . . . . 75.140000000000001 109.685 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.52 91.85 2.32 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.18 -1.045 . . . . 72.239999999999995 108.18 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 273' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 23.2 m -131.37 144.67 51.4 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 121.66 0.743 . . . . 75.340000000000003 110.893 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . 0.412 ' HD3' ' HB2' ' C' ' 287' ' ' TRP . 55.2 mtt85 -136.26 127.6 28.35 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 105.723 -1.954 . . . . 74.439999999999998 105.723 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . 0.407 ' HB ' HG22 ' C' ' 239' ' ' VAL . 6.9 t -138.19 140.1 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 109.486 -0.561 . . . . 71.329999999999998 109.486 -175.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.3 tt -128.71 111.93 13.68 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.074 -1.084 . . . . 74.239999999999995 108.074 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 58.1 mt -111.82 103.96 16.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.575 -0.898 . . . . 74.120000000000005 108.575 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.67 -136.02 7.57 Favored Glycine 0 N--CA 1.424 -2.131 0 N-CA-C 110.992 -0.843 . . . . 54.329999999999998 110.992 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 94.3 m-20 -127.88 156.34 42.74 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 110.111 -0.329 . . . . 75.040000000000006 110.111 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.88 138.25 24.18 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.013 -0.539 . . . . 72.0 110.049 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -130.12 122.33 28.05 Favored 'General case' 0 N--CA 1.415 -2.204 0 N-CA-C 107.37 -1.344 . . . . 73.299999999999997 107.37 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.57 -14.14 58.84 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.309 -0.859 . . . . 71.349999999999994 112.447 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -64.78 -58.18 10.6 Favored Glycine 0 CA--C 1.497 -1.038 0 N-CA-C 111.613 -0.595 . . . . 74.439999999999998 111.613 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . 0.53 ' NZ ' ' HB2' ' C' ' 284' ' ' LYS . 6.7 mtmp? 65.84 31.37 9.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.561 1.144 . . . . 71.319999999999993 108.344 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.19 97.15 2.38 Favored Glycine 0 N--CA 1.417 -2.567 0 N-CA-C 108.493 -1.843 . . . . 52.130000000000003 108.493 -172.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -76.22 41.64 0.24 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.262 1.03 . . . . 74.239999999999995 110.844 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . 0.412 ' HB2' ' HD3' ' C' ' 274' ' ' ARG . 1.3 p90 . . . . . 0 N--CA 1.414 -2.272 0 CA-C-O 122.318 1.056 . . . . 72.510000000000005 113.254 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.516 ' HG2' HH11 ' A' ' 225' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 109.839 -0.43 . . . . 74.310000000000002 109.839 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -106.62 123.89 48.8 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.945 -1.131 . . . . 72.25 107.945 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 12.2 m -123.91 136.83 54.59 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 116.109 -0.496 . . . . 62.140000000000001 110.393 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.31 138.16 44.76 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.68 -1.23 . . . . 75.25 107.68 175.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -93.43 -53.86 3.9 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.676 -0.49 . . . . 73.230000000000004 109.676 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.83 139.23 52.77 Favored 'General case' 0 C--O 1.252 1.191 0 N-CA-C 109.835 -0.432 . . . . 74.400000000000006 109.835 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 28.4 mm -128.08 116.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 106.279 -1.749 . . . . 75.340000000000003 106.279 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 31.5 ttp-105 -134.43 115.87 14.49 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.606 0.717 . . . . 73.140000000000001 111.489 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.62 ' HB ' ' CB ' ' A' ' 237' ' ' ALA . 4.8 p -129.1 140.47 51.55 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.493 -0.776 . . . . 74.120000000000005 111.227 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -121.04 143.16 49.2 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.542 0.687 . . . . 70.230000000000004 112.573 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 68.79 -100.66 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.394 1.627 . . . . 73.409999999999997 115.394 171.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.615 ' HD2' ' OE2' ' A' ' 272' ' ' GLU . 16.8 mtm180 -99.08 23.39 9.1 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.476 1.131 . . . . 75.409999999999997 110.128 -171.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.62 ' CB ' ' HB ' ' A' ' 233' ' ' THR . . . -84.13 156.17 22.25 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.591 -1.64 . . . . 73.040000000000006 111.835 -176.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . 0.434 ' HD3' ' HG2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -146.18 137.85 24.86 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.502 -0.772 . . . . 64.120000000000005 110.202 174.201 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.487 HG11 ' HB ' ' A' ' 275' ' ' VAL . 29.7 m -132.21 142.49 42.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.394 0.616 . . . . 74.319999999999993 111.892 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.455 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 56.5 tp60 -123.48 135.38 54.03 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.535 -0.757 . . . . 64.340000000000003 109.003 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -123.19 118.17 27.01 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.735 -1.58 . . . . 75.439999999999998 106.735 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.412 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 126.8 -113.0 1.67 Allowed Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 119.756 -1.211 . . . . 74.530000000000001 114.572 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -143.98 131.92 21.57 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 110.114 -0.328 . . . . 73.420000000000002 110.114 -172.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.429 ' CG2' ' HG2' ' A' ' 240' ' ' GLN . 48.9 t -122.14 123.63 69.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.324 -0.621 . . . . 70.239999999999995 109.324 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 12.3 m -113.59 114.62 47.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.176 0.513 . . . . 75.230000000000004 110.364 174.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 24.4 m -96.97 159.76 14.73 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.842 -0.799 . . . . 52.130000000000003 108.842 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.47 75.73 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 123.249 0.62 . . . . 70.129999999999995 111.567 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.25 -42.84 78.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.06 -0.973 . . . . 64.420000000000002 111.985 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.431 0 CA-C-N 116.368 -0.378 . . . . 71.329999999999998 110.545 -178.282 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 52.9 m . . . . . 0 N--CA 1.433 -1.323 0 N-CA-C 107.529 -1.285 . . . . 74.319999999999993 107.529 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 37.2 t-20 -127.11 138.32 53.16 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.197 -0.668 . . . . 65.400000000000006 109.197 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.5 m -128.62 123.14 32.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.737 -0.468 . . . . 75.25 109.737 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.92 150.12 34.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 N-CA-C 110.455 -0.202 . . . . 73.129999999999995 110.455 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.687 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 3.7 tp10 -85.46 -74.91 0.39 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.096 0.559 . . . . 74.319999999999993 110.097 178.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 32.2 m -128.59 134.71 48.68 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 122.146 -0.346 . . . . 72.430000000000007 111.234 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.59 127.07 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.659 -1.237 . . . . 74.239999999999995 107.659 172.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 10.1 p -127.23 134.84 65.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 116.439 -0.346 . . . . 73.349999999999994 110.897 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.424 ' HA2' ' HG1' ' B' ' 233' ' ' THR . . . -128.92 132.75 7.32 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.669 -0.776 . . . . 70.140000000000001 111.999 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -132.09 116.64 17.3 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.748 -0.464 . . . . 74.230000000000004 109.748 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 109.93 -131.56 10.53 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.882 -0.887 . . . . 62.119999999999997 110.882 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.615 ' OE2' ' HD2' ' A' ' 236' ' ' ARG . 10.0 mp0 -92.5 32.3 1.23 Allowed 'General case' 0 C--O 1.252 1.22 0 C-N-CA 125.133 1.373 . . . . 73.420000000000002 110.087 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 16.7 m -81.77 145.22 30.57 Favored 'General case' 0 C--O 1.287 3.077 0 CA-C-O 122.927 1.346 . . . . 54.200000000000003 112.708 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . 0.434 ' HG2' ' HD3' ' A' ' 238' ' ' ARG . 72.1 mtm-85 -127.08 127.79 45.23 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.697 -1.592 . . . . 74.219999999999999 109.27 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.487 ' HB ' HG11 ' A' ' 239' ' ' VAL . 48.9 t -127.81 132.29 69.01 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 CA-C-N 115.957 -0.565 . . . . 73.319999999999993 109.947 -175.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.455 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.8 tt -125.01 128.41 48.52 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 118.151 -1.42 . . . . 74.219999999999999 109.677 173.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 35.0 mm -112.56 105.62 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.657 -0.868 . . . . 74.439999999999998 108.657 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 138.78 -134.02 6.56 Favored Glycine 0 C--N 1.31 -0.883 0 C-N-CA 120.648 -0.787 . . . . 61.43 113.297 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' B' ' 243' ' ' ASN . 15.1 m120 -115.87 128.27 55.67 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 122.574 0.35 . . . . 71.340000000000003 110.816 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.06 118.67 34.05 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.657 -1.609 . . . . 73.010000000000005 106.657 176.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -106.38 123.33 47.89 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.369 -1.345 . . . . 74.329999999999998 107.369 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.56 -50.66 0.79 Allowed Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.391 -1.083 . . . . 70.299999999999997 110.391 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.64 53.3 Favored Glycine 0 C--N 1.308 -1.02 0 N-CA-C 110.747 -0.941 . . . . 34.420000000000002 110.747 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -179.85 27.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.286 1.034 . . . . 74.209999999999994 110.562 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -85.61 -120.72 1.08 Allowed Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 119.944 -1.122 . . . . 54.109999999999999 111.642 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.445 ' HB3' ' HE1' ' B' ' 287' ' ' TRP . 86.8 t80 62.53 -89.07 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.106 0.562 . . . . 73.0 111.362 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 . . . . . 0 CA--C 1.508 -0.672 0 C-N-CA 127.35 2.26 . . . . 71.0 107.206 178.715 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.493 -1.218 0 N-CA-C 107.132 -1.433 . . . . 75.109999999999999 107.132 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 29.6 m-80 -103.87 130.18 51.44 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 107.991 -1.115 . . . . 71.200000000000003 107.991 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 28.6 m -128.61 137.04 51.48 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-O 121.197 0.523 . . . . 71.140000000000001 110.615 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.59 155.55 47.33 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.791 -1.188 . . . . 75.530000000000001 107.791 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.687 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 0.1 OUTLIER -109.0 -61.72 1.58 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 119.51 -0.876 . . . . 73.010000000000005 108.854 -178.435 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -126.63 137.8 53.35 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.84 -0.8 . . . . 75.420000000000002 108.84 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 18.5 mm -131.66 117.55 35.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 106.874 -1.528 . . . . 73.140000000000001 106.874 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -130.38 118.81 21.78 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.345 0.593 . . . . 73.519999999999996 111.492 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' THR . . . . . 0.424 ' HG1' ' HA2' ' A' ' 269' ' ' GLY . 34.5 p -110.72 128.14 55.61 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.352 -0.84 . . . . 71.319999999999993 109.31 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -125.01 142.38 51.52 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.035 0.445 . . . . 73.319999999999993 111.04 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 74.76 -102.37 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.388 0 C-N-CA 125.011 1.324 . . . . 72.030000000000001 113.084 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.659 ' HD3' ' N ' ' B' ' 236' ' ' ARG . 0.7 OUTLIER -110.37 25.49 11.73 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.723 0.773 . . . . 73.019999999999996 109.448 -175.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -82.99 142.45 31.36 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 122.568 1.175 . . . . 75.420000000000002 112.759 -175.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -131.65 135.86 47.25 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.542 -1.208 . . . . 73.200000000000003 109.506 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.512 HG12 ' HB ' ' B' ' 275' ' ' VAL . 2.6 m -125.31 141.27 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 CA-C-O 121.869 0.843 . . . . 71.530000000000001 111.538 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.443 ' HB3' ' HG ' ' B' ' 276' ' ' LEU . 5.9 tp-100 -116.41 128.38 55.45 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 114.074 -1.421 . . . . 72.230000000000004 107.643 174.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -120.38 117.31 27.41 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.927 -1.509 . . . . 72.439999999999998 106.927 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.405 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 125.92 -112.23 1.61 Allowed Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.554 -1.308 . . . . 74.310000000000002 113.143 176.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . 0.46 ' HB3' ' ND2' ' A' ' 279' ' ' ASN . 25.7 t-20 -144.97 138.36 26.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 111.556 0.206 . . . . 72.349999999999994 111.556 -174.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.436 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 45.2 t -119.9 133.7 65.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.605 -0.887 . . . . 73.450000000000003 108.605 175.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 19.3 t -122.28 112.11 33.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 108.943 -0.762 . . . . 72.040000000000006 108.943 177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 23.5 m -95.49 158.95 15.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.97 -1.122 . . . . 62.329999999999998 107.97 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.39 -39.7 94.37 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.792 0.806 . . . . 74.400000000000006 110.553 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.89 -34.47 65.57 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.425 -1.716 . . . . 64.120000000000005 114.157 -175.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.03 -33.27 74.27 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.313 0.486 . . . . 74.310000000000002 112.313 -176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 N--CA 1.488 1.45 0 C-N-CA 124.182 0.993 . . . . 75.510000000000005 111.135 -175.626 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 260' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' C' ' 243' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.396 -3.142 0 N-CA-C 113.665 0.987 . . . . 64.200000000000003 113.665 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 63.9 m -100.74 105.95 17.33 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 104.139 -2.541 . . . . 73.230000000000004 104.139 167.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . 0.416 HD22 HD21 ' C' ' 241' ' ' LEU . 54.7 t30 -128.44 142.02 51.22 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.097 -0.956 . . . . 73.319999999999993 109.886 -171.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 39.6 m -137.2 128.07 27.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.807 0.337 . . . . 63.409999999999997 110.948 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.2 p -128.39 153.72 38.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.795 -0.817 . . . . 74.409999999999997 108.795 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -96.2 -76.35 0.51 Allowed 'General case' 0 N--CA 1.418 -2.029 0 C-N-CA 120.156 -0.617 . . . . 64.310000000000002 111.452 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -116.37 128.43 55.52 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.765 -0.774 . . . . 72.019999999999996 112.635 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 11.8 m -118.45 129.08 75.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.197 0 N-CA-C 107.793 -1.188 . . . . 74.129999999999995 107.793 171.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.83 128.25 70.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.978 -0.555 . . . . 74.519999999999996 111.126 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . 0.449 ' HA2' ' HG1' ' C' ' 233' ' ' THR . . . -116.06 132.01 9.95 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.361 -1.096 . . . . 63.039999999999999 110.361 175.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -131.99 116.4 17.06 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.491 -0.559 . . . . 75.200000000000003 109.491 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 100.56 -137.66 13.39 Favored Glycine 0 C--N 1.309 -0.92 0 N-CA-C 111.139 -0.784 . . . . 73.349999999999994 111.139 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 2.4 mp0 -77.22 40.43 0.27 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.993 1.317 . . . . 75.530000000000001 110.177 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 273' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 39.0 m -82.92 144.66 29.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.979 0.895 . . . . 73.310000000000002 112.503 -169.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 32.5 mtt180 -130.75 127.21 38.3 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.58 -1.637 . . . . 73.530000000000001 106.58 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.512 ' HB ' HG12 ' B' ' 239' ' ' VAL . 89.4 t -135.06 130.34 51.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.377 -0.601 . . . . 72.310000000000002 109.377 -176.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 7.0 tt -122.09 125.41 46.14 Favored 'General case' 0 C--N 1.277 -2.553 0 C-N-CA 117.7 -1.6 . . . . 73.319999999999993 110.144 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 29.1 mm -110.51 103.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.043 -1.465 . . . . 75.530000000000001 107.043 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 139.76 -147.65 19.35 Favored Glycine 0 C--N 1.308 -0.976 0 C-N-CA 120.197 -1.002 . . . . 62.43 113.694 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 0.9 OUTLIER -106.64 129.8 54.49 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.957 -0.386 . . . . 71.439999999999998 109.957 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.94 118.69 36.17 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.511 -1.663 . . . . 71.109999999999999 106.511 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -107.62 123.15 48.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.694 -0.854 . . . . 75.349999999999994 108.694 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 139.46 -50.17 0.79 Allowed Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 109.79 -1.324 . . . . 72.049999999999997 109.79 -176.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 94.53 17.05 40.48 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.738 -0.945 . . . . 72.109999999999999 110.738 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt 174.05 27.77 0.0 OUTLIER 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.784 1.234 . . . . 73.519999999999996 109.726 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.22 -113.36 0.23 Allowed Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.011 -0.836 . . . . 75.420000000000002 111.011 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.428 ' H ' HG12 ' B' ' 244' ' ' VAL . 92.7 t80 60.61 -83.53 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.39 0.676 . . . . 73.329999999999998 111.646 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.445 ' HE1' ' HB3' ' A' ' 286' ' ' PHE . 3.5 m-90 . . . . . 0 C--O 1.241 0.613 0 C-N-CA 126.477 1.911 . . . . 74.230000000000004 108.672 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.287 0 N-CA-C 108.756 -0.831 . . . . 75.129999999999995 108.756 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 40.8 m-80 -110.25 132.63 54.0 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 108.028 -1.101 . . . . 64.400000000000006 108.028 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 17.2 m -129.38 136.72 50.33 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 116.318 -0.401 . . . . 74.140000000000001 110.019 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -137.4 147.08 45.18 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.565 -0.902 . . . . 73.109999999999999 108.565 178.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.86 -64.65 1.03 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.936 -0.394 . . . . 75.120000000000005 109.936 -177.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.59 138.03 52.75 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 108.928 -0.767 . . . . 70.129999999999995 108.928 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 10.9 mm -132.0 117.46 33.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 106.552 -1.648 . . . . 75.540000000000006 106.552 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -126.03 122.12 34.96 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.585 -0.846 . . . . 74.409999999999997 112.413 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 233' ' ' THR . . . . . 0.531 ' CG2' HG11 ' C' ' 239' ' ' VAL . 17.3 p -110.47 126.99 54.92 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.051 -0.977 . . . . 73.329999999999998 109.19 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -128.93 142.77 50.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.036 0.446 . . . . 65.140000000000001 111.087 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 51.9 mt-10 78.75 -90.01 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 125.571 1.548 . . . . 72.400000000000006 113.971 173.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.46 ' HD3' ' OE2' ' C' ' 272' ' ' GLU . 0.0 OUTLIER -126.25 28.67 5.98 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.043 -1.095 . . . . 74.329999999999998 108.043 -177.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -82.58 146.42 29.17 Favored 'General case' 0 C--O 1.265 1.882 0 CA-C-O 122.794 1.283 . . . . 71.450000000000003 113.844 -174.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.1 OUTLIER -131.84 135.53 46.78 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.23 -1.35 . . . . 72.049999999999997 109.541 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.531 HG11 ' CG2' ' C' ' 233' ' ' THR . 25.8 m -134.91 141.74 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 CA-C-O 121.936 0.874 . . . . 73.510000000000005 111.94 176.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . 0.429 HE22 HD22 ' B' ' 276' ' ' LEU . 48.7 tp60 -110.83 133.19 53.57 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 113.985 -1.461 . . . . 74.310000000000002 108.304 176.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.416 HD21 HD22 ' B' ' 262' ' ' ASN . 3.1 tm? -125.26 117.01 22.87 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 106.249 -1.76 . . . . 75.239999999999995 106.249 177.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 125.88 -115.14 2.26 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 119.407 -1.378 . . . . 64.409999999999997 113.624 176.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 12.9 t-20 -144.34 137.54 27.22 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 110.008 -0.367 . . . . 73.030000000000001 110.008 -173.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . 0.46 HG13 ' H ' ' C' ' 286' ' ' PHE . 60.1 t -124.26 124.84 69.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.377 -0.601 . . . . 74.140000000000001 109.377 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 32.4 t -116.21 111.85 37.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.853 -0.795 . . . . 75.120000000000005 108.853 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.8 m -94.93 159.68 14.92 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.226 -1.028 . . . . 63.340000000000003 108.226 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.45 -39.96 94.82 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.685 0.755 . . . . 74.319999999999993 110.418 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -33.23 61.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.608 -1.633 . . . . 75.340000000000003 112.155 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 116.15 -0.477 . . . . 50.130000000000003 112.132 -177.856 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.412 -2.371 0 N-CA-C 104.771 -2.307 . . . . 72.319999999999993 104.771 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 49.6 t30 -125.82 139.24 53.66 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.086 -0.506 . . . . 64.310000000000002 111.095 -168.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 13.1 t -129.38 123.5 31.87 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.438 -0.949 . . . . 61.140000000000001 108.438 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.01 153.92 34.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.165 -1.05 . . . . 73.120000000000005 108.165 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -97.56 -79.87 0.46 Allowed 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 120.028 -0.669 . . . . 72.409999999999997 111.403 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 29.2 m -120.07 127.73 52.82 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.145 -0.622 . . . . 72.140000000000001 111.812 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.9 m -118.7 127.3 75.66 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-O 121.621 0.724 . . . . 73.319999999999993 109.292 174.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.05 120.22 63.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.406 -0.815 . . . . 74.329999999999998 109.23 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.83 131.67 9.93 Favored Glycine 0 N--CA 1.416 -2.682 0 C-N-CA 119.635 -1.269 . . . . 71.150000000000006 111.114 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -133.33 133.84 43.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.491 -0.929 . . . . 63.530000000000001 108.491 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.77 -132.84 11.43 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.264 -0.969 . . . . 63.100000000000001 111.469 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . 0.46 ' OE2' ' HD3' ' C' ' 236' ' ' ARG . 4.5 mp0 -91.37 52.83 2.16 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.945 -1.131 . . . . 74.129999999999995 107.945 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 273' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 21.7 t -83.71 145.63 28.64 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 115.141 -0.936 . . . . 64.109999999999999 110.974 -174.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 17.2 mtm180 -141.12 127.5 19.87 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.785 -1.191 . . . . 73.439999999999998 107.785 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' C' ' 239' ' ' VAL . 13.6 t -137.2 138.95 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.14 -1.059 . . . . 63.32 108.14 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 8.8 tt -123.99 114.75 20.19 Favored 'General case' 0 N--CA 1.404 -2.768 0 C-N-CA 118.875 -1.13 . . . . 73.019999999999996 109.916 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 47.5 mm -102.51 103.04 14.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 106.674 -1.602 . . . . 74.040000000000006 106.674 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.54 -145.67 15.09 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.014 -1.089 . . . . 73.140000000000001 113.232 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.46 131.83 55.89 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 122.868 0.467 . . . . 64.030000000000001 109.764 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.64 118.54 32.39 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.702 -1.592 . . . . 64.239999999999995 106.702 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.29 123.34 49.92 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.63 -0.878 . . . . 72.120000000000005 108.63 176.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.98 -45.06 0.96 Allowed Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 110.632 -0.987 . . . . 74.530000000000001 110.632 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 94.28 4.36 62.75 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.61 -0.996 . . . . 55.119999999999997 110.61 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -170.71 28.75 0.02 OUTLIER 'General case' 0 C--O 1.247 0.948 0 C-N-CA 123.756 0.822 . . . . 75.010000000000005 109.671 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.37 -124.45 0.44 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.766 -0.933 . . . . 63.119999999999997 110.766 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . 0.46 ' H ' HG13 ' C' ' 244' ' ' VAL . 88.1 t80 65.91 -78.67 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.351 0.66 . . . . 65.239999999999995 111.187 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.31 -1.124 0 C-N-CA 124.574 1.15 . . . . 75.310000000000002 109.045 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 . . . . . 0 N--CA 1.442 -0.87 0 CA-C-O 120.904 0.383 . . . . 72.519999999999996 110.041 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -112.53 130.87 55.86 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.295 -1.372 . . . . 75.0 107.295 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.7 m -135.62 136.77 41.28 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.146 0.498 . . . . 63.340000000000003 111.044 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . 0.449 ' HB1' HG21 ' A' ' 277' ' ' ILE . . . -116.2 131.17 57.02 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.334 -0.988 . . . . 64.299999999999997 108.334 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 4.1 tmmm? -81.39 -62.08 1.76 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.701 -0.481 . . . . 75.209999999999994 109.701 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -130.17 140.25 50.77 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.57 0.224 . . . . 75.219999999999999 111.401 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 48.7 mt -131.84 119.47 41.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.857 -0.794 . . . . 72.019999999999996 108.857 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -112.04 126.1 54.8 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.835 -0.431 . . . . 74.25 109.835 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.48 128.2 30.97 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 120.979 0.419 . . . . 74.099999999999994 110.395 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.25 159.73 39.15 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.416 -0.811 . . . . 73.030000000000001 109.956 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 63.3 72.2 0.49 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.551 0.741 . . . . 73.549999999999997 112.634 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.31 22.71 8.04 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.177 0.991 . . . . 74.25 113.031 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.41 145.76 28.82 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.107 0.48 . . . . 65.129999999999995 111.077 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -127.63 134.94 49.64 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.787 -0.642 . . . . 74.319999999999993 110.382 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 77.8 t -123.44 132.32 71.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.566 -0.743 . . . . 74.25 110.493 -174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.478 ' CG ' HD13 ' A' ' 276' ' ' LEU . 55.5 tp60 -118.23 114.81 23.58 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.252 -1.018 . . . . 74.329999999999998 108.252 174.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -115.69 121.97 44.12 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.275 -1.379 . . . . 74.409999999999997 107.275 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.48 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 136.48 -119.74 2.04 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 119.946 -1.121 . . . . 61.240000000000002 112.525 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -144.18 129.04 18.4 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 110.09 -0.337 . . . . 70.519999999999996 110.09 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.0 t -112.57 120.98 64.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.452 -0.573 . . . . 73.329999999999998 109.452 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 25.8 m -117.99 112.17 37.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.594 0.711 . . . . 72.450000000000003 109.665 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 17.1 m -77.8 159.65 28.87 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.755 -0.657 . . . . 73.420000000000002 109.665 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.14 90.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.206 0.527 . . . . 73.510000000000005 110.654 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.64 -33.33 63.95 Favored 'General case' 0 C--O 1.211 -0.973 0 C-N-CA 124.891 1.276 . . . . 73.329999999999998 112.325 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.308 -1.231 0 CA-C-N 115.366 -0.834 . . . . 73.430000000000007 112.865 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.433 -1.292 0 N-CA-C 108.118 -1.067 . . . . 71.409999999999997 108.118 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' B' ' 226' ' ' ASN . 15.4 m120 -120.87 140.4 51.84 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.999 0.428 . . . . 75.219999999999999 110.162 -176.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 42.6 m -142.13 123.8 15.06 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.846 -0.427 . . . . 71.310000000000002 109.846 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.3 p -122.53 138.48 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 109.971 -0.381 . . . . 73.530000000000001 109.971 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 65.1 mm-40 -81.17 -68.67 0.67 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.406 -0.361 . . . . 74.140000000000001 111.387 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 99.1 m -125.56 128.33 47.78 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.432 -0.507 . . . . 75.319999999999993 112.296 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.3 p -125.02 123.77 66.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.685 -0.857 . . . . 73.129999999999995 108.685 173.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.07 139.54 51.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.888 0.375 . . . . 75.200000000000003 111.077 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.76 132.34 8.13 Favored Glycine 0 N--CA 1.423 -2.18 0 C-N-CA 121.019 -0.61 . . . . 71.5 111.756 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -133.23 116.46 16.24 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.431 -0.581 . . . . 73.450000000000003 109.431 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.59 73.78 1.15 Allowed Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.386 -0.911 . . . . 74.200000000000003 113.322 173.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 56.35 53.65 8.53 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 113.788 1.033 . . . . 75.450000000000003 113.788 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 50.3 m -88.09 144.4 26.52 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 107.352 -1.351 . . . . 75.129999999999995 107.352 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 2.3 mpt_? -128.1 125.31 38.97 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 105.479 -2.045 . . . . 73.340000000000003 105.479 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.402 HG11 HG22 ' B' ' 239' ' ' VAL . 4.4 m -130.54 140.19 49.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 C-N-CA 119.936 -0.706 . . . . 72.530000000000001 110.122 -174.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.502 ' HB3' ' CZ2' ' A' ' 287' ' ' TRP . 11.1 tp -125.11 118.64 26.58 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.649 0.738 . . . . 74.420000000000002 109.62 175.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.449 HG21 ' HB1' ' A' ' 228' ' ' ALA . 14.4 mt -113.18 104.43 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.936 0 CA-C-N 113.942 -1.481 . . . . 71.010000000000005 107.229 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.507 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 151.8 -129.08 2.71 Favored Glycine 0 N--CA 1.423 -2.206 0 C-N-CA 120.278 -0.963 . . . . 51.210000000000001 112.658 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -123.92 141.76 51.75 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.181 -0.674 . . . . 74.049999999999997 109.181 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.424 ' HB2' HE22 ' B' ' 240' ' ' GLN . 5.6 tm-20 -130.72 123.05 28.39 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.257 -1.016 . . . . 72.430000000000007 108.257 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . 0.482 ' HD1' ' O ' ' B' ' 245' ' ' VAL . 7.4 t80 -116.01 124.01 49.43 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 107.96 -1.126 . . . . 72.219999999999999 107.96 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 249' ' ' ALA . . . 144.68 -64.34 0.46 Allowed Glycine 0 N--CA 1.424 -2.139 0 CA-C-N 115.323 -0.853 . . . . 74.019999999999996 111.434 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 124.51 25.1 1.65 Allowed Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 120.44 -0.886 . . . . 42.539999999999999 113.018 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.91 -5.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.159 0.8 . . . . 73.120000000000005 113.159 174.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.28 -132.26 38.23 Favored Glycine 0 CA--C 1.505 -0.588 0 N-CA-C 115.157 0.823 . . . . 63.109999999999999 115.157 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -98.77 -3.25 36.06 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.4 -0.593 . . . . 74.310000000000002 109.4 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . 0.502 ' CZ2' ' HB3' ' A' ' 276' ' ' LEU . 10.9 m-90 . . . . . 0 CA--C 1.49 -1.34 0 CA-C-N 115.711 -0.677 . . . . 73.439999999999998 110.506 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . 0.401 ' HB2' ' OG1' ' B' ' 261' ' ' THR . 97.5 mtt180 . . . . . 0 CA--C 1.489 -1.4 0 N-CA-C 108.673 -0.862 . . . . 65.019999999999996 108.673 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.468 ' HB3' ' ND2' ' A' ' 262' ' ' ASN . 25.1 t-20 -116.46 115.95 26.76 Favored 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 108.01 -1.107 . . . . 72.209999999999994 108.01 175.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 16.3 m -121.25 136.8 54.91 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-O 121.377 0.608 . . . . 71.120000000000005 110.799 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -124.66 124.09 41.45 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.649 -1.16 . . . . 74.040000000000006 108.357 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 0.3 OUTLIER -81.04 -57.5 3.5 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.658 -0.497 . . . . 74.400000000000006 109.658 -178.412 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -136.36 138.4 41.58 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.126 -0.63 . . . . 73.150000000000006 110.568 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 18.5 mt -130.36 119.19 45.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.419 -1.326 . . . . 70.239999999999995 107.419 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -117.16 115.53 25.51 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.733 -0.84 . . . . 74.019999999999996 108.733 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 69.4 p -112.84 127.29 56.14 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.303 -0.999 . . . . 74.510000000000005 108.303 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -134.55 139.25 45.27 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 120.07 -0.652 . . . . 73.129999999999995 109.398 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . 0.445 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 44.8 mt-10 59.82 93.62 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 115.717 1.747 . . . . 75.310000000000002 115.717 170.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.445 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 2.8 mpt_? 62.75 20.12 11.9 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.1 -0.955 . . . . 72.439999999999998 110.954 172.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -84.1 141.83 30.83 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.935 -0.575 . . . . 63.520000000000003 110.48 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 7.9 mpt_? -124.69 133.93 53.04 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.788 -1.56 . . . . 74.200000000000003 106.788 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.454 ' CG1' HG23 ' B' ' 275' ' ' VAL . 23.4 m -135.84 147.56 28.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.559 -0.856 . . . . 74.230000000000004 111.467 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.589 ' CG ' HD11 ' B' ' 276' ' ' LEU . 5.5 tp-100 -124.01 120.33 32.12 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.226 -1.352 . . . . 75.120000000000005 108.425 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . 0.429 HD12 HG22 ' A' ' 277' ' ' ILE . 2.9 tm? -118.09 117.71 29.93 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.133 -1.803 . . . . 75.120000000000005 106.133 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.513 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 139.82 -121.39 2.02 Favored Glycine 0 N--CA 1.412 -2.909 0 C-N-CA 119.398 -1.382 . . . . 73.099999999999994 112.902 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . 0.459 HD22 HG12 ' B' ' 245' ' ' VAL . 8.2 t30 -143.27 130.35 20.71 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.083 0.468 . . . . 72.140000000000001 111.528 -174.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 98.5 t -112.58 126.7 70.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.382 -0.826 . . . . 74.420000000000002 109.254 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . 0.482 ' O ' ' HD1' ' A' ' 281' ' ' TYR . 4.1 m -122.03 113.7 39.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 108.134 -1.061 . . . . 73.140000000000001 108.134 173.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 246' ' ' THR . . . . . 0.446 HG22 ' HD3' ' B' ' 284' ' ' LYS . 17.3 m -77.43 160.7 28.53 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.708 -0.849 . . . . 74.319999999999993 108.708 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 249' ' ' ALA . . . -61.74 -46.26 90.4 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 122.406 1.098 . . . . 63.450000000000003 109.807 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.39 -34.29 68.71 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 112.843 -1.98 . . . . 74.129999999999995 112.991 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' C' ' 247' ' ' ALA . . . -59.86 -26.86 66.18 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.224 0.61 . . . . 74.140000000000001 112.563 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 122.286 1.041 . . . . 73.319999999999993 112.248 -179.064 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.238 0.471 0 N-CA-C 109.432 -0.581 . . . . 74.329999999999998 109.432 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 261' ' ' THR . . . . . 0.553 ' CG2' ' HG2' ' C' ' 225' ' ' ARG . 9.0 t -107.18 132.47 53.01 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.537 0.684 . . . . 74.150000000000006 109.373 177.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . 0.538 ' ND2' ' HB3' ' C' ' 226' ' ' ASN . 15.3 m120 -123.23 137.61 54.84 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.458 -0.792 . . . . 70.030000000000001 108.95 -177.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.3 m -139.24 123.62 18.2 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.667 -0.494 . . . . 74.299999999999997 109.667 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 9.2 p -117.77 141.14 38.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 120.866 0.365 . . . . 75.040000000000006 110.559 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 21.8 mm-40 -81.7 -69.03 0.64 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.595 -0.73 . . . . 62.530000000000001 110.745 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 29.2 m -133.1 127.44 33.99 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.796 -0.762 . . . . 73.099999999999994 112.183 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 3.6 p -123.51 124.18 69.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.972 -0.751 . . . . 74.25 108.972 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 8.5 p -127.32 136.97 59.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.131 0.491 . . . . 74.109999999999999 111.766 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.99 133.07 10.6 Favored Glycine 0 CA--C 1.471 -2.686 0 CA-C-N 115.514 -0.766 . . . . 74.340000000000003 111.283 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -133.19 115.13 14.65 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 109.358 -0.608 . . . . 75.540000000000006 109.358 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.16 95.28 0.03 OUTLIER Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.924 -0.58 . . . . 75.040000000000006 114.532 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 63.36 31.54 15.13 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.502 0.556 . . . . 75.299999999999997 112.502 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.9 m -84.99 145.06 27.91 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.352 -0.386 . . . . 75.019999999999996 110.638 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 9.7 mpt_? -132.28 126.41 33.32 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.268 -1.382 . . . . 75.140000000000001 107.268 172.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.454 HG23 ' CG1' ' B' ' 239' ' ' VAL . 1.1 m -132.65 140.61 47.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 118.958 -1.097 . . . . 72.439999999999998 110.362 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . 0.589 HD11 ' CG ' ' B' ' 240' ' ' GLN . 8.1 tp -122.86 117.17 24.98 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.024 0.916 . . . . 73.239999999999995 110.036 173.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . 0.465 HG23 ' HB3' ' C' ' 241' ' ' LEU . 1.3 pt -112.13 103.89 16.17 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.026 0 CA-C-N 113.79 -1.55 . . . . 74.109999999999999 107.279 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 154.22 -147.18 16.09 Favored Glycine 0 N--CA 1.417 -2.598 0 CA-C-N 115.219 -0.9 . . . . 62.020000000000003 112.823 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -104.9 138.28 41.39 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.064 -1.088 . . . . 63.229999999999997 108.064 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -127.41 118.2 23.63 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.796 -1.557 . . . . 75.239999999999995 106.796 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -115.6 123.73 49.16 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 108.565 -0.902 . . . . 74.030000000000001 108.565 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.07 -55.32 0.68 Allowed Glycine 0 N--CA 1.416 -2.679 0 N-CA-C 109.328 -1.509 . . . . 74.230000000000004 109.328 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 102.2 44.02 1.94 Allowed Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.576 -1.009 . . . . 54.219999999999999 110.576 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . 0.446 ' HD3' HG22 ' B' ' 246' ' ' THR . 11.8 ptmm? -174.9 -18.14 0.01 OUTLIER 'General case' 0 C--O 1.253 1.278 0 O-C-N 123.713 0.302 . . . . 74.530000000000001 111.522 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 54.02 -141.99 32.23 Favored Glycine 0 CA--C 1.5 -0.898 0 CA-C-N 115.574 -0.739 . . . . 74.409999999999997 114.251 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -96.39 4.57 52.11 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.172 -0.677 . . . . 72.319999999999993 109.172 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.448 ' CH2' ' HB3' ' B' ' 276' ' ' LEU . 8.5 m-90 . . . . . 0 N--CA 1.433 -1.29 0 CA-C-N 115.441 -0.8 . . . . 73.230000000000004 112.023 -174.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . 0.553 ' HG2' ' CG2' ' B' ' 261' ' ' THR . 82.8 mtm180 . . . . . 0 N--CA 1.436 -1.152 0 CA-C-O 121.015 0.436 . . . . 73.349999999999994 110.163 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . 0.538 ' HB3' ' ND2' ' B' ' 262' ' ' ASN . 25.9 t-20 -116.4 123.25 47.1 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.525 -0.917 . . . . 75.239999999999995 108.525 178.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 227' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' C' ' 263' ' ' SER . 46.7 t -121.94 137.52 54.76 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.854 -0.612 . . . . 73.030000000000001 109.955 -175.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -126.08 124.38 40.48 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.488 -0.93 . . . . 70.209999999999994 108.488 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -83.74 -64.84 1.09 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.554 -0.535 . . . . 74.25 109.554 -177.201 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -127.49 138.12 52.85 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 109.617 -0.512 . . . . 70.120000000000005 109.617 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . 0.427 HG22 HG11 ' C' ' 267' ' ' VAL . 13.7 mt -133.48 117.44 27.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.15 -1.796 . . . . 70.400000000000006 106.15 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 17.0 ptp180 -124.88 115.65 20.96 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.634 0.731 . . . . 75.409999999999997 110.052 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 49.2 p -110.64 128.34 55.65 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.949 -0.76 . . . . 71.209999999999994 108.949 -175.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -132.33 139.45 48.16 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.23 -0.655 . . . . 71.439999999999998 109.23 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . 0.508 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 44.3 mt-10 59.07 93.05 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.283 1.586 . . . . 74.349999999999994 115.283 171.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.508 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 1.3 mpt_? 61.35 17.17 8.07 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.164 0.985 . . . . 73.299999999999997 111.772 175.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -80.15 136.59 36.54 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.082 0.468 . . . . 64.230000000000004 110.525 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.6 OUTLIER -124.95 133.07 53.17 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.385 -1.339 . . . . 72.0 107.385 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.432 ' CG1' HG22 ' C' ' 275' ' ' VAL . 19.2 m -136.52 149.69 27.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.563 -0.855 . . . . 74.019999999999996 111.772 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . 0.503 ' CG ' HD11 ' C' ' 276' ' ' LEU . 47.7 tp60 -126.07 120.74 31.0 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 114.043 -1.435 . . . . 73.420000000000002 109.079 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.465 ' HB3' HG23 ' B' ' 277' ' ' ILE . 2.1 tm? -120.99 118.55 30.13 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.744 -1.576 . . . . 75.420000000000002 106.744 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.455 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 139.66 -122.91 2.35 Favored Glycine 0 N--CA 1.417 -2.63 0 C-N-CA 119.619 -1.277 . . . . 60.130000000000003 111.91 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -137.76 129.47 28.39 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 110.274 -0.269 . . . . 73.400000000000006 110.274 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . 0.455 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 86.0 t -112.56 123.21 68.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.0 -0.741 . . . . 73.230000000000004 109.0 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 1.6 p -122.67 111.93 32.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 N-CA-C 108.236 -1.024 . . . . 65.120000000000005 108.236 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 20.0 m -70.59 160.53 32.34 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 116.163 -0.472 . . . . 54.229999999999997 109.894 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' B' ' 249' ' ' ALA . . . -59.28 -46.29 88.93 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.172 0.987 . . . . 74.140000000000001 110.14 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.49 73.48 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 113.633 -1.622 . . . . 75.349999999999994 112.567 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . 0.488 ' HB3' ' CD2' ' C' ' 281' ' ' TYR . . . . . . . . 0 N--CA 1.44 -0.963 0 CA-C-N 115.441 -0.799 . . . . 73.230000000000004 111.537 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.433 -1.286 0 N-CA-C 108.578 -0.897 . . . . 74.230000000000004 108.578 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -109.9 123.25 49.28 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.265 -0.643 . . . . 73.310000000000002 109.265 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 263' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' C' ' 227' ' ' SER . 13.0 p -125.37 127.64 46.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 110.185 -0.302 . . . . 63.009999999999998 110.185 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.05 137.04 46.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.573 -0.528 . . . . 73.310000000000002 109.573 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 62.3 mm-40 -80.5 -64.61 1.15 Allowed 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 123.043 0.215 . . . . 64.049999999999997 110.759 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 19.0 m -131.98 127.36 36.12 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 119.644 -0.822 . . . . 75.530000000000001 110.299 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . 0.427 HG11 HG22 ' C' ' 231' ' ' ILE . 2.6 p -126.44 122.89 62.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.927 -0.768 . . . . 74.329999999999998 108.927 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 6.0 p -124.0 142.78 39.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.885 -0.598 . . . . 65.239999999999995 110.762 -175.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.92 132.16 9.27 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 110.315 -1.114 . . . . 65.230000000000004 110.315 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -134.28 115.74 14.46 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 109.009 -0.737 . . . . 73.439999999999998 109.009 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.68 94.19 0.04 OUTLIER Glycine 0 CA--C 1.523 0.542 0 O-C-N 123.506 0.504 . . . . 73.140000000000001 114.249 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . 0.48 ' CD ' HH12 ' C' ' 238' ' ' ARG . 43.6 mm-40 62.2 25.64 15.35 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.506 0.928 . . . . 62.43 113.506 176.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 25.0 m -82.28 144.42 30.63 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.679 -0.808 . . . . 72.230000000000004 110.303 -176.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 63.3 mtt180 -135.86 126.11 26.45 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 105.831 -1.914 . . . . 72.310000000000002 105.831 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . 0.432 HG22 ' CG1' ' C' ' 239' ' ' VAL . 1.5 m -137.88 142.0 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 119.573 -0.851 . . . . 72.409999999999997 111.496 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.503 HD11 ' CG ' ' C' ' 240' ' ' GLN . 7.5 tp -122.46 112.59 18.24 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.037 0.922 . . . . 75.219999999999999 110.798 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 1.9 pt -108.67 104.98 17.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-N 114.054 -1.43 . . . . 72.129999999999995 108.544 175.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 149.97 -149.44 21.35 Favored Glycine 0 N--CA 1.419 -2.454 0 CA-C-N 115.408 -0.815 . . . . 63.32 111.533 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -98.1 145.67 26.32 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.499 -0.926 . . . . 75.310000000000002 108.499 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -137.12 117.91 14.09 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.857 -1.535 . . . . 55.240000000000002 106.857 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' C' ' 249' ' ' ALA . 42.9 t80 -118.47 124.57 47.92 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 108.882 -0.785 . . . . 73.409999999999997 108.882 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 140.49 -52.95 0.68 Allowed Glycine 0 N--CA 1.416 -2.66 0 N-CA-C 109.371 -1.492 . . . . 73.540000000000006 109.371 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 115.27 -11.31 19.7 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.664 -0.779 . . . . 75.129999999999995 111.787 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -125.12 -5.33 7.33 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 112.581 0.586 . . . . 73.230000000000004 112.581 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.33 -121.96 19.25 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 115.777 -0.647 . . . . 72.230000000000004 113.178 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -125.47 13.16 8.15 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.296 -1.001 . . . . 75.340000000000003 108.296 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' C' ' 276' ' ' LEU . 18.0 m-90 . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 114.452 1.279 . . . . 72.340000000000003 114.452 -171.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 . . . . . 0 N--CA 1.436 -1.148 0 N-CA-C 109.355 -0.609 . . . . 72.329999999999998 109.355 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -116.55 137.96 51.77 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.423 -1.695 . . . . 75.540000000000006 106.423 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 7.9 p -128.4 137.43 51.86 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 113.474 0.916 . . . . 73.450000000000003 113.474 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.77 150.44 51.08 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.523 -1.288 . . . . 71.010000000000005 107.523 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -103.3 -50.95 3.34 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.763 -0.829 . . . . 74.230000000000004 108.763 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -127.36 140.71 52.0 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 109.577 -0.527 . . . . 65.239999999999995 109.577 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 55.0 mt -136.64 117.09 17.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 105.817 -1.92 . . . . 75.409999999999997 105.817 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -128.5 128.91 45.24 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.702 -0.481 . . . . 71.510000000000005 109.702 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 36.2 p -121.53 137.5 54.7 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 116.535 -0.302 . . . . 75.140000000000001 110.752 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -131.11 157.22 43.7 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 120.55 -0.46 . . . . 71.040000000000006 110.878 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 63.82 -85.77 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.942 1.297 . . . . 75.239999999999995 113.504 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.76 20.31 4.21 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 121.683 0.754 . . . . 72.209999999999994 109.331 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -69.86 130.98 43.72 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.792 -0.64 . . . . 75.540000000000006 109.989 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -125.42 135.15 52.07 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 108.075 -1.083 . . . . 74.340000000000003 108.075 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.56 HG22 ' CG2' ' A' ' 275' ' ' VAL . 96.2 t -132.42 145.37 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 121.037 0.446 . . . . 70.209999999999994 110.504 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.435 ' CG ' HD13 ' A' ' 276' ' ' LEU . 6.4 tp-100 -120.21 122.77 41.67 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.204 -1.406 . . . . 71.540000000000006 107.204 172.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.82 119.31 38.15 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.075 -1.083 . . . . 75.540000000000006 108.075 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.634 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 125.55 -132.92 8.15 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 111.305 -0.718 . . . . 73.430000000000007 111.305 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -125.1 143.82 50.73 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 117.198 0.499 . . . . 75.010000000000005 110.654 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 95.7 t -110.74 116.7 53.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.645 -1.243 . . . . 71.530000000000001 107.645 176.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.4 t -113.94 111.79 37.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 107.914 -1.143 . . . . 73.400000000000006 107.914 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.9 m -101.05 160.62 14.23 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 109.339 -0.615 . . . . 74.109999999999999 109.339 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.11 -32.76 66.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.89 1.276 . . . . 61.409999999999997 111.609 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.32 -48.19 74.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.685 0.794 . . . . 75.209999999999994 113.047 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.428 ' HB3' ' HA2' ' A' ' 282' ' ' GLY . . . . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.294 -0.632 . . . . 63.32 109.294 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 10.0 t . . . . . 0 N--CA 1.423 -1.786 0 N-CA-C 108.662 -0.866 . . . . 72.319999999999993 108.662 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.557 ' OD1' ' HB3' ' B' ' 226' ' ' ASN . 3.8 t30 -126.54 133.0 51.22 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.018 -0.734 . . . . 74.420000000000002 109.018 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.6 m -117.93 123.5 45.94 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.587 0.555 . . . . 71.400000000000006 109.706 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 10.2 p -126.92 143.42 40.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.248 -0.649 . . . . 63.310000000000002 109.248 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.591 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 36.8 tt0 -83.6 -82.61 0.15 Allowed 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 120.677 -0.409 . . . . 72.120000000000005 111.004 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 81.0 m -115.45 126.69 54.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.663 -0.648 . . . . 71.219999999999999 111.897 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 11.5 t -118.68 120.95 65.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 107.278 -1.379 . . . . 73.409999999999997 107.278 177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 20.9 m -123.83 136.52 59.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 120.216 -0.594 . . . . 72.150000000000006 111.102 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.48 133.17 10.38 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.92 -0.582 . . . . 75.310000000000002 111.943 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -129.6 147.2 51.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.158 -1.052 . . . . 65.129999999999995 108.158 -177.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.27 -133.39 42.45 Favored Glycine 0 C--O 1.239 0.436 0 C-N-CA 120.972 -0.632 . . . . 75.140000000000001 112.226 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -90.69 83.56 5.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.769 -0.826 . . . . 74.0 108.769 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 75.3 m -104.62 144.07 32.21 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.555 -0.858 . . . . 73.230000000000004 110.693 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 28.0 mmm-85 -133.39 123.05 24.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.05 -2.204 . . . . 74.340000000000003 105.05 171.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.56 ' CG2' HG22 ' A' ' 239' ' ' VAL . 30.6 m -140.0 140.58 35.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.239 0.542 . . . . 61.539999999999999 111.627 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.585 ' HB3' ' CH2' ' A' ' 287' ' ' TRP . 9.4 tp -122.37 124.58 44.0 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 115.663 -0.699 . . . . 74.129999999999995 109.687 175.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.443 HG23 HD12 ' B' ' 241' ' ' LEU . 71.6 mt -110.72 103.45 15.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 107.642 -1.244 . . . . 74.420000000000002 107.642 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 145.52 -135.77 6.13 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.283 -0.871 . . . . 72.430000000000007 111.504 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 46.1 t-20 -129.59 137.64 50.83 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 122.17 -0.606 . . . . 72.329999999999998 109.509 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.17 127.28 55.54 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.396 -0.964 . . . . 65.019999999999996 108.396 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 99.7 m-85 -113.73 124.52 52.47 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.681 -0.859 . . . . 74.239999999999995 108.681 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 249' ' ' ALA . . . 138.99 -87.09 0.21 Allowed Glycine 0 CA--C 1.467 -2.916 0 C-N-CA 120.397 -0.906 . . . . 74.310000000000002 112.211 177.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 141.9 96.94 0.27 Allowed Glycine 0 N--CA 1.406 -3.314 0 N-CA-C 108.555 -1.818 . . . . 72.420000000000002 108.555 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp 80.24 45.25 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 O-C-N 125.106 1.121 . . . . 72.120000000000005 110.296 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -78.17 -54.87 4.24 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 115.431 -0.804 . . . . 54.140000000000001 111.683 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -89.62 -33.83 16.53 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.146 0.498 . . . . 74.219999999999999 110.708 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . 0.585 ' CH2' ' HB3' ' A' ' 276' ' ' LEU . 29.6 m-90 . . . . . 0 C--N 1.303 -1.452 0 CA-C-N 116.334 -0.393 . . . . 71.140000000000001 110.466 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 261' ' ' THR . 40.6 ptt180 . . . . . 0 N--CA 1.423 -1.81 0 CA-C-O 121.059 0.457 . . . . 75.209999999999994 110.543 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.557 ' HB3' ' OD1' ' A' ' 262' ' ' ASN . 51.0 t-20 -116.18 148.43 40.38 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 105.285 -2.117 . . . . 74.200000000000003 105.285 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 3.2 p -139.01 136.78 35.69 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 121.515 0.674 . . . . 73.5 111.829 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -132.13 144.25 50.57 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.726 -1.125 . . . . 60.119999999999997 108.571 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.591 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 5.9 tmtm? -96.74 -61.32 1.43 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.948 -0.76 . . . . 74.310000000000002 108.948 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -127.18 139.38 52.98 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 121.807 -0.558 . . . . 74.310000000000002 110.089 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 6.9 mt -134.96 120.65 31.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.713 -1.588 . . . . 74.450000000000003 106.713 175.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -123.36 120.44 33.03 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.408 -0.59 . . . . 74.530000000000001 109.408 -178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' THR . . . . . 0.468 ' HB ' ' HB2' ' B' ' 237' ' ' ALA . 81.0 p -109.99 128.87 55.66 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.139 -1.059 . . . . 70.25 108.139 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -137.25 157.17 47.24 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.598 -0.519 . . . . 73.450000000000003 109.598 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . 0.53 ' HB3' ' HD2' ' B' ' 236' ' ' ARG . 6.2 mp0 63.09 -89.09 0.03 OUTLIER 'General case' 0 C--O 1.21 -1.01 0 C-N-CA 124.425 1.09 . . . . 73.239999999999995 113.496 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.53 ' HD2' ' HB3' ' B' ' 235' ' ' GLU . 0.0 OUTLIER -137.2 59.27 1.69 Allowed 'General case' 0 C--O 1.245 0.843 0 N-CA-C 107.701 -1.222 . . . . 75.439999999999998 107.701 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . 0.468 ' HB2' ' HB ' ' B' ' 233' ' ' THR . . . -99.61 135.19 41.4 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-O 122.353 1.073 . . . . 75.010000000000005 110.399 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 6.1 mpt_? -124.28 133.21 53.54 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 105.691 -1.966 . . . . 75.310000000000002 105.691 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 69.7 t -142.48 133.08 24.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.847 0.832 . . . . 73.340000000000003 111.239 -175.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.544 ' CG ' HD12 ' B' ' 276' ' ' LEU . 44.0 tp60 -105.23 132.51 51.35 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.678 -1.23 . . . . 75.530000000000001 107.678 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . 0.443 HD12 HG23 ' A' ' 277' ' ' ILE . 3.4 tm? -121.85 117.01 25.46 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 106.354 -1.721 . . . . 65.310000000000002 106.354 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.687 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 117.84 -130.05 8.58 Favored Glycine 0 C--O 1.206 -1.632 0 N-CA-C 111.189 -0.764 . . . . 73.439999999999998 111.189 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 5.8 m-20 -124.41 148.4 47.61 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 122.0 -0.706 . . . . 62.340000000000003 112.255 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.541 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 98.5 t -118.3 114.69 45.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.647 -1.242 . . . . 74.510000000000005 107.647 175.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 58.9 t -117.86 111.98 36.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 108.698 -0.853 . . . . 74.430000000000007 108.698 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 246' ' ' THR . . . . . 0.481 ' OG1' ' HA3' ' B' ' 282' ' ' GLY . 13.6 p -93.69 161.98 14.12 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 119.895 -0.722 . . . . 74.310000000000002 109.57 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.25 -32.54 70.09 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.475 1.131 . . . . 65.430000000000007 109.636 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.57 -35.16 65.46 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 112.655 -2.066 . . . . 74.010000000000005 113.5 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.403 ' HA ' ' HB1' ' C' ' 247' ' ' ALA . . . -62.31 -26.42 68.41 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.069 0.461 . . . . 75.349999999999994 110.406 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 N--CA 1.433 -1.314 0 CA-C-O 121.807 0.813 . . . . 72.030000000000001 109.022 177.866 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 CA--C 1.559 1.314 0 N-CA-C 108.805 -0.813 . . . . 64.439999999999998 108.805 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 261' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 9.0 t -91.99 132.86 36.22 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.082 0.468 . . . . 73.230000000000004 109.78 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -126.56 146.66 50.05 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.695 -0.854 . . . . 74.329999999999998 108.695 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 49.3 m -135.65 123.48 22.56 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.023 0.439 . . . . 63.539999999999999 110.207 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.7 p -123.38 150.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.183 -0.673 . . . . 75.450000000000003 109.183 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 39.3 tt0 -93.5 -69.27 0.76 Allowed 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.539 -0.864 . . . . 72.420000000000002 110.409 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 15.6 m -119.53 127.63 53.2 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.104 -1.039 . . . . 65.099999999999994 112.301 -176.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 25.7 t -119.08 120.59 64.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.652 -1.24 . . . . 74.150000000000006 107.652 174.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.83 131.59 69.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 112.248 0.462 . . . . 72.25 112.248 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.66 133.89 11.89 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.608 -0.724 . . . . 62.409999999999997 111.886 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -131.8 130.23 41.52 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 124.826 1.25 . . . . 74.099999999999994 109.546 -178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.28 -133.47 14.06 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 110.551 -1.019 . . . . 43.240000000000002 110.551 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 77.1 mm-40 -87.25 97.9 11.03 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 107.849 -1.167 . . . . 74.519999999999996 107.849 176.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 66.1 m -117.86 143.42 46.32 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 119.342 -0.943 . . . . 74.099999999999994 110.417 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 18.9 mmm-85 -133.99 123.83 25.26 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 104.259 -2.497 . . . . 74.310000000000002 104.259 172.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.3 t -139.22 140.73 37.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.515 -0.921 . . . . 75.219999999999999 108.515 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . 0.711 ' HB3' ' CH2' ' B' ' 287' ' ' TRP . 3.0 tp -126.79 122.06 33.71 Favored 'General case' 0 C--N 1.26 -3.299 0 N-CA-C 109.651 -0.5 . . . . 72.5 109.651 173.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . 0.46 HG21 HD13 ' C' ' 241' ' ' LEU . 3.2 mp -107.01 103.72 15.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 106.386 -1.709 . . . . 75.219999999999999 106.386 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 152.48 -140.9 8.01 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 121.061 -0.59 . . . . 71.310000000000002 112.245 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -128.86 135.29 48.89 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.621 -0.881 . . . . 73.040000000000006 108.621 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -111.77 133.69 53.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.814 0.34 . . . . 71.030000000000001 110.225 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -121.87 125.65 46.91 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 115.885 -0.598 . . . . 74.230000000000004 110.988 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . 0.481 ' HA3' ' OG1' ' B' ' 246' ' ' THR . . . 133.37 -99.55 0.37 Allowed Glycine 0 CA--C 1.48 -2.156 0 C-N-CA 120.559 -0.829 . . . . 71.549999999999997 112.725 174.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 178.34 112.32 0.33 Allowed Glycine 0 C--N 1.277 -2.706 0 N-CA-C 108.106 -1.997 . . . . 64.409999999999997 108.106 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? 78.01 -50.88 0.5 Allowed 'General case' 0 C--O 1.197 -1.677 0 C-N-CA 124.217 1.007 . . . . 71.019999999999996 112.537 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 46.5 -102.31 0.04 OUTLIER Glycine 0 C--O 1.244 0.779 0 O-C-N 124.439 1.087 . . . . 71.099999999999994 114.983 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -70.75 -28.42 64.68 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 123.959 0.904 . . . . 75.430000000000007 111.382 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.711 ' CH2' ' HB3' ' B' ' 276' ' ' LEU . 22.8 m-90 . . . . . 0 C--N 1.309 -1.152 0 O-C-N 122.052 -0.405 . . . . 74.540000000000006 111.645 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' B' ' 261' ' ' THR . 56.4 ttp180 . . . . . 0 N--CA 1.437 -1.08 0 CA-C-O 120.904 0.383 . . . . 73.019999999999996 110.304 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -106.95 142.76 36.06 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.72 -1.956 . . . . 72.450000000000003 105.72 175.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 9.1 p -139.98 137.31 34.6 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.216 -0.994 . . . . 74.310000000000002 113.101 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -127.45 142.02 51.52 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.101 -0.954 . . . . 62.140000000000001 109.435 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 49.0 tptt -87.81 -66.61 0.89 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.964 -0.562 . . . . 74.230000000000004 110.537 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -133.68 138.93 46.13 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.959 -0.756 . . . . 72.140000000000001 108.959 -175.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 10.7 mt -135.38 120.52 28.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.721 -1.214 . . . . 63.32 107.721 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 77.7 ttt180 -122.85 121.64 36.73 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 109.351 -0.611 . . . . 74.450000000000003 109.351 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 233' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' C' ' 237' ' ' ALA . 68.5 p -110.46 127.92 55.36 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.466 -0.939 . . . . 75.5 108.466 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -130.13 152.27 49.75 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 119.99 -0.684 . . . . 62.0 112.0 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 48.8 mt-10 69.8 -77.81 0.05 Allowed 'General case' 0 C--O 1.194 -1.84 0 CA-C-N 113.84 -1.527 . . . . 71.409999999999997 113.854 172.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.1 56.8 1.47 Allowed 'General case' 0 C--O 1.245 0.819 0 N-CA-C 107.134 -1.432 . . . . 74.230000000000004 107.134 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' C' ' 233' ' ' THR . . . -104.12 135.11 46.23 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 122.492 1.139 . . . . 65.530000000000001 111.292 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 4.8 mpt_? -124.86 133.16 53.19 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 106.071 -1.825 . . . . 75.109999999999999 106.071 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 94.9 t -141.52 134.68 30.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.418 0.628 . . . . 74.209999999999994 110.766 -176.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . 0.542 ' CG ' HD11 ' C' ' 276' ' ' LEU . 5.1 tp-100 -105.3 129.5 53.63 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.646 -1.242 . . . . 75.439999999999998 107.646 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.46 HD13 HG21 ' B' ' 277' ' ' ILE . 3.4 tm? -122.42 116.01 23.24 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.048 -1.834 . . . . 72.400000000000006 106.048 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.428 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 130.0 -111.07 1.11 Allowed Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 119.668 -1.253 . . . . 64.439999999999998 112.859 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.01 148.91 34.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.738 -0.467 . . . . 72.519999999999996 109.738 -174.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . 0.507 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 91.6 t -126.94 114.94 39.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.852 -0.795 . . . . 75.120000000000005 108.852 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.87 111.77 37.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.859 -0.793 . . . . 74.340000000000003 108.859 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.3 m -85.56 160.97 19.52 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.548 -0.908 . . . . 62.439999999999998 108.548 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . 0.403 ' HB1' ' HA ' ' B' ' 249' ' ' ALA . . . -63.09 -34.24 77.17 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 122.444 1.116 . . . . 63.119999999999997 109.294 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.92 -35.62 66.81 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 113.14 -1.846 . . . . 73.010000000000005 111.671 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.814 0 CA-C-N 116.383 -0.371 . . . . 72.129999999999995 111.387 -178.108 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.419 -1.994 0 N-CA-C 108.369 -0.975 . . . . 73.099999999999994 108.369 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -113.52 128.07 56.31 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.317 -0.856 . . . . 65.329999999999998 109.58 -176.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.2 m -117.61 123.25 45.73 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.033 -0.728 . . . . 75.319999999999993 109.033 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -117.67 148.74 20.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.178 -1.045 . . . . 74.420000000000002 108.178 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 43.0 tt0 -90.44 -84.66 0.23 Allowed 'General case' 0 N--CA 1.415 -2.184 0 C-N-CA 120.355 -0.538 . . . . 54.409999999999997 110.269 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 20.0 m -110.59 130.31 55.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.774 -0.77 . . . . 74.150000000000006 110.477 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 40.6 t -117.85 120.77 65.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.72 -1.215 . . . . 74.219999999999999 107.72 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.1 p -127.61 131.96 69.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 120.411 -0.515 . . . . 73.109999999999999 110.987 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.14 133.61 11.7 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 108.912 -1.675 . . . . 71.310000000000002 108.912 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -132.33 132.95 43.45 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.716 -0.846 . . . . 75.340000000000003 108.716 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.5 -125.23 10.21 Favored Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 120.428 -0.891 . . . . 72.150000000000006 111.346 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -91.84 97.55 11.05 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.521 -1.288 . . . . 74.319999999999993 107.521 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 33.4 m -127.61 145.07 51.0 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 113.45 0.907 . . . . 43.509999999999998 113.45 -175.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 34.5 mmm-85 -133.46 124.79 27.69 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 104.919 -2.252 . . . . 74.219999999999999 104.919 173.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 4.2 t -139.4 140.55 37.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 118.634 0.652 . . . . 75.230000000000004 109.729 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.675 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 5.1 tp -126.94 119.73 27.42 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-O 121.374 0.606 . . . . 72.230000000000004 109.397 172.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 54.9 mt -108.45 103.4 15.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 105.719 -1.956 . . . . 75.120000000000005 105.719 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 146.24 -146.71 17.05 Favored Glycine 0 N--CA 1.427 -1.944 0 C-N-CA 120.721 -0.752 . . . . 54.039999999999999 111.352 -175.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -121.72 140.33 52.45 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.577 -0.897 . . . . 62.43 108.577 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . 0.439 ' HB2' ' CD2' ' C' ' 276' ' ' LEU . 36.0 tt0 -118.63 118.35 31.41 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.973 -0.751 . . . . 74.329999999999998 108.973 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -107.72 125.82 51.85 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 109.92 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 131.28 -129.25 5.66 Favored Glycine 0 N--CA 1.427 -1.935 0 C-N-CA 120.749 -0.738 . . . . 60.119999999999997 112.332 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -157.02 111.58 0.49 Allowed Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.52 -1.432 . . . . 73.430000000000007 109.52 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 63.56 38.14 9.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.957 0.903 . . . . 74.239999999999995 109.785 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -60.93 -68.15 1.8 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.355 -0.839 . . . . 73.099999999999994 113.53 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -89.72 -46.17 8.8 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.661 -0.496 . . . . 74.530000000000001 109.661 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . 0.675 ' CH2' ' HB3' ' C' ' 276' ' ' LEU . 24.4 m-90 . . . . . 0 CA--C 1.493 -1.215 0 CA-C-N 116.101 -0.5 . . . . 71.109999999999999 109.892 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.879 0 CA-C-O 121.227 0.536 . . . . 74.299999999999997 110.877 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -80.84 131.86 35.42 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.017 -1.846 . . . . 73.049999999999997 106.017 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 10.6 m -120.98 137.88 54.42 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 120.061 -0.656 . . . . 73.109999999999999 111.484 -171.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.76 118.46 19.07 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.584 -1.636 . . . . 70.099999999999994 106.584 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.511 ' HE2' ' O ' ' A' ' 265' ' ' GLU . 5.7 tmmm? -86.36 -38.58 17.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.832 -0.433 . . . . 73.030000000000001 109.832 -176.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -143.82 138.77 28.93 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.142 -0.688 . . . . 61.409999999999997 109.142 174.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 60.7 mt -130.77 126.7 60.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 105.149 -2.167 . . . . 74.430000000000007 105.149 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.416 ' HE ' ' HB2' ' A' ' 232' ' ' ARG . 10.1 ttm180 -134.44 116.21 14.89 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.954 -0.758 . . . . 63.340000000000003 108.954 -177.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 31.3 p -123.42 127.74 48.86 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 110.121 -0.325 . . . . 74.439999999999998 110.121 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -144.65 145.97 32.02 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 120.86 0.362 . . . . 75.310000000000002 111.304 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 63.49 86.68 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.968 1.307 . . . . 75.439999999999998 113.989 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.51 26.43 16.06 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.014 -0.994 . . . . 75.200000000000003 111.865 177.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.49 144.64 27.16 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.825 -0.625 . . . . 65.239999999999995 109.855 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -127.24 135.49 50.69 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.932 -0.766 . . . . 74.420000000000002 108.932 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 3.3 p -132.98 145.21 34.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.952 0.882 . . . . 72.049999999999997 112.738 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -124.84 130.42 52.35 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.062 -1.458 . . . . 64.120000000000005 107.062 170.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -128.43 118.56 23.33 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.533 -1.284 . . . . 74.099999999999994 107.533 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.19 -116.79 1.8 Allowed Glycine 0 N--CA 1.427 -1.945 0 C-N-CA 119.603 -1.284 . . . . 71.340000000000003 114.123 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . 0.42 ' OD1' HG11 ' A' ' 245' ' ' VAL . 15.6 t-20 -144.48 128.69 17.73 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 122.968 0.507 . . . . 75.049999999999997 110.178 -175.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 50.2 t -108.77 114.01 45.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.376 -0.602 . . . . 75.230000000000004 109.376 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . 0.42 HG11 ' OD1' ' A' ' 243' ' ' ASN . 15.7 m -103.33 121.82 55.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.885 -0.783 . . . . 71.209999999999994 108.885 175.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.574 ' OG1' ' HA3' ' A' ' 282' ' ' GLY . 24.0 p -92.64 160.63 14.92 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.591 -1.244 . . . . 73.140000000000001 111.18 176.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.27 -34.5 78.26 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 123.78 0.832 . . . . 71.140000000000001 112.564 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -70.14 -35.37 74.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.079 0.466 . . . . 71.430000000000007 111.959 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.447 ' HB1' ' CA ' ' A' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.311 -1.09 0 CA-C-N 115.704 -0.68 . . . . 64.219999999999999 111.201 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 8.0 m . . . . . 0 N--CA 1.424 -1.76 0 N-CA-C 109.285 -0.635 . . . . 74.239999999999995 109.285 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -120.26 133.61 55.44 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.046 -1.094 . . . . 73.219999999999999 108.046 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 18.2 m -142.31 130.4 22.0 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.974 -0.454 . . . . 73.409999999999997 112.218 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -114.1 133.35 60.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 109.529 -0.545 . . . . 73.230000000000004 109.529 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.511 ' O ' ' HE2' ' A' ' 229' ' ' LYS . 71.5 mm-40 -78.4 -50.87 10.94 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 116.331 -0.395 . . . . 72.430000000000007 110.09 177.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 90.5 m -145.92 127.24 14.88 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.34 -0.85 . . . . 72.120000000000005 111.275 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.0 p -120.81 120.39 62.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.566 -0.743 . . . . 74.420000000000002 109.053 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.7 130.48 72.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.58 -0.737 . . . . 75.120000000000005 109.447 -175.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.42 131.92 8.56 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.293 -1.123 . . . . 72.519999999999996 110.293 174.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 22.8 tptt -134.01 116.7 15.83 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 110.057 -0.349 . . . . 73.549999999999997 110.057 -177.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.33 90.47 0.21 Allowed Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.33 -0.938 . . . . 70.200000000000003 113.303 174.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.494 ' HB3' ' NH1' ' A' ' 274' ' ' ARG . 19.5 mt-10 58.58 37.89 25.34 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.598 0.962 . . . . 75.0 113.598 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 15.5 m -88.43 143.7 26.83 Favored 'General case' 0 C--N 1.274 -2.682 0 C-N-CA 118.639 -1.224 . . . . 72.420000000000002 109.386 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . 0.494 ' NH1' ' HB3' ' A' ' 272' ' ' GLU . 9.2 mpt_? -116.6 127.03 54.11 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.369 -1.715 . . . . 73.219999999999999 106.369 174.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.537 HG11 ' CG1' ' B' ' 239' ' ' VAL . 17.2 m -126.41 123.42 63.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-O 121.458 0.647 . . . . 72.5 109.952 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 5.4 tt -113.57 111.77 22.43 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.744 -1.576 . . . . 72.200000000000003 106.744 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.444 HG22 HD12 ' B' ' 241' ' ' LEU . 60.0 mt -112.36 107.33 22.7 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 CA-C-O 121.612 0.72 . . . . 63.43 110.122 -177.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 137.61 -135.27 7.47 Favored Glycine 0 N--CA 1.426 -1.993 0 CA-C-N 115.533 -0.758 . . . . 63.439999999999998 112.139 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 3.1 m120 -104.09 134.34 47.51 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 112.06 0.392 . . . . 73.319999999999993 112.06 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -113.2 117.92 33.25 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 103.401 -2.814 . . . . 74.5 103.401 167.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 16.0 t80 -130.13 123.61 30.76 Favored 'General case' 0 C--O 1.264 1.818 0 CA-C-O 122.54 1.162 . . . . 73.120000000000005 113.514 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.574 ' HA3' ' OG1' ' A' ' 246' ' ' THR . . . 129.98 -77.27 0.4 Allowed Glycine 0 N--CA 1.415 -2.734 0 CA-C-N 113.475 -1.693 . . . . 64.340000000000003 114.938 175.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -61.27 -81.74 0.08 OUTLIER Glycine 0 C--N 1.317 -0.508 0 N-CA-C 115.708 1.043 . . . . 72.430000000000007 115.708 -170.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -178.67 -35.95 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.122 -1.807 . . . . 73.019999999999996 106.122 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' B' ' 287' ' ' TRP . . . -158.35 -167.41 19.16 Favored Glycine 0 N--CA 1.401 -3.652 0 CA-C-N 113.73 -1.577 . . . . 74.319999999999993 109.541 176.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.415 ' HE1' ' CZ2' ' B' ' 287' ' ' TRP . 41.7 p90 -104.25 -169.66 1.66 Allowed 'General case' 0 C--N 1.294 -1.825 0 O-C-N 124.105 0.532 . . . . 72.340000000000003 110.468 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 27.8 p90 . . . . . 0 C--N 1.313 -0.985 0 C-N-CA 124.455 1.102 . . . . 71.409999999999997 113.02 179.177 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 261' ' ' THR . 14.7 ttt180 . . . . . 0 N--CA 1.437 -1.082 0 CA-C-O 120.793 0.33 . . . . 73.530000000000001 111.707 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -85.92 126.34 34.02 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.213 -2.143 . . . . 44.420000000000002 105.213 171.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' B' ' 263' ' ' SER . 18.7 m -121.25 136.61 54.94 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.789 -0.765 . . . . 74.010000000000005 111.746 -174.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.62 119.19 26.43 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.474 -1.306 . . . . 74.409999999999997 107.474 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 33.5 ttmt -75.74 -61.73 1.82 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.059 -0.719 . . . . 74.040000000000006 109.059 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -128.32 137.7 52.05 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 109.373 -0.602 . . . . 74.230000000000004 109.373 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 40.0 mt -128.6 128.16 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.791 0 N-CA-C 104.956 -2.238 . . . . 75.040000000000006 104.956 174.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . 0.441 ' HB3' HG12 ' B' ' 268' ' ' VAL . 16.0 ttm180 -132.25 114.09 14.03 Favored 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 108.537 -0.912 . . . . 73.030000000000001 108.537 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 45.7 p -110.04 127.89 55.1 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.243 -1.762 . . . . 74.219999999999999 106.243 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' B' ' 270' ' ' LYS . 48.4 mt-10 -143.31 140.5 30.61 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.007 -0.738 . . . . 74.040000000000006 109.007 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 60.89 97.66 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 O-C-N 124.032 0.833 . . . . 63.310000000000002 113.212 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.47 ' HB2' ' H ' ' B' ' 272' ' ' GLU . 2.0 mpt_? 60.37 22.61 12.15 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.031 0.533 . . . . 73.450000000000003 111.533 173.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.58 140.53 33.63 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.189 0.519 . . . . 74.230000000000004 110.895 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.94 134.76 46.01 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.685 -0.688 . . . . 74.549999999999997 109.498 178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.537 ' CG1' HG11 ' A' ' 275' ' ' VAL . 7.2 p -137.53 150.01 25.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.271 0.558 . . . . 55.329999999999998 110.204 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.422 HE22 ' N ' ' B' ' 243' ' ' ASN . 22.5 tm0? -122.63 128.13 50.26 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 105.663 -1.977 . . . . 64.230000000000004 105.663 170.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . 0.444 HD12 HG22 ' A' ' 277' ' ' ILE . 3.3 tm? -118.33 117.91 30.37 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.16 -2.163 . . . . 74.540000000000006 105.16 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.424 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 143.19 -125.56 2.6 Favored Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 118.695 -1.717 . . . . 50.229999999999997 112.852 -178.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 2.8 t-20 -144.44 128.22 17.28 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 110.292 -0.262 . . . . 75.400000000000006 110.292 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 30.0 t -99.54 128.0 51.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.105 -1.442 . . . . 74.340000000000003 107.105 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 10.5 t -122.51 116.07 47.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 107.381 -1.34 . . . . 74.230000000000004 107.381 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.9 p -85.02 158.07 20.57 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 117.1 -1.84 . . . . 72.25 111.065 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -66.57 -47.1 73.85 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.61 1.195 . . . . 71.310000000000002 110.035 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.81 -33.49 61.6 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.243 -2.253 . . . . 71.219999999999999 113.795 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.42 ' HB3' ' HA3' ' B' ' 282' ' ' GLY . . . -58.7 -42.84 89.54 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.078 0.551 . . . . 71.209999999999994 111.171 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 N--CA 1.484 1.244 0 C-N-CA 124.807 1.243 . . . . 72.340000000000003 112.549 -179.103 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.399 -2.996 0 N-CA-C 103.618 -2.734 . . . . 75.010000000000005 103.618 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 261' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 13.9 m -94.47 108.44 20.38 Favored 'General case' 0 N--CA 1.417 -2.114 0 C-N-CA 119.208 -0.997 . . . . 74.099999999999994 109.446 -175.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -104.19 128.54 51.92 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.147 -1.057 . . . . 72.010000000000005 108.147 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 263' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' B' ' 227' ' ' SER . 38.6 t -142.78 136.09 28.51 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-O 121.074 0.464 . . . . 74.519999999999996 111.747 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 9.4 p -116.39 137.25 50.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.982 -0.554 . . . . 74.510000000000005 110.076 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.575 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 31.7 mm-40 -78.02 -57.44 3.79 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.866 -0.79 . . . . 75.200000000000003 108.866 176.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 88.0 m -146.96 126.98 13.65 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.661 0.743 . . . . 73.010000000000005 111.387 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.3 p -121.91 120.51 61.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.271 -0.877 . . . . 73.430000000000007 109.603 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . 0.441 HG12 ' HB3' ' B' ' 232' ' ' ARG . 34.2 m -121.06 145.59 27.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 116.044 -0.526 . . . . 73.219999999999999 110.194 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -143.82 132.79 5.06 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 120.097 -1.049 . . . . 71.549999999999997 112.4 176.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' B' ' 234' ' ' GLU . 65.0 mttm -133.92 131.01 38.56 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.724 0.81 . . . . 73.319999999999993 112.319 176.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.03 86.57 0.59 Allowed Glycine 0 C--N 1.296 -1.679 0 N-CA-C 114.476 0.551 . . . . 54.219999999999999 114.476 172.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . 0.47 ' H ' ' HB2' ' B' ' 236' ' ' ARG . 65.3 mm-40 65.95 27.65 10.76 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 112.193 0.442 . . . . 74.439999999999998 112.193 173.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 12.9 m -83.54 143.15 30.37 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.29 0.567 . . . . 74.530000000000001 110.149 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . 0.486 ' HB2' ' HG3' ' C' ' 238' ' ' ARG . 10.9 mpt_? -123.47 127.63 48.66 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.521 -1.659 . . . . 74.430000000000007 106.521 174.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.48 ' HB ' HG21 ' B' ' 239' ' ' VAL . 5.9 t -127.41 133.9 66.91 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 108.45 -0.945 . . . . 71.329999999999998 108.45 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . 0.451 HD22 HE21 ' C' ' 240' ' ' GLN . 4.4 tt -121.99 112.82 18.75 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.011 -1.477 . . . . 73.129999999999995 107.011 171.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . 0.429 HG23 HD13 ' C' ' 241' ' ' LEU . 39.4 mt -112.83 107.0 21.87 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 109.131 -0.692 . . . . 73.239999999999995 109.131 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 149.95 -137.58 6.28 Favored Glycine 0 N--CA 1.405 -3.38 0 C-N-CA 119.948 -1.12 . . . . 71.319999999999993 112.188 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . 0.581 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 27.7 t-20 -119.03 133.18 55.97 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.998 -0.601 . . . . 54.310000000000002 110.133 -178.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -109.89 118.64 37.01 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 104.603 -2.369 . . . . 74.239999999999995 104.603 177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -120.05 123.43 43.39 Favored 'General case' 0 C--O 1.274 2.369 0 CA-C-O 122.535 1.16 . . . . 74.329999999999998 110.379 -172.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' B' ' 249' ' ' ALA . . . 111.91 -55.66 0.5 Allowed Glycine 0 N--CA 1.398 -3.9 0 CA-C-N 114.064 -1.425 . . . . 64.150000000000006 115.385 172.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.43 -97.91 0.03 OUTLIER Glycine 0 C--N 1.313 -0.737 0 N-CA-C 115.655 1.022 . . . . 72.299999999999997 115.655 -171.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 42.8 tptt 173.92 -42.06 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 103.94 -2.615 . . . . 74.340000000000003 103.94 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -147.09 161.68 28.49 Favored Glycine 1 N--CA 1.387 -4.591 0 N-CA-C 106.215 -2.754 . . . . 74.530000000000001 106.215 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -83.4 -153.63 0.14 Allowed 'General case' 0 C--N 1.278 -2.509 0 O-C-N 124.358 0.681 . . . . 75.150000000000006 110.56 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.469 ' HB3' ' HA3' ' A' ' 285' ' ' GLY . 34.4 p90 . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 125.756 1.623 . . . . 65.140000000000001 113.629 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' B' ' 261' ' ' THR . 47.5 ttt180 . . . . . 0 N--CA 1.436 -1.156 0 CA-C-O 120.822 0.344 . . . . 75.340000000000003 111.301 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -93.23 124.93 37.56 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 104.962 -2.236 . . . . 75.120000000000005 104.962 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 8.1 m -121.69 136.22 54.95 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.976 -0.689 . . . . 71.120000000000005 110.856 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.38 119.02 30.92 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.829 -1.545 . . . . 70.430000000000007 106.829 174.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.8 OUTLIER -82.17 -54.72 5.04 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 116.301 -0.409 . . . . 74.439999999999998 109.958 -174.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -131.46 137.41 48.58 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.462 -1.31 . . . . 71.200000000000003 107.462 173.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 30.8 mt -130.73 128.79 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 104.983 -2.228 . . . . 73.319999999999993 104.983 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.412 ' HB3' HG12 ' C' ' 268' ' ' VAL . 10.7 ttm180 -133.05 113.85 13.26 Favored 'General case' 0 N--CA 1.401 -2.896 0 N-CA-C 108.758 -0.831 . . . . 74.340000000000003 108.758 -176.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 233' ' ' THR . . . . . 0.426 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 40.9 p -110.79 126.22 54.39 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.856 -1.164 . . . . 72.430000000000007 107.856 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 48.4 mt-10 -145.14 142.24 29.45 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 110.271 -0.27 . . . . 75.340000000000003 110.271 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 64.49 89.59 0.09 Allowed 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.437 1.085 . . . . 70.109999999999999 113.113 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? 64.75 15.99 10.13 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.993 -1.003 . . . . 71.430000000000007 112.026 174.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.47 140.97 28.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.289 0.566 . . . . 64.219999999999999 112.481 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.486 ' HG3' ' HB2' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -128.47 135.75 49.89 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.021 -0.733 . . . . 70.519999999999996 109.021 178.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' C' ' 275' ' ' VAL . 7.1 p -138.85 147.53 24.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.452 0.644 . . . . 75.040000000000006 111.469 -177.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . 0.451 HE21 HD22 ' B' ' 276' ' ' LEU . 13.3 tm0? -117.35 132.54 56.57 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 104.506 -2.405 . . . . 74.120000000000005 104.506 172.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.429 HD13 HG23 ' B' ' 277' ' ' ILE . 3.4 tm? -129.68 117.79 20.88 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 106.319 -1.734 . . . . 75.319999999999993 106.319 177.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.31 -117.65 1.66 Allowed Glycine 0 N--CA 1.426 -1.999 0 C-N-CA 119.912 -1.137 . . . . 73.519999999999996 112.474 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 18.1 t-20 -144.4 134.33 23.91 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.798 0.333 . . . . 74.25 111.435 -176.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.31 123.61 68.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.49 -0.93 . . . . 74.540000000000006 108.49 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . 0.453 HG11 ' OD1' ' C' ' 243' ' ' ASN . 31.5 m -121.43 117.2 51.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-O 121.625 0.726 . . . . 72.109999999999999 109.143 177.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 246' ' ' THR . . . . . 0.511 ' OG1' ' HA3' ' C' ' 282' ' ' GLY . 12.4 p -83.76 158.55 21.7 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 117.871 -1.532 . . . . 63.130000000000003 109.969 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.93 89.73 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.934 1.35 . . . . 73.329999999999998 108.632 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.19 62.36 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 112.374 -2.193 . . . . 73.200000000000003 112.826 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.549 0 N-CA-C 112.908 0.707 . . . . 74.329999999999998 112.908 -177.322 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.427 -1.614 0 CA-C-O 120.666 0.27 . . . . 72.409999999999997 110.706 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -97.89 138.81 34.68 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.213 -1.402 . . . . 74.230000000000004 107.213 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 45.6 m -142.58 136.12 28.91 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.639 -0.663 . . . . 71.5 111.11 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.96 130.56 74.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.101 -0.703 . . . . 64.329999999999998 109.101 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 5.5 mm-40 -75.09 -47.14 30.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.051 0.453 . . . . 65.540000000000006 110.904 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 69.8 m -150.41 127.88 11.47 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 122.005 -0.434 . . . . 74.109999999999999 110.623 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 1.1 p -126.1 119.8 55.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.983 -0.747 . . . . 75.109999999999999 108.983 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . 0.412 HG12 ' HB3' ' C' ' 232' ' ' ARG . 25.8 m -121.04 144.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.262 -0.644 . . . . 75.340000000000003 109.262 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.33 132.42 6.65 Favored Glycine 0 CA--C 1.473 -2.558 0 N-CA-C 110.705 -0.958 . . . . 54.240000000000002 110.705 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.59 128.83 36.0 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 109.499 -0.556 . . . . 75.310000000000002 109.499 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.6 75.49 1.15 Allowed Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.357 -0.925 . . . . 72.420000000000002 113.718 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 60.52 40.81 16.53 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.389 0.676 . . . . 75.049999999999997 112.269 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.4 m -81.98 143.81 31.33 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 119.221 -0.992 . . . . 73.0 109.482 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . 0.413 ' HB3' ' HE1' ' C' ' 287' ' ' TRP . 1.3 mpp_? -120.2 127.0 52.04 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.545 -1.65 . . . . 74.150000000000006 106.545 173.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . 0.434 ' HB ' HG23 ' C' ' 239' ' ' VAL . 3.0 t -135.54 140.18 45.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 109.315 -0.624 . . . . 73.310000000000002 109.315 -175.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.523 HD11 ' CZ3' ' C' ' 287' ' ' TRP . 4.0 tt -128.17 115.6 18.64 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.145 -1.798 . . . . 72.409999999999997 106.145 170.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 56.7 mt -112.73 104.31 16.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.047 -1.464 . . . . 74.540000000000006 107.047 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.12 -139.5 6.72 Favored Glycine 0 N--CA 1.403 -3.507 0 C-N-CA 119.89 -1.147 . . . . 71.109999999999999 111.476 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . 0.404 ' HB3' HD21 ' C' ' 243' ' ' ASN . 28.5 t-20 -122.87 130.29 52.69 Favored 'General case' 0 C--N 1.279 -2.466 0 O-C-N 123.807 0.357 . . . . 74.420000000000002 110.237 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.88 117.9 34.64 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.618 -1.623 . . . . 75.040000000000006 106.618 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -124.77 123.94 41.06 Favored 'General case' 0 C--O 1.272 2.245 0 CA-C-O 122.394 1.092 . . . . 75.209999999999994 111.794 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . 0.511 ' HA3' ' OG1' ' C' ' 246' ' ' THR . . . 128.2 -53.91 0.79 Allowed Glycine 0 N--CA 1.419 -2.459 0 CA-C-N 114.193 -1.367 . . . . 63.409999999999997 113.515 178.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -80.48 -97.62 0.35 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.493 -0.86 . . . . 75.510000000000005 114.104 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 52.5 tttp 170.43 -34.11 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 104.877 -2.268 . . . . 74.109999999999999 104.877 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -143.05 156.31 26.4 Favored Glycine 0 N--CA 1.404 -3.442 0 N-CA-C 106.479 -2.649 . . . . 60.530000000000001 106.479 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -89.08 -166.09 1.51 Allowed 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 117.258 0.529 . . . . 74.25 109.719 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . 0.523 ' CZ3' HD11 ' C' ' 276' ' ' LEU . 43.4 p90 . . . . . 0 C--O 1.248 1.01 0 C-N-CA 123.409 0.684 . . . . 65.219999999999999 110.756 178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 121.616 0.722 . . . . 72.409999999999997 111.318 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.47 ' HB2' ' OD1' ' A' ' 262' ' ' ASN . 23.4 p-10 -116.88 156.0 28.09 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 125.23 1.412 . . . . 71.120000000000005 111.675 -173.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 263' ' ' SER . 23.4 m -116.99 136.53 52.87 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 108.813 -0.81 . . . . 63.210000000000001 108.813 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.7 135.34 43.98 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.267 -0.879 . . . . 73.230000000000004 110.285 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 1.9 tmtp? -87.84 -63.93 1.23 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.723 -0.671 . . . . 73.340000000000003 110.367 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -131.03 139.03 49.89 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.166 -0.334 . . . . 73.030000000000001 110.52 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.6 mt -137.8 128.15 36.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.029 -1.471 . . . . 73.430000000000007 107.029 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.404 ' HB2' HG11 ' A' ' 268' ' ' VAL . 65.0 mtt180 -134.41 115.14 13.67 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.437 -0.505 . . . . 75.329999999999998 109.706 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.451 HG23 ' HB ' ' A' ' 239' ' ' VAL . 28.9 p -118.95 128.31 54.29 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.415 -0.514 . . . . 74.349999999999994 109.868 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.3 153.29 46.42 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.904 -0.406 . . . . 55.32 109.904 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 63.46 83.44 0.16 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.603 1.161 . . . . 71.5 113.036 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 236' ' ' ARG . 6.1 mpt_? 58.83 22.79 10.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.913 1.285 . . . . 75.239999999999995 112.436 176.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.6 142.03 27.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 122.173 -0.329 . . . . 62.409999999999997 110.445 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.75 137.16 53.8 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.825 -0.435 . . . . 74.439999999999998 109.825 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 233' ' ' THR . 3.1 p -129.16 142.59 43.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.453 0.644 . . . . 44.439999999999998 111.777 -176.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -125.99 125.38 42.6 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 108.496 -0.928 . . . . 73.329999999999998 108.496 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 59.7 tp -115.88 123.87 49.22 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.454 -0.943 . . . . 74.239999999999995 108.454 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.558 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 121.09 -123.54 5.57 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.382 -0.913 . . . . 71.299999999999997 112.166 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . 0.575 ' ND2' HD21 ' A' ' 279' ' ' ASN . 2.1 t-20 -141.76 128.57 20.51 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 122.196 -0.591 . . . . 73.099999999999994 111.524 -174.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 51.3 t -104.11 122.45 56.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.201 -1.407 . . . . 74.510000000000005 107.201 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.7 t -118.17 116.26 50.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.401 -0.592 . . . . 73.109999999999999 109.401 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.3 t -114.34 162.1 17.05 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 119.977 -0.689 . . . . 72.150000000000006 109.393 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.37 -32.0 62.24 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 114.862 1.43 . . . . 75.430000000000007 114.862 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.41 -37.54 65.19 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.823 1.416 . . . . 71.340000000000003 114.823 -173.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.919 0 N-CA-C 112.542 0.571 . . . . 73.530000000000001 112.542 179.814 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.435 -1.211 0 N-CA-C 107.543 -1.28 . . . . 73.109999999999999 107.543 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 25.0 t-20 -86.45 121.45 29.01 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 119.847 -0.741 . . . . 73.349999999999994 109.378 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 227' ' ' SER . 50.8 m -142.32 132.77 25.09 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.554 -0.748 . . . . 72.540000000000006 111.079 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.4 p -126.82 138.22 55.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.603 -0.272 . . . . 74.519999999999996 111.6 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 55.3 mm-40 -78.11 -66.48 0.84 Allowed 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 116.031 -0.532 . . . . 74.230000000000004 110.825 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 30.1 m -133.63 126.97 32.01 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.23 -0.588 . . . . 73.519999999999996 110.41 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.72 121.68 55.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.637 -0.711 . . . . 75.099999999999994 109.601 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.404 HG11 ' HB2' ' A' ' 232' ' ' ARG . 15.9 m -126.05 146.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-O 121.112 0.482 . . . . 74.430000000000007 111.568 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -130.02 131.26 6.54 Favored Glycine 0 N--CA 1.425 -2.073 0 N-CA-C 109.096 -1.601 . . . . 74.230000000000004 109.096 174.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.453 ' HB2' ' HG2' ' B' ' 234' ' ' GLU . 29.8 mmmt -133.25 116.14 15.82 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 120.565 0.221 . . . . 72.549999999999997 110.946 -176.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 83.68 84.05 0.91 Allowed Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 119.314 -1.422 . . . . 42.420000000000002 113.657 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 60.2 27.27 16.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.88 0.872 . . . . 73.530000000000001 111.74 171.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 17.4 m -84.11 145.49 28.4 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.281 0.563 . . . . 64.439999999999998 110.85 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -113.2 127.44 56.18 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.989 -1.856 . . . . 75.129999999999995 105.989 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 1.2 p -133.66 123.1 44.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-O 121.379 0.609 . . . . 70.129999999999995 111.418 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.524 HD23 ' CH2' ' A' ' 287' ' ' TRP . 18.3 tp -117.03 119.37 35.06 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.489 -0.93 . . . . 73.209999999999994 108.489 174.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.413 HG22 ' HB3' ' B' ' 241' ' ' LEU . 2.7 pt -113.67 104.91 17.73 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.146 0 CA-C-N 114.194 -1.367 . . . . 72.239999999999995 109.505 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 149.09 -122.78 1.51 Allowed Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.941 -0.572 . . . . 71.239999999999995 113.036 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.575 HD21 ' ND2' ' A' ' 243' ' ' ASN . 9.8 t30 -129.75 135.31 48.31 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 122.232 -0.569 . . . . 73.099999999999994 111.673 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.489 ' HG2' ' NE1' ' A' ' 287' ' ' TRP . 7.2 tp10 -111.75 118.27 35.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 105.854 -1.906 . . . . 75.530000000000001 105.854 174.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -117.8 123.13 45.2 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 105.721 -1.955 . . . . 75.430000000000007 105.721 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 121.82 -48.51 0.94 Allowed Glycine 0 C--N 1.284 -2.335 0 N-CA-C 108.192 -1.963 . . . . 64.140000000000001 108.192 -172.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 99.52 16.39 29.41 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 120.809 -0.71 . . . . 75.140000000000001 112.112 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.444 ' HB3' ' NZ ' ' A' ' 284' ' ' LYS . 0.1 OUTLIER 176.82 66.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.849 0.859 . . . . 71.219999999999999 112.728 178.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -109.72 -51.22 0.66 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 109.633 -1.387 . . . . 70.109999999999999 109.633 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -96.73 -5.82 37.76 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.243 0.544 . . . . 74.019999999999996 110.591 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . 0.585 ' CH2' ' HB2' ' B' ' 240' ' ' GLN . 2.5 m95 . . . . . 0 CA--C 1.493 -1.222 0 N-CA-C 114.526 1.306 . . . . 75.299999999999997 114.526 -174.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 . . . . . 0 C--O 1.211 -0.969 0 CA-C-O 121.995 0.902 . . . . 75.200000000000003 111.564 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 21.2 p-10 -118.23 155.34 30.71 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 125.328 1.451 . . . . 75.209999999999994 114.27 -174.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' B' ' 263' ' ' SER . 20.7 m -117.38 135.93 53.52 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 122.362 1.077 . . . . 72.120000000000005 108.149 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -134.06 139.21 45.83 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.004 -0.998 . . . . 63.240000000000002 109.695 -174.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 37.2 ttmt -86.58 -65.53 1.0 Allowed 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.832 -0.622 . . . . 73.340000000000003 110.747 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -126.24 137.83 53.56 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.148 -1.021 . . . . 73.239999999999995 110.489 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 44.9 mt -135.39 121.74 32.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.425 -1.324 . . . . 73.540000000000006 107.425 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 58.4 mtt180 -128.17 114.85 17.52 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.804 -0.813 . . . . 75.430000000000007 108.804 177.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' THR . . . . . 0.424 HG22 ' HB ' ' B' ' 239' ' ' VAL . 45.3 p -116.37 126.59 53.69 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.778 -1.564 . . . . 74.349999999999994 106.778 175.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.469 ' HB2' ' HE3' ' B' ' 270' ' ' LYS . 32.7 mt-10 -141.67 151.91 43.44 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.88 -0.785 . . . . 72.299999999999997 108.88 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 61.38 80.38 0.22 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.536 1.134 . . . . 73.439999999999998 112.466 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.54 ' HD3' ' N ' ' B' ' 236' ' ' ARG . 0.0 OUTLIER 62.78 25.16 14.95 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.821 0.674 . . . . 75.400000000000006 112.821 173.4 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -84.86 150.66 24.84 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.323 0.583 . . . . 65.129999999999995 110.802 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -125.54 135.14 51.94 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.122 -1.436 . . . . 74.25 107.122 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 5.8 p -136.76 141.95 39.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.304 0.573 . . . . 73.209999999999994 111.635 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.585 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 4.4 tp60 -122.26 125.87 46.95 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-N 114.306 -1.315 . . . . 74.140000000000001 107.867 171.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . 0.525 ' HG ' HD22 ' A' ' 262' ' ' ASN . 52.5 tp -117.3 118.54 32.55 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 107.934 -1.135 . . . . 74.25 107.934 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.554 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 128.33 -117.12 2.46 Favored Glycine 0 N--CA 1.421 -2.347 0 C-N-CA 120.389 -0.91 . . . . 70.409999999999997 111.644 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . 0.594 HD21 ' N ' ' B' ' 244' ' ' VAL . 0.2 OUTLIER -144.57 136.41 25.87 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 120.022 -0.671 . . . . 75.5 110.243 -176.213 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.594 ' N ' HD21 ' B' ' 243' ' ' ASN . 48.1 t -108.54 120.28 59.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.258 -1.386 . . . . 73.329999999999998 107.258 174.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.16 115.23 46.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 120.894 -0.323 . . . . 74.109999999999999 110.598 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.9 t -113.93 162.25 16.63 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.626 -0.879 . . . . 74.120000000000005 108.626 171.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.03 -32.19 70.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.657 1.183 . . . . 62.509999999999998 114.017 -173.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.91 -41.07 67.26 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 114.417 1.266 . . . . 71.040000000000006 114.417 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.444 ' HB2' ' CD2' ' B' ' 281' ' ' TYR . . . -74.27 -25.98 59.94 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 114.273 1.212 . . . . 73.030000000000001 114.273 -175.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 41.6 tp . . . . . 0 C--N 1.323 -0.561 0 CA-C-O 121.312 0.577 . . . . 64.010000000000005 111.896 -173.893 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 260' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' C' ' 225' ' ' ARG . 18.0 p . . . . . 0 N--CA 1.397 -3.079 0 N-CA-C 109.249 -0.649 . . . . 72.099999999999994 109.249 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 8.2 t -127.75 141.65 51.53 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.798 -1.186 . . . . 74.030000000000001 107.798 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . 0.653 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 25.7 t-20 -87.06 119.13 26.95 Favored 'General case' 0 CA--C 1.479 -1.768 0 N-CA-C 107.846 -1.168 . . . . 74.409999999999997 107.846 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 263' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' B' ' 227' ' ' SER . 49.7 m -142.56 128.03 18.98 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.394 -0.821 . . . . 74.310000000000002 110.889 -177.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.4 p -125.82 141.42 45.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.277 -0.569 . . . . 70.219999999999999 112.462 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 16.6 mm-40 -79.33 -59.3 2.82 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.568 -0.742 . . . . 72.109999999999999 110.938 177.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 97.0 m -143.6 127.37 17.18 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.023 -0.671 . . . . 75.5 112.694 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 24.0 m -121.07 127.81 75.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 109.056 -0.72 . . . . 72.019999999999996 109.056 172.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 5.5 p -128.64 135.37 62.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-N 116.16 -0.473 . . . . 73.510000000000005 111.877 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.7 132.58 7.99 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 110.494 -1.043 . . . . 75.439999999999998 110.494 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.469 ' HE3' ' HB2' ' B' ' 234' ' ' GLU . 13.9 mmmm -132.84 117.71 18.08 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 122.451 0.3 . . . . 74.430000000000007 111.648 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.87 87.32 0.9 Allowed Glycine 0 C--N 1.307 -1.069 0 C-N-CA 120.379 -0.915 . . . . 74.140000000000001 113.171 173.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 55.16 30.35 14.31 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.953 0.901 . . . . 63.450000000000003 111.899 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.8 m -83.06 145.08 29.48 Favored 'General case' 0 N--CA 1.422 -1.863 0 C-N-CA 120.489 -0.484 . . . . 65.219999999999999 110.355 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -116.84 127.62 54.47 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.088 -1.819 . . . . 74.219999999999999 106.088 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 1.5 p -133.03 123.14 47.57 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 121.517 0.675 . . . . 71.209999999999994 111.252 178.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . 0.515 ' HG ' ' OE1' ' C' ' 240' ' ' GLN . 8.0 tp -113.85 119.86 38.77 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.18 -1.045 . . . . 73.019999999999996 108.18 174.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 2.0 mt -112.14 103.56 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.887 0 N-CA-C 105.192 -2.151 . . . . 75.310000000000002 105.192 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 147.85 -126.96 2.48 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 119.136 -1.507 . . . . 75.420000000000002 114.635 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -128.91 135.42 49.02 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.159 0.504 . . . . 65.5 111.04 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . 0.425 ' HG2' ' NE1' ' B' ' 287' ' ' TRP . 13.9 tp10 -113.45 118.5 34.7 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.776 -1.564 . . . . 74.430000000000007 106.776 177.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . 0.444 ' CD2' ' HB2' ' B' ' 249' ' ' ALA . 4.6 t80 -115.25 122.75 46.94 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 106.144 -1.799 . . . . 64.329999999999998 106.144 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' B' ' 249' ' ' ALA . . . 114.72 -51.37 0.72 Allowed Glycine 0 C--N 1.288 -2.094 0 N-CA-C 108.226 -1.95 . . . . 71.439999999999998 108.226 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 89.97 15.17 58.2 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 111.204 -0.758 . . . . 64.25 111.204 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -145.75 19.92 1.47 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.157 0.503 . . . . 75.430000000000007 109.992 -178.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -81.93 -79.81 0.95 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.393 -0.908 . . . . 74.230000000000004 113.116 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -76.95 -13.36 59.98 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.812 0.671 . . . . 73.420000000000002 112.812 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.589 ' CH2' ' HB2' ' C' ' 240' ' ' GLN . 6.4 m95 . . . . . 0 C--N 1.305 -1.345 0 CA-C-O 121.107 0.48 . . . . 73.430000000000007 112.177 -173.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . 0.511 ' O ' ' HB ' ' B' ' 260' ' ' THR . 24.9 mmt180 . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 122.079 0.942 . . . . 73.310000000000002 111.99 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . 0.653 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 28.3 p-10 -117.49 155.67 29.32 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 113.419 -1.719 . . . . 72.420000000000002 114.242 -171.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 227' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' C' ' 263' ' ' SER . 23.9 t -117.75 136.37 53.42 Favored 'General case' 0 N--CA 1.409 -2.487 0 N-CA-C 107.671 -1.233 . . . . 73.010000000000005 107.671 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.43 137.92 52.07 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.872 -1.058 . . . . 74.430000000000007 108.842 -175.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 5.2 tmmm? -90.83 -62.0 1.55 Allowed 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 120.062 -0.655 . . . . 75.010000000000005 110.527 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -127.56 137.09 52.5 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 108.392 -0.966 . . . . 74.019999999999996 108.392 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 17.4 mt -137.82 123.59 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.145 -1.057 . . . . 74.230000000000004 108.145 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 81.5 mtt180 -128.32 115.1 17.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.418 -0.586 . . . . 74.040000000000006 109.418 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 233' ' ' THR . . . . . 0.458 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 33.1 p -112.31 126.87 55.72 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.342 -1.355 . . . . 74.129999999999995 107.342 175.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' B' ' 270' ' ' LYS . 43.1 mt-10 -138.87 145.78 40.38 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 120.328 -0.549 . . . . 73.030000000000001 110.508 -178.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 65.52 84.26 0.16 Allowed 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.637 1.175 . . . . 73.439999999999998 112.506 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? 61.3 23.31 13.56 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.345 1.058 . . . . 73.439999999999998 111.752 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . 0.404 ' HB1' ' HB ' ' C' ' 233' ' ' THR . . . -87.18 151.2 23.39 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.031 0.443 . . . . 75.049999999999997 111.423 -176.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -125.53 135.24 52.06 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.686 -1.227 . . . . 75.430000000000007 107.686 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 2.5 p -130.83 136.31 58.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.459 0.647 . . . . 73.299999999999997 110.929 176.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . 0.589 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 3.9 tp60 -114.56 121.35 43.2 Favored 'General case' 0 N--CA 1.4 -2.967 0 CA-C-N 114.247 -1.342 . . . . 71.239999999999995 107.479 170.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.568 ' HG ' HD22 ' B' ' 262' ' ' ASN . 64.7 tp -115.53 118.16 32.36 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 108.32 -0.992 . . . . 72.299999999999997 108.32 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.538 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 129.5 -115.08 1.84 Allowed Glycine 0 N--CA 1.416 -2.657 0 C-N-CA 120.347 -0.93 . . . . 60.450000000000003 112.47 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . 0.459 ' ND2' HG21 ' C' ' 245' ' ' VAL . 5.9 t30 -144.94 136.28 25.16 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 122.651 -0.323 . . . . 75.230000000000004 110.934 -173.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . 0.445 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 61.0 t -114.79 125.85 72.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.195 0 N-CA-C 108.244 -1.021 . . . . 73.140000000000001 108.244 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . 0.459 HG21 ' ND2' ' C' ' 243' ' ' ASN . 85.5 t -122.06 118.58 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 118.104 0.411 . . . . 72.310000000000002 110.294 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.8 t -114.07 162.28 16.67 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 108.242 -1.021 . . . . 74.439999999999998 108.242 170.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.68 -31.86 73.16 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 114.229 1.196 . . . . 72.530000000000001 114.229 -172.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.41 -34.29 57.2 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.749 1.388 . . . . 71.430000000000007 114.749 -169.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . 0.453 ' HB1' ' HA2' ' C' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.321 -0.667 0 C-N-CA 120.194 -0.602 . . . . 75.310000000000002 112.128 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 108.588 -0.893 . . . . 75.510000000000005 108.588 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -87.99 120.38 29.28 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.297 0.57 . . . . 73.040000000000006 110.177 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 263' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' C' ' 227' ' ' SER . 46.8 m -139.6 132.77 29.74 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.601 -0.727 . . . . 74.25 109.047 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 12.3 p -123.91 139.52 50.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.964 0.411 . . . . 72.409999999999997 111.129 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 9.1 mm-40 -75.88 -64.12 1.16 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.913 -0.585 . . . . 75.230000000000004 111.794 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 87.4 m -144.85 127.91 16.56 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 122.058 -0.402 . . . . 75.540000000000006 109.966 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.86 123.67 63.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 115.323 -0.853 . . . . 70.129999999999995 109.638 178.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 26.5 m -124.65 146.61 29.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.179 -0.464 . . . . 75.099999999999994 110.337 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -130.85 132.52 6.9 Favored Glycine 0 CA--C 1.481 -2.062 0 N-CA-C 109.348 -1.501 . . . . 70.450000000000003 109.348 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -132.78 116.55 16.7 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.735 0.268 . . . . 72.209999999999994 111.592 -175.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.95 84.42 0.85 Allowed Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.022 -1.085 . . . . 73.209999999999994 113.868 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 59.19 29.07 18.56 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.267 1.027 . . . . 74.140000000000001 111.629 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 15.8 m -82.87 145.55 29.38 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.102 -0.499 . . . . 75.319999999999993 111.102 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -113.43 128.4 56.44 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.06 -1.83 . . . . 74.140000000000001 106.06 174.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 6.6 p -137.95 123.57 25.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.533 0.682 . . . . 74.340000000000003 111.317 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.531 HD11 ' CG ' ' C' ' 240' ' ' GLN . 5.3 tp -113.88 112.17 22.9 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.866 -0.79 . . . . 75.140000000000001 108.866 175.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 5.4 mt -103.9 103.71 15.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 105.256 -2.127 . . . . 73.400000000000006 105.256 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 143.51 -144.83 14.18 Favored Glycine 0 N--CA 1.421 -2.314 0 C-N-CA 119.869 -1.158 . . . . 74.0 112.809 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -110.18 139.81 44.94 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.114 0.483 . . . . 71.409999999999997 110.342 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . 0.571 ' HG2' ' NE1' ' C' ' 287' ' ' TRP . 12.9 tp10 -118.06 117.46 29.26 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 105.933 -1.877 . . . . 72.540000000000006 105.933 175.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -111.51 123.39 50.13 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.01 -1.848 . . . . 74.409999999999997 106.01 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . 0.453 ' HA2' ' HB1' ' C' ' 249' ' ' ALA . . . 109.58 -51.29 0.71 Allowed Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 109.548 -1.421 . . . . 72.109999999999999 109.548 -173.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 86.13 24.35 41.13 Favored Glycine 0 CA--C 1.496 -1.156 0 C-N-CA 120.94 -0.648 . . . . 75.420000000000002 111.634 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -148.53 13.89 0.95 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 122.979 0.512 . . . . 71.140000000000001 110.247 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.43 -79.63 0.81 Allowed Glycine 0 N--CA 1.422 -2.263 0 C-N-CA 120.096 -1.049 . . . . 74.25 112.82 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -80.23 -19.78 46.11 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.126 0.787 . . . . 74.129999999999995 113.126 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . 0.571 ' NE1' ' HG2' ' C' ' 280' ' ' GLU . 9.2 m95 . . . . . 0 C--N 1.307 -1.282 0 N-CA-C 114.261 1.208 . . . . 73.209999999999994 114.261 -171.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 . . . . . 0 CA--C 1.49 -1.348 0 CA-C-O 121.123 0.487 . . . . 73.239999999999995 111.504 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -115.62 114.35 24.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.038 -1.467 . . . . 71.219999999999999 107.038 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 10.1 p -129.07 137.64 51.39 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.457 0.646 . . . . 74.349999999999994 112.385 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.22 129.51 37.82 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.073 -1.084 . . . . 64.329999999999998 108.073 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -82.31 -55.84 4.27 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.798 -0.445 . . . . 74.430000000000007 109.798 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 266' ' ' THR . 26.3 t0 -138.55 139.46 38.69 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 119.95 -0.7 . . . . 73.340000000000003 111.985 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 30.8 mm -128.33 127.79 67.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 106.889 -1.523 . . . . 73.299999999999997 106.889 -176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 31.0 ttt180 -134.14 115.42 14.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.283 -0.567 . . . . 72.109999999999999 110.079 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 40.8 p -110.66 127.59 55.35 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.335 -0.987 . . . . 74.030000000000001 108.335 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -128.08 148.96 50.58 Favored 'General case' 0 CA--C 1.482 -1.67 0 C-N-CA 120.089 -0.644 . . . . 60.020000000000003 109.865 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.582 ' C ' ' HD2' ' A' ' 236' ' ' ARG . 44.4 mt-10 59.27 91.24 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 O-C-N 125.12 1.512 . . . . 64.230000000000004 114.029 173.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.582 ' HD2' ' C ' ' A' ' 235' ' ' GLU . 0.1 OUTLIER 61.33 2.23 0.61 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.345 1.458 . . . . 71.319999999999993 113.401 174.065 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -69.92 149.58 47.66 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.398 0.679 . . . . 64.310000000000002 112.156 -175.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.34 139.01 54.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.701 -0.681 . . . . 53.32 109.805 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 6.0 p -124.85 141.93 43.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 116.052 -0.522 . . . . 72.299999999999997 110.018 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -123.26 117.7 25.9 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.739 -0.664 . . . . 74.540000000000006 109.361 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 277' ' ' ILE . 2.9 tm? -111.63 118.76 36.56 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.64 -1.615 . . . . 73.040000000000006 106.64 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.459 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 136.66 -140.2 11.28 Favored Glycine 0 N--CA 1.422 -2.278 0 C-N-CA 119.707 -1.235 . . . . 62.109999999999999 112.061 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -124.52 133.73 53.23 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 120.972 0.415 . . . . 75.519999999999996 111.411 -173.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.7 t -119.01 121.02 65.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.387 -1.338 . . . . 72.140000000000001 107.387 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.28 129.65 74.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.262 0.553 . . . . 71.109999999999999 112.366 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 5.3 m -109.79 160.53 16.26 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.808 -1.182 . . . . 75.209999999999994 107.808 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.99 76.8 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 122.918 0.487 . . . . 73.409999999999997 111.941 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.18 -34.08 63.54 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.926 1.29 . . . . 72.530000000000001 113.741 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.458 ' CB ' ' HB3' ' A' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.32 -0.713 0 N-CA-C 113.106 0.78 . . . . 72.439999999999998 113.106 -175.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.435 -1.197 0 N-CA-C 108.874 -0.787 . . . . 75.129999999999995 108.874 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.432 HD22 HD21 ' B' ' 241' ' ' LEU . 64.9 t30 -106.29 121.63 44.61 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.801 -0.814 . . . . 74.450000000000003 108.801 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.9 m -137.86 123.97 20.34 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.878 0.37 . . . . 73.340000000000003 111.726 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.2 p -119.76 135.27 60.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.855 0.36 . . . . 74.219999999999999 111.102 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -69.36 -65.05 0.76 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.883 -0.599 . . . . 74.310000000000002 111.469 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 29.5 m -144.58 132.76 21.68 Favored 'General case' 0 C--O 1.25 1.117 0 C-N-CA 120.184 -0.607 . . . . 74.209999999999994 112.501 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.03 129.56 74.21 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 107.932 -1.136 . . . . 74.329999999999998 107.932 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 7.8 p -127.59 130.86 70.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-O 121.186 0.517 . . . . 72.340000000000003 111.677 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.06 133.32 11.53 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 109.719 -1.352 . . . . 74.510000000000005 109.719 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -132.56 144.69 50.58 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 117.121 0.46 . . . . 74.400000000000006 111.131 -175.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.65 -65.76 3.89 Favored Glycine 0 C--O 1.244 0.755 0 N-CA-C 110.768 -0.933 . . . . 63.439999999999998 110.768 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -176.96 125.86 0.15 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.999 -2.223 . . . . 73.019999999999996 104.999 172.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 25.0 m -149.94 160.13 43.84 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.531 -0.544 . . . . 64.140000000000001 109.531 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 54.3 mtm180 -122.72 127.36 49.12 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.142 -1.059 . . . . 73.349999999999994 108.142 172.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 1.4 p -128.18 129.17 69.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 116.154 -0.475 . . . . 74.299999999999997 109.942 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 4.1 tt -121.0 121.24 37.54 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.854 -1.165 . . . . 74.040000000000006 107.854 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 241' ' ' LEU . 3.2 pt -113.03 104.59 17.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 C-N-CA 124.063 0.945 . . . . 73.420000000000002 109.107 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 155.18 -122.84 1.26 Allowed Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.554 -0.832 . . . . 74.239999999999995 113.156 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 42.4 m-80 -128.3 148.96 50.68 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.62 0.247 . . . . 71.450000000000003 110.585 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.0 OUTLIER -136.6 121.6 18.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.172 -2.159 . . . . 72.420000000000002 105.172 173.587 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . 0.458 ' HB3' ' CB ' ' A' ' 249' ' ' ALA . 57.0 m-85 -107.81 123.59 48.8 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 109.37 -0.604 . . . . 71.030000000000001 109.37 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.405 ' N ' ' HB3' ' A' ' 249' ' ' ALA . . . 104.91 -43.73 1.61 Allowed Glycine 0 N--CA 1.42 -2.387 0 CA-C-N 115.178 -0.919 . . . . 70.329999999999998 111.209 -177.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 76.29 14.42 82.36 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.916 -0.874 . . . . 73.439999999999998 110.916 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -126.43 13.6 7.63 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.899 0.857 . . . . 75.319999999999993 109.377 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -101.48 -55.44 0.9 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.156 -1.021 . . . . 73.519999999999996 110.92 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.466 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 31.1 t80 -93.04 -18.04 23.13 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.904 -0.406 . . . . 74.319999999999993 109.904 -177.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . 0.629 ' CH2' ' HB2' ' B' ' 240' ' ' GLN . 12.6 m-90 . . . . . 0 C--O 1.242 0.707 0 N-CA-C 115.893 1.812 . . . . 64.010000000000005 115.893 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 . . . . . 0 CA--C 1.488 -1.433 0 CA-C-O 121.265 0.555 . . . . 75.010000000000005 111.281 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.476 ' OD1' ' HA2' ' C' ' 242' ' ' GLY . 63.3 t30 -113.5 114.62 26.79 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 106.181 -1.785 . . . . 73.340000000000003 106.181 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 227' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' B' ' 263' ' ' SER . 20.1 m -125.4 137.06 54.0 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.513 0.673 . . . . 74.420000000000002 111.351 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.33 132.85 48.61 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.236 -0.893 . . . . 75.319999999999993 108.74 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.548 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -88.72 -68.12 0.79 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.976 -0.379 . . . . 74.219999999999999 109.976 -177.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.91 138.6 53.33 Favored 'General case' 0 CA--C 1.481 -1.673 0 C-N-CA 119.355 -0.938 . . . . 71.409999999999997 111.327 177.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 29.4 mm -130.91 118.4 41.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.576 -1.268 . . . . 75.430000000000007 107.576 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -118.77 117.76 29.76 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.483 -0.562 . . . . 74.150000000000006 109.483 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 49.7 p -109.5 127.2 54.26 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.903 -1.517 . . . . 75.219999999999999 106.903 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.28 155.75 46.61 Favored 'General case' 0 CA--C 1.471 -2.083 0 N-CA-C 108.759 -0.83 . . . . 73.25 108.759 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . 0.56 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 83.8 mt-10 55.16 84.49 0.07 Allowed 'General case' 0 C--N 1.311 -1.065 0 O-C-N 125.016 1.447 . . . . 74.099999999999994 114.055 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.56 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 60.91 6.93 1.31 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.07 1.348 . . . . 74.409999999999997 113.151 173.437 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -69.9 148.43 49.0 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.201 0.524 . . . . 64.319999999999993 112.138 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 1.0 OUTLIER -127.87 136.09 50.92 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 108.806 -0.812 . . . . 73.340000000000003 108.806 179.216 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.408 ' HB ' HG11 ' B' ' 275' ' ' VAL . 5.4 p -127.65 142.23 44.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 116.335 -0.393 . . . . 71.409999999999997 110.853 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.629 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 5.8 tp-100 -112.89 134.62 54.31 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.918 -1.512 . . . . 71.120000000000005 106.918 173.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . 0.432 HD21 HD22 ' A' ' 262' ' ' ASN . 2.8 tm? -129.28 117.44 20.69 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 105.953 -1.869 . . . . 73.319999999999993 105.953 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.453 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 137.67 -115.29 1.19 Allowed Glycine 0 N--CA 1.404 -3.489 0 C-N-CA 119.006 -1.568 . . . . 72.209999999999994 113.292 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 6.4 t30 -145.35 129.15 17.28 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 113.275 0.843 . . . . 72.030000000000001 113.275 -171.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 280' ' ' GLU . 99.2 t -119.64 125.56 74.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.339 -0.986 . . . . 72.430000000000007 108.339 176.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . 0.441 ' HB ' ' CD2' ' A' ' 281' ' ' TYR . 57.7 t -122.29 129.66 75.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 120.843 -0.343 . . . . 75.230000000000004 111.285 -177.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 246' ' ' THR . . . . . 0.462 HG23 ' HB3' ' B' ' 284' ' ' LYS . 2.2 m -104.48 161.41 14.12 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.439 -0.948 . . . . 72.109999999999999 108.439 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.33 -32.57 74.02 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.756 0.788 . . . . 73.519999999999996 110.486 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.18 -36.06 65.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.026 -1.443 . . . . 74.219999999999999 113.805 -176.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.485 ' HB2' ' N ' ' B' ' 282' ' ' GLY . . . -74.67 -38.74 62.34 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 121.201 -0.2 . . . . 73.540000000000006 110.886 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 60.2 tp . . . . . 0 CA--C 1.547 0.86 0 C-N-CA 124.732 1.213 . . . . 73.230000000000004 112.002 -177.763 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.255 0 CA-C-O 121.182 0.515 . . . . 73.420000000000002 111.9 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 261' ' ' THR . . . . . 0.479 ' HB ' ' HG2' ' C' ' 225' ' ' ARG . 4.7 m -116.23 108.24 15.87 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.18 -1.415 . . . . 75.319999999999993 107.18 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . 0.45 HD22 HD23 ' C' ' 241' ' ' LEU . 64.2 t30 -108.7 126.17 52.7 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.215 -1.032 . . . . 72.049999999999997 108.215 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 263' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' C' ' 227' ' ' SER . 31.9 m -142.42 123.75 14.74 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.237 0.542 . . . . 73.230000000000004 111.813 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 14.5 p -110.31 140.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.459 -0.571 . . . . 73.209999999999994 109.459 176.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.548 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 3.4 tm-20 -80.45 -69.26 0.61 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.423 -0.954 . . . . 73.349999999999994 108.423 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 90.7 m -137.3 128.85 28.45 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 121.629 -0.669 . . . . 72.329999999999998 112.683 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 48.9 t -118.49 128.83 75.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.08 -1.082 . . . . 61.450000000000003 108.08 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 8.6 p -127.4 134.44 65.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.131 0.491 . . . . 72.010000000000005 111.295 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.09 133.25 11.18 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.723 -1.351 . . . . 65.129999999999995 109.723 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -133.18 147.22 52.04 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 117.059 0.43 . . . . 75.400000000000006 111.349 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.58 -63.96 4.04 Favored Glycine 0 CA--C 1.498 -1.014 0 N-CA-C 110.812 -0.915 . . . . 73.25 110.812 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -178.99 126.72 0.1 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 103.624 -2.732 . . . . 72.319999999999993 103.624 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 45.7 m -147.61 161.29 41.45 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 120.949 0.404 . . . . 73.030000000000001 110.809 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . 0.712 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 14.7 mtp180 -127.7 127.33 43.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.436 -1.32 . . . . 71.310000000000002 107.436 174.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.408 HG11 ' HB ' ' B' ' 239' ' ' VAL . 0.7 OUTLIER -134.8 137.31 51.13 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.109 0 N-CA-C 109.716 -0.476 . . . . 71.0 109.716 179.196 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . 0.466 HD13 ' CG ' ' B' ' 286' ' ' PHE . 5.4 tt -124.15 124.23 42.04 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.059 -1.459 . . . . 74.099999999999994 107.059 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 6.7 mt -113.0 103.81 16.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 106.334 -1.728 . . . . 71.340000000000003 106.334 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 152.0 -141.31 8.41 Favored Glycine 0 CA--C 1.474 -2.53 0 C-N-CA 119.164 -1.493 . . . . 71.430000000000007 113.751 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 45.3 m-80 -111.57 136.93 50.09 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.109 -0.545 . . . . 71.5 109.625 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . 0.5 ' HB2' ' NE2' ' C' ' 240' ' ' GLN . 0.1 OUTLIER -125.67 118.39 25.53 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 104.931 -2.248 . . . . 71.450000000000003 104.931 175.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -105.58 124.07 48.95 Favored 'General case' 0 N--CA 1.401 -2.885 0 CA-C-O 121.564 0.697 . . . . 75.129999999999995 110.239 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . 0.485 ' N ' ' HB2' ' B' ' 249' ' ' ALA . . . 108.14 -45.55 1.29 Allowed Glycine 0 N--CA 1.416 -2.638 0 CA-C-N 114.991 -1.004 . . . . 62.009999999999998 110.971 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 70.79 26.26 74.33 Favored Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 109.845 -1.302 . . . . 75.400000000000006 109.845 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . 0.462 ' HB3' HG23 ' B' ' 246' ' ' THR . 24.8 tptp -136.73 14.21 3.15 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.423 -0.954 . . . . 74.349999999999994 108.423 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -112.23 -59.11 0.44 Allowed Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.569 -0.741 . . . . 73.0 111.429 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.466 ' CG ' HD13 ' B' ' 276' ' ' LEU . 19.0 t80 -90.41 -20.66 22.53 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.185 -1.043 . . . . 70.349999999999994 108.185 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.502 ' CH2' ' HB2' ' C' ' 240' ' ' GLN . 14.3 m-90 . . . . . 0 C--N 1.296 -1.727 0 CA-C-N 115.002 -0.999 . . . . 73.209999999999994 108.79 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . 0.479 ' HG2' ' HB ' ' B' ' 261' ' ' THR . 70.5 mtt180 . . . . . 0 CA--C 1.493 -1.224 0 N-CA-C 112.691 0.626 . . . . 70.409999999999997 112.691 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -116.57 116.92 28.51 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.367 -1.345 . . . . 74.239999999999995 107.367 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 227' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' B' ' 263' ' ' SER . 15.7 p -128.72 139.39 52.24 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 121.569 0.699 . . . . 72.150000000000006 111.423 -176.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.91 129.49 48.29 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.015 -0.993 . . . . 52.420000000000002 108.469 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 13.8 tmtt? -87.48 -60.35 2.0 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.288 0.368 . . . . 74.439999999999998 111.614 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.32 138.04 53.54 Favored 'General case' 0 CA--C 1.484 -1.565 0 O-C-N 121.741 -0.599 . . . . 72.319999999999993 110.074 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 41.5 mm -133.13 119.12 35.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.777 -1.194 . . . . 72.409999999999997 107.777 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 44.9 ttt180 -122.65 115.22 21.73 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 109.479 -0.563 . . . . 71.439999999999998 109.479 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 42.5 p -110.61 127.39 55.23 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.725 -1.583 . . . . 63.340000000000003 106.725 176.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -141.58 153.62 44.93 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 120.143 -0.623 . . . . 74.530000000000001 110.107 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . 0.495 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 43.4 mt-10 61.31 85.41 0.12 Allowed 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.889 1.368 . . . . 71.319999999999993 113.156 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.495 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 1.4 mpt_? 59.18 5.17 0.53 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.813 1.645 . . . . 72.340000000000003 113.393 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -69.6 147.5 50.61 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.461 0.648 . . . . 62.240000000000002 112.073 -174.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.712 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 1.5 mpt_? -126.98 135.02 50.29 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.273 -0.876 . . . . 75.430000000000007 108.959 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.2 p -128.32 139.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.066 0.46 . . . . 72.209999999999994 111.326 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . 0.502 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 5.4 tp-100 -110.47 120.02 41.07 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.053 -0.976 . . . . 73.219999999999999 108.815 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.45 HD23 HD22 ' B' ' 262' ' ' ASN . 3.1 tm? -115.16 116.52 28.5 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 105.339 -2.097 . . . . 73.510000000000005 105.339 172.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.476 ' HA2' ' OD1' ' B' ' 226' ' ' ASN . . . 142.45 -121.88 1.86 Allowed Glycine 0 N--CA 1.41 -3.073 0 C-N-CA 118.56 -1.781 . . . . 50.200000000000003 113.174 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 35.8 t30 -144.63 128.48 17.36 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 123.621 0.248 . . . . 74.439999999999998 111.608 -171.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' B' ' 280' ' ' GLU . 92.0 t -118.52 122.98 70.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.221 -1.029 . . . . 75.140000000000001 108.221 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.94 128.85 75.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 120.533 -0.467 . . . . 73.439999999999998 110.454 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 2.6 m -99.33 161.05 13.84 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.196 -1.038 . . . . 73.439999999999998 108.196 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.3 -32.29 69.91 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.832 0.853 . . . . 74.109999999999999 110.959 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.48 -35.49 63.11 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.21 -1.359 . . . . 71.209999999999994 112.522 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.573 0 CA-C-O 121.012 0.434 . . . . 53.520000000000003 111.686 -178.331 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.411 -2.388 0 N-CA-C 104.706 -2.331 . . . . 75.439999999999998 104.706 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -113.86 123.95 51.03 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.228 -1.027 . . . . 74.209999999999994 108.228 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 34.8 m -134.86 122.81 22.54 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.789 -0.819 . . . . 73.340000000000003 108.789 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 12.1 p -108.94 144.27 17.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.012 -0.736 . . . . 74.409999999999997 109.012 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -78.79 -77.17 0.17 Allowed 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 108.625 -0.88 . . . . 72.200000000000003 108.625 -176.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 85.8 m -132.82 134.12 44.25 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.133 -0.354 . . . . 65.310000000000002 110.357 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 25.6 t -118.43 129.17 75.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.245 -1.391 . . . . 72.329999999999998 107.245 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.4 p -127.79 132.35 68.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 120.919 -0.313 . . . . 74.010000000000005 111.159 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.16 132.86 11.24 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 108.869 -1.692 . . . . 74.230000000000004 108.869 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -133.86 145.55 49.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.978 0.389 . . . . 73.409999999999997 110.569 -174.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.41 -65.83 3.92 Favored Glycine 0 CA--C 1.5 -0.865 0 N-CA-C 110.631 -0.988 . . . . 64.109999999999999 110.631 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 179.89 118.94 0.06 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 126.614 1.966 . . . . 74.430000000000007 105.738 174.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 35.7 m -141.02 154.14 45.86 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.311 0.485 . . . . 70.340000000000003 112.311 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -118.89 126.76 52.52 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.366 -1.346 . . . . 74.340000000000003 107.366 171.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 2.1 p -139.08 138.51 41.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 123.044 0.215 . . . . 75.040000000000006 110.776 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.9 tt -128.6 122.63 31.39 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.385 -0.598 . . . . 62.219999999999999 109.385 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.4 104.47 17.04 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 C-N-CA 123.915 0.886 . . . . 74.430000000000007 109.772 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.9 -140.43 7.9 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 119.655 -1.26 . . . . 65.400000000000006 113.123 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -100.15 139.75 35.37 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.623 -0.788 . . . . 74.200000000000003 109.521 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -142.08 118.46 10.86 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 103.324 -2.843 . . . . 75.120000000000005 103.324 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -116.84 124.99 50.87 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.329 0.585 . . . . 75.340000000000003 111.508 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 116.44 -41.52 2.1 Favored Glycine 0 N--CA 1.407 -3.277 0 CA-C-N 114.596 -1.184 . . . . 61.399999999999999 110.612 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 67.07 30.08 75.38 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 109.361 -1.496 . . . . 74.430000000000007 109.361 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -141.92 17.39 2.13 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 108.461 -0.941 . . . . 74.040000000000006 108.461 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -114.32 -72.85 0.57 Allowed Glycine 0 N--CA 1.424 -2.11 0 C-N-CA 120.218 -0.991 . . . . 74.439999999999998 110.725 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -79.64 -25.91 41.24 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.049 0.452 . . . . 72.409999999999997 110.049 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 . . . . . 0 C--N 1.302 -1.495 0 N-CA-C 108.6 -0.889 . . . . 74.030000000000001 108.6 178.295 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 109.614 -0.513 . . . . 74.430000000000007 109.614 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . 0.404 ' ND2' ' HA2' ' A' ' 278' ' ' GLY . 44.9 t-20 -117.82 114.83 23.85 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 106.147 -1.797 . . . . 74.299999999999997 106.147 168.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 33.6 m -120.59 137.01 54.64 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.388 0.613 . . . . 54.310000000000002 111.149 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.77 130.31 51.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.851 -1.166 . . . . 64.310000000000002 107.851 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 39.4 ttmt -79.04 -63.97 1.29 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.816 -0.354 . . . . 74.439999999999998 111.911 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -126.51 139.25 53.37 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 118.914 -1.114 . . . . 75.140000000000001 110.261 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.3 mt -130.75 119.57 45.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.634 -0.876 . . . . 74.439999999999998 108.634 -175.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -125.08 115.05 19.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.755 -1.202 . . . . 75.519999999999996 107.755 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.447 HG23 ' CG2' ' A' ' 239' ' ' VAL . 40.4 p -128.24 128.66 45.1 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 120.567 -0.453 . . . . 72.340000000000003 109.838 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -126.6 166.07 18.0 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 119.751 -0.78 . . . . 73.0 112.608 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 71.42 -88.09 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.603 -1.635 . . . . 65.099999999999994 114.311 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . 0.497 ' HD3' ' OE2' ' A' ' 272' ' ' GLU . 0.0 OUTLIER -135.48 26.66 3.43 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.162 -1.051 . . . . 75.439999999999998 108.162 -176.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -69.04 149.45 48.74 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.598 -0.728 . . . . 72.230000000000004 111.245 -174.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.83 134.9 53.52 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 105.932 -1.877 . . . . 74.310000000000002 105.932 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.447 ' CG2' HG23 ' A' ' 233' ' ' THR . 9.8 t -135.17 139.0 47.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.981 0.419 . . . . 65.310000000000002 110.659 -170.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.425 ' HG2' ' CG2' ' A' ' 244' ' ' VAL . 6.3 tp-100 -131.2 135.28 47.26 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.595 -1.261 . . . . 72.510000000000005 107.595 172.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.1 tt -130.42 120.2 23.85 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.947 -1.501 . . . . 73.329999999999998 106.947 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.596 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 128.93 -113.91 1.65 Allowed Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.7 -0.762 . . . . 61.340000000000003 111.386 177.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -144.39 144.33 31.37 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.613 -0.345 . . . . 74.129999999999995 110.087 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.425 ' CG2' ' HG2' ' A' ' 240' ' ' GLN . 83.6 t -118.75 118.3 57.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.811 -1.181 . . . . 63.439999999999998 107.811 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.57 112.8 35.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 N-CA-C 109.135 -0.691 . . . . 71.5 109.135 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.417 HG22 ' HA3' ' A' ' 282' ' ' GLY . 8.9 t -94.92 161.0 14.33 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.034 -1.066 . . . . 74.299999999999997 109.863 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.45 -33.61 75.94 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.42 0.688 . . . . 51.210000000000001 111.778 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.83 65.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.399 -0.819 . . . . 75.340000000000003 111.579 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.028 -0.533 . . . . 73.430000000000007 111.706 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 25.8 p . . . . . 0 N--CA 1.434 -1.246 0 N-CA-C 108.554 -0.906 . . . . 64.239999999999995 108.554 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 7.9 t30 -117.99 138.46 52.18 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.419 -0.912 . . . . 75.25 111.065 -176.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 39.8 m -138.59 123.33 18.69 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.147 -0.479 . . . . 74.510000000000005 109.935 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 10.7 p -128.89 145.59 35.5 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-N 116.259 -0.428 . . . . 74.140000000000001 110.939 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 12.0 mm-40 -84.66 -75.68 0.34 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.429 -0.351 . . . . 70.010000000000005 110.945 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.7 p -118.36 127.91 54.14 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.659 0.614 . . . . 64.219999999999999 112.659 -175.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 26.7 m -124.87 127.11 72.33 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 109.396 -0.594 . . . . 74.219999999999999 109.396 174.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.14 132.18 70.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 121.205 0.526 . . . . 74.349999999999994 111.863 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.519 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -113.66 131.67 10.11 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 109.919 -1.272 . . . . 75.420000000000002 109.919 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -132.12 116.42 17.01 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 111.99 0.367 . . . . 74.530000000000001 111.99 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 92.96 -123.39 7.32 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 120.747 -0.74 . . . . 72.25 112.386 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.497 ' OE2' ' HD3' ' A' ' 236' ' ' ARG . 40.9 mm-40 -92.39 35.48 1.01 Allowed 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.333 1.053 . . . . 73.400000000000006 109.335 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 50.1 m -81.68 144.36 31.22 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.069 0.938 . . . . 54.549999999999997 111.04 -174.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -130.5 126.73 37.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 104.809 -2.293 . . . . 72.310000000000002 104.809 176.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.94 134.0 41.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 121.565 0.697 . . . . 73.25 111.509 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.411 HD11 ' CG ' ' A' ' 240' ' ' GLN . 11.0 tp -120.23 121.64 39.17 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.228 -0.896 . . . . 74.099999999999994 110.671 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.419 HG23 HD11 ' B' ' 241' ' ' LEU . 81.6 mt -104.39 104.27 16.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 114.107 -1.406 . . . . 75.099999999999994 108.073 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 140.22 -153.86 23.66 Favored Glycine 0 N--CA 1.427 -1.918 0 C-N-CA 120.181 -1.009 . . . . 70.530000000000001 113.866 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -91.96 128.48 37.82 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.828 0.851 . . . . 74.420000000000002 110.295 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -111.1 118.69 36.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.838 -2.282 . . . . 71.439999999999998 104.838 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -120.02 122.23 40.67 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.473 -1.306 . . . . 73.299999999999997 107.473 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.417 ' HA3' HG22 ' A' ' 246' ' ' THR . . . 125.24 -41.38 1.7 Allowed Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.351 -1.295 . . . . 71.340000000000003 110.744 -175.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 125.05 -57.96 0.67 Allowed Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 110.46 -1.056 . . . . 64.219999999999999 110.46 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -145.08 80.6 1.62 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.084 0.945 . . . . 72.430000000000007 112.517 177.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -100.86 -40.35 2.91 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 114.748 -1.115 . . . . 52.329999999999998 110.467 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -69.81 -36.53 75.71 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.17 0.51 . . . . 74.0 110.477 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . 0.441 ' CZ2' ' HE1' ' B' ' 286' ' ' PHE . 27.8 m-90 . . . . . 0 C--N 1.295 -1.763 0 N-CA-C 108.481 -0.933 . . . . 74.329999999999998 108.481 175.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 . . . . . 0 N--CA 1.428 -1.532 0 CA-C-O 120.85 0.357 . . . . 73.019999999999996 110.893 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.455 ' ND2' ' HA2' ' B' ' 278' ' ' GLY . 38.3 t-20 -117.17 127.79 54.47 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.615 -1.624 . . . . 63.43 106.615 169.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 58.0 m -129.98 137.25 50.21 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-O 121.625 0.726 . . . . 73.109999999999999 111.078 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -125.63 137.42 53.88 Favored 'General case' 0 N--CA 1.404 -2.756 0 CA-C-N 114.146 -1.388 . . . . 74.010000000000005 107.56 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 3.5 ttmp? -84.28 -70.77 0.55 Allowed 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.309 -0.956 . . . . 73.349999999999994 110.467 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -127.25 137.71 52.93 Favored 'General case' 0 N--CA 1.428 -1.557 0 C-N-CA 119.684 -0.807 . . . . 63.530000000000001 109.736 -174.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 6.3 mt -134.16 117.97 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.207 -1.034 . . . . 64.430000000000007 108.207 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -113.42 119.31 37.18 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.018 -1.104 . . . . 74.010000000000005 108.018 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 233' ' ' THR . . . . . 0.519 ' OG1' ' HA2' ' A' ' 269' ' ' GLY . 22.2 p -116.72 126.95 53.9 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 106.05 -1.833 . . . . 73.329999999999998 106.05 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -134.22 153.93 51.56 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.476 0.655 . . . . 71.439999999999998 112.366 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 71.88 -83.64 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 113.642 -1.617 . . . . 73.409999999999997 114.016 171.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.414 ' HD3' ' N ' ' B' ' 236' ' ' ARG . 0.4 OUTLIER -136.61 42.28 2.51 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 107.964 -1.124 . . . . 75.239999999999995 107.964 -178.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -82.81 139.56 33.45 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.886 -1.052 . . . . 73.519999999999996 111.773 -177.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 5.8 mpt_? -123.74 132.52 53.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 103.751 -2.685 . . . . 72.129999999999995 103.751 173.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 86.7 t -142.93 132.62 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-O 121.604 0.716 . . . . 63.32 112.006 -172.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.552 ' CG ' HD13 ' B' ' 276' ' ' LEU . 55.1 tp60 -112.43 132.02 55.26 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 106.901 -1.518 . . . . 74.230000000000004 106.901 173.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . 0.419 HD11 HG23 ' A' ' 277' ' ' ILE . 1.7 tm? -130.04 117.44 20.03 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.856 -1.164 . . . . 75.219999999999999 107.856 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.571 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 129.08 -114.1 1.68 Allowed Glycine 0 C--N 1.309 -0.935 0 N-CA-C 110.817 -0.913 . . . . 74.540000000000006 110.817 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -145.38 153.66 41.45 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 122.048 -0.678 . . . . 73.239999999999995 110.467 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.551 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 61.7 t -129.53 120.26 50.2 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 108.566 -0.902 . . . . 74.200000000000003 108.566 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.14 112.37 33.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 109.528 -0.545 . . . . 74.340000000000003 109.528 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 246' ' ' THR . . . . . 0.471 HG23 ' HA3' ' B' ' 282' ' ' GLY . 6.7 t -86.82 161.31 18.41 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.577 -0.849 . . . . 75.310000000000002 111.382 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.4 -33.62 75.94 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 122.434 1.111 . . . . 74.519999999999996 109.727 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.64 78.53 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 112.708 -2.042 . . . . 72.219999999999999 113.104 -177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.409 ' HA ' ' HB1' ' C' ' 247' ' ' ALA . . . -60.12 -46.66 88.87 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.186 0.595 . . . . 61.149999999999999 112.031 -174.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.286 -2.183 0 N-CA-C 101.45 -3.537 . . . . 75.349999999999994 101.45 -176.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.421 -1.914 0 CA-C-O 121.473 0.654 . . . . 65.329999999999998 112.764 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 61.8 m -91.19 108.85 20.15 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 106.653 -1.61 . . . . 74.129999999999995 106.653 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . 0.423 HD22 HD11 ' C' ' 241' ' ' LEU . 7.5 t30 -106.25 145.67 31.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.199 0.523 . . . . 72.400000000000006 112.123 -171.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.9 m -138.57 123.86 19.29 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.218 -0.66 . . . . 72.120000000000005 109.218 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 15.0 p -127.37 143.84 39.3 Favored 'Isoleucine or valine' 0 C--O 1.249 1.027 0 N-CA-C 109.802 -0.444 . . . . 72.310000000000002 109.802 178.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.503 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 48.7 mm-40 -90.48 -71.71 0.61 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.559 -0.291 . . . . 64.329999999999998 110.437 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 26.9 m -121.66 127.06 50.39 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.086 -0.646 . . . . 73.400000000000006 110.816 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.87 123.54 56.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 116.086 -0.506 . . . . 75.230000000000004 110.163 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.17 133.92 67.12 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 CA-C-O 121.491 0.662 . . . . 71.200000000000003 112.425 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . 0.504 ' HA2' ' OG1' ' C' ' 233' ' ' THR . . . -111.23 131.64 10.44 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 110.415 -1.074 . . . . 63.25 110.415 175.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -132.89 116.71 16.82 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 123.665 0.786 . . . . 75.549999999999997 111.761 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.42 -133.81 11.75 Favored Glycine 0 C--N 1.299 -1.486 0 N-CA-C 110.711 -0.955 . . . . 54.520000000000003 110.711 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 77.8 mm-40 -85.31 48.14 1.53 Allowed 'General case' 0 C--O 1.258 1.527 0 C-N-CA 123.3 0.64 . . . . 73.040000000000006 109.939 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 273' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 74.7 m -82.09 144.68 30.63 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 122.386 1.089 . . . . 55.009999999999998 111.826 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 7.5 mtm180 -135.66 124.72 24.34 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 106.559 -1.645 . . . . 74.219999999999999 106.559 172.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' C' ' 239' ' ' VAL . 7.4 p -140.5 138.17 36.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-O 121.216 0.532 . . . . 65.120000000000005 111.303 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . 0.552 HD13 ' CG ' ' B' ' 240' ' ' GLN . 4.5 tp -119.43 115.82 24.86 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.463 -0.79 . . . . 71.239999999999995 109.881 175.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 3.9 mp -98.9 103.37 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 N-CA-C 106.332 -1.729 . . . . 71.430000000000007 106.332 177.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 147.74 -157.21 27.28 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 119.563 -1.304 . . . . 52.450000000000003 114.436 178.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -96.44 124.64 40.5 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 124.084 0.954 . . . . 74.030000000000001 109.964 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -111.1 118.98 37.47 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.891 -1.892 . . . . 72.430000000000007 105.891 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . 0.401 ' CD1' HG12 ' C' ' 245' ' ' VAL . 0.9 OUTLIER -119.4 122.52 41.96 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 107.129 -1.434 . . . . 75.439999999999998 107.129 178.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . 0.471 ' HA3' HG23 ' B' ' 246' ' ' THR . . . 130.16 -38.44 1.97 Allowed Glycine 0 N--CA 1.417 -2.61 0 CA-C-N 114.612 -1.177 . . . . 71.319999999999993 111.332 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 116.95 -52.21 0.69 Allowed Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.02 -1.232 . . . . 72.010000000000005 110.02 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . 0.647 ' HD2' ' O ' ' B' ' 284' ' ' LYS . 0.1 OUTLIER -148.5 72.77 1.21 Allowed 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 122.403 1.097 . . . . 73.530000000000001 111.315 -178.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -90.17 -51.86 2.68 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.115 -1.194 . . . . 63.520000000000003 110.115 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.441 ' HE1' ' CZ2' ' A' ' 287' ' ' TRP . 56.3 t80 -65.52 -35.22 80.22 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.416 0.627 . . . . 75.420000000000002 110.561 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.561 ' O ' ' HB2' ' B' ' 284' ' ' LYS . 29.0 m-90 . . . . . 0 C--N 1.309 -1.176 0 N-CA-C 108.151 -1.055 . . . . 74.430000000000007 108.151 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 . . . . . 0 N--CA 1.42 -1.973 0 CA-C-O 121.224 0.535 . . . . 74.430000000000007 109.69 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . 0.475 ' ND2' ' HA2' ' C' ' 278' ' ' GLY . 37.3 t-20 -117.75 128.69 55.13 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 105.906 -1.887 . . . . 75.340000000000003 105.906 170.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.1 m -128.77 136.51 50.63 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-O 121.457 0.646 . . . . 75.450000000000003 110.264 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . 0.548 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.92 127.47 41.82 Favored 'General case' 0 N--CA 1.417 -2.103 0 N-CA-C 107.92 -1.141 . . . . 74.450000000000003 107.92 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 37.7 ttmt -80.26 -60.68 2.23 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.996 -0.682 . . . . 71.209999999999994 112.097 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -126.21 137.49 53.55 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.076 -1.083 . . . . 74.109999999999999 108.076 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 24.8 mt -136.19 117.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.202 -1.036 . . . . 74.400000000000006 108.202 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 92.5 mtt180 -120.11 119.45 33.34 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.19 -1.041 . . . . 73.549999999999997 108.19 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 233' ' ' THR . . . . . 0.504 ' OG1' ' HA2' ' B' ' 269' ' ' GLY . 28.9 p -119.75 127.83 53.19 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.462 -1.681 . . . . 73.430000000000007 106.462 -177.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -133.58 155.31 49.86 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.454 0.645 . . . . 70.430000000000007 112.075 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 46.6 mt-10 72.26 -86.54 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.199 0 CA-C-N 113.896 -1.502 . . . . 71.030000000000001 114.693 170.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.51 ' HD3' ' N ' ' C' ' 236' ' ' ARG . 0.3 OUTLIER -131.11 31.32 4.44 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.654 -0.869 . . . . 73.25 108.654 -177.487 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -75.11 138.39 42.04 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 122.333 1.063 . . . . 75.230000000000004 113.547 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 4.3 mpt_? -123.91 133.37 53.75 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 103.765 -2.68 . . . . 75.439999999999998 103.765 172.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' B' ' 275' ' ' VAL . 85.8 t -141.16 132.31 27.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.252 0.549 . . . . 74.409999999999997 111.218 -174.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . 0.58 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 51.8 tp60 -111.68 128.71 56.15 Favored 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 107.05 -1.463 . . . . 74.540000000000006 107.05 174.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.423 HD11 HD22 ' B' ' 262' ' ' ASN . 1.7 tm? -128.62 117.54 21.4 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.411 -0.959 . . . . 64.230000000000004 108.411 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.527 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 131.4 -111.68 1.11 Allowed Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 110.333 -1.107 . . . . 73.450000000000003 110.333 -177.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -145.71 155.19 42.81 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 122.109 -0.642 . . . . 65.129999999999995 110.371 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . 0.58 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 58.8 t -131.22 122.02 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 108.635 -0.876 . . . . 75.129999999999995 108.635 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . 0.401 HG12 ' CD1' ' B' ' 281' ' ' TYR . 2.7 p -122.18 112.01 32.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.54 -0.911 . . . . 74.319999999999993 108.54 173.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 246' ' ' THR . . . . . 0.427 HG21 ' HA3' ' C' ' 282' ' ' GLY . 5.0 t -81.39 162.38 23.39 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.225 0.824 . . . . 72.219999999999999 113.225 -174.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' B' ' 249' ' ' ALA . . . -60.36 -35.17 75.05 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 124.693 1.197 . . . . 73.329999999999998 109.678 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.49 -34.77 69.41 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.345 -1.298 . . . . 62.200000000000003 111.584 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 CA-C-N 116.129 -0.487 . . . . 62.219999999999999 110.85 -179.612 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.416 -2.143 0 N-CA-C 108.704 -0.85 . . . . 73.25 108.704 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -111.86 141.44 45.48 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.576 -0.738 . . . . 64.420000000000002 111.497 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 22.0 m -134.74 124.09 24.67 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.073 -1.084 . . . . 75.230000000000004 108.073 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.23 143.8 39.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.863 0.363 . . . . 72.349999999999994 110.613 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 53.9 mm-40 -80.42 -65.43 1.01 Allowed 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 115.955 -0.566 . . . . 63.350000000000001 111.459 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 59.2 m -140.8 130.79 24.61 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.107 -0.637 . . . . 62.25 110.906 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.0 m -123.51 133.88 67.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.852 -0.613 . . . . 73.129999999999995 109.393 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 8.3 p -128.02 140.23 49.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 116.181 -0.463 . . . . 75.329999999999998 109.945 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.03 132.87 9.61 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.988 -1.245 . . . . 73.5 109.988 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -131.36 141.19 49.85 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.25 0.62 . . . . 74.219999999999999 110.177 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 70.64 -132.02 22.05 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.883 -0.675 . . . . 65.219999999999999 112.166 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -85.94 49.35 1.76 Allowed 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 123.582 0.753 . . . . 75.329999999999998 110.502 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 273' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 67.9 m -83.22 145.07 29.36 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.602 0.964 . . . . 72.239999999999995 113.602 -174.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 41.7 mtt180 -138.68 125.68 21.23 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 103.586 -2.746 . . . . 75.400000000000006 103.586 172.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . 0.403 ' CG1' HG23 ' C' ' 239' ' ' VAL . 4.6 p -140.28 137.78 37.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 C-N-CA 120.297 -0.561 . . . . 73.400000000000006 111.827 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.401 HD12 ' CG ' ' C' ' 240' ' ' GLN . 13.0 tp -113.15 112.43 23.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.644 0.735 . . . . 74.010000000000005 109.74 175.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 30.7 mt -101.21 103.29 14.66 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 104.996 -2.224 . . . . 75.310000000000002 104.996 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 144.26 -159.63 27.73 Favored Glycine 0 N--CA 1.42 -2.384 0 C-N-CA 118.916 -1.611 . . . . 75.040000000000006 113.863 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -92.6 129.41 38.54 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.793 -0.703 . . . . 74.400000000000006 109.848 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -111.99 122.35 47.51 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 105.435 -2.061 . . . . 71.349999999999994 105.435 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.75 124.26 40.62 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 108.517 -0.92 . . . . 74.430000000000007 108.517 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . 0.427 ' HA3' HG21 ' C' ' 246' ' ' THR . . . 122.42 -34.65 3.73 Favored Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.628 -0.715 . . . . 53.420000000000002 112.087 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 122.88 -62.63 0.55 Allowed Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.886 -0.673 . . . . 72.519999999999996 111.645 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . 0.609 ' HD2' ' O ' ' C' ' 284' ' ' LYS 0.255 0.1 OUTLIER -136.0 70.02 1.42 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.855 0.836 . . . . 74.450000000000003 112.171 178.525 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.29 -64.06 1.96 Allowed Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.66 -1.257 . . . . 70.430000000000007 110.749 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -65.03 -24.32 67.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.637 0.732 . . . . 74.310000000000002 110.911 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 . . . . . 0 C--N 1.307 -1.248 0 CA-C-N 115.804 -0.634 . . . . 75.319999999999993 110.354 179.041 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 23.6 ptt85 . . . . . 0 N--CA 1.434 -1.255 0 CA-C-O 121.135 0.493 . . . . 71.510000000000005 111.984 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -99.3 114.25 27.0 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.201 -1.777 . . . . 72.319999999999993 106.201 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.4 m -126.15 136.66 53.13 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.667 -0.813 . . . . 75.120000000000005 111.756 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -120.71 119.41 32.7 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.171 -1.418 . . . . 64.349999999999994 107.171 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -75.8 -58.2 3.42 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 123.803 0.69 . . . . 74.329999999999998 110.165 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -126.57 140.48 52.4 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.137 0.494 . . . . 73.140000000000001 111.345 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.0 mt -134.16 124.95 47.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.162 -1.051 . . . . 73.540000000000006 108.162 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -128.76 122.74 31.27 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.613 -0.514 . . . . 72.239999999999995 109.613 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 20.2 p -112.31 128.23 56.22 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.269 -1.382 . . . . 75.129999999999995 107.269 171.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -147.37 146.4 29.62 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.815 -1.18 . . . . 75.140000000000001 107.815 -175.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 60.14 72.96 0.5 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.248 0.619 . . . . 75.329999999999998 112.634 -175.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 65.28 22.87 12.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.054 0.541 . . . . 65.450000000000003 112.264 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.41 134.97 36.36 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.274 -0.421 . . . . 73.310000000000002 109.893 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.93 139.99 53.0 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.126 -0.488 . . . . 72.450000000000003 111.636 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 p -124.18 138.49 53.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.545 -0.752 . . . . 74.329999999999998 111.513 -176.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.468 ' HB3' HD21 ' A' ' 276' ' ' LEU . 6.4 tp-100 -111.15 118.64 36.53 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.688 -1.227 . . . . 75.209999999999994 107.688 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.87 118.87 36.7 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.257 -1.016 . . . . 64.310000000000002 108.257 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.564 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 134.89 -136.72 8.73 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.437 -0.887 . . . . 61.399999999999999 111.843 177.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -130.12 128.58 42.11 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.568 -0.901 . . . . 73.510000000000005 108.568 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.4 115.38 43.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.025 -1.102 . . . . 73.109999999999999 108.025 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 45.5 t -113.87 114.39 46.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.701 -0.851 . . . . 63.409999999999997 108.701 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.443 ' HB ' ' HA3' ' A' ' 282' ' ' GLY . 10.7 m -105.06 161.15 14.48 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.895 -1.15 . . . . 74.329999999999998 107.895 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.73 72.34 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.991 0.916 . . . . 75.140000000000001 113.087 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.59 -34.49 64.88 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.899 1.444 . . . . 51.200000000000003 114.899 -174.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . 0.446 ' HB2' ' N ' ' A' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.321 -0.644 0 N-CA-C 113.801 1.038 . . . . 73.409999999999997 113.801 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 N--CA 1.415 -2.189 0 CA-C-O 121.814 0.816 . . . . 71.049999999999997 108.863 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -124.69 138.37 54.3 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.372 -1.344 . . . . 73.430000000000007 107.372 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.6 m -137.63 123.83 20.48 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.935 -0.706 . . . . 74.129999999999995 111.953 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 11.7 p -122.46 137.76 54.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 115.864 -0.607 . . . . 73.140000000000001 109.721 175.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.573 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 3.7 tp10 -79.0 -65.34 1.01 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.055 -0.52 . . . . 74.200000000000003 109.937 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 30.8 m -136.97 129.78 30.53 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 121.77 -0.581 . . . . 74.420000000000002 111.973 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 35.3 m -117.79 126.45 74.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 N-CA-C 108.368 -0.975 . . . . 74.140000000000001 108.368 174.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.93 126.68 66.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 121.38 0.61 . . . . 75.109999999999999 111.518 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.57 132.49 11.0 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 109.937 -1.265 . . . . 73.5 109.937 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 30.5 mmmt -133.13 116.43 16.29 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.514 0.726 . . . . 74.540000000000006 110.284 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.43 86.29 0.9 Allowed Glycine 0 C--N 1.296 -1.67 0 C-N-CA 119.483 -1.342 . . . . 64.340000000000003 113.734 174.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 55.23 31.01 15.65 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.635 1.174 . . . . 72.530000000000001 111.618 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 23.6 m -83.04 149.18 27.1 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.485 0.66 . . . . 64.310000000000002 112.169 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -119.49 128.15 53.71 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.69 -0.856 . . . . 74.329999999999998 108.69 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 24.7 t -122.54 129.99 74.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.999 -0.741 . . . . 74.099999999999994 108.999 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 286' ' ' PHE . 0.9 OUTLIER -119.78 117.36 27.99 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.556 -1.646 . . . . 73.230000000000004 106.556 173.321 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . 0.456 HG21 HD13 ' B' ' 241' ' ' LEU . 42.7 mm -112.89 104.89 17.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.411 -0.959 . . . . 75.230000000000004 108.411 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 144.31 -127.7 3.05 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 119.746 -1.216 . . . . 71.209999999999994 113.007 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -128.36 150.76 49.95 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 120.711 0.291 . . . . 73.109999999999999 110.404 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -129.15 123.62 32.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.803 -1.925 . . . . 74.340000000000003 105.803 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -120.45 123.54 43.23 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.016 -1.475 . . . . 74.230000000000004 107.016 174.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . 0.446 ' N ' ' HB2' ' A' ' 249' ' ' ALA . . . 145.36 -82.49 0.2 Allowed Glycine 0 N--CA 1.412 -2.923 0 C-N-CA 118.905 -1.617 . . . . 72.439999999999998 112.692 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -142.02 16.97 2.56 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.71 -1.233 . . . . 73.030000000000001 113.317 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.487 ' CD ' ' HA ' ' B' ' 286' ' ' PHE . 62.7 mttm 71.57 -38.28 0.42 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.887 1.675 . . . . 71.239999999999995 113.843 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.512 ' HA2' ' CD1' ' B' ' 287' ' ' TRP . . . -72.0 -28.84 67.84 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 117.391 1.717 . . . . 61.509999999999998 117.391 -170.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 276' ' ' LEU 0.325 51.9 p90 53.33 -78.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.468 1.107 . . . . 63.43 113.917 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.3 m0 . . . . . 0 C--N 1.319 -0.76 0 O-C-N 121.677 -0.639 . . . . 73.019999999999996 110.051 177.695 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 . . . . . 0 CA--C 1.504 -0.81 0 N-CA-C 113.561 0.949 . . . . 72.430000000000007 113.561 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -101.04 114.38 28.27 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 104.408 -2.442 . . . . 75.099999999999994 104.408 167.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 55.6 m -130.2 136.01 48.77 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 118.875 -1.13 . . . . 75.409999999999997 112.885 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -120.53 126.0 49.26 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.559 -1.655 . . . . 72.549999999999997 107.443 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 13.2 tmtt? -86.29 -59.34 2.31 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 116.137 -0.483 . . . . 74.540000000000006 110.747 -176.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -126.24 138.26 53.61 Favored 'General case' 0 C--O 1.25 1.12 0 C-N-CA 119.524 -0.87 . . . . 73.299999999999997 109.352 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . 0.404 HG21 HG21 ' B' ' 239' ' ' VAL . 28.1 mt -130.54 121.59 51.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.803 -1.184 . . . . 74.120000000000005 107.803 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 29.3 ttt180 -127.03 118.45 24.47 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-O 121.049 0.452 . . . . 75.230000000000004 109.987 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 24.9 p -109.57 127.55 54.57 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.635 -1.987 . . . . 74.409999999999997 105.635 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.614 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 33.5 tt0 -139.81 138.54 35.9 Favored 'General case' 0 N--CA 1.406 -2.674 0 C-N-CA 119.977 -0.689 . . . . 71.239999999999995 109.564 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . 0.624 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 46.8 mt-10 60.69 91.39 0.06 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.961 1.097 . . . . 75.519999999999996 113.961 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.624 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 61.35 23.79 13.98 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.999 0.92 . . . . 74.409999999999997 110.598 175.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -94.57 144.52 25.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.84 -0.618 . . . . 65.040000000000006 110.973 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -125.16 142.27 51.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.549 -1.278 . . . . 72.400000000000006 107.549 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.5 p -130.75 131.98 64.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 121.479 0.657 . . . . 73.420000000000002 110.699 174.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.509 ' CG ' HD11 ' B' ' 276' ' ' LEU . 5.8 tp-100 -108.15 120.71 43.11 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 105.807 -1.923 . . . . 74.430000000000007 105.807 173.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . 0.456 HD13 HG21 ' A' ' 277' ' ' ILE . 3.1 tm? -125.86 117.68 23.88 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.332 -0.988 . . . . 71.519999999999996 108.332 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.27 -122.49 2.55 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.768 -0.73 . . . . 72.439999999999998 111.423 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -144.32 128.1 17.28 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.094 -0.706 . . . . 71.510000000000005 109.094 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 73.8 t -102.91 117.99 49.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.473 -0.936 . . . . 74.299999999999997 108.473 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.16 112.72 35.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.426 0.631 . . . . 74.230000000000004 109.565 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.2 m -105.49 161.66 14.15 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.555 -0.906 . . . . 75.430000000000007 108.555 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 249' ' ' ALA . . . -56.8 -33.33 66.59 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.848 0.859 . . . . 64.230000000000004 111.919 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.04 -34.14 59.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.453 -1.249 . . . . 74.319999999999993 113.14 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.43 -25.45 65.03 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 122.773 0.429 . . . . 74.430000000000007 112.092 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 tt . . . . . 0 C--O 1.238 0.486 0 N-CA-C 108.594 -0.891 . . . . 72.099999999999994 108.594 -178.124 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.411 -2.405 0 N-CA-C 107.688 -1.227 . . . . 73.340000000000003 107.688 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 91.1 m -91.25 107.87 19.49 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 107.884 -1.154 . . . . 53.310000000000002 107.884 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -120.9 131.31 54.31 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.388 -1.278 . . . . 74.400000000000006 107.559 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 51.5 m -138.86 126.49 21.96 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 120.937 0.399 . . . . 73.120000000000005 110.897 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.3 138.0 53.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.798 -0.761 . . . . 74.109999999999999 110.349 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.608 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 19.8 tp10 -79.24 -59.29 2.83 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.9 -0.591 . . . . 73.109999999999999 109.686 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 39.7 m -145.4 128.11 16.22 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.62 -0.675 . . . . 71.200000000000003 111.924 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.54 128.22 74.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.18 -1.044 . . . . 74.349999999999994 108.18 173.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 6.5 p -128.02 129.77 69.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-N 116.062 -0.517 . . . . 64.109999999999999 112.139 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . 0.426 ' HA2' ' HG1' ' C' ' 233' ' ' THR . . . -109.6 132.98 11.35 Favored Glycine 0 CA--C 1.475 -2.412 0 N-CA-C 110.037 -1.225 . . . . 73.120000000000005 110.037 176.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 27.3 mmmt -133.9 115.99 15.09 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 123.184 0.594 . . . . 74.340000000000003 111.621 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 77.54 92.29 0.27 Allowed Glycine 0 C--N 1.299 -1.5 0 C-N-CA 119.872 -1.156 . . . . 73.109999999999999 113.588 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 61.59 24.82 14.86 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.886 0.875 . . . . 74.430000000000007 111.638 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 273' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 41.6 m -83.04 152.39 25.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.476 0.917 . . . . 74.120000000000005 113.476 -171.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . 0.447 ' HB3' ' CE3' ' B' ' 287' ' ' TRP . 94.9 mtt180 -128.34 127.96 43.66 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.467 -0.938 . . . . 75.510000000000005 108.467 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 47.2 t -126.28 128.17 71.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 122.41 0.284 . . . . 74.340000000000003 110.304 -175.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . 0.509 HD11 ' CG ' ' B' ' 240' ' ' GLN . 5.8 tp -122.43 114.62 20.97 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.569 -0.852 . . . . 64.310000000000002 110.597 169.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . 0.474 HG21 HD13 ' C' ' 241' ' ' LEU . 40.1 mm -108.01 104.55 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 N-CA-C 106.997 -1.483 . . . . 74.519999999999996 106.997 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.84 -148.95 20.75 Favored Glycine 0 CA--C 1.476 -2.389 0 C-N-CA 119.267 -1.444 . . . . 65.519999999999996 112.98 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 18.4 m120 -112.38 136.59 51.67 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.089 -0.708 . . . . 63.530000000000001 109.089 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . 0.409 ' CD ' ' HZ3' ' A' ' 284' ' ' LYS . 0.0 OUTLIER -111.88 118.81 36.54 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.167 -1.79 . . . . 71.109999999999999 106.167 178.307 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . 0.475 ' CE2' ' HB ' ' C' ' 245' ' ' VAL . 77.7 m-85 -118.98 124.01 45.95 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.012 0.911 . . . . 73.209999999999994 109.921 175.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . 0.406 ' HA3' ' HZ1' ' A' ' 284' ' ' LYS . . . 139.29 -64.92 0.54 Allowed Glycine 0 N--CA 1.412 -2.928 0 C-N-CA 119.745 -1.217 . . . . 75.409999999999997 113.5 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -169.73 37.01 0.19 Allowed Glycine 0 C--O 1.21 -1.381 0 C-N-CA 117.371 -2.347 . . . . 74.519999999999996 115.367 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . 0.472 ' HZ3' ' CD ' ' C' ' 280' ' ' GLU . 64.6 mmtt 70.87 -66.37 0.3 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.637 1.175 . . . . 73.019999999999996 113.188 170.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -81.7 89.84 1.43 Allowed Glycine 0 CA--C 1.494 -1.265 0 CA-C-N 115.458 -0.792 . . . . 63.32 114.033 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.487 ' HA ' ' CD ' ' A' ' 284' ' ' LYS . 6.6 p90 -60.49 -66.45 0.53 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.815 0.846 . . . . 63.32 112.437 176.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.512 ' CD1' ' HA2' ' A' ' 285' ' ' GLY . 5.0 m-90 . . . . . 0 C--N 1.305 -1.358 0 N-CA-C 107.739 -1.208 . . . . 73.409999999999997 107.739 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 . . . . . 0 N--CA 1.422 -1.853 0 CA-C-O 121.276 0.56 . . . . 71.310000000000002 111.146 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -101.17 116.32 32.55 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.674 -1.972 . . . . 74.230000000000004 105.674 173.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 50.0 m -131.58 136.98 48.23 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.542 -0.863 . . . . 73.510000000000005 111.887 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.12 130.93 52.03 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.8 -1.091 . . . . 74.439999999999998 108.308 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.621 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.1 OUTLIER -80.27 -67.83 0.73 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.613 -0.884 . . . . 74.120000000000005 108.613 -178.364 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -125.54 139.19 53.82 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 119.869 -0.732 . . . . 74.239999999999995 109.258 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 20.3 mt -133.42 118.76 32.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.242 -1.392 . . . . 75.109999999999999 107.242 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -120.0 124.52 46.13 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.601 -0.44 . . . . 74.400000000000006 110.222 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 233' ' ' THR . . . . . 0.426 ' HG1' ' HA2' ' B' ' 269' ' ' GLY . 27.8 p -109.58 126.52 53.68 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 104.599 -2.371 . . . . 75.409999999999997 104.599 173.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 32.6 tt0 -140.86 138.81 34.22 Favored 'General case' 0 N--CA 1.415 -2.193 0 C-N-CA 119.804 -0.758 . . . . 70.510000000000005 109.132 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . 0.614 ' C ' ' HD3' ' C' ' 236' ' ' ARG . 56.4 mt-10 62.91 85.74 0.13 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.303 1.002 . . . . 74.519999999999996 112.939 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.681 ' HD3' ' N ' ' C' ' 236' ' ' ARG . 0.1 OUTLIER 64.9 21.82 12.39 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.882 0.873 . . . . 75.430000000000007 111.473 174.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -91.68 147.48 22.97 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.294 0.569 . . . . 54.049999999999997 111.447 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 5.2 mpt_? -125.1 144.41 50.43 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.863 -1.162 . . . . 74.439999999999998 107.863 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.85 135.52 55.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.351 0.596 . . . . 75.140000000000001 111.377 175.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -110.41 117.81 34.59 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 106.913 -1.514 . . . . 74.230000000000004 106.913 172.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.474 HD13 HG21 ' B' ' 277' ' ' ILE . 3.2 tm? -121.88 117.69 27.11 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.947 -1.501 . . . . 75.430000000000007 106.947 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.65 -128.38 4.1 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.551 -0.833 . . . . 70.439999999999998 111.024 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 51.5 t-20 -140.14 128.83 23.08 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.426 -0.953 . . . . 74.019999999999996 108.426 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.23 115.12 44.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.637 -1.246 . . . . 74.310000000000002 107.637 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . 0.475 ' HB ' ' CE2' ' B' ' 281' ' ' TYR . 43.4 t -120.51 112.57 36.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.949 -0.76 . . . . 70.120000000000005 108.949 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.1 m -101.57 160.91 14.04 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.069 -0.715 . . . . 74.329999999999998 109.069 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.91 -31.77 68.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.957 1.303 . . . . 74.109999999999999 110.519 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.31 59.24 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.043 -1.89 . . . . 73.230000000000004 113.616 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.456 0 C-N-CA 120.426 -0.51 . . . . 71.019999999999996 111.412 -176.579 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.42 -1.959 0 CA-C-O 121.561 0.696 . . . . 73.510000000000005 109.259 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -121.24 137.21 54.79 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.803 -1.184 . . . . 75.5 107.803 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 18.1 t -135.95 123.3 21.92 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 108.929 -0.767 . . . . 70.209999999999994 108.929 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.02 131.34 72.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.26 -0.882 . . . . 72.349999999999994 109.119 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.621 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 17.2 tp10 -88.36 -54.76 4.03 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.534 -0.543 . . . . 70.519999999999996 109.534 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 55.0 m -150.22 127.44 11.31 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.349 -0.845 . . . . 72.510000000000005 110.842 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 5.1 m -121.21 128.42 75.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.706 -0.849 . . . . 73.319999999999993 108.706 171.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.09 135.53 63.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 116.34 -0.391 . . . . 74.549999999999997 110.352 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.53 133.49 11.4 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 109.866 -1.294 . . . . 73.540000000000006 109.866 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -132.31 116.24 16.64 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.801 -0.444 . . . . 74.430000000000007 109.801 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.32 93.16 0.56 Allowed Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.345 -0.931 . . . . 64.239999999999995 113.309 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 55.38 28.4 11.42 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.696 1.198 . . . . 75.219999999999999 111.653 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 273' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 46.3 m -82.37 154.89 25.01 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.953 1.094 . . . . 61.409999999999997 113.953 -169.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -122.85 128.26 50.14 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.871 -1.059 . . . . 74.409999999999997 108.254 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 11.0 t -125.64 130.53 72.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.073 -0.714 . . . . 74.519999999999996 109.073 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -123.55 110.59 15.23 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.284 -1.376 . . . . 75.150000000000006 107.284 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 40.8 mm -113.53 103.95 16.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.072 -1.455 . . . . 63.530000000000001 107.072 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.05 -152.65 24.53 Favored Glycine 0 CA--C 1.471 -2.676 0 C-N-CA 120.034 -1.079 . . . . 74.209999999999994 111.216 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.56 141.15 48.44 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 109.213 -0.662 . . . . 73.239999999999995 109.213 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . 0.472 ' CD ' ' HZ3' ' B' ' 284' ' ' LYS . 0.1 OUTLIER -112.69 118.37 34.84 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.143 -1.428 . . . . 74.299999999999997 107.143 -178.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -119.08 124.29 46.55 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.76 0.791 . . . . 71.439999999999998 110.828 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.51 -52.92 0.74 Allowed Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 120.072 -1.061 . . . . 44.119999999999997 113.151 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -151.59 -4.16 0.18 Allowed Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 117.434 -2.317 . . . . 65.129999999999995 115.207 -173.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm 78.47 -40.65 0.28 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.832 1.253 . . . . 72.430000000000007 109.616 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -86.03 110.38 3.47 Favored Glycine 0 N--CA 1.41 -3.067 0 N-CA-C 109.823 -1.311 . . . . 75.239999999999995 109.823 174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -79.97 -85.84 0.08 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 112.88 0.696 . . . . 61.25 112.88 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 7.9 m0 . . . . . 0 C--N 1.316 -0.857 0 O-C-N 120.91 -1.119 . . . . 74.040000000000006 111.486 -176.851 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 . . . . . 0 C--O 1.244 0.767 0 CA-C-O 120.826 0.346 . . . . 75.239999999999995 110.475 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -113.83 127.83 56.16 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.606 -1.257 . . . . 75.420000000000002 107.606 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 28.0 m -123.41 137.66 54.76 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.93 -0.396 . . . . 71.450000000000003 109.93 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.62 125.38 28.63 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.25 -0.432 . . . . 72.120000000000005 110.284 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 12.9 tmtt? -76.3 -62.72 1.52 Allowed 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.723 0.639 . . . . 73.409999999999997 109.749 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -133.72 139.14 46.21 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-O 121.319 0.581 . . . . 72.040000000000006 112.543 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 34.5 mm -123.39 117.12 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 106.774 -1.565 . . . . 72.150000000000006 106.774 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -118.75 115.89 25.41 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.328 0.585 . . . . 74.349999999999994 110.201 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.4 128.27 50.73 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.597 -0.89 . . . . 74.140000000000001 108.597 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -137.1 164.1 29.24 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.258 0.349 . . . . 73.430000000000007 110.607 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 66.99 -88.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.777 1.231 . . . . 74.450000000000003 113.443 174.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.18 27.25 2.62 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 108.174 -1.047 . . . . 73.019999999999996 108.174 -177.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -75.13 149.19 39.13 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.166 -0.925 . . . . 65.209999999999994 110.107 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -125.57 135.06 51.82 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 104.861 -2.274 . . . . 75.099999999999994 104.861 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.14 148.47 30.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.7 0.762 . . . . 73.25 111.924 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.474 ' CG ' ' HG ' ' A' ' 276' ' ' LEU . 49.9 tp60 -126.87 128.58 46.72 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.96 -1.018 . . . . 72.219999999999999 108.878 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -126.48 118.72 25.51 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.66 -1.607 . . . . 74.200000000000003 106.66 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.49 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 135.86 -135.17 7.64 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.197 -1.001 . . . . 61.43 112.409 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -128.82 128.43 43.9 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 122.687 -0.302 . . . . 74.239999999999995 110.272 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 91.3 t -118.29 127.17 75.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.718 -0.845 . . . . 75.129999999999995 108.718 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.11 112.76 39.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.563 -0.902 . . . . 72.319999999999993 108.563 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 50.6 m -81.14 160.08 24.49 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.554 -1.276 . . . . 72.0 107.554 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.49 84.33 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.543 0.571 . . . . 74.450000000000003 112.543 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.54 -34.89 65.11 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 114.32 1.23 . . . . 73.120000000000005 114.32 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 113.75 1.019 . . . . 63.310000000000002 113.75 -173.203 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 36.2 p . . . . . 0 N--CA 1.42 -1.946 0 N-CA-C 106.539 -1.652 . . . . 75.319999999999993 106.539 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.52 122.21 34.51 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.102 -0.703 . . . . 74.400000000000006 109.102 -174.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 35.3 m -122.92 123.15 40.29 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.697 -0.483 . . . . 74.420000000000002 109.697 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.1 p -115.74 140.52 37.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.01 0.433 . . . . 65.209999999999994 110.629 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.588 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 22.7 tp10 -82.78 -69.2 0.64 Allowed 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.165 -0.925 . . . . 73.420000000000002 110.548 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 13.5 m -133.73 129.22 36.4 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 121.535 -0.728 . . . . 74.019999999999996 111.814 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 24.0 m -118.1 127.28 75.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.814 -1.18 . . . . 73.340000000000003 107.814 170.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.72 127.07 73.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-O 121.116 0.484 . . . . 74.439999999999998 111.533 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.84 133.57 11.53 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.623 -0.717 . . . . 64.510000000000005 111.762 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -125.06 144.17 50.54 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 124.179 0.992 . . . . 72.099999999999994 109.28 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 65.21 -132.06 35.99 Favored Glycine 0 C--N 1.305 -1.149 0 C-N-CA 121.212 -0.518 . . . . 74.209999999999994 112.931 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' B' ' 235' ' ' GLU . 8.7 mm-40 -92.79 53.65 2.07 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 125.201 1.4 . . . . 75.099999999999994 111.413 -177.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 73.5 m -83.1 150.03 26.53 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.166 0.508 . . . . 72.340000000000003 112.113 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -128.61 127.47 42.32 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.183 -1.414 . . . . 74.519999999999996 107.183 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 16.4 t -132.71 130.09 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 109.094 -0.706 . . . . 73.120000000000005 109.094 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.474 ' HG ' ' CG ' ' A' ' 240' ' ' GLN . 5.8 tt -118.31 121.55 40.67 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.879 -1.156 . . . . 75.420000000000002 107.879 174.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.23 104.36 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.982 0 N-CA-C 107.303 -1.369 . . . . 73.010000000000005 107.303 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 151.54 -145.27 12.88 Favored Glycine 0 N--CA 1.421 -2.309 0 N-CA-C 111.064 -0.814 . . . . 74.140000000000001 111.064 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.503 ' OD1' ' HB3' ' B' ' 243' ' ' ASN . 95.7 m-20 -114.3 140.2 48.81 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 116.735 0.267 . . . . 72.409999999999997 110.594 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.8 OUTLIER -128.16 129.54 46.68 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.796 -1.557 . . . . 73.209999999999994 106.796 178.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -119.4 124.62 47.0 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 109.349 -0.612 . . . . 75.200000000000003 109.349 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.42 -50.65 0.83 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 111.254 -0.739 . . . . 72.239999999999995 111.254 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 98.12 39.21 3.84 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 109.546 -1.422 . . . . 73.049999999999997 109.546 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -141.04 -56.37 0.5 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.318 -0.553 . . . . 75.129999999999995 109.641 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . 0.601 ' HA3' ' CZ3' ' A' ' 287' ' ' TRP . . . 72.21 -159.53 53.74 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.494 -0.776 . . . . 70.239999999999995 114.907 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -105.24 -0.18 26.62 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.351 -0.425 . . . . 75.25 109.92 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . 0.601 ' CZ3' ' HA3' ' A' ' 285' ' ' GLY . 24.2 m-90 . . . . . 0 C--O 1.237 0.431 0 CA-C-N 115.54 -0.755 . . . . 72.129999999999995 111.944 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 261' ' ' THR . 13.9 ptt180 . . . . . 0 N--CA 1.433 -1.321 0 CA-C-O 121.589 0.709 . . . . 75.109999999999999 111.527 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -116.85 127.63 54.48 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.342 -1.725 . . . . 72.420000000000002 106.342 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 19.5 m -125.75 136.37 53.09 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 109.11 -0.7 . . . . 74.25 109.11 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.39 127.66 37.97 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.808 -0.633 . . . . 75.439999999999998 110.447 -175.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.588 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 12.1 tmtt? -81.73 -68.12 0.72 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.686 -0.688 . . . . 71.239999999999995 109.656 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -127.38 137.48 52.77 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 119.374 -0.93 . . . . 71.230000000000004 110.961 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 35.9 mm -129.77 117.13 40.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 106.544 -1.65 . . . . 74.299999999999997 106.544 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . 0.561 ' HD3' ' OE2' ' B' ' 234' ' ' GLU . 18.2 ttm180 -118.47 124.31 47.29 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 120.696 0.284 . . . . 74.349999999999994 110.59 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 73.1 p -115.46 128.23 55.87 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.252 -1.018 . . . . 72.420000000000002 108.252 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.561 ' OE2' ' HD3' ' B' ' 232' ' ' ARG . 59.3 mt-10 -127.01 156.24 41.94 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.132 0.491 . . . . 74.340000000000003 111.043 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 272' ' ' GLU . 49.3 mt-10 66.68 -86.85 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.443 0 N-CA-C 114.38 1.252 . . . . 75.329999999999998 114.38 172.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . 0.442 ' N ' ' HD2' ' B' ' 236' ' ' ARG . 0.8 OUTLIER -135.59 31.84 3.08 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.31 -0.996 . . . . 64.120000000000005 108.31 -178.297 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -76.56 141.91 40.99 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.106 -0.952 . . . . 74.5 111.745 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 7.1 mpt_? -125.12 133.86 52.68 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.895 -1.52 . . . . 71.329999999999998 106.895 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 21.7 m -140.97 151.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.419 0.628 . . . . 54.229999999999997 112.331 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.52 ' CG ' ' HG ' ' B' ' 276' ' ' LEU . 38.3 tp60 -119.43 137.31 53.85 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.019 -1.446 . . . . 73.109999999999999 108.728 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -129.39 117.96 21.43 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.212 -1.773 . . . . 75.420000000000002 106.212 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.551 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 131.33 -131.8 6.53 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.504 -0.855 . . . . 73.200000000000003 112.886 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . 0.503 ' HB3' ' OD1' ' A' ' 279' ' ' ASN . 23.8 t-20 -125.38 136.3 53.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 122.491 -0.417 . . . . 74.209999999999994 110.912 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 280' ' ' GLU . 93.8 t -126.77 128.36 70.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.366 -0.975 . . . . 74.209999999999994 108.366 175.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 61.9 t -120.38 112.83 38.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.182 -1.044 . . . . 72.549999999999997 108.182 174.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 28.4 m -76.68 160.74 29.11 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 106.776 -1.564 . . . . 73.430000000000007 106.776 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.08 -33.87 76.38 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.109 0.956 . . . . 74.140000000000001 110.74 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.5 -34.4 64.58 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.404 -1.725 . . . . 71.5 114.117 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' B' ' 250' ' ' LEU . . . -59.83 -26.09 65.52 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.562 0.949 . . . . 75.439999999999998 113.562 -174.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' B' ' 249' ' ' ALA . 53.6 tp . . . . . 0 C--O 1.246 0.895 0 O-C-N 124.473 1.108 . . . . 72.219999999999999 110.781 -174.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.436 -1.148 0 CA-C-O 121.055 0.455 . . . . 75.519999999999996 110.831 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -126.77 108.75 11.32 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.356 -1.72 . . . . 62.229999999999997 106.356 166.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 0.2 OUTLIER -124.42 128.25 48.75 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.279 -1.008 . . . . 72.209999999999994 108.279 -172.475 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 33.1 m -129.27 123.66 32.47 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.889 -0.411 . . . . 73.430000000000007 109.889 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.51 141.22 28.77 Favored 'Isoleucine or valine' 0 C--O 1.25 1.121 0 CA-C-N 115.977 -0.556 . . . . 72.519999999999996 109.749 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . 0.535 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 20.7 tp10 -83.37 -58.04 3.0 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.582 -0.735 . . . . 74.409999999999997 110.315 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 266' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' C' ' 230' ' ' ASP . 80.4 m -149.75 133.16 16.55 Favored 'General case' 0 C--N 1.31 -1.125 0 O-C-N 121.372 -0.83 . . . . 73.239999999999995 112.428 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 12.2 m -118.5 134.68 61.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.767 -1.197 . . . . 74.329999999999998 107.767 171.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 m -125.88 122.82 62.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.033 0.444 . . . . 75.230000000000004 110.629 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.99 132.86 11.26 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.466 -0.873 . . . . 74.150000000000006 111.893 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.39 147.12 49.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 124.213 1.005 . . . . 73.129999999999995 109.236 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.41 -136.25 34.23 Favored Glycine 0 C--O 1.228 -0.259 0 C-N-CA 120.009 -1.091 . . . . 71.299999999999997 110.516 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -97.35 69.55 2.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.866 0.841 . . . . 72.430000000000007 111.277 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 72.3 m -85.67 146.46 26.83 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.12 -0.945 . . . . 74.140000000000001 111.366 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 8.8 mpt_? -127.49 127.11 43.47 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.706 -1.59 . . . . 74.519999999999996 106.706 169.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.404 HG11 HG23 ' C' ' 239' ' ' VAL . 21.7 t -134.16 139.13 48.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 108.282 -1.007 . . . . 75.549999999999997 108.282 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . 0.52 ' HG ' ' CG ' ' B' ' 240' ' ' GLN . 6.5 tt -123.56 125.44 44.87 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 106.706 -1.59 . . . . 75.109999999999999 106.706 173.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.57 104.06 16.44 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 105.903 -1.888 . . . . 74.420000000000002 105.903 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 153.35 -149.24 20.74 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.164 -1.017 . . . . 60.210000000000001 113.26 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -110.04 133.56 53.07 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.019 -0.734 . . . . 64.219999999999999 109.019 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' C' ' 244' ' ' VAL . 2.2 tm-20 -126.65 128.08 46.2 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 106.507 -1.664 . . . . 75.430000000000007 106.507 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -118.58 125.06 49.0 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 109.143 -0.688 . . . . 72.519999999999996 109.143 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.02 -43.29 1.24 Allowed Glycine 0 N--CA 1.417 -2.621 0 N-CA-C 110.498 -1.041 . . . . 43.210000000000001 110.498 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.39 36.14 9.0 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.319 -1.512 . . . . 73.109999999999999 109.319 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -142.56 -62.27 0.43 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.873 -0.417 . . . . 71.319999999999993 109.873 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . 0.427 ' HA3' ' CZ3' ' B' ' 287' ' ' TRP . . . 68.95 -159.67 52.66 Favored Glycine 0 N--CA 1.44 -1.079 0 O-C-N 123.408 0.443 . . . . 74.5 113.821 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -102.26 -6.8 22.72 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 121.086 -0.246 . . . . 75.430000000000007 111.223 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . 0.427 ' CZ3' ' HA3' ' B' ' 285' ' ' GLY . 26.6 m-90 . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 121.907 0.86 . . . . 74.430000000000007 110.169 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 . . . . . 0 N--CA 1.439 -1.015 0 CA-C-O 121.301 0.572 . . . . 73.129999999999995 111.753 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 26.5 t-20 -117.28 127.0 53.64 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.743 -1.206 . . . . 73.329999999999998 107.743 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 227' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' C' ' 263' ' ' SER . 19.5 m -126.37 137.22 53.43 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 108.785 -0.82 . . . . 74.5 108.785 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.29 132.39 35.66 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.887 -0.325 . . . . 64.150000000000006 110.639 -176.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . 0.599 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.0 OUTLIER -80.14 -76.34 0.23 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.274 -0.639 . . . . 75.510000000000005 109.274 178.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' B' ' 266' ' ' THR . 2.1 p-10 -129.09 140.51 51.54 Favored 'General case' 0 C--O 1.264 1.848 0 C-N-CA 118.062 -1.455 . . . . 70.230000000000004 112.216 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 28.0 mm -119.27 117.07 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 113.055 -1.884 . . . . 75.450000000000003 106.26 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . 0.452 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 17.9 ttm180 -111.75 123.67 50.73 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.907 -0.405 . . . . 74.319999999999993 109.907 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 72.0 p -116.96 128.37 55.13 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.003 -1.11 . . . . 74.340000000000003 108.003 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . 0.452 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 49.2 mt-10 -127.31 160.74 30.42 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 120.586 -0.446 . . . . 73.319999999999993 111.361 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 63.43 -82.02 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.908 0 C-N-CA 124.94 1.296 . . . . 71.540000000000006 114.343 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.435 ' O ' ' HD2' ' C' ' 238' ' ' ARG . 0.2 OUTLIER -139.44 25.95 2.39 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.595 -0.891 . . . . 74.299999999999997 108.595 -178.433 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -71.23 141.83 50.59 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.826 0.822 . . . . 74.439999999999998 112.106 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 9.1 mpt_? -124.55 133.43 53.3 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 106.454 -1.684 . . . . 75.120000000000005 106.454 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 21.2 m -142.94 150.18 18.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.707 0.765 . . . . 74.329999999999998 112.397 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . 0.41 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 5.2 tp60 -112.33 137.42 50.5 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.248 -1.342 . . . . 73.200000000000003 109.062 176.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' C' ' 277' ' ' ILE . 2.8 tm? -128.13 117.53 21.78 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.278 -2.119 . . . . 74.510000000000005 105.278 172.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.475 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 130.93 -133.07 7.11 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.191 -1.004 . . . . 62.240000000000002 112.721 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -128.99 138.56 52.02 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 122.233 -0.569 . . . . 73.109999999999999 110.716 -176.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' B' ' 280' ' ' GLU . 96.7 t -126.09 118.48 51.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.213 -0.662 . . . . 74.109999999999999 109.213 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.12 112.72 41.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.347 -0.983 . . . . 75.219999999999999 108.347 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 19.4 m -79.52 160.38 26.53 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.054 -1.461 . . . . 61.119999999999997 107.054 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.86 -33.07 72.52 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.1 0.952 . . . . 75.319999999999993 110.644 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.48 -33.33 63.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.236 -1.802 . . . . 75.340000000000003 113.848 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 114.536 1.31 . . . . 74.349999999999994 114.536 -172.534 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.411 -2.376 0 N-CA-C 105.236 -2.135 . . . . 64.120000000000005 105.236 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -126.72 139.0 53.47 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.497 -0.774 . . . . 70.209999999999994 110.922 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 263' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' C' ' 227' ' ' SER . 42.3 m -139.89 123.56 17.33 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 107.863 -1.162 . . . . 74.299999999999997 107.863 176.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.6 p -109.87 152.88 11.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.819 -0.352 . . . . 65.129999999999995 110.104 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 10.1 tp10 -88.25 -69.72 0.68 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.154 -0.475 . . . . 65.209999999999994 109.989 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 90.5 m -140.46 130.73 25.08 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.897 -0.409 . . . . 75.049999999999997 109.897 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.21 133.6 67.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.804 -0.813 . . . . 74.510000000000005 108.804 171.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 29.7 m -121.5 129.05 75.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.166 0.508 . . . . 64.510000000000005 111.154 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.54 133.47 11.5 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.433 -1.067 . . . . 53.32 110.433 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -132.07 131.52 42.48 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.124 0.569 . . . . 74.420000000000002 109.852 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 68.56 -133.02 27.51 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.782 -0.645 . . . . 74.340000000000003 112.263 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -79.35 47.39 0.8 Allowed 'General case' 0 C--N 1.305 -1.37 0 C-N-CA 125.063 1.345 . . . . 71.420000000000002 113.127 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 50.7 m -83.4 145.44 29.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.555 0.693 . . . . 74.519999999999996 112.853 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 10.2 mpt_? -130.6 127.04 38.2 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 106.537 -1.653 . . . . 62.310000000000002 106.537 170.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 10.0 t -137.83 140.73 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 108.771 -0.826 . . . . 72.5 108.771 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . 0.426 ' HB3' ' CZ2' ' C' ' 287' ' ' TRP . 6.8 tt -123.32 114.14 19.8 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.815 -1.18 . . . . 72.310000000000002 107.815 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 3.4 mp -104.57 104.19 16.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 105.532 -2.025 . . . . 75.140000000000001 105.532 176.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 159.26 -139.67 6.36 Favored Glycine 0 N--CA 1.41 -3.059 0 C-N-CA 119.4 -1.381 . . . . 73.230000000000004 112.402 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -127.79 142.97 51.15 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.165 -1.42 . . . . 73.239999999999995 107.165 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -141.93 132.62 25.56 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.218 -0.66 . . . . 60.310000000000002 109.218 -174.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.48 133.58 55.05 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.221 0.534 . . . . 74.129999999999995 111.023 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 122.86 -36.39 3.12 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 110.002 -1.239 . . . . 73.239999999999995 110.002 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 86.28 32.87 15.53 Favored Glycine 0 N--CA 1.419 -2.436 0 N-CA-C 111.422 -0.671 . . . . 64.340000000000003 111.422 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -131.92 -54.78 0.99 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.837 -0.801 . . . . 75.349999999999994 108.837 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . 0.41 ' HA3' ' CE3' ' C' ' 287' ' ' TRP . . . 69.21 -172.28 38.07 Favored Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 115.244 -0.889 . . . . 75.549999999999997 112.45 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -91.2 -5.73 54.47 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 110.429 -0.212 . . . . 73.5 110.429 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' C' ' 276' ' ' LEU . 27.6 m-90 . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 121.55 0.69 . . . . 75.150000000000006 110.518 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.467 ' HG2' ' OG1' ' A' ' 261' ' ' THR . 14.0 ptt180 . . . . . 0 N--CA 1.445 -0.682 0 N-CA-C 109.19 -0.671 . . . . 74.349999999999994 109.19 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -116.19 114.72 24.83 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.063 -0.717 . . . . 63.5 109.063 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 26.9 m -134.83 137.91 43.74 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.453 0.538 . . . . 62.119999999999997 112.453 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.9 135.33 45.51 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.418 -1.327 . . . . 71.200000000000003 107.418 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -55.25 3.36 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.578 -0.849 . . . . 74.420000000000002 110.493 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -139.63 139.05 36.62 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 122.279 -0.263 . . . . 75.450000000000003 110.491 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ILE . . . . . 0.438 HG22 HG21 ' A' ' 239' ' ' VAL . 30.0 mt -137.82 125.8 31.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 108.822 -0.807 . . . . 63.109999999999999 108.822 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 35.2 ttt180 -126.05 122.34 35.55 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.151 -1.055 . . . . 72.329999999999998 108.151 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' THR . . . . . 0.532 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 14.3 t -135.27 130.78 35.69 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 120.014 -0.674 . . . . 65.200000000000003 109.396 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -135.2 140.75 45.56 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 112.177 0.436 . . . . 71.420000000000002 112.177 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 66.68 106.53 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.02 1.328 . . . . 65.329999999999998 113.361 174.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 57.46 35.01 25.41 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.807 1.289 . . . . 75.319999999999993 107.564 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.532 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -83.7 128.71 34.73 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 112.81 -1.996 . . . . 70.450000000000003 112.633 -170.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -129.86 135.06 47.94 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 106.878 -1.527 . . . . 72.409999999999997 106.878 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 6.7 p -143.68 140.1 25.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.646 -0.501 . . . . 74.519999999999996 109.646 175.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . 0.541 ' HB2' ' CD1' ' A' ' 286' ' ' PHE . 11.7 tm0? -125.82 136.99 53.74 Favored 'General case' 0 N--CA 1.405 -2.68 0 N-CA-C 106.431 -1.692 . . . . 75.109999999999999 106.431 177.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 tt -128.73 117.22 20.76 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 105.704 -1.962 . . . . 75.340000000000003 105.704 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.497 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 135.26 -119.23 2.06 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.367 -0.92 . . . . 74.329999999999998 113.338 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -144.43 139.53 28.42 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.032 -1.099 . . . . 73.549999999999997 108.032 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.5 t -125.79 121.44 59.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 109.465 -0.568 . . . . 70.019999999999996 109.465 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.76 112.64 34.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.996 -1.113 . . . . 72.430000000000007 107.996 170.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 281' ' ' TYR . 6.4 t -89.35 160.55 16.79 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.7 -1.2 . . . . 73.409999999999997 109.588 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.67 74.38 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 123.156 0.582 . . . . 74.519999999999996 110.15 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -35.5 66.82 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.167 -0.924 . . . . 53.43 112.138 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.343 0 CA-C-N 116.543 -0.299 . . . . 73.109999999999999 110.614 -179.746 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 225' ' ' ARG . 10.8 t . . . . . 0 N--CA 1.397 -3.082 0 N-CA-C 105.138 -2.171 . . . . 70.319999999999993 105.138 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 23.2 t-20 -122.1 127.07 49.71 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.564 -0.744 . . . . 65.420000000000002 111.786 -168.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.3 t -135.68 123.75 22.91 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 109.046 -0.724 . . . . 73.239999999999995 109.046 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.5 p -126.55 147.42 31.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 109.044 -0.725 . . . . 63.229999999999997 109.044 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -96.91 -75.86 0.53 Allowed 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 119.612 -0.835 . . . . 73.219999999999999 111.208 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 63.3 m -117.33 127.27 53.89 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.336 0.588 . . . . 74.329999999999998 110.831 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.0 123.99 45.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.876 -0.602 . . . . 70.409999999999997 110.903 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 21.6 m -124.4 138.27 54.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.536 -0.756 . . . . 74.420000000000002 111.517 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.2 131.38 7.68 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 109.508 -1.437 . . . . 70.5 109.508 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.31 116.18 14.95 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 122.66 0.384 . . . . 73.409999999999997 110.976 -174.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.47 74.12 1.06 Allowed Glycine 0 N--CA 1.465 0.614 0 C-N-CA 120.079 -1.058 . . . . 74.140000000000001 112.868 172.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 58.37 77.01 0.31 Allowed 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 125.753 1.621 . . . . 70.319999999999993 110.465 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 25.7 m -121.91 143.76 49.26 Favored 'General case' 0 N--CA 1.39 -3.426 0 CA-C-N 114.977 -1.01 . . . . 70.5 109.049 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -122.51 126.15 47.23 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.001 -1.481 . . . . 73.420000000000002 107.001 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 53.2 t -124.13 126.23 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.018 0 O-C-N 123.878 0.736 . . . . 73.420000000000002 109.389 -174.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' LEU . . . . . 0.439 HD22 ' HG2' ' B' ' 240' ' ' GLN . 17.7 tp -122.31 121.47 36.81 Favored 'General case' 0 C--N 1.267 -3.008 0 C-N-CA 118.758 -1.177 . . . . 70.430000000000007 110.749 174.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 74.6 mt -109.75 103.93 16.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.489 -0.93 . . . . 75.200000000000003 108.489 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLY . . . . . 0.518 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 139.64 -141.04 11.29 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.614 -0.803 . . . . 74.040000000000006 112.717 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 44.8 t-20 -123.69 140.08 53.35 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.363 -0.977 . . . . 60.409999999999997 108.363 -176.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.72 119.91 31.16 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.487 -0.931 . . . . 70.530000000000001 108.487 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' TYR . . . . . 0.463 ' O ' HG21 ' A' ' 246' ' ' THR . 22.1 m-85 -103.72 121.78 43.71 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.037 -1.838 . . . . 63.140000000000001 106.037 174.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 110.98 -51.7 0.68 Allowed Glycine 0 N--CA 1.423 -2.193 0 N-CA-C 110.077 -1.209 . . . . 75.040000000000006 110.077 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.528 ' C ' ' HD2' ' A' ' 284' ' ' LYS . . . 84.04 3.45 89.06 Favored Glycine 0 C--O 1.223 -0.567 0 CA-C-O 121.241 0.356 . . . . 62.509999999999998 112.269 177.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.528 ' HD2' ' C ' ' A' ' 283' ' ' GLY . 3.6 mptp? -135.52 18.12 3.35 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.148 0.499 . . . . 75.409999999999997 110.27 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -90.51 -39.72 5.87 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.615 -0.994 . . . . 55.340000000000003 110.615 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 240' ' ' GLN . 29.1 t80 -79.95 -37.49 34.35 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 112.134 0.42 . . . . 73.200000000000003 112.134 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 113.675 0.991 . . . . 74.450000000000003 113.675 -175.859 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 . . . . . 0 N--CA 1.439 -0.986 0 N-CA-C 109.762 -0.458 . . . . 74.439999999999998 109.762 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 226' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 27.4 t-20 -116.55 114.65 24.45 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.08 -0.711 . . . . 74.540000000000006 109.08 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 11.1 p -139.48 137.62 35.7 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 112.644 0.609 . . . . 74.510000000000005 112.644 -177.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -126.53 137.24 53.34 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.819 -1.082 . . . . 73.109999999999999 108.49 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.19 -66.67 0.89 Allowed 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.154 -0.619 . . . . 73.540000000000006 110.418 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -127.0 138.61 53.28 Favored 'General case' 0 C--O 1.264 1.822 0 CA-C-O 121.401 0.619 . . . . 71.109999999999999 109.561 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 231' ' ' ILE . . . . . 0.408 HG22 HG23 ' B' ' 239' ' ' VAL . 8.7 mt -131.48 117.39 35.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.495 -1.298 . . . . 75.209999999999994 107.495 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -116.46 115.65 26.2 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 110.01 -0.367 . . . . 75.049999999999997 110.01 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 22.3 p -114.31 127.54 55.91 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.167 -1.42 . . . . 71.439999999999998 107.167 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -143.31 138.66 29.68 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 109.434 -0.58 . . . . 71.230000000000004 109.434 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 62.59 91.32 0.07 Allowed 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 124.778 1.299 . . . . 72.209999999999994 112.569 171.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 65.59 34.85 7.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.22 -0.659 . . . . 71.439999999999998 109.22 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 237' ' ' ALA . . . . . 0.59 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -101.54 149.26 24.28 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 122.696 1.236 . . . . 75.120000000000005 113.744 -172.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 238' ' ' ARG . . . . . 0.45 ' HD2' ' C ' ' B' ' 237' ' ' ALA . 3.7 mpt_? -134.35 136.37 43.37 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.12 -1.437 . . . . 71.430000000000007 107.12 175.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 239' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 12.1 p -137.17 137.83 46.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-O 121.696 0.76 . . . . 64.219999999999999 109.882 176.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.621 ' HB2' ' CD1' ' B' ' 286' ' ' PHE . 16.5 tm0? -118.29 132.49 56.29 Favored 'General case' 0 N--CA 1.39 -3.469 0 N-CA-C 105.068 -2.197 . . . . 71.129999999999995 105.068 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 241' ' ' LEU . . . . . 0.476 ' CD1' HD22 ' A' ' 262' ' ' ASN . 0.8 OUTLIER -130.32 116.3 18.13 Favored 'General case' 0 C--N 1.263 -3.195 0 N-CA-C 106.957 -1.497 . . . . 75.519999999999996 106.957 178.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 242' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 130.91 -114.15 1.53 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 115.882 -0.599 . . . . 73.099999999999994 112.165 -176.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 243' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 6.8 t30 -144.74 145.75 31.85 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.379 0.59 . . . . 74.099999999999994 110.635 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.437 ' CG2' ' HG3' ' B' ' 240' ' ' GLN . 69.0 t -132.69 126.71 54.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 N-CA-C 109.571 -0.529 . . . . 72.450000000000003 109.571 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 2.7 p -123.86 111.74 30.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.967 -1.123 . . . . 75.209999999999994 107.967 169.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 8.8 t -83.12 160.77 21.8 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.069 -1.052 . . . . 75.200000000000003 111.459 -176.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.12 82.81 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 122.386 1.089 . . . . 62.439999999999998 109.699 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.3 -35.55 73.97 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 113.243 -1.799 . . . . 75.150000000000006 111.6 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 249' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' C' ' 247' ' ' ALA . . . -74.7 -26.84 60.1 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.387 -0.37 . . . . 61.340000000000003 110.863 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 52.8 tp . . . . . 0 N--CA 1.439 -0.994 0 CA-C-O 122.062 0.934 . . . . 73.109999999999999 111.976 -175.564 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.417 -2.088 0 CA-C-O 121.321 0.582 . . . . 70.549999999999997 112.2 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 261' ' ' THR . . . . . 0.412 HG23 ' HA ' ' C' ' 225' ' ' ARG . 5.1 t -104.7 108.13 19.43 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 105.798 -1.927 . . . . 71.319999999999993 105.798 167.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 262' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 25.1 t-20 -116.09 131.18 57.01 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.328 -0.851 . . . . 63.210000000000001 110.902 -172.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -140.97 123.2 15.71 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.163 0.506 . . . . 64.030000000000001 110.529 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 264' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 11.7 p -124.95 152.11 31.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.662 -0.866 . . . . 72.439999999999998 108.662 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -103.2 -56.77 2.16 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 119.273 -0.971 . . . . 73.430000000000007 112.045 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 266' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' C' ' 230' ' ' ASP . 29.5 m -135.86 127.13 28.27 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.029 -1.068 . . . . 74.310000000000002 111.35 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 21.6 m -123.62 134.3 66.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.138 -0.689 . . . . 71.549999999999997 109.138 171.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 29.3 m -127.69 134.6 65.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.99 -0.55 . . . . 74.120000000000005 110.514 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.57 131.58 5.57 Favored Glycine 0 CA--C 1.476 -2.405 0 C-N-CA 119.254 -1.451 . . . . 52.0 112.621 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 270' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 62.9 tttp -135.57 144.9 46.45 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.278 0.634 . . . . 72.120000000000005 110.864 176.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 81.02 52.73 4.19 Favored Glycine 0 CA--C 1.486 -1.78 0 C-N-CA 120.877 -0.677 . . . . 62.030000000000001 112.238 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 65.11 89.18 0.1 Allowed 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.548 1.139 . . . . 75.230000000000004 109.835 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 273' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 21.0 m -121.75 144.12 48.98 Favored 'General case' 0 N--CA 1.405 -2.695 0 C-N-CA 119.652 -0.819 . . . . 73.310000000000002 110.162 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 29.0 mmt-85 -117.22 126.8 53.35 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 104.48 -2.415 . . . . 75.140000000000001 104.48 171.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 275' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 62.0 t -132.63 123.94 50.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 108.772 -0.825 . . . . 71.219999999999999 108.772 -178.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 8.7 tt -120.48 128.39 53.1 Favored 'General case' 0 C--N 1.268 -2.946 0 C-N-CA 117.595 -1.642 . . . . 74.409999999999997 110.693 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 277' ' ' ILE . . . . . 0.429 HG21 HD11 ' C' ' 241' ' ' LEU . 50.7 mt -112.58 102.63 14.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 106.467 -1.679 . . . . 75.319999999999993 106.467 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 278' ' ' GLY . . . . . 0.587 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 144.09 -136.02 6.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.69 -1.243 . . . . 73.349999999999994 114.245 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 279' ' ' ASN . . . . . 0.484 ' ND2' ' HB3' ' C' ' 243' ' ' ASN . 9.0 t-20 -127.3 141.42 51.72 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.88 -1.156 . . . . 75.109999999999999 107.88 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 280' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' C' ' 244' ' ' VAL . 0.2 OUTLIER -131.01 120.07 22.95 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.818 -0.808 . . . . 71.200000000000003 108.818 -177.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -103.31 122.38 44.68 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 106.713 -1.588 . . . . 74.319999999999993 106.713 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 110.71 -51.73 0.68 Allowed Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.828 -0.909 . . . . 63.219999999999999 110.828 -176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 283' ' ' GLY . . . . . 0.44 ' C ' ' HD2' ' B' ' 284' ' ' LYS . . . 88.41 -8.4 78.93 Favored Glycine 0 C--N 1.314 -0.656 0 N-CA-C 111.618 -0.593 . . . . 54.240000000000002 111.618 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 284' ' ' LYS . . . . . 0.44 ' HD2' ' C ' ' B' ' 283' ' ' GLY . 4.0 mptp? -124.97 17.53 8.53 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 120.913 0.387 . . . . 75.340000000000003 110.681 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -81.49 -60.03 2.28 Favored Glycine 0 N--CA 1.418 -2.507 0 N-CA-C 109.098 -1.601 . . . . 71.140000000000001 109.098 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 286' ' ' PHE . . . . . 0.621 ' CD1' ' HB2' ' B' ' 240' ' ' GLN . 28.1 t80 -67.4 -39.4 85.55 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 124.393 0.702 . . . . 65.129999999999995 112.228 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 9.9 m-90 . . . . . 0 C--N 1.307 -1.27 0 N-CA-C 114.143 1.164 . . . . 75.409999999999997 114.143 -176.279 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 225' ' ' ARG . . . . . 0.412 ' HA ' HG23 ' B' ' 261' ' ' THR . 14.5 ptt-85 . . . . . 0 CA--C 1.492 -1.275 0 N-CA-C 110.106 -0.331 . . . . 72.409999999999997 110.106 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 226' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 26.6 t-20 -116.81 114.22 23.64 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.451 -1.314 . . . . 63.539999999999999 107.451 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 227' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' C' ' 263' ' ' SER . 12.9 t -135.16 137.64 42.93 Favored 'General case' 0 N--CA 1.411 -2.408 0 CA-C-O 121.226 0.536 . . . . 70.040000000000006 109.931 -175.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . 0.65 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -132.44 135.01 45.78 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.24 -1.392 . . . . 74.200000000000003 107.24 177.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -57.12 3.17 Favored 'General case' 0 C--N 1.287 -2.145 0 C-N-CA 119.793 -0.763 . . . . 75.140000000000001 109.828 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 230' ' ' ASP . . . . . 0.538 ' O ' ' HA ' ' C' ' 266' ' ' THR . 30.8 t70 -139.36 138.96 37.05 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.992 0.425 . . . . 75.109999999999999 110.651 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 231' ' ' ILE . . . . . 0.444 HG21 ' CG2' ' C' ' 267' ' ' VAL . 6.0 mt -137.28 117.64 16.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.18 -1.044 . . . . 73.450000000000003 108.18 -176.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -111.81 117.17 32.09 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.084 0.469 . . . . 75.219999999999999 111.233 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 233' ' ' THR . . . . . 0.441 ' HB ' ' CB ' ' C' ' 237' ' ' ALA . 15.7 p -110.53 128.32 55.58 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.56 -0.745 . . . . 75.5 109.569 176.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 234' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 28.6 tt0 -143.21 137.01 28.68 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.244 -1.021 . . . . 73.209999999999994 108.244 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 57.81 106.18 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.14 1.533 . . . . 72.200000000000003 115.14 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 236' ' ' ARG . . . . . 0.411 ' HB2' ' HA ' ' C' ' 272' ' ' GLU . 5.5 mpt_? 59.34 33.07 22.31 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.242 -0.651 . . . . 65.329999999999998 109.242 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 237' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -96.38 138.14 34.42 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 113.755 1.02 . . . . 74.329999999999998 113.755 -168.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 238' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 5.0 mpt_? -133.45 134.73 43.93 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.022 -1.103 . . . . 71.140000000000001 108.022 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 239' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 17.3 m -138.01 145.81 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 CA-C-O 122.065 0.936 . . . . 72.030000000000001 111.02 171.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 240' ' ' GLN . . . . . 0.51 ' HB2' ' CD1' ' C' ' 286' ' ' PHE . 0.3 OUTLIER -126.06 122.86 37.02 Favored 'General case' 0 C--N 1.26 -3.284 0 N-CA-C 104.425 -2.435 . . . . 73.230000000000004 104.425 176.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 241' ' ' LEU . . . . . 0.429 HD11 HG21 ' B' ' 277' ' ' ILE . 0.8 OUTLIER -121.77 115.4 22.6 Favored 'General case' 0 C--N 1.26 -3.319 0 N-CA-C 106.992 -1.485 . . . . 75.409999999999997 106.992 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 242' ' ' GLY . . . . . 0.587 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 131.14 -121.71 3.26 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 115.527 -0.76 . . . . 72.310000000000002 111.477 -174.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 243' ' ' ASN . . . . . 0.484 ' HB3' ' ND2' ' B' ' 279' ' ' ASN . 48.9 t-20 -145.1 141.34 28.73 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.035 0.917 . . . . 54.409999999999997 110.648 -177.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 244' ' ' VAL . . . . . 0.458 HG22 ' NE2' ' C' ' 240' ' ' GLN . 80.9 t -131.36 131.45 63.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 C-N-CA 123.334 0.654 . . . . 72.239999999999995 110.623 178.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 6.1 p -122.42 116.77 50.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.426 -1.694 . . . . 64.340000000000003 106.426 168.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 15.0 t -77.21 160.58 28.82 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.467 -1.293 . . . . 71.019999999999996 111.581 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 247' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.4 -39.17 93.33 Favored 'General case' 0 CA--C 1.492 -1.25 0 CA-C-N 115.715 -0.675 . . . . 75.109999999999999 109.525 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.67 -33.4 60.72 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.517 -1.674 . . . . 71.340000000000003 112.102 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.654 0 CA-C-N 116.382 -0.372 . . . . 75.109999999999999 111.268 179.286 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 13.9 t . . . . . 0 N--CA 1.409 -2.502 0 N-CA-C 105.192 -2.151 . . . . 72.549999999999997 105.192 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -123.59 137.53 54.73 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.241 -0.89 . . . . 73.420000000000002 111.36 -166.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 263' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' C' ' 227' ' ' SER . 49.0 m -142.59 123.9 14.71 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.013 -0.736 . . . . 74.010000000000005 109.013 175.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.5 p -128.64 151.85 35.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.736 -0.468 . . . . 73.420000000000002 109.736 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.49 -80.21 0.19 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 109.421 -0.585 . . . . 71.239999999999995 109.421 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 266' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 8.1 t -139.22 129.29 25.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.751 -0.593 . . . . 75.420000000000002 109.995 -177.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 267' ' ' VAL . . . . . 0.444 ' CG2' HG21 ' C' ' 231' ' ' ILE . 27.0 m -120.78 135.3 61.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 116.254 -0.43 . . . . 74.329999999999998 110.033 177.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.25 140.98 45.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 116.357 -0.383 . . . . 74.109999999999999 110.604 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.43 131.53 6.11 Favored Glycine 0 CA--C 1.474 -2.483 0 N-CA-C 110.342 -1.103 . . . . 72.409999999999997 110.342 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -135.06 119.88 18.41 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.998 -1.112 . . . . 74.030000000000001 107.998 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.95 76.95 1.02 Allowed Glycine 0 N--CA 1.465 0.608 0 C-N-CA 120.829 -0.7 . . . . 70.439999999999998 113.178 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 272' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' C' ' 236' ' ' ARG . 45.8 mt-10 63.03 82.38 0.18 Allowed 'General case' 0 CA--C 1.48 -1.718 0 C-N-CA 124.689 1.196 . . . . 73.439999999999998 110.478 -178.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 51.7 m -125.48 143.71 50.87 Favored 'General case' 0 N--CA 1.399 -3.021 0 C-N-CA 119.036 -1.066 . . . . 73.510000000000005 109.9 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 274' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 79.0 mtt85 -136.61 126.05 25.07 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 104.148 -2.538 . . . . 75.200000000000003 104.148 174.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 275' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 8.1 t -138.1 134.41 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 N-CA-C 108.012 -1.107 . . . . 74.349999999999994 108.012 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 8.9 tt -119.74 115.51 24.05 Favored 'General case' 0 N--CA 1.384 -3.767 0 C-N-CA 118.846 -1.141 . . . . 74.099999999999994 108.991 174.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.0 mp -93.59 102.43 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 104.52 -2.4 . . . . 75.439999999999998 104.52 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 278' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 139.21 -147.01 18.87 Favored Glycine 0 CA--C 1.49 -1.482 0 C-N-CA 119.317 -1.42 . . . . 72.319999999999993 113.888 -177.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -118.56 149.37 41.46 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.563 -1.273 . . . . 73.219999999999999 107.563 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 280' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' C' ' 244' ' ' VAL . 15.6 tm-20 -146.36 121.11 9.87 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.839 -1.911 . . . . 75.209999999999994 105.839 -176.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -104.12 125.05 50.13 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.58 -0.896 . . . . 75.239999999999995 108.58 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 119.46 -47.32 1.04 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 111.298 -0.721 . . . . 74.140000000000001 111.298 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 283' ' ' GLY . . . . . 0.496 ' C ' ' HD2' ' C' ' 284' ' ' LYS . . . 94.86 -9.71 70.58 Favored Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 111.022 -0.831 . . . . 62.43 111.022 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 284' ' ' LYS . . . . . 0.496 ' HD2' ' C ' ' C' ' 283' ' ' GLY . 13.4 mptt -126.92 6.35 6.61 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.766 -0.717 . . . . 73.140000000000001 112.69 -172.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -73.14 -57.96 4.94 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 119.802 -1.189 . . . . 50.310000000000002 112.182 -176.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 286' ' ' PHE . . . . . 0.51 ' CD1' ' HB2' ' C' ' 240' ' ' GLN . 23.0 t80 -75.67 -31.23 59.69 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.633 1.345 . . . . 74.439999999999998 114.633 -174.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 . . . . . 0 C--N 1.308 -1.218 0 N-CA-C 115.405 1.632 . . . . 65.209999999999994 115.405 -172.915 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.483 ' SD ' ' HG3' ' A' ' 218' ' ' LYS . 1.9 tmt? . . . . . 0 CA--C 1.518 -0.27 0 N-CA-C 107.031 -1.47 . . . . 75.129999999999995 107.031 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.483 ' HG3' ' SD ' ' A' ' 217' ' ' MET . 99.1 mttt -139.31 91.55 2.51 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.451 -1.314 . . . . 73.430000000000007 107.451 170.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.8 pt -122.88 136.5 59.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.756 0.789 . . . . 74.439999999999998 112.495 -174.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -121.21 -25.85 5.19 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.592 -1.185 . . . . 75.439999999999998 108.347 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -93.88 120.56 34.3 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.013 -1.106 . . . . 75.109999999999999 108.013 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 86.4 mt -83.61 138.64 18.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.685 0.755 . . . . 73.230000000000004 111.222 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.7 t -99.5 119.49 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.833 0 CA-C-N 114.963 -1.017 . . . . 63.109999999999999 108.369 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.421 ' HA2' ' HB ' ' A' ' 261' ' ' THR . . . 149.39 82.77 0.04 OUTLIER Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 109.637 -1.385 . . . . 72.230000000000004 109.637 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -106.4 139.59 40.64 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.21 0.448 . . . . 73.439999999999998 112.21 -174.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 9.2 t30 -104.39 120.56 41.49 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.055 -1.461 . . . . 75.439999999999998 107.055 167.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 42.5 m -121.59 146.18 47.23 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 120.838 0.352 . . . . 75.120000000000005 111.359 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 264' ' ' VAL . . . -138.66 144.58 39.72 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.548 -1.279 . . . . 72.420000000000002 107.548 175.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -97.71 -60.01 1.65 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.127 0.489 . . . . 72.420000000000002 110.176 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.95 139.45 50.05 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.892 -0.594 . . . . 74.120000000000005 110.812 -175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 25.6 mt -136.15 131.82 49.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.002 -1.11 . . . . 60.43 108.002 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -129.09 116.52 19.4 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.666 -0.865 . . . . 74.400000000000006 108.666 175.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.404 HG23 ' HB ' ' A' ' 239' ' ' VAL . 12.4 p -119.57 127.42 52.96 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.171 -0.677 . . . . 71.030000000000001 109.171 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -135.86 144.24 45.51 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 116.592 -0.276 . . . . 73.329999999999998 111.063 -177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.545 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 41.6 mt-10 62.34 88.88 0.09 Allowed 'General case' 0 C--O 1.215 -0.715 0 O-C-N 124.908 1.38 . . . . 71.310000000000002 113.181 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.545 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.0 OUTLIER 59.45 21.72 10.17 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.868 0.867 . . . . 72.109999999999999 112.131 174.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.08 142.13 28.08 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.725 -0.472 . . . . 73.120000000000005 109.725 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -125.03 137.17 54.23 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.592 -0.521 . . . . 75.150000000000006 109.592 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 4.3 p -129.98 132.77 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 123.996 0.81 . . . . 75.329999999999998 111.285 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.461 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 57.9 tp60 -111.95 117.0 31.51 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 107.885 -1.154 . . . . 74.439999999999998 107.885 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.73 118.5 35.77 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.767 -0.827 . . . . 72.329999999999998 108.767 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.507 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 132.87 -114.23 1.38 Allowed Glycine 0 N--CA 1.439 -1.167 0 C-N-CA 120.679 -0.772 . . . . 73.120000000000005 113.203 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -145.4 139.19 26.76 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.452 -0.944 . . . . 75.430000000000007 108.452 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 t -123.57 114.56 42.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.965 -1.124 . . . . 75.329999999999998 107.965 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 80.4 t -111.13 119.79 60.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 109.367 -0.605 . . . . 75.099999999999994 109.367 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 28.5 m -88.44 158.01 18.49 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.211 -1.774 . . . . 64.439999999999998 106.211 172.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.42 87.58 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.392 0.515 . . . . 72.219999999999999 112.392 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.66 98.91 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.145 1.165 . . . . 73.409999999999997 114.145 -175.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.44 -45.51 65.67 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.877 0.37 . . . . 74.129999999999995 110.883 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.5 pp -168.06 147.1 4.63 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 106.383 -1.71 . . . . 71.219999999999999 106.383 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -93.81 -63.53 1.19 Allowed 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.837 -0.745 . . . . 74.239999999999995 111.239 -173.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -133.14 50.35 0.88 Allowed Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 111.25 -0.74 . . . . 65.120000000000005 111.25 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 106.71 -109.78 3.16 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 120.642 -0.789 . . . . 62.219999999999999 113.384 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 41.3 mm 70.85 82.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 124.637 1.175 . . . . 75.129999999999995 108.883 -172.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 63.92 179.06 0.17 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.723 -1.58 . . . . 72.120000000000005 109.581 -175.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.503 ' O ' ' HD2' ' B' ' 255' ' ' ARG . 22.8 pt -97.51 92.45 2.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 N-CA-C 107.038 -1.467 . . . . 74.299999999999997 107.038 168.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.3 t -64.92 -42.25 94.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.181 -0.918 . . . . 75.230000000000004 108.856 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.46 140.16 27.37 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.68 -1.146 . . . . 74.329999999999998 110.05 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -155.19 39.33 0.41 Allowed 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 125.571 1.548 . . . . 54.520000000000003 107.747 174.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 26.6 p -66.81 135.54 54.08 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.309 0.576 . . . . 74.230000000000004 110.749 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.421 ' HB ' ' HA2' ' A' ' 224' ' ' GLY . 6.0 t -92.87 127.13 38.26 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 121.566 0.698 . . . . 70.129999999999995 111.767 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.609 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 7.9 t30 -126.57 143.13 51.31 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.238 -1.023 . . . . 65.319999999999993 108.238 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.6 m -138.36 125.6 21.63 Favored 'General case' 0 C--N 1.29 -1.984 0 O-C-N 121.718 -0.614 . . . . 60.130000000000003 109.721 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.6 p -126.89 145.94 33.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.244 -0.65 . . . . 63.240000000000002 109.244 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 59.9 mt-10 -87.14 -79.11 0.28 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 119.755 -0.778 . . . . 73.420000000000002 110.364 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.2 t -116.65 132.02 56.8 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.641 0.734 . . . . 65.129999999999995 111.46 -174.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.88 124.77 47.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.151 -0.931 . . . . 65.340000000000003 110.405 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 4.0 p -127.25 129.06 70.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 116.056 -0.52 . . . . 74.340000000000003 111.421 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.418 ' HA2' ' HG1' ' B' ' 233' ' ' THR . . . -123.09 131.06 8.04 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 109.469 -1.453 . . . . 61.329999999999998 109.469 175.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -134.19 120.67 20.34 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 120.142 -0.623 . . . . 72.409999999999997 111.583 -175.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.56 83.77 1.61 Allowed Glycine 0 C--N 1.306 -1.124 0 C-N-CA 120.33 -0.938 . . . . 54.130000000000003 112.974 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 55.19 28.26 10.84 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.68 1.592 . . . . 73.310000000000002 112.424 173.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 17.7 m -82.67 151.51 26.24 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.893 0.701 . . . . 72.129999999999995 112.893 -170.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -113.09 127.71 56.28 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.361 -0.836 . . . . 71.219999999999999 108.931 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.4 p -137.03 123.54 28.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.362 0.601 . . . . 73.0 110.572 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.461 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.1 tt -117.3 124.27 48.58 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.654 -1.239 . . . . 73.049999999999997 107.654 175.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.46 HG23 HD11 ' B' ' 241' ' ' LEU . 72.4 mt -113.17 103.7 15.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.14 -1.059 . . . . 70.109999999999999 108.14 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 141.65 -151.13 22.5 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 111.433 -0.667 . . . . 60.420000000000002 111.433 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -111.76 131.88 55.02 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 122.216 -0.579 . . . . 74.200000000000003 109.775 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 8.1 tp10 -113.97 118.57 34.53 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 124.401 1.08 . . . . 71.129999999999995 108.153 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -108.74 124.56 50.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.075 -1.083 . . . . 72.420000000000002 108.075 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.13 -52.71 0.64 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 111.323 -0.711 . . . . 71.239999999999995 111.323 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 88.13 18.37 55.87 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.335 -1.106 . . . . 61.020000000000003 110.335 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -122.35 -2.35 9.03 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.598 -0.519 . . . . 72.140000000000001 109.598 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -78.56 -75.69 0.97 Allowed Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.269 -0.967 . . . . 73.340000000000003 113.507 -174.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.416 ' CB ' HD13 ' A' ' 276' ' ' LEU . 59.6 t80 -79.59 -35.02 40.29 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.797 -0.361 . . . . 63.140000000000001 111.634 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 30.0 p90 -127.55 -175.72 3.54 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.857 -0.794 . . . . 72.239999999999995 108.857 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -144.18 -177.85 5.66 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 103.512 -2.773 . . . . 71.150000000000006 103.512 171.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . 0.474 ' HB3' ' OD2' ' B' ' 288' ' ' ASP . 21.6 m120 -78.58 153.86 30.81 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 118.405 0.548 . . . . 72.129999999999995 109.991 -175.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -120.01 -168.61 1.64 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.639 0.978 . . . . 64.340000000000003 113.639 -169.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -118.97 103.7 9.83 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 105.717 -1.957 . . . . 62.340000000000003 105.717 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . 0.518 ' CE1' ' HD2' ' C' ' 238' ' ' ARG . 54.3 t-80 -121.3 142.72 49.68 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.559 -0.904 . . . . 73.209999999999994 108.559 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -78.98 109.55 13.38 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.059 -1.089 . . . . 62.109999999999999 108.059 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . 0.284 29.3 m80 77.47 133.67 0.06 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 125.474 1.51 . . . . 72.420000000000002 112.841 -174.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . 0.438 ' C ' HH21 ' C' ' 238' ' ' ARG . 13.0 t-160 . . . . . 0 C--N 1.293 -1.848 0 CA-C-N 113.376 -1.738 . . . . 70.209999999999994 108.431 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' MET . . . . . 0.43 ' HA ' ' OD1' ' C' ' 220' ' ' ASP . 25.4 ttt . . . . . 0 C--O 1.243 0.756 0 N-CA-C 108.584 -0.895 . . . . 73.019999999999996 108.584 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt 81.53 87.15 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.91 1.684 . . . . 73.310000000000002 110.034 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . 0.423 HG12 ' H ' ' B' ' 221' ' ' ALA . 13.1 tt -134.51 141.38 43.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.093 -0.958 . . . . 74.439999999999998 108.972 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . 0.514 ' CB ' ' HG2' ' C' ' 218' ' ' LYS . 6.9 p-10 -128.1 11.96 6.57 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.544 0.687 . . . . 74.140000000000001 110.433 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . 0.423 ' H ' HG12 ' B' ' 219' ' ' ILE . . . -98.53 -159.93 0.77 Allowed 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.027 -0.988 . . . . 75.420000000000002 110.731 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' B' ' 257' ' ' SER . 75.5 mt -83.82 133.33 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.898 -0.592 . . . . 75.219999999999999 110.764 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 2.9 p -135.78 137.81 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.031 0 CA-C-N 115.316 -0.856 . . . . 74.209999999999994 108.72 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 135.27 99.09 0.59 Allowed Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 109.573 -1.411 . . . . 63.109999999999999 109.573 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -113.52 145.39 41.3 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.267 0.556 . . . . 71.319999999999993 112.238 -175.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.609 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 9.1 t30 -110.54 133.73 53.03 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.484 -2.043 . . . . 71.209999999999994 105.484 171.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 50.8 m -133.89 149.57 51.32 Favored 'General case' 0 C--N 1.281 -2.404 0 O-C-N 121.197 -0.939 . . . . 74.519999999999996 111.769 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.643 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -135.99 146.29 47.05 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.929 -1.137 . . . . 70.439999999999998 107.929 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 3.5 tmtm? -101.88 -57.93 1.98 Allowed 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.917 -0.771 . . . . 75.549999999999997 108.917 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -135.26 139.21 44.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.255 -0.43 . . . . 74.120000000000005 109.998 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 21.8 mt -135.9 127.62 44.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.254 -1.017 . . . . 73.549999999999997 108.254 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 38.1 ttm180 -125.95 115.61 20.2 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.636 -0.876 . . . . 73.010000000000005 108.636 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' THR . . . . . 0.418 ' HG1' ' HA2' ' A' ' 269' ' ' GLY . 81.7 p -110.75 126.49 54.64 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.173 -1.417 . . . . 64.430000000000007 107.173 176.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -133.29 138.86 46.6 Favored 'General case' 0 CA--C 1.493 -1.239 0 C-N-CA 120.34 -0.544 . . . . 73.340000000000003 109.753 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.627 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 43.1 mt-10 64.37 97.93 0.04 OUTLIER 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.758 1.392 . . . . 74.030000000000001 114.758 171.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.627 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.0 OUTLIER 57.71 29.25 17.04 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.57 0.748 . . . . 72.099999999999994 109.95 174.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.55 140.14 30.81 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-O 122.022 0.915 . . . . 75.530000000000001 110.984 -175.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.81 134.27 51.74 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 105.863 -1.903 . . . . 74.109999999999999 105.863 177.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.6 p -134.06 134.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.895 0.855 . . . . 74.129999999999995 111.097 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.537 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 35.4 tp60 -110.64 121.0 44.25 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 114.16 -1.382 . . . . 73.219999999999999 107.271 172.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . 0.46 HD11 HG23 ' A' ' 277' ' ' ILE . 2.9 tm? -117.24 118.76 33.19 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 107.072 -1.455 . . . . 70.140000000000001 107.072 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.508 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 127.6 -109.51 1.06 Allowed Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.472 -0.871 . . . . 71.340000000000003 112.42 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . 0.577 ' OD1' HG23 ' B' ' 245' ' ' VAL . 24.1 t-20 -144.4 146.58 32.59 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 122.286 -0.538 . . . . 72.150000000000006 110.699 -176.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.537 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 25.0 t -133.06 120.42 40.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.175 -1.046 . . . . 74.209999999999994 108.175 172.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . 0.577 HG23 ' OD1' ' B' ' 243' ' ' ASN . 88.6 t -115.57 119.37 61.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.65 -0.5 . . . . 70.209999999999994 109.65 176.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 24.8 m -79.02 157.44 28.08 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 106.003 -1.851 . . . . 74.019999999999996 106.003 174.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.11 -46.36 81.36 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.99 0.9 . . . . 63.439999999999998 112.201 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.29 74.33 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 113.831 -1.531 . . . . 72.049999999999997 113.576 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.47 ' HA ' ' HB3' ' C' ' 247' ' ' ALA . . . -70.48 -46.43 63.77 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.543 0.942 . . . . 71.430000000000007 113.543 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 44.2 tp -161.0 124.57 3.36 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.967 -0.693 . . . . 75.329999999999998 110.518 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -135.92 93.64 2.96 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.83 -0.623 . . . . 71.230000000000004 109.437 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 63.42 -138.94 43.39 Favored Glycine 0 C--O 1.243 0.699 0 CA-C-N 115.585 -0.734 . . . . 74.230000000000004 114.111 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 69.36 -166.16 48.69 Favored Glycine 0 C--O 1.244 0.762 0 CA-C-N 115.338 -0.431 . . . . 63.530000000000001 112.957 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 3.0 mp -91.29 74.74 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.277 -1.749 . . . . 74.450000000000003 106.277 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 256' ' ' ILE . 0.0 OUTLIER -94.0 -176.61 4.06 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.118 -1.401 . . . . 74.430000000000007 111.017 -175.341 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . 0.424 HG22 ' O ' ' C' ' 253' ' ' GLY . 22.0 pt -55.77 147.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 124.815 1.246 . . . . 74.109999999999999 111.669 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' B' ' 222' ' ' ILE . 68.7 m -141.79 21.39 2.15 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.603 -1.258 . . . . 74.430000000000007 107.603 174.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.408 ' OD1' ' HB2' ' C' ' 217' ' ' MET . 5.5 m-20 -144.16 133.31 22.95 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 105.026 -2.213 . . . . 62.049999999999997 105.026 -176.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . 0.459 ' NE2' HD13 ' C' ' 256' ' ' ILE . 23.1 mm-40 -143.26 167.15 22.82 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 123.344 0.403 . . . . 73.310000000000002 111.264 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 24.6 p -76.23 139.08 41.01 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.348 -0.842 . . . . 74.140000000000001 110.507 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 7.4 t -94.33 127.69 40.37 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-O 121.429 0.633 . . . . 52.109999999999999 110.857 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . 0.52 ' HB3' ' OD1' ' B' ' 226' ' ' ASN . 54.5 t30 -126.66 143.56 51.19 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.127 -1.064 . . . . 74.510000000000005 108.127 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' C' ' 227' ' ' SER . 24.3 m -141.97 126.31 17.63 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 122.019 -0.426 . . . . 74.040000000000006 110.074 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.7 p -120.16 152.28 22.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 109.09 -0.708 . . . . 73.519999999999996 109.09 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.461 ' HA ' ' CB ' ' B' ' 229' ' ' LYS . 27.8 mt-10 -92.8 -86.42 0.25 Allowed 'General case' 0 N--CA 1.404 -2.768 0 C-N-CA 119.455 -0.898 . . . . 64.200000000000003 111.151 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 11.3 t -109.42 130.13 55.51 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.604 -0.839 . . . . 71.140000000000001 111.745 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.5 p -132.29 124.48 52.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.114 -0.948 . . . . 75.140000000000001 110.54 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 7.7 p -127.1 134.52 65.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 116.078 -0.51 . . . . 73.299999999999997 111.718 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . 0.432 ' HA2' ' HG1' ' C' ' 233' ' ' THR . . . -114.78 132.28 10.32 Favored Glycine 0 CA--C 1.479 -2.208 0 N-CA-C 110.062 -1.215 . . . . 72.120000000000005 110.062 176.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -133.59 116.66 16.15 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 120.778 0.323 . . . . 74.439999999999998 111.281 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.69 86.31 0.57 Allowed Glycine 0 C--O 1.25 1.123 0 C-N-CA 120.583 -0.818 . . . . 73.010000000000005 114.094 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 61.59 31.08 18.86 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.284 1.034 . . . . 73.019999999999996 111.961 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 24.5 m -83.25 145.64 29.01 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.575 0.702 . . . . 74.299999999999997 112.12 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.462 ' NH2' ' HA ' ' B' ' 287' ' ' TRP . 39.6 mtp180 -115.14 125.93 54.03 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.236 -2.135 . . . . 75.030000000000001 105.236 173.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 1.6 p -135.84 127.09 44.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-O 120.958 0.408 . . . . 74.120000000000005 110.498 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . 0.434 HD12 ' CB ' ' B' ' 286' ' ' PHE . 5.5 tt -120.15 121.76 39.5 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.361 -1.348 . . . . 74.400000000000006 107.361 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . 0.449 HG21 HD12 ' C' ' 241' ' ' LEU . 36.7 mt -113.06 103.72 15.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 N-CA-C 106.767 -1.568 . . . . 63.340000000000003 106.767 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 145.11 -147.54 18.76 Favored Glycine 0 N--CA 1.416 -2.637 0 C-N-CA 120.917 -0.658 . . . . 73.409999999999997 111.783 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -115.01 128.71 56.43 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 120.937 -0.305 . . . . 74.319999999999993 111.392 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . 0.528 ' HG2' ' CZ2' ' B' ' 287' ' ' TRP . 9.7 tp10 -112.46 121.47 44.92 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.921 -1.14 . . . . 75.340000000000003 107.921 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . 0.463 ' CD2' ' HB ' ' C' ' 245' ' ' VAL . 86.7 m-85 -111.53 124.03 51.45 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.378 -0.971 . . . . 73.230000000000004 108.378 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.29 -61.59 0.31 Allowed Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 111.014 -0.834 . . . . 74.319999999999993 111.014 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . 0.42 ' C ' ' HD2' ' B' ' 284' ' ' LYS . . . 94.53 26.02 14.44 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.314 -0.715 . . . . 74.450000000000003 111.314 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . 0.42 ' HD2' ' C ' ' B' ' 283' ' ' GLY . 3.2 mptp? -134.09 2.57 3.35 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 110.39 -0.226 . . . . 73.129999999999995 110.39 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -78.53 -66.76 1.69 Allowed Glycine 0 N--CA 1.417 -2.633 0 C-N-CA 119.952 -1.118 . . . . 74.319999999999993 112.371 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.434 ' CB ' HD12 ' B' ' 276' ' ' LEU . 75.9 t80 -87.67 -37.84 16.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.914 0.709 . . . . 74.019999999999996 112.914 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.528 ' CZ2' ' HG2' ' B' ' 280' ' ' GLU . 20.8 p90 -109.2 152.91 24.53 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.86 0.689 . . . . 74.120000000000005 112.86 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 289' ' ' ASN . 5.2 p-10 -168.53 172.59 8.06 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.579 -1.192 . . . . 73.530000000000001 108.012 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -89.56 -67.3 0.85 Allowed 'General case' 0 C--N 1.31 -1.121 0 O-C-N 123.846 0.716 . . . . 74.310000000000002 111.589 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . 0.541 ' O ' ' HB3' ' C' ' 295' ' ' HIS . 14.5 t-80 -161.25 112.71 1.79 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.656 -0.498 . . . . 74.239999999999995 109.656 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -129.69 -168.91 2.02 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.629 0.252 . . . . 71.0 111.516 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -87.55 83.82 7.2 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 116.568 -0.287 . . . . 73.0 111.177 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' A' ' 289' ' ' ASN . 7.3 p80 -80.47 103.84 10.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.024 -1.102 . . . . 74.230000000000004 108.024 174.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -101.67 -10.26 20.17 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.476 -0.784 . . . . 74.120000000000005 112.366 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 40.0 m80 . . . . . 0 C--O 1.259 1.561 0 N-CA-C 107.562 -1.273 . . . . 75.409999999999997 107.562 173.466 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 217' ' ' MET . . . . . 0.533 ' HG3' ' H ' ' C' ' 218' ' ' LYS . 8.1 tpt . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.279 -1.378 . . . . 75.430000000000007 107.279 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . 0.533 ' H ' ' HG3' ' C' ' 217' ' ' MET . 87.3 mttt -84.81 15.23 4.05 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 113.764 1.024 . . . . 74.400000000000006 113.764 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 3.4 mp -83.17 122.74 37.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.856 -1.535 . . . . 75.120000000000005 106.856 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . 0.43 ' OD1' ' HA ' ' B' ' 217' ' ' MET . 36.9 t70 -77.53 100.49 6.09 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.263 -0.426 . . . . 70.510000000000005 110.83 -176.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 78.84 132.29 0.05 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.929 1.691 . . . . 65.340000000000003 113.051 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 45.1 mt -96.71 128.89 47.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.563 -0.744 . . . . 72.219999999999999 109.246 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 12.1 p -108.22 127.61 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.07 0 CA-C-N 115.733 -0.667 . . . . 75.019999999999996 109.229 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 135.2 89.64 0.31 Allowed Glycine 0 N--CA 1.434 -1.439 0 N-CA-C 109.447 -1.461 . . . . 75.129999999999995 109.447 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' B' ' 261' ' ' THR . 14.9 ptt180 -115.25 147.98 39.71 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.464 0.65 . . . . 74.230000000000004 111.102 -176.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 7.4 t30 -108.85 141.55 40.73 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.017 -2.216 . . . . 55.030000000000001 105.017 169.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 227' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' B' ' 263' ' ' SER . 54.0 m -139.8 139.48 36.41 Favored 'General case' 0 C--N 1.278 -2.542 0 O-C-N 121.818 -0.551 . . . . 62.109999999999999 110.889 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -127.45 143.19 51.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.782 -1.192 . . . . 65.150000000000006 107.782 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 9.3 tmtt? -102.77 -53.1 2.93 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.588 -0.523 . . . . 74.120000000000005 109.588 -174.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.21 137.96 43.14 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.248 -0.649 . . . . 64.200000000000003 109.248 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 33.5 mt -136.67 130.31 46.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.01 -1.107 . . . . 75.420000000000002 108.01 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -133.6 119.1 19.0 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.43 -0.952 . . . . 73.099999999999994 108.43 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 233' ' ' THR . . . . . 0.451 HG23 ' CG1' ' C' ' 239' ' ' VAL . 45.0 p -110.49 126.41 54.33 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.19 -1.411 . . . . 73.140000000000001 107.19 174.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -127.91 139.22 52.73 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 110.05 -0.352 . . . . 63.240000000000002 110.05 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . 0.596 ' C ' ' HD3' ' C' ' 236' ' ' ARG . 62.5 mt-10 63.13 93.43 0.05 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.664 1.227 . . . . 74.140000000000001 114.218 170.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.596 ' HD3' ' C ' ' C' ' 235' ' ' GLU . 0.7 OUTLIER 56.37 26.91 11.22 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 123.889 0.875 . . . . 74.439999999999998 111.387 172.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.5 148.46 24.91 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.751 -0.659 . . . . 64.430000000000007 110.576 -176.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.518 ' HD2' ' CE1' ' A' ' 292' ' ' HIS . 1.2 mpp_? -124.66 134.22 52.96 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.17 -1.418 . . . . 72.140000000000001 107.17 177.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 4.7 p -135.96 135.14 50.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.622 0.725 . . . . 72.239999999999995 111.188 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . 0.488 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 36.4 tp60 -114.37 115.17 26.91 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-N 114.28 -1.327 . . . . 75.5 108.152 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.469 HD11 ' ND2' ' B' ' 262' ' ' ASN . 3.0 tm? -111.85 117.79 33.76 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 105.596 -2.002 . . . . 73.319999999999993 105.596 176.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.533 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 138.65 -130.62 4.99 Favored Glycine 0 CA--C 1.485 -1.837 0 C-N-CA 119.577 -1.297 . . . . 72.150000000000006 111.724 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -141.06 131.26 24.88 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 120.956 0.408 . . . . 71.420000000000002 109.911 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . 0.488 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 21.4 t -114.52 129.87 69.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.668 -0.864 . . . . 73.310000000000002 108.668 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . 0.463 ' HB ' ' CD2' ' B' ' 281' ' ' TYR . 95.8 t -122.11 118.53 55.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 109.195 -0.668 . . . . 73.349999999999994 109.195 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 21.4 m -79.43 159.42 27.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.949 -1.871 . . . . 75.319999999999993 105.949 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' B' ' 249' ' ' ALA . . . -62.63 -47.63 82.92 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-O 122.08 0.943 . . . . 74.530000000000001 110.772 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.88 -34.76 65.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 113.718 -1.583 . . . . 74.140000000000001 112.806 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -74.15 -45.31 49.57 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 113.74 1.015 . . . . 72.510000000000005 113.74 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 91.6 mt -150.11 107.71 3.66 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.671 0.619 . . . . 73.010000000000005 112.671 -174.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -108.93 -69.24 0.87 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.226 -1.027 . . . . 64.120000000000005 108.226 169.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -96.72 36.58 3.81 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.353 -0.84 . . . . 74.420000000000002 113.688 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . 0.424 ' O ' HG22 ' B' ' 256' ' ' ILE . . . -83.12 64.18 4.36 Favored Glycine 0 C--N 1.316 -0.564 0 N-CA-C 111.058 -0.817 . . . . 63.149999999999999 111.058 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 6.3 tp -80.41 66.58 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 113.367 0.877 . . . . 65.5 113.367 -175.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 154.94 108.91 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 127.605 2.362 . . . . 73.109999999999999 109.309 169.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . 0.459 HD13 ' NE2' ' B' ' 259' ' ' GLN . 9.8 pt -147.24 98.7 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.796 -1.187 . . . . 75.209999999999994 107.796 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 15.2 m -130.63 15.2 5.41 Favored 'General case' 0 C--O 1.254 1.294 0 C-N-CA 119.953 -0.699 . . . . 71.430000000000007 112.679 -171.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -147.25 94.49 2.4 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.169 0.985 . . . . 71.329999999999998 109.236 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -125.72 -178.05 4.13 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.827 -1.078 . . . . 74.25 111.719 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 5.6 m -77.07 138.98 39.87 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 123.768 0.827 . . . . 64.510000000000005 110.794 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 15.4 t -108.86 116.23 31.6 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-O 121.889 0.852 . . . . 75.099999999999994 110.169 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 9.0 t30 -127.77 126.7 42.25 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.808 -0.558 . . . . 73.420000000000002 111.661 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 68.4 m -121.43 134.39 55.09 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 122.126 -0.359 . . . . 73.530000000000001 110.731 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -128.32 150.55 34.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.166 -1.05 . . . . 65.340000000000003 108.166 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.408 ' HA ' ' HB2' ' C' ' 229' ' ' LYS . 49.1 mt-10 -91.11 -88.49 0.18 Allowed 'General case' 0 N--CA 1.419 -1.978 0 C-N-CA 119.374 -0.931 . . . . 73.010000000000005 111.045 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 5.8 t -107.78 132.65 53.17 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.652 -0.819 . . . . 72.329999999999998 111.914 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.02 131.34 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.162 -0.926 . . . . 73.400000000000006 109.119 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.79 135.76 62.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 116.104 -0.498 . . . . 74.530000000000001 110.652 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.04 9.86 Favored Glycine 0 CA--C 1.474 -2.511 0 N-CA-C 109.086 -1.605 . . . . 73.510000000000005 109.086 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -134.03 116.27 15.3 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 110.227 -0.286 . . . . 72.239999999999995 110.227 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.57 83.48 0.73 Allowed Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.513 -0.851 . . . . 75.129999999999995 114.217 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 60.44 33.88 20.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.409 1.084 . . . . 75.030000000000001 112.319 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 10.7 m -83.72 145.18 28.88 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.925 0.713 . . . . 71.430000000000007 112.925 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -105.87 128.13 53.56 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.486 -1.301 . . . . 74.439999999999998 107.486 168.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 7.5 p -139.22 127.59 27.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 120.974 0.416 . . . . 75.129999999999995 111.226 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.495 HD13 ' CB ' ' C' ' 286' ' ' PHE . 7.2 tt -117.19 120.35 38.02 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.41 -0.959 . . . . 74.310000000000002 108.41 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 28.2 mt -113.26 103.6 15.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 106.991 -1.485 . . . . 72.120000000000005 106.991 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 144.85 -146.04 16.02 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.764 -0.935 . . . . 52.140000000000001 110.764 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -115.45 133.25 56.21 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 110.1 -0.333 . . . . 74.140000000000001 110.1 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -113.35 118.21 33.93 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.869 -1.159 . . . . 75.409999999999997 107.869 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -108.86 124.94 51.42 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.325 0.583 . . . . 73.120000000000005 109.861 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 106.08 -38.59 3.23 Favored Glycine 0 N--CA 1.417 -2.602 0 CA-C-N 115.089 -0.96 . . . . 63.100000000000001 110.957 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 72.76 35.06 58.92 Favored Glycine 0 CA--C 1.489 -1.569 0 N-CA-C 109.507 -1.437 . . . . 73.230000000000004 109.507 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -146.88 -7.3 0.49 Allowed 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 114.851 -0.675 . . . . 74.049999999999997 109.906 -173.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . 0.407 ' HA3' ' CG1' ' C' ' 244' ' ' VAL . . . -76.45 -70.15 1.31 Allowed Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 120.789 -0.719 . . . . 72.150000000000006 112.843 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.495 ' CB ' HD13 ' C' ' 276' ' ' LEU . 70.9 t80 -77.07 -51.16 11.53 Favored 'General case' 0 CA--C 1.49 -1.355 0 C-N-CA 120.411 -0.516 . . . . 75.319999999999993 110.097 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . 0.317 28.5 p90 -87.46 65.77 8.78 Favored 'General case' 0 N--CA 1.412 -2.348 0 C-N-CA 118.504 -1.278 . . . . 75.549999999999997 112.2 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.61 118.42 15.51 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 105.556 -2.016 . . . . 74.420000000000002 105.556 172.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -67.52 177.43 1.96 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.252 -0.885 . . . . 73.219999999999999 110.224 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -70.71 87.79 0.69 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.303 -0.628 . . . . 74.219999999999999 109.303 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -103.22 -28.69 11.74 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.908 -0.587 . . . . 72.040000000000006 110.215 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -114.37 86.59 2.46 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.214 -0.448 . . . . 72.420000000000002 111.179 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -88.25 -14.43 38.44 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.61 0.719 . . . . 74.129999999999995 109.88 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -81.01 0.28 36.41 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.021 -0.99 . . . . 70.329999999999998 112.052 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . 0.541 ' HB3' ' O ' ' B' ' 290' ' ' HIS . 33.6 m-70 . . . . . 0 C--N 1.304 -1.374 0 CA-C-N 116.537 -0.301 . . . . 72.120000000000005 111.424 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 C--O 1.235 0.297 0 N-CA-C 109.867 -0.42 . . . . 74.329999999999998 109.867 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -147.58 83.56 1.54 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.518 -0.31 . . . . 74.409999999999997 111.066 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 13.7 tt -106.74 -9.05 10.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.351 -1.352 . . . . 64.239999999999995 107.351 172.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.49 111.66 4.24 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 113.639 -1.619 . . . . 73.349999999999994 108.738 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -158.29 165.17 35.46 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.54 -0.911 . . . . 72.299999999999997 108.54 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.416 HG13 ' CE1' ' A' ' 281' ' ' TYR . 7.1 tt -83.48 118.03 30.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.886 -0.783 . . . . 73.310000000000002 108.886 177.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.5 m -131.96 145.32 35.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.574 -0.739 . . . . 75.319999999999993 110.745 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 149.75 114.52 0.71 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 111.547 -0.621 . . . . 72.030000000000001 111.547 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 261' ' ' THR . 37.4 ttm180 -89.63 123.49 33.72 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.921 0.36 . . . . 74.239999999999995 110.235 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.53 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 34.1 t-20 -116.88 149.23 40.43 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.527 -0.916 . . . . 73.540000000000006 108.527 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.3 m -137.09 137.52 39.39 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.97 -0.752 . . . . 72.519999999999996 108.97 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.401 ' HB2' HG21 ' A' ' 277' ' ' ILE . . . -137.17 132.06 33.42 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 110.109 -0.33 . . . . 70.420000000000002 110.109 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 5.2 tmmm? -90.87 -55.06 3.7 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.122 -0.49 . . . . 74.299999999999997 110.971 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -131.59 139.4 49.17 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.972 -0.381 . . . . 74.450000000000003 109.972 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 68.0 mt -137.29 121.03 22.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.546 -0.909 . . . . 74.239999999999995 108.546 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -131.27 129.21 41.25 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.325 0.583 . . . . 72.349999999999994 112.011 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 27.2 p -132.32 128.49 37.85 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.415 -0.811 . . . . 74.5 109.029 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -121.48 147.99 45.04 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 111.841 0.311 . . . . 72.530000000000001 111.841 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 67.07 -87.23 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.729 1.212 . . . . 73.310000000000002 113.859 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 25.0 mtm-85 -116.31 3.02 13.33 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.191 0.596 . . . . 74.329999999999998 110.487 -175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -69.64 136.71 51.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.308 -0.86 . . . . 75.450000000000003 111.33 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -125.45 135.38 52.28 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.36 -0.978 . . . . 74.200000000000003 108.36 -177.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.9 p -129.68 146.03 34.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.573 0.701 . . . . 64.519999999999996 110.809 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.48 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 6.1 tp-100 -123.72 130.01 51.98 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 107.929 -1.137 . . . . 75.329999999999998 107.929 174.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -123.32 118.68 28.08 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.469 -0.937 . . . . 74.040000000000006 108.469 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.513 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 130.27 -114.12 1.58 Allowed Glycine 0 N--CA 1.433 -1.566 0 CA-C-N 115.825 -0.625 . . . . 75.219999999999999 111.618 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -145.19 138.75 26.75 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 122.437 -0.449 . . . . 74.450000000000003 111.375 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 85.5 t -122.45 114.08 41.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.806 -1.553 . . . . 74.340000000000003 106.806 174.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.78 114.35 41.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 C-N-CA 120.334 -0.546 . . . . 75.349999999999994 110.607 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 22.8 m -79.92 158.9 26.54 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.826 -1.176 . . . . 74.230000000000004 107.826 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.97 -41.49 95.41 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.054 0.455 . . . . 52.420000000000002 111.368 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -35.9 67.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.408 -1.269 . . . . 72.299999999999997 113.895 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -64.95 -26.28 68.23 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 122.766 0.426 . . . . 74.319999999999993 112.126 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 61.9 tp 81.04 114.53 0.06 Allowed 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 125.039 1.336 . . . . 73.319999999999993 112.09 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -132.23 150.8 52.07 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.257 -0.883 . . . . 74.510000000000005 109.179 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.91 44.87 1.17 Allowed Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 111.45 -0.66 . . . . 75.530000000000001 111.45 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.15 -162.11 21.76 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 121.159 -0.544 . . . . 71.140000000000001 112.398 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 42.1 mm -118.13 130.99 72.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.191 -1.04 . . . . 73.310000000000002 108.191 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -105.53 -83.92 0.51 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.975 0.417 . . . . 73.219999999999999 111.006 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.6 tt -159.38 135.47 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.053 -1.462 . . . . 75.340000000000003 107.053 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.442 ' HB3' ' N ' ' A' ' 225' ' ' ARG . 48.3 m -80.14 84.15 5.9 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.755 0.788 . . . . 70.519999999999996 109.887 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -126.12 156.41 40.11 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.299 -1.319 . . . . 73.420000000000002 108.878 -175.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 72.19 -49.79 0.69 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.594 1.558 . . . . 74.109999999999999 112.771 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' B' ' 224' ' ' GLY . 36.5 m -90.24 117.64 29.14 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.534 -1.284 . . . . 74.400000000000006 107.534 170.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 225' ' ' ARG . 29.3 m -138.46 123.06 18.57 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.177 -1.046 . . . . 72.430000000000007 108.177 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 226' ' ' ASN . 38.9 t-20 -126.15 136.77 53.27 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.14 -1.43 . . . . 71.450000000000003 107.14 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.6 m -138.15 134.53 34.69 Favored 'General case' 0 C--N 1.285 -2.21 0 O-C-N 122.077 -0.389 . . . . 75.129999999999995 110.289 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 13.1 p -128.43 141.88 45.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.211 0.529 . . . . 75.010000000000005 111.118 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.596 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 6.4 mm-40 -78.58 -72.18 0.39 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.652 -0.703 . . . . 73.219999999999999 110.961 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -128.8 127.84 42.76 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.854 -0.738 . . . . 62.310000000000002 112.713 -175.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 35.5 m -119.97 126.9 75.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.975 -0.557 . . . . 73.510000000000005 110.07 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.55 136.88 59.53 Favored 'Isoleucine or valine' 0 C--O 1.257 1.473 0 CA-C-O 121.358 0.599 . . . . 73.310000000000002 112.115 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.09 131.34 8.38 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.725 -1.35 . . . . 72.120000000000005 109.725 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -124.24 117.57 24.88 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.412 0.625 . . . . 75.129999999999995 111.536 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.24 -118.87 5.41 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.106 -1.198 . . . . 74.329999999999998 110.106 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -102.63 90.66 3.9 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.449 -1.315 . . . . 62.219999999999999 107.449 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.59 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 31.5 m -130.7 145.35 51.91 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.607 -1.179 . . . . 71.120000000000005 108.643 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . 0.504 ' NH1' ' HB3' ' A' ' 288' ' ' ASP . 94.0 mtt180 -130.45 127.51 39.39 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.445 -1.302 . . . . 74.120000000000005 108.225 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.5 p -132.76 130.38 59.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.961 0.886 . . . . 71.420000000000002 111.327 -173.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.48 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.6 tt -117.51 126.13 52.06 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.972 -1.122 . . . . 74.340000000000003 107.972 176.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.401 HG21 ' HB2' ' A' ' 228' ' ' ALA . 34.6 mm -112.68 103.51 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 107.075 -1.454 . . . . 75.430000000000007 107.075 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.616 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 150.44 -141.17 8.5 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.881 -1.152 . . . . 73.519999999999996 112.85 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -113.02 134.14 54.65 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.798 -1.186 . . . . 74.450000000000003 107.798 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.4 OUTLIER -129.74 120.36 24.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.966 0.889 . . . . 73.5 109.104 176.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.416 ' CE1' HG13 ' A' ' 222' ' ' ILE . 2.8 m-85 -113.97 124.65 52.67 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.858 -1.064 . . . . 73.010000000000005 108.951 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 129.72 -42.6 1.4 Allowed Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.841 -0.695 . . . . 74.0 112.407 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' B' ' 286' ' ' PHE . . . 100.61 -15.95 58.12 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.81 -0.916 . . . . 54.509999999999998 110.81 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.07 83.96 2.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.002 -0.74 . . . . 74.239999999999995 109.002 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -84.88 -121.75 1.02 Allowed Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.653 -0.703 . . . . 73.430000000000007 112.312 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -87.98 15.89 6.69 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.104 0.478 . . . . 75.010000000000005 110.223 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . 0.442 ' CH2' ' HB2' ' A' ' 276' ' ' LEU . 78.0 m95 -65.96 -16.52 63.95 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 114.686 1.365 . . . . 74.420000000000002 114.686 -170.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.504 ' HB3' ' NH1' ' A' ' 274' ' ' ARG . 1.3 t70 70.73 132.18 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.006 0.816 . . . . 75.230000000000004 112.361 -177.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -130.91 34.88 4.02 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.13 -1.063 . . . . 74.439999999999998 108.13 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -82.56 -22.39 34.92 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.883 -1.155 . . . . 73.439999999999998 107.883 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -89.5 107.81 19.29 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.74 -1.118 . . . . 73.450000000000003 108.716 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -110.63 117.53 33.74 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 110.009 -0.367 . . . . 74.310000000000002 110.009 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -84.09 85.8 7.29 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.673 -0.811 . . . . 73.040000000000006 109.356 173.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -76.72 -69.98 0.48 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.739 -1.119 . . . . 75.310000000000002 108.57 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 30.6 m170 . . . . . 0 C--N 1.313 -1.015 0 N-CA-C 106.39 -1.708 . . . . 72.209999999999994 106.39 176.462 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 27.0 ptm . . . . . 0 CA--C 1.514 -0.425 0 N-CA-C 109.4 -0.593 . . . . 72.099999999999994 109.4 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -84.31 102.39 12.66 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.661 -1.237 . . . . 74.540000000000006 107.661 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 10.6 tt -123.19 -65.63 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 113.712 1.004 . . . . 72.299999999999997 113.712 -176.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . 0.449 ' HA ' ' HA3' ' B' ' 253' ' ' GLY . 33.3 t70 -108.29 133.07 53.03 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.303 0.482 . . . . 62.43 112.303 -171.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -175.32 -169.99 0.41 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.643 1.177 . . . . 65.120000000000005 108.517 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . 0.54 HG13 ' CZ ' ' B' ' 281' ' ' TYR . 8.4 tt -105.83 130.73 56.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.661 -0.866 . . . . 73.25 108.661 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 19.1 m -124.82 159.96 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 112.282 0.475 . . . . 75.409999999999997 112.282 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 260' ' ' THR . . . 145.83 127.87 1.93 Allowed Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.86 -0.496 . . . . 63.439999999999998 111.86 176.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . 0.447 ' HD2' ' HB ' ' A' ' 261' ' ' THR . 8.1 tpt180 -106.64 117.6 34.48 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.524 -1.287 . . . . 74.409999999999997 107.524 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.506 HD22 HG22 ' B' ' 277' ' ' ILE . 7.3 t30 -120.95 144.56 48.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 120.747 0.308 . . . . 72.019999999999996 111.79 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' B' ' 263' ' ' SER . 50.5 m -136.33 136.96 40.14 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.179 -0.674 . . . . 70.420000000000002 109.179 173.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.03 142.94 49.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.537 -0.542 . . . . 72.299999999999997 109.537 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.596 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 2.3 tmmm? -100.69 -64.1 1.07 Allowed 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 120.393 -0.523 . . . . 74.129999999999995 110.267 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -127.85 138.33 52.66 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 108.959 -0.756 . . . . 73.430000000000007 108.959 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 16.9 mt -135.57 119.91 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.095 -0.705 . . . . 73.010000000000005 109.095 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -123.23 115.71 22.18 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.873 0.368 . . . . 74.129999999999995 110.651 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' B' ' 237' ' ' ALA . 52.6 p -111.69 127.66 55.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.625 -1.25 . . . . 73.099999999999994 107.625 175.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -130.18 149.68 51.77 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.457 -0.497 . . . . 73.450000000000003 111.028 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . 0.251 33.5 mt-10 75.87 -74.16 0.08 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 115.733 1.753 . . . . 64.129999999999995 115.733 170.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.26 24.72 2.3 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.334 -0.987 . . . . 75.209999999999994 108.334 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.439 ' C ' ' HD2' ' B' ' 238' ' ' ARG . . . -84.91 142.93 29.34 Favored 'General case' 0 C--O 1.275 2.444 0 CA-C-O 122.954 1.359 . . . . 75.340000000000003 113.895 -172.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' B' ' 237' ' ' ALA . 3.7 mpt_? -125.93 135.21 51.61 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.487 -1.233 . . . . 73.430000000000007 110.845 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 14.1 p -134.29 143.4 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.201 1.001 . . . . 74.129999999999995 110.51 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.541 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 4.8 tp-100 -121.12 125.17 46.56 Favored 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 114.108 -1.405 . . . . 65.239999999999995 107.857 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -119.16 117.04 27.6 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.176 -1.787 . . . . 74.120000000000005 106.176 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 139.05 -121.33 2.08 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 110.487 -1.045 . . . . 73.430000000000007 110.487 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -145.34 139.1 26.79 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.932 0.366 . . . . 73.129999999999995 110.853 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 280' ' ' GLU . 44.8 t -122.41 122.61 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 107.989 -1.115 . . . . 73.409999999999997 107.989 175.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . 0.506 HG22 ' O ' ' B' ' 250' ' ' LEU . 7.0 p -123.67 125.67 71.68 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 C-N-CA 120.052 -0.659 . . . . 75.420000000000002 110.89 175.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 2.1 m -81.88 160.82 23.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.393 -1.336 . . . . 74.450000000000003 107.393 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.94 79.97 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 120.986 0.422 . . . . 74.519999999999996 111.636 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.33 -52.28 64.0 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.698 -1.137 . . . . 72.030000000000001 112.566 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.16 -46.42 34.38 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.707 -0.397 . . . . 75.299999999999997 110.414 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . 0.506 ' O ' HG22 ' B' ' 245' ' ' VAL . 52.1 tp 65.53 -79.97 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.916 1.286 . . . . 75.310000000000002 113.138 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -143.72 167.78 21.46 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.869 -0.789 . . . . 74.040000000000006 108.869 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -156.16 67.32 0.3 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.54 -1.024 . . . . 70.420000000000002 110.54 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' B' ' 220' ' ' ASP . . . -117.13 149.79 18.63 Favored Glycine 0 N--CA 1.424 -2.113 0 C-N-CA 119.206 -1.473 . . . . 54.030000000000001 114.433 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' C' ' 219' ' ' ILE . 10.7 pt -168.93 -156.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 101.97 -3.345 . . . . 74.310000000000002 101.97 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -138.55 144.12 39.76 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 120.24 1.382 . . . . 75.209999999999994 110.163 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 6.9 tp -127.01 -56.54 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 O-C-N 123.756 0.66 . . . . 73.329999999999998 110.858 176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 58.1 m -169.06 -61.28 0.02 OUTLIER 'General case' 0 C--O 1.242 0.666 0 C-N-CA 122.918 0.487 . . . . 55.149999999999999 111.559 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -152.39 -172.03 4.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 106.365 -1.717 . . . . 73.439999999999998 106.365 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -115.6 177.5 4.64 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 119.196 0.907 . . . . 74.349999999999994 112.376 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' THR . . . . . 0.483 ' OG1' HG12 ' C' ' 222' ' ' ILE . 86.1 m -82.25 131.55 35.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.116 -0.947 . . . . 73.219999999999999 108.92 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 29.1 m -126.58 112.88 16.03 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.92 -0.77 . . . . 70.510000000000005 108.92 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -121.05 138.18 54.3 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.936 -1.135 . . . . 71.230000000000004 107.936 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' C' ' 227' ' ' SER . 43.6 m -138.6 138.88 38.31 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 120.739 0.304 . . . . 71.140000000000001 110.219 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 12.5 p -128.51 150.33 34.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 120.87 0.367 . . . . 64.409999999999997 110.527 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 44.0 mm-40 -86.01 -76.21 0.35 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.834 -0.621 . . . . 71.109999999999999 110.691 174.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 27.8 m -128.81 127.87 42.8 Favored 'General case' 0 C--O 1.249 1.034 0 C-N-CA 119.931 -0.707 . . . . 74.219999999999999 112.454 -176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.46 129.31 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.696 -0.684 . . . . 64.420000000000002 109.265 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 8.8 p -127.58 128.87 70.11 Favored 'Isoleucine or valine' 0 C--O 1.266 1.922 0 CA-C-O 121.716 0.769 . . . . 70.340000000000003 112.237 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.91 132.82 10.93 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 110.46 -1.056 . . . . 61.109999999999999 110.46 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -124.09 121.29 34.77 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 122.472 0.309 . . . . 72.439999999999998 111.127 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.24 -130.0 9.42 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.65 -1.38 . . . . 61.43 109.65 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.93 98.4 11.35 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.653 -1.98 . . . . 74.340000000000003 105.653 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.4 t -130.03 143.03 50.57 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.989 -1.005 . . . . 72.349999999999994 108.764 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.468 ' HB2' ' HG3' ' C' ' 238' ' ' ARG . 76.3 mtt180 -131.3 127.05 36.91 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 118.565 -1.254 . . . . 73.329999999999998 108.376 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.0 p -135.9 132.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 115.094 -0.957 . . . . 73.219999999999999 110.918 -175.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . 0.502 ' HB3' ' OE1' ' C' ' 240' ' ' GLN . 5.9 tt -119.96 125.41 48.34 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 107.546 -1.279 . . . . 74.200000000000003 107.546 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . 0.506 HG22 HD22 ' B' ' 226' ' ' ASN . 30.0 mm -112.54 103.56 15.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 N-CA-C 106.772 -1.566 . . . . 74.25 106.772 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.563 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 147.21 -143.77 11.73 Favored Glycine 0 N--CA 1.427 -1.951 0 C-N-CA 120.422 -0.894 . . . . 51.549999999999997 113.829 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -108.76 132.25 54.15 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.721 -0.844 . . . . 62.0 108.721 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . 0.583 ' O ' ' HA ' ' C' ' 244' ' ' VAL . 0.0 OUTLIER -127.8 122.49 32.85 Favored 'General case' 0 C--O 1.265 1.88 0 CA-C-O 122.324 1.059 . . . . 73.299999999999997 108.593 177.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . 0.54 ' CZ ' HG13 ' B' ' 222' ' ' ILE . 2.3 m-85 -120.52 124.11 44.57 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.407 -1.27 . . . . 72.329999999999998 107.7 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 128.94 -40.05 1.76 Allowed Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.333 -0.937 . . . . 73.420000000000002 111.524 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' C' ' 286' ' ' PHE . . . 97.01 -16.54 60.77 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 110.576 -1.01 . . . . 72.530000000000001 110.576 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.29 77.56 1.68 Allowed 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.208 -0.496 . . . . 75.040000000000006 110.577 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -76.3 -128.86 0.3 Allowed Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 115.013 -0.994 . . . . 70.120000000000005 112.007 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 5.0 p90 -81.99 13.55 3.29 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.484 0.659 . . . . 73.530000000000001 111.391 -175.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.496 ' CH2' ' HB2' ' B' ' 276' ' ' LEU . 39.9 m95 -74.1 -57.18 4.13 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.037 -0.528 . . . . 75.230000000000004 109.647 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 35.1 t70 56.18 101.0 0.01 OUTLIER 'General case' 0 C--O 1.254 1.336 0 C-N-CA 126.091 1.756 . . . . 71.150000000000006 114.339 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -63.96 149.62 46.87 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.745 -0.661 . . . . 71.340000000000003 109.716 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -153.59 30.35 0.47 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.279 1.038 . . . . 75.430000000000007 108.963 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . 0.485 ' HB3' ' CE1' ' B' ' 293' ' ' HIS . 46.9 m-70 -80.27 93.34 5.88 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.325 -1.307 . . . . 72.310000000000002 110.461 -177.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -80.55 -24.88 38.96 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.975 -0.557 . . . . 75.439999999999998 110.038 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . 0.485 ' CE1' ' HB3' ' B' ' 291' ' ' HIS . 29.9 m170 53.81 58.62 4.93 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.171 1.545 . . . . 74.439999999999998 115.171 176.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -150.24 144.99 25.95 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 123.222 0.609 . . . . 74.299999999999997 109.497 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 C--N 1.3 -1.58 0 N-CA-C 107.977 -1.12 . . . . 74.540000000000006 107.977 177.214 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 217' ' ' MET . . . . . 0.617 ' SD ' ' HG3' ' C' ' 218' ' ' LYS . 1.4 tmt? . . . . . 0 C--O 1.241 0.658 0 N-CA-C 107.431 -1.322 . . . . 73.319999999999993 107.431 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . 0.617 ' HG3' ' SD ' ' C' ' 217' ' ' MET . 68.7 mttm -138.03 111.04 7.76 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 104.438 -2.43 . . . . 62.439999999999998 104.438 169.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' B' ' 254' ' ' ILE . 69.9 mt 89.75 97.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 O-C-N 125.683 1.865 . . . . 72.140000000000001 106.378 -162.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -167.61 161.7 13.75 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 124.48 1.112 . . . . 72.25 109.888 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -162.85 -45.9 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.995 -1.113 . . . . 72.530000000000001 107.995 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . 0.518 HG13 ' CE1' ' C' ' 281' ' ' TYR . 12.6 tt -89.38 115.98 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-N 114.101 -1.409 . . . . 72.450000000000003 109.741 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 35.2 m -112.42 156.21 13.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.916 -0.584 . . . . 72.140000000000001 109.981 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' B' ' 260' ' ' THR . . . 149.55 154.23 6.32 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.418 -1.073 . . . . 75.129999999999995 110.418 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' C' ' 261' ' ' THR . 28.4 ttt180 -138.56 119.48 14.31 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.023 -0.732 . . . . 74.099999999999994 109.023 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . 0.489 HD22 HG22 ' C' ' 277' ' ' ILE . 7.2 t30 -118.78 148.97 42.26 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 116.182 -0.463 . . . . 65.129999999999995 110.475 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 227' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' C' ' 263' ' ' SER . 31.9 m -136.68 136.53 39.15 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.195 -1.039 . . . . 74.310000000000002 108.195 172.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.7 138.23 49.91 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.469 -0.567 . . . . 75.430000000000007 109.469 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 2.9 tmmm? -93.38 -64.22 1.12 Allowed 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.556 -0.458 . . . . 74.120000000000005 110.943 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -127.37 137.79 52.85 Favored 'General case' 0 C--O 1.253 1.243 0 C-N-CA 120.1 -0.64 . . . . 63.539999999999999 109.682 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 31.3 mt -133.95 118.94 30.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.889 -0.782 . . . . 64.519999999999996 108.889 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -118.99 122.38 42.07 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.792 -0.448 . . . . 73.200000000000003 109.792 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 31.7 p -122.24 127.9 50.49 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.865 -0.791 . . . . 75.530000000000001 108.865 176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -129.35 150.28 50.78 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 120.985 0.421 . . . . 73.129999999999995 111.596 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 74.42 -73.05 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.951 1.834 . . . . 71.510000000000005 115.951 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -139.53 29.81 2.15 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 107.498 -1.297 . . . . 70.439999999999998 107.498 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -91.3 137.6 32.24 Favored 'General case' 0 C--O 1.277 2.524 0 CA-C-O 122.571 1.177 . . . . 54.310000000000002 113.102 -173.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.468 ' HG3' ' HB2' ' B' ' 274' ' ' ARG . 2.9 mpt_? -125.7 134.71 51.72 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.891 -1.504 . . . . 75.409999999999997 109.426 176.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 8.5 p -133.42 139.4 49.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.832 0.825 . . . . 75.430000000000007 110.887 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . 0.598 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 49.0 tp60 -114.85 118.89 34.79 Favored 'General case' 0 N--CA 1.401 -2.91 0 CA-C-N 114.228 -1.351 . . . . 73.030000000000001 108.425 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.74 118.77 36.52 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 105.416 -2.068 . . . . 72.209999999999994 105.416 175.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 135.97 -120.0 2.15 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.898 -1.281 . . . . 74.450000000000003 109.898 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 7.8 p30 -144.75 144.25 31.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 116.542 0.171 . . . . 75.319999999999993 111.156 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . 0.598 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 48.9 t -124.08 114.64 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.595 0 N-CA-C 107.075 -1.454 . . . . 70.510000000000005 107.075 172.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.87 129.17 74.47 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 C-N-CA 119.298 -0.961 . . . . 74.439999999999998 111.098 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.5 m -88.91 159.2 17.79 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.219 -1.4 . . . . 74.25 107.219 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.79 94.37 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.726 0.774 . . . . 73.340000000000003 110.702 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.98 -34.27 63.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.111 -1.404 . . . . 64.209999999999994 112.464 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.42 -31.53 70.93 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.297 0.851 . . . . 73.420000000000002 113.297 -175.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 89.4 mt -88.53 70.26 8.93 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.044 0.926 . . . . 71.219999999999999 113.042 -172.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -144.18 -51.41 0.31 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.941 -1.481 . . . . 71.319999999999993 107.098 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -100.63 176.73 27.7 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 110.375 -1.09 . . . . 72.530000000000001 110.375 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 98.52 93.87 2.0 Favored Glycine 0 C--N 1.306 -1.107 0 N-CA-C 109.589 -1.404 . . . . 73.230000000000004 109.589 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 62.3 mt -87.12 -41.3 14.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 120.486 0.184 . . . . 73.310000000000002 110.868 -174.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 67.74 174.87 0.26 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.769 0.828 . . . . 74.420000000000002 110.597 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . 0.405 HD12 ' N ' ' C' ' 256' ' ' ILE . 3.5 mp -108.32 -54.11 5.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.403 -1.332 . . . . 73.219999999999999 107.403 176.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 23.1 t 172.42 -32.69 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 105.367 -2.086 . . . . 73.349999999999994 105.367 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -34.86 106.67 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 113.212 -1.813 . . . . 70.140000000000001 114.724 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -87.59 96.51 10.44 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 105.523 -2.028 . . . . 70.450000000000003 105.523 168.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 5.3 m -63.35 121.37 13.59 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.616 -1.174 . . . . 75.299999999999997 108.903 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 261' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 21.8 m -107.34 108.56 20.0 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 109.275 -0.639 . . . . 73.140000000000001 109.275 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -111.04 141.12 44.95 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.207 -1.034 . . . . 62.210000000000001 108.207 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 263' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' C' ' 227' ' ' SER . 21.7 m -140.01 140.25 36.19 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 122.035 -0.416 . . . . 75.040000000000006 110.163 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.18 142.87 42.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 121.195 -0.202 . . . . 71.0 111.086 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 9.7 mm-40 -80.91 -52.73 7.14 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 111.798 0.295 . . . . 73.230000000000004 111.798 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 37.5 m -150.18 133.05 16.03 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.162 -0.615 . . . . 71.530000000000001 111.063 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 17.1 m -126.05 135.08 64.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 109.178 -0.675 . . . . 75.150000000000006 109.178 171.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.08 129.15 71.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 109.746 -0.464 . . . . 72.129999999999995 109.746 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.65 132.8 11.25 Favored Glycine 0 N--CA 1.428 -1.884 0 N-CA-C 108.37 -1.892 . . . . 74.120000000000005 108.37 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -128.24 117.05 20.82 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 120.925 0.393 . . . . 71.519999999999996 110.094 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.85 -136.23 17.2 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 109.811 -1.316 . . . . 55.310000000000002 109.811 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.3 96.52 6.66 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.342 -1.355 . . . . 74.040000000000006 107.342 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 273' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 51.0 m -134.99 145.04 47.72 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 115.254 -0.884 . . . . 62.119999999999997 109.502 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -135.21 126.59 28.46 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 107.05 -1.463 . . . . 73.519999999999996 107.05 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 6.2 p -139.33 139.65 38.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.874 -0.603 . . . . 75.209999999999994 110.301 -176.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 7.0 tt -123.2 122.35 38.19 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 107.71 -1.218 . . . . 72.209999999999994 107.71 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . 0.489 HG22 HD22 ' C' ' 226' ' ' ASN . 42.8 mm -110.65 103.79 16.04 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.843 0 N-CA-C 106.791 -1.559 . . . . 74.420000000000002 106.791 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.06 -133.67 5.05 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 119.918 -1.134 . . . . 71.409999999999997 113.548 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 17.9 m120 -115.07 134.07 55.49 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 120.816 0.341 . . . . 72.140000000000001 110.201 -177.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.64 119.58 19.58 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.61 -1.256 . . . . 75.540000000000006 107.61 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . 0.518 ' CE1' HG13 ' C' ' 222' ' ' ILE . 3.4 m-85 -119.17 124.91 47.95 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.488 -0.931 . . . . 74.109999999999999 108.488 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.2 -36.91 1.95 Allowed Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.195 -0.762 . . . . 43.140000000000001 111.195 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 100.03 -27.29 20.98 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.264 -1.134 . . . . 72.140000000000001 110.264 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -132.84 87.34 2.4 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.845 -1.169 . . . . 74.420000000000002 107.845 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' C' ' 287' ' ' TRP . . . -84.44 -130.31 2.0 Allowed Glycine 0 C--N 1.308 -0.991 0 C-N-CA 120.944 -0.646 . . . . 75.25 112.291 178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' B' ' 283' ' ' GLY . 1.4 p90 -73.67 18.32 0.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.336 0.589 . . . . 65.109999999999999 112.007 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . 0.407 ' H ' ' C ' ' C' ' 285' ' ' GLY . 53.3 m95 -79.04 32.36 0.21 Allowed 'General case' 0 C--O 1.244 0.768 0 O-C-N 121.407 -0.808 . . . . 74.450000000000003 110.304 -175.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' C' ' 286' ' ' PHE . 39.2 t70 -61.63 117.48 5.83 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.791 1.236 . . . . 74.310000000000002 111.127 -175.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 177.16 -34.49 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 105.024 -2.213 . . . . 74.450000000000003 105.024 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -78.4 127.62 32.46 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 105.989 -1.856 . . . . 72.510000000000005 105.989 170.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 35.5 m80 59.15 61.07 2.18 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 124.188 0.93 . . . . 72.420000000000002 110.456 -172.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -80.88 119.62 23.66 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.378 0.609 . . . . 73.140000000000001 110.431 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -122.05 107.72 12.53 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.414 -0.812 . . . . 71.310000000000002 109.925 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -143.89 -69.77 0.31 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.872 -1.529 . . . . 71.349999999999994 106.872 176.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 126.929 2.092 . . . . 75.25 114.325 173.738 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.596 ' HA ' ' OD2' ' B' ' 220' ' ' ASP . 24.3 ptm . . . . . 0 CA--C 1.517 -0.322 0 CA-C-O 121.644 0.735 . . . . 74.099999999999994 111.263 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -89.25 -63.14 1.33 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 109.108 -0.701 . . . . 73.299999999999997 109.108 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.8 mt 53.63 84.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 1.0 0 O-C-N 124.275 0.985 . . . . 72.400000000000006 112.248 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -102.76 113.84 27.58 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 120.824 0.345 . . . . 65.409999999999997 110.773 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -86.11 67.26 9.92 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.687 0.756 . . . . 71.219999999999999 110.32 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 60.8 mt -116.19 133.34 63.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.12 -1.067 . . . . 63.119999999999997 108.12 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.9 119.06 48.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 120.291 -0.563 . . . . 71.420000000000002 111.82 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 45.68 67.91 1.15 Allowed Glycine 0 N--CA 1.469 0.852 0 N-CA-C 116.164 1.226 . . . . 74.420000000000002 116.164 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -109.83 134.16 52.35 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.069 -1.052 . . . . 75.129999999999995 110.637 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.485 ' ND2' ' HA2' ' A' ' 278' ' ' GLY . 8.7 p30 -104.3 141.0 37.07 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.132 -1.433 . . . . 71.140000000000001 107.132 172.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.6 m -121.52 137.1 54.87 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.982 -0.377 . . . . 74.329999999999998 109.982 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.74 119.65 32.35 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.075 -1.454 . . . . 62.009999999999998 107.075 176.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -88.69 -41.31 12.67 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 116.206 -0.452 . . . . 73.319999999999993 110.807 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -140.71 138.99 34.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.915 0.388 . . . . 65.140000000000001 110.352 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.6 mt -131.41 121.85 49.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 107.673 -1.232 . . . . 74.400000000000006 107.673 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 60.4 ttt180 -132.58 115.1 15.03 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.493 0.663 . . . . 73.349999999999994 109.369 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.403 HG22 ' HB ' ' A' ' 239' ' ' VAL . 22.6 p -125.88 128.77 48.11 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.988 -1.116 . . . . 73.329999999999998 107.988 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -125.47 162.14 25.54 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.679 -0.808 . . . . 71.420000000000002 111.469 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 65.27 -84.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.122 1.369 . . . . 62.420000000000002 113.979 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -140.2 26.14 2.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.126 -0.943 . . . . 73.150000000000006 109.011 -168.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.67 151.62 30.41 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.832 -1.076 . . . . 75.209999999999994 109.763 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -124.11 135.43 53.52 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.241 -1.763 . . . . 73.230000000000004 106.241 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.5 p -135.87 139.59 45.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.038 0.447 . . . . 75.140000000000001 110.175 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -129.89 130.85 45.69 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.438 -0.949 . . . . 70.129999999999995 108.438 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -120.81 120.57 35.96 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.751 -1.203 . . . . 65.400000000000006 107.751 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.53 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 137.17 -140.09 11.09 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 120.22 -0.991 . . . . 61.210000000000001 112.127 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -123.85 128.32 49.32 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.906 -0.775 . . . . 73.439999999999998 108.906 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.4 118.71 57.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 107.897 -1.149 . . . . 74.209999999999994 107.897 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.39 112.75 41.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.835 -0.802 . . . . 74.5 108.835 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 29.6 m -101.53 159.6 15.15 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 108.128 -1.064 . . . . 73.430000000000007 108.128 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.59 74.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.637 0.977 . . . . 72.439999999999998 113.637 -175.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.02 -49.46 71.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 113.377 0.88 . . . . 70.430000000000007 113.377 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' B' ' 247' ' ' ALA . . . -76.2 -48.31 20.88 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 113.686 0.995 . . . . 53.119999999999997 113.686 -176.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 77.6 mt -151.98 105.63 3.11 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.767 -0.457 . . . . 73.510000000000005 109.767 -169.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -104.24 -19.28 14.17 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.256 -1.016 . . . . 75.340000000000003 108.256 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -86.91 -34.8 10.57 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.045 -0.98 . . . . 70.040000000000006 113.226 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -173.69 134.22 2.81 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.613 -0.803 . . . . 50.140000000000001 111.237 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.0 mp -76.16 -38.37 34.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.831 0.824 . . . . 61.229999999999997 108.877 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 69.03 -88.61 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 125.212 1.405 . . . . 75.450000000000003 113.527 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 15.0 pt -138.45 167.99 20.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.405 0.621 . . . . 75.109999999999999 112.316 -170.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 14.2 t -101.57 -163.8 1.04 Allowed 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.603 -1.258 . . . . 74.310000000000002 107.603 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -108.56 173.23 6.41 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.346 -0.388 . . . . 74.109999999999999 110.325 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -17.56 27.52 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 113.008 0.744 . . . . 73.530000000000001 113.008 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' B' ' 224' ' ' GLY . 94.7 m -69.54 123.47 21.39 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.611 0.72 . . . . 61.100000000000001 112.239 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.2 t -101.05 116.51 33.01 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.086 -0.961 . . . . 71.030000000000001 108.465 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -95.57 144.16 26.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.721 -0.672 . . . . 73.209999999999994 109.195 -176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' B' ' 227' ' ' SER . 20.3 m -140.42 123.24 16.41 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.484 -0.562 . . . . 63.039999999999999 109.484 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.9 p -128.51 140.14 50.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.418 0.152 . . . . 75.340000000000003 110.985 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.642 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 62.6 mm-40 -77.73 -78.4 0.14 Allowed 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 116.384 -0.371 . . . . 71.040000000000006 110.273 176.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.1 t -124.42 130.82 53.17 Favored 'General case' 0 C--O 1.261 1.672 0 N-CA-C 112.986 0.735 . . . . 74.019999999999996 112.986 -174.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.49 HG12 HD11 ' B' ' 231' ' ' ILE . 17.0 m -118.09 125.35 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 115.109 -0.951 . . . . 73.200000000000003 109.167 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 5.1 p -127.4 125.91 66.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.17 0.509 . . . . 74.299999999999997 111.99 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.85 133.03 11.07 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.561 -0.745 . . . . 54.210000000000001 111.498 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -123.66 141.51 51.95 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.27 0.628 . . . . 71.239999999999995 110.437 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.41 -127.58 29.35 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.919 -0.658 . . . . 71.340000000000003 111.938 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.419 ' HB3' ' NH1' ' A' ' 274' ' ' ARG . 60.9 mm-40 -93.35 57.55 2.67 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.817 0.847 . . . . 73.099999999999994 110.407 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 70.7 m -88.74 145.09 25.83 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 120.115 -0.634 . . . . 75.140000000000001 111.969 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . 0.419 ' NH1' ' HB3' ' A' ' 272' ' ' GLU . 10.4 mpt_? -121.47 127.69 51.34 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.193 -1.41 . . . . 75.519999999999996 107.193 173.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.1 p -136.0 123.57 34.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-O 121.536 0.684 . . . . 74.299999999999997 110.852 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.432 ' HG ' HE22 ' B' ' 240' ' ' GLN . 13.3 tp -121.97 124.3 43.7 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.542 0.687 . . . . 71.319999999999993 110.256 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.411 HG23 ' HB3' ' B' ' 241' ' ' LEU . 2.9 pt -112.7 104.55 17.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.402 -1.272 . . . . 73.439999999999998 110.056 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 146.0 -148.91 20.95 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 115.53 -0.759 . . . . 74.540000000000006 111.731 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 7.0 m-20 -101.94 149.58 24.07 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 122.752 -0.263 . . . . 74.129999999999995 110.709 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.1 125.94 24.09 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.776 -1.935 . . . . 72.299999999999997 105.776 175.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -109.29 122.81 48.15 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.493 -1.299 . . . . 72.140000000000001 107.493 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 134.11 -53.03 0.8 Allowed Glycine 0 C--N 1.283 -2.373 0 N-CA-C 108.939 -1.664 . . . . 63.32 108.939 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 103.32 -7.67 51.67 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.931 -1.268 . . . . 73.099999999999994 109.931 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -160.07 53.23 0.34 Allowed 'General case' 0 C--O 1.253 1.252 0 CA-C-N 114.755 -0.722 . . . . 75.329999999999998 111.15 -175.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -95.22 -57.87 1.19 Allowed Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.57 -0.741 . . . . 62.240000000000002 113.99 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -78.66 -2.03 37.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.363 1.078 . . . . 73.409999999999997 110.788 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . 0.444 ' CZ2' ' HD1' ' B' ' 286' ' ' PHE . 36.9 p90 -151.61 175.31 12.48 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 105.162 -2.162 . . . . 61.439999999999998 105.162 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -121.65 -62.66 1.39 Allowed 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 105.12 -2.178 . . . . 75.140000000000001 105.12 171.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 167.47 -177.17 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.13 1 N-CA-C 99.748 -4.167 . . . . 65.200000000000003 99.748 170.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -135.55 107.87 7.3 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 123.168 2.713 . . . . 75.030000000000001 116.466 -173.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 60.29 23.53 12.97 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 115.531 1.678 . . . . 73.040000000000006 115.531 169.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . 0.494 ' CD2' HH12 ' B' ' 274' ' ' ARG . 89.1 m-70 -94.79 85.47 4.44 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 121.549 -0.719 . . . . 74.150000000000006 109.47 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -81.1 -9.27 59.84 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.046 -0.524 . . . . 71.239999999999995 112.057 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -154.45 -61.88 0.13 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.068 -0.715 . . . . 73.510000000000005 109.068 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.481 0 N-CA-C 108.426 -0.953 . . . . 74.209999999999994 108.426 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 C--O 1.223 -0.302 0 CA-C-O 120.82 0.343 . . . . 73.409999999999997 111.0 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -150.59 131.76 14.45 Favored 'General case' 0 C--O 1.209 -1.055 0 N-CA-C 109.223 -0.658 . . . . 73.510000000000005 109.223 -176.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . 0.432 ' H ' HD12 ' B' ' 219' ' ' ILE . 0.1 OUTLIER -99.82 168.44 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.52 -0.548 . . . . 73.099999999999994 109.52 174.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . 0.596 ' OD2' ' HA ' ' A' ' 217' ' ' MET . 7.6 p-10 -73.24 147.19 44.87 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 113.245 0.832 . . . . 72.510000000000005 113.245 -171.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 72.03 35.38 1.31 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.331 1.452 . . . . 74.319999999999993 113.983 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 59.3 mt -100.94 132.49 46.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 108.39 -0.967 . . . . 73.329999999999998 108.39 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . 0.405 ' HA ' ' HG3' ' B' ' 259' ' ' GLN . 7.4 p -107.24 124.55 63.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-O 119.752 -0.166 . . . . 75.109999999999999 111.119 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 260' ' ' THR . . . 48.79 87.82 0.01 OUTLIER Glycine 0 C--N 1.354 1.533 0 O-C-N 124.504 1.127 . . . . 75.540000000000006 114.29 174.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.06 134.4 42.32 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.215 -0.994 . . . . 72.129999999999995 111.326 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' B' ' 262' ' ' ASN . 20.1 p-10 -116.67 140.29 49.57 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.381 -0.97 . . . . 75.109999999999999 108.381 174.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 263' ' ' SER . 18.2 m -121.48 136.5 54.95 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 109.526 -0.546 . . . . 64.400000000000006 109.526 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -120.8 131.53 54.51 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 106.989 -1.486 . . . . 74.219999999999999 106.989 175.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.642 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 1.4 tmtp? -93.31 -62.3 1.4 Allowed 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.121 -0.696 . . . . 72.340000000000003 109.121 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -127.95 137.36 52.23 Favored 'General case' 0 C--N 1.3 -1.543 0 N-CA-C 109.575 -0.528 . . . . 63.100000000000001 109.575 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . 0.49 HD11 HG12 ' A' ' 267' ' ' VAL . 18.7 mt -133.8 122.36 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 108.523 -0.917 . . . . 74.25 108.523 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 38.9 ttp180 -123.54 115.68 21.92 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.904 -0.776 . . . . 73.310000000000002 108.904 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 70.6 p -109.24 127.75 54.5 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 105.831 -1.915 . . . . 74.140000000000001 105.831 177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.55 161.67 26.65 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.207 -0.597 . . . . 72.519999999999996 111.48 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 67.52 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.251 -1.34 . . . . 72.099999999999994 113.41 172.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.06 18.3 2.28 Favored 'General case' 0 C--O 1.195 -1.783 0 N-CA-C 108.248 -1.019 . . . . 74.540000000000006 108.248 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -68.69 149.17 49.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.903 0.859 . . . . 74.409999999999997 113.016 -172.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -125.54 135.35 52.16 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.149 -0.932 . . . . 74.219999999999999 108.628 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 8.4 p -132.38 138.7 51.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.665 0.745 . . . . 72.409999999999997 110.763 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.514 ' CG ' HD12 ' B' ' 276' ' ' LEU . 52.5 tp60 -117.5 125.83 51.55 Favored 'General case' 0 N--CA 1.401 -2.887 0 CA-C-N 114.495 -1.229 . . . . 64.450000000000003 108.398 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . 0.452 ' HA ' HG13 ' B' ' 277' ' ' ILE . 2.4 tm? -118.15 119.14 33.82 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.9 -1.889 . . . . 74.5 105.9 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.652 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 136.12 -147.01 19.0 Favored Glycine 0 C--N 1.278 -2.646 0 C-N-CA 119.721 -1.228 . . . . 73.319999999999993 110.875 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 86.2 m-20 -124.93 129.13 49.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.157 0.503 . . . . 73.450000000000003 110.017 -174.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 93.7 t -111.04 129.26 66.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.758 -0.83 . . . . 75.510000000000005 108.758 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 61.1 t -118.4 111.79 35.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.229 -1.026 . . . . 71.450000000000003 108.229 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 28.2 m -96.67 161.1 14.03 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.785 -0.821 . . . . 72.450000000000003 108.785 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.442 ' HB3' ' HA ' ' A' ' 249' ' ' ALA . . . -63.69 -33.95 76.77 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.273 0.629 . . . . 73.530000000000001 112.331 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.53 -37.16 67.58 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 115.222 1.564 . . . . 55.549999999999997 115.222 -173.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.44 ' HB2' ' N ' ' B' ' 282' ' ' GLY . . . -74.78 -37.79 62.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.148 0.796 . . . . 72.299999999999997 113.148 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.8 mp 54.51 89.34 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.864 -0.791 . . . . 74.030000000000001 108.864 -167.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 35.6 p-80 -60.97 118.5 6.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.132 -0.94 . . . . 73.430000000000007 113.465 -168.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -123.05 -70.61 0.24 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.172 -0.922 . . . . 73.150000000000006 111.167 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -82.46 72.38 2.82 Favored Glycine 0 C--O 1.218 -0.881 0 N-CA-C 111.256 -0.738 . . . . 72.109999999999999 111.256 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 12.2 tt -129.04 80.28 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 122.19 0.995 . . . . 71.439999999999998 111.83 -176.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -179.61 -50.19 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 124.986 1.314 . . . . 75.329999999999998 108.002 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 4.5 tp -122.61 87.96 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.142 0.972 . . . . 72.5 108.699 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' C' ' 252' ' ' GLY . 29.8 t -160.22 113.04 2.08 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 106.454 -1.684 . . . . 73.129999999999995 106.454 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 18.2 t70 69.48 166.82 0.28 Allowed 'General case' 0 N--CA 1.484 1.244 0 O-C-N 124.336 1.022 . . . . 73.349999999999994 112.039 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . 0.405 ' HG3' ' HA ' ' B' ' 223' ' ' VAL . 43.6 tt0 -161.24 29.21 0.14 Allowed 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 108.842 -0.799 . . . . 72.319999999999993 108.842 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 67.3 m -64.92 137.21 57.61 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.562 -0.744 . . . . 72.530000000000001 110.459 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 63.4 m -105.28 108.5 20.05 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.982 -0.747 . . . . 74.439999999999998 108.982 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' B' ' 226' ' ' ASN . 15.8 m120 -100.98 138.61 37.8 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.109 -0.7 . . . . 62.329999999999998 109.109 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' C' ' 227' ' ' SER . 4.1 p -143.28 123.94 14.11 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 122.259 -0.276 . . . . 75.200000000000003 110.899 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 7.1 p -124.88 142.3 42.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 110.263 -0.273 . . . . 74.239999999999995 110.263 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 43.2 mm-40 -82.47 -78.81 0.2 Allowed 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 123.202 0.314 . . . . 65.140000000000001 110.282 175.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 10.2 t -120.86 130.43 53.93 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.992 -1.083 . . . . 71.230000000000004 112.54 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . 0.421 ' HB ' HD13 ' C' ' 231' ' ' ILE . 1.5 p -125.05 124.8 68.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.711 -1.131 . . . . 64.230000000000004 110.182 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 14.8 p -127.01 140.57 48.71 Favored 'Isoleucine or valine' 0 C--O 1.267 2.013 0 CA-C-O 121.782 0.801 . . . . 75.099999999999994 111.395 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.78 133.08 9.53 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 110.609 -0.996 . . . . 74.010000000000005 110.609 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -127.59 116.51 20.45 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.154 0.582 . . . . 74.319999999999993 110.515 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.62 -131.03 10.57 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.126 -1.035 . . . . 71.140000000000001 110.87 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 67.5 mm-40 -91.85 52.1 1.95 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.324 0.583 . . . . 72.420000000000002 109.511 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 33.3 m -82.9 145.59 29.33 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.499 0.666 . . . . 72.409999999999997 111.558 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.494 HH12 ' CD2' ' A' ' 292' ' ' HIS . 16.8 mtm180 -132.4 126.35 32.94 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.754 -1.112 . . . . 75.310000000000002 108.724 176.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 0.8 OUTLIER -135.92 127.07 43.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.245 -0.889 . . . . 75.209999999999994 111.076 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . 0.514 HD12 ' CG ' ' B' ' 240' ' ' GLN . 11.9 tp -122.43 121.87 37.64 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.154 0.978 . . . . 74.129999999999995 110.523 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . 0.498 HG23 ' HB3' ' C' ' 241' ' ' LEU . 4.6 pt -112.62 104.33 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-N 114.175 -1.375 . . . . 74.150000000000006 109.131 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.652 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 160.7 -148.83 17.44 Favored Glycine 0 N--CA 1.42 -2.418 0 C-N-CA 120.887 -0.673 . . . . 71.519999999999996 111.691 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 54.7 t30 -120.63 130.01 53.97 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.161 -1.052 . . . . 71.129999999999995 108.161 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . 0.403 ' HG3' ' CH2' ' B' ' 287' ' ' TRP . 0.3 OUTLIER -117.96 130.52 56.26 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.038 -1.097 . . . . 74.540000000000006 108.038 -174.68 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -108.32 122.93 47.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.304 0.574 . . . . 74.109999999999999 109.991 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . 0.44 ' N ' ' HB2' ' B' ' 249' ' ' ALA . . . 129.05 -53.23 0.81 Allowed Glycine 0 N--CA 1.421 -2.31 0 N-CA-C 109.378 -1.489 . . . . 72.420000000000002 109.378 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 105.95 -7.77 41.75 Favored Glycine 0 N--CA 1.434 -1.459 0 C-N-CA 120.742 -0.742 . . . . 54.130000000000003 111.84 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . 0.545 ' HA ' ' NE1' ' B' ' 287' ' ' TRP . 11.0 ptmm? -155.95 36.73 0.35 Allowed 'General case' 0 C--O 1.251 1.183 0 N-CA-C 111.774 0.287 . . . . 75.340000000000003 111.774 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -74.43 -76.03 0.75 Allowed Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.252 -0.975 . . . . 70.319999999999993 112.809 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.444 ' HD1' ' CZ2' ' A' ' 287' ' ' TRP . 75.3 t80 -56.36 -26.48 52.95 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.987 0.898 . . . . 75.030000000000001 111.419 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.545 ' NE1' ' HA ' ' B' ' 284' ' ' LYS . 26.8 p90 -115.18 71.85 0.78 Allowed 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.383 -0.826 . . . . 75.219999999999999 109.426 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.35 -35.46 67.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.862 -0.608 . . . . 74.010000000000005 110.936 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 t30 61.75 34.06 17.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.9 0.88 . . . . 71.349999999999994 110.103 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . 0.405 ' HA ' ' HB3' ' B' ' 293' ' ' HIS . 31.5 t-80 71.26 85.99 0.12 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.184 -1.371 . . . . 74.230000000000004 113.114 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -145.6 -51.42 0.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.617 -1.174 . . . . 75.120000000000005 108.123 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -103.24 -29.61 11.17 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.167 -1.049 . . . . 74.129999999999995 108.167 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . 0.405 ' HB3' ' HA ' ' B' ' 290' ' ' HIS . 8.9 t60 -43.41 132.51 4.55 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.728 1.611 . . . . 72.049999999999997 114.326 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -149.0 100.65 3.09 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.292 -1.322 . . . . 75.310000000000002 109.35 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 78.0 t60 . . . . . 0 C--O 1.264 1.854 0 C-N-CA 125.486 1.515 . . . . 70.329999999999998 113.95 175.025 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 45.8 ttm . . . . . 0 CA--C 1.502 -0.873 0 N-CA-C 109.142 -0.688 . . . . 75.319999999999993 109.142 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -157.45 114.37 2.99 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.84 -1.17 . . . . 74.129999999999995 107.84 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.49 96.87 4.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.123 -1.806 . . . . 75.319999999999993 106.123 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.73 -166.14 1.48 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.15 -1.386 . . . . 61.450000000000003 110.963 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 70.14 79.66 0.18 Allowed 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 124.427 1.091 . . . . 74.349999999999994 109.23 -174.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 52.0 mt -116.1 138.26 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 CA-C-N 114.771 -1.104 . . . . 75.319999999999993 108.7 -175.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.74 119.87 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 CA-C-N 116.414 -0.357 . . . . 74.209999999999994 110.892 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 51.06 67.42 1.96 Allowed Glycine 0 CA--C 1.5 -0.854 0 CA-C-N 114.794 -1.094 . . . . 72.120000000000005 114.438 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' B' ' 261' ' ' THR . 1.5 ptp180 -95.88 138.03 34.11 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 118.203 -1.399 . . . . 74.019999999999996 112.814 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -116.46 115.02 25.03 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 106.695 -1.594 . . . . 72.129999999999995 106.695 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 227' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' B' ' 263' ' ' SER . 8.3 p -121.13 136.6 54.95 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 122.025 0.917 . . . . 74.540000000000006 112.402 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -121.2 135.83 55.08 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.358 -1.292 . . . . 74.019999999999996 107.639 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 1.1 tmtp? -93.62 -55.7 3.17 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 109.486 -0.561 . . . . 74.200000000000003 109.486 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -131.45 138.52 49.07 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.773 0.321 . . . . 75.420000000000002 110.403 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . 0.421 HD13 ' HB ' ' B' ' 267' ' ' VAL . 28.3 mt -131.35 117.83 37.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 107.95 -1.13 . . . . 75.230000000000004 107.95 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 11.4 ttp180 -122.94 114.92 21.09 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.612 -0.514 . . . . 73.420000000000002 109.612 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 40.7 p -113.18 127.8 56.29 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.094 -1.076 . . . . 72.439999999999998 108.094 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -128.18 165.79 19.77 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.913 -0.715 . . . . 74.319999999999993 110.714 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 43.9 mt-10 68.52 -84.7 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 114.791 -1.095 . . . . 63.049999999999997 112.836 175.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.499 ' O ' ' HD2' ' C' ' 238' ' ' ARG . 0.3 OUTLIER -141.25 21.5 2.24 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 108.155 -1.054 . . . . 73.129999999999995 108.155 178.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -68.42 148.32 50.81 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.623 0.725 . . . . 73.430000000000007 112.174 -173.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' C' ' 236' ' ' ARG . 3.4 mpt_? -124.27 135.18 53.21 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.318 -1.364 . . . . 75.109999999999999 107.318 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.2 141.16 45.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.318 0.58 . . . . 74.239999999999995 111.183 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -122.82 123.3 40.7 Favored 'General case' 0 N--CA 1.408 -2.539 0 CA-C-N 114.545 -1.207 . . . . 71.340000000000003 108.808 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.498 ' HB3' HG23 ' B' ' 277' ' ' ILE . 2.1 tm? -120.48 119.16 32.2 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.586 -1.264 . . . . 72.030000000000001 107.586 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.525 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 134.7 -125.43 3.77 Favored Glycine 0 N--CA 1.411 -3.005 0 N-CA-C 110.158 -1.177 . . . . 71.209999999999994 110.158 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 92.7 m-20 -130.22 150.59 51.41 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 120.909 0.385 . . . . 72.239999999999995 110.49 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 83.1 t -128.8 118.38 46.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.449 -1.315 . . . . 74.519999999999996 107.449 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 47.5 t -114.56 112.3 39.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.784 -0.821 . . . . 74.230000000000004 108.784 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 15.4 m -100.37 160.91 13.96 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 115.561 -0.745 . . . . 62.520000000000003 109.503 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.06 -32.21 72.71 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.773 0.796 . . . . 75.049999999999997 110.508 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.97 -42.13 72.02 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.062 -1.427 . . . . 61.210000000000001 112.367 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . 0.468 ' HB1' ' N ' ' C' ' 282' ' ' GLY . . . -75.34 -40.31 58.43 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.009 0.433 . . . . 71.0 110.014 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 67.4 tp 72.72 -61.49 0.5 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.646 1.578 . . . . 73.329999999999998 113.114 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -130.01 129.13 43.32 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.255 0.55 . . . . 63.310000000000002 111.354 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' B' ' 257' ' ' SER . . . -118.92 39.38 2.56 Favored Glycine 0 C--N 1.299 -1.481 0 N-CA-C 107.891 -2.084 . . . . 64.219999999999999 107.891 172.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -74.93 81.95 0.88 Allowed Glycine 0 CA--C 1.496 -1.152 0 CA-C-N 114.216 -0.992 . . . . 72.109999999999999 113.35 -174.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 11.1 tt -168.29 137.8 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.934 -1.136 . . . . 75.310000000000002 107.934 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -79.58 96.06 6.05 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.676 -0.861 . . . . 74.319999999999993 108.676 174.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 18.1 pt -59.87 117.85 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 107.881 -1.155 . . . . 72.5 107.881 174.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 13.0 m -106.31 -31.26 8.69 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 116.185 -0.461 . . . . 73.239999999999995 111.735 -173.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -126.85 99.35 5.71 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.236 -1.024 . . . . 63.219999999999999 108.236 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -118.81 174.55 6.22 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.058 -0.519 . . . . 74.120000000000005 110.663 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 18.6 m -84.85 134.86 34.27 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.633 -0.877 . . . . 75.140000000000001 108.633 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 9.9 t -91.36 131.05 37.1 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.182 -1.414 . . . . 75.340000000000003 107.182 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -119.57 135.83 54.62 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.778 -0.453 . . . . 71.439999999999998 109.778 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 20.8 m -142.47 125.38 16.13 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.194 -0.669 . . . . 71.099999999999994 109.194 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.1 p -128.16 143.59 40.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 110.195 -0.298 . . . . 74.230000000000004 110.195 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.575 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 64.2 mm-40 -76.44 -69.74 0.49 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.531 -0.304 . . . . 74.299999999999997 110.762 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 8.8 t -136.95 133.91 36.16 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 119.004 -1.078 . . . . 64.150000000000006 112.061 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.98 133.49 65.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.503 -0.925 . . . . 72.209999999999994 108.503 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 11.6 p -127.32 138.99 53.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 116.387 -0.369 . . . . 65.310000000000002 110.256 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.92 132.98 9.95 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.685 -0.966 . . . . 64.219999999999999 110.685 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -132.85 129.74 38.85 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 123.66 0.784 . . . . 75.109999999999999 109.951 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.85 -122.32 9.09 Favored Glycine 0 C--N 1.304 -1.198 0 C-N-CA 121.051 -0.595 . . . . 71.299999999999997 112.043 -176.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -96.79 51.89 1.16 Allowed 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.511 0.724 . . . . 64.349999999999994 110.463 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 56.3 m -83.67 144.36 29.45 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.778 0.799 . . . . 72.329999999999998 112.179 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . 0.453 ' HB3' ' CE2' ' C' ' 286' ' ' PHE . 7.6 mpt_? -127.64 127.72 44.27 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.369 -2.085 . . . . 75.030000000000001 105.369 172.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 3.4 p -138.53 124.03 23.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.099 0.476 . . . . 75.519999999999996 111.309 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 20.1 tp -113.41 120.12 39.96 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.728 0.775 . . . . 74.120000000000005 110.479 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.9 pt -112.51 103.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 N-CA-C 107.769 -1.197 . . . . 74.439999999999998 107.769 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 152.1 -161.14 29.23 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.073 -1.06 . . . . 73.319999999999993 111.812 -176.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -109.0 136.07 49.14 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.319 -0.623 . . . . 75.049999999999997 109.319 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.95 144.64 45.32 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.204 -1.406 . . . . 74.510000000000005 107.204 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -124.06 122.9 39.12 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.33 -0.618 . . . . 73.230000000000004 109.33 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . 0.468 ' N ' ' HB1' ' C' ' 249' ' ' ALA . . . 127.14 -48.33 0.97 Allowed Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 108.738 -1.745 . . . . 54.340000000000003 108.738 -174.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' C' ' 293' ' ' HIS . . . 103.04 -8.01 53.26 Favored Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.907 -0.877 . . . . 54.350000000000001 110.907 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . 0.562 ' HA ' ' NE1' ' C' ' 287' ' ' TRP . 17.3 ptmt -154.46 36.2 0.42 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.25 0.62 . . . . 72.450000000000003 110.761 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -70.23 -78.0 0.42 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.359 -0.924 . . . . 73.239999999999995 112.423 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.537 ' HD1' ' CZ2' ' B' ' 287' ' ' TRP . 67.5 t80 -53.79 -19.64 4.59 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.583 1.153 . . . . 74.129999999999995 112.658 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . 0.562 ' NE1' ' HA ' ' C' ' 284' ' ' LYS . 23.8 p90 -125.92 97.2 5.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.527 0.68 . . . . 74.129999999999995 111.679 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -97.93 19.7 13.43 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 123.518 1.628 . . . . 62.229999999999997 107.921 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -153.6 -176.75 5.96 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 102.788 -3.042 . . . . 64.400000000000006 102.788 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 68.49 -173.99 0.19 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.305 0.957 . . . . 75.030000000000001 110.26 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -128.26 138.06 52.27 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.655 -0.498 . . . . 73.340000000000003 109.655 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -179.5 -36.18 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 O-C-N 124.145 0.903 . . . . 71.319999999999993 108.616 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . 0.438 ' HB3' ' O ' ' C' ' 283' ' ' GLY . 9.3 p80 -69.29 101.79 1.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.551 0.691 . . . . 74.340000000000003 111.317 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -146.76 111.28 5.21 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 105.522 -2.029 . . . . 75.319999999999993 105.522 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 8.9 p80 . . . . . 0 C--N 1.295 -1.794 0 CA-C-O 117.977 -1.011 . . . . 75.219999999999999 112.825 -172.945 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.894 0 N-CA-C 109.152 -0.684 . . . . 72.230000000000004 109.152 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -156.12 -84.79 0.05 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 105.002 -2.222 . . . . 75.140000000000001 105.002 171.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 46.8 mm -141.19 97.04 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 101.783 -3.414 . . . . 73.310000000000002 101.783 173.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -113.58 -22.21 10.41 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.719 -0.673 . . . . 75.099999999999994 111.672 -168.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . 57.15 61.73 2.46 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.018 0.927 . . . . 54.109999999999999 111.475 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 49.7 mm -116.92 138.71 46.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.301 -0.863 . . . . 74.420000000000002 110.213 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.79 148.85 18.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.805 -0.442 . . . . 75.409999999999997 109.805 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -99.12 109.88 3.87 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 109.837 -1.305 . . . . 51.530000000000001 109.837 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -103.83 135.02 46.15 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.175 0.512 . . . . 73.409999999999997 110.868 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -92.71 126.18 37.67 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.929 -1.508 . . . . 64.299999999999997 106.929 174.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 14.1 m -121.84 136.81 54.94 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.216 0.531 . . . . 73.219999999999999 110.23 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.81 124.06 16.63 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.897 -1.149 . . . . 73.420000000000002 107.897 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 265' ' ' GLU . 4.8 mmmm -76.76 -64.29 1.16 Allowed 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 114.431 1.271 . . . . 73.409999999999997 114.431 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -127.74 140.08 52.28 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.058 -1.057 . . . . 73.519999999999996 110.999 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 30.1 mm -121.15 118.21 55.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.902 -0.777 . . . . 75.329999999999998 108.902 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 80.2 mtt180 -124.76 116.74 22.79 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.921 0.391 . . . . 74.230000000000004 111.046 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 27.3 p -120.44 126.76 51.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.135 -0.691 . . . . 72.099999999999994 109.135 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.485 ' O ' ' HA ' ' A' ' 270' ' ' LYS . 47.4 mt-10 -139.94 139.47 36.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.596 -0.52 . . . . 64.530000000000001 109.596 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 51.71 97.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.824 1.25 . . . . 74.319999999999993 114.229 174.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? 64.59 20.94 12.31 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.373 1.069 . . . . 75.519999999999996 110.985 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.1 129.4 45.36 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.368 0.604 . . . . 72.140000000000001 110.292 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.85 140.15 52.2 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.455 -0.793 . . . . 74.409999999999997 109.343 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 5.9 p -129.35 146.72 33.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 121.001 0.429 . . . . 55.340000000000003 111.165 -174.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -119.15 124.1 45.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.089 -1.449 . . . . 75.519999999999996 107.089 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -118.58 122.76 43.39 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.686 -0.487 . . . . 74.310000000000002 109.686 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.473 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 120.45 -156.85 15.92 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.906 -0.664 . . . . 74.409999999999997 112.453 175.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -102.23 132.87 47.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.104 -0.702 . . . . 72.430000000000007 109.104 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.444 HG11 ' HA3' ' A' ' 285' ' ' GLY . 15.7 t -116.33 122.11 69.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.76 -0.83 . . . . 73.519999999999996 108.76 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 48.5 t -113.11 112.69 41.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.19 -1.041 . . . . 75.109999999999999 108.19 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 54.3 m -89.44 160.73 16.64 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.243 -0.435 . . . . 70.430000000000007 109.972 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.14 -37.2 86.26 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.33 0.652 . . . . 74.219999999999999 110.9 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.36 -35.04 64.81 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.238 1.015 . . . . 73.329999999999998 113.589 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.51 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -73.99 -36.75 64.56 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.79 0.663 . . . . 61.140000000000001 112.79 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 64.71 -172.2 0.18 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.227 0.611 . . . . 74.239999999999995 109.773 -171.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -82.9 82.8 8.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 122.227 1.013 . . . . 61.409999999999997 111.867 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -105.95 25.32 24.24 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.76 -1.109 . . . . 60.539999999999999 111.807 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -70.01 -14.85 71.28 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 111.87 -0.492 . . . . 75.209999999999994 111.87 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 28.6 pt -61.22 -29.59 46.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 123.289 0.636 . . . . 74.310000000000002 111.241 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.15 79.74 5.71 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 108.545 -0.909 . . . . 70.109999999999999 108.545 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 13.2 tt -102.22 111.93 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 CA-C-O 122.281 1.038 . . . . 73.120000000000005 109.972 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 46.5 m -134.08 25.99 3.9 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.596 -1.261 . . . . 70.530000000000001 107.596 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -113.45 122.78 48.35 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.542 -1.663 . . . . 73.329999999999998 111.19 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -139.17 22.2 2.59 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.302 -1.74 . . . . 73.420000000000002 106.302 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 4.1 m -76.52 121.59 23.36 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 114.306 -1.315 . . . . 70.239999999999995 110.438 -173.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.5 m -99.61 108.15 20.46 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.455 -1.313 . . . . 75.140000000000001 107.455 175.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -96.07 142.77 27.88 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.323 -0.991 . . . . 74.430000000000007 108.323 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.5 m -139.72 123.63 17.61 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.724 -0.391 . . . . 71.230000000000004 111.21 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 12.3 p -128.85 144.9 36.68 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.685 -0.487 . . . . 74.340000000000003 109.685 173.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.516 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 4.2 tp10 -84.34 -75.85 0.33 Allowed 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 109.572 -0.529 . . . . 73.120000000000005 109.572 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 14.6 m -123.28 134.5 54.07 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.227 -0.921 . . . . 71.140000000000001 111.3 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 32.5 m -119.3 124.33 72.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 107.972 -1.121 . . . . 74.109999999999999 107.972 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 10.4 p -127.6 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 110.221 -0.288 . . . . 74.549999999999997 110.221 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.581 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -134.19 131.48 5.98 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 119.969 -1.11 . . . . 72.430000000000007 111.94 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 234' ' ' GLU . 27.5 ttmt -135.77 144.87 46.03 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.867 0.692 . . . . 73.340000000000003 112.867 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.72 -54.37 1.43 Allowed Glycine 0 CA--C 1.5 -0.906 0 N-CA-C 111.827 -0.509 . . . . 65.420000000000002 111.827 173.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.531 ' HB3' ' H ' ' B' ' 236' ' ' ARG . 23.1 tt0 -176.76 102.98 0.06 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 105.485 -2.043 . . . . 61.310000000000002 105.485 174.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 59.8 m -135.05 145.18 47.75 Favored 'General case' 0 C--N 1.281 -2.41 0 C-N-CA 119.923 -0.711 . . . . 74.310000000000002 110.795 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -126.7 126.22 43.14 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 104.713 -2.329 . . . . 75.310000000000002 104.713 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 1.6 p -135.75 123.99 37.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 CA-C-O 121.06 0.457 . . . . 75.310000000000002 110.763 -176.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 6.7 tt -111.52 121.21 44.56 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.963 -1.125 . . . . 73.420000000000002 107.963 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 43.5 mm -112.1 104.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 107.967 -1.123 . . . . 75.109999999999999 107.967 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.509 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 149.99 -128.87 2.81 Favored Glycine 0 N--CA 1.427 -1.936 0 C-N-CA 119.241 -1.457 . . . . 60.0 113.627 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -128.71 128.88 44.93 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.205 -1.035 . . . . 75.230000000000004 108.205 -175.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -112.93 118.7 35.59 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.741 -0.837 . . . . 75.239999999999995 108.741 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 90.2 m-85 -114.79 123.85 50.27 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.969 -0.752 . . . . 74.340000000000003 108.969 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.43 ' CA ' ' HB1' ' A' ' 249' ' ' ALA . . . 105.94 -47.12 1.09 Allowed Glycine 0 C--N 1.297 -1.611 0 N-CA-C 110.905 -0.878 . . . . 62.240000000000002 110.905 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.498 ' HA2' ' H ' ' B' ' 286' ' ' PHE . . . 89.98 47.28 3.94 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.931 -0.652 . . . . 72.310000000000002 113.155 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -174.78 30.87 0.01 OUTLIER 'General case' 0 C--O 1.247 0.933 0 CA-C-O 122.151 0.977 . . . . 74.420000000000002 109.372 -177.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.444 ' HA3' HG11 ' A' ' 244' ' ' VAL . . . -86.73 128.08 8.73 Favored Glycine 0 N--CA 1.411 -3.007 0 C-N-CA 120.351 -0.928 . . . . 73.230000000000004 112.161 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 27.0 t80 73.86 -51.69 0.69 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.917 1.287 . . . . 75.230000000000004 112.396 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.54 -175.65 4.81 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.988 0.736 . . . . 73.25 112.988 -172.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.524 ' OD1' ' HA ' ' B' ' 287' ' ' TRP . 41.1 t0 171.97 155.18 0.08 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.369 2.267 . . . . 70.329999999999998 107.726 171.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -168.97 66.39 0.06 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.0 -1.482 . . . . 74.400000000000006 107.0 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -96.88 92.77 6.28 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 122.415 1.102 . . . . 75.040000000000006 111.523 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -122.86 133.19 54.43 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 104.969 -2.234 . . . . 74.510000000000005 104.969 174.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -71.76 -32.77 68.05 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.085 -1.046 . . . . 71.420000000000002 110.144 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -111.62 116.89 31.56 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 106.783 -1.562 . . . . 75.420000000000002 106.783 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -102.9 -57.0 2.12 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.203 0.525 . . . . 63.549999999999997 109.979 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 8.4 p80 . . . . . 0 N--CA 1.428 -1.563 0 N-CA-C 108.259 -1.015 . . . . 74.109999999999999 108.259 178.782 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 108.973 -0.751 . . . . 74.400000000000006 108.973 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt 73.43 -74.6 0.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.848 1.259 . . . . 75.420000000000002 108.69 -173.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 43.8 pt -116.56 144.0 25.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 104.289 -2.486 . . . . 75.140000000000001 104.289 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -101.27 80.82 2.14 Favored 'General case' 0 C--N 1.263 -3.186 0 C-N-CA 117.746 -1.581 . . . . 62.140000000000001 108.286 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -81.23 15.16 2.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.694 -1.594 . . . . 73.120000000000005 111.614 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 51.0 mm -83.85 115.12 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 105.648 -1.982 . . . . 73.310000000000002 105.648 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . 0.419 ' HA ' ' OE1' ' B' ' 259' ' ' GLN . 26.9 m -123.35 152.72 28.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 116.212 -0.449 . . . . 71.329999999999998 110.497 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -86.26 121.38 5.71 Favored Glycine 0 N--CA 1.423 -2.219 0 N-CA-C 110.754 -0.938 . . . . 73.530000000000001 110.754 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -102.69 147.73 26.46 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.306 0.574 . . . . 75.430000000000007 109.798 176.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -112.67 130.52 56.02 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 105.191 -2.152 . . . . 74.519999999999996 105.191 171.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 14.5 m -132.53 135.81 46.22 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 118.356 -1.338 . . . . 62.420000000000002 110.977 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.92 134.5 42.71 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 107.178 -1.416 . . . . 71.409999999999997 107.178 175.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' B' ' 265' ' ' GLU . 24.6 mmtp -80.17 -71.23 0.47 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.659 -0.416 . . . . 75.209999999999994 112.058 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -127.11 138.59 53.21 Favored 'General case' 0 N--CA 1.414 -2.274 0 C-N-CA 118.555 -1.258 . . . . 72.310000000000002 109.597 -173.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 31.1 mm -123.41 116.98 50.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.791 -1.189 . . . . 72.450000000000003 107.791 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -117.4 115.23 24.8 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 120.299 -0.561 . . . . 75.310000000000002 109.52 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' THR . . . . . 0.581 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 40.8 p -110.8 126.43 54.62 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.206 -1.405 . . . . 75.010000000000005 107.206 176.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 51.0 mt-10 -143.43 138.83 29.6 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 109.811 -0.44 . . . . 73.349999999999994 109.811 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 56.49 98.22 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.868 0 O-C-N 125.292 1.62 . . . . 73.530000000000001 113.041 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.531 ' H ' ' HB3' ' A' ' 272' ' ' GLU . 1.1 mpt_? 60.89 35.66 19.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.857 0.863 . . . . 75.319999999999993 109.718 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -103.76 138.88 39.75 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.586 0.707 . . . . 72.209999999999994 111.106 -175.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.586 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 1.4 mpt_? -133.84 136.35 44.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.978 -1.119 . . . . 71.230000000000004 107.978 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 5.7 p -137.37 137.66 45.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-O 121.578 0.704 . . . . 73.150000000000006 112.059 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -110.64 117.65 34.06 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.113 -1.44 . . . . 71.150000000000006 107.113 175.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -119.33 127.4 53.15 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.085 -0.709 . . . . 72.319999999999993 109.085 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 122.7 -121.3 4.59 Favored Glycine 0 CA--C 1.473 -2.542 0 N-CA-C 109.636 -1.385 . . . . 62.420000000000002 109.636 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 33.8 p30 -144.1 154.77 43.55 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 119.739 -0.784 . . . . 54.229999999999997 111.41 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.513 ' CG1' ' HA3' ' B' ' 285' ' ' GLY . 65.6 t -123.49 130.37 74.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.176 -0.92 . . . . 75.510000000000005 109.69 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 57.8 t -122.66 111.58 30.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.643 -1.243 . . . . 74.400000000000006 107.643 171.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' THR . . . . . 0.446 ' HB ' ' HA3' ' B' ' 282' ' ' GLY . 16.8 m -88.02 160.72 17.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.548 -0.908 . . . . 75.109999999999999 108.548 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.4 -43.85 96.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 122.056 0.932 . . . . 74.510000000000005 110.532 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.51 -35.63 65.83 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.65 -1.614 . . . . 74.439999999999998 112.282 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.419 ' HB2' ' CA ' ' B' ' 282' ' ' GLY . . . -63.52 -25.54 68.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.07 0.767 . . . . 71.439999999999998 113.07 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 tt -57.41 110.36 0.85 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.269 0.557 . . . . 75.340000000000003 110.215 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -150.07 167.78 25.78 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.785 -0.821 . . . . 73.530000000000001 108.785 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -71.21 91.71 0.46 Allowed Glycine 0 N--CA 1.442 -0.957 0 O-C-N 124.178 0.924 . . . . 71.530000000000001 112.256 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -174.22 64.64 0.11 Allowed Glycine 0 N--CA 1.428 -1.873 0 C-N-CA 120.797 -0.716 . . . . 64.430000000000007 111.936 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 49.9 mm -74.11 114.75 14.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.826 -0.805 . . . . 73.439999999999998 108.826 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 72.69 103.83 0.07 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.536 1.147 . . . . 74.230000000000004 110.558 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 38.7 pt -113.96 158.47 14.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.878 -1.156 . . . . 73.019999999999996 107.878 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 70.5 m -93.01 76.88 4.71 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 114.347 1.24 . . . . 72.439999999999998 114.347 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -143.11 103.99 4.23 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 106.569 -1.641 . . . . 75.530000000000001 106.569 168.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . 0.419 ' OE1' ' HA ' ' B' ' 223' ' ' VAL . 29.2 mt-30 -130.01 44.1 3.02 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.262 -1.384 . . . . 74.099999999999994 107.262 175.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 68.8 m -63.88 121.32 13.77 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 113.232 -1.804 . . . . 73.409999999999997 108.324 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 62.8 m -90.29 112.96 24.7 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.665 -0.865 . . . . 74.200000000000003 108.665 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -96.47 128.62 43.56 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-N 114.891 -1.05 . . . . 71.209999999999994 109.899 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 14.5 m -121.49 121.13 36.83 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.194 -1.039 . . . . 74.5 108.194 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.8 p -129.61 145.82 35.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.302 -0.999 . . . . 73.230000000000004 108.302 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 20.5 tt0 -93.0 -75.44 0.49 Allowed 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 119.03 -1.068 . . . . 74.409999999999997 112.033 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' THR . . . . . 0.406 ' HG1' ' HG2' ' B' ' 265' ' ' GLU . 32.8 m -124.95 134.54 52.59 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.806 -1.158 . . . . 73.019999999999996 111.478 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 10.0 m -118.4 134.33 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 108.018 -1.104 . . . . 71.129999999999995 108.018 173.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 85.1 t -123.97 128.49 74.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 115.636 -0.711 . . . . 72.400000000000006 110.036 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . 0.452 ' HA2' ' HG1' ' C' ' 233' ' ' THR . . . -115.22 131.69 9.89 Favored Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 110.293 -1.123 . . . . 71.439999999999998 110.293 174.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.441 ' HB3' ' HG2' ' C' ' 234' ' ' GLU . 2.2 tpmt? -135.53 137.85 42.47 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 122.943 0.497 . . . . 75.140000000000001 111.073 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.29 -52.74 4.54 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 114.746 0.658 . . . . 64.010000000000005 114.746 169.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . 0.592 ' HB3' ' H ' ' C' ' 236' ' ' ARG . 1.6 tm-20 -177.4 105.28 0.05 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 103.156 -2.905 . . . . 75.140000000000001 103.156 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 273' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 44.4 m -145.24 144.95 31.09 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-O 121.07 0.462 . . . . 71.219999999999999 110.764 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.586 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 60.4 mtt180 -135.68 127.28 28.89 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 106.373 -1.714 . . . . 75.099999999999994 106.373 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.2 p -132.68 129.61 58.64 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.824 0 O-C-N 123.695 0.622 . . . . 75.329999999999998 110.364 -175.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 6.6 tt -110.59 115.75 30.14 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.976 -1.12 . . . . 75.109999999999999 107.976 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . 0.411 HG21 HD13 ' C' ' 241' ' ' LEU . 37.2 mm -106.9 103.82 16.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.031 -1.1 . . . . 71.030000000000001 108.031 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 144.04 -140.39 9.39 Favored Glycine 0 N--CA 1.424 -2.167 0 C-N-CA 119.53 -1.319 . . . . 72.319999999999993 113.285 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -111.76 129.48 56.11 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.55 -0.537 . . . . 74.540000000000006 109.55 -175.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' C' ' 244' ' ' VAL . 8.0 tp10 -114.5 118.28 33.33 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.345 -0.983 . . . . 74.349999999999994 108.345 175.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.22 124.52 49.27 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 109.227 -0.657 . . . . 74.439999999999998 109.227 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . 0.446 ' HA3' ' HB ' ' B' ' 246' ' ' THR . . . 103.99 -46.86 1.14 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 110.139 -1.185 . . . . 73.239999999999995 110.139 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . 0.557 ' O ' ' HE2' ' B' ' 284' ' ' LYS . . . 95.5 37.31 5.09 Favored Glycine 0 N--CA 1.411 -3.016 0 C-N-CA 120.899 -0.667 . . . . 74.349999999999994 112.748 176.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . 0.557 ' HE2' ' O ' ' B' ' 283' ' ' GLY . 9.9 tppt? -161.64 35.24 0.13 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 119.21 -0.996 . . . . 74.25 112.34 -175.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . 0.513 ' HA3' ' CG1' ' B' ' 244' ' ' VAL . . . -89.61 144.78 17.99 Favored Glycine 0 CA--C 1.488 -1.595 0 C-N-CA 119.28 -1.438 . . . . 72.25 113.572 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.498 ' H ' ' HA2' ' A' ' 283' ' ' GLY . 0.2 OUTLIER 68.78 -71.31 0.12 Allowed 'General case' 0 C--O 1.245 0.854 0 C-N-CA 124.872 1.269 . . . . 74.0 110.18 178.669 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.524 ' HA ' ' OD1' ' A' ' 288' ' ' ASP . 0.0 OUTLIER -99.96 142.19 31.77 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.047 -0.979 . . . . 74.549999999999997 112.973 -173.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' B' ' 289' ' ' ASN 0.274 30.0 t70 88.27 169.55 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 126.835 2.054 . . . . 61.329999999999998 110.662 177.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . 0.424 ' H ' ' CG ' ' B' ' 288' ' ' ASP . 20.1 t-20 74.78 27.32 1.26 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 104.621 -2.363 . . . . 62.539999999999999 104.621 -165.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -85.27 -26.9 26.36 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 112.574 -2.103 . . . . 63.340000000000003 107.078 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -80.93 66.23 6.37 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.067 -1.456 . . . . 74.200000000000003 107.067 172.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -147.1 91.25 1.97 Allowed 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 103.057 -2.942 . . . . 73.120000000000005 103.057 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -80.81 71.83 7.75 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.041 0.924 . . . . 74.200000000000003 113.129 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -121.13 78.31 1.39 Allowed 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 106.838 -1.541 . . . . 71.129999999999995 106.838 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 . . . . . 0 C--N 1.298 -1.659 0 N-CA-C 107.588 -1.264 . . . . 70.030000000000001 107.588 -178.878 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 CA--C 1.51 -0.587 0 N-CA-C 110.067 -0.345 . . . . 74.329999999999998 110.067 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -143.45 97.93 3.16 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.068 -0.715 . . . . 72.540000000000006 109.068 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.29 160.17 10.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.702 -0.481 . . . . 63.32 109.702 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.77 146.96 30.72 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.222 -1.029 . . . . 75.439999999999998 108.222 172.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -150.28 22.18 0.84 Allowed 'General case' 0 N--CA 1.427 -1.604 0 O-C-N 123.351 0.407 . . . . 73.319999999999993 110.881 -175.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 49.2 mm -83.4 113.02 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 118.346 -1.341 . . . . 73.450000000000003 109.407 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 29.1 m -140.08 165.26 21.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 114.817 -1.083 . . . . 74.450000000000003 109.09 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -91.99 130.89 10.52 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 109.325 -1.51 . . . . 64.540000000000006 109.325 173.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -120.71 140.97 50.88 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 120.424 -0.511 . . . . 73.129999999999995 109.802 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -114.93 124.55 51.97 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.933 -1.506 . . . . 74.400000000000006 106.933 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 23.6 m -121.93 136.68 54.94 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 121.185 0.517 . . . . 72.329999999999998 110.35 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -139.51 129.72 25.29 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 107.878 -1.156 . . . . 74.25 107.878 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' C' ' 265' ' ' GLU . 17.5 mmtp -78.46 -71.46 0.43 Allowed 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.266 0.555 . . . . 74.219999999999999 112.361 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -127.69 138.92 52.96 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.203 -0.908 . . . . 70.430000000000007 108.833 -170.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 23.5 mm -129.34 117.83 44.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.564 -1.272 . . . . 71.420000000000002 107.564 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 78.5 mtt180 -122.08 115.56 22.69 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.201 0.524 . . . . 72.230000000000004 109.612 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 233' ' ' THR . . . . . 0.452 ' HG1' ' HA2' ' B' ' 269' ' ' GLY . 20.0 p -110.21 126.46 54.15 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 106.843 -1.54 . . . . 74.319999999999993 106.843 177.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . 0.441 ' HG2' ' HB3' ' B' ' 270' ' ' LYS . 48.0 mt-10 -137.59 138.38 39.48 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 108.74 -0.837 . . . . 74.209999999999994 108.74 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 50.65 92.01 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.661 1.356 . . . . 72.450000000000003 114.661 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.592 ' H ' ' HB3' ' B' ' 272' ' ' GLU . 3.5 mpt_? 66.85 34.59 5.36 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.23 1.412 . . . . 73.409999999999997 109.952 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . 0.59 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -104.44 128.85 52.42 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.23 -0.895 . . . . 65.420000000000002 110.661 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.523 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.0 OUTLIER -124.98 135.3 52.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.504 -0.924 . . . . 75.129999999999995 108.504 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.6 p -139.65 142.68 32.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.862 0.839 . . . . 64.420000000000002 112.212 -176.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -110.92 130.19 55.66 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.152 -1.425 . . . . 64.549999999999997 107.152 175.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' C' ' 277' ' ' ILE . 2.8 tm? -130.13 128.79 42.52 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.008 -0.738 . . . . 74.239999999999995 109.008 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 122.25 -121.9 4.87 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 109.919 -1.273 . . . . 72.450000000000003 109.919 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -139.39 153.28 47.6 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 120.508 -0.477 . . . . 73.329999999999998 111.087 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . 0.458 HG12 ' HA3' ' C' ' 285' ' ' GLY . 63.8 t -127.58 124.23 63.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.663 -0.699 . . . . 73.140000000000001 109.61 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 59.2 t -122.15 110.76 28.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.429 -1.322 . . . . 71.439999999999998 107.429 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 246' ' ' THR . . . . . 0.409 ' HB ' ' HA3' ' C' ' 282' ' ' GLY . 37.7 m -87.78 161.92 17.31 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.154 -0.684 . . . . 72.400000000000006 109.154 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.93 -39.18 74.0 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.509 0.723 . . . . 72.140000000000001 110.83 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.41 -34.5 64.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.642 -1.617 . . . . 75.239999999999995 113.381 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -59.73 -34.78 73.38 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.255 0.465 . . . . 74.140000000000001 112.255 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 56.5 tp 47.92 78.46 0.08 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.392 1.077 . . . . 74.439999999999998 112.538 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 73.6 t60 70.92 -52.3 0.68 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.898 1.279 . . . . 74.120000000000005 112.838 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.01 -72.56 1.84 Allowed Glycine 0 C--N 1.308 -1.023 0 C-N-CA 121.309 -0.472 . . . . 52.450000000000003 111.973 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -174.94 146.52 8.49 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.961 -0.856 . . . . 62.409999999999997 110.961 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 9.1 tp -100.44 -23.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.748 0.785 . . . . 74.219999999999999 110.149 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -133.25 -37.26 0.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.765 -0.584 . . . . 74.140000000000001 111.323 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 16.1 tt -86.87 90.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 122.559 1.171 . . . . 74.019999999999996 110.723 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 25.5 t -135.4 141.94 45.56 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 105.584 -2.006 . . . . 71.540000000000006 105.584 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.17 -62.08 1.56 Allowed 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 112.271 0.471 . . . . 73.310000000000002 112.271 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 48.16 60.3 3.69 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 124.316 1.01 . . . . 74.430000000000007 111.069 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 29.1 m -77.99 140.07 39.17 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.681 -1.145 . . . . 72.420000000000002 108.656 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 85.0 m -89.11 117.25 27.97 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.976 0.894 . . . . 73.129999999999995 109.516 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -119.9 144.12 47.59 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.058 -1.428 . . . . 71.129999999999995 109.135 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -142.08 131.16 23.24 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 110.182 -0.303 . . . . 74.040000000000006 110.182 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 12.2 p -128.98 145.43 35.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.451 -0.944 . . . . 75.209999999999994 108.451 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.646 ' O ' ' HB2' ' C' ' 229' ' ' LYS . 7.0 tp10 -79.76 -81.49 0.12 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 109.135 -0.691 . . . . 61.119999999999997 109.135 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 90.0 m -131.72 137.01 48.06 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.397 -0.815 . . . . 73.120000000000005 110.825 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.06 130.71 74.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.962 -0.755 . . . . 73.329999999999998 108.962 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.4 p -127.56 137.38 57.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 116.635 -0.257 . . . . 71.299999999999997 110.473 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.93 132.88 9.65 Favored Glycine 0 CA--C 1.483 -1.934 0 N-CA-C 110.352 -1.099 . . . . 70.219999999999999 110.352 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -134.6 147.73 50.28 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.145 -0.687 . . . . 74.519999999999996 109.145 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.26 -60.86 4.7 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 112.293 -0.323 . . . . 73.109999999999999 112.293 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . 0.4 ' HA ' ' HB2' ' C' ' 236' ' ' ARG . 36.4 tt0 -173.18 130.79 0.48 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.914 -2.254 . . . . 74.109999999999999 104.914 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 273' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 17.8 t -156.11 148.08 23.18 Favored 'General case' 0 N--CA 1.413 -2.324 0 C-N-CA 120.074 -0.65 . . . . 55.43 109.926 -176.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . 0.523 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 46.2 mtm180 -138.12 125.43 21.76 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.212 -1.773 . . . . 74.140000000000001 106.212 172.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 5.1 p -139.57 135.44 39.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 123.548 0.53 . . . . 70.200000000000003 110.693 -176.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 7.0 tt -115.93 111.58 20.61 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.912 -0.773 . . . . 73.219999999999999 108.912 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 47.7 mm -102.28 104.21 16.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.871 -1.159 . . . . 73.510000000000005 107.871 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 147.84 -144.39 12.34 Favored Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.009 -1.636 . . . . 55.140000000000001 109.009 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -127.96 150.61 49.82 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 120.869 0.366 . . . . 73.200000000000003 110.405 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . 0.521 ' HG2' ' ND2' ' C' ' 289' ' ' ASN . 6.2 tp10 -126.64 118.14 24.19 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.618 -0.719 . . . . 74.420000000000002 109.801 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -109.18 124.12 50.32 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.913 -0.773 . . . . 73.450000000000003 108.913 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . 0.409 ' HA3' ' HB ' ' C' ' 246' ' ' THR . . . 102.94 -53.17 0.76 Allowed Glycine 0 N--CA 1.434 -1.497 0 N-CA-C 110.502 -1.039 . . . . 73.439999999999998 110.502 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' C' ' 289' ' ' ASN . . . 95.14 54.64 1.46 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.416 -0.897 . . . . 74.439999999999998 113.207 176.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . 0.456 ' HZ2' ' CG ' ' C' ' 288' ' ' ASP . 35.6 tptt -164.2 21.65 0.07 Allowed 'General case' 0 C--O 1.238 0.47 0 C-N-CA 119.903 -0.719 . . . . 74.420000000000002 110.947 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . 0.458 ' HA3' HG12 ' C' ' 244' ' ' VAL . . . -74.92 138.75 24.14 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 115.011 0.764 . . . . 65.340000000000003 115.011 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 67.43 -79.37 0.04 OUTLIER 'General case' 0 C--O 1.252 1.196 0 C-N-CA 124.786 1.234 . . . . 74.239999999999995 110.934 174.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -93.51 -69.93 0.73 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 121.078 -0.249 . . . . 73.219999999999999 111.273 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . 0.456 ' CG ' ' HZ2' ' C' ' 284' ' ' LYS . 6.7 t70 -175.54 -168.86 0.33 Allowed 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 104.055 -2.572 . . . . 70.400000000000006 104.055 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . 0.521 ' ND2' ' HG2' ' C' ' 280' ' ' GLU . 33.1 t-20 177.16 -58.73 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.786 0.721 . . . . 72.239999999999995 109.506 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -143.47 155.24 44.31 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.552 -0.295 . . . . 73.349999999999994 110.853 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 33.4 t60 66.45 104.78 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.233 1.413 . . . . 73.310000000000002 112.385 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -70.64 122.15 19.25 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.138 0.792 . . . . 74.409999999999997 113.138 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 49.7 m80 60.53 105.41 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 116.456 2.021 . . . . 74.540000000000006 116.456 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -168.76 132.99 1.5 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.116 -1.809 . . . . 72.140000000000001 106.116 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 . . . . . 0 C--O 1.246 0.889 0 C-N-CA 123.993 0.917 . . . . 73.019999999999996 109.58 177.276 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 59.7 mtm . . . . . 0 CA--C 1.494 -1.195 0 N-CA-C 110.17 -0.307 . . . . 71.5 110.17 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -162.22 161.88 28.02 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.832 -1.914 . . . . 72.540000000000006 105.832 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.3 pt -74.58 106.08 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 N-CA-C 107.297 -1.372 . . . . 72.439999999999998 107.297 168.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.31 169.91 15.26 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.207 -0.906 . . . . 72.219999999999999 109.77 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -72.68 -33.71 66.7 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.715 -0.846 . . . . 64.150000000000006 108.715 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.24 117.58 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 CA-C-N 114.812 -1.086 . . . . 73.530000000000001 108.088 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 45.9 t -100.82 118.67 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 108.332 -0.988 . . . . 75.319999999999993 108.332 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 146.99 63.1 0.01 OUTLIER Glycine 0 C--N 1.287 -2.146 0 N-CA-C 107.016 -2.434 . . . . 71.209999999999994 107.016 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.588 ' NH2' ' HZ2' ' B' ' 218' ' ' LYS . 23.1 ptt-85 -134.43 146.7 50.07 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 107.919 -1.141 . . . . 74.030000000000001 107.919 -173.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.549 ' OD1' ' HA2' ' B' ' 242' ' ' GLY . 41.4 m-80 -109.96 135.32 50.99 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.094 -1.076 . . . . 74.310000000000002 108.094 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.9 m -121.55 136.5 54.95 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.578 0.704 . . . . 73.040000000000006 110.874 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.68 127.99 47.12 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.137 -1.431 . . . . 53.109999999999999 107.137 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -78.88 -60.42 2.39 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.913 -0.773 . . . . 74.420000000000002 108.913 -177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -137.5 139.3 40.46 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.538 0.685 . . . . 75.430000000000007 110.831 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 67.3 mt -128.78 122.47 57.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.257 -1.016 . . . . 74.299999999999997 108.257 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 7.1 tmm_? -130.69 115.01 16.1 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.721 0.772 . . . . 74.049999999999997 111.329 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.562 ' CG2' HG11 ' A' ' 239' ' ' VAL . 6.8 p -111.99 137.06 50.52 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.226 -0.897 . . . . 74.409999999999997 109.75 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -133.97 147.17 51.0 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 116.066 -0.516 . . . . 75.010000000000005 110.989 -174.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 73.38 -79.0 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.589 1.156 . . . . 73.510000000000005 112.727 170.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -136.16 15.81 3.25 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.09 0.947 . . . . 75.349999999999994 109.077 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.08 133.37 34.23 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.65 -1.159 . . . . 64.530000000000001 109.791 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -132.11 144.02 50.42 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.621 0.724 . . . . 74.310000000000002 112.006 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.562 HG11 ' CG2' ' A' ' 233' ' ' THR . 15.4 m -123.69 150.4 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 CA-C-N 114.832 -1.076 . . . . 72.230000000000004 111.804 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -116.85 120.83 39.7 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-N 114.259 -1.337 . . . . 75.120000000000005 108.148 175.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -111.26 118.2 35.26 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.049 -1.834 . . . . 75.439999999999998 106.049 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.02 -155.71 21.13 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 119.828 -1.177 . . . . 44.350000000000001 112.892 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -110.83 128.58 55.82 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.136 0.574 . . . . 71.109999999999999 110.658 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.408 ' CG1' ' HA3' ' A' ' 285' ' ' GLY . 48.6 t -116.34 115.05 47.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.369 -0.974 . . . . 74.409999999999997 108.369 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 281' ' ' TYR . 7.3 p -114.42 124.82 71.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.277 0.56 . . . . 73.5 112.46 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 23.8 p -117.24 166.59 12.09 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 116.001 -0.545 . . . . 71.209999999999994 111.366 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.74 74.13 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.536 0.734 . . . . 71.430000000000007 112.757 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.37 66.29 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.634 0.975 . . . . 73.420000000000002 113.634 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.642 ' HB2' ' N ' ' A' ' 282' ' ' GLY . . . -75.52 -26.36 58.0 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 112.536 0.569 . . . . 73.319999999999993 112.536 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 6.9 mp 65.34 -170.48 0.19 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.795 -1.187 . . . . 71.450000000000003 107.795 -168.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -112.19 11.35 20.27 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.237 -0.914 . . . . 74.409999999999997 110.292 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -73.11 -24.74 75.1 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.391 -0.822 . . . . 74.030000000000001 112.381 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -79.81 -12.3 83.67 Favored Glycine 0 C--O 1.25 1.119 0 N-CA-C 111.385 -0.686 . . . . 61.439999999999998 111.385 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 55.6 mt -82.97 76.15 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 122.667 1.223 . . . . 75.340000000000003 109.12 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -155.32 -34.94 0.09 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 112.618 -2.083 . . . . 75.049999999999997 107.377 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.478 HD12 ' CD2' ' B' ' 281' ' ' TYR . 6.5 pt -94.79 -54.64 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.082 -0.963 . . . . 73.140000000000001 109.316 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 14.9 m 55.97 -157.8 0.24 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.773 0.829 . . . . 62.43 111.786 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.422 ' HA ' ' OD1' ' B' ' 243' ' ' ASN . 3.6 m-20 -68.97 122.2 18.18 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 109.493 -0.558 . . . . 62.409999999999997 109.493 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -135.46 -51.67 0.75 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.663 -0.698 . . . . 70.25 110.073 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 40.9 m -67.9 126.06 28.24 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.398 -0.964 . . . . 74.329999999999998 108.398 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 10.6 t -92.91 133.94 35.6 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-O 121.292 0.568 . . . . 74.109999999999999 109.617 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -126.33 142.2 51.62 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.12 -0.696 . . . . 74.109999999999999 109.12 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 22.7 t -127.69 130.71 49.34 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 108.721 -0.844 . . . . 74.230000000000004 108.721 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.02 139.73 51.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.967 -0.383 . . . . 73.349999999999994 109.967 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 15.3 mt-10 -79.1 -70.64 0.49 Allowed 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 119.823 -0.751 . . . . 71.439999999999998 111.525 176.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 13.6 m -119.44 126.86 52.33 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.889 -0.724 . . . . 64.519999999999996 111.949 -174.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.39 122.26 67.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 N-CA-C 109.118 -0.697 . . . . 72.340000000000003 109.118 171.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 35.7 m -124.56 146.67 29.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.643 0.735 . . . . 72.239999999999995 112.593 -177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.73 133.28 7.78 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.14 -0.936 . . . . 61.439999999999998 111.002 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.27 116.0 17.75 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.074 -1.084 . . . . 74.140000000000001 108.074 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.16 -136.84 13.02 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.147 -1.581 . . . . 75.25 109.147 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -99.24 53.22 0.96 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.942 0.877 . . . . 73.019999999999996 109.701 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 7.1 m -83.02 148.22 27.69 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.167 -0.924 . . . . 74.140000000000001 111.209 -174.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . 0.539 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 45.8 mtm180 -130.02 128.19 41.48 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.287 -0.415 . . . . 75.310000000000002 109.946 175.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.462 ' HB ' HG12 ' A' ' 239' ' ' VAL . 17.9 t -130.46 140.42 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 N-CA-C 108.095 -1.076 . . . . 61.340000000000003 108.095 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.43 HD11 ' HB3' ' A' ' 286' ' ' PHE . 5.5 tt -126.17 121.1 31.83 Favored 'General case' 0 C--N 1.275 -2.655 0 C-N-CA 118.913 -1.115 . . . . 74.329999999999998 108.426 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 3.5 mp -107.92 104.61 17.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 106.316 -1.735 . . . . 74.519999999999996 106.316 177.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.13 -134.77 5.37 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.435 -1.066 . . . . 62.109999999999999 110.435 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 45.2 t-20 -130.15 134.58 47.42 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 117.103 0.451 . . . . 72.5 111.396 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 287' ' ' TRP . 10.3 tp10 -111.23 122.85 48.93 Favored 'General case' 0 C--O 1.269 2.084 0 N-CA-C 106.746 -1.576 . . . . 74.219999999999999 106.746 174.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.462 ' HB2' ' HA ' ' A' ' 245' ' ' VAL . 12.0 m-85 -109.24 122.81 48.14 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.751 -1.944 . . . . 73.140000000000001 105.751 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.642 ' N ' ' HB2' ' A' ' 249' ' ' ALA . . . 103.86 -51.85 0.79 Allowed Glycine 0 C--N 1.297 -1.617 0 C-N-CA 120.445 -0.883 . . . . 74.140000000000001 112.999 177.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.41 30.54 18.88 Favored Glycine 0 CA--C 1.498 -0.986 0 N-CA-C 109.9 -1.28 . . . . 60.520000000000003 109.9 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -129.81 -8.98 4.47 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.465 -0.867 . . . . 73.209999999999994 111.456 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.408 ' HA3' ' CG1' ' A' ' 244' ' ' VAL . . . -86.61 -80.27 1.19 Allowed Glycine 0 CA--C 1.487 -1.661 0 C-N-CA 119.386 -1.388 . . . . 72.25 112.415 -175.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.43 ' HB3' HD11 ' A' ' 276' ' ' LEU . 75.6 t80 -99.98 -22.74 15.14 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.504 -1.295 . . . . 75.450000000000003 107.504 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . 0.56 ' HA ' ' CE3' ' A' ' 287' ' ' TRP . 0.2 OUTLIER -91.7 174.61 7.26 Favored 'General case' 0 N--CA 1.41 -2.469 0 N-CA-C 115.741 1.756 . . . . 74.310000000000002 115.741 178.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -164.17 163.83 22.85 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 111.599 -2.546 . . . . 71.040000000000006 105.394 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.76 42.91 3.22 Favored 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 106.861 -1.533 . . . . 74.200000000000003 106.861 171.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -86.71 171.54 10.86 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-N 112.614 -2.084 . . . . 72.420000000000002 108.82 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 79.87 85.52 0.05 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.44 1.496 . . . . 74.340000000000003 111.862 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -149.53 145.11 26.68 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 124.677 1.191 . . . . 63.509999999999998 107.878 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -129.78 -30.62 2.03 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.241 -1.022 . . . . 62.229999999999997 108.241 172.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 67.24 24.75 9.07 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.038 1.735 . . . . 70.349999999999994 110.536 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 . . . . . 0 N--CA 1.435 -1.192 0 N-CA-C 106.671 -1.603 . . . . 74.329999999999998 106.671 178.538 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' MET . . . . . 0.413 ' N ' ' SD ' ' B' ' 217' ' ' MET . 1.5 mpt? . . . . . 0 CA--C 1.502 -0.894 0 N-CA-C 107.572 -1.27 . . . . 73.430000000000007 107.572 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.588 ' HZ2' ' NH2' ' A' ' 225' ' ' ARG . 1.7 mmmp? -113.21 107.5 15.99 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.661 -0.866 . . . . 73.140000000000001 108.661 177.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 62.7 mt -95.46 83.01 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 106.9 -1.518 . . . . 70.349999999999994 106.9 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -138.25 172.95 12.15 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.596 -1.184 . . . . 74.109999999999999 107.887 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -92.08 6.28 47.07 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.612 0.72 . . . . 72.219999999999999 110.386 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.29 121.02 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-N 115.739 -0.664 . . . . 73.409999999999997 109.272 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.89 126.17 55.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 106.711 -1.589 . . . . 75.319999999999993 106.711 174.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 140.96 60.38 0.03 OUTLIER Glycine 0 C--N 1.294 -1.799 0 N-CA-C 106.305 -2.718 . . . . 74.310000000000002 106.305 -174.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 261' ' ' THR . 30.3 ptt85 -140.11 139.95 35.93 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.007 -1.096 . . . . 70.230000000000004 110.859 -170.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.483 ' OD1' ' HA2' ' C' ' 242' ' ' GLY . 51.1 m-80 -108.18 148.52 29.78 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.919 -1.141 . . . . 75.409999999999997 107.919 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 31.2 m -135.95 137.44 41.3 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.572 0.701 . . . . 71.329999999999998 111.163 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.51 129.85 51.37 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.631 -1.168 . . . . 74.120000000000005 108.449 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 5.3 tmtt? -78.55 -66.49 0.85 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.384 -0.826 . . . . 73.0 108.816 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -134.82 139.05 44.78 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 116.524 -0.307 . . . . 73.409999999999997 110.347 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 10.8 mt -132.23 117.72 33.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.241 -1.022 . . . . 65.530000000000001 108.241 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . 0.423 ' HB3' HG13 ' B' ' 268' ' ' VAL . 25.8 ttt180 -113.64 122.46 47.25 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.938 -0.574 . . . . 74.319999999999993 110.735 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 76.0 p -110.7 132.16 54.44 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.945 -1.131 . . . . 75.450000000000003 107.945 175.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -133.72 150.83 51.51 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.353 -0.539 . . . . 73.439999999999998 109.778 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 70.13 -95.19 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 124.556 1.142 . . . . 73.209999999999994 113.455 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.04 31.13 4.95 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.425 -1.324 . . . . 75.209999999999994 107.425 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -76.24 137.25 39.84 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.29 -0.868 . . . . 74.329999999999998 110.701 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 1.7 mpp_? -125.34 134.35 52.24 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.031 -0.986 . . . . 65.400000000000006 108.514 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.431 HG11 ' HB ' ' B' ' 275' ' ' VAL . 19.6 m -135.58 140.83 43.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.8 0.809 . . . . 74.230000000000004 111.265 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.437 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 38.8 tp60 -105.15 135.79 45.84 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 114.211 -1.359 . . . . 70.340000000000003 108.463 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -125.97 117.02 22.39 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 104.911 -2.255 . . . . 75.010000000000005 104.911 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.561 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 125.19 -146.12 16.0 Favored Glycine 0 N--CA 1.42 -2.407 0 C-N-CA 119.549 -1.31 . . . . 63.450000000000003 111.844 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . 0.568 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 0.7 OUTLIER -113.81 146.17 40.34 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.442 -0.577 . . . . 74.430000000000007 109.442 -176.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.437 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 59.2 t -126.78 122.48 60.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.015 -1.476 . . . . 71.310000000000002 107.015 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.53 126.0 72.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.369 -1.333 . . . . 75.319999999999993 113.49 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 24.4 p -120.28 163.13 18.27 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.947 -0.569 . . . . 75.340000000000003 112.034 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.64 -31.82 58.06 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.723 1.209 . . . . 75.420000000000002 112.201 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.36 70.17 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.885 0.698 . . . . 75.430000000000007 112.885 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.48 ' HB3' ' N ' ' B' ' 282' ' ' GLY . . . -75.01 -44.37 48.44 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.484 -0.486 . . . . 72.340000000000003 109.988 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 63.8 tp 64.76 -72.49 0.06 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.131 1.372 . . . . 70.310000000000002 110.36 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -130.34 77.55 1.79 Allowed 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 107.147 -1.427 . . . . 73.310000000000002 107.147 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . 0.427 ' H ' HD11 ' A' ' 256' ' ' ILE . . . -85.31 73.59 2.58 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.57 -1.195 . . . . 73.510000000000005 111.198 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 137.62 -151.79 21.37 Favored Glycine 0 N--CA 1.42 -2.4 0 N-CA-C 109.93 -1.268 . . . . 72.439999999999998 109.93 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 64.4 mt -139.78 -66.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 105.85 -1.908 . . . . 73.140000000000001 105.85 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -147.84 -157.23 0.79 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 104.625 -2.361 . . . . 74.140000000000001 104.625 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 11.2 tt -71.28 89.26 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 122.469 1.128 . . . . 73.510000000000005 111.118 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 14.0 m -101.72 6.88 42.03 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.534 -1.212 . . . . 74.340000000000003 109.967 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -125.1 157.67 35.74 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.039 -0.528 . . . . 72.409999999999997 111.173 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.21 28.66 0.58 Allowed 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 124.307 1.043 . . . . 63.310000000000002 110.178 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 58.2 m -79.01 135.44 36.9 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.136 -0.69 . . . . 75.430000000000007 109.136 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 10.2 t -123.53 134.54 53.85 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 121.558 0.694 . . . . 75.099999999999994 110.182 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -125.16 138.15 54.15 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.582 -0.896 . . . . 71.530000000000001 108.582 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 263' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' C' ' 227' ' ' SER . 41.8 m -130.33 132.51 45.88 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.691 -0.485 . . . . 74.099999999999994 109.691 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 7.3 p -125.68 142.35 42.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 116.123 -0.489 . . . . 70.329999999999998 110.923 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 10.4 mm-40 -82.68 -69.02 0.66 Allowed 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 123.793 0.683 . . . . 75.109999999999999 109.703 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.5 m -126.06 127.21 45.48 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 119.572 -0.851 . . . . 73.510000000000005 112.252 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 48.0 t -118.66 120.76 65.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.359 -1.348 . . . . 74.150000000000006 107.359 176.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' B' ' 232' ' ' ARG . 27.4 m -125.6 137.46 57.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.69 0.757 . . . . 71.439999999999998 112.152 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.71 133.65 11.01 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 110.279 -1.128 . . . . 72.430000000000007 110.279 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -132.08 115.88 16.34 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.359 0.599 . . . . 75.040000000000006 109.566 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.75 -132.28 10.95 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 119.996 -1.097 . . . . 44.409999999999997 111.178 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -96.14 48.28 1.1 Allowed 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.746 0.818 . . . . 72.329999999999998 110.437 -177.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 15.5 m -81.46 150.27 28.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.156 -0.929 . . . . 72.329999999999998 112.93 -171.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 49.2 mtm180 -133.26 128.09 35.09 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.887 -0.597 . . . . 75.140000000000001 110.016 173.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.431 ' HB ' HG11 ' B' ' 239' ' ' VAL . 22.0 t -131.83 138.69 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.778 0 N-CA-C 108.366 -0.976 . . . . 71.400000000000006 108.366 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 5.9 tt -120.99 116.32 24.86 Favored 'General case' 0 C--N 1.277 -2.561 0 C-N-CA 118.849 -1.14 . . . . 74.129999999999995 108.148 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . 0.428 ' HA ' ' HB3' ' C' ' 241' ' ' LEU . 4.0 mp -106.31 103.5 15.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 106.313 -1.736 . . . . 74.209999999999994 106.313 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 149.67 -135.02 5.13 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.729 -0.748 . . . . 74.420000000000002 112.501 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 48.5 t-20 -128.72 130.0 46.53 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.201 -0.666 . . . . 72.219999999999999 109.201 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -111.35 118.67 36.47 Favored 'General case' 0 C--O 1.268 2.034 0 N-CA-C 106.992 -1.484 . . . . 74.519999999999996 106.992 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . 0.478 ' CD2' HD12 ' A' ' 256' ' ' ILE . 69.8 m-85 -105.04 122.31 45.6 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 106.919 -1.511 . . . . 72.409999999999997 106.919 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . 0.48 ' N ' ' HB3' ' B' ' 249' ' ' ALA . . . 101.09 -52.29 0.91 Allowed Glycine 0 C--N 1.297 -1.638 0 C-N-CA 120.37 -0.919 . . . . 74.439999999999998 112.524 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.58 32.75 12.58 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.962 -1.113 . . . . 74.150000000000006 111.39 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -136.68 2.09 2.63 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.569 0.581 . . . . 72.239999999999995 112.569 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . 0.427 ' HA3' ' CG1' ' B' ' 244' ' ' VAL . . . -86.15 -77.86 1.21 Allowed Glycine 0 CA--C 1.487 -1.707 0 C-N-CA 118.712 -1.708 . . . . 70.239999999999995 110.739 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -97.01 -21.29 17.5 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.545 -1.28 . . . . 73.530000000000001 107.545 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.508 ' HA ' ' CE3' ' B' ' 287' ' ' TRP . 0.0 OUTLIER -93.6 173.31 7.76 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.309 -1.314 . . . . 72.239999999999995 114.374 177.545 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -140.87 149.38 41.88 Favored 'General case' 0 N--CA 1.407 -2.605 0 N-CA-C 103.952 -2.61 . . . . 74.230000000000004 103.952 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -80.14 -15.52 56.9 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.453 -0.499 . . . . 73.540000000000006 112.044 -174.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . 0.58 ' CE1' ' HA ' ' C' ' 291' ' ' HIS . 10.3 t60 -173.73 -54.54 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.934 -1.135 . . . . 72.030000000000001 107.934 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -159.66 145.98 16.17 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 106.198 -1.779 . . . . 73.239999999999995 106.198 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -154.2 130.05 10.14 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.466 -1.309 . . . . 70.219999999999999 107.466 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -82.96 94.39 7.73 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.935 0.874 . . . . 74.310000000000002 110.464 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -101.25 72.56 1.45 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.256 -1.386 . . . . 74.239999999999995 107.256 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 . . . . . 0 C--N 1.3 -1.571 0 N-CA-C 108.273 -1.01 . . . . 63.5 108.273 -176.026 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 217' ' ' MET . . . . . 0.496 ' HG2' ' H ' ' C' ' 218' ' ' LYS . 17.6 ttt . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 106.157 -1.794 . . . . 63.32 106.157 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . 0.496 ' H ' ' HG2' ' C' ' 217' ' ' MET . 0.0 OUTLIER 68.56 130.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 119.456 1.026 . . . . 74.340000000000003 111.569 -174.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 10.8 tt -90.27 132.46 34.84 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 CA-C-O 121.497 0.665 . . . . 75.209999999999994 112.594 -176.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -142.4 -174.86 4.25 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 104.518 -2.401 . . . . 70.129999999999995 104.518 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -79.91 96.82 6.49 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.428 -2.064 . . . . 51.240000000000002 105.428 168.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.96 114.96 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-O 122.003 0.906 . . . . 73.25 111.8 -171.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.4 t -100.99 119.34 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 107.305 -1.368 . . . . 71.040000000000006 107.305 175.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 145.54 56.23 0.02 OUTLIER Glycine 0 C--N 1.289 -2.06 0 N-CA-C 107.504 -2.238 . . . . 52.210000000000001 107.504 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -122.99 144.48 49.22 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-N 114.639 -0.781 . . . . 75.310000000000002 109.715 -174.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -102.22 142.18 33.88 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 106.64 -1.615 . . . . 75.420000000000002 106.64 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 227' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' B' ' 263' ' ' SER . 55.5 m -136.98 137.91 39.99 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.382 0.611 . . . . 71.450000000000003 111.19 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.19 130.23 50.55 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.417 -0.81 . . . . 71.329999999999998 109.262 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -84.07 -61.58 1.78 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.578 -0.527 . . . . 74.049999999999997 109.578 -177.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -129.14 138.18 51.63 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 122.152 -0.342 . . . . 70.540000000000006 110.538 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 18.4 mt -136.04 117.32 19.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 107.614 -1.254 . . . . 74.540000000000006 107.614 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -119.4 126.0 50.33 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.481 0.658 . . . . 73.019999999999996 110.82 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 24.5 p -110.17 135.44 50.95 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.431 -0.951 . . . . 62.450000000000003 108.431 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -134.89 149.83 50.35 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.757 -0.831 . . . . 63.530000000000001 108.757 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 64.58 -99.02 0.07 Allowed 'General case' 0 C--O 1.203 -1.372 0 C-N-CA 124.556 1.142 . . . . 65.329999999999998 113.698 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.498 ' HD3' ' N ' ' C' ' 236' ' ' ARG . 0.2 OUTLIER -122.62 35.52 4.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 108.221 -1.029 . . . . 74.510000000000005 108.221 -177.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -81.3 134.38 35.58 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 114.563 -1.198 . . . . 72.519999999999996 110.659 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.601 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 2.0 mpp_? -125.33 133.88 52.43 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.616 -1.174 . . . . 70.319999999999993 107.942 176.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.427 HG23 HG11 ' B' ' 275' ' ' VAL . 29.4 m -134.67 141.26 43.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.649 0.738 . . . . 73.030000000000001 110.922 177.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . 0.419 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 45.1 tp60 -104.79 136.05 45.03 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 114.648 -1.16 . . . . 75.519999999999996 108.495 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.428 ' HB3' ' HA ' ' B' ' 277' ' ' ILE . 1.6 tm? -126.42 116.96 21.97 Favored 'General case' 0 N--CA 1.402 -2.848 0 N-CA-C 104.864 -2.273 . . . . 74.109999999999999 104.864 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.492 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 121.66 -131.42 8.52 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 119.618 -1.277 . . . . 75.540000000000006 113.31 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 13.1 m120 -122.23 139.7 53.46 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.884 -0.413 . . . . 73.099999999999994 109.884 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . 0.419 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 48.4 t -126.34 117.46 48.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 106.545 -1.65 . . . . 74.239999999999995 106.545 172.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.03 127.85 74.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.797 -1.161 . . . . 71.439999999999998 113.104 -175.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 20.2 p -114.0 162.63 16.18 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.093 -0.503 . . . . 63.130000000000003 111.185 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.33 -32.04 69.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.445 0.698 . . . . 71.129999999999995 110.836 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.32 -33.61 59.26 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.505 1.122 . . . . 72.430000000000007 112.533 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -63.57 -26.7 68.81 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 112.244 0.461 . . . . 73.329999999999998 112.244 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -75.42 79.94 2.47 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.285 1.041 . . . . 73.129999999999995 110.082 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -167.81 -39.8 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 105.984 -1.858 . . . . 75.099999999999994 105.984 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 174.52 156.64 14.28 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 110.775 -0.93 . . . . 70.209999999999994 110.775 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 116.38 -2.36 20.45 Favored Glycine 0 C--N 1.31 -0.911 0 C-N-CA 120.529 -0.843 . . . . 74.420000000000002 112.617 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 30.0 pt -114.81 130.34 69.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 120.801 0.334 . . . . 73.319999999999993 110.437 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -148.76 -73.66 0.18 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.341 -0.985 . . . . 74.109999999999999 108.341 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 2.5 mp -135.83 -66.35 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 106.855 -1.535 . . . . 74.530000000000001 106.855 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 14.4 t 166.9 -160.11 0.01 OUTLIER 'General case' 0 C--O 1.258 1.539 0 N-CA-C 102.267 -3.235 . . . . 74.530000000000001 102.267 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -134.2 141.31 47.0 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.234 -1.024 . . . . 73.439999999999998 108.234 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -74.8 18.18 0.18 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.466 0.913 . . . . 74.150000000000006 113.466 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 89.1 m -83.73 122.0 28.05 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 109.281 -0.637 . . . . 74.040000000000006 109.281 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 8.6 t -109.03 119.95 41.07 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.592 0.71 . . . . 71.310000000000002 109.34 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -114.68 125.63 53.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.749 -0.66 . . . . 71.219999999999999 109.513 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 263' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' C' ' 227' ' ' SER . 28.5 t -117.78 135.37 54.1 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 108.179 -1.045 . . . . 74.209999999999994 108.179 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.0 141.44 42.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 116.402 -0.363 . . . . 73.230000000000004 110.333 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -78.42 -66.45 0.85 Allowed 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 122.493 0.317 . . . . 73.340000000000003 111.047 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.8 m -129.03 132.37 47.48 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 120.523 -0.471 . . . . 75.340000000000003 111.441 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.75 123.95 72.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.074 -1.454 . . . . 65.030000000000001 107.074 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 20.1 m -124.99 143.59 38.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.3 0.571 . . . . 70.109999999999999 112.338 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.2 133.78 9.16 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.331 -1.108 . . . . 74.209999999999994 110.331 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -133.84 125.09 27.66 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 123.643 0.777 . . . . 73.209999999999994 109.708 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.24 -136.99 21.32 Favored Glycine 0 CA--C 1.506 -0.512 0 N-CA-C 110.108 -1.197 . . . . 63.329999999999998 110.108 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -81.26 98.12 7.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.528 -0.916 . . . . 74.099999999999994 108.528 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 50.5 m -120.35 149.94 41.53 Favored 'General case' 0 C--N 1.278 -2.5 0 C-N-CA 120.121 -0.632 . . . . 72.439999999999998 110.845 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . 0.588 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 75.6 mtm180 -140.1 127.49 21.36 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.022 -1.103 . . . . 71.420000000000002 108.022 174.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 7.8 t -135.29 140.06 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.678 0 N-CA-C 107.561 -1.274 . . . . 64.129999999999995 107.561 176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 7.0 tt -120.65 111.74 18.01 Favored 'General case' 0 N--CA 1.403 -2.789 0 C-N-CA 118.894 -1.122 . . . . 71.310000000000002 108.871 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.66 103.18 14.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 105.272 -2.122 . . . . 74.519999999999996 105.272 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 149.11 -140.32 8.09 Favored Glycine 0 CA--C 1.492 -1.401 0 C-N-CA 120.286 -0.959 . . . . 64.150000000000006 111.852 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -128.45 133.89 48.63 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.417 -0.586 . . . . 72.310000000000002 109.417 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . 0.464 ' HG2' ' HB2' ' C' ' 287' ' ' TRP . 10.2 tp10 -111.75 118.72 36.37 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.351 -1.351 . . . . 74.319999999999993 107.351 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -105.31 123.58 48.1 Favored 'General case' 0 C--O 1.253 1.282 0 N-CA-C 107.713 -1.218 . . . . 73.430000000000007 107.713 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.35 -42.03 2.04 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.958 -0.857 . . . . 74.040000000000006 110.958 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 73.06 43.4 40.36 Favored Glycine 0 CA--C 1.482 -1.996 0 N-CA-C 109.219 -1.552 . . . . 75.329999999999998 109.219 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -151.46 6.23 0.47 Allowed 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.236 -0.482 . . . . 73.510000000000005 110.027 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -92.01 -80.6 1.43 Allowed Glycine 0 CA--C 1.491 -1.442 0 C-N-CA 119.943 -1.122 . . . . 33.229999999999997 110.693 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -95.42 -27.7 15.29 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.136 -1.061 . . . . 74.510000000000005 108.136 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . 0.5 ' HA ' ' CE3' ' C' ' 287' ' ' TRP . 0.0 OUTLIER -88.57 153.74 20.89 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.61 -1.177 . . . . 74.010000000000005 112.984 177.146 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -170.0 174.1 5.69 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 106.799 -1.556 . . . . 72.329999999999998 106.799 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -152.25 56.45 0.83 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 104.839 -2.282 . . . . 73.319999999999993 104.839 170.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -127.1 47.85 2.29 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.259 -1.792 . . . . 73.400000000000006 106.409 -176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . 0.58 ' HA ' ' CE1' ' B' ' 290' ' ' HIS . 69.8 m80 -62.19 118.66 7.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.56 -1.655 . . . . 74.120000000000005 110.886 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -97.51 88.04 4.27 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.028 0.918 . . . . 74.319999999999993 111.769 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -94.46 93.08 7.44 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.018 -0.537 . . . . 73.310000000000002 110.915 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -73.88 104.21 4.68 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.74 -0.664 . . . . 74.030000000000001 109.507 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 . . . . . 0 C--N 1.3 -1.56 0 CA-C-O 118.157 -0.925 . . . . 74.349999999999994 109.729 -178.702 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 111.88 0.326 . . . . 72.230000000000004 111.88 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -106.61 -70.96 0.77 Allowed 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 108.094 -1.076 . . . . 75.439999999999998 108.094 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.28 11.36 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 CA-C-O 122.08 0.943 . . . . 74.129999999999995 110.449 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.76 170.43 9.45 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.383 -1.281 . . . . 75.540000000000006 109.818 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.24 92.62 0.08 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 114.498 1.296 . . . . 74.439999999999998 114.498 -172.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 7.0 tp -117.05 132.28 67.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 106.026 -1.842 . . . . 73.439999999999998 106.026 170.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 6.0 m -139.24 161.98 27.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 111.886 0.328 . . . . 75.420000000000002 111.886 -174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -77.33 -161.94 15.44 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.579 -0.737 . . . . 72.120000000000005 113.314 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 17.0 ptt85 -131.44 125.99 33.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.776 0.798 . . . . 74.129999999999995 112.588 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -98.41 147.55 24.6 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.714 -1.958 . . . . 73.209999999999994 105.714 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.5 m -121.8 136.37 54.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.531 0.681 . . . . 73.420000000000002 111.28 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.4 129.17 37.0 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.481 -1.303 . . . . 71.519999999999996 107.481 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -89.08 -43.93 10.72 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.292 -0.633 . . . . 74.120000000000005 109.292 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -139.86 138.93 36.13 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.693 0.283 . . . . 74.409999999999997 110.267 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 56.2 mt -137.09 123.48 28.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 106.497 -1.668 . . . . 73.409999999999997 106.497 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 60.4 ttt-85 -128.88 115.27 17.61 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.201 -1.037 . . . . 71.540000000000006 108.201 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 30.9 p -120.5 128.41 53.11 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.982 -0.448 . . . . 52.219999999999999 110.789 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -127.78 140.34 52.11 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 110.083 -0.34 . . . . 72.439999999999998 110.083 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.41 ' C ' ' HD2' ' A' ' 236' ' ' ARG . 40.1 mt-10 59.87 105.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.529 1.677 . . . . 74.200000000000003 115.529 169.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 272' ' ' GLU . 1.2 mpt_? 53.0 24.15 3.28 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.071 1.348 . . . . 72.319999999999993 111.526 176.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.97 151.67 23.07 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 120.981 0.42 . . . . 72.200000000000003 110.553 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.32 135.55 38.99 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.649 -0.705 . . . . 74.420000000000002 109.241 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 3.2 p -133.11 140.17 47.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.863 -0.608 . . . . 70.340000000000003 110.526 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -116.32 124.42 50.08 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.63 -1.248 . . . . 75.340000000000003 107.63 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tt -119.07 117.47 28.83 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 105.527 -2.027 . . . . 75.140000000000001 105.527 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.58 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 131.32 -162.28 23.65 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 109.662 -1.375 . . . . 71.230000000000004 109.662 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -117.43 134.74 54.49 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 109.172 -0.677 . . . . 71.409999999999997 109.172 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 30.8 t -107.0 121.61 60.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.29 -1.004 . . . . 74.439999999999998 108.29 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 56.2 t -113.58 114.95 48.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.502 -0.925 . . . . 72.230000000000004 108.502 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 12.3 m -96.96 160.37 14.39 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.259 -1.015 . . . . 74.349999999999994 108.259 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.19 75.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.176 0.59 . . . . 74.219999999999999 111.067 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.38 66.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.353 1.061 . . . . 72.430000000000007 113.399 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.16 -26.09 58.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.854 0.359 . . . . 63.25 110.954 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 9.5 mp 74.53 176.68 0.23 Allowed 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 125.203 1.401 . . . . 74.329999999999998 110.219 -172.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -127.35 93.07 3.63 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.931 0.872 . . . . 60.43 109.891 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -160.48 160.28 31.65 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 110.488 -1.045 . . . . 64.140000000000001 110.488 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -154.52 -165.26 13.71 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 110.044 -1.222 . . . . 71.310000000000002 110.044 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 47.2 mm -119.02 -55.61 3.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 120.886 0.374 . . . . 72.420000000000002 110.58 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -150.67 168.16 25.16 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.754 -0.462 . . . . 73.140000000000001 109.754 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.82 160.43 4.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 112.853 0.686 . . . . 73.319999999999993 112.853 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 17.2 p -154.23 -175.19 5.27 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.577 -0.897 . . . . 73.230000000000004 108.577 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 259' ' ' GLN . 12.5 t70 -95.13 -158.89 0.68 Allowed 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.673 -0.862 . . . . 71.450000000000003 108.673 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.437 ' H ' ' CG ' ' A' ' 258' ' ' ASP . 79.6 mt-30 -97.38 118.13 33.15 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.267 0.556 . . . . 75.230000000000004 111.337 -177.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' THR . . . . . 0.494 ' OG1' ' HA ' ' B' ' 222' ' ' ILE . 84.3 m -64.38 133.01 51.75 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.954 -1.021 . . . . 73.409999999999997 108.861 174.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 26.9 m -134.6 132.16 38.71 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 110.135 -0.32 . . . . 74.109999999999999 110.135 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -126.25 150.2 48.57 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 104.953 -2.239 . . . . 72.530000000000001 104.953 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 26.7 m -134.93 123.77 23.91 Favored 'General case' 0 C--O 1.263 1.797 0 N-CA-C 114.494 1.294 . . . . 74.140000000000001 114.494 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -121.76 134.5 64.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 CA-C-N 115.108 -0.951 . . . . 72.349999999999994 110.616 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -77.35 -73.19 0.31 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.611 -0.722 . . . . 73.209999999999994 110.804 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 32.3 m -126.12 126.82 44.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 120.882 -0.327 . . . . 73.099999999999994 110.227 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.4 p -129.64 120.85 51.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.848 0.832 . . . . 74.099999999999994 110.874 176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 44.7 t -118.71 135.28 59.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.073 -0.967 . . . . 75.25 110.892 -175.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.455 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -121.37 131.12 8.45 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 108.411 -1.875 . . . . 71.120000000000005 108.411 172.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.428 ' HB3' ' HG2' ' B' ' 234' ' ' GLU . 7.1 tmtm? -134.91 115.02 13.12 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.437 -0.579 . . . . 72.510000000000005 109.437 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.37 82.71 0.68 Allowed Glycine 0 C--O 1.216 -0.977 0 C-N-CA 120.672 -0.775 . . . . 64.400000000000006 114.309 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 236' ' ' ARG . 41.5 mt-10 63.62 24.32 13.91 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.438 1.095 . . . . 71.049999999999997 112.414 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 48.8 m -82.46 145.12 30.0 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 121.715 0.769 . . . . 75.439999999999998 111.491 -176.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -109.09 127.86 54.5 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 106.42 -1.696 . . . . 75.439999999999998 106.42 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.4 p -129.23 123.55 58.48 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.665 0 N-CA-C 108.94 -0.763 . . . . 74.010000000000005 108.94 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.432 HD12 HE22 ' B' ' 240' ' ' GLN . 4.5 tt -113.53 120.21 40.2 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 107.88 -1.155 . . . . 74.430000000000007 107.88 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 41.7 mm -112.45 103.49 15.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.716 -1.216 . . . . 73.310000000000002 107.716 177.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.634 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 147.15 -145.06 13.38 Favored Glycine 0 C--N 1.301 -1.381 0 N-CA-C 110.452 -1.059 . . . . 65.310000000000002 110.452 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -127.53 143.3 51.2 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.628 -0.879 . . . . 74.329999999999998 108.628 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.75 120.23 37.94 Favored 'General case' 0 C--O 1.259 1.605 0 N-CA-C 106.849 -1.537 . . . . 73.239999999999995 106.849 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -107.12 123.11 47.77 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 106.854 -1.536 . . . . 75.450000000000003 106.854 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 98.96 -48.08 1.33 Allowed Glycine 0 C--N 1.295 -1.701 0 C-N-CA 120.54 -0.838 . . . . 72.530000000000001 111.356 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 82.93 15.04 73.72 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.829 -0.7 . . . . 63.219999999999999 113.036 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -127.47 5.91 6.27 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.264 -0.551 . . . . 74.349999999999994 111.755 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -85.71 -54.79 2.69 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 110.173 -1.171 . . . . 73.510000000000005 110.173 -178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -111.86 -30.68 7.2 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.143 -0.529 . . . . 72.340000000000003 109.674 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . 0.464 ' CH2' ' HB2' ' B' ' 238' ' ' ARG 0.283 11.3 t-105 -68.03 120.75 14.78 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 118.441 -1.304 . . . . 74.010000000000005 113.684 -173.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -111.14 111.17 22.06 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 112.872 -1.967 . . . . 71.340000000000003 108.619 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -171.29 87.66 0.1 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.587 -1.264 . . . . 73.420000000000002 107.587 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -96.23 69.64 2.71 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.599 -0.728 . . . . 73.530000000000001 112.138 -172.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 69.47 144.43 0.05 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.464 1.105 . . . . 72.109999999999999 112.288 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -142.04 -61.67 0.45 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.993 -0.549 . . . . 75.040000000000006 110.081 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -145.31 -79.97 0.17 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.918 -0.313 . . . . 74.549999999999997 110.905 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.527 ' CD2' ' HA ' ' B' ' 291' ' ' HIS . 23.6 t-80 -160.36 -51.74 0.05 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.782 -1.192 . . . . 74.519999999999996 107.782 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . 0.503 ' CE1' ' HB3' ' C' ' 288' ' ' ASP . 42.4 p-80 . . . . . 0 CA--C 1.496 -1.106 0 N-CA-C 104.584 -2.376 . . . . 72.129999999999995 104.584 172.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 80.9 mtp . . . . . 0 C--O 1.238 0.463 0 CA-C-O 119.51 -0.281 . . . . 75.299999999999997 111.483 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -147.05 -70.95 0.23 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.57 0.623 . . . . 75.430000000000007 110.097 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 38.8 pt -98.05 -21.44 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-O 121.525 0.678 . . . . 71.420000000000002 109.865 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -73.71 143.47 46.15 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.665 -1.152 . . . . 74.129999999999995 108.682 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -73.39 123.68 24.31 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 115.244 -0.889 . . . . 74.420000000000002 110.467 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . 0.494 ' HA ' ' OG1' ' A' ' 260' ' ' THR . 6.1 tp -82.92 114.74 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 105.471 -2.048 . . . . 74.340000000000003 105.471 173.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 10.5 m -136.17 164.49 31.55 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 115.093 -0.958 . . . . 73.030000000000001 110.806 -174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . 0.504 ' HA3' ' HB ' ' B' ' 260' ' ' THR . . . -67.93 176.14 26.12 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 117.069 1.587 . . . . 65.340000000000003 117.069 -173.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . 0.653 ' O ' ' HA ' ' B' ' 261' ' ' THR . 8.7 ptm180 -105.24 121.09 43.12 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 112.757 -1.721 . . . . 75.030000000000001 110.621 -176.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -103.69 149.11 25.27 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 104.576 -2.379 . . . . 71.409999999999997 104.576 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 23.9 m -125.75 134.74 51.65 Favored 'General case' 0 N--CA 1.411 -2.386 0 C-N-CA 119.252 -0.979 . . . . 74.439999999999998 110.497 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.24 121.74 25.3 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.156 -1.384 . . . . 75.349999999999994 110.331 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -76.1 -67.14 0.71 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.156 -0.929 . . . . 72.319999999999993 112.164 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -127.16 137.07 52.87 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 118.327 -1.349 . . . . 74.230000000000004 108.752 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . 0.413 HG23 HG21 ' B' ' 239' ' ' VAL . 43.3 mt -131.93 117.68 34.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.35 -1.352 . . . . 65.219999999999999 107.35 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -126.09 115.15 19.38 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.226 -0.657 . . . . 70.299999999999997 109.226 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' THR . . . . . 0.455 ' OG1' ' HA2' ' A' ' 269' ' ' GLY . 71.2 p -112.66 127.24 56.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.844 -1.169 . . . . 63.409999999999997 107.844 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' B' ' 270' ' ' LYS . 52.2 mt-10 -131.44 139.89 49.49 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 122.072 -0.392 . . . . 73.420000000000002 111.1 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.528 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 28.9 mt-10 60.56 93.62 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 O-C-N 124.711 1.257 . . . . 73.310000000000002 114.037 171.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.528 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 1.4 mpt_? 63.0 15.6 8.56 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 125.036 1.335 . . . . 73.239999999999995 111.06 175.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -78.15 156.57 29.82 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.197 0.522 . . . . 75.340000000000003 111.071 -176.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.464 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -139.75 135.15 32.8 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.362 -0.607 . . . . 73.530000000000001 109.362 177.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.581 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.4 p -133.32 142.45 41.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.632 0.73 . . . . 73.510000000000005 111.381 -178.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.68 ' HB2' ' CE2' ' B' ' 286' ' ' PHE . 5.8 tp-100 -109.35 131.99 54.55 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.382 -1.34 . . . . 65.129999999999995 107.382 173.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -129.72 115.58 17.53 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 104.801 -2.296 . . . . 75.040000000000006 104.801 171.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 135.96 -136.32 8.36 Favored Glycine 0 N--CA 1.417 -2.578 0 N-CA-C 109.057 -1.617 . . . . 61.240000000000002 109.057 -175.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -142.3 148.71 38.47 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 117.575 0.688 . . . . 74.239999999999995 109.682 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 17.2 t -114.8 124.11 71.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.538 -1.282 . . . . 72.219999999999999 107.538 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.15 113.37 38.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 120.178 -0.609 . . . . 74.030000000000001 109.494 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' THR . . . . . 0.409 HG22 ' HB2' ' B' ' 284' ' ' LYS . 7.4 m -95.09 159.5 14.99 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.353 -1.351 . . . . 74.120000000000005 107.353 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.481 ' HB2' ' CE1' ' B' ' 251' ' ' HIS . . . -64.15 -32.13 73.58 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.941 0.876 . . . . 72.430000000000007 110.241 177.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.89 -44.47 74.13 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.383 -1.735 . . . . 73.140000000000001 113.366 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -75.74 -47.7 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.273 -0.571 . . . . 71.030000000000001 111.16 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 94.1 mt -165.94 149.5 7.74 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.929 0.892 . . . . 71.140000000000001 109.296 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . 0.481 ' CE1' ' HB2' ' B' ' 247' ' ' ALA . 86.4 m-70 -102.32 84.84 2.53 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 105.358 -2.09 . . . . 75.430000000000007 105.358 168.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.26 -84.88 0.93 Allowed Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 108.603 -1.799 . . . . 64.239999999999995 108.603 -172.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . 0.443 ' CA ' ' HA ' ' C' ' 217' ' ' MET . . . 51.67 49.9 45.04 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 114.64 0.616 . . . . 53.520000000000003 114.64 175.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . 0.474 HG22 ' H ' ' B' ' 222' ' ' ILE . 17.5 pt -102.56 141.45 18.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 113.503 0.927 . . . . 71.230000000000004 113.503 -173.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . 0.452 ' HB3' ' OD1' ' C' ' 220' ' ' ASP . 37.7 ttt180 -110.81 -20.82 12.34 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 124.731 1.212 . . . . 74.420000000000002 109.444 178.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . 0.481 14.4 tt 71.84 68.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.957 0 C-N-CA 128.338 2.655 . . . . 73.219999999999999 113.336 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' SER . . . . . 0.604 ' O ' ' HB ' ' C' ' 222' ' ' ILE . 1.6 m -124.3 98.71 5.88 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.025 -1.843 . . . . 64.319999999999993 106.025 173.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -149.06 137.18 20.77 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.969 1.47 . . . . 75.549999999999997 114.969 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -164.54 23.58 0.06 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.839 -1.911 . . . . 73.420000000000002 105.839 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' THR . . . . . 0.504 ' HB ' ' HA3' ' B' ' 224' ' ' GLY . 3.7 m -70.93 125.21 26.23 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.904 -1.044 . . . . 72.510000000000005 108.44 -175.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' THR . . . . . 0.653 ' HA ' ' O ' ' B' ' 225' ' ' ARG . 25.3 m -132.96 135.18 45.36 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.639 -1.615 . . . . 65.340000000000003 106.639 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -126.67 146.05 50.34 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.192 -1.781 . . . . 73.209999999999994 106.192 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 263' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' C' ' 227' ' ' SER . 40.5 m -125.6 123.51 39.18 Favored 'General case' 0 C--O 1.256 1.434 0 C-N-CA 118.536 -1.266 . . . . 74.409999999999997 114.043 -170.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.3 p -128.63 137.31 57.67 Favored 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 120.088 -0.645 . . . . 75.239999999999995 111.212 172.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.555 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 10.4 tp10 -86.34 -63.36 1.33 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.025 -0.534 . . . . 73.439999999999998 110.01 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 25.1 m -137.15 127.56 26.58 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.346 -0.847 . . . . 75.040000000000006 112.408 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.56 128.41 75.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 115.882 -0.599 . . . . 71.209999999999994 109.815 173.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.41 130.63 74.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.61 -0.723 . . . . 65.549999999999997 109.98 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.44 132.95 9.28 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 110.585 -1.006 . . . . 70.519999999999996 110.585 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.465 ' HD2' ' HB2' ' B' ' 234' ' ' GLU . 31.2 mmmt -132.91 115.64 15.49 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 123.218 0.607 . . . . 74.109999999999999 111.108 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.61 80.67 0.61 Allowed Glycine 0 C--N 1.304 -1.196 0 C-N-CA 120.445 -0.883 . . . . 51.420000000000002 114.589 172.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 63.7 28.64 14.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.159 0.984 . . . . 63.450000000000003 112.509 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 273' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 50.1 m -81.97 145.19 30.41 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.351 0.596 . . . . 73.239999999999995 111.175 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.411 ' HD3' ' HB3' ' C' ' 238' ' ' ARG . 6.1 mpt_? -109.5 128.72 55.38 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 106.849 -1.537 . . . . 73.049999999999997 106.849 174.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.4 p -130.96 123.06 53.32 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 N-CA-C 108.17 -1.048 . . . . 74.400000000000006 108.17 172.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . 0.44 HD12 ' CD1' ' B' ' 286' ' ' PHE . 6.1 tt -114.08 116.79 29.7 Favored 'General case' 0 C--N 1.277 -2.571 0 C-N-CA 119.36 -0.936 . . . . 74.230000000000004 108.599 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 34.0 mm -106.46 102.54 14.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 106.834 -1.543 . . . . 71.209999999999994 106.834 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 146.82 -164.36 28.53 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 110.856 -0.897 . . . . 62.130000000000003 110.856 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -109.54 139.66 44.28 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.159 -0.682 . . . . 72.140000000000001 109.159 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.95 118.89 36.73 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.256 -1.757 . . . . 74.120000000000005 106.256 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -105.91 122.95 47.17 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.891 -1.151 . . . . 73.439999999999998 107.891 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.44 -46.47 1.28 Allowed Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.669 -0.696 . . . . 73.549999999999997 111.682 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 74.59 29.25 61.86 Favored Glycine 0 CA--C 1.506 -0.486 0 N-CA-C 111.555 -0.618 . . . . 52.439999999999998 111.555 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . 0.409 ' HB2' HG22 ' B' ' 246' ' ' THR . 73.1 mmtt -137.25 11.41 3.03 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.528 -0.336 . . . . 72.319999999999993 110.624 -177.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -103.78 -47.05 1.31 Allowed Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 119.729 -1.224 . . . . 75.319999999999993 110.686 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.68 ' CE2' ' HB2' ' B' ' 240' ' ' GLN . 6.3 t80 -110.03 -42.11 4.29 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.996 0.427 . . . . 75.409999999999997 110.39 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.514 ' CZ2' ' HB2' ' C' ' 238' ' ' ARG . 11.2 t-105 -70.93 148.85 47.3 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 115.483 1.661 . . . . 75.150000000000006 115.483 -165.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.55 22.59 0.08 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.683 1.593 . . . . 74.019999999999996 111.222 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' B' ' 287' ' ' TRP . 22.4 t30 -80.21 88.98 5.45 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 122.536 1.16 . . . . 74.230000000000004 110.233 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -133.3 71.38 1.47 Allowed 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 114.039 -1.437 . . . . 74.310000000000002 108.908 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . 0.527 ' HA ' ' CD2' ' A' ' 294' ' ' HIS . 20.5 p80 -76.35 133.46 39.96 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 113.917 -1.492 . . . . 72.319999999999993 110.772 -176.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . 0.4 ' H ' ' CD2' ' A' ' 294' ' ' HIS . 9.4 t-80 -87.28 84.76 7.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.419 -0.81 . . . . 72.340000000000003 109.499 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . 0.42 ' HB3' ' HD1' ' B' ' 291' ' ' HIS . 23.9 t-80 -168.04 33.07 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 104.662 -2.347 . . . . 75.409999999999997 104.662 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . 0.4 ' HA ' ' CD2' ' C' ' 292' ' ' HIS . 9.2 p80 -90.16 75.77 6.98 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.19 -1.368 . . . . 75.409999999999997 113.822 -173.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 . . . . . 0 C--N 1.312 -1.033 0 CA-C-N 113.506 -1.679 . . . . 74.450000000000003 107.2 177.109 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 217' ' ' MET . . . . . 0.443 ' HA ' ' CA ' ' B' ' 253' ' ' GLY . 65.7 mtt . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 111.585 0.217 . . . . 72.209999999999994 111.585 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -77.15 -12.37 59.94 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.966 0.888 . . . . 75.010000000000005 109.857 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.02 137.98 56.24 Favored 'Isoleucine or valine' 0 C--O 1.256 1.439 0 N-CA-C 105.438 -2.06 . . . . 74.109999999999999 105.438 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . 0.452 ' OD1' ' HB3' ' B' ' 255' ' ' ARG . 28.8 p-10 -114.38 -167.88 1.28 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.649 -0.871 . . . . 61.109999999999999 108.649 176.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.8 111.44 14.21 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.939 1.088 . . . . 74.209999999999994 113.939 -173.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . 0.604 ' HB ' ' O ' ' B' ' 257' ' ' SER . 0.0 OUTLIER -115.95 133.34 62.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 104.572 -2.381 . . . . 74.310000000000002 104.572 171.885 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . 0.423 ' O ' HG23 ' B' ' 260' ' ' THR . 4.8 t -127.06 164.18 28.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 120.659 -0.417 . . . . 70.310000000000002 110.519 -172.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -74.62 -168.75 21.2 Favored Glycine 0 C--O 1.245 0.806 0 N-CA-C 111.303 -0.719 . . . . 75.519999999999996 111.303 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 15.8 ptt-85 -121.92 147.52 45.92 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 118.7 -1.2 . . . . 74.310000000000002 114.115 -173.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -116.25 147.41 41.51 Favored 'General case' 0 N--CA 1.399 -2.985 0 N-CA-C 105.26 -2.126 . . . . 75.25 105.26 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 227' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' C' ' 263' ' ' SER . 24.1 m -130.03 136.55 49.52 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 121.269 0.557 . . . . 72.319999999999993 110.117 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . 0.4 ' HB1' HG21 ' C' ' 277' ' ' ILE . . . -130.41 134.37 47.08 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 109.198 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.555 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -85.95 -61.32 1.78 Allowed 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 115.266 -0.879 . . . . 73.540000000000006 109.193 -178.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -129.56 137.97 51.05 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.953 -0.699 . . . . 71.239999999999995 110.345 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 34.5 mt -135.18 119.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.879 -0.785 . . . . 74.420000000000002 108.879 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -125.56 115.92 20.94 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.998 0.428 . . . . 75.209999999999994 110.078 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 38.9 p -112.61 127.5 56.11 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.452 -0.944 . . . . 74.129999999999995 108.452 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -131.55 139.43 49.23 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.437 -0.505 . . . . 72.120000000000005 110.691 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . 0.454 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 38.2 mt-10 62.81 92.16 0.06 Allowed 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 124.926 1.391 . . . . 74.230000000000004 114.133 170.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.454 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 2.8 mpt_? 63.55 12.04 6.14 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.859 1.264 . . . . 74.239999999999995 111.21 175.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -77.97 149.01 34.18 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.204 0.526 . . . . 62.509999999999998 111.64 -174.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.514 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.0 OUTLIER -133.65 134.96 43.8 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.943 -0.572 . . . . 72.329999999999998 111.511 176.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.6 p -132.97 137.86 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 115.276 -0.875 . . . . 72.099999999999994 111.534 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -106.03 129.79 54.07 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 114.127 -1.397 . . . . 74.150000000000006 107.863 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -125.15 116.32 21.85 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.069 -1.826 . . . . 71.129999999999995 106.069 173.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.632 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 126.98 -148.18 17.21 Favored Glycine 0 C--N 1.284 -2.348 0 N-CA-C 108.278 -1.929 . . . . 65.409999999999997 108.278 -176.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -126.96 150.16 49.51 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 118.336 1.068 . . . . 72.409999999999997 110.621 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.78 126.56 74.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.614 -1.254 . . . . 74.420000000000002 107.614 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 65.4 t -122.52 118.59 55.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 120.439 -0.504 . . . . 74.340000000000003 109.98 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 9.4 m -95.27 159.42 15.02 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 108.114 -1.069 . . . . 71.409999999999997 108.114 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -64.05 -33.76 76.48 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.354 0.597 . . . . 63.240000000000002 110.776 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.14 -47.76 74.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.405 -1.271 . . . . 72.120000000000005 111.464 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.32 -42.51 44.9 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.941 0.4 . . . . 74.219999999999999 111.367 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 52.5 tp 76.7 -61.67 0.43 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.619 1.567 . . . . 75.209999999999994 113.248 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -155.03 170.34 22.0 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.379 0.536 . . . . 74.0 111.459 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 179.83 100.33 0.14 Allowed Glycine 0 CA--C 1.527 0.811 0 O-C-N 123.435 0.459 . . . . 72.0 112.312 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.07 33.55 2.16 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.286 -0.483 . . . . 54.240000000000002 112.816 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . 0.506 ' HA ' ' CG2' ' C' ' 222' ' ' ILE . 44.1 pt -75.44 0.77 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 113.845 1.054 . . . . 74.230000000000004 113.845 -174.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -85.75 -2.3 58.08 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.782 -0.821 . . . . 74.400000000000006 108.782 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . 0.47 ' HA ' HD11 ' C' ' 222' ' ' ILE . 1.9 mp 77.7 91.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 CA-C-O 122.611 1.196 . . . . 74.439999999999998 108.575 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 22.9 m -99.36 29.73 3.85 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.984 -1.462 . . . . 73.340000000000003 110.831 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -75.81 72.26 2.7 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 122.205 1.002 . . . . 61.43 111.07 176.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -164.77 -19.25 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 128.618 2.767 . . . . 74.319999999999993 107.837 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 22.2 m -64.35 121.34 14.09 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 104.527 -2.397 . . . . 72.450000000000003 104.527 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 22.0 m -133.52 112.44 11.52 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 109.584 -0.524 . . . . 75.319999999999993 109.584 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -112.51 124.48 52.61 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.064 -1.828 . . . . 71.129999999999995 106.064 173.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 263' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' C' ' 227' ' ' SER . 10.7 p -130.37 144.79 51.6 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 113.735 1.013 . . . . 75.409999999999997 113.735 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 10.0 p -128.51 149.58 33.43 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.494 -0.775 . . . . 65.140000000000001 110.296 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -81.03 -68.28 0.7 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.626 0.25 . . . . 74.099999999999994 111.284 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 61.8 m -138.59 127.6 23.94 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 120.367 -0.533 . . . . 75.120000000000005 110.646 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.1 m -118.68 134.6 61.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.466 -0.568 . . . . 64.049999999999997 109.466 172.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 13.6 m -127.1 135.53 63.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-N 115.634 -0.712 . . . . 74.510000000000005 110.485 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.15 132.35 9.08 Favored Glycine 0 CA--C 1.47 -2.739 0 N-CA-C 109.089 -1.604 . . . . 44.299999999999997 109.089 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -134.4 115.21 13.75 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.603 -0.888 . . . . 75.120000000000005 108.603 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.39 91.61 0.19 Allowed Glycine 0 C--O 1.242 0.653 0 C-N-CA 121.139 -0.553 . . . . 71.150000000000006 113.427 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 56.5 29.65 15.77 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.638 1.175 . . . . 72.519999999999996 112.158 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 23.2 m -82.8 145.24 29.62 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 119.561 -0.856 . . . . 63.200000000000003 111.547 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -118.72 127.65 53.76 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 107.908 -1.145 . . . . 71.409999999999997 107.908 177.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 4.0 p -138.25 128.5 35.06 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-N 115.592 -0.731 . . . . 74.349999999999994 109.292 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.7 tt -116.62 115.3 25.45 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.485 -0.931 . . . . 72.420000000000002 108.485 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . 0.4 HG21 ' HB1' ' C' ' 228' ' ' ALA . 43.1 mm -105.9 102.97 14.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 106.509 -1.663 . . . . 74.409999999999997 106.509 178.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 141.42 -163.2 26.84 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 111.028 -0.829 . . . . 62.409999999999997 111.028 -174.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -114.08 135.87 53.55 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.818 -0.808 . . . . 75.239999999999995 108.818 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.69 118.68 36.31 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.169 -1.789 . . . . 75.310000000000002 106.169 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -105.26 123.39 47.76 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 109.097 -0.705 . . . . 75.239999999999995 109.097 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.19 -43.65 1.66 Allowed Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 109.957 -1.257 . . . . 64.430000000000007 109.957 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 80.1 21.68 64.84 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.359 -0.697 . . . . 70.409999999999997 111.359 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' C' ' 287' ' ' TRP . 33.3 mttm -145.68 20.5 1.49 Allowed 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 113.987 1.106 . . . . 73.409999999999997 113.987 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -94.58 -45.5 3.18 Favored Glycine 0 N--CA 1.427 -1.922 0 N-CA-C 107.794 -2.123 . . . . 72.329999999999998 107.794 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.53 -50.91 3.11 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.578 -1.267 . . . . 74.25 107.578 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . 0.563 ' O ' ' HA ' ' C' ' 284' ' ' LYS . 0.8 OUTLIER -88.23 161.91 16.95 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.268 -0.878 . . . . 73.219999999999999 112.097 -169.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . 0.503 ' HB3' ' CE1' ' A' ' 295' ' ' HIS . 17.4 t70 -122.68 105.54 10.17 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.549 0.69 . . . . 74.329999999999998 112.222 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -92.82 149.34 21.35 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 105.802 -1.925 . . . . 73.099999999999994 105.802 167.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -68.44 98.46 0.85 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.771 0.796 . . . . 75.409999999999997 111.365 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -171.86 169.86 5.65 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 104.224 -2.51 . . . . 74.010000000000005 104.224 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . 0.4 ' CD2' ' HA ' ' B' ' 294' ' ' HIS . 13.4 t-80 -94.86 149.88 20.78 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 119.37 0.986 . . . . 72.5 110.569 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . 0.457 ' CB ' ' HD3' ' C' ' 284' ' ' LYS . 11.7 t-160 -166.26 76.26 0.21 Allowed 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.987 0.915 . . . . 73.310000000000002 110.274 173.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 56.5 -171.75 0.08 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.066 1.136 . . . . 75.25 114.066 176.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 5.8 p80 . . . . . 0 N--CA 1.427 -1.62 0 CA-C-N 114.621 -1.172 . . . . 75.230000000000004 110.013 177.785 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 66.3 mtm . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.675 0.274 . . . . 64.209999999999994 110.875 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -132.7 -42.4 0.92 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.96 -0.385 . . . . 75.340000000000003 109.96 173.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.0 mp -102.66 127.69 56.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 120.836 0.35 . . . . 74.340000000000003 110.152 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -136.09 102.46 5.03 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.975 -1.12 . . . . 73.010000000000005 107.975 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -134.41 135.7 42.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.706 -0.85 . . . . 74.200000000000003 108.706 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 63.1 mt -113.95 114.67 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 108.116 -1.068 . . . . 74.519999999999996 108.116 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.51 124.71 29.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.743 -0.662 . . . . 74.129999999999995 110.163 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -113.82 58.86 0.41 Allowed Glycine 0 C--N 1.294 -1.783 0 N-CA-C 107.458 -2.257 . . . . 63.420000000000002 107.458 175.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -100.59 132.17 46.12 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.695 0.759 . . . . 75.310000000000002 112.053 -172.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -110.28 134.96 51.74 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.301 -1.318 . . . . 74.219999999999999 108.677 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.6 m -126.19 136.71 53.17 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 109.326 -0.62 . . . . 74.099999999999994 109.326 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.18 132.19 27.83 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.453 -1.684 . . . . 73.349999999999994 106.453 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.17 -56.85 2.5 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.873 -0.731 . . . . 74.310000000000002 111.656 -174.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.81 139.57 52.57 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.129 -0.693 . . . . 64.019999999999996 109.129 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.2 mm -131.92 118.72 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.884 -0.784 . . . . 73.209999999999994 108.884 -174.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -120.56 127.01 51.75 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.846 -0.428 . . . . 74.349999999999994 109.846 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 45.1 p -133.46 128.64 35.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.684 -0.487 . . . . 65.230000000000004 109.684 -176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -142.8 139.71 31.07 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 121.059 -0.256 . . . . 74.319999999999993 110.773 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.6 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 38.7 mt-10 64.18 95.64 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 114.748 1.388 . . . . 63.0 114.748 170.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.6 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.1 mpp_? 60.31 26.85 16.37 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.674 1.19 . . . . 74.340000000000003 110.435 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -92.35 125.95 37.23 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 115.252 -0.886 . . . . 75.140000000000001 110.614 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.448 ' HD3' ' HG2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -128.05 134.94 49.25 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.621 -0.881 . . . . 74.400000000000006 108.621 176.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.487 HG11 ' HB ' ' A' ' 275' ' ' VAL . 33.1 m -134.32 150.12 30.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 116.116 -0.493 . . . . 72.540000000000006 110.711 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.598 HE21 ' HG ' ' A' ' 276' ' ' LEU . 0.9 OUTLIER -123.14 125.34 44.96 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.336 -1.357 . . . . 75.340000000000003 107.336 178.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -116.12 117.75 30.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.65 -1.241 . . . . 75.230000000000004 107.65 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.45 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 126.59 -159.57 20.86 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 111.337 -0.705 . . . . 73.140000000000001 111.337 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 279' ' ' ASN . 39.3 t30 -107.0 137.86 44.27 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 122.935 0.494 . . . . 75.319999999999993 110.383 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 99.9 t -113.27 114.33 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.249 -0.649 . . . . 73.030000000000001 109.249 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.441 ' HA ' ' HB3' ' A' ' 281' ' ' TYR . 27.4 m -99.32 118.39 45.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 119.844 -0.742 . . . . 74.230000000000004 110.711 176.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 17.6 m -102.0 158.95 15.78 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.562 -0.533 . . . . 73.150000000000006 109.562 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.79 -35.27 80.24 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.639 0.977 . . . . 71.329999999999998 113.639 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -39.03 68.01 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.476 1.288 . . . . 74.329999999999998 114.476 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.423 ' HB3' ' HA2' ' A' ' 282' ' ' GLY . . . -74.6 -23.72 58.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.217 0.451 . . . . 74.420000000000002 112.217 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 6.7 mp 72.91 -162.26 0.1 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.066 0.947 . . . . 73.340000000000003 108.509 -172.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 72.5 m80 69.38 177.81 0.26 Allowed 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.743 0.817 . . . . 72.239999999999995 111.142 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -167.0 41.51 0.25 Allowed Glycine 0 CA--C 1.483 -1.965 0 C-N-CA 120.268 -0.968 . . . . 53.130000000000003 111.127 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -168.14 161.25 35.0 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 109.949 -1.26 . . . . 54.539999999999999 109.949 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 33.0 pt -96.33 113.89 31.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.61 0.719 . . . . 75.040000000000006 109.933 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -95.36 179.85 5.03 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.277 -1.749 . . . . 75.019999999999996 106.277 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 42.6 mm -76.66 92.86 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 119.568 1.076 . . . . 70.120000000000005 111.933 -174.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 47.7 m -139.27 -45.06 0.46 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.256 -0.884 . . . . 70.129999999999995 110.706 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.08 89.09 5.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.668 0.747 . . . . 75.219999999999999 112.265 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -103.05 9.09 38.71 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.984 -1.487 . . . . 73.420000000000002 106.984 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 6.1 m -75.6 122.88 24.58 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 112.984 -1.916 . . . . 70.019999999999996 111.127 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 m -107.56 108.6 19.97 Favored 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 106.204 -1.776 . . . . 74.349999999999994 106.204 174.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 17.2 m120 -104.91 130.8 53.0 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.797 -0.816 . . . . 74.319999999999993 108.797 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 59.5 m -138.96 123.43 18.34 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.53 -0.545 . . . . 70.230000000000004 109.53 174.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 12.7 p -128.19 149.18 32.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.844 -1.169 . . . . 73.129999999999995 107.844 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 32.1 tt0 -92.91 -67.6 0.85 Allowed 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 120.005 -0.678 . . . . 73.420000000000002 110.339 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 20.7 m -123.74 133.08 53.91 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.235 -0.586 . . . . 74.439999999999998 111.429 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.84 131.71 72.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 108.492 -0.929 . . . . 72.319999999999993 108.492 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 6.4 p -127.26 131.51 70.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 110.207 -0.294 . . . . 72.239999999999995 110.207 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.461 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -122.71 131.49 8.31 Favored Glycine 0 CA--C 1.485 -1.837 0 C-N-CA 120.34 -0.933 . . . . 71.239999999999995 111.347 176.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -134.41 115.84 14.48 Favored 'General case' 0 N--CA 1.428 -1.531 0 O-C-N 123.679 0.282 . . . . 74.540000000000006 110.828 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.63 99.7 0.49 Allowed Glycine 0 C--O 1.245 0.801 0 C-N-CA 120.717 -0.754 . . . . 73.25 113.878 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 60.55 24.18 13.87 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.432 1.093 . . . . 73.209999999999994 110.597 175.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 18.9 m -82.57 144.63 30.22 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.987 0.899 . . . . 74.239999999999995 112.784 -169.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . 0.448 ' HG2' ' HD3' ' A' ' 238' ' ' ARG . 82.9 mtt180 -135.31 126.21 27.57 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.124 -1.436 . . . . 75.239999999999995 107.124 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.487 ' HB ' HG11 ' A' ' 239' ' ' VAL . 46.4 t -136.19 133.67 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.989 0 N-CA-C 109.691 -0.485 . . . . 71.140000000000001 109.691 -176.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.598 ' HG ' HE21 ' A' ' 240' ' ' GLN . 6.3 tt -119.45 117.98 29.89 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.507 -1.277 . . . . 74.340000000000003 108.849 171.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 2.7 pt -112.54 104.38 16.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-O 121.622 0.725 . . . . 74.430000000000007 109.508 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.673 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 148.21 -133.45 4.62 Favored Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 115.843 -0.617 . . . . 63.539999999999999 111.568 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' A' ' 243' ' ' ASN . 14.3 m120 -128.29 153.5 46.92 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.507 -0.923 . . . . 74.109999999999999 108.507 -176.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.17 143.45 34.25 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.945 0.878 . . . . 73.540000000000006 110.475 170.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.441 ' HB3' ' HA ' ' A' ' 245' ' ' VAL 0.252 5.3 t80 -119.45 124.63 46.98 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 105.801 -1.926 . . . . 74.319999999999993 105.801 -175.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 249' ' ' ALA . . . 144.2 -52.13 0.62 Allowed Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.003 -1.094 . . . . 72.129999999999995 112.974 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 119.87 -34.74 4.08 Favored Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 108.816 -1.714 . . . . 40.130000000000003 108.816 -175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -135.89 87.47 2.31 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.609 -1.626 . . . . 72.099999999999994 106.609 170.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -95.97 -132.81 7.26 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.812 -0.915 . . . . 63.119999999999997 110.812 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 26.0 t80 52.07 -130.1 2.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 107.819 -1.178 . . . . 75.310000000000002 107.819 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -124.22 14.8 9.05 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.318 -1.364 . . . . 70.25 107.318 172.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.51 ' C ' HD21 ' A' ' 289' ' ' ASN . 23.1 t70 51.21 -163.64 0.06 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.231 -1.35 . . . . 72.430000000000007 108.35 -172.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . 0.51 HD21 ' C ' ' A' ' 288' ' ' ASP . 0.9 OUTLIER -124.94 -2.42 7.74 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.727 -1.233 . . . . 75.420000000000002 109.428 178.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 75.62 84.79 0.09 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 126.065 1.746 . . . . 72.030000000000001 108.969 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 67.0 t60 63.79 82.34 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.632 -1.622 . . . . 65.329999999999998 109.562 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -78.85 79.21 5.27 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.879 -1.055 . . . . 73.409999999999997 109.891 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -157.45 141.64 16.21 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.677 -0.86 . . . . 61.240000000000002 108.677 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.547 ' H ' ' CD2' ' B' ' 291' ' ' HIS . 30.8 t-80 74.01 1.44 3.9 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.249 1.82 . . . . 75.230000000000004 112.117 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . 0.408 ' C ' HH22 ' B' ' 238' ' ' ARG . 48.8 p-80 . . . . . 0 C--N 1.303 -1.428 0 N-CA-C 106.792 -1.559 . . . . 74.349999999999994 106.792 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 13.8 tpt . . . . . 0 CA--C 1.507 -0.681 0 CA-C-O 120.898 0.38 . . . . 75.25 110.788 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -96.2 140.66 30.58 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.454 -0.943 . . . . 41.119999999999997 108.454 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . 0.46 HG13 ' O ' ' C' ' 219' ' ' ILE . 18.3 pt -93.65 -164.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 112.796 0.665 . . . . 75.219999999999999 112.796 -174.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -141.53 127.09 18.93 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.822 -0.807 . . . . 73.519999999999996 108.822 -173.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 178.57 136.63 0.09 Allowed 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.743 0.652 . . . . 64.430000000000007 111.77 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 63.5 mt -94.6 114.9 32.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 106.096 -1.816 . . . . 75.319999999999993 106.096 171.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.22 136.07 41.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 120.976 0.417 . . . . 74.230000000000004 111.944 -175.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -105.42 84.13 0.4 Allowed Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 107.948 -2.061 . . . . 70.310000000000002 107.948 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -90.06 121.1 31.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.255 0.465 . . . . 75.129999999999995 112.255 -174.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 6.9 t30 -118.58 113.39 21.18 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.654 -0.869 . . . . 74.409999999999997 108.654 169.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 46.7 m -121.26 136.61 54.94 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-O 121.725 0.774 . . . . 63.439999999999998 110.124 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.569 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.21 147.58 52.0 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.999 -1.482 . . . . 55.539999999999999 106.999 178.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.522 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 10.0 tmtt? -104.51 -67.76 0.89 Allowed 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.677 -0.809 . . . . 75.420000000000002 109.299 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -128.01 138.7 52.69 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.435 -0.58 . . . . 73.400000000000006 109.435 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . 0.417 HD11 ' HB3' ' B' ' 228' ' ' ALA . 39.9 mm -128.88 117.57 44.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.637 -0.875 . . . . 75.409999999999997 108.637 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -114.31 114.51 26.02 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.895 -0.78 . . . . 72.420000000000002 108.895 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' THR . . . . . 0.461 ' OG1' ' HA2' ' A' ' 269' ' ' GLY . 78.2 p -111.53 127.24 55.65 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 107.664 -1.235 . . . . 71.329999999999998 107.664 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -139.34 138.93 37.07 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 120.842 -0.343 . . . . 73.129999999999995 111.019 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.627 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 44.5 mt-10 57.99 98.4 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 125.098 1.499 . . . . 73.209999999999994 114.908 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.627 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.2 OUTLIER 60.75 26.21 16.02 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.859 -1.064 . . . . 71.219999999999999 110.198 174.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -91.35 136.03 33.4 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.121 -0.945 . . . . 63.439999999999998 111.882 -175.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 3.5 mpt_? -125.94 134.41 51.55 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.711 -1.218 . . . . 74.230000000000004 107.711 176.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 19.7 m -138.97 147.41 24.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.234 0.54 . . . . 73.140000000000001 110.945 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -122.06 127.93 50.78 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.66 -1.608 . . . . 74.219999999999999 106.66 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' B' ' 277' ' ' ILE . 2.3 tm? -122.5 117.67 26.49 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.892 -1.522 . . . . 73.510000000000005 106.892 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.673 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 136.92 -126.39 3.7 Favored Glycine 0 N--CA 1.428 -1.861 0 C-N-CA 120.804 -0.713 . . . . 71.340000000000003 111.761 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . 0.552 ' HA ' ' O ' ' B' ' 279' ' ' ASN . 43.9 t30 -142.78 134.86 27.23 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 110.286 -0.264 . . . . 73.430000000000007 110.286 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.445 HG11 ' H ' ' B' ' 286' ' ' PHE . 68.7 t -114.94 114.91 47.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 109.539 -0.541 . . . . 74.310000000000002 109.539 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . 0.441 ' HA ' ' HB3' ' B' ' 281' ' ' TYR . 28.5 m -104.15 112.72 38.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.69 -0.804 . . . . 64.209999999999994 111.192 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 42.0 m -81.72 158.19 24.29 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 121.047 0.451 . . . . 75.010000000000005 110.914 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.23 93.24 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.322 1.049 . . . . 73.519999999999996 112.342 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.31 -44.29 75.65 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.068 -1.424 . . . . 73.129999999999995 114.065 -173.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.495 ' HB3' ' HA2' ' B' ' 282' ' ' GLY . . . -74.95 -25.76 59.12 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 120.9 0.381 . . . . 62.530000000000001 110.744 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 8.8 mp 75.85 157.8 0.19 Allowed 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 125.186 1.395 . . . . 74.230000000000004 109.458 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -83.86 91.54 7.58 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.4 -0.963 . . . . 73.439999999999998 108.4 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -92.14 111.69 4.08 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.038 -0.983 . . . . 75.340000000000003 112.374 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.06 62.19 4.26 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.995 -0.842 . . . . 62.439999999999998 110.995 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 9.2 tp -98.34 -15.37 7.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.121 -0.539 . . . . 74.439999999999998 109.981 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 69.73 135.08 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.486 1.114 . . . . 75.109999999999999 113.123 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 50.1 mm -71.72 113.94 9.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 105.259 -2.126 . . . . 75.219999999999999 105.259 172.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 15.1 m -113.92 25.25 11.33 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.295 -0.562 . . . . 64.120000000000005 112.266 -171.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.5 ' OD2' ' HD2' ' C' ' 255' ' ' ARG . 4.5 p30 -111.17 -164.63 0.93 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.083 -0.508 . . . . 72.439999999999998 110.552 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -124.66 33.59 5.19 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.18 -0.464 . . . . 71.519999999999996 110.475 -175.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' C' ' 224' ' ' GLY . 16.7 m -64.51 120.97 13.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.936 0.874 . . . . 74.140000000000001 111.254 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 33.9 m -124.11 108.91 12.83 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 115.039 -0.982 . . . . 71.219999999999999 108.565 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -108.49 132.59 53.66 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 109.65 -0.5 . . . . 63.409999999999997 109.65 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 37.3 t -142.19 123.86 15.06 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.418 -0.586 . . . . 75.239999999999995 109.418 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.9 p -123.7 148.64 27.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.535 -0.913 . . . . 73.329999999999998 108.535 177.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.522 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 37.4 tt0 -89.21 -72.79 0.53 Allowed 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 119.576 -0.85 . . . . 73.430000000000007 110.529 175.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 25.1 m -127.81 133.97 49.44 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.917 -1.114 . . . . 73.329999999999998 112.471 -176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.82 135.27 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.793 -1.188 . . . . 72.530000000000001 107.793 173.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 5.3 p -127.48 125.43 65.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 121.024 0.44 . . . . 74.209999999999994 110.677 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . 0.447 ' HA2' ' HG1' ' C' ' 233' ' ' THR . . . -114.57 132.52 10.5 Favored Glycine 0 CA--C 1.476 -2.406 0 N-CA-C 111.137 -0.785 . . . . 60.43 111.137 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.437 ' HB3' ' HG2' ' C' ' 234' ' ' GLU . 40.6 tptt -134.12 115.83 14.7 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 109.987 -0.375 . . . . 75.420000000000002 109.987 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.97 99.74 0.06 OUTLIER Glycine 0 CA--C 1.527 0.782 0 N-CA-C 114.159 0.424 . . . . 64.340000000000003 114.159 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 63.91 26.83 14.33 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.161 0.984 . . . . 74.540000000000006 112.421 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 273' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 37.4 m -83.41 144.79 29.38 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.444 -0.902 . . . . 71.549999999999997 113.066 -171.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 4.8 mtt-85 -135.55 127.23 29.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.001 -1.111 . . . . 75.239999999999995 108.001 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 55.6 t -136.49 138.44 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.594 0 N-CA-C 109.165 -0.68 . . . . 75.010000000000005 109.165 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 6.1 tt -123.44 120.88 34.25 Favored 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 119.095 -1.042 . . . . 72.340000000000003 108.434 169.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' B' ' 241' ' ' LEU . 1.5 pt -112.43 104.28 16.79 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 C-N-CA 123.991 0.916 . . . . 74.310000000000002 109.502 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.496 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 145.45 -133.63 5.14 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.804 -0.635 . . . . 64.319999999999993 111.699 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' B' ' 243' ' ' ASN . 12.5 m120 -127.28 152.29 47.63 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-O 121.218 0.532 . . . . 70.5 109.978 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -137.68 150.01 47.0 Favored 'General case' 0 N--CA 1.409 -2.52 0 N-CA-C 107.962 -1.125 . . . . 72.140000000000001 107.962 170.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . 0.441 ' HB3' ' HA ' ' B' ' 245' ' ' VAL . 11.2 t80 -125.51 124.34 41.12 Favored 'General case' 0 N--CA 1.395 -3.175 0 N-CA-C 107.623 -1.251 . . . . 64.409999999999997 107.623 -174.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' B' ' 249' ' ' ALA . . . 143.6 -48.03 0.77 Allowed Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.653 -0.784 . . . . 75.209999999999994 111.747 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 111.59 -23.72 17.03 Favored Glycine 0 C--O 1.206 -1.62 0 N-CA-C 108.578 -1.809 . . . . 60.409999999999997 108.578 -175.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . 0.539 ' HE2' ' CD2' ' C' ' 290' ' ' HIS . 62.4 mttm -141.92 81.88 1.78 Allowed 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 106.886 -1.524 . . . . 75.409999999999997 106.886 173.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -103.88 -159.93 24.61 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.492 -1.443 . . . . 74.540000000000006 109.492 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.445 ' H ' HG11 ' B' ' 244' ' ' VAL . 71.3 t80 63.3 -175.04 0.15 Allowed 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 122.912 0.485 . . . . 73.0 110.54 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -96.5 -16.77 20.95 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.528 -1.357 . . . . 74.200000000000003 112.292 -174.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.34 6.89 47.79 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.379 0.609 . . . . 72.439999999999998 112.227 -172.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -70.89 -4.32 23.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.933 . . . . 71.519999999999996 112.014 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -102.53 5.79 39.57 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.325 1.06 . . . . 64.239999999999995 108.709 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . 0.547 ' CD2' ' H ' ' A' ' 294' ' ' HIS . 17.9 t-160 -124.37 26.61 7.29 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 122.221 1.01 . . . . 74.439999999999998 109.333 -176.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -75.98 164.78 25.83 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-N 114.99 -1.004 . . . . 74.230000000000004 110.458 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -111.72 -39.02 4.7 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 111.926 0.343 . . . . 72.329999999999998 111.926 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -89.47 127.55 35.86 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.123 -1.066 . . . . 74.209999999999994 108.123 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 . . . . . 0 C--N 1.288 -2.101 0 N-CA-C 108.149 -1.056 . . . . 74.409999999999997 108.149 178.108 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.245 0 N-CA-C 109.779 -0.452 . . . . 72.310000000000002 109.779 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.67 128.96 34.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.908 0.385 . . . . 73.430000000000007 110.936 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . 0.46 ' O ' HG13 ' B' ' 219' ' ' ILE . 21.7 pt -141.29 -174.01 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 106.405 -1.702 . . . . 72.140000000000001 106.405 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -119.62 -170.96 2.04 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.812 -1.181 . . . . 64.319999999999993 107.812 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.93 -20.03 31.29 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.524 -0.917 . . . . 74.129999999999995 108.524 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 56.8 mt -107.21 126.75 63.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 105.811 -1.922 . . . . 71.109999999999999 105.811 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.89 120.62 52.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 113.559 0.948 . . . . 73.099999999999994 113.559 -174.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' B' ' 260' ' ' THR . . . -104.34 82.75 0.37 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 107.356 -2.298 . . . . 65.230000000000004 107.356 173.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -118.47 133.45 55.86 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 113.707 1.003 . . . . 75.329999999999998 113.707 -169.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -117.24 120.58 38.68 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.03 -1.441 . . . . 74.239999999999995 108.706 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 227' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' C' ' 263' ' ' SER . 42.7 m -121.17 137.08 54.84 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.706 -0.479 . . . . 74.200000000000003 109.706 177.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -133.3 144.38 49.66 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.458 -0.942 . . . . 72.420000000000002 108.458 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -58.78 1.82 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.544 -0.862 . . . . 74.120000000000005 110.883 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' C' ' 266' ' ' THR . 1.2 m-20 -127.23 139.47 52.9 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.295 0.569 . . . . 75.150000000000006 110.734 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 32.6 mm -128.87 118.05 46.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 106.454 -1.684 . . . . 74.099999999999994 106.454 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -118.91 115.1 23.67 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.841 -0.429 . . . . 72.150000000000006 109.841 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 233' ' ' THR . . . . . 0.447 ' HG1' ' HA2' ' B' ' 269' ' ' GLY . 80.5 p -112.19 127.4 55.93 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 108.326 -0.99 . . . . 73.230000000000004 108.326 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' B' ' 270' ' ' LYS . 43.8 mt-10 -138.9 139.34 38.02 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 121.119 -0.232 . . . . 71.510000000000005 110.41 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . 0.552 ' HB3' ' NH1' ' C' ' 236' ' ' ARG . 49.2 mt-10 56.76 95.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 115.539 1.681 . . . . 73.340000000000003 115.539 174.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.552 ' NH1' ' HB3' ' C' ' 235' ' ' GLU . 0.5 OUTLIER 61.06 24.14 14.26 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.164 0.986 . . . . 70.25 111.712 175.08 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -91.8 139.57 30.54 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.958 0.885 . . . . 75.5 112.774 -175.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 8.8 mpt_? -125.65 135.45 52.16 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.17 -1.377 . . . . 72.109999999999999 108.309 177.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 30.5 m -138.13 147.34 25.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.313 0.578 . . . . 71.019999999999996 110.66 172.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -121.1 129.53 53.35 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.089 -1.819 . . . . 75.349999999999994 106.089 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' C' ' 277' ' ' ILE . 2.8 tm? -122.0 118.58 29.16 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 106.162 -1.792 . . . . 74.200000000000003 106.162 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 135.54 -127.77 4.42 Favored Glycine 0 N--CA 1.416 -2.7 0 C-N-CA 120.179 -1.01 . . . . 53.240000000000002 111.421 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 45.9 t30 -144.34 130.36 19.47 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.525 0.202 . . . . 74.230000000000004 110.783 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 85.2 t -110.92 117.88 56.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 123.713 0.805 . . . . 73.310000000000002 109.258 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 18.3 m -107.82 119.26 57.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 120.147 -0.621 . . . . 74.239999999999995 110.479 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 29.7 m -84.6 158.66 20.82 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 120.943 -0.303 . . . . 73.319999999999993 111.223 -176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.15 -47.83 78.4 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 122.159 0.98 . . . . 71.040000000000006 110.871 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.38 -35.98 65.87 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.265 -1.789 . . . . 72.109999999999999 112.807 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . 0.427 ' HB1' ' HA2' ' C' ' 282' ' ' GLY . . . -74.11 -29.91 62.07 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.166 -0.47 . . . . 64.450000000000003 111.967 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.22 98.24 7.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 122.272 1.034 . . . . 63.43 110.912 -174.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -98.32 -50.62 4.26 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.018 -1.447 . . . . 73.120000000000005 107.655 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -175.58 45.24 0.12 Allowed Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.689 -0.767 . . . . 55.210000000000001 112.778 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 164.19 136.33 1.98 Allowed Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.058 -1.068 . . . . 75.439999999999998 112.482 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 46.0 mm -106.87 89.2 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.896 -1.15 . . . . 75.430000000000007 107.896 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . 0.5 ' HD2' ' OD2' ' B' ' 258' ' ' ASP . 86.0 mtt180 58.77 -168.08 0.14 Allowed 'General case' 0 C--O 1.239 0.544 0 O-C-N 124.2 0.938 . . . . 75.409999999999997 113.259 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 12.8 tt -151.91 -38.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.994 -1.003 . . . . 73.239999999999995 109.5 174.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 26.9 t -162.48 121.37 2.23 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 109.888 -0.412 . . . . 73.219999999999999 109.888 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -125.95 138.3 53.76 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.032 -1.099 . . . . 74.129999999999995 108.032 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -130.93 36.19 3.89 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.352 1.072 . . . . 72.340000000000003 109.975 -175.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 10.3 m -82.88 138.49 33.88 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.614 -0.721 . . . . 71.129999999999995 109.704 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 38.4 m -126.86 111.55 14.29 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.651 -0.656 . . . . 73.239999999999995 110.048 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -123.71 136.02 54.21 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 120.989 0.423 . . . . 71.230000000000004 109.862 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 263' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' C' ' 227' ' ' SER . 33.2 m -142.83 130.41 21.3 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.133 -0.692 . . . . 73.329999999999998 109.133 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.38 153.42 34.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.507 -0.553 . . . . 62.450000000000003 109.507 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -85.35 -74.76 0.39 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.477 -0.564 . . . . 75.430000000000007 109.477 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 266' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 60.4 m -138.41 134.11 33.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.687 -0.633 . . . . 72.349999999999994 110.693 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.54 136.04 57.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 108.374 -0.973 . . . . 73.349999999999994 108.374 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.18 137.16 58.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 116.514 -0.312 . . . . 71.319999999999993 110.308 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.48 133.02 7.51 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 110.933 -0.867 . . . . 71.219999999999999 110.933 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -133.91 115.03 13.95 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.847 -0.797 . . . . 73.129999999999995 108.847 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 74.47 108.75 0.08 OUTLIER Glycine 0 CA--C 1.527 0.834 0 O-C-N 123.843 0.714 . . . . 74.019999999999996 114.42 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 58.64 20.32 7.61 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 123.716 0.807 . . . . 72.519999999999996 112.282 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 273' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 24.4 m -83.76 144.2 29.48 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-O 121.233 0.539 . . . . 72.310000000000002 110.504 -173.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 0.0 OUTLIER -150.32 128.34 11.87 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.907 -0.588 . . . . 73.230000000000004 109.677 174.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 10.1 t -136.75 140.93 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 O-C-N 123.78 0.675 . . . . 71.129999999999995 109.232 -173.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.9 tt -112.03 116.67 30.93 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 107.939 -1.134 . . . . 73.430000000000007 107.939 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 3.2 mp -101.27 104.45 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 106.555 -1.646 . . . . 71.030000000000001 106.555 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . 0.428 ' C ' HD21 ' C' ' 279' ' ' ASN . . . 138.13 -128.48 4.22 Favored Glycine 0 N--CA 1.409 -3.152 0 C-N-CA 119.446 -1.359 . . . . 32.039999999999999 112.092 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 1.0 OUTLIER -128.04 138.96 52.77 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.057 0.456 . . . . 73.420000000000002 111.822 -173.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -126.62 145.79 50.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.325 -1.361 . . . . 72.230000000000004 107.325 168.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -125.85 123.35 38.49 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 108.305 -0.998 . . . . 75.120000000000005 108.305 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . 0.427 ' HA2' ' HB1' ' C' ' 249' ' ' ALA . . . 134.03 9.77 1.87 Allowed Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.59 -0.732 . . . . 72.230000000000004 113.989 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 80.99 -47.93 3.66 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-N 117.92 0.86 . . . . 55.43 111.771 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . 0.507 ' HD3' ' OD1' ' C' ' 289' ' ' ASN . 96.0 mttt -136.65 96.61 3.37 Favored 'General case' 0 N--CA 1.413 -2.302 0 N-CA-C 107.473 -1.306 . . . . 73.409999999999997 107.473 174.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -110.06 -159.74 17.73 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 108.666 -1.773 . . . . 74.129999999999995 108.666 173.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 60.6 t80 73.87 169.97 0.3 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.803 0.841 . . . . 75.310000000000002 110.993 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -71.01 -27.54 63.77 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 116.81 2.152 . . . . 74.319999999999993 116.81 -167.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -78.11 -78.53 0.14 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 119.824 -0.75 . . . . 74.209999999999994 112.277 -171.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . 0.507 ' OD1' ' HD3' ' C' ' 284' ' ' LYS . 17.3 t-20 -120.13 130.87 54.82 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.361 -0.607 . . . . 74.450000000000003 109.361 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . 0.539 ' CD2' ' HE2' ' B' ' 284' ' ' LYS . 0.3 OUTLIER -133.57 -171.0 2.6 Favored 'General case' 0 C--O 1.25 1.1 0 C-N-CA 120.798 -0.361 . . . . 73.219999999999999 110.782 -174.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 80.32 105.26 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.006 1.323 . . . . 71.030000000000001 112.567 175.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -170.05 172.9 6.22 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 105.665 -1.976 . . . . 75.140000000000001 105.665 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -123.36 98.87 6.05 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.531 -0.914 . . . . 75.230000000000004 108.531 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -177.61 -179.96 0.86 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 104.402 -2.444 . . . . 73.129999999999995 104.402 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 56.4 m170 . . . . . 0 C--N 1.304 -1.403 0 N-CA-C 108.335 -0.987 . . . . 72.150000000000006 108.335 174.473 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.552 ' HB3' ' HB2' ' B' ' 258' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.49 0 N-CA-C 109.617 -0.512 . . . . 73.209999999999994 109.617 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -138.49 148.68 44.59 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.362 -2.088 . . . . 75.340000000000003 105.362 171.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.5 pt -92.77 147.94 5.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.424 -0.511 . . . . 74.450000000000003 111.827 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . 0.516 ' CG ' ' H ' ' A' ' 221' ' ' ALA . 10.5 t70 64.31 -169.64 0.2 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.546 1.538 . . . . 74.349999999999994 111.812 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.516 ' H ' ' CG ' ' A' ' 220' ' ' ASP . . . 70.79 163.14 0.25 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 125.805 1.642 . . . . 74.310000000000002 108.549 -170.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 3.1 mp -83.9 112.32 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 116.495 -2.082 . . . . 74.129999999999995 107.523 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 24.2 m -140.11 165.54 21.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 107.743 -1.206 . . . . 71.219999999999999 107.743 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 96.06 34.78 5.78 Favored Glycine 0 C--N 1.289 -2.028 0 C-N-CA 119.16 -1.495 . . . . 70.549999999999997 112.225 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 154.52 44.92 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.43 -0.952 . . . . 75.319999999999993 108.43 175.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -86.34 133.89 33.77 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.479 -1.304 . . . . 73.340000000000003 107.479 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 32.9 m -133.63 141.79 47.79 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.318 0.58 . . . . 75.299999999999997 112.386 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.34 137.88 37.79 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.003 -1.851 . . . . 74.099999999999994 106.003 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.41 -48.04 10.06 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.684 -0.858 . . . . 74.040000000000006 108.684 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -140.15 140.64 36.0 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 119.76 -0.776 . . . . 71.019999999999996 111.646 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 62.6 mt -126.49 117.17 47.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 106.806 -1.553 . . . . 73.519999999999996 106.806 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -118.92 115.96 25.47 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.619 -0.833 . . . . 73.409999999999997 110.127 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.1 t -113.11 128.69 56.56 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.602 -0.726 . . . . 65.519999999999996 109.276 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.4 ' HG2' ' HG3' ' A' ' 235' ' ' GLU . 40.3 tt0 -150.23 139.81 21.58 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 108.435 -0.95 . . . . 73.540000000000006 108.435 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.4 ' HG3' ' HG2' ' A' ' 234' ' ' GLU . 43.9 mt-10 65.6 89.14 0.1 Allowed 'General case' 0 C--O 1.22 -0.48 0 O-C-N 124.409 1.068 . . . . 73.409999999999997 113.075 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 271' ' ' GLY . 36.2 mtt85 66.33 -4.82 0.65 Allowed 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 124.448 1.099 . . . . 74.200000000000003 113.136 171.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -70.61 143.44 51.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 123.352 0.661 . . . . 75.019999999999996 111.2 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -126.37 135.81 51.92 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.979 -1.119 . . . . 73.510000000000005 107.979 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 34.7 m -128.73 150.82 34.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 120.844 0.354 . . . . 74.439999999999998 111.666 -175.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -134.05 134.55 42.5 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.137 -0.938 . . . . 75.129999999999995 108.831 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -128.14 119.28 24.97 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.583 -1.266 . . . . 74.310000000000002 107.583 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.491 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 132.35 -115.67 1.67 Allowed Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 119.991 -1.1 . . . . 74.120000000000005 112.689 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -143.51 135.86 27.05 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.301 -0.629 . . . . 70.019999999999996 109.301 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 99.0 t -116.94 120.63 65.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.46 -1.311 . . . . 74.340000000000003 107.46 175.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.73 117.19 51.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 108.996 -0.742 . . . . 73.099999999999994 108.996 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 90.5 m -77.48 159.72 29.17 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.064 -0.717 . . . . 75.019999999999996 109.064 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.38 -38.83 91.1 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.538 0.735 . . . . 64.310000000000002 112.122 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.13 -33.74 72.57 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.861 0.864 . . . . 72.120000000000005 111.551 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.56 -26.86 64.69 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.642 -0.708 . . . . 74.0 112.223 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.09 122.73 18.42 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.869 -0.419 . . . . 74.209999999999994 109.869 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 6.4 t60 69.98 86.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.828 1.251 . . . . 72.420000000000002 108.275 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -162.33 103.13 0.21 Allowed Glycine 0 N--CA 1.42 -2.376 0 N-CA-C 108.779 -1.729 . . . . 75.140000000000001 108.779 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 84.75 172.37 49.05 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.503 -0.856 . . . . 72.439999999999998 111.644 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 13.8 tt -109.57 -20.75 6.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.065 0.459 . . . . 74.540000000000006 111.29 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -129.63 147.58 51.43 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.024 0.75 . . . . 74.5 113.024 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 8.0 tt -108.07 91.3 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 107.144 -1.428 . . . . 64.140000000000001 107.144 172.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 16.1 m -80.48 -44.75 18.66 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.705 -1.134 . . . . 71.209999999999994 113.824 -172.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -86.04 127.19 34.61 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.873 -0.731 . . . . 62.420000000000002 111.486 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -135.31 66.57 1.52 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.831 -1.174 . . . . 73.140000000000001 107.831 174.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.68 138.42 58.38 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 114.367 1.247 . . . . 72.310000000000002 114.367 -177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.1 m -101.75 115.68 31.07 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 106.701 -1.592 . . . . 75.140000000000001 106.701 172.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -121.15 141.43 50.83 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.213 -1.032 . . . . 73.329999999999998 108.213 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.7 p -136.23 123.4 21.71 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.056 -0.52 . . . . 74.430000000000007 111.588 -172.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 13.4 p -129.0 148.28 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 108.917 -0.772 . . . . 72.439999999999998 108.917 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 34.5 tt0 -85.89 -69.16 0.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.686 -0.487 . . . . 74.230000000000004 109.686 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 28.6 m -126.09 128.06 46.77 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.315 -0.554 . . . . 72.400000000000006 111.404 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 36.0 m -119.77 125.67 74.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.049 0 N-CA-C 109.101 -0.704 . . . . 72.439999999999998 109.101 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.14 134.9 64.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 116.078 -0.51 . . . . 73.230000000000004 112.063 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -123.96 132.27 8.31 Favored Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 111.298 -0.721 . . . . 74.420000000000002 111.298 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 26.3 mmmt -133.76 147.6 51.31 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.117 0.967 . . . . 73.120000000000005 112.175 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' A' ' 236' ' ' ARG . . . 84.53 -57.82 5.01 Favored Glycine 0 CA--C 1.502 -0.732 0 CA-C-N 115.981 -0.554 . . . . 75.530000000000001 112.453 174.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.481 ' HG3' ' CE1' ' A' ' 292' ' ' HIS . 0.7 OUTLIER 179.6 121.3 0.06 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 103.468 -2.79 . . . . 63.509999999999998 103.468 176.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 68.6 m -151.28 155.88 39.67 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.902 0.382 . . . . 52.210000000000001 110.685 -175.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' B' ' 238' ' ' ARG . 2.2 mpt_? -127.75 127.92 44.45 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.206 -1.776 . . . . 75.319999999999993 106.206 174.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 33.5 t -129.1 129.79 67.92 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 109.583 -0.525 . . . . 74.530000000000001 109.583 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.492 ' HB3' ' OE1' ' B' ' 240' ' ' GLN . 4.8 tt -125.32 118.94 27.04 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.197 -1.038 . . . . 72.140000000000001 108.197 172.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 43.5 mm -107.99 104.86 17.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.957 -1.127 . . . . 72.540000000000006 107.957 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 144.77 -140.04 8.91 Favored Glycine 0 N--CA 1.419 -2.464 0 C-N-CA 120.66 -0.781 . . . . 74.400000000000006 111.794 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -115.18 140.36 49.14 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 109.72 -0.474 . . . . 73.230000000000004 109.72 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.43 129.52 53.93 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.193 -2.151 . . . . 72.200000000000003 105.193 174.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 2.0 t80 -127.49 122.81 34.4 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 107.228 -1.397 . . . . 72.319999999999993 107.228 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.72 -52.95 0.63 Allowed Glycine 0 N--CA 1.412 -2.93 0 N-CA-C 108.624 -1.79 . . . . 61.25 108.624 -175.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 139.02 -57.84 0.62 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 111.17 -0.772 . . . . 74.040000000000006 111.17 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.541 ' HA ' ' NE1' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -132.18 35.2 3.72 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.948 0.88 . . . . 74.040000000000006 110.617 -176.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -57.29 -31.26 62.29 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 116.002 1.161 . . . . 70.019999999999996 116.002 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.443 ' CB ' HD13 ' A' ' 276' ' ' LEU . 71.0 t80 -114.72 0.22 13.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.908 0.861 . . . . 72.530000000000001 110.535 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . 0.541 ' NE1' ' HA ' ' A' ' 284' ' ' LYS . 10.5 p90 -137.66 87.41 2.26 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.888 0.852 . . . . 73.340000000000003 111.291 -177.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -86.86 -45.57 10.74 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.415 -0.811 . . . . 75.109999999999999 109.698 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -156.62 165.15 37.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.591 -0.731 . . . . 75.150000000000006 111.474 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -103.68 74.55 1.25 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.861 0.839 . . . . 71.129999999999995 110.9 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -68.57 80.41 0.27 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.667 -1.151 . . . . 72.340000000000003 110.175 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . 0.481 ' CE1' ' HG3' ' A' ' 272' ' ' GLU . 3.6 m170 169.51 84.92 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 127.961 2.504 . . . . 74.200000000000003 109.91 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -94.75 -22.09 18.31 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.98 -1.119 . . . . 73.549999999999997 107.98 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 64.78 22.11 12.49 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.366 1.466 . . . . 74.25 112.155 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 16.7 t60 . . . . . 0 C--N 1.313 -0.979 0 N-CA-C 107.353 -1.351 . . . . 73.340000000000003 107.353 176.271 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 110.093 -0.336 . . . . 71.409999999999997 110.093 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -72.93 104.54 4.1 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.294 0.638 . . . . 73.510000000000005 110.978 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . 0.45 ' H ' HD11 ' B' ' 219' ' ' ILE . 0.2 OUTLIER -89.16 -17.16 8.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.295 -0.412 . . . . 74.049999999999997 110.593 176.597 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 2.2 t0 75.28 -173.99 0.12 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.719 1.608 . . . . 60.009999999999998 110.832 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -114.89 19.9 15.52 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.765 0.654 . . . . 72.140000000000001 112.765 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 2.1 mp -84.06 125.14 40.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 109.195 -0.669 . . . . 74.010000000000005 109.195 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 27.7 m -100.03 163.82 2.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.306 -0.406 . . . . 72.150000000000006 110.277 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 98.47 43.43 2.73 Favored Glycine 0 CA--C 1.49 -1.524 0 N-CA-C 110.253 -1.139 . . . . 63.210000000000001 110.253 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -142.13 154.23 44.72 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 121.019 0.438 . . . . 74.150000000000006 110.077 -175.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -94.03 129.86 40.39 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 103.865 -2.643 . . . . 63.119999999999997 103.865 167.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 23.9 m -131.69 137.08 48.14 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.104 -1.038 . . . . 72.530000000000001 111.63 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -132.2 135.82 46.6 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.611 -1.255 . . . . 74.450000000000003 107.611 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 0.1 OUTLIER -82.77 -61.47 1.86 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.747 -0.835 . . . . 72.329999999999998 108.747 -178.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -134.24 139.46 45.78 Favored 'General case' 0 C--O 1.254 1.318 0 C-N-CA 120.036 -0.666 . . . . 75.540000000000006 109.409 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 10.9 mt -128.43 116.77 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.199 -1.408 . . . . 75.340000000000003 107.199 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -113.3 118.83 35.71 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.216 -0.447 . . . . 75.519999999999996 110.286 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' THR . . . . . 0.463 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 0.0 OUTLIER -110.82 128.65 55.85 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 108.713 -0.847 . . . . 75.219999999999999 108.713 175.025 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 33.9 tt0 -147.46 138.88 23.84 Favored 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 108.543 -0.91 . . . . 74.030000000000001 108.543 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.539 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 52.5 mt-10 65.09 94.85 0.06 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 124.675 1.235 . . . . 60.549999999999997 113.273 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.539 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 58.6 15.78 3.88 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 125.459 1.503 . . . . 70.540000000000006 112.711 171.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -92.33 149.05 21.66 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 121.526 0.679 . . . . 74.400000000000006 111.911 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.443 ' CZ ' ' HG3' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -129.45 135.75 49.05 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 115.612 -0.722 . . . . 72.549999999999997 110.183 175.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.461 HG12 ' HB ' ' B' ' 275' ' ' VAL . 30.4 m -125.87 136.8 59.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 124.089 0.868 . . . . 74.230000000000004 109.987 -177.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.492 ' OE1' ' HB3' ' A' ' 276' ' ' LEU . 38.8 tp60 -115.92 132.94 56.5 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.866 -1.061 . . . . 74.150000000000006 108.693 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.28 118.36 24.94 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.348 -1.353 . . . . 75.0 107.348 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 134.04 -114.12 1.28 Allowed Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 120.044 -1.074 . . . . 72.349999999999994 111.924 177.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -144.31 140.32 29.08 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.796 -0.446 . . . . 75.400000000000006 109.796 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.487 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 97.7 t -122.11 114.87 44.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.239 -1.393 . . . . 72.010000000000005 107.239 175.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . 0.442 ' CG2' ' HB2' ' B' ' 250' ' ' LEU . 4.2 p -122.13 118.5 55.66 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-O 121.21 0.529 . . . . 74.230000000000004 109.803 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 28.7 m -71.09 158.85 35.76 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 109.05 -0.722 . . . . 72.140000000000001 109.05 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.98 -47.41 80.47 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.038 0.923 . . . . 71.319999999999993 111.291 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.77 79.17 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.896 -1.502 . . . . 64.200000000000003 111.847 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.494 ' HA ' ' CB ' ' C' ' 247' ' ' ALA . . . -67.88 -40.31 83.55 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.506 0.928 . . . . 72.25 113.506 -173.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . 0.442 ' HB2' ' CG2' ' B' ' 245' ' ' VAL . 26.6 tp -83.7 75.4 10.07 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.043 -0.663 . . . . 71.340000000000003 111.93 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -84.8 -54.5 4.64 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.42 -0.809 . . . . 74.510000000000005 110.373 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 176.47 -160.1 27.46 Favored Glycine 0 N--CA 1.417 -2.627 0 C-N-CA 120.314 -0.946 . . . . 64.219999999999999 111.788 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 138.94 -147.21 19.06 Favored Glycine 0 N--CA 1.423 -2.193 0 N-CA-C 109.358 -1.497 . . . . 64.209999999999994 109.358 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 49.9 mm -117.27 136.02 55.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.627 -1.249 . . . . 75.439999999999998 107.627 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -60.62 125.21 22.83 Favored 'General case' 0 C--O 1.245 0.854 0 O-C-N 123.527 0.517 . . . . 72.319999999999993 109.683 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.5 pp -111.39 154.24 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.006 0 CA-C-O 121.045 0.45 . . . . 74.239999999999995 110.549 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 13.0 m -128.44 13.96 6.57 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.404 -1.332 . . . . 75.510000000000005 107.404 174.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.552 ' HB2' ' HB3' ' A' ' 217' ' ' MET . 15.6 t70 -173.27 130.78 0.47 Allowed 'General case' 0 CA--C 1.493 -1.225 0 CA-C-N 114.081 -1.418 . . . . 73.400000000000006 108.14 -175.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . 0.289 1.1 pt20 -144.03 -97.44 0.11 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 123.624 0.578 . . . . 61.409999999999997 111.193 173.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' THR . . . . . 0.402 ' HA ' ' OD2' ' C' ' 258' ' ' ASP . 16.2 p -94.3 131.84 39.5 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 118.757 0.708 . . . . 71.200000000000003 111.379 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 53.9 m -106.11 108.16 19.53 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 107.459 -1.312 . . . . 64.409999999999997 107.459 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -124.65 131.83 53.45 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.641 -1.244 . . . . 64.409999999999997 107.641 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 15.7 m -121.54 123.79 42.85 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.835 -0.62 . . . . 72.049999999999997 110.521 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 8.4 p -126.29 149.86 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 108.024 -1.102 . . . . 75.200000000000003 108.024 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 12.8 tt0 -93.95 -77.94 0.44 Allowed 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.97 -0.752 . . . . 75.420000000000002 108.97 175.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 28.8 m -113.26 127.54 56.19 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 120.25 -0.58 . . . . 72.219999999999999 110.854 -175.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.83 120.68 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-O 121.695 0.759 . . . . 72.409999999999997 109.512 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.92 141.55 45.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.623 -0.717 . . . . 72.120000000000005 112.199 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.72 132.41 7.92 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.982 -0.847 . . . . 61.420000000000002 110.982 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 25.4 mmmt -133.87 148.83 51.3 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 124.205 1.002 . . . . 74.209999999999994 112.541 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . 0.455 ' O ' ' HD3' ' B' ' 236' ' ' ARG . . . 85.57 -57.99 4.88 Favored Glycine 0 CA--C 1.499 -0.945 0 C-N-CA 121.362 -0.447 . . . . 71.349999999999994 112.954 174.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 176.24 114.17 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 103.279 -2.86 . . . . 75.219999999999999 103.279 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 273' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 67.1 m -146.79 160.22 42.53 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.734 0.778 . . . . 72.540000000000006 112.448 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.478 ' HD3' ' HB3' ' C' ' 238' ' ' ARG . 0.7 OUTLIER -129.48 127.58 41.14 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 105.799 -1.926 . . . . 71.340000000000003 105.799 176.354 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.461 ' HB ' HG12 ' B' ' 239' ' ' VAL . 41.5 t -132.02 126.31 56.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.658 -0.497 . . . . 74.530000000000001 109.658 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . 0.481 ' HB3' ' OE1' ' C' ' 240' ' ' GLN . 4.7 tt -121.78 118.7 29.69 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.752 -1.179 . . . . 74.310000000000002 108.029 173.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 44.6 mm -108.18 104.23 16.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 106.952 -1.499 . . . . 75.319999999999993 106.952 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 146.36 -158.02 27.57 Favored Glycine 0 CA--C 1.476 -2.39 0 C-N-CA 120.358 -0.925 . . . . 61.130000000000003 113.204 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -96.38 138.86 33.35 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.293 -0.632 . . . . 73.030000000000001 109.293 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -121.32 126.8 50.37 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 105.801 -1.925 . . . . 74.420000000000002 105.801 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . 0.537 ' CD1' HG13 ' C' ' 245' ' ' VAL . 1.3 t80 -123.63 123.56 40.83 Favored 'General case' 0 N--CA 1.405 -2.716 0 N-CA-C 107.304 -1.369 . . . . 74.140000000000001 107.304 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.59 -43.98 1.01 Allowed Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 108.809 -1.716 . . . . 72.129999999999995 108.809 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.24 -29.0 8.26 Favored Glycine 0 N--CA 1.423 -2.215 0 N-CA-C 111.678 -0.569 . . . . 61.100000000000001 111.678 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . 0.543 ' HA ' ' CD1' ' B' ' 287' ' ' TRP . 42.6 pttt -149.04 19.84 0.98 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.679 -0.409 . . . . 73.299999999999997 111.974 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -53.97 -43.49 71.96 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.117 -0.563 . . . . 75.319999999999993 114.226 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.479 ' CB ' HD12 ' B' ' 276' ' ' LEU . 62.1 t80 -97.69 -1.09 44.31 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.685 0.755 . . . . 73.450000000000003 111.202 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.543 ' CD1' ' HA ' ' B' ' 284' ' ' LYS . 13.6 p90 -145.74 95.09 2.59 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.329 0.585 . . . . 75.430000000000007 110.926 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . 0.466 ' OD2' ' HA ' ' B' ' 291' ' ' HIS . 37.4 t70 -77.51 81.95 3.95 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 122.004 0.907 . . . . 74.329999999999998 110.096 -177.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -80.14 -53.59 6.54 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.464 -1.244 . . . . 72.329999999999998 108.773 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -82.18 101.64 10.59 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 103.409 -2.811 . . . . 74.299999999999997 103.409 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . 0.466 ' HA ' ' OD2' ' B' ' 288' ' ' ASP . 51.9 t-80 -53.29 127.26 23.96 Favored 'General case' 0 C--O 1.248 0.982 0 O-C-N 124.154 0.909 . . . . 75.340000000000003 112.278 -169.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -60.45 152.58 25.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.197 -0.91 . . . . 73.540000000000006 111.47 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -94.65 -86.38 0.28 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.637 -1.616 . . . . 71.430000000000007 106.637 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -146.1 -177.6 5.69 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 105.965 -1.865 . . . . 74.310000000000002 105.965 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 . . . . . 0 C--N 1.294 -1.841 0 C-N-CA 120.538 -0.465 . . . . 72.420000000000002 109.822 178.44 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 217' ' ' MET . . . . . 0.421 ' SD ' ' N ' ' C' ' 218' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 105.715 -1.957 . . . . 73.430000000000007 105.715 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . 0.421 ' N ' ' SD ' ' C' ' 217' ' ' MET . 7.1 tmtm? -78.7 -40.99 32.23 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.924 -1.51 . . . . 75.510000000000005 106.924 177.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 15.8 tt -144.8 136.34 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 108.927 -0.768 . . . . 63.520000000000003 108.927 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -150.31 141.2 22.85 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 122.846 0.458 . . . . 70.540000000000006 110.438 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 60.79 88.47 0.08 Allowed 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.602 1.161 . . . . 63.0 112.858 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . 0.55 ' HB ' ' NH2' ' C' ' 225' ' ' ARG . 3.5 mp -106.67 114.49 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 107.563 -1.273 . . . . 74.540000000000006 107.563 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.92 165.34 9.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.102 -0.954 . . . . 74.230000000000004 109.938 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.13 51.84 4.03 Favored Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 109.674 -1.37 . . . . 64.120000000000005 109.674 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . 0.55 ' NH2' ' HB ' ' C' ' 222' ' ' ILE . 8.5 ptp180 -143.3 154.44 43.78 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.955 -1.128 . . . . 73.400000000000006 107.955 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -93.29 133.2 36.76 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.569 -1.271 . . . . 73.310000000000002 107.569 172.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 48.8 m -140.67 141.8 34.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.549 0.944 . . . . 65.349999999999994 113.549 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -137.37 133.03 34.38 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.222 -1.029 . . . . 75.209999999999994 108.222 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -76.67 -57.98 3.54 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.24 -0.652 . . . . 70.120000000000005 109.24 -178.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.14 140.0 41.56 Favored 'General case' 0 C--O 1.265 1.881 0 C-N-CA 120.041 -0.663 . . . . 74.400000000000006 110.84 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.22 116.97 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 107.898 -1.149 . . . . 72.200000000000003 107.898 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 38.1 ttt180 -118.02 118.1 31.02 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.263 0.554 . . . . 75.319999999999993 110.625 177.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 233' ' ' THR . . . . . 0.459 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 0.0 OUTLIER -110.53 129.88 55.69 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 108.707 -0.849 . . . . 65.219999999999999 108.707 175.389 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . 0.508 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 33.6 tt0 -144.13 138.56 28.28 Favored 'General case' 0 N--CA 1.415 -2.204 0 C-N-CA 120.317 -0.553 . . . . 73.340000000000003 109.515 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . 0.559 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 51.0 mt-10 59.72 97.76 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.617 1.167 . . . . 74.120000000000005 114.018 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.559 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 0.2 OUTLIER 61.87 13.59 5.63 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.426 1.49 . . . . 73.340000000000003 112.333 172.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . 0.4 ' HB3' ' OG1' ' C' ' 233' ' ' THR . . . -94.38 151.46 19.38 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.443 0.64 . . . . 74.219999999999999 111.964 -174.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.478 ' HB3' ' HD3' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -132.91 135.47 45.58 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-N 115.44 -0.8 . . . . 73.319999999999993 110.823 178.191 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.422 HG12 ' HB ' ' C' ' 275' ' ' VAL . 33.1 m -127.85 138.32 55.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.228 -0.897 . . . . 73.329999999999998 110.234 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . 0.481 ' OE1' ' HB3' ' B' ' 276' ' ' LEU . 38.4 tp60 -116.19 133.35 56.12 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.799 -1.091 . . . . 71.319999999999993 108.873 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.27 118.41 24.17 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.802 -1.555 . . . . 74.129999999999995 106.802 175.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.458 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 133.68 -117.94 1.98 Allowed Glycine 0 N--CA 1.422 -2.269 0 C-N-CA 119.918 -1.134 . . . . 75.319999999999993 111.007 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -144.67 140.01 28.36 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 123.582 0.224 . . . . 70.530000000000001 111.066 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . 0.472 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 86.2 t -121.58 116.19 48.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 108.408 -0.96 . . . . 64.329999999999998 108.408 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . 0.537 HG13 ' CD1' ' B' ' 281' ' ' TYR . 2.7 p -122.62 123.48 68.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 109.46 -0.571 . . . . 74.109999999999999 109.46 176.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 24.9 m -77.84 159.29 29.06 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 109.561 -0.533 . . . . 74.099999999999994 109.561 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . 0.494 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.96 -46.53 81.18 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.308 1.052 . . . . 65.409999999999997 110.739 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.81 67.85 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.215 -1.811 . . . . 75.400000000000006 112.245 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . 0.418 ' HB1' ' HA2' ' C' ' 282' ' ' GLY . . . -69.14 -26.6 64.96 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 113.085 0.772 . . . . 73.409999999999997 113.085 -176.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 9.5 mp 69.82 110.48 0.05 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.401 1.08 . . . . 75.230000000000004 112.236 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -61.27 -52.38 64.96 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.779 -0.823 . . . . 75.319999999999993 108.779 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 69.28 -126.84 20.19 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 115.081 -0.963 . . . . 73.150000000000006 111.014 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.45 170.87 15.84 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 120.624 -0.798 . . . . 64.409999999999997 112.066 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 6.1 tt -64.29 124.57 19.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 123.537 0.735 . . . . 72.109999999999999 111.484 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 60.6 ttp85 -147.43 83.64 1.55 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 108.824 -0.806 . . . . 75.420000000000002 108.824 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 48.8 mm 69.25 -51.63 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 125.27 1.428 . . . . 63.119999999999997 113.213 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 11.1 m 69.22 -73.28 0.09 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 126.204 1.802 . . . . 71.519999999999996 111.863 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' B' ' 260' ' ' THR . 12.0 m-20 -85.99 75.37 9.97 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.734 0.778 . . . . 74.430000000000007 109.409 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -90.48 -20.73 22.38 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.591 -0.731 . . . . 73.549999999999997 109.755 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 3.1 p -100.83 121.2 41.29 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.043 -1.095 . . . . 74.209999999999994 108.043 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 55.9 m -105.01 108.48 20.02 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.654 -0.869 . . . . 72.540000000000006 108.654 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -119.45 131.93 55.71 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.867 -0.606 . . . . 75.209999999999994 109.39 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 14.9 m -117.76 122.98 44.88 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.439 0.638 . . . . 63.0 110.014 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.25 129.86 65.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.163 -0.926 . . . . 73.400000000000006 111.79 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -72.49 -75.68 0.13 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.488 -0.93 . . . . 71.140000000000001 108.488 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 86.9 m -148.94 136.56 20.42 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.22 -0.925 . . . . 73.540000000000006 110.006 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 15.9 m -124.05 129.96 73.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 116.012 -0.54 . . . . 71.209999999999994 109.758 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 31.0 m -123.66 140.02 48.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 120.926 0.393 . . . . 71.310000000000002 110.602 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.31 132.58 9.64 Favored Glycine 0 C--N 1.299 -1.495 0 N-CA-C 110.879 -0.888 . . . . 65.439999999999998 110.879 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -134.54 128.92 34.25 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 123.432 0.693 . . . . 74.349999999999994 111.624 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 64.23 56.28 18.87 Favored Glycine 0 C--N 1.318 -0.462 0 O-C-N 123.553 0.533 . . . . 75.549999999999997 113.046 175.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 71.48 102.85 0.07 Allowed 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.467 1.507 . . . . 71.310000000000002 109.601 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.1 m -139.4 148.79 43.3 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.935 -1.029 . . . . 75.439999999999998 108.771 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -121.54 126.34 48.94 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.067 -1.827 . . . . 73.219999999999999 106.067 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . 0.422 ' HB ' HG12 ' C' ' 239' ' ' VAL . 31.0 t -138.13 128.79 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 110.042 -0.355 . . . . 75.010000000000005 110.042 -175.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.72 117.91 25.27 Favored 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 107.97 -1.122 . . . . 72.25 107.97 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 50.1 mm -109.34 104.43 17.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.059 -1.089 . . . . 73.430000000000007 108.059 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 146.06 -154.85 26.21 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 120.565 -0.826 . . . . 64.540000000000006 111.978 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.41 128.17 44.67 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.7 -0.482 . . . . 74.299999999999997 109.7 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -111.93 125.46 54.08 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.876 -1.527 . . . . 75.519999999999996 106.876 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -130.18 123.9 31.34 Favored 'General case' 0 N--CA 1.404 -2.765 0 CA-C-O 121.663 0.744 . . . . 64.319999999999993 109.432 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . 0.418 ' HA2' ' HB1' ' C' ' 249' ' ' ALA . . . 151.58 -46.92 0.59 Allowed Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 108.873 -1.691 . . . . 50.439999999999998 108.873 -176.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 128.4 -25.02 4.88 Favored Glycine 0 CA--C 1.481 -2.077 0 C-N-CA 120.07 -1.062 . . . . 63.130000000000003 111.255 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' C' ' 287' ' ' TRP . 56.3 pttt -151.93 -62.09 0.17 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.177 -0.511 . . . . 74.420000000000002 110.486 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . 0.432 ' H ' ' HG3' ' C' ' 284' ' ' LYS . . . 50.5 -86.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.114 0 N-CA-C 115.503 0.961 . . . . 75.219999999999999 115.503 176.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.427 ' HA ' ' NE1' ' B' ' 287' ' ' TRP . 42.6 t80 -65.79 -29.72 70.25 Favored 'General case' 0 C--O 1.255 1.379 0 C-N-CA 125.192 1.397 . . . . 74.120000000000005 110.62 -176.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . 0.577 ' O ' ' HB2' ' C' ' 284' ' ' LYS . 20.1 p90 -125.25 151.57 45.75 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.669 -0.696 . . . . 73.209999999999994 109.884 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -97.67 126.67 43.12 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.668 -0.864 . . . . 73.420000000000002 108.668 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -156.28 -152.65 0.39 Allowed 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 103.339 -2.837 . . . . 74.120000000000005 103.339 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -55.99 143.5 32.05 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 119.323 0.965 . . . . 72.430000000000007 110.413 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -58.53 -82.85 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 114.807 1.41 . . . . 74.409999999999997 114.807 -172.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 60.15 97.91 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 O-C-N 124.127 0.892 . . . . 71.299999999999997 109.865 -175.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -99.12 -43.63 6.58 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 113.176 0.806 . . . . 73.329999999999998 113.176 -171.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 7.8 m170 75.5 149.31 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.122 0.969 . . . . 74.5 111.982 -171.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 80.9 t60 . . . . . 0 C--O 1.256 1.443 0 C-N-CA 124.869 1.267 . . . . 74.109999999999999 111.21 179.475 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 108.949 -0.76 . . . . 70.239999999999995 108.949 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? 50.89 64.21 1.92 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.723 1.209 . . . . 64.140000000000001 113.352 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 21.4 pt -75.62 138.97 19.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.863 -0.608 . . . . 74.040000000000006 110.421 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -98.44 -25.27 14.85 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.674 -0.694 . . . . 72.439999999999998 110.282 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -90.73 77.1 6.35 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 116.012 -0.54 . . . . 74.430000000000007 109.696 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 67.3 mt -99.39 132.56 44.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 115.648 -0.706 . . . . 72.209999999999994 109.315 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 10.3 p -139.21 164.29 25.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 106.16 -1.793 . . . . 75.209999999999994 106.16 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -75.37 77.86 1.18 Allowed Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.856 -0.687 . . . . 74.140000000000001 111.645 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -122.0 151.69 40.55 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.569 -0.901 . . . . 75.510000000000005 108.569 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.434 ' OD1' ' HB3' ' A' ' 262' ' ' ASN . 62.9 t30 -99.01 136.9 38.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.757 -1.201 . . . . 71.109999999999999 107.757 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 43.4 m -126.59 136.87 53.1 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.854 0.835 . . . . 75.340000000000003 112.478 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.72 138.93 46.08 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.208 -1.775 . . . . 73.450000000000003 106.208 174.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -92.75 -60.91 1.7 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.359 -0.978 . . . . 75.310000000000002 108.359 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -129.78 140.55 51.03 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.49 0.662 . . . . 73.409999999999997 110.921 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 70.7 mt -125.43 123.26 64.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.408 -1.33 . . . . 74.219999999999999 107.408 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 57.1 ttt180 -130.01 115.89 17.78 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.491 -0.484 . . . . 74.420000000000002 109.975 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.413 HG23 HG23 ' A' ' 239' ' ' VAL . 31.4 p -126.65 128.58 46.98 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.045 0.45 . . . . 75.150000000000006 110.064 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -131.8 143.31 50.12 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 109.649 -0.5 . . . . 75.299999999999997 109.649 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.517 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 41.2 mt-10 66.11 96.88 0.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.275 1.583 . . . . 73.310000000000002 115.275 172.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.517 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.1 mpt_? 60.93 11.78 3.5 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 124.961 1.304 . . . . 74.450000000000003 111.926 175.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -88.37 140.72 29.18 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 110.096 -0.335 . . . . 63.140000000000001 110.096 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.05 142.21 51.62 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.051 -0.522 . . . . 73.140000000000001 110.601 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.413 HG23 HG23 ' A' ' 233' ' ' THR . 12.6 t -122.27 149.58 25.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 O-C-N 123.396 0.435 . . . . 73.329999999999998 110.928 -170.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -138.0 120.63 16.21 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.423 -0.955 . . . . 74.010000000000005 108.423 168.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -117.64 122.55 43.88 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.106 -1.072 . . . . 72.25 108.106 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.77 -114.08 1.11 Allowed Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.008 -1.091 . . . . 74.340000000000003 112.599 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -145.48 133.99 22.01 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.883 -0.414 . . . . 73.310000000000002 109.883 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 92.3 t -107.51 115.47 48.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.947 -0.76 . . . . 64.329999999999998 108.947 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.5 112.24 39.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.75 -0.833 . . . . 65.040000000000006 108.75 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 24.6 m -91.11 159.3 16.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.516 -0.92 . . . . 73.239999999999995 108.516 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.57 -33.72 76.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.062 0.764 . . . . 73.239999999999995 113.062 -176.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.78 -39.98 94.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.087 0.773 . . . . 75.530000000000001 113.087 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.451 ' HA ' ' HB1' ' B' ' 247' ' ' ALA . . . -74.95 -35.95 62.11 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.418 0.155 . . . . 64.510000000000005 111.418 -177.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.0 mp 68.43 -80.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.306 1.042 . . . . 74.019999999999996 109.465 -171.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -174.28 174.53 2.83 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 126.305 1.842 . . . . 73.219999999999999 108.358 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -148.07 132.74 4.34 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.677 -0.773 . . . . 61.219999999999999 111.381 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -170.91 -174.65 38.93 Favored Glycine 0 N--CA 1.437 -1.259 0 N-CA-C 111.027 -0.829 . . . . 61.030000000000001 111.027 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 6.6 tt -167.52 -53.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 123.894 0.878 . . . . 65.349999999999994 109.01 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.542 ' O ' ' HB ' ' A' ' 256' ' ' ILE . 37.8 ttm180 -165.67 102.36 0.69 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 103.088 -2.93 . . . . 73.450000000000003 103.088 176.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.542 ' HB ' ' O ' ' A' ' 255' ' ' ARG . 29.9 mm 78.11 137.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 124.395 1.059 . . . . 71.430000000000007 108.65 -170.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 19.2 m -90.98 -175.59 4.37 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.288 -0.634 . . . . 63.329999999999998 109.288 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -59.5 136.83 58.1 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.891 0.376 . . . . 74.340000000000003 111.141 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -128.18 30.55 5.2 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.121 -0.49 . . . . 75.329999999999998 110.85 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 58.2 m -65.37 121.25 14.4 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 120.401 -0.52 . . . . 73.230000000000004 109.693 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -105.88 126.15 51.83 Favored 'General case' 0 N--CA 1.405 -2.723 0 N-CA-C 108.417 -0.957 . . . . 64.019999999999996 108.417 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.434 ' HB3' ' OD1' ' A' ' 226' ' ' ASN . 45.3 t-20 -126.38 146.83 49.9 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.7 -1.963 . . . . 75.200000000000003 105.7 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 29.6 m -142.22 125.12 16.09 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 121.122 0.487 . . . . 75.340000000000003 110.501 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 14.7 p -128.18 150.51 33.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.677 -1.231 . . . . 62.119999999999997 107.677 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . 0.351 9.1 pt-20 -98.81 -50.66 4.14 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 117.794 -1.562 . . . . 74.409999999999997 113.298 174.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 61.8 m -127.19 126.97 43.76 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 117.958 -1.497 . . . . 74.510000000000005 112.439 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.75 126.83 75.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.687 -0.857 . . . . 74.230000000000004 108.687 173.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 7.9 p -127.76 133.65 67.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-O 121.005 0.431 . . . . 71.230000000000004 111.6 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -126.26 133.11 8.04 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 111.355 -0.698 . . . . 52.240000000000002 111.355 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.462 ' HB2' ' HG2' ' B' ' 234' ' ' GLU . 29.6 mmmt -130.04 116.65 18.85 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 122.587 0.355 . . . . 75.140000000000001 111.25 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.2 100.76 0.24 Allowed Glycine 0 C--N 1.308 -0.992 0 N-CA-C 115.361 0.905 . . . . 74.010000000000005 115.361 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 61.57 20.82 11.59 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.601 0.761 . . . . 75.310000000000002 112.855 169.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 19.4 m -92.79 145.18 24.6 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.464 0.65 . . . . 61.229999999999997 112.264 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . 0.442 ' O ' HG21 ' B' ' 239' ' ' VAL . 66.0 mtt180 -108.3 127.17 53.63 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.147 -2.168 . . . . 74.540000000000006 105.147 173.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 6.1 t -121.45 123.22 69.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 120.179 -0.608 . . . . 72.409999999999997 109.37 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.611 ' HG ' ' OE1' ' B' ' 240' ' ' GLN . 26.8 tp -120.24 120.3 35.72 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.028 -1.069 . . . . 74.140000000000001 111.344 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.71 104.79 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 107.627 -1.249 . . . . 61.409999999999997 107.627 176.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.461 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 158.28 -145.2 11.35 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.227 -0.987 . . . . 74.349999999999994 111.858 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 45.4 t-20 -120.13 146.85 45.57 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 106.047 -1.834 . . . . 62.219999999999999 106.047 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -123.22 117.45 25.35 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.163 -1.051 . . . . 75.200000000000003 108.163 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -109.71 124.41 51.17 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.8 -1.185 . . . . 74.140000000000001 107.8 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 146.18 -46.55 0.75 Allowed Glycine 0 CA--C 1.473 -2.555 0 N-CA-C 109.896 -1.282 . . . . 53.210000000000001 109.896 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.537 ' O ' ' HG2' ' A' ' 284' ' ' LYS . . . 103.36 72.57 0.92 Allowed Glycine 0 N--CA 1.417 -2.575 0 N-CA-C 109.451 -1.46 . . . . 73.310000000000002 109.451 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 283' ' ' GLY . 4.6 ptpp? 82.09 19.4 0.33 Allowed 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 127.706 2.402 . . . . 74.010000000000005 111.419 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -47.82 -38.22 15.94 Favored Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.267 1.267 . . . . 73.510000000000005 116.267 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.448 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 80.1 t80 -83.56 -3.13 57.4 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 117.378 0.589 . . . . 73.349999999999994 112.453 -175.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . 0.448 ' CE3' ' HB3' ' A' ' 286' ' ' PHE . 32.8 p90 -151.59 -170.23 3.59 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 121.473 -0.767 . . . . 74.299999999999997 111.592 -177.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.01 -71.67 0.25 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.618 0.767 . . . . 73.329999999999998 110.514 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 52.97 63.46 2.23 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.829 1.252 . . . . 62.539999999999999 112.158 -174.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.491 ' HB2' ' ND2' ' B' ' 289' ' ' ASN . 56.4 t-80 -147.01 -38.5 0.21 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.415 -1.266 . . . . 75.400000000000006 109.2 172.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -60.49 21.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.033 1.864 . . . . 71.530000000000001 116.033 -174.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . 0.444 ' H ' ' C ' ' A' ' 290' ' ' HIS . 10.6 p80 -153.41 -52.98 0.1 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 123.526 0.73 . . . . 75.310000000000002 109.452 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -171.13 128.05 0.71 Allowed 'General case' 0 C--O 1.242 0.704 0 C-N-CA 122.869 0.467 . . . . 74.120000000000005 110.027 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.431 ' CD2' HH21 ' B' ' 274' ' ' ARG . 43.6 t-80 -161.0 172.58 16.64 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.204 -1.406 . . . . 73.030000000000001 107.204 174.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 . . . . . 0 N--CA 1.432 -1.339 0 N-CA-C 107.497 -1.297 . . . . 74.120000000000005 107.497 177.129 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 11.7 tpt . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 109.705 -0.48 . . . . 72.420000000000002 109.705 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -136.28 149.44 48.46 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.804 -0.813 . . . . 74.099999999999994 108.804 176.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 46.3 pt -82.55 167.78 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.289 0.566 . . . . 74.120000000000005 111.702 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -85.74 106.66 17.16 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.007 -1.109 . . . . 64.319999999999993 108.007 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -119.29 31.23 6.71 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.823 -1.547 . . . . 65.140000000000001 106.823 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 64.6 mt -105.91 115.47 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-N 114.507 -1.224 . . . . 73.5 110.937 -173.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 11.8 p -105.86 164.91 4.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 N-CA-C 106.402 -1.703 . . . . 71.040000000000006 106.402 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' B' ' 259' ' ' GLN . . . -73.57 73.78 1.14 Allowed Glycine 0 CA--C 1.503 -0.702 0 C-N-CA 121.011 -0.614 . . . . 64.099999999999994 111.982 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -108.11 145.0 34.72 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 115.025 -0.588 . . . . 72.120000000000005 110.086 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -98.08 136.7 37.94 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 104.536 -2.394 . . . . 74.219999999999999 104.536 171.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 20.1 m -131.85 136.39 47.43 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 120.109 -0.636 . . . . 72.200000000000003 111.255 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -129.2 134.84 48.18 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.689 -1.226 . . . . 64.319999999999993 107.689 175.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -65.98 0.95 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.017 -0.734 . . . . 74.340000000000003 109.017 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -128.46 140.07 52.01 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-O 121.022 0.439 . . . . 73.129999999999995 109.988 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 27.7 mt -124.72 122.64 64.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.245 -1.391 . . . . 74.400000000000006 107.245 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . 0.533 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 22.1 ttt180 -122.84 114.55 20.65 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.746 -0.835 . . . . 73.120000000000005 108.746 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' THR . . . . . 0.478 HG21 ' CG2' ' B' ' 239' ' ' VAL . 72.4 p -117.88 127.2 53.63 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.021 -1.103 . . . . 74.340000000000003 108.021 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 270' ' ' LYS . 34.0 mt-10 -137.61 139.79 40.55 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.201 -0.599 . . . . 73.129999999999995 110.322 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.497 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 46.8 mt-10 67.5 96.71 0.06 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.542 1.312 . . . . 74.400000000000006 114.542 173.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.497 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.0 OUTLIER 58.14 27.98 15.78 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.474 1.11 . . . . 73.209999999999994 110.897 175.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.415 ' CB ' ' HB ' ' B' ' 233' ' ' THR . . . -84.77 150.89 24.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.163 0.506 . . . . 74.299999999999997 110.6 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.441 ' HD3' ' HG2' ' B' ' 274' ' ' ARG . 4.4 mpt_? -125.66 134.5 51.83 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.647 -1.983 . . . . 75.400000000000006 105.647 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.478 ' CG2' HG21 ' B' ' 233' ' ' THR . 2.4 t -125.41 139.67 50.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 123.404 0.44 . . . . 74.349999999999994 110.02 -172.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.611 ' OE1' ' HG ' ' A' ' 276' ' ' LEU . 24.5 tp60 -138.48 114.84 10.38 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.864 0.728 . . . . 73.349999999999994 109.8 170.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.0 118.73 34.24 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.431 -1.322 . . . . 65.230000000000004 107.431 177.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 141.19 -114.06 0.9 Allowed Glycine 0 N--CA 1.422 -2.268 0 C-N-CA 120.276 -0.964 . . . . 53.520000000000003 111.07 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 55.0 t30 -145.46 149.54 34.87 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.981 -0.748 . . . . 74.25 108.981 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 98.1 t -121.61 122.66 67.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.429 -0.952 . . . . 74.200000000000003 108.429 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 48.7 t -122.19 111.84 32.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.975 -0.75 . . . . 73.519999999999996 108.975 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 23.8 m -83.15 159.28 22.08 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.195 -1.039 . . . . 75.129999999999995 108.195 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' A' ' 249' ' ' ALA . . . -64.6 -42.48 95.53 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 123.207 1.48 . . . . 74.319999999999993 109.749 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.68 -34.01 61.67 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 111.762 -2.472 . . . . 74.129999999999995 112.827 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.452 ' HA ' ' HB1' ' C' ' 247' ' ' ALA . . . -62.9 -26.81 68.97 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.678 0.791 . . . . 65.530000000000001 112.482 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -79.65 76.13 6.3 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.981 0.896 . . . . 74.319999999999993 108.867 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -103.55 -44.69 5.04 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.179 -1.373 . . . . 73.349999999999994 108.109 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 152.68 -172.75 31.77 Favored Glycine 0 N--CA 1.42 -2.376 0 N-CA-C 107.226 -2.35 . . . . 65.319999999999993 107.226 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 80.41 -49.97 3.93 Favored Glycine 0 C--N 1.304 -1.21 0 CA-C-N 118.119 0.959 . . . . 74.319999999999993 113.161 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.74 109.45 9.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.151 -0.685 . . . . 72.140000000000001 109.151 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -116.62 -14.74 10.85 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.263 -1.014 . . . . 73.420000000000002 108.263 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 12.4 pt -155.53 177.75 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.153 0 N-CA-C 105.887 -1.894 . . . . 70.109999999999999 105.887 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 23.9 t -96.64 146.4 24.88 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.154 -1.054 . . . . 53.130000000000003 108.154 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -74.04 119.08 17.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.423 0.63 . . . . 64.340000000000003 109.431 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . 0.416 ' HB3' ' HA3' ' B' ' 224' ' ' GLY . 88.9 mt-30 -83.5 57.31 3.97 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 114.289 1.218 . . . . 73.299999999999997 114.289 -173.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' C' ' 257' ' ' SER . 55.1 m -87.03 123.17 31.82 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.338 -0.986 . . . . 62.43 108.338 172.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -91.55 127.93 37.18 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 121.799 0.809 . . . . 73.439999999999998 110.405 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -126.82 142.23 51.6 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.946 -1.872 . . . . 74.299999999999997 105.946 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 47.4 m -139.64 133.01 30.05 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 118.313 0.506 . . . . 73.239999999999995 111.655 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.1 p -128.22 144.17 38.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 116.056 -0.52 . . . . 74.209999999999994 110.658 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 38.2 mm-40 -81.05 -63.73 1.34 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.193 0.521 . . . . 75.439999999999998 110.801 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 38.2 m -137.59 127.13 25.08 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 118.138 -1.425 . . . . 75.450000000000003 111.915 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.05 121.13 66.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.891 -1.05 . . . . 72.129999999999995 108.704 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 5.4 p -127.38 138.79 53.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.721 -0.672 . . . . 74.120000000000005 112.266 -176.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.7 133.97 8.81 Favored Glycine 0 CA--C 1.485 -1.8 0 CA-C-N 115.793 -0.64 . . . . 64.329999999999998 112.134 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.437 ' HB2' ' HG2' ' C' ' 234' ' ' GLU . 30.9 mmmt -128.96 115.95 18.6 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 123.748 0.322 . . . . 74.329999999999998 110.689 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 81.58 93.31 0.51 Allowed Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.46 -0.876 . . . . 74.230000000000004 114.626 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 64.01 17.25 10.49 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.341 1.056 . . . . 75.400000000000006 111.89 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 273' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 19.8 m -82.88 145.19 29.58 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.743 0.783 . . . . 63.25 111.383 -172.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.49 ' HB3' ' CE1' ' B' ' 286' ' ' PHE . 51.1 mtm180 -116.84 127.44 54.3 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 108.739 -0.837 . . . . 73.439999999999998 108.739 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.432 HG13 ' CG1' ' C' ' 239' ' ' VAL . 29.2 m -120.64 123.58 70.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-O 121.394 0.616 . . . . 75.109999999999999 110.547 -176.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . 0.562 ' HG ' ' OE1' ' C' ' 240' ' ' GLN . 26.4 tp -115.06 114.78 25.81 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.989 -0.745 . . . . 74.430000000000007 108.989 173.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . 0.446 HG22 HD11 ' C' ' 241' ' ' LEU . 3.4 mp -112.78 103.63 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.609 0 N-CA-C 106.025 -1.843 . . . . 73.239999999999995 106.025 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.433 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 161.3 -150.83 20.86 Favored Glycine 0 N--CA 1.416 -2.662 0 C-N-CA 119.798 -1.192 . . . . 72.140000000000001 112.835 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -113.77 151.81 31.47 Favored 'General case' 0 C--N 1.273 -2.753 0 N-CA-C 104.791 -2.3 . . . . 63.43 104.791 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -130.06 118.87 22.2 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.94 -1.133 . . . . 72.219999999999999 107.94 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -113.1 124.28 52.21 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.911 0.862 . . . . 75.340000000000003 110.927 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.01 -47.32 0.94 Allowed Glycine 0 N--CA 1.417 -2.619 0 CA-C-N 114.37 -1.286 . . . . 74.439999999999998 110.442 178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' B' ' 284' ' ' LYS . . . 108.25 90.92 2.15 Favored Glycine 0 N--CA 1.414 -2.79 0 N-CA-C 108.363 -1.895 . . . . 72.140000000000001 108.363 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' B' ' 287' ' ' TRP . 50.0 mtmt 90.95 -59.45 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 126.408 1.883 . . . . 75.049999999999997 109.681 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 49.87 -84.27 0.01 OUTLIER Glycine 0 N--CA 1.478 1.459 0 O-C-N 124.279 0.987 . . . . 73.310000000000002 115.101 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.49 ' CE1' ' HB3' ' B' ' 274' ' ' ARG . 1.3 t80 -52.0 -45.95 64.72 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.466 1.906 . . . . 75.519999999999996 109.908 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.572 ' O ' ' HB3' ' B' ' 284' ' ' LYS . 48.9 p90 -116.93 152.38 34.67 Favored 'General case' 0 C--O 1.201 -1.484 0 N-CA-C 106.741 -1.578 . . . . 73.439999999999998 106.741 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 11.5 t70 169.87 -78.34 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 106.802 -1.555 . . . . 73.109999999999999 106.802 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . 0.491 ' ND2' ' HB2' ' A' ' 290' ' ' HIS . 15.0 m120 62.56 19.96 11.63 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 114.116 -1.402 . . . . 62.219999999999999 112.417 173.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -87.96 109.39 19.78 Favored 'General case' 0 C--O 1.248 1.016 0 N-CA-C 108.01 -1.107 . . . . 73.510000000000005 108.01 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.61 22.34 13.26 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.336 1.055 . . . . 75.299999999999997 110.066 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . 0.457 ' HB2' ' HA ' ' B' ' 289' ' ' ASN . 17.0 m80 -111.19 117.04 32.14 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.899 -1.046 . . . . 72.150000000000006 109.331 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 72.26 -63.26 0.44 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.243 1.417 . . . . 75.099999999999994 111.588 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 6.9 m170 55.49 100.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.918 1.821 . . . . 75.540000000000006 115.918 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--N 1.296 -1.746 0 N-CA-C 105.587 -2.005 . . . . 72.040000000000006 105.587 176.492 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.516 -0.356 0 N-CA-C 109.353 -0.61 . . . . 74.420000000000002 109.353 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.23 167.24 11.15 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.188 0.81 . . . . 63.43 113.188 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.45 174.12 4.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 114.885 -1.052 . . . . 75.329999999999998 111.704 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -93.04 -65.87 0.97 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.378 -0.971 . . . . 75.219999999999999 108.378 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -77.06 127.84 33.4 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 107.859 -1.163 . . . . 71.219999999999999 107.859 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 78.6 mt -82.73 115.55 25.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.579 0.704 . . . . 72.549999999999997 111.324 -174.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 12.2 p -104.74 164.03 4.0 Favored 'Isoleucine or valine' 0 C--O 1.257 1.481 0 N-CA-C 106.699 -1.593 . . . . 72.5 106.699 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -74.34 76.56 1.1 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.95 -0.643 . . . . 74.25 111.649 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' C' ' 261' ' ' THR . 4.9 ptp180 -111.68 154.22 25.27 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.085 0.469 . . . . 74.340000000000003 110.731 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -109.98 140.74 43.65 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.248 -2.131 . . . . 74.209999999999994 105.248 173.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 227' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' C' ' 263' ' ' SER . 45.0 m -139.74 137.95 35.53 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.892 -0.505 . . . . 75.340000000000003 111.399 -176.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.65 128.92 45.09 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.421 -0.955 . . . . 74.209999999999994 108.421 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 27.9 tptp -75.31 -62.17 1.65 Allowed 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.395 -0.594 . . . . 73.140000000000001 109.395 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . 0.411 ' O ' ' HA ' ' C' ' 266' ' ' THR . 16.5 m-20 -134.85 139.86 45.38 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.066 0.46 . . . . 73.549999999999997 110.719 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . 0.451 HG23 HG23 ' C' ' 239' ' ' VAL . 35.6 mt -127.53 123.52 61.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 106.96 -1.496 . . . . 65.430000000000007 106.96 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 31.6 ttt180 -126.9 114.98 18.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.755 -0.832 . . . . 73.230000000000004 108.755 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 39.4 p -110.62 127.36 55.22 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.71 -1.219 . . . . 64.540000000000006 107.71 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . 0.437 ' HG2' ' HB2' ' B' ' 270' ' ' LYS . 40.5 mt-10 -135.07 139.62 44.89 Favored 'General case' 0 N--CA 1.42 -1.943 0 C-N-CA 120.396 -0.522 . . . . 75.209999999999994 110.31 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 64.43 101.29 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 O-C-N 124.621 1.201 . . . . 73.400000000000006 114.117 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 59.6 13.88 3.63 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.669 1.188 . . . . 75.340000000000003 111.27 173.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.38 151.58 22.97 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.619 0.6 . . . . 73.430000000000007 112.619 -172.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.05 135.24 41.15 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.02 -1.474 . . . . 74.530000000000001 107.02 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.451 HG23 HG23 ' C' ' 231' ' ' ILE . 6.9 p -132.38 146.08 33.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.058 0.456 . . . . 70.400000000000006 111.437 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . 0.562 ' OE1' ' HG ' ' B' ' 276' ' ' LEU . 23.2 tp60 -124.6 120.16 31.12 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.67 -1.15 . . . . 72.540000000000006 108.829 172.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.446 HD11 HG22 ' B' ' 277' ' ' ILE . 3.4 tm? -113.66 117.78 32.54 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.966 -1.494 . . . . 71.040000000000006 106.966 177.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 139.14 -114.36 1.01 Allowed Glycine 0 N--CA 1.424 -2.116 0 C-N-CA 119.972 -1.109 . . . . 62.350000000000001 112.02 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -145.39 143.79 30.29 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.571 -0.529 . . . . 73.239999999999995 109.571 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 69.5 t -117.44 118.43 58.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.432 -0.581 . . . . 74.340000000000003 109.432 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 47.9 t -121.8 111.99 33.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.452 -0.573 . . . . 74.340000000000003 109.452 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 31.4 m -78.07 159.47 28.68 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.239 -1.023 . . . . 63.340000000000003 108.239 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . 0.452 ' HB1' ' HA ' ' B' ' 249' ' ' ALA . . . -63.46 -43.38 97.53 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.482 1.134 . . . . 72.420000000000002 109.48 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.29 65.6 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.891 -1.959 . . . . 74.099999999999994 112.776 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.14 -37.21 80.83 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 111.995 0.368 . . . . 73.409999999999997 111.995 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 79.2 mt 69.39 -163.96 0.18 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 124.35 1.031 . . . . 70.430000000000007 110.677 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -152.65 -54.65 0.12 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.937 0.398 . . . . 74.200000000000003 110.056 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 107.08 -17.51 37.78 Favored Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 120.742 -0.742 . . . . 45.039999999999999 112.602 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 89.93 21.17 40.28 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 110.795 -0.922 . . . . 72.239999999999995 110.795 -178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 10.1 tt -139.88 136.82 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 108.22 -1.03 . . . . 75.129999999999995 108.22 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -59.8 115.45 3.38 Favored 'General case' 0 C--O 1.248 1.001 0 O-C-N 123.697 0.623 . . . . 72.310000000000002 110.154 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 62.5 mt -90.14 -56.79 4.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 107.48 -1.304 . . . . 74.049999999999997 107.48 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 257' ' ' SER . . . . . 0.497 ' HA ' ' OG1' ' B' ' 260' ' ' THR . 14.9 m 65.82 146.08 0.03 OUTLIER 'General case' 0 C--O 1.243 0.742 0 C-N-CA 125.867 1.667 . . . . 75.129999999999995 114.088 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . 0.469 ' OD1' ' HB ' ' C' ' 260' ' ' THR . 10.9 t0 -51.22 -50.61 58.78 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.024 -1.102 . . . . 70.219999999999999 108.024 176.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 76.12 -24.19 0.23 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.721 1.608 . . . . 74.120000000000005 111.852 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 260' ' ' THR . . . . . 0.469 ' HB ' ' OD1' ' C' ' 258' ' ' ASP . 88.2 m -85.11 133.73 34.21 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 108.687 -0.857 . . . . 72.109999999999999 108.687 176.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 261' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 39.2 m -92.33 108.69 20.14 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 108.173 -1.047 . . . . 72.25 108.173 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -124.26 127.85 48.29 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.733 -0.84 . . . . 73.510000000000005 108.733 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 263' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' C' ' 227' ' ' SER . 41.4 m -133.43 136.22 45.08 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 110.069 -0.345 . . . . 51.530000000000001 110.069 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.22 153.5 37.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.295 -0.632 . . . . 72.349999999999994 109.295 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.581 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 35.2 mm-40 -81.13 -88.5 0.08 Allowed 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 110.197 -0.297 . . . . 75.230000000000004 110.197 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 266' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 51.4 m -121.85 131.33 53.98 Favored 'General case' 0 N--CA 1.417 -2.09 0 C-N-CA 119.581 -0.848 . . . . 72.299999999999997 111.061 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 26.2 m -117.87 132.53 67.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.33 -0.989 . . . . 71.439999999999998 108.33 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.8 p -127.38 139.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.4 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.99 133.66 9.47 Favored Glycine 0 CA--C 1.476 -2.362 0 N-CA-C 110.155 -1.178 . . . . 75.310000000000002 110.155 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -131.36 115.55 16.39 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 111.988 0.366 . . . . 74.329999999999998 111.988 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 70.05 97.39 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.859 -1.064 . . . . 73.319999999999993 114.415 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 68.09 21.66 8.64 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.782 0.833 . . . . 52.240000000000002 111.955 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.5 m -83.77 144.7 29.14 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.027 0.751 . . . . 73.540000000000006 113.027 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -110.07 128.36 55.39 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.207 -1.775 . . . . 74.430000000000007 106.207 171.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 1.5 t -128.08 123.9 61.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 119.726 -0.79 . . . . 70.120000000000005 109.199 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 30.8 tp -117.62 117.96 30.82 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.902 -0.719 . . . . 74.540000000000006 110.3 174.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' C' ' 228' ' ' ALA . 3.7 mp -112.48 103.47 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.893 0 N-CA-C 105.902 -1.888 . . . . 75.510000000000005 105.902 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.35 -168.24 30.27 Favored Glycine 0 CA--C 1.478 -2.223 0 C-N-CA 120.546 -0.835 . . . . 74.420000000000002 111.456 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -96.7 156.8 16.19 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.46 -0.941 . . . . 74.120000000000005 108.46 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . 0.471 ' HB3' ' ND1' ' C' ' 294' ' ' HIS . 2.9 tm-20 -129.12 121.3 27.5 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.944 -1.132 . . . . 74.430000000000007 107.944 -175.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -116.54 125.12 51.44 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.945 0.403 . . . . 72.239999999999995 110.078 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.47 -37.74 1.84 Allowed Glycine 0 N--CA 1.437 -1.3 0 N-CA-C 111.668 -0.573 . . . . 73.140000000000001 111.668 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 104.4 103.04 2.8 Favored Glycine 0 CA--C 1.48 -2.137 0 N-CA-C 107.304 -2.319 . . . . 45.119999999999997 107.304 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' C' ' 288' ' ' ASP . 94.8 mttt 75.07 -57.78 0.59 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.785 1.234 . . . . 73.129999999999995 109.169 -172.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 57.63 -86.22 0.01 OUTLIER Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.307 0.956 . . . . 61.140000000000001 113.961 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.559 ' HB3' ' CE3' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -56.67 -39.57 73.99 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.023 1.729 . . . . 73.040000000000006 110.642 -178.635 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . 0.559 ' CE3' ' HB3' ' C' ' 286' ' ' PHE . 24.6 p90 -129.99 -171.66 2.58 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.067 0.46 . . . . 73.049999999999997 111.622 -171.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' C' ' 284' ' ' LYS . 21.0 t70 -131.11 -36.27 1.33 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.981 -1.009 . . . . 63.329999999999998 109.692 169.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' C' ' 290' ' ' HIS . 26.5 t-20 -81.91 72.95 8.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.876 -0.602 . . . . 73.120000000000005 111.25 -177.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . 0.54 ' HB3' ' CD1' ' C' ' 287' ' ' TRP . 9.2 t60 163.9 116.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.887 2.075 . . . . 73.140000000000001 105.936 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -99.52 95.28 6.89 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 113.406 0.891 . . . . 74.219999999999999 113.406 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -152.37 135.66 15.87 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.75 -1.113 . . . . 74.439999999999998 110.512 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -124.24 133.68 53.45 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.745 -1.205 . . . . 73.140000000000001 107.745 173.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . 0.471 ' ND1' ' HB3' ' C' ' 280' ' ' GLU . 76.8 m80 -95.85 -46.61 6.49 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 112.935 0.717 . . . . 74.109999999999999 112.935 -173.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 . . . . . 0 C--N 1.303 -1.414 0 CA-C-O 118.528 -0.748 . . . . 72.209999999999994 109.509 -177.616 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 CA--C 1.51 -0.593 0 CA-C-O 121.591 0.71 . . . . 71.049999999999997 109.41 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -164.01 77.12 0.37 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.841 -1.072 . . . . 70.409999999999997 110.272 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 64.3 mt -78.61 88.22 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 122.129 0.966 . . . . 72.329999999999998 108.534 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -151.97 -36.08 0.12 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.48 -1.691 . . . . 73.319999999999993 107.594 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.04 146.93 10.27 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 114.553 -1.203 . . . . 52.240000000000002 110.748 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.9 mp -83.35 124.31 39.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.138 -0.69 . . . . 64.120000000000005 109.138 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.458 HG21 HG21 ' B' ' 222' ' ' ILE . 14.9 p -100.1 148.91 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 109.501 -0.555 . . . . 72.400000000000006 109.501 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 103.6 15.07 23.81 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 109.149 -1.58 . . . . 52.439999999999998 109.149 -174.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -90.01 141.89 28.23 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.685 -0.757 . . . . 74.549999999999997 109.948 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 48.1 t-20 -116.75 123.97 48.48 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.644 -1.614 . . . . 71.150000000000006 106.644 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.1 m -121.65 137.42 54.75 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 120.342 -0.543 . . . . 74.120000000000005 111.239 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.4 134.06 46.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.052 -0.722 . . . . 73.299999999999997 109.052 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -91.49 -46.87 7.74 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.643 -0.253 . . . . 71.329999999999998 110.836 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -136.9 139.71 41.8 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.372 -0.603 . . . . 75.219999999999999 109.372 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 66.1 mt -137.28 119.34 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.388 -1.338 . . . . 75.239999999999995 107.388 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -134.22 122.81 23.3 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.909 0.385 . . . . 74.549999999999997 110.834 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 33.4 p -129.43 128.65 43.39 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.053 -0.351 . . . . 73.219999999999999 110.053 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -125.67 166.16 17.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.141 0.496 . . . . 74.409999999999997 111.91 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 64.9 -85.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.73 1.612 . . . . 72.140000000000001 113.961 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -130.65 11.7 5.28 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 109.373 -0.602 . . . . 74.219999999999999 109.373 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -73.14 134.25 44.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.495 -0.775 . . . . 71.299999999999997 110.563 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.1 145.25 50.56 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.839 -0.8 . . . . 72.040000000000006 108.839 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.7 p -132.3 141.8 44.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.719 0.771 . . . . 52.25 111.438 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -105.14 128.25 53.29 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.678 -1.23 . . . . 75.040000000000006 107.678 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -122.32 117.85 27.07 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.281 -1.377 . . . . 71.299999999999997 107.281 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 113.25 -159.79 13.48 Favored Glycine 0 C--N 1.306 -1.113 0 C-N-CA 121.23 -0.51 . . . . 61.43 111.925 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -98.78 137.39 37.44 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 122.628 0.371 . . . . 73.549999999999997 110.916 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 61.7 t -114.73 116.32 52.21 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 N-CA-C 107.22 -1.4 . . . . 74.329999999999998 107.22 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.2 p -122.44 114.37 42.23 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 N-CA-C 108.46 -0.941 . . . . 75.349999999999994 108.46 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 15.0 m -84.22 157.18 21.69 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 118.406 -1.318 . . . . 71.510000000000005 110.045 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.01 -47.09 72.51 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.41 0.624 . . . . 73.439999999999998 111.552 176.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.38 -34.42 68.85 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.561 1.545 . . . . 72.140000000000001 112.649 -175.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.458 ' HB1' ' HA3' ' A' ' 282' ' ' GLY . . . -59.42 -26.52 65.24 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.145 0.978 . . . . 72.430000000000007 111.548 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 33.9 tp 67.07 73.61 0.34 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.662 1.185 . . . . 63.200000000000003 111.456 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -82.69 103.16 11.99 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.7 -1.222 . . . . 72.430000000000007 107.7 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.42 73.72 0.46 Allowed Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 110.475 -1.05 . . . . 72.129999999999995 110.475 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 174.05 -174.42 46.33 Favored Glycine 0 N--CA 1.422 -2.279 0 N-CA-C 110.341 -1.104 . . . . 71.340000000000003 110.341 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 3.4 mp -90.23 124.78 43.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.289 -1.004 . . . . 73.0 108.289 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.67 84.87 5.44 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.995 -1.113 . . . . 72.25 107.995 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 15.1 tt -114.87 -13.14 11.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.791 -1.559 . . . . 72.430000000000007 106.791 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 16.3 m -68.66 148.36 50.53 Favored 'General case' 0 C--O 1.256 1.396 0 CA-C-N 113.993 -1.458 . . . . 73.209999999999994 108.138 175.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 27.6 t70 70.45 120.55 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.689 1.196 . . . . 64.140000000000001 110.655 -174.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -129.14 23.95 5.6 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.659 -0.867 . . . . 72.319999999999993 108.659 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' B' ' 224' ' ' GLY . 23.6 m -74.57 124.21 26.23 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.925 -1.034 . . . . 73.519999999999996 110.102 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.9 t -110.83 130.45 55.57 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 106.044 -1.836 . . . . 75.409999999999997 106.044 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 38.3 t-20 -126.38 140.35 52.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.911 -0.716 . . . . 73.409999999999997 109.151 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.9 m -133.76 123.1 24.31 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 120.809 -0.356 . . . . 63.039999999999999 110.392 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 8.7 p -128.92 145.1 36.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 110.128 -0.323 . . . . 75.329999999999998 110.128 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 76.9 mm-40 -85.38 -79.09 0.24 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 121.0 -0.28 . . . . 74.420000000000002 110.747 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 25.9 m -116.29 127.65 54.89 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.182 0.438 . . . . 74.140000000000001 112.182 -172.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.421 HG21 HD12 ' A' ' 277' ' ' ILE . 17.4 m -120.69 132.78 69.34 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.276 0.56 . . . . 64.230000000000004 109.583 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 3.3 p -127.98 131.81 69.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 116.358 -0.383 . . . . 73.409999999999997 111.637 178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.86 131.06 7.65 Favored Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 109.3 -1.52 . . . . 34.140000000000001 109.3 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 18.9 tptm -134.17 140.55 46.6 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.6 -0.518 . . . . 75.129999999999995 109.6 -177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 81.56 -136.71 16.41 Favored Glycine 0 CA--C 1.487 -1.672 0 N-CA-C 107.78 -2.128 . . . . 73.230000000000004 107.78 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -101.36 85.41 2.79 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 118.443 1.122 . . . . 73.519999999999996 109.356 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.581 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 21.6 m -104.39 144.98 30.92 Favored 'General case' 0 N--CA 1.408 -2.562 0 CA-C-N 114.923 -1.035 . . . . 71.439999999999998 108.934 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . 0.517 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 98.8 mtt180 -122.73 125.93 46.51 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 106.138 -1.801 . . . . 72.129999999999995 106.138 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 26.9 t -131.62 131.63 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 N-CA-C 108.973 -0.751 . . . . 71.129999999999995 108.973 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 5.4 tt -125.88 114.77 18.97 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 118.429 -1.308 . . . . 75.420000000000002 108.444 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.421 HD12 HG21 ' A' ' 267' ' ' VAL . 68.5 mt -111.02 104.33 16.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.098 -0.704 . . . . 72.239999999999995 109.098 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.512 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 144.27 -143.93 12.76 Favored Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 110.969 -0.852 . . . . 73.420000000000002 110.969 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -124.29 143.53 50.5 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.213 -1.032 . . . . 73.140000000000001 108.213 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.96 130.01 46.17 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.502 0.668 . . . . 72.239999999999995 109.314 174.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -113.55 121.56 44.58 Favored 'General case' 0 N--CA 1.409 -2.493 0 N-CA-C 107.383 -1.34 . . . . 72.019999999999996 107.383 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.458 ' HA3' ' HB1' ' A' ' 249' ' ' ALA . . . 62.81 24.82 66.95 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.407 -1.269 . . . . 75.450000000000003 113.903 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -86.69 -47.63 4.76 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.037 -1.225 . . . . 71.219999999999999 110.037 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.432 ' HB2' ' NZ ' ' A' ' 284' ' ' LYS . 0.1 OUTLIER 68.28 23.51 7.72 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.043 1.337 . . . . 74.299999999999997 110.03 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 287' ' ' TRP . . . 115.02 92.91 1.88 Allowed Glycine 0 N--CA 1.407 -3.249 0 C-N-CA 120.129 -1.034 . . . . 55.439999999999998 110.768 -176.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -73.1 33.78 0.07 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-O 122.54 1.162 . . . . 75.239999999999995 109.398 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . 0.517 ' CE3' ' HB3' ' A' ' 274' ' ' ARG . 2.5 m95 -97.03 -49.76 4.88 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.407 -0.815 . . . . 73.400000000000006 111.979 -174.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -113.57 -97.26 0.44 Allowed 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 118.645 -1.222 . . . . 72.030000000000001 113.203 -169.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -149.29 178.27 8.92 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.201 -1.407 . . . . 75.310000000000002 107.201 -176.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -100.47 56.58 0.91 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 122.24 1.019 . . . . 75.329999999999998 110.907 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -112.35 -46.0 3.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.529 -1.214 . . . . 74.319999999999993 108.199 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 64.03 37.87 8.94 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 122.271 1.034 . . . . 75.5 112.143 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -79.5 152.98 29.9 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.025 -1.443 . . . . 75.540000000000006 107.383 175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.507 ' CE1' ' HA ' ' B' ' 290' ' ' HIS . 10.1 t60 -47.15 111.06 0.36 Allowed 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.601 0.715 . . . . 72.310000000000002 112.405 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 . . . . . 0 N--CA 1.417 -2.08 0 N-CA-C 103.945 -2.613 . . . . 74.030000000000001 103.945 176.406 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 CA--C 1.506 -0.719 0 CA-C-O 121.412 0.625 . . . . 75.450000000000003 111.238 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -144.66 49.45 1.31 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.917 -1.142 . . . . 73.409999999999997 107.917 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.71 84.44 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 114.379 -1.282 . . . . 73.120000000000005 108.92 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -91.62 -28.78 17.28 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.246 -1.343 . . . . 60.229999999999997 110.12 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -70.78 137.73 49.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.075 -0.966 . . . . 71.530000000000001 109.757 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . 0.458 HG21 HG21 ' A' ' 223' ' ' VAL . 3.5 mp -83.51 139.27 17.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.333 -0.988 . . . . 75.349999999999994 108.333 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 13.6 p -98.27 153.93 3.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.693 -1.225 . . . . 73.409999999999997 107.693 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 260' ' ' THR . . . 93.31 48.92 2.71 Favored Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 107.629 -2.189 . . . . 75.25 107.629 -171.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -134.14 141.49 47.13 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.792 -0.704 . . . . 73.430000000000007 109.637 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 39.1 t-20 -118.06 141.7 48.19 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.545 -1.28 . . . . 74.299999999999997 107.545 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 52.5 m -133.81 137.38 45.05 Favored 'General case' 0 C--N 1.275 -2.663 0 O-C-N 122.075 -0.39 . . . . 72.400000000000006 110.172 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -127.72 160.77 30.67 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.21 -1.404 . . . . 73.099999999999994 107.21 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.578 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 4.6 tmmm? -121.67 -54.63 1.95 Allowed 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 119.599 -0.841 . . . . 74.340000000000003 109.045 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -131.76 138.03 48.43 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.81 -1.552 . . . . 74.150000000000006 106.81 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' B' ' 267' ' ' VAL . 12.5 mt -133.85 120.04 34.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 106.795 -1.557 . . . . 70.109999999999999 106.795 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . 0.604 ' NH1' ' HB2' ' B' ' 232' ' ' ARG . 0.0 OUTLIER -115.39 119.9 37.8 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 109.191 -0.67 . . . . 75.310000000000002 109.191 -176.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 38.4 p -121.88 129.16 52.36 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.613 -1.254 . . . . 74.5 107.613 175.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -144.69 150.51 37.45 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 120.12 -0.632 . . . . 71.129999999999995 110.398 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 77.82 -79.19 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 125.798 1.639 . . . . 75.099999999999994 113.021 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -140.57 27.1 2.08 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.569 -0.9 . . . . 65.219999999999999 108.569 -172.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -86.71 143.65 27.47 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 112.9 0.704 . . . . 64.010000000000005 112.9 -173.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -124.4 136.46 54.08 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.311 -1.366 . . . . 73.200000000000003 107.311 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.5 p -134.14 136.14 53.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.996 0.903 . . . . 74.019999999999996 111.396 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.427 ' HB2' ' CE2' ' B' ' 286' ' ' PHE . 44.1 tp60 -104.57 130.99 52.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 106.884 -1.524 . . . . 64.409999999999997 106.884 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -130.27 116.28 18.14 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 106.561 -1.644 . . . . 74.109999999999999 106.561 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 123.05 -129.39 7.41 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.634 -0.793 . . . . 53.049999999999997 112.05 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -132.53 137.38 47.13 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.17 0.485 . . . . 75.349999999999994 109.862 -177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 54.4 t -114.63 114.87 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.595 -1.261 . . . . 73.150000000000006 107.595 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 3.6 p -122.42 114.3 41.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 C-N-CA 119.492 -0.883 . . . . 63.130000000000003 110.165 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 42.3 m -80.34 155.0 27.42 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 117.419 -1.713 . . . . 74.200000000000003 109.92 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.56 66.03 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.254 1.026 . . . . 74.409999999999997 111.249 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.31 -35.13 67.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.195 -1.82 . . . . 64.120000000000005 112.246 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' B' ' 250' ' ' LEU . . . -60.56 -47.03 88.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.989 -0.55 . . . . 54.340000000000003 110.381 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 18.1 tp 165.8 161.34 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 105.316 -2.105 . . . . 73.230000000000004 105.316 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -76.63 83.03 3.28 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 118.397 0.544 . . . . 75.109999999999999 111.394 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.96 13.34 83.25 Favored Glycine 0 CA--C 1.51 -0.228 0 N-CA-C 111.551 -0.62 . . . . 63.25 111.551 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 70.66 -160.96 53.81 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 110.813 -0.915 . . . . 52.130000000000003 110.813 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 70.7 mt -89.52 -34.92 7.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 108.763 -0.829 . . . . 73.230000000000004 108.763 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -159.97 -46.27 0.05 Allowed 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 124.281 1.032 . . . . 75.420000000000002 109.612 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 60.3 mt 62.76 81.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.38 1.086 . . . . 74.140000000000001 110.112 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 23.7 m -156.13 134.7 11.67 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.943 -1.503 . . . . 75.099999999999994 106.943 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -145.24 -171.83 3.74 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.785 -1.191 . . . . 73.430000000000007 107.785 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -106.34 9.3 31.93 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.168 -0.613 . . . . 73.329999999999998 111.64 -173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 12.0 m -77.78 120.78 23.17 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 121.915 0.864 . . . . 74.299999999999997 110.171 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' THR . . . . . 0.405 HG21 ' CB ' ' C' ' 225' ' ' ARG . 5.1 t -115.82 120.51 39.49 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 105.687 -1.968 . . . . 72.510000000000005 105.687 171.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' B' ' 226' ' ' ASN . 37.0 t-20 -126.39 138.35 53.54 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.072 -0.651 . . . . 65.420000000000002 109.268 -172.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 263' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' C' ' 227' ' ' SER . 51.9 m -142.08 129.54 21.29 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.152 0.501 . . . . 71.439999999999998 111.336 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 14.1 p -121.11 153.16 24.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.831 -0.803 . . . . 75.129999999999995 108.831 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 75.8 mm-40 -91.94 -78.34 0.41 Allowed 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 109.583 -0.525 . . . . 63.210000000000001 109.583 171.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.6 m -114.35 127.97 56.12 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.944 -0.473 . . . . 74.430000000000007 111.192 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' B' ' 231' ' ' ILE . 1.4 p -131.27 120.74 47.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 109.162 -0.681 . . . . 75.400000000000006 109.162 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 5.4 m -124.76 148.33 29.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 121.246 0.546 . . . . 74.340000000000003 111.301 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -137.34 132.43 5.95 Favored Glycine 0 N--CA 1.415 -2.755 0 N-CA-C 109.489 -1.444 . . . . 75.439999999999998 109.489 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -132.51 116.19 16.44 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.524 0.678 . . . . 73.010000000000005 110.057 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 104.08 -139.19 14.45 Favored Glycine 0 CA--C 1.471 -2.715 0 N-CA-C 109.213 -1.555 . . . . 73.25 109.213 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . 0.513 ' HB3' ' O ' ' C' ' 235' ' ' GLU . 11.1 tp10 -86.42 80.65 8.6 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.133 -1.432 . . . . 74.430000000000007 107.133 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 273' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 20.6 m -113.96 144.29 43.32 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.429 -1.26 . . . . 63.219999999999999 109.061 -177.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.507 ' HB3' ' CE3' ' B' ' 287' ' ' TRP . 76.3 mtt180 -134.4 127.35 31.41 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.013 -1.106 . . . . 73.420000000000002 108.013 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 10.9 t -131.2 137.77 54.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 116.101 -0.5 . . . . 73.010000000000005 109.714 -173.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 4.5 tt -126.56 113.87 17.35 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 106.872 -1.529 . . . . 74.230000000000004 106.872 173.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . 0.411 HG22 HD12 ' C' ' 241' ' ' LEU . 58.2 mt -112.72 103.19 15.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.509 -0.923 . . . . 74.0 108.509 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 140.98 -146.11 17.18 Favored Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 111.141 -0.784 . . . . 70.409999999999997 111.141 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 5.5 m-20 -123.58 138.24 54.59 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.316 -0.624 . . . . 73.530000000000001 109.316 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.81 137.85 54.29 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.075 -0.713 . . . . 72.420000000000002 109.075 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 87.4 t80 -124.03 121.92 36.52 Favored 'General case' 0 C--O 1.271 2.226 0 N-CA-C 108.493 -0.929 . . . . 74.120000000000005 108.493 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' B' ' 249' ' ' ALA . . . 81.65 -1.17 86.82 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 114.311 -1.313 . . . . 74.019999999999996 113.979 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -71.33 -60.11 4.58 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.922 -0.871 . . . . 75.519999999999996 110.922 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm 74.24 21.64 2.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.283 1.433 . . . . 74.340000000000003 109.1 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.9 90.07 0.83 Allowed Glycine 0 N--CA 1.409 -3.109 0 N-CA-C 109.48 -1.448 . . . . 75.439999999999998 109.48 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' B' ' 240' ' ' GLN . 44.5 t80 -72.73 40.54 0.09 Allowed 'General case' 0 CA--C 1.573 1.857 0 C-N-CA 124.689 1.195 . . . . 73.219999999999999 110.118 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.507 ' CE3' ' HB3' ' B' ' 274' ' ' ARG . 8.0 m95 -117.3 123.45 46.58 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.347 -0.982 . . . . 73.400000000000006 108.347 -176.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.44 115.83 10.07 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.725 -1.583 . . . . 73.239999999999995 106.725 172.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' B' ' 292' ' ' HIS . 5.6 p30 -155.76 -172.67 4.22 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.363 -0.535 . . . . 64.230000000000004 111.114 -171.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . 0.507 ' HA ' ' CE1' ' A' ' 294' ' ' HIS . 62.6 m-70 -57.49 -37.23 72.59 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.86 0.864 . . . . 61.409999999999997 112.447 -178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -88.06 44.96 1.23 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.041 -0.726 . . . . 71.430000000000007 109.041 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' B' ' 289' ' ' ASN . 1.9 t60 -78.49 87.4 4.48 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.566 -1.272 . . . . 74.340000000000003 107.566 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -85.21 88.78 7.51 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.883 1.068 . . . . 72.420000000000002 113.883 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -96.36 -30.52 13.35 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.857 -1.905 . . . . 74.219999999999999 105.857 167.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 79.9 t60 . . . . . 0 N--CA 1.427 -1.594 0 N-CA-C 104.284 -2.487 . . . . 73.420000000000002 104.284 174.584 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 55.6 ttp . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 108.06 -1.089 . . . . 63.140000000000001 108.06 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -104.03 148.99 25.59 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.794 -1.187 . . . . 72.200000000000003 107.794 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.73 130.27 20.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.27 0 CA-C-O 122.15 0.976 . . . . 74.230000000000004 112.084 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -108.17 154.47 21.68 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 113.982 -1.463 . . . . 74.409999999999997 108.453 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.23 16.49 4.11 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.043 0.449 . . . . 54.210000000000001 110.473 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 3.1 mp -105.55 140.62 23.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 123.143 0.577 . . . . 75.340000000000003 109.579 -175.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 13.1 p -98.66 136.83 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.328 -0.99 . . . . 74.439999999999998 108.328 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 109.97 48.29 0.78 Allowed Glycine 0 C--N 1.307 -1.073 0 N-CA-C 108.1 -2.0 . . . . 52.109999999999999 108.1 -172.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' C' ' 261' ' ' THR . 26.8 ptt180 -131.36 143.15 50.28 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.671 -0.765 . . . . 75.200000000000003 110.553 -173.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . 0.433 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 37.9 t-20 -117.81 136.96 53.07 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.877 -1.527 . . . . 71.319999999999993 106.877 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 227' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' B' ' 263' ' ' SER . 32.8 m -134.34 137.28 44.04 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-O 121.041 0.448 . . . . 73.299999999999997 110.622 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -125.18 150.75 46.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.52 -0.919 . . . . 72.120000000000005 108.52 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 1.0 OUTLIER -108.26 -54.21 2.53 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 109.131 -0.692 . . . . 73.030000000000001 109.131 -177.05 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . 0.407 ' CG ' HH21 ' C' ' 232' ' ' ARG . 11.8 t70 -132.8 137.62 46.85 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.495 -1.298 . . . . 63.219999999999999 107.495 176.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 19.1 mt -137.25 120.48 21.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.454 -2.054 . . . . 74.030000000000001 105.454 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.407 HH21 ' CG ' ' C' ' 230' ' ' ASP . 19.0 ptp180 -126.11 120.4 30.06 Favored 'General case' 0 C--N 1.274 -2.678 0 C-N-CA 119.815 -0.754 . . . . 71.420000000000002 111.42 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 233' ' ' THR . . . . . 0.426 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 33.0 p -111.0 134.76 52.35 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.892 -1.049 . . . . 55.350000000000001 108.854 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -144.93 148.03 33.39 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.561 -0.456 . . . . 65.439999999999998 110.062 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' B' ' 272' ' ' GLU . 64.7 mt-10 73.93 -74.02 0.09 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.231 1.567 . . . . 72.239999999999995 115.231 176.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -136.48 17.0 3.14 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.206 -0.665 . . . . 74.200000000000003 109.206 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -78.71 131.11 36.48 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.998 0.904 . . . . 72.439999999999998 113.293 -173.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.504 ' HB3' ' HB2' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -128.5 135.74 49.84 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 114.887 -1.051 . . . . 74.209999999999994 111.157 174.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.407 HG22 ' HB ' ' C' ' 275' ' ' VAL . 7.2 p -130.99 142.59 43.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.375 -0.829 . . . . 74.140000000000001 111.529 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -104.7 132.25 51.17 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 114.363 -1.29 . . . . 75.430000000000007 107.698 171.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' C' ' 277' ' ' ILE . 2.7 tm? -130.13 116.03 17.89 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 105.303 -2.11 . . . . 72.409999999999997 105.303 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 129.63 -132.4 7.06 Favored Glycine 0 C--N 1.3 -1.462 0 C-N-CA 120.147 -1.025 . . . . 63.229999999999997 111.416 -178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 44.2 t30 -137.2 135.56 37.39 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.047 0.451 . . . . 73.439999999999998 110.492 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.07 117.46 51.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.283 0 N-CA-C 107.863 -1.162 . . . . 71.099999999999994 107.863 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 2.8 p -123.56 112.83 34.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 118.691 0.678 . . . . 72.099999999999994 110.455 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.4 m -81.98 156.05 24.89 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 117.444 -1.702 . . . . 73.209999999999994 110.298 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.64 -48.79 65.71 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.744 0.783 . . . . 73.040000000000006 112.042 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.17 75.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.116 -1.402 . . . . 71.430000000000007 112.253 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -74.93 -27.95 60.4 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.929 -0.578 . . . . 71.010000000000005 111.561 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -77.59 93.94 4.28 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.6 0.714 . . . . 70.329999999999998 109.62 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -168.28 98.05 0.43 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.423 -1.262 . . . . 74.019999999999996 107.889 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 158.67 -49.43 0.41 Allowed Glycine 0 C--N 1.293 -1.832 0 N-CA-C 109.99 -1.244 . . . . 53.109999999999999 109.99 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 179.42 145.87 6.5 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 110.845 -0.902 . . . . 71.349999999999994 110.845 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 40.4 pt -94.61 -171.74 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 108.6 -0.889 . . . . 63.210000000000001 108.6 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 66.89 87.57 0.12 Allowed 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 123.313 0.645 . . . . 72.010000000000005 110.385 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 46.4 mm -85.48 88.7 2.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.228 -1.397 . . . . 64.230000000000004 107.228 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 21.5 m -89.88 89.57 7.8 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.334 -0.848 . . . . 65.219999999999999 110.673 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -106.96 139.69 40.96 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.819 -1.178 . . . . 72.140000000000001 107.819 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.55 28.93 8.19 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.151 0.797 . . . . 74.310000000000002 113.151 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 30.6 m -87.59 121.73 30.4 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.347 -0.612 . . . . 71.409999999999997 109.347 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 261' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 10.5 t -99.91 122.78 43.36 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 108.334 -0.987 . . . . 62.229999999999997 108.334 174.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -123.7 137.1 54.77 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.876 -1.157 . . . . 72.409999999999997 107.876 -176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 32.2 t -142.2 125.72 16.75 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.272 -0.64 . . . . 75.129999999999995 109.272 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.15 147.0 32.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.161 -0.681 . . . . 71.549999999999997 109.161 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 27.0 mm-40 -90.03 -76.04 0.44 Allowed 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 110.18 -0.304 . . . . 72.299999999999997 110.18 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 11.2 m -114.31 127.85 56.07 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.211 -0.996 . . . . 74.530000000000001 111.707 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 1.3 p -128.52 122.46 57.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.511 0.672 . . . . 74.319999999999993 110.028 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.7 133.73 68.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.547 -0.751 . . . . 75.109999999999999 112.13 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.34 130.57 6.64 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 108.404 -1.878 . . . . 64.409999999999997 108.404 170.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -134.41 116.51 15.26 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.667 -1.234 . . . . 74.430000000000007 107.667 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.9 -139.81 14.7 Favored Glycine 0 C--N 1.291 -1.939 0 N-CA-C 109.685 -1.366 . . . . 75.140000000000001 109.685 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.52 91.85 2.32 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.18 -1.045 . . . . 72.239999999999995 108.18 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 273' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 23.2 m -131.37 144.67 51.4 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 121.66 0.743 . . . . 75.340000000000003 110.893 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . 0.412 ' HD3' ' HB2' ' C' ' 287' ' ' TRP . 55.2 mtt85 -136.26 127.6 28.35 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 105.723 -1.954 . . . . 74.439999999999998 105.723 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . 0.407 ' HB ' HG22 ' C' ' 239' ' ' VAL . 6.9 t -138.19 140.1 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 109.486 -0.561 . . . . 71.329999999999998 109.486 -175.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.3 tt -128.71 111.93 13.68 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.074 -1.084 . . . . 74.239999999999995 108.074 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 58.1 mt -111.82 103.96 16.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.575 -0.898 . . . . 74.120000000000005 108.575 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.67 -136.02 7.57 Favored Glycine 0 N--CA 1.424 -2.131 0 N-CA-C 110.992 -0.843 . . . . 54.329999999999998 110.992 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 94.3 m-20 -127.88 156.34 42.74 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 110.111 -0.329 . . . . 75.040000000000006 110.111 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.88 138.25 24.18 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.013 -0.539 . . . . 72.0 110.049 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -130.12 122.33 28.05 Favored 'General case' 0 N--CA 1.415 -2.204 0 N-CA-C 107.37 -1.344 . . . . 73.299999999999997 107.37 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.57 -14.14 58.84 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.309 -0.859 . . . . 71.349999999999994 112.447 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -64.78 -58.18 10.6 Favored Glycine 0 CA--C 1.497 -1.038 0 N-CA-C 111.613 -0.595 . . . . 74.439999999999998 111.613 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . 0.53 ' NZ ' ' HB2' ' C' ' 284' ' ' LYS . 6.7 mtmp? 65.84 31.37 9.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.561 1.144 . . . . 71.319999999999993 108.344 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.19 97.15 2.38 Favored Glycine 0 N--CA 1.417 -2.567 0 N-CA-C 108.493 -1.843 . . . . 52.130000000000003 108.493 -172.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -76.22 41.64 0.24 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.262 1.03 . . . . 74.239999999999995 110.844 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . 0.412 ' HB2' ' HD3' ' C' ' 274' ' ' ARG . 1.3 p90 -148.93 156.39 42.22 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-O 122.318 1.056 . . . . 72.510000000000005 113.254 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.36 24.41 0.19 Allowed 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 127.072 2.149 . . . . 72.549999999999997 112.371 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -135.78 5.59 3.13 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.986 -0.686 . . . . 72.150000000000006 110.857 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -147.99 108.4 4.12 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.914 -0.714 . . . . 74.239999999999995 111.359 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -146.04 97.65 2.98 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.191 -1.411 . . . . 65.439999999999998 107.191 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -109.36 -61.91 1.56 Allowed 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.304 -0.862 . . . . 74.430000000000007 110.282 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -174.43 179.26 1.82 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 103.801 -2.666 . . . . 73.129999999999995 103.801 -172.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -79.33 88.17 4.97 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.758 -2.312 . . . . 74.439999999999998 104.758 171.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 . . . . . 0 C--O 1.249 1.048 0 O-C-N 124.886 1.366 . . . . 73.409999999999997 107.811 -169.364 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 C--O 1.244 0.79 0 N-CA-C 109.143 -0.688 . . . . 74.129999999999995 109.143 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp 64.3 -92.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 114.611 1.337 . . . . 71.239999999999995 114.611 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.416 ' H ' HG12 ' B' ' 222' ' ' ILE . 41.8 mt 57.92 28.84 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.382 0 N-CA-C 106.524 -1.658 . . . . 64.400000000000006 106.524 -168.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -95.3 -39.92 9.8 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 113.988 -1.46 . . . . 71.540000000000006 109.968 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -70.59 158.94 35.28 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.695 -1.224 . . . . 63.32 107.695 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 64.2 mt -83.05 114.92 24.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 122.167 0.984 . . . . 74.319999999999993 111.097 -170.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 22.4 m -114.88 164.28 11.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 114.575 -1.193 . . . . 74.319999999999993 108.018 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 114.73 52.28 0.43 Allowed Glycine 0 C--N 1.288 -2.099 0 C-N-CA 119.941 -1.123 . . . . 62.219999999999999 110.493 -174.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.516 ' HG2' HH11 ' A' ' 225' ' ' ARG . 0.0 OUTLIER -114.93 121.73 44.08 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.839 -0.43 . . . . 74.310000000000002 109.839 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -106.62 123.89 48.8 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.945 -1.131 . . . . 72.25 107.945 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 12.2 m -123.91 136.83 54.59 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 116.109 -0.496 . . . . 62.140000000000001 110.393 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.31 138.16 44.76 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.68 -1.23 . . . . 75.25 107.68 175.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -93.43 -53.86 3.9 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.676 -0.49 . . . . 73.230000000000004 109.676 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.83 139.23 52.77 Favored 'General case' 0 C--O 1.252 1.191 0 N-CA-C 109.835 -0.432 . . . . 74.400000000000006 109.835 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 28.4 mm -128.08 116.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 106.279 -1.749 . . . . 75.340000000000003 106.279 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 31.5 ttp-105 -134.43 115.87 14.49 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.606 0.717 . . . . 73.140000000000001 111.489 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.62 ' HB ' ' CB ' ' A' ' 237' ' ' ALA . 4.8 p -129.1 140.47 51.55 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.493 -0.776 . . . . 74.120000000000005 111.227 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -121.04 143.16 49.2 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.542 0.687 . . . . 70.230000000000004 112.573 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 68.79 -100.66 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.394 1.627 . . . . 73.409999999999997 115.394 171.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.615 ' HD2' ' OE2' ' A' ' 272' ' ' GLU . 16.8 mtm180 -99.08 23.39 9.1 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.476 1.131 . . . . 75.409999999999997 110.128 -171.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.62 ' CB ' ' HB ' ' A' ' 233' ' ' THR . . . -84.13 156.17 22.25 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.591 -1.64 . . . . 73.040000000000006 111.835 -176.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . 0.434 ' HD3' ' HG2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -146.18 137.85 24.86 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.502 -0.772 . . . . 64.120000000000005 110.202 174.201 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.487 HG11 ' HB ' ' A' ' 275' ' ' VAL . 29.7 m -132.21 142.49 42.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.394 0.616 . . . . 74.319999999999993 111.892 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.455 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 56.5 tp60 -123.48 135.38 54.03 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.535 -0.757 . . . . 64.340000000000003 109.003 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -123.19 118.17 27.01 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.735 -1.58 . . . . 75.439999999999998 106.735 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.412 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 126.8 -113.0 1.67 Allowed Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 119.756 -1.211 . . . . 74.530000000000001 114.572 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -143.98 131.92 21.57 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 110.114 -0.328 . . . . 73.420000000000002 110.114 -172.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.429 ' CG2' ' HG2' ' A' ' 240' ' ' GLN . 48.9 t -122.14 123.63 69.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.324 -0.621 . . . . 70.239999999999995 109.324 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 12.3 m -113.59 114.62 47.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.176 0.513 . . . . 75.230000000000004 110.364 174.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 24.4 m -96.97 159.76 14.73 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.842 -0.799 . . . . 52.130000000000003 108.842 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.47 75.73 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 123.249 0.62 . . . . 70.129999999999995 111.567 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.25 -42.84 78.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.06 -0.973 . . . . 64.420000000000002 111.985 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -74.38 -45.56 46.06 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.368 -0.378 . . . . 71.329999999999998 110.545 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 59.6 tp 48.34 -95.04 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.19 1.396 . . . . 74.430000000000007 112.622 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -131.49 78.29 1.82 Allowed 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.212 -0.662 . . . . 75.219999999999999 109.212 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -99.02 -55.48 1.05 Allowed Glycine 0 C--N 1.298 -1.565 0 N-CA-C 108.247 -1.941 . . . . 70.310000000000002 108.247 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -162.89 121.96 1.06 Allowed Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 108.428 -1.869 . . . . 74.049999999999997 108.428 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 22.7 pt -128.67 108.06 16.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 117.273 0.537 . . . . 75.340000000000003 110.902 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 60.34 54.68 3.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 122.917 1.341 . . . . 75.549999999999997 110.644 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 69.7 mt -124.16 -52.29 2.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 114.154 -1.385 . . . . 75.310000000000002 109.322 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' B' ' 253' ' ' GLY . 8.6 t -135.22 -4.92 2.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 122.552 1.168 . . . . 70.140000000000001 109.374 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -88.31 19.5 3.75 Favored 'General case' 0 C--N 1.281 -2.377 0 C-N-CA 125.979 1.712 . . . . 71.510000000000005 112.914 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -101.18 86.25 2.98 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.727 0.775 . . . . 74.519999999999996 110.847 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 87.2 m -91.14 138.36 31.66 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.594 -1.185 . . . . 73.540000000000006 109.926 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 52.9 m -102.85 108.12 19.22 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.529 -1.285 . . . . 74.319999999999993 107.529 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 37.2 t-20 -127.11 138.32 53.16 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.197 -0.668 . . . . 65.400000000000006 109.197 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.5 m -128.62 123.14 32.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.737 -0.468 . . . . 75.25 109.737 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.92 150.12 34.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 N-CA-C 110.455 -0.202 . . . . 73.129999999999995 110.455 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.687 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 3.7 tp10 -85.46 -74.91 0.39 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.096 0.559 . . . . 74.319999999999993 110.097 178.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 32.2 m -128.59 134.71 48.68 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 122.146 -0.346 . . . . 72.430000000000007 111.234 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.59 127.07 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.659 -1.237 . . . . 74.239999999999995 107.659 172.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 10.1 p -127.23 134.84 65.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 116.439 -0.346 . . . . 73.349999999999994 110.897 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.424 ' HA2' ' HG1' ' B' ' 233' ' ' THR . . . -128.92 132.75 7.32 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.669 -0.776 . . . . 70.140000000000001 111.999 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -132.09 116.64 17.3 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.748 -0.464 . . . . 74.230000000000004 109.748 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 109.93 -131.56 10.53 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.882 -0.887 . . . . 62.119999999999997 110.882 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.615 ' OE2' ' HD2' ' A' ' 236' ' ' ARG . 10.0 mp0 -92.5 32.3 1.23 Allowed 'General case' 0 C--O 1.252 1.22 0 C-N-CA 125.133 1.373 . . . . 73.420000000000002 110.087 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 16.7 m -81.77 145.22 30.57 Favored 'General case' 0 C--O 1.287 3.077 0 CA-C-O 122.927 1.346 . . . . 54.200000000000003 112.708 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . 0.434 ' HG2' ' HD3' ' A' ' 238' ' ' ARG . 72.1 mtm-85 -127.08 127.79 45.23 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.697 -1.592 . . . . 74.219999999999999 109.27 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.487 ' HB ' HG11 ' A' ' 239' ' ' VAL . 48.9 t -127.81 132.29 69.01 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 CA-C-N 115.957 -0.565 . . . . 73.319999999999993 109.947 -175.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.455 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.8 tt -125.01 128.41 48.52 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 118.151 -1.42 . . . . 74.219999999999999 109.677 173.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 35.0 mm -112.56 105.62 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.657 -0.868 . . . . 74.439999999999998 108.657 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 138.78 -134.02 6.56 Favored Glycine 0 C--N 1.31 -0.883 0 C-N-CA 120.648 -0.787 . . . . 61.43 113.297 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' B' ' 243' ' ' ASN . 15.1 m120 -115.87 128.27 55.67 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 122.574 0.35 . . . . 71.340000000000003 110.816 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.06 118.67 34.05 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.657 -1.609 . . . . 73.010000000000005 106.657 176.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -106.38 123.33 47.89 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.369 -1.345 . . . . 74.329999999999998 107.369 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.56 -50.66 0.79 Allowed Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.391 -1.083 . . . . 70.299999999999997 110.391 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.64 53.3 Favored Glycine 0 C--N 1.308 -1.02 0 N-CA-C 110.747 -0.941 . . . . 34.420000000000002 110.747 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -179.85 27.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.286 1.034 . . . . 74.209999999999994 110.562 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -85.61 -120.72 1.08 Allowed Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 119.944 -1.122 . . . . 54.109999999999999 111.642 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.445 ' HB3' ' HE1' ' B' ' 287' ' ' TRP . 86.8 t80 62.53 -89.07 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.106 0.562 . . . . 73.0 111.362 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -166.89 15.84 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 127.35 2.26 . . . . 71.0 107.206 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -85.2 104.71 15.32 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 104.707 -2.331 . . . . 71.129999999999995 104.707 -176.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.16 135.22 57.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.805 -0.634 . . . . 72.019999999999996 112.183 -171.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -52.11 113.25 0.96 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.054 -0.975 . . . . 74.439999999999998 111.327 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.41 ' H ' ' CD2' ' A' ' 293' ' ' HIS . 58.6 m-70 78.72 6.32 2.34 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.284 1.433 . . . . 74.209999999999994 113.709 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . 0.401 ' C ' ' H ' ' A' ' 294' ' ' HIS . 81.6 t60 -96.74 7.31 46.88 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.274 -1.38 . . . . 72.420000000000002 107.274 174.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . 0.41 ' CD2' ' H ' ' A' ' 291' ' ' HIS . 13.3 m-70 -80.28 14.56 1.89 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.287 -1.324 . . . . 75.340000000000003 109.601 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.401 ' H ' ' C ' ' A' ' 292' ' ' HIS . 3.8 p80 -77.13 62.65 2.26 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.868 1.432 . . . . 75.310000000000002 114.868 -170.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 . . . . . 0 C--N 1.301 -1.537 0 N-CA-C 106.394 -1.706 . . . . 74.450000000000003 106.394 172.175 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 54.1 ttm . . . . . 0 CA--C 1.508 -0.654 0 N-CA-C 109.578 -0.527 . . . . 72.209999999999994 109.578 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 86.6 tttt 75.51 -72.26 0.11 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.429 1.091 . . . . 72.420000000000002 109.799 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 14.8 tt -167.63 13.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 107.52 -1.289 . . . . 74.349999999999994 107.52 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -140.03 150.4 44.35 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.561 -0.745 . . . . 72.439999999999998 109.102 -173.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -96.84 -12.23 23.82 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 112.501 0.556 . . . . 63.109999999999999 112.501 -175.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 219' ' ' ILE . 58.6 mt -90.76 116.09 31.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 120.68 0.276 . . . . 64.310000000000002 110.372 -174.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . 0.402 HG11 HG22 ' C' ' 222' ' ' ILE . 31.0 m -106.22 146.47 12.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 120.815 0.341 . . . . 75.239999999999995 110.639 176.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' B' ' 258' ' ' ASP . . . 134.3 81.43 0.16 Allowed Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 109.719 -1.352 . . . . 55.020000000000003 109.719 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.72 129.5 20.46 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 107.132 -1.433 . . . . 75.109999999999999 107.132 178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 29.6 m-80 -103.87 130.18 51.44 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 107.991 -1.115 . . . . 71.200000000000003 107.991 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 28.6 m -128.61 137.04 51.48 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-O 121.197 0.523 . . . . 71.140000000000001 110.615 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.59 155.55 47.33 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.791 -1.188 . . . . 75.530000000000001 107.791 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.687 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 0.1 OUTLIER -109.0 -61.72 1.58 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 119.51 -0.876 . . . . 73.010000000000005 108.854 -178.435 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -126.63 137.8 53.35 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.84 -0.8 . . . . 75.420000000000002 108.84 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 18.5 mm -131.66 117.55 35.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 106.874 -1.528 . . . . 73.140000000000001 106.874 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -130.38 118.81 21.78 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.345 0.593 . . . . 73.519999999999996 111.492 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' THR . . . . . 0.424 ' HG1' ' HA2' ' A' ' 269' ' ' GLY . 34.5 p -110.72 128.14 55.61 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.352 -0.84 . . . . 71.319999999999993 109.31 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -125.01 142.38 51.52 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.035 0.445 . . . . 73.319999999999993 111.04 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 74.76 -102.37 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.388 0 C-N-CA 125.011 1.324 . . . . 72.030000000000001 113.084 174.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.659 ' HD3' ' N ' ' B' ' 236' ' ' ARG . 0.7 OUTLIER -110.37 25.49 11.73 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.723 0.773 . . . . 73.019999999999996 109.448 -175.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -82.99 142.45 31.36 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 122.568 1.175 . . . . 75.420000000000002 112.759 -175.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -131.65 135.86 47.25 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.542 -1.208 . . . . 73.200000000000003 109.506 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.512 HG12 ' HB ' ' B' ' 275' ' ' VAL . 2.6 m -125.31 141.27 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 CA-C-O 121.869 0.843 . . . . 71.530000000000001 111.538 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.443 ' HB3' ' HG ' ' B' ' 276' ' ' LEU . 5.9 tp-100 -116.41 128.38 55.45 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 114.074 -1.421 . . . . 72.230000000000004 107.643 174.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -120.38 117.31 27.41 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.927 -1.509 . . . . 72.439999999999998 106.927 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.405 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 125.92 -112.23 1.61 Allowed Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.554 -1.308 . . . . 74.310000000000002 113.143 176.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . 0.46 ' HB3' ' ND2' ' A' ' 279' ' ' ASN . 25.7 t-20 -144.97 138.36 26.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 111.556 0.206 . . . . 72.349999999999994 111.556 -174.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.436 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 45.2 t -119.9 133.7 65.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.605 -0.887 . . . . 73.450000000000003 108.605 175.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 19.3 t -122.28 112.11 33.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 108.943 -0.762 . . . . 72.040000000000006 108.943 177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 23.5 m -95.49 158.95 15.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.97 -1.122 . . . . 62.329999999999998 107.97 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.39 -39.7 94.37 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.792 0.806 . . . . 74.400000000000006 110.553 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.89 -34.47 65.57 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.425 -1.716 . . . . 64.120000000000005 114.157 -175.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.03 -33.27 74.27 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.313 0.486 . . . . 74.310000000000002 112.313 -176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 90.8 mt 68.23 165.05 0.24 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.182 0.993 . . . . 75.510000000000005 111.135 -175.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -86.61 66.74 9.62 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.669 1.224 . . . . 72.439999999999998 110.783 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' C' ' 252' ' ' GLY . . . -91.11 -15.85 55.12 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 109.499 -1.44 . . . . 75.030000000000001 109.499 176.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 257' ' ' SER . . . -85.76 119.49 5.11 Favored Glycine 0 N--CA 1.419 -2.471 0 CA-C-N 114.857 -0.672 . . . . 64.439999999999998 111.702 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 10.0 tt -125.73 -36.9 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.171 0.51 . . . . 72.109999999999999 110.523 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -112.76 -14.49 13.1 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.929 -0.482 . . . . 74.010000000000005 110.696 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . 0.463 HG13 ' NE2' ' B' ' 259' ' ' GLN . 17.0 tt -78.95 3.28 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 CA-C-O 121.383 0.611 . . . . 73.519999999999996 111.119 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.8 m -58.01 98.3 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.301 1.44 . . . . 74.310000000000002 111.454 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.491 ' O ' ' HA3' ' B' ' 224' ' ' GLY . 34.5 t0 37.54 85.3 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.871 2.068 . . . . 73.409999999999997 113.488 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . 0.463 ' NE2' HG13 ' B' ' 256' ' ' ILE . 42.0 mt-30 -87.25 -36.18 18.08 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.278 -1.328 . . . . 74.530000000000001 109.414 -178.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 260' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' C' ' 243' ' ' ASN . 0.1 OUTLIER -65.02 120.65 13.02 Favored 'General case' 0 N--CA 1.396 -3.142 0 CA-C-N 113.33 -1.759 . . . . 64.200000000000003 113.665 -172.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 63.9 m -100.74 105.95 17.33 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 104.139 -2.541 . . . . 73.230000000000004 104.139 167.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . 0.416 HD22 HD21 ' C' ' 241' ' ' LEU . 54.7 t30 -128.44 142.02 51.22 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.097 -0.956 . . . . 73.319999999999993 109.886 -171.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 39.6 m -137.2 128.07 27.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.807 0.337 . . . . 63.409999999999997 110.948 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.2 p -128.39 153.72 38.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.795 -0.817 . . . . 74.409999999999997 108.795 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -96.2 -76.35 0.51 Allowed 'General case' 0 N--CA 1.418 -2.029 0 C-N-CA 120.156 -0.617 . . . . 64.310000000000002 111.452 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -116.37 128.43 55.52 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.765 -0.774 . . . . 72.019999999999996 112.635 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 11.8 m -118.45 129.08 75.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.197 0 N-CA-C 107.793 -1.188 . . . . 74.129999999999995 107.793 171.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.83 128.25 70.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.978 -0.555 . . . . 74.519999999999996 111.126 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . 0.449 ' HA2' ' HG1' ' C' ' 233' ' ' THR . . . -116.06 132.01 9.95 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.361 -1.096 . . . . 63.039999999999999 110.361 175.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -131.99 116.4 17.06 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.491 -0.559 . . . . 75.200000000000003 109.491 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 100.56 -137.66 13.39 Favored Glycine 0 C--N 1.309 -0.92 0 N-CA-C 111.139 -0.784 . . . . 73.349999999999994 111.139 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 2.4 mp0 -77.22 40.43 0.27 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.993 1.317 . . . . 75.530000000000001 110.177 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 273' ' ' SER . . . . . 0.549 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 39.0 m -82.92 144.66 29.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.979 0.895 . . . . 73.310000000000002 112.503 -169.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 32.5 mtt180 -130.75 127.21 38.3 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.58 -1.637 . . . . 73.530000000000001 106.58 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.512 ' HB ' HG12 ' B' ' 239' ' ' VAL . 89.4 t -135.06 130.34 51.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.377 -0.601 . . . . 72.310000000000002 109.377 -176.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 7.0 tt -122.09 125.41 46.14 Favored 'General case' 0 C--N 1.277 -2.553 0 C-N-CA 117.7 -1.6 . . . . 73.319999999999993 110.144 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 29.1 mm -110.51 103.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.043 -1.465 . . . . 75.530000000000001 107.043 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 139.76 -147.65 19.35 Favored Glycine 0 C--N 1.308 -0.976 0 C-N-CA 120.197 -1.002 . . . . 62.43 113.694 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 0.9 OUTLIER -106.64 129.8 54.49 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.957 -0.386 . . . . 71.439999999999998 109.957 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.94 118.69 36.17 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.511 -1.663 . . . . 71.109999999999999 106.511 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -107.62 123.15 48.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.694 -0.854 . . . . 75.349999999999994 108.694 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 139.46 -50.17 0.79 Allowed Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 109.79 -1.324 . . . . 72.049999999999997 109.79 -176.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 94.53 17.05 40.48 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.738 -0.945 . . . . 72.109999999999999 110.738 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt 174.05 27.77 0.0 OUTLIER 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.784 1.234 . . . . 73.519999999999996 109.726 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.22 -113.36 0.23 Allowed Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.011 -0.836 . . . . 75.420000000000002 111.011 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.428 ' H ' HG12 ' B' ' 244' ' ' VAL . 92.7 t80 60.61 -83.53 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.39 0.676 . . . . 73.329999999999998 111.646 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.445 ' HE1' ' HB3' ' A' ' 286' ' ' PHE . 3.5 m-90 -162.63 48.86 0.17 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 126.477 1.911 . . . . 74.230000000000004 108.672 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 9.0 t70 67.2 -166.38 0.21 Allowed 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 114.562 -1.199 . . . . 71.129999999999995 109.392 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -153.33 127.37 9.01 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 121.505 -0.747 . . . . 75.349999999999994 112.138 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -121.57 178.6 4.76 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.003 -0.74 . . . . 74.230000000000004 109.003 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -100.18 -75.64 0.57 Allowed 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 114.174 1.176 . . . . 73.200000000000003 114.174 -173.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -135.73 129.35 32.49 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.803 -0.359 . . . . 75.109999999999999 110.999 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -144.14 165.87 26.61 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 105.704 -1.961 . . . . 73.120000000000005 105.704 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -165.88 151.24 8.75 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.075 -0.713 . . . . 75.409999999999997 109.075 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 73.2 t60 . . . . . 0 C--N 1.299 -1.618 0 N-CA-C 107.807 -1.182 . . . . 74.230000000000004 107.807 176.715 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 CA--C 1.508 -0.637 0 N-CA-C 110.063 -0.347 . . . . 74.129999999999995 110.063 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -126.47 114.94 18.82 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.692 -0.484 . . . . 74.409999999999997 109.692 -172.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . 0.466 HD11 ' H ' ' C' ' 219' ' ' ILE . 0.2 OUTLIER -96.56 68.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-O 122.221 1.01 . . . . 73.109999999999999 110.295 178.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -155.11 144.49 21.17 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 114.25 -1.341 . . . . 72.319999999999993 108.831 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 68.77 -72.21 0.1 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.411 1.484 . . . . 73.209999999999994 114.076 173.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . 0.402 HG22 HG11 ' B' ' 223' ' ' VAL . 66.9 mt -83.91 114.66 24.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.364 0.602 . . . . 75.420000000000002 110.324 -175.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' C' ' 258' ' ' ASP . 26.8 m -112.05 143.05 22.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.522 -0.918 . . . . 75.030000000000001 108.522 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' C' ' 260' ' ' THR . . . 137.64 52.39 0.06 OUTLIER Glycine 0 C--N 1.297 -1.602 0 C-N-CA 119.798 -1.192 . . . . 61.009999999999998 111.513 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.24 138.58 52.24 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.756 -0.831 . . . . 75.129999999999995 108.756 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 40.8 m-80 -110.25 132.63 54.0 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 108.028 -1.101 . . . . 64.400000000000006 108.028 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 17.2 m -129.38 136.72 50.33 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 116.318 -0.401 . . . . 74.140000000000001 110.019 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -137.4 147.08 45.18 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.565 -0.902 . . . . 73.109999999999999 108.565 178.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.86 -64.65 1.03 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.936 -0.394 . . . . 75.120000000000005 109.936 -177.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.59 138.03 52.75 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 108.928 -0.767 . . . . 70.129999999999995 108.928 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 10.9 mm -132.0 117.46 33.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 106.552 -1.648 . . . . 75.540000000000006 106.552 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -126.03 122.12 34.96 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.585 -0.846 . . . . 74.409999999999997 112.413 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 233' ' ' THR . . . . . 0.531 ' CG2' HG11 ' C' ' 239' ' ' VAL . 17.3 p -110.47 126.99 54.92 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.051 -0.977 . . . . 73.329999999999998 109.19 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -128.93 142.77 50.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.036 0.446 . . . . 65.140000000000001 111.087 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 51.9 mt-10 78.75 -90.01 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 125.571 1.548 . . . . 72.400000000000006 113.971 173.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.46 ' HD3' ' OE2' ' C' ' 272' ' ' GLU . 0.0 OUTLIER -126.25 28.67 5.98 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.043 -1.095 . . . . 74.329999999999998 108.043 -177.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -82.58 146.42 29.17 Favored 'General case' 0 C--O 1.265 1.882 0 CA-C-O 122.794 1.283 . . . . 71.450000000000003 113.844 -174.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.1 OUTLIER -131.84 135.53 46.78 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.23 -1.35 . . . . 72.049999999999997 109.541 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.531 HG11 ' CG2' ' C' ' 233' ' ' THR . 25.8 m -134.91 141.74 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 CA-C-O 121.936 0.874 . . . . 73.510000000000005 111.94 176.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . 0.429 HE22 HD22 ' B' ' 276' ' ' LEU . 48.7 tp60 -110.83 133.19 53.57 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 113.985 -1.461 . . . . 74.310000000000002 108.304 176.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.416 HD21 HD22 ' B' ' 262' ' ' ASN . 3.1 tm? -125.26 117.01 22.87 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 106.249 -1.76 . . . . 75.239999999999995 106.249 177.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 125.88 -115.14 2.26 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 119.407 -1.378 . . . . 64.409999999999997 113.624 176.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 12.9 t-20 -144.34 137.54 27.22 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 110.008 -0.367 . . . . 73.030000000000001 110.008 -173.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . 0.46 HG13 ' H ' ' C' ' 286' ' ' PHE . 60.1 t -124.26 124.84 69.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.377 -0.601 . . . . 74.140000000000001 109.377 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 32.4 t -116.21 111.85 37.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.853 -0.795 . . . . 75.120000000000005 108.853 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.8 m -94.93 159.68 14.92 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.226 -1.028 . . . . 63.340000000000003 108.226 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.45 -39.96 94.82 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.685 0.755 . . . . 74.319999999999993 110.418 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -33.23 61.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.608 -1.633 . . . . 75.340000000000003 112.155 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.77 -45.96 63.79 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.15 -0.477 . . . . 50.130000000000003 112.132 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . 0.409 ' C ' ' H ' ' C' ' 252' ' ' GLY 0.25 1.2 pt? 49.4 28.17 2.28 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.745 1.387 . . . . 72.349999999999994 114.745 -175.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -80.45 28.87 0.31 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.762 -0.586 . . . . 75.319999999999993 110.085 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' C' ' 250' ' ' LEU . . . -75.5 -27.06 64.12 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 114.55 0.58 . . . . 42.32 114.55 -172.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -97.68 22.64 39.76 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 121.242 -0.504 . . . . 73.219999999999999 113.05 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 9.0 tp -149.93 158.82 5.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.357 -0.979 . . . . 75.450000000000003 108.357 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -119.04 141.29 48.85 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.4 0.619 . . . . 74.409999999999997 111.734 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 6.7 tt -136.79 68.05 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 106.567 -1.642 . . . . 75.219999999999999 106.567 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 257' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' B' ' 259' ' ' GLN . 47.4 t -103.56 15.49 28.81 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 112.695 -2.048 . . . . 63.32 107.275 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . 0.441 ' OD2' ' HG3' ' C' ' 259' ' ' GLN . 8.1 p-10 -128.5 -177.22 4.08 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 113.754 -1.566 . . . . 71.219999999999999 107.573 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . 0.441 ' HG3' ' OD2' ' C' ' 258' ' ' ASP . 96.7 mt-30 72.37 -65.96 0.33 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.15 0.98 . . . . 72.409999999999997 111.999 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 260' ' ' THR . . . . . 0.496 ' O ' ' HA2' ' C' ' 224' ' ' GLY . 23.6 m -86.84 118.36 26.18 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.855 -0.738 . . . . 75.340000000000003 110.358 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 7.7 t -136.05 108.28 7.27 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 104.771 -2.307 . . . . 72.319999999999993 104.771 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 49.6 t30 -125.82 139.24 53.66 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.086 -0.506 . . . . 64.310000000000002 111.095 -168.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 13.1 t -129.38 123.5 31.87 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.438 -0.949 . . . . 61.140000000000001 108.438 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.01 153.92 34.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.165 -1.05 . . . . 73.120000000000005 108.165 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -97.56 -79.87 0.46 Allowed 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 120.028 -0.669 . . . . 72.409999999999997 111.403 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 29.2 m -120.07 127.73 52.82 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.145 -0.622 . . . . 72.140000000000001 111.812 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.9 m -118.7 127.3 75.66 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-O 121.621 0.724 . . . . 73.319999999999993 109.292 174.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.05 120.22 63.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.406 -0.815 . . . . 74.329999999999998 109.23 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.83 131.67 9.93 Favored Glycine 0 N--CA 1.416 -2.682 0 C-N-CA 119.635 -1.269 . . . . 71.150000000000006 111.114 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -133.33 133.84 43.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.491 -0.929 . . . . 63.530000000000001 108.491 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.77 -132.84 11.43 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.264 -0.969 . . . . 63.100000000000001 111.469 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . 0.46 ' OE2' ' HD3' ' C' ' 236' ' ' ARG . 4.5 mp0 -91.37 52.83 2.16 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.945 -1.131 . . . . 74.129999999999995 107.945 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 273' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 21.7 t -83.71 145.63 28.64 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 115.141 -0.936 . . . . 64.109999999999999 110.974 -174.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 17.2 mtm180 -141.12 127.5 19.87 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.785 -1.191 . . . . 73.439999999999998 107.785 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . 0.471 ' HB ' HG12 ' C' ' 239' ' ' VAL . 13.6 t -137.2 138.95 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.14 -1.059 . . . . 63.32 108.14 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 8.8 tt -123.99 114.75 20.19 Favored 'General case' 0 N--CA 1.404 -2.768 0 C-N-CA 118.875 -1.13 . . . . 73.019999999999996 109.916 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 47.5 mm -102.51 103.04 14.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 106.674 -1.602 . . . . 74.040000000000006 106.674 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 145.54 -145.67 15.09 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.014 -1.089 . . . . 73.140000000000001 113.232 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.46 131.83 55.89 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 122.868 0.467 . . . . 64.030000000000001 109.764 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.64 118.54 32.39 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.702 -1.592 . . . . 64.239999999999995 106.702 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.29 123.34 49.92 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.63 -0.878 . . . . 72.120000000000005 108.63 176.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.98 -45.06 0.96 Allowed Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 110.632 -0.987 . . . . 74.530000000000001 110.632 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 94.28 4.36 62.75 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.61 -0.996 . . . . 55.119999999999997 110.61 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -170.71 28.75 0.02 OUTLIER 'General case' 0 C--O 1.247 0.948 0 C-N-CA 123.756 0.822 . . . . 75.010000000000005 109.671 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.37 -124.45 0.44 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.766 -0.933 . . . . 63.119999999999997 110.766 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.46 ' H ' HG13 ' C' ' 244' ' ' VAL . 88.1 t80 65.91 -78.67 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.351 0.66 . . . . 65.239999999999995 111.187 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -157.34 23.24 0.3 Allowed 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.574 1.15 . . . . 75.310000000000002 109.045 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 10.4 t70 61.57 -150.6 0.39 Allowed 'General case' 0 C--O 1.254 1.298 0 N-CA-C 105.096 -2.187 . . . . 72.519999999999996 105.096 -173.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 m120 68.41 149.82 0.07 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.644 1.177 . . . . 72.25 111.719 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 69.08 148.7 0.07 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.985 0.897 . . . . 74.340000000000003 112.407 173.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -79.1 96.77 5.92 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.145 -1.428 . . . . 75.319999999999993 107.145 172.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -58.98 119.07 6.56 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.986 -1.461 . . . . 53.119999999999997 111.213 -170.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -87.55 128.68 35.25 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.043 -1.465 . . . . 75.439999999999998 107.043 176.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -78.94 139.78 38.19 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.81 0.815 . . . . 74.230000000000004 112.27 -175.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 . . . . . 0 C--N 1.288 -2.083 0 N-CA-C 106.858 -1.534 . . . . 74.340000000000003 106.858 175.163 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 16.0 tmm? . . . . . 0 C--O 1.24 0.567 0 N-CA-C 107.963 -1.125 . . . . 72.319999999999993 107.963 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -73.61 95.67 2.34 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 123.398 0.679 . . . . 73.109999999999999 111.883 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 43.4 pt -87.69 149.17 4.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.812 -0.631 . . . . 75.530000000000001 109.516 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -92.27 80.27 5.0 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.097 0.951 . . . . 75.010000000000005 110.62 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -144.54 81.95 1.67 Allowed 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.03 -1.441 . . . . 73.319999999999993 107.617 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 3.3 mp -111.81 124.62 68.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.312 -0.858 . . . . 73.200000000000003 110.355 -177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.8 m -107.25 164.99 4.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.367 -1.345 . . . . 74.540000000000006 107.367 173.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -65.73 87.49 0.1 Allowed Glycine 0 C--N 1.316 -0.578 0 C-N-CA 121.132 -0.556 . . . . 74.549999999999997 111.999 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -94.63 123.62 38.18 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.904 0.383 . . . . 72.519999999999996 110.041 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -112.53 130.87 55.86 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.295 -1.372 . . . . 75.0 107.295 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.7 m -135.62 136.77 41.28 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.146 0.498 . . . . 63.340000000000003 111.044 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . 0.449 ' HB1' HG21 ' A' ' 277' ' ' ILE . . . -116.2 131.17 57.02 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.334 -0.988 . . . . 64.299999999999997 108.334 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 4.1 tmmm? -81.39 -62.08 1.76 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.701 -0.481 . . . . 75.209999999999994 109.701 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -130.17 140.25 50.77 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.57 0.224 . . . . 75.219999999999999 111.401 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 48.7 mt -131.84 119.47 41.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.857 -0.794 . . . . 72.019999999999996 108.857 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -112.04 126.1 54.8 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.835 -0.431 . . . . 74.25 109.835 176.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.48 128.2 30.97 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 120.979 0.419 . . . . 74.099999999999994 110.395 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.25 159.73 39.15 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.416 -0.811 . . . . 73.030000000000001 109.956 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 63.3 72.2 0.49 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.551 0.741 . . . . 73.549999999999997 112.634 177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.31 22.71 8.04 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.177 0.991 . . . . 74.25 113.031 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.41 145.76 28.82 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.107 0.48 . . . . 65.129999999999995 111.077 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -127.63 134.94 49.64 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.787 -0.642 . . . . 74.319999999999993 110.382 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 77.8 t -123.44 132.32 71.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.566 -0.743 . . . . 74.25 110.493 -174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.478 ' CG ' HD13 ' A' ' 276' ' ' LEU . 55.5 tp60 -118.23 114.81 23.58 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.252 -1.018 . . . . 74.329999999999998 108.252 174.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -115.69 121.97 44.12 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.275 -1.379 . . . . 74.409999999999997 107.275 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.48 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 136.48 -119.74 2.04 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 119.946 -1.121 . . . . 61.240000000000002 112.525 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -144.18 129.04 18.4 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 110.09 -0.337 . . . . 70.519999999999996 110.09 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.0 t -112.57 120.98 64.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.452 -0.573 . . . . 73.329999999999998 109.452 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 25.8 m -117.99 112.17 37.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.594 0.711 . . . . 72.450000000000003 109.665 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 17.1 m -77.8 159.65 28.87 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.755 -0.657 . . . . 73.420000000000002 109.665 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.14 90.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.206 0.527 . . . . 73.510000000000005 110.654 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.64 -33.33 63.95 Favored 'General case' 0 C--O 1.211 -0.973 0 C-N-CA 124.891 1.276 . . . . 73.329999999999998 112.325 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' B' ' 247' ' ' ALA . . . -67.24 -32.48 73.55 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.366 -0.834 . . . . 73.430000000000007 112.865 -176.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 60.85 99.8 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 O-C-N 123.855 0.722 . . . . 70.510000000000005 109.747 -170.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -72.59 86.46 1.19 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.213 0.82 . . . . 70.439999999999998 113.213 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -156.89 81.31 0.16 Allowed Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 109.124 -1.591 . . . . 74.239999999999995 109.124 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -71.03 154.89 52.46 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 112.493 -0.243 . . . . 51.329999999999998 112.493 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 62.6 mt -113.47 94.73 3.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.388 -0.597 . . . . 72.230000000000004 109.388 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 51.3 94.78 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.6 1.333 . . . . 74.420000000000002 114.6 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 49.9 mt -84.04 83.81 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 106.861 -1.533 . . . . 63.140000000000001 106.861 174.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 39.8 m -85.82 -53.91 4.84 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.037 -0.983 . . . . 73.319999999999993 112.808 -173.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.402 ' CG ' HH22 ' C' ' 255' ' ' ARG . 8.5 t70 -130.0 101.01 5.65 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.207 -1.034 . . . . 73.329999999999998 108.207 -174.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.13 161.1 18.86 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.633 -0.712 . . . . 74.400000000000006 109.912 -174.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 51.9 m -87.08 138.44 31.49 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 124.646 1.178 . . . . 73.340000000000003 110.995 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -97.0 136.2 37.91 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 108.118 -1.067 . . . . 71.409999999999997 108.118 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' B' ' 226' ' ' ASN . 15.4 m120 -120.87 140.4 51.84 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.999 0.428 . . . . 75.219999999999999 110.162 -176.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 42.6 m -142.13 123.8 15.06 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.846 -0.427 . . . . 71.310000000000002 109.846 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.3 p -122.53 138.48 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 109.971 -0.381 . . . . 73.530000000000001 109.971 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 65.1 mm-40 -81.17 -68.67 0.67 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.406 -0.361 . . . . 74.140000000000001 111.387 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 99.1 m -125.56 128.33 47.78 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.432 -0.507 . . . . 75.319999999999993 112.296 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.3 p -125.02 123.77 66.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.685 -0.857 . . . . 73.129999999999995 108.685 173.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.07 139.54 51.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.888 0.375 . . . . 75.200000000000003 111.077 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.76 132.34 8.13 Favored Glycine 0 N--CA 1.423 -2.18 0 C-N-CA 121.019 -0.61 . . . . 71.5 111.756 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -133.23 116.46 16.24 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.431 -0.581 . . . . 73.450000000000003 109.431 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.59 73.78 1.15 Allowed Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.386 -0.911 . . . . 74.200000000000003 113.322 173.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 56.35 53.65 8.53 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 113.788 1.033 . . . . 75.450000000000003 113.788 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 50.3 m -88.09 144.4 26.52 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 107.352 -1.351 . . . . 75.129999999999995 107.352 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 2.3 mpt_? -128.1 125.31 38.97 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 105.479 -2.045 . . . . 73.340000000000003 105.479 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.402 HG11 HG22 ' B' ' 239' ' ' VAL . 4.4 m -130.54 140.19 49.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 C-N-CA 119.936 -0.706 . . . . 72.530000000000001 110.122 -174.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.502 ' HB3' ' CZ2' ' A' ' 287' ' ' TRP . 11.1 tp -125.11 118.64 26.58 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.649 0.738 . . . . 74.420000000000002 109.62 175.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.449 HG21 ' HB1' ' A' ' 228' ' ' ALA . 14.4 mt -113.18 104.43 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.936 0 CA-C-N 113.942 -1.481 . . . . 71.010000000000005 107.229 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.507 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 151.8 -129.08 2.71 Favored Glycine 0 N--CA 1.423 -2.206 0 C-N-CA 120.278 -0.963 . . . . 51.210000000000001 112.658 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -123.92 141.76 51.75 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.181 -0.674 . . . . 74.049999999999997 109.181 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.424 ' HB2' HE22 ' B' ' 240' ' ' GLN . 5.6 tm-20 -130.72 123.05 28.39 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.257 -1.016 . . . . 72.430000000000007 108.257 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.482 ' HD1' ' O ' ' B' ' 245' ' ' VAL . 7.4 t80 -116.01 124.01 49.43 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 107.96 -1.126 . . . . 72.219999999999999 107.96 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.421 ' HA2' ' HB3' ' A' ' 249' ' ' ALA . . . 144.68 -64.34 0.46 Allowed Glycine 0 N--CA 1.424 -2.139 0 CA-C-N 115.323 -0.853 . . . . 74.019999999999996 111.434 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 124.51 25.1 1.65 Allowed Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 120.44 -0.886 . . . . 42.539999999999999 113.018 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.91 -5.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.159 0.8 . . . . 73.120000000000005 113.159 174.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.28 -132.26 38.23 Favored Glycine 0 CA--C 1.505 -0.588 0 N-CA-C 115.157 0.823 . . . . 63.109999999999999 115.157 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -98.77 -3.25 36.06 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.4 -0.593 . . . . 74.310000000000002 109.4 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . 0.502 ' CZ2' ' HB3' ' A' ' 276' ' ' LEU . 10.9 m-90 -80.55 -48.02 13.36 Favored 'General case' 0 CA--C 1.49 -1.34 0 CA-C-N 115.711 -0.677 . . . . 73.439999999999998 110.506 -176.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 30.5 t70 62.6 92.94 0.05 Allowed 'General case' 0 CA--C 1.508 -0.636 0 O-C-N 125.589 1.805 . . . . 70.409999999999997 108.112 -169.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.86 119.85 39.28 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.224 -0.898 . . . . 73.019999999999996 111.908 -171.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -77.85 114.62 16.88 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.974 -1.121 . . . . 75.530000000000001 107.974 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -76.61 122.4 24.58 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 106.553 -1.647 . . . . 75.420000000000002 106.553 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -63.24 106.24 0.85 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.626 0.727 . . . . 64.329999999999998 109.472 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -53.04 -54.65 32.28 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.76 -1.564 . . . . 75.109999999999999 113.362 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -154.78 163.72 39.85 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.355 -0.609 . . . . 73.340000000000003 109.355 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 . . . . . 0 C--N 1.307 -1.246 0 N-CA-C 108.102 -1.073 . . . . 70.040000000000006 108.102 -177.195 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.519 -0.223 0 N-CA-C 107.382 -1.34 . . . . 73.230000000000004 107.382 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.494 ' HB2' ' HZ2' ' B' ' 218' ' ' LYS . 9.9 mtmp? -125.58 56.75 1.36 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.753 -0.832 . . . . 73.109999999999999 108.753 174.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 82.6 mt -76.48 115.69 18.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 114.945 -1.025 . . . . 74.409999999999997 110.203 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . 0.468 ' O ' HD13 ' B' ' 222' ' ' ILE . 12.9 t70 -85.39 104.33 15.1 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 105.604 -1.999 . . . . 70.230000000000004 105.604 176.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.54 113.7 3.47 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 123.465 0.478 . . . . 72.0 111.121 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . 0.468 HD13 ' O ' ' B' ' 220' ' ' ASP . 3.5 mp -82.92 114.82 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 108.602 -0.888 . . . . 74.510000000000005 108.602 178.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . 0.488 ' O ' ' HG3' ' B' ' 225' ' ' ARG . 26.9 m -106.52 166.62 3.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 107.004 -1.48 . . . . 74.120000000000005 107.004 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . 0.413 ' N ' ' HB3' ' B' ' 259' ' ' GLN . . . -54.36 115.45 5.27 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.228 -1.149 . . . . 70.030000000000001 110.228 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' B' ' 223' ' ' VAL . 97.5 mtt180 -116.75 122.42 44.42 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.673 -0.862 . . . . 65.019999999999996 108.673 -177.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.468 ' HB3' ' ND2' ' A' ' 262' ' ' ASN . 25.1 t-20 -116.46 115.95 26.76 Favored 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 108.01 -1.107 . . . . 72.209999999999994 108.01 175.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 16.3 m -121.25 136.8 54.91 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-O 121.377 0.608 . . . . 71.120000000000005 110.799 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.541 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -124.66 124.09 41.45 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.649 -1.16 . . . . 74.040000000000006 108.357 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 0.3 OUTLIER -81.04 -57.5 3.5 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.658 -0.497 . . . . 74.400000000000006 109.658 -178.412 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -136.36 138.4 41.58 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.126 -0.63 . . . . 73.150000000000006 110.568 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 18.5 mt -130.36 119.19 45.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.419 -1.326 . . . . 70.239999999999995 107.419 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -117.16 115.53 25.51 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.733 -0.84 . . . . 74.019999999999996 108.733 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 69.4 p -112.84 127.29 56.14 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.303 -0.999 . . . . 74.510000000000005 108.303 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -134.55 139.25 45.27 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 120.07 -0.652 . . . . 73.129999999999995 109.398 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.445 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 44.8 mt-10 59.82 93.62 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 115.717 1.747 . . . . 75.310000000000002 115.717 170.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.445 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 2.8 mpt_? 62.75 20.12 11.9 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.1 -0.955 . . . . 72.439999999999998 110.954 172.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -84.1 141.83 30.83 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.935 -0.575 . . . . 63.520000000000003 110.48 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 7.9 mpt_? -124.69 133.93 53.04 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.788 -1.56 . . . . 74.200000000000003 106.788 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.454 ' CG1' HG23 ' B' ' 275' ' ' VAL . 23.4 m -135.84 147.56 28.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.559 -0.856 . . . . 74.230000000000004 111.467 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.589 ' CG ' HD11 ' B' ' 276' ' ' LEU . 5.5 tp-100 -124.01 120.33 32.12 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.226 -1.352 . . . . 75.120000000000005 108.425 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . 0.429 HD12 HG22 ' A' ' 277' ' ' ILE . 2.9 tm? -118.09 117.71 29.93 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.133 -1.803 . . . . 75.120000000000005 106.133 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.513 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 139.82 -121.39 2.02 Favored Glycine 0 N--CA 1.412 -2.909 0 C-N-CA 119.398 -1.382 . . . . 73.099999999999994 112.902 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . 0.459 HD22 HG12 ' B' ' 245' ' ' VAL . 8.2 t30 -143.27 130.35 20.71 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.083 0.468 . . . . 72.140000000000001 111.528 -174.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 98.5 t -112.58 126.7 70.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.382 -0.826 . . . . 74.420000000000002 109.254 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . 0.482 ' O ' ' HD1' ' A' ' 281' ' ' TYR . 4.1 m -122.03 113.7 39.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 108.134 -1.061 . . . . 73.140000000000001 108.134 173.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' THR . . . . . 0.446 HG22 ' HD3' ' B' ' 284' ' ' LYS . 17.3 m -77.43 160.7 28.53 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.708 -0.849 . . . . 74.319999999999993 108.708 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 249' ' ' ALA . . . -61.74 -46.26 90.4 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 122.406 1.098 . . . . 63.450000000000003 109.807 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.39 -34.29 68.71 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 112.843 -1.98 . . . . 74.129999999999995 112.991 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.41 ' HA ' ' HB3' ' C' ' 247' ' ' ALA . . . -59.86 -26.86 66.18 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.224 0.61 . . . . 74.140000000000001 112.563 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 9.3 mp -75.7 80.96 2.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.286 1.041 . . . . 73.319999999999993 112.248 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -122.89 6.82 9.31 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.237 -1.764 . . . . 73.340000000000003 106.237 174.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -163.48 -153.77 7.43 Favored Glycine 0 N--CA 1.428 -1.847 0 N-CA-C 109.155 -1.578 . . . . 62.32 109.155 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -98.61 158.04 20.33 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.757 -0.735 . . . . 73.549999999999997 111.542 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 64.3 mt -82.74 91.86 2.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 122.203 1.002 . . . . 73.329999999999998 110.029 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -155.19 144.69 21.22 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.653 -1.158 . . . . 75.049999999999997 107.958 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 30.5 pt -88.44 163.83 2.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 120.584 -0.446 . . . . 75.040000000000006 110.864 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.3 p -67.58 -69.9 0.29 Allowed 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 122.545 0.338 . . . . 74.140000000000001 110.631 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -129.22 159.48 35.95 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.768 -1.197 . . . . 74.299999999999997 107.768 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . 0.413 ' HB3' ' N ' ' B' ' 224' ' ' GLY . 25.2 mt-30 -94.17 90.86 6.52 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.193 0.521 . . . . 74.099999999999994 110.605 -172.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 29.8 m -90.49 139.13 30.98 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.419 -0.81 . . . . 74.329999999999998 109.432 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 261' ' ' THR . . . . . 0.553 ' CG2' ' HG2' ' C' ' 225' ' ' ARG . 9.0 t -107.18 132.47 53.01 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.537 0.684 . . . . 74.150000000000006 109.373 177.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . 0.538 ' ND2' ' HB3' ' C' ' 226' ' ' ASN . 15.3 m120 -123.23 137.61 54.84 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.458 -0.792 . . . . 70.030000000000001 108.95 -177.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.3 m -139.24 123.62 18.2 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.667 -0.494 . . . . 74.299999999999997 109.667 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 9.2 p -117.77 141.14 38.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 120.866 0.365 . . . . 75.040000000000006 110.559 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 21.8 mm-40 -81.7 -69.03 0.64 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.595 -0.73 . . . . 62.530000000000001 110.745 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 29.2 m -133.1 127.44 33.99 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.796 -0.762 . . . . 73.099999999999994 112.183 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 3.6 p -123.51 124.18 69.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.972 -0.751 . . . . 74.25 108.972 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 8.5 p -127.32 136.97 59.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.131 0.491 . . . . 74.109999999999999 111.766 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.99 133.07 10.6 Favored Glycine 0 CA--C 1.471 -2.686 0 CA-C-N 115.514 -0.766 . . . . 74.340000000000003 111.283 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -133.19 115.13 14.65 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 109.358 -0.608 . . . . 75.540000000000006 109.358 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.16 95.28 0.03 OUTLIER Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.924 -0.58 . . . . 75.040000000000006 114.532 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 63.36 31.54 15.13 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.502 0.556 . . . . 75.299999999999997 112.502 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.9 m -84.99 145.06 27.91 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.352 -0.386 . . . . 75.019999999999996 110.638 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 9.7 mpt_? -132.28 126.41 33.32 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.268 -1.382 . . . . 75.140000000000001 107.268 172.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.454 HG23 ' CG1' ' B' ' 239' ' ' VAL . 1.1 m -132.65 140.61 47.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 118.958 -1.097 . . . . 72.439999999999998 110.362 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . 0.589 HD11 ' CG ' ' B' ' 240' ' ' GLN . 8.1 tp -122.86 117.17 24.98 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.024 0.916 . . . . 73.239999999999995 110.036 173.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . 0.465 HG23 ' HB3' ' C' ' 241' ' ' LEU . 1.3 pt -112.13 103.89 16.17 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.026 0 CA-C-N 113.79 -1.55 . . . . 74.109999999999999 107.279 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 154.22 -147.18 16.09 Favored Glycine 0 N--CA 1.417 -2.598 0 CA-C-N 115.219 -0.9 . . . . 62.020000000000003 112.823 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -104.9 138.28 41.39 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.064 -1.088 . . . . 63.229999999999997 108.064 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -127.41 118.2 23.63 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.796 -1.557 . . . . 75.239999999999995 106.796 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -115.6 123.73 49.16 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 108.565 -0.902 . . . . 74.030000000000001 108.565 178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.07 -55.32 0.68 Allowed Glycine 0 N--CA 1.416 -2.679 0 N-CA-C 109.328 -1.509 . . . . 74.230000000000004 109.328 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 102.2 44.02 1.94 Allowed Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.576 -1.009 . . . . 54.219999999999999 110.576 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . 0.446 ' HD3' HG22 ' B' ' 246' ' ' THR . 11.8 ptmm? -174.9 -18.14 0.01 OUTLIER 'General case' 0 C--O 1.253 1.278 0 O-C-N 123.713 0.302 . . . . 74.530000000000001 111.522 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 54.02 -141.99 32.23 Favored Glycine 0 CA--C 1.5 -0.898 0 CA-C-N 115.574 -0.739 . . . . 74.409999999999997 114.251 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -96.39 4.57 52.11 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.172 -0.677 . . . . 72.319999999999993 109.172 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.448 ' CH2' ' HB3' ' B' ' 276' ' ' LEU . 8.5 m-90 -83.32 -45.92 13.21 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.441 -0.8 . . . . 73.230000000000004 112.023 -174.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -89.27 103.45 16.08 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.726 1.01 . . . . 72.5 113.726 -173.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -168.34 174.38 7.05 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 103.698 -2.704 . . . . 74.430000000000007 103.698 173.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -115.32 -73.76 0.64 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 119.8 1.182 . . . . 73.239999999999995 112.588 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -151.97 131.16 12.74 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.281 -0.968 . . . . 74.010000000000005 112.345 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 22.4 t60 68.72 -74.02 0.08 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.79 1.636 . . . . 74.010000000000005 111.751 171.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -156.55 -54.28 0.08 Allowed 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.71 -1.589 . . . . 75.439999999999998 106.71 -176.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -147.1 83.57 1.57 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.658 -1.156 . . . . 72.409999999999997 108.757 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 34.1 t60 . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 124.826 1.25 . . . . 72.519999999999996 112.645 175.308 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 89.0 mtp . . . . . 0 CA--C 1.502 -0.889 0 N-CA-C 107.808 -1.182 . . . . 73.299999999999997 107.808 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -133.33 154.73 50.46 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 119.825 -0.75 . . . . 74.310000000000002 110.031 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 10.1 tt -154.29 96.27 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-O 121.728 0.775 . . . . 73.510000000000005 110.351 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -95.32 166.26 11.97 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.446 -0.946 . . . . 64.239999999999995 108.446 175.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 73.53 146.37 0.08 Allowed 'General case' 0 C--O 1.243 0.735 0 O-C-N 124.639 1.212 . . . . 73.230000000000004 110.44 -172.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.3 mp -94.61 115.82 34.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 121.723 0.773 . . . . 74.099999999999994 109.914 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . 0.494 ' O ' ' HG3' ' C' ' 225' ' ' ARG . 30.5 m -117.28 166.41 11.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 107.076 -1.453 . . . . 73.540000000000006 107.076 177.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -58.24 116.59 8.63 Favored Glycine 0 C--O 1.245 0.799 0 N-CA-C 110.625 -0.99 . . . . 64.030000000000001 110.625 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . 0.553 ' HG2' ' CG2' ' B' ' 261' ' ' THR . 82.8 mtm180 -122.76 121.9 37.41 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.015 0.436 . . . . 73.349999999999994 110.163 -176.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . 0.538 ' HB3' ' ND2' ' B' ' 262' ' ' ASN . 25.9 t-20 -116.4 123.25 47.1 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.525 -0.917 . . . . 75.239999999999995 108.525 178.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 227' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' C' ' 263' ' ' SER . 46.7 t -121.94 137.52 54.76 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.854 -0.612 . . . . 73.030000000000001 109.955 -175.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -126.08 124.38 40.48 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.488 -0.93 . . . . 70.209999999999994 108.488 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -83.74 -64.84 1.09 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.554 -0.535 . . . . 74.25 109.554 -177.201 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -127.49 138.12 52.85 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 109.617 -0.512 . . . . 70.120000000000005 109.617 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . 0.427 HG22 HG11 ' C' ' 267' ' ' VAL . 13.7 mt -133.48 117.44 27.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.15 -1.796 . . . . 70.400000000000006 106.15 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 17.0 ptp180 -124.88 115.65 20.96 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.634 0.731 . . . . 75.409999999999997 110.052 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 49.2 p -110.64 128.34 55.65 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.949 -0.76 . . . . 71.209999999999994 108.949 -175.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -132.33 139.45 48.16 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.23 -0.655 . . . . 71.439999999999998 109.23 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . 0.508 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 44.3 mt-10 59.07 93.05 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.283 1.586 . . . . 74.349999999999994 115.283 171.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.508 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 1.3 mpt_? 61.35 17.17 8.07 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.164 0.985 . . . . 73.299999999999997 111.772 175.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -80.15 136.59 36.54 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.082 0.468 . . . . 64.230000000000004 110.525 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.6 OUTLIER -124.95 133.07 53.17 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.385 -1.339 . . . . 72.0 107.385 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.432 ' CG1' HG22 ' C' ' 275' ' ' VAL . 19.2 m -136.52 149.69 27.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.563 -0.855 . . . . 74.019999999999996 111.772 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . 0.503 ' CG ' HD11 ' C' ' 276' ' ' LEU . 47.7 tp60 -126.07 120.74 31.0 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 114.043 -1.435 . . . . 73.420000000000002 109.079 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.465 ' HB3' HG23 ' B' ' 277' ' ' ILE . 2.1 tm? -120.99 118.55 30.13 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.744 -1.576 . . . . 75.420000000000002 106.744 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.455 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 139.66 -122.91 2.35 Favored Glycine 0 N--CA 1.417 -2.63 0 C-N-CA 119.619 -1.277 . . . . 60.130000000000003 111.91 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -137.76 129.47 28.39 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 110.274 -0.269 . . . . 73.400000000000006 110.274 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . 0.455 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 86.0 t -112.56 123.21 68.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.0 -0.741 . . . . 73.230000000000004 109.0 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 1.6 p -122.67 111.93 32.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 N-CA-C 108.236 -1.024 . . . . 65.120000000000005 108.236 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 20.0 m -70.59 160.53 32.34 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 116.163 -0.472 . . . . 54.229999999999997 109.894 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' B' ' 249' ' ' ALA . . . -59.28 -46.29 88.93 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.172 0.987 . . . . 74.140000000000001 110.14 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.49 73.48 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 113.633 -1.622 . . . . 75.349999999999994 112.567 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . 0.488 ' HB3' ' CD2' ' C' ' 281' ' ' TYR . . . -64.0 -45.3 89.61 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.441 -0.799 . . . . 73.230000000000004 111.537 -175.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -83.87 70.57 10.43 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 122.825 1.298 . . . . 71.549999999999997 107.887 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -99.53 -21.99 15.68 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.061 -1.427 . . . . 70.340000000000003 107.377 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -150.22 169.11 30.23 Favored Glycine 0 N--CA 1.421 -2.323 0 N-CA-C 109.355 -1.498 . . . . 75.010000000000005 109.355 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -86.66 69.25 3.14 Favored Glycine 0 C--N 1.302 -1.34 0 C-N-CA 120.88 -0.676 . . . . 60.509999999999998 111.868 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.28 126.48 43.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.497 -0.927 . . . . 73.109999999999999 108.497 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . 0.402 HH22 ' CG ' ' A' ' 258' ' ' ASP . 19.1 ttm180 -131.26 86.31 2.35 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.564 0.697 . . . . 73.439999999999998 111.671 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 16.2 pt -159.12 167.77 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 106.309 -1.738 . . . . 73.409999999999997 106.309 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 55.9 p -162.73 177.01 9.71 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.582 -0.896 . . . . 62.039999999999999 108.582 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -96.6 94.24 7.22 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.413 -1.699 . . . . 72.010000000000005 106.413 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . 0.256 15.8 pm0 -75.42 73.75 2.48 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 122.209 1.005 . . . . 75.340000000000003 113.544 -174.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 99.5 m -102.81 139.27 38.6 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 114.126 -1.397 . . . . 71.219999999999999 108.931 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 7.1 t -91.4 110.04 21.34 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.578 -0.897 . . . . 74.230000000000004 108.578 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -109.9 123.25 49.28 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.265 -0.643 . . . . 73.310000000000002 109.265 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 263' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' C' ' 227' ' ' SER . 13.0 p -125.37 127.64 46.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 110.185 -0.302 . . . . 63.009999999999998 110.185 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.05 137.04 46.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.573 -0.528 . . . . 73.310000000000002 109.573 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 62.3 mm-40 -80.5 -64.61 1.15 Allowed 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 123.043 0.215 . . . . 64.049999999999997 110.759 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 19.0 m -131.98 127.36 36.12 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 119.644 -0.822 . . . . 75.530000000000001 110.299 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . 0.427 HG11 HG22 ' C' ' 231' ' ' ILE . 2.6 p -126.44 122.89 62.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.927 -0.768 . . . . 74.329999999999998 108.927 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 6.0 p -124.0 142.78 39.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.885 -0.598 . . . . 65.239999999999995 110.762 -175.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.92 132.16 9.27 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 110.315 -1.114 . . . . 65.230000000000004 110.315 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -134.28 115.74 14.46 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 109.009 -0.737 . . . . 73.439999999999998 109.009 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.68 94.19 0.04 OUTLIER Glycine 0 CA--C 1.523 0.542 0 O-C-N 123.506 0.504 . . . . 73.140000000000001 114.249 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . 0.48 ' CD ' HH12 ' C' ' 238' ' ' ARG . 43.6 mm-40 62.2 25.64 15.35 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.506 0.928 . . . . 62.43 113.506 176.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 25.0 m -82.28 144.42 30.63 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.679 -0.808 . . . . 72.230000000000004 110.303 -176.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 63.3 mtt180 -135.86 126.11 26.45 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 105.831 -1.914 . . . . 72.310000000000002 105.831 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . 0.432 HG22 ' CG1' ' C' ' 239' ' ' VAL . 1.5 m -137.88 142.0 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 119.573 -0.851 . . . . 72.409999999999997 111.496 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.503 HD11 ' CG ' ' C' ' 240' ' ' GLN . 7.5 tp -122.46 112.59 18.24 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.037 0.922 . . . . 75.219999999999999 110.798 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 1.9 pt -108.67 104.98 17.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-N 114.054 -1.43 . . . . 72.129999999999995 108.544 175.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 149.97 -149.44 21.35 Favored Glycine 0 N--CA 1.419 -2.454 0 CA-C-N 115.408 -0.815 . . . . 63.32 111.533 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -98.1 145.67 26.32 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.499 -0.926 . . . . 75.310000000000002 108.499 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -137.12 117.91 14.09 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.857 -1.535 . . . . 55.240000000000002 106.857 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' C' ' 249' ' ' ALA . 42.9 t80 -118.47 124.57 47.92 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 108.882 -0.785 . . . . 73.409999999999997 108.882 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 140.49 -52.95 0.68 Allowed Glycine 0 N--CA 1.416 -2.66 0 N-CA-C 109.371 -1.492 . . . . 73.540000000000006 109.371 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 115.27 -11.31 19.7 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.664 -0.779 . . . . 75.129999999999995 111.787 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -125.12 -5.33 7.33 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 112.581 0.586 . . . . 73.230000000000004 112.581 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.33 -121.96 19.25 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 115.777 -0.647 . . . . 72.230000000000004 113.178 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -125.47 13.16 8.15 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.296 -1.001 . . . . 75.340000000000003 108.296 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' C' ' 276' ' ' LEU . 18.0 m-90 -77.6 -57.04 4.03 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 114.452 1.279 . . . . 72.340000000000003 114.452 -171.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -165.88 -167.55 1.11 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.548 -0.908 . . . . 71.040000000000006 108.548 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 72.78 105.94 0.07 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 126.217 1.807 . . . . 73.540000000000006 111.559 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 62.4 m170 75.79 -57.85 0.56 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.288 1.435 . . . . 74.400000000000006 113.096 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . 0.372 5.1 p80 50.61 -73.32 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.637 1.975 . . . . 71.25 114.168 -174.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -87.85 80.91 7.7 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.33 -0.856 . . . . 74.049999999999997 110.765 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -162.37 151.93 15.92 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.908 -2.256 . . . . 71.340000000000003 104.908 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -84.2 23.92 1.01 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 120.874 0.369 . . . . 72.319999999999993 111.27 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 . . . . . 0 N--CA 1.438 -1.059 0 CA-C-O 118.007 -0.997 . . . . 74.519999999999996 108.532 -177.134 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 112.763 0.653 . . . . 73.239999999999995 112.763 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -103.57 90.88 3.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.754 -0.832 . . . . 73.239999999999995 108.754 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.1 pt -130.48 150.56 34.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 116.224 -0.444 . . . . 74.349999999999994 111.242 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -112.59 89.45 3.08 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 103.65 -2.722 . . . . 74.519999999999996 103.65 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.97 16.02 4.51 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 114.985 1.476 . . . . 75.219999999999999 114.985 -165.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.459 HD11 ' H ' ' A' ' 222' ' ' ILE . 0.1 OUTLIER -90.0 114.34 27.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 118.496 -1.282 . . . . 75.5 109.454 173.804 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 12.3 m -134.54 144.9 33.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 114.313 -1.312 . . . . 75.140000000000001 108.406 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -82.57 51.33 4.51 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 121.141 -0.552 . . . . 63.200000000000003 113.532 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -120.86 140.25 52.03 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.355 -0.609 . . . . 72.329999999999998 109.355 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -116.55 137.96 51.77 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.423 -1.695 . . . . 75.540000000000006 106.423 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 7.9 p -128.4 137.43 51.86 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 113.474 0.916 . . . . 73.450000000000003 113.474 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.77 150.44 51.08 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.523 -1.288 . . . . 71.010000000000005 107.523 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -103.3 -50.95 3.34 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.763 -0.829 . . . . 74.230000000000004 108.763 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -127.36 140.71 52.0 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 109.577 -0.527 . . . . 65.239999999999995 109.577 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 55.0 mt -136.64 117.09 17.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 105.817 -1.92 . . . . 75.409999999999997 105.817 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -128.5 128.91 45.24 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.702 -0.481 . . . . 71.510000000000005 109.702 -178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 36.2 p -121.53 137.5 54.7 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 116.535 -0.302 . . . . 75.140000000000001 110.752 -179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -131.11 157.22 43.7 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 120.55 -0.46 . . . . 71.040000000000006 110.878 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 63.82 -85.77 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.942 1.297 . . . . 75.239999999999995 113.504 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.76 20.31 4.21 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 121.683 0.754 . . . . 72.209999999999994 109.331 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -69.86 130.98 43.72 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.792 -0.64 . . . . 75.540000000000006 109.989 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -125.42 135.15 52.07 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 108.075 -1.083 . . . . 74.340000000000003 108.075 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.56 HG22 ' CG2' ' A' ' 275' ' ' VAL . 96.2 t -132.42 145.37 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 121.037 0.446 . . . . 70.209999999999994 110.504 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.435 ' CG ' HD13 ' A' ' 276' ' ' LEU . 6.4 tp-100 -120.21 122.77 41.67 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.204 -1.406 . . . . 71.540000000000006 107.204 172.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.82 119.31 38.15 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.075 -1.083 . . . . 75.540000000000006 108.075 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.634 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 125.55 -132.92 8.15 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 111.305 -0.718 . . . . 73.430000000000007 111.305 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -125.1 143.82 50.73 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 117.198 0.499 . . . . 75.010000000000005 110.654 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 95.7 t -110.74 116.7 53.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.645 -1.243 . . . . 71.530000000000001 107.645 176.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.4 t -113.94 111.79 37.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 107.914 -1.143 . . . . 73.400000000000006 107.914 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.9 m -101.05 160.62 14.23 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 109.339 -0.615 . . . . 74.109999999999999 109.339 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.11 -32.76 66.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.89 1.276 . . . . 61.409999999999997 111.609 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.32 -48.19 74.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.685 0.794 . . . . 75.209999999999994 113.047 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.428 ' HB3' ' HA2' ' A' ' 282' ' ' GLY . . . -74.17 -26.71 60.45 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.294 -0.632 . . . . 63.32 109.294 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.571 ' HG ' ' CD2' ' A' ' 251' ' ' HIS . 55.4 tp 76.61 -62.17 0.42 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 126.102 1.761 . . . . 65.319999999999993 110.583 -175.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.571 ' CD2' ' HG ' ' A' ' 250' ' ' LEU . 97.3 m-70 -129.52 140.59 51.2 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.367 -0.975 . . . . 75.430000000000007 108.367 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -85.24 70.62 3.07 Favored Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 120.8 -0.714 . . . . 73.0 112.678 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.37 166.56 18.45 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 121.251 -0.5 . . . . 74.439999999999998 112.426 177.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 38.7 pt -130.3 -166.39 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.647 -1.242 . . . . 72.129999999999995 107.647 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -49.66 110.62 0.4 Allowed 'General case' 0 C--O 1.24 0.557 0 O-C-N 124.091 0.87 . . . . 73.319999999999993 111.025 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 50.6 mm 66.51 84.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 124.684 1.194 . . . . 74.519999999999996 110.055 -176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 18.5 t -85.97 162.56 18.47 Favored 'General case' 0 C--O 1.256 1.434 0 CA-C-N 114.594 -1.185 . . . . 75.409999999999997 109.102 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -97.0 112.79 24.39 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.99 -1.115 . . . . 72.0 107.99 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -114.51 111.32 21.21 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.412 -0.813 . . . . 72.439999999999998 109.355 -177.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 20.9 m -101.31 137.23 39.93 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.292 -1.373 . . . . 73.510000000000005 107.292 175.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 10.0 t -98.74 136.86 38.18 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.662 -0.866 . . . . 72.319999999999993 108.662 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.557 ' OD1' ' HB3' ' B' ' 226' ' ' ASN . 3.8 t30 -126.54 133.0 51.22 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.018 -0.734 . . . . 74.420000000000002 109.018 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.6 m -117.93 123.5 45.94 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.587 0.555 . . . . 71.400000000000006 109.706 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 10.2 p -126.92 143.42 40.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.248 -0.649 . . . . 63.310000000000002 109.248 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.591 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 36.8 tt0 -83.6 -82.61 0.15 Allowed 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 120.677 -0.409 . . . . 72.120000000000005 111.004 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 81.0 m -115.45 126.69 54.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.663 -0.648 . . . . 71.219999999999999 111.897 -174.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 11.5 t -118.68 120.95 65.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 107.278 -1.379 . . . . 73.409999999999997 107.278 177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 20.9 m -123.83 136.52 59.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 120.216 -0.594 . . . . 72.150000000000006 111.102 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -117.48 133.17 10.38 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.92 -0.582 . . . . 75.310000000000002 111.943 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -129.6 147.2 51.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.158 -1.052 . . . . 65.129999999999995 108.158 -177.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.27 -133.39 42.45 Favored Glycine 0 C--O 1.239 0.436 0 C-N-CA 120.972 -0.632 . . . . 75.140000000000001 112.226 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -90.69 83.56 5.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.769 -0.826 . . . . 74.0 108.769 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 75.3 m -104.62 144.07 32.21 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.555 -0.858 . . . . 73.230000000000004 110.693 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 28.0 mmm-85 -133.39 123.05 24.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.05 -2.204 . . . . 74.340000000000003 105.05 171.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.56 ' CG2' HG22 ' A' ' 239' ' ' VAL . 30.6 m -140.0 140.58 35.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.239 0.542 . . . . 61.539999999999999 111.627 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.585 ' HB3' ' CH2' ' A' ' 287' ' ' TRP . 9.4 tp -122.37 124.58 44.0 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 115.663 -0.699 . . . . 74.129999999999995 109.687 175.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.443 HG23 HD12 ' B' ' 241' ' ' LEU . 71.6 mt -110.72 103.45 15.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 107.642 -1.244 . . . . 74.420000000000002 107.642 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.634 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 145.52 -135.77 6.13 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.283 -0.871 . . . . 72.430000000000007 111.504 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 46.1 t-20 -129.59 137.64 50.83 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 122.17 -0.606 . . . . 72.329999999999998 109.509 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.17 127.28 55.54 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.396 -0.964 . . . . 65.019999999999996 108.396 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 99.7 m-85 -113.73 124.52 52.47 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.681 -0.859 . . . . 74.239999999999995 108.681 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 249' ' ' ALA . . . 138.99 -87.09 0.21 Allowed Glycine 0 CA--C 1.467 -2.916 0 C-N-CA 120.397 -0.906 . . . . 74.310000000000002 112.211 177.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 141.9 96.94 0.27 Allowed Glycine 0 N--CA 1.406 -3.314 0 N-CA-C 108.555 -1.818 . . . . 72.420000000000002 108.555 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.441 ' HE3' ' HB3' ' B' ' 288' ' ' ASP . 35.4 mmtp 80.24 45.25 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 O-C-N 125.106 1.121 . . . . 72.120000000000005 110.296 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -78.17 -54.87 4.24 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 115.431 -0.804 . . . . 54.140000000000001 111.683 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -89.62 -33.83 16.53 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.146 0.498 . . . . 74.219999999999999 110.708 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . 0.585 ' CH2' ' HB3' ' A' ' 276' ' ' LEU . 29.6 m-90 -102.19 117.62 35.17 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.334 -0.393 . . . . 71.140000000000001 110.466 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -97.86 158.06 15.73 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.926 -0.768 . . . . 74.349999999999994 108.926 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . 0.477 HD21 ' HB2' ' A' ' 292' ' ' HIS . 56.8 t30 71.05 173.49 0.31 Allowed 'General case' 0 CA--C 1.558 1.265 0 O-C-N 124.404 1.065 . . . . 72.430000000000007 110.925 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -79.78 -40.47 28.6 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.303 -0.873 . . . . 73.0 111.202 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -140.83 -68.48 0.4 Allowed 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 120.035 -0.666 . . . . 64.129999999999995 110.517 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . 0.477 ' HB2' HD21 ' A' ' 289' ' ' ASN . 7.8 t60 79.47 93.19 0.05 Allowed 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 125.885 1.674 . . . . 71.129999999999995 108.963 -177.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 76.74 140.05 0.07 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.537 1.135 . . . . 74.319999999999993 108.598 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -157.81 81.48 0.87 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.607 0.718 . . . . 55.310000000000002 111.935 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 . . . . . 0 C--O 1.258 1.532 0 CA-C-O 117.653 -1.165 . . . . 74.519999999999996 112.437 -178.939 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 20.1 ptp . . . . . 0 N--CA 1.467 0.405 0 N-CA-C 112.8 0.667 . . . . 74.219999999999999 112.8 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -141.9 94.03 2.62 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 118.604 0.638 . . . . 64.239999999999995 110.903 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 2.5 mp -134.25 -70.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.454 0.645 . . . . 75.109999999999999 109.463 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -156.53 173.97 16.13 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 106.511 -1.663 . . . . 70.409999999999997 106.511 -176.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -142.55 -172.55 3.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.103 -0.703 . . . . 75.239999999999995 109.103 -177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . 0.491 ' H ' HD12 ' B' ' 222' ' ' ILE . 0.2 OUTLIER -82.67 115.45 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 122.161 0.981 . . . . 75.319999999999993 109.21 177.065 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . 0.412 ' O ' ' HB ' ' B' ' 261' ' ' THR . 27.1 m -100.84 135.27 37.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 114.248 -1.342 . . . . 74.510000000000005 110.229 -177.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -83.44 73.65 2.64 Favored Glycine 0 N--CA 1.428 -1.866 0 C-N-CA 120.611 -0.804 . . . . 62.329999999999998 113.047 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 261' ' ' THR . 40.6 ptt180 -138.17 142.74 40.06 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.059 0.457 . . . . 75.209999999999994 110.543 178.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.557 ' HB3' ' OD1' ' A' ' 262' ' ' ASN . 51.0 t-20 -116.18 148.43 40.38 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 105.285 -2.117 . . . . 74.200000000000003 105.285 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 3.2 p -139.01 136.78 35.69 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 121.515 0.674 . . . . 73.5 111.829 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -132.13 144.25 50.57 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.726 -1.125 . . . . 60.119999999999997 108.571 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.591 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 5.9 tmtm? -96.74 -61.32 1.43 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.948 -0.76 . . . . 74.310000000000002 108.948 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -127.18 139.38 52.98 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 121.807 -0.558 . . . . 74.310000000000002 110.089 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 6.9 mt -134.96 120.65 31.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.713 -1.588 . . . . 74.450000000000003 106.713 175.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -123.36 120.44 33.03 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.408 -0.59 . . . . 74.530000000000001 109.408 -178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' THR . . . . . 0.468 ' HB ' ' HB2' ' B' ' 237' ' ' ALA . 81.0 p -109.99 128.87 55.66 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.139 -1.059 . . . . 70.25 108.139 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -137.25 157.17 47.24 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.598 -0.519 . . . . 73.450000000000003 109.598 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.53 ' HB3' ' HD2' ' B' ' 236' ' ' ARG . 6.2 mp0 63.09 -89.09 0.03 OUTLIER 'General case' 0 C--O 1.21 -1.01 0 C-N-CA 124.425 1.09 . . . . 73.239999999999995 113.496 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.53 ' HD2' ' HB3' ' B' ' 235' ' ' GLU . 0.0 OUTLIER -137.2 59.27 1.69 Allowed 'General case' 0 C--O 1.245 0.843 0 N-CA-C 107.701 -1.222 . . . . 75.439999999999998 107.701 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.468 ' HB2' ' HB ' ' B' ' 233' ' ' THR . . . -99.61 135.19 41.4 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-O 122.353 1.073 . . . . 75.010000000000005 110.399 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 6.1 mpt_? -124.28 133.21 53.54 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 105.691 -1.966 . . . . 75.310000000000002 105.691 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 69.7 t -142.48 133.08 24.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.847 0.832 . . . . 73.340000000000003 111.239 -175.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.544 ' CG ' HD12 ' B' ' 276' ' ' LEU . 44.0 tp60 -105.23 132.51 51.35 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.678 -1.23 . . . . 75.530000000000001 107.678 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . 0.443 HD12 HG23 ' A' ' 277' ' ' ILE . 3.4 tm? -121.85 117.01 25.46 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 106.354 -1.721 . . . . 65.310000000000002 106.354 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.687 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 117.84 -130.05 8.58 Favored Glycine 0 C--O 1.206 -1.632 0 N-CA-C 111.189 -0.764 . . . . 73.439999999999998 111.189 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 5.8 m-20 -124.41 148.4 47.61 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 122.0 -0.706 . . . . 62.340000000000003 112.255 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.541 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 98.5 t -118.3 114.69 45.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.647 -1.242 . . . . 74.510000000000005 107.647 175.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 58.9 t -117.86 111.98 36.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 108.698 -0.853 . . . . 74.430000000000007 108.698 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' THR . . . . . 0.481 ' OG1' ' HA3' ' B' ' 282' ' ' GLY . 13.6 p -93.69 161.98 14.12 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 119.895 -0.722 . . . . 74.310000000000002 109.57 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.25 -32.54 70.09 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.475 1.131 . . . . 65.430000000000007 109.636 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.57 -35.16 65.46 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 112.655 -2.066 . . . . 74.010000000000005 113.5 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.403 ' HA ' ' HB1' ' C' ' 247' ' ' ALA . . . -62.31 -26.42 68.41 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.069 0.461 . . . . 75.349999999999994 110.406 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.8 mp -86.08 75.52 9.92 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.807 0.813 . . . . 72.030000000000001 109.022 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -92.85 -44.41 8.49 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.459 -1.312 . . . . 74.340000000000003 107.459 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -125.11 21.29 6.53 Favored Glycine 0 C--N 1.311 -0.858 0 N-CA-C 108.94 -1.664 . . . . 51.399999999999999 108.94 173.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 102.82 147.78 19.44 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.273 -1.131 . . . . 72.099999999999994 110.273 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.5 139.17 18.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.975 -0.75 . . . . 74.120000000000005 108.975 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -136.3 154.89 50.74 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.152 -1.796 . . . . 74.140000000000001 106.152 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 30.1 pt -70.32 134.76 29.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.593 0.711 . . . . 75.450000000000003 111.828 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 71.9 p -98.44 -163.3 1.03 Allowed 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.903 -1.044 . . . . 75.040000000000006 111.031 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -97.8 119.54 36.59 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.1 -1.444 . . . . 73.340000000000003 107.1 174.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 20.5 mp0 -98.44 82.76 2.92 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.296 -0.561 . . . . 74.540000000000006 110.8 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.2 m -64.76 135.5 55.9 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 108.805 -0.813 . . . . 64.439999999999998 108.805 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 261' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 9.0 t -91.99 132.86 36.22 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.082 0.468 . . . . 73.230000000000004 109.78 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -126.56 146.66 50.05 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.695 -0.854 . . . . 74.329999999999998 108.695 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 49.3 m -135.65 123.48 22.56 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.023 0.439 . . . . 63.539999999999999 110.207 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.7 p -123.38 150.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.183 -0.673 . . . . 75.450000000000003 109.183 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 39.3 tt0 -93.5 -69.27 0.76 Allowed 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.539 -0.864 . . . . 72.420000000000002 110.409 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 15.6 m -119.53 127.63 53.2 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.104 -1.039 . . . . 65.099999999999994 112.301 -176.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 25.7 t -119.08 120.59 64.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.652 -1.24 . . . . 74.150000000000006 107.652 174.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.83 131.59 69.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 112.248 0.462 . . . . 72.25 112.248 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.66 133.89 11.89 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.608 -0.724 . . . . 62.409999999999997 111.886 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -131.8 130.23 41.52 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 124.826 1.25 . . . . 74.099999999999994 109.546 -178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.28 -133.47 14.06 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 110.551 -1.019 . . . . 43.240000000000002 110.551 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 77.1 mm-40 -87.25 97.9 11.03 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 107.849 -1.167 . . . . 74.519999999999996 107.849 176.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 66.1 m -117.86 143.42 46.32 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 119.342 -0.943 . . . . 74.099999999999994 110.417 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 18.9 mmm-85 -133.99 123.83 25.26 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 104.259 -2.497 . . . . 74.310000000000002 104.259 172.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.3 t -139.22 140.73 37.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.515 -0.921 . . . . 75.219999999999999 108.515 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . 0.711 ' HB3' ' CH2' ' B' ' 287' ' ' TRP . 3.0 tp -126.79 122.06 33.71 Favored 'General case' 0 C--N 1.26 -3.299 0 N-CA-C 109.651 -0.5 . . . . 72.5 109.651 173.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . 0.46 HG21 HD13 ' C' ' 241' ' ' LEU . 3.2 mp -107.01 103.72 15.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 106.386 -1.709 . . . . 75.219999999999999 106.386 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 152.48 -140.9 8.01 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 121.061 -0.59 . . . . 71.310000000000002 112.245 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -128.86 135.29 48.89 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.621 -0.881 . . . . 73.040000000000006 108.621 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -111.77 133.69 53.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.814 0.34 . . . . 71.030000000000001 110.225 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -121.87 125.65 46.91 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 115.885 -0.598 . . . . 74.230000000000004 110.988 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . 0.481 ' HA3' ' OG1' ' B' ' 246' ' ' THR . . . 133.37 -99.55 0.37 Allowed Glycine 0 CA--C 1.48 -2.156 0 C-N-CA 120.559 -0.829 . . . . 71.549999999999997 112.725 174.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 178.34 112.32 0.33 Allowed Glycine 0 C--N 1.277 -2.706 0 N-CA-C 108.106 -1.997 . . . . 64.409999999999997 108.106 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . 0.437 ' HB3' ' HA ' ' B' ' 288' ' ' ASP . 1.1 mptm? 78.01 -50.88 0.5 Allowed 'General case' 0 C--O 1.197 -1.677 0 C-N-CA 124.217 1.007 . . . . 71.019999999999996 112.537 -178.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 46.5 -102.31 0.04 OUTLIER Glycine 0 C--O 1.244 0.779 0 O-C-N 124.439 1.087 . . . . 71.099999999999994 114.983 175.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -70.75 -28.42 64.68 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 123.959 0.904 . . . . 75.430000000000007 111.382 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.711 ' CH2' ' HB3' ' B' ' 276' ' ' LEU . 22.8 m-90 -105.82 23.44 13.92 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 122.052 -0.405 . . . . 74.540000000000006 111.645 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . 0.441 ' HB3' ' HE3' ' A' ' 284' ' ' LYS . 30.0 t70 -65.95 101.18 0.64 Allowed 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 119.738 -0.785 . . . . 74.120000000000005 110.123 174.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -117.21 97.74 6.07 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-N 114.594 -1.185 . . . . 72.040000000000006 109.07 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -124.21 127.22 47.39 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.121 -1.437 . . . . 72.530000000000001 107.121 173.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -69.67 80.27 0.43 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 114.873 1.434 . . . . 73.200000000000003 114.873 -173.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -89.1 -16.48 31.4 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.133 0.968 . . . . 75.230000000000004 108.502 170.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -126.56 -170.64 2.24 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 105.236 -2.135 . . . . 74.519999999999996 105.236 171.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -136.93 27.78 2.93 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.672 -1.233 . . . . 74.25 107.672 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 69.3 t60 . . . . . 0 C--N 1.307 -1.249 0 N-CA-C 108.298 -1.001 . . . . 73.420000000000002 108.298 -176.853 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 110.472 -0.196 . . . . 74.129999999999995 110.472 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt 56.18 81.36 0.13 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.825 1.25 . . . . 71.120000000000005 113.252 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 41.6 pt -141.36 147.97 21.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.299 -0.63 . . . . 74.140000000000001 109.299 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -141.67 167.81 21.27 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.931 -1.507 . . . . 65.420000000000002 106.931 175.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 61.39 -154.5 0.36 Allowed 'General case' 0 C--O 1.243 0.747 0 O-C-N 124.345 1.028 . . . . 73.349999999999994 109.279 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . 0.484 HD12 ' H ' ' C' ' 222' ' ' ILE . 0.2 OUTLIER -116.11 138.05 47.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 121.265 0.555 . . . . 71.439999999999998 110.901 -178.779 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 28.8 m -121.7 148.59 25.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.615 -0.883 . . . . 74.0 108.615 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -81.36 63.89 4.26 Favored Glycine 0 CA--C 1.495 -1.169 0 C-N-CA 121.228 -0.51 . . . . 54.340000000000003 111.89 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' B' ' 261' ' ' THR . 56.4 ttp180 -126.07 122.69 36.51 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 120.904 0.383 . . . . 73.019999999999996 110.304 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -106.95 142.76 36.06 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.72 -1.956 . . . . 72.450000000000003 105.72 175.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 9.1 p -139.98 137.31 34.6 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.216 -0.994 . . . . 74.310000000000002 113.101 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . 0.501 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -127.45 142.02 51.52 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.101 -0.954 . . . . 62.140000000000001 109.435 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.498 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 49.0 tptt -87.81 -66.61 0.89 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.964 -0.562 . . . . 74.230000000000004 110.537 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -133.68 138.93 46.13 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.959 -0.756 . . . . 72.140000000000001 108.959 -175.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 10.7 mt -135.38 120.52 28.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.721 -1.214 . . . . 63.32 107.721 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 77.7 ttt180 -122.85 121.64 36.73 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 109.351 -0.611 . . . . 74.450000000000003 109.351 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 233' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' C' ' 237' ' ' ALA . 68.5 p -110.46 127.92 55.36 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.466 -0.939 . . . . 75.5 108.466 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -130.13 152.27 49.75 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 119.99 -0.684 . . . . 62.0 112.0 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 48.8 mt-10 69.8 -77.81 0.05 Allowed 'General case' 0 C--O 1.194 -1.84 0 CA-C-N 113.84 -1.527 . . . . 71.409999999999997 113.854 172.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.1 56.8 1.47 Allowed 'General case' 0 C--O 1.245 0.819 0 N-CA-C 107.134 -1.432 . . . . 74.230000000000004 107.134 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' C' ' 233' ' ' THR . . . -104.12 135.11 46.23 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 122.492 1.139 . . . . 65.530000000000001 111.292 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 4.8 mpt_? -124.86 133.16 53.19 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 106.071 -1.825 . . . . 75.109999999999999 106.071 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 94.9 t -141.52 134.68 30.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.418 0.628 . . . . 74.209999999999994 110.766 -176.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . 0.542 ' CG ' HD11 ' C' ' 276' ' ' LEU . 5.1 tp-100 -105.3 129.5 53.63 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.646 -1.242 . . . . 75.439999999999998 107.646 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.46 HD13 HG21 ' B' ' 277' ' ' ILE . 3.4 tm? -122.42 116.01 23.24 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.048 -1.834 . . . . 72.400000000000006 106.048 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.428 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 130.0 -111.07 1.11 Allowed Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 119.668 -1.253 . . . . 64.439999999999998 112.859 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.01 148.91 34.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.738 -0.467 . . . . 72.519999999999996 109.738 -174.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . 0.507 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 91.6 t -126.94 114.94 39.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.852 -0.795 . . . . 75.120000000000005 108.852 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.87 111.77 37.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.859 -0.793 . . . . 74.340000000000003 108.859 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.3 m -85.56 160.97 19.52 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.548 -0.908 . . . . 62.439999999999998 108.548 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . 0.403 ' HB1' ' HA ' ' B' ' 249' ' ' ALA . . . -63.09 -34.24 77.17 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 122.444 1.116 . . . . 63.119999999999997 109.294 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.92 -35.62 66.81 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 113.14 -1.846 . . . . 73.010000000000005 111.671 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.0 -26.19 62.13 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 116.383 -0.371 . . . . 72.129999999999995 111.387 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 90.2 mt -76.54 62.4 1.9 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.628 0.728 . . . . 72.200000000000003 112.012 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -96.21 -46.81 6.3 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.114 -1.81 . . . . 75.140000000000001 106.114 173.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -113.47 -142.99 8.41 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 110.558 -1.017 . . . . 65.25 110.558 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -170.27 102.43 0.18 Allowed Glycine 0 C--N 1.299 -1.479 0 N-CA-C 110.084 -1.207 . . . . 65.439999999999998 110.084 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 34.4 pt -122.94 164.09 20.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 112.165 0.431 . . . . 74.109999999999999 112.165 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -150.12 107.14 3.57 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 105.923 -1.88 . . . . 74.420000000000002 105.923 173.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 25.4 pt -124.61 149.28 28.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-O 121.563 0.696 . . . . 72.409999999999997 112.484 -173.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 22.8 t -95.42 -16.19 22.47 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.399 -0.963 . . . . 64.349999999999994 108.399 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . 0.444 ' HA ' ' CG1' ' C' ' 222' ' ' ILE . 12.0 t70 -78.89 80.01 5.26 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.299 1.047 . . . . 72.540000000000006 108.672 177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -122.69 172.79 8.16 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 114.32 -1.309 . . . . 72.25 107.614 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 10.4 m -101.24 121.85 42.61 Favored 'General case' 0 N--CA 1.405 -2.676 0 N-CA-C 107.408 -1.33 . . . . 74.129999999999995 107.408 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -91.21 110.2 21.48 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 119.206 -0.998 . . . . 73.099999999999994 108.369 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -113.52 128.07 56.31 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.317 -0.856 . . . . 65.329999999999998 109.58 -176.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.2 m -117.61 123.25 45.73 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.033 -0.728 . . . . 75.319999999999993 109.033 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -117.67 148.74 20.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.178 -1.045 . . . . 74.420000000000002 108.178 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 43.0 tt0 -90.44 -84.66 0.23 Allowed 'General case' 0 N--CA 1.415 -2.184 0 C-N-CA 120.355 -0.538 . . . . 54.409999999999997 110.269 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 20.0 m -110.59 130.31 55.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.774 -0.77 . . . . 74.150000000000006 110.477 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 40.6 t -117.85 120.77 65.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.72 -1.215 . . . . 74.219999999999999 107.72 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.1 p -127.61 131.96 69.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 120.411 -0.515 . . . . 73.109999999999999 110.987 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.14 133.61 11.7 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 108.912 -1.675 . . . . 71.310000000000002 108.912 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -132.33 132.95 43.45 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.716 -0.846 . . . . 75.340000000000003 108.716 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.5 -125.23 10.21 Favored Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 120.428 -0.891 . . . . 72.150000000000006 111.346 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -91.84 97.55 11.05 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.521 -1.288 . . . . 74.319999999999993 107.521 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 33.4 m -127.61 145.07 51.0 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 113.45 0.907 . . . . 43.509999999999998 113.45 -175.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 34.5 mmm-85 -133.46 124.79 27.69 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 104.919 -2.252 . . . . 74.219999999999999 104.919 173.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 4.2 t -139.4 140.55 37.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 118.634 0.652 . . . . 75.230000000000004 109.729 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.675 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 5.1 tp -126.94 119.73 27.42 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-O 121.374 0.606 . . . . 72.230000000000004 109.397 172.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 54.9 mt -108.45 103.4 15.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 105.719 -1.956 . . . . 75.120000000000005 105.719 178.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 146.24 -146.71 17.05 Favored Glycine 0 N--CA 1.427 -1.944 0 C-N-CA 120.721 -0.752 . . . . 54.039999999999999 111.352 -175.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -121.72 140.33 52.45 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.577 -0.897 . . . . 62.43 108.577 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . 0.439 ' HB2' ' CD2' ' C' ' 276' ' ' LEU . 36.0 tt0 -118.63 118.35 31.41 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.973 -0.751 . . . . 74.329999999999998 108.973 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -107.72 125.82 51.85 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 109.92 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 131.28 -129.25 5.66 Favored Glycine 0 N--CA 1.427 -1.935 0 C-N-CA 120.749 -0.738 . . . . 60.119999999999997 112.332 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -157.02 111.58 0.49 Allowed Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.52 -1.432 . . . . 73.430000000000007 109.52 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 63.56 38.14 9.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.957 0.903 . . . . 74.239999999999995 109.785 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -60.93 -68.15 1.8 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.355 -0.839 . . . . 73.099999999999994 113.53 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -89.72 -46.17 8.8 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.661 -0.496 . . . . 74.530000000000001 109.661 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . 0.675 ' CH2' ' HB3' ' C' ' 276' ' ' LEU . 24.4 m-90 -94.22 105.25 17.24 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 116.101 -0.5 . . . . 71.109999999999999 109.892 177.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -99.91 102.63 14.08 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.37 1.081 . . . . 75.25 112.163 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -97.23 138.88 34.03 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 104.107 -2.553 . . . . 64.540000000000006 104.107 172.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -62.86 99.04 0.14 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.536 1.16 . . . . 74.209999999999994 111.736 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . 0.408 ' CE1' ' HD1' ' C' ' 293' ' ' HIS . 5.2 t-160 -138.13 -49.66 0.56 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.242 -1.762 . . . . 73.400000000000006 106.242 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 34.0 t60 54.92 67.37 1.03 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.471 -1.24 . . . . 64.230000000000004 111.077 176.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . 0.408 ' HD1' ' CE1' ' C' ' 291' ' ' HIS . 36.4 m80 -143.82 -176.85 5.14 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.587 -0.894 . . . . 72.030000000000001 108.587 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -77.96 -7.33 56.66 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.72 0.772 . . . . 73.209999999999994 109.325 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 . . . . . 0 N--CA 1.423 -1.808 0 CA-C-N 115.291 -0.868 . . . . 72.540000000000006 110.46 179.874 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.584 0 CA-C-O 120.681 0.277 . . . . 73.430000000000007 110.308 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -82.15 99.62 9.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.322 -1.732 . . . . 74.200000000000003 106.322 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.444 ' O ' HD13 ' A' ' 219' ' ' ILE 0.274 2.6 pp -78.68 124.85 37.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 113.31 0.855 . . . . 74.099999999999994 113.31 -174.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -142.77 169.48 17.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.647 -1.612 . . . . 75.200000000000003 106.647 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -102.84 -0.56 31.12 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 122.949 0.5 . . . . 65.439999999999998 111.301 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.6 tt -81.72 115.7 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.55 -0.907 . . . . 73.439999999999998 108.55 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 26.9 m -116.02 149.17 18.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.561 -0.745 . . . . 73.239999999999995 111.613 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 53.84 57.71 15.19 Favored Glycine 0 CA--C 1.507 -0.422 0 O-C-N 124.817 1.323 . . . . 74.409999999999997 113.486 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.74 124.47 43.61 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.618 -0.833 . . . . 74.299999999999997 110.877 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -80.84 131.86 35.42 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.017 -1.846 . . . . 73.049999999999997 106.017 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 10.6 m -120.98 137.88 54.42 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 120.061 -0.656 . . . . 73.109999999999999 111.484 -171.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.76 118.46 19.07 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.584 -1.636 . . . . 70.099999999999994 106.584 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.511 ' HE2' ' O ' ' A' ' 265' ' ' GLU . 5.7 tmmm? -86.36 -38.58 17.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.832 -0.433 . . . . 73.030000000000001 109.832 -176.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -143.82 138.77 28.93 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.142 -0.688 . . . . 61.409999999999997 109.142 174.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 60.7 mt -130.77 126.7 60.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 105.149 -2.167 . . . . 74.430000000000007 105.149 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.416 ' HE ' ' HB2' ' A' ' 232' ' ' ARG . 10.1 ttm180 -134.44 116.21 14.89 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.954 -0.758 . . . . 63.340000000000003 108.954 -177.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 31.3 p -123.42 127.74 48.86 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 110.121 -0.325 . . . . 74.439999999999998 110.121 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -144.65 145.97 32.02 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 120.86 0.362 . . . . 75.310000000000002 111.304 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 63.49 86.68 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.968 1.307 . . . . 75.439999999999998 113.989 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.51 26.43 16.06 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.014 -0.994 . . . . 75.200000000000003 111.865 177.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.49 144.64 27.16 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.825 -0.625 . . . . 65.239999999999995 109.855 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -127.24 135.49 50.69 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.932 -0.766 . . . . 74.420000000000002 108.932 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 3.3 p -132.98 145.21 34.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.952 0.882 . . . . 72.049999999999997 112.738 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -124.84 130.42 52.35 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.062 -1.458 . . . . 64.120000000000005 107.062 170.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -128.43 118.56 23.33 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.533 -1.284 . . . . 74.099999999999994 107.533 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.19 -116.79 1.8 Allowed Glycine 0 N--CA 1.427 -1.945 0 C-N-CA 119.603 -1.284 . . . . 71.340000000000003 114.123 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . 0.42 ' OD1' HG11 ' A' ' 245' ' ' VAL . 15.6 t-20 -144.48 128.69 17.73 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 122.968 0.507 . . . . 75.049999999999997 110.178 -175.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 50.2 t -108.77 114.01 45.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.376 -0.602 . . . . 75.230000000000004 109.376 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . 0.42 HG11 ' OD1' ' A' ' 243' ' ' ASN . 15.7 m -103.33 121.82 55.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.885 -0.783 . . . . 71.209999999999994 108.885 175.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.574 ' OG1' ' HA3' ' A' ' 282' ' ' GLY . 24.0 p -92.64 160.63 14.92 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.591 -1.244 . . . . 73.140000000000001 111.18 176.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.27 -34.5 78.26 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 123.78 0.832 . . . . 71.140000000000001 112.564 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -70.14 -35.37 74.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.079 0.466 . . . . 71.430000000000007 111.959 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.447 ' HB1' ' CA ' ' A' ' 282' ' ' GLY . . . -73.84 -39.15 64.21 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.704 -0.68 . . . . 64.219999999999999 111.201 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 5.0 mp 54.3 -98.27 0.08 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.18 1.392 . . . . 74.310000000000002 111.427 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -145.34 29.62 1.15 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.725 -1.213 . . . . 73.310000000000002 107.725 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -67.66 -27.21 73.6 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.708 -1.133 . . . . 74.329999999999998 111.633 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -78.77 73.56 2.26 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.578 -1.409 . . . . 73.439999999999998 109.578 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 13.6 tt -75.67 -33.99 27.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 124.273 1.029 . . . . 71.25 112.86 -173.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.7 mmt85 -117.28 89.81 3.2 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.938 0.875 . . . . 73.109999999999999 112.37 -177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 9.3 tp -137.76 28.63 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 123.339 1.542 . . . . 60.32 107.365 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 13.2 m -98.83 36.17 1.72 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.259 -1.337 . . . . 74.109999999999999 110.038 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.561 ' HA ' ' O ' ' B' ' 254' ' ' ILE . 5.7 t70 -79.14 -178.33 6.1 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.288 -0.634 . . . . 73.239999999999995 109.288 -174.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -101.43 23.56 10.89 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.835 -0.541 . . . . 65.430000000000007 111.091 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.2 m -65.16 120.76 13.29 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.954 -0.758 . . . . 74.120000000000005 108.954 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 8.0 m -118.55 122.88 43.7 Favored 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 119.55 -0.86 . . . . 74.239999999999995 109.285 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -120.26 133.61 55.44 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.046 -1.094 . . . . 73.219999999999999 108.046 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 18.2 m -142.31 130.4 22.0 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.974 -0.454 . . . . 73.409999999999997 112.218 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -114.1 133.35 60.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 109.529 -0.545 . . . . 73.230000000000004 109.529 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.511 ' O ' ' HE2' ' A' ' 229' ' ' LYS . 71.5 mm-40 -78.4 -50.87 10.94 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 116.331 -0.395 . . . . 72.430000000000007 110.09 177.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 90.5 m -145.92 127.24 14.88 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.34 -0.85 . . . . 72.120000000000005 111.275 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.0 p -120.81 120.39 62.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.566 -0.743 . . . . 74.420000000000002 109.053 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.7 130.48 72.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.58 -0.737 . . . . 75.120000000000005 109.447 -175.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.42 131.92 8.56 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.293 -1.123 . . . . 72.519999999999996 110.293 174.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 22.8 tptt -134.01 116.7 15.83 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 110.057 -0.349 . . . . 73.549999999999997 110.057 -177.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.33 90.47 0.21 Allowed Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.33 -0.938 . . . . 70.200000000000003 113.303 174.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.494 ' HB3' ' NH1' ' A' ' 274' ' ' ARG . 19.5 mt-10 58.58 37.89 25.34 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.598 0.962 . . . . 75.0 113.598 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 15.5 m -88.43 143.7 26.83 Favored 'General case' 0 C--N 1.274 -2.682 0 C-N-CA 118.639 -1.224 . . . . 72.420000000000002 109.386 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . 0.494 ' NH1' ' HB3' ' A' ' 272' ' ' GLU . 9.2 mpt_? -116.6 127.03 54.11 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.369 -1.715 . . . . 73.219999999999999 106.369 174.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.537 HG11 ' CG1' ' B' ' 239' ' ' VAL . 17.2 m -126.41 123.42 63.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-O 121.458 0.647 . . . . 72.5 109.952 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 5.4 tt -113.57 111.77 22.43 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.744 -1.576 . . . . 72.200000000000003 106.744 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.444 HG22 HD12 ' B' ' 241' ' ' LEU . 60.0 mt -112.36 107.33 22.7 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 CA-C-O 121.612 0.72 . . . . 63.43 110.122 -177.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 137.61 -135.27 7.47 Favored Glycine 0 N--CA 1.426 -1.993 0 CA-C-N 115.533 -0.758 . . . . 63.439999999999998 112.139 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 3.1 m120 -104.09 134.34 47.51 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 112.06 0.392 . . . . 73.319999999999993 112.06 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -113.2 117.92 33.25 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 103.401 -2.814 . . . . 74.5 103.401 167.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.542 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 16.0 t80 -130.13 123.61 30.76 Favored 'General case' 0 C--O 1.264 1.818 0 CA-C-O 122.54 1.162 . . . . 73.120000000000005 113.514 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.574 ' HA3' ' OG1' ' A' ' 246' ' ' THR . . . 129.98 -77.27 0.4 Allowed Glycine 0 N--CA 1.415 -2.734 0 CA-C-N 113.475 -1.693 . . . . 64.340000000000003 114.938 175.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -61.27 -81.74 0.08 OUTLIER Glycine 0 C--N 1.317 -0.508 0 N-CA-C 115.708 1.043 . . . . 72.430000000000007 115.708 -170.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -178.67 -35.95 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.122 -1.807 . . . . 73.019999999999996 106.122 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' B' ' 287' ' ' TRP . . . -158.35 -167.41 19.16 Favored Glycine 0 N--CA 1.401 -3.652 0 CA-C-N 113.73 -1.577 . . . . 74.319999999999993 109.541 176.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.415 ' HE1' ' CZ2' ' B' ' 287' ' ' TRP . 41.7 p90 -104.25 -169.66 1.66 Allowed 'General case' 0 C--N 1.294 -1.825 0 O-C-N 124.105 0.532 . . . . 72.340000000000003 110.468 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 27.8 p90 -53.02 104.2 0.09 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 124.455 1.102 . . . . 71.409999999999997 113.02 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -140.01 152.88 46.61 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.622 -1.622 . . . . 70.209999999999994 106.622 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.79 -29.91 63.66 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 123.143 0.277 . . . . 73.340000000000003 110.287 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.424 ' NE2' ' HA ' ' B' ' 289' ' ' ASN . 42.1 t-80 58.46 75.43 0.39 Allowed 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.003 1.321 . . . . 71.239999999999995 108.665 -175.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -82.12 155.2 25.15 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.868 -1.06 . . . . 74.120000000000005 110.16 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -77.19 105.6 8.39 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.339 -0.846 . . . . 75.439999999999998 109.688 -176.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -124.54 102.6 7.71 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.253 -0.647 . . . . 72.319999999999993 109.253 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -171.66 17.72 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.41 0.893 . . . . 75.409999999999997 113.41 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 . . . . . 0 C--O 1.261 1.685 0 N-CA-C 107.979 -1.119 . . . . 74.420000000000002 107.979 175.641 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.469 0.495 0 CA-C-O 120.742 0.306 . . . . 74.310000000000002 111.083 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -124.81 134.46 52.75 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 122.331 0.252 . . . . 72.209999999999994 110.359 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 7.2 tp -128.36 -40.39 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.603 -0.888 . . . . 74.409999999999997 108.603 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 219' ' ' ILE . 16.5 t70 57.23 -92.73 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.845 1.258 . . . . 72.010000000000005 111.542 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -180.0 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.242 -1.762 . . . . 73.019999999999996 106.242 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 17.7 tt -107.32 113.05 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 CA-C-O 122.204 1.002 . . . . 74.25 111.085 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . 0.46 ' CG2' HH12 ' C' ' 255' ' ' ARG . 1.9 m -140.93 119.62 10.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 114.568 -1.196 . . . . 71.450000000000003 110.075 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.15 72.18 1.29 Allowed Glycine 0 C--N 1.308 -0.994 0 N-CA-C 109.674 -1.37 . . . . 75.409999999999997 109.674 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 261' ' ' THR . 14.7 ttt180 -108.94 121.81 45.91 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.128 -0.536 . . . . 73.530000000000001 111.707 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -85.92 126.34 34.02 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.213 -2.143 . . . . 44.420000000000002 105.213 171.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' B' ' 263' ' ' SER . 18.7 m -121.25 136.61 54.94 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.789 -0.765 . . . . 74.010000000000005 111.746 -174.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.62 119.19 26.43 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.474 -1.306 . . . . 74.409999999999997 107.474 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 33.5 ttmt -75.74 -61.73 1.82 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.059 -0.719 . . . . 74.040000000000006 109.059 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -128.32 137.7 52.05 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 109.373 -0.602 . . . . 74.230000000000004 109.373 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 40.0 mt -128.6 128.16 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.791 0 N-CA-C 104.956 -2.238 . . . . 75.040000000000006 104.956 174.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . 0.441 ' HB3' HG12 ' B' ' 268' ' ' VAL . 16.0 ttm180 -132.25 114.09 14.03 Favored 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 108.537 -0.912 . . . . 73.030000000000001 108.537 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 45.7 p -110.04 127.89 55.1 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.243 -1.762 . . . . 74.219999999999999 106.243 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' B' ' 270' ' ' LYS . 48.4 mt-10 -143.31 140.5 30.61 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.007 -0.738 . . . . 74.040000000000006 109.007 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 60.89 97.66 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 O-C-N 124.032 0.833 . . . . 63.310000000000002 113.212 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.47 ' HB2' ' H ' ' B' ' 272' ' ' GLU . 2.0 mpt_? 60.37 22.61 12.15 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.031 0.533 . . . . 73.450000000000003 111.533 173.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.58 140.53 33.63 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.189 0.519 . . . . 74.230000000000004 110.895 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.94 134.76 46.01 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.685 -0.688 . . . . 74.549999999999997 109.498 178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.537 ' CG1' HG11 ' A' ' 275' ' ' VAL . 7.2 p -137.53 150.01 25.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.271 0.558 . . . . 55.329999999999998 110.204 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.422 HE22 ' N ' ' B' ' 243' ' ' ASN . 22.5 tm0? -122.63 128.13 50.26 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 105.663 -1.977 . . . . 64.230000000000004 105.663 170.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . 0.444 HD12 HG22 ' A' ' 277' ' ' ILE . 3.3 tm? -118.33 117.91 30.37 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.16 -2.163 . . . . 74.540000000000006 105.16 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.424 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 143.19 -125.56 2.6 Favored Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 118.695 -1.717 . . . . 50.229999999999997 112.852 -178.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 2.8 t-20 -144.44 128.22 17.28 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 110.292 -0.262 . . . . 75.400000000000006 110.292 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 30.0 t -99.54 128.0 51.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.105 -1.442 . . . . 74.340000000000003 107.105 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 10.5 t -122.51 116.07 47.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 107.381 -1.34 . . . . 74.230000000000004 107.381 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.9 p -85.02 158.07 20.57 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 117.1 -1.84 . . . . 72.25 111.065 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -66.57 -47.1 73.85 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.61 1.195 . . . . 71.310000000000002 110.035 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.81 -33.49 61.6 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.243 -2.253 . . . . 71.219999999999999 113.795 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.42 ' HB3' ' HA3' ' B' ' 282' ' ' GLY . . . -58.7 -42.84 89.54 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.078 0.551 . . . . 71.209999999999994 111.171 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 90.7 mt 65.68 -69.05 0.11 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.807 1.243 . . . . 72.340000000000003 112.549 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -154.18 166.67 32.38 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.067 -0.515 . . . . 73.549999999999997 110.12 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 171.83 -63.37 0.15 Allowed Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 109.771 -1.331 . . . . 71.450000000000003 109.771 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -95.15 147.61 18.67 Favored Glycine 0 C--N 1.303 -1.284 0 CA-C-N 115.362 -0.419 . . . . 73.200000000000003 112.063 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 258' ' ' ASP . 54.1 mt -138.8 -45.66 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 107.396 -1.335 . . . . 74.030000000000001 107.396 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.96 62.4 0.35 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.358 1.075 . . . . 74.329999999999998 108.323 169.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 10.5 tp -128.18 5.77 3.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.22 -0.9 . . . . 73.450000000000003 112.233 -174.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 24.6 m -65.9 98.41 0.41 Allowed 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 107.848 -1.167 . . . . 75.140000000000001 107.848 173.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.28 146.73 46.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.187 -0.461 . . . . 64.549999999999997 110.634 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -76.29 71.77 3.01 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.83 0.824 . . . . 73.019999999999996 112.025 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 15.4 m -101.29 120.64 40.56 Favored 'General case' 0 N--CA 1.399 -2.996 0 N-CA-C 103.618 -2.734 . . . . 75.010000000000005 103.618 170.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 261' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 13.9 m -94.47 108.44 20.38 Favored 'General case' 0 N--CA 1.417 -2.114 0 C-N-CA 119.208 -0.997 . . . . 74.099999999999994 109.446 -175.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -104.19 128.54 51.92 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.147 -1.057 . . . . 72.010000000000005 108.147 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 263' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' B' ' 227' ' ' SER . 38.6 t -142.78 136.09 28.51 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-O 121.074 0.464 . . . . 74.519999999999996 111.747 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 9.4 p -116.39 137.25 50.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.982 -0.554 . . . . 74.510000000000005 110.076 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.575 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 31.7 mm-40 -78.02 -57.44 3.79 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.866 -0.79 . . . . 75.200000000000003 108.866 176.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 88.0 m -146.96 126.98 13.65 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.661 0.743 . . . . 73.010000000000005 111.387 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.3 p -121.91 120.51 61.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.271 -0.877 . . . . 73.430000000000007 109.603 176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . 0.441 HG12 ' HB3' ' B' ' 232' ' ' ARG . 34.2 m -121.06 145.59 27.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 116.044 -0.526 . . . . 73.219999999999999 110.194 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -143.82 132.79 5.06 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 120.097 -1.049 . . . . 71.549999999999997 112.4 176.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.538 ' HA ' ' O ' ' B' ' 234' ' ' GLU . 65.0 mttm -133.92 131.01 38.56 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.724 0.81 . . . . 73.319999999999993 112.319 176.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.03 86.57 0.59 Allowed Glycine 0 C--N 1.296 -1.679 0 N-CA-C 114.476 0.551 . . . . 54.219999999999999 114.476 172.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . 0.47 ' H ' ' HB2' ' B' ' 236' ' ' ARG . 65.3 mm-40 65.95 27.65 10.76 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 112.193 0.442 . . . . 74.439999999999998 112.193 173.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 12.9 m -83.54 143.15 30.37 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.29 0.567 . . . . 74.530000000000001 110.149 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.486 ' HB2' ' HG3' ' C' ' 238' ' ' ARG . 10.9 mpt_? -123.47 127.63 48.66 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.521 -1.659 . . . . 74.430000000000007 106.521 174.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.48 ' HB ' HG21 ' B' ' 239' ' ' VAL . 5.9 t -127.41 133.9 66.91 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 108.45 -0.945 . . . . 71.329999999999998 108.45 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . 0.451 HD22 HE21 ' C' ' 240' ' ' GLN . 4.4 tt -121.99 112.82 18.75 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.011 -1.477 . . . . 73.129999999999995 107.011 171.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . 0.429 HG23 HD13 ' C' ' 241' ' ' LEU . 39.4 mt -112.83 107.0 21.87 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 109.131 -0.692 . . . . 73.239999999999995 109.131 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 149.95 -137.58 6.28 Favored Glycine 0 N--CA 1.405 -3.38 0 C-N-CA 119.948 -1.12 . . . . 71.319999999999993 112.188 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . 0.581 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 27.7 t-20 -119.03 133.18 55.97 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.998 -0.601 . . . . 54.310000000000002 110.133 -178.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -109.89 118.64 37.01 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 104.603 -2.369 . . . . 74.239999999999995 104.603 177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -120.05 123.43 43.39 Favored 'General case' 0 C--O 1.274 2.369 0 CA-C-O 122.535 1.16 . . . . 74.329999999999998 110.379 -172.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . 0.42 ' HA3' ' HB3' ' B' ' 249' ' ' ALA . . . 111.91 -55.66 0.5 Allowed Glycine 0 N--CA 1.398 -3.9 0 CA-C-N 114.064 -1.425 . . . . 64.150000000000006 115.385 172.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.43 -97.91 0.03 OUTLIER Glycine 0 C--N 1.313 -0.737 0 N-CA-C 115.655 1.022 . . . . 72.299999999999997 115.655 -171.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 42.8 tptt 173.92 -42.06 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 103.94 -2.615 . . . . 74.340000000000003 103.94 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -147.09 161.68 28.49 Favored Glycine 1 N--CA 1.387 -4.591 0 N-CA-C 106.215 -2.754 . . . . 74.530000000000001 106.215 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -83.4 -153.63 0.14 Allowed 'General case' 0 C--N 1.278 -2.509 0 O-C-N 124.358 0.681 . . . . 75.150000000000006 110.56 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.469 ' HB3' ' HA3' ' A' ' 285' ' ' GLY . 34.4 p90 -64.66 43.5 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.756 1.623 . . . . 65.140000000000001 113.629 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -76.34 170.18 16.83 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.031 -1.1 . . . . 65.209999999999994 108.031 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . 0.424 ' HA ' ' NE2' ' A' ' 290' ' ' HIS . 16.0 m120 -86.24 26.95 0.97 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 114.616 1.339 . . . . 74.209999999999994 114.616 -165.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 32.6 m170 62.99 80.42 0.23 Allowed 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 124.653 1.181 . . . . 71.439999999999998 113.431 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -111.0 -32.42 6.81 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.074 -1.824 . . . . 73.329999999999998 106.074 171.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 59.46 -88.9 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.965 1.706 . . . . 74.230000000000004 112.525 171.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -115.53 40.09 2.82 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.384 0.612 . . . . 74.5 109.576 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 51.0 t60 -76.04 82.86 2.9 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.723 -1.214 . . . . 70.299999999999997 107.723 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 . . . . . 0 C--N 1.295 -1.793 0 CA-C-N 114.885 -1.052 . . . . 75.109999999999999 108.55 -174.063 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 46.7 ttm . . . . . 0 C--O 1.218 -0.562 0 N-CA-C 109.765 -0.457 . . . . 73.040000000000006 109.765 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -145.48 113.13 6.33 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.413 -0.958 . . . . 73.439999999999998 108.413 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 65.1 mt -148.36 144.01 18.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.842 -1.54 . . . . 72.129999999999995 106.842 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -86.35 -56.62 3.35 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.243 0.474 . . . . 72.510000000000005 109.99 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -141.18 137.19 32.49 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.09 -1.078 . . . . 74.329999999999998 108.09 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 13.9 tt -116.81 118.86 60.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.102 0.477 . . . . 72.049999999999997 111.91 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 22.0 m -134.11 151.52 32.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.935 -0.765 . . . . 65.349999999999994 108.935 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 57.26 65.81 3.3 Favored Glycine 0 C--N 1.335 0.526 0 O-C-N 124.095 0.872 . . . . 62.509999999999998 112.071 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' B' ' 261' ' ' THR . 47.5 ttt180 -97.72 121.48 39.68 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.513 -0.475 . . . . 75.340000000000003 111.301 -177.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -93.23 124.93 37.56 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 104.962 -2.236 . . . . 75.120000000000005 104.962 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 8.1 m -121.69 136.22 54.95 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.976 -0.689 . . . . 71.120000000000005 110.856 -174.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.38 119.02 30.92 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.829 -1.545 . . . . 70.430000000000007 106.829 174.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.8 OUTLIER -82.17 -54.72 5.04 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 116.301 -0.409 . . . . 74.439999999999998 109.958 -174.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -131.46 137.41 48.58 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.462 -1.31 . . . . 71.200000000000003 107.462 173.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 30.8 mt -130.73 128.79 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 104.983 -2.228 . . . . 73.319999999999993 104.983 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.412 ' HB3' HG12 ' C' ' 268' ' ' VAL . 10.7 ttm180 -133.05 113.85 13.26 Favored 'General case' 0 N--CA 1.401 -2.896 0 N-CA-C 108.758 -0.831 . . . . 74.340000000000003 108.758 -176.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 233' ' ' THR . . . . . 0.426 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 40.9 p -110.79 126.22 54.39 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.856 -1.164 . . . . 72.430000000000007 107.856 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 48.4 mt-10 -145.14 142.24 29.45 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 110.271 -0.27 . . . . 75.340000000000003 110.271 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 64.49 89.59 0.09 Allowed 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.437 1.085 . . . . 70.109999999999999 113.113 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? 64.75 15.99 10.13 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.993 -1.003 . . . . 71.430000000000007 112.026 174.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.47 140.97 28.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.289 0.566 . . . . 64.219999999999999 112.481 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.486 ' HG3' ' HB2' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -128.47 135.75 49.89 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.021 -0.733 . . . . 70.519999999999996 109.021 178.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' C' ' 275' ' ' VAL . 7.1 p -138.85 147.53 24.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.452 0.644 . . . . 75.040000000000006 111.469 -177.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . 0.451 HE21 HD22 ' B' ' 276' ' ' LEU . 13.3 tm0? -117.35 132.54 56.57 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 104.506 -2.405 . . . . 74.120000000000005 104.506 172.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.429 HD13 HG23 ' B' ' 277' ' ' ILE . 3.4 tm? -129.68 117.79 20.88 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 106.319 -1.734 . . . . 75.319999999999993 106.319 177.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.31 -117.65 1.66 Allowed Glycine 0 N--CA 1.426 -1.999 0 C-N-CA 119.912 -1.137 . . . . 73.519999999999996 112.474 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 18.1 t-20 -144.4 134.33 23.91 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.798 0.333 . . . . 74.25 111.435 -176.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.31 123.61 68.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.49 -0.93 . . . . 74.540000000000006 108.49 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . 0.453 HG11 ' OD1' ' C' ' 243' ' ' ASN . 31.5 m -121.43 117.2 51.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-O 121.625 0.726 . . . . 72.109999999999999 109.143 177.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 246' ' ' THR . . . . . 0.511 ' OG1' ' HA3' ' C' ' 282' ' ' GLY . 12.4 p -83.76 158.55 21.7 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 117.871 -1.532 . . . . 63.130000000000003 109.969 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.93 89.73 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.934 1.35 . . . . 73.329999999999998 108.632 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.19 62.36 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 112.374 -2.193 . . . . 73.200000000000003 112.826 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -59.4 -35.0 73.15 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 112.908 0.707 . . . . 74.329999999999998 112.908 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 96.5 mt 64.53 -178.92 0.17 Allowed 'General case' 0 C--O 1.247 0.964 0 O-C-N 124.235 0.959 . . . . 73.25 110.842 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -104.3 140.5 37.78 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 120.54 -0.464 . . . . 74.329999999999998 110.206 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -87.39 -162.2 37.5 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 111.314 -0.714 . . . . 63.340000000000003 111.314 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -100.45 83.69 0.55 Allowed Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 121.019 -0.61 . . . . 72.310000000000002 111.991 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 66.2 mt 72.04 148.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 C-N-CA 123.871 0.868 . . . . 74.319999999999993 111.145 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . 0.46 HH12 ' CG2' ' B' ' 223' ' ' VAL . 59.5 mtp180 -66.74 149.74 50.09 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.89 0.876 . . . . 75.140000000000001 109.703 -175.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 29.5 pt -121.23 -37.73 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 113.837 1.051 . . . . 72.010000000000005 113.837 -173.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 87.2 p 68.91 130.53 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 127.121 2.168 . . . . 74.099999999999994 113.018 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -97.69 148.87 22.89 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.026 -1.472 . . . . 74.150000000000006 107.026 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -109.26 5.21 23.51 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.032 0.753 . . . . 73.450000000000003 113.032 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 37.8 p -82.26 131.55 35.23 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 119.855 -0.738 . . . . 75.349999999999994 111.383 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 11.2 p -102.46 108.74 20.16 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.861 -0.609 . . . . 72.409999999999997 110.706 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -97.89 138.81 34.68 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.213 -1.402 . . . . 74.230000000000004 107.213 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 45.6 m -142.58 136.12 28.91 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.639 -0.663 . . . . 71.5 111.11 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.96 130.56 74.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.101 -0.703 . . . . 64.329999999999998 109.101 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 5.5 mm-40 -75.09 -47.14 30.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.051 0.453 . . . . 65.540000000000006 110.904 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 69.8 m -150.41 127.88 11.47 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 122.005 -0.434 . . . . 74.109999999999999 110.623 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 1.1 p -126.1 119.8 55.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.983 -0.747 . . . . 75.109999999999999 108.983 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . 0.412 HG12 ' HB3' ' C' ' 232' ' ' ARG . 25.8 m -121.04 144.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.262 -0.644 . . . . 75.340000000000003 109.262 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.33 132.42 6.65 Favored Glycine 0 CA--C 1.473 -2.558 0 N-CA-C 110.705 -0.958 . . . . 54.240000000000002 110.705 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.59 128.83 36.0 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 109.499 -0.556 . . . . 75.310000000000002 109.499 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.6 75.49 1.15 Allowed Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.357 -0.925 . . . . 72.420000000000002 113.718 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 60.52 40.81 16.53 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.389 0.676 . . . . 75.049999999999997 112.269 175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.4 m -81.98 143.81 31.33 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 119.221 -0.992 . . . . 73.0 109.482 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . 0.413 ' HB3' ' HE1' ' C' ' 287' ' ' TRP . 1.3 mpp_? -120.2 127.0 52.04 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.545 -1.65 . . . . 74.150000000000006 106.545 173.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . 0.434 ' HB ' HG23 ' C' ' 239' ' ' VAL . 3.0 t -135.54 140.18 45.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 109.315 -0.624 . . . . 73.310000000000002 109.315 -175.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.523 HD11 ' CZ3' ' C' ' 287' ' ' TRP . 4.0 tt -128.17 115.6 18.64 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.145 -1.798 . . . . 72.409999999999997 106.145 170.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 56.7 mt -112.73 104.31 16.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.047 -1.464 . . . . 74.540000000000006 107.047 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.12 -139.5 6.72 Favored Glycine 0 N--CA 1.403 -3.507 0 C-N-CA 119.89 -1.147 . . . . 71.109999999999999 111.476 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . 0.404 ' HB3' HD21 ' C' ' 243' ' ' ASN . 28.5 t-20 -122.87 130.29 52.69 Favored 'General case' 0 C--N 1.279 -2.466 0 O-C-N 123.807 0.357 . . . . 74.420000000000002 110.237 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.88 117.9 34.64 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.618 -1.623 . . . . 75.040000000000006 106.618 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -124.77 123.94 41.06 Favored 'General case' 0 C--O 1.272 2.245 0 CA-C-O 122.394 1.092 . . . . 75.209999999999994 111.794 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . 0.511 ' HA3' ' OG1' ' C' ' 246' ' ' THR . . . 128.2 -53.91 0.79 Allowed Glycine 0 N--CA 1.419 -2.459 0 CA-C-N 114.193 -1.367 . . . . 63.409999999999997 113.515 178.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -80.48 -97.62 0.35 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.493 -0.86 . . . . 75.510000000000005 114.104 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 52.5 tttp 170.43 -34.11 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 104.877 -2.268 . . . . 74.109999999999999 104.877 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -143.05 156.31 26.4 Favored Glycine 0 N--CA 1.404 -3.442 0 N-CA-C 106.479 -2.649 . . . . 60.530000000000001 106.479 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -89.08 -166.09 1.51 Allowed 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 117.258 0.529 . . . . 74.25 109.719 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . 0.523 ' CZ3' HD11 ' C' ' 276' ' ' LEU . 43.4 p90 -53.97 144.9 17.8 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 123.409 0.684 . . . . 65.219999999999999 110.756 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' C' ' 287' ' ' TRP . 2.4 m-20 75.01 -81.35 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.508 0.723 . . . . 74.209999999999994 111.527 -176.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -161.77 159.67 27.39 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.489 -0.93 . . . . 72.219999999999999 108.489 -173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -78.53 94.89 5.05 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.229 -1.026 . . . . 75.230000000000004 108.229 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -86.32 -57.67 2.92 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.606 -0.725 . . . . 74.239999999999995 109.831 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -143.63 165.26 28.12 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.16 -0.681 . . . . 74.519999999999996 109.16 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -162.09 -69.89 0.05 Allowed 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.928 -1.138 . . . . 75.129999999999995 107.928 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -131.1 145.87 52.15 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.587 -0.894 . . . . 63.219999999999999 108.587 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 C--N 1.285 -2.206 0 N-CA-C 106.462 -1.681 . . . . 73.510000000000005 106.462 175.267 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 83.0 mtp . . . . . 0 CA--C 1.5 -0.945 0 N-CA-C 108.11 -1.07 . . . . 73.040000000000006 108.11 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -130.76 -65.38 0.79 Allowed 'General case' 0 C--N 1.316 -0.89 0 O-C-N 123.234 0.334 . . . . 73.030000000000001 110.638 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.9 mt 68.84 104.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.06 0.944 . . . . 74.099999999999994 111.937 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 7.0 t70 66.97 -156.7 0.23 Allowed 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.22 -1.355 . . . . 74.019999999999996 108.407 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -125.41 30.34 5.81 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.935 -0.765 . . . . 74.510000000000005 108.935 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 50.2 mm -83.56 121.71 36.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.639 -0.71 . . . . 75.010000000000005 110.627 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.95 119.59 57.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.1 0.476 . . . . 73.219999999999999 111.239 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 52.07 52.48 35.4 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 114.487 -1.233 . . . . 75.150000000000006 115.738 174.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -100.57 134.3 43.74 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.616 0.722 . . . . 72.409999999999997 111.318 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.47 ' HB2' ' OD1' ' A' ' 262' ' ' ASN . 23.4 p-10 -116.88 156.0 28.09 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 125.23 1.412 . . . . 71.120000000000005 111.675 -173.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 263' ' ' SER . 23.4 m -116.99 136.53 52.87 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 108.813 -0.81 . . . . 63.210000000000001 108.813 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.7 135.34 43.98 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.267 -0.879 . . . . 73.230000000000004 110.285 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 1.9 tmtp? -87.84 -63.93 1.23 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.723 -0.671 . . . . 73.340000000000003 110.367 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -131.03 139.03 49.89 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.166 -0.334 . . . . 73.030000000000001 110.52 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.6 mt -137.8 128.15 36.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.029 -1.471 . . . . 73.430000000000007 107.029 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.404 ' HB2' HG11 ' A' ' 268' ' ' VAL . 65.0 mtt180 -134.41 115.14 13.67 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.437 -0.505 . . . . 75.329999999999998 109.706 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.451 HG23 ' HB ' ' A' ' 239' ' ' VAL . 28.9 p -118.95 128.31 54.29 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.415 -0.514 . . . . 74.349999999999994 109.868 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.3 153.29 46.42 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.904 -0.406 . . . . 55.32 109.904 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 63.46 83.44 0.16 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.603 1.161 . . . . 71.5 113.036 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 236' ' ' ARG . 6.1 mpt_? 58.83 22.79 10.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.913 1.285 . . . . 75.239999999999995 112.436 176.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.6 142.03 27.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 122.173 -0.329 . . . . 62.409999999999997 110.445 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.75 137.16 53.8 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.825 -0.435 . . . . 74.439999999999998 109.825 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 233' ' ' THR . 3.1 p -129.16 142.59 43.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.453 0.644 . . . . 44.439999999999998 111.777 -176.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -125.99 125.38 42.6 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 108.496 -0.928 . . . . 73.329999999999998 108.496 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 59.7 tp -115.88 123.87 49.22 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.454 -0.943 . . . . 74.239999999999995 108.454 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.558 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 121.09 -123.54 5.57 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.382 -0.913 . . . . 71.299999999999997 112.166 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . 0.575 ' ND2' HD21 ' A' ' 279' ' ' ASN . 2.1 t-20 -141.76 128.57 20.51 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 122.196 -0.591 . . . . 73.099999999999994 111.524 -174.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 51.3 t -104.11 122.45 56.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.201 -1.407 . . . . 74.510000000000005 107.201 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.7 t -118.17 116.26 50.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.401 -0.592 . . . . 73.109999999999999 109.401 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.3 t -114.34 162.1 17.05 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 119.977 -0.689 . . . . 72.150000000000006 109.393 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.37 -32.0 62.24 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 114.862 1.43 . . . . 75.430000000000007 114.862 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.41 -37.54 65.19 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.823 1.416 . . . . 71.340000000000003 114.823 -173.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.11 -25.93 55.9 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.542 0.571 . . . . 73.530000000000001 112.542 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 69.26 -94.22 0.03 OUTLIER 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.232 1.013 . . . . 75.540000000000006 109.131 -170.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 171.33 139.04 0.03 OUTLIER 'General case' 0 C--O 1.247 0.967 0 C-N-CA 124.638 1.175 . . . . 74.409999999999997 108.674 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -159.28 171.74 35.83 Favored Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 110.77 -0.932 . . . . 64.340000000000003 110.77 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -70.91 124.0 11.33 Favored Glycine 0 CA--C 1.498 -0.985 0 N-CA-C 109.705 -1.358 . . . . 72.519999999999996 109.705 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 8.8 tp -134.59 118.33 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 121.773 0.797 . . . . 74.019999999999996 112.719 -172.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.43 149.74 33.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.26 -0.882 . . . . 73.140000000000001 109.837 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 4.0 mm -156.27 -36.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 112.515 0.561 . . . . 72.129999999999995 112.515 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 25.2 t -151.54 96.0 2.2 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.063 -1.458 . . . . 75.319999999999993 107.063 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -84.41 -1.07 54.99 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.745 -1.116 . . . . 75.150000000000006 113.722 -166.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -104.59 -21.93 13.34 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.587 0.708 . . . . 75.420000000000002 110.289 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' THR . . . . . 0.546 ' HB ' ' O ' ' B' ' 225' ' ' ARG . 29.6 p -91.72 138.55 31.47 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 113.943 1.09 . . . . 74.310000000000002 113.943 -169.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.4 t -120.19 143.28 48.33 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.543 -1.28 . . . . 73.109999999999999 107.543 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 25.0 t-20 -86.45 121.45 29.01 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 119.847 -0.741 . . . . 73.349999999999994 109.378 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 227' ' ' SER . 50.8 m -142.32 132.77 25.09 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.554 -0.748 . . . . 72.540000000000006 111.079 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.4 p -126.82 138.22 55.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.603 -0.272 . . . . 74.519999999999996 111.6 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 55.3 mm-40 -78.11 -66.48 0.84 Allowed 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 116.031 -0.532 . . . . 74.230000000000004 110.825 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 30.1 m -133.63 126.97 32.01 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.23 -0.588 . . . . 73.519999999999996 110.41 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.72 121.68 55.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.637 -0.711 . . . . 75.099999999999994 109.601 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.404 HG11 ' HB2' ' A' ' 232' ' ' ARG . 15.9 m -126.05 146.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-O 121.112 0.482 . . . . 74.430000000000007 111.568 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -130.02 131.26 6.54 Favored Glycine 0 N--CA 1.425 -2.073 0 N-CA-C 109.096 -1.601 . . . . 74.230000000000004 109.096 174.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.453 ' HB2' ' HG2' ' B' ' 234' ' ' GLU . 29.8 mmmt -133.25 116.14 15.82 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 120.565 0.221 . . . . 72.549999999999997 110.946 -176.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 83.68 84.05 0.91 Allowed Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 119.314 -1.422 . . . . 42.420000000000002 113.657 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 60.2 27.27 16.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.88 0.872 . . . . 73.530000000000001 111.74 171.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 17.4 m -84.11 145.49 28.4 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.281 0.563 . . . . 64.439999999999998 110.85 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -113.2 127.44 56.18 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.989 -1.856 . . . . 75.129999999999995 105.989 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 1.2 p -133.66 123.1 44.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-O 121.379 0.609 . . . . 70.129999999999995 111.418 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.524 HD23 ' CH2' ' A' ' 287' ' ' TRP . 18.3 tp -117.03 119.37 35.06 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.489 -0.93 . . . . 73.209999999999994 108.489 174.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.413 HG22 ' HB3' ' B' ' 241' ' ' LEU . 2.7 pt -113.67 104.91 17.73 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.146 0 CA-C-N 114.194 -1.367 . . . . 72.239999999999995 109.505 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 149.09 -122.78 1.51 Allowed Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.941 -0.572 . . . . 71.239999999999995 113.036 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.575 HD21 ' ND2' ' A' ' 243' ' ' ASN . 9.8 t30 -129.75 135.31 48.31 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 122.232 -0.569 . . . . 73.099999999999994 111.673 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.489 ' HG2' ' NE1' ' A' ' 287' ' ' TRP . 7.2 tp10 -111.75 118.27 35.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 105.854 -1.906 . . . . 75.530000000000001 105.854 174.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -117.8 123.13 45.2 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 105.721 -1.955 . . . . 75.430000000000007 105.721 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 121.82 -48.51 0.94 Allowed Glycine 0 C--N 1.284 -2.335 0 N-CA-C 108.192 -1.963 . . . . 64.140000000000001 108.192 -172.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 99.52 16.39 29.41 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 120.809 -0.71 . . . . 75.140000000000001 112.112 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.444 ' HB3' ' NZ ' ' A' ' 284' ' ' LYS . 0.1 OUTLIER 176.82 66.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.849 0.859 . . . . 71.219999999999999 112.728 178.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -109.72 -51.22 0.66 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 109.633 -1.387 . . . . 70.109999999999999 109.633 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -96.73 -5.82 37.76 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.243 0.544 . . . . 74.019999999999996 110.591 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . 0.585 ' CH2' ' HB2' ' B' ' 240' ' ' GLN . 2.5 m95 -69.06 152.16 45.55 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 114.526 1.306 . . . . 75.299999999999997 114.526 -174.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -138.14 140.72 40.0 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 113.611 -1.631 . . . . 73.310000000000002 107.342 -174.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -140.09 155.14 47.15 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.164 -0.31 . . . . 63.530000000000001 110.164 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -147.72 3.6 0.74 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.705 0.402 . . . . 75.129999999999995 110.289 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -106.25 149.76 26.56 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.963 0.411 . . . . 74.120000000000005 111.591 -172.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -143.2 167.94 20.95 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.395 -1.335 . . . . 75.409999999999997 107.395 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -146.61 -42.2 0.19 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.224 0.535 . . . . 74.519999999999996 110.806 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -107.81 -53.02 2.68 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.459 -0.941 . . . . 65.200000000000003 108.459 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 34.4 m170 . . . . . 0 C--N 1.304 -1.378 0 N-CA-C 107.199 -1.408 . . . . 63.399999999999999 107.199 176.498 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 N-CA-C 109.649 -0.5 . . . . 73.420000000000002 109.649 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 40.6 tttm 75.0 124.45 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.921 1.289 . . . . 75.340000000000003 111.713 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . 0.41 ' HB ' ' H ' ' B' ' 220' ' ' ASP . 52.0 mt -129.69 -74.85 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 105.799 -1.926 . . . . 64.310000000000002 105.799 174.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . 0.41 ' H ' ' HB ' ' B' ' 219' ' ' ILE . 25.1 m-20 66.88 -173.71 0.19 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.83 -1.532 . . . . 71.400000000000006 108.65 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 64.29 27.19 13.79 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.966 0.906 . . . . 75.549999999999997 111.339 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 59.4 mt -94.82 138.48 20.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.756 0.789 . . . . 75.519999999999996 109.903 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 14.1 p -101.0 119.32 48.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 121.244 -0.91 . . . . 74.239999999999995 112.143 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 31.78 83.85 0.01 OUTLIER Glycine 0 N--CA 1.48 1.608 0 C-N-CA 126.164 1.84 . . . . 31.420000000000002 117.472 171.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . 0.546 ' O ' ' HB ' ' A' ' 260' ' ' THR . 17.6 mmt180 -118.35 138.77 52.19 Favored 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 118.025 0.912 . . . . 75.200000000000003 111.564 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 21.2 p-10 -118.23 155.34 30.71 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 125.328 1.451 . . . . 75.209999999999994 114.27 -174.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' B' ' 263' ' ' SER . 20.7 m -117.38 135.93 53.52 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 122.362 1.077 . . . . 72.120000000000005 108.149 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -134.06 139.21 45.83 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.004 -0.998 . . . . 63.240000000000002 109.695 -174.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 37.2 ttmt -86.58 -65.53 1.0 Allowed 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.832 -0.622 . . . . 73.340000000000003 110.747 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -126.24 137.83 53.56 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.148 -1.021 . . . . 73.239999999999995 110.489 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 44.9 mt -135.39 121.74 32.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.425 -1.324 . . . . 73.540000000000006 107.425 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 58.4 mtt180 -128.17 114.85 17.52 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.804 -0.813 . . . . 75.430000000000007 108.804 177.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' THR . . . . . 0.424 HG22 ' HB ' ' B' ' 239' ' ' VAL . 45.3 p -116.37 126.59 53.69 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.778 -1.564 . . . . 74.349999999999994 106.778 175.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.469 ' HB2' ' HE3' ' B' ' 270' ' ' LYS . 32.7 mt-10 -141.67 151.91 43.44 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.88 -0.785 . . . . 72.299999999999997 108.88 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 61.38 80.38 0.22 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.536 1.134 . . . . 73.439999999999998 112.466 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.54 ' HD3' ' N ' ' B' ' 236' ' ' ARG . 0.0 OUTLIER 62.78 25.16 14.95 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.821 0.674 . . . . 75.400000000000006 112.821 173.4 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -84.86 150.66 24.84 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.323 0.583 . . . . 65.129999999999995 110.802 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -125.54 135.14 51.94 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.122 -1.436 . . . . 74.25 107.122 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 5.8 p -136.76 141.95 39.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.304 0.573 . . . . 73.209999999999994 111.635 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.585 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 4.4 tp60 -122.26 125.87 46.95 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-N 114.306 -1.315 . . . . 74.140000000000001 107.867 171.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . 0.525 ' HG ' HD22 ' A' ' 262' ' ' ASN . 52.5 tp -117.3 118.54 32.55 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 107.934 -1.135 . . . . 74.25 107.934 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.554 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 128.33 -117.12 2.46 Favored Glycine 0 N--CA 1.421 -2.347 0 C-N-CA 120.389 -0.91 . . . . 70.409999999999997 111.644 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . 0.594 HD21 ' N ' ' B' ' 244' ' ' VAL . 0.2 OUTLIER -144.57 136.41 25.87 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 120.022 -0.671 . . . . 75.5 110.243 -176.213 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.594 ' N ' HD21 ' B' ' 243' ' ' ASN . 48.1 t -108.54 120.28 59.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.258 -1.386 . . . . 73.329999999999998 107.258 174.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.16 115.23 46.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 120.894 -0.323 . . . . 74.109999999999999 110.598 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.9 t -113.93 162.25 16.63 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.626 -0.879 . . . . 74.120000000000005 108.626 171.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.03 -32.19 70.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.657 1.183 . . . . 62.509999999999998 114.017 -173.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.91 -41.07 67.26 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 114.417 1.266 . . . . 71.040000000000006 114.417 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.444 ' HB2' ' CD2' ' B' ' 281' ' ' TYR . . . -74.27 -25.98 59.94 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 114.273 1.212 . . . . 73.030000000000001 114.273 -175.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 41.6 tp -65.19 91.83 0.11 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.312 0.577 . . . . 64.010000000000005 111.896 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -161.75 -38.81 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 126.57 1.948 . . . . 74.349999999999994 108.965 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -156.9 -160.06 9.86 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.496 -1.042 . . . . 73.209999999999994 110.496 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 128.48 67.92 0.13 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 111.212 -0.755 . . . . 74.340000000000003 111.212 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 46.9 mm -73.44 126.17 33.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 109.971 -0.381 . . . . 74.120000000000005 109.971 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -113.49 116.16 29.15 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.576 -0.738 . . . . 75.219999999999999 112.337 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 71.3 mt -145.26 135.08 18.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 106.895 -1.52 . . . . 74.329999999999998 106.895 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 20.6 t -178.14 -169.11 0.18 Allowed 'General case' 0 C--O 1.247 0.953 0 N-CA-C 107.459 -1.311 . . . . 72.450000000000003 107.459 174.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -93.11 -159.66 0.7 Allowed 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.473 -1.677 . . . . 73.129999999999995 106.473 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -84.09 75.15 10.19 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.382 -0.97 . . . . 74.129999999999995 108.382 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 260' ' ' THR . . . . . 0.576 ' O ' HG22 ' C' ' 222' ' ' ILE . 18.0 p -96.49 131.51 43.01 Favored 'General case' 0 N--CA 1.397 -3.079 0 CA-C-N 115.579 -0.737 . . . . 72.099999999999994 109.249 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 8.2 t -127.75 141.65 51.53 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.798 -1.186 . . . . 74.030000000000001 107.798 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . 0.653 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 25.7 t-20 -87.06 119.13 26.95 Favored 'General case' 0 CA--C 1.479 -1.768 0 N-CA-C 107.846 -1.168 . . . . 74.409999999999997 107.846 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 263' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' B' ' 227' ' ' SER . 49.7 m -142.56 128.03 18.98 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.394 -0.821 . . . . 74.310000000000002 110.889 -177.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.4 p -125.82 141.42 45.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.277 -0.569 . . . . 70.219999999999999 112.462 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.509 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 16.6 mm-40 -79.33 -59.3 2.82 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.568 -0.742 . . . . 72.109999999999999 110.938 177.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 97.0 m -143.6 127.37 17.18 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.023 -0.671 . . . . 75.5 112.694 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 24.0 m -121.07 127.81 75.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 109.056 -0.72 . . . . 72.019999999999996 109.056 172.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 5.5 p -128.64 135.37 62.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-N 116.16 -0.473 . . . . 73.510000000000005 111.877 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.7 132.58 7.99 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 110.494 -1.043 . . . . 75.439999999999998 110.494 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.469 ' HE3' ' HB2' ' B' ' 234' ' ' GLU . 13.9 mmmm -132.84 117.71 18.08 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 122.451 0.3 . . . . 74.430000000000007 111.648 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.87 87.32 0.9 Allowed Glycine 0 C--N 1.307 -1.069 0 C-N-CA 120.379 -0.915 . . . . 74.140000000000001 113.171 173.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 55.16 30.35 14.31 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.953 0.901 . . . . 63.450000000000003 111.899 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.8 m -83.06 145.08 29.48 Favored 'General case' 0 N--CA 1.422 -1.863 0 C-N-CA 120.489 -0.484 . . . . 65.219999999999999 110.355 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -116.84 127.62 54.47 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.088 -1.819 . . . . 74.219999999999999 106.088 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 1.5 p -133.03 123.14 47.57 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 121.517 0.675 . . . . 71.209999999999994 111.252 178.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . 0.515 ' HG ' ' OE1' ' C' ' 240' ' ' GLN . 8.0 tp -113.85 119.86 38.77 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.18 -1.045 . . . . 73.019999999999996 108.18 174.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 2.0 mt -112.14 103.56 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.887 0 N-CA-C 105.192 -2.151 . . . . 75.310000000000002 105.192 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 147.85 -126.96 2.48 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 119.136 -1.507 . . . . 75.420000000000002 114.635 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -128.91 135.42 49.02 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.159 0.504 . . . . 65.5 111.04 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . 0.425 ' HG2' ' NE1' ' B' ' 287' ' ' TRP . 13.9 tp10 -113.45 118.5 34.7 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.776 -1.564 . . . . 74.430000000000007 106.776 177.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . 0.444 ' CD2' ' HB2' ' B' ' 249' ' ' ALA . 4.6 t80 -115.25 122.75 46.94 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 106.144 -1.799 . . . . 64.329999999999998 106.144 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' B' ' 249' ' ' ALA . . . 114.72 -51.37 0.72 Allowed Glycine 0 C--N 1.288 -2.094 0 N-CA-C 108.226 -1.95 . . . . 71.439999999999998 108.226 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 89.97 15.17 58.2 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 111.204 -0.758 . . . . 64.25 111.204 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . 0.478 ' HE3' ' O ' ' B' ' 290' ' ' HIS . 41.4 mmtm -145.75 19.92 1.47 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.157 0.503 . . . . 75.430000000000007 109.992 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -81.93 -79.81 0.95 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.393 -0.908 . . . . 74.230000000000004 113.116 -178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -76.95 -13.36 59.98 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.812 0.671 . . . . 73.420000000000002 112.812 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.589 ' CH2' ' HB2' ' C' ' 240' ' ' GLN . 6.4 m95 -74.0 135.34 43.12 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.107 0.48 . . . . 73.430000000000007 112.177 -173.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -86.94 -0.25 56.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.234 1.016 . . . . 70.510000000000005 108.7 174.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -82.41 151.31 26.67 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 106.959 -1.497 . . . . 74.349999999999994 106.959 172.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . 0.514 ' NE2' ' HA ' ' B' ' 294' ' ' HIS . 2.5 p80 -104.55 -160.78 0.78 Allowed 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.681 -0.489 . . . . 74.230000000000004 109.681 -174.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -65.65 169.6 6.1 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.468 0.307 . . . . 73.439999999999998 111.309 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . 0.432 ' NE2' ' HA ' ' C' ' 289' ' ' ASN . 65.3 t-80 -83.67 64.99 8.27 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 122.558 1.171 . . . . 70.439999999999998 108.347 -176.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -143.95 35.7 1.26 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 113.302 -1.772 . . . . 75.329999999999998 106.917 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . 0.514 ' HA ' ' NE2' ' B' ' 290' ' ' HIS . 8.3 p-80 -47.54 -47.65 27.99 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 114.357 -1.292 . . . . 75.319999999999993 113.227 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 3.3 t60 . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 107.259 -1.386 . . . . 73.519999999999996 107.259 177.484 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 121.161 0.505 . . . . 73.25 110.529 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -101.97 -33.29 9.8 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.718 -1.216 . . . . 73.040000000000006 107.718 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 49.3 mm -102.59 109.25 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 105.137 -2.172 . . . . 75.340000000000003 105.137 169.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -115.16 27.94 9.04 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.32 0.581 . . . . 64.219999999999999 109.852 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -72.57 101.3 2.97 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.167 -0.924 . . . . 74.129999999999995 108.985 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . 0.576 HG22 ' O ' ' B' ' 260' ' ' THR . 66.5 mt -116.25 139.19 44.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 115.135 -0.939 . . . . 75.439999999999998 108.532 -177.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.06 122.4 68.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 120.885 -0.326 . . . . 71.230000000000004 111.508 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 44.06 74.18 0.22 Allowed Glycine 0 N--CA 1.469 0.885 0 O-C-N 125.15 1.531 . . . . 75.010000000000005 116.684 172.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . 0.511 ' O ' ' HB ' ' B' ' 260' ' ' THR . 24.9 mmt180 -115.92 131.54 56.91 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 122.079 0.942 . . . . 73.310000000000002 111.99 177.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . 0.653 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 28.3 p-10 -117.49 155.67 29.32 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 113.419 -1.719 . . . . 72.420000000000002 114.242 -171.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 227' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' C' ' 263' ' ' SER . 23.9 t -117.75 136.37 53.42 Favored 'General case' 0 N--CA 1.409 -2.487 0 N-CA-C 107.671 -1.233 . . . . 73.010000000000005 107.671 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.43 137.92 52.07 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.872 -1.058 . . . . 74.430000000000007 108.842 -175.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 5.2 tmmm? -90.83 -62.0 1.55 Allowed 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 120.062 -0.655 . . . . 75.010000000000005 110.527 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -127.56 137.09 52.5 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 108.392 -0.966 . . . . 74.019999999999996 108.392 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 17.4 mt -137.82 123.59 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.145 -1.057 . . . . 74.230000000000004 108.145 177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 81.5 mtt180 -128.32 115.1 17.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.418 -0.586 . . . . 74.040000000000006 109.418 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 233' ' ' THR . . . . . 0.458 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 33.1 p -112.31 126.87 55.72 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.342 -1.355 . . . . 74.129999999999995 107.342 175.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' B' ' 270' ' ' LYS . 43.1 mt-10 -138.87 145.78 40.38 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 120.328 -0.549 . . . . 73.030000000000001 110.508 -178.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 65.52 84.26 0.16 Allowed 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.637 1.175 . . . . 73.439999999999998 112.506 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? 61.3 23.31 13.56 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.345 1.058 . . . . 73.439999999999998 111.752 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . 0.404 ' HB1' ' HB ' ' C' ' 233' ' ' THR . . . -87.18 151.2 23.39 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.031 0.443 . . . . 75.049999999999997 111.423 -176.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -125.53 135.24 52.06 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.686 -1.227 . . . . 75.430000000000007 107.686 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 2.5 p -130.83 136.31 58.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.459 0.647 . . . . 73.299999999999997 110.929 176.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . 0.589 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 3.9 tp60 -114.56 121.35 43.2 Favored 'General case' 0 N--CA 1.4 -2.967 0 CA-C-N 114.247 -1.342 . . . . 71.239999999999995 107.479 170.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.568 ' HG ' HD22 ' B' ' 262' ' ' ASN . 64.7 tp -115.53 118.16 32.36 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 108.32 -0.992 . . . . 72.299999999999997 108.32 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.538 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 129.5 -115.08 1.84 Allowed Glycine 0 N--CA 1.416 -2.657 0 C-N-CA 120.347 -0.93 . . . . 60.450000000000003 112.47 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . 0.459 ' ND2' HG21 ' C' ' 245' ' ' VAL . 5.9 t30 -144.94 136.28 25.16 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 122.651 -0.323 . . . . 75.230000000000004 110.934 -173.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . 0.445 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 61.0 t -114.79 125.85 72.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.195 0 N-CA-C 108.244 -1.021 . . . . 73.140000000000001 108.244 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . 0.459 HG21 ' ND2' ' C' ' 243' ' ' ASN . 85.5 t -122.06 118.58 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 118.104 0.411 . . . . 72.310000000000002 110.294 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 14.8 t -114.07 162.28 16.67 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 108.242 -1.021 . . . . 74.439999999999998 108.242 170.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.68 -31.86 73.16 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 114.229 1.196 . . . . 72.530000000000001 114.229 -172.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.41 -34.29 57.2 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.749 1.388 . . . . 71.430000000000007 114.749 -169.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . 0.453 ' HB1' ' HA2' ' C' ' 282' ' ' GLY . . . -73.26 -43.34 61.27 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.194 -0.602 . . . . 75.310000000000002 112.128 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 64.52 -65.89 0.13 Allowed 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 124.231 1.013 . . . . 72.540000000000006 109.065 -168.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -136.62 114.54 11.34 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 126.319 1.848 . . . . 74.439999999999998 106.246 173.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -87.78 -124.89 2.1 Favored Glycine 0 C--N 1.304 -1.245 0 C-N-CA 120.551 -0.833 . . . . 43.149999999999999 113.156 -173.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -134.49 66.96 0.56 Allowed Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 110.113 -1.195 . . . . 75.430000000000007 110.113 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.5 tp -75.53 124.27 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-O 121.558 0.694 . . . . 74.430000000000007 109.532 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -93.73 -173.67 3.23 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.644 -1.243 . . . . 75.040000000000006 107.644 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 12.8 tt -73.87 130.84 35.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.109 0.48 . . . . 74.329999999999998 110.185 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 25.1 m -128.79 101.38 6.09 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 107.682 -1.229 . . . . 70.109999999999999 107.682 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -133.7 -52.1 0.86 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.527 0.679 . . . . 74.239999999999995 110.164 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -111.92 -21.06 11.78 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.789 -0.641 . . . . 74.519999999999996 110.481 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 7.4 m -84.52 121.64 27.87 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.756 -0.461 . . . . 72.530000000000001 109.756 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 10.9 t -134.34 142.68 47.32 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.588 -0.893 . . . . 75.510000000000005 108.588 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -87.99 120.38 29.28 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.297 0.57 . . . . 73.040000000000006 110.177 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 263' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' C' ' 227' ' ' SER . 46.8 m -139.6 132.77 29.74 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.601 -0.727 . . . . 74.25 109.047 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 12.3 p -123.91 139.52 50.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.964 0.411 . . . . 72.409999999999997 111.129 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 9.1 mm-40 -75.88 -64.12 1.16 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.913 -0.585 . . . . 75.230000000000004 111.794 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 87.4 m -144.85 127.91 16.56 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 122.058 -0.402 . . . . 75.540000000000006 109.966 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -126.86 123.67 63.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 115.323 -0.853 . . . . 70.129999999999995 109.638 178.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 26.5 m -124.65 146.61 29.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.179 -0.464 . . . . 75.099999999999994 110.337 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -130.85 132.52 6.9 Favored Glycine 0 CA--C 1.481 -2.062 0 N-CA-C 109.348 -1.501 . . . . 70.450000000000003 109.348 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -132.78 116.55 16.7 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.735 0.268 . . . . 72.209999999999994 111.592 -175.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.95 84.42 0.85 Allowed Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.022 -1.085 . . . . 73.209999999999994 113.868 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 59.19 29.07 18.56 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.267 1.027 . . . . 74.140000000000001 111.629 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 15.8 m -82.87 145.55 29.38 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.102 -0.499 . . . . 75.319999999999993 111.102 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -113.43 128.4 56.44 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.06 -1.83 . . . . 74.140000000000001 106.06 174.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 6.6 p -137.95 123.57 25.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.533 0.682 . . . . 74.340000000000003 111.317 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.531 HD11 ' CG ' ' C' ' 240' ' ' GLN . 5.3 tp -113.88 112.17 22.9 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.866 -0.79 . . . . 75.140000000000001 108.866 175.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 5.4 mt -103.9 103.71 15.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 105.256 -2.127 . . . . 73.400000000000006 105.256 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 143.51 -144.83 14.18 Favored Glycine 0 N--CA 1.421 -2.314 0 C-N-CA 119.869 -1.158 . . . . 74.0 112.809 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -110.18 139.81 44.94 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.114 0.483 . . . . 71.409999999999997 110.342 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . 0.571 ' HG2' ' NE1' ' C' ' 287' ' ' TRP . 12.9 tp10 -118.06 117.46 29.26 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 105.933 -1.877 . . . . 72.540000000000006 105.933 175.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -111.51 123.39 50.13 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.01 -1.848 . . . . 74.409999999999997 106.01 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . 0.453 ' HA2' ' HB1' ' C' ' 249' ' ' ALA . . . 109.58 -51.29 0.71 Allowed Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 109.548 -1.421 . . . . 72.109999999999999 109.548 -173.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 86.13 24.35 41.13 Favored Glycine 0 CA--C 1.496 -1.156 0 C-N-CA 120.94 -0.648 . . . . 75.420000000000002 111.634 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -148.53 13.89 0.95 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 122.979 0.512 . . . . 71.140000000000001 110.247 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.43 -79.63 0.81 Allowed Glycine 0 N--CA 1.422 -2.263 0 C-N-CA 120.096 -1.049 . . . . 74.25 112.82 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -80.23 -19.78 46.11 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.126 0.787 . . . . 74.129999999999995 113.126 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . 0.571 ' NE1' ' HG2' ' C' ' 280' ' ' GLU . 9.2 m95 -73.87 139.83 45.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 114.261 1.208 . . . . 73.209999999999994 114.261 -171.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.25 -44.86 71.1 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.446 -0.946 . . . . 60.439999999999998 108.446 170.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . 0.432 ' HA ' ' NE2' ' B' ' 292' ' ' HIS . 54.2 t-20 -145.57 133.99 21.91 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.784 -1.191 . . . . 62.409999999999997 107.784 -176.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -153.9 101.23 2.42 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 123.036 0.21 . . . . 75.340000000000003 110.594 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 50.8 t60 71.06 -22.75 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 125.105 1.362 . . . . 74.329999999999998 114.411 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . 0.313 14.5 m80 81.88 99.21 0.05 Allowed 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 114.69 1.367 . . . . 75.340000000000003 114.69 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -160.07 142.56 13.35 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 104.377 -2.453 . . . . 74.310000000000002 104.377 173.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -82.27 134.86 35.3 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 121.609 0.719 . . . . 75.409999999999997 112.047 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 73.8 t60 . . . . . 0 C--N 1.296 -1.72 0 N-CA-C 106.931 -1.507 . . . . 70.310000000000002 106.931 -179.85 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 107.985 -1.117 . . . . 74.519999999999996 107.985 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -126.83 12.26 7.28 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.11 0.481 . . . . 73.319999999999993 109.751 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 8.5 tp -117.91 150.58 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 115.238 -0.892 . . . . 74.409999999999997 109.935 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -121.44 -165.66 1.27 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 106.675 -1.602 . . . . 73.519999999999996 106.675 175.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.96 81.62 8.82 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 119.222 0.919 . . . . 71.5 112.424 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.462 ' O ' ' HB3' ' A' ' 259' ' ' GLN . 47.1 mm -116.12 114.41 46.05 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 N-CA-C 107.387 -1.338 . . . . 72.519999999999996 107.387 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 15.4 m -138.08 119.21 16.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 117.747 0.249 . . . . 74.019999999999996 110.353 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 45.46 53.78 7.94 Favored Glycine 0 C--N 1.337 0.629 0 O-C-N 124.332 1.02 . . . . 75.219999999999999 113.166 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -89.93 124.87 35.09 Favored 'General case' 0 CA--C 1.49 -1.348 0 C-N-CA 119.792 -0.763 . . . . 73.239999999999995 111.504 -176.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -115.62 114.35 24.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.038 -1.467 . . . . 71.219999999999999 107.038 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 10.1 p -129.07 137.64 51.39 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.457 0.646 . . . . 74.349999999999994 112.385 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.22 129.51 37.82 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.073 -1.084 . . . . 64.329999999999998 108.073 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -82.31 -55.84 4.27 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.798 -0.445 . . . . 74.430000000000007 109.798 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 266' ' ' THR . 26.3 t0 -138.55 139.46 38.69 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 119.95 -0.7 . . . . 73.340000000000003 111.985 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 30.8 mm -128.33 127.79 67.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 106.889 -1.523 . . . . 73.299999999999997 106.889 -176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 31.0 ttt180 -134.14 115.42 14.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.283 -0.567 . . . . 72.109999999999999 110.079 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 40.8 p -110.66 127.59 55.35 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.335 -0.987 . . . . 74.030000000000001 108.335 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -128.08 148.96 50.58 Favored 'General case' 0 CA--C 1.482 -1.67 0 C-N-CA 120.089 -0.644 . . . . 60.020000000000003 109.865 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.582 ' C ' ' HD2' ' A' ' 236' ' ' ARG . 44.4 mt-10 59.27 91.24 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 O-C-N 125.12 1.512 . . . . 64.230000000000004 114.029 173.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.582 ' HD2' ' C ' ' A' ' 235' ' ' GLU . 0.1 OUTLIER 61.33 2.23 0.61 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.345 1.458 . . . . 71.319999999999993 113.401 174.065 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -69.92 149.58 47.66 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.398 0.679 . . . . 64.310000000000002 112.156 -175.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.34 139.01 54.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.701 -0.681 . . . . 53.32 109.805 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 6.0 p -124.85 141.93 43.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 116.052 -0.522 . . . . 72.299999999999997 110.018 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -123.26 117.7 25.9 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.739 -0.664 . . . . 74.540000000000006 109.361 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 277' ' ' ILE . 2.9 tm? -111.63 118.76 36.56 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.64 -1.615 . . . . 73.040000000000006 106.64 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.459 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 136.66 -140.2 11.28 Favored Glycine 0 N--CA 1.422 -2.278 0 C-N-CA 119.707 -1.235 . . . . 62.109999999999999 112.061 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -124.52 133.73 53.23 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 120.972 0.415 . . . . 75.519999999999996 111.411 -173.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.7 t -119.01 121.02 65.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.387 -1.338 . . . . 72.140000000000001 107.387 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.28 129.65 74.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.262 0.553 . . . . 71.109999999999999 112.366 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 5.3 m -109.79 160.53 16.26 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.808 -1.182 . . . . 75.209999999999994 107.808 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.99 76.8 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 122.918 0.487 . . . . 73.409999999999997 111.941 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.18 -34.08 63.54 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.926 1.29 . . . . 72.530000000000001 113.741 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.458 ' CB ' ' HB3' ' A' ' 281' ' ' TYR . . . -66.54 -38.95 88.26 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.106 0.78 . . . . 72.439999999999998 113.106 -175.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 61.5 tp 72.26 -35.29 0.32 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.459 0.703 . . . . 72.430000000000007 112.706 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.447 ' H ' ' C ' ' A' ' 249' ' ' ALA . 80.5 m80 79.78 113.69 0.07 Allowed 'General case' 0 C--O 1.247 0.933 0 C-N-CA 125.887 1.675 . . . . 75.030000000000001 110.617 -177.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -89.67 134.17 12.22 Favored Glycine 0 N--CA 1.431 -1.663 0 CA-C-N 115.043 -0.981 . . . . 73.129999999999995 112.288 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -143.14 122.93 1.99 Allowed Glycine 0 N--CA 1.425 -2.072 0 C-N-CA 121.069 -0.586 . . . . 74.349999999999994 111.977 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 10.1 tt -175.49 -48.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 124.589 1.155 . . . . 72.230000000000004 108.366 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -138.64 164.64 28.99 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.174 -1.417 . . . . 75.230000000000004 107.174 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 257' ' ' SER . 13.2 tt -79.89 156.34 4.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 O-C-N 123.703 0.627 . . . . 65.430000000000007 109.806 -176.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' SER . . . . . 0.4 ' O ' HG12 ' A' ' 256' ' ' ILE . 28.8 m -79.19 147.31 32.68 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 105.635 -1.987 . . . . 75.120000000000005 105.635 170.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.457 ' N ' ' HA3' ' B' ' 253' ' ' GLY . 1.0 OUTLIER -66.55 171.09 5.36 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.058 0.762 . . . . 71.120000000000005 113.058 -169.304 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 222' ' ' ILE . 12.7 mt-30 -87.47 84.1 7.2 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.091 0.948 . . . . 75.430000000000007 110.892 -170.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 16.7 p -97.42 139.66 33.03 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 113.816 -1.538 . . . . 72.409999999999997 111.751 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.9 m -115.28 108.78 17.02 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.874 -0.787 . . . . 75.129999999999995 108.874 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.432 HD22 HD21 ' B' ' 241' ' ' LEU . 64.9 t30 -106.29 121.63 44.61 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.801 -0.814 . . . . 74.450000000000003 108.801 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.9 m -137.86 123.97 20.34 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.878 0.37 . . . . 73.340000000000003 111.726 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.2 p -119.76 135.27 60.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.855 0.36 . . . . 74.219999999999999 111.102 176.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -69.36 -65.05 0.76 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.883 -0.599 . . . . 74.310000000000002 111.469 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 29.5 m -144.58 132.76 21.68 Favored 'General case' 0 C--O 1.25 1.117 0 C-N-CA 120.184 -0.607 . . . . 74.209999999999994 112.501 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.03 129.56 74.21 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 107.932 -1.136 . . . . 74.329999999999998 107.932 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 7.8 p -127.59 130.86 70.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-O 121.186 0.517 . . . . 72.340000000000003 111.677 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.06 133.32 11.53 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 109.719 -1.352 . . . . 74.510000000000005 109.719 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -132.56 144.69 50.58 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 117.121 0.46 . . . . 74.400000000000006 111.131 -175.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.65 -65.76 3.89 Favored Glycine 0 C--O 1.244 0.755 0 N-CA-C 110.768 -0.933 . . . . 63.439999999999998 110.768 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -176.96 125.86 0.15 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.999 -2.223 . . . . 73.019999999999996 104.999 172.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 25.0 m -149.94 160.13 43.84 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.531 -0.544 . . . . 64.140000000000001 109.531 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 54.3 mtm180 -122.72 127.36 49.12 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.142 -1.059 . . . . 73.349999999999994 108.142 172.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 1.4 p -128.18 129.17 69.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 116.154 -0.475 . . . . 74.299999999999997 109.942 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 4.1 tt -121.0 121.24 37.54 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.854 -1.165 . . . . 74.040000000000006 107.854 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 241' ' ' LEU . 3.2 pt -113.03 104.59 17.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 C-N-CA 124.063 0.945 . . . . 73.420000000000002 109.107 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 155.18 -122.84 1.26 Allowed Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.554 -0.832 . . . . 74.239999999999995 113.156 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 42.4 m-80 -128.3 148.96 50.68 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.62 0.247 . . . . 71.450000000000003 110.585 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.0 OUTLIER -136.6 121.6 18.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.172 -2.159 . . . . 72.420000000000002 105.172 173.587 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.458 ' HB3' ' CB ' ' A' ' 249' ' ' ALA . 57.0 m-85 -107.81 123.59 48.8 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 109.37 -0.604 . . . . 71.030000000000001 109.37 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.405 ' N ' ' HB3' ' A' ' 249' ' ' ALA . . . 104.91 -43.73 1.61 Allowed Glycine 0 N--CA 1.42 -2.387 0 CA-C-N 115.178 -0.919 . . . . 70.329999999999998 111.209 -177.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 76.29 14.42 82.36 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.916 -0.874 . . . . 73.439999999999998 110.916 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -126.43 13.6 7.63 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.899 0.857 . . . . 75.319999999999993 109.377 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -101.48 -55.44 0.9 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.156 -1.021 . . . . 73.519999999999996 110.92 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.466 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 31.1 t80 -93.04 -18.04 23.13 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.904 -0.406 . . . . 74.319999999999993 109.904 -177.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . 0.629 ' CH2' ' HB2' ' B' ' 240' ' ' GLN . 12.6 m-90 -115.12 157.84 23.02 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 115.893 1.812 . . . . 64.010000000000005 115.893 -176.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . 0.505 ' CG ' ' H ' ' A' ' 289' ' ' ASN . 8.2 p-10 -73.75 -72.45 0.27 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 126.282 1.833 . . . . 73.439999999999998 112.439 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . 0.505 ' H ' ' CG ' ' A' ' 288' ' ' ASP 0.398 6.9 m-20 103.33 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 117.515 2.413 . . . . 73.25 117.515 171.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 46.4 m80 71.41 148.04 0.08 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 116.716 2.117 . . . . 73.25 116.716 169.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -166.8 33.46 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 103.927 -2.62 . . . . 74.319999999999993 103.927 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -86.89 145.5 26.54 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.231 -1.35 . . . . 74.310000000000002 113.003 -169.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -120.94 117.37 27.14 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.687 -1.597 . . . . 74.409999999999997 106.687 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -89.14 140.74 29.15 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.025 0.44 . . . . 72.120000000000005 110.253 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--N 1.299 -1.625 0 N-CA-C 107.324 -1.362 . . . . 73.340000000000003 107.324 177.986 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 CA--C 1.512 -0.487 0 N-CA-C 108.353 -0.98 . . . . 63.039999999999999 108.353 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -89.85 -58.89 2.36 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 106.898 -1.519 . . . . 73.209999999999994 106.898 174.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 33.9 pt -138.1 157.43 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.086 -0.961 . . . . 73.209999999999994 109.512 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -173.95 -56.38 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 106.152 -1.796 . . . . 74.099999999999994 106.152 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 68.18 164.38 0.23 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 113.805 -1.543 . . . . 65.340000000000003 112.703 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . 0.415 HG21 ' OG1' ' B' ' 261' ' ' THR . 42.2 mm -98.52 113.77 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 N-CA-C 106.55 -1.648 . . . . 72.319999999999993 106.55 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 23.9 m -132.5 118.32 34.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 109.451 -0.574 . . . . 72.239999999999995 109.451 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 43.39 50.97 6.59 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 114.522 -1.217 . . . . 65.230000000000004 112.937 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -89.3 121.74 31.87 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 119.729 -0.788 . . . . 75.010000000000005 111.281 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.476 ' OD1' ' HA2' ' C' ' 242' ' ' GLY . 63.3 t30 -113.5 114.62 26.79 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 106.181 -1.785 . . . . 73.340000000000003 106.181 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' B' ' 263' ' ' SER . 20.1 m -125.4 137.06 54.0 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.513 0.673 . . . . 74.420000000000002 111.351 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -128.33 132.85 48.61 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.236 -0.893 . . . . 75.319999999999993 108.74 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.548 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -88.72 -68.12 0.79 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.976 -0.379 . . . . 74.219999999999999 109.976 -177.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.91 138.6 53.33 Favored 'General case' 0 CA--C 1.481 -1.673 0 C-N-CA 119.355 -0.938 . . . . 71.409999999999997 111.327 177.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 29.4 mm -130.91 118.4 41.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.576 -1.268 . . . . 75.430000000000007 107.576 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -118.77 117.76 29.76 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.483 -0.562 . . . . 74.150000000000006 109.483 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 49.7 p -109.5 127.2 54.26 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.903 -1.517 . . . . 75.219999999999999 106.903 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.28 155.75 46.61 Favored 'General case' 0 CA--C 1.471 -2.083 0 N-CA-C 108.759 -0.83 . . . . 73.25 108.759 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.56 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 83.8 mt-10 55.16 84.49 0.07 Allowed 'General case' 0 C--N 1.311 -1.065 0 O-C-N 125.016 1.447 . . . . 74.099999999999994 114.055 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.56 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 60.91 6.93 1.31 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.07 1.348 . . . . 74.409999999999997 113.151 173.437 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -69.9 148.43 49.0 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.201 0.524 . . . . 64.319999999999993 112.138 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 1.0 OUTLIER -127.87 136.09 50.92 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 108.806 -0.812 . . . . 73.340000000000003 108.806 179.216 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.408 ' HB ' HG11 ' B' ' 275' ' ' VAL . 5.4 p -127.65 142.23 44.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 116.335 -0.393 . . . . 71.409999999999997 110.853 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.629 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 5.8 tp-100 -112.89 134.62 54.31 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.918 -1.512 . . . . 71.120000000000005 106.918 173.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . 0.432 HD21 HD22 ' A' ' 262' ' ' ASN . 2.8 tm? -129.28 117.44 20.69 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 105.953 -1.869 . . . . 73.319999999999993 105.953 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.453 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 137.67 -115.29 1.19 Allowed Glycine 0 N--CA 1.404 -3.489 0 C-N-CA 119.006 -1.568 . . . . 72.209999999999994 113.292 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 6.4 t30 -145.35 129.15 17.28 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 113.275 0.843 . . . . 72.030000000000001 113.275 -171.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 280' ' ' GLU . 99.2 t -119.64 125.56 74.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.339 -0.986 . . . . 72.430000000000007 108.339 176.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . 0.441 ' HB ' ' CD2' ' A' ' 281' ' ' TYR . 57.7 t -122.29 129.66 75.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 120.843 -0.343 . . . . 75.230000000000004 111.285 -177.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 246' ' ' THR . . . . . 0.462 HG23 ' HB3' ' B' ' 284' ' ' LYS . 2.2 m -104.48 161.41 14.12 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.439 -0.948 . . . . 72.109999999999999 108.439 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.33 -32.57 74.02 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.756 0.788 . . . . 73.519999999999996 110.486 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.18 -36.06 65.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.026 -1.443 . . . . 74.219999999999999 113.805 -176.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.485 ' HB2' ' N ' ' B' ' 282' ' ' GLY . . . -74.67 -38.74 62.34 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 121.201 -0.2 . . . . 73.540000000000006 110.886 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 60.2 tp 73.34 -37.25 0.37 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.732 1.213 . . . . 73.230000000000004 112.002 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -169.01 179.06 4.21 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.517 -1.66 . . . . 74.25 106.517 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' B' ' 281' ' ' TYR . . . -166.43 56.68 0.24 Allowed Glycine 0 N--CA 1.429 -1.81 0 C-N-CA 118.437 -1.84 . . . . 74.310000000000002 113.146 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . 0.457 ' HA3' ' N ' ' A' ' 258' ' ' ASP . . . 170.74 179.15 41.86 Favored Glycine 0 N--CA 1.419 -2.436 0 C-N-CA 119.746 -1.216 . . . . 71.129999999999995 112.26 177.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . 0.471 HD11 ' H ' ' B' ' 255' ' ' ARG . 0.8 OUTLIER -147.43 -61.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 124.429 0.723 . . . . 72.450000000000003 111.492 179.089 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . 0.471 ' H ' HD11 ' B' ' 254' ' ' ILE . 10.6 ptm180 177.44 81.9 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.852 1.661 . . . . 74.310000000000002 109.648 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 48.1 mm 73.32 89.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 C-N-CA 124.317 1.047 . . . . 74.340000000000003 110.332 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 40.3 t -54.43 -73.71 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.754 -1.112 . . . . 52.520000000000003 109.438 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -155.5 -179.79 8.43 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.973 -1.121 . . . . 73.239999999999995 107.973 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -114.03 78.56 1.16 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.593 0.711 . . . . 75.109999999999999 111.009 -176.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.24 139.73 36.51 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.646 -1.161 . . . . 73.420000000000002 111.9 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 261' ' ' THR . . . . . 0.479 ' HB ' ' HG2' ' C' ' 225' ' ' ARG . 4.7 m -116.23 108.24 15.87 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.18 -1.415 . . . . 75.319999999999993 107.18 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . 0.45 HD22 HD23 ' C' ' 241' ' ' LEU . 64.2 t30 -108.7 126.17 52.7 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.215 -1.032 . . . . 72.049999999999997 108.215 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 263' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' C' ' 227' ' ' SER . 31.9 m -142.42 123.75 14.74 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.237 0.542 . . . . 73.230000000000004 111.813 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 14.5 p -110.31 140.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.459 -0.571 . . . . 73.209999999999994 109.459 176.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.548 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 3.4 tm-20 -80.45 -69.26 0.61 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.423 -0.954 . . . . 73.349999999999994 108.423 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 90.7 m -137.3 128.85 28.45 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 121.629 -0.669 . . . . 72.329999999999998 112.683 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 48.9 t -118.49 128.83 75.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.08 -1.082 . . . . 61.450000000000003 108.08 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 8.6 p -127.4 134.44 65.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.131 0.491 . . . . 72.010000000000005 111.295 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.09 133.25 11.18 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.723 -1.351 . . . . 65.129999999999995 109.723 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -133.18 147.22 52.04 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 117.059 0.43 . . . . 75.400000000000006 111.349 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.58 -63.96 4.04 Favored Glycine 0 CA--C 1.498 -1.014 0 N-CA-C 110.812 -0.915 . . . . 73.25 110.812 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -178.99 126.72 0.1 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 103.624 -2.732 . . . . 72.319999999999993 103.624 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 45.7 m -147.61 161.29 41.45 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 120.949 0.404 . . . . 73.030000000000001 110.809 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.712 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 14.7 mtp180 -127.7 127.33 43.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.436 -1.32 . . . . 71.310000000000002 107.436 174.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.408 HG11 ' HB ' ' B' ' 239' ' ' VAL . 0.7 OUTLIER -134.8 137.31 51.13 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.109 0 N-CA-C 109.716 -0.476 . . . . 71.0 109.716 179.196 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . 0.466 HD13 ' CG ' ' B' ' 286' ' ' PHE . 5.4 tt -124.15 124.23 42.04 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.059 -1.459 . . . . 74.099999999999994 107.059 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 6.7 mt -113.0 103.81 16.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 106.334 -1.728 . . . . 71.340000000000003 106.334 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 152.0 -141.31 8.41 Favored Glycine 0 CA--C 1.474 -2.53 0 C-N-CA 119.164 -1.493 . . . . 71.430000000000007 113.751 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 45.3 m-80 -111.57 136.93 50.09 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.109 -0.545 . . . . 71.5 109.625 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . 0.5 ' HB2' ' NE2' ' C' ' 240' ' ' GLN . 0.1 OUTLIER -125.67 118.39 25.53 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 104.931 -2.248 . . . . 71.450000000000003 104.931 175.83 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . 0.402 ' CE1' ' HA3' ' B' ' 252' ' ' GLY . 87.1 m-85 -105.58 124.07 48.95 Favored 'General case' 0 N--CA 1.401 -2.885 0 CA-C-O 121.564 0.697 . . . . 75.129999999999995 110.239 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . 0.485 ' N ' ' HB2' ' B' ' 249' ' ' ALA . . . 108.14 -45.55 1.29 Allowed Glycine 0 N--CA 1.416 -2.638 0 CA-C-N 114.991 -1.004 . . . . 62.009999999999998 110.971 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 70.79 26.26 74.33 Favored Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 109.845 -1.302 . . . . 75.400000000000006 109.845 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . 0.462 ' HB3' HG23 ' B' ' 246' ' ' THR . 24.8 tptp -136.73 14.21 3.15 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.423 -0.954 . . . . 74.349999999999994 108.423 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -112.23 -59.11 0.44 Allowed Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.569 -0.741 . . . . 73.0 111.429 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.466 ' CG ' HD13 ' B' ' 276' ' ' LEU . 19.0 t80 -90.41 -20.66 22.53 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.185 -1.043 . . . . 70.349999999999994 108.185 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.502 ' CH2' ' HB2' ' C' ' 240' ' ' GLN . 14.3 m-90 -132.33 -166.68 1.77 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.002 -0.999 . . . . 73.209999999999994 108.79 176.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -146.85 145.07 29.74 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.156 -1.053 . . . . 74.150000000000006 108.156 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -71.03 -26.94 63.32 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 123.96 0.788 . . . . 72.439999999999998 110.563 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . 0.401 ' CG ' ' H ' ' B' ' 291' ' ' HIS . 43.2 t-80 -123.27 -173.44 2.72 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.325 -0.991 . . . . 74.310000000000002 108.325 -176.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . 0.401 ' H ' ' CG ' ' B' ' 290' ' ' HIS . 35.8 t60 -66.51 124.1 21.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.063 -1.458 . . . . 75.450000000000003 107.063 174.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -103.89 110.05 22.03 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.373 0.606 . . . . 72.340000000000003 111.696 -174.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -163.26 96.95 0.89 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.469 -1.678 . . . . 75.430000000000007 106.469 171.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -86.84 138.69 31.36 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.43 -0.952 . . . . 71.219999999999999 108.43 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 . . . . . 0 C--N 1.293 -1.882 0 N-CA-C 107.895 -1.15 . . . . 74.219999999999999 107.895 -178.981 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 CA--C 1.505 -0.783 0 N-CA-C 109.633 -0.506 . . . . 75.239999999999995 109.633 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -70.83 105.94 3.41 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.523 -0.547 . . . . 74.340000000000003 109.523 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 12.9 pt -85.76 80.92 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 121.583 0.706 . . . . 71.329999999999998 110.24 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -93.36 92.79 7.83 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-N 115.534 -0.757 . . . . 73.099999999999994 109.766 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 67.91 164.23 0.22 Allowed 'General case' 0 C--O 1.241 0.65 0 O-C-N 125.125 1.515 . . . . 72.230000000000004 113.402 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 34.8 mm -88.94 131.83 35.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.713 -1.588 . . . . 75.5 106.713 174.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 29.8 m -100.55 118.22 46.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 119.282 -0.967 . . . . 71.099999999999994 112.911 -175.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 39.73 55.08 2.78 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 113.642 -1.617 . . . . 74.530000000000001 115.646 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . 0.479 ' HG2' ' HB ' ' B' ' 261' ' ' THR . 70.5 mtt180 -92.23 121.07 33.4 Favored 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 118.62 -1.232 . . . . 70.409999999999997 112.691 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -116.57 116.92 28.51 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.367 -1.345 . . . . 74.239999999999995 107.367 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 227' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' B' ' 263' ' ' SER . 15.7 p -128.72 139.39 52.24 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 121.569 0.699 . . . . 72.150000000000006 111.423 -176.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.91 129.49 48.29 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.015 -0.993 . . . . 52.420000000000002 108.469 179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 13.8 tmtt? -87.48 -60.35 2.0 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.288 0.368 . . . . 74.439999999999998 111.614 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.32 138.04 53.54 Favored 'General case' 0 CA--C 1.484 -1.565 0 O-C-N 121.741 -0.599 . . . . 72.319999999999993 110.074 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 41.5 mm -133.13 119.12 35.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.777 -1.194 . . . . 72.409999999999997 107.777 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 44.9 ttt180 -122.65 115.22 21.73 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 109.479 -0.563 . . . . 71.439999999999998 109.479 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 42.5 p -110.61 127.39 55.23 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.725 -1.583 . . . . 63.340000000000003 106.725 176.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -141.58 153.62 44.93 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 120.143 -0.623 . . . . 74.530000000000001 110.107 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . 0.495 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 43.4 mt-10 61.31 85.41 0.12 Allowed 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.889 1.368 . . . . 71.319999999999993 113.156 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.495 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 1.4 mpt_? 59.18 5.17 0.53 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.813 1.645 . . . . 72.340000000000003 113.393 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -69.6 147.5 50.61 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.461 0.648 . . . . 62.240000000000002 112.073 -174.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.712 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 1.5 mpt_? -126.98 135.02 50.29 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.273 -0.876 . . . . 75.430000000000007 108.959 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.2 p -128.32 139.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.066 0.46 . . . . 72.209999999999994 111.326 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . 0.502 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 5.4 tp-100 -110.47 120.02 41.07 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.053 -0.976 . . . . 73.219999999999999 108.815 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.45 HD23 HD22 ' B' ' 262' ' ' ASN . 3.1 tm? -115.16 116.52 28.5 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 105.339 -2.097 . . . . 73.510000000000005 105.339 172.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.476 ' HA2' ' OD1' ' B' ' 226' ' ' ASN . . . 142.45 -121.88 1.86 Allowed Glycine 0 N--CA 1.41 -3.073 0 C-N-CA 118.56 -1.781 . . . . 50.200000000000003 113.174 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 35.8 t30 -144.63 128.48 17.36 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 123.621 0.248 . . . . 74.439999999999998 111.608 -171.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' B' ' 280' ' ' GLU . 92.0 t -118.52 122.98 70.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.221 -1.029 . . . . 75.140000000000001 108.221 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.94 128.85 75.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 120.533 -0.467 . . . . 73.439999999999998 110.454 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 2.6 m -99.33 161.05 13.84 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.196 -1.038 . . . . 73.439999999999998 108.196 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.3 -32.29 69.91 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.832 0.853 . . . . 74.109999999999999 110.959 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.48 -35.49 63.11 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.21 -1.359 . . . . 71.209999999999994 112.522 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.95 -26.45 61.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.012 0.434 . . . . 53.520000000000003 111.686 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.96 28.0 0.62 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.047 0.758 . . . . 75.430000000000007 113.047 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -66.04 -24.63 66.78 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.811 0.815 . . . . 73.420000000000002 109.767 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -168.48 -48.91 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 109.178 -1.569 . . . . 64.299999999999997 109.178 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 148.27 172.58 18.35 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 109.426 -1.47 . . . . 73.010000000000005 109.426 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 10.2 tt -147.3 114.07 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.576 -0.528 . . . . 73.019999999999996 109.576 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -115.59 16.12 16.54 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.288 -0.415 . . . . 72.409999999999997 110.881 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 50.2 mm -61.59 99.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.158 -0.682 . . . . 73.519999999999996 109.158 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 14.7 m -102.63 173.85 6.15 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.493 -0.776 . . . . 73.219999999999999 109.436 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -158.11 159.82 36.65 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.233 -1.025 . . . . 63.009999999999998 108.233 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -71.29 71.04 0.61 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 122.52 1.153 . . . . 70.239999999999995 109.361 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 2.8 p -102.31 123.13 45.58 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 115.685 1.735 . . . . 72.319999999999993 115.685 -171.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 32.0 m -133.54 107.09 7.8 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 104.706 -2.331 . . . . 75.439999999999998 104.706 167.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -113.86 123.95 51.03 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.228 -1.027 . . . . 74.209999999999994 108.228 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 34.8 m -134.86 122.81 22.54 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.789 -0.819 . . . . 73.340000000000003 108.789 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 12.1 p -108.94 144.27 17.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.012 -0.736 . . . . 74.409999999999997 109.012 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -78.79 -77.17 0.17 Allowed 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 108.625 -0.88 . . . . 72.200000000000003 108.625 -176.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 85.8 m -132.82 134.12 44.25 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.133 -0.354 . . . . 65.310000000000002 110.357 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 25.6 t -118.43 129.17 75.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.245 -1.391 . . . . 72.329999999999998 107.245 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.4 p -127.79 132.35 68.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 120.919 -0.313 . . . . 74.010000000000005 111.159 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.16 132.86 11.24 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 108.869 -1.692 . . . . 74.230000000000004 108.869 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -133.86 145.55 49.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.978 0.389 . . . . 73.409999999999997 110.569 -174.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.41 -65.83 3.92 Favored Glycine 0 CA--C 1.5 -0.865 0 N-CA-C 110.631 -0.988 . . . . 64.109999999999999 110.631 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 179.89 118.94 0.06 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 126.614 1.966 . . . . 74.430000000000007 105.738 174.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 35.7 m -141.02 154.14 45.86 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.311 0.485 . . . . 70.340000000000003 112.311 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -118.89 126.76 52.52 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.366 -1.346 . . . . 74.340000000000003 107.366 171.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 2.1 p -139.08 138.51 41.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 123.044 0.215 . . . . 75.040000000000006 110.776 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.9 tt -128.6 122.63 31.39 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.385 -0.598 . . . . 62.219999999999999 109.385 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 1.3 pt -113.4 104.47 17.04 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 C-N-CA 123.915 0.886 . . . . 74.430000000000007 109.772 173.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.9 -140.43 7.9 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 119.655 -1.26 . . . . 65.400000000000006 113.123 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -100.15 139.75 35.37 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.623 -0.788 . . . . 74.200000000000003 109.521 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -142.08 118.46 10.86 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 103.324 -2.843 . . . . 75.120000000000005 103.324 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -116.84 124.99 50.87 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.329 0.585 . . . . 75.340000000000003 111.508 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 116.44 -41.52 2.1 Favored Glycine 0 N--CA 1.407 -3.277 0 CA-C-N 114.596 -1.184 . . . . 61.399999999999999 110.612 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 67.07 30.08 75.38 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 109.361 -1.496 . . . . 74.430000000000007 109.361 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -141.92 17.39 2.13 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 108.461 -0.941 . . . . 74.040000000000006 108.461 -174.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -114.32 -72.85 0.57 Allowed Glycine 0 N--CA 1.424 -2.11 0 C-N-CA 120.218 -0.991 . . . . 74.439999999999998 110.725 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -79.64 -25.91 41.24 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.049 0.452 . . . . 72.409999999999997 110.049 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -137.41 167.41 21.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.6 -0.889 . . . . 74.030000000000001 108.6 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -112.55 114.48 27.16 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 105.964 -1.865 . . . . 71.450000000000003 105.964 171.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -76.2 5.17 7.28 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 113.625 0.972 . . . . 63.200000000000003 113.625 -175.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -117.39 -70.12 0.81 Allowed 'General case' 0 C--N 1.307 -1.282 0 O-C-N 122.496 -0.127 . . . . 75.219999999999999 111.021 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -178.81 137.82 0.15 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.122 -1.066 . . . . 73.530000000000001 108.122 -172.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -63.31 116.99 5.99 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.411 0.624 . . . . 72.230000000000004 110.643 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . 0.417 ' CG ' ' H ' ' C' ' 294' ' ' HIS . 7.4 p80 -80.16 -92.1 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.675 -0.693 . . . . 73.530000000000001 112.482 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . 0.417 ' H ' ' CG ' ' C' ' 293' ' ' HIS . 4.9 p80 -177.22 152.91 0.91 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.597 -1.26 . . . . 63.43 107.597 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 . . . . . 0 C--N 1.296 -1.731 0 CA-C-O 118.545 -0.741 . . . . 72.040000000000006 109.675 -176.439 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 CA--C 1.499 -0.986 0 N-CA-C 110.083 -0.34 . . . . 73.219999999999999 110.083 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -139.7 78.01 1.64 Allowed 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.361 -0.978 . . . . 74.019999999999996 108.361 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 219' ' ' ILE . 3.3 mp -104.35 -64.48 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.108 -1.442 . . . . 75.549999999999997 107.108 -179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 55.3 82.65 0.1 Allowed 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 124.712 1.205 . . . . 74.200000000000003 112.998 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -143.23 -178.81 6.04 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.407 -1.331 . . . . 71.299999999999997 107.407 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 7.9 tp -83.03 130.2 36.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.512 -0.551 . . . . 75.439999999999998 109.512 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.0 m -99.58 161.96 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 109.16 -0.682 . . . . 74.209999999999994 109.16 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.4 ' H ' HG21 ' A' ' 261' ' ' THR . . . 78.77 28.95 53.74 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 109.734 -1.346 . . . . 50.039999999999999 109.734 -170.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -113.7 138.5 50.14 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.614 -0.513 . . . . 74.430000000000007 109.614 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . 0.404 ' ND2' ' HA2' ' A' ' 278' ' ' GLY . 44.9 t-20 -117.82 114.83 23.85 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 106.147 -1.797 . . . . 74.299999999999997 106.147 168.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 33.6 m -120.59 137.01 54.64 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.388 0.613 . . . . 54.310000000000002 111.149 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.77 130.31 51.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.851 -1.166 . . . . 64.310000000000002 107.851 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.432 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 39.4 ttmt -79.04 -63.97 1.29 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.816 -0.354 . . . . 74.439999999999998 111.911 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -126.51 139.25 53.37 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 118.914 -1.114 . . . . 75.140000000000001 110.261 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.3 mt -130.75 119.57 45.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.634 -0.876 . . . . 74.439999999999998 108.634 -175.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -125.08 115.05 19.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.755 -1.202 . . . . 75.519999999999996 107.755 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.447 HG23 ' CG2' ' A' ' 239' ' ' VAL . 40.4 p -128.24 128.66 45.1 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 120.567 -0.453 . . . . 72.340000000000003 109.838 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -126.6 166.07 18.0 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 119.751 -0.78 . . . . 73.0 112.608 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 71.42 -88.09 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.603 -1.635 . . . . 65.099999999999994 114.311 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . 0.497 ' HD3' ' OE2' ' A' ' 272' ' ' GLU . 0.0 OUTLIER -135.48 26.66 3.43 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.162 -1.051 . . . . 75.439999999999998 108.162 -176.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -69.04 149.45 48.74 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.598 -0.728 . . . . 72.230000000000004 111.245 -174.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.83 134.9 53.52 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 105.932 -1.877 . . . . 74.310000000000002 105.932 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.447 ' CG2' HG23 ' A' ' 233' ' ' THR . 9.8 t -135.17 139.0 47.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.981 0.419 . . . . 65.310000000000002 110.659 -170.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.425 ' HG2' ' CG2' ' A' ' 244' ' ' VAL . 6.3 tp-100 -131.2 135.28 47.26 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.595 -1.261 . . . . 72.510000000000005 107.595 172.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.1 tt -130.42 120.2 23.85 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.947 -1.501 . . . . 73.329999999999998 106.947 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.596 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 128.93 -113.91 1.65 Allowed Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.7 -0.762 . . . . 61.340000000000003 111.386 177.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -144.39 144.33 31.37 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.613 -0.345 . . . . 74.129999999999995 110.087 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.425 ' CG2' ' HG2' ' A' ' 240' ' ' GLN . 83.6 t -118.75 118.3 57.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.811 -1.181 . . . . 63.439999999999998 107.811 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.57 112.8 35.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 N-CA-C 109.135 -0.691 . . . . 71.5 109.135 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.417 HG22 ' HA3' ' A' ' 282' ' ' GLY . 8.9 t -94.92 161.0 14.33 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.034 -1.066 . . . . 74.299999999999997 109.863 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.45 -33.61 75.94 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.42 0.688 . . . . 51.210000000000001 111.778 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.83 65.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.399 -0.819 . . . . 75.340000000000003 111.579 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -66.72 -29.27 69.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.028 -0.533 . . . . 73.430000000000007 111.706 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.93 82.81 7.43 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 113.578 0.955 . . . . 73.230000000000004 113.578 -174.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -116.88 1.59 12.7 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.521 -1.218 . . . . 64.129999999999995 108.304 171.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 161.69 -172.13 37.8 Favored Glycine 0 N--CA 1.419 -2.446 0 N-CA-C 107.633 -2.187 . . . . 73.209999999999994 107.633 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.45 74.46 0.69 Allowed Glycine 0 N--CA 1.428 -1.868 0 C-N-CA 120.141 -1.028 . . . . 71.530000000000001 112.011 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 7.9 tp -74.64 -47.76 37.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-O 120.658 0.266 . . . . 71.030000000000001 111.226 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.427 ' O ' ' HA3' ' B' ' 253' ' ' GLY . 37.0 ttm180 -90.34 83.82 5.98 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 121.28 0.562 . . . . 75.329999999999998 109.527 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 12.6 tt -89.8 117.94 34.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.606 -0.887 . . . . 73.230000000000004 108.606 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 50.1 m -147.85 153.96 39.81 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.533 -0.758 . . . . 74.049999999999997 108.968 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -88.2 100.17 12.77 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.915 -1.513 . . . . 61.409999999999997 106.915 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.78 -22.6 49.9 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.325 -0.398 . . . . 73.239999999999995 111.641 -177.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 10.3 m -101.12 121.71 42.31 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 115.962 -0.563 . . . . 72.439999999999998 109.939 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.4 HG21 ' H ' ' A' ' 224' ' ' GLY . 25.8 p -93.88 117.14 29.7 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.554 -0.906 . . . . 64.239999999999995 108.554 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 7.9 t30 -117.99 138.46 52.18 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.419 -0.912 . . . . 75.25 111.065 -176.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 39.8 m -138.59 123.33 18.69 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.147 -0.479 . . . . 74.510000000000005 109.935 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 10.7 p -128.89 145.59 35.5 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-N 116.259 -0.428 . . . . 74.140000000000001 110.939 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 12.0 mm-40 -84.66 -75.68 0.34 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.429 -0.351 . . . . 70.010000000000005 110.945 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.7 p -118.36 127.91 54.14 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.659 0.614 . . . . 64.219999999999999 112.659 -175.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 26.7 m -124.87 127.11 72.33 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 109.396 -0.594 . . . . 74.219999999999999 109.396 174.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.14 132.18 70.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 121.205 0.526 . . . . 74.349999999999994 111.863 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.519 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -113.66 131.67 10.11 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 109.919 -1.272 . . . . 75.420000000000002 109.919 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -132.12 116.42 17.01 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 111.99 0.367 . . . . 74.530000000000001 111.99 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 92.96 -123.39 7.32 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 120.747 -0.74 . . . . 72.25 112.386 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.497 ' OE2' ' HD3' ' A' ' 236' ' ' ARG . 40.9 mm-40 -92.39 35.48 1.01 Allowed 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.333 1.053 . . . . 73.400000000000006 109.335 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 50.1 m -81.68 144.36 31.22 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.069 0.938 . . . . 54.549999999999997 111.04 -174.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -130.5 126.73 37.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 104.809 -2.293 . . . . 72.310000000000002 104.809 176.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.94 134.0 41.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 121.565 0.697 . . . . 73.25 111.509 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.411 HD11 ' CG ' ' A' ' 240' ' ' GLN . 11.0 tp -120.23 121.64 39.17 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.228 -0.896 . . . . 74.099999999999994 110.671 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.419 HG23 HD11 ' B' ' 241' ' ' LEU . 81.6 mt -104.39 104.27 16.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 114.107 -1.406 . . . . 75.099999999999994 108.073 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 140.22 -153.86 23.66 Favored Glycine 0 N--CA 1.427 -1.918 0 C-N-CA 120.181 -1.009 . . . . 70.530000000000001 113.866 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -91.96 128.48 37.82 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.828 0.851 . . . . 74.420000000000002 110.295 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -111.1 118.69 36.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.838 -2.282 . . . . 71.439999999999998 104.838 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.488 ' OH ' ' HA3' ' B' ' 252' ' ' GLY . 1.7 t80 -120.02 122.23 40.67 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.473 -1.306 . . . . 73.299999999999997 107.473 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.417 ' HA3' HG22 ' A' ' 246' ' ' THR . . . 125.24 -41.38 1.7 Allowed Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.351 -1.295 . . . . 71.340000000000003 110.744 -175.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 125.05 -57.96 0.67 Allowed Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 110.46 -1.056 . . . . 64.219999999999999 110.46 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -145.08 80.6 1.62 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.084 0.945 . . . . 72.430000000000007 112.517 177.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -100.86 -40.35 2.91 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 114.748 -1.115 . . . . 52.329999999999998 110.467 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -69.81 -36.53 75.71 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.17 0.51 . . . . 74.0 110.477 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . 0.441 ' CZ2' ' HE1' ' B' ' 286' ' ' PHE . 27.8 m-90 -92.45 131.17 37.83 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.481 -0.933 . . . . 74.329999999999998 108.481 175.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -50.93 -39.62 55.23 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.455 1.097 . . . . 73.530000000000001 110.692 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.7 t30 173.09 176.33 0.1 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 102.397 -3.186 . . . . 74.219999999999999 102.397 174.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.439 ' CE1' ' HD3' ' B' ' 274' ' ' ARG . 63.5 t60 -129.57 120.35 25.17 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 107.411 -1.329 . . . . 75.549999999999997 107.411 174.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -65.17 138.21 58.12 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.44 -0.578 . . . . 74.310000000000002 109.44 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -69.85 80.52 0.46 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.462 1.125 . . . . 63.340000000000003 113.604 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -86.84 80.85 8.35 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.291 -1.744 . . . . 74.319999999999993 106.291 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -139.48 171.37 14.35 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.735 -1.121 . . . . 72.450000000000003 111.039 -173.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 70.2 t60 . . . . . 0 C--N 1.324 -0.527 0 C-N-CA 126.147 1.779 . . . . 70.299999999999997 106.55 175.785 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.505 -0.779 0 N-CA-C 107.553 -1.277 . . . . 73.430000000000007 107.553 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -70.17 -39.18 75.45 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.46 -0.496 . . . . 62.350000000000001 109.943 177.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 41.5 pt -68.76 134.18 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.539 -0.755 . . . . 72.450000000000003 110.078 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -148.34 -167.69 2.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.193 -1.41 . . . . 73.430000000000007 107.193 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 65.71 -178.78 0.19 Allowed 'General case' 0 C--O 1.252 1.213 0 C-N-CA 124.358 1.063 . . . . 53.130000000000003 111.782 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 6.2 tp -86.7 131.97 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 107.893 -1.151 . . . . 71.200000000000003 107.893 173.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.34 147.63 7.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.051 -1.092 . . . . 75.430000000000007 108.051 -177.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 85.0 36.82 10.68 Favored Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 107.554 -2.219 . . . . 72.310000000000002 107.554 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -123.45 128.7 50.19 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 113.63 -1.285 . . . . 73.019999999999996 110.893 -173.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.455 ' ND2' ' HA2' ' B' ' 278' ' ' GLY . 38.3 t-20 -117.17 127.79 54.47 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.615 -1.624 . . . . 63.43 106.615 169.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 58.0 m -129.98 137.25 50.21 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-O 121.625 0.726 . . . . 73.109999999999999 111.078 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -125.63 137.42 53.88 Favored 'General case' 0 N--CA 1.404 -2.756 0 CA-C-N 114.146 -1.388 . . . . 74.010000000000005 107.56 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 3.5 ttmp? -84.28 -70.77 0.55 Allowed 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.309 -0.956 . . . . 73.349999999999994 110.467 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -127.25 137.71 52.93 Favored 'General case' 0 N--CA 1.428 -1.557 0 C-N-CA 119.684 -0.807 . . . . 63.530000000000001 109.736 -174.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 6.3 mt -134.16 117.97 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.207 -1.034 . . . . 64.430000000000007 108.207 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -113.42 119.31 37.18 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.018 -1.104 . . . . 74.010000000000005 108.018 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' THR . . . . . 0.519 ' OG1' ' HA2' ' A' ' 269' ' ' GLY . 22.2 p -116.72 126.95 53.9 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 106.05 -1.833 . . . . 73.329999999999998 106.05 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -134.22 153.93 51.56 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.476 0.655 . . . . 71.439999999999998 112.366 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 71.88 -83.64 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 113.642 -1.617 . . . . 73.409999999999997 114.016 171.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.414 ' HD3' ' N ' ' B' ' 236' ' ' ARG . 0.4 OUTLIER -136.61 42.28 2.51 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 107.964 -1.124 . . . . 75.239999999999995 107.964 -178.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -82.81 139.56 33.45 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.886 -1.052 . . . . 73.519999999999996 111.773 -177.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 5.8 mpt_? -123.74 132.52 53.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 103.751 -2.685 . . . . 72.129999999999995 103.751 173.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 86.7 t -142.93 132.62 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-O 121.604 0.716 . . . . 63.32 112.006 -172.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.552 ' CG ' HD13 ' B' ' 276' ' ' LEU . 55.1 tp60 -112.43 132.02 55.26 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 106.901 -1.518 . . . . 74.230000000000004 106.901 173.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . 0.419 HD11 HG23 ' A' ' 277' ' ' ILE . 1.7 tm? -130.04 117.44 20.03 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.856 -1.164 . . . . 75.219999999999999 107.856 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.571 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 129.08 -114.1 1.68 Allowed Glycine 0 C--N 1.309 -0.935 0 N-CA-C 110.817 -0.913 . . . . 74.540000000000006 110.817 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -145.38 153.66 41.45 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 122.048 -0.678 . . . . 73.239999999999995 110.467 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.551 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 61.7 t -129.53 120.26 50.2 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 108.566 -0.902 . . . . 74.200000000000003 108.566 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.14 112.37 33.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 109.528 -0.545 . . . . 74.340000000000003 109.528 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 246' ' ' THR . . . . . 0.471 HG23 ' HA3' ' B' ' 282' ' ' GLY . 6.7 t -86.82 161.31 18.41 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.577 -0.849 . . . . 75.310000000000002 111.382 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.4 -33.62 75.94 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 122.434 1.111 . . . . 74.519999999999996 109.727 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.64 78.53 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 112.708 -2.042 . . . . 72.219999999999999 113.104 -177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.409 ' HA ' ' HB1' ' C' ' 247' ' ' ALA . . . -60.12 -46.66 88.87 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.186 0.595 . . . . 61.149999999999999 112.031 -174.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.51 157.75 1.31 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 101.45 -3.537 . . . . 75.349999999999994 101.45 -176.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -79.33 70.42 5.74 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 119.611 1.096 . . . . 64.319999999999993 113.164 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . 0.488 ' HA3' ' OH ' ' A' ' 281' ' ' TYR . . . 62.09 -144.63 49.17 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.085 -1.416 . . . . 72.219999999999999 115.539 174.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 255' ' ' ARG . . . -74.01 60.78 2.19 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 114.514 -0.843 . . . . 65.209999999999994 114.849 -175.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.23 3.78 4.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 106.861 -1.533 . . . . 75.430000000000007 106.861 170.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -160.03 138.81 10.6 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.124 -2.547 . . . . 73.0 104.124 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 39.0 pt -127.81 140.73 48.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 118.814 0.734 . . . . 75.209999999999994 110.151 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.9 t -149.06 119.65 7.46 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 120.402 -0.519 . . . . 64.239999999999995 110.396 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -152.06 146.09 25.28 Favored 'General case' 0 C--O 1.253 1.257 0 N-CA-C 103.03 -2.952 . . . . 74.420000000000002 103.03 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . 0.409 ' HA ' HG12 ' C' ' 256' ' ' ILE . 55.7 mt-30 -146.61 -63.96 0.3 Allowed 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 113.649 0.981 . . . . 72.120000000000005 113.649 -172.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 31.5 m -83.48 127.11 33.45 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.243 -0.889 . . . . 65.329999999999998 112.764 -169.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 61.8 m -91.19 108.85 20.15 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 106.653 -1.61 . . . . 74.129999999999995 106.653 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . 0.423 HD22 HD11 ' C' ' 241' ' ' LEU . 7.5 t30 -106.25 145.67 31.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.199 0.523 . . . . 72.400000000000006 112.123 -171.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.9 m -138.57 123.86 19.29 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.218 -0.66 . . . . 72.120000000000005 109.218 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 15.0 p -127.37 143.84 39.3 Favored 'Isoleucine or valine' 0 C--O 1.249 1.027 0 N-CA-C 109.802 -0.444 . . . . 72.310000000000002 109.802 178.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.503 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 48.7 mm-40 -90.48 -71.71 0.61 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.559 -0.291 . . . . 64.329999999999998 110.437 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 26.9 m -121.66 127.06 50.39 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.086 -0.646 . . . . 73.400000000000006 110.816 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.87 123.54 56.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 116.086 -0.506 . . . . 75.230000000000004 110.163 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.17 133.92 67.12 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 CA-C-O 121.491 0.662 . . . . 71.200000000000003 112.425 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . 0.504 ' HA2' ' OG1' ' C' ' 233' ' ' THR . . . -111.23 131.64 10.44 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 110.415 -1.074 . . . . 63.25 110.415 175.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -132.89 116.71 16.82 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 123.665 0.786 . . . . 75.549999999999997 111.761 -176.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.42 -133.81 11.75 Favored Glycine 0 C--N 1.299 -1.486 0 N-CA-C 110.711 -0.955 . . . . 54.520000000000003 110.711 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 77.8 mm-40 -85.31 48.14 1.53 Allowed 'General case' 0 C--O 1.258 1.527 0 C-N-CA 123.3 0.64 . . . . 73.040000000000006 109.939 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 273' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 74.7 m -82.09 144.68 30.63 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 122.386 1.089 . . . . 55.009999999999998 111.826 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 7.5 mtm180 -135.66 124.72 24.34 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 106.559 -1.645 . . . . 74.219999999999999 106.559 172.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' C' ' 239' ' ' VAL . 7.4 p -140.5 138.17 36.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-O 121.216 0.532 . . . . 65.120000000000005 111.303 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . 0.552 HD13 ' CG ' ' B' ' 240' ' ' GLN . 4.5 tp -119.43 115.82 24.86 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.463 -0.79 . . . . 71.239999999999995 109.881 175.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 3.9 mp -98.9 103.37 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 N-CA-C 106.332 -1.729 . . . . 71.430000000000007 106.332 177.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 147.74 -157.21 27.28 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 119.563 -1.304 . . . . 52.450000000000003 114.436 178.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -96.44 124.64 40.5 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 124.084 0.954 . . . . 74.030000000000001 109.964 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -111.1 118.98 37.47 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.891 -1.892 . . . . 72.430000000000007 105.891 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . 0.401 ' CD1' HG12 ' C' ' 245' ' ' VAL . 0.9 OUTLIER -119.4 122.52 41.96 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 107.129 -1.434 . . . . 75.439999999999998 107.129 178.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . 0.471 ' HA3' HG23 ' B' ' 246' ' ' THR . . . 130.16 -38.44 1.97 Allowed Glycine 0 N--CA 1.417 -2.61 0 CA-C-N 114.612 -1.177 . . . . 71.319999999999993 111.332 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 116.95 -52.21 0.69 Allowed Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.02 -1.232 . . . . 72.010000000000005 110.02 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . 0.647 ' HD2' ' O ' ' B' ' 284' ' ' LYS . 0.1 OUTLIER -148.5 72.77 1.21 Allowed 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 122.403 1.097 . . . . 73.530000000000001 111.315 -178.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -90.17 -51.86 2.68 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.115 -1.194 . . . . 63.520000000000003 110.115 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.441 ' HE1' ' CZ2' ' A' ' 287' ' ' TRP . 56.3 t80 -65.52 -35.22 80.22 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.416 0.627 . . . . 75.420000000000002 110.561 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.561 ' O ' ' HB2' ' B' ' 284' ' ' LYS . 29.0 m-90 -110.36 88.4 2.76 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.151 -1.055 . . . . 74.430000000000007 108.151 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -77.48 86.35 3.84 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.911 -1.116 . . . . 75.120000000000005 111.857 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -72.4 93.88 1.58 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.078 -1.453 . . . . 72.430000000000007 107.078 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -156.16 163.01 40.13 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.582 -1.636 . . . . 73.549999999999997 106.582 -176.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -85.41 90.43 7.94 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.449 0.642 . . . . 74.400000000000006 110.553 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -92.1 -42.68 9.8 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.977 -1.01 . . . . 75.420000000000002 111.454 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 57.39 103.86 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.675 1.19 . . . . 61.210000000000001 112.151 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -129.59 135.38 48.5 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.009 -0.737 . . . . 72.239999999999995 109.009 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 40.5 m80 . . . . . 0 C--N 1.308 -1.2 0 CA-C-O 118.325 -0.845 . . . . 75.420000000000002 108.956 179.888 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 CA--C 1.511 -0.543 0 CA-C-O 120.71 0.291 . . . . 74.129999999999995 110.57 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -105.73 -11.0 16.45 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.023 -0.732 . . . . 74.120000000000005 109.023 175.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 11.5 tt -71.75 155.34 7.39 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-N 114.94 -1.027 . . . . 74.530000000000001 108.422 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . 0.542 ' HA ' ' NH2' ' C' ' 225' ' ' ARG . 21.3 t70 -99.88 -61.26 1.39 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.206 -0.665 . . . . 70.420000000000002 109.206 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 65.55 -71.63 0.08 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.562 1.545 . . . . 71.010000000000005 113.923 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . 0.42 HG21 ' HD3' ' C' ' 225' ' ' ARG . 6.3 tp -83.69 130.19 36.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.174 0.512 . . . . 74.109999999999999 110.207 -175.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 49.1 t -99.81 140.23 19.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 106.955 -1.498 . . . . 75.530000000000001 106.955 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 91.02 28.21 16.18 Favored Glycine 0 N--CA 1.431 -1.637 0 N-CA-C 109.743 -1.343 . . . . 54.43 109.743 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . 0.542 ' NH2' ' HA ' ' C' ' 220' ' ' ASP . 17.8 ptt180 -112.35 144.01 42.49 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 115.108 -0.546 . . . . 74.430000000000007 109.69 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . 0.475 ' ND2' ' HA2' ' C' ' 278' ' ' GLY . 37.3 t-20 -117.75 128.69 55.13 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 105.906 -1.887 . . . . 75.340000000000003 105.906 170.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.1 m -128.77 136.51 50.63 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-O 121.457 0.646 . . . . 75.450000000000003 110.264 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . 0.548 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.92 127.47 41.82 Favored 'General case' 0 N--CA 1.417 -2.103 0 N-CA-C 107.92 -1.141 . . . . 74.450000000000003 107.92 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 37.7 ttmt -80.26 -60.68 2.23 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.996 -0.682 . . . . 71.209999999999994 112.097 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -126.21 137.49 53.55 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.076 -1.083 . . . . 74.109999999999999 108.076 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 24.8 mt -136.19 117.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.202 -1.036 . . . . 74.400000000000006 108.202 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 92.5 mtt180 -120.11 119.45 33.34 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.19 -1.041 . . . . 73.549999999999997 108.19 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 233' ' ' THR . . . . . 0.504 ' OG1' ' HA2' ' B' ' 269' ' ' GLY . 28.9 p -119.75 127.83 53.19 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.462 -1.681 . . . . 73.430000000000007 106.462 -177.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -133.58 155.31 49.86 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.454 0.645 . . . . 70.430000000000007 112.075 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 46.6 mt-10 72.26 -86.54 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.199 0 CA-C-N 113.896 -1.502 . . . . 71.030000000000001 114.693 170.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.51 ' HD3' ' N ' ' C' ' 236' ' ' ARG . 0.3 OUTLIER -131.11 31.32 4.44 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.654 -0.869 . . . . 73.25 108.654 -177.487 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -75.11 138.39 42.04 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 122.333 1.063 . . . . 75.230000000000004 113.547 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 4.3 mpt_? -123.91 133.37 53.75 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 103.765 -2.68 . . . . 75.439999999999998 103.765 172.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' B' ' 275' ' ' VAL . 85.8 t -141.16 132.31 27.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.252 0.549 . . . . 74.409999999999997 111.218 -174.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . 0.58 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 51.8 tp60 -111.68 128.71 56.15 Favored 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 107.05 -1.463 . . . . 74.540000000000006 107.05 174.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.423 HD11 HD22 ' B' ' 262' ' ' ASN . 1.7 tm? -128.62 117.54 21.4 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.411 -0.959 . . . . 64.230000000000004 108.411 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.527 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 131.4 -111.68 1.11 Allowed Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 110.333 -1.107 . . . . 73.450000000000003 110.333 -177.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -145.71 155.19 42.81 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 122.109 -0.642 . . . . 65.129999999999995 110.371 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . 0.58 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 58.8 t -131.22 122.02 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 108.635 -0.876 . . . . 75.129999999999995 108.635 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . 0.401 HG12 ' CD1' ' B' ' 281' ' ' TYR . 2.7 p -122.18 112.01 32.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.54 -0.911 . . . . 74.319999999999993 108.54 173.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 246' ' ' THR . . . . . 0.427 HG21 ' HA3' ' C' ' 282' ' ' GLY . 5.0 t -81.39 162.38 23.39 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.225 0.824 . . . . 72.219999999999999 113.225 -174.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' B' ' 249' ' ' ALA . . . -60.36 -35.17 75.05 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 124.693 1.197 . . . . 73.329999999999998 109.678 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.49 -34.77 69.41 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.345 -1.298 . . . . 62.200000000000003 111.584 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.59 -36.48 76.27 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.129 -0.487 . . . . 62.219999999999999 110.85 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 97.4 mt 55.97 27.97 11.99 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.585 0.754 . . . . 75.140000000000001 111.302 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -102.74 145.99 28.9 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.114 -0.494 . . . . 74.010000000000005 110.946 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -171.07 60.05 0.17 Allowed Glycine 0 N--CA 1.423 -2.181 0 N-CA-C 109.685 -1.366 . . . . 75.120000000000005 109.685 175.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.77 27.46 6.82 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.528 -0.844 . . . . 74.439999999999998 112.085 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 45.7 mm 43.77 81.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.112 1.365 . . . . 73.549999999999997 113.231 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.82 89.39 3.85 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.398 -0.814 . . . . 73.219999999999999 111.218 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . 0.409 HG12 ' HA ' ' B' ' 259' ' ' GLN . 25.4 mt -123.13 13.55 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 107.823 -1.177 . . . . 64.349999999999994 107.823 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 5.9 m -62.55 -42.34 99.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.92 -1.036 . . . . 64.430000000000007 109.207 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -161.25 126.35 3.61 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.993 -1.484 . . . . 71.219999999999999 106.993 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -143.39 154.3 43.57 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.039 -1.837 . . . . 75.239999999999995 106.039 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 26.0 m -64.57 120.24 11.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.404 0.621 . . . . 71.209999999999994 110.58 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 31.2 m -94.56 108.88 20.82 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 115.272 -0.876 . . . . 73.25 108.704 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -111.86 141.44 45.48 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.576 -0.738 . . . . 64.420000000000002 111.497 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 22.0 m -134.74 124.09 24.67 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.073 -1.084 . . . . 75.230000000000004 108.073 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.23 143.8 39.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.863 0.363 . . . . 72.349999999999994 110.613 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 53.9 mm-40 -80.42 -65.43 1.01 Allowed 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 115.955 -0.566 . . . . 63.350000000000001 111.459 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 59.2 m -140.8 130.79 24.61 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.107 -0.637 . . . . 62.25 110.906 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.0 m -123.51 133.88 67.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.852 -0.613 . . . . 73.129999999999995 109.393 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 8.3 p -128.02 140.23 49.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 116.181 -0.463 . . . . 75.329999999999998 109.945 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.03 132.87 9.61 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.988 -1.245 . . . . 73.5 109.988 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -131.36 141.19 49.85 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.25 0.62 . . . . 74.219999999999999 110.177 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 70.64 -132.02 22.05 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.883 -0.675 . . . . 65.219999999999999 112.166 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -85.94 49.35 1.76 Allowed 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 123.582 0.753 . . . . 75.329999999999998 110.502 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 273' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 67.9 m -83.22 145.07 29.36 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.602 0.964 . . . . 72.239999999999995 113.602 -174.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 41.7 mtt180 -138.68 125.68 21.23 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 103.586 -2.746 . . . . 75.400000000000006 103.586 172.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . 0.403 ' CG1' HG23 ' C' ' 239' ' ' VAL . 4.6 p -140.28 137.78 37.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 C-N-CA 120.297 -0.561 . . . . 73.400000000000006 111.827 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.401 HD12 ' CG ' ' C' ' 240' ' ' GLN . 13.0 tp -113.15 112.43 23.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.644 0.735 . . . . 74.010000000000005 109.74 175.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 30.7 mt -101.21 103.29 14.66 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 104.996 -2.224 . . . . 75.310000000000002 104.996 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 144.26 -159.63 27.73 Favored Glycine 0 N--CA 1.42 -2.384 0 C-N-CA 118.916 -1.611 . . . . 75.040000000000006 113.863 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -92.6 129.41 38.54 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.793 -0.703 . . . . 74.400000000000006 109.848 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -111.99 122.35 47.51 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 105.435 -2.061 . . . . 71.349999999999994 105.435 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.75 124.26 40.62 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 108.517 -0.92 . . . . 74.430000000000007 108.517 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . 0.427 ' HA3' HG21 ' C' ' 246' ' ' THR . . . 122.42 -34.65 3.73 Favored Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.628 -0.715 . . . . 53.420000000000002 112.087 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 122.88 -62.63 0.55 Allowed Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.886 -0.673 . . . . 72.519999999999996 111.645 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . 0.609 ' HD2' ' O ' ' C' ' 284' ' ' LYS 0.255 0.1 OUTLIER -136.0 70.02 1.42 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.855 0.836 . . . . 74.450000000000003 112.171 178.525 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.29 -64.06 1.96 Allowed Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.66 -1.257 . . . . 70.430000000000007 110.749 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -65.03 -24.32 67.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.637 0.732 . . . . 74.310000000000002 110.911 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -115.51 45.86 1.6 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.804 -0.634 . . . . 75.319999999999993 110.354 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.25 179.79 2.73 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 120.106 -0.638 . . . . 70.219999999999999 109.749 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -93.34 166.03 12.5 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 114.139 1.163 . . . . 72.519999999999996 114.139 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -56.76 -27.63 59.81 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.895 1.678 . . . . 73.219999999999999 114.44 -170.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -138.78 84.46 2.02 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.284 0.564 . . . . 74.319999999999993 109.556 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -77.01 133.81 39.02 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.532 -0.914 . . . . 73.209999999999994 108.532 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -97.09 171.12 8.67 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.746 -0.464 . . . . 75.120000000000005 109.746 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -95.78 150.6 20.22 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 120.015 -0.674 . . . . 74.230000000000004 109.448 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 . . . . . 0 C--N 1.297 -1.717 0 N-CA-C 107.766 -1.198 . . . . 74.209999999999994 107.766 -178.389 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 C--O 1.24 0.586 0 N-CA-C 109.8 -0.444 . . . . 74.200000000000003 109.8 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 45.8 mttp 70.12 140.44 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.212 1.19 . . . . 74.349999999999994 114.212 174.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 9.6 tt -76.94 116.18 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 105.796 -1.927 . . . . 73.510000000000005 105.796 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -73.31 102.81 3.8 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.503 0.668 . . . . 74.049999999999997 112.145 -173.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -109.33 126.62 53.58 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.703 -1.135 . . . . 71.400000000000006 108.396 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 75.9 mt -101.18 126.99 54.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-O 121.146 0.498 . . . . 71.319999999999993 111.292 -175.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 39.9 t -138.15 119.28 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 105.616 -1.994 . . . . 71.219999999999999 105.616 172.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -129.82 112.46 1.32 Allowed Glycine 0 C--N 1.297 -1.611 0 C-N-CA 120.17 -1.014 . . . . 70.129999999999995 111.18 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 23.6 ptt85 -137.97 142.24 40.49 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.135 0.493 . . . . 71.510000000000005 111.984 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -99.3 114.25 27.0 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.201 -1.777 . . . . 72.319999999999993 106.201 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.4 m -126.15 136.66 53.13 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.667 -0.813 . . . . 75.120000000000005 111.756 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -120.71 119.41 32.7 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.171 -1.418 . . . . 64.349999999999994 107.171 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -75.8 -58.2 3.42 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 123.803 0.69 . . . . 74.329999999999998 110.165 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -126.57 140.48 52.4 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.137 0.494 . . . . 73.140000000000001 111.345 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.0 mt -134.16 124.95 47.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.162 -1.051 . . . . 73.540000000000006 108.162 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -128.76 122.74 31.27 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.613 -0.514 . . . . 72.239999999999995 109.613 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 20.2 p -112.31 128.23 56.22 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.269 -1.382 . . . . 75.129999999999995 107.269 171.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -147.37 146.4 29.62 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.815 -1.18 . . . . 75.140000000000001 107.815 -175.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 60.14 72.96 0.5 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.248 0.619 . . . . 75.329999999999998 112.634 -175.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 65.28 22.87 12.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.054 0.541 . . . . 65.450000000000003 112.264 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.41 134.97 36.36 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.274 -0.421 . . . . 73.310000000000002 109.893 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.93 139.99 53.0 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.126 -0.488 . . . . 72.450000000000003 111.636 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 p -124.18 138.49 53.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.545 -0.752 . . . . 74.329999999999998 111.513 -176.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.468 ' HB3' HD21 ' A' ' 276' ' ' LEU . 6.4 tp-100 -111.15 118.64 36.53 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.688 -1.227 . . . . 75.209999999999994 107.688 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.87 118.87 36.7 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.257 -1.016 . . . . 64.310000000000002 108.257 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.564 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 134.89 -136.72 8.73 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.437 -0.887 . . . . 61.399999999999999 111.843 177.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -130.12 128.58 42.11 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.568 -0.901 . . . . 73.510000000000005 108.568 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.4 115.38 43.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.025 -1.102 . . . . 73.109999999999999 108.025 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 45.5 t -113.87 114.39 46.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.701 -0.851 . . . . 63.409999999999997 108.701 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.443 ' HB ' ' HA3' ' A' ' 282' ' ' GLY . 10.7 m -105.06 161.15 14.48 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.895 -1.15 . . . . 74.329999999999998 107.895 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.73 72.34 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.991 0.916 . . . . 75.140000000000001 113.087 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.59 -34.49 64.88 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.899 1.444 . . . . 51.200000000000003 114.899 -174.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . 0.446 ' HB2' ' N ' ' A' ' 282' ' ' GLY . . . -73.81 -45.8 49.21 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.801 1.038 . . . . 73.409999999999997 113.801 -174.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 58.88 -151.39 0.42 Allowed 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.256 -1.016 . . . . 72.200000000000003 108.256 -172.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -153.68 -161.98 1.36 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.116 -1.439 . . . . 75.049999999999997 107.116 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 167.58 -158.39 31.23 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 110.818 -0.913 . . . . 73.450000000000003 110.818 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -72.72 118.24 6.44 Favored Glycine 0 N--CA 1.441 -0.997 0 O-C-N 124.015 0.479 . . . . 63.32 111.956 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 43.2 mm -96.78 -55.72 5.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 122.879 -0.189 . . . . 73.540000000000006 110.675 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 65.31 -86.75 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.884 1.274 . . . . 74.530000000000001 111.777 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.424 HD13 ' O ' ' A' ' 256' ' ' ILE 0.338 2.7 pp -121.48 109.49 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-O 122.681 1.229 . . . . 74.25 113.6 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 49.6 m -146.84 137.28 23.68 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.754 -1.573 . . . . 63.130000000000003 106.754 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -98.22 -171.31 2.12 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.817 -0.809 . . . . 74.450000000000003 108.817 -173.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -125.42 103.87 8.14 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.265 -0.643 . . . . 74.0 109.265 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 8.3 m -64.78 125.65 25.47 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.442 -0.799 . . . . 71.109999999999999 110.284 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.5 t -91.89 129.04 37.93 Favored 'General case' 0 N--CA 1.415 -2.189 0 C-N-CA 119.653 -0.819 . . . . 71.049999999999997 108.863 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -124.69 138.37 54.3 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.372 -1.344 . . . . 73.430000000000007 107.372 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.6 m -137.63 123.83 20.48 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.935 -0.706 . . . . 74.129999999999995 111.953 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 11.7 p -122.46 137.76 54.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 115.864 -0.607 . . . . 73.140000000000001 109.721 175.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.573 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 3.7 tp10 -79.0 -65.34 1.01 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.055 -0.52 . . . . 74.200000000000003 109.937 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 30.8 m -136.97 129.78 30.53 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 121.77 -0.581 . . . . 74.420000000000002 111.973 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 35.3 m -117.79 126.45 74.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 N-CA-C 108.368 -0.975 . . . . 74.140000000000001 108.368 174.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.93 126.68 66.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 121.38 0.61 . . . . 75.109999999999999 111.518 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.57 132.49 11.0 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 109.937 -1.265 . . . . 73.5 109.937 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 30.5 mmmt -133.13 116.43 16.29 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.514 0.726 . . . . 74.540000000000006 110.284 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.43 86.29 0.9 Allowed Glycine 0 C--N 1.296 -1.67 0 C-N-CA 119.483 -1.342 . . . . 64.340000000000003 113.734 174.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 55.23 31.01 15.65 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.635 1.174 . . . . 72.530000000000001 111.618 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 23.6 m -83.04 149.18 27.1 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.485 0.66 . . . . 64.310000000000002 112.169 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -119.49 128.15 53.71 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.69 -0.856 . . . . 74.329999999999998 108.69 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 24.7 t -122.54 129.99 74.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.999 -0.741 . . . . 74.099999999999994 108.999 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 286' ' ' PHE . 0.9 OUTLIER -119.78 117.36 27.99 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.556 -1.646 . . . . 73.230000000000004 106.556 173.321 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.456 HG21 HD13 ' B' ' 241' ' ' LEU . 42.7 mm -112.89 104.89 17.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.411 -0.959 . . . . 75.230000000000004 108.411 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 144.31 -127.7 3.05 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 119.746 -1.216 . . . . 71.209999999999994 113.007 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -128.36 150.76 49.95 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 120.711 0.291 . . . . 73.109999999999999 110.404 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -129.15 123.62 32.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.803 -1.925 . . . . 74.340000000000003 105.803 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -120.45 123.54 43.23 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.016 -1.475 . . . . 74.230000000000004 107.016 174.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . 0.446 ' N ' ' HB2' ' A' ' 249' ' ' ALA . . . 145.36 -82.49 0.2 Allowed Glycine 0 N--CA 1.412 -2.923 0 C-N-CA 118.905 -1.617 . . . . 72.439999999999998 112.692 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -142.02 16.97 2.56 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.71 -1.233 . . . . 73.030000000000001 113.317 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.487 ' CD ' ' HA ' ' B' ' 286' ' ' PHE . 62.7 mttm 71.57 -38.28 0.42 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.887 1.675 . . . . 71.239999999999995 113.843 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.512 ' HA2' ' CD1' ' B' ' 287' ' ' TRP . . . -72.0 -28.84 67.84 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 117.391 1.717 . . . . 61.509999999999998 117.391 -170.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.508 ' CZ ' ' HB2' ' A' ' 276' ' ' LEU 0.325 51.9 p90 53.33 -78.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.468 1.107 . . . . 63.43 113.917 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.3 m0 -95.47 -34.09 12.21 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.677 -0.639 . . . . 73.019999999999996 110.051 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -92.9 175.56 6.75 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.668 -1.234 . . . . 73.230000000000004 107.668 175.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' B' ' 289' ' ' ASN . 26.7 t-20 -176.79 -67.23 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.957 0.798 . . . . 72.420000000000002 111.419 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.3 t60 167.85 -43.22 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 104.557 -2.386 . . . . 75.230000000000004 104.557 -169.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -69.34 -58.26 4.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 113.313 -1.767 . . . . 75.040000000000006 107.478 175.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -89.07 124.49 34.35 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.964 -1.495 . . . . 72.329999999999998 106.964 172.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -154.49 -27.56 0.12 Allowed 'General case' 0 C--N 1.311 -1.066 0 O-C-N 123.791 0.682 . . . . 73.340000000000003 111.707 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -93.39 78.07 4.44 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.401 0.619 . . . . 73.510000000000005 111.695 -174.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 C--N 1.305 -1.326 0 N-CA-C 105.605 -1.998 . . . . 73.340000000000003 105.605 175.528 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 108.902 -0.777 . . . . 72.420000000000002 108.902 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . 0.522 ' O ' ' HD2' ' B' ' 218' ' ' LYS . 0.1 OUTLIER -87.8 132.92 33.99 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.999 -0.681 . . . . 73.230000000000004 111.425 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 13.5 tt -178.84 108.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 124.693 1.197 . . . . 73.230000000000004 108.409 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -135.07 132.97 38.84 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.5 1.143 . . . . 73.109999999999999 113.017 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -156.68 47.16 0.44 Allowed 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 102.765 -3.05 . . . . 73.430000000000007 102.765 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 75.4 mt -81.87 112.85 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 CA-C-N 113.721 -1.581 . . . . 73.239999999999995 112.678 -166.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 46.9 t -141.32 119.79 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.28 0 N-CA-C 105.433 -2.062 . . . . 75.420000000000002 105.433 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' B' ' 259' ' ' GLN . . . -98.15 125.89 8.69 Favored Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 109.398 -1.481 . . . . 74.129999999999995 109.398 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 -141.93 121.73 13.53 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 118.146 0.973 . . . . 72.430000000000007 113.561 -175.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -101.04 114.38 28.27 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 104.408 -2.442 . . . . 75.099999999999994 104.408 167.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 55.6 m -130.2 136.01 48.77 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 118.875 -1.13 . . . . 75.409999999999997 112.885 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -120.53 126.0 49.26 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.559 -1.655 . . . . 72.549999999999997 107.443 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 13.2 tmtt? -86.29 -59.34 2.31 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 116.137 -0.483 . . . . 74.540000000000006 110.747 -176.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -126.24 138.26 53.61 Favored 'General case' 0 C--O 1.25 1.12 0 C-N-CA 119.524 -0.87 . . . . 73.299999999999997 109.352 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . 0.404 HG21 HG21 ' B' ' 239' ' ' VAL . 28.1 mt -130.54 121.59 51.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.803 -1.184 . . . . 74.120000000000005 107.803 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 29.3 ttt180 -127.03 118.45 24.47 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-O 121.049 0.452 . . . . 75.230000000000004 109.987 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 24.9 p -109.57 127.55 54.57 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.635 -1.987 . . . . 74.409999999999997 105.635 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.614 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 33.5 tt0 -139.81 138.54 35.9 Favored 'General case' 0 N--CA 1.406 -2.674 0 C-N-CA 119.977 -0.689 . . . . 71.239999999999995 109.564 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.624 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 46.8 mt-10 60.69 91.39 0.06 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.961 1.097 . . . . 75.519999999999996 113.961 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.624 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 61.35 23.79 13.98 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.999 0.92 . . . . 74.409999999999997 110.598 175.901 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.587 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -94.57 144.52 25.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.84 -0.618 . . . . 65.040000000000006 110.973 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -125.16 142.27 51.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.549 -1.278 . . . . 72.400000000000006 107.549 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.5 p -130.75 131.98 64.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 121.479 0.657 . . . . 73.420000000000002 110.699 174.149 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.509 ' CG ' HD11 ' B' ' 276' ' ' LEU . 5.8 tp-100 -108.15 120.71 43.11 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 105.807 -1.923 . . . . 74.430000000000007 105.807 173.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . 0.456 HD13 HG21 ' A' ' 277' ' ' ILE . 3.1 tm? -125.86 117.68 23.88 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.332 -0.988 . . . . 71.519999999999996 108.332 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.27 -122.49 2.55 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.768 -0.73 . . . . 72.439999999999998 111.423 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -144.32 128.1 17.28 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.094 -0.706 . . . . 71.510000000000005 109.094 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 73.8 t -102.91 117.99 49.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.473 -0.936 . . . . 74.299999999999997 108.473 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.16 112.72 35.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.426 0.631 . . . . 74.230000000000004 109.565 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.2 m -105.49 161.66 14.15 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.555 -0.906 . . . . 75.430000000000007 108.555 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 249' ' ' ALA . . . -56.8 -33.33 66.59 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.848 0.859 . . . . 64.230000000000004 111.919 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' B' ' 294' ' ' HIS . . . -54.04 -34.14 59.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.453 -1.249 . . . . 74.319999999999993 113.14 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.43 -25.45 65.03 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 122.773 0.429 . . . . 74.430000000000007 112.092 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 tt -68.7 104.07 1.9 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.594 -0.891 . . . . 72.099999999999994 108.594 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -153.69 137.53 16.2 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.157 -1.053 . . . . 64.319999999999993 108.157 -177.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 53.01 -106.57 0.42 Allowed Glycine 0 C--O 1.243 0.703 0 O-C-N 124.293 0.995 . . . . 71.519999999999996 113.766 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -165.04 171.33 40.39 Favored Glycine 0 N--CA 1.419 -2.462 0 N-CA-C 107.867 -2.093 . . . . 74.430000000000007 107.867 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 66.9 mt 69.85 92.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 123.692 0.797 . . . . 75.310000000000002 110.757 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -154.37 151.64 29.28 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.181 -0.674 . . . . 74.030000000000001 109.181 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . 0.541 ' HA ' ' OH ' ' B' ' 281' ' ' TYR . 44.7 mt 59.97 79.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 C-N-CA 124.315 1.046 . . . . 73.549999999999997 112.043 176.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 72.6 m -163.07 115.6 1.56 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.632 -1.247 . . . . 70.420000000000002 107.632 175.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -134.88 159.93 39.85 Favored 'General case' 0 C--O 1.257 1.452 0 C-N-CA 120.99 -0.284 . . . . 75.25 110.932 -173.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' B' ' 259' ' ' GLN . 45.0 tt0 -149.32 18.53 0.95 Allowed 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.063 -1.088 . . . . 74.329999999999998 108.063 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 19.9 m -75.3 121.85 22.82 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.688 -1.227 . . . . 73.340000000000003 107.688 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 91.1 m -91.25 107.87 19.49 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 107.884 -1.154 . . . . 53.310000000000002 107.884 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -120.9 131.31 54.31 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.388 -1.278 . . . . 74.400000000000006 107.559 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 51.5 m -138.86 126.49 21.96 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 120.937 0.399 . . . . 73.120000000000005 110.897 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.3 138.0 53.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.798 -0.761 . . . . 74.109999999999999 110.349 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.608 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 19.8 tp10 -79.24 -59.29 2.83 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.9 -0.591 . . . . 73.109999999999999 109.686 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 39.7 m -145.4 128.11 16.22 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.62 -0.675 . . . . 71.200000000000003 111.924 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.54 128.22 74.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.18 -1.044 . . . . 74.349999999999994 108.18 173.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 6.5 p -128.02 129.77 69.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-N 116.062 -0.517 . . . . 64.109999999999999 112.139 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . 0.426 ' HA2' ' HG1' ' C' ' 233' ' ' THR . . . -109.6 132.98 11.35 Favored Glycine 0 CA--C 1.475 -2.412 0 N-CA-C 110.037 -1.225 . . . . 73.120000000000005 110.037 176.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 27.3 mmmt -133.9 115.99 15.09 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 123.184 0.594 . . . . 74.340000000000003 111.621 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 77.54 92.29 0.27 Allowed Glycine 0 C--N 1.299 -1.5 0 C-N-CA 119.872 -1.156 . . . . 73.109999999999999 113.588 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 16.0 mp0 61.59 24.82 14.86 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.886 0.875 . . . . 74.430000000000007 111.638 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 273' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 41.6 m -83.04 152.39 25.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.476 0.917 . . . . 74.120000000000005 113.476 -171.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.447 ' HB3' ' CE3' ' B' ' 287' ' ' TRP . 94.9 mtt180 -128.34 127.96 43.66 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.467 -0.938 . . . . 75.510000000000005 108.467 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 47.2 t -126.28 128.17 71.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 122.41 0.284 . . . . 74.340000000000003 110.304 -175.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . 0.509 HD11 ' CG ' ' B' ' 240' ' ' GLN . 5.8 tp -122.43 114.62 20.97 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.569 -0.852 . . . . 64.310000000000002 110.597 169.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . 0.474 HG21 HD13 ' C' ' 241' ' ' LEU . 40.1 mm -108.01 104.55 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 N-CA-C 106.997 -1.483 . . . . 74.519999999999996 106.997 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.84 -148.95 20.75 Favored Glycine 0 CA--C 1.476 -2.389 0 C-N-CA 119.267 -1.444 . . . . 65.519999999999996 112.98 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 18.4 m120 -112.38 136.59 51.67 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.089 -0.708 . . . . 63.530000000000001 109.089 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . 0.409 ' CD ' ' HZ3' ' A' ' 284' ' ' LYS . 0.0 OUTLIER -111.88 118.81 36.54 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.167 -1.79 . . . . 71.109999999999999 106.167 178.307 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' B' ' 256' ' ' ILE . 77.7 m-85 -118.98 124.01 45.95 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.012 0.911 . . . . 73.209999999999994 109.921 175.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . 0.406 ' HA3' ' HZ1' ' A' ' 284' ' ' LYS . . . 139.29 -64.92 0.54 Allowed Glycine 0 N--CA 1.412 -2.928 0 C-N-CA 119.745 -1.217 . . . . 75.409999999999997 113.5 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -169.73 37.01 0.19 Allowed Glycine 0 C--O 1.21 -1.381 0 C-N-CA 117.371 -2.347 . . . . 74.519999999999996 115.367 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . 0.472 ' HZ3' ' CD ' ' C' ' 280' ' ' GLU . 64.6 mmtt 70.87 -66.37 0.3 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.637 1.175 . . . . 73.019999999999996 113.188 170.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -81.7 89.84 1.43 Allowed Glycine 0 CA--C 1.494 -1.265 0 CA-C-N 115.458 -0.792 . . . . 63.32 114.033 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.487 ' HA ' ' CD ' ' A' ' 284' ' ' LYS . 6.6 p90 -60.49 -66.45 0.53 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.815 0.846 . . . . 63.32 112.437 176.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.512 ' CD1' ' HA2' ' A' ' 285' ' ' GLY . 5.0 m-90 -102.56 80.29 1.91 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.739 -1.208 . . . . 73.409999999999997 107.739 176.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -150.07 -59.43 0.2 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.745 -1.205 . . . . 73.519999999999996 107.745 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' A' ' 289' ' ' ASN . 59.2 t30 38.02 79.95 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 O-C-N 125.418 1.699 . . . . 75.540000000000006 115.053 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -118.23 25.38 10.36 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 105.175 -2.158 . . . . 73.329999999999998 105.175 171.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 27.7 m80 61.71 73.67 0.47 Allowed 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.187 -2.153 . . . . 73.510000000000005 105.187 -170.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -71.54 148.02 47.11 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.515 -1.675 . . . . 72.140000000000001 111.631 -167.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -76.77 156.56 32.28 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.722 -1.126 . . . . 75.319999999999993 110.105 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' B' ' 248' ' ' ALA . 10.4 m170 -89.41 -23.92 22.03 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.782 -1.192 . . . . 75.510000000000005 107.782 177.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 . . . . . 0 C--O 1.251 1.156 0 CA-C-N 113.182 -1.826 . . . . 72.219999999999999 109.142 -175.645 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 17.0 mmt . . . . . 0 CA--C 1.496 -1.105 0 CA-C-O 120.784 0.326 . . . . 73.129999999999995 111.49 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -106.67 84.93 2.08 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.575 -1.269 . . . . 75.349999999999994 107.575 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 14.3 tt -125.18 149.83 29.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 115.172 -0.922 . . . . 73.349999999999994 108.901 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -81.74 93.14 6.75 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.35 0.595 . . . . 71.5 112.009 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -164.46 -100.22 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.839 -1.073 . . . . 73.310000000000002 108.439 174.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 47.0 mm -116.53 115.44 49.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 106.949 -1.5 . . . . 75.319999999999993 106.949 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.07 118.15 35.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.685 0.755 . . . . 75.310000000000002 111.095 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -121.79 120.29 4.33 Favored Glycine 0 N--CA 1.42 -2.37 0 N-CA-C 108.779 -1.729 . . . . 75.239999999999995 108.779 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -142.83 148.25 36.77 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-O 121.276 0.56 . . . . 71.310000000000002 111.146 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -101.17 116.32 32.55 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.674 -1.972 . . . . 74.230000000000004 105.674 173.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 50.0 m -131.58 136.98 48.23 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.542 -0.863 . . . . 73.510000000000005 111.887 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.12 130.93 52.03 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.8 -1.091 . . . . 74.439999999999998 108.308 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.621 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.1 OUTLIER -80.27 -67.83 0.73 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.613 -0.884 . . . . 74.120000000000005 108.613 -178.364 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -125.54 139.19 53.82 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 119.869 -0.732 . . . . 74.239999999999995 109.258 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 20.3 mt -133.42 118.76 32.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.242 -1.392 . . . . 75.109999999999999 107.242 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -120.0 124.52 46.13 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.601 -0.44 . . . . 74.400000000000006 110.222 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 233' ' ' THR . . . . . 0.426 ' HG1' ' HA2' ' B' ' 269' ' ' GLY . 27.8 p -109.58 126.52 53.68 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 104.599 -2.371 . . . . 75.409999999999997 104.599 173.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 32.6 tt0 -140.86 138.81 34.22 Favored 'General case' 0 N--CA 1.415 -2.193 0 C-N-CA 119.804 -0.758 . . . . 70.510000000000005 109.132 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . 0.614 ' C ' ' HD3' ' C' ' 236' ' ' ARG . 56.4 mt-10 62.91 85.74 0.13 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.303 1.002 . . . . 74.519999999999996 112.939 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.681 ' HD3' ' N ' ' C' ' 236' ' ' ARG . 0.1 OUTLIER 64.9 21.82 12.39 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.882 0.873 . . . . 75.430000000000007 111.473 174.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -91.68 147.48 22.97 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.294 0.569 . . . . 54.049999999999997 111.447 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.419 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 5.2 mpt_? -125.1 144.41 50.43 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.863 -1.162 . . . . 74.439999999999998 107.863 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 5.7 p -133.85 135.52 55.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.351 0.596 . . . . 75.140000000000001 111.377 175.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -110.41 117.81 34.59 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 106.913 -1.514 . . . . 74.230000000000004 106.913 172.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.474 HD13 HG21 ' B' ' 277' ' ' ILE . 3.2 tm? -121.88 117.69 27.11 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.947 -1.501 . . . . 75.430000000000007 106.947 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.65 -128.38 4.1 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.551 -0.833 . . . . 70.439999999999998 111.024 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 51.5 t-20 -140.14 128.83 23.08 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.426 -0.953 . . . . 74.019999999999996 108.426 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.23 115.12 44.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.637 -1.246 . . . . 74.310000000000002 107.637 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . 0.475 ' HB ' ' CE2' ' B' ' 281' ' ' TYR . 43.4 t -120.51 112.57 36.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.949 -0.76 . . . . 70.120000000000005 108.949 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.1 m -101.57 160.91 14.04 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.069 -0.715 . . . . 74.329999999999998 109.069 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.91 -31.77 68.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.957 1.303 . . . . 74.109999999999999 110.519 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.31 59.24 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.043 -1.89 . . . . 73.230000000000004 113.616 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.49 -46.5 69.53 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.426 -0.51 . . . . 71.019999999999996 111.412 -176.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 25.3 tp 46.15 35.8 2.8 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.636 1.174 . . . . 74.230000000000004 111.318 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -86.58 121.94 29.82 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.945 -0.57 . . . . 74.109999999999999 111.615 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -82.1 63.55 4.38 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.137 -0.785 . . . . 45.340000000000003 111.137 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -154.57 82.27 0.17 Allowed Glycine 0 C--N 1.293 -1.831 0 N-CA-C 108.947 -1.661 . . . . 74.420000000000002 108.947 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 20.3 pt -117.86 142.53 31.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 115.516 -0.342 . . . . 74.200000000000003 111.536 -175.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . 0.425 ' HG3' ' HB2' ' B' ' 259' ' ' GLN . 39.0 ttm180 56.92 78.71 0.21 Allowed 'General case' 0 CA--C 1.534 0.346 0 O-C-N 124.432 1.082 . . . . 74.540000000000006 112.988 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 29.6 pt -132.78 152.39 36.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 114.766 -1.106 . . . . 74.519999999999996 108.145 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 19.4 m -79.84 112.32 17.02 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 120.756 0.313 . . . . 75.420000000000002 110.654 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -81.32 155.04 26.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.759 -0.655 . . . . 62.439999999999998 110.429 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -120.12 -4.05 10.06 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.814 -0.63 . . . . 75.420000000000002 109.574 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 9.4 m -78.02 121.2 23.91 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.192 0.52 . . . . 62.450000000000003 109.772 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -111.78 124.55 52.59 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.561 0.696 . . . . 73.510000000000005 109.259 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -121.24 137.21 54.79 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.803 -1.184 . . . . 75.5 107.803 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 18.1 t -135.95 123.3 21.92 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 108.929 -0.767 . . . . 70.209999999999994 108.929 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.02 131.34 72.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.26 -0.882 . . . . 72.349999999999994 109.119 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.621 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 17.2 tp10 -88.36 -54.76 4.03 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.534 -0.543 . . . . 70.519999999999996 109.534 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 55.0 m -150.22 127.44 11.31 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.349 -0.845 . . . . 72.510000000000005 110.842 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 5.1 m -121.21 128.42 75.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.706 -0.849 . . . . 73.319999999999993 108.706 171.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.09 135.53 63.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 116.34 -0.391 . . . . 74.549999999999997 110.352 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.53 133.49 11.4 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 109.866 -1.294 . . . . 73.540000000000006 109.866 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -132.31 116.24 16.64 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.801 -0.444 . . . . 74.430000000000007 109.801 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.32 93.16 0.56 Allowed Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.345 -0.931 . . . . 64.239999999999995 113.309 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 55.38 28.4 11.42 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.696 1.198 . . . . 75.219999999999999 111.653 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 273' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 46.3 m -82.37 154.89 25.01 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.953 1.094 . . . . 61.409999999999997 113.953 -169.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -122.85 128.26 50.14 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.871 -1.059 . . . . 74.409999999999997 108.254 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 11.0 t -125.64 130.53 72.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.073 -0.714 . . . . 74.519999999999996 109.073 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -123.55 110.59 15.23 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.284 -1.376 . . . . 75.150000000000006 107.284 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 40.8 mm -113.53 103.95 16.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.072 -1.455 . . . . 63.530000000000001 107.072 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.05 -152.65 24.53 Favored Glycine 0 CA--C 1.471 -2.676 0 C-N-CA 120.034 -1.079 . . . . 74.209999999999994 111.216 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.56 141.15 48.44 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 109.213 -0.662 . . . . 73.239999999999995 109.213 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . 0.472 ' CD ' ' HZ3' ' B' ' 284' ' ' LYS . 0.1 OUTLIER -112.69 118.37 34.84 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.143 -1.428 . . . . 74.299999999999997 107.143 -178.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -119.08 124.29 46.55 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.76 0.791 . . . . 71.439999999999998 110.828 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.51 -52.92 0.74 Allowed Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 120.072 -1.061 . . . . 44.119999999999997 113.151 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -151.59 -4.16 0.18 Allowed Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 117.434 -2.317 . . . . 65.129999999999995 115.207 -173.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm 78.47 -40.65 0.28 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.832 1.253 . . . . 72.430000000000007 109.616 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' C' ' 289' ' ' ASN . . . -86.03 110.38 3.47 Favored Glycine 0 N--CA 1.41 -3.067 0 N-CA-C 109.823 -1.311 . . . . 75.239999999999995 109.823 174.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -79.97 -85.84 0.08 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 112.88 0.696 . . . . 61.25 112.88 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -85.12 3.14 40.37 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 120.91 -1.119 . . . . 74.040000000000006 111.486 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 38.4 t70 179.62 145.26 0.18 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.842 -1.91 . . . . 74.310000000000002 105.842 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . 0.49 ' HA ' ' HA3' ' C' ' 285' ' ' GLY . 33.4 t-20 -88.89 98.95 12.02 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.176 -1.01 . . . . 74.310000000000002 109.497 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -78.21 -11.09 59.9 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.27 -0.877 . . . . 74.409999999999997 110.459 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 67.9 m80 69.2 -61.36 0.43 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.568 1.547 . . . . 71.349999999999994 112.173 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -90.83 90.37 7.89 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.376 0.608 . . . . 71.540000000000006 109.452 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -135.23 149.57 49.9 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.632 -1.248 . . . . 75.430000000000007 107.632 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -83.57 85.26 7.29 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.983 -0.287 . . . . 73.329999999999998 110.919 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 . . . . . 0 C--O 1.25 1.102 0 N-CA-C 105.674 -1.973 . . . . 72.040000000000006 105.674 172.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' MET . . . . . 0.411 ' SD ' ' HA ' ' B' ' 221' ' ' ALA . 82.6 mtp . . . . . 0 CA--C 1.512 -0.496 0 N-CA-C 108.528 -0.916 . . . . 72.439999999999998 108.528 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt 59.6 36.03 22.63 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.174 0.99 . . . . 71.540000000000006 109.299 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.2 mp 60.51 71.17 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.052 -1.431 . . . . 73.400000000000006 110.741 -177.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -111.11 1.61 17.41 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.799 -1.091 . . . . 73.420000000000002 109.189 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -86.29 175.4 8.47 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.08 -0.964 . . . . 62.229999999999997 109.529 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 4.7 tp -82.32 119.17 31.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 121.691 0.758 . . . . 65.129999999999995 109.11 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 11.8 p -100.75 147.87 7.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.105 -0.952 . . . . 72.120000000000005 108.611 -176.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.21 59.04 2.1 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.1 -1.2 . . . . 64.430000000000007 110.1 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -142.43 135.33 28.4 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 123.301 0.64 . . . . 75.239999999999995 110.475 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -113.83 127.83 56.16 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.606 -1.257 . . . . 75.420000000000002 107.606 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 28.0 m -123.41 137.66 54.76 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.93 -0.396 . . . . 71.450000000000003 109.93 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.62 125.38 28.63 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.25 -0.432 . . . . 72.120000000000005 110.284 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 12.9 tmtt? -76.3 -62.72 1.52 Allowed 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.723 0.639 . . . . 73.409999999999997 109.749 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -133.72 139.14 46.21 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-O 121.319 0.581 . . . . 72.040000000000006 112.543 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 34.5 mm -123.39 117.12 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 106.774 -1.565 . . . . 72.150000000000006 106.774 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -118.75 115.89 25.41 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.328 0.585 . . . . 74.349999999999994 110.201 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.4 128.27 50.73 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.597 -0.89 . . . . 74.140000000000001 108.597 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -137.1 164.1 29.24 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.258 0.349 . . . . 73.430000000000007 110.607 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 66.99 -88.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.777 1.231 . . . . 74.450000000000003 113.443 174.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.18 27.25 2.62 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 108.174 -1.047 . . . . 73.019999999999996 108.174 -177.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -75.13 149.19 39.13 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.166 -0.925 . . . . 65.209999999999994 110.107 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -125.57 135.06 51.82 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 104.861 -2.274 . . . . 75.099999999999994 104.861 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.14 148.47 30.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.7 0.762 . . . . 73.25 111.924 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.474 ' CG ' ' HG ' ' A' ' 276' ' ' LEU . 49.9 tp60 -126.87 128.58 46.72 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.96 -1.018 . . . . 72.219999999999999 108.878 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -126.48 118.72 25.51 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.66 -1.607 . . . . 74.200000000000003 106.66 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.49 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 135.86 -135.17 7.64 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.197 -1.001 . . . . 61.43 112.409 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -128.82 128.43 43.9 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 122.687 -0.302 . . . . 74.239999999999995 110.272 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 91.3 t -118.29 127.17 75.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.718 -0.845 . . . . 75.129999999999995 108.718 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.11 112.76 39.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.563 -0.902 . . . . 72.319999999999993 108.563 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 50.6 m -81.14 160.08 24.49 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.554 -1.276 . . . . 72.0 107.554 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.49 84.33 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.543 0.571 . . . . 74.450000000000003 112.543 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.54 -34.89 65.11 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 114.32 1.23 . . . . 73.120000000000005 114.32 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -63.27 -46.06 88.59 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.75 1.019 . . . . 63.310000000000002 113.75 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 66.4 tp 57.86 71.54 0.57 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.352 1.072 . . . . 65.25 109.953 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -86.32 155.18 20.74 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.825 -1.079 . . . . 73.239999999999995 108.691 -177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -147.35 -127.35 1.75 Allowed Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 110.611 -0.996 . . . . 65.310000000000002 110.611 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -149.64 43.05 0.77 Allowed Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 120.513 -0.851 . . . . 74.310000000000002 112.445 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 6.4 pt -107.86 121.15 60.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 120.696 0.284 . . . . 74.319999999999993 110.24 176.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.81 -178.04 0.21 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.57 1.148 . . . . 72.430000000000007 110.219 -172.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.3 tt -107.64 108.37 25.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.346 -1.353 . . . . 75.439999999999998 107.346 173.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.1 m -83.35 -34.8 25.54 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.12 -0.491 . . . . 71.129999999999995 111.397 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -102.24 106.64 17.49 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.375 -0.93 . . . . 64.400000000000006 111.719 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -119.8 20.57 12.23 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.213 -1.358 . . . . 75.409999999999997 108.078 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 11.0 m -81.23 124.77 29.58 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 115.783 -0.644 . . . . 71.030000000000001 110.957 -175.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 36.2 p -107.92 108.18 19.22 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 106.539 -1.652 . . . . 75.319999999999993 106.539 168.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -126.52 122.21 34.51 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.102 -0.703 . . . . 74.400000000000006 109.102 -174.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 35.3 m -122.92 123.15 40.29 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.697 -0.483 . . . . 74.420000000000002 109.697 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.1 p -115.74 140.52 37.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.01 0.433 . . . . 65.209999999999994 110.629 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.588 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 22.7 tp10 -82.78 -69.2 0.64 Allowed 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.165 -0.925 . . . . 73.420000000000002 110.548 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 13.5 m -133.73 129.22 36.4 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 121.535 -0.728 . . . . 74.019999999999996 111.814 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 24.0 m -118.1 127.28 75.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.814 -1.18 . . . . 73.340000000000003 107.814 170.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.72 127.07 73.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-O 121.116 0.484 . . . . 74.439999999999998 111.533 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.84 133.57 11.53 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.623 -0.717 . . . . 64.510000000000005 111.762 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -125.06 144.17 50.54 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 124.179 0.992 . . . . 72.099999999999994 109.28 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 65.21 -132.06 35.99 Favored Glycine 0 C--N 1.305 -1.149 0 C-N-CA 121.212 -0.518 . . . . 74.209999999999994 112.931 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' B' ' 235' ' ' GLU . 8.7 mm-40 -92.79 53.65 2.07 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 125.201 1.4 . . . . 75.099999999999994 111.413 -177.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 73.5 m -83.1 150.03 26.53 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.166 0.508 . . . . 72.340000000000003 112.113 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -128.61 127.47 42.32 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.183 -1.414 . . . . 74.519999999999996 107.183 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 16.4 t -132.71 130.09 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 109.094 -0.706 . . . . 73.120000000000005 109.094 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.474 ' HG ' ' CG ' ' A' ' 240' ' ' GLN . 5.8 tt -118.31 121.55 40.67 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.879 -1.156 . . . . 75.420000000000002 107.879 174.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.23 104.36 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.982 0 N-CA-C 107.303 -1.369 . . . . 73.010000000000005 107.303 177.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.49 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 151.54 -145.27 12.88 Favored Glycine 0 N--CA 1.421 -2.309 0 N-CA-C 111.064 -0.814 . . . . 74.140000000000001 111.064 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.503 ' OD1' ' HB3' ' B' ' 243' ' ' ASN . 95.7 m-20 -114.3 140.2 48.81 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 116.735 0.267 . . . . 72.409999999999997 110.594 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.8 OUTLIER -128.16 129.54 46.68 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.796 -1.557 . . . . 73.209999999999994 106.796 178.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -119.4 124.62 47.0 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 109.349 -0.612 . . . . 75.200000000000003 109.349 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.42 -50.65 0.83 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 111.254 -0.739 . . . . 72.239999999999995 111.254 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 98.12 39.21 3.84 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 109.546 -1.422 . . . . 73.049999999999997 109.546 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -141.04 -56.37 0.5 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.318 -0.553 . . . . 75.129999999999995 109.641 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.601 ' HA3' ' CZ3' ' A' ' 287' ' ' TRP . . . 72.21 -159.53 53.74 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.494 -0.776 . . . . 70.239999999999995 114.907 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -105.24 -0.18 26.62 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.351 -0.425 . . . . 75.25 109.92 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . 0.601 ' CZ3' ' HA3' ' A' ' 285' ' ' GLY . 24.2 m-90 -58.9 -27.18 64.99 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.54 -0.755 . . . . 72.129999999999995 111.944 -174.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -167.2 140.94 3.66 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.288 -1.005 . . . . 73.439999999999998 108.288 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -109.04 24.34 13.26 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 121.641 0.734 . . . . 64.209999999999994 110.405 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -125.05 163.9 21.36 Favored 'General case' 0 C--O 1.252 1.194 0 O-C-N 121.026 -1.046 . . . . 74.129999999999995 109.976 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -81.77 87.68 6.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 104.682 -2.34 . . . . 74.420000000000002 104.682 165.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . 0.448 ' CG ' ' H ' ' A' ' 293' ' ' HIS . 2.7 p80 -94.41 -82.18 0.37 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 114.59 1.33 . . . . 71.030000000000001 114.59 -169.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . 0.448 ' H ' ' CG ' ' A' ' 292' ' ' HIS . 75.9 m-70 -133.69 87.67 2.4 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.603 0.716 . . . . 74.040000000000006 112.783 -175.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -122.62 76.06 1.31 Allowed 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 104.407 -2.442 . . . . 73.409999999999997 104.407 171.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 107.835 -1.172 . . . . 54.329999999999998 107.835 -171.127 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 67.7 mtm . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 111.665 0.246 . . . . 74.239999999999995 111.665 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -81.52 16.41 1.72 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.824 -0.547 . . . . 71.040000000000006 111.474 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 11.5 tt -163.22 137.82 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.919 0 C-N-CA 124.018 0.927 . . . . 74.329999999999998 108.852 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.42 117.23 19.38 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.952 -1.499 . . . . 72.299999999999997 106.952 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . 0.411 ' HA ' ' SD ' ' A' ' 217' ' ' MET . . . -162.66 -171.75 2.85 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.373 -0.973 . . . . 74.349999999999994 108.373 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 7.0 tp -83.84 129.35 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 108.462 -0.94 . . . . 74.329999999999998 108.462 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 5.5 p -124.41 151.85 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.239 0 N-CA-C 107.08 -1.452 . . . . 72.120000000000005 107.08 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 92.86 39.01 5.33 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 108.866 -1.693 . . . . 72.420000000000002 108.866 -173.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 261' ' ' THR . 13.9 ptt180 -124.38 141.34 52.16 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 121.589 0.709 . . . . 75.109999999999999 111.527 -176.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -116.85 127.63 54.48 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.342 -1.725 . . . . 72.420000000000002 106.342 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 19.5 m -125.75 136.37 53.09 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 109.11 -0.7 . . . . 74.25 109.11 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -131.39 127.66 37.97 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.808 -0.633 . . . . 75.439999999999998 110.447 -175.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.588 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 12.1 tmtt? -81.73 -68.12 0.72 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.686 -0.688 . . . . 71.239999999999995 109.656 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -127.38 137.48 52.77 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 119.374 -0.93 . . . . 71.230000000000004 110.961 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 35.9 mm -129.77 117.13 40.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 106.544 -1.65 . . . . 74.299999999999997 106.544 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . 0.561 ' HD3' ' OE2' ' B' ' 234' ' ' GLU . 18.2 ttm180 -118.47 124.31 47.29 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 120.696 0.284 . . . . 74.349999999999994 110.59 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 73.1 p -115.46 128.23 55.87 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.252 -1.018 . . . . 72.420000000000002 108.252 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.561 ' OE2' ' HD3' ' B' ' 232' ' ' ARG . 59.3 mt-10 -127.01 156.24 41.94 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.132 0.491 . . . . 74.340000000000003 111.043 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 272' ' ' GLU . 49.3 mt-10 66.68 -86.85 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.443 0 N-CA-C 114.38 1.252 . . . . 75.329999999999998 114.38 172.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . 0.442 ' N ' ' HD2' ' B' ' 236' ' ' ARG . 0.8 OUTLIER -135.59 31.84 3.08 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.31 -0.996 . . . . 64.120000000000005 108.31 -178.297 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -76.56 141.91 40.99 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.106 -0.952 . . . . 74.5 111.745 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.529 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 7.1 mpt_? -125.12 133.86 52.68 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.895 -1.52 . . . . 71.329999999999998 106.895 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 21.7 m -140.97 151.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.419 0.628 . . . . 54.229999999999997 112.331 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.52 ' CG ' ' HG ' ' B' ' 276' ' ' LEU . 38.3 tp60 -119.43 137.31 53.85 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.019 -1.446 . . . . 73.109999999999999 108.728 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -129.39 117.96 21.43 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.212 -1.773 . . . . 75.420000000000002 106.212 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.551 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 131.33 -131.8 6.53 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.504 -0.855 . . . . 73.200000000000003 112.886 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . 0.503 ' HB3' ' OD1' ' A' ' 279' ' ' ASN . 23.8 t-20 -125.38 136.3 53.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 122.491 -0.417 . . . . 74.209999999999994 110.912 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 280' ' ' GLU . 93.8 t -126.77 128.36 70.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.366 -0.975 . . . . 74.209999999999994 108.366 175.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 61.9 t -120.38 112.83 38.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.182 -1.044 . . . . 72.549999999999997 108.182 174.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 28.4 m -76.68 160.74 29.11 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 106.776 -1.564 . . . . 73.430000000000007 106.776 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.08 -33.87 76.38 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.109 0.956 . . . . 74.140000000000001 110.74 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.5 -34.4 64.58 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.404 -1.725 . . . . 71.5 114.117 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' B' ' 250' ' ' LEU . . . -59.83 -26.09 65.52 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.562 0.949 . . . . 75.439999999999998 113.562 -174.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . 0.445 ' HB3' ' O ' ' B' ' 249' ' ' ALA . 53.6 tp 78.92 86.76 0.06 Allowed 'General case' 0 C--O 1.246 0.895 0 O-C-N 124.473 1.108 . . . . 72.219999999999999 110.781 -174.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -59.96 114.45 2.83 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.408 -1.269 . . . . 75.430000000000007 110.346 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 82.44 17.39 68.88 Favored Glycine 0 N--CA 1.435 -1.37 0 CA-C-N 115.563 -0.744 . . . . 61.25 113.586 176.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -69.88 -48.91 38.37 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.5 -0.857 . . . . 62.140000000000001 112.02 177.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 10.4 tp -165.91 160.99 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 105.957 -1.868 . . . . 73.340000000000003 105.957 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -87.28 136.55 32.89 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 118.695 0.68 . . . . 64.409999999999997 109.615 176.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.2 mp -129.17 79.06 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.135 -1.432 . . . . 74.129999999999995 107.135 172.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 4.7 p -92.21 102.94 15.46 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.534 -0.757 . . . . 73.549999999999997 110.849 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.04 165.58 13.94 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.627 -0.715 . . . . 72.430000000000007 109.933 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . 0.41 ' HG3' HD12 ' C' ' 254' ' ' ILE . 97.9 mt-30 -100.99 40.56 1.26 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 122.907 0.483 . . . . 75.230000000000004 109.977 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 2.4 m -64.78 121.53 14.78 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.62 -0.718 . . . . 75.519999999999996 110.831 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -126.77 108.75 11.32 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.356 -1.72 . . . . 62.229999999999997 106.356 166.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 0.2 OUTLIER -124.42 128.25 48.75 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.279 -1.008 . . . . 72.209999999999994 108.279 -172.475 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 33.1 m -129.27 123.66 32.47 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.889 -0.411 . . . . 73.430000000000007 109.889 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.51 141.22 28.77 Favored 'Isoleucine or valine' 0 C--O 1.25 1.121 0 CA-C-N 115.977 -0.556 . . . . 72.519999999999996 109.749 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . 0.535 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 20.7 tp10 -83.37 -58.04 3.0 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.582 -0.735 . . . . 74.409999999999997 110.315 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 266' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' C' ' 230' ' ' ASP . 80.4 m -149.75 133.16 16.55 Favored 'General case' 0 C--N 1.31 -1.125 0 O-C-N 121.372 -0.83 . . . . 73.239999999999995 112.428 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 12.2 m -118.5 134.68 61.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.767 -1.197 . . . . 74.329999999999998 107.767 171.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 m -125.88 122.82 62.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.033 0.444 . . . . 75.230000000000004 110.629 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.99 132.86 11.26 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.466 -0.873 . . . . 74.150000000000006 111.893 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.39 147.12 49.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 124.213 1.005 . . . . 73.129999999999995 109.236 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.41 -136.25 34.23 Favored Glycine 0 C--O 1.228 -0.259 0 C-N-CA 120.009 -1.091 . . . . 71.299999999999997 110.516 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -97.35 69.55 2.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.866 0.841 . . . . 72.430000000000007 111.277 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 72.3 m -85.67 146.46 26.83 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.12 -0.945 . . . . 74.140000000000001 111.366 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 8.8 mpt_? -127.49 127.11 43.47 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.706 -1.59 . . . . 74.519999999999996 106.706 169.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.404 HG11 HG23 ' C' ' 239' ' ' VAL . 21.7 t -134.16 139.13 48.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 108.282 -1.007 . . . . 75.549999999999997 108.282 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . 0.52 ' HG ' ' CG ' ' B' ' 240' ' ' GLN . 6.5 tt -123.56 125.44 44.87 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 106.706 -1.59 . . . . 75.109999999999999 106.706 173.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.57 104.06 16.44 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 105.903 -1.888 . . . . 74.420000000000002 105.903 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 153.35 -149.24 20.74 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.164 -1.017 . . . . 60.210000000000001 113.26 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -110.04 133.56 53.07 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.019 -0.734 . . . . 64.219999999999999 109.019 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' C' ' 244' ' ' VAL . 2.2 tm-20 -126.65 128.08 46.2 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 106.507 -1.664 . . . . 75.430000000000007 106.507 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -118.58 125.06 49.0 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 109.143 -0.688 . . . . 72.519999999999996 109.143 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.02 -43.29 1.24 Allowed Glycine 0 N--CA 1.417 -2.621 0 N-CA-C 110.498 -1.041 . . . . 43.210000000000001 110.498 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.39 36.14 9.0 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.319 -1.512 . . . . 73.109999999999999 109.319 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' B' ' 289' ' ' ASN . 49.4 tptt -142.56 -62.27 0.43 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.873 -0.417 . . . . 71.319999999999993 109.873 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . 0.427 ' HA3' ' CZ3' ' B' ' 287' ' ' TRP . . . 68.95 -159.67 52.66 Favored Glycine 0 N--CA 1.44 -1.079 0 O-C-N 123.408 0.443 . . . . 74.5 113.821 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -102.26 -6.8 22.72 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 121.086 -0.246 . . . . 75.430000000000007 111.223 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . 0.427 ' CZ3' ' HA3' ' B' ' 285' ' ' GLY . 26.6 m-90 -57.88 -64.97 0.72 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.907 0.86 . . . . 74.430000000000007 110.169 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -118.65 79.74 1.43 Allowed 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 101.947 -3.353 . . . . 72.209999999999994 101.947 173.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . 0.471 ' O ' ' HE3' ' B' ' 284' ' ' LYS 0.279 18.0 p30 -49.47 -76.21 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 118.731 2.863 . . . . 75.519999999999996 118.731 -164.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -155.5 151.13 27.33 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 118.234 -1.386 . . . . 64.340000000000003 112.925 -171.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -67.67 158.89 31.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.97 -1.863 . . . . 75.540000000000006 105.97 170.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -68.14 86.27 0.26 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.405 1.098 . . . . 75.510000000000005 113.248 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -93.75 109.99 21.64 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 105.331 -2.1 . . . . 75.109999999999999 105.331 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -82.4 68.85 9.0 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.384 1.088 . . . . 72.439999999999998 111.821 -176.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 N--CA 1.422 -1.836 0 N-CA-C 104.349 -2.463 . . . . 75.439999999999998 104.349 -179.867 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 56.9 ttp . . . . . 0 CA--C 1.517 -0.323 0 N-CA-C 109.888 -0.412 . . . . 74.239999999999995 109.888 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt 77.9 -30.71 0.16 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.861 1.264 . . . . 65.430000000000007 113.553 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 39.3 mm -61.51 -39.74 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 106.201 -1.778 . . . . 72.349999999999994 106.201 169.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.05 -73.19 0.15 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 112.905 -1.952 . . . . 74.409999999999997 109.479 170.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 65.09 -71.92 0.07 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.962 1.705 . . . . 74.510000000000005 113.224 176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 7.7 tp -84.59 115.75 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-O 121.803 0.811 . . . . 75.420000000000002 110.889 -176.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 10.3 p -115.92 142.39 29.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.766 -1.198 . . . . 61.200000000000003 107.766 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 95.96 44.78 3.01 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 109.51 -1.436 . . . . 54.240000000000002 109.51 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -128.98 145.71 51.17 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.097 -0.641 . . . . 73.129999999999995 111.753 -175.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 26.5 t-20 -117.28 127.0 53.64 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.743 -1.206 . . . . 73.329999999999998 107.743 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 227' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' C' ' 263' ' ' SER . 19.5 m -126.37 137.22 53.43 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 108.785 -0.82 . . . . 74.5 108.785 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -136.29 132.39 35.66 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.887 -0.325 . . . . 64.150000000000006 110.639 -176.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . 0.599 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.0 OUTLIER -80.14 -76.34 0.23 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.274 -0.639 . . . . 75.510000000000005 109.274 178.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' B' ' 266' ' ' THR . 2.1 p-10 -129.09 140.51 51.54 Favored 'General case' 0 C--O 1.264 1.848 0 C-N-CA 118.062 -1.455 . . . . 70.230000000000004 112.216 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 28.0 mm -119.27 117.07 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 113.055 -1.884 . . . . 75.450000000000003 106.26 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . 0.452 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 17.9 ttm180 -111.75 123.67 50.73 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.907 -0.405 . . . . 74.319999999999993 109.907 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 72.0 p -116.96 128.37 55.13 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.003 -1.11 . . . . 74.340000000000003 108.003 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . 0.452 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 49.2 mt-10 -127.31 160.74 30.42 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 120.586 -0.446 . . . . 73.319999999999993 111.361 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 63.43 -82.02 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.908 0 C-N-CA 124.94 1.296 . . . . 71.540000000000006 114.343 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.435 ' O ' ' HD2' ' C' ' 238' ' ' ARG . 0.2 OUTLIER -139.44 25.95 2.39 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.595 -0.891 . . . . 74.299999999999997 108.595 -178.433 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -71.23 141.83 50.59 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.826 0.822 . . . . 74.439999999999998 112.106 -177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.544 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 9.1 mpt_? -124.55 133.43 53.3 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 106.454 -1.684 . . . . 75.120000000000005 106.454 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 21.2 m -142.94 150.18 18.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.707 0.765 . . . . 74.329999999999998 112.397 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . 0.41 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 5.2 tp60 -112.33 137.42 50.5 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.248 -1.342 . . . . 73.200000000000003 109.062 176.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' C' ' 277' ' ' ILE . 2.8 tm? -128.13 117.53 21.78 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.278 -2.119 . . . . 74.510000000000005 105.278 172.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.475 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 130.93 -133.07 7.11 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.191 -1.004 . . . . 62.240000000000002 112.721 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -128.99 138.56 52.02 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 122.233 -0.569 . . . . 73.109999999999999 110.716 -176.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' B' ' 280' ' ' GLU . 96.7 t -126.09 118.48 51.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.213 -0.662 . . . . 74.109999999999999 109.213 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.12 112.72 41.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.347 -0.983 . . . . 75.219999999999999 108.347 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 19.4 m -79.52 160.38 26.53 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.054 -1.461 . . . . 61.119999999999997 107.054 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.86 -33.07 72.52 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.1 0.952 . . . . 75.319999999999993 110.644 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.48 -33.33 63.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.236 -1.802 . . . . 75.340000000000003 113.848 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -62.62 -46.72 86.95 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.536 1.31 . . . . 74.349999999999994 114.536 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 54.44 -86.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.835 0.854 . . . . 73.049999999999997 112.158 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . 0.464 ' CD2' ' HA ' ' C' ' 254' ' ' ILE . 3.7 t60 67.96 -54.85 0.5 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.456 1.902 . . . . 64.239999999999995 112.696 176.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.56 65.64 1.15 Allowed Glycine 0 CA--C 1.501 -0.809 0 N-CA-C 109.873 -1.291 . . . . 75.439999999999998 109.873 -177.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 79.03 -140.27 22.92 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 107.24 -2.344 . . . . 61.25 107.24 -171.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . 0.464 ' HA ' ' CD2' ' C' ' 251' ' ' HIS . 41.6 pt -138.27 133.7 43.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 117.799 0.799 . . . . 63.329999999999998 109.606 172.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -81.11 -27.27 35.65 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.66 -1.607 . . . . 72.430000000000007 106.66 173.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 13.2 tt 176.9 145.4 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 105.105 -2.183 . . . . 71.319999999999993 105.105 174.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 6.7 m -74.82 -68.93 0.5 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.053 -1.462 . . . . 75.120000000000005 107.053 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 31.0 t70 168.17 161.74 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 103.57 -2.752 . . . . 71.299999999999997 103.57 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -88.18 39.72 0.91 Allowed 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 118.683 0.674 . . . . 75.299999999999997 110.103 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 18.4 m -70.57 121.9 18.71 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.194 -0.912 . . . . 74.430000000000007 111.031 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 10.3 t -129.03 107.87 9.94 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 105.236 -2.135 . . . . 64.120000000000005 105.236 168.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -126.72 139.0 53.47 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.497 -0.774 . . . . 70.209999999999994 110.922 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 263' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' C' ' 227' ' ' SER . 42.3 m -139.89 123.56 17.33 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 107.863 -1.162 . . . . 74.299999999999997 107.863 176.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.6 p -109.87 152.88 11.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.819 -0.352 . . . . 65.129999999999995 110.104 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . 0.599 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 10.1 tp10 -88.25 -69.72 0.68 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.154 -0.475 . . . . 65.209999999999994 109.989 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 90.5 m -140.46 130.73 25.08 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.897 -0.409 . . . . 75.049999999999997 109.897 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.21 133.6 67.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.804 -0.813 . . . . 74.510000000000005 108.804 171.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 29.7 m -121.5 129.05 75.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.166 0.508 . . . . 64.510000000000005 111.154 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.54 133.47 11.5 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.433 -1.067 . . . . 53.32 110.433 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -132.07 131.52 42.48 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.124 0.569 . . . . 74.420000000000002 109.852 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 68.56 -133.02 27.51 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.782 -0.645 . . . . 74.340000000000003 112.263 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -79.35 47.39 0.8 Allowed 'General case' 0 C--N 1.305 -1.37 0 C-N-CA 125.063 1.345 . . . . 71.420000000000002 113.127 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 50.7 m -83.4 145.44 29.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.555 0.693 . . . . 74.519999999999996 112.853 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . 0.544 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 10.2 mpt_? -130.6 127.04 38.2 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 106.537 -1.653 . . . . 62.310000000000002 106.537 170.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 10.0 t -137.83 140.73 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 108.771 -0.826 . . . . 72.5 108.771 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . 0.426 ' HB3' ' CZ2' ' C' ' 287' ' ' TRP . 6.8 tt -123.32 114.14 19.8 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.815 -1.18 . . . . 72.310000000000002 107.815 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 3.4 mp -104.57 104.19 16.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 105.532 -2.025 . . . . 75.140000000000001 105.532 176.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 159.26 -139.67 6.36 Favored Glycine 0 N--CA 1.41 -3.059 0 C-N-CA 119.4 -1.381 . . . . 73.230000000000004 112.402 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -127.79 142.97 51.15 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.165 -1.42 . . . . 73.239999999999995 107.165 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -141.93 132.62 25.56 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.218 -0.66 . . . . 60.310000000000002 109.218 -174.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.48 133.58 55.05 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.221 0.534 . . . . 74.129999999999995 111.023 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 122.86 -36.39 3.12 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 110.002 -1.239 . . . . 73.239999999999995 110.002 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 86.28 32.87 15.53 Favored Glycine 0 N--CA 1.419 -2.436 0 N-CA-C 111.422 -0.671 . . . . 64.340000000000003 111.422 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -131.92 -54.78 0.99 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.837 -0.801 . . . . 75.349999999999994 108.837 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . 0.41 ' HA3' ' CE3' ' C' ' 287' ' ' TRP . . . 69.21 -172.28 38.07 Favored Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 115.244 -0.889 . . . . 75.549999999999997 112.45 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -91.2 -5.73 54.47 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 110.429 -0.212 . . . . 73.5 110.429 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' C' ' 276' ' ' LEU . 27.6 m-90 -51.75 -50.13 61.25 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.55 0.69 . . . . 75.150000000000006 110.518 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -143.89 112.28 6.42 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.563 -1.198 . . . . 75.329999999999998 108.844 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -135.46 86.45 2.24 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 107.462 -1.31 . . . . 72.319999999999993 107.462 173.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -136.11 129.92 32.55 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.815 -1.539 . . . . 74.409999999999997 106.912 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -83.45 -34.83 25.35 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.816 -0.354 . . . . 75.319999999999993 110.801 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 33.7 m170 67.87 27.82 7.2 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.095 0.958 . . . . 74.530000000000001 110.453 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -94.57 98.85 11.12 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 114.625 -1.171 . . . . 63.310000000000002 108.145 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -75.8 125.73 29.64 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.171 -0.922 . . . . 74.329999999999998 109.788 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 . . . . . 0 C--O 1.24 0.58 0 O-C-N 124.396 1.06 . . . . 63.0 111.651 174.416 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 121.328 0.585 . . . . 63.32 109.96 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -133.6 131.1 39.25 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.605 -0.887 . . . . 75.409999999999997 108.605 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.503 ' HB ' ' CB ' ' B' ' 221' ' ' ALA . 2.5 mp -107.15 74.11 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 105.545 -2.02 . . . . 74.239999999999995 105.545 170.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -123.42 85.37 2.41 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 112.95 -1.932 . . . . 71.510000000000005 108.286 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -161.46 -178.45 6.63 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 105.413 -2.069 . . . . 73.310000000000002 105.413 -176.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.4 mp -83.15 114.81 24.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.346 -0.983 . . . . 65.019999999999996 108.346 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.0 122.41 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.934 0 N-CA-C 108.904 -0.776 . . . . 73.129999999999995 108.904 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 169.76 55.12 0.04 OUTLIER Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 110.048 -1.221 . . . . 51.200000000000003 110.048 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.467 ' HG2' ' OG1' ' A' ' 261' ' ' THR . 14.0 ptt180 -92.24 139.34 30.71 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.19 -0.671 . . . . 74.349999999999994 109.19 -177.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -116.19 114.72 24.83 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.063 -0.717 . . . . 63.5 109.063 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 26.9 m -134.83 137.91 43.74 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.453 0.538 . . . . 62.119999999999997 112.453 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.9 135.33 45.51 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.418 -1.327 . . . . 71.200000000000003 107.418 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -55.25 3.36 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.578 -0.849 . . . . 74.420000000000002 110.493 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -139.63 139.05 36.62 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 122.279 -0.263 . . . . 75.450000000000003 110.491 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.438 HG22 HG21 ' A' ' 239' ' ' VAL . 30.0 mt -137.82 125.8 31.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 108.822 -0.807 . . . . 63.109999999999999 108.822 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 35.2 ttt180 -126.05 122.34 35.55 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.151 -1.055 . . . . 72.329999999999998 108.151 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.532 ' OG1' ' HB3' ' A' ' 237' ' ' ALA . 14.3 t -135.27 130.78 35.69 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 120.014 -0.674 . . . . 65.200000000000003 109.396 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -135.2 140.75 45.56 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 112.177 0.436 . . . . 71.420000000000002 112.177 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 66.68 106.53 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.02 1.328 . . . . 65.329999999999998 113.361 174.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 47.6 mtt85 57.46 35.01 25.41 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.807 1.289 . . . . 75.319999999999993 107.564 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.532 ' HB3' ' OG1' ' A' ' 233' ' ' THR . . . -83.7 128.71 34.73 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 112.81 -1.996 . . . . 70.450000000000003 112.633 -170.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -129.86 135.06 47.94 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 106.878 -1.527 . . . . 72.409999999999997 106.878 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 6.7 p -143.68 140.1 25.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.646 -0.501 . . . . 74.519999999999996 109.646 175.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . 0.541 ' HB2' ' CD1' ' A' ' 286' ' ' PHE . 11.7 tm0? -125.82 136.99 53.74 Favored 'General case' 0 N--CA 1.405 -2.68 0 N-CA-C 106.431 -1.692 . . . . 75.109999999999999 106.431 177.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 tt -128.73 117.22 20.76 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 105.704 -1.962 . . . . 75.340000000000003 105.704 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.497 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 135.26 -119.23 2.06 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.367 -0.92 . . . . 74.329999999999998 113.338 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -144.43 139.53 28.42 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.032 -1.099 . . . . 73.549999999999997 108.032 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 22.5 t -125.79 121.44 59.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 109.465 -0.568 . . . . 70.019999999999996 109.465 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.76 112.64 34.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.996 -1.113 . . . . 72.430000000000007 107.996 170.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 281' ' ' TYR . 6.4 t -89.35 160.55 16.79 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.7 -1.2 . . . . 73.409999999999997 109.588 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.67 74.38 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 123.156 0.582 . . . . 74.519999999999996 110.15 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -35.5 66.82 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.167 -0.924 . . . . 53.43 112.138 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.71 -37.49 73.55 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.543 -0.299 . . . . 73.109999999999999 110.614 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 24.0 tp 65.65 33.31 8.51 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.447 1.099 . . . . 72.409999999999997 110.011 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 32.6 m80 69.19 119.41 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.363 1.465 . . . . 73.409999999999997 113.579 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.436 ' O ' HG13 ' B' ' 254' ' ' ILE . . . -79.83 70.95 2.8 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 109.563 -1.415 . . . . 74.409999999999997 109.563 175.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 135.36 -141.32 12.52 Favored Glycine 0 N--CA 1.425 -2.056 0 N-CA-C 108.962 -1.655 . . . . 61.509999999999998 108.962 -176.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 33.3 pt -91.11 -32.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.905 0.86 . . . . 73.209999999999994 109.231 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -146.46 -156.73 0.74 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 103.572 -2.751 . . . . 75.230000000000004 103.572 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 35.0 pt -75.62 148.85 7.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 106.306 -1.738 . . . . 75.140000000000001 106.306 170.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 10.8 p -93.7 -68.59 0.79 Allowed 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 119.688 -0.805 . . . . 72.439999999999998 109.72 -178.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . 0.383 4.2 m-20 59.67 170.61 0.08 Allowed 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 117.111 2.263 . . . . 71.049999999999997 117.111 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.438 ' NE2' ' HA3' ' B' ' 224' ' ' GLY . 0.4 OUTLIER 167.31 -21.51 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.105 -2.183 . . . . 71.120000000000005 105.105 -169.197 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -63.16 119.71 10.08 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 113.558 -1.656 . . . . 65.540000000000006 110.36 -174.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.467 ' OG1' ' HG2' ' A' ' 225' ' ' ARG . 10.8 t -112.65 115.33 28.41 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 105.138 -2.171 . . . . 70.319999999999993 105.138 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' ASN . . . . . 0.558 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 23.2 t-20 -122.1 127.07 49.71 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.564 -0.744 . . . . 65.420000000000002 111.786 -168.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.3 t -135.68 123.75 22.91 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 109.046 -0.724 . . . . 73.239999999999995 109.046 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.5 p -126.55 147.42 31.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 109.044 -0.725 . . . . 63.229999999999997 109.044 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -96.91 -75.86 0.53 Allowed 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 119.612 -0.835 . . . . 73.219999999999999 111.208 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 63.3 m -117.33 127.27 53.89 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.336 0.588 . . . . 74.329999999999998 110.831 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 1.4 p -134.0 123.99 45.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.876 -0.602 . . . . 70.409999999999997 110.903 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 21.6 m -124.4 138.27 54.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.536 -0.756 . . . . 74.420000000000002 111.517 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.2 131.38 7.68 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 109.508 -1.437 . . . . 70.5 109.508 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.31 116.18 14.95 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 122.66 0.384 . . . . 73.409999999999997 110.976 -174.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.47 74.12 1.06 Allowed Glycine 0 N--CA 1.465 0.614 0 C-N-CA 120.079 -1.058 . . . . 74.140000000000001 112.868 172.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 58.37 77.01 0.31 Allowed 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 125.753 1.621 . . . . 70.319999999999993 110.465 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.59 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 25.7 m -121.91 143.76 49.26 Favored 'General case' 0 N--CA 1.39 -3.426 0 CA-C-N 114.977 -1.01 . . . . 70.5 109.049 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -122.51 126.15 47.23 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.001 -1.481 . . . . 73.420000000000002 107.001 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 53.2 t -124.13 126.23 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.018 0 O-C-N 123.878 0.736 . . . . 73.420000000000002 109.389 -174.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' LEU . . . . . 0.439 HD22 ' HG2' ' B' ' 240' ' ' GLN . 17.7 tp -122.31 121.47 36.81 Favored 'General case' 0 C--N 1.267 -3.008 0 C-N-CA 118.758 -1.177 . . . . 70.430000000000007 110.749 174.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 74.6 mt -109.75 103.93 16.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.489 -0.93 . . . . 75.200000000000003 108.489 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . 0.518 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 139.64 -141.04 11.29 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.614 -0.803 . . . . 74.040000000000006 112.717 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 44.8 t-20 -123.69 140.08 53.35 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.363 -0.977 . . . . 60.409999999999997 108.363 -176.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.72 119.91 31.16 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.487 -0.931 . . . . 70.530000000000001 108.487 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' TYR . . . . . 0.463 ' O ' HG21 ' A' ' 246' ' ' THR . 22.1 m-85 -103.72 121.78 43.71 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.037 -1.838 . . . . 63.140000000000001 106.037 174.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 110.98 -51.7 0.68 Allowed Glycine 0 N--CA 1.423 -2.193 0 N-CA-C 110.077 -1.209 . . . . 75.040000000000006 110.077 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.528 ' C ' ' HD2' ' A' ' 284' ' ' LYS . . . 84.04 3.45 89.06 Favored Glycine 0 C--O 1.223 -0.567 0 CA-C-O 121.241 0.356 . . . . 62.509999999999998 112.269 177.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.528 ' HD2' ' C ' ' A' ' 283' ' ' GLY . 3.6 mptp? -135.52 18.12 3.35 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.148 0.499 . . . . 75.409999999999997 110.27 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -90.51 -39.72 5.87 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.615 -0.994 . . . . 55.340000000000003 110.615 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 240' ' ' GLN . 29.1 t80 -79.95 -37.49 34.35 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 112.134 0.42 . . . . 73.200000000000003 112.134 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -73.24 123.14 23.11 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 113.675 0.991 . . . . 74.450000000000003 113.675 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.54 136.01 36.2 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.722 -1.126 . . . . 64.540000000000006 109.199 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -82.76 72.37 9.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.686 1.365 . . . . 72.230000000000004 114.686 -171.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 173.37 111.34 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 126.074 1.749 . . . . 72.430000000000007 106.857 170.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' HIS . . . . . 0.493 ' HB2' ' NH2' ' B' ' 238' ' ' ARG . 0.4 OUTLIER -138.0 160.81 38.36 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.459 -0.791 . . . . 73.439999999999998 109.826 -175.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -125.2 104.44 8.51 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 121.552 0.692 . . . . 74.340000000000003 110.753 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -126.27 135.36 51.46 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.079 -1.452 . . . . 65.219999999999999 107.079 174.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' HIS . . . . . 0.49 ' CE1' ' HB3' ' C' ' 294' ' ' HIS . 57.1 t-80 -151.41 135.04 16.29 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.15 -1.426 . . . . 74.299999999999997 107.15 -165.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' HIS . . . . . 0.538 ' CE1' ' HD1' ' C' ' 290' ' ' HIS . 1.2 p-80 . . . . . 0 CA--C 1.551 1.0 0 N-CA-C 113.545 0.943 . . . . 75.519999999999996 113.545 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 119.416 -0.326 . . . . 62.439999999999998 110.123 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.23 106.7 0.77 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.799 0.809 . . . . 75.140000000000001 109.387 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 2.3 pp -101.94 174.61 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 113.857 1.058 . . . . 73.340000000000003 113.857 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -129.65 121.69 27.53 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 103.97 -2.604 . . . . 74.430000000000007 103.97 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . 0.503 ' CB ' ' HB ' ' A' ' 219' ' ' ILE . . . -154.25 157.71 39.15 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.633 -0.827 . . . . 73.519999999999996 112.3 -169.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 2.4 mp -83.95 115.81 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 105.111 -2.181 . . . . 75.019999999999996 105.111 167.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 8.7 p -100.67 122.87 53.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.057 0.456 . . . . 72.109999999999999 111.489 -174.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . 0.438 ' HA3' ' NE2' ' A' ' 259' ' ' GLN . . . 174.63 57.45 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.487 -0.778 . . . . 54.25 111.242 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -100.0 128.09 46.13 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.208 -0.597 . . . . 74.439999999999998 109.762 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 27.4 t-20 -116.55 114.65 24.45 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.08 -0.711 . . . . 74.540000000000006 109.08 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 11.1 p -139.48 137.62 35.7 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 112.644 0.609 . . . . 74.510000000000005 112.644 -177.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . 0.547 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -126.53 137.24 53.34 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.819 -1.082 . . . . 73.109999999999999 108.49 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.19 -66.67 0.89 Allowed 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.154 -0.619 . . . . 73.540000000000006 110.418 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -127.0 138.61 53.28 Favored 'General case' 0 C--O 1.264 1.822 0 CA-C-O 121.401 0.619 . . . . 71.109999999999999 109.561 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' ILE . . . . . 0.408 HG22 HG23 ' B' ' 239' ' ' VAL . 8.7 mt -131.48 117.39 35.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.495 -1.298 . . . . 75.209999999999994 107.495 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -116.46 115.65 26.2 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 110.01 -0.367 . . . . 75.049999999999997 110.01 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 22.3 p -114.31 127.54 55.91 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.167 -1.42 . . . . 71.439999999999998 107.167 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -143.31 138.66 29.68 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 109.434 -0.58 . . . . 71.230000000000004 109.434 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 62.59 91.32 0.07 Allowed 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 124.778 1.299 . . . . 72.209999999999994 112.569 171.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 65.59 34.85 7.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.22 -0.659 . . . . 71.439999999999998 109.22 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 237' ' ' ALA . . . . . 0.59 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -101.54 149.26 24.28 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 122.696 1.236 . . . . 75.120000000000005 113.744 -172.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 238' ' ' ARG . . . . . 0.493 ' NH2' ' HB2' ' A' ' 291' ' ' HIS . 3.7 mpt_? -134.35 136.37 43.37 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.12 -1.437 . . . . 71.430000000000007 107.12 175.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 12.1 p -137.17 137.83 46.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-O 121.696 0.76 . . . . 64.219999999999999 109.882 176.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.621 ' HB2' ' CD1' ' B' ' 286' ' ' PHE . 16.5 tm0? -118.29 132.49 56.29 Favored 'General case' 0 N--CA 1.39 -3.469 0 N-CA-C 105.068 -2.197 . . . . 71.129999999999995 105.068 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . 0.476 ' CD1' HD22 ' A' ' 262' ' ' ASN . 0.8 OUTLIER -130.32 116.3 18.13 Favored 'General case' 0 C--N 1.263 -3.195 0 N-CA-C 106.957 -1.497 . . . . 75.519999999999996 106.957 178.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 242' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 130.91 -114.15 1.53 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 115.882 -0.599 . . . . 73.099999999999994 112.165 -176.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 243' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 6.8 t30 -144.74 145.75 31.85 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.379 0.59 . . . . 74.099999999999994 110.635 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.437 ' CG2' ' HG3' ' B' ' 240' ' ' GLN . 69.0 t -132.69 126.71 54.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 N-CA-C 109.571 -0.529 . . . . 72.450000000000003 109.571 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 2.7 p -123.86 111.74 30.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.967 -1.123 . . . . 75.209999999999994 107.967 169.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 8.8 t -83.12 160.77 21.8 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.069 -1.052 . . . . 75.200000000000003 111.459 -176.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.12 82.81 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 122.386 1.089 . . . . 62.439999999999998 109.699 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.3 -35.55 73.97 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 113.243 -1.799 . . . . 75.150000000000006 111.6 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 249' ' ' ALA . . . . . 0.464 ' HA ' ' CB ' ' C' ' 247' ' ' ALA . . . -74.7 -26.84 60.1 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.387 -0.37 . . . . 61.340000000000003 110.863 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 52.8 tp -74.62 75.95 2.01 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 122.062 0.934 . . . . 73.109999999999999 111.976 -175.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 251' ' ' HIS . . . . . 0.418 ' CG ' HD22 ' C' ' 250' ' ' LEU . 21.0 t60 -100.21 -36.27 9.36 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.457 -2.053 . . . . 64.5 105.457 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -170.24 157.52 28.9 Favored Glycine 0 N--CA 1.418 -2.531 0 N-CA-C 107.339 -2.305 . . . . 45.409999999999997 107.339 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 104.74 -176.07 22.79 Favored Glycine 0 C--N 1.294 -1.759 0 C-N-CA 120.584 -0.817 . . . . 52.109999999999999 111.545 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 254' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 252' ' ' GLY . 9.2 tt -164.15 -41.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-O 121.145 0.498 . . . . 75.430000000000007 110.853 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -167.25 113.05 0.75 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.612 -1.996 . . . . 74.430000000000007 105.612 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.58 -54.96 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 119.51 -0.876 . . . . 71.230000000000004 112.562 -174.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 11.4 p -84.95 28.7 0.68 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 122.805 0.442 . . . . 71.129999999999995 111.028 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -131.0 102.78 6.18 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 114.065 1.135 . . . . 73.209999999999994 114.065 -176.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -137.87 23.35 2.85 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 102.97 -2.974 . . . . 74.400000000000006 102.97 170.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 2.4 m -76.79 120.58 22.14 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 113.415 -1.72 . . . . 70.549999999999997 112.2 -167.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 261' ' ' THR . . . . . 0.412 HG23 ' HA ' ' C' ' 225' ' ' ARG . 5.1 t -104.7 108.13 19.43 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 105.798 -1.927 . . . . 71.319999999999993 105.798 167.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 262' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 25.1 t-20 -116.09 131.18 57.01 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.328 -0.851 . . . . 63.210000000000001 110.902 -172.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -140.97 123.2 15.71 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.163 0.506 . . . . 64.030000000000001 110.529 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 264' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 11.7 p -124.95 152.11 31.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.662 -0.866 . . . . 72.439999999999998 108.662 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 265' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -103.2 -56.77 2.16 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 119.273 -0.971 . . . . 73.430000000000007 112.045 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 266' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' C' ' 230' ' ' ASP . 29.5 m -135.86 127.13 28.27 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.029 -1.068 . . . . 74.310000000000002 111.35 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 21.6 m -123.62 134.3 66.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.138 -0.689 . . . . 71.549999999999997 109.138 171.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 29.3 m -127.69 134.6 65.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.99 -0.55 . . . . 74.120000000000005 110.514 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.57 131.58 5.57 Favored Glycine 0 CA--C 1.476 -2.405 0 C-N-CA 119.254 -1.451 . . . . 52.0 112.621 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 270' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 62.9 tttp -135.57 144.9 46.45 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.278 0.634 . . . . 72.120000000000005 110.864 176.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 81.02 52.73 4.19 Favored Glycine 0 CA--C 1.486 -1.78 0 C-N-CA 120.877 -0.677 . . . . 62.030000000000001 112.238 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 65.11 89.18 0.1 Allowed 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.548 1.139 . . . . 75.230000000000004 109.835 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 273' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 21.0 m -121.75 144.12 48.98 Favored 'General case' 0 N--CA 1.405 -2.695 0 C-N-CA 119.652 -0.819 . . . . 73.310000000000002 110.162 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 29.0 mmt-85 -117.22 126.8 53.35 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 104.48 -2.415 . . . . 75.140000000000001 104.48 171.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 275' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 62.0 t -132.63 123.94 50.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 108.772 -0.825 . . . . 71.219999999999999 108.772 -178.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 8.7 tt -120.48 128.39 53.1 Favored 'General case' 0 C--N 1.268 -2.946 0 C-N-CA 117.595 -1.642 . . . . 74.409999999999997 110.693 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 277' ' ' ILE . . . . . 0.429 HG21 HD11 ' C' ' 241' ' ' LEU . 50.7 mt -112.58 102.63 14.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 106.467 -1.679 . . . . 75.319999999999993 106.467 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 278' ' ' GLY . . . . . 0.587 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 144.09 -136.02 6.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.69 -1.243 . . . . 73.349999999999994 114.245 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 279' ' ' ASN . . . . . 0.484 ' ND2' ' HB3' ' C' ' 243' ' ' ASN . 9.0 t-20 -127.3 141.42 51.72 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.88 -1.156 . . . . 75.109999999999999 107.88 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 280' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' C' ' 244' ' ' VAL . 0.2 OUTLIER -131.01 120.07 22.95 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.818 -0.808 . . . . 71.200000000000003 108.818 -177.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -103.31 122.38 44.68 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 106.713 -1.588 . . . . 74.319999999999993 106.713 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 110.71 -51.73 0.68 Allowed Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.828 -0.909 . . . . 63.219999999999999 110.828 -176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 283' ' ' GLY . . . . . 0.44 ' C ' ' HD2' ' B' ' 284' ' ' LYS . . . 88.41 -8.4 78.93 Favored Glycine 0 C--N 1.314 -0.656 0 N-CA-C 111.618 -0.593 . . . . 54.240000000000002 111.618 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . 0.44 ' HD2' ' C ' ' B' ' 283' ' ' GLY . 4.0 mptp? -124.97 17.53 8.53 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 120.913 0.387 . . . . 75.340000000000003 110.681 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -81.49 -60.03 2.28 Favored Glycine 0 N--CA 1.418 -2.507 0 N-CA-C 109.098 -1.601 . . . . 71.140000000000001 109.098 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 286' ' ' PHE . . . . . 0.621 ' CD1' ' HB2' ' B' ' 240' ' ' GLN . 28.1 t80 -67.4 -39.4 85.55 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 124.393 0.702 . . . . 65.129999999999995 112.228 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 9.9 m-90 -68.36 102.52 1.42 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 114.143 1.164 . . . . 75.409999999999997 114.143 -176.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -85.93 106.84 17.41 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.845 -1.525 . . . . 62.149999999999999 109.426 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -144.18 84.93 1.78 Allowed 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.525 -0.734 . . . . 75.209999999999994 110.281 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -144.65 72.04 1.32 Allowed 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.774 -1.195 . . . . 75.319999999999993 107.774 176.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -66.91 110.59 3.39 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.517 -0.765 . . . . 74.340000000000003 109.648 -176.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -75.3 -73.89 0.23 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.82 -0.627 . . . . 74.420000000000002 109.831 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -164.85 168.89 17.26 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.383 -1.71 . . . . 74.299999999999997 106.383 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -95.65 -81.78 0.4 Allowed 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.404 -1.332 . . . . 73.420000000000002 107.404 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 . . . . . 0 CA--C 1.502 -0.902 0 C-N-CA 124.541 1.136 . . . . 74.120000000000005 108.535 175.537 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 56.0 ttp . . . . . 0 C--O 1.241 0.64 0 CA-C-O 121.783 0.801 . . . . 74.329999999999998 110.111 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -147.5 -56.82 0.24 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.55 -1.278 . . . . 74.129999999999995 107.55 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 12.5 pt -99.02 77.43 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-O 122.297 1.046 . . . . 75.319999999999993 109.286 175.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -91.19 154.63 19.17 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.505 -1.225 . . . . 73.450000000000003 108.392 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -51.83 -67.07 0.28 Allowed 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.87 0.731 . . . . 65.310000000000002 111.374 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 3.0 mp -103.81 115.38 45.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 105.38 -2.082 . . . . 75.310000000000002 105.38 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 12.2 p -113.32 119.72 61.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 C-N-CA 119.733 -0.787 . . . . 75.450000000000003 110.494 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -174.77 55.9 0.13 Allowed Glycine 0 C--N 1.297 -1.587 0 N-CA-C 109.174 -1.571 . . . . 73.049999999999997 109.174 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 225' ' ' ARG . . . . . 0.412 ' HA ' HG23 ' B' ' 261' ' ' THR . 14.5 ptt-85 -98.1 132.56 43.53 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 120.737 -0.385 . . . . 72.409999999999997 110.106 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 226' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 26.6 t-20 -116.81 114.22 23.64 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.451 -1.314 . . . . 63.539999999999999 107.451 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 227' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' C' ' 263' ' ' SER . 12.9 t -135.16 137.64 42.93 Favored 'General case' 0 N--CA 1.411 -2.408 0 CA-C-O 121.226 0.536 . . . . 70.040000000000006 109.931 -175.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . 0.65 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -132.44 135.01 45.78 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.24 -1.392 . . . . 74.200000000000003 107.24 177.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -57.12 3.17 Favored 'General case' 0 C--N 1.287 -2.145 0 C-N-CA 119.793 -0.763 . . . . 75.140000000000001 109.828 -178.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 230' ' ' ASP . . . . . 0.538 ' O ' ' HA ' ' C' ' 266' ' ' THR . 30.8 t70 -139.36 138.96 37.05 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.992 0.425 . . . . 75.109999999999999 110.651 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 231' ' ' ILE . . . . . 0.444 HG21 ' CG2' ' C' ' 267' ' ' VAL . 6.0 mt -137.28 117.64 16.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.18 -1.044 . . . . 73.450000000000003 108.18 -176.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -111.81 117.17 32.09 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.084 0.469 . . . . 75.219999999999999 111.233 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 233' ' ' THR . . . . . 0.441 ' HB ' ' CB ' ' C' ' 237' ' ' ALA . 15.7 p -110.53 128.32 55.58 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.56 -0.745 . . . . 75.5 109.569 176.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 234' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 28.6 tt0 -143.21 137.01 28.68 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.244 -1.021 . . . . 73.209999999999994 108.244 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 57.81 106.18 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.14 1.533 . . . . 72.200000000000003 115.14 177.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 236' ' ' ARG . . . . . 0.422 ' HG3' ' HB2' ' A' ' 295' ' ' HIS . 5.5 mpt_? 59.34 33.07 22.31 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.242 -0.651 . . . . 65.329999999999998 109.242 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 237' ' ' ALA . . . . . 0.524 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -96.38 138.14 34.42 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 113.755 1.02 . . . . 74.329999999999998 113.755 -168.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 238' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 5.0 mpt_? -133.45 134.73 43.93 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.022 -1.103 . . . . 71.140000000000001 108.022 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 239' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 17.3 m -138.01 145.81 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 CA-C-O 122.065 0.936 . . . . 72.030000000000001 111.02 171.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 240' ' ' GLN . . . . . 0.51 ' HB2' ' CD1' ' C' ' 286' ' ' PHE . 0.3 OUTLIER -126.06 122.86 37.02 Favored 'General case' 0 C--N 1.26 -3.284 0 N-CA-C 104.425 -2.435 . . . . 73.230000000000004 104.425 176.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . 0.429 HD11 HG21 ' B' ' 277' ' ' ILE . 0.8 OUTLIER -121.77 115.4 22.6 Favored 'General case' 0 C--N 1.26 -3.319 0 N-CA-C 106.992 -1.485 . . . . 75.409999999999997 106.992 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 242' ' ' GLY . . . . . 0.587 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 131.14 -121.71 3.26 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 115.527 -0.76 . . . . 72.310000000000002 111.477 -174.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 243' ' ' ASN . . . . . 0.484 ' HB3' ' ND2' ' B' ' 279' ' ' ASN . 48.9 t-20 -145.1 141.34 28.73 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.035 0.917 . . . . 54.409999999999997 110.648 -177.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 244' ' ' VAL . . . . . 0.458 HG22 ' NE2' ' C' ' 240' ' ' GLN . 80.9 t -131.36 131.45 63.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 C-N-CA 123.334 0.654 . . . . 72.239999999999995 110.623 178.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 6.1 p -122.42 116.77 50.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.426 -1.694 . . . . 64.340000000000003 106.426 168.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 15.0 t -77.21 160.58 28.82 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.467 -1.293 . . . . 71.019999999999996 111.581 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 247' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.4 -39.17 93.33 Favored 'General case' 0 CA--C 1.492 -1.25 0 CA-C-N 115.715 -0.675 . . . . 75.109999999999999 109.525 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.67 -33.4 60.72 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.517 -1.674 . . . . 71.340000000000003 112.102 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -65.39 -26.72 68.12 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.382 -0.372 . . . . 75.109999999999999 111.268 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 250' ' ' LEU . . . . . 0.418 HD22 ' CG ' ' B' ' 251' ' ' HIS . 84.9 mt 47.98 75.72 0.13 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.647 1.179 . . . . 73.530000000000001 111.048 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 251' ' ' HIS . . . . . 0.409 ' NE2' ' HB2' ' C' ' 255' ' ' ARG . 24.0 t-80 -85.47 136.52 33.4 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 119.517 -0.873 . . . . 75.25 111.676 -172.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.14 119.44 1.91 Allowed Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.855 -1.298 . . . . 65.099999999999994 109.855 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.15 -158.92 21.24 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 109.931 -1.267 . . . . 61.350000000000001 109.931 -177.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 35.4 pt -124.48 110.03 24.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 117.675 0.737 . . . . 73.099999999999994 110.769 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 255' ' ' ARG . . . . . 0.409 ' HB2' ' NE2' ' C' ' 251' ' ' HIS . 57.5 mtm180 -131.34 92.51 3.2 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.792 -0.447 . . . . 74.099999999999994 109.792 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 3.0 mp -94.97 78.79 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 106.272 -1.751 . . . . 75.239999999999995 106.272 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 12.5 p -58.74 -61.53 2.55 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.273 -1.33 . . . . 70.420000000000002 111.723 -175.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -94.41 116.72 29.13 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.613 -0.884 . . . . 73.25 108.613 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -81.77 89.27 6.28 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.535 -1.283 . . . . 74.219999999999999 107.535 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 5.0 m -86.52 121.84 29.62 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 113.158 0.799 . . . . 75.409999999999997 113.158 -171.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 13.9 t -133.34 109.33 9.29 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 105.192 -2.151 . . . . 72.549999999999997 105.192 168.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -123.59 137.53 54.73 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.241 -0.89 . . . . 73.420000000000002 111.36 -166.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 263' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' C' ' 227' ' ' SER . 49.0 m -142.59 123.9 14.71 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.013 -0.736 . . . . 74.010000000000005 109.013 175.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.5 p -128.64 151.85 35.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.736 -0.468 . . . . 73.420000000000002 109.736 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.49 -80.21 0.19 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 109.421 -0.585 . . . . 71.239999999999995 109.421 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 266' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 8.1 t -139.22 129.29 25.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.751 -0.593 . . . . 75.420000000000002 109.995 -177.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . 0.444 ' CG2' HG21 ' C' ' 231' ' ' ILE . 27.0 m -120.78 135.3 61.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 116.254 -0.43 . . . . 74.329999999999998 110.033 177.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.25 140.98 45.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 116.357 -0.383 . . . . 74.109999999999999 110.604 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.43 131.53 6.11 Favored Glycine 0 CA--C 1.474 -2.483 0 N-CA-C 110.342 -1.103 . . . . 72.409999999999997 110.342 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -135.06 119.88 18.41 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.998 -1.112 . . . . 74.030000000000001 107.998 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.95 76.95 1.02 Allowed Glycine 0 N--CA 1.465 0.608 0 C-N-CA 120.829 -0.7 . . . . 70.439999999999998 113.178 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 272' ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' C' ' 236' ' ' ARG . 45.8 mt-10 63.03 82.38 0.18 Allowed 'General case' 0 CA--C 1.48 -1.718 0 C-N-CA 124.689 1.196 . . . . 73.439999999999998 110.478 -178.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 51.7 m -125.48 143.71 50.87 Favored 'General case' 0 N--CA 1.399 -3.021 0 C-N-CA 119.036 -1.066 . . . . 73.510000000000005 109.9 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 274' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 79.0 mtt85 -136.61 126.05 25.07 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 104.148 -2.538 . . . . 75.200000000000003 104.148 174.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 275' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 8.1 t -138.1 134.41 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 N-CA-C 108.012 -1.107 . . . . 74.349999999999994 108.012 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 8.9 tt -119.74 115.51 24.05 Favored 'General case' 0 N--CA 1.384 -3.767 0 C-N-CA 118.846 -1.141 . . . . 74.099999999999994 108.991 174.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.0 mp -93.59 102.43 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 104.52 -2.4 . . . . 75.439999999999998 104.52 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 278' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 139.21 -147.01 18.87 Favored Glycine 0 CA--C 1.49 -1.482 0 C-N-CA 119.317 -1.42 . . . . 72.319999999999993 113.888 -177.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -118.56 149.37 41.46 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.563 -1.273 . . . . 73.219999999999999 107.563 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 280' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' C' ' 244' ' ' VAL . 15.6 tm-20 -146.36 121.11 9.87 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.839 -1.911 . . . . 75.209999999999994 105.839 -176.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -104.12 125.05 50.13 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.58 -0.896 . . . . 75.239999999999995 108.58 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 119.46 -47.32 1.04 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 111.298 -0.721 . . . . 74.140000000000001 111.298 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 283' ' ' GLY . . . . . 0.496 ' C ' ' HD2' ' C' ' 284' ' ' LYS . . . 94.86 -9.71 70.58 Favored Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 111.022 -0.831 . . . . 62.43 111.022 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 284' ' ' LYS . . . . . 0.496 ' HD2' ' C ' ' C' ' 283' ' ' GLY . 13.4 mptt -126.92 6.35 6.61 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.766 -0.717 . . . . 73.140000000000001 112.69 -172.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -73.14 -57.96 4.94 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 119.802 -1.189 . . . . 50.310000000000002 112.182 -176.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 286' ' ' PHE . . . . . 0.51 ' CD1' ' HB2' ' C' ' 240' ' ' GLN . 23.0 t80 -75.67 -31.23 59.69 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.633 1.345 . . . . 74.439999999999998 114.633 -174.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -68.45 89.3 0.35 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 115.405 1.632 . . . . 65.209999999999994 115.405 -172.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -72.35 151.42 42.7 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 124.904 1.282 . . . . 70.140000000000001 111.488 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -105.45 -86.59 0.47 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.609 0.596 . . . . 73.140000000000001 112.609 -173.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 290' ' ' HIS . . . . . 0.538 ' HD1' ' CE1' ' A' ' 295' ' ' HIS . 24.3 t-80 67.2 132.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.833 1.653 . . . . 74.340000000000003 111.903 -174.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -135.23 87.11 2.3 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.295 -0.412 . . . . 73.540000000000006 110.352 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 292' ' ' HIS . . . . . 0.428 ' HB3' ' CE1' ' C' ' 290' ' ' HIS . 17.9 t60 -169.94 117.37 0.57 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.729 -1.212 . . . . 74.299999999999997 107.729 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -128.25 132.36 48.74 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.816 -0.354 . . . . 71.129999999999995 111.514 -174.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 294' ' ' HIS . . . . . 0.49 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 37.3 t-80 -172.23 -6.81 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 123.359 0.664 . . . . 72.120000000000005 111.311 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 67.4 m80 . . . . . 0 N--CA 1.494 1.741 0 C-N-CA 125.748 1.619 . . . . 71.25 112.707 -178.779 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 112.21 0.448 . . . . 73.439999999999998 112.21 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.536 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 9.2 t30 -104.39 120.56 41.49 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.055 -1.461 . . . . 75.439999999999998 107.055 167.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 42.5 m -121.59 146.18 47.23 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 120.838 0.352 . . . . 74.140000000000001 111.359 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 264' ' ' VAL . . . -138.66 144.58 39.72 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.548 -1.279 . . . . 72.420000000000002 107.548 175.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -97.71 -60.01 1.65 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.127 0.489 . . . . 72.420000000000002 110.176 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.95 139.45 50.05 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.892 -0.594 . . . . 74.120000000000005 110.812 -175.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 25.6 mt -136.15 131.82 49.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.002 -1.11 . . . . 53.340000000000003 108.002 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 31.2 ttm180 -129.09 116.52 19.4 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.666 -0.865 . . . . 65.219999999999999 108.666 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.449 HG21 ' HB ' ' A' ' 239' ' ' VAL . 12.4 p -119.57 127.42 52.96 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.171 -0.677 . . . . 43.409999999999997 109.171 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.41 ' HB2' ' HG3' ' A' ' 270' ' ' LYS . 43.9 mt-10 -135.86 144.24 45.51 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 116.592 -0.276 . . . . 72.129999999999995 111.063 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.551 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 41.6 mt-10 62.34 88.88 0.09 Allowed 'General case' 0 C--O 1.215 -0.715 0 O-C-N 124.908 1.38 . . . . 71.310000000000002 113.181 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.551 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.0 OUTLIER 59.45 21.72 10.17 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.868 0.867 . . . . 72.109999999999999 112.131 174.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.08 142.13 28.08 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.725 -0.472 . . . . 52.43 109.725 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -125.03 137.17 54.23 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.592 -0.521 . . . . 71.219999999999999 109.592 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 4.3 p -129.98 132.77 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 123.996 0.81 . . . . 73.25 111.285 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.511 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 57.9 tp60 -111.95 117.0 31.51 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 107.885 -1.154 . . . . 71.430000000000007 107.885 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.73 118.5 35.77 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.767 -0.827 . . . . 65.140000000000001 108.767 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.522 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 132.87 -114.23 1.38 Allowed Glycine 0 N--CA 1.439 -1.167 0 C-N-CA 120.679 -0.772 . . . . 73.120000000000005 113.203 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -145.4 139.19 26.76 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.452 -0.944 . . . . 73.340000000000003 108.452 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.445 HG11 ' HA3' ' A' ' 285' ' ' GLY . 27.0 t -123.57 114.56 42.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.965 -1.124 . . . . 64.329999999999998 107.965 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 80.4 t -111.13 119.79 60.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 109.367 -0.605 . . . . 70.349999999999994 109.367 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 28.5 m -88.44 158.01 18.49 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.211 -1.774 . . . . 64.439999999999998 106.211 172.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.42 87.58 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.392 0.515 . . . . 52.450000000000003 112.392 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.66 98.91 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.145 1.165 . . . . 72.530000000000001 114.145 -175.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 120.877 0.37 . . . . 53.109999999999999 110.883 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.425 -1.686 0 CA-C-O 121.566 0.698 . . . . 44.049999999999997 111.767 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 7.9 t30 -126.57 143.13 51.31 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.238 -1.023 . . . . 65.319999999999993 108.238 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.6 m -138.36 125.6 21.63 Favored 'General case' 0 C--N 1.29 -1.984 0 O-C-N 121.718 -0.614 . . . . 42.539999999999999 109.721 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.6 p -126.89 145.94 33.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.244 -0.65 . . . . 63.240000000000002 109.244 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 59.9 mt-10 -87.14 -79.11 0.28 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 119.755 -0.778 . . . . 73.420000000000002 110.364 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.2 t -116.65 132.02 56.8 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.641 0.734 . . . . 62.149999999999999 111.46 -174.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.88 124.77 47.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.151 -0.931 . . . . 62.520000000000003 110.405 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 4.0 p -127.25 129.06 70.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 116.056 -0.52 . . . . 74.030000000000001 111.421 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.09 131.06 8.04 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 109.469 -1.453 . . . . 61.329999999999998 109.469 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.41 ' HG3' ' HB2' ' A' ' 234' ' ' GLU . 45.4 tttm -134.19 120.67 20.34 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 120.142 -0.623 . . . . 52.240000000000002 111.583 -175.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.56 83.77 1.61 Allowed Glycine 0 C--N 1.306 -1.124 0 C-N-CA 120.33 -0.938 . . . . 53.420000000000002 112.974 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 55.19 28.26 10.84 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.68 1.592 . . . . 73.310000000000002 112.424 173.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 17.7 m -82.67 151.51 26.24 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.893 0.701 . . . . 72.129999999999995 112.893 -170.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -113.09 127.71 56.28 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.361 -0.836 . . . . 71.049999999999997 108.931 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.4 p -137.03 123.54 28.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.362 0.601 . . . . 73.0 110.572 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.1 tt -117.3 124.27 48.58 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.654 -1.239 . . . . 73.049999999999997 107.654 175.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.686 HG23 HD12 ' B' ' 241' ' ' LEU . 72.4 mt -113.17 103.7 15.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.14 -1.059 . . . . 70.109999999999999 108.14 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 141.65 -151.13 22.5 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 111.433 -0.667 . . . . 60.420000000000002 111.433 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -111.76 131.88 55.02 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 122.216 -0.579 . . . . 74.120000000000005 109.775 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 8.1 tp10 -113.97 118.57 34.53 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 124.401 1.08 . . . . 71.049999999999997 108.153 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -108.74 124.56 50.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.075 -1.083 . . . . 72.420000000000002 108.075 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.13 -52.71 0.64 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 111.323 -0.711 . . . . 60.420000000000002 111.323 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 88.13 18.37 55.87 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.335 -1.106 . . . . 61.020000000000003 110.335 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 284' ' ' LYS . 11.5 mmpt? -122.35 -2.35 9.03 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.598 -0.519 . . . . 72.140000000000001 109.598 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.445 ' HA3' HG11 ' A' ' 244' ' ' VAL . . . -78.56 -75.69 0.97 Allowed Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.269 -0.967 . . . . 32.310000000000002 113.507 -174.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.432 ' CB ' HD12 ' A' ' 276' ' ' LEU . 59.6 t80 -79.59 -35.02 40.29 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.797 -0.361 . . . . 63.140000000000001 111.634 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 30.0 p90 . . . . . 0 C--N 1.298 -1.65 0 N-CA-C 108.857 -0.794 . . . . 72.239999999999995 108.857 178.798 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 . . . . . 0 CA--C 1.511 -0.55 0 CA-C-O 121.267 0.556 . . . . 71.129999999999995 112.238 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 9.1 t30 -110.54 133.73 53.03 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.484 -2.043 . . . . 71.209999999999994 105.484 171.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 50.8 m -133.89 149.57 51.32 Favored 'General case' 0 C--N 1.281 -2.404 0 O-C-N 121.197 -0.939 . . . . 74.519999999999996 111.769 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.648 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -135.99 146.29 47.05 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.929 -1.137 . . . . 70.120000000000005 107.929 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 3.5 tmtm? -101.88 -57.93 1.98 Allowed 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.917 -0.771 . . . . 45.020000000000003 108.917 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -135.26 139.21 44.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.255 -0.43 . . . . 74.120000000000005 109.998 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.436 HD13 HD12 ' B' ' 277' ' ' ILE . 21.8 mt -135.9 127.62 44.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.254 -1.017 . . . . 73.549999999999997 108.254 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 38.1 ttm180 -125.95 115.61 20.2 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.636 -0.876 . . . . 73.010000000000005 108.636 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.418 HG21 ' CG1' ' B' ' 239' ' ' VAL . 81.7 p -110.75 126.49 54.64 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.173 -1.417 . . . . 64.430000000000007 107.173 176.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -133.29 138.86 46.6 Favored 'General case' 0 CA--C 1.493 -1.239 0 C-N-CA 120.34 -0.544 . . . . 73.340000000000003 109.753 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.588 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 43.1 mt-10 64.37 97.93 0.04 OUTLIER 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.758 1.392 . . . . 74.030000000000001 114.758 171.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.588 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.0 OUTLIER 57.71 29.25 17.04 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.57 0.748 . . . . 71.239999999999995 109.95 174.347 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.55 140.14 30.81 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-O 122.022 0.915 . . . . 75.349999999999994 110.984 -175.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.407 ' HD2' ' N ' ' B' ' 238' ' ' ARG . 0.5 OUTLIER -125.81 134.27 51.74 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 105.863 -1.903 . . . . 74.019999999999996 105.863 177.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.6 p -134.06 134.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.895 0.855 . . . . 42.0 111.097 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.548 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 35.4 tp60 -110.64 121.0 44.25 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 114.16 -1.382 . . . . 73.219999999999999 107.271 172.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.686 HD12 HG23 ' A' ' 277' ' ' ILE . 2.9 tm? -117.24 118.76 33.19 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 107.072 -1.455 . . . . 70.140000000000001 107.072 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.523 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 127.6 -109.51 1.06 Allowed Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.472 -0.871 . . . . 62.130000000000003 112.42 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 243' ' ' ASN . . . . . 0.586 ' OD1' HG23 ' B' ' 245' ' ' VAL . 24.1 t-20 -144.4 146.58 32.59 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 122.286 -0.538 . . . . 71.439999999999998 110.699 -176.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.548 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 25.0 t -133.06 120.42 40.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.175 -1.046 . . . . 74.209999999999994 108.175 172.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.586 HG23 ' OD1' ' B' ' 243' ' ' ASN . 88.6 t -115.57 119.37 61.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.65 -0.5 . . . . 70.209999999999994 109.65 176.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 24.8 m -79.02 157.44 28.08 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 106.003 -1.851 . . . . 74.019999999999996 106.003 174.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -65.11 -46.36 81.36 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.99 0.9 . . . . 61.509999999999998 112.201 -176.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.29 74.33 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 113.831 -1.531 . . . . 72.049999999999997 113.576 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.711 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -70.48 -46.43 63.77 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.543 0.942 . . . . 71.430000000000007 113.543 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 44.2 tp . . . . . 0 C--N 1.313 -1.017 0 C-N-CA 119.967 -0.693 . . . . 42.130000000000003 110.518 -175.556 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 24.6 p . . . . . 0 N--CA 1.428 -1.566 0 CA-C-O 120.953 0.406 . . . . 74.140000000000001 110.507 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 7.4 t -94.33 127.69 40.37 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-O 121.429 0.633 . . . . 34.539999999999999 110.857 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.513 ' HB3' ' OD1' ' B' ' 226' ' ' ASN . 54.5 t30 -126.66 143.56 51.19 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.127 -1.064 . . . . 74.510000000000005 108.127 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 263' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' C' ' 227' ' ' SER . 24.3 m -141.97 126.31 17.63 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 122.019 -0.426 . . . . 71.120000000000005 110.074 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.7 p -120.16 152.28 22.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 109.09 -0.708 . . . . 73.519999999999996 109.09 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.467 ' HA ' ' CB ' ' B' ' 229' ' ' LYS . 27.8 mt-10 -92.8 -86.42 0.25 Allowed 'General case' 0 N--CA 1.404 -2.768 0 C-N-CA 119.455 -0.898 . . . . 64.200000000000003 111.151 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 11.3 t -109.42 130.13 55.51 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.604 -0.839 . . . . 71.140000000000001 111.745 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.5 p -132.29 124.48 52.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.114 -0.948 . . . . 75.140000000000001 110.54 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 268' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 7.7 p -127.1 134.52 65.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 116.078 -0.51 . . . . 70.120000000000005 111.718 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.78 132.28 10.32 Favored Glycine 0 CA--C 1.479 -2.208 0 N-CA-C 110.062 -1.215 . . . . 41.439999999999998 110.062 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -133.59 116.66 16.15 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 120.778 0.323 . . . . 73.329999999999998 111.281 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.69 86.31 0.57 Allowed Glycine 0 C--O 1.25 1.123 0 C-N-CA 120.583 -0.818 . . . . 73.010000000000005 114.094 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 61.59 31.08 18.86 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.284 1.034 . . . . 73.019999999999996 111.961 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 24.5 m -83.25 145.64 29.01 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.575 0.702 . . . . 74.299999999999997 112.12 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.461 ' NH2' ' HA ' ' B' ' 287' ' ' TRP . 39.6 mtp180 -115.14 125.93 54.03 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.236 -2.135 . . . . 75.030000000000001 105.236 173.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 1.6 p -135.84 127.09 44.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-O 120.958 0.408 . . . . 64.409999999999997 110.498 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' B' ' 286' ' ' PHE . 5.5 tt -120.15 121.76 39.5 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.361 -1.348 . . . . 74.200000000000003 107.361 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.638 HG23 HD12 ' C' ' 241' ' ' LEU . 36.7 mt -113.06 103.72 15.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 N-CA-C 106.767 -1.568 . . . . 53.520000000000003 106.767 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 145.11 -147.54 18.76 Favored Glycine 0 N--CA 1.416 -2.637 0 C-N-CA 120.917 -0.658 . . . . 73.409999999999997 111.783 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -115.01 128.71 56.43 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 120.937 -0.305 . . . . 74.319999999999993 111.392 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.542 ' HG2' ' CZ2' ' B' ' 287' ' ' TRP . 9.7 tp10 -112.46 121.47 44.92 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.921 -1.14 . . . . 75.340000000000003 107.921 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.463 ' CD2' ' HB ' ' C' ' 245' ' ' VAL . 86.7 m-85 -111.53 124.03 51.45 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.378 -0.971 . . . . 73.230000000000004 108.378 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.29 -61.59 0.31 Allowed Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 111.014 -0.834 . . . . 74.319999999999993 111.014 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 283' ' ' GLY . . . . . 0.407 ' C ' ' HD2' ' B' ' 284' ' ' LYS . . . 94.53 26.02 14.44 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.314 -0.715 . . . . 74.450000000000003 111.314 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 284' ' ' LYS . . . . . 0.407 ' HD2' ' C ' ' B' ' 283' ' ' GLY . 3.2 mptp? -134.09 2.57 3.35 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 110.39 -0.226 . . . . 72.420000000000002 110.39 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 285' ' ' GLY . . . . . 0.495 ' HA3' HG11 ' B' ' 244' ' ' VAL . . . -78.53 -66.76 1.69 Allowed Glycine 0 N--CA 1.417 -2.633 0 C-N-CA 119.952 -1.118 . . . . 74.319999999999993 112.371 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.501 ' HB3' HD12 ' B' ' 276' ' ' LEU . 75.9 t80 -87.67 -37.84 16.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.914 0.709 . . . . 63.539999999999999 112.914 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.542 ' CZ2' ' HG2' ' B' ' 280' ' ' GLU . 20.8 p90 . . . . . 0 C--N 1.312 -1.064 0 N-CA-C 112.86 0.689 . . . . 70.120000000000005 112.86 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' C' ' 261' ' ' THR . 14.9 ptt180 . . . . . 0 N--CA 1.437 -1.109 0 CA-C-O 121.464 0.65 . . . . 73.530000000000001 111.102 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 7.4 t30 -108.85 141.55 40.73 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.017 -2.216 . . . . 55.030000000000001 105.017 169.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 227' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' B' ' 263' ' ' SER . 54.0 m -139.8 139.48 36.41 Favored 'General case' 0 C--N 1.278 -2.542 0 O-C-N 121.818 -0.551 . . . . 62.109999999999999 110.889 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -127.45 143.19 51.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.782 -1.192 . . . . 62.140000000000001 107.782 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' C' ' 265' ' ' GLU . 9.3 tmtt? -102.77 -53.1 2.93 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.588 -0.523 . . . . 63.329999999999998 109.588 -174.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.21 137.96 43.14 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.248 -0.649 . . . . 64.200000000000003 109.248 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 33.5 mt -136.67 130.31 46.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.01 -1.107 . . . . 75.420000000000002 108.01 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -133.6 119.1 19.0 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.43 -0.952 . . . . 73.099999999999994 108.43 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 45.0 p -110.49 126.41 54.33 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.19 -1.411 . . . . 73.140000000000001 107.19 174.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -127.91 139.22 52.73 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 110.05 -0.352 . . . . 63.240000000000002 110.05 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.571 ' C ' ' HD3' ' C' ' 236' ' ' ARG . 62.5 mt-10 63.13 93.43 0.05 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.664 1.227 . . . . 74.140000000000001 114.218 170.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.571 ' HD3' ' C ' ' C' ' 235' ' ' GLU . 0.7 OUTLIER 56.37 26.91 11.22 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 123.889 0.875 . . . . 73.549999999999997 111.387 172.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -87.5 148.46 24.91 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.751 -0.659 . . . . 62.520000000000003 110.576 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -124.66 134.22 52.96 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.17 -1.418 . . . . 72.140000000000001 107.17 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 4.7 p -135.96 135.14 50.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.622 0.725 . . . . 71.239999999999995 111.188 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.501 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 36.4 tp60 -114.37 115.17 26.91 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-N 114.28 -1.327 . . . . 70.530000000000001 108.152 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.638 HD12 HG23 ' B' ' 277' ' ' ILE . 3.0 tm? -111.85 117.79 33.76 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 105.596 -2.002 . . . . 73.319999999999993 105.596 176.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.546 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 138.65 -130.62 4.99 Favored Glycine 0 CA--C 1.485 -1.837 0 C-N-CA 119.577 -1.297 . . . . 53.539999999999999 111.724 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -141.06 131.26 24.88 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 120.956 0.408 . . . . 70.340000000000003 109.911 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.501 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 21.4 t -114.52 129.87 69.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.668 -0.864 . . . . 73.310000000000002 108.668 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.463 ' HB ' ' CD2' ' B' ' 281' ' ' TYR . 95.8 t -122.11 118.53 55.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 109.195 -0.668 . . . . 64.219999999999999 109.195 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 21.4 m -79.43 159.42 27.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.949 -1.871 . . . . 74.109999999999999 105.949 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.711 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -62.63 -47.63 82.92 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-O 122.08 0.943 . . . . 64.230000000000004 110.772 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.88 -34.76 65.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 113.718 -1.583 . . . . 53.140000000000001 112.806 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.023 0 N-CA-C 113.74 1.015 . . . . 72.510000000000005 113.74 -174.028 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 15.4 t . . . . . 0 CA--C 1.56 1.342 0 CA-C-O 121.889 0.852 . . . . 63.439999999999998 110.169 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 9.0 t30 -127.77 126.7 42.25 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.808 -0.558 . . . . 62.119999999999997 111.661 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 68.4 m -121.43 134.39 55.09 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 122.126 -0.359 . . . . 33.240000000000002 110.731 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -128.32 150.55 34.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.166 -1.05 . . . . 53.219999999999999 108.166 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' C' ' 229' ' ' LYS . 49.1 mt-10 -91.11 -88.49 0.18 Allowed 'General case' 0 N--CA 1.419 -1.978 0 C-N-CA 119.374 -0.931 . . . . 71.5 111.045 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 5.8 t -107.78 132.65 53.17 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.652 -0.819 . . . . 72.25 111.914 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.02 131.34 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.162 -0.926 . . . . 73.400000000000006 109.119 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.79 135.76 62.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 116.104 -0.498 . . . . 74.209999999999994 110.652 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.04 9.86 Favored Glycine 0 CA--C 1.474 -2.511 0 N-CA-C 109.086 -1.605 . . . . 73.510000000000005 109.086 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -134.03 116.27 15.3 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 110.227 -0.286 . . . . 72.239999999999995 110.227 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.57 83.48 0.73 Allowed Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.513 -0.851 . . . . 75.129999999999995 114.217 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 60.44 33.88 20.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.409 1.084 . . . . 75.030000000000001 112.319 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 10.7 m -83.72 145.18 28.88 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.925 0.713 . . . . 52.240000000000002 112.925 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -105.87 128.13 53.56 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.486 -1.301 . . . . 74.439999999999998 107.486 168.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 7.5 p -139.22 127.59 27.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 120.974 0.416 . . . . 73.340000000000003 111.226 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.516 HD12 ' CB ' ' C' ' 286' ' ' PHE . 7.2 tt -117.19 120.35 38.02 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.41 -0.959 . . . . 74.310000000000002 108.41 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 28.2 mt -113.26 103.6 15.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 106.991 -1.485 . . . . 72.120000000000005 106.991 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 278' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 144.85 -146.04 16.02 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.764 -0.935 . . . . 44.399999999999999 110.764 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -115.45 133.25 56.21 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 110.1 -0.333 . . . . 74.140000000000001 110.1 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.416 ' HG2' ' CZ2' ' C' ' 287' ' ' TRP . 10.5 tp10 -113.35 118.21 33.93 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.869 -1.159 . . . . 75.409999999999997 107.869 177.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -108.86 124.94 51.42 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.325 0.583 . . . . 73.120000000000005 109.861 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 106.08 -38.59 3.23 Favored Glycine 0 N--CA 1.417 -2.602 0 CA-C-N 115.089 -0.96 . . . . 63.100000000000001 110.957 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 72.76 35.06 58.92 Favored Glycine 0 CA--C 1.489 -1.569 0 N-CA-C 109.507 -1.437 . . . . 53.350000000000001 109.507 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -146.88 -7.3 0.49 Allowed 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 114.851 -0.675 . . . . 71.519999999999996 109.906 -173.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 285' ' ' GLY . . . . . 0.457 ' HA3' HG11 ' C' ' 244' ' ' VAL . . . -76.45 -70.15 1.31 Allowed Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 120.789 -0.719 . . . . 72.150000000000006 112.843 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.516 ' CB ' HD12 ' C' ' 276' ' ' LEU . 70.9 t80 -77.07 -51.16 11.53 Favored 'General case' 0 CA--C 1.49 -1.355 0 C-N-CA 120.411 -0.516 . . . . 75.319999999999993 110.097 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.416 ' CZ2' ' HG2' ' C' ' 280' ' ' GLU 0.317 28.5 p90 . . . . . 0 N--CA 1.412 -2.348 0 C-N-CA 118.504 -1.278 . . . . 75.549999999999997 112.2 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 261' ' ' THR . 37.4 ttm180 . . . . . 0 CA--C 1.507 -0.693 0 N-CA-C 110.235 -0.283 . . . . 73.430000000000007 110.235 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 34.1 t-20 -116.88 149.23 40.43 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.527 -0.916 . . . . 73.540000000000006 108.527 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.3 m -137.09 137.52 39.39 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.97 -0.752 . . . . 71.140000000000001 108.97 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 277' ' ' ILE . . . -137.17 132.06 33.42 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 110.109 -0.33 . . . . 53.240000000000002 110.109 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 5.2 tmmm? -90.87 -55.06 3.7 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.122 -0.49 . . . . 74.299999999999997 110.971 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -131.59 139.4 49.17 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.972 -0.381 . . . . 71.099999999999994 109.972 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 68.0 mt -137.29 121.03 22.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.546 -0.909 . . . . 74.239999999999995 108.546 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -131.27 129.21 41.25 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.325 0.583 . . . . 72.349999999999994 112.011 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.44 HG21 ' HB ' ' A' ' 239' ' ' VAL . 27.2 p -132.32 128.49 37.85 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.415 -0.811 . . . . 74.5 109.029 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -121.48 147.99 45.04 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 111.841 0.311 . . . . 72.530000000000001 111.841 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 67.07 -87.23 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.729 1.212 . . . . 73.310000000000002 113.859 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 25.0 mtm-85 -116.31 3.02 13.33 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.191 0.596 . . . . 72.129999999999995 110.487 -175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -69.64 136.71 51.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.308 -0.86 . . . . 75.450000000000003 111.33 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -125.45 135.38 52.28 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.36 -0.978 . . . . 74.200000000000003 108.36 -177.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.9 p -129.68 146.03 34.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.573 0.701 . . . . 62.329999999999998 110.809 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.53 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 51.1 tp60 -123.72 130.01 51.98 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 107.929 -1.137 . . . . 75.329999999999998 107.929 174.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -123.32 118.68 28.08 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.469 -0.937 . . . . 74.040000000000006 108.469 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.528 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 130.27 -114.12 1.58 Allowed Glycine 0 N--CA 1.433 -1.566 0 CA-C-N 115.825 -0.625 . . . . 75.219999999999999 111.618 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -145.19 138.75 26.75 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 122.437 -0.449 . . . . 60.149999999999999 111.375 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 85.5 t -122.45 114.08 41.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.806 -1.553 . . . . 73.25 106.806 174.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.457 ' HA ' ' HB2' ' A' ' 281' ' ' TYR . 7.3 p -122.78 114.35 41.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 C-N-CA 120.334 -0.546 . . . . 72.239999999999995 110.607 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 22.8 m -79.92 158.9 26.54 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.826 -1.176 . . . . 74.230000000000004 107.826 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.97 -41.49 95.41 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.054 0.455 . . . . 34.229999999999997 111.368 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -35.9 67.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.408 -1.269 . . . . 70.099999999999994 113.895 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.324 -0.51 0 C-N-CA 122.766 0.426 . . . . 54.130000000000003 112.126 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.555 ' HB ' ' HD2' ' B' ' 225' ' ' ARG . 29.3 m . . . . . 0 N--CA 1.419 -1.985 0 N-CA-C 108.177 -1.046 . . . . 72.430000000000007 108.177 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.546 ' O ' ' HA ' ' A' ' 226' ' ' ASN . 38.9 t-20 -126.15 136.77 53.27 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.14 -1.43 . . . . 54.240000000000002 107.14 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.6 m -138.15 134.53 34.69 Favored 'General case' 0 C--N 1.285 -2.21 0 O-C-N 122.077 -0.389 . . . . 75.129999999999995 110.289 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 13.1 p -128.43 141.88 45.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.211 0.529 . . . . 75.010000000000005 111.118 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.608 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 6.4 mm-40 -78.58 -72.18 0.39 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.652 -0.703 . . . . 54.149999999999999 110.961 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -128.8 127.84 42.76 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.854 -0.738 . . . . 62.310000000000002 112.713 -175.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.425 HG12 HD12 ' B' ' 231' ' ' ILE . 35.5 m -119.97 126.9 75.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.975 -0.557 . . . . 54.420000000000002 110.07 175.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.55 136.88 59.53 Favored 'Isoleucine or valine' 0 C--O 1.257 1.473 0 CA-C-O 121.358 0.599 . . . . 73.310000000000002 112.115 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.09 131.34 8.38 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.725 -1.35 . . . . 72.120000000000005 109.725 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -124.24 117.57 24.88 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.412 0.625 . . . . 75.129999999999995 111.536 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.24 -118.87 5.41 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.106 -1.198 . . . . 74.329999999999998 110.106 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -102.63 90.66 3.9 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.449 -1.315 . . . . 62.109999999999999 107.449 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 31.5 m -130.7 145.35 51.91 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.607 -1.179 . . . . 71.120000000000005 108.643 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ARG . . . . . 0.529 ' HB2' ' HG3' ' B' ' 238' ' ' ARG . 94.0 mtt180 -130.45 127.51 39.39 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.445 -1.302 . . . . 74.120000000000005 108.225 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.5 p -132.76 130.38 59.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.961 0.886 . . . . 64.349999999999994 111.327 -173.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.6 tt -117.51 126.13 52.06 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.972 -1.122 . . . . 72.450000000000003 107.972 176.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.454 HG21 ' HB2' ' A' ' 228' ' ' ALA . 34.6 mm -112.68 103.51 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 107.075 -1.454 . . . . 61.420000000000002 107.075 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.625 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 150.44 -141.17 8.5 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.881 -1.152 . . . . 72.140000000000001 112.85 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -113.02 134.14 54.65 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.798 -1.186 . . . . 74.450000000000003 107.798 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.4 OUTLIER -129.74 120.36 24.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.966 0.889 . . . . 71.430000000000007 109.104 176.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.457 ' HB2' ' HA ' ' A' ' 245' ' ' VAL . 2.8 m-85 -113.97 124.65 52.67 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.858 -1.064 . . . . 73.010000000000005 108.951 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 129.72 -42.6 1.4 Allowed Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.841 -0.695 . . . . 74.0 112.407 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' B' ' 286' ' ' PHE . . . 100.61 -15.95 58.12 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.81 -0.916 . . . . 54.509999999999998 110.81 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.07 83.96 2.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.002 -0.74 . . . . 70.129999999999995 109.002 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -84.88 -121.75 1.02 Allowed Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.653 -0.703 . . . . 73.430000000000007 112.312 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -87.98 15.89 6.69 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.104 0.478 . . . . 75.010000000000005 110.223 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.428 ' CH2' ' HB2' ' A' ' 276' ' ' LEU . 78.0 m95 . . . . . 0 C--N 1.316 -0.866 0 N-CA-C 114.686 1.365 . . . . 74.420000000000002 114.686 -170.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.555 ' HD2' ' HB ' ' A' ' 261' ' ' THR . 8.1 tpt180 . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 107.524 -1.287 . . . . 74.409999999999997 107.524 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.594 HD21 HG22 ' B' ' 277' ' ' ILE . 7.3 t30 -120.95 144.56 48.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 120.747 0.308 . . . . 55.130000000000003 111.79 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 227' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' B' ' 263' ' ' SER . 50.5 m -136.33 136.96 40.14 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.179 -0.674 . . . . 70.420000000000002 109.179 173.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.03 142.94 49.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.537 -0.542 . . . . 61.009999999999998 109.537 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.608 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 2.3 tmmm? -100.69 -64.1 1.07 Allowed 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 120.393 -0.523 . . . . 73.299999999999997 110.267 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -127.85 138.33 52.66 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 108.959 -0.756 . . . . 73.430000000000007 108.959 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.425 HD12 HG12 ' A' ' 267' ' ' VAL . 16.9 mt -135.57 119.91 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.095 -0.705 . . . . 73.010000000000005 109.095 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -123.23 115.71 22.18 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.873 0.368 . . . . 73.299999999999997 110.651 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 52.6 p -111.69 127.66 55.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.625 -1.25 . . . . 73.099999999999994 107.625 175.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -130.18 149.68 51.77 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.457 -0.497 . . . . 73.450000000000003 111.028 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . 0.251 33.5 mt-10 75.87 -74.16 0.08 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 115.733 1.753 . . . . 64.129999999999995 115.733 170.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.26 24.72 2.3 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.334 -0.987 . . . . 75.209999999999994 108.334 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -84.91 142.93 29.34 Favored 'General case' 0 C--O 1.275 2.444 0 CA-C-O 122.954 1.359 . . . . 75.340000000000003 113.895 -172.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.529 ' HG3' ' HB2' ' A' ' 274' ' ' ARG . 3.7 mpt_? -125.93 135.21 51.61 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.487 -1.233 . . . . 62.039999999999999 110.845 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.515 HG13 HG23 ' A' ' 275' ' ' VAL . 14.1 p -134.29 143.4 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.201 1.001 . . . . 74.099999999999994 110.51 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.56 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 4.8 tp-100 -121.12 125.17 46.56 Favored 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 114.108 -1.405 . . . . 64.200000000000003 107.857 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.407 HD12 HG23 ' A' ' 277' ' ' ILE . 3.2 tm? -119.16 117.04 27.6 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.176 -1.787 . . . . 61.200000000000003 106.176 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 139.05 -121.33 2.08 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 110.487 -1.045 . . . . 61.200000000000003 110.487 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -145.34 139.1 26.79 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.932 0.366 . . . . 71.120000000000005 110.853 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.56 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 44.8 t -122.41 122.61 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 107.989 -1.115 . . . . 73.409999999999997 107.989 175.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.516 HG21 ' O ' ' B' ' 250' ' ' LEU . 7.0 p -123.67 125.67 71.68 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 C-N-CA 120.052 -0.659 . . . . 75.109999999999999 110.89 175.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 2.1 m -81.88 160.82 23.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.393 -1.336 . . . . 63.049999999999997 107.393 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -61.97 -35.94 79.97 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 120.986 0.422 . . . . 74.519999999999996 111.636 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.33 -52.28 64.0 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.698 -1.137 . . . . 72.030000000000001 112.566 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.16 -46.42 34.38 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.707 -0.397 . . . . 20.41 110.414 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.516 ' O ' HG21 ' B' ' 245' ' ' VAL . 52.1 tp . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 124.916 1.286 . . . . 70.049999999999997 113.138 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 86.1 m . . . . . 0 N--CA 1.431 -1.397 0 N-CA-C 108.92 -0.771 . . . . 73.219999999999999 108.92 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 29.1 m -126.58 112.88 16.03 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.92 -0.77 . . . . 70.510000000000005 108.92 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -121.05 138.18 54.3 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.936 -1.135 . . . . 60.450000000000003 107.936 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 263' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' C' ' 227' ' ' SER . 43.6 m -138.6 138.88 38.31 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 120.739 0.304 . . . . 54.039999999999999 110.219 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' C' ' 228' ' ' ALA . 12.5 p -128.51 150.33 34.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 120.87 0.367 . . . . 52.310000000000002 110.527 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 44.0 mm-40 -86.01 -76.21 0.35 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.834 -0.621 . . . . 71.109999999999999 110.691 174.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 27.8 m -128.81 127.87 42.8 Favored 'General case' 0 C--O 1.249 1.034 0 C-N-CA 119.931 -0.707 . . . . 63.229999999999997 112.454 -176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.412 HG12 ' HB ' ' C' ' 231' ' ' ILE . 35.1 m -118.46 129.31 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.696 -0.684 . . . . 62.509999999999998 109.265 175.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 8.8 p -127.58 128.87 70.11 Favored 'Isoleucine or valine' 0 C--O 1.266 1.922 0 CA-C-O 121.716 0.769 . . . . 70.340000000000003 112.237 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.91 132.82 10.93 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 110.46 -1.056 . . . . 61.109999999999999 110.46 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -124.09 121.29 34.77 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 122.472 0.309 . . . . 72.439999999999998 111.127 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.24 -130.0 9.42 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.65 -1.38 . . . . 44.109999999999999 109.65 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.93 98.4 11.35 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.653 -1.98 . . . . 52.240000000000002 105.653 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.4 t -130.03 143.03 50.57 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.989 -1.005 . . . . 72.349999999999994 108.764 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.549 ' HB2' ' HG3' ' C' ' 238' ' ' ARG . 76.3 mtt180 -131.3 127.05 36.91 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 118.565 -1.254 . . . . 73.329999999999998 108.376 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.0 p -135.9 132.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 115.094 -0.957 . . . . 73.219999999999999 110.918 -175.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.521 ' HB3' ' OE1' ' C' ' 240' ' ' GLN . 5.9 tt -119.96 125.41 48.34 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 107.546 -1.279 . . . . 63.310000000000002 107.546 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.594 HG22 HD21 ' B' ' 226' ' ' ASN . 30.0 mm -112.54 103.56 15.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 N-CA-C 106.772 -1.566 . . . . 74.140000000000001 106.772 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.567 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 147.21 -143.77 11.73 Favored Glycine 0 N--CA 1.427 -1.951 0 C-N-CA 120.422 -0.894 . . . . 51.549999999999997 113.829 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -108.76 132.25 54.15 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.721 -0.844 . . . . 53.0 108.721 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' C' ' 244' ' ' VAL . 0.0 OUTLIER -127.8 122.49 32.85 Favored 'General case' 0 C--O 1.265 1.88 0 CA-C-O 122.324 1.059 . . . . 73.299999999999997 108.593 177.39 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -120.52 124.11 44.57 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.407 -1.27 . . . . 71.299999999999997 107.7 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 128.94 -40.05 1.76 Allowed Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.333 -0.937 . . . . 31.399999999999999 111.524 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 283' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' C' ' 286' ' ' PHE . . . 97.01 -16.54 60.77 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 110.576 -1.01 . . . . 61.329999999999998 110.576 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.29 77.56 1.68 Allowed 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.208 -0.496 . . . . 73.099999999999994 110.577 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -76.3 -128.86 0.3 Allowed Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 115.013 -0.994 . . . . 43.119999999999997 112.007 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 5.0 p90 -81.99 13.55 3.29 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.484 0.659 . . . . 71.209999999999994 111.391 -175.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.465 ' CH2' ' HB2' ' B' ' 276' ' ' LEU . 39.9 m95 . . . . . 0 C--N 1.315 -0.92 0 CA-C-N 116.037 -0.528 . . . . 71.430000000000007 109.647 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' C' ' 261' ' ' THR . 28.4 ttt180 . . . . . 0 N--CA 1.42 -1.931 0 N-CA-C 109.023 -0.732 . . . . 74.099999999999994 109.023 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.568 HD21 HG22 ' C' ' 277' ' ' ILE . 7.2 t30 -118.78 148.97 42.26 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 116.182 -0.463 . . . . 65.129999999999995 110.475 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 227' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' C' ' 263' ' ' SER . 31.9 m -136.68 136.53 39.15 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.195 -1.039 . . . . 63.200000000000003 108.195 172.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.472 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -130.7 138.23 49.91 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.469 -0.567 . . . . 75.430000000000007 109.469 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 2.9 tmmm? -93.38 -64.22 1.12 Allowed 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.556 -0.458 . . . . 74.120000000000005 110.943 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 230' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' C' ' 266' ' ' THR . 28.4 t70 -127.37 137.79 52.85 Favored 'General case' 0 C--O 1.253 1.243 0 C-N-CA 120.1 -0.64 . . . . 63.539999999999999 109.682 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.412 ' HB ' HG12 ' B' ' 267' ' ' VAL . 31.3 mt -133.95 118.94 30.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.889 -0.782 . . . . 62.539999999999999 108.889 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -118.99 122.38 42.07 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.792 -0.448 . . . . 73.200000000000003 109.792 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 31.7 p -122.24 127.9 50.49 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.865 -0.791 . . . . 75.530000000000001 108.865 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -129.35 150.28 50.78 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 120.985 0.421 . . . . 53.5 111.596 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 74.42 -73.05 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.951 1.834 . . . . 71.510000000000005 115.951 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -139.53 29.81 2.15 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 107.498 -1.297 . . . . 70.439999999999998 107.498 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -91.3 137.6 32.24 Favored 'General case' 0 C--O 1.277 2.524 0 CA-C-O 122.571 1.177 . . . . 51.210000000000001 113.102 -173.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' B' ' 274' ' ' ARG . 2.9 mpt_? -125.7 134.71 51.72 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.891 -1.504 . . . . 72.140000000000001 109.426 176.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.523 HG23 HG13 ' C' ' 275' ' ' VAL . 8.5 p -133.42 139.4 49.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.832 0.825 . . . . 75.430000000000007 110.887 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.611 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 49.0 tp60 -114.85 118.89 34.79 Favored 'General case' 0 N--CA 1.401 -2.91 0 CA-C-N 114.228 -1.351 . . . . 64.140000000000001 108.425 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.437 HD12 HG23 ' B' ' 277' ' ' ILE . 3.2 tm? -111.74 118.77 36.52 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 105.416 -2.068 . . . . 72.209999999999994 105.416 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 135.97 -120.0 2.15 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.898 -1.281 . . . . 72.400000000000006 109.898 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 7.8 p30 -144.75 144.25 31.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 116.542 0.171 . . . . 55.100000000000001 111.156 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.611 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 48.9 t -124.08 114.64 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.595 0 N-CA-C 107.075 -1.454 . . . . 70.510000000000005 107.075 172.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' C' ' 281' ' ' TYR . 7.1 p -123.87 129.17 74.47 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 C-N-CA 119.298 -0.961 . . . . 70.239999999999995 111.098 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.5 m -88.91 159.2 17.79 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.219 -1.4 . . . . 73.400000000000006 107.219 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.79 94.37 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.726 0.774 . . . . 61.509999999999998 110.702 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.98 -34.27 63.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.111 -1.404 . . . . 64.209999999999994 112.464 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 249' ' ' ALA . . . . . 0.419 ' HB2' ' HA2' ' C' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.313 -1.017 0 N-CA-C 113.297 0.851 . . . . 73.420000000000002 113.297 -175.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 21.8 m . . . . . 0 N--CA 1.425 -1.702 0 N-CA-C 109.275 -0.639 . . . . 73.140000000000001 109.275 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -111.04 141.12 44.95 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.207 -1.034 . . . . 53.520000000000003 108.207 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 263' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' C' ' 227' ' ' SER . 21.7 m -140.01 140.25 36.19 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 122.035 -0.416 . . . . 53.229999999999997 110.163 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.459 HG21 HG13 ' C' ' 267' ' ' VAL . 7.2 p -129.18 142.87 42.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 121.195 -0.202 . . . . 71.0 111.086 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 9.7 mm-40 -80.91 -52.73 7.14 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 111.798 0.295 . . . . 73.230000000000004 111.798 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 266' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 37.5 m -150.18 133.05 16.03 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.162 -0.615 . . . . 71.530000000000001 111.063 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.459 HG13 HG21 ' C' ' 264' ' ' VAL . 17.1 m -126.05 135.08 64.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 109.178 -0.675 . . . . 62.32 109.178 171.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.08 129.15 71.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 109.746 -0.464 . . . . 72.129999999999995 109.746 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.65 132.8 11.25 Favored Glycine 0 N--CA 1.428 -1.884 0 N-CA-C 108.37 -1.892 . . . . 74.120000000000005 108.37 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -128.24 117.05 20.82 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 120.925 0.393 . . . . 71.319999999999993 110.094 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.85 -136.23 17.2 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 109.811 -1.316 . . . . 50.119999999999997 109.811 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.3 96.52 6.66 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.342 -1.355 . . . . 74.040000000000006 107.342 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 273' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 51.0 m -134.99 145.04 47.72 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 115.254 -0.884 . . . . 62.119999999999997 109.502 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -135.21 126.59 28.46 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 107.05 -1.463 . . . . 73.109999999999999 107.05 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.523 HG13 HG23 ' C' ' 239' ' ' VAL . 6.2 p -139.33 139.65 38.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.874 -0.603 . . . . 75.209999999999994 110.301 -176.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 7.0 tt -123.2 122.35 38.19 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 107.71 -1.218 . . . . 65.439999999999998 107.71 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.568 HG22 HD21 ' C' ' 226' ' ' ASN . 42.8 mm -110.65 103.79 16.04 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.843 0 N-CA-C 106.791 -1.559 . . . . 62.140000000000001 106.791 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.06 -133.67 5.05 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 119.918 -1.134 . . . . 71.409999999999997 113.548 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 279' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 17.9 m120 -115.07 134.07 55.49 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 120.816 0.341 . . . . 72.140000000000001 110.201 -177.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.64 119.58 19.58 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.61 -1.256 . . . . 75.540000000000006 107.61 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.445 ' HB2' HG23 ' C' ' 245' ' ' VAL . 3.4 m-85 -119.17 124.91 47.95 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.488 -0.931 . . . . 74.109999999999999 108.488 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 282' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' C' ' 249' ' ' ALA . . . 136.2 -36.91 1.95 Allowed Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.195 -0.762 . . . . 43.140000000000001 111.195 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 100.03 -27.29 20.98 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.264 -1.134 . . . . 72.140000000000001 110.264 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -132.84 87.34 2.4 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.845 -1.169 . . . . 74.219999999999999 107.845 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -84.44 -130.31 2.0 Allowed Glycine 0 C--N 1.308 -0.991 0 C-N-CA 120.944 -0.646 . . . . 71.239999999999995 112.291 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' B' ' 283' ' ' GLY . 1.4 p90 -73.67 18.32 0.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.336 0.589 . . . . 64.340000000000003 112.007 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 53.3 m95 . . . . . 0 C--O 1.244 0.768 0 O-C-N 121.407 -0.808 . . . . 73.430000000000007 110.304 -175.63 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 . . . . . 0 CA--C 1.508 -0.66 0 CA-C-O 120.591 0.234 . . . . 70.25 110.637 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -104.3 141.0 37.07 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.132 -1.433 . . . . 71.140000000000001 107.132 172.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.6 m -121.52 137.1 54.87 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.982 -0.377 . . . . 74.329999999999998 109.982 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.74 119.65 32.35 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.075 -1.454 . . . . 43.009999999999998 107.075 176.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -88.69 -41.31 12.67 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 116.206 -0.452 . . . . 63.009999999999998 110.807 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -140.71 138.99 34.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.915 0.388 . . . . 65.140000000000001 110.352 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.6 mt -131.41 121.85 49.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 107.673 -1.232 . . . . 64.230000000000004 107.673 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 60.4 ttt180 -132.58 115.1 15.03 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.493 0.663 . . . . 73.349999999999994 109.369 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 22.6 p -125.88 128.77 48.11 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.988 -1.116 . . . . 73.329999999999998 107.988 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -125.47 162.14 25.54 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.679 -0.808 . . . . 71.420000000000002 111.469 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 65.27 -84.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.122 1.369 . . . . 61.409999999999997 113.979 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -140.2 26.14 2.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.126 -0.943 . . . . 73.150000000000006 109.011 -168.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -79.67 151.62 30.41 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.832 -1.076 . . . . 75.209999999999994 109.763 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -124.11 135.43 53.52 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.241 -1.763 . . . . 73.230000000000004 106.241 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.5 p -135.87 139.59 45.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.038 0.447 . . . . 53.409999999999997 110.175 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.455 ' HB3' HD13 ' A' ' 276' ' ' LEU . 62.3 tp60 -129.89 130.85 45.69 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.438 -0.949 . . . . 60.240000000000002 108.438 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.41 ' HA ' HG13 ' A' ' 277' ' ' ILE . 2.7 tm? -120.81 120.57 35.96 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.751 -1.203 . . . . 65.040000000000006 107.751 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.539 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 137.17 -140.09 11.09 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 120.22 -0.991 . . . . 61.210000000000001 112.127 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -123.85 128.32 49.32 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.906 -0.775 . . . . 73.310000000000002 108.906 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.4 118.71 57.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 107.897 -1.149 . . . . 53.030000000000001 107.897 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.39 112.75 41.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.835 -0.802 . . . . 72.120000000000005 108.835 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.409 ' OG1' ' HA3' ' A' ' 285' ' ' GLY . 29.6 m -101.53 159.6 15.15 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 108.128 -1.064 . . . . 73.430000000000007 108.128 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.59 74.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.637 0.977 . . . . 72.439999999999998 113.637 -175.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.02 -49.46 71.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 113.377 0.88 . . . . 63.140000000000001 113.377 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.609 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 CA--C 1.502 -0.874 0 N-CA-C 113.686 0.995 . . . . 53.119999999999997 113.686 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.416 -2.13 0 N-CA-C 108.465 -0.939 . . . . 71.030000000000001 108.465 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -95.57 144.16 26.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.721 -0.672 . . . . 73.209999999999994 109.195 -176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' B' ' 227' ' ' SER . 20.3 m -140.42 123.24 16.41 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.484 -0.562 . . . . 51.229999999999997 109.484 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.9 p -128.51 140.14 50.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.418 0.152 . . . . 75.340000000000003 110.985 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.65 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 62.6 mm-40 -77.73 -78.4 0.14 Allowed 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 116.384 -0.371 . . . . 71.040000000000006 110.273 176.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.1 t -124.42 130.82 53.17 Favored 'General case' 0 C--O 1.261 1.672 0 N-CA-C 112.986 0.735 . . . . 74.019999999999996 112.986 -174.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.768 HG12 HD12 ' B' ' 231' ' ' ILE . 17.0 m -118.09 125.35 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 115.109 -0.951 . . . . 61.32 109.167 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 5.1 p -127.4 125.91 66.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.17 0.509 . . . . 74.299999999999997 111.99 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.85 133.03 11.07 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.561 -0.745 . . . . 54.210000000000001 111.498 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -123.66 141.51 51.95 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.27 0.628 . . . . 71.239999999999995 110.437 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.41 -127.58 29.35 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.919 -0.658 . . . . 44.509999999999998 111.938 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.431 ' HB3' ' NH1' ' A' ' 274' ' ' ARG . 60.9 mm-40 -93.35 57.55 2.67 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.817 0.847 . . . . 73.099999999999994 110.407 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 70.7 m -88.74 145.09 25.83 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 120.115 -0.634 . . . . 51.219999999999999 111.969 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ARG . . . . . 0.431 ' NH1' ' HB3' ' A' ' 272' ' ' GLU . 10.4 mpt_? -121.47 127.69 51.34 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.193 -1.41 . . . . 75.519999999999996 107.193 173.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.1 p -136.0 123.57 34.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-O 121.536 0.684 . . . . 74.299999999999997 110.852 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 240' ' ' GLN . 13.3 tp -121.97 124.3 43.7 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.542 0.687 . . . . 62.329999999999998 110.256 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.562 HG22 ' HB3' ' B' ' 241' ' ' LEU . 2.9 pt -112.7 104.55 17.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.402 -1.272 . . . . 73.420000000000002 110.056 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 146.0 -148.91 20.95 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 115.53 -0.759 . . . . 71.329999999999998 111.731 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 7.0 m-20 -101.94 149.58 24.07 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 122.752 -0.263 . . . . 74.129999999999995 110.709 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.1 125.94 24.09 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.776 -1.935 . . . . 62.020000000000003 105.776 175.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -109.29 122.81 48.15 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.493 -1.299 . . . . 64.519999999999996 107.493 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 134.11 -53.03 0.8 Allowed Glycine 0 C--N 1.283 -2.373 0 N-CA-C 108.939 -1.664 . . . . 60.32 108.939 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 103.32 -7.67 51.67 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.931 -1.268 . . . . 73.099999999999994 109.931 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -160.07 53.23 0.34 Allowed 'General case' 0 C--O 1.253 1.252 0 CA-C-N 114.755 -0.722 . . . . 74.019999999999996 111.15 -175.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.409 ' HA3' ' OG1' ' A' ' 246' ' ' THR . . . -95.22 -57.87 1.19 Allowed Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.57 -0.741 . . . . 62.240000000000002 113.99 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -78.66 -2.03 37.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.363 1.078 . . . . 64.239999999999995 110.788 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.447 ' CZ2' ' HD1' ' B' ' 286' ' ' PHE . 36.9 p90 . . . . . 0 C--N 1.292 -1.935 0 N-CA-C 105.162 -2.162 . . . . 61.229999999999997 105.162 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.492 -1.28 0 CA-C-O 120.839 0.352 . . . . 64.230000000000004 111.326 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' B' ' 262' ' ' ASN . 20.1 p-10 -116.67 140.29 49.57 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.381 -0.97 . . . . 54.030000000000001 108.381 174.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 227' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 263' ' ' SER . 18.2 m -121.48 136.5 54.95 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 109.526 -0.546 . . . . 64.400000000000006 109.526 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -120.8 131.53 54.51 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 106.989 -1.486 . . . . 74.219999999999999 106.989 175.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.65 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 1.4 tmtp? -93.31 -62.3 1.4 Allowed 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.121 -0.696 . . . . 71.510000000000005 109.121 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -127.95 137.36 52.23 Favored 'General case' 0 C--N 1.3 -1.543 0 N-CA-C 109.575 -0.528 . . . . 63.100000000000001 109.575 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.768 HD12 HG12 ' A' ' 267' ' ' VAL . 18.7 mt -133.8 122.36 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 108.523 -0.917 . . . . 74.25 108.523 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 38.9 ttp180 -123.54 115.68 21.92 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.904 -0.776 . . . . 73.310000000000002 108.904 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 70.6 p -109.24 127.75 54.5 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 105.831 -1.915 . . . . 74.129999999999995 105.831 177.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.55 161.67 26.65 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.207 -0.597 . . . . 72.519999999999996 111.48 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 67.52 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.251 -1.34 . . . . 71.450000000000003 113.41 172.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.06 18.3 2.28 Favored 'General case' 0 C--O 1.195 -1.783 0 N-CA-C 108.248 -1.019 . . . . 74.540000000000006 108.248 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.52 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -68.69 149.17 49.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.903 0.859 . . . . 74.409999999999997 113.016 -172.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -125.54 135.35 52.16 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.149 -0.932 . . . . 74.219999999999999 108.628 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 8.4 p -132.38 138.7 51.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.665 0.745 . . . . 54.32 110.763 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.541 ' CG ' HD13 ' B' ' 276' ' ' LEU . 52.5 tp60 -117.5 125.83 51.55 Favored 'General case' 0 N--CA 1.401 -2.887 0 CA-C-N 114.495 -1.229 . . . . 64.450000000000003 108.398 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.562 ' HB3' HG22 ' A' ' 277' ' ' ILE . 2.4 tm? -118.15 119.14 33.82 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.9 -1.889 . . . . 54.439999999999998 105.9 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.668 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 136.12 -147.01 19.0 Favored Glycine 0 C--N 1.278 -2.646 0 C-N-CA 119.721 -1.228 . . . . 41.149999999999999 110.875 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 243' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 86.2 m-20 -124.93 129.13 49.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.157 0.503 . . . . 64.129999999999995 110.017 -174.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 93.7 t -111.04 129.26 66.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.758 -0.83 . . . . 73.239999999999995 108.758 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 61.1 t -118.4 111.79 35.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.229 -1.026 . . . . 64.209999999999994 108.229 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.404 ' OG1' ' HA3' ' B' ' 285' ' ' GLY . 28.2 m -96.67 161.1 14.03 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.785 -0.821 . . . . 63.240000000000002 108.785 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.609 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.69 -33.95 76.77 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.273 0.629 . . . . 73.530000000000001 112.331 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.53 -37.16 67.58 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 115.222 1.564 . . . . 55.549999999999997 115.222 -173.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.441 ' HB2' ' N ' ' B' ' 282' ' ' GLY . . . -74.78 -37.79 62.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.148 0.796 . . . . 72.299999999999997 113.148 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 108.864 -0.791 . . . . 73.519999999999996 108.864 -167.978 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 67.3 m . . . . . 0 C--O 1.244 0.775 0 CA-C-O 121.454 0.645 . . . . 70.239999999999995 110.459 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 63.4 m -105.28 108.5 20.05 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.982 -0.747 . . . . 74.439999999999998 108.982 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' B' ' 226' ' ' ASN . 21.9 m-80 -100.98 138.61 37.8 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.109 -0.7 . . . . 62.329999999999998 109.109 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 263' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' C' ' 227' ' ' SER . 4.1 p -143.28 123.94 14.11 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 122.259 -0.276 . . . . 65.5 110.899 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 7.1 p -124.88 142.3 42.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 110.263 -0.273 . . . . 63.219999999999999 110.263 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 43.2 mm-40 -82.47 -78.81 0.2 Allowed 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 123.202 0.314 . . . . 65.140000000000001 110.282 175.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 10.2 t -120.86 130.43 53.93 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.992 -1.083 . . . . 65.310000000000002 112.54 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.533 HG21 HG21 ' B' ' 275' ' ' VAL . 1.5 p -125.05 124.8 68.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.711 -1.131 . . . . 64.230000000000004 110.182 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 268' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 14.8 p -127.01 140.57 48.71 Favored 'Isoleucine or valine' 0 C--O 1.267 2.013 0 CA-C-O 121.782 0.801 . . . . 75.099999999999994 111.395 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.78 133.08 9.53 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 110.609 -0.996 . . . . 74.010000000000005 110.609 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -127.59 116.51 20.45 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.154 0.582 . . . . 65.230000000000004 110.515 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.62 -131.03 10.57 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.126 -1.035 . . . . 71.140000000000001 110.87 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 272' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 67.5 mm-40 -91.85 52.1 1.95 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.324 0.583 . . . . 72.420000000000002 109.511 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 33.3 m -82.9 145.59 29.33 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.499 0.666 . . . . 72.109999999999999 111.558 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -132.4 126.35 32.94 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.754 -1.112 . . . . 74.349999999999994 108.724 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.533 HG21 HG21 ' B' ' 267' ' ' VAL . 0.8 OUTLIER -135.92 127.07 43.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.245 -0.889 . . . . 75.209999999999994 111.076 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.541 HD13 ' CG ' ' B' ' 240' ' ' GLN . 11.9 tp -122.43 121.87 37.64 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.154 0.978 . . . . 74.129999999999995 110.523 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.788 HG22 ' HB3' ' C' ' 241' ' ' LEU . 4.6 pt -112.62 104.33 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-N 114.175 -1.375 . . . . 74.150000000000006 109.131 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.668 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 160.7 -148.83 17.44 Favored Glycine 0 N--CA 1.42 -2.418 0 C-N-CA 120.887 -0.673 . . . . 53.130000000000003 111.691 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 279' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 54.7 t30 -120.63 130.01 53.97 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.161 -1.052 . . . . 71.129999999999995 108.161 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.406 ' HG3' ' CH2' ' B' ' 287' ' ' TRP . 0.3 OUTLIER -117.96 130.52 56.26 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.038 -1.097 . . . . 74.540000000000006 108.038 -174.68 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -108.32 122.93 47.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.304 0.574 . . . . 74.109999999999999 109.991 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.441 ' N ' ' HB2' ' B' ' 249' ' ' ALA . . . 129.05 -53.23 0.81 Allowed Glycine 0 N--CA 1.421 -2.31 0 N-CA-C 109.378 -1.489 . . . . 64.230000000000004 109.378 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 105.95 -7.77 41.75 Favored Glycine 0 N--CA 1.434 -1.459 0 C-N-CA 120.742 -0.742 . . . . 54.130000000000003 111.84 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 284' ' ' LYS . . . . . 0.555 ' HA ' ' NE1' ' B' ' 287' ' ' TRP . 11.0 ptmm? -155.95 36.73 0.35 Allowed 'General case' 0 C--O 1.251 1.183 0 N-CA-C 111.774 0.287 . . . . 75.340000000000003 111.774 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 285' ' ' GLY . . . . . 0.404 ' HA3' ' OG1' ' B' ' 246' ' ' THR . . . -74.43 -76.03 0.75 Allowed Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.252 -0.975 . . . . 70.319999999999993 112.809 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.447 ' HD1' ' CZ2' ' A' ' 287' ' ' TRP . 75.3 t80 -56.36 -26.48 52.95 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.987 0.898 . . . . 75.030000000000001 111.419 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.555 ' NE1' ' HA ' ' B' ' 284' ' ' LYS . 26.8 p90 . . . . . 0 C--N 1.301 -1.5 0 CA-C-N 115.383 -0.826 . . . . 73.450000000000003 109.426 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' B' ' 261' ' ' THR . 1.5 ptp180 . . . . . 0 N--CA 1.429 -1.479 0 CA-C-O 121.968 0.89 . . . . 74.019999999999996 112.814 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -116.46 115.02 25.03 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 106.695 -1.594 . . . . 72.129999999999995 106.695 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 227' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' B' ' 263' ' ' SER . 8.3 p -121.13 136.6 54.95 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 122.025 0.917 . . . . 74.530000000000001 112.402 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -121.2 135.83 55.08 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.358 -1.292 . . . . 74.019999999999996 107.639 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.578 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 1.1 tmtp? -93.62 -55.7 3.17 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 109.486 -0.561 . . . . 74.140000000000001 109.486 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -131.45 138.52 49.07 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.773 0.321 . . . . 75.420000000000002 110.403 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.438 HD12 ' HB ' ' B' ' 267' ' ' VAL . 28.3 mt -131.35 117.83 37.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 107.95 -1.13 . . . . 61.020000000000003 107.95 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 11.4 ttp180 -122.94 114.92 21.09 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.612 -0.514 . . . . 73.420000000000002 109.612 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 40.7 p -113.18 127.8 56.29 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.094 -1.076 . . . . 62.109999999999999 108.094 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -128.18 165.79 19.77 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.913 -0.715 . . . . 74.239999999999995 110.714 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 43.9 mt-10 68.52 -84.7 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 114.791 -1.095 . . . . 63.049999999999997 112.836 175.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.507 ' O ' ' HD2' ' C' ' 238' ' ' ARG . 0.3 OUTLIER -141.25 21.5 2.24 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 108.155 -1.054 . . . . 73.129999999999995 108.155 178.686 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.506 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -68.42 148.32 50.81 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.623 0.725 . . . . 73.430000000000007 112.174 -173.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' C' ' 236' ' ' ARG . 3.4 mpt_? -124.27 135.18 53.21 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.318 -1.364 . . . . 75.109999999999999 107.318 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.2 141.16 45.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.318 0.58 . . . . 71.129999999999995 111.183 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -122.82 123.3 40.7 Favored 'General case' 0 N--CA 1.408 -2.539 0 CA-C-N 114.545 -1.207 . . . . 51.240000000000002 108.808 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.788 ' HB3' HG22 ' B' ' 277' ' ' ILE . 2.1 tm? -120.48 119.16 32.2 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.586 -1.264 . . . . 55.520000000000003 107.586 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.54 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 134.7 -125.43 3.77 Favored Glycine 0 N--CA 1.411 -3.005 0 N-CA-C 110.158 -1.177 . . . . 51.409999999999997 110.158 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 92.7 m-20 -130.22 150.59 51.41 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 120.909 0.385 . . . . 55.109999999999999 110.49 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 83.1 t -128.8 118.38 46.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.449 -1.315 . . . . 62.240000000000002 107.449 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 47.5 t -114.56 112.3 39.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.784 -0.821 . . . . 74.230000000000004 108.784 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 15.4 m -100.37 160.91 13.96 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 115.561 -0.745 . . . . 62.520000000000003 109.503 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.06 -32.21 72.71 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.773 0.796 . . . . 55.210000000000001 110.508 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.97 -42.13 72.02 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.062 -1.427 . . . . 52.32 112.367 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 249' ' ' ALA . . . . . 0.474 ' HB2' ' N ' ' C' ' 282' ' ' GLY . . . . . . . . 0 CA--C 1.507 -0.698 0 CA-C-O 121.009 0.433 . . . . 70.329999999999998 110.014 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 107.182 -1.414 . . . . 75.340000000000003 107.182 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -119.57 135.83 54.62 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.778 -0.453 . . . . 71.439999999999998 109.778 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 20.8 m -142.47 125.38 16.13 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.194 -0.669 . . . . 64.5 109.194 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.1 p -128.16 143.59 40.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 110.195 -0.298 . . . . 53.149999999999999 110.195 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 64.2 mm-40 -76.44 -69.74 0.49 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.531 -0.304 . . . . 65.010000000000005 110.762 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 8.8 t -136.95 133.91 36.16 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 119.004 -1.078 . . . . 64.150000000000006 112.061 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.98 133.49 65.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.503 -0.925 . . . . 62.140000000000001 108.503 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 268' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 11.6 p -127.32 138.99 53.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 116.387 -0.369 . . . . 65.310000000000002 110.256 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.92 132.98 9.95 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.685 -0.966 . . . . 64.219999999999999 110.685 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -132.85 129.74 38.85 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 123.66 0.784 . . . . 74.409999999999997 109.951 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.85 -122.32 9.09 Favored Glycine 0 C--N 1.304 -1.198 0 C-N-CA 121.051 -0.595 . . . . 33.100000000000001 112.043 -176.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -96.79 51.89 1.16 Allowed 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.511 0.724 . . . . 53.119999999999997 110.463 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 56.3 m -83.67 144.36 29.45 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.778 0.799 . . . . 72.329999999999998 112.179 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 274' ' ' ARG . . . . . 0.463 ' HB3' ' CE2' ' C' ' 286' ' ' PHE . 7.6 mpt_? -127.64 127.72 44.27 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.369 -2.085 . . . . 73.030000000000001 105.369 172.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 3.4 p -138.53 124.03 23.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.099 0.476 . . . . 75.420000000000002 111.309 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 20.1 tp -113.41 120.12 39.96 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.728 0.775 . . . . 74.120000000000005 110.479 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.444 HG13 ' HA ' ' C' ' 241' ' ' LEU . 3.9 pt -112.51 103.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 N-CA-C 107.769 -1.197 . . . . 74.439999999999998 107.769 174.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 278' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 152.1 -161.14 29.23 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.073 -1.06 . . . . 73.319999999999993 111.812 -176.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -109.0 136.07 49.14 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.319 -0.623 . . . . 73.319999999999993 109.319 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.95 144.64 45.32 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.204 -1.406 . . . . 74.439999999999998 107.204 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -124.06 122.9 39.12 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.33 -0.618 . . . . 73.230000000000004 109.33 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 282' ' ' GLY . . . . . 0.474 ' N ' ' HB2' ' C' ' 249' ' ' ALA . . . 127.14 -48.33 0.97 Allowed Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 108.738 -1.745 . . . . 54.340000000000003 108.738 -174.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 103.04 -8.01 53.26 Favored Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.907 -0.877 . . . . 54.329999999999998 110.907 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 284' ' ' LYS . . . . . 0.576 ' HA ' ' NE1' ' C' ' 287' ' ' TRP . 17.3 ptmt -154.46 36.2 0.42 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.25 0.62 . . . . 71.340000000000003 110.761 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -70.23 -78.0 0.42 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.359 -0.924 . . . . 73.239999999999995 112.423 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.539 ' HD1' ' CZ2' ' B' ' 287' ' ' TRP . 67.5 t80 -53.79 -19.64 4.59 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.583 1.153 . . . . 74.129999999999995 112.658 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.576 ' NE1' ' HA ' ' C' ' 284' ' ' LYS . 23.8 p90 . . . . . 0 C--N 1.315 -0.894 0 CA-C-O 121.527 0.68 . . . . 72.319999999999993 111.679 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 . . . . . 0 N--CA 1.441 -0.885 0 CA-C-O 121.175 0.512 . . . . 54.009999999999998 110.868 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.43 HD22 ' HA2' ' A' ' 278' ' ' GLY . 53.6 t30 -92.71 126.18 37.67 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.929 -1.508 . . . . 64.129999999999995 106.929 174.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 14.1 m -121.84 136.81 54.94 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.216 0.531 . . . . 73.219999999999999 110.23 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.81 124.06 16.63 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.897 -1.149 . . . . 62.509999999999998 107.897 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 265' ' ' GLU . 4.8 mmmm -76.76 -64.29 1.16 Allowed 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 114.431 1.271 . . . . 73.409999999999997 114.431 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -127.74 140.08 52.28 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.058 -1.057 . . . . 73.519999999999996 110.999 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 30.1 mm -121.15 118.21 55.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.902 -0.777 . . . . 75.329999999999998 108.902 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 80.2 mtt180 -124.76 116.74 22.79 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.921 0.391 . . . . 64.420000000000002 111.046 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 27.3 p -120.44 126.76 51.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.135 -0.691 . . . . 72.099999999999994 109.135 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 270' ' ' LYS . 47.4 mt-10 -139.94 139.47 36.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.596 -0.52 . . . . 53.420000000000002 109.596 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 51.71 97.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.824 1.25 . . . . 74.319999999999993 114.229 174.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? 64.59 20.94 12.31 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.373 1.069 . . . . 75.519999999999996 110.985 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.1 129.4 45.36 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.368 0.604 . . . . 71.420000000000002 110.292 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.85 140.15 52.2 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.455 -0.793 . . . . 71.019999999999996 109.343 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 5.9 p -129.35 146.72 33.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 121.001 0.429 . . . . 55.340000000000003 111.165 -174.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -119.15 124.1 45.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.089 -1.449 . . . . 75.519999999999996 107.089 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -118.58 122.76 43.39 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.686 -0.487 . . . . 74.310000000000002 109.686 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.481 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 120.45 -156.85 15.92 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.906 -0.664 . . . . 74.409999999999997 112.453 175.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -102.23 132.87 47.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.104 -0.702 . . . . 72.430000000000007 109.104 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.638 HG11 ' HA3' ' A' ' 285' ' ' GLY . 15.7 t -116.33 122.11 69.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.76 -0.83 . . . . 73.519999999999996 108.76 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 48.5 t -113.11 112.69 41.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.19 -1.041 . . . . 74.239999999999995 108.19 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.43 HG21 ' HB3' ' A' ' 284' ' ' LYS . 54.3 m -89.44 160.73 16.64 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.243 -0.435 . . . . 60.130000000000003 109.972 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.14 -37.2 86.26 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.33 0.652 . . . . 64.430000000000007 110.9 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.36 -35.04 64.81 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.238 1.015 . . . . 54.130000000000003 113.589 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 112.79 0.663 . . . . 55.210000000000001 112.79 -175.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.5 m . . . . . 0 N--CA 1.407 -2.583 0 N-CA-C 107.455 -1.313 . . . . 75.140000000000001 107.455 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -96.07 142.77 27.88 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.323 -0.991 . . . . 61.219999999999999 108.323 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.5 m -139.72 123.63 17.61 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.724 -0.391 . . . . 71.230000000000004 111.21 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 12.3 p -128.85 144.9 36.68 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.685 -0.487 . . . . 72.439999999999998 109.685 173.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.525 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 4.2 tp10 -84.34 -75.85 0.33 Allowed 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 109.572 -0.529 . . . . 73.120000000000005 109.572 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 14.6 m -123.28 134.5 54.07 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.227 -0.921 . . . . 71.140000000000001 111.3 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 32.5 m -119.3 124.33 72.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 107.972 -1.121 . . . . 74.109999999999999 107.972 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 10.4 p -127.6 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 110.221 -0.288 . . . . 64.540000000000006 110.221 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.591 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -134.19 131.48 5.98 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 119.969 -1.11 . . . . 72.430000000000007 111.94 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 234' ' ' GLU . 27.5 ttmt -135.77 144.87 46.03 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.867 0.692 . . . . 73.340000000000003 112.867 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.72 -54.37 1.43 Allowed Glycine 0 CA--C 1.5 -0.906 0 N-CA-C 111.827 -0.509 . . . . 64.239999999999995 111.827 173.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.635 ' HB3' ' H ' ' B' ' 236' ' ' ARG . 23.1 tt0 -176.76 102.98 0.06 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 105.485 -2.043 . . . . 61.310000000000002 105.485 174.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 59.8 m -135.05 145.18 47.75 Favored 'General case' 0 C--N 1.281 -2.41 0 C-N-CA 119.923 -0.711 . . . . 74.310000000000002 110.795 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -126.7 126.22 43.14 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 104.713 -2.329 . . . . 75.310000000000002 104.713 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 1.6 p -135.75 123.99 37.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 CA-C-O 121.06 0.457 . . . . 72.129999999999995 110.763 -176.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 6.7 tt -111.52 121.21 44.56 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.963 -1.125 . . . . 73.420000000000002 107.963 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.508 HG23 HD12 ' B' ' 241' ' ' LEU . 43.5 mm -112.1 104.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 107.967 -1.123 . . . . 72.420000000000002 107.967 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.512 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 149.99 -128.87 2.81 Favored Glycine 0 N--CA 1.427 -1.936 0 C-N-CA 119.241 -1.457 . . . . 30.039999999999999 113.627 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -128.71 128.88 44.93 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.205 -1.035 . . . . 62.109999999999999 108.205 -175.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -112.93 118.7 35.59 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.741 -0.837 . . . . 75.239999999999995 108.741 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 90.2 m-85 -114.79 123.85 50.27 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.969 -0.752 . . . . 74.340000000000003 108.969 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.447 ' CA ' ' HB2' ' A' ' 249' ' ' ALA . . . 105.94 -47.12 1.09 Allowed Glycine 0 C--N 1.297 -1.611 0 N-CA-C 110.905 -0.878 . . . . 61.119999999999997 110.905 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.536 ' HA2' ' H ' ' B' ' 286' ' ' PHE . . . 89.98 47.28 3.94 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.931 -0.652 . . . . 72.310000000000002 113.155 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.43 ' HB3' HG21 ' A' ' 246' ' ' THR . 0.9 OUTLIER -174.78 30.87 0.01 OUTLIER 'General case' 0 C--O 1.247 0.933 0 CA-C-O 122.151 0.977 . . . . 51.350000000000001 109.372 -177.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.638 ' HA3' HG11 ' A' ' 244' ' ' VAL . . . -86.73 128.08 8.73 Favored Glycine 0 N--CA 1.411 -3.007 0 C-N-CA 120.351 -0.928 . . . . 73.230000000000004 112.161 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 27.0 t80 73.86 -51.69 0.69 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.917 1.287 . . . . 62.350000000000001 112.396 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.309 -1.154 0 N-CA-C 112.988 0.736 . . . . 73.200000000000003 112.988 -172.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 . . . . . 0 N--CA 1.429 -1.503 0 CA-C-O 121.306 0.574 . . . . 75.430000000000007 109.798 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -112.67 130.52 56.02 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 105.191 -2.152 . . . . 74.519999999999996 105.191 171.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 14.5 m -132.53 135.81 46.22 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 118.356 -1.338 . . . . 62.420000000000002 110.977 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.92 134.5 42.71 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 107.178 -1.416 . . . . 71.409999999999997 107.178 175.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' B' ' 265' ' ' GLU . 24.6 mmtp -80.17 -71.23 0.47 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.659 -0.416 . . . . 75.209999999999994 112.058 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -127.11 138.59 53.21 Favored 'General case' 0 N--CA 1.414 -2.274 0 C-N-CA 118.555 -1.258 . . . . 72.310000000000002 109.597 -173.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 31.1 mm -123.41 116.98 50.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.791 -1.189 . . . . 72.450000000000003 107.791 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -117.4 115.23 24.8 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 120.299 -0.561 . . . . 75.310000000000002 109.52 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.591 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 40.8 p -110.8 126.43 54.62 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.206 -1.405 . . . . 73.099999999999994 107.206 176.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 234' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 51.0 mt-10 -143.43 138.83 29.6 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 109.811 -0.44 . . . . 73.349999999999994 109.811 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.481 ' HB2' ' H ' ' B' ' 271' ' ' GLY . 41.1 mt-10 56.49 98.22 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.868 0 O-C-N 125.292 1.62 . . . . 73.530000000000001 113.041 174.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.635 ' H ' ' HB3' ' A' ' 272' ' ' GLU . 1.1 mpt_? 60.89 35.66 19.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.857 0.863 . . . . 75.319999999999993 109.718 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -103.76 138.88 39.75 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.586 0.707 . . . . 72.209999999999994 111.106 -175.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 1.4 mpt_? -133.84 136.35 44.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.978 -1.119 . . . . 71.230000000000004 107.978 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 5.7 p -137.37 137.66 45.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-O 121.578 0.704 . . . . 64.530000000000001 112.059 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.423 ' HB3' ' HG ' ' B' ' 276' ' ' LEU . 47.4 tp60 -110.64 117.65 34.06 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.113 -1.44 . . . . 71.150000000000006 107.113 175.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.508 HD12 HG23 ' A' ' 277' ' ' ILE . 3.0 tm? -119.33 127.4 53.15 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.085 -0.709 . . . . 72.319999999999993 109.085 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 122.7 -121.3 4.59 Favored Glycine 0 CA--C 1.473 -2.542 0 N-CA-C 109.636 -1.385 . . . . 62.420000000000002 109.636 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 33.8 p30 -144.1 154.77 43.55 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 119.739 -0.784 . . . . 52.039999999999999 111.41 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.701 HG11 ' HA3' ' B' ' 285' ' ' GLY . 65.6 t -123.49 130.37 74.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.176 -0.92 . . . . 71.329999999999998 109.69 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 57.8 t -122.66 111.58 30.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.643 -1.243 . . . . 74.400000000000006 107.643 171.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.47 ' HB ' ' HA3' ' B' ' 282' ' ' GLY . 16.8 m -88.02 160.72 17.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.548 -0.908 . . . . 72.510000000000005 108.548 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.4 -43.85 96.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 122.056 0.932 . . . . 74.510000000000005 110.532 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.51 -35.63 65.83 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.65 -1.614 . . . . 74.439999999999998 112.282 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.451 ' HB2' ' CA ' ' B' ' 282' ' ' GLY . . . -63.52 -25.54 68.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.07 0.767 . . . . 71.439999999999998 113.07 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 tt . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 121.269 0.557 . . . . 75.340000000000003 110.215 -177.321 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.41 -2.434 0 N-CA-C 108.324 -0.991 . . . . 72.040000000000006 108.324 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 62.8 m -90.29 112.96 24.7 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.665 -0.865 . . . . 63.109999999999999 108.665 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -96.47 128.62 43.56 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-N 114.891 -1.05 . . . . 60.130000000000003 109.899 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 14.5 m -121.49 121.13 36.83 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.194 -1.039 . . . . 74.5 108.194 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.8 p -129.61 145.82 35.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.302 -0.999 . . . . 64.200000000000003 108.302 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 20.5 tt0 -93.0 -75.44 0.49 Allowed 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 119.03 -1.068 . . . . 74.409999999999997 112.033 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 32.8 m -124.95 134.54 52.59 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.806 -1.158 . . . . 73.019999999999996 111.478 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.47 HG12 ' HB ' ' C' ' 231' ' ' ILE . 10.0 m -118.4 134.33 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 108.018 -1.104 . . . . 71.129999999999995 108.018 173.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 85.1 t -123.97 128.49 74.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 115.636 -0.711 . . . . 72.400000000000006 110.036 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.22 131.69 9.89 Favored Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 110.293 -1.123 . . . . 71.439999999999998 110.293 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.495 ' HB3' ' HG2' ' C' ' 234' ' ' GLU . 2.2 tpmt? -135.53 137.85 42.47 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 122.943 0.497 . . . . 75.140000000000001 111.073 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 271' ' ' GLY . . . . . 0.481 ' H ' ' HB2' ' B' ' 235' ' ' GLU . . . 86.29 -52.74 4.54 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 114.746 0.658 . . . . 43.43 114.746 169.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 272' ' ' GLU . . . . . 0.721 ' HB3' ' H ' ' C' ' 236' ' ' ARG . 1.6 tm-20 -177.4 105.28 0.05 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 103.156 -2.905 . . . . 71.209999999999994 103.156 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 273' ' ' SER . . . . . 0.603 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 44.4 m -145.24 144.95 31.09 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-O 121.07 0.462 . . . . 55.329999999999998 110.764 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 60.4 mtt180 -135.68 127.28 28.89 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 106.373 -1.714 . . . . 73.040000000000006 106.373 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.2 p -132.68 129.61 58.64 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.824 0 O-C-N 123.695 0.622 . . . . 74.209999999999994 110.364 -175.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.423 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 6.6 tt -110.59 115.75 30.14 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.976 -1.12 . . . . 75.109999999999999 107.976 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.468 HG23 HD12 ' C' ' 241' ' ' LEU . 37.2 mm -106.9 103.82 16.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.031 -1.1 . . . . 71.030000000000001 108.031 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 144.04 -140.39 9.39 Favored Glycine 0 N--CA 1.424 -2.167 0 C-N-CA 119.53 -1.319 . . . . 63.32 113.285 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 279' ' ' ASN . . . . . 0.405 ' HB3' ' CE2' ' B' ' 281' ' ' TYR . 1.7 m-20 -111.76 129.48 56.11 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.55 -0.537 . . . . 72.530000000000001 109.55 -175.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -114.5 118.28 33.33 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.345 -0.983 . . . . 74.349999999999994 108.345 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.405 ' CE2' ' HB3' ' B' ' 279' ' ' ASN . 97.8 m-85 -117.22 124.52 49.27 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 109.227 -0.657 . . . . 74.439999999999998 109.227 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.47 ' HA3' ' HB ' ' B' ' 246' ' ' THR . . . 103.99 -46.86 1.14 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 110.139 -1.185 . . . . 71.150000000000006 110.139 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 283' ' ' GLY . . . . . 0.555 ' O ' ' HE2' ' B' ' 284' ' ' LYS . . . 95.5 37.31 5.09 Favored Glycine 0 N--CA 1.411 -3.016 0 C-N-CA 120.899 -0.667 . . . . 74.349999999999994 112.748 176.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 284' ' ' LYS . . . . . 0.555 ' HE2' ' O ' ' B' ' 283' ' ' GLY . 9.9 tppt? -161.64 35.24 0.13 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 119.21 -0.996 . . . . 74.25 112.34 -175.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 285' ' ' GLY . . . . . 0.701 ' HA3' HG11 ' B' ' 244' ' ' VAL . . . -89.61 144.78 17.99 Favored Glycine 0 CA--C 1.488 -1.595 0 C-N-CA 119.28 -1.438 . . . . 72.25 113.572 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.536 ' H ' ' HA2' ' A' ' 283' ' ' GLY . 0.2 OUTLIER 68.78 -71.31 0.12 Allowed 'General case' 0 C--O 1.245 0.854 0 C-N-CA 124.872 1.269 . . . . 74.0 110.18 178.669 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.755 0 CA-C-N 115.047 -0.979 . . . . 70.310000000000002 112.973 -173.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 109.802 -0.444 . . . . 73.129999999999995 109.802 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -114.93 124.55 51.97 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.933 -1.506 . . . . 72.209999999999994 106.933 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 23.6 m -121.93 136.68 54.94 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 121.185 0.517 . . . . 60.450000000000003 110.35 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -139.51 129.72 25.29 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 107.878 -1.156 . . . . 74.25 107.878 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' C' ' 265' ' ' GLU . 17.5 mmtp -78.46 -71.46 0.43 Allowed 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.266 0.555 . . . . 74.209999999999994 112.361 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 230' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' C' ' 266' ' ' THR . 10.1 t0 -127.69 138.92 52.96 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.203 -0.908 . . . . 70.430000000000007 108.833 -170.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.47 ' HB ' HG12 ' B' ' 267' ' ' VAL . 23.5 mm -129.34 117.83 44.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.564 -1.272 . . . . 71.420000000000002 107.564 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 78.5 mtt180 -122.08 115.56 22.69 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.201 0.524 . . . . 71.239999999999995 109.612 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 20.0 p -110.21 126.46 54.15 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 106.843 -1.54 . . . . 74.019999999999996 106.843 177.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' B' ' 270' ' ' LYS . 48.0 mt-10 -137.59 138.38 39.48 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 108.74 -0.837 . . . . 74.209999999999994 108.74 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 50.65 92.01 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.661 1.356 . . . . 72.450000000000003 114.661 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.721 ' H ' ' HB3' ' B' ' 272' ' ' GLU . 3.5 mpt_? 66.85 34.59 5.36 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.23 1.412 . . . . 71.129999999999995 109.952 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.603 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -104.44 128.85 52.42 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.23 -0.895 . . . . 51.439999999999998 110.661 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.0 OUTLIER -124.98 135.3 52.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.504 -0.924 . . . . 73.019999999999996 108.504 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.6 p -139.65 142.68 32.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.862 0.839 . . . . 64.400000000000006 112.212 -176.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.407 ' HB3' ' HG ' ' C' ' 276' ' ' LEU . 48.2 tp60 -110.92 130.19 55.66 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.152 -1.425 . . . . 64.549999999999997 107.152 175.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.468 HD12 HG23 ' B' ' 277' ' ' ILE . 2.8 tm? -130.13 128.79 42.52 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.008 -0.738 . . . . 64.430000000000007 109.008 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 122.25 -121.9 4.87 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 109.919 -1.273 . . . . 72.450000000000003 109.919 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -139.39 153.28 47.6 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 120.508 -0.477 . . . . 73.329999999999998 111.087 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.793 HG11 ' HA3' ' C' ' 285' ' ' GLY . 63.8 t -127.58 124.23 63.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.663 -0.699 . . . . 53.119999999999997 109.61 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 59.2 t -122.15 110.76 28.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.429 -1.322 . . . . 63.240000000000002 107.429 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 246' ' ' THR . . . . . 0.417 ' HB ' ' HA3' ' C' ' 282' ' ' GLY . 37.7 m -87.78 161.92 17.31 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.154 -0.684 . . . . 72.400000000000006 109.154 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.93 -39.18 74.0 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.509 0.723 . . . . 72.140000000000001 110.83 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.41 -34.5 64.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.642 -1.617 . . . . 75.239999999999995 113.381 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.327 0 N-CA-C 112.255 0.465 . . . . 74.140000000000001 112.255 -175.445 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.433 -1.295 0 CA-C-O 121.976 0.894 . . . . 70.219999999999999 109.516 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -119.9 144.12 47.59 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.058 -1.428 . . . . 71.129999999999995 109.135 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -142.08 131.16 23.24 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 110.182 -0.303 . . . . 74.040000000000006 110.182 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 12.2 p -128.98 145.43 35.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.451 -0.944 . . . . 75.209999999999994 108.451 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' C' ' 229' ' ' LYS . 7.0 tp10 -79.76 -81.49 0.12 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 109.135 -0.691 . . . . 53.409999999999997 109.135 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 266' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 90.0 m -131.72 137.01 48.06 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.397 -0.815 . . . . 73.120000000000005 110.825 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.06 130.71 74.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.962 -0.755 . . . . 63.32 108.962 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 268' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.4 p -127.56 137.38 57.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 116.635 -0.257 . . . . 71.299999999999997 110.473 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.93 132.88 9.65 Favored Glycine 0 CA--C 1.483 -1.934 0 N-CA-C 110.352 -1.099 . . . . 70.219999999999999 110.352 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -134.6 147.73 50.28 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.145 -0.687 . . . . 65.25 109.145 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.26 -60.86 4.7 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 112.293 -0.323 . . . . 71.019999999999996 112.293 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 272' ' ' GLU . . . . . 0.533 ' HA ' ' HB2' ' C' ' 236' ' ' ARG . 36.4 tt0 -173.18 130.79 0.48 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.914 -2.254 . . . . 72.239999999999995 104.914 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 273' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 17.8 t -156.11 148.08 23.18 Favored 'General case' 0 N--CA 1.413 -2.324 0 C-N-CA 120.074 -0.65 . . . . 54.439999999999998 109.926 -176.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 274' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 46.2 mtm180 -138.12 125.43 21.76 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.212 -1.773 . . . . 74.140000000000001 106.212 172.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 5.1 p -139.57 135.44 39.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 123.548 0.53 . . . . 62.509999999999998 110.693 -176.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' C' ' 240' ' ' GLN . 7.0 tt -115.93 111.58 20.61 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.912 -0.773 . . . . 72.129999999999995 108.912 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 47.7 mm -102.28 104.21 16.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.871 -1.159 . . . . 73.209999999999994 107.871 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 278' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 147.84 -144.39 12.34 Favored Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.009 -1.636 . . . . 55.140000000000001 109.009 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -127.96 150.61 49.82 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 120.869 0.366 . . . . 73.200000000000003 110.405 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.424 ' HA ' ' HB ' ' C' ' 244' ' ' VAL . 6.2 tp10 -126.64 118.14 24.19 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.618 -0.719 . . . . 74.420000000000002 109.801 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -109.18 124.12 50.32 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.913 -0.773 . . . . 73.450000000000003 108.913 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 282' ' ' GLY . . . . . 0.417 ' HA3' ' HB ' ' C' ' 246' ' ' THR . . . 102.94 -53.17 0.76 Allowed Glycine 0 N--CA 1.434 -1.497 0 N-CA-C 110.502 -1.039 . . . . 62.32 110.502 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 95.14 54.64 1.46 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.416 -0.897 . . . . 21.550000000000001 113.207 176.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -164.2 21.65 0.07 Allowed 'General case' 0 C--O 1.238 0.47 0 C-N-CA 119.903 -0.719 . . . . 64.200000000000003 110.947 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 285' ' ' GLY . . . . . 0.793 ' HA3' HG11 ' C' ' 244' ' ' VAL . . . -74.92 138.75 24.14 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 115.011 0.764 . . . . 65.340000000000003 115.011 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.413 ' H ' ' HA2' ' B' ' 283' ' ' GLY . 0.1 OUTLIER 67.43 -79.37 0.04 OUTLIER 'General case' 0 C--O 1.252 1.196 0 C-N-CA 124.786 1.234 . . . . 73.310000000000002 110.934 174.543 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 17.7 p90 . . . . . 0 N--CA 1.427 -1.623 0 C-N-CA 121.078 -0.249 . . . . 73.219999999999999 111.273 -177.221 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 23.1 ptt-85 . . . . . 0 N--CA 1.425 -1.681 0 N-CA-C 107.919 -1.141 . . . . 73.349999999999994 107.919 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.561 ' OD1' ' HA2' ' B' ' 242' ' ' GLY . 41.4 m-80 -109.96 135.32 50.99 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.094 -1.076 . . . . 74.239999999999995 108.094 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.9 m -121.55 136.5 54.95 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.578 0.704 . . . . 62.409999999999997 110.874 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.68 127.99 47.12 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.137 -1.431 . . . . 53.109999999999999 107.137 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -78.88 -60.42 2.39 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.913 -0.773 . . . . 74.129999999999995 108.913 -177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -137.5 139.3 40.46 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.538 0.685 . . . . 75.430000000000007 110.831 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 67.3 mt -128.78 122.47 57.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.257 -1.016 . . . . 33.200000000000003 108.257 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -130.69 115.01 16.1 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.721 0.772 . . . . 73.400000000000006 111.329 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.643 HG21 HG13 ' A' ' 239' ' ' VAL . 6.8 p -111.99 137.06 50.52 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.226 -0.897 . . . . 74.409999999999997 109.75 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.404 ' OE2' ' HE3' ' A' ' 270' ' ' LYS . 40.5 tt0 -133.97 147.17 51.0 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 116.066 -0.516 . . . . 64.109999999999999 110.989 -174.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.429 ' HG2' ' HE ' ' A' ' 236' ' ' ARG . 32.3 tt0 73.38 -79.0 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.589 1.156 . . . . 71.150000000000006 112.727 170.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.429 ' HE ' ' HG2' ' A' ' 235' ' ' GLU . 75.1 mtm180 -136.16 15.81 3.25 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.09 0.947 . . . . 74.510000000000005 109.077 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.08 133.37 34.23 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.65 -1.159 . . . . 64.530000000000001 109.791 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -132.11 144.02 50.42 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.621 0.724 . . . . 74.120000000000005 112.006 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.934 HG12 ' HB ' ' A' ' 275' ' ' VAL . 15.4 m -123.69 150.4 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 CA-C-N 114.832 -1.076 . . . . 70.230000000000004 111.804 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -116.85 120.83 39.7 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-N 114.259 -1.337 . . . . 74.129999999999995 108.148 175.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -111.26 118.2 35.26 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.049 -1.834 . . . . 74.209999999999994 106.049 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.02 -155.71 21.13 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 119.828 -1.177 . . . . 33.0 112.892 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -110.83 128.58 55.82 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.136 0.574 . . . . 71.109999999999999 110.658 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.421 ' CG1' ' HA3' ' A' ' 285' ' ' GLY . 48.6 t -116.34 115.05 47.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.369 -0.974 . . . . 74.409999999999997 108.369 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' A' ' 281' ' ' TYR . 7.3 p -114.42 124.82 71.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.277 0.56 . . . . 53.43 112.46 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 23.8 p -117.24 166.59 12.09 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 116.001 -0.545 . . . . 71.209999999999994 111.366 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.74 74.13 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.536 0.734 . . . . 71.239999999999995 112.757 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.37 66.29 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.634 0.975 . . . . 64.209999999999994 113.634 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.645 ' HB2' ' N ' ' A' ' 282' ' ' GLY . . . . . . . . 0 CA--C 1.503 -0.854 0 N-CA-C 112.536 0.569 . . . . 73.319999999999993 112.536 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 10.6 t . . . . . 0 N--CA 1.427 -1.595 0 CA-C-O 121.292 0.568 . . . . 73.150000000000006 109.617 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -126.33 142.2 51.62 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.12 -0.696 . . . . 73.530000000000001 109.12 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' B' ' 227' ' ' SER . 22.7 t -127.69 130.71 49.34 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 108.721 -0.844 . . . . 74.230000000000004 108.721 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.02 139.73 51.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.967 -0.383 . . . . 73.349999999999994 109.967 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 15.3 mt-10 -79.1 -70.64 0.49 Allowed 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 119.823 -0.751 . . . . 71.439999999999998 111.525 176.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 13.6 m -119.44 126.86 52.33 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.889 -0.724 . . . . 40.340000000000003 111.949 -174.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.39 122.26 67.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 N-CA-C 109.118 -0.697 . . . . 51.539999999999999 109.118 171.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.56 146.67 29.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.643 0.735 . . . . 62.240000000000002 112.593 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.73 133.28 7.78 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.14 -0.936 . . . . 34.32 111.002 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.404 ' HE3' ' OE2' ' A' ' 234' ' ' GLU . 0.2 OUTLIER -130.27 116.0 17.75 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.074 -1.084 . . . . 54.43 108.074 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.16 -136.84 13.02 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.147 -1.581 . . . . 75.25 109.147 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -99.24 53.22 0.96 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.942 0.877 . . . . 73.019999999999996 109.701 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 7.1 m -83.02 148.22 27.69 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.167 -0.924 . . . . 61.5 111.209 -174.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 45.8 mtm180 -130.02 128.19 41.48 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.287 -0.415 . . . . 75.310000000000002 109.946 175.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.934 ' HB ' HG12 ' A' ' 239' ' ' VAL . 17.9 t -130.46 140.42 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 N-CA-C 108.095 -1.076 . . . . 55.340000000000003 108.095 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 286' ' ' PHE . 5.5 tt -126.17 121.1 31.83 Favored 'General case' 0 C--N 1.275 -2.655 0 C-N-CA 118.913 -1.115 . . . . 74.019999999999996 108.426 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.406 ' HA ' ' HB3' ' B' ' 241' ' ' LEU . 3.5 mp -107.92 104.61 17.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 106.316 -1.735 . . . . 62.329999999999998 106.316 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.13 -134.77 5.37 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.435 -1.066 . . . . 62.109999999999999 110.435 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 45.2 t-20 -130.15 134.58 47.42 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 117.103 0.451 . . . . 62.200000000000003 111.396 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 287' ' ' TRP . 10.3 tp10 -111.23 122.85 48.93 Favored 'General case' 0 C--O 1.269 2.084 0 N-CA-C 106.746 -1.576 . . . . 74.219999999999999 106.746 174.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.506 ' HB2' ' HA ' ' A' ' 245' ' ' VAL . 12.0 m-85 -109.24 122.81 48.14 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.751 -1.944 . . . . 73.140000000000001 105.751 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.645 ' N ' ' HB2' ' A' ' 249' ' ' ALA . . . 103.86 -51.85 0.79 Allowed Glycine 0 C--N 1.297 -1.617 0 C-N-CA 120.445 -0.883 . . . . 74.140000000000001 112.999 177.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.41 30.54 18.88 Favored Glycine 0 CA--C 1.498 -0.986 0 N-CA-C 109.9 -1.28 . . . . 60.520000000000003 109.9 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -129.81 -8.98 4.47 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.465 -0.867 . . . . 73.209999999999994 111.456 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.421 ' HA3' ' CG1' ' A' ' 244' ' ' VAL . . . -86.61 -80.27 1.19 Allowed Glycine 0 CA--C 1.487 -1.661 0 C-N-CA 119.386 -1.388 . . . . 72.25 112.415 -175.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.477 ' HB3' HD12 ' A' ' 276' ' ' LEU . 75.6 t80 -99.98 -22.74 15.14 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.504 -1.295 . . . . 75.450000000000003 107.504 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.576 ' HA ' ' CE3' ' A' ' 287' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.41 -2.469 0 N-CA-C 115.741 1.756 . . . . 74.230000000000004 115.741 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 261' ' ' THR . 30.3 ptt85 . . . . . 0 N--CA 1.422 -1.847 0 CA-C-O 121.025 0.441 . . . . 70.230000000000004 110.859 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.496 ' OD1' ' HA2' ' C' ' 242' ' ' GLY . 51.1 m-80 -108.18 148.52 29.78 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.919 -1.141 . . . . 72.230000000000004 107.919 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 227' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 263' ' ' SER . 31.2 m -135.95 137.44 41.3 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.572 0.701 . . . . 70.430000000000007 111.163 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.51 129.85 51.37 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.631 -1.168 . . . . 74.120000000000005 108.449 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 5.3 tmtt? -78.55 -66.49 0.85 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.384 -0.826 . . . . 72.400000000000006 108.816 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -134.82 139.05 44.78 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 116.524 -0.307 . . . . 51.399999999999999 110.347 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 10.8 mt -132.23 117.72 33.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.241 -1.022 . . . . 65.530000000000001 108.241 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.455 ' HB3' HG12 ' B' ' 268' ' ' VAL . 25.8 ttt180 -113.64 122.46 47.25 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.938 -0.574 . . . . 65.010000000000005 110.735 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 76.0 p -110.7 132.16 54.44 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.945 -1.131 . . . . 75.450000000000003 107.945 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -133.72 150.83 51.51 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.353 -0.539 . . . . 73.439999999999998 109.778 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.413 ' HB3' ' HD2' ' B' ' 236' ' ' ARG . 42.4 mt-10 70.13 -95.19 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 124.556 1.142 . . . . 73.209999999999994 113.455 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' B' ' 272' ' ' GLU . 0.0 OUTLIER -129.04 31.13 4.95 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.425 -1.324 . . . . 75.209999999999994 107.425 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -76.24 137.25 39.84 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.29 -0.868 . . . . 74.329999999999998 110.701 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 1.7 mpp_? -125.34 134.35 52.24 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.031 -0.986 . . . . 65.400000000000006 108.514 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.549 HG12 ' HB ' ' B' ' 275' ' ' VAL . 19.6 m -135.58 140.83 43.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.8 0.809 . . . . 52.409999999999997 111.265 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.441 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 38.8 tp60 -105.15 135.79 45.84 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 114.211 -1.359 . . . . 60.030000000000001 108.463 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.406 ' HB3' ' HA ' ' A' ' 277' ' ' ILE . 1.5 tm? -125.97 117.02 22.39 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 104.911 -2.255 . . . . 63.200000000000003 104.911 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.574 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 125.19 -146.12 16.0 Favored Glycine 0 N--CA 1.42 -2.407 0 C-N-CA 119.549 -1.31 . . . . 44.43 111.844 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 243' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 2.4 m-20 -113.81 146.17 40.34 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.442 -0.577 . . . . 74.430000000000007 109.442 -176.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.441 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 59.2 t -126.78 122.48 60.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.015 -1.476 . . . . 71.310000000000002 107.015 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.53 126.0 72.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.369 -1.333 . . . . 75.319999999999993 113.49 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 24.4 p -120.28 163.13 18.27 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.947 -0.569 . . . . 75.340000000000003 112.034 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.64 -31.82 58.06 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.723 1.209 . . . . 31.140000000000001 112.201 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.36 70.17 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.885 0.698 . . . . 75.430000000000007 112.885 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.48 ' HB2' ' N ' ' B' ' 282' ' ' GLY . . . -75.01 -44.37 48.44 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.484 -0.486 . . . . 34.229999999999997 109.988 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 63.8 tp . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 125.131 1.372 . . . . 52.539999999999999 110.36 -176.502 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.437 -1.082 0 N-CA-C 109.136 -0.69 . . . . 75.340000000000003 109.136 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 10.2 t -123.53 134.54 53.85 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 121.558 0.694 . . . . 75.099999999999994 110.182 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -125.16 138.15 54.15 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.582 -0.896 . . . . 71.530000000000001 108.582 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 263' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' C' ' 227' ' ' SER . 41.8 m -130.33 132.51 45.88 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.691 -0.485 . . . . 74.099999999999994 109.691 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 7.3 p -125.68 142.35 42.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 116.123 -0.489 . . . . 70.329999999999998 110.923 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.552 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 10.4 mm-40 -82.68 -69.02 0.66 Allowed 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 123.793 0.683 . . . . 75.109999999999999 109.703 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.5 m -126.06 127.21 45.48 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 119.572 -0.851 . . . . 73.510000000000005 112.252 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.46 HG11 HG11 ' B' ' 275' ' ' VAL . 48.0 t -118.66 120.76 65.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.359 -1.348 . . . . 53.409999999999997 107.359 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 268' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' B' ' 232' ' ' ARG . 27.4 m -125.6 137.46 57.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.69 0.757 . . . . 70.409999999999997 112.152 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.71 133.65 11.01 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 110.279 -1.128 . . . . 71.430000000000007 110.279 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -132.08 115.88 16.34 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.359 0.599 . . . . 75.040000000000006 109.566 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.75 -132.28 10.95 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 119.996 -1.097 . . . . 15.44 111.178 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 272' ' ' GLU . . . . . 0.415 ' HG3' HH11 ' B' ' 236' ' ' ARG . 21.5 mt-10 -96.14 48.28 1.1 Allowed 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.746 0.818 . . . . 72.329999999999998 110.437 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 15.5 m -81.46 150.27 28.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.156 -0.929 . . . . 72.329999999999998 112.93 -171.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 49.2 mtm180 -133.26 128.09 35.09 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.887 -0.597 . . . . 75.140000000000001 110.016 173.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.641 HG13 HG23 ' C' ' 239' ' ' VAL . 22.0 t -131.83 138.69 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.778 0 N-CA-C 108.366 -0.976 . . . . 61.310000000000002 108.366 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.414 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 5.9 tt -120.99 116.32 24.86 Favored 'General case' 0 C--N 1.277 -2.561 0 C-N-CA 118.849 -1.14 . . . . 63.439999999999998 108.148 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.479 ' HA ' ' HB3' ' C' ' 241' ' ' LEU . 4.0 mp -106.31 103.5 15.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 106.313 -1.736 . . . . 72.099999999999994 106.313 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 149.67 -135.02 5.13 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.729 -0.748 . . . . 74.420000000000002 112.501 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 279' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 48.5 t-20 -128.72 130.0 46.53 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.201 -0.666 . . . . 63.340000000000003 109.201 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -111.35 118.67 36.47 Favored 'General case' 0 C--O 1.268 2.034 0 N-CA-C 106.992 -1.484 . . . . 73.230000000000004 106.992 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -105.04 122.31 45.6 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 106.919 -1.511 . . . . 72.409999999999997 106.919 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.48 ' N ' ' HB2' ' B' ' 249' ' ' ALA . . . 101.09 -52.29 0.91 Allowed Glycine 0 C--N 1.297 -1.638 0 C-N-CA 120.37 -0.919 . . . . 74.439999999999998 112.524 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.58 32.75 12.58 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.962 -1.113 . . . . 62.340000000000003 111.39 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -136.68 2.09 2.63 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.569 0.581 . . . . 65.219999999999999 112.569 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 285' ' ' GLY . . . . . 0.435 ' HA3' ' CG1' ' B' ' 244' ' ' VAL . . . -86.15 -77.86 1.21 Allowed Glycine 0 CA--C 1.487 -1.707 0 C-N-CA 118.712 -1.708 . . . . 40.420000000000002 110.739 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -97.01 -21.29 17.5 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.545 -1.28 . . . . 73.530000000000001 107.545 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.547 ' HA ' ' CE3' ' B' ' 287' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.418 -2.05 0 CA-C-N 114.309 -1.314 . . . . 72.239999999999995 114.374 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 . . . . . 0 N--CA 1.412 -2.365 0 N-CA-C 109.715 -0.476 . . . . 75.310000000000002 109.715 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -102.22 142.18 33.88 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 106.64 -1.615 . . . . 75.420000000000002 106.64 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 227' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' B' ' 263' ' ' SER . 55.5 m -136.98 137.91 39.99 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.382 0.611 . . . . 71.450000000000003 111.19 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.19 130.23 50.55 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.417 -0.81 . . . . 71.230000000000004 109.262 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -84.07 -61.58 1.78 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.578 -0.527 . . . . 74.049999999999997 109.578 -177.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -129.14 138.18 51.63 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 122.152 -0.342 . . . . 70.540000000000006 110.538 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 18.4 mt -136.04 117.32 19.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 107.614 -1.254 . . . . 74.540000000000006 107.614 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -119.4 126.0 50.33 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.481 0.658 . . . . 63.329999999999998 110.82 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 24.5 p -110.17 135.44 50.95 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.431 -0.951 . . . . 62.450000000000003 108.431 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -134.89 149.83 50.35 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.757 -0.831 . . . . 63.530000000000001 108.757 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.518 ' HB3' ' HD3' ' C' ' 236' ' ' ARG . 36.6 mt-10 64.58 -99.02 0.07 Allowed 'General case' 0 C--O 1.203 -1.372 0 C-N-CA 124.556 1.142 . . . . 62.240000000000002 113.698 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.518 ' HD3' ' HB3' ' C' ' 235' ' ' GLU . 0.2 OUTLIER -122.62 35.52 4.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 108.221 -1.029 . . . . 74.510000000000005 108.221 -177.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -81.3 134.38 35.58 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 114.563 -1.198 . . . . 72.519999999999996 110.659 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 2.0 mpp_? -125.33 133.88 52.43 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.616 -1.174 . . . . 63.119999999999997 107.942 176.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.641 HG23 HG13 ' B' ' 275' ' ' VAL . 29.4 m -134.67 141.26 43.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.649 0.738 . . . . 73.030000000000001 110.922 177.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.422 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 45.1 tp60 -104.79 136.05 45.03 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 114.648 -1.16 . . . . 75.519999999999996 108.495 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.479 ' HB3' ' HA ' ' B' ' 277' ' ' ILE . 1.6 tm? -126.42 116.96 21.97 Favored 'General case' 0 N--CA 1.402 -2.848 0 N-CA-C 104.864 -2.273 . . . . 74.109999999999999 104.864 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.501 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 121.66 -131.42 8.52 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 119.618 -1.277 . . . . 75.540000000000006 113.31 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.626 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 13.1 m120 -122.23 139.7 53.46 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.884 -0.413 . . . . 63.009999999999998 109.884 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.422 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 48.4 t -126.34 117.46 48.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 106.545 -1.65 . . . . 74.209999999999994 106.545 172.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.03 127.85 74.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.797 -1.161 . . . . 71.439999999999998 113.104 -175.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 20.2 p -114.0 162.63 16.18 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.093 -0.503 . . . . 63.130000000000003 111.185 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.33 -32.04 69.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.445 0.698 . . . . 63.509999999999998 110.836 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.32 -33.61 59.26 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.505 1.122 . . . . 72.430000000000007 112.533 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.654 0 N-CA-C 112.244 0.461 . . . . 64.439999999999998 112.244 -179.566 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.415 -2.203 0 CA-C-O 121.592 0.71 . . . . 53.439999999999998 109.34 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -114.68 125.63 53.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.749 -0.66 . . . . 71.219999999999999 109.513 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 263' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' C' ' 227' ' ' SER . 28.5 t -117.78 135.37 54.1 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 108.179 -1.045 . . . . 62.219999999999999 108.179 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.0 141.44 42.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 116.402 -0.363 . . . . 73.230000000000004 110.333 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -78.42 -66.45 0.85 Allowed 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 122.493 0.317 . . . . 73.340000000000003 111.047 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.8 m -129.03 132.37 47.48 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 120.523 -0.471 . . . . 72.239999999999995 111.441 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.75 123.95 72.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.074 -1.454 . . . . 65.030000000000001 107.074 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 20.1 m -124.99 143.59 38.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.3 0.571 . . . . 70.109999999999999 112.338 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.2 133.78 9.16 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.331 -1.108 . . . . 64.530000000000001 110.331 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -133.84 125.09 27.66 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 123.643 0.777 . . . . 60.509999999999998 109.708 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.24 -136.99 21.32 Favored Glycine 0 CA--C 1.506 -0.512 0 N-CA-C 110.108 -1.197 . . . . 45.210000000000001 110.108 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -81.26 98.12 7.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.528 -0.916 . . . . 74.099999999999994 108.528 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 50.5 m -120.35 149.94 41.53 Favored 'General case' 0 C--N 1.278 -2.5 0 C-N-CA 120.121 -0.632 . . . . 70.349999999999994 110.845 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 274' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 75.6 mtm180 -140.1 127.49 21.36 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.022 -1.103 . . . . 70.140000000000001 108.022 174.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.416 ' HB ' HG12 ' C' ' 239' ' ' VAL . 7.8 t -135.29 140.06 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.678 0 N-CA-C 107.561 -1.274 . . . . 64.129999999999995 107.561 176.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 7.0 tt -120.65 111.74 18.01 Favored 'General case' 0 N--CA 1.403 -2.789 0 C-N-CA 118.894 -1.122 . . . . 63.509999999999998 108.871 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.66 103.18 14.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 105.272 -2.122 . . . . 74.140000000000001 105.272 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 278' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 149.11 -140.32 8.09 Favored Glycine 0 CA--C 1.492 -1.401 0 C-N-CA 120.286 -0.959 . . . . 64.150000000000006 111.852 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -128.45 133.89 48.63 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.417 -0.586 . . . . 72.310000000000002 109.417 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' C' ' 287' ' ' TRP . 10.2 tp10 -111.75 118.72 36.37 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.351 -1.351 . . . . 74.319999999999993 107.351 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -105.31 123.58 48.1 Favored 'General case' 0 C--O 1.253 1.282 0 N-CA-C 107.713 -1.218 . . . . 73.430000000000007 107.713 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.35 -42.03 2.04 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.958 -0.857 . . . . 73.099999999999994 110.958 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 73.06 43.4 40.36 Favored Glycine 0 CA--C 1.482 -1.996 0 N-CA-C 109.219 -1.552 . . . . 53.439999999999998 109.219 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -151.46 6.23 0.47 Allowed 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.236 -0.482 . . . . 72.010000000000005 110.027 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -92.01 -80.6 1.43 Allowed Glycine 0 CA--C 1.491 -1.442 0 C-N-CA 119.943 -1.122 . . . . 21.210000000000001 110.693 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -95.42 -27.7 15.29 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.136 -1.061 . . . . 74.510000000000005 108.136 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.529 ' HA ' ' CE3' ' C' ' 287' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.168 0 CA-C-N 114.61 -1.177 . . . . 74.010000000000005 112.984 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 17.0 ptt85 . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 121.776 0.798 . . . . 74.099999999999994 112.588 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -98.41 147.55 24.6 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.714 -1.958 . . . . 65.150000000000006 105.714 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.5 m -121.8 136.37 54.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.531 0.681 . . . . 73.420000000000002 111.28 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.4 129.17 37.0 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.481 -1.303 . . . . 63.149999999999999 107.481 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -89.08 -43.93 10.72 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.292 -0.633 . . . . 74.120000000000005 109.292 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -139.86 138.93 36.13 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.693 0.283 . . . . 74.409999999999997 110.267 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 56.2 mt -137.09 123.48 28.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 106.497 -1.668 . . . . 70.430000000000007 106.497 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 60.4 ttt-85 -128.88 115.27 17.61 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.201 -1.037 . . . . 70.219999999999999 108.201 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 30.9 p -120.5 128.41 53.11 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.982 -0.448 . . . . 44.299999999999997 110.789 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -127.78 140.34 52.11 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 110.083 -0.34 . . . . 72.439999999999998 110.083 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.422 ' C ' ' HD2' ' A' ' 236' ' ' ARG . 40.1 mt-10 59.87 105.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.529 1.677 . . . . 53.439999999999998 115.529 169.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 272' ' ' GLU . 1.2 mpt_? 53.0 24.15 3.28 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.071 1.348 . . . . 72.319999999999993 111.526 176.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.97 151.67 23.07 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 120.981 0.42 . . . . 64.099999999999994 110.553 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.32 135.55 38.99 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.649 -0.705 . . . . 73.450000000000003 109.241 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 3.2 p -133.11 140.17 47.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.863 -0.608 . . . . 70.340000000000003 110.526 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -116.32 124.42 50.08 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.63 -1.248 . . . . 75.340000000000003 107.63 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tt -119.07 117.47 28.83 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 105.527 -2.027 . . . . 70.209999999999994 105.527 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.592 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 131.32 -162.28 23.65 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 109.662 -1.375 . . . . 44.25 109.662 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -117.43 134.74 54.49 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 109.172 -0.677 . . . . 71.409999999999997 109.172 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 30.8 t -107.0 121.61 60.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.29 -1.004 . . . . 74.439999999999998 108.29 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 56.2 t -113.58 114.95 48.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.502 -0.925 . . . . 72.230000000000004 108.502 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.437 HG21 ' HB2' ' A' ' 284' ' ' LYS . 12.3 m -96.96 160.37 14.39 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.259 -1.015 . . . . 74.349999999999994 108.259 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.19 75.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.176 0.59 . . . . 74.219999999999999 111.067 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.38 66.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.353 1.061 . . . . 72.430000000000007 113.399 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.316 -0.862 0 CA-C-O 120.854 0.359 . . . . 61.329999999999998 110.954 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.213 -0.827 0 N-CA-C 110.135 -0.32 . . . . 74.109999999999999 110.135 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -126.25 150.2 48.57 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 104.953 -2.239 . . . . 72.530000000000001 104.953 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 26.7 m -134.93 123.77 23.91 Favored 'General case' 0 C--O 1.263 1.797 0 N-CA-C 114.494 1.294 . . . . 74.140000000000001 114.494 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -121.76 134.5 64.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 CA-C-N 115.108 -0.951 . . . . 72.349999999999994 110.616 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -77.35 -73.19 0.31 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.611 -0.722 . . . . 73.209999999999994 110.804 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 32.3 m -126.12 126.82 44.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 120.882 -0.327 . . . . 53.020000000000003 110.227 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.458 HG11 HD11 ' A' ' 277' ' ' ILE . 3.4 p -129.64 120.85 51.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.848 0.832 . . . . 64.349999999999994 110.874 176.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 44.7 t -118.71 135.28 59.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.073 -0.967 . . . . 42.32 110.892 -175.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.472 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -121.37 131.12 8.45 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 108.411 -1.875 . . . . 71.120000000000005 108.411 172.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.493 ' HB3' ' HG2' ' B' ' 234' ' ' GLU . 7.1 tmtm? -134.91 115.02 13.12 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.437 -0.579 . . . . 72.319999999999993 109.437 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.37 82.71 0.68 Allowed Glycine 0 C--O 1.216 -0.977 0 C-N-CA 120.672 -0.775 . . . . 64.400000000000006 114.309 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 236' ' ' ARG . 41.5 mt-10 63.62 24.32 13.91 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.438 1.095 . . . . 64.510000000000005 112.414 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 48.8 m -82.46 145.12 30.0 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 121.715 0.769 . . . . 75.439999999999998 111.491 -176.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -109.09 127.86 54.5 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 106.42 -1.696 . . . . 75.439999999999998 106.42 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.4 p -129.23 123.55 58.48 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.665 0 N-CA-C 108.94 -0.763 . . . . 74.010000000000005 108.94 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.432 HD13 HE22 ' B' ' 240' ' ' GLN . 4.5 tt -113.53 120.21 40.2 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 107.88 -1.155 . . . . 64.400000000000006 107.88 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.458 HD11 HG11 ' A' ' 267' ' ' VAL . 41.7 mm -112.45 103.49 15.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.716 -1.216 . . . . 73.310000000000002 107.716 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.645 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 147.15 -145.06 13.38 Favored Glycine 0 C--N 1.301 -1.381 0 N-CA-C 110.452 -1.059 . . . . 34.399999999999999 110.452 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -127.53 143.3 51.2 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.628 -0.879 . . . . 74.329999999999998 108.628 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.75 120.23 37.94 Favored 'General case' 0 C--O 1.259 1.605 0 N-CA-C 106.849 -1.537 . . . . 73.239999999999995 106.849 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -107.12 123.11 47.77 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 106.854 -1.536 . . . . 75.450000000000003 106.854 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 98.96 -48.08 1.33 Allowed Glycine 0 C--N 1.295 -1.701 0 C-N-CA 120.54 -0.838 . . . . 72.530000000000001 111.356 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 82.93 15.04 73.72 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.829 -0.7 . . . . 63.219999999999999 113.036 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.437 ' HB2' HG21 ' A' ' 246' ' ' THR . 32.1 mmtp -127.47 5.91 6.27 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.264 -0.551 . . . . 74.349999999999994 111.755 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -85.71 -54.79 2.69 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 110.173 -1.171 . . . . 72.329999999999998 110.173 -178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -111.86 -30.68 7.2 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.143 -0.529 . . . . 72.340000000000003 109.674 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.481 ' CH2' ' HB2' ' B' ' 238' ' ' ARG 0.283 11.3 t-105 . . . . . 0 N--CA 1.413 -2.285 0 C-N-CA 118.441 -1.304 . . . . 74.010000000000005 113.684 -173.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.66 ' O ' ' HA ' ' B' ' 261' ' ' THR . 8.7 ptm180 . . . . . 0 N--CA 1.425 -1.724 0 CA-C-O 121.711 0.767 . . . . 75.030000000000001 110.621 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -103.69 149.11 25.27 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 104.576 -2.379 . . . . 71.409999999999997 104.576 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 23.9 m -125.75 134.74 51.65 Favored 'General case' 0 N--CA 1.411 -2.386 0 C-N-CA 119.252 -0.979 . . . . 74.439999999999998 110.497 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.428 ' HB2' HG21 ' B' ' 277' ' ' ILE . . . -131.24 121.74 25.3 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.156 -1.384 . . . . 75.349999999999994 110.331 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -76.1 -67.14 0.71 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.156 -0.929 . . . . 72.319999999999993 112.164 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -127.16 137.07 52.87 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 118.327 -1.349 . . . . 74.230000000000004 108.752 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.475 HG21 HG21 ' B' ' 239' ' ' VAL . 43.3 mt -131.93 117.68 34.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.35 -1.352 . . . . 64.439999999999998 107.35 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -126.09 115.15 19.38 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.226 -0.657 . . . . 61.240000000000002 109.226 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.472 ' OG1' ' HA2' ' A' ' 269' ' ' GLY . 71.2 p -112.66 127.24 56.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.844 -1.169 . . . . 55.130000000000003 107.844 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 234' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' B' ' 270' ' ' LYS . 52.2 mt-10 -131.44 139.89 49.49 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 122.072 -0.392 . . . . 72.420000000000002 111.1 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.542 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 28.9 mt-10 60.56 93.62 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 O-C-N 124.711 1.257 . . . . 73.310000000000002 114.037 171.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.542 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 1.4 mpt_? 63.0 15.6 8.56 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 125.036 1.335 . . . . 73.239999999999995 111.06 175.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -78.15 156.57 29.82 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.197 0.522 . . . . 75.340000000000003 111.071 -176.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.481 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -139.75 135.15 32.8 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.362 -0.607 . . . . 60.009999999999998 109.362 177.093 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.4 p -133.32 142.45 41.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.632 0.73 . . . . 72.319999999999993 111.381 -178.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.692 ' HB2' ' CE2' ' B' ' 286' ' ' PHE . 5.8 tp-100 -109.35 131.99 54.55 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.382 -1.34 . . . . 65.129999999999995 107.382 173.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.409 ' HB3' HD13 ' A' ' 277' ' ' ILE . 3.3 tm? -129.72 115.58 17.53 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 104.801 -2.296 . . . . 75.040000000000006 104.801 171.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 135.96 -136.32 8.36 Favored Glycine 0 N--CA 1.417 -2.578 0 N-CA-C 109.057 -1.617 . . . . 61.240000000000002 109.057 -175.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -142.3 148.71 38.47 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 117.575 0.688 . . . . 74.239999999999995 109.682 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 17.2 t -114.8 124.11 71.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.538 -1.282 . . . . 72.219999999999999 107.538 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.15 113.37 38.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 120.178 -0.609 . . . . 73.200000000000003 109.494 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.475 HG21 ' HB2' ' B' ' 284' ' ' LYS . 7.4 m -95.09 159.5 14.99 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.353 -1.351 . . . . 70.200000000000003 107.353 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -64.15 -32.13 73.58 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.941 0.876 . . . . 72.430000000000007 110.241 177.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.89 -44.47 74.13 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.383 -1.735 . . . . 71.019999999999996 113.366 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -75.74 -47.7 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.273 -0.571 . . . . 71.030000000000001 111.16 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 N--CA 1.467 0.423 0 C-N-CA 123.929 0.892 . . . . 71.140000000000001 109.296 -175.448 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 3.7 m . . . . . 0 CA--C 1.506 -0.719 0 N-CA-C 108.44 -0.948 . . . . 72.510000000000005 108.44 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' B' ' 225' ' ' ARG . 25.3 m -132.96 135.18 45.36 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.639 -1.615 . . . . 62.039999999999999 106.639 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -126.67 146.05 50.34 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.192 -1.781 . . . . 72.530000000000001 106.192 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 263' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' C' ' 227' ' ' SER . 40.5 m -125.6 123.51 39.18 Favored 'General case' 0 C--O 1.256 1.434 0 C-N-CA 118.536 -1.266 . . . . 72.409999999999997 114.043 -170.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.439 HG21 HG13 ' B' ' 267' ' ' VAL . 11.3 p -128.63 137.31 57.67 Favored 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 120.088 -0.645 . . . . 75.239999999999995 111.212 172.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.562 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 10.4 tp10 -86.34 -63.36 1.33 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.025 -0.534 . . . . 73.439999999999998 110.01 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 25.1 m -137.15 127.56 26.58 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.346 -0.847 . . . . 70.040000000000006 112.408 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.465 HG12 HD12 ' C' ' 231' ' ' ILE . 30.4 m -118.56 128.41 75.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 115.882 -0.599 . . . . 63.109999999999999 109.815 173.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.41 130.63 74.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.61 -0.723 . . . . 65.219999999999999 109.98 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.44 132.95 9.28 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 110.585 -1.006 . . . . 70.519999999999996 110.585 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.528 ' HD2' ' HB2' ' B' ' 234' ' ' GLU . 31.2 mmmt -132.91 115.64 15.49 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 123.218 0.607 . . . . 70.140000000000001 111.108 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.61 80.67 0.61 Allowed Glycine 0 C--N 1.304 -1.196 0 C-N-CA 120.445 -0.883 . . . . 43.340000000000003 114.589 172.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 63.7 28.64 14.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.159 0.984 . . . . 54.219999999999999 112.509 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 273' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 50.1 m -81.97 145.19 30.41 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.351 0.596 . . . . 73.239999999999995 111.175 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.436 ' HD3' ' HB3' ' C' ' 238' ' ' ARG . 6.1 mpt_? -109.5 128.72 55.38 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 106.849 -1.537 . . . . 64.319999999999993 106.849 174.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.4 p -130.96 123.06 53.32 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 N-CA-C 108.17 -1.048 . . . . 74.400000000000006 108.17 172.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 6.1 tt -114.08 116.79 29.7 Favored 'General case' 0 C--N 1.277 -2.571 0 C-N-CA 119.36 -0.936 . . . . 55.119999999999997 108.599 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.465 HG23 HD12 ' C' ' 241' ' ' LEU . 34.0 mm -106.46 102.54 14.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 106.834 -1.543 . . . . 61.140000000000001 106.834 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 146.82 -164.36 28.53 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 110.856 -0.897 . . . . 10.109999999999999 110.856 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -109.54 139.66 44.28 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.159 -0.682 . . . . 72.140000000000001 109.159 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.95 118.89 36.73 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.256 -1.757 . . . . 74.120000000000005 106.256 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -105.91 122.95 47.17 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.891 -1.151 . . . . 73.439999999999998 107.891 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.44 -46.47 1.28 Allowed Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.669 -0.696 . . . . 73.549999999999997 111.682 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 74.59 29.25 61.86 Favored Glycine 0 CA--C 1.506 -0.486 0 N-CA-C 111.555 -0.618 . . . . 23.010000000000002 111.555 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 284' ' ' LYS . . . . . 0.475 ' HB2' HG21 ' B' ' 246' ' ' THR . 73.1 mmtt -137.25 11.41 3.03 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.528 -0.336 . . . . 72.319999999999993 110.624 -177.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -103.78 -47.05 1.31 Allowed Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 119.729 -1.224 . . . . 75.319999999999993 110.686 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.692 ' CE2' ' HB2' ' B' ' 240' ' ' GLN . 6.3 t80 -110.03 -42.11 4.29 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.996 0.427 . . . . 75.409999999999997 110.39 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.517 ' CZ2' ' HB2' ' C' ' 238' ' ' ARG . 11.2 t-105 . . . . . 0 N--CA 1.427 -1.586 0 N-CA-C 115.483 1.661 . . . . 75.150000000000006 115.483 -165.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' B' ' 261' ' ' THR . 15.8 ptt-85 . . . . . 0 N--CA 1.433 -1.316 0 CA-C-O 122.614 1.197 . . . . 70.439999999999998 114.115 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -116.25 147.41 41.51 Favored 'General case' 0 N--CA 1.399 -2.985 0 N-CA-C 105.26 -2.126 . . . . 75.25 105.26 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 227' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' C' ' 263' ' ' SER . 24.1 m -130.03 136.55 49.52 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 121.269 0.557 . . . . 62.039999999999999 110.117 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.511 ' HB2' HG21 ' C' ' 277' ' ' ILE . . . -130.41 134.37 47.08 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 109.198 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.562 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -85.95 -61.32 1.78 Allowed 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 115.266 -0.879 . . . . 71.400000000000006 109.193 -178.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -129.56 137.97 51.05 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.953 -0.699 . . . . 71.239999999999995 110.345 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.465 HD12 HG12 ' B' ' 267' ' ' VAL . 34.5 mt -135.18 119.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.879 -0.785 . . . . 70.109999999999999 108.879 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.429 ' HB3' HG12 ' C' ' 268' ' ' VAL . 30.9 ttt180 -125.56 115.92 20.94 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.998 0.428 . . . . 72.129999999999995 110.078 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 38.9 p -112.61 127.5 56.11 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.452 -0.944 . . . . 74.129999999999995 108.452 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -131.55 139.43 49.23 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.437 -0.505 . . . . 71.010000000000005 110.691 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.459 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 38.2 mt-10 62.81 92.16 0.06 Allowed 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 124.926 1.391 . . . . 45.399999999999999 114.133 170.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.459 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 2.8 mpt_? 63.55 12.04 6.14 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.859 1.264 . . . . 55.32 111.21 175.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -77.97 149.01 34.18 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.204 0.526 . . . . 62.509999999999998 111.64 -174.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.517 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.0 OUTLIER -133.65 134.96 43.8 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.943 -0.572 . . . . 72.329999999999998 111.511 176.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.6 p -132.97 137.86 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 115.276 -0.875 . . . . 70.319999999999993 111.534 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -106.03 129.79 54.07 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 114.127 -1.397 . . . . 63.539999999999999 107.863 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.465 HD12 HG23 ' B' ' 277' ' ' ILE . 3.2 tm? -125.15 116.32 21.85 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.069 -1.826 . . . . 71.129999999999995 106.069 173.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.653 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 126.98 -148.18 17.21 Favored Glycine 0 C--N 1.284 -2.348 0 N-CA-C 108.278 -1.929 . . . . 65.409999999999997 108.278 -176.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -126.96 150.16 49.51 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 118.336 1.068 . . . . 72.409999999999997 110.621 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.78 126.56 74.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.614 -1.254 . . . . 73.340000000000003 107.614 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 65.4 t -122.52 118.59 55.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 120.439 -0.504 . . . . 63.43 109.98 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 9.4 m -95.27 159.42 15.02 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 108.114 -1.069 . . . . 71.409999999999997 108.114 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -64.05 -33.76 76.48 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.354 0.597 . . . . 55.329999999999998 110.776 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.14 -47.76 74.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.405 -1.271 . . . . 71.409999999999997 111.464 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.515 0 CA-C-O 120.941 0.4 . . . . 54.229999999999997 111.367 177.155 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.415 -2.195 0 N-CA-C 109.584 -0.524 . . . . 75.319999999999993 109.584 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -112.51 124.48 52.61 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.064 -1.828 . . . . 70.409999999999997 106.064 173.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 263' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' C' ' 227' ' ' SER . 10.7 p -130.37 144.79 51.6 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 113.735 1.013 . . . . 71.209999999999994 113.735 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 10.0 p -128.51 149.58 33.43 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.494 -0.775 . . . . 64.450000000000003 110.296 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -81.03 -68.28 0.7 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.626 0.25 . . . . 74.099999999999994 111.284 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 61.8 m -138.59 127.6 23.94 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 120.367 -0.533 . . . . 75.120000000000005 110.646 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.1 m -118.68 134.6 61.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.466 -0.568 . . . . 63.439999999999998 109.466 172.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 268' ' ' VAL . . . . . 0.429 HG12 ' HB3' ' C' ' 232' ' ' ARG . 13.6 m -127.1 135.53 63.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-N 115.634 -0.712 . . . . 53.119999999999997 110.485 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.15 132.35 9.08 Favored Glycine 0 CA--C 1.47 -2.739 0 N-CA-C 109.089 -1.604 . . . . 44.299999999999997 109.089 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -134.4 115.21 13.75 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.603 -0.888 . . . . 75.120000000000005 108.603 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.39 91.61 0.19 Allowed Glycine 0 C--O 1.242 0.653 0 C-N-CA 121.139 -0.553 . . . . 71.150000000000006 113.427 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 56.5 29.65 15.77 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.638 1.175 . . . . 72.519999999999996 112.158 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 23.2 m -82.8 145.24 29.62 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 119.561 -0.856 . . . . 63.200000000000003 111.547 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 274' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' C' ' 274' ' ' ARG . 6.5 mtm180 -118.72 127.65 53.76 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 107.908 -1.145 . . . . 71.409999999999997 107.908 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 4.0 p -138.25 128.5 35.06 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-N 115.592 -0.731 . . . . 64.0 109.292 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.7 tt -116.62 115.3 25.45 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.485 -0.931 . . . . 72.420000000000002 108.485 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' C' ' 228' ' ' ALA . 43.1 mm -105.9 102.97 14.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 106.509 -1.663 . . . . 73.120000000000005 106.509 178.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 278' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 141.42 -163.2 26.84 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 111.028 -0.829 . . . . 53.399999999999999 111.028 -174.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -114.08 135.87 53.55 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.818 -0.808 . . . . 75.239999999999995 108.818 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.69 118.68 36.31 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.169 -1.789 . . . . 75.310000000000002 106.169 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -105.26 123.39 47.76 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 109.097 -0.705 . . . . 75.239999999999995 109.097 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.19 -43.65 1.66 Allowed Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 109.957 -1.257 . . . . 64.430000000000007 109.957 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 80.1 21.68 64.84 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.359 -0.697 . . . . 70.409999999999997 111.359 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 284' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' C' ' 287' ' ' TRP . 33.3 mttm -145.68 20.5 1.49 Allowed 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 113.987 1.106 . . . . 61.119999999999997 113.987 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -94.58 -45.5 3.18 Favored Glycine 0 N--CA 1.427 -1.922 0 N-CA-C 107.794 -2.123 . . . . 64.420000000000002 107.794 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.53 -50.91 3.11 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.578 -1.267 . . . . 74.25 107.578 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.574 ' O ' ' HA ' ' C' ' 284' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.308 -1.204 0 CA-C-N 115.268 -0.878 . . . . 71.450000000000003 112.097 -169.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 . . . . . 0 N--CA 1.426 -1.674 0 CA-C-O 121.695 0.759 . . . . 75.310000000000002 112.053 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -110.28 134.96 51.74 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.301 -1.318 . . . . 62.229999999999997 108.677 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.6 m -126.19 136.71 53.17 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 109.326 -0.62 . . . . 74.099999999999994 109.326 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.18 132.19 27.83 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.453 -1.684 . . . . 70.129999999999995 106.453 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.17 -56.85 2.5 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.873 -0.731 . . . . 71.109999999999999 111.656 -174.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.81 139.57 52.57 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.129 -0.693 . . . . 64.019999999999996 109.129 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.2 mm -131.92 118.72 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.884 -0.784 . . . . 73.209999999999994 108.884 -174.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -120.56 127.01 51.75 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.846 -0.428 . . . . 72.439999999999998 109.846 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 45.1 p -133.46 128.64 35.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.684 -0.487 . . . . 65.230000000000004 109.684 -176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.424 ' HB2' ' HD3' ' A' ' 270' ' ' LYS . 42.7 mt-10 -142.8 139.71 31.07 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 121.059 -0.256 . . . . 74.319999999999993 110.773 176.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.606 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 38.7 mt-10 64.18 95.64 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 114.748 1.388 . . . . 50.140000000000001 114.748 170.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.606 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.1 mpp_? 60.31 26.85 16.37 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.674 1.19 . . . . 74.340000000000003 110.435 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -92.35 125.95 37.23 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 115.252 -0.886 . . . . 75.140000000000001 110.614 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.539 ' HD3' ' HG2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -128.05 134.94 49.25 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.621 -0.881 . . . . 70.299999999999997 108.621 176.665 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.657 HG12 ' HB ' ' A' ' 275' ' ' VAL . 33.1 m -134.32 150.12 30.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 116.116 -0.493 . . . . 72.040000000000006 110.711 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 15.7 tm0? -123.14 125.34 44.96 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.336 -1.357 . . . . 71.219999999999999 107.336 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -116.12 117.75 30.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.65 -1.241 . . . . 75.230000000000004 107.65 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.452 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 126.59 -159.57 20.86 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 111.337 -0.705 . . . . 73.140000000000001 111.337 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' A' ' 279' ' ' ASN . 39.3 t30 -107.0 137.86 44.27 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 122.935 0.494 . . . . 72.430000000000007 110.383 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 99.9 t -113.27 114.33 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.249 -0.649 . . . . 45.420000000000002 109.249 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.513 ' HA ' ' HB3' ' A' ' 281' ' ' TYR . 27.4 m -99.32 118.39 45.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 119.844 -0.742 . . . . 65.129999999999995 110.711 176.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 17.6 m -102.0 158.95 15.78 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.562 -0.533 . . . . 73.150000000000006 109.562 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.79 -35.27 80.24 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.639 0.977 . . . . 50.109999999999999 113.639 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -39.03 68.01 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.476 1.288 . . . . 62.439999999999998 114.476 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.571 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.318 -0.763 0 N-CA-C 112.217 0.451 . . . . 74.420000000000002 112.217 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.408 -2.54 0 N-CA-C 106.204 -1.776 . . . . 74.349999999999994 106.204 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 24.9 m-80 -104.91 130.8 53.0 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.797 -0.816 . . . . 63.200000000000003 108.797 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 59.5 m -138.96 123.43 18.34 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.53 -0.545 . . . . 54.210000000000001 109.53 174.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 12.7 p -128.19 149.18 32.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.844 -1.169 . . . . 73.109999999999999 107.844 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 32.1 tt0 -92.91 -67.6 0.85 Allowed 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 120.005 -0.678 . . . . 73.420000000000002 110.339 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 20.7 m -123.74 133.08 53.91 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.235 -0.586 . . . . 74.439999999999998 111.429 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.84 131.71 72.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 108.492 -0.929 . . . . 72.319999999999993 108.492 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 6.4 p -127.26 131.51 70.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 110.207 -0.294 . . . . 62.439999999999998 110.207 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.486 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -122.71 131.49 8.31 Favored Glycine 0 CA--C 1.485 -1.837 0 C-N-CA 120.34 -0.933 . . . . 34.409999999999997 111.347 176.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 234' ' ' GLU . 15.9 tptm -134.41 115.84 14.48 Favored 'General case' 0 N--CA 1.428 -1.531 0 O-C-N 123.679 0.282 . . . . 70.430000000000007 110.828 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.63 99.7 0.49 Allowed Glycine 0 C--O 1.245 0.801 0 C-N-CA 120.717 -0.754 . . . . 73.25 113.878 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' B' ' 236' ' ' ARG . 51.8 mm-40 60.55 24.18 13.87 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.432 1.093 . . . . 63.240000000000002 110.597 175.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 18.9 m -82.57 144.63 30.22 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.987 0.899 . . . . 74.239999999999995 112.784 -169.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' ARG . . . . . 0.539 ' HG2' ' HD3' ' A' ' 238' ' ' ARG . 82.9 mtt180 -135.31 126.21 27.57 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.124 -1.436 . . . . 75.239999999999995 107.124 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.657 ' HB ' HG12 ' A' ' 239' ' ' VAL . 46.4 t -136.19 133.67 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.989 0 N-CA-C 109.691 -0.485 . . . . 65.030000000000001 109.691 -176.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 6.3 tt -119.45 117.98 29.89 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.507 -1.277 . . . . 74.340000000000003 108.849 171.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.432 HG22 ' HB3' ' B' ' 241' ' ' LEU . 2.7 pt -112.54 104.38 16.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-O 121.622 0.725 . . . . 74.430000000000007 109.508 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.687 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 148.21 -133.45 4.62 Favored Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 115.843 -0.617 . . . . 63.539999999999999 111.568 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 243' ' ' ASN . 14.3 m120 -128.29 153.5 46.92 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.507 -0.923 . . . . 74.109999999999999 108.507 -176.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.17 143.45 34.25 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.945 0.878 . . . . 73.420000000000002 110.475 170.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.513 ' HB3' ' HA ' ' A' ' 245' ' ' VAL 0.252 5.3 t80 -119.45 124.63 46.98 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 105.801 -1.926 . . . . 74.319999999999993 105.801 -175.277 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 144.2 -52.13 0.62 Allowed Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.003 -1.094 . . . . 61.329999999999998 112.974 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.453 ' HA3' HG23 ' B' ' 246' ' ' THR . . . 119.87 -34.74 4.08 Favored Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 108.816 -1.714 . . . . 40.130000000000003 108.816 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -135.89 87.47 2.31 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.609 -1.626 . . . . 72.099999999999994 106.609 170.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -95.97 -132.81 7.26 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.812 -0.915 . . . . 45.420000000000002 110.812 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 26.0 t80 52.07 -130.1 2.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 107.819 -1.178 . . . . 75.310000000000002 107.819 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 . . . . . 0 C--N 1.299 -1.627 0 N-CA-C 107.318 -1.364 . . . . 70.25 107.318 172.693 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 . . . . . 0 CA--C 1.502 -0.891 0 N-CA-C 112.255 0.465 . . . . 73.420000000000002 112.255 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 6.9 t30 -118.58 113.39 21.18 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.654 -0.869 . . . . 74.409999999999997 108.654 169.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 46.7 m -121.26 136.61 54.94 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-O 121.725 0.774 . . . . 61.520000000000003 110.124 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.21 147.58 52.0 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.999 -1.482 . . . . 55.539999999999999 106.999 178.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 10.0 tmtt? -104.51 -67.76 0.89 Allowed 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.677 -0.809 . . . . 75.420000000000002 109.299 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 230' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' B' ' 266' ' ' THR . 33.3 t70 -128.01 138.7 52.69 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.435 -0.58 . . . . 73.400000000000006 109.435 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.48 HD11 ' HB1' ' B' ' 228' ' ' ALA . 39.9 mm -128.88 117.57 44.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.637 -0.875 . . . . 71.400000000000006 108.637 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -114.31 114.51 26.02 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.895 -0.78 . . . . 72.420000000000002 108.895 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.486 ' OG1' ' HA2' ' A' ' 269' ' ' GLY . 78.2 p -111.53 127.24 55.65 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 107.664 -1.235 . . . . 54.539999999999999 107.664 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -139.34 138.93 37.07 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 120.842 -0.343 . . . . 73.129999999999995 111.019 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.6 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 44.5 mt-10 57.99 98.4 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 125.098 1.499 . . . . 70.299999999999997 114.908 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.6 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.2 OUTLIER 60.75 26.21 16.02 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.859 -1.064 . . . . 71.219999999999999 110.198 174.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -91.35 136.03 33.4 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.121 -0.945 . . . . 62.219999999999999 111.882 -175.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 3.5 mpt_? -125.94 134.41 51.55 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.711 -1.218 . . . . 74.230000000000004 107.711 176.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.629 HG12 ' HB ' ' B' ' 275' ' ' VAL . 19.7 m -138.97 147.41 24.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.234 0.54 . . . . 61.240000000000002 110.945 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -122.06 127.93 50.78 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.66 -1.608 . . . . 74.219999999999999 106.66 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' B' ' 277' ' ' ILE . 2.3 tm? -122.5 117.67 26.49 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.892 -1.522 . . . . 53.439999999999998 106.892 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 136.92 -126.39 3.7 Favored Glycine 0 N--CA 1.428 -1.861 0 C-N-CA 120.804 -0.713 . . . . 52.340000000000003 111.761 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 243' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' B' ' 279' ' ' ASN . 43.9 t30 -142.78 134.86 27.23 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 110.286 -0.264 . . . . 73.430000000000007 110.286 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.55 HG11 ' H ' ' B' ' 286' ' ' PHE . 68.7 t -114.94 114.91 47.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 109.539 -0.541 . . . . 64.129999999999995 109.539 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.499 ' HA ' ' HB3' ' B' ' 281' ' ' TYR . 28.5 m -104.15 112.72 38.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.69 -0.804 . . . . 61.140000000000001 111.192 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.484 HG22 ' H ' ' B' ' 248' ' ' ALA . 42.0 m -81.72 158.19 24.29 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 121.047 0.451 . . . . 75.010000000000005 110.914 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.23 93.24 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.322 1.049 . . . . 63.310000000000002 112.342 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 248' ' ' ALA . . . . . 0.484 ' H ' HG22 ' B' ' 246' ' ' THR . . . -55.31 -44.29 75.65 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.068 -1.424 . . . . 33.299999999999997 114.065 -173.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.71 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -74.95 -25.76 59.12 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 120.9 0.381 . . . . 62.530000000000001 110.744 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 CA--C 1.515 -0.389 0 C-N-CA 125.186 1.395 . . . . 74.230000000000004 109.458 -171.155 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 16.7 m . . . . . 0 CA--C 1.541 0.614 0 CA-C-O 121.936 0.874 . . . . 64.129999999999995 111.254 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 33.9 m -124.11 108.91 12.83 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 115.039 -0.982 . . . . 71.219999999999999 108.565 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -108.49 132.59 53.66 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 109.65 -0.5 . . . . 63.409999999999997 109.65 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 263' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' C' ' 227' ' ' SER . 37.3 t -142.19 123.86 15.06 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.418 -0.586 . . . . 75.239999999999995 109.418 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.9 p -123.7 148.64 27.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.535 -0.913 . . . . 73.329999999999998 108.535 177.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 37.4 tt0 -89.21 -72.79 0.53 Allowed 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 119.576 -0.85 . . . . 73.430000000000007 110.529 175.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 25.1 m -127.81 133.97 49.44 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.917 -1.114 . . . . 73.329999999999998 112.471 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.82 135.27 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.793 -1.188 . . . . 72.530000000000001 107.793 173.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 5.3 p -127.48 125.43 65.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 121.024 0.44 . . . . 74.209999999999994 110.677 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.57 132.52 10.5 Favored Glycine 0 CA--C 1.476 -2.406 0 N-CA-C 111.137 -0.785 . . . . 53.520000000000003 111.137 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.502 ' HB3' ' HG2' ' C' ' 234' ' ' GLU . 40.6 tptt -134.12 115.83 14.7 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 109.987 -0.375 . . . . 70.230000000000004 109.987 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.97 99.74 0.06 OUTLIER Glycine 0 CA--C 1.527 0.782 0 N-CA-C 114.159 0.424 . . . . 61.32 114.159 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 63.91 26.83 14.33 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.161 0.984 . . . . 74.540000000000006 112.421 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 273' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 37.4 m -83.41 144.79 29.38 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.444 -0.902 . . . . 64.120000000000005 113.066 -171.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 4.8 mtt-85 -135.55 127.23 29.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.001 -1.111 . . . . 72.439999999999998 108.001 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.629 ' HB ' HG12 ' B' ' 239' ' ' VAL . 55.6 t -136.49 138.44 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.594 0 N-CA-C 109.165 -0.68 . . . . 75.010000000000005 109.165 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 6.1 tt -123.44 120.88 34.25 Favored 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 119.095 -1.042 . . . . 72.340000000000003 108.434 169.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.496 HG22 ' HB3' ' C' ' 241' ' ' LEU . 1.5 pt -112.43 104.28 16.79 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 C-N-CA 123.991 0.916 . . . . 74.310000000000002 109.502 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.504 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 145.45 -133.63 5.14 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.804 -0.635 . . . . 60.109999999999999 111.699 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 279' ' ' ASN . . . . . 0.562 ' O ' ' HA ' ' B' ' 243' ' ' ASN . 86.6 m-20 -127.28 152.29 47.63 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-O 121.218 0.532 . . . . 70.5 109.978 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -137.68 150.01 47.0 Favored 'General case' 0 N--CA 1.409 -2.52 0 N-CA-C 107.962 -1.125 . . . . 72.140000000000001 107.962 170.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.499 ' HB3' ' HA ' ' B' ' 245' ' ' VAL . 11.2 t80 -125.51 124.34 41.12 Favored 'General case' 0 N--CA 1.395 -3.175 0 N-CA-C 107.623 -1.251 . . . . 61.509999999999998 107.623 -174.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.71 ' HA2' ' HB2' ' B' ' 249' ' ' ALA . . . 143.6 -48.03 0.77 Allowed Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.653 -0.784 . . . . 75.209999999999994 111.747 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 283' ' ' GLY . . . . . 0.446 ' HA3' HG23 ' C' ' 246' ' ' THR . . . 111.59 -23.72 17.03 Favored Glycine 0 C--O 1.206 -1.62 0 N-CA-C 108.578 -1.809 . . . . 60.409999999999997 108.578 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -141.92 81.88 1.78 Allowed 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 106.886 -1.524 . . . . 75.409999999999997 106.886 173.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -103.88 -159.93 24.61 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.492 -1.443 . . . . 64.439999999999998 109.492 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.55 ' H ' HG11 ' B' ' 244' ' ' VAL . 71.3 t80 63.3 -175.04 0.15 Allowed 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 122.912 0.485 . . . . 71.540000000000006 110.54 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 . . . . . 0 C--N 1.303 -1.44 0 O-C-N 120.528 -1.357 . . . . 74.200000000000003 112.292 -174.072 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 N--CA 1.432 -1.351 0 N-CA-C 113.707 1.003 . . . . 72.019999999999996 113.707 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -117.24 120.58 38.68 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.03 -1.441 . . . . 74.239999999999995 108.706 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 227' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' C' ' 263' ' ' SER . 42.7 m -121.17 137.08 54.84 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.706 -0.479 . . . . 74.200000000000003 109.706 177.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -133.3 144.38 49.66 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.458 -0.942 . . . . 72.420000000000002 108.458 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -58.78 1.82 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.544 -0.862 . . . . 73.230000000000004 110.883 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 230' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' C' ' 266' ' ' THR . 1.2 m-20 -127.23 139.47 52.9 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.295 0.569 . . . . 75.150000000000006 110.734 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.428 HD11 ' HB1' ' C' ' 228' ' ' ALA . 32.6 mm -128.87 118.05 46.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 106.454 -1.684 . . . . 74.0 106.454 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -118.91 115.1 23.67 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.841 -0.429 . . . . 71.329999999999998 109.841 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 80.5 p -112.19 127.4 55.93 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 108.326 -0.99 . . . . 73.230000000000004 108.326 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.502 ' HG2' ' HB3' ' B' ' 270' ' ' LYS . 43.8 mt-10 -138.9 139.34 38.02 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 121.119 -0.232 . . . . 71.510000000000005 110.41 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.559 ' HB3' ' NH1' ' C' ' 236' ' ' ARG . 49.2 mt-10 56.76 95.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 115.539 1.681 . . . . 62.200000000000003 115.539 174.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.559 ' NH1' ' HB3' ' C' ' 235' ' ' GLU . 0.5 OUTLIER 61.06 24.14 14.26 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.164 0.986 . . . . 61.030000000000001 111.712 175.08 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -91.8 139.57 30.54 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.958 0.885 . . . . 75.5 112.774 -175.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.618 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 8.8 mpt_? -125.65 135.45 52.16 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.17 -1.377 . . . . 72.109999999999999 108.309 177.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.497 HG23 HG13 ' B' ' 275' ' ' VAL . 30.5 m -138.13 147.34 25.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.313 0.578 . . . . 64.450000000000003 110.66 172.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -121.1 129.53 53.35 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.089 -1.819 . . . . 75.349999999999994 106.089 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.496 ' HB3' HG22 ' B' ' 277' ' ' ILE . 2.8 tm? -122.0 118.58 29.16 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 106.162 -1.792 . . . . 74.200000000000003 106.162 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 135.54 -127.77 4.42 Favored Glycine 0 N--CA 1.416 -2.7 0 C-N-CA 120.179 -1.01 . . . . 53.240000000000002 111.421 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.596 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 45.9 t30 -144.34 130.36 19.47 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.525 0.202 . . . . 63.229999999999997 110.783 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.408 HG11 ' H ' ' C' ' 286' ' ' PHE . 85.2 t -110.92 117.88 56.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 123.713 0.805 . . . . 70.129999999999995 109.258 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 18.3 m -107.82 119.26 57.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 120.147 -0.621 . . . . 71.239999999999995 110.479 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 246' ' ' THR . . . . . 0.446 HG23 ' HA3' ' B' ' 283' ' ' GLY . 29.7 m -84.6 158.66 20.82 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 120.943 -0.303 . . . . 54.149999999999999 111.223 -176.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.15 -47.83 78.4 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 122.159 0.98 . . . . 55.240000000000002 110.871 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.38 -35.98 65.87 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.265 -1.789 . . . . 72.109999999999999 112.807 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 249' ' ' ALA . . . . . 0.666 ' HB2' ' HA2' ' C' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.31 -1.126 0 CA-C-N 116.166 -0.47 . . . . 41.420000000000002 111.967 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.435 -1.175 0 CA-C-O 120.899 0.38 . . . . 73.239999999999995 110.048 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -123.71 136.02 54.21 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 120.989 0.423 . . . . 71.230000000000004 109.862 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 263' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' C' ' 227' ' ' SER . 33.2 m -142.83 130.41 21.3 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.133 -0.692 . . . . 73.329999999999998 109.133 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.38 153.42 34.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.507 -0.553 . . . . 61.119999999999997 109.507 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -85.35 -74.76 0.39 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.477 -0.564 . . . . 75.219999999999999 109.477 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 266' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 60.4 m -138.41 134.11 33.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.687 -0.633 . . . . 72.349999999999994 110.693 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.54 136.04 57.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 108.374 -0.973 . . . . 72.519999999999996 108.374 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.18 137.16 58.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 116.514 -0.312 . . . . 70.439999999999998 110.308 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.48 133.02 7.51 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 110.933 -0.867 . . . . 71.219999999999999 110.933 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -133.91 115.03 13.95 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.847 -0.797 . . . . 73.129999999999995 108.847 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 74.47 108.75 0.08 OUTLIER Glycine 0 CA--C 1.527 0.834 0 O-C-N 123.843 0.714 . . . . 74.019999999999996 114.42 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 58.64 20.32 7.61 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 123.716 0.807 . . . . 72.519999999999996 112.282 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 273' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 24.4 m -83.76 144.2 29.48 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-O 121.233 0.539 . . . . 72.310000000000002 110.504 -173.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 274' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 0.0 OUTLIER -150.32 128.34 11.87 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.907 -0.588 . . . . 73.230000000000004 109.677 174.064 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 10.1 t -136.75 140.93 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 O-C-N 123.78 0.675 . . . . 60.420000000000002 109.232 -173.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.9 tt -112.03 116.67 30.93 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 107.939 -1.134 . . . . 61.219999999999999 107.939 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 3.2 mp -101.27 104.45 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 106.555 -1.646 . . . . 71.030000000000001 106.555 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 138.13 -128.48 4.22 Favored Glycine 0 N--CA 1.409 -3.152 0 C-N-CA 119.446 -1.359 . . . . 32.039999999999999 112.092 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 279' ' ' ASN . . . . . 0.596 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 11.8 m-20 -128.04 138.96 52.77 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.057 0.456 . . . . 73.420000000000002 111.822 -173.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -126.62 145.79 50.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.325 -1.361 . . . . 71.519999999999996 107.325 168.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -125.85 123.35 38.49 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 108.305 -0.998 . . . . 75.120000000000005 108.305 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 282' ' ' GLY . . . . . 0.666 ' HA2' ' HB2' ' C' ' 249' ' ' ALA . . . 134.03 9.77 1.87 Allowed Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.59 -0.732 . . . . 72.109999999999999 113.989 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 80.99 -47.93 3.66 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-N 117.92 0.86 . . . . 35.329999999999998 111.771 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -136.65 96.61 3.37 Favored 'General case' 0 N--CA 1.413 -2.302 0 N-CA-C 107.473 -1.306 . . . . 73.409999999999997 107.473 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -110.06 -159.74 17.73 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 108.666 -1.773 . . . . 44.329999999999998 108.666 173.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.408 ' H ' HG11 ' C' ' 244' ' ' VAL . 60.6 t80 73.87 169.97 0.3 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.803 0.841 . . . . 75.310000000000002 110.993 176.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 5.5 m0 . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 116.81 2.152 . . . . 74.219999999999999 116.81 -167.631 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.492 -1.267 0 N-CA-C 108.43 -0.952 . . . . 75.319999999999993 108.43 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -86.34 133.89 33.77 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.479 -1.304 . . . . 71.349999999999994 107.479 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 32.9 m -133.63 141.79 47.79 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.318 0.58 . . . . 75.299999999999997 112.386 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.34 137.88 37.79 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.003 -1.851 . . . . 74.099999999999994 106.003 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.41 -48.04 10.06 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.684 -0.858 . . . . 73.230000000000004 108.684 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -140.15 140.64 36.0 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 119.76 -0.776 . . . . 71.019999999999996 111.646 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 62.6 mt -126.49 117.17 47.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 106.806 -1.553 . . . . 71.439999999999998 106.806 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -118.92 115.96 25.47 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.619 -0.833 . . . . 63.539999999999999 110.127 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.1 t -113.11 128.69 56.56 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.602 -0.726 . . . . 65.239999999999995 109.276 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.425 ' HG2' ' HG3' ' A' ' 235' ' ' GLU . 40.3 tt0 -150.23 139.81 21.58 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 108.435 -0.95 . . . . 73.540000000000006 108.435 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.425 ' HG3' ' HG2' ' A' ' 234' ' ' GLU . 43.9 mt-10 65.6 89.14 0.1 Allowed 'General case' 0 C--O 1.22 -0.48 0 O-C-N 124.409 1.068 . . . . 73.120000000000005 113.075 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 271' ' ' GLY . 36.2 mtt85 66.33 -4.82 0.65 Allowed 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 124.448 1.099 . . . . 62.210000000000001 113.136 171.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.431 ' HA ' ' H ' ' A' ' 273' ' ' SER . . . -70.61 143.44 51.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 123.352 0.661 . . . . 74.439999999999998 111.2 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -126.37 135.81 51.92 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.979 -1.119 . . . . 71.540000000000006 107.979 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.431 HG12 ' HB ' ' A' ' 275' ' ' VAL . 34.7 m -128.73 150.82 34.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 120.844 0.354 . . . . 70.329999999999998 111.666 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.409 ' HG2' ' CG2' ' A' ' 244' ' ' VAL . 55.0 tp60 -134.05 134.55 42.5 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.137 -0.938 . . . . 75.129999999999995 108.831 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -128.14 119.28 24.97 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.583 -1.266 . . . . 74.310000000000002 107.583 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.501 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 132.35 -115.67 1.67 Allowed Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 119.991 -1.1 . . . . 63.149999999999999 112.689 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -143.51 135.86 27.05 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.301 -0.629 . . . . 53.25 109.301 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.409 ' CG2' ' HG2' ' A' ' 240' ' ' GLN . 99.0 t -116.94 120.63 65.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.46 -1.311 . . . . 73.129999999999995 107.46 175.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.73 117.19 51.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 108.996 -0.742 . . . . 64.209999999999994 108.996 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 90.5 m -77.48 159.72 29.17 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.064 -0.717 . . . . 75.019999999999996 109.064 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.38 -38.83 91.1 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.538 0.735 . . . . 64.310000000000002 112.122 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.13 -33.74 72.57 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.861 0.864 . . . . 72.120000000000005 111.551 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.542 0 CA-C-N 115.642 -0.708 . . . . 61.340000000000003 112.223 -176.638 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.1 m . . . . . 0 N--CA 1.424 -1.756 0 N-CA-C 106.701 -1.592 . . . . 75.140000000000001 106.701 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -121.15 141.43 50.83 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.213 -1.032 . . . . 73.329999999999998 108.213 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.7 p -136.23 123.4 21.71 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.056 -0.52 . . . . 74.430000000000007 111.588 -172.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 13.4 p -129.0 148.28 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 108.917 -0.772 . . . . 72.439999999999998 108.917 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 34.5 tt0 -85.89 -69.16 0.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.686 -0.487 . . . . 74.230000000000004 109.686 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 28.6 m -126.09 128.06 46.77 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.315 -0.554 . . . . 72.400000000000006 111.404 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 36.0 m -119.77 125.67 74.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.049 0 N-CA-C 109.101 -0.704 . . . . 71.109999999999999 109.101 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.14 134.9 64.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 116.078 -0.51 . . . . 55.329999999999998 112.063 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -123.96 132.27 8.31 Favored Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 111.298 -0.721 . . . . 60.439999999999998 111.298 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 26.3 mmmt -133.76 147.6 51.31 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.117 0.967 . . . . 71.209999999999994 112.175 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.439 ' O ' ' HD2' ' A' ' 236' ' ' ARG . . . 84.53 -57.82 5.01 Favored Glycine 0 CA--C 1.502 -0.732 0 CA-C-N 115.981 -0.554 . . . . 75.530000000000001 112.453 174.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 179.6 121.3 0.06 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 103.468 -2.79 . . . . 63.509999999999998 103.468 176.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 68.6 m -151.28 155.88 39.67 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.902 0.382 . . . . 52.210000000000001 110.685 -175.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' B' ' 238' ' ' ARG . 2.2 mpt_? -127.75 127.92 44.45 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.206 -1.776 . . . . 74.030000000000001 106.206 174.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.431 ' HB ' HG12 ' A' ' 239' ' ' VAL . 33.5 t -129.1 129.79 67.92 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 109.583 -0.525 . . . . 74.420000000000002 109.583 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.502 ' HB3' ' OE1' ' B' ' 240' ' ' GLN . 4.8 tt -125.32 118.94 27.04 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.197 -1.038 . . . . 63.009999999999998 108.197 172.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 43.5 mm -107.99 104.86 17.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.957 -1.127 . . . . 71.040000000000006 107.957 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 144.77 -140.04 8.91 Favored Glycine 0 N--CA 1.419 -2.464 0 C-N-CA 120.66 -0.781 . . . . 71.219999999999999 111.794 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -115.18 140.36 49.14 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 109.72 -0.474 . . . . 73.230000000000004 109.72 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.43 129.52 53.93 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.193 -2.151 . . . . 63.109999999999999 105.193 174.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 2.0 t80 -127.49 122.81 34.4 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 107.228 -1.397 . . . . 72.319999999999993 107.228 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.72 -52.95 0.63 Allowed Glycine 0 N--CA 1.412 -2.93 0 N-CA-C 108.624 -1.79 . . . . 61.25 108.624 -175.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 139.02 -57.84 0.62 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 111.17 -0.772 . . . . 64.140000000000001 111.17 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.557 ' HA ' ' NE1' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -132.18 35.2 3.72 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.948 0.88 . . . . 74.040000000000006 110.617 -176.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -57.29 -31.26 62.29 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 116.002 1.161 . . . . 70.019999999999996 116.002 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.455 ' CB ' HD12 ' A' ' 276' ' ' LEU . 71.0 t80 -114.72 0.22 13.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.908 0.861 . . . . 72.530000000000001 110.535 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.557 ' NE1' ' HA ' ' A' ' 284' ' ' LYS . 10.5 p90 . . . . . 0 C--N 1.305 -1.347 0 CA-C-O 121.888 0.852 . . . . 73.340000000000003 111.291 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 N--CA 1.435 -1.18 0 CA-C-O 121.019 0.438 . . . . 72.329999999999998 110.077 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -94.03 129.86 40.39 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 103.865 -2.643 . . . . 54.25 103.865 167.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 23.9 m -131.69 137.08 48.14 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.104 -1.038 . . . . 72.530000000000001 111.63 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.501 ' HB2' HG21 ' B' ' 277' ' ' ILE . . . -132.2 135.82 46.6 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.611 -1.255 . . . . 74.450000000000003 107.611 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 0.1 OUTLIER -82.77 -61.47 1.86 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.747 -0.835 . . . . 70.209999999999994 108.747 -178.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -134.24 139.46 45.78 Favored 'General case' 0 C--O 1.254 1.318 0 C-N-CA 120.036 -0.666 . . . . 75.540000000000006 109.409 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 10.9 mt -128.43 116.77 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.199 -1.408 . . . . 72.25 107.199 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.412 ' HB3' HG12 ' B' ' 268' ' ' VAL . 56.1 ttt180 -113.3 118.83 35.71 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.216 -0.447 . . . . 72.349999999999994 110.286 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.46 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 0.0 OUTLIER -110.82 128.65 55.85 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 108.713 -0.847 . . . . 75.219999999999999 108.713 175.025 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 234' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 33.9 tt0 -147.46 138.88 23.84 Favored 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 108.543 -0.91 . . . . 74.030000000000001 108.543 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.556 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 52.5 mt-10 65.09 94.85 0.06 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 124.675 1.235 . . . . 60.549999999999997 113.273 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.556 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 58.6 15.78 3.88 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 125.459 1.503 . . . . 70.540000000000006 112.711 171.102 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -92.33 149.05 21.66 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 121.526 0.679 . . . . 74.400000000000006 111.911 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -129.45 135.75 49.05 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 115.612 -0.722 . . . . 72.430000000000007 110.183 175.775 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.518 HG12 ' HB ' ' B' ' 275' ' ' VAL . 30.4 m -125.87 136.8 59.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 124.089 0.868 . . . . 65.239999999999995 109.987 -177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.502 ' OE1' ' HB3' ' A' ' 276' ' ' LEU . 38.8 tp60 -115.92 132.94 56.5 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.866 -1.061 . . . . 73.140000000000001 108.693 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.28 118.36 24.94 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.348 -1.353 . . . . 75.0 107.348 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 134.04 -114.12 1.28 Allowed Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 120.044 -1.074 . . . . 72.349999999999994 111.924 177.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -144.31 140.32 29.08 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.796 -0.446 . . . . 73.109999999999999 109.796 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.499 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 97.7 t -122.11 114.87 44.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.239 -1.393 . . . . 71.200000000000003 107.239 175.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' B' ' 250' ' ' LEU . 4.2 p -122.13 118.5 55.66 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-O 121.21 0.529 . . . . 65.340000000000003 109.803 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 28.7 m -71.09 158.85 35.76 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 109.05 -0.722 . . . . 72.140000000000001 109.05 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.98 -47.41 80.47 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.038 0.923 . . . . 65.349999999999994 111.291 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.77 79.17 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.896 -1.502 . . . . 64.200000000000003 111.847 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.497 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -67.88 -40.31 83.55 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.506 0.928 . . . . 72.25 113.506 -173.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.453 ' HB2' ' CG2' ' B' ' 245' ' ' VAL . 26.6 tp . . . . . 0 C--N 1.31 -1.126 0 C-N-CA 120.043 -0.663 . . . . 64.209999999999994 111.93 -173.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.435 -1.176 0 CA-C-O 121.212 0.529 . . . . 71.200000000000003 111.379 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 53.9 m -106.11 108.16 19.53 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 107.459 -1.312 . . . . 60.32 107.459 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -124.65 131.83 53.45 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.641 -1.244 . . . . 64.409999999999997 107.641 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 15.7 m -121.54 123.79 42.85 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.835 -0.62 . . . . 40.149999999999999 110.521 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 8.4 p -126.29 149.86 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 108.024 -1.102 . . . . 63.409999999999997 108.024 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 12.8 tt0 -93.95 -77.94 0.44 Allowed 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.97 -0.752 . . . . 75.420000000000002 108.97 175.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 28.8 m -113.26 127.54 56.19 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 120.25 -0.58 . . . . 62.100000000000001 110.854 -175.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.83 120.68 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-O 121.695 0.759 . . . . 61.32 109.512 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 268' ' ' VAL . . . . . 0.412 HG12 ' HB3' ' B' ' 232' ' ' ARG . 27.0 m -126.92 141.55 45.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.623 -0.717 . . . . 72.120000000000005 112.199 -174.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 269' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.72 132.41 7.92 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.982 -0.847 . . . . 61.420000000000002 110.982 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 25.4 mmmt -133.87 148.83 51.3 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 124.205 1.002 . . . . 52.020000000000003 112.541 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 271' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' B' ' 236' ' ' ARG . . . 85.57 -57.99 4.88 Favored Glycine 0 CA--C 1.499 -0.945 0 C-N-CA 121.362 -0.447 . . . . 71.349999999999994 112.954 174.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 176.24 114.17 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 103.279 -2.86 . . . . 72.25 103.279 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 273' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 67.1 m -146.79 160.22 42.53 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.734 0.778 . . . . 72.540000000000006 112.448 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.532 ' HD3' ' HB3' ' C' ' 238' ' ' ARG . 0.7 OUTLIER -129.48 127.58 41.14 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 105.799 -1.926 . . . . 70.099999999999994 105.799 176.354 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.518 ' HB ' HG12 ' B' ' 239' ' ' VAL . 41.5 t -132.02 126.31 56.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.658 -0.497 . . . . 71.340000000000003 109.658 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.495 HD12 ' CB ' ' B' ' 286' ' ' PHE . 4.7 tt -121.78 118.7 29.69 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.752 -1.179 . . . . 74.310000000000002 108.029 173.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.501 HG21 ' HB2' ' B' ' 228' ' ' ALA . 44.6 mm -108.18 104.23 16.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 106.952 -1.499 . . . . 75.319999999999993 106.952 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 146.36 -158.02 27.57 Favored Glycine 0 CA--C 1.476 -2.39 0 C-N-CA 120.358 -0.925 . . . . 61.130000000000003 113.204 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -96.38 138.86 33.35 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.293 -0.632 . . . . 73.030000000000001 109.293 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -121.32 126.8 50.37 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 105.801 -1.925 . . . . 73.239999999999995 105.801 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.543 ' CD1' HG13 ' C' ' 245' ' ' VAL . 1.3 t80 -123.63 123.56 40.83 Favored 'General case' 0 N--CA 1.405 -2.716 0 N-CA-C 107.304 -1.369 . . . . 60.219999999999999 107.304 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' B' ' 249' ' ' ALA . . . 142.59 -43.98 1.01 Allowed Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 108.809 -1.716 . . . . 72.129999999999995 108.809 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.24 -29.0 8.26 Favored Glycine 0 N--CA 1.423 -2.215 0 N-CA-C 111.678 -0.569 . . . . 44.219999999999999 111.678 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 284' ' ' LYS . . . . . 0.533 ' HA ' ' CD1' ' B' ' 287' ' ' TRP . 42.6 pttt -149.04 19.84 0.98 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.679 -0.409 . . . . 73.299999999999997 111.974 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -53.97 -43.49 71.96 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.117 -0.563 . . . . 75.319999999999993 114.226 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.495 ' CB ' HD12 ' B' ' 276' ' ' LEU . 62.1 t80 -97.69 -1.09 44.31 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.685 0.755 . . . . 73.450000000000003 111.202 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.533 ' CD1' ' HA ' ' B' ' 284' ' ' LYS . 13.6 p90 . . . . . 0 C--N 1.315 -0.893 0 CA-C-O 121.329 0.585 . . . . 75.430000000000007 110.926 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 . . . . . 0 N--CA 1.433 -1.289 0 N-CA-C 107.955 -1.128 . . . . 62.329999999999998 107.955 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -93.29 133.2 36.76 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.569 -1.271 . . . . 73.310000000000002 107.569 172.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 48.8 m -140.67 141.8 34.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.549 0.944 . . . . 64.409999999999997 113.549 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -137.37 133.03 34.38 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.222 -1.029 . . . . 52.439999999999998 108.222 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -76.67 -57.98 3.54 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.24 -0.652 . . . . 61.32 109.24 -178.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.14 140.0 41.56 Favored 'General case' 0 C--O 1.265 1.881 0 C-N-CA 120.041 -0.663 . . . . 74.400000000000006 110.84 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.442 HG23 HG23 ' C' ' 267' ' ' VAL . 11.9 mt -130.22 116.97 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 107.898 -1.149 . . . . 63.340000000000003 107.898 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.45 ' HB3' HG12 ' C' ' 268' ' ' VAL . 38.1 ttt180 -118.02 118.1 31.02 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.263 0.554 . . . . 73.329999999999998 110.625 177.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.469 ' HB ' HG13 ' C' ' 239' ' ' VAL . 0.0 OUTLIER -110.53 129.88 55.69 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 108.707 -0.849 . . . . 65.219999999999999 108.707 175.389 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 33.6 tt0 -144.13 138.56 28.28 Favored 'General case' 0 N--CA 1.415 -2.204 0 C-N-CA 120.317 -0.553 . . . . 73.109999999999999 109.515 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.571 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 51.0 mt-10 59.72 97.76 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.617 1.167 . . . . 63.439999999999998 114.018 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.571 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 0.2 OUTLIER 61.87 13.59 5.63 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.426 1.49 . . . . 73.340000000000003 112.333 172.315 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.38 151.46 19.38 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.443 0.64 . . . . 71.040000000000006 111.964 -174.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.532 ' HB3' ' HD3' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -132.91 135.47 45.58 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-N 115.44 -0.8 . . . . 73.319999999999993 110.823 178.191 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.475 HG12 ' HB ' ' C' ' 275' ' ' VAL . 33.1 m -127.85 138.32 55.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.228 -0.897 . . . . 71.329999999999998 110.234 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.489 ' OE1' ' HB3' ' B' ' 276' ' ' LEU . 38.4 tp60 -116.19 133.35 56.12 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.799 -1.091 . . . . 71.319999999999993 108.873 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.27 118.41 24.17 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.802 -1.555 . . . . 63.5 106.802 175.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.474 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 133.68 -117.94 1.98 Allowed Glycine 0 N--CA 1.422 -2.269 0 C-N-CA 119.918 -1.134 . . . . 75.319999999999993 111.007 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -144.67 140.01 28.36 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 123.582 0.224 . . . . 64.299999999999997 111.066 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.485 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 86.2 t -121.58 116.19 48.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 108.408 -0.96 . . . . 64.329999999999998 108.408 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.543 HG13 ' CD1' ' B' ' 281' ' ' TYR . 2.7 p -122.62 123.48 68.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 109.46 -0.571 . . . . 74.109999999999999 109.46 176.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 24.9 m -77.84 159.29 29.06 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 109.561 -0.533 . . . . 62.049999999999997 109.561 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.96 -46.53 81.18 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.308 1.052 . . . . 65.409999999999997 110.739 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.81 67.85 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.215 -1.811 . . . . 72.439999999999998 112.245 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 249' ' ' ALA . . . . . 0.555 ' HB2' ' HA2' ' C' ' 282' ' ' GLY . . . . . . . . 0 C--O 1.244 0.791 0 N-CA-C 113.085 0.772 . . . . 73.409999999999997 113.085 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 55.9 m . . . . . 0 N--CA 1.428 -1.561 0 N-CA-C 108.654 -0.869 . . . . 71.120000000000005 108.654 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -119.45 131.93 55.71 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.867 -0.606 . . . . 75.209999999999994 109.39 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 14.9 m -117.76 122.98 44.88 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.439 0.638 . . . . 52.119999999999997 110.014 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.25 129.86 65.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.163 -0.926 . . . . 73.400000000000006 111.79 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -72.49 -75.68 0.13 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.488 -0.93 . . . . 64.310000000000002 108.488 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 86.9 m -148.94 136.56 20.42 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.22 -0.925 . . . . 73.540000000000006 110.006 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.442 HG23 HG23 ' C' ' 231' ' ' ILE . 15.9 m -124.05 129.96 73.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 116.012 -0.54 . . . . 71.209999999999994 109.758 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 268' ' ' VAL . . . . . 0.45 HG12 ' HB3' ' C' ' 232' ' ' ARG . 31.0 m -123.66 140.02 48.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 120.926 0.393 . . . . 71.310000000000002 110.602 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.31 132.58 9.64 Favored Glycine 0 C--N 1.299 -1.495 0 N-CA-C 110.879 -0.888 . . . . 65.439999999999998 110.879 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -134.54 128.92 34.25 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 123.432 0.693 . . . . 74.25 111.624 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 64.23 56.28 18.87 Favored Glycine 0 C--N 1.318 -0.462 0 O-C-N 123.553 0.533 . . . . 75.549999999999997 113.046 175.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 71.48 102.85 0.07 Allowed 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.467 1.507 . . . . 71.310000000000002 109.601 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.1 m -139.4 148.79 43.3 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.935 -1.029 . . . . 60.509999999999998 108.771 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -121.54 126.34 48.94 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.067 -1.827 . . . . 54.32 106.067 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.475 ' HB ' HG12 ' C' ' 239' ' ' VAL . 31.0 t -138.13 128.79 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 110.042 -0.355 . . . . 65.319999999999993 110.042 -175.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.72 117.91 25.27 Favored 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 107.97 -1.122 . . . . 53.43 107.97 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.438 HG21 ' HB2' ' C' ' 228' ' ' ALA . 50.1 mm -109.34 104.43 17.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.059 -1.089 . . . . 72.239999999999995 108.059 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 278' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 146.06 -154.85 26.21 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 120.565 -0.826 . . . . 25.050000000000001 111.978 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.41 128.17 44.67 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.7 -0.482 . . . . 74.299999999999997 109.7 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -111.93 125.46 54.08 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.876 -1.527 . . . . 75.519999999999996 106.876 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -130.18 123.9 31.34 Favored 'General case' 0 N--CA 1.404 -2.765 0 CA-C-O 121.663 0.744 . . . . 64.319999999999993 109.432 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 282' ' ' GLY . . . . . 0.555 ' HA2' ' HB2' ' C' ' 249' ' ' ALA . . . 151.58 -46.92 0.59 Allowed Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 108.873 -1.691 . . . . 43.240000000000002 108.873 -176.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 128.4 -25.02 4.88 Favored Glycine 0 CA--C 1.481 -2.077 0 C-N-CA 120.07 -1.062 . . . . 63.130000000000003 111.255 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 284' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' C' ' 287' ' ' TRP . 56.3 pttt -151.93 -62.09 0.17 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.177 -0.511 . . . . 74.420000000000002 110.486 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 285' ' ' GLY . . . . . 0.437 ' H ' ' HG3' ' C' ' 284' ' ' LYS . . . 50.5 -86.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.114 0 N-CA-C 115.503 0.961 . . . . 74.129999999999995 115.503 176.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.408 ' HA ' ' NE1' ' B' ' 287' ' ' TRP . 42.6 t80 -65.79 -29.72 70.25 Favored 'General case' 0 C--O 1.255 1.379 0 C-N-CA 125.192 1.397 . . . . 73.25 110.62 -176.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.579 ' O ' ' HB2' ' C' ' 284' ' ' LYS . 20.1 p90 . . . . . 0 C--N 1.303 -1.416 0 CA-C-N 115.669 -0.696 . . . . 73.209999999999994 109.884 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 . . . . . 0 N--CA 1.434 -1.231 0 N-CA-C 108.569 -0.901 . . . . 72.120000000000005 108.569 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.467 HD22 ' HA2' ' A' ' 278' ' ' GLY . 62.9 t30 -99.01 136.9 38.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.757 -1.201 . . . . 71.109999999999999 107.757 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 43.4 m -126.59 136.87 53.1 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.854 0.835 . . . . 30.309999999999999 112.478 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 277' ' ' ILE . . . -133.72 138.93 46.08 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.208 -1.775 . . . . 73.450000000000003 106.208 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -92.75 -60.91 1.7 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.359 -0.978 . . . . 75.310000000000002 108.359 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -129.78 140.55 51.03 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.49 0.662 . . . . 73.409999999999997 110.921 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 70.7 mt -125.43 123.26 64.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.408 -1.33 . . . . 74.219999999999999 107.408 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 57.1 ttt180 -130.01 115.89 17.78 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.491 -0.484 . . . . 74.420000000000002 109.975 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.563 HG21 HG22 ' A' ' 239' ' ' VAL . 31.4 p -126.65 128.58 46.98 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.045 0.45 . . . . 55.310000000000002 110.064 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -131.8 143.31 50.12 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 109.649 -0.5 . . . . 75.299999999999997 109.649 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.52 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 41.2 mt-10 66.11 96.88 0.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.275 1.583 . . . . 73.310000000000002 115.275 172.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.52 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.1 mpt_? 60.93 11.78 3.5 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 124.961 1.304 . . . . 73.549999999999997 111.926 175.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -88.37 140.72 29.18 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 110.096 -0.335 . . . . 63.140000000000001 110.096 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.05 142.21 51.62 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.051 -0.522 . . . . 65.140000000000001 110.601 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.563 HG22 HG21 ' A' ' 233' ' ' THR . 12.6 t -122.27 149.58 25.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 O-C-N 123.396 0.435 . . . . 73.329999999999998 110.928 -170.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -138.0 120.63 16.21 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.423 -0.955 . . . . 63.009999999999998 108.423 168.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -117.64 122.55 43.88 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.106 -1.072 . . . . 72.25 108.106 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.77 -114.08 1.11 Allowed Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.008 -1.091 . . . . 62.420000000000002 112.599 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -145.48 133.99 22.01 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.883 -0.414 . . . . 73.310000000000002 109.883 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 92.3 t -107.51 115.47 48.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.947 -0.76 . . . . 64.329999999999998 108.947 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.5 112.24 39.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.75 -0.833 . . . . 62.130000000000003 108.75 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 24.6 m -91.11 159.3 16.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.516 -0.92 . . . . 73.239999999999995 108.516 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.57 -33.72 76.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.062 0.764 . . . . 64.219999999999999 113.062 -176.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.78 -39.98 94.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.087 0.773 . . . . 61.020000000000003 113.087 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.321 -0.639 0 N-CA-C 111.418 0.155 . . . . 64.510000000000005 111.418 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.405 -2.723 0 N-CA-C 108.417 -0.957 . . . . 61.0 108.417 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.437 ' HB3' ' OD1' ' A' ' 226' ' ' ASN . 45.3 t-20 -126.38 146.83 49.9 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.7 -1.963 . . . . 64.439999999999998 105.7 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 29.6 m -142.22 125.12 16.09 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 121.122 0.487 . . . . 71.129999999999995 110.501 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 14.7 p -128.18 150.51 33.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.677 -1.231 . . . . 62.119999999999997 107.677 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . 0.351 9.1 pt-20 -98.81 -50.66 4.14 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 117.794 -1.562 . . . . 74.409999999999997 113.298 174.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 61.8 m -127.19 126.97 43.76 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 117.958 -1.497 . . . . 74.510000000000005 112.439 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.75 126.83 75.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.687 -0.857 . . . . 62.399999999999999 108.687 173.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 7.9 p -127.76 133.65 67.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-O 121.005 0.431 . . . . 65.230000000000004 111.6 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -126.26 133.11 8.04 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 111.355 -0.698 . . . . 43.140000000000001 111.355 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.53 ' HB2' ' HG2' ' B' ' 234' ' ' GLU . 29.6 mmmt -130.04 116.65 18.85 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 122.587 0.355 . . . . 75.140000000000001 111.25 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.2 100.76 0.24 Allowed Glycine 0 C--N 1.308 -0.992 0 N-CA-C 115.361 0.905 . . . . 62.420000000000002 115.361 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.435 ' H ' ' HB2' ' A' ' 236' ' ' ARG . 34.9 mt-10 61.57 20.82 11.59 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.601 0.761 . . . . 74.420000000000002 112.855 169.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 19.4 m -92.79 145.18 24.6 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.464 0.65 . . . . 52.049999999999997 112.264 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' ARG . . . . . 0.457 ' O ' HG23 ' B' ' 239' ' ' VAL . 66.0 mtt180 -108.3 127.17 53.63 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.147 -2.168 . . . . 74.109999999999999 105.147 173.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 6.1 t -121.45 123.22 69.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 120.179 -0.608 . . . . 72.409999999999997 109.37 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.626 ' HG ' ' OE1' ' B' ' 240' ' ' GLN . 26.8 tp -120.24 120.3 35.72 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.028 -1.069 . . . . 74.140000000000001 111.344 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 228' ' ' ALA . 3.6 mp -113.71 104.79 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 107.627 -1.249 . . . . 61.409999999999997 107.627 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.467 ' HA2' HD22 ' A' ' 226' ' ' ASN . . . 158.28 -145.2 11.35 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.227 -0.987 . . . . 74.200000000000003 111.858 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 45.4 t-20 -120.13 146.85 45.57 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 106.047 -1.834 . . . . 62.219999999999999 106.047 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -123.22 117.45 25.35 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.163 -1.051 . . . . 75.200000000000003 108.163 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -109.71 124.41 51.17 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.8 -1.185 . . . . 73.109999999999999 107.8 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 146.18 -46.55 0.75 Allowed Glycine 0 CA--C 1.473 -2.555 0 N-CA-C 109.896 -1.282 . . . . 45.0 109.896 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.533 ' O ' ' HG2' ' A' ' 284' ' ' LYS . . . 103.36 72.57 0.92 Allowed Glycine 0 N--CA 1.417 -2.575 0 N-CA-C 109.451 -1.46 . . . . 73.310000000000002 109.451 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 283' ' ' GLY . 4.6 ptpp? 82.09 19.4 0.33 Allowed 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 127.706 2.402 . . . . 71.540000000000006 111.419 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -47.82 -38.22 15.94 Favored Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.267 1.267 . . . . 73.510000000000005 116.267 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.458 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 80.1 t80 -83.56 -3.13 57.4 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 117.378 0.589 . . . . 73.349999999999994 112.453 -175.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.458 ' CE3' ' HB3' ' A' ' 286' ' ' PHE . 32.8 p90 . . . . . 0 N--CA 1.478 0.941 0 O-C-N 121.473 -0.767 . . . . 74.299999999999997 111.592 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 . . . . . 0 N--CA 1.423 -1.813 0 CA-C-O 121.153 0.501 . . . . 52.329999999999998 110.086 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -98.08 136.7 37.94 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 104.536 -2.394 . . . . 70.430000000000007 104.536 171.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 20.1 m -131.85 136.39 47.43 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 120.109 -0.636 . . . . 70.400000000000006 111.255 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -129.2 134.84 48.18 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.689 -1.226 . . . . 54.329999999999998 107.689 175.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -82.2 -65.98 0.95 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.017 -0.734 . . . . 72.299999999999997 109.017 178.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -128.46 140.07 52.01 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-O 121.022 0.439 . . . . 73.120000000000005 109.988 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 27.7 mt -124.72 122.64 64.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.245 -1.391 . . . . 64.310000000000002 107.245 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 22.1 ttt180 -122.84 114.55 20.65 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.746 -0.835 . . . . 64.329999999999998 108.746 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.73 HG21 HG22 ' B' ' 239' ' ' VAL . 72.4 p -117.88 127.2 53.63 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.021 -1.103 . . . . 74.340000000000003 108.021 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 234' ' ' GLU . . . . . 0.53 ' HG2' ' HB2' ' A' ' 270' ' ' LYS . 34.0 mt-10 -137.61 139.79 40.55 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.201 -0.599 . . . . 62.399999999999999 110.322 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.497 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 46.8 mt-10 67.5 96.71 0.06 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.542 1.312 . . . . 73.099999999999994 114.542 173.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.497 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.0 OUTLIER 58.14 27.98 15.78 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.474 1.11 . . . . 73.209999999999994 110.897 175.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.425 ' CB ' ' HB ' ' B' ' 233' ' ' THR . . . -84.77 150.89 24.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.163 0.506 . . . . 74.299999999999997 110.6 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.502 ' HD3' ' HG2' ' B' ' 274' ' ' ARG . 4.4 mpt_? -125.66 134.5 51.83 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.647 -1.983 . . . . 75.400000000000006 105.647 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.73 HG22 HG21 ' B' ' 233' ' ' THR . 2.4 t -125.41 139.67 50.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 123.404 0.44 . . . . 65.109999999999999 110.02 -172.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.626 ' OE1' ' HG ' ' A' ' 276' ' ' LEU . 24.5 tp60 -138.48 114.84 10.38 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.864 0.728 . . . . 73.349999999999994 109.8 170.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.464 HD12 HG23 ' A' ' 277' ' ' ILE . 3.4 tm? -115.0 118.73 34.24 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.431 -1.322 . . . . 65.230000000000004 107.431 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 141.19 -114.06 0.9 Allowed Glycine 0 N--CA 1.422 -2.268 0 C-N-CA 120.276 -0.964 . . . . 53.439999999999998 111.07 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 243' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 55.0 t30 -145.46 149.54 34.87 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.981 -0.748 . . . . 61.549999999999997 108.981 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 98.1 t -121.61 122.66 67.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.429 -0.952 . . . . 74.200000000000003 108.429 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 48.7 t -122.19 111.84 32.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.975 -0.75 . . . . 64.209999999999994 108.975 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 23.8 m -83.15 159.28 22.08 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.195 -1.039 . . . . 75.129999999999995 108.195 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -64.6 -42.48 95.53 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 123.207 1.48 . . . . 52.229999999999997 109.749 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.68 -34.01 61.67 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 111.762 -2.472 . . . . 74.129999999999995 112.827 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.671 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -62.9 -26.81 68.97 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.678 0.791 . . . . 65.530000000000001 112.482 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 1.2 tm? . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.981 0.896 . . . . 74.319999999999993 108.867 -177.322 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 108.338 -0.986 . . . . 62.43 108.338 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -91.55 127.93 37.18 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 121.799 0.809 . . . . 73.340000000000003 110.405 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -126.82 142.23 51.6 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.946 -1.872 . . . . 74.299999999999997 105.946 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 47.4 m -139.64 133.01 30.05 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 118.313 0.506 . . . . 70.530000000000001 111.655 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.1 p -128.22 144.17 38.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 116.056 -0.52 . . . . 72.239999999999995 110.658 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 38.2 mm-40 -81.05 -63.73 1.34 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.193 0.521 . . . . 75.439999999999998 110.801 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 38.2 m -137.59 127.13 25.08 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 118.138 -1.425 . . . . 75.450000000000003 111.915 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.05 121.13 66.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.891 -1.05 . . . . 72.129999999999995 108.704 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 268' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 5.4 p -127.38 138.79 53.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.721 -0.672 . . . . 72.510000000000005 112.266 -176.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.7 133.97 8.81 Favored Glycine 0 CA--C 1.485 -1.8 0 CA-C-N 115.793 -0.64 . . . . 61.450000000000003 112.134 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.47 ' HB2' ' HG2' ' C' ' 234' ' ' GLU . 30.9 mmmt -128.96 115.95 18.6 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 123.748 0.322 . . . . 73.340000000000003 110.689 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 81.58 93.31 0.51 Allowed Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.46 -0.876 . . . . 71.430000000000007 114.626 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 64.01 17.25 10.49 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.341 1.056 . . . . 75.400000000000006 111.89 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 273' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 19.8 m -82.88 145.19 29.58 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.743 0.783 . . . . 63.25 111.383 -172.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.539 ' HB3' ' CE1' ' B' ' 286' ' ' PHE . 51.1 mtm180 -116.84 127.44 54.3 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 108.739 -0.837 . . . . 73.439999999999998 108.739 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.44 HG12 ' CG1' ' C' ' 239' ' ' VAL . 29.2 m -120.64 123.58 70.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-O 121.394 0.616 . . . . 74.519999999999996 110.547 -176.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.583 ' HG ' ' OE1' ' C' ' 240' ' ' GLN . 26.4 tp -115.06 114.78 25.81 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.989 -0.745 . . . . 54.340000000000003 108.989 173.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.521 HG23 HD12 ' C' ' 241' ' ' LEU . 3.4 mp -112.78 103.63 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.609 0 N-CA-C 106.025 -1.843 . . . . 53.219999999999999 106.025 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.434 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 161.3 -150.83 20.86 Favored Glycine 0 N--CA 1.416 -2.662 0 C-N-CA 119.798 -1.192 . . . . 72.140000000000001 112.835 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -113.77 151.81 31.47 Favored 'General case' 0 C--N 1.273 -2.753 0 N-CA-C 104.791 -2.3 . . . . 63.43 104.791 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.4 ' OE1' HG13 ' C' ' 244' ' ' VAL . 1.5 tm-20 -130.06 118.87 22.2 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.94 -1.133 . . . . 62.350000000000001 107.94 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -113.1 124.28 52.21 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.911 0.862 . . . . 75.340000000000003 110.927 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' B' ' 249' ' ' ALA . . . 138.01 -47.32 0.94 Allowed Glycine 0 N--CA 1.417 -2.619 0 CA-C-N 114.37 -1.286 . . . . 73.040000000000006 110.442 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 283' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' B' ' 284' ' ' LYS . . . 108.25 90.92 2.15 Favored Glycine 0 N--CA 1.414 -2.79 0 N-CA-C 108.363 -1.895 . . . . 72.140000000000001 108.363 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 284' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' B' ' 287' ' ' TRP . 50.0 mtmt 90.95 -59.45 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 126.408 1.883 . . . . 75.049999999999997 109.681 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 49.87 -84.27 0.01 OUTLIER Glycine 0 N--CA 1.478 1.459 0 O-C-N 124.279 0.987 . . . . 55.219999999999999 115.101 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' B' ' 274' ' ' ARG . 1.3 t80 -52.0 -45.95 64.72 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.466 1.906 . . . . 75.519999999999996 109.908 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.581 ' O ' ' HB3' ' B' ' 284' ' ' LYS . 48.9 p90 . . . . . 0 C--O 1.201 -1.484 0 N-CA-C 106.741 -1.578 . . . . 70.230000000000004 106.741 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' C' ' 261' ' ' THR . 4.9 ptp180 . . . . . 0 N--CA 1.43 -1.431 0 CA-C-O 121.085 0.469 . . . . 60.420000000000002 110.731 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -109.98 140.74 43.65 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.248 -2.131 . . . . 73.519999999999996 105.248 173.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 227' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' C' ' 263' ' ' SER . 45.0 m -139.74 137.95 35.53 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.892 -0.505 . . . . 74.439999999999998 111.399 -176.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.65 128.92 45.09 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.421 -0.955 . . . . 74.209999999999994 108.421 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.58 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 27.9 tptp -75.31 -62.17 1.65 Allowed 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.395 -0.594 . . . . 64.310000000000002 109.395 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 230' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' C' ' 266' ' ' THR . 16.5 m-20 -134.85 139.86 45.38 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.066 0.46 . . . . 73.549999999999997 110.719 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.493 HG21 HG21 ' C' ' 239' ' ' VAL . 35.6 mt -127.53 123.52 61.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 106.96 -1.496 . . . . 65.109999999999999 106.96 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.491 ' HG3' HG13 ' B' ' 268' ' ' VAL . 31.6 ttt180 -126.9 114.98 18.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.755 -0.832 . . . . 71.230000000000004 108.755 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.412 HG21 ' HB ' ' C' ' 239' ' ' VAL . 39.4 p -110.62 127.36 55.22 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.71 -1.219 . . . . 64.540000000000006 107.71 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' B' ' 270' ' ' LYS . 40.5 mt-10 -135.07 139.62 44.89 Favored 'General case' 0 N--CA 1.42 -1.943 0 C-N-CA 120.396 -0.522 . . . . 75.209999999999994 110.31 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 64.43 101.29 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 O-C-N 124.621 1.201 . . . . 71.030000000000001 114.117 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 59.6 13.88 3.63 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.669 1.188 . . . . 75.340000000000003 111.27 173.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.38 151.58 22.97 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.619 0.6 . . . . 73.430000000000007 112.619 -172.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.05 135.24 41.15 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.02 -1.474 . . . . 73.549999999999997 107.02 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.493 HG21 HG21 ' C' ' 231' ' ' ILE . 6.9 p -132.38 146.08 33.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.058 0.456 . . . . 70.349999999999994 111.437 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.583 ' OE1' ' HG ' ' B' ' 276' ' ' LEU . 23.2 tp60 -124.6 120.16 31.12 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.67 -1.15 . . . . 72.540000000000006 108.829 172.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.521 HD12 HG23 ' B' ' 277' ' ' ILE . 3.4 tm? -113.66 117.78 32.54 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.966 -1.494 . . . . 44.530000000000001 106.966 177.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 139.14 -114.36 1.01 Allowed Glycine 0 N--CA 1.424 -2.116 0 C-N-CA 119.972 -1.109 . . . . 44.219999999999999 112.02 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -145.39 143.79 30.29 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.571 -0.529 . . . . 73.239999999999995 109.571 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.4 HG13 ' OE1' ' B' ' 280' ' ' GLU . 69.5 t -117.44 118.43 58.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.432 -0.581 . . . . 74.340000000000003 109.432 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' C' ' 281' ' ' TYR . 47.9 t -121.8 111.99 33.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.452 -0.573 . . . . 74.340000000000003 109.452 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 31.4 m -78.07 159.47 28.68 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.239 -1.023 . . . . 61.030000000000001 108.239 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.671 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -63.46 -43.38 97.53 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.482 1.134 . . . . 72.420000000000002 109.48 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.29 65.6 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.891 -1.959 . . . . 74.099999999999994 112.776 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.643 0 N-CA-C 111.995 0.368 . . . . 73.409999999999997 111.995 -176.409 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 39.2 m . . . . . 0 N--CA 1.413 -2.31 0 N-CA-C 108.173 -1.047 . . . . 41.240000000000002 108.173 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -124.26 127.85 48.29 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.733 -0.84 . . . . 70.239999999999995 108.733 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 263' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' C' ' 227' ' ' SER . 41.4 m -133.43 136.22 45.08 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 110.069 -0.345 . . . . 51.299999999999997 110.069 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.22 153.5 37.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.295 -0.632 . . . . 71.420000000000002 109.295 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.58 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 35.2 mm-40 -81.13 -88.5 0.08 Allowed 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 110.197 -0.297 . . . . 75.230000000000004 110.197 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 266' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 51.4 m -121.85 131.33 53.98 Favored 'General case' 0 N--CA 1.417 -2.09 0 C-N-CA 119.581 -0.848 . . . . 54.130000000000003 111.061 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 26.2 m -117.87 132.53 67.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.33 -0.989 . . . . 71.439999999999998 108.33 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 268' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.8 p -127.38 139.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 116.206 -0.452 . . . . 70.109999999999999 110.4 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.99 133.66 9.47 Favored Glycine 0 CA--C 1.476 -2.362 0 N-CA-C 110.155 -1.178 . . . . 75.310000000000002 110.155 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -131.36 115.55 16.39 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 111.988 0.366 . . . . 74.329999999999998 111.988 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 70.05 97.39 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.859 -1.064 . . . . 73.319999999999993 114.415 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 68.09 21.66 8.64 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.782 0.833 . . . . 50.409999999999997 111.955 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.5 m -83.77 144.7 29.14 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.027 0.751 . . . . 40.520000000000003 113.027 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -110.07 128.36 55.39 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.207 -1.775 . . . . 64.530000000000001 106.207 171.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 1.5 t -128.08 123.9 61.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 119.726 -0.79 . . . . 70.120000000000005 109.199 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.41 ' CD1' ' HG3' ' C' ' 240' ' ' GLN . 30.8 tp -117.62 117.96 30.82 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.902 -0.719 . . . . 74.540000000000006 110.3 174.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.503 HG21 ' HB2' ' C' ' 228' ' ' ALA . 3.7 mp -112.48 103.47 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.893 0 N-CA-C 105.902 -1.888 . . . . 75.510000000000005 105.902 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.35 -168.24 30.27 Favored Glycine 0 CA--C 1.478 -2.223 0 C-N-CA 120.546 -0.835 . . . . 74.420000000000002 111.456 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -96.7 156.8 16.19 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.46 -0.941 . . . . 74.120000000000005 108.46 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -129.12 121.3 27.5 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.944 -1.132 . . . . 74.430000000000007 107.944 -175.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.407 ' HB2' ' HA ' ' C' ' 245' ' ' VAL . 96.6 m-85 -116.54 125.12 51.44 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.945 0.403 . . . . 72.239999999999995 110.078 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.47 -37.74 1.84 Allowed Glycine 0 N--CA 1.437 -1.3 0 N-CA-C 111.668 -0.573 . . . . 71.230000000000004 111.668 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 104.4 103.04 2.8 Favored Glycine 0 CA--C 1.48 -2.137 0 N-CA-C 107.304 -2.319 . . . . 45.119999999999997 107.304 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 75.07 -57.78 0.59 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.785 1.234 . . . . 73.129999999999995 109.169 -172.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 57.63 -86.22 0.01 OUTLIER Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.307 0.956 . . . . 61.140000000000001 113.961 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.571 ' HB3' ' CE3' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -56.67 -39.57 73.99 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.023 1.729 . . . . 73.040000000000006 110.642 -178.635 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.571 ' CE3' ' HB3' ' C' ' 286' ' ' PHE . 24.6 p90 . . . . . 0 C--N 1.306 -1.296 0 CA-C-O 121.067 0.46 . . . . 61.439999999999998 111.622 -171.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 109.948 -0.39 . . . . 74.549999999999997 109.948 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 48.1 t-20 -116.75 123.97 48.48 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.644 -1.614 . . . . 53.119999999999997 106.644 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.1 m -121.65 137.42 54.75 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 120.342 -0.543 . . . . 73.530000000000001 111.239 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.4 134.06 46.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.052 -0.722 . . . . 65.329999999999998 109.052 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -91.49 -46.87 7.74 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.643 -0.253 . . . . 55.329999999999998 110.836 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -136.9 139.71 41.8 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.372 -0.603 . . . . 53.520000000000003 109.372 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 66.1 mt -137.28 119.34 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.388 -1.338 . . . . 75.239999999999995 107.388 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -134.22 122.81 23.3 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.909 0.385 . . . . 74.549999999999997 110.834 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 33.4 p -129.43 128.65 43.39 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.053 -0.351 . . . . 71.409999999999997 110.053 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.423 ' HB2' ' HD3' ' A' ' 270' ' ' LYS . 45.0 mt-10 -125.67 166.16 17.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.141 0.496 . . . . 74.409999999999997 111.91 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.426 ' HB3' ' HD2' ' A' ' 236' ' ' ARG . 41.1 mt-10 64.9 -85.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.73 1.612 . . . . 72.140000000000001 113.961 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.426 ' HD2' ' HB3' ' A' ' 235' ' ' GLU . 0.6 OUTLIER -130.65 11.7 5.28 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 109.373 -0.602 . . . . 72.540000000000006 109.373 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -73.14 134.25 44.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.495 -0.775 . . . . 71.299999999999997 110.563 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.1 145.25 50.56 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.839 -0.8 . . . . 72.040000000000006 108.839 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.7 p -132.3 141.8 44.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.719 0.771 . . . . 52.240000000000002 111.438 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -105.14 128.25 53.29 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.678 -1.23 . . . . 71.129999999999995 107.678 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -122.32 117.85 27.07 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.281 -1.377 . . . . 34.229999999999997 107.281 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 113.25 -159.79 13.48 Favored Glycine 0 C--N 1.306 -1.113 0 C-N-CA 121.23 -0.51 . . . . 61.43 111.925 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -98.78 137.39 37.44 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 122.628 0.371 . . . . 73.549999999999997 110.916 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 61.7 t -114.73 116.32 52.21 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 N-CA-C 107.22 -1.4 . . . . 74.329999999999998 107.22 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.2 p -122.44 114.37 42.23 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 N-CA-C 108.46 -0.941 . . . . 42.5 108.46 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 15.0 m -84.22 157.18 21.69 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 118.406 -1.318 . . . . 64.409999999999997 110.045 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.01 -47.09 72.51 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.41 0.624 . . . . 63.450000000000003 111.552 176.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.38 -34.42 68.85 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.561 1.545 . . . . 72.140000000000001 112.649 -175.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.608 ' HB2' ' HA3' ' A' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.31 -1.121 0 C-N-CA 124.145 0.978 . . . . 72.430000000000007 111.548 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.406 -2.639 0 N-CA-C 106.044 -1.836 . . . . 60.340000000000003 106.044 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 38.3 t-20 -126.38 140.35 52.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.911 -0.716 . . . . 73.409999999999997 109.151 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.9 m -133.76 123.1 24.31 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 120.809 -0.356 . . . . 43.409999999999997 110.392 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 8.7 p -128.92 145.1 36.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 110.128 -0.323 . . . . 72.099999999999994 110.128 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.591 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 76.9 mm-40 -85.38 -79.09 0.24 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 121.0 -0.28 . . . . 74.420000000000002 110.747 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 25.9 m -116.29 127.65 54.89 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.182 0.438 . . . . 74.140000000000001 112.182 -172.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.528 HG21 HD11 ' A' ' 277' ' ' ILE . 17.4 m -120.69 132.78 69.34 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.276 0.56 . . . . 63.310000000000002 109.583 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' B' ' 232' ' ' ARG . 3.3 p -127.98 131.81 69.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 116.358 -0.383 . . . . 73.409999999999997 111.637 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.86 131.06 7.65 Favored Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 109.3 -1.52 . . . . 32.109999999999999 109.3 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 234' ' ' GLU . 18.9 tptm -134.17 140.55 46.6 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.6 -0.518 . . . . 72.310000000000002 109.6 -177.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 81.56 -136.71 16.41 Favored Glycine 0 CA--C 1.487 -1.672 0 N-CA-C 107.78 -2.128 . . . . 73.230000000000004 107.78 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -101.36 85.41 2.79 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 118.443 1.122 . . . . 73.519999999999996 109.356 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 21.6 m -104.39 144.98 30.92 Favored 'General case' 0 N--CA 1.408 -2.562 0 CA-C-N 114.923 -1.035 . . . . 71.439999999999998 108.934 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' ARG . . . . . 0.537 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 98.8 mtt180 -122.73 125.93 46.51 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 106.138 -1.801 . . . . 72.129999999999995 106.138 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 26.9 t -131.62 131.63 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 N-CA-C 108.973 -0.751 . . . . 71.129999999999995 108.973 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 5.4 tt -125.88 114.77 18.97 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 118.429 -1.308 . . . . 72.030000000000001 108.444 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.579 HG23 HD12 ' B' ' 241' ' ' LEU . 68.5 mt -111.02 104.33 16.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.098 -0.704 . . . . 64.209999999999994 109.098 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.514 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 144.27 -143.93 12.76 Favored Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 110.969 -0.852 . . . . 73.420000000000002 110.969 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -124.29 143.53 50.5 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.213 -1.032 . . . . 45.439999999999998 108.213 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.96 130.01 46.17 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.502 0.668 . . . . 71.439999999999998 109.314 174.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -113.55 121.56 44.58 Favored 'General case' 0 N--CA 1.409 -2.493 0 N-CA-C 107.383 -1.34 . . . . 72.019999999999996 107.383 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.608 ' HA3' ' HB2' ' A' ' 249' ' ' ALA . . . 62.81 24.82 66.95 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.407 -1.269 . . . . 73.010000000000005 113.903 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -86.69 -47.63 4.76 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.037 -1.225 . . . . 62.329999999999998 110.037 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.425 ' HB2' ' NZ ' ' A' ' 284' ' ' LYS . 0.1 OUTLIER 68.28 23.51 7.72 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.043 1.337 . . . . 74.299999999999997 110.03 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 287' ' ' TRP . . . 115.02 92.91 1.88 Allowed Glycine 0 N--CA 1.407 -3.249 0 C-N-CA 120.129 -1.034 . . . . 55.439999999999998 110.768 -176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -73.1 33.78 0.07 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-O 122.54 1.162 . . . . 75.239999999999995 109.398 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.537 ' CE3' ' HB3' ' A' ' 274' ' ' ARG . 2.5 m95 . . . . . 0 N--CA 1.432 -1.337 0 CA-C-N 115.407 -0.815 . . . . 72.430000000000007 111.979 -174.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 . . . . . 0 N--CA 1.424 -1.73 0 N-CA-C 109.637 -0.505 . . . . 73.430000000000007 109.637 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 39.1 t-20 -118.06 141.7 48.19 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.545 -1.28 . . . . 54.149999999999999 107.545 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 52.5 m -133.81 137.38 45.05 Favored 'General case' 0 C--N 1.275 -2.663 0 O-C-N 122.075 -0.39 . . . . 54.219999999999999 110.172 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -127.72 160.77 30.67 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.21 -1.404 . . . . 73.099999999999994 107.21 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 4.6 tmmm? -121.67 -54.63 1.95 Allowed 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 119.599 -0.841 . . . . 74.340000000000003 109.045 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -131.76 138.03 48.43 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.81 -1.552 . . . . 73.340000000000003 106.81 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 12.5 mt -133.85 120.04 34.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 106.795 -1.557 . . . . 70.109999999999999 106.795 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.631 ' NH1' ' HB2' ' B' ' 232' ' ' ARG . 0.0 OUTLIER -115.39 119.9 37.8 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 109.191 -0.67 . . . . 75.120000000000005 109.191 -176.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 38.4 p -121.88 129.16 52.36 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.613 -1.254 . . . . 62.020000000000003 107.613 175.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 234' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 27.5 tt0 -144.69 150.51 37.45 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 120.12 -0.632 . . . . 71.129999999999995 110.398 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 77.82 -79.19 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 125.798 1.639 . . . . 75.099999999999994 113.021 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -140.57 27.1 2.08 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.569 -0.9 . . . . 65.219999999999999 108.569 -172.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -86.71 143.65 27.47 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 112.9 0.704 . . . . 64.010000000000005 112.9 -173.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -124.4 136.46 54.08 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.311 -1.366 . . . . 61.530000000000001 107.311 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.5 p -134.14 136.14 53.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.996 0.903 . . . . 74.019999999999996 111.396 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.428 ' HB2' ' CE2' ' B' ' 286' ' ' PHE . 44.1 tp60 -104.57 130.99 52.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 106.884 -1.524 . . . . 64.230000000000004 106.884 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.579 HD12 HG23 ' A' ' 277' ' ' ILE . 2.7 tm? -130.27 116.28 18.14 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 106.561 -1.644 . . . . 72.430000000000007 106.561 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 123.05 -129.39 7.41 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.634 -0.793 . . . . 53.049999999999997 112.05 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 243' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' B' ' 279' ' ' ASN . 53.3 t-20 -132.53 137.38 47.13 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.17 0.485 . . . . 75.349999999999994 109.862 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 54.4 t -114.63 114.87 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.595 -1.261 . . . . 73.150000000000006 107.595 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 3.6 p -122.42 114.3 41.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 C-N-CA 119.492 -0.883 . . . . 63.130000000000003 110.165 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 42.3 m -80.34 155.0 27.42 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 117.419 -1.713 . . . . 72.510000000000005 109.92 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.56 66.03 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.254 1.026 . . . . 74.409999999999997 111.249 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.31 -35.13 67.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.195 -1.82 . . . . 64.120000000000005 112.246 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.503 ' HB2' ' HA3' ' B' ' 282' ' ' GLY . . . -60.56 -47.03 88.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.989 -0.55 . . . . 45.219999999999999 110.381 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 18.1 tp . . . . . 0 CA--C 1.517 -0.309 0 N-CA-C 105.316 -2.105 . . . . 73.230000000000004 105.316 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.428 -1.556 0 CA-C-O 121.915 0.864 . . . . 51.200000000000003 110.171 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.495 HG23 ' HB3' ' C' ' 225' ' ' ARG . 5.1 t -115.82 120.51 39.49 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 105.687 -1.968 . . . . 72.099999999999994 105.687 171.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' B' ' 226' ' ' ASN . 37.0 t-20 -126.39 138.35 53.54 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.072 -0.651 . . . . 65.420000000000002 109.268 -172.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 263' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' C' ' 227' ' ' SER . 51.9 m -142.08 129.54 21.29 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.152 0.501 . . . . 63.140000000000001 111.336 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 14.1 p -121.11 153.16 24.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.831 -0.803 . . . . 64.450000000000003 108.831 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 75.8 mm-40 -91.94 -78.34 0.41 Allowed 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 109.583 -0.525 . . . . 63.210000000000001 109.583 171.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.6 m -114.35 127.97 56.12 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.944 -0.473 . . . . 61.329999999999998 111.192 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.27 120.74 47.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 109.162 -0.681 . . . . 71.209999999999994 109.162 176.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 5.4 m -124.76 148.33 29.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 121.246 0.546 . . . . 74.219999999999999 111.301 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 269' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -137.34 132.43 5.95 Favored Glycine 0 N--CA 1.415 -2.755 0 N-CA-C 109.489 -1.444 . . . . 61.119999999999997 109.489 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -132.51 116.19 16.44 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.524 0.678 . . . . 73.010000000000005 110.057 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 104.08 -139.19 14.45 Favored Glycine 0 CA--C 1.471 -2.715 0 N-CA-C 109.213 -1.555 . . . . 73.25 109.213 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 272' ' ' GLU . . . . . 0.517 ' HB3' ' O ' ' C' ' 235' ' ' GLU . 11.1 tp10 -86.42 80.65 8.6 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.133 -1.432 . . . . 74.430000000000007 107.133 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 273' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 20.6 m -113.96 144.29 43.32 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.429 -1.26 . . . . 63.219999999999999 109.061 -177.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' C' ' 238' ' ' ARG . 76.3 mtt180 -134.4 127.35 31.41 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.013 -1.106 . . . . 73.420000000000002 108.013 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 10.9 t -131.2 137.77 54.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 116.101 -0.5 . . . . 73.010000000000005 109.714 -173.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 4.5 tt -126.56 113.87 17.35 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 106.872 -1.529 . . . . 74.230000000000004 106.872 173.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.536 HG23 HD12 ' C' ' 241' ' ' LEU . 58.2 mt -112.72 103.19 15.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.509 -0.923 . . . . 73.420000000000002 108.509 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' B' ' 226' ' ' ASN . . . 140.98 -146.11 17.18 Favored Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 111.141 -0.784 . . . . 70.409999999999997 111.141 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 279' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 5.5 m-20 -123.58 138.24 54.59 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.316 -0.624 . . . . 73.530000000000001 109.316 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.81 137.85 54.29 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.075 -0.713 . . . . 72.420000000000002 109.075 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 87.4 t80 -124.03 121.92 36.52 Favored 'General case' 0 C--O 1.271 2.226 0 N-CA-C 108.493 -0.929 . . . . 71.150000000000006 108.493 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' B' ' 249' ' ' ALA . . . 81.65 -1.17 86.82 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 114.311 -1.313 . . . . 72.129999999999995 113.979 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -71.33 -60.11 4.58 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.922 -0.871 . . . . 75.519999999999996 110.922 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm 74.24 21.64 2.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.283 1.433 . . . . 73.030000000000001 109.1 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.9 90.07 0.83 Allowed Glycine 0 N--CA 1.409 -3.109 0 N-CA-C 109.48 -1.448 . . . . 75.439999999999998 109.48 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' B' ' 240' ' ' GLN . 44.5 t80 -72.73 40.54 0.09 Allowed 'General case' 0 CA--C 1.573 1.857 0 C-N-CA 124.689 1.195 . . . . 73.219999999999999 110.118 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.534 ' CE3' ' HB3' ' B' ' 274' ' ' ARG . 8.0 m95 . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 108.347 -0.982 . . . . 73.400000000000006 108.347 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.495 ' HB3' HG23 ' B' ' 261' ' ' THR . 26.8 ptt180 . . . . . 0 N--CA 1.42 -1.964 0 CA-C-O 120.702 0.287 . . . . 75.109999999999999 110.553 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 37.9 t-20 -117.81 136.96 53.07 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.877 -1.527 . . . . 62.149999999999999 106.877 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 227' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' B' ' 263' ' ' SER . 32.8 m -134.34 137.28 44.04 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-O 121.041 0.448 . . . . 73.299999999999997 110.622 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -125.18 150.75 46.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.52 -0.919 . . . . 72.120000000000005 108.52 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 1.0 OUTLIER -108.26 -54.21 2.53 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 109.131 -0.692 . . . . 73.030000000000001 109.131 -177.05 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 230' ' ' ASP . . . . . 0.416 ' CG ' HH21 ' C' ' 232' ' ' ARG . 11.8 t70 -132.8 137.62 46.85 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.495 -1.298 . . . . 63.219999999999999 107.495 176.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.424 ' HA ' HG13 ' C' ' 267' ' ' VAL . 19.1 mt -137.25 120.48 21.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.454 -2.054 . . . . 62.340000000000003 105.454 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.416 HH21 ' CG ' ' C' ' 230' ' ' ASP . 19.0 ptp180 -126.11 120.4 30.06 Favored 'General case' 0 C--N 1.274 -2.678 0 C-N-CA 119.815 -0.754 . . . . 45.109999999999999 111.42 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.436 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 33.0 p -111.0 134.76 52.35 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.892 -1.049 . . . . 55.350000000000001 108.854 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -144.93 148.03 33.39 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.561 -0.456 . . . . 65.439999999999998 110.062 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' B' ' 272' ' ' GLU . 64.7 mt-10 73.93 -74.02 0.09 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.231 1.567 . . . . 72.239999999999995 115.231 176.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.44 ' HD2' ' HB3' ' C' ' 235' ' ' GLU . 8.0 mpt_? -136.48 17.0 3.14 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.206 -0.665 . . . . 71.239999999999995 109.206 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -78.71 131.11 36.48 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.998 0.904 . . . . 72.439999999999998 113.293 -173.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.575 ' HB3' ' HB2' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -128.5 135.74 49.84 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 114.887 -1.051 . . . . 61.219999999999999 111.157 174.588 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.474 HG23 ' HB ' ' C' ' 275' ' ' VAL . 7.2 p -130.99 142.59 43.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.375 -0.829 . . . . 53.130000000000003 111.529 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -104.7 132.25 51.17 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 114.363 -1.29 . . . . 75.310000000000002 107.698 171.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.536 HD12 HG23 ' B' ' 277' ' ' ILE . 2.7 tm? -130.13 116.03 17.89 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 105.303 -2.11 . . . . 72.409999999999997 105.303 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 129.63 -132.4 7.06 Favored Glycine 0 C--N 1.3 -1.462 0 C-N-CA 120.147 -1.025 . . . . 63.229999999999997 111.416 -178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 44.2 t30 -137.2 135.56 37.39 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.047 0.451 . . . . 73.439999999999998 110.492 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.07 117.46 51.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.283 0 N-CA-C 107.863 -1.162 . . . . 71.099999999999994 107.863 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 2.8 p -123.56 112.83 34.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 118.691 0.678 . . . . 72.099999999999994 110.455 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.4 m -81.98 156.05 24.89 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 117.444 -1.702 . . . . 73.209999999999994 110.298 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.445 ' HB2' ' HB1' ' B' ' 249' ' ' ALA . . . -67.64 -48.79 65.71 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.744 0.783 . . . . 73.040000000000006 112.042 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.17 75.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.116 -1.402 . . . . 65.109999999999999 112.253 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.157 0 CA-C-N 115.929 -0.578 . . . . 64.340000000000003 111.561 -179.293 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 10.5 t . . . . . 0 N--CA 1.422 -1.826 0 N-CA-C 108.334 -0.987 . . . . 34.420000000000002 108.334 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 53.1 t-20 -123.7 137.1 54.77 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.876 -1.157 . . . . 54.43 107.876 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 32.2 t -142.2 125.72 16.75 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.272 -0.64 . . . . 74.310000000000002 109.272 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.15 147.0 32.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.161 -0.681 . . . . 61.439999999999998 109.161 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 27.0 mm-40 -90.03 -76.04 0.44 Allowed 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 110.18 -0.304 . . . . 72.299999999999997 110.18 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 11.2 m -114.31 127.85 56.07 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.211 -0.996 . . . . 74.530000000000001 111.707 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' C' ' 231' ' ' ILE . 1.3 p -128.52 122.46 57.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.511 0.672 . . . . 74.319999999999993 110.028 175.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.7 133.73 68.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.547 -0.751 . . . . 75.109999999999999 112.13 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.34 130.57 6.64 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 108.404 -1.878 . . . . 35.43 108.404 170.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -134.41 116.51 15.26 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.667 -1.234 . . . . 74.120000000000005 107.667 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.9 -139.81 14.7 Favored Glycine 0 C--N 1.291 -1.939 0 N-CA-C 109.685 -1.366 . . . . 73.340000000000003 109.685 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.52 91.85 2.32 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.18 -1.045 . . . . 52.450000000000003 108.18 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 273' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 23.2 m -131.37 144.67 51.4 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 121.66 0.743 . . . . 75.340000000000003 110.893 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 274' ' ' ARG . . . . . 0.462 ' HD3' ' HB2' ' C' ' 287' ' ' TRP . 55.2 mtt85 -136.26 127.6 28.35 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 105.723 -1.954 . . . . 74.099999999999994 105.723 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.474 ' HB ' HG23 ' C' ' 239' ' ' VAL . 6.9 t -138.19 140.1 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 109.486 -0.561 . . . . 71.25 109.486 -175.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.3 tt -128.71 111.93 13.68 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.074 -1.084 . . . . 74.239999999999995 108.074 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 58.1 mt -111.82 103.96 16.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.575 -0.898 . . . . 74.040000000000006 108.575 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.67 -136.02 7.57 Favored Glycine 0 N--CA 1.424 -2.131 0 N-CA-C 110.992 -0.843 . . . . 44.530000000000001 110.992 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 279' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 94.3 m-20 -127.88 156.34 42.74 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 110.111 -0.329 . . . . 75.040000000000006 110.111 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.88 138.25 24.18 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.013 -0.539 . . . . 72.0 110.049 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -130.12 122.33 28.05 Favored 'General case' 0 N--CA 1.415 -2.204 0 N-CA-C 107.37 -1.344 . . . . 73.299999999999997 107.37 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.57 -14.14 58.84 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.309 -0.859 . . . . 70.219999999999999 112.447 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -64.78 -58.18 10.6 Favored Glycine 0 CA--C 1.497 -1.038 0 N-CA-C 111.613 -0.595 . . . . 73.329999999999998 111.613 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 284' ' ' LYS . . . . . 0.534 ' NZ ' ' HB2' ' C' ' 284' ' ' LYS . 6.7 mtmp? 65.84 31.37 9.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.561 1.144 . . . . 62.329999999999998 108.344 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.19 97.15 2.38 Favored Glycine 0 N--CA 1.417 -2.567 0 N-CA-C 108.493 -1.843 . . . . 43.350000000000001 108.493 -172.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -76.22 41.64 0.24 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.262 1.03 . . . . 74.239999999999995 110.844 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.462 ' HB2' ' HD3' ' C' ' 274' ' ' ARG . 1.3 p90 . . . . . 0 N--CA 1.414 -2.272 0 CA-C-O 122.318 1.056 . . . . 72.510000000000005 113.254 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.616 ' HG2' HH11 ' A' ' 225' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 109.839 -0.43 . . . . 74.310000000000002 109.839 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -106.62 123.89 48.8 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.945 -1.131 . . . . 72.25 107.945 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 12.2 m -123.91 136.83 54.59 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 116.109 -0.496 . . . . 62.140000000000001 110.393 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.31 138.16 44.76 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.68 -1.23 . . . . 62.130000000000003 107.68 175.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -93.43 -53.86 3.9 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.676 -0.49 . . . . 62.539999999999999 109.676 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.83 139.23 52.77 Favored 'General case' 0 C--O 1.252 1.191 0 N-CA-C 109.835 -0.432 . . . . 74.310000000000002 109.835 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 28.4 mm -128.08 116.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 106.279 -1.749 . . . . 63.409999999999997 106.279 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 31.5 ttp-105 -134.43 115.87 14.49 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.606 0.717 . . . . 73.140000000000001 111.489 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.64 ' HB ' ' CB ' ' A' ' 237' ' ' ALA . 4.8 p -129.1 140.47 51.55 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.493 -0.776 . . . . 51.130000000000003 111.227 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -121.04 143.16 49.2 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.542 0.687 . . . . 70.230000000000004 112.573 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 68.79 -100.66 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.394 1.627 . . . . 55.420000000000002 115.394 171.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.622 ' HD2' ' OE2' ' A' ' 272' ' ' GLU . 16.8 mtm180 -99.08 23.39 9.1 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.476 1.131 . . . . 73.310000000000002 110.128 -171.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.64 ' CB ' ' HB ' ' A' ' 233' ' ' THR . . . -84.13 156.17 22.25 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.591 -1.64 . . . . 73.040000000000006 111.835 -176.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ARG . . . . . 0.474 ' HD3' ' HG2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -146.18 137.85 24.86 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.502 -0.772 . . . . 62.439999999999998 110.202 174.201 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.53 HG12 ' HB ' ' A' ' 275' ' ' VAL . 29.7 m -132.21 142.49 42.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.394 0.616 . . . . 61.340000000000003 111.892 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.463 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 56.5 tp60 -123.48 135.38 54.03 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.535 -0.757 . . . . 43.530000000000001 109.003 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -123.19 118.17 27.01 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.735 -1.58 . . . . 75.439999999999998 106.735 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.424 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 126.8 -113.0 1.67 Allowed Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 119.756 -1.211 . . . . 62.030000000000001 114.572 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -143.98 131.92 21.57 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 110.114 -0.328 . . . . 73.420000000000002 110.114 -172.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.539 HG11 ' H ' ' A' ' 286' ' ' PHE . 48.9 t -122.14 123.63 69.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.324 -0.621 . . . . 65.219999999999999 109.324 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.406 ' HA ' ' HB2' ' A' ' 281' ' ' TYR . 12.3 m -113.59 114.62 47.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.176 0.513 . . . . 75.230000000000004 110.364 174.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 24.4 m -96.97 159.76 14.73 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.842 -0.799 . . . . 52.119999999999997 108.842 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.47 75.73 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 123.249 0.62 . . . . 70.129999999999995 111.567 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.25 -42.84 78.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.06 -0.973 . . . . 50.409999999999997 111.985 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.435 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.431 0 CA-C-N 116.368 -0.378 . . . . 71.329999999999998 110.545 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 52.9 m . . . . . 0 N--CA 1.433 -1.323 0 N-CA-C 107.529 -1.285 . . . . 74.319999999999993 107.529 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 37.2 t-20 -127.11 138.32 53.16 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.197 -0.668 . . . . 65.400000000000006 109.197 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.5 m -128.62 123.14 32.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.737 -0.468 . . . . 75.25 109.737 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.92 150.12 34.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 N-CA-C 110.455 -0.202 . . . . 72.420000000000002 110.455 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.694 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 3.7 tp10 -85.46 -74.91 0.39 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.096 0.559 . . . . 74.319999999999993 110.097 178.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 32.2 m -128.59 134.71 48.68 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 122.146 -0.346 . . . . 71.019999999999996 111.234 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.59 127.07 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.659 -1.237 . . . . 74.239999999999995 107.659 172.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 10.1 p -127.23 134.84 65.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 116.439 -0.346 . . . . 73.349999999999994 110.897 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.92 132.75 7.32 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.669 -0.776 . . . . 41.140000000000001 111.999 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -132.09 116.64 17.3 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.748 -0.464 . . . . 74.219999999999999 109.748 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 109.93 -131.56 10.53 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.882 -0.887 . . . . 61.149999999999999 110.882 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.622 ' OE2' ' HD2' ' A' ' 236' ' ' ARG . 10.0 mp0 -92.5 32.3 1.23 Allowed 'General case' 0 C--O 1.252 1.22 0 C-N-CA 125.133 1.373 . . . . 51.299999999999997 110.087 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 16.7 m -81.77 145.22 30.57 Favored 'General case' 0 C--O 1.287 3.077 0 CA-C-O 122.927 1.346 . . . . 54.200000000000003 112.708 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' ARG . . . . . 0.474 ' HG2' ' HD3' ' A' ' 238' ' ' ARG . 72.1 mtm-85 -127.08 127.79 45.23 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.697 -1.592 . . . . 74.219999999999999 109.27 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.53 ' HB ' HG12 ' A' ' 239' ' ' VAL . 48.9 t -127.81 132.29 69.01 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 CA-C-N 115.957 -0.565 . . . . 52.020000000000003 109.947 -175.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.8 tt -125.01 128.41 48.52 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 118.151 -1.42 . . . . 65.540000000000006 109.677 173.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.445 HG23 HD12 ' B' ' 241' ' ' LEU . 35.0 mm -112.56 105.62 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.657 -0.868 . . . . 63.119999999999997 108.657 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 138.78 -134.02 6.56 Favored Glycine 0 C--N 1.31 -0.883 0 C-N-CA 120.648 -0.787 . . . . 61.43 113.297 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 28.3 m-80 -115.87 128.27 55.67 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 122.574 0.35 . . . . 71.340000000000003 110.816 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.06 118.67 34.05 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.657 -1.609 . . . . 73.010000000000005 106.657 176.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.406 ' HB2' ' HA ' ' A' ' 245' ' ' VAL . 22.4 m-85 -106.38 123.33 47.89 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.369 -1.345 . . . . 74.329999999999998 107.369 176.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.56 -50.66 0.79 Allowed Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.391 -1.083 . . . . 70.299999999999997 110.391 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.64 53.3 Favored Glycine 0 C--N 1.308 -1.02 0 N-CA-C 110.747 -0.941 . . . . 34.420000000000002 110.747 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' B' ' 287' ' ' TRP . 17.8 ptpt -179.85 27.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.286 1.034 . . . . 74.099999999999994 110.562 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -85.61 -120.72 1.08 Allowed Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 119.944 -1.122 . . . . 54.109999999999999 111.642 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.539 ' H ' HG11 ' A' ' 244' ' ' VAL . 86.8 t80 62.53 -89.07 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.106 0.562 . . . . 73.0 111.362 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 . . . . . 0 CA--C 1.508 -0.672 0 C-N-CA 127.35 2.26 . . . . 61.119999999999997 107.206 178.715 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.493 -1.218 0 N-CA-C 107.132 -1.433 . . . . 73.420000000000002 107.132 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.537 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 29.6 m-80 -103.87 130.18 51.44 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 107.991 -1.115 . . . . 50.350000000000001 107.991 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 28.6 m -128.61 137.04 51.48 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-O 121.197 0.523 . . . . 71.140000000000001 110.615 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.498 ' HB1' HD11 ' B' ' 231' ' ' ILE . . . -131.59 155.55 47.33 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.791 -1.188 . . . . 75.530000000000001 107.791 177.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.694 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 0.1 OUTLIER -109.0 -61.72 1.58 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 119.51 -0.876 . . . . 71.409999999999997 108.854 -178.435 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -126.63 137.8 53.35 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.84 -0.8 . . . . 75.420000000000002 108.84 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.498 HD11 ' HB1' ' B' ' 228' ' ' ALA . 18.5 mm -131.66 117.55 35.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 106.874 -1.528 . . . . 72.340000000000003 106.874 -178.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.444 ' HG3' HG23 ' B' ' 268' ' ' VAL . 7.0 ptm180 -130.38 118.81 21.78 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.345 0.593 . . . . 72.439999999999998 111.492 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 34.5 p -110.72 128.14 55.61 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.352 -0.84 . . . . 61.229999999999997 109.31 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -125.01 142.38 51.52 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.035 0.445 . . . . 73.319999999999993 111.04 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.461 ' HB3' ' HD3' ' B' ' 236' ' ' ARG . 45.0 mt-10 74.76 -102.37 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.388 0 C-N-CA 125.011 1.324 . . . . 72.030000000000001 113.084 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.565 ' HD3' ' N ' ' B' ' 236' ' ' ARG . 0.7 OUTLIER -110.37 25.49 11.73 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.723 0.773 . . . . 64.319999999999993 109.448 -175.293 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -82.99 142.45 31.36 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 122.568 1.175 . . . . 55.32 112.759 -175.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -131.65 135.86 47.25 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.542 -1.208 . . . . 63.340000000000003 109.506 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.832 HG12 ' HB ' ' B' ' 275' ' ' VAL . 2.6 m -125.31 141.27 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 CA-C-O 121.869 0.843 . . . . 71.530000000000001 111.538 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.492 ' HB3' ' HG ' ' B' ' 276' ' ' LEU . 5.9 tp-100 -116.41 128.38 55.45 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 114.074 -1.421 . . . . 65.329999999999998 107.643 174.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.445 HD12 HG23 ' A' ' 277' ' ' ILE . 3.0 tm? -120.38 117.31 27.41 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.927 -1.509 . . . . 72.439999999999998 106.927 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.417 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 125.92 -112.23 1.61 Allowed Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.554 -1.308 . . . . 73.140000000000001 113.143 176.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 243' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 2.2 t30 -144.97 138.36 26.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 111.556 0.206 . . . . 72.349999999999994 111.556 -174.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.515 HG11 ' H ' ' B' ' 286' ' ' PHE . 45.2 t -119.9 133.7 65.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.605 -0.887 . . . . 51.420000000000002 108.605 175.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 19.3 t -122.28 112.11 33.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 108.943 -0.762 . . . . 63.310000000000002 108.943 177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 23.5 m -95.49 158.95 15.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.97 -1.122 . . . . 62.329999999999998 107.97 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.435 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -64.39 -39.7 94.37 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.792 0.806 . . . . 74.400000000000006 110.553 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.89 -34.47 65.57 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.425 -1.716 . . . . 53.409999999999997 114.157 -175.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.439 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -68.03 -33.27 74.27 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.313 0.486 . . . . 63.25 112.313 -176.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 N--CA 1.488 1.45 0 C-N-CA 124.182 0.993 . . . . 75.010000000000005 111.135 -175.626 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 260' ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' C' ' 243' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.396 -3.142 0 N-CA-C 113.665 0.987 . . . . 63.210000000000001 113.665 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 63.9 m -100.74 105.95 17.33 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 104.139 -2.541 . . . . 65.409999999999997 104.139 167.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 1.8 t-20 -128.44 142.02 51.22 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.097 -0.956 . . . . 73.209999999999994 109.886 -171.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 39.6 m -137.2 128.07 27.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.807 0.337 . . . . 53.140000000000001 110.948 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.2 p -128.39 153.72 38.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.795 -0.817 . . . . 74.409999999999997 108.795 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 38.4 tt0 -96.2 -76.35 0.51 Allowed 'General case' 0 N--CA 1.418 -2.029 0 C-N-CA 120.156 -0.617 . . . . 64.310000000000002 111.452 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -116.37 128.43 55.52 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.765 -0.774 . . . . 72.019999999999996 112.635 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 11.8 m -118.45 129.08 75.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.197 0 N-CA-C 107.793 -1.188 . . . . 62.039999999999999 107.793 171.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 268' ' ' VAL . . . . . 0.444 HG23 ' HG3' ' B' ' 232' ' ' ARG . 4.1 p -126.83 128.25 70.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.978 -0.555 . . . . 63.210000000000001 111.126 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 269' ' ' GLY . . . . . 0.407 ' HA2' ' OG1' ' C' ' 233' ' ' THR . . . -116.06 132.01 9.95 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.361 -1.096 . . . . 21.420000000000002 110.361 175.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -131.99 116.4 17.06 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.491 -0.559 . . . . 72.219999999999999 109.491 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 100.56 -137.66 13.39 Favored Glycine 0 C--N 1.309 -0.92 0 N-CA-C 111.139 -0.784 . . . . 71.239999999999995 111.139 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 272' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 2.4 mp0 -77.22 40.43 0.27 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.993 1.317 . . . . 55.140000000000001 110.177 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 273' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 39.0 m -82.92 144.66 29.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.979 0.895 . . . . 73.310000000000002 112.503 -169.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 32.5 mtt180 -130.75 127.21 38.3 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.58 -1.637 . . . . 73.530000000000001 106.58 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.832 ' HB ' HG12 ' B' ' 239' ' ' VAL . 89.4 t -135.06 130.34 51.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.377 -0.601 . . . . 70.140000000000001 109.377 -176.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 7.0 tt -122.09 125.41 46.14 Favored 'General case' 0 C--N 1.277 -2.553 0 C-N-CA 117.7 -1.6 . . . . 73.319999999999993 110.144 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.43 HG23 HD12 ' C' ' 241' ' ' LEU . 29.1 mm -110.51 103.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.043 -1.465 . . . . 71.349999999999994 107.043 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 139.76 -147.65 19.35 Favored Glycine 0 C--N 1.308 -0.976 0 C-N-CA 120.197 -1.002 . . . . 62.43 113.694 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 279' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 5.2 m-20 -106.64 129.8 54.49 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.957 -0.386 . . . . 55.25 109.957 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.94 118.69 36.17 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.511 -1.663 . . . . 71.109999999999999 106.511 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -107.62 123.15 48.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.694 -0.854 . . . . 75.349999999999994 108.694 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 139.46 -50.17 0.79 Allowed Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 109.79 -1.324 . . . . 50.43 109.79 -176.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 94.53 17.05 40.48 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.738 -0.945 . . . . 62.210000000000001 110.738 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt 174.05 27.77 0.0 OUTLIER 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.784 1.234 . . . . 70.120000000000005 109.726 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.22 -113.36 0.23 Allowed Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.011 -0.836 . . . . 75.420000000000002 111.011 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.515 ' H ' HG11 ' B' ' 244' ' ' VAL . 92.7 t80 60.61 -83.53 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.39 0.676 . . . . 73.329999999999998 111.646 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.508 ' HE1' ' HB3' ' A' ' 286' ' ' PHE . 3.5 m-90 . . . . . 0 C--O 1.241 0.613 0 C-N-CA 126.477 1.911 . . . . 74.230000000000004 108.672 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.581 ' N ' ' HG1' ' C' ' 261' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.287 0 N-CA-C 108.756 -0.831 . . . . 72.409999999999997 108.756 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 40.8 m-80 -110.25 132.63 54.0 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 108.028 -1.101 . . . . 62.100000000000001 108.028 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 17.2 m -129.38 136.72 50.33 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 116.318 -0.401 . . . . 73.400000000000006 110.019 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.527 ' HB1' HD11 ' C' ' 231' ' ' ILE . . . -137.4 147.08 45.18 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.565 -0.902 . . . . 63.240000000000002 108.565 178.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -100.86 -64.65 1.03 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.936 -0.394 . . . . 71.040000000000006 109.936 -177.158 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.59 138.03 52.75 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 108.928 -0.767 . . . . 70.129999999999995 108.928 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.527 HD11 ' HB1' ' C' ' 228' ' ' ALA . 10.9 mm -132.0 117.46 33.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 106.552 -1.648 . . . . 74.150000000000006 106.552 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -126.03 122.12 34.96 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.585 -0.846 . . . . 74.409999999999997 112.413 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.431 ' CG2' HG13 ' C' ' 239' ' ' VAL . 17.3 p -110.47 126.99 54.92 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.051 -0.977 . . . . 70.230000000000004 109.19 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -128.93 142.77 50.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.036 0.446 . . . . 65.140000000000001 111.087 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 51.9 mt-10 78.75 -90.01 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 125.571 1.548 . . . . 72.400000000000006 113.971 173.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.474 ' HD3' ' OE2' ' C' ' 272' ' ' GLU . 0.0 OUTLIER -126.25 28.67 5.98 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.043 -1.095 . . . . 73.439999999999998 108.043 -177.251 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -82.58 146.42 29.17 Favored 'General case' 0 C--O 1.265 1.882 0 CA-C-O 122.794 1.283 . . . . 63.009999999999998 113.844 -174.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.1 OUTLIER -131.84 135.53 46.78 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.23 -1.35 . . . . 72.049999999999997 109.541 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.694 HG12 ' HB ' ' C' ' 275' ' ' VAL . 25.8 m -134.91 141.74 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 CA-C-O 121.936 0.874 . . . . 72.310000000000002 111.94 176.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.455 HE22 HD22 ' B' ' 276' ' ' LEU . 48.7 tp60 -110.83 133.19 53.57 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 113.985 -1.461 . . . . 73.140000000000001 108.304 176.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.43 HD12 HG23 ' B' ' 277' ' ' ILE . 3.1 tm? -125.26 117.01 22.87 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 106.249 -1.76 . . . . 55.109999999999999 106.249 177.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.409 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 125.88 -115.14 2.26 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 119.407 -1.378 . . . . 51.240000000000002 113.624 176.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 1.8 t30 -144.34 137.54 27.22 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 110.008 -0.367 . . . . 64.439999999999998 110.008 -173.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.544 HG11 ' H ' ' C' ' 286' ' ' PHE . 60.1 t -124.26 124.84 69.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.377 -0.601 . . . . 74.140000000000001 109.377 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 32.4 t -116.21 111.85 37.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.853 -0.795 . . . . 54.43 108.853 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.8 m -94.93 159.68 14.92 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.226 -1.028 . . . . 63.340000000000003 108.226 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -64.45 -39.96 94.82 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.685 0.755 . . . . 74.319999999999993 110.418 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -33.23 61.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.608 -1.633 . . . . 75.340000000000003 112.155 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 116.15 -0.477 . . . . 34.310000000000002 112.132 -177.856 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.581 ' HG1' ' N ' ' C' ' 225' ' ' ARG . 7.7 t . . . . . 0 N--CA 1.412 -2.371 0 N-CA-C 104.771 -2.307 . . . . 72.319999999999993 104.771 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 262' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 49.6 t30 -125.82 139.24 53.66 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.086 -0.506 . . . . 64.310000000000002 111.095 -168.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 13.1 t -129.38 123.5 31.87 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.438 -0.949 . . . . 54.509999999999998 108.438 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.01 153.92 34.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.165 -1.05 . . . . 73.120000000000005 108.165 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -97.56 -79.87 0.46 Allowed 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 120.028 -0.669 . . . . 72.409999999999997 111.403 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 29.2 m -120.07 127.73 52.82 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.145 -0.622 . . . . 71.239999999999995 111.812 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.9 m -118.7 127.3 75.66 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-O 121.621 0.724 . . . . 73.319999999999993 109.292 174.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.05 120.22 63.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.406 -0.815 . . . . 55.119999999999997 109.23 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.83 131.67 9.93 Favored Glycine 0 N--CA 1.416 -2.682 0 C-N-CA 119.635 -1.269 . . . . 53.149999999999999 111.114 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -133.33 133.84 43.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.491 -0.929 . . . . 55.539999999999999 108.491 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.77 -132.84 11.43 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.264 -0.969 . . . . 61.409999999999997 111.469 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 272' ' ' GLU . . . . . 0.474 ' OE2' ' HD3' ' C' ' 236' ' ' ARG . 4.5 mp0 -91.37 52.83 2.16 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.945 -1.131 . . . . 74.129999999999995 107.945 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 273' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 21.7 t -83.71 145.63 28.64 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 115.141 -0.936 . . . . 62.32 110.974 -174.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 274' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 17.2 mtm180 -141.12 127.5 19.87 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.785 -1.191 . . . . 73.439999999999998 107.785 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.694 ' HB ' HG12 ' C' ' 239' ' ' VAL . 13.6 t -137.2 138.95 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.14 -1.059 . . . . 63.32 108.14 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 8.8 tt -123.99 114.75 20.19 Favored 'General case' 0 N--CA 1.404 -2.768 0 C-N-CA 118.875 -1.13 . . . . 73.019999999999996 109.916 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 47.5 mm -102.51 103.04 14.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 106.674 -1.602 . . . . 74.040000000000006 106.674 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 278' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 145.54 -145.67 15.09 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.014 -1.089 . . . . 71.109999999999999 113.232 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -113.46 131.83 55.89 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 122.868 0.467 . . . . 64.030000000000001 109.764 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.64 118.54 32.39 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.702 -1.592 . . . . 64.150000000000006 106.702 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.29 123.34 49.92 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.63 -0.878 . . . . 72.120000000000005 108.63 176.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.98 -45.06 0.96 Allowed Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 110.632 -0.987 . . . . 62.210000000000001 110.632 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 94.28 4.36 62.75 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.61 -0.996 . . . . 55.119999999999997 110.61 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -170.71 28.75 0.02 OUTLIER 'General case' 0 C--O 1.247 0.948 0 C-N-CA 123.756 0.822 . . . . 64.340000000000003 109.671 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.37 -124.45 0.44 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.766 -0.933 . . . . 63.119999999999997 110.766 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.544 ' H ' HG11 ' C' ' 244' ' ' VAL . 88.1 t80 65.91 -78.67 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.351 0.66 . . . . 63.539999999999999 111.187 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.31 -1.124 0 C-N-CA 124.574 1.15 . . . . 75.200000000000003 109.045 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 . . . . . 0 N--CA 1.442 -0.87 0 CA-C-O 120.904 0.383 . . . . 64.25 110.041 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -112.53 130.87 55.86 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.295 -1.372 . . . . 75.0 107.295 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.7 m -135.62 136.77 41.28 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.146 0.498 . . . . 32.420000000000002 111.044 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 277' ' ' ILE . . . -116.2 131.17 57.02 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.334 -0.988 . . . . 62.310000000000002 108.334 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 4.1 tmmm? -81.39 -62.08 1.76 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.701 -0.481 . . . . 75.209999999999994 109.701 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -130.17 140.25 50.77 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.57 0.224 . . . . 75.219999999999999 111.401 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 48.7 mt -131.84 119.47 41.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.857 -0.794 . . . . 72.019999999999996 108.857 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.421 ' HB3' HG23 ' A' ' 268' ' ' VAL . 2.5 mpt_? -112.04 126.1 54.8 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.835 -0.431 . . . . 71.010000000000005 109.835 176.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.48 128.2 30.97 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 120.979 0.419 . . . . 52.329999999999998 110.395 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.25 159.73 39.15 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.416 -0.811 . . . . 73.030000000000001 109.956 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.494 ' HB2' ' H ' ' A' ' 271' ' ' GLY . 28.2 mm-40 63.3 72.2 0.49 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.551 0.741 . . . . 70.129999999999995 112.634 177.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.31 22.71 8.04 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.177 0.991 . . . . 73.200000000000003 113.031 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.41 145.76 28.82 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.107 0.48 . . . . 65.129999999999995 111.077 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -127.63 134.94 49.64 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.787 -0.642 . . . . 74.319999999999993 110.382 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 77.8 t -123.44 132.32 71.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.566 -0.743 . . . . 74.25 110.493 -174.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.524 ' HG3' HD13 ' A' ' 276' ' ' LEU . 55.5 tp60 -118.23 114.81 23.58 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.252 -1.018 . . . . 74.329999999999998 108.252 174.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -115.69 121.97 44.12 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.275 -1.379 . . . . 73.329999999999998 107.275 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.49 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 136.48 -119.74 2.04 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 119.946 -1.121 . . . . 61.240000000000002 112.525 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -144.18 129.04 18.4 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 110.09 -0.337 . . . . 70.519999999999996 110.09 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.0 t -112.57 120.98 64.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.452 -0.573 . . . . 72.530000000000001 109.452 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 25.8 m -117.99 112.17 37.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.594 0.711 . . . . 61.43 109.665 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 17.1 m -77.8 159.65 28.87 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.755 -0.657 . . . . 73.420000000000002 109.665 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.14 90.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.206 0.527 . . . . 73.510000000000005 110.654 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.64 -33.33 63.95 Favored 'General case' 0 C--O 1.211 -0.973 0 C-N-CA 124.891 1.276 . . . . 73.329999999999998 112.325 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.308 -1.231 0 CA-C-N 115.366 -0.834 . . . . 73.430000000000007 112.865 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.433 -1.292 0 N-CA-C 108.118 -1.067 . . . . 71.409999999999997 108.118 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.434 ' CG ' ' HA2' ' B' ' 242' ' ' GLY . 18.2 m-80 -120.87 140.4 51.84 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.999 0.428 . . . . 54.32 110.162 -176.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 42.6 m -142.13 123.8 15.06 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.846 -0.427 . . . . 71.310000000000002 109.846 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.3 p -122.53 138.48 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 109.971 -0.381 . . . . 64.340000000000003 109.971 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 65.1 mm-40 -81.17 -68.67 0.67 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.406 -0.361 . . . . 71.099999999999994 111.387 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 99.1 m -125.56 128.33 47.78 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.432 -0.507 . . . . 75.319999999999993 112.296 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.415 ' HB ' HD12 ' B' ' 231' ' ' ILE . 3.3 p -125.02 123.77 66.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.685 -0.857 . . . . 72.299999999999997 108.685 173.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 232' ' ' ARG . 7.3 p -127.07 139.54 51.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.888 0.375 . . . . 75.200000000000003 111.077 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.76 132.34 8.13 Favored Glycine 0 N--CA 1.423 -2.18 0 C-N-CA 121.019 -0.61 . . . . 71.5 111.756 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -133.23 116.46 16.24 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.431 -0.581 . . . . 73.450000000000003 109.431 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.494 ' H ' ' HB2' ' A' ' 235' ' ' GLU . . . 80.59 73.78 1.15 Allowed Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.386 -0.911 . . . . 74.200000000000003 113.322 173.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 56.35 53.65 8.53 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 113.788 1.033 . . . . 75.450000000000003 113.788 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 50.3 m -88.09 144.4 26.52 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 107.352 -1.351 . . . . 75.129999999999995 107.352 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 2.3 mpt_? -128.1 125.31 38.97 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 105.479 -2.045 . . . . 72.230000000000004 105.479 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.481 HG12 HG22 ' B' ' 239' ' ' VAL . 4.4 m -130.54 140.19 49.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 C-N-CA 119.936 -0.706 . . . . 72.530000000000001 110.122 -174.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.524 HD13 ' HG3' ' A' ' 240' ' ' GLN . 11.1 tp -125.11 118.64 26.58 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.649 0.738 . . . . 74.420000000000002 109.62 175.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.534 HG23 HD12 ' B' ' 241' ' ' LEU . 14.4 mt -113.18 104.43 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.936 0 CA-C-N 113.942 -1.481 . . . . 64.409999999999997 107.229 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.516 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 151.8 -129.08 2.71 Favored Glycine 0 N--CA 1.423 -2.206 0 C-N-CA 120.278 -0.963 . . . . 51.210000000000001 112.658 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -123.92 141.76 51.75 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.181 -0.674 . . . . 74.049999999999997 109.181 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.491 ' HB2' HE22 ' B' ' 240' ' ' GLN . 5.6 tm-20 -130.72 123.05 28.39 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.257 -1.016 . . . . 72.430000000000007 108.257 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.482 ' HD1' ' O ' ' B' ' 245' ' ' VAL . 7.4 t80 -116.01 124.01 49.43 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 107.96 -1.126 . . . . 72.219999999999999 107.96 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.592 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 144.68 -64.34 0.46 Allowed Glycine 0 N--CA 1.424 -2.139 0 CA-C-N 115.323 -0.853 . . . . 74.019999999999996 111.434 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 124.51 25.1 1.65 Allowed Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 120.44 -0.886 . . . . 42.539999999999999 113.018 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.91 -5.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.159 0.8 . . . . 73.120000000000005 113.159 174.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.28 -132.26 38.23 Favored Glycine 0 CA--C 1.505 -0.588 0 N-CA-C 115.157 0.823 . . . . 63.109999999999999 115.157 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -98.77 -3.25 36.06 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.4 -0.593 . . . . 74.310000000000002 109.4 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.505 ' CZ2' ' HB3' ' A' ' 276' ' ' LEU . 10.9 m-90 . . . . . 0 CA--C 1.49 -1.34 0 CA-C-N 115.711 -0.677 . . . . 73.439999999999998 110.506 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.413 ' HB2' ' OG1' ' B' ' 261' ' ' THR . 97.5 mtt180 . . . . . 0 CA--C 1.489 -1.4 0 N-CA-C 108.673 -0.862 . . . . 52.240000000000002 108.673 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 4.2 t30 -116.46 115.95 26.76 Favored 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 108.01 -1.107 . . . . 62.5 108.01 175.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 16.3 m -121.25 136.8 54.91 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-O 121.377 0.608 . . . . 71.120000000000005 110.799 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -124.66 124.09 41.45 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.649 -1.16 . . . . 71.439999999999998 108.357 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 0.3 OUTLIER -81.04 -57.5 3.5 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.658 -0.497 . . . . 74.400000000000006 109.658 -178.412 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -136.36 138.4 41.58 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.126 -0.63 . . . . 63.119999999999997 110.568 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.415 HD12 ' HB ' ' A' ' 267' ' ' VAL . 18.5 mt -130.36 119.19 45.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.419 -1.326 . . . . 53.420000000000002 107.419 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 69.8 mtt180 -117.16 115.53 25.51 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.733 -0.84 . . . . 64.219999999999999 108.733 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 69.4 p -112.84 127.29 56.14 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.303 -0.999 . . . . 63.119999999999997 108.303 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -134.55 139.25 45.27 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 120.07 -0.652 . . . . 73.129999999999995 109.398 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.463 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 44.8 mt-10 59.82 93.62 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 115.717 1.747 . . . . 75.310000000000002 115.717 170.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.463 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 2.8 mpt_? 62.75 20.12 11.9 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.1 -0.955 . . . . 72.109999999999999 110.954 172.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -84.1 141.83 30.83 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.935 -0.575 . . . . 43.350000000000001 110.48 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 7.9 mpt_? -124.69 133.93 53.04 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.788 -1.56 . . . . 62.310000000000002 106.788 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.55 HG12 HG22 ' B' ' 275' ' ' VAL . 23.4 m -135.84 147.56 28.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.559 -0.856 . . . . 62.109999999999999 111.467 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.606 ' CG ' HD13 ' B' ' 276' ' ' LEU . 5.5 tp-100 -124.01 120.33 32.12 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.226 -1.352 . . . . 75.120000000000005 108.425 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.534 HD12 HG23 ' A' ' 277' ' ' ILE . 2.9 tm? -118.09 117.71 29.93 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.133 -1.803 . . . . 75.120000000000005 106.133 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.524 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 139.82 -121.39 2.02 Favored Glycine 0 N--CA 1.412 -2.909 0 C-N-CA 119.398 -1.382 . . . . 61.43 112.902 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 243' ' ' ASN . . . . . 0.558 HD21 HG13 ' B' ' 245' ' ' VAL . 8.2 t30 -143.27 130.35 20.71 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.083 0.468 . . . . 72.140000000000001 111.528 -174.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 98.5 t -112.58 126.7 70.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.382 -0.826 . . . . 73.040000000000006 109.254 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.558 HG13 HD21 ' B' ' 243' ' ' ASN . 4.1 m -122.03 113.7 39.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 108.134 -1.061 . . . . 73.140000000000001 108.134 173.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.474 HG21 ' HD3' ' B' ' 284' ' ' LYS . 17.3 m -77.43 160.7 28.53 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.708 -0.849 . . . . 74.319999999999993 108.708 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -61.74 -46.26 90.4 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 122.406 1.098 . . . . 51.43 109.807 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.39 -34.29 68.71 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 112.843 -1.98 . . . . 74.129999999999995 112.991 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.61 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -59.86 -26.86 66.18 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.224 0.61 . . . . 74.140000000000001 112.563 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 122.286 1.041 . . . . 73.319999999999993 112.248 -179.064 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.238 0.471 0 N-CA-C 109.432 -0.581 . . . . 74.329999999999998 109.432 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.563 ' CG2' ' HG2' ' C' ' 225' ' ' ARG . 9.0 t -107.18 132.47 53.01 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.537 0.684 . . . . 74.150000000000006 109.373 177.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 16.5 m-80 -123.23 137.61 54.84 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.458 -0.792 . . . . 70.030000000000001 108.95 -177.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.3 m -139.24 123.62 18.2 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.667 -0.494 . . . . 74.299999999999997 109.667 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 9.2 p -117.77 141.14 38.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 120.866 0.365 . . . . 75.040000000000006 110.559 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 21.8 mm-40 -81.7 -69.03 0.64 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.595 -0.73 . . . . 62.530000000000001 110.745 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 29.2 m -133.1 127.44 33.99 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.796 -0.762 . . . . 52.310000000000002 112.183 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 3.6 p -123.51 124.18 69.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.972 -0.751 . . . . 74.25 108.972 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 268' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 8.5 p -127.32 136.97 59.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.131 0.491 . . . . 70.540000000000006 111.766 -176.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.99 133.07 10.6 Favored Glycine 0 CA--C 1.471 -2.686 0 CA-C-N 115.514 -0.766 . . . . 73.109999999999999 111.283 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -133.19 115.13 14.65 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 109.358 -0.608 . . . . 75.019999999999996 109.358 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.16 95.28 0.03 OUTLIER Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.924 -0.58 . . . . 75.040000000000006 114.532 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 63.36 31.54 15.13 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.502 0.556 . . . . 64.329999999999998 112.502 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.9 m -84.99 145.06 27.91 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.352 -0.386 . . . . 72.540000000000006 110.638 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 9.7 mpt_? -132.28 126.41 33.32 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.268 -1.382 . . . . 75.140000000000001 107.268 172.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.55 HG22 HG12 ' B' ' 239' ' ' VAL . 1.1 m -132.65 140.61 47.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 118.958 -1.097 . . . . 71.109999999999999 110.362 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.606 HD13 ' CG ' ' B' ' 240' ' ' GLN . 8.1 tp -122.86 117.17 24.98 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.024 0.916 . . . . 53.5 110.036 173.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.69 HG22 ' HB3' ' C' ' 241' ' ' LEU . 1.3 pt -112.13 103.89 16.17 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.026 0 CA-C-N 113.79 -1.55 . . . . 73.120000000000005 107.279 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 154.22 -147.18 16.09 Favored Glycine 0 N--CA 1.417 -2.598 0 CA-C-N 115.219 -0.9 . . . . 62.020000000000003 112.823 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -104.9 138.28 41.39 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.064 -1.088 . . . . 63.229999999999997 108.064 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -127.41 118.2 23.63 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.796 -1.557 . . . . 73.430000000000007 106.796 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.458 ' HB3' HG12 ' B' ' 245' ' ' VAL . 20.5 t80 -115.6 123.73 49.16 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 108.565 -0.902 . . . . 74.030000000000001 108.565 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.07 -55.32 0.68 Allowed Glycine 0 N--CA 1.416 -2.679 0 N-CA-C 109.328 -1.509 . . . . 74.230000000000004 109.328 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 102.2 44.02 1.94 Allowed Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.576 -1.009 . . . . 54.219999999999999 110.576 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 284' ' ' LYS . . . . . 0.474 ' HD3' HG21 ' B' ' 246' ' ' THR . 11.8 ptmm? -174.9 -18.14 0.01 OUTLIER 'General case' 0 C--O 1.253 1.278 0 O-C-N 123.713 0.302 . . . . 74.010000000000005 111.522 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 54.02 -141.99 32.23 Favored Glycine 0 CA--C 1.5 -0.898 0 CA-C-N 115.574 -0.739 . . . . 72.319999999999993 114.251 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -96.39 4.57 52.11 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.172 -0.677 . . . . 54.299999999999997 109.172 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.455 ' CH2' ' HB3' ' B' ' 276' ' ' LEU . 8.5 m-90 . . . . . 0 N--CA 1.433 -1.29 0 CA-C-N 115.441 -0.8 . . . . 73.230000000000004 112.023 -174.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.563 ' HG2' ' CG2' ' B' ' 261' ' ' THR . 82.8 mtm180 . . . . . 0 N--CA 1.436 -1.152 0 CA-C-O 121.015 0.436 . . . . 73.349999999999994 110.163 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 4.4 t30 -116.4 123.25 47.1 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.525 -0.917 . . . . 75.239999999999995 108.525 178.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 227' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' C' ' 263' ' ' SER . 46.7 t -121.94 137.52 54.76 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.854 -0.612 . . . . 73.030000000000001 109.955 -175.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -126.08 124.38 40.48 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.488 -0.93 . . . . 70.209999999999994 108.488 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -83.74 -64.84 1.09 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.554 -0.535 . . . . 73.319999999999993 109.554 -177.201 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -127.49 138.12 52.85 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 109.617 -0.512 . . . . 70.120000000000005 109.617 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.531 HG23 HG13 ' C' ' 267' ' ' VAL . 13.7 mt -133.48 117.44 27.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.15 -1.796 . . . . 64.409999999999997 106.15 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 17.0 ptp180 -124.88 115.65 20.96 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.634 0.731 . . . . 75.409999999999997 110.052 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 49.2 p -110.64 128.34 55.65 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.949 -0.76 . . . . 71.209999999999994 108.949 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -132.33 139.45 48.16 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.23 -0.655 . . . . 52.310000000000002 109.23 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.501 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 44.3 mt-10 59.07 93.05 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.283 1.586 . . . . 70.439999999999998 115.283 171.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.501 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 1.3 mpt_? 61.35 17.17 8.07 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.164 0.985 . . . . 60.32 111.772 175.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -80.15 136.59 36.54 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.082 0.468 . . . . 64.230000000000004 110.525 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.6 OUTLIER -124.95 133.07 53.17 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.385 -1.339 . . . . 72.0 107.385 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.529 HG12 HG22 ' C' ' 275' ' ' VAL . 19.2 m -136.52 149.69 27.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.563 -0.855 . . . . 74.019999999999996 111.772 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.59 ' HG3' HD13 ' C' ' 276' ' ' LEU . 47.7 tp60 -126.07 120.74 31.0 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 114.043 -1.435 . . . . 70.030000000000001 109.079 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.69 ' HB3' HG22 ' B' ' 277' ' ' ILE . 2.1 tm? -120.99 118.55 30.13 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.744 -1.576 . . . . 65.239999999999995 106.744 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.463 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 139.66 -122.91 2.35 Favored Glycine 0 N--CA 1.417 -2.63 0 C-N-CA 119.619 -1.277 . . . . 60.130000000000003 111.91 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -137.76 129.47 28.39 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 110.274 -0.269 . . . . 44.399999999999999 110.274 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.454 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 86.0 t -112.56 123.21 68.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.0 -0.741 . . . . 73.230000000000004 109.0 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 1.6 p -122.67 111.93 32.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 N-CA-C 108.236 -1.024 . . . . 63.409999999999997 108.236 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 20.0 m -70.59 160.53 32.34 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 116.163 -0.472 . . . . 54.229999999999997 109.894 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.61 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -59.28 -46.29 88.93 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.172 0.987 . . . . 50.420000000000002 110.14 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.49 73.48 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 113.633 -1.622 . . . . 72.230000000000004 112.567 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 249' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' C' ' 281' ' ' TYR . . . . . . . . 0 N--CA 1.44 -0.963 0 CA-C-N 115.441 -0.799 . . . . 54.140000000000001 111.537 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.433 -1.286 0 N-CA-C 108.578 -0.897 . . . . 54.240000000000002 108.578 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -109.9 123.25 49.28 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.265 -0.643 . . . . 73.310000000000002 109.265 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 263' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' C' ' 227' ' ' SER . 13.0 p -125.37 127.64 46.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 110.185 -0.302 . . . . 53.219999999999999 110.185 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.05 137.04 46.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.573 -0.528 . . . . 61.509999999999998 109.573 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 62.3 mm-40 -80.5 -64.61 1.15 Allowed 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 123.043 0.215 . . . . 51.310000000000002 110.759 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 19.0 m -131.98 127.36 36.12 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 119.644 -0.822 . . . . 75.530000000000001 110.299 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.531 HG13 HG23 ' C' ' 231' ' ' ILE . 2.6 p -126.44 122.89 62.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.927 -0.768 . . . . 74.329999999999998 108.927 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 268' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 6.0 p -124.0 142.78 39.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.885 -0.598 . . . . 60.240000000000002 110.762 -175.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.92 132.16 9.27 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 110.315 -1.114 . . . . 65.230000000000004 110.315 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -134.28 115.74 14.46 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 109.009 -0.737 . . . . 71.319999999999993 109.009 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.68 94.19 0.04 OUTLIER Glycine 0 CA--C 1.523 0.542 0 O-C-N 123.506 0.504 . . . . 42.539999999999999 114.249 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 272' ' ' GLU . . . . . 0.491 ' CD ' HH12 ' C' ' 238' ' ' ARG . 43.6 mm-40 62.2 25.64 15.35 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.506 0.928 . . . . 62.43 113.506 176.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 25.0 m -82.28 144.42 30.63 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.679 -0.808 . . . . 64.099999999999994 110.303 -176.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 274' ' ' ARG . . . . . 0.628 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 63.3 mtt180 -135.86 126.11 26.45 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 105.831 -1.914 . . . . 71.140000000000001 105.831 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.529 HG22 HG12 ' C' ' 239' ' ' VAL . 1.5 m -137.88 142.0 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 119.573 -0.851 . . . . 52.229999999999997 111.496 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.59 HD13 ' HG3' ' C' ' 240' ' ' GLN . 7.5 tp -122.46 112.59 18.24 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.037 0.922 . . . . 63.240000000000002 110.798 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.422 HD11 HD13 ' C' ' 231' ' ' ILE . 1.9 pt -108.67 104.98 17.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-N 114.054 -1.43 . . . . 72.129999999999995 108.544 175.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 278' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 149.97 -149.44 21.35 Favored Glycine 0 N--CA 1.419 -2.454 0 CA-C-N 115.408 -0.815 . . . . 54.32 111.533 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -98.1 145.67 26.32 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.499 -0.926 . . . . 75.310000000000002 108.499 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.488 ' HB2' HD21 ' C' ' 276' ' ' LEU . 2.9 tm-20 -137.12 117.91 14.09 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.857 -1.535 . . . . 54.439999999999998 106.857 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.509 ' CD2' ' HB1' ' C' ' 249' ' ' ALA . 42.9 t80 -118.47 124.57 47.92 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 108.882 -0.785 . . . . 61.100000000000001 108.882 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 140.49 -52.95 0.68 Allowed Glycine 0 N--CA 1.416 -2.66 0 N-CA-C 109.371 -1.492 . . . . 73.540000000000006 109.371 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 115.27 -11.31 19.7 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.664 -0.779 . . . . 73.299999999999997 111.787 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -125.12 -5.33 7.33 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 112.581 0.586 . . . . 60.43 112.581 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.33 -121.96 19.25 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 115.777 -0.647 . . . . 72.230000000000004 113.178 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -125.47 13.16 8.15 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.296 -1.001 . . . . 75.340000000000003 108.296 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' C' ' 276' ' ' LEU . 18.0 m-90 . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 114.452 1.279 . . . . 72.340000000000003 114.452 -171.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 . . . . . 0 N--CA 1.436 -1.148 0 N-CA-C 109.355 -0.609 . . . . 72.329999999999998 109.355 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -116.55 137.96 51.77 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.423 -1.695 . . . . 43.409999999999997 106.423 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 7.9 p -128.4 137.43 51.86 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 113.474 0.916 . . . . 63.149999999999999 113.474 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.77 150.44 51.08 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.523 -1.288 . . . . 71.010000000000005 107.523 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -103.3 -50.95 3.34 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.763 -0.829 . . . . 70.129999999999995 108.763 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.441 ' HB2' HG23 ' A' ' 266' ' ' THR . 18.2 m-20 -127.36 140.71 52.0 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 109.577 -0.527 . . . . 65.239999999999995 109.577 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 55.0 mt -136.64 117.09 17.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 105.817 -1.92 . . . . 75.409999999999997 105.817 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.407 ' HB3' HG12 ' A' ' 268' ' ' VAL . 36.7 ttt180 -128.5 128.91 45.24 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.702 -0.481 . . . . 71.510000000000005 109.702 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 36.2 p -121.53 137.5 54.7 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 116.535 -0.302 . . . . 72.319999999999993 110.752 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -131.11 157.22 43.7 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 120.55 -0.46 . . . . 71.040000000000006 110.878 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 63.82 -85.77 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.942 1.297 . . . . 63.109999999999999 113.504 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.76 20.31 4.21 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 121.683 0.754 . . . . 53.210000000000001 109.331 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.523 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -69.86 130.98 43.72 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.792 -0.64 . . . . 75.540000000000006 109.989 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -125.42 135.15 52.07 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 108.075 -1.083 . . . . 74.340000000000003 108.075 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.557 HG22 ' CG2' ' A' ' 275' ' ' VAL . 96.2 t -132.42 145.37 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 121.037 0.446 . . . . 65.420000000000002 110.504 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.455 ' CG ' HD13 ' A' ' 276' ' ' LEU . 6.4 tp-100 -120.21 122.77 41.67 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.204 -1.406 . . . . 71.540000000000006 107.204 172.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.82 119.31 38.15 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.075 -1.083 . . . . 72.219999999999999 108.075 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.642 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 125.55 -132.92 8.15 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 111.305 -0.718 . . . . 52.32 111.305 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -125.1 143.82 50.73 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 117.198 0.499 . . . . 41.32 110.654 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.414 ' CG2' ' HG2' ' A' ' 240' ' ' GLN . 95.7 t -110.74 116.7 53.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.645 -1.243 . . . . 71.530000000000001 107.645 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.4 t -113.94 111.79 37.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 107.914 -1.143 . . . . 73.109999999999999 107.914 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.9 m -101.05 160.62 14.23 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 109.339 -0.615 . . . . 74.109999999999999 109.339 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.11 -32.76 66.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.89 1.276 . . . . 61.409999999999997 111.609 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.32 -48.19 74.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.685 0.794 . . . . 63.32 113.047 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.57 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.294 -0.632 . . . . 63.32 109.294 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 10.0 t . . . . . 0 N--CA 1.423 -1.786 0 N-CA-C 108.662 -0.866 . . . . 72.319999999999993 108.662 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.56 ' OD1' ' HB3' ' B' ' 226' ' ' ASN . 3.8 t30 -126.54 133.0 51.22 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.018 -0.734 . . . . 74.420000000000002 109.018 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' B' ' 227' ' ' SER . 19.6 m -117.93 123.5 45.94 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.587 0.555 . . . . 65.120000000000005 109.706 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 10.2 p -126.92 143.42 40.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.248 -0.649 . . . . 63.310000000000002 109.248 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.594 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 36.8 tt0 -83.6 -82.61 0.15 Allowed 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 120.677 -0.409 . . . . 72.120000000000005 111.004 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 230' ' ' ASP . 81.0 m -115.45 126.69 54.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.663 -0.648 . . . . 71.120000000000005 111.897 -174.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 11.5 t -118.68 120.95 65.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 107.278 -1.379 . . . . 72.150000000000006 107.278 177.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.425 HG23 ' HG3' ' B' ' 232' ' ' ARG . 20.9 m -123.83 136.52 59.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 120.216 -0.594 . . . . 72.140000000000001 111.102 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.408 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -117.48 133.17 10.38 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.92 -0.582 . . . . 75.310000000000002 111.943 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -129.6 147.2 51.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.158 -1.052 . . . . 61.520000000000003 108.158 -177.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.27 -133.39 42.45 Favored Glycine 0 C--O 1.239 0.436 0 C-N-CA 120.972 -0.632 . . . . 75.140000000000001 112.226 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -90.69 83.56 5.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.769 -0.826 . . . . 74.0 108.769 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 75.3 m -104.62 144.07 32.21 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.555 -0.858 . . . . 73.230000000000004 110.693 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 28.0 mmm-85 -133.39 123.05 24.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.05 -2.204 . . . . 73.439999999999998 105.05 171.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.58 HG12 ' HB ' ' B' ' 239' ' ' VAL . 30.6 m -140.0 140.58 35.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.239 0.542 . . . . 61.539999999999999 111.627 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.594 ' HB3' ' CH2' ' A' ' 287' ' ' TRP . 9.4 tp -122.37 124.58 44.0 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 115.663 -0.699 . . . . 64.310000000000002 109.687 175.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.728 HG23 HD12 ' B' ' 241' ' ' LEU . 71.6 mt -110.72 103.45 15.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 107.642 -1.244 . . . . 74.420000000000002 107.642 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 145.52 -135.77 6.13 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.283 -0.871 . . . . 70.329999999999998 111.504 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 46.1 t-20 -129.59 137.64 50.83 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 122.17 -0.606 . . . . 72.329999999999998 109.509 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 285' ' ' GLY . 34.4 tt0 -111.17 127.28 55.54 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.396 -0.964 . . . . 65.019999999999996 108.396 177.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 99.7 m-85 -113.73 124.52 52.47 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.681 -0.859 . . . . 73.310000000000002 108.681 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.57 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 138.99 -87.09 0.21 Allowed Glycine 0 CA--C 1.467 -2.916 0 C-N-CA 120.397 -0.906 . . . . 74.310000000000002 112.211 177.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 141.9 96.94 0.27 Allowed Glycine 0 N--CA 1.406 -3.314 0 N-CA-C 108.555 -1.818 . . . . 72.420000000000002 108.555 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp 80.24 45.25 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 O-C-N 125.106 1.121 . . . . 72.120000000000005 110.296 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.464 ' H ' ' CD ' ' A' ' 280' ' ' GLU . . . -78.17 -54.87 4.24 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 115.431 -0.804 . . . . 54.140000000000001 111.683 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -89.62 -33.83 16.53 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.146 0.498 . . . . 73.010000000000005 110.708 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.594 ' CH2' ' HB3' ' A' ' 276' ' ' LEU . 29.6 m-90 . . . . . 0 C--N 1.303 -1.452 0 CA-C-N 116.334 -0.393 . . . . 55.329999999999998 110.466 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.632 ' HA ' ' O ' ' A' ' 261' ' ' THR . 40.6 ptt180 . . . . . 0 N--CA 1.423 -1.81 0 CA-C-O 121.059 0.457 . . . . 75.209999999999994 110.543 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.56 ' HB3' ' OD1' ' A' ' 262' ' ' ASN . 51.0 t-20 -116.18 148.43 40.38 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 105.285 -2.117 . . . . 74.140000000000001 105.285 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 227' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 263' ' ' SER . 3.2 p -139.01 136.78 35.69 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 121.515 0.674 . . . . 73.5 111.829 -175.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -132.13 144.25 50.57 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.726 -1.125 . . . . 54.229999999999997 108.571 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 5.9 tmtm? -96.74 -61.32 1.43 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.948 -0.76 . . . . 62.310000000000002 108.948 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -127.18 139.38 52.98 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 121.807 -0.558 . . . . 61.399999999999999 110.089 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.437 HG21 HG11 ' B' ' 239' ' ' VAL . 6.9 mt -134.96 120.65 31.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.713 -1.588 . . . . 72.140000000000001 106.713 175.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.425 ' HG3' HG23 ' A' ' 268' ' ' VAL . 78.8 ttt-85 -123.36 120.44 33.03 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.408 -0.59 . . . . 74.530000000000001 109.408 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 81.0 p -109.99 128.87 55.66 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.139 -1.059 . . . . 64.519999999999996 108.139 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -137.25 157.17 47.24 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.598 -0.519 . . . . 73.129999999999995 109.598 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.593 ' HB3' ' HD2' ' B' ' 236' ' ' ARG . 6.2 mp0 63.09 -89.09 0.03 OUTLIER 'General case' 0 C--O 1.21 -1.01 0 C-N-CA 124.425 1.09 . . . . 71.409999999999997 113.496 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.593 ' HD2' ' HB3' ' B' ' 235' ' ' GLU . 0.0 OUTLIER -137.2 59.27 1.69 Allowed 'General case' 0 C--O 1.245 0.843 0 N-CA-C 107.701 -1.222 . . . . 73.439999999999998 107.701 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.66 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -99.61 135.19 41.4 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-O 122.353 1.073 . . . . 74.439999999999998 110.399 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 6.1 mpt_? -124.28 133.21 53.54 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 105.691 -1.966 . . . . 73.519999999999996 105.691 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.58 ' HB ' HG12 ' A' ' 275' ' ' VAL . 69.7 t -142.48 133.08 24.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.847 0.832 . . . . 63.420000000000002 111.239 -175.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.584 ' CG ' HD13 ' B' ' 276' ' ' LEU . 44.0 tp60 -105.23 132.51 51.35 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.678 -1.23 . . . . 75.530000000000001 107.678 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.728 HD12 HG23 ' A' ' 277' ' ' ILE . 3.4 tm? -121.85 117.01 25.46 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 106.354 -1.721 . . . . 51.240000000000002 106.354 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.695 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 117.84 -130.05 8.58 Favored Glycine 0 C--O 1.206 -1.632 0 N-CA-C 111.189 -0.764 . . . . 72.209999999999994 111.189 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 243' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 5.8 m-20 -124.41 148.4 47.61 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 122.0 -0.706 . . . . 62.340000000000003 112.255 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.551 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 98.5 t -118.3 114.69 45.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.647 -1.242 . . . . 32.299999999999997 107.647 175.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 58.9 t -117.86 111.98 36.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 108.698 -0.853 . . . . 74.430000000000007 108.698 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.492 ' OG1' ' HA3' ' B' ' 282' ' ' GLY . 13.6 p -93.69 161.98 14.12 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 119.895 -0.722 . . . . 54.130000000000003 109.57 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -59.25 -32.54 70.09 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.475 1.131 . . . . 43.439999999999998 109.636 176.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.57 -35.16 65.46 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 112.655 -2.066 . . . . 53.140000000000001 113.5 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -62.31 -26.42 68.41 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.069 0.461 . . . . 71.530000000000001 110.406 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 N--CA 1.433 -1.314 0 CA-C-O 121.807 0.813 . . . . 72.030000000000001 109.022 177.866 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 CA--C 1.559 1.314 0 N-CA-C 108.805 -0.813 . . . . 60.530000000000001 108.805 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 9.0 t -91.99 132.86 36.22 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.082 0.468 . . . . 73.109999999999999 109.78 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 39.9 t-20 -126.56 146.66 50.05 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.695 -0.854 . . . . 74.329999999999998 108.695 -178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 49.3 m -135.65 123.48 22.56 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.023 0.439 . . . . 63.539999999999999 110.207 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.7 p -123.38 150.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.183 -0.673 . . . . 71.340000000000003 109.183 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 39.3 tt0 -93.5 -69.27 0.76 Allowed 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.539 -0.864 . . . . 72.420000000000002 110.409 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 15.6 m -119.53 127.63 53.2 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.104 -1.039 . . . . 65.099999999999994 112.301 -176.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 25.7 t -119.08 120.59 64.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.652 -1.24 . . . . 73.439999999999998 107.652 174.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.83 131.59 69.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 112.248 0.462 . . . . 72.25 112.248 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 269' ' ' GLY . . . . . 0.409 ' HA2' ' OG1' ' C' ' 233' ' ' THR . . . -109.66 133.89 11.89 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.608 -0.724 . . . . 62.409999999999997 111.886 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.428 ' HB3' ' HG2' ' C' ' 234' ' ' GLU . 16.3 tppt? -131.8 130.23 41.52 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 124.826 1.25 . . . . 71.310000000000002 109.546 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.28 -133.47 14.06 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 110.551 -1.019 . . . . 43.240000000000002 110.551 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 272' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 77.1 mm-40 -87.25 97.9 11.03 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 107.849 -1.167 . . . . 74.519999999999996 107.849 176.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 66.1 m -117.86 143.42 46.32 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 119.342 -0.943 . . . . 55.0 110.417 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 18.9 mmm-85 -133.99 123.83 25.26 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 104.259 -2.497 . . . . 65.530000000000001 104.259 172.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.3 t -139.22 140.73 37.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.515 -0.921 . . . . 75.219999999999999 108.515 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.723 ' HB3' ' CH2' ' B' ' 287' ' ' TRP . 3.0 tp -126.79 122.06 33.71 Favored 'General case' 0 C--N 1.26 -3.299 0 N-CA-C 109.651 -0.5 . . . . 72.5 109.651 173.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.493 HG23 HD12 ' C' ' 241' ' ' LEU . 3.2 mp -107.01 103.72 15.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 106.386 -1.709 . . . . 73.239999999999995 106.386 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.695 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 152.48 -140.9 8.01 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 121.061 -0.59 . . . . 25.109999999999999 112.245 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -128.86 135.29 48.89 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.621 -0.881 . . . . 55.450000000000003 108.621 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.426 ' HB2' HD21 ' B' ' 276' ' ' LEU . 41.5 tt0 -111.77 133.69 53.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.814 0.34 . . . . 61.240000000000002 110.225 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -121.87 125.65 46.91 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 115.885 -0.598 . . . . 72.239999999999995 110.988 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.492 ' HA3' ' OG1' ' B' ' 246' ' ' THR . . . 133.37 -99.55 0.37 Allowed Glycine 0 CA--C 1.48 -2.156 0 C-N-CA 120.559 -0.829 . . . . 71.549999999999997 112.725 174.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 178.34 112.32 0.33 Allowed Glycine 0 C--N 1.277 -2.706 0 N-CA-C 108.106 -1.997 . . . . 60.240000000000002 108.106 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? 78.01 -50.88 0.5 Allowed 'General case' 0 C--O 1.197 -1.677 0 C-N-CA 124.217 1.007 . . . . 71.019999999999996 112.537 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 285' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' B' ' 246' ' ' THR . . . 46.5 -102.31 0.04 OUTLIER Glycine 0 C--O 1.244 0.779 0 O-C-N 124.439 1.087 . . . . 12.210000000000001 114.983 175.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -70.75 -28.42 64.68 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 123.959 0.904 . . . . 75.430000000000007 111.382 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.723 ' CH2' ' HB3' ' B' ' 276' ' ' LEU . 22.8 m-90 . . . . . 0 C--N 1.309 -1.152 0 O-C-N 122.052 -0.405 . . . . 74.540000000000006 111.645 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.577 ' HA ' ' O ' ' B' ' 261' ' ' THR . 56.4 ttp180 . . . . . 0 N--CA 1.437 -1.08 0 CA-C-O 120.904 0.383 . . . . 73.019999999999996 110.304 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 23.2 t-20 -106.95 142.76 36.06 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.72 -1.956 . . . . 62.030000000000001 105.72 175.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 9.1 p -139.98 137.31 34.6 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.216 -0.994 . . . . 74.310000000000002 113.101 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -127.45 142.02 51.52 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.101 -0.954 . . . . 60.43 109.435 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 49.0 tptt -87.81 -66.61 0.89 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.964 -0.562 . . . . 70.409999999999997 110.537 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -133.68 138.93 46.13 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.959 -0.756 . . . . 71.400000000000006 108.959 -175.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.413 HG23 ' HB ' ' C' ' 267' ' ' VAL . 10.7 mt -135.38 120.52 28.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.721 -1.214 . . . . 62.310000000000002 107.721 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 77.7 ttt180 -122.85 121.64 36.73 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 109.351 -0.611 . . . . 74.450000000000003 109.351 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 68.5 p -110.46 127.92 55.36 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.466 -0.939 . . . . 30.510000000000002 108.466 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' B' ' 270' ' ' LYS . 34.5 mt-10 -130.13 152.27 49.75 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 119.99 -0.684 . . . . 50.329999999999998 112.0 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 48.8 mt-10 69.8 -77.81 0.05 Allowed 'General case' 0 C--O 1.194 -1.84 0 CA-C-N 113.84 -1.527 . . . . 71.409999999999997 113.854 172.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.1 56.8 1.47 Allowed 'General case' 0 C--O 1.245 0.819 0 N-CA-C 107.134 -1.432 . . . . 74.140000000000001 107.134 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -104.12 135.11 46.23 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 122.492 1.139 . . . . 65.530000000000001 111.292 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 4.8 mpt_? -124.86 133.16 53.19 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 106.071 -1.825 . . . . 75.109999999999999 106.071 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.492 HG22 ' HB ' ' C' ' 275' ' ' VAL . 94.9 t -141.52 134.68 30.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.418 0.628 . . . . 74.209999999999994 110.766 -176.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.566 ' CG ' HD13 ' C' ' 276' ' ' LEU . 5.1 tp-100 -105.3 129.5 53.63 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.646 -1.242 . . . . 72.439999999999998 107.646 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.493 HD12 HG23 ' B' ' 277' ' ' ILE . 3.4 tm? -122.42 116.01 23.24 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.048 -1.834 . . . . 72.400000000000006 106.048 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.447 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 130.0 -111.07 1.11 Allowed Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 119.668 -1.253 . . . . 64.439999999999998 112.859 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.01 148.91 34.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.738 -0.467 . . . . 72.519999999999996 109.738 -174.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.515 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 91.6 t -126.94 114.94 39.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.852 -0.795 . . . . 75.120000000000005 108.852 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.87 111.77 37.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.859 -0.793 . . . . 74.340000000000003 108.859 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.3 m -85.56 160.97 19.52 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.548 -0.908 . . . . 60.5 108.548 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -63.09 -34.24 77.17 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 122.444 1.116 . . . . 63.119999999999997 109.294 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.92 -35.62 66.81 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 113.14 -1.846 . . . . 72.109999999999999 111.671 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.814 0 CA-C-N 116.383 -0.371 . . . . 54.009999999999998 111.387 -178.108 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.419 -1.994 0 N-CA-C 108.369 -0.975 . . . . 73.099999999999994 108.369 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -113.52 128.07 56.31 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.317 -0.856 . . . . 65.329999999999998 109.58 -176.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.2 m -117.61 123.25 45.73 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.033 -0.728 . . . . 75.319999999999993 109.033 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -117.67 148.74 20.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.178 -1.045 . . . . 74.329999999999998 108.178 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 43.0 tt0 -90.44 -84.66 0.23 Allowed 'General case' 0 N--CA 1.415 -2.184 0 C-N-CA 120.355 -0.538 . . . . 54.409999999999997 110.269 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 20.0 m -110.59 130.31 55.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.774 -0.77 . . . . 74.150000000000006 110.477 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.413 ' HB ' HG23 ' C' ' 231' ' ' ILE . 40.6 t -117.85 120.77 65.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.72 -1.215 . . . . 74.219999999999999 107.72 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 268' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.1 p -127.61 131.96 69.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 120.411 -0.515 . . . . 73.109999999999999 110.987 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.14 133.61 11.7 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 108.912 -1.675 . . . . 71.310000000000002 108.912 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -132.33 132.95 43.45 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.716 -0.846 . . . . 73.219999999999999 108.716 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.5 -125.23 10.21 Favored Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 120.428 -0.891 . . . . 41.409999999999997 111.346 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -91.84 97.55 11.05 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.521 -1.288 . . . . 74.319999999999993 107.521 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 33.4 m -127.61 145.07 51.0 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 113.45 0.907 . . . . 43.509999999999998 113.45 -175.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 34.5 mmm-85 -133.46 124.79 27.69 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 104.919 -2.252 . . . . 70.420000000000002 104.919 173.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.492 ' HB ' HG22 ' C' ' 239' ' ' VAL . 4.2 t -139.4 140.55 37.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 118.634 0.652 . . . . 61.32 109.729 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.685 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 5.1 tp -126.94 119.73 27.42 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-O 121.374 0.606 . . . . 72.209999999999994 109.397 172.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.405 HD12 HD13 ' C' ' 231' ' ' ILE . 54.9 mt -108.45 103.4 15.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 105.719 -1.956 . . . . 75.120000000000005 105.719 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 278' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 146.24 -146.71 17.05 Favored Glycine 0 N--CA 1.427 -1.944 0 C-N-CA 120.721 -0.752 . . . . 54.039999999999999 111.352 -175.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -121.72 140.33 52.45 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.577 -0.897 . . . . 62.049999999999997 108.577 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.527 ' HB2' HD21 ' C' ' 276' ' ' LEU . 36.0 tt0 -118.63 118.35 31.41 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.973 -0.751 . . . . 74.329999999999998 108.973 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -107.72 125.82 51.85 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 109.92 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 131.28 -129.25 5.66 Favored Glycine 0 N--CA 1.427 -1.935 0 C-N-CA 120.749 -0.738 . . . . 52.229999999999997 112.332 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -157.02 111.58 0.49 Allowed Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.52 -1.432 . . . . 62.450000000000003 109.52 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 63.56 38.14 9.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.957 0.903 . . . . 62.030000000000001 109.785 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -60.93 -68.15 1.8 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.355 -0.839 . . . . 65.420000000000002 113.53 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -89.72 -46.17 8.8 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.661 -0.496 . . . . 74.530000000000001 109.661 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.685 ' CH2' ' HB3' ' C' ' 276' ' ' LEU . 24.4 m-90 . . . . . 0 CA--C 1.493 -1.215 0 CA-C-N 116.101 -0.5 . . . . 71.109999999999999 109.892 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.879 0 CA-C-O 121.227 0.536 . . . . 74.299999999999997 110.877 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -80.84 131.86 35.42 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.017 -1.846 . . . . 73.049999999999997 106.017 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 10.6 m -120.98 137.88 54.42 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 120.061 -0.656 . . . . 73.109999999999999 111.484 -171.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.76 118.46 19.07 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.584 -1.636 . . . . 64.409999999999997 106.584 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.523 ' HE2' ' O ' ' A' ' 265' ' ' GLU . 5.7 tmmm? -86.36 -38.58 17.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.832 -0.433 . . . . 73.019999999999996 109.832 -176.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -143.82 138.77 28.93 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.142 -0.688 . . . . 61.409999999999997 109.142 174.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 60.7 mt -130.77 126.7 60.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 105.149 -2.167 . . . . 74.349999999999994 105.149 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.413 ' HE ' ' HB2' ' A' ' 232' ' ' ARG . 10.1 ttm180 -134.44 116.21 14.89 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.954 -0.758 . . . . 61.200000000000003 108.954 -177.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 31.3 p -123.42 127.74 48.86 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 110.121 -0.325 . . . . 74.230000000000004 110.121 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -144.65 145.97 32.02 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 120.86 0.362 . . . . 74.409999999999997 111.304 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 63.49 86.68 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.968 1.307 . . . . 75.439999999999998 113.989 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.51 26.43 16.06 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.014 -0.994 . . . . 74.219999999999999 111.865 177.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.49 144.64 27.16 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.825 -0.625 . . . . 63.109999999999999 109.855 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -127.24 135.49 50.69 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.932 -0.766 . . . . 74.420000000000002 108.932 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 3.3 p -132.98 145.21 34.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.952 0.882 . . . . 72.049999999999997 112.738 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -124.84 130.42 52.35 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.062 -1.458 . . . . 64.120000000000005 107.062 170.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -128.43 118.56 23.33 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.533 -1.284 . . . . 54.350000000000001 107.533 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.19 -116.79 1.8 Allowed Glycine 0 N--CA 1.427 -1.945 0 C-N-CA 119.603 -1.284 . . . . 31.539999999999999 114.123 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ASN . . . . . 0.426 ' OD1' HG13 ' A' ' 245' ' ' VAL . 15.6 t-20 -144.48 128.69 17.73 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 122.968 0.507 . . . . 75.049999999999997 110.178 -175.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 50.2 t -108.77 114.01 45.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.376 -0.602 . . . . 75.230000000000004 109.376 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' VAL . . . . . 0.43 HG12 ' HD2' ' A' ' 281' ' ' TYR . 15.7 m -103.33 121.82 55.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.885 -0.783 . . . . 71.209999999999994 108.885 175.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.587 ' OG1' ' HA3' ' A' ' 282' ' ' GLY . 24.0 p -92.64 160.63 14.92 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.591 -1.244 . . . . 51.520000000000003 111.18 176.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.27 -34.5 78.26 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 123.78 0.832 . . . . 71.140000000000001 112.564 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -70.14 -35.37 74.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.079 0.466 . . . . 65.219999999999999 111.959 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.612 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.311 -1.09 0 CA-C-N 115.704 -0.68 . . . . 64.109999999999999 111.201 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 8.0 m . . . . . 0 N--CA 1.424 -1.76 0 N-CA-C 109.285 -0.635 . . . . 63.32 109.285 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -120.26 133.61 55.44 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.046 -1.094 . . . . 73.219999999999999 108.046 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 18.2 m -142.31 130.4 22.0 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.974 -0.454 . . . . 50.119999999999997 112.218 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -114.1 133.35 60.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 109.529 -0.545 . . . . 73.230000000000004 109.529 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.523 ' O ' ' HE2' ' A' ' 229' ' ' LYS . 71.5 mm-40 -78.4 -50.87 10.94 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 116.331 -0.395 . . . . 72.430000000000007 110.09 177.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 90.5 m -145.92 127.24 14.88 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.34 -0.85 . . . . 62.149999999999999 111.275 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.0 p -120.81 120.39 62.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.566 -0.743 . . . . 74.420000000000002 109.053 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.7 130.48 72.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.58 -0.737 . . . . 72.239999999999995 109.447 -175.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.42 131.92 8.56 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.293 -1.123 . . . . 72.519999999999996 110.293 174.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 22.8 tptt -134.01 116.7 15.83 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 110.057 -0.349 . . . . 73.549999999999997 110.057 -177.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.33 90.47 0.21 Allowed Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.33 -0.938 . . . . 70.200000000000003 113.303 174.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.498 ' HB3' ' NH1' ' A' ' 274' ' ' ARG . 19.5 mt-10 58.58 37.89 25.34 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.598 0.962 . . . . 72.219999999999999 113.598 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 15.5 m -88.43 143.7 26.83 Favored 'General case' 0 C--N 1.274 -2.682 0 C-N-CA 118.639 -1.224 . . . . 72.420000000000002 109.386 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' ARG . . . . . 0.498 ' NH1' ' HB3' ' A' ' 272' ' ' GLU . 9.2 mpt_? -116.6 127.03 54.11 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.369 -1.715 . . . . 71.439999999999998 106.369 174.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.551 HG12 ' CG1' ' B' ' 239' ' ' VAL . 17.2 m -126.41 123.42 63.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-O 121.458 0.647 . . . . 72.209999999999994 109.952 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 5.4 tt -113.57 111.77 22.43 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.744 -1.576 . . . . 55.210000000000001 106.744 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.623 HG23 HD12 ' B' ' 241' ' ' LEU . 60.0 mt -112.36 107.33 22.7 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 CA-C-O 121.612 0.72 . . . . 63.340000000000003 110.122 -177.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 137.61 -135.27 7.47 Favored Glycine 0 N--CA 1.426 -1.993 0 CA-C-N 115.533 -0.758 . . . . 61.219999999999999 112.139 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 3.1 m120 -104.09 134.34 47.51 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 112.06 0.392 . . . . 73.319999999999993 112.06 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -113.2 117.92 33.25 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 103.401 -2.814 . . . . 74.010000000000005 103.401 167.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 16.0 t80 -130.13 123.61 30.76 Favored 'General case' 0 C--O 1.264 1.818 0 CA-C-O 122.54 1.162 . . . . 73.120000000000005 113.514 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.612 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 129.98 -77.27 0.4 Allowed Glycine 0 N--CA 1.415 -2.734 0 CA-C-N 113.475 -1.693 . . . . 42.539999999999999 114.938 175.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -61.27 -81.74 0.08 OUTLIER Glycine 0 C--N 1.317 -0.508 0 N-CA-C 115.708 1.043 . . . . 72.430000000000007 115.708 -170.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -178.67 -35.95 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.122 -1.807 . . . . 73.019999999999996 106.122 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' B' ' 287' ' ' TRP . . . -158.35 -167.41 19.16 Favored Glycine 0 N--CA 1.401 -3.652 0 CA-C-N 113.73 -1.577 . . . . 74.239999999999995 109.541 176.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.416 ' HE1' ' CZ2' ' B' ' 287' ' ' TRP . 41.7 p90 -104.25 -169.66 1.66 Allowed 'General case' 0 C--N 1.294 -1.825 0 O-C-N 124.105 0.532 . . . . 72.129999999999995 110.468 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 27.8 p90 . . . . . 0 C--N 1.313 -0.985 0 C-N-CA 124.455 1.102 . . . . 70.109999999999999 113.02 179.177 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 261' ' ' THR . 14.7 ttt180 . . . . . 0 N--CA 1.437 -1.082 0 CA-C-O 120.793 0.33 . . . . 71.409999999999997 111.707 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -85.92 126.34 34.02 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.213 -2.143 . . . . 40.439999999999998 105.213 171.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 227' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' B' ' 263' ' ' SER . 18.7 m -121.25 136.61 54.94 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.789 -0.765 . . . . 74.010000000000005 111.746 -174.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.62 119.19 26.43 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.474 -1.306 . . . . 74.409999999999997 107.474 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.582 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 33.5 ttmt -75.74 -61.73 1.82 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.059 -0.719 . . . . 73.209999999999994 109.059 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -128.32 137.7 52.05 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 109.373 -0.602 . . . . 74.230000000000004 109.373 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.451 ' HA ' HG13 ' B' ' 267' ' ' VAL . 40.0 mt -128.6 128.16 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.791 0 N-CA-C 104.956 -2.238 . . . . 44.039999999999999 104.956 174.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.513 ' HB3' HG12 ' B' ' 268' ' ' VAL . 16.0 ttm180 -132.25 114.09 14.03 Favored 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 108.537 -0.912 . . . . 73.030000000000001 108.537 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 45.7 p -110.04 127.89 55.1 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.243 -1.762 . . . . 72.230000000000004 106.243 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 234' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' B' ' 270' ' ' LYS . 48.4 mt-10 -143.31 140.5 30.61 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.007 -0.738 . . . . 74.040000000000006 109.007 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 60.89 97.66 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 O-C-N 124.032 0.833 . . . . 61.450000000000003 113.212 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.535 ' HB2' ' H ' ' B' ' 272' ' ' GLU . 2.0 mpt_? 60.37 22.61 12.15 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.031 0.533 . . . . 61.399999999999999 111.533 173.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.58 140.53 33.63 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.189 0.519 . . . . 54.25 110.895 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.94 134.76 46.01 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.685 -0.688 . . . . 74.549999999999997 109.498 178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.582 HG23 ' HB ' ' B' ' 275' ' ' VAL . 7.2 p -137.53 150.01 25.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.271 0.558 . . . . 31.309999999999999 110.204 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.485 HE22 ' N ' ' B' ' 243' ' ' ASN . 22.5 tm0? -122.63 128.13 50.26 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 105.663 -1.977 . . . . 54.140000000000001 105.663 170.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.623 HD12 HG23 ' A' ' 277' ' ' ILE . 3.3 tm? -118.33 117.91 30.37 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.16 -2.163 . . . . 74.540000000000006 105.16 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.437 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 143.19 -125.56 2.6 Favored Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 118.695 -1.717 . . . . 43.439999999999998 112.852 -178.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 243' ' ' ASN . . . . . 0.533 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 25.6 t30 -144.44 128.22 17.28 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 110.292 -0.262 . . . . 74.019999999999996 110.292 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.418 HG21 ' HZ3' ' B' ' 287' ' ' TRP . 30.0 t -99.54 128.0 51.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.105 -1.442 . . . . 74.340000000000003 107.105 177.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 10.5 t -122.51 116.07 47.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 107.381 -1.34 . . . . 74.230000000000004 107.381 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.9 p -85.02 158.07 20.57 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 117.1 -1.84 . . . . 72.25 111.065 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -66.57 -47.1 73.85 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.61 1.195 . . . . 71.310000000000002 110.035 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.81 -33.49 61.6 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.243 -2.253 . . . . 51.219999999999999 113.795 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.532 ' HB2' ' HA3' ' B' ' 282' ' ' GLY . . . -58.7 -42.84 89.54 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.078 0.551 . . . . 53.240000000000002 111.171 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 N--CA 1.484 1.244 0 C-N-CA 124.807 1.243 . . . . 72.340000000000003 112.549 -179.103 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.399 -2.996 0 N-CA-C 103.618 -2.734 . . . . 63.32 103.618 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 13.9 m -94.47 108.44 20.38 Favored 'General case' 0 N--CA 1.417 -2.114 0 C-N-CA 119.208 -0.997 . . . . 74.099999999999994 109.446 -175.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -104.19 128.54 51.92 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.147 -1.057 . . . . 72.010000000000005 108.147 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 263' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' B' ' 227' ' ' SER . 38.6 t -142.78 136.09 28.51 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-O 121.074 0.464 . . . . 73.109999999999999 111.747 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 9.4 p -116.39 137.25 50.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.982 -0.554 . . . . 74.510000000000005 110.076 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.582 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 31.7 mm-40 -78.02 -57.44 3.79 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.866 -0.79 . . . . 75.200000000000003 108.866 176.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 88.0 m -146.96 126.98 13.65 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.661 0.743 . . . . 73.010000000000005 111.387 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' B' ' 231' ' ' ILE . 1.3 p -121.91 120.51 61.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.271 -0.877 . . . . 73.430000000000007 109.603 176.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 268' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' B' ' 232' ' ' ARG . 34.2 m -121.06 145.59 27.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 116.044 -0.526 . . . . 73.219999999999999 110.194 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 269' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -143.82 132.79 5.06 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 120.097 -1.049 . . . . 43.520000000000003 112.4 176.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' B' ' 234' ' ' GLU . 65.0 mttm -133.92 131.01 38.56 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.724 0.81 . . . . 73.319999999999993 112.319 176.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.03 86.57 0.59 Allowed Glycine 0 C--N 1.296 -1.679 0 N-CA-C 114.476 0.551 . . . . 54.219999999999999 114.476 172.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 272' ' ' GLU . . . . . 0.535 ' H ' ' HB2' ' B' ' 236' ' ' ARG . 65.3 mm-40 65.95 27.65 10.76 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 112.193 0.442 . . . . 74.439999999999998 112.193 173.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 12.9 m -83.54 143.15 30.37 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.29 0.567 . . . . 74.109999999999999 110.149 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.539 ' HB2' ' HG3' ' C' ' 238' ' ' ARG . 10.9 mpt_? -123.47 127.63 48.66 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.521 -1.659 . . . . 64.5 106.521 174.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.582 ' HB ' HG23 ' B' ' 239' ' ' VAL . 5.9 t -127.41 133.9 66.91 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 108.45 -0.945 . . . . 65.439999999999998 108.45 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 4.4 tt -121.99 112.82 18.75 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.011 -1.477 . . . . 73.129999999999995 107.011 171.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.675 HG23 HD12 ' C' ' 241' ' ' LEU . 39.4 mt -112.83 107.0 21.87 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 109.131 -0.692 . . . . 62.520000000000003 109.131 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 149.95 -137.58 6.28 Favored Glycine 0 N--CA 1.405 -3.38 0 C-N-CA 119.948 -1.12 . . . . 41.229999999999997 112.188 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 279' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 7.5 t30 -119.03 133.18 55.97 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.998 -0.601 . . . . 44.420000000000002 110.133 -178.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -109.89 118.64 37.01 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 104.603 -2.369 . . . . 74.239999999999995 104.603 177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -120.05 123.43 43.39 Favored 'General case' 0 C--O 1.274 2.369 0 CA-C-O 122.535 1.16 . . . . 73.5 110.379 -172.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' B' ' 249' ' ' ALA . . . 111.91 -55.66 0.5 Allowed Glycine 0 N--CA 1.398 -3.9 0 CA-C-N 114.064 -1.425 . . . . 53.130000000000003 115.385 172.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.43 -97.91 0.03 OUTLIER Glycine 0 C--N 1.313 -0.737 0 N-CA-C 115.655 1.022 . . . . 72.299999999999997 115.655 -171.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 42.8 tptt 173.92 -42.06 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 103.94 -2.615 . . . . 72.319999999999993 103.94 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -147.09 161.68 28.49 Favored Glycine 1 N--CA 1.387 -4.591 0 N-CA-C 106.215 -2.754 . . . . 62.240000000000002 106.215 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -83.4 -153.63 0.14 Allowed 'General case' 0 C--N 1.278 -2.509 0 O-C-N 124.358 0.681 . . . . 75.150000000000006 110.56 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.5 ' HE1' ' HB3' ' B' ' 274' ' ' ARG . 34.4 p90 . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 125.756 1.623 . . . . 65.140000000000001 113.629 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' B' ' 261' ' ' THR . 47.5 ttt180 . . . . . 0 N--CA 1.436 -1.156 0 CA-C-O 120.822 0.344 . . . . 71.329999999999998 111.301 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -93.23 124.93 37.56 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 104.962 -2.236 . . . . 75.120000000000005 104.962 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 227' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' B' ' 263' ' ' SER . 8.1 m -121.69 136.22 54.95 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.976 -0.689 . . . . 71.120000000000005 110.856 -174.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.38 119.02 30.92 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.829 -1.545 . . . . 70.430000000000007 106.829 174.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.543 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.8 OUTLIER -82.17 -54.72 5.04 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 116.301 -0.409 . . . . 74.140000000000001 109.958 -174.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -131.46 137.41 48.58 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.462 -1.31 . . . . 71.200000000000003 107.462 173.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.433 ' HA ' HG13 ' C' ' 267' ' ' VAL . 30.8 mt -130.73 128.79 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 104.983 -2.228 . . . . 73.319999999999993 104.983 174.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.491 ' HB3' HG12 ' C' ' 268' ' ' VAL . 10.7 ttm180 -133.05 113.85 13.26 Favored 'General case' 0 N--CA 1.401 -2.896 0 N-CA-C 108.758 -0.831 . . . . 72.319999999999993 108.758 -176.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.44 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 40.9 p -110.79 126.22 54.39 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.856 -1.164 . . . . 63.530000000000001 107.856 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 48.4 mt-10 -145.14 142.24 29.45 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 110.271 -0.27 . . . . 75.340000000000003 110.271 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 64.49 89.59 0.09 Allowed 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.437 1.085 . . . . 61.350000000000001 113.113 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.459 ' HB2' ' H ' ' C' ' 272' ' ' GLU . 4.8 mpt_? 64.75 15.99 10.13 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.993 -1.003 . . . . 71.430000000000007 112.026 174.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.47 140.97 28.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.289 0.566 . . . . 64.219999999999999 112.481 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.539 ' HG3' ' HB2' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -128.47 135.75 49.89 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.021 -0.733 . . . . 70.519999999999996 109.021 178.811 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' C' ' 275' ' ' VAL . 7.1 p -138.85 147.53 24.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.452 0.644 . . . . 72.530000000000001 111.469 -177.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.35 132.54 56.57 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 104.506 -2.405 . . . . 74.120000000000005 104.506 172.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.675 HD12 HG23 ' B' ' 277' ' ' ILE . 3.4 tm? -129.68 117.79 20.88 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 106.319 -1.734 . . . . 72.120000000000005 106.319 177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.31 -117.65 1.66 Allowed Glycine 0 N--CA 1.426 -1.999 0 C-N-CA 119.912 -1.137 . . . . 64.049999999999997 112.474 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.734 HD22 HG13 ' C' ' 245' ' ' VAL . 5.8 t30 -144.4 134.33 23.91 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.798 0.333 . . . . 65.430000000000007 111.435 -176.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.31 123.61 68.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.49 -0.93 . . . . 74.310000000000002 108.49 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.734 HG13 HD22 ' C' ' 243' ' ' ASN . 31.5 m -121.43 117.2 51.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-O 121.625 0.726 . . . . 72.109999999999999 109.143 177.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 246' ' ' THR . . . . . 0.526 ' OG1' ' HA3' ' C' ' 282' ' ' GLY . 12.4 p -83.76 158.55 21.7 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 117.871 -1.532 . . . . 63.130000000000003 109.969 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.93 89.73 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.934 1.35 . . . . 71.109999999999999 108.632 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.19 62.36 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 112.374 -2.193 . . . . 34.100000000000001 112.826 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.549 0 N-CA-C 112.908 0.707 . . . . 74.329999999999998 112.908 -177.322 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.427 -1.614 0 CA-C-O 120.666 0.27 . . . . 72.409999999999997 110.706 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -97.89 138.81 34.68 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.213 -1.402 . . . . 73.129999999999995 107.213 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 45.6 m -142.58 136.12 28.91 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.639 -0.663 . . . . 54.030000000000001 111.11 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.96 130.56 74.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.101 -0.703 . . . . 64.329999999999998 109.101 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 5.5 mm-40 -75.09 -47.14 30.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.051 0.453 . . . . 65.540000000000006 110.904 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 69.8 m -150.41 127.88 11.47 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 122.005 -0.434 . . . . 74.109999999999999 110.623 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' C' ' 231' ' ' ILE . 1.1 p -126.1 119.8 55.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.983 -0.747 . . . . 75.109999999999999 108.983 174.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 268' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' C' ' 232' ' ' ARG . 25.8 m -121.04 144.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.262 -0.644 . . . . 75.340000000000003 109.262 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.33 132.42 6.65 Favored Glycine 0 CA--C 1.473 -2.558 0 N-CA-C 110.705 -0.958 . . . . 52.530000000000001 110.705 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.59 128.83 36.0 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 109.499 -0.556 . . . . 75.310000000000002 109.499 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.6 75.49 1.15 Allowed Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.357 -0.925 . . . . 44.450000000000003 113.718 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 272' ' ' GLU . . . . . 0.459 ' H ' ' HB2' ' C' ' 236' ' ' ARG . 53.1 mt-10 60.52 40.81 16.53 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.389 0.676 . . . . 61.219999999999999 112.269 175.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.4 m -81.98 143.81 31.33 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 119.221 -0.992 . . . . 73.0 109.482 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 274' ' ' ARG . . . . . 0.445 ' HB3' ' HE1' ' C' ' 287' ' ' TRP . 1.3 mpp_? -120.2 127.0 52.04 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.545 -1.65 . . . . 73.129999999999995 106.545 173.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' C' ' 239' ' ' VAL . 3.0 t -135.54 140.18 45.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 109.315 -0.624 . . . . 62.509999999999998 109.315 -175.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.534 HD12 ' CZ3' ' C' ' 287' ' ' TRP . 4.0 tt -128.17 115.6 18.64 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.145 -1.798 . . . . 64.400000000000006 106.145 170.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.416 HD12 HD13 ' C' ' 231' ' ' ILE . 56.7 mt -112.73 104.31 16.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.047 -1.464 . . . . 74.540000000000006 107.047 176.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.12 -139.5 6.72 Favored Glycine 0 N--CA 1.403 -3.507 0 C-N-CA 119.89 -1.147 . . . . 71.109999999999999 111.476 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -122.87 130.29 52.69 Favored 'General case' 0 C--N 1.279 -2.466 0 O-C-N 123.807 0.357 . . . . 64.519999999999996 110.237 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.88 117.9 34.64 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.618 -1.623 . . . . 75.040000000000006 106.618 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -124.77 123.94 41.06 Favored 'General case' 0 C--O 1.272 2.245 0 CA-C-O 122.394 1.092 . . . . 72.319999999999993 111.794 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 282' ' ' GLY . . . . . 0.526 ' HA3' ' OG1' ' C' ' 246' ' ' THR . . . 128.2 -53.91 0.79 Allowed Glycine 0 N--CA 1.419 -2.459 0 CA-C-N 114.193 -1.367 . . . . 63.409999999999997 113.515 178.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -80.48 -97.62 0.35 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.493 -0.86 . . . . 74.519999999999996 114.104 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 52.5 tttp 170.43 -34.11 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 104.877 -2.268 . . . . 74.109999999999999 104.877 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -143.05 156.31 26.4 Favored Glycine 0 N--CA 1.404 -3.442 0 N-CA-C 106.479 -2.649 . . . . 52.039999999999999 106.479 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -89.08 -166.09 1.51 Allowed 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 117.258 0.529 . . . . 70.340000000000003 109.719 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.534 ' CZ3' HD12 ' C' ' 276' ' ' LEU . 43.4 p90 . . . . . 0 C--O 1.248 1.01 0 C-N-CA 123.409 0.684 . . . . 64.409999999999997 110.756 178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 225' ' ' ARG . 24.5 mmt180 . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 121.616 0.722 . . . . 72.409999999999997 111.318 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.484 ' HB2' ' OD1' ' A' ' 262' ' ' ASN . 23.4 p-10 -116.88 156.0 28.09 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 125.23 1.412 . . . . 71.120000000000005 111.675 -173.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 263' ' ' SER . 23.4 m -116.99 136.53 52.87 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 108.813 -0.81 . . . . 63.030000000000001 108.813 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.7 135.34 43.98 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.267 -0.879 . . . . 70.409999999999997 110.285 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 1.9 tmtp? -87.84 -63.93 1.23 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.723 -0.671 . . . . 63.130000000000003 110.367 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -131.03 139.03 49.89 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.166 -0.334 . . . . 61.509999999999998 110.52 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.6 mt -137.8 128.15 36.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.029 -1.471 . . . . 73.319999999999993 107.029 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.467 ' HB2' HG12 ' A' ' 268' ' ' VAL . 65.0 mtt180 -134.41 115.14 13.67 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.437 -0.505 . . . . 71.430000000000007 109.706 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.505 HG21 ' HB ' ' A' ' 239' ' ' VAL . 28.9 p -118.95 128.31 54.29 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.415 -0.514 . . . . 74.349999999999994 109.868 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.3 153.29 46.42 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.904 -0.406 . . . . 55.32 109.904 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 63.46 83.44 0.16 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.603 1.161 . . . . 71.5 113.036 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 236' ' ' ARG . 6.1 mpt_? 58.83 22.79 10.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.913 1.285 . . . . 73.109999999999999 112.436 176.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.6 142.03 27.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 122.173 -0.329 . . . . 34.149999999999999 110.445 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.75 137.16 53.8 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.825 -0.435 . . . . 72.040000000000006 109.825 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.505 ' HB ' HG21 ' A' ' 233' ' ' THR . 3.1 p -129.16 142.59 43.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.453 0.644 . . . . 44.439999999999998 111.777 -176.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -125.99 125.38 42.6 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 108.496 -0.928 . . . . 72.439999999999998 108.496 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.422 ' HA ' HG13 ' A' ' 277' ' ' ILE . 59.7 tp -115.88 123.87 49.22 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.454 -0.943 . . . . 74.239999999999995 108.454 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.564 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 121.09 -123.54 5.57 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.382 -0.913 . . . . 71.299999999999997 112.166 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 279' ' ' ASN . 20.8 t30 -141.76 128.57 20.51 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 122.196 -0.591 . . . . 61.43 111.524 -174.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 51.3 t -104.11 122.45 56.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.201 -1.407 . . . . 73.430000000000007 107.201 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.7 t -118.17 116.26 50.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.401 -0.592 . . . . 60.439999999999998 109.401 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.3 t -114.34 162.1 17.05 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 119.977 -0.689 . . . . 71.5 109.393 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.37 -32.0 62.24 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 114.862 1.43 . . . . 75.430000000000007 114.862 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.41 -37.54 65.19 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.823 1.416 . . . . 71.340000000000003 114.823 -173.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.919 0 N-CA-C 112.542 0.571 . . . . 62.219999999999999 112.542 179.814 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.435 -1.211 0 N-CA-C 107.543 -1.28 . . . . 73.109999999999999 107.543 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 25.0 t-20 -86.45 121.45 29.01 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 119.847 -0.741 . . . . 73.349999999999994 109.378 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 227' ' ' SER . 50.8 m -142.32 132.77 25.09 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.554 -0.748 . . . . 72.540000000000006 111.079 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.4 p -126.82 138.22 55.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.603 -0.272 . . . . 73.340000000000003 111.6 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 55.3 mm-40 -78.11 -66.48 0.84 Allowed 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 116.031 -0.532 . . . . 74.230000000000004 110.825 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 30.1 m -133.63 126.97 32.01 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.23 -0.588 . . . . 73.519999999999996 110.41 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.72 121.68 55.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.637 -0.711 . . . . 75.099999999999994 109.601 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 232' ' ' ARG . 15.9 m -126.05 146.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-O 121.112 0.482 . . . . 74.430000000000007 111.568 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -130.02 131.26 6.54 Favored Glycine 0 N--CA 1.425 -2.073 0 N-CA-C 109.096 -1.601 . . . . 61.119999999999997 109.096 174.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.498 ' HB2' ' HG2' ' B' ' 234' ' ' GLU . 29.8 mmmt -133.25 116.14 15.82 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 120.565 0.221 . . . . 44.32 110.946 -176.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 83.68 84.05 0.91 Allowed Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 119.314 -1.422 . . . . 42.420000000000002 113.657 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 60.2 27.27 16.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.88 0.872 . . . . 73.530000000000001 111.74 171.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 17.4 m -84.11 145.49 28.4 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.281 0.563 . . . . 63.439999999999998 110.85 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -113.2 127.44 56.18 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.989 -1.856 . . . . 74.099999999999994 105.989 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 1.2 p -133.66 123.1 44.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-O 121.379 0.609 . . . . 70.129999999999995 111.418 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.529 HD23 ' CH2' ' A' ' 287' ' ' TRP . 18.3 tp -117.03 119.37 35.06 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.489 -0.93 . . . . 73.209999999999994 108.489 174.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.51 HG22 ' HB3' ' B' ' 241' ' ' LEU . 2.7 pt -113.67 104.91 17.73 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.146 0 CA-C-N 114.194 -1.367 . . . . 62.409999999999997 109.505 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 149.09 -122.78 1.51 Allowed Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.941 -0.572 . . . . 71.239999999999995 113.036 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 243' ' ' ASN . 9.8 t30 -129.75 135.31 48.31 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 122.232 -0.569 . . . . 62.240000000000002 111.673 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.493 ' HG2' ' NE1' ' A' ' 287' ' ' TRP . 7.2 tp10 -111.75 118.27 35.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 105.854 -1.906 . . . . 75.530000000000001 105.854 174.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -117.8 123.13 45.2 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 105.721 -1.955 . . . . 75.430000000000007 105.721 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 121.82 -48.51 0.94 Allowed Glycine 0 C--N 1.284 -2.335 0 N-CA-C 108.192 -1.963 . . . . 50.409999999999997 108.192 -172.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 99.52 16.39 29.41 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 120.809 -0.71 . . . . 73.239999999999995 112.112 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.454 ' HB3' ' NZ ' ' A' ' 284' ' ' LYS . 0.1 OUTLIER 176.82 66.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.849 0.859 . . . . 63.520000000000003 112.728 178.302 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -109.72 -51.22 0.66 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 109.633 -1.387 . . . . 70.109999999999999 109.633 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -96.73 -5.82 37.76 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.243 0.544 . . . . 71.150000000000006 110.591 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.603 ' CH2' ' HB2' ' B' ' 240' ' ' GLN . 2.5 m95 . . . . . 0 CA--C 1.493 -1.222 0 N-CA-C 114.526 1.306 . . . . 75.299999999999997 114.526 -174.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 . . . . . 0 C--O 1.211 -0.969 0 CA-C-O 121.995 0.902 . . . . 75.200000000000003 111.564 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.612 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 21.2 p-10 -118.23 155.34 30.71 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 125.328 1.451 . . . . 75.209999999999994 114.27 -174.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 227' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' B' ' 263' ' ' SER . 20.7 m -117.38 135.93 53.52 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 122.362 1.077 . . . . 72.120000000000005 108.149 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -134.06 139.21 45.83 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.004 -0.998 . . . . 62.450000000000003 109.695 -174.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 37.2 ttmt -86.58 -65.53 1.0 Allowed 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.832 -0.622 . . . . 71.239999999999995 110.747 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -126.24 137.83 53.56 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.148 -1.021 . . . . 73.239999999999995 110.489 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 44.9 mt -135.39 121.74 32.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.425 -1.324 . . . . 71.310000000000002 107.425 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 58.4 mtt180 -128.17 114.85 17.52 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.804 -0.813 . . . . 75.430000000000007 108.804 177.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 45.3 p -116.37 126.59 53.69 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.778 -1.564 . . . . 71.129999999999995 106.778 175.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 234' ' ' GLU . . . . . 0.561 ' HB2' ' HE3' ' B' ' 270' ' ' LYS . 32.7 mt-10 -141.67 151.91 43.44 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.88 -0.785 . . . . 63.399999999999999 108.88 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 61.38 80.38 0.22 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.536 1.134 . . . . 71.340000000000003 112.466 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.523 ' HD3' ' N ' ' B' ' 236' ' ' ARG . 0.0 OUTLIER 62.78 25.16 14.95 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.821 0.674 . . . . 72.040000000000006 112.821 173.4 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -84.86 150.66 24.84 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.323 0.583 . . . . 65.129999999999995 110.802 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -125.54 135.14 51.94 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.122 -1.436 . . . . 72.420000000000002 107.122 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.464 ' HB ' HG21 ' B' ' 233' ' ' THR . 5.8 p -136.76 141.95 39.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.304 0.573 . . . . 73.209999999999994 111.635 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.603 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 4.4 tp60 -122.26 125.87 46.95 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-N 114.306 -1.315 . . . . 74.140000000000001 107.867 171.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.577 ' HG ' HD21 ' A' ' 262' ' ' ASN . 52.5 tp -117.3 118.54 32.55 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 107.934 -1.135 . . . . 72.329999999999998 107.934 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.567 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 128.33 -117.12 2.46 Favored Glycine 0 N--CA 1.421 -2.347 0 C-N-CA 120.389 -0.91 . . . . 70.409999999999997 111.644 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -144.57 136.41 25.87 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 120.022 -0.671 . . . . 74.319999999999993 110.243 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.489 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 48.1 t -108.54 120.28 59.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.258 -1.386 . . . . 33.200000000000003 107.258 174.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.16 115.23 46.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 120.894 -0.323 . . . . 72.439999999999998 110.598 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.439 HG22 ' HA3' ' B' ' 282' ' ' GLY . 14.9 t -113.93 162.25 16.63 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.626 -0.879 . . . . 73.109999999999999 108.626 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.03 -32.19 70.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.657 1.183 . . . . 62.509999999999998 114.017 -173.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.91 -41.07 67.26 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 114.417 1.266 . . . . 53.109999999999999 114.417 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.464 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -74.27 -25.98 59.94 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 114.273 1.212 . . . . 70.150000000000006 114.273 -175.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 41.6 tp . . . . . 0 C--N 1.323 -0.561 0 CA-C-O 121.312 0.577 . . . . 50.009999999999998 111.896 -173.893 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 260' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' C' ' 225' ' ' ARG . 18.0 p . . . . . 0 N--CA 1.397 -3.079 0 N-CA-C 109.249 -0.649 . . . . 72.099999999999994 109.249 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 8.2 t -127.75 141.65 51.53 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.798 -1.186 . . . . 55.210000000000001 107.798 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.663 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 25.7 t-20 -87.06 119.13 26.95 Favored 'General case' 0 CA--C 1.479 -1.768 0 N-CA-C 107.846 -1.168 . . . . 65.140000000000001 107.846 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 263' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' B' ' 227' ' ' SER . 49.7 m -142.56 128.03 18.98 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.394 -0.821 . . . . 73.219999999999999 110.889 -177.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.4 p -125.82 141.42 45.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.277 -0.569 . . . . 62.229999999999997 112.462 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 16.6 mm-40 -79.33 -59.3 2.82 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.568 -0.742 . . . . 72.109999999999999 110.938 177.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 97.0 m -143.6 127.37 17.18 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.023 -0.671 . . . . 72.25 112.694 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.519 HG12 HD12 ' C' ' 231' ' ' ILE . 24.0 m -121.07 127.81 75.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 109.056 -0.72 . . . . 72.019999999999996 109.056 172.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 268' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 5.5 p -128.64 135.37 62.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-N 116.16 -0.473 . . . . 62.100000000000001 111.877 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 269' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.7 132.58 7.99 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 110.494 -1.043 . . . . 43.009999999999998 110.494 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.561 ' HE3' ' HB2' ' B' ' 234' ' ' GLU . 13.9 mmmm -132.84 117.71 18.08 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 122.451 0.3 . . . . 74.420000000000002 111.648 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.87 87.32 0.9 Allowed Glycine 0 C--N 1.307 -1.069 0 C-N-CA 120.379 -0.915 . . . . 74.140000000000001 113.171 173.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 55.16 30.35 14.31 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.953 0.901 . . . . 55.399999999999999 111.899 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.8 m -83.06 145.08 29.48 Favored 'General case' 0 N--CA 1.422 -1.863 0 C-N-CA 120.489 -0.484 . . . . 65.219999999999999 110.355 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -116.84 127.62 54.47 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.088 -1.819 . . . . 73.409999999999997 106.088 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 1.5 p -133.03 123.14 47.57 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 121.517 0.675 . . . . 71.209999999999994 111.252 178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.54 ' HG ' ' OE1' ' C' ' 240' ' ' GLN . 8.0 tp -113.85 119.86 38.77 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.18 -1.045 . . . . 73.019999999999996 108.18 174.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.517 HG23 HD23 ' C' ' 241' ' ' LEU . 2.0 mt -112.14 103.56 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.887 0 N-CA-C 105.192 -2.151 . . . . 75.310000000000002 105.192 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 147.85 -126.96 2.48 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 119.136 -1.507 . . . . 24.25 114.635 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -128.91 135.42 49.02 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.159 0.504 . . . . 65.5 111.04 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.431 ' HG2' ' NE1' ' B' ' 287' ' ' TRP . 13.9 tp10 -113.45 118.5 34.7 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.776 -1.564 . . . . 74.430000000000007 106.776 177.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.443 ' CD2' ' HB3' ' B' ' 249' ' ' ALA . 4.6 t80 -115.25 122.75 46.94 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 106.144 -1.799 . . . . 62.109999999999999 106.144 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' B' ' 249' ' ' ALA . . . 114.72 -51.37 0.72 Allowed Glycine 0 C--N 1.288 -2.094 0 N-CA-C 108.226 -1.95 . . . . 71.439999999999998 108.226 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 89.97 15.17 58.2 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 111.204 -0.758 . . . . 63.100000000000001 111.204 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -145.75 19.92 1.47 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.157 0.503 . . . . 75.430000000000007 109.992 -178.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 285' ' ' GLY . . . . . 0.406 ' HA3' HG11 ' B' ' 244' ' ' VAL . . . -81.93 -79.81 0.95 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.393 -0.908 . . . . 60.530000000000001 113.116 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.447 ' HB2' HG21 ' B' ' 244' ' ' VAL . 86.9 t80 -76.95 -13.36 59.98 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.812 0.671 . . . . 72.310000000000002 112.812 -176.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.609 ' CH2' ' HB2' ' C' ' 240' ' ' GLN . 6.4 m95 . . . . . 0 C--N 1.305 -1.345 0 CA-C-O 121.107 0.48 . . . . 64.120000000000005 112.177 -173.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' B' ' 260' ' ' THR . 24.9 mmt180 . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 122.079 0.942 . . . . 73.310000000000002 111.99 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.663 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 28.3 p-10 -117.49 155.67 29.32 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 113.419 -1.719 . . . . 72.420000000000002 114.242 -171.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 227' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' C' ' 263' ' ' SER . 23.9 t -117.75 136.37 53.42 Favored 'General case' 0 N--CA 1.409 -2.487 0 N-CA-C 107.671 -1.233 . . . . 73.010000000000005 107.671 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.43 137.92 52.07 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.872 -1.058 . . . . 74.430000000000007 108.842 -175.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 5.2 tmmm? -90.83 -62.0 1.55 Allowed 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 120.062 -0.655 . . . . 73.230000000000004 110.527 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -127.56 137.09 52.5 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 108.392 -0.966 . . . . 55.049999999999997 108.392 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.519 HD12 HG12 ' B' ' 267' ' ' VAL . 17.4 mt -137.82 123.59 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.145 -1.057 . . . . 73.25 108.145 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 81.5 mtt180 -128.32 115.1 17.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.418 -0.586 . . . . 74.040000000000006 109.418 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.469 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 33.1 p -112.31 126.87 55.72 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.342 -1.355 . . . . 74.129999999999995 107.342 175.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.526 ' HG2' ' HB2' ' B' ' 270' ' ' LYS . 43.1 mt-10 -138.87 145.78 40.38 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 120.328 -0.549 . . . . 73.030000000000001 110.508 -178.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 65.52 84.26 0.16 Allowed 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.637 1.175 . . . . 73.439999999999998 112.506 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? 61.3 23.31 13.56 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.345 1.058 . . . . 73.299999999999997 111.752 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -87.18 151.2 23.39 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.031 0.443 . . . . 71.549999999999997 111.423 -176.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -125.53 135.24 52.06 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.686 -1.227 . . . . 62.219999999999999 107.686 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 2.5 p -130.83 136.31 58.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.459 0.647 . . . . 72.439999999999998 110.929 176.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.609 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 3.9 tp60 -114.56 121.35 43.2 Favored 'General case' 0 N--CA 1.4 -2.967 0 CA-C-N 114.247 -1.342 . . . . 53.229999999999997 107.479 170.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.635 ' HG ' HD21 ' B' ' 262' ' ' ASN . 64.7 tp -115.53 118.16 32.36 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 108.32 -0.992 . . . . 72.209999999999994 108.32 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.549 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 129.5 -115.08 1.84 Allowed Glycine 0 N--CA 1.416 -2.657 0 C-N-CA 120.347 -0.93 . . . . 33.450000000000003 112.47 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.479 ' ND2' HG23 ' C' ' 245' ' ' VAL . 5.9 t30 -144.94 136.28 25.16 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 122.651 -0.323 . . . . 75.230000000000004 110.934 -173.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.453 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 61.0 t -114.79 125.85 72.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.195 0 N-CA-C 108.244 -1.021 . . . . 73.140000000000001 108.244 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.479 HG23 ' ND2' ' C' ' 243' ' ' ASN . 85.5 t -122.06 118.58 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 118.104 0.411 . . . . 72.310000000000002 110.294 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 246' ' ' THR . . . . . 0.41 HG22 ' HA3' ' C' ' 282' ' ' GLY . 14.8 t -114.07 162.28 16.67 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 108.242 -1.021 . . . . 74.319999999999993 108.242 170.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.68 -31.86 73.16 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 114.229 1.196 . . . . 55.509999999999998 114.229 -172.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.41 -34.29 57.2 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.749 1.388 . . . . 63.530000000000001 114.749 -169.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 249' ' ' ALA . . . . . 0.514 ' HB2' ' HA2' ' C' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.321 -0.667 0 C-N-CA 120.194 -0.602 . . . . 34.030000000000001 112.128 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 108.588 -0.893 . . . . 15.35 108.588 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -87.99 120.38 29.28 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.297 0.57 . . . . 64.310000000000002 110.177 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 263' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' C' ' 227' ' ' SER . 46.8 m -139.6 132.77 29.74 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.601 -0.727 . . . . 74.25 109.047 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 12.3 p -123.91 139.52 50.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.964 0.411 . . . . 64.310000000000002 111.129 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 9.1 mm-40 -75.88 -64.12 1.16 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.913 -0.585 . . . . 75.230000000000004 111.794 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 87.4 m -144.85 127.91 16.56 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 122.058 -0.402 . . . . 72.420000000000002 109.966 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.402 HG11 HD13 ' C' ' 277' ' ' ILE . 0.9 OUTLIER -126.86 123.67 63.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 115.323 -0.853 . . . . 70.129999999999995 109.638 178.488 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 268' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 26.5 m -124.65 146.61 29.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.179 -0.464 . . . . 65.25 110.337 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -130.85 132.52 6.9 Favored Glycine 0 CA--C 1.481 -2.062 0 N-CA-C 109.348 -1.501 . . . . 70.450000000000003 109.348 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -132.78 116.55 16.7 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.735 0.268 . . . . 72.209999999999994 111.592 -175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.95 84.42 0.85 Allowed Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.022 -1.085 . . . . 73.209999999999994 113.868 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 59.19 29.07 18.56 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.267 1.027 . . . . 74.140000000000001 111.629 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 15.8 m -82.87 145.55 29.38 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.102 -0.499 . . . . 75.319999999999993 111.102 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -113.43 128.4 56.44 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.06 -1.83 . . . . 64.150000000000006 106.06 174.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 6.6 p -137.95 123.57 25.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.533 0.682 . . . . 74.340000000000003 111.317 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.572 HD13 ' CG ' ' C' ' 240' ' ' GLN . 5.3 tp -113.88 112.17 22.9 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.866 -0.79 . . . . 61.039999999999999 108.866 175.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.402 HD13 HG11 ' C' ' 267' ' ' VAL . 5.4 mt -103.9 103.71 15.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 105.256 -2.127 . . . . 73.400000000000006 105.256 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 278' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 143.51 -144.83 14.18 Favored Glycine 0 N--CA 1.421 -2.314 0 C-N-CA 119.869 -1.158 . . . . 74.0 112.809 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -110.18 139.81 44.94 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.114 0.483 . . . . 71.200000000000003 110.342 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.583 ' HG2' ' NE1' ' C' ' 287' ' ' TRP . 12.9 tp10 -118.06 117.46 29.26 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 105.933 -1.877 . . . . 72.540000000000006 105.933 175.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 281' ' ' TYR . . . . . 0.42 ' HB3' ' HA ' ' C' ' 245' ' ' VAL . 6.5 t80 -111.51 123.39 50.13 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.01 -1.848 . . . . 74.409999999999997 106.01 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 282' ' ' GLY . . . . . 0.514 ' HA2' ' HB2' ' C' ' 249' ' ' ALA . . . 109.58 -51.29 0.71 Allowed Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 109.548 -1.421 . . . . 44.420000000000002 109.548 -173.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 86.13 24.35 41.13 Favored Glycine 0 CA--C 1.496 -1.156 0 C-N-CA 120.94 -0.648 . . . . 62.210000000000001 111.634 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -148.53 13.89 0.95 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 122.979 0.512 . . . . 64.340000000000003 110.247 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.43 -79.63 0.81 Allowed Glycine 0 N--CA 1.422 -2.263 0 C-N-CA 120.096 -1.049 . . . . 21.420000000000002 112.82 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -80.23 -19.78 46.11 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.126 0.787 . . . . 74.129999999999995 113.126 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.583 ' NE1' ' HG2' ' C' ' 280' ' ' GLU . 9.2 m95 . . . . . 0 C--N 1.307 -1.282 0 N-CA-C 114.261 1.208 . . . . 71.439999999999998 114.261 -171.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 . . . . . 0 CA--C 1.49 -1.348 0 CA-C-O 121.123 0.487 . . . . 73.239999999999995 111.504 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -115.62 114.35 24.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.038 -1.467 . . . . 61.229999999999997 107.038 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 10.1 p -129.07 137.64 51.39 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.457 0.646 . . . . 74.349999999999994 112.385 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 231' ' ' ILE . . . -133.22 129.51 37.82 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.073 -1.084 . . . . 64.329999999999998 108.073 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -82.31 -55.84 4.27 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.798 -0.445 . . . . 74.430000000000007 109.798 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 266' ' ' THR . 26.3 t0 -138.55 139.46 38.69 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 119.95 -0.7 . . . . 73.340000000000003 111.985 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.484 HD11 ' HB1' ' A' ' 228' ' ' ALA . 30.8 mm -128.33 127.79 67.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 106.889 -1.523 . . . . 73.299999999999997 106.889 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 31.0 ttt180 -134.14 115.42 14.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.283 -0.567 . . . . 72.109999999999999 110.079 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 40.8 p -110.66 127.59 55.35 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.335 -0.987 . . . . 54.310000000000002 108.335 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -128.08 148.96 50.58 Favored 'General case' 0 CA--C 1.482 -1.67 0 C-N-CA 120.089 -0.644 . . . . 52.229999999999997 109.865 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.589 ' C ' ' HD2' ' A' ' 236' ' ' ARG . 44.4 mt-10 59.27 91.24 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 O-C-N 125.12 1.512 . . . . 64.230000000000004 114.029 173.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.589 ' HD2' ' C ' ' A' ' 235' ' ' GLU . 0.1 OUTLIER 61.33 2.23 0.61 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.345 1.458 . . . . 71.310000000000002 113.401 174.065 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -69.92 149.58 47.66 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.398 0.679 . . . . 44.140000000000001 112.156 -175.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.34 139.01 54.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.701 -0.681 . . . . 51.399999999999999 109.805 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 6.0 p -124.85 141.93 43.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 116.052 -0.522 . . . . 60.25 110.018 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -123.26 117.7 25.9 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.739 -0.664 . . . . 63.420000000000002 109.361 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 277' ' ' ILE . 2.9 tm? -111.63 118.76 36.56 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.64 -1.615 . . . . 73.040000000000006 106.64 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.468 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 136.66 -140.2 11.28 Favored Glycine 0 N--CA 1.422 -2.278 0 C-N-CA 119.707 -1.235 . . . . 54.299999999999997 112.061 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -124.52 133.73 53.23 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 120.972 0.415 . . . . 62.030000000000001 111.411 -173.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.7 t -119.01 121.02 65.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.387 -1.338 . . . . 54.340000000000003 107.387 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.28 129.65 74.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.262 0.553 . . . . 54.119999999999997 112.366 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 5.3 m -109.79 160.53 16.26 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.808 -1.182 . . . . 75.209999999999994 107.808 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.99 76.8 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 122.918 0.487 . . . . 73.409999999999997 111.941 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.18 -34.08 63.54 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.926 1.29 . . . . 63.450000000000003 113.741 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.32 -0.713 0 N-CA-C 113.106 0.78 . . . . 71.409999999999997 113.106 -175.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.435 -1.197 0 N-CA-C 108.874 -0.787 . . . . 75.129999999999995 108.874 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.547 HD21 HD22 ' B' ' 241' ' ' LEU . 64.9 t30 -106.29 121.63 44.61 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.801 -0.814 . . . . 74.450000000000003 108.801 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' B' ' 227' ' ' SER . 46.9 m -137.86 123.97 20.34 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.878 0.37 . . . . 73.340000000000003 111.726 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' B' ' 228' ' ' ALA . 11.2 p -119.76 135.27 60.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.855 0.36 . . . . 74.219999999999999 111.102 176.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -69.36 -65.05 0.76 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.883 -0.599 . . . . 73.299999999999997 111.469 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 29.5 m -144.58 132.76 21.68 Favored 'General case' 0 C--O 1.25 1.117 0 C-N-CA 120.184 -0.607 . . . . 74.209999999999994 112.501 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.415 HG12 ' HB ' ' B' ' 231' ' ' ILE . 27.4 m -118.03 129.56 74.21 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 107.932 -1.136 . . . . 74.329999999999998 107.932 172.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 7.8 p -127.59 130.86 70.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-O 121.186 0.517 . . . . 72.340000000000003 111.677 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.06 133.32 11.53 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 109.719 -1.352 . . . . 74.510000000000005 109.719 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -132.56 144.69 50.58 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 117.121 0.46 . . . . 74.400000000000006 111.131 -175.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.65 -65.76 3.89 Favored Glycine 0 C--O 1.244 0.755 0 N-CA-C 110.768 -0.933 . . . . 63.439999999999998 110.768 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -176.96 125.86 0.15 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.999 -2.223 . . . . 73.019999999999996 104.999 172.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 25.0 m -149.94 160.13 43.84 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.531 -0.544 . . . . 64.140000000000001 109.531 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 54.3 mtm180 -122.72 127.36 49.12 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.142 -1.059 . . . . 73.349999999999994 108.142 172.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 1.4 p -128.18 129.17 69.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 116.154 -0.475 . . . . 63.100000000000001 109.942 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 4.1 tt -121.0 121.24 37.54 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.854 -1.165 . . . . 74.040000000000006 107.854 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.584 HG22 ' HB3' ' B' ' 241' ' ' LEU . 3.2 pt -113.03 104.59 17.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 C-N-CA 124.063 0.945 . . . . 63.310000000000002 109.107 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 155.18 -122.84 1.26 Allowed Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.554 -0.832 . . . . 74.239999999999995 113.156 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 42.4 m-80 -128.3 148.96 50.68 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.62 0.247 . . . . 65.319999999999993 110.585 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.0 OUTLIER -136.6 121.6 18.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.172 -2.159 . . . . 54.140000000000001 105.172 173.587 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.469 ' HB3' ' CB ' ' A' ' 249' ' ' ALA . 57.0 m-85 -107.81 123.59 48.8 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 109.37 -0.604 . . . . 71.030000000000001 109.37 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.442 ' N ' ' HB2' ' A' ' 249' ' ' ALA . . . 104.91 -43.73 1.61 Allowed Glycine 0 N--CA 1.42 -2.387 0 CA-C-N 115.178 -0.919 . . . . 70.329999999999998 111.209 -177.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 76.29 14.42 82.36 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.916 -0.874 . . . . 73.439999999999998 110.916 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -126.43 13.6 7.63 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.899 0.857 . . . . 75.319999999999993 109.377 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -101.48 -55.44 0.9 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.156 -1.021 . . . . 73.519999999999996 110.92 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.473 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 31.1 t80 -93.04 -18.04 23.13 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.904 -0.406 . . . . 74.319999999999993 109.904 -177.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.639 ' CH2' ' HB2' ' B' ' 240' ' ' GLN . 12.6 m-90 . . . . . 0 C--O 1.242 0.707 0 N-CA-C 115.893 1.812 . . . . 64.010000000000005 115.893 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 . . . . . 0 CA--C 1.488 -1.433 0 CA-C-O 121.265 0.555 . . . . 75.010000000000005 111.281 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.486 ' OD1' ' HA2' ' C' ' 242' ' ' GLY . 63.3 t30 -113.5 114.62 26.79 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 106.181 -1.785 . . . . 51.140000000000001 106.181 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 227' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' B' ' 263' ' ' SER . 20.1 m -125.4 137.06 54.0 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.513 0.673 . . . . 74.420000000000002 111.351 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.423 ' HB1' HD11 ' B' ' 231' ' ' ILE . . . -128.33 132.85 48.61 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.236 -0.893 . . . . 75.319999999999993 108.74 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.554 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -88.72 -68.12 0.79 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.976 -0.379 . . . . 74.219999999999999 109.976 -177.484 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.91 138.6 53.33 Favored 'General case' 0 CA--C 1.481 -1.673 0 C-N-CA 119.355 -0.938 . . . . 71.409999999999997 111.327 177.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.423 HD11 ' HB1' ' B' ' 228' ' ' ALA . 29.4 mm -130.91 118.4 41.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.576 -1.268 . . . . 64.519999999999996 107.576 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -118.77 117.76 29.76 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.483 -0.562 . . . . 43.420000000000002 109.483 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 49.7 p -109.5 127.2 54.26 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.903 -1.517 . . . . 75.219999999999999 106.903 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.28 155.75 46.61 Favored 'General case' 0 CA--C 1.471 -2.083 0 N-CA-C 108.759 -0.83 . . . . 73.25 108.759 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.572 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 83.8 mt-10 55.16 84.49 0.07 Allowed 'General case' 0 C--N 1.311 -1.065 0 O-C-N 125.016 1.447 . . . . 65.230000000000004 114.055 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.572 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 60.91 6.93 1.31 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.07 1.348 . . . . 74.409999999999997 113.151 173.437 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -69.9 148.43 49.0 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.201 0.524 . . . . 64.319999999999993 112.138 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 1.0 OUTLIER -127.87 136.09 50.92 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 108.806 -0.812 . . . . 73.340000000000003 108.806 179.216 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.437 ' HB ' HG13 ' B' ' 275' ' ' VAL . 5.4 p -127.65 142.23 44.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 116.335 -0.393 . . . . 61.5 110.853 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.639 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 5.8 tp-100 -112.89 134.62 54.31 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.918 -1.512 . . . . 71.120000000000005 106.918 173.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.584 ' HB3' HG22 ' A' ' 277' ' ' ILE . 2.8 tm? -129.28 117.44 20.69 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 105.953 -1.869 . . . . 73.319999999999993 105.953 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.466 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 137.67 -115.29 1.19 Allowed Glycine 0 N--CA 1.404 -3.489 0 C-N-CA 119.006 -1.568 . . . . 72.209999999999994 113.292 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 243' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 6.4 t30 -145.35 129.15 17.28 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 113.275 0.843 . . . . 50.219999999999999 113.275 -171.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 280' ' ' GLU . 99.2 t -119.64 125.56 74.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.339 -0.986 . . . . 63.149999999999999 108.339 176.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.449 ' HB ' ' CD2' ' A' ' 281' ' ' TYR . 57.7 t -122.29 129.66 75.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 120.843 -0.343 . . . . 75.230000000000004 111.285 -177.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.557 HG21 ' HB3' ' B' ' 284' ' ' LYS . 2.2 m -104.48 161.41 14.12 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.439 -0.948 . . . . 72.109999999999999 108.439 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.33 -32.57 74.02 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.756 0.788 . . . . 73.519999999999996 110.486 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.18 -36.06 65.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.026 -1.443 . . . . 73.099999999999994 113.805 -176.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.495 ' HB2' ' N ' ' B' ' 282' ' ' GLY . . . -74.67 -38.74 62.34 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 121.201 -0.2 . . . . 73.540000000000006 110.886 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 60.2 tp . . . . . 0 CA--C 1.547 0.86 0 C-N-CA 124.732 1.213 . . . . 71.200000000000003 112.002 -177.763 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.255 0 CA-C-O 121.182 0.515 . . . . 73.420000000000002 111.9 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.535 ' HB ' ' HG2' ' C' ' 225' ' ' ARG . 4.7 m -116.23 108.24 15.87 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.18 -1.415 . . . . 73.310000000000002 107.18 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.572 HD21 HD22 ' C' ' 241' ' ' LEU . 64.2 t30 -108.7 126.17 52.7 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.215 -1.032 . . . . 71.319999999999993 108.215 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 263' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' C' ' 227' ' ' SER . 31.9 m -142.42 123.75 14.74 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.237 0.542 . . . . 61.43 111.813 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' C' ' 228' ' ' ALA . 14.5 p -110.31 140.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.459 -0.571 . . . . 70.239999999999995 109.459 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 3.4 tm-20 -80.45 -69.26 0.61 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.423 -0.954 . . . . 71.150000000000006 108.423 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 90.7 m -137.3 128.85 28.45 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 121.629 -0.669 . . . . 72.329999999999998 112.683 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 48.9 t -118.49 128.83 75.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.08 -1.082 . . . . 52.210000000000001 108.08 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 8.6 p -127.4 134.44 65.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.131 0.491 . . . . 72.010000000000005 111.295 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.09 133.25 11.18 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.723 -1.351 . . . . 65.129999999999995 109.723 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -133.18 147.22 52.04 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 117.059 0.43 . . . . 75.200000000000003 111.349 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.58 -63.96 4.04 Favored Glycine 0 CA--C 1.498 -1.014 0 N-CA-C 110.812 -0.915 . . . . 73.25 110.812 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -178.99 126.72 0.1 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 103.624 -2.732 . . . . 72.319999999999993 103.624 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 45.7 m -147.61 161.29 41.45 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 120.949 0.404 . . . . 73.030000000000001 110.809 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.706 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 14.7 mtp180 -127.7 127.33 43.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.436 -1.32 . . . . 71.310000000000002 107.436 174.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' B' ' 239' ' ' VAL . 0.7 OUTLIER -134.8 137.31 51.13 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.109 0 N-CA-C 109.716 -0.476 . . . . 44.520000000000003 109.716 179.196 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.456 HD12 ' CG ' ' B' ' 286' ' ' PHE . 5.4 tt -124.15 124.23 42.04 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.059 -1.459 . . . . 61.009999999999998 107.059 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.464 HG23 HD12 ' C' ' 241' ' ' LEU . 6.7 mt -113.0 103.81 16.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 106.334 -1.728 . . . . 71.340000000000003 106.334 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 152.0 -141.31 8.41 Favored Glycine 0 CA--C 1.474 -2.53 0 C-N-CA 119.164 -1.493 . . . . 71.430000000000007 113.751 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 279' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 45.3 m-80 -111.57 136.93 50.09 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.109 -0.545 . . . . 71.5 109.625 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.506 ' HB2' ' NE2' ' C' ' 240' ' ' GLN . 0.1 OUTLIER -125.67 118.39 25.53 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 104.931 -2.248 . . . . 71.450000000000003 104.931 175.83 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -105.58 124.07 48.95 Favored 'General case' 0 N--CA 1.401 -2.885 0 CA-C-O 121.564 0.697 . . . . 54.439999999999998 110.239 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.495 ' N ' ' HB2' ' B' ' 249' ' ' ALA . . . 108.14 -45.55 1.29 Allowed Glycine 0 N--CA 1.416 -2.638 0 CA-C-N 114.991 -1.004 . . . . 62.009999999999998 110.971 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 70.79 26.26 74.33 Favored Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 109.845 -1.302 . . . . 75.400000000000006 109.845 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 284' ' ' LYS . . . . . 0.557 ' HB3' HG21 ' B' ' 246' ' ' THR . 24.8 tptp -136.73 14.21 3.15 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.423 -0.954 . . . . 74.349999999999994 108.423 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -112.23 -59.11 0.44 Allowed Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.569 -0.741 . . . . 61.350000000000001 111.429 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.456 ' CG ' HD12 ' B' ' 276' ' ' LEU . 19.0 t80 -90.41 -20.66 22.53 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.185 -1.043 . . . . 63.299999999999997 108.185 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.507 ' HE1' ' HB2' ' C' ' 238' ' ' ARG . 14.3 m-90 . . . . . 0 C--N 1.296 -1.727 0 CA-C-N 115.002 -0.999 . . . . 73.209999999999994 108.79 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.535 ' HG2' ' HB ' ' B' ' 261' ' ' THR . 70.5 mtt180 . . . . . 0 CA--C 1.493 -1.224 0 N-CA-C 112.691 0.626 . . . . 70.409999999999997 112.691 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -116.57 116.92 28.51 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.367 -1.345 . . . . 74.239999999999995 107.367 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 227' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' B' ' 263' ' ' SER . 15.7 p -128.72 139.39 52.24 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 121.569 0.699 . . . . 53.439999999999998 111.423 -176.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.5 ' HB1' HD11 ' C' ' 231' ' ' ILE . . . -126.91 129.49 48.29 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.015 -0.993 . . . . 52.420000000000002 108.469 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 13.8 tmtt? -87.48 -60.35 2.0 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.288 0.368 . . . . 74.439999999999998 111.614 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.32 138.04 53.54 Favored 'General case' 0 CA--C 1.484 -1.565 0 O-C-N 121.741 -0.599 . . . . 72.319999999999993 110.074 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.5 HD11 ' HB1' ' C' ' 228' ' ' ALA . 41.5 mm -133.13 119.12 35.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.777 -1.194 . . . . 72.409999999999997 107.777 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 44.9 ttt180 -122.65 115.22 21.73 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 109.479 -0.563 . . . . 71.439999999999998 109.479 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 42.5 p -110.61 127.39 55.23 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.725 -1.583 . . . . 63.340000000000003 106.725 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -141.58 153.62 44.93 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 120.143 -0.623 . . . . 74.530000000000001 110.107 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.511 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 43.4 mt-10 61.31 85.41 0.12 Allowed 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.889 1.368 . . . . 71.319999999999993 113.156 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.511 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 1.4 mpt_? 59.18 5.17 0.53 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.813 1.645 . . . . 72.340000000000003 113.393 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -69.6 147.5 50.61 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.461 0.648 . . . . 41.100000000000001 112.073 -174.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.706 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 1.5 mpt_? -126.98 135.02 50.29 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.273 -0.876 . . . . 75.030000000000001 108.959 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.2 p -128.32 139.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.066 0.46 . . . . 72.209999999999994 111.326 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.506 ' NE2' ' HB2' ' B' ' 280' ' ' GLU . 5.4 tp-100 -110.47 120.02 41.07 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.053 -0.976 . . . . 61.399999999999999 108.815 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.572 HD22 HD21 ' B' ' 262' ' ' ASN . 3.1 tm? -115.16 116.52 28.5 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 105.339 -2.097 . . . . 73.209999999999994 105.339 172.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.486 ' HA2' ' OD1' ' B' ' 226' ' ' ASN . . . 142.45 -121.88 1.86 Allowed Glycine 0 N--CA 1.41 -3.073 0 C-N-CA 118.56 -1.781 . . . . 42.200000000000003 113.174 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 35.8 t30 -144.63 128.48 17.36 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 123.621 0.248 . . . . 74.439999999999998 111.608 -171.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' B' ' 280' ' ' GLU . 92.0 t -118.52 122.98 70.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.221 -1.029 . . . . 64.400000000000006 108.221 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.94 128.85 75.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 120.533 -0.467 . . . . 73.439999999999998 110.454 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 246' ' ' THR . . . . . 0.432 HG21 ' HB3' ' C' ' 284' ' ' LYS . 2.6 m -99.33 161.05 13.84 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.196 -1.038 . . . . 65.409999999999997 108.196 174.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.3 -32.29 69.91 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.832 0.853 . . . . 74.109999999999999 110.959 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.48 -35.49 63.11 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.21 -1.359 . . . . 64.140000000000001 112.522 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.573 0 CA-C-O 121.012 0.434 . . . . 53.520000000000003 111.686 -178.331 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.411 -2.388 0 N-CA-C 104.706 -2.331 . . . . 64.019999999999996 104.706 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -113.86 123.95 51.03 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.228 -1.027 . . . . 74.209999999999994 108.228 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 34.8 m -134.86 122.81 22.54 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.789 -0.819 . . . . 51.210000000000001 108.789 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 264' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' C' ' 228' ' ' ALA . 12.1 p -108.94 144.27 17.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.012 -0.736 . . . . 72.219999999999999 109.012 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -78.79 -77.17 0.17 Allowed 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 108.625 -0.88 . . . . 64.209999999999994 108.625 -176.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 85.8 m -132.82 134.12 44.25 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.133 -0.354 . . . . 65.310000000000002 110.357 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 25.6 t -118.43 129.17 75.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.245 -1.391 . . . . 65.0 107.245 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 268' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.4 p -127.79 132.35 68.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 120.919 -0.313 . . . . 42.409999999999997 111.159 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.16 132.86 11.24 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 108.869 -1.692 . . . . 74.230000000000004 108.869 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -133.86 145.55 49.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.978 0.389 . . . . 62.520000000000003 110.569 -174.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.41 -65.83 3.92 Favored Glycine 0 CA--C 1.5 -0.865 0 N-CA-C 110.631 -0.988 . . . . 63.229999999999997 110.631 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 179.89 118.94 0.06 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 126.614 1.966 . . . . 72.140000000000001 105.738 174.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 35.7 m -141.02 154.14 45.86 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.311 0.485 . . . . 70.340000000000003 112.311 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -118.89 126.76 52.52 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.366 -1.346 . . . . 74.340000000000003 107.366 171.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 2.1 p -139.08 138.51 41.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 123.044 0.215 . . . . 74.510000000000005 110.776 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.9 tt -128.6 122.63 31.39 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.385 -0.598 . . . . 62.219999999999999 109.385 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.506 HD12 HD23 ' C' ' 241' ' ' LEU . 1.3 pt -113.4 104.47 17.04 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 C-N-CA 123.915 0.886 . . . . 74.430000000000007 109.772 173.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.9 -140.43 7.9 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 119.655 -1.26 . . . . 51.229999999999997 113.123 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -100.15 139.75 35.37 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.623 -0.788 . . . . 74.200000000000003 109.521 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -142.08 118.46 10.86 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 103.324 -2.843 . . . . 74.239999999999995 103.324 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -116.84 124.99 50.87 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.329 0.585 . . . . 75.340000000000003 111.508 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 116.44 -41.52 2.1 Favored Glycine 0 N--CA 1.407 -3.277 0 CA-C-N 114.596 -1.184 . . . . 61.399999999999999 110.612 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 67.07 30.08 75.38 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 109.361 -1.496 . . . . 74.430000000000007 109.361 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 284' ' ' LYS . . . . . 0.432 ' HB3' HG21 ' C' ' 246' ' ' THR . 52.9 tptt -141.92 17.39 2.13 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 108.461 -0.941 . . . . 74.040000000000006 108.461 -174.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -114.32 -72.85 0.57 Allowed Glycine 0 N--CA 1.424 -2.11 0 C-N-CA 120.218 -0.991 . . . . 73.310000000000002 110.725 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -79.64 -25.91 41.24 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.049 0.452 . . . . 72.109999999999999 110.049 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 . . . . . 0 C--N 1.302 -1.495 0 N-CA-C 108.6 -0.889 . . . . 73.239999999999995 108.6 178.295 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 109.614 -0.513 . . . . 52.030000000000001 109.614 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.403 ' ND2' ' HA2' ' A' ' 278' ' ' GLY . 44.9 t-20 -117.82 114.83 23.85 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 106.147 -1.797 . . . . 74.299999999999997 106.147 168.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 33.6 m -120.59 137.01 54.64 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.388 0.613 . . . . 54.310000000000002 111.149 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.77 130.31 51.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.851 -1.166 . . . . 64.310000000000002 107.851 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 39.4 ttmt -79.04 -63.97 1.29 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.816 -0.354 . . . . 74.140000000000001 111.911 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -126.51 139.25 53.37 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 118.914 -1.114 . . . . 75.140000000000001 110.261 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.3 mt -130.75 119.57 45.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.634 -0.876 . . . . 72.329999999999998 108.634 -175.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 87.2 mtt180 -125.08 115.05 19.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.755 -1.202 . . . . 71.409999999999997 107.755 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.474 HG21 HG22 ' A' ' 239' ' ' VAL . 40.4 p -128.24 128.66 45.1 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 120.567 -0.453 . . . . 72.340000000000003 109.838 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -126.6 166.07 18.0 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 119.751 -0.78 . . . . 73.0 112.608 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 71.42 -88.09 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.603 -1.635 . . . . 54.130000000000003 114.311 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.494 ' HD3' ' OE2' ' A' ' 272' ' ' GLU . 0.0 OUTLIER -135.48 26.66 3.43 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.162 -1.051 . . . . 70.329999999999998 108.162 -176.324 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -69.04 149.45 48.74 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.598 -0.728 . . . . 64.439999999999998 111.245 -174.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.83 134.9 53.52 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 105.932 -1.877 . . . . 70.510000000000005 105.932 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.474 HG22 HG21 ' A' ' 233' ' ' THR . 9.8 t -135.17 139.0 47.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.981 0.419 . . . . 53.399999999999999 110.659 -170.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.479 ' HB3' HD13 ' A' ' 276' ' ' LEU . 6.3 tp-100 -131.2 135.28 47.26 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.595 -1.261 . . . . 71.200000000000003 107.595 172.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.1 tt -130.42 120.2 23.85 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.947 -1.501 . . . . 64.120000000000005 106.947 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.608 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 128.93 -113.91 1.65 Allowed Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.7 -0.762 . . . . 61.340000000000003 111.386 177.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -144.39 144.33 31.37 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.613 -0.345 . . . . 71.140000000000001 110.087 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.441 ' CG2' ' HG2' ' A' ' 240' ' ' GLN . 83.6 t -118.75 118.3 57.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.811 -1.181 . . . . 63.439999999999998 107.811 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.57 112.8 35.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 N-CA-C 109.135 -0.691 . . . . 55.549999999999997 109.135 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.474 HG22 ' HA3' ' A' ' 282' ' ' GLY . 8.9 t -94.92 161.0 14.33 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.034 -1.066 . . . . 74.299999999999997 109.863 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.45 -33.61 75.94 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.42 0.688 . . . . 33.200000000000003 111.778 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.83 65.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.399 -0.819 . . . . 75.340000000000003 111.579 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.703 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.028 -0.533 . . . . 73.430000000000007 111.706 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 25.8 p . . . . . 0 N--CA 1.434 -1.246 0 N-CA-C 108.554 -0.906 . . . . 54.009999999999998 108.554 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 7.9 t30 -117.99 138.46 52.18 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.419 -0.912 . . . . 75.25 111.065 -176.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 39.8 m -138.59 123.33 18.69 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.147 -0.479 . . . . 55.130000000000003 109.935 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 10.7 p -128.89 145.59 35.5 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-N 116.259 -0.428 . . . . 74.140000000000001 110.939 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 12.0 mm-40 -84.66 -75.68 0.34 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.429 -0.351 . . . . 62.240000000000002 110.945 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.7 p -118.36 127.91 54.14 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.659 0.614 . . . . 64.219999999999999 112.659 -175.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 277' ' ' ILE . 26.7 m -124.87 127.11 72.33 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 109.396 -0.594 . . . . 74.219999999999999 109.396 174.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 7.3 p -127.14 132.18 70.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 121.205 0.526 . . . . 63.100000000000001 111.863 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.541 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -113.66 131.67 10.11 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 109.919 -1.272 . . . . 75.420000000000002 109.919 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -132.12 116.42 17.01 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 111.99 0.367 . . . . 74.530000000000001 111.99 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 92.96 -123.39 7.32 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 120.747 -0.74 . . . . 65.430000000000007 112.386 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.494 ' OE2' ' HD3' ' A' ' 236' ' ' ARG . 40.9 mm-40 -92.39 35.48 1.01 Allowed 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.333 1.053 . . . . 63.439999999999998 109.335 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 50.1 m -81.68 144.36 31.22 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.069 0.938 . . . . 51.32 111.04 -174.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -130.5 126.73 37.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 104.809 -2.293 . . . . 71.409999999999997 104.809 176.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.94 134.0 41.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 121.565 0.697 . . . . 73.25 111.509 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.479 HD13 ' HB3' ' A' ' 240' ' ' GLN . 11.0 tp -120.23 121.64 39.17 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.228 -0.896 . . . . 74.099999999999994 110.671 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 267' ' ' VAL . 81.6 mt -104.39 104.27 16.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 114.107 -1.406 . . . . 75.099999999999994 108.073 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 140.22 -153.86 23.66 Favored Glycine 0 N--CA 1.427 -1.918 0 C-N-CA 120.181 -1.009 . . . . 45.219999999999999 113.866 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -91.96 128.48 37.82 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.828 0.851 . . . . 74.420000000000002 110.295 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -111.1 118.69 36.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.838 -2.282 . . . . 71.439999999999998 104.838 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -120.02 122.23 40.67 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.473 -1.306 . . . . 64.150000000000006 107.473 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.474 ' HA3' HG22 ' A' ' 246' ' ' THR . . . 125.24 -41.38 1.7 Allowed Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.351 -1.295 . . . . 71.340000000000003 110.744 -175.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 125.05 -57.96 0.67 Allowed Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 110.46 -1.056 . . . . 64.219999999999999 110.46 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -145.08 80.6 1.62 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.084 0.945 . . . . 72.430000000000007 112.517 177.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -100.86 -40.35 2.91 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 114.748 -1.115 . . . . 52.329999999999998 110.467 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -69.81 -36.53 75.71 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.17 0.51 . . . . 70.510000000000005 110.477 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.44 ' CZ2' ' HE1' ' B' ' 286' ' ' PHE . 27.8 m-90 . . . . . 0 C--N 1.295 -1.763 0 N-CA-C 108.481 -0.933 . . . . 74.329999999999998 108.481 175.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 261' ' ' THR . 36.1 ttt180 . . . . . 0 N--CA 1.428 -1.532 0 CA-C-O 120.85 0.357 . . . . 73.019999999999996 110.893 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.487 HD22 ' HA2' ' B' ' 278' ' ' GLY . 38.3 t-20 -117.17 127.79 54.47 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.615 -1.624 . . . . 63.43 106.615 169.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 58.0 m -129.98 137.25 50.21 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-O 121.625 0.726 . . . . 73.109999999999999 111.078 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -125.63 137.42 53.88 Favored 'General case' 0 N--CA 1.404 -2.756 0 CA-C-N 114.146 -1.388 . . . . 74.010000000000005 107.56 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 3.5 ttmp? -84.28 -70.77 0.55 Allowed 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.309 -0.956 . . . . 70.5 110.467 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -127.25 137.71 52.93 Favored 'General case' 0 N--CA 1.428 -1.557 0 C-N-CA 119.684 -0.807 . . . . 63.530000000000001 109.736 -174.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 6.3 mt -134.16 117.97 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.207 -1.034 . . . . 64.430000000000007 108.207 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -113.42 119.31 37.18 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.018 -1.104 . . . . 74.010000000000005 108.018 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.551 HG22 HG21 ' B' ' 239' ' ' VAL . 22.2 p -116.72 126.95 53.9 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 106.05 -1.833 . . . . 73.329999999999998 106.05 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 234' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' B' ' 270' ' ' LYS . 52.1 mt-10 -134.22 153.93 51.56 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.476 0.655 . . . . 71.439999999999998 112.366 -176.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.522 ' HB3' ' HD3' ' B' ' 236' ' ' ARG . 45.0 mt-10 71.88 -83.64 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 113.642 -1.617 . . . . 73.409999999999997 114.016 171.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.522 ' HD3' ' HB3' ' B' ' 235' ' ' GLU . 0.4 OUTLIER -136.61 42.28 2.51 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 107.964 -1.124 . . . . 73.239999999999995 107.964 -178.4 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -82.81 139.56 33.45 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.886 -1.052 . . . . 73.519999999999996 111.773 -177.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 5.8 mpt_? -123.74 132.52 53.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 103.751 -2.685 . . . . 72.129999999999995 103.751 173.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.551 HG21 HG22 ' B' ' 233' ' ' THR . 86.7 t -142.93 132.62 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-O 121.604 0.716 . . . . 61.149999999999999 112.006 -172.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.562 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 55.1 tp60 -112.43 132.02 55.26 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 106.901 -1.518 . . . . 74.230000000000004 106.901 173.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.475 HD12 HG23 ' A' ' 277' ' ' ILE . 1.7 tm? -130.04 117.44 20.03 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.856 -1.164 . . . . 75.219999999999999 107.856 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.59 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 129.08 -114.1 1.68 Allowed Glycine 0 C--N 1.309 -0.935 0 N-CA-C 110.817 -0.913 . . . . 74.540000000000006 110.817 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -145.38 153.66 41.45 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 122.048 -0.678 . . . . 71.25 110.467 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.562 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 61.7 t -129.53 120.26 50.2 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 108.566 -0.902 . . . . 74.200000000000003 108.566 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.14 112.37 33.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 109.528 -0.545 . . . . 74.340000000000003 109.528 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.543 HG22 ' HA3' ' B' ' 282' ' ' GLY . 6.7 t -86.82 161.31 18.41 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.577 -0.849 . . . . 54.32 111.382 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.703 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.4 -33.62 75.94 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 122.434 1.111 . . . . 53.299999999999997 109.727 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.64 78.53 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 112.708 -2.042 . . . . 72.219999999999999 113.104 -177.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -60.12 -46.66 88.87 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.186 0.595 . . . . 61.149999999999999 112.031 -174.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.286 -2.183 0 N-CA-C 101.45 -3.537 . . . . 75.349999999999994 101.45 -176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.421 -1.914 0 CA-C-O 121.473 0.654 . . . . 65.329999999999998 112.764 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 61.8 m -91.19 108.85 20.15 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 106.653 -1.61 . . . . 74.129999999999995 106.653 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.519 HD21 HD11 ' C' ' 241' ' ' LEU . 7.5 t30 -106.25 145.67 31.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.199 0.523 . . . . 72.400000000000006 112.123 -171.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.9 m -138.57 123.86 19.29 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.218 -0.66 . . . . 72.120000000000005 109.218 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 15.0 p -127.37 143.84 39.3 Favored 'Isoleucine or valine' 0 C--O 1.249 1.027 0 N-CA-C 109.802 -0.444 . . . . 54.119999999999997 109.802 178.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 48.7 mm-40 -90.48 -71.71 0.61 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.559 -0.291 . . . . 64.239999999999995 110.437 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 26.9 m -121.66 127.06 50.39 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.086 -0.646 . . . . 73.400000000000006 110.816 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.87 123.54 56.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 116.086 -0.506 . . . . 71.319999999999993 110.163 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.17 133.92 67.12 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 CA-C-O 121.491 0.662 . . . . 71.200000000000003 112.425 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 269' ' ' GLY . . . . . 0.524 ' HA2' ' OG1' ' C' ' 233' ' ' THR . . . -111.23 131.64 10.44 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 110.415 -1.074 . . . . 63.25 110.415 175.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.416 ' HD2' ' HB2' ' B' ' 234' ' ' GLU . 29.1 mmmt -132.89 116.71 16.82 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 123.665 0.786 . . . . 75.019999999999996 111.761 -176.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.42 -133.81 11.75 Favored Glycine 0 C--N 1.299 -1.486 0 N-CA-C 110.711 -0.955 . . . . 54.520000000000003 110.711 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 272' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 77.8 mm-40 -85.31 48.14 1.53 Allowed 'General case' 0 C--O 1.258 1.527 0 C-N-CA 123.3 0.64 . . . . 73.010000000000005 109.939 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 273' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 74.7 m -82.09 144.68 30.63 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 122.386 1.089 . . . . 44.520000000000003 111.826 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 7.5 mtm180 -135.66 124.72 24.34 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 106.559 -1.645 . . . . 74.219999999999999 106.559 172.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' C' ' 239' ' ' VAL . 7.4 p -140.5 138.17 36.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-O 121.216 0.532 . . . . 55.43 111.303 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.561 HD13 ' CG ' ' B' ' 240' ' ' GLN . 4.5 tp -119.43 115.82 24.86 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.463 -0.79 . . . . 64.129999999999995 109.881 175.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.463 HG23 HD12 ' C' ' 241' ' ' LEU . 3.9 mp -98.9 103.37 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 N-CA-C 106.332 -1.729 . . . . 71.430000000000007 106.332 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.59 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 147.74 -157.21 27.28 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 119.563 -1.304 . . . . 52.450000000000003 114.436 178.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -96.44 124.64 40.5 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 124.084 0.954 . . . . 62.200000000000003 109.964 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -111.1 118.98 37.47 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.891 -1.892 . . . . 72.109999999999999 105.891 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.409 ' CD1' HG13 ' C' ' 245' ' ' VAL . 0.9 OUTLIER -119.4 122.52 41.96 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 107.129 -1.434 . . . . 64.319999999999993 107.129 178.284 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.543 ' HA3' HG22 ' B' ' 246' ' ' THR . . . 130.16 -38.44 1.97 Allowed Glycine 0 N--CA 1.417 -2.61 0 CA-C-N 114.612 -1.177 . . . . 71.319999999999993 111.332 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 116.95 -52.21 0.69 Allowed Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.02 -1.232 . . . . 72.010000000000005 110.02 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 284' ' ' LYS . . . . . 0.647 ' HD2' ' O ' ' B' ' 284' ' ' LYS . 0.1 OUTLIER -148.5 72.77 1.21 Allowed 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 122.403 1.097 . . . . 73.530000000000001 111.315 -178.878 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -90.17 -51.86 2.68 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.115 -1.194 . . . . 63.520000000000003 110.115 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.44 ' HE1' ' CZ2' ' A' ' 287' ' ' TRP . 56.3 t80 -65.52 -35.22 80.22 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.416 0.627 . . . . 75.420000000000002 110.561 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.567 ' O ' ' HB2' ' B' ' 284' ' ' LYS . 29.0 m-90 . . . . . 0 C--N 1.309 -1.176 0 N-CA-C 108.151 -1.055 . . . . 74.430000000000007 108.151 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 . . . . . 0 N--CA 1.42 -1.973 0 CA-C-O 121.224 0.535 . . . . 74.430000000000007 109.69 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.484 HD22 ' HA2' ' C' ' 278' ' ' GLY . 37.3 t-20 -117.75 128.69 55.13 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 105.906 -1.887 . . . . 52.329999999999998 105.906 170.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.1 m -128.77 136.51 50.63 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-O 121.457 0.646 . . . . 63.130000000000003 110.264 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.92 127.47 41.82 Favored 'General case' 0 N--CA 1.417 -2.103 0 N-CA-C 107.92 -1.141 . . . . 74.450000000000003 107.92 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 37.7 ttmt -80.26 -60.68 2.23 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.996 -0.682 . . . . 70.120000000000005 112.097 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -126.21 137.49 53.55 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.076 -1.083 . . . . 74.109999999999999 108.076 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 24.8 mt -136.19 117.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.202 -1.036 . . . . 74.109999999999999 108.202 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 92.5 mtt180 -120.11 119.45 33.34 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.19 -1.041 . . . . 73.549999999999997 108.19 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.566 HG22 HG21 ' C' ' 239' ' ' VAL . 28.9 p -119.75 127.83 53.19 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.462 -1.681 . . . . 64.299999999999997 106.462 -177.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.425 ' HB2' ' HD2' ' C' ' 270' ' ' LYS . 54.2 mt-10 -133.58 155.31 49.86 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.454 0.645 . . . . 61.310000000000002 112.075 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.518 ' HB3' ' HD3' ' C' ' 236' ' ' ARG . 46.6 mt-10 72.26 -86.54 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.199 0 CA-C-N 113.896 -1.502 . . . . 71.030000000000001 114.693 170.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.518 ' HD3' ' HB3' ' C' ' 235' ' ' GLU . 0.3 OUTLIER -131.11 31.32 4.44 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.654 -0.869 . . . . 71.209999999999994 108.654 -177.487 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -75.11 138.39 42.04 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 122.333 1.063 . . . . 71.540000000000006 113.547 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 4.3 mpt_? -123.91 133.37 53.75 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 103.765 -2.68 . . . . 72.519999999999996 103.765 172.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.566 HG21 HG22 ' C' ' 233' ' ' THR . 85.8 t -141.16 132.31 27.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.252 0.549 . . . . 70.120000000000005 111.218 -174.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.603 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 51.8 tp60 -111.68 128.71 56.15 Favored 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 107.05 -1.463 . . . . 64.540000000000006 107.05 174.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.519 HD11 HD21 ' B' ' 262' ' ' ASN . 1.7 tm? -128.62 117.54 21.4 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.411 -0.959 . . . . 62.310000000000002 108.411 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.545 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 131.4 -111.68 1.11 Allowed Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 110.333 -1.107 . . . . 73.450000000000003 110.333 -177.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -145.71 155.19 42.81 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 122.109 -0.642 . . . . 64.200000000000003 110.371 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.603 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 58.8 t -131.22 122.02 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 108.635 -0.876 . . . . 75.129999999999995 108.635 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.409 HG13 ' CD1' ' B' ' 281' ' ' TYR . 2.7 p -122.18 112.01 32.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.54 -0.911 . . . . 54.539999999999999 108.54 173.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 246' ' ' THR . . . . . 0.485 HG22 ' HA3' ' C' ' 282' ' ' GLY . 5.0 t -81.39 162.38 23.39 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.225 0.824 . . . . 72.219999999999999 113.225 -174.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.54 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -60.36 -35.17 75.05 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 124.693 1.197 . . . . 73.329999999999998 109.678 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.49 -34.77 69.41 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.345 -1.298 . . . . 62.200000000000003 111.584 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 CA-C-N 116.129 -0.487 . . . . 51.039999999999999 110.85 -179.612 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.416 -2.143 0 N-CA-C 108.704 -0.85 . . . . 73.25 108.704 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -111.86 141.44 45.48 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.576 -0.738 . . . . 64.420000000000002 111.497 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 22.0 m -134.74 124.09 24.67 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.073 -1.084 . . . . 75.230000000000004 108.073 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.23 143.8 39.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.863 0.363 . . . . 71.510000000000005 110.613 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 53.9 mm-40 -80.42 -65.43 1.01 Allowed 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 115.955 -0.566 . . . . 61.119999999999997 111.459 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 59.2 m -140.8 130.79 24.61 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.107 -0.637 . . . . 62.25 110.906 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.0 m -123.51 133.88 67.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.852 -0.613 . . . . 73.129999999999995 109.393 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 268' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 8.3 p -128.02 140.23 49.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 116.181 -0.463 . . . . 45.329999999999998 109.945 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.03 132.87 9.61 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.988 -1.245 . . . . 73.5 109.988 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.425 ' HD2' ' HB2' ' C' ' 234' ' ' GLU . 29.8 mmmt -131.36 141.19 49.85 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.25 0.62 . . . . 72.310000000000002 110.177 -177.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 70.64 -132.02 22.05 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.883 -0.675 . . . . 64.439999999999998 112.166 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -85.94 49.35 1.76 Allowed 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 123.582 0.753 . . . . 74.349999999999994 110.502 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 273' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 67.9 m -83.22 145.07 29.36 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.602 0.964 . . . . 72.239999999999995 113.602 -174.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 274' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 41.7 mtt180 -138.68 125.68 21.23 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 103.586 -2.746 . . . . 71.420000000000002 103.586 172.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.481 ' CG1' HG22 ' C' ' 239' ' ' VAL . 4.6 p -140.28 137.78 37.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 C-N-CA 120.297 -0.561 . . . . 63.340000000000003 111.827 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.419 HD13 ' CG ' ' C' ' 240' ' ' GLN . 13.0 tp -113.15 112.43 23.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.644 0.735 . . . . 73.340000000000003 109.74 175.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 30.7 mt -101.21 103.29 14.66 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 104.996 -2.224 . . . . 63.439999999999998 104.996 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 278' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 144.26 -159.63 27.73 Favored Glycine 0 N--CA 1.42 -2.384 0 C-N-CA 118.916 -1.611 . . . . 53.039999999999999 113.863 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -92.6 129.41 38.54 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.793 -0.703 . . . . 74.400000000000006 109.848 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -111.99 122.35 47.51 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 105.435 -2.061 . . . . 71.349999999999994 105.435 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.75 124.26 40.62 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 108.517 -0.92 . . . . 65.400000000000006 108.517 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 282' ' ' GLY . . . . . 0.485 ' HA3' HG22 ' C' ' 246' ' ' THR . . . 122.42 -34.65 3.73 Favored Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.628 -0.715 . . . . 51.130000000000003 112.087 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 122.88 -62.63 0.55 Allowed Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.886 -0.673 . . . . 72.519999999999996 111.645 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 284' ' ' LYS . . . . . 0.622 ' HD2' ' O ' ' C' ' 284' ' ' LYS 0.255 0.1 OUTLIER -136.0 70.02 1.42 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.855 0.836 . . . . 74.450000000000003 112.171 178.525 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.29 -64.06 1.96 Allowed Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.66 -1.257 . . . . 70.430000000000007 110.749 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -65.03 -24.32 67.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.637 0.732 . . . . 54.219999999999999 110.911 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 . . . . . 0 C--N 1.307 -1.248 0 CA-C-N 115.804 -0.634 . . . . 75.040000000000006 110.354 179.041 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 23.6 ptt85 . . . . . 0 N--CA 1.434 -1.255 0 CA-C-O 121.135 0.493 . . . . 71.510000000000005 111.984 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.445 HD22 ' HA2' ' A' ' 278' ' ' GLY . 34.5 t30 -99.3 114.25 27.0 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.201 -1.777 . . . . 60.119999999999997 106.201 173.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.4 m -126.15 136.66 53.13 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.667 -0.813 . . . . 75.120000000000005 111.756 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -120.71 119.41 32.7 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.171 -1.418 . . . . 64.349999999999994 107.171 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -75.8 -58.2 3.42 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 123.803 0.69 . . . . 74.329999999999998 110.165 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -126.57 140.48 52.4 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.137 0.494 . . . . 73.140000000000001 111.345 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.0 mt -134.16 124.95 47.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.162 -1.051 . . . . 65.129999999999995 108.162 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -128.76 122.74 31.27 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.613 -0.514 . . . . 72.239999999999995 109.613 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 20.2 p -112.31 128.23 56.22 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.269 -1.382 . . . . 75.129999999999995 107.269 171.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -147.37 146.4 29.62 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.815 -1.18 . . . . 73.129999999999995 107.815 -175.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 60.14 72.96 0.5 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.248 0.619 . . . . 65.540000000000006 112.634 -175.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 65.28 22.87 12.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.054 0.541 . . . . 65.450000000000003 112.264 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.41 134.97 36.36 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.274 -0.421 . . . . 73.310000000000002 109.893 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.93 139.99 53.0 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.126 -0.488 . . . . 71.420000000000002 111.636 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 p -124.18 138.49 53.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.545 -0.752 . . . . 64.140000000000001 111.513 -176.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.576 ' HB3' HD22 ' A' ' 276' ' ' LEU . 55.0 tp60 -111.15 118.64 36.53 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.688 -1.227 . . . . 63.32 107.688 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.87 118.87 36.7 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.257 -1.016 . . . . 63.020000000000003 108.257 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.572 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 134.89 -136.72 8.73 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.437 -0.887 . . . . 61.399999999999999 111.843 177.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -130.12 128.58 42.11 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.568 -0.901 . . . . 73.510000000000005 108.568 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.4 115.38 43.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.025 -1.102 . . . . 71.230000000000004 108.025 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 45.5 t -113.87 114.39 46.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.701 -0.851 . . . . 63.409999999999997 108.701 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.497 ' HB ' ' HA3' ' A' ' 282' ' ' GLY . 10.7 m -105.06 161.15 14.48 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.895 -1.15 . . . . 62.219999999999999 107.895 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.73 72.34 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.991 0.916 . . . . 75.140000000000001 113.087 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.59 -34.49 64.88 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.899 1.444 . . . . 51.200000000000003 114.899 -174.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.321 -0.644 0 N-CA-C 113.801 1.038 . . . . 53.299999999999997 113.801 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 N--CA 1.415 -2.189 0 CA-C-O 121.814 0.816 . . . . 71.049999999999997 108.863 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -124.69 138.37 54.3 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.372 -1.344 . . . . 73.430000000000007 107.372 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.6 m -137.63 123.83 20.48 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.935 -0.706 . . . . 74.129999999999995 111.953 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 11.7 p -122.46 137.76 54.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 115.864 -0.607 . . . . 62.25 109.721 175.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 3.7 tp10 -79.0 -65.34 1.01 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.055 -0.52 . . . . 72.230000000000004 109.937 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 30.8 m -136.97 129.78 30.53 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 121.77 -0.581 . . . . 74.420000000000002 111.973 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.445 HG12 HD12 ' B' ' 231' ' ' ILE . 35.3 m -117.79 126.45 74.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 N-CA-C 108.368 -0.975 . . . . 74.140000000000001 108.368 174.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.93 126.68 66.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 121.38 0.61 . . . . 74.420000000000002 111.518 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.57 132.49 11.0 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 109.937 -1.265 . . . . 54.32 109.937 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' LYS . . . . . 0.644 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 30.5 mmmt -133.13 116.43 16.29 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.514 0.726 . . . . 73.530000000000001 110.284 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.43 86.29 0.9 Allowed Glycine 0 C--N 1.296 -1.67 0 C-N-CA 119.483 -1.342 . . . . 64.340000000000003 113.734 174.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 55.23 31.01 15.65 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.635 1.174 . . . . 71.239999999999995 111.618 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 23.6 m -83.04 149.18 27.1 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.485 0.66 . . . . 32.350000000000001 112.169 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -119.49 128.15 53.71 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.69 -0.856 . . . . 73.209999999999994 108.69 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 24.7 t -122.54 129.99 74.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.999 -0.741 . . . . 74.099999999999994 108.999 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.576 HD22 ' HB3' ' A' ' 240' ' ' GLN . 0.9 OUTLIER -119.78 117.36 27.99 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.556 -1.646 . . . . 73.230000000000004 106.556 173.321 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.496 HD13 ' HB3' ' B' ' 241' ' ' LEU . 42.7 mm -112.89 104.89 17.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.411 -0.959 . . . . 74.140000000000001 108.411 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 144.31 -127.7 3.05 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 119.746 -1.216 . . . . 71.209999999999994 113.007 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -128.36 150.76 49.95 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 120.711 0.291 . . . . 65.010000000000005 110.404 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -129.15 123.62 32.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.803 -1.925 . . . . 74.340000000000003 105.803 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -120.45 123.54 43.23 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.016 -1.475 . . . . 74.200000000000003 107.016 174.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.497 ' HA3' ' HB ' ' A' ' 246' ' ' THR . . . 145.36 -82.49 0.2 Allowed Glycine 0 N--CA 1.412 -2.923 0 C-N-CA 118.905 -1.617 . . . . 72.439999999999998 112.692 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -142.02 16.97 2.56 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.71 -1.233 . . . . 73.030000000000001 113.317 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.505 ' HD3' ' HA ' ' B' ' 286' ' ' PHE . 62.7 mttm 71.57 -38.28 0.42 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.887 1.675 . . . . 71.239999999999995 113.843 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.537 ' HA2' ' CD1' ' B' ' 287' ' ' TRP . . . -72.0 -28.84 67.84 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 117.391 1.717 . . . . 61.509999999999998 117.391 -170.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 276' ' ' LEU 0.325 51.9 p90 53.33 -78.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.468 1.107 . . . . 63.43 113.917 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.3 m0 . . . . . 0 C--N 1.319 -0.76 0 O-C-N 121.677 -0.639 . . . . 73.019999999999996 110.051 177.695 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 . . . . . 0 CA--C 1.504 -0.81 0 N-CA-C 113.561 0.949 . . . . 72.430000000000007 113.561 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -101.04 114.38 28.27 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 104.408 -2.442 . . . . 63.530000000000001 104.408 167.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 55.6 m -130.2 136.01 48.77 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 118.875 -1.13 . . . . 75.409999999999997 112.885 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -120.53 126.0 49.26 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.559 -1.655 . . . . 60.240000000000002 107.443 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 13.2 tmtt? -86.29 -59.34 2.31 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 116.137 -0.483 . . . . 74.540000000000006 110.747 -176.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -126.24 138.26 53.61 Favored 'General case' 0 C--O 1.25 1.12 0 C-N-CA 119.524 -0.87 . . . . 63.229999999999997 109.352 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.449 HG21 HG21 ' B' ' 239' ' ' VAL . 28.1 mt -130.54 121.59 51.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.803 -1.184 . . . . 74.120000000000005 107.803 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 29.3 ttt180 -127.03 118.45 24.47 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-O 121.049 0.452 . . . . 75.230000000000004 109.987 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 24.9 p -109.57 127.55 54.57 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.635 -1.987 . . . . 74.409999999999997 105.635 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 234' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 33.5 tt0 -139.81 138.54 35.9 Favored 'General case' 0 N--CA 1.406 -2.674 0 C-N-CA 119.977 -0.689 . . . . 65.439999999999998 109.564 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.559 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 46.8 mt-10 60.69 91.39 0.06 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.961 1.097 . . . . 75.519999999999996 113.961 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.559 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 61.35 23.79 13.98 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.999 0.92 . . . . 74.409999999999997 110.598 175.901 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -94.57 144.52 25.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.84 -0.618 . . . . 65.040000000000006 110.973 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -125.16 142.27 51.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.549 -1.278 . . . . 72.340000000000003 107.549 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.449 HG21 HG21 ' B' ' 231' ' ' ILE . 7.5 p -130.75 131.98 64.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 121.479 0.657 . . . . 73.209999999999994 110.699 174.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.549 ' HG3' HD13 ' B' ' 276' ' ' LEU . 5.8 tp-100 -108.15 120.71 43.11 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 105.807 -1.923 . . . . 74.430000000000007 105.807 173.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.496 ' HB3' HD13 ' A' ' 277' ' ' ILE . 3.1 tm? -125.86 117.68 23.88 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.332 -0.988 . . . . 61.240000000000002 108.332 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.27 -122.49 2.55 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.768 -0.73 . . . . 72.439999999999998 111.423 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -144.32 128.1 17.28 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.094 -0.706 . . . . 71.510000000000005 109.094 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 73.8 t -102.91 117.99 49.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.473 -0.936 . . . . 70.209999999999994 108.473 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.16 112.72 35.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.426 0.631 . . . . 73.540000000000006 109.565 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.2 m -105.49 161.66 14.15 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.555 -0.906 . . . . 54.310000000000002 108.555 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 249' ' ' ALA . . . -56.8 -33.33 66.59 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.848 0.859 . . . . 64.230000000000004 111.919 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.04 -34.14 59.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.453 -1.249 . . . . 73.319999999999993 113.14 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -68.43 -25.45 65.03 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 122.773 0.429 . . . . 74.430000000000007 112.092 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 tt . . . . . 0 C--O 1.238 0.486 0 N-CA-C 108.594 -0.891 . . . . 65.109999999999999 108.594 -178.124 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.411 -2.405 0 N-CA-C 107.688 -1.227 . . . . 63.399999999999999 107.688 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 91.1 m -91.25 107.87 19.49 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 107.884 -1.154 . . . . 53.310000000000002 107.884 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -120.9 131.31 54.31 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.388 -1.278 . . . . 61.240000000000002 107.559 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 51.5 m -138.86 126.49 21.96 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 120.937 0.399 . . . . 73.120000000000005 110.897 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.3 138.0 53.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.798 -0.761 . . . . 74.109999999999999 110.349 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.613 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 19.8 tp10 -79.24 -59.29 2.83 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.9 -0.591 . . . . 73.109999999999999 109.686 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 39.7 m -145.4 128.11 16.22 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.62 -0.675 . . . . 54.450000000000003 111.924 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.404 HG12 ' HB ' ' C' ' 231' ' ' ILE . 35.7 m -117.54 128.22 74.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.18 -1.044 . . . . 71.140000000000001 108.18 173.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 268' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 6.5 p -128.02 129.77 69.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-N 116.062 -0.517 . . . . 61.329999999999998 112.139 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.6 132.98 11.35 Favored Glycine 0 CA--C 1.475 -2.412 0 N-CA-C 110.037 -1.225 . . . . 73.120000000000005 110.037 176.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.591 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 27.3 mmmt -133.9 115.99 15.09 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 123.184 0.594 . . . . 74.340000000000003 111.621 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 77.54 92.29 0.27 Allowed Glycine 0 C--N 1.299 -1.5 0 C-N-CA 119.872 -1.156 . . . . 72.140000000000001 113.588 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 272' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' B' ' 236' ' ' ARG . 16.0 mp0 61.59 24.82 14.86 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.886 0.875 . . . . 71.219999999999999 111.638 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 273' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 41.6 m -83.04 152.39 25.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.476 0.917 . . . . 74.120000000000005 113.476 -171.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.452 ' HB3' ' CE3' ' B' ' 287' ' ' TRP . 94.9 mtt180 -128.34 127.96 43.66 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.467 -0.938 . . . . 75.510000000000005 108.467 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 47.2 t -126.28 128.17 71.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 122.41 0.284 . . . . 72.049999999999997 110.304 -175.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.549 HD13 ' HG3' ' B' ' 240' ' ' GLN . 5.8 tp -122.43 114.62 20.97 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.569 -0.852 . . . . 64.310000000000002 110.597 169.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.614 HG23 HD12 ' C' ' 241' ' ' LEU . 40.1 mm -108.01 104.55 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 N-CA-C 106.997 -1.483 . . . . 74.519999999999996 106.997 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.84 -148.95 20.75 Favored Glycine 0 CA--C 1.476 -2.389 0 C-N-CA 119.267 -1.444 . . . . 25.329999999999998 112.98 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 279' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 36.2 m-80 -112.38 136.59 51.67 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.089 -0.708 . . . . 63.530000000000001 109.089 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.88 118.81 36.54 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.167 -1.79 . . . . 71.109999999999999 106.167 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.476 ' CE2' ' HB ' ' C' ' 245' ' ' VAL . 77.7 m-85 -118.98 124.01 45.95 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.012 0.911 . . . . 65.120000000000005 109.921 175.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 139.29 -64.92 0.54 Allowed Glycine 0 N--CA 1.412 -2.928 0 C-N-CA 119.745 -1.217 . . . . 75.409999999999997 113.5 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -169.73 37.01 0.19 Allowed Glycine 0 C--O 1.21 -1.381 0 C-N-CA 117.371 -2.347 . . . . 74.519999999999996 115.367 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt 70.87 -66.37 0.3 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.637 1.175 . . . . 61.539999999999999 113.188 170.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -81.7 89.84 1.43 Allowed Glycine 0 CA--C 1.494 -1.265 0 CA-C-N 115.458 -0.792 . . . . 33.32 114.033 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.505 ' HA ' ' HD3' ' A' ' 284' ' ' LYS . 6.6 p90 -60.49 -66.45 0.53 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.815 0.846 . . . . 52.210000000000001 112.437 176.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.537 ' CD1' ' HA2' ' A' ' 285' ' ' GLY . 5.0 m-90 . . . . . 0 C--N 1.305 -1.358 0 N-CA-C 107.739 -1.208 . . . . 72.409999999999997 107.739 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 . . . . . 0 N--CA 1.422 -1.853 0 CA-C-O 121.276 0.56 . . . . 71.310000000000002 111.146 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -101.17 116.32 32.55 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.674 -1.972 . . . . 63.329999999999998 105.674 173.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 50.0 m -131.58 136.98 48.23 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.542 -0.863 . . . . 73.510000000000005 111.887 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.12 130.93 52.03 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.8 -1.091 . . . . 74.439999999999998 108.308 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.629 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.1 OUTLIER -80.27 -67.83 0.73 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.613 -0.884 . . . . 60.219999999999999 108.613 -178.364 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -125.54 139.19 53.82 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 119.869 -0.732 . . . . 74.239999999999995 109.258 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.417 HG23 HG23 ' C' ' 267' ' ' VAL . 20.3 mt -133.42 118.76 32.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.242 -1.392 . . . . 62.299999999999997 107.242 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -120.0 124.52 46.13 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.601 -0.44 . . . . 74.400000000000006 110.222 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 27.8 p -109.58 126.52 53.68 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 104.599 -2.371 . . . . 75.409999999999997 104.599 173.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 32.6 tt0 -140.86 138.81 34.22 Favored 'General case' 0 N--CA 1.415 -2.193 0 C-N-CA 119.804 -0.758 . . . . 63.420000000000002 109.132 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.531 ' C ' ' HD3' ' C' ' 236' ' ' ARG . 56.4 mt-10 62.91 85.74 0.13 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.303 1.002 . . . . 74.519999999999996 112.939 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.579 ' HD3' ' N ' ' C' ' 236' ' ' ARG . 0.1 OUTLIER 64.9 21.82 12.39 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.882 0.873 . . . . 75.25 111.473 174.162 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -91.68 147.48 22.97 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.294 0.569 . . . . 54.049999999999997 111.447 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.418 ' HG3' ' HB2' ' B' ' 274' ' ' ARG . 5.2 mpt_? -125.1 144.41 50.43 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.863 -1.162 . . . . 73.329999999999998 107.863 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.41 HG21 HG21 ' C' ' 231' ' ' ILE . 5.7 p -133.85 135.52 55.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.351 0.596 . . . . 64.209999999999994 111.377 175.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -110.41 117.81 34.59 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 106.913 -1.514 . . . . 72.0 106.913 172.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.614 HD12 HG23 ' B' ' 277' ' ' ILE . 3.2 tm? -121.88 117.69 27.11 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.947 -1.501 . . . . 74.030000000000001 106.947 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.65 -128.38 4.1 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.551 -0.833 . . . . 70.439999999999998 111.024 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 51.5 t-20 -140.14 128.83 23.08 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.426 -0.953 . . . . 71.219999999999999 108.426 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.23 115.12 44.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.637 -1.246 . . . . 71.420000000000002 107.637 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 245' ' ' VAL . . . . . 0.476 ' HB ' ' CE2' ' B' ' 281' ' ' TYR . 43.4 t -120.51 112.57 36.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.949 -0.76 . . . . 63.32 108.949 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.1 m -101.57 160.91 14.04 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.069 -0.715 . . . . 65.200000000000003 109.069 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -58.91 -31.77 68.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.957 1.303 . . . . 74.109999999999999 110.519 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.31 59.24 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.043 -1.89 . . . . 60.310000000000002 113.616 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.456 0 C-N-CA 120.426 -0.51 . . . . 70.239999999999995 111.412 -176.579 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.42 -1.959 0 CA-C-O 121.561 0.696 . . . . 73.510000000000005 109.259 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -121.24 137.21 54.79 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.803 -1.184 . . . . 75.5 107.803 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 18.1 t -135.95 123.3 21.92 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 108.929 -0.767 . . . . 70.209999999999994 108.929 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.02 131.34 72.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.26 -0.882 . . . . 72.349999999999994 109.119 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.629 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 17.2 tp10 -88.36 -54.76 4.03 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.534 -0.543 . . . . 70.519999999999996 109.534 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 55.0 m -150.22 127.44 11.31 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.349 -0.845 . . . . 50.340000000000003 110.842 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.417 HG23 HG23 ' C' ' 231' ' ' ILE . 5.1 m -121.21 128.42 75.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.706 -0.849 . . . . 45.32 108.706 171.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.09 135.53 63.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 116.34 -0.391 . . . . 74.549999999999997 110.352 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.53 133.49 11.4 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 109.866 -1.294 . . . . 51.240000000000002 109.866 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -132.31 116.24 16.64 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.801 -0.444 . . . . 74.430000000000007 109.801 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.32 93.16 0.56 Allowed Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.345 -0.931 . . . . 64.099999999999994 113.309 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 55.38 28.4 11.42 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.696 1.198 . . . . 75.219999999999999 111.653 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 273' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 46.3 m -82.37 154.89 25.01 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.953 1.094 . . . . 61.409999999999997 113.953 -169.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -122.85 128.26 50.14 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.871 -1.059 . . . . 71.140000000000001 108.254 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 11.0 t -125.64 130.53 72.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.073 -0.714 . . . . 74.519999999999996 109.073 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -123.55 110.59 15.23 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.284 -1.376 . . . . 75.150000000000006 107.284 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 40.8 mm -113.53 103.95 16.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.072 -1.455 . . . . 62.140000000000001 107.072 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.05 -152.65 24.53 Favored Glycine 0 CA--C 1.471 -2.676 0 C-N-CA 120.034 -1.079 . . . . 54.310000000000002 111.216 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.56 141.15 48.44 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 109.213 -0.662 . . . . 73.239999999999995 109.213 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.69 118.37 34.84 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.143 -1.428 . . . . 74.299999999999997 107.143 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -119.08 124.29 46.55 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.76 0.791 . . . . 71.439999999999998 110.828 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.51 -52.92 0.74 Allowed Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 120.072 -1.061 . . . . 22.420000000000002 113.151 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -151.59 -4.16 0.18 Allowed Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 117.434 -2.317 . . . . 64.409999999999997 115.207 -173.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm 78.47 -40.65 0.28 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.832 1.253 . . . . 71.430000000000007 109.616 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -86.03 110.38 3.47 Favored Glycine 0 N--CA 1.41 -3.067 0 N-CA-C 109.823 -1.311 . . . . 61.299999999999997 109.823 174.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -79.97 -85.84 0.08 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 112.88 0.696 . . . . 61.25 112.88 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 7.9 m0 . . . . . 0 C--N 1.316 -0.857 0 O-C-N 120.91 -1.119 . . . . 74.040000000000006 111.486 -176.851 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 . . . . . 0 C--O 1.244 0.767 0 CA-C-O 120.826 0.346 . . . . 72.310000000000002 110.475 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -113.83 127.83 56.16 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.606 -1.257 . . . . 74.140000000000001 107.606 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 28.0 m -123.41 137.66 54.76 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.93 -0.396 . . . . 71.450000000000003 109.93 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.62 125.38 28.63 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.25 -0.432 . . . . 70.540000000000006 110.284 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 12.9 tmtt? -76.3 -62.72 1.52 Allowed 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.723 0.639 . . . . 73.409999999999997 109.749 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -133.72 139.14 46.21 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-O 121.319 0.581 . . . . 53.200000000000003 112.543 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 34.5 mm -123.39 117.12 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 106.774 -1.565 . . . . 71.140000000000001 106.774 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -118.75 115.89 25.41 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.328 0.585 . . . . 71.230000000000004 110.201 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.4 128.27 50.73 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.597 -0.89 . . . . 74.140000000000001 108.597 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -137.1 164.1 29.24 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.258 0.349 . . . . 73.430000000000007 110.607 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 236' ' ' ARG . 34.7 mt-10 66.99 -88.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.777 1.231 . . . . 64.5 113.443 174.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.435 ' HD2' ' HB3' ' A' ' 235' ' ' GLU . 0.2 OUTLIER -138.18 27.25 2.62 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 108.174 -1.047 . . . . 71.409999999999997 108.174 -177.494 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -75.13 149.19 39.13 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.166 -0.925 . . . . 61.509999999999998 110.107 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -125.57 135.06 51.82 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 104.861 -2.274 . . . . 75.099999999999994 104.861 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.14 148.47 30.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.7 0.762 . . . . 71.209999999999994 111.924 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.461 ' CG ' ' HG ' ' A' ' 276' ' ' LEU . 49.9 tp60 -126.87 128.58 46.72 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.96 -1.018 . . . . 72.219999999999999 108.878 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -126.48 118.72 25.51 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.66 -1.607 . . . . 53.119999999999997 106.66 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.499 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 135.86 -135.17 7.64 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.197 -1.001 . . . . 61.43 112.409 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -128.82 128.43 43.9 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 122.687 -0.302 . . . . 74.239999999999995 110.272 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 91.3 t -118.29 127.17 75.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.718 -0.845 . . . . 74.209999999999994 108.718 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.11 112.76 39.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.563 -0.902 . . . . 71.409999999999997 108.563 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 50.6 m -81.14 160.08 24.49 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.554 -1.276 . . . . 72.0 107.554 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.49 84.33 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.543 0.571 . . . . 74.450000000000003 112.543 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.54 -34.89 65.11 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 114.32 1.23 . . . . 73.120000000000005 114.32 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 113.75 1.019 . . . . 62.210000000000001 113.75 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 36.2 p . . . . . 0 N--CA 1.42 -1.946 0 N-CA-C 106.539 -1.652 . . . . 71.340000000000003 106.539 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 31.8 t-20 -126.52 122.21 34.51 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.102 -0.703 . . . . 72.329999999999998 109.102 -174.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 35.3 m -122.92 123.15 40.29 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.697 -0.483 . . . . 74.420000000000002 109.697 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.1 p -115.74 140.52 37.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.01 0.433 . . . . 65.209999999999994 110.629 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.597 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 22.7 tp10 -82.78 -69.2 0.64 Allowed 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.165 -0.925 . . . . 71.540000000000006 110.548 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 13.5 m -133.73 129.22 36.4 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 121.535 -0.728 . . . . 62.310000000000002 111.814 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 24.0 m -118.1 127.28 75.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.814 -1.18 . . . . 72.209999999999994 107.814 170.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.72 127.07 73.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-O 121.116 0.484 . . . . 74.439999999999998 111.533 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.84 133.57 11.53 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.623 -0.717 . . . . 64.510000000000005 111.762 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -125.06 144.17 50.54 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 124.179 0.992 . . . . 61.310000000000002 109.28 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 65.21 -132.06 35.99 Favored Glycine 0 C--N 1.305 -1.149 0 C-N-CA 121.212 -0.518 . . . . 63.409999999999997 112.931 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' B' ' 235' ' ' GLU . 8.7 mm-40 -92.79 53.65 2.07 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 125.201 1.4 . . . . 75.099999999999994 111.413 -177.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 73.5 m -83.1 150.03 26.53 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.166 0.508 . . . . 72.340000000000003 112.113 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -128.61 127.47 42.32 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.183 -1.414 . . . . 64.409999999999997 107.183 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.463 HG13 HG23 ' B' ' 239' ' ' VAL . 16.4 t -132.71 130.09 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 109.094 -0.706 . . . . 73.120000000000005 109.094 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.461 ' HG ' ' CG ' ' A' ' 240' ' ' GLN . 5.8 tt -118.31 121.55 40.67 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.879 -1.156 . . . . 72.409999999999997 107.879 174.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.448 HG23 HD12 ' B' ' 241' ' ' LEU . 3.5 mp -112.23 104.36 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.982 0 N-CA-C 107.303 -1.369 . . . . 55.140000000000001 107.303 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 151.54 -145.27 12.88 Favored Glycine 0 N--CA 1.421 -2.309 0 N-CA-C 111.064 -0.814 . . . . 25.530000000000001 111.064 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' B' ' 243' ' ' ASN . 95.7 m-20 -114.3 140.2 48.81 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 116.735 0.267 . . . . 72.409999999999997 110.594 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.8 OUTLIER -128.16 129.54 46.68 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.796 -1.557 . . . . 73.209999999999994 106.796 178.486 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -119.4 124.62 47.0 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 109.349 -0.612 . . . . 71.519999999999996 109.349 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' GLY . . . . . 0.417 ' CA ' ' HB2' ' A' ' 249' ' ' ALA . . . 136.42 -50.65 0.83 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 111.254 -0.739 . . . . 72.239999999999995 111.254 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 98.12 39.21 3.84 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 109.546 -1.422 . . . . 73.049999999999997 109.546 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -141.04 -56.37 0.5 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.318 -0.553 . . . . 75.129999999999995 109.641 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' GLY . . . . . 0.612 ' HA3' ' CZ3' ' A' ' 287' ' ' TRP . . . 72.21 -159.53 53.74 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.494 -0.776 . . . . 65.030000000000001 114.907 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -105.24 -0.18 26.62 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.351 -0.425 . . . . 71.209999999999994 109.92 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' TRP . . . . . 0.612 ' CZ3' ' HA3' ' A' ' 285' ' ' GLY . 24.2 m-90 . . . . . 0 C--O 1.237 0.431 0 CA-C-N 115.54 -0.755 . . . . 63.549999999999997 111.944 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 261' ' ' THR . 13.9 ptt180 . . . . . 0 N--CA 1.433 -1.321 0 CA-C-O 121.589 0.709 . . . . 75.109999999999999 111.527 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 48.0 t-20 -116.85 127.63 54.48 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.342 -1.725 . . . . 72.420000000000002 106.342 172.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 19.5 m -125.75 136.37 53.09 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 109.11 -0.7 . . . . 74.25 109.11 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.502 ' HB1' HD11 ' B' ' 231' ' ' ILE . . . -131.39 127.66 37.97 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.808 -0.633 . . . . 62.420000000000002 110.447 -175.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.597 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 12.1 tmtt? -81.73 -68.12 0.72 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.686 -0.688 . . . . 44.420000000000002 109.656 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -127.38 137.48 52.77 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 119.374 -0.93 . . . . 71.230000000000004 110.961 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.502 HD11 ' HB1' ' B' ' 228' ' ' ALA . 35.9 mm -129.77 117.13 40.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 106.544 -1.65 . . . . 72.230000000000004 106.544 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 232' ' ' ARG . . . . . 0.585 ' HD3' ' OE2' ' B' ' 234' ' ' GLU . 18.2 ttm180 -118.47 124.31 47.29 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 120.696 0.284 . . . . 71.109999999999999 110.59 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 73.1 p -115.46 128.23 55.87 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.252 -1.018 . . . . 72.420000000000002 108.252 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 234' ' ' GLU . . . . . 0.585 ' OE2' ' HD3' ' B' ' 232' ' ' ARG . 59.3 mt-10 -127.01 156.24 41.94 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.132 0.491 . . . . 74.340000000000003 111.043 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' B' ' 236' ' ' ARG . 49.3 mt-10 66.68 -86.85 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.443 0 N-CA-C 114.38 1.252 . . . . 75.329999999999998 114.38 172.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 236' ' ' ARG . . . . . 0.462 ' HD2' ' HB3' ' B' ' 235' ' ' GLU . 0.8 OUTLIER -135.59 31.84 3.08 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.31 -0.996 . . . . 60.119999999999997 108.31 -178.297 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -76.56 141.91 40.99 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.106 -0.952 . . . . 74.5 111.745 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 7.1 mpt_? -125.12 133.86 52.68 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.895 -1.52 . . . . 70.549999999999997 106.895 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.573 HG12 ' HB ' ' B' ' 275' ' ' VAL . 21.7 m -140.97 151.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.419 0.628 . . . . 54.229999999999997 112.331 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.502 ' CG ' ' HG ' ' B' ' 276' ' ' LEU . 38.3 tp60 -119.43 137.31 53.85 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.019 -1.446 . . . . 71.340000000000003 108.728 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.448 HD12 HG23 ' A' ' 277' ' ' ILE . 2.7 tm? -129.39 117.96 21.43 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.212 -1.773 . . . . 75.420000000000002 106.212 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.564 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 131.33 -131.8 6.53 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.504 -0.855 . . . . 40.219999999999999 112.886 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 243' ' ' ASN . . . . . 0.515 ' HB3' ' OD1' ' A' ' 279' ' ' ASN . 23.8 t-20 -125.38 136.3 53.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 122.491 -0.417 . . . . 70.150000000000006 110.912 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 280' ' ' GLU . 93.8 t -126.77 128.36 70.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.366 -0.975 . . . . 74.209999999999994 108.366 175.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 61.9 t -120.38 112.83 38.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.182 -1.044 . . . . 72.549999999999997 108.182 174.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.45 HG21 ' HB3' ' B' ' 284' ' ' LYS . 28.4 m -76.68 160.74 29.11 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 106.776 -1.564 . . . . 73.430000000000007 106.776 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.08 -33.87 76.38 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.109 0.956 . . . . 51.329999999999998 110.74 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.5 -34.4 64.58 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.404 -1.725 . . . . 71.5 114.117 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' B' ' 250' ' ' LEU . . . -59.83 -26.09 65.52 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.562 0.949 . . . . 73.349999999999994 113.562 -174.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' B' ' 249' ' ' ALA . 53.6 tp . . . . . 0 C--O 1.246 0.895 0 O-C-N 124.473 1.108 . . . . 70.420000000000002 110.781 -174.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 260' ' ' THR . . . . . 0.401 HG21 ' HB2' ' C' ' 243' ' ' ASN . 2.4 m . . . . . 0 N--CA 1.436 -1.148 0 CA-C-O 121.055 0.455 . . . . 75.519999999999996 110.831 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -126.77 108.75 11.32 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.356 -1.72 . . . . 54.109999999999999 106.356 166.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 18.3 t-20 -124.42 128.25 48.75 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.279 -1.008 . . . . 61.299999999999997 108.279 -172.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 33.1 m -129.27 123.66 32.47 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.889 -0.411 . . . . 73.430000000000007 109.889 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.51 141.22 28.77 Favored 'Isoleucine or valine' 0 C--O 1.25 1.121 0 CA-C-N 115.977 -0.556 . . . . 70.25 109.749 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 20.7 tp10 -83.37 -58.04 3.0 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.582 -0.735 . . . . 74.040000000000006 110.315 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' C' ' 230' ' ' ASP . 80.4 m -149.75 133.16 16.55 Favored 'General case' 0 C--N 1.31 -1.125 0 O-C-N 121.372 -0.83 . . . . 61.119999999999997 112.428 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 12.2 m -118.5 134.68 61.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.767 -1.197 . . . . 74.329999999999998 107.767 171.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 m -125.88 122.82 62.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.033 0.444 . . . . 75.230000000000004 110.629 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.99 132.86 11.26 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.466 -0.873 . . . . 74.150000000000006 111.893 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' C' ' 234' ' ' GLU . 29.3 mmmt -126.39 147.12 49.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 124.213 1.005 . . . . 72.230000000000004 109.236 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.41 -136.25 34.23 Favored Glycine 0 C--O 1.228 -0.259 0 C-N-CA 120.009 -1.091 . . . . 62.140000000000001 110.516 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -97.35 69.55 2.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.866 0.841 . . . . 72.25 111.277 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 72.3 m -85.67 146.46 26.83 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.12 -0.945 . . . . 74.140000000000001 111.366 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 274' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 8.8 mpt_? -127.49 127.11 43.47 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.706 -1.59 . . . . 74.519999999999996 106.706 169.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.573 ' HB ' HG12 ' B' ' 239' ' ' VAL . 21.7 t -134.16 139.13 48.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 108.282 -1.007 . . . . 52.43 108.282 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 276' ' ' LEU . . . . . 0.502 ' HG ' ' CG ' ' B' ' 240' ' ' GLN . 6.5 tt -123.56 125.44 44.87 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 106.706 -1.59 . . . . 65.219999999999999 106.706 173.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.411 HG23 HD12 ' C' ' 241' ' ' LEU . 4.0 mp -112.57 104.06 16.44 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 105.903 -1.888 . . . . 73.439999999999998 105.903 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 153.35 -149.24 20.74 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.164 -1.017 . . . . 60.210000000000001 113.26 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -110.04 133.56 53.07 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.019 -0.734 . . . . 64.219999999999999 109.019 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 280' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' C' ' 244' ' ' VAL . 2.2 tm-20 -126.65 128.08 46.2 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 106.507 -1.664 . . . . 70.420000000000002 106.507 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -118.58 125.06 49.0 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 109.143 -0.688 . . . . 64.349999999999994 109.143 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.02 -43.29 1.24 Allowed Glycine 0 N--CA 1.417 -2.621 0 N-CA-C 110.498 -1.041 . . . . 43.210000000000001 110.498 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.39 36.14 9.0 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.319 -1.512 . . . . 73.109999999999999 109.319 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 284' ' ' LYS . . . . . 0.45 ' HB3' HG21 ' B' ' 246' ' ' THR . 49.4 tptt -142.56 -62.27 0.43 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.873 -0.417 . . . . 71.319999999999993 109.873 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 285' ' ' GLY . . . . . 0.438 ' HA3' ' CZ3' ' B' ' 287' ' ' TRP . . . 68.95 -159.67 52.66 Favored Glycine 0 N--CA 1.44 -1.079 0 O-C-N 123.408 0.443 . . . . 63.149999999999999 113.821 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -102.26 -6.8 22.72 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 121.086 -0.246 . . . . 75.430000000000007 111.223 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 287' ' ' TRP . . . . . 0.477 ' HB3' ' HG2' ' C' ' 238' ' ' ARG . 26.6 m-90 . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 121.907 0.86 . . . . 74.430000000000007 110.169 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 . . . . . 0 N--CA 1.439 -1.015 0 CA-C-O 121.301 0.572 . . . . 71.349999999999994 111.753 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 26.5 t-20 -117.28 127.0 53.64 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.743 -1.206 . . . . 72.349999999999994 107.743 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 227' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' C' ' 263' ' ' SER . 19.5 m -126.37 137.22 53.43 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 108.785 -0.82 . . . . 74.5 108.785 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.41 ' HB1' HD11 ' C' ' 231' ' ' ILE . . . -136.29 132.39 35.66 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.887 -0.325 . . . . 64.150000000000006 110.639 -176.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.613 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.0 OUTLIER -80.14 -76.34 0.23 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.274 -0.639 . . . . 75.510000000000005 109.274 178.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 230' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' B' ' 266' ' ' THR . 2.1 p-10 -129.09 140.51 51.54 Favored 'General case' 0 C--O 1.264 1.848 0 C-N-CA 118.062 -1.455 . . . . 70.230000000000004 112.216 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.41 HD11 ' HB1' ' C' ' 228' ' ' ALA . 28.0 mm -119.27 117.07 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 113.055 -1.884 . . . . 63.299999999999997 106.26 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 232' ' ' ARG . . . . . 0.47 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 17.9 ttm180 -111.75 123.67 50.73 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.907 -0.405 . . . . 73.430000000000007 109.907 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 72.0 p -116.96 128.37 55.13 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.003 -1.11 . . . . 71.239999999999995 108.003 175.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.47 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 49.2 mt-10 -127.31 160.74 30.42 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 120.586 -0.446 . . . . 73.319999999999993 111.361 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 63.43 -82.02 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.908 0 C-N-CA 124.94 1.296 . . . . 71.540000000000006 114.343 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.45 ' O ' ' HD2' ' C' ' 238' ' ' ARG . 0.2 OUTLIER -139.44 25.95 2.39 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.595 -0.891 . . . . 71.430000000000007 108.595 -178.433 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.53 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -71.23 141.83 50.59 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.826 0.822 . . . . 74.439999999999998 112.106 -177.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 9.1 mpt_? -124.55 133.43 53.3 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 106.454 -1.684 . . . . 75.030000000000001 106.454 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.503 HG23 HG13 ' B' ' 275' ' ' VAL . 21.2 m -142.94 150.18 18.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.707 0.765 . . . . 65.409999999999997 112.397 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.415 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 5.2 tp60 -112.33 137.42 50.5 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.248 -1.342 . . . . 73.200000000000003 109.062 176.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' C' ' 277' ' ' ILE . 2.8 tm? -128.13 117.53 21.78 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.278 -2.119 . . . . 72.450000000000003 105.278 172.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.485 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 130.93 -133.07 7.11 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.191 -1.004 . . . . 43.219999999999999 112.721 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 243' ' ' ASN . . . . . 0.401 ' HB2' HG21 ' B' ' 260' ' ' THR . 40.8 t30 -128.99 138.56 52.02 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 122.233 -0.569 . . . . 73.109999999999999 110.716 -176.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' B' ' 280' ' ' GLU . 96.7 t -126.09 118.48 51.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.213 -0.662 . . . . 63.140000000000001 109.213 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.12 112.72 41.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.347 -0.983 . . . . 71.0 108.347 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 19.4 m -79.52 160.38 26.53 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.054 -1.461 . . . . 54.43 107.054 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.86 -33.07 72.52 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.1 0.952 . . . . 75.319999999999993 110.644 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.48 -33.33 63.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.236 -1.802 . . . . 75.340000000000003 113.848 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 114.536 1.31 . . . . 64.430000000000007 114.536 -172.534 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.411 -2.376 0 N-CA-C 105.236 -2.135 . . . . 64.120000000000005 105.236 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -126.72 139.0 53.47 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.497 -0.774 . . . . 63.329999999999998 110.922 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 263' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' C' ' 227' ' ' SER . 42.3 m -139.89 123.56 17.33 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 107.863 -1.162 . . . . 74.299999999999997 107.863 176.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.6 p -109.87 152.88 11.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.819 -0.352 . . . . 65.129999999999995 110.104 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 265' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 10.1 tp10 -88.25 -69.72 0.68 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.154 -0.475 . . . . 61.140000000000001 109.989 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 90.5 m -140.46 130.73 25.08 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.897 -0.409 . . . . 73.340000000000003 109.897 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.21 133.6 67.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.804 -0.813 . . . . 74.340000000000003 108.804 171.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 29.7 m -121.5 129.05 75.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.166 0.508 . . . . 64.510000000000005 111.154 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.54 133.47 11.5 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.433 -1.067 . . . . 53.32 110.433 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 270' ' ' LYS . . . . . 0.427 ' HD2' ' HB2' ' C' ' 234' ' ' GLU . 28.4 mmmt -132.07 131.52 42.48 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.124 0.569 . . . . 52.240000000000002 109.852 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 68.56 -133.02 27.51 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.782 -0.645 . . . . 43.420000000000002 112.263 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -79.35 47.39 0.8 Allowed 'General case' 0 C--N 1.305 -1.37 0 C-N-CA 125.063 1.345 . . . . 71.420000000000002 113.127 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 50.7 m -83.4 145.44 29.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.555 0.693 . . . . 74.519999999999996 112.853 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 274' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 10.2 mpt_? -130.6 127.04 38.2 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 106.537 -1.653 . . . . 62.310000000000002 106.537 170.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.439 ' HB ' HG12 ' C' ' 239' ' ' VAL . 10.0 t -137.83 140.73 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 108.771 -0.826 . . . . 61.049999999999997 108.771 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 276' ' ' LEU . . . . . 0.456 ' HB3' ' CZ2' ' C' ' 287' ' ' TRP . 6.8 tt -123.32 114.14 19.8 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.815 -1.18 . . . . 72.310000000000002 107.815 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 277' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 3.4 mp -104.57 104.19 16.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 105.532 -2.025 . . . . 64.420000000000002 105.532 176.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 278' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 159.26 -139.67 6.36 Favored Glycine 0 N--CA 1.41 -3.059 0 C-N-CA 119.4 -1.381 . . . . 73.230000000000004 112.402 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -127.79 142.97 51.15 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.165 -1.42 . . . . 73.209999999999994 107.165 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -141.93 132.62 25.56 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.218 -0.66 . . . . 60.310000000000002 109.218 -174.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.48 133.58 55.05 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.221 0.534 . . . . 74.129999999999995 111.023 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 122.86 -36.39 3.12 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 110.002 -1.239 . . . . 73.239999999999995 110.002 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 86.28 32.87 15.53 Favored Glycine 0 N--CA 1.419 -2.436 0 N-CA-C 111.422 -0.671 . . . . 54.219999999999999 111.422 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -131.92 -54.78 0.99 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.837 -0.801 . . . . 74.299999999999997 108.837 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 285' ' ' GLY . . . . . 0.414 ' HA3' ' CE3' ' C' ' 287' ' ' TRP . . . 69.21 -172.28 38.07 Favored Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 115.244 -0.889 . . . . 75.549999999999997 112.45 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -91.2 -5.73 54.47 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 110.429 -0.212 . . . . 73.409999999999997 110.429 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 287' ' ' TRP . . . . . 0.456 ' CZ2' ' HB3' ' C' ' 276' ' ' LEU . 27.6 m-90 . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 121.55 0.69 . . . . 75.150000000000006 110.518 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.484 ' HG2' ' OG1' ' A' ' 261' ' ' THR . 14.0 ptt180 . . . . . 0 N--CA 1.445 -0.682 0 N-CA-C 109.19 -0.671 . . . . 74.319999999999993 109.19 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ASN . . . . . 0.401 HD21 HG22 ' A' ' 277' ' ' ILE . 24.2 t-20 -116.19 114.72 24.83 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.063 -0.717 . . . . 63.5 109.063 178.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 26.9 m -134.83 137.91 43.74 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.453 0.538 . . . . 62.119999999999997 112.453 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.9 135.33 45.51 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.418 -1.327 . . . . 70.530000000000001 107.418 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -55.25 3.36 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.578 -0.849 . . . . 74.420000000000002 110.493 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -139.63 139.05 36.62 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 122.279 -0.263 . . . . 61.130000000000003 110.491 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ILE . . . . . 0.483 HG21 HG21 ' A' ' 239' ' ' VAL . 30.0 mt -137.82 125.8 31.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 108.822 -0.807 . . . . 62.229999999999997 108.822 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ARG . . . . . 0.494 ' HB3' HG12 ' A' ' 268' ' ' VAL . 35.2 ttt180 -126.05 122.34 35.55 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.151 -1.055 . . . . 72.329999999999998 108.151 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' THR . . . . . 0.509 ' OG1' ' HB1' ' A' ' 237' ' ' ALA . 14.3 t -135.27 130.78 35.69 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 120.014 -0.674 . . . . 41.310000000000002 109.396 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -135.2 140.75 45.56 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 112.177 0.436 . . . . 71.420000000000002 112.177 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 66.68 106.53 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.02 1.328 . . . . 54.329999999999998 113.361 174.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 272' ' ' GLU . 47.6 mtt85 57.46 35.01 25.41 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.807 1.289 . . . . 74.549999999999997 107.564 176.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.509 ' HB1' ' OG1' ' A' ' 233' ' ' THR . . . -83.7 128.71 34.73 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 112.81 -1.996 . . . . 70.450000000000003 112.633 -170.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -129.86 135.06 47.94 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 106.878 -1.527 . . . . 72.409999999999997 106.878 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.483 HG21 HG21 ' A' ' 231' ' ' ILE . 6.7 p -143.68 140.1 25.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.646 -0.501 . . . . 74.519999999999996 109.646 175.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' GLN . . . . . 0.55 ' HB2' ' CD1' ' A' ' 286' ' ' PHE . 11.7 tm0? -125.82 136.99 53.74 Favored 'General case' 0 N--CA 1.405 -2.68 0 N-CA-C 106.431 -1.692 . . . . 70.109999999999999 106.431 177.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 tt -128.73 117.22 20.76 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 105.704 -1.962 . . . . 74.430000000000007 105.704 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.513 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 135.26 -119.23 2.06 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.367 -0.92 . . . . 53.119999999999997 113.338 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -144.43 139.53 28.42 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.032 -1.099 . . . . 73.549999999999997 108.032 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.435 ' HB ' ' HG2' ' A' ' 280' ' ' GLU . 22.5 t -125.79 121.44 59.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 109.465 -0.568 . . . . 42.549999999999997 109.465 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.76 112.64 34.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.996 -1.113 . . . . 52.219999999999999 107.996 170.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 281' ' ' TYR . 6.4 t -89.35 160.55 16.79 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.7 -1.2 . . . . 73.409999999999997 109.588 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.67 74.38 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 123.156 0.582 . . . . 74.230000000000004 110.15 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -35.5 66.82 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.167 -0.924 . . . . 53.43 112.138 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 N--CA 1.466 0.343 0 CA-C-N 116.543 -0.299 . . . . 73.109999999999999 110.614 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' A' ' 225' ' ' ARG . 10.8 t . . . . . 0 N--CA 1.397 -3.082 0 N-CA-C 105.138 -2.171 . . . . 70.319999999999993 105.138 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' ASN . . . . . 0.588 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 7.2 t30 -122.1 127.07 49.71 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.564 -0.744 . . . . 63.32 111.786 -168.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.3 t -135.68 123.75 22.91 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 109.046 -0.724 . . . . 63.119999999999997 109.046 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.5 p -126.55 147.42 31.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 109.044 -0.725 . . . . 63.229999999999997 109.044 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -96.91 -75.86 0.53 Allowed 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 119.612 -0.835 . . . . 62.119999999999997 111.208 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 63.3 m -117.33 127.27 53.89 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.336 0.588 . . . . 62.450000000000003 110.831 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.449 HG11 HD11 ' A' ' 277' ' ' ILE . 1.4 p -134.0 123.99 45.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.876 -0.602 . . . . 70.409999999999997 110.903 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 232' ' ' ARG . 21.6 m -124.4 138.27 54.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.536 -0.756 . . . . 61.140000000000001 111.517 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.2 131.38 7.68 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 109.508 -1.437 . . . . 70.5 109.508 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.31 116.18 14.95 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 122.66 0.384 . . . . 60.119999999999997 110.976 -174.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.47 74.12 1.06 Allowed Glycine 0 N--CA 1.465 0.614 0 C-N-CA 120.079 -1.058 . . . . 50.420000000000002 112.868 172.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' GLU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 236' ' ' ARG . 35.4 tt0 58.37 77.01 0.31 Allowed 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 125.753 1.621 . . . . 54.140000000000001 110.465 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 25.7 m -121.91 143.76 49.26 Favored 'General case' 0 N--CA 1.39 -3.426 0 CA-C-N 114.977 -1.01 . . . . 70.5 109.049 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -122.51 126.15 47.23 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.001 -1.481 . . . . 70.430000000000007 107.001 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 53.2 t -124.13 126.23 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.018 0 O-C-N 123.878 0.736 . . . . 73.239999999999995 109.389 -174.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' LEU . . . . . 0.491 HD23 ' HG2' ' B' ' 240' ' ' GLN . 17.7 tp -122.31 121.47 36.81 Favored 'General case' 0 C--N 1.267 -3.008 0 C-N-CA 118.758 -1.177 . . . . 70.430000000000007 110.749 174.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' ILE . . . . . 0.449 HD11 HG11 ' A' ' 267' ' ' VAL . 74.6 mt -109.75 103.93 16.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.489 -0.93 . . . . 75.200000000000003 108.489 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLY . . . . . 0.519 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 139.64 -141.04 11.29 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.614 -0.803 . . . . 54.020000000000003 112.717 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 44.8 t-20 -123.69 140.08 53.35 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.363 -0.977 . . . . 55.520000000000003 108.363 -176.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.435 ' HG2' ' HB ' ' A' ' 244' ' ' VAL . 0.0 OUTLIER -123.72 119.91 31.16 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.487 -0.931 . . . . 70.530000000000001 108.487 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 281' ' ' TYR . . . . . 0.483 ' O ' HG22 ' A' ' 246' ' ' THR . 22.1 m-85 -103.72 121.78 43.71 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.037 -1.838 . . . . 62.329999999999998 106.037 174.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 110.98 -51.7 0.68 Allowed Glycine 0 N--CA 1.423 -2.193 0 N-CA-C 110.077 -1.209 . . . . 61.420000000000002 110.077 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.525 ' C ' ' HD2' ' A' ' 284' ' ' LYS . . . 84.04 3.45 89.06 Favored Glycine 0 C--O 1.223 -0.567 0 CA-C-O 121.241 0.356 . . . . 62.509999999999998 112.269 177.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.525 ' HD2' ' C ' ' A' ' 283' ' ' GLY . 3.6 mptp? -135.52 18.12 3.35 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.148 0.499 . . . . 75.409999999999997 110.27 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -90.51 -39.72 5.87 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.615 -0.994 . . . . 55.340000000000003 110.615 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 240' ' ' GLN . 29.1 t80 -79.95 -37.49 34.35 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 112.134 0.42 . . . . 73.200000000000003 112.134 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 113.675 0.991 . . . . 74.129999999999995 113.675 -175.859 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 225' ' ' ARG . . . . . 0.422 ' HA ' ' CG2' ' A' ' 261' ' ' THR . 13.8 ptt180 . . . . . 0 N--CA 1.439 -0.986 0 N-CA-C 109.762 -0.458 . . . . 73.439999999999998 109.762 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 226' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 6.4 t30 -116.55 114.65 24.45 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.08 -0.711 . . . . 64.239999999999995 109.08 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 11.1 p -139.48 137.62 35.7 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 112.644 0.609 . . . . 74.510000000000005 112.644 -177.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 228' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -126.53 137.24 53.34 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.819 -1.082 . . . . 73.109999999999999 108.49 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -87.19 -66.67 0.89 Allowed 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.154 -0.619 . . . . 73.540000000000006 110.418 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -127.0 138.61 53.28 Favored 'General case' 0 C--O 1.264 1.822 0 CA-C-O 121.401 0.619 . . . . 63.25 109.561 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 231' ' ' ILE . . . . . 0.49 HG21 HG21 ' B' ' 239' ' ' VAL . 8.7 mt -131.48 117.39 35.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.495 -1.298 . . . . 75.209999999999994 107.495 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -116.46 115.65 26.2 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 110.01 -0.367 . . . . 72.540000000000006 110.01 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 233' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 22.3 p -114.31 127.54 55.91 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.167 -1.42 . . . . 62.409999999999997 107.167 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -143.31 138.66 29.68 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 109.434 -0.58 . . . . 43.149999999999999 109.434 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 235' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' B' ' 271' ' ' GLY . 33.2 tt0 62.59 91.32 0.07 Allowed 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 124.778 1.299 . . . . 64.420000000000002 112.569 171.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 65.59 34.85 7.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.22 -0.659 . . . . 64.540000000000006 109.22 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 237' ' ' ALA . . . . . 0.619 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -101.54 149.26 24.28 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 122.696 1.236 . . . . 73.420000000000002 113.744 -172.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 238' ' ' ARG . . . . . 0.459 ' HD2' ' C ' ' B' ' 237' ' ' ALA . 3.7 mpt_? -134.35 136.37 43.37 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.12 -1.437 . . . . 62.149999999999999 107.12 175.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 239' ' ' VAL . . . . . 0.49 HG21 HG21 ' B' ' 231' ' ' ILE . 12.1 p -137.17 137.83 46.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-O 121.696 0.76 . . . . 62.020000000000003 109.882 176.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.634 ' HB2' ' CD1' ' B' ' 286' ' ' PHE . 16.5 tm0? -118.29 132.49 56.29 Favored 'General case' 0 N--CA 1.39 -3.469 0 N-CA-C 105.068 -2.197 . . . . 62.409999999999997 105.068 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 241' ' ' LEU . . . . . 0.42 ' CD1' HD22 ' A' ' 262' ' ' ASN . 0.8 OUTLIER -130.32 116.3 18.13 Favored 'General case' 0 C--N 1.263 -3.195 0 N-CA-C 106.957 -1.497 . . . . 74.450000000000003 106.957 178.21 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 242' ' ' GLY . . . . . 0.522 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 130.91 -114.15 1.53 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 115.882 -0.599 . . . . 73.099999999999994 112.165 -176.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 243' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 6.8 t30 -144.74 145.75 31.85 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.379 0.59 . . . . 74.099999999999994 110.635 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 244' ' ' VAL . . . . . 0.461 ' CG2' ' HG3' ' B' ' 240' ' ' GLN . 69.0 t -132.69 126.71 54.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 N-CA-C 109.571 -0.529 . . . . 71.140000000000001 109.571 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 245' ' ' VAL . . . . . 0.5 ' HA ' ' HB2' ' B' ' 281' ' ' TYR . 2.7 p -123.86 111.74 30.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.967 -1.123 . . . . 75.209999999999994 107.967 169.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 246' ' ' THR . . . . . 0.461 HG22 ' HA3' ' B' ' 282' ' ' GLY . 8.8 t -83.12 160.77 21.8 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.069 -1.052 . . . . 75.200000000000003 111.459 -176.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 247' ' ' ALA . . . . . 0.53 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.71 -36.12 82.81 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 122.386 1.089 . . . . 54.119999999999997 109.699 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.3 -35.55 73.97 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 113.243 -1.799 . . . . 75.150000000000006 111.6 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 249' ' ' ALA . . . . . 0.46 ' HA ' ' CB ' ' C' ' 247' ' ' ALA . . . -74.7 -26.84 60.1 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.387 -0.37 . . . . 45.409999999999997 110.863 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 52.8 tp . . . . . 0 N--CA 1.439 -0.994 0 CA-C-O 122.062 0.934 . . . . 73.109999999999999 111.976 -175.564 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.417 -2.088 0 CA-C-O 121.321 0.582 . . . . 51.32 112.2 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 261' ' ' THR . . . . . 0.553 HG23 ' HA ' ' C' ' 225' ' ' ARG . 5.1 t -104.7 108.13 19.43 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 105.798 -1.927 . . . . 63.420000000000002 105.798 167.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 262' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 6.4 t30 -116.09 131.18 57.01 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.328 -0.851 . . . . 63.210000000000001 110.902 -172.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -140.97 123.2 15.71 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.163 0.506 . . . . 62.409999999999997 110.529 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 264' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 11.7 p -124.95 152.11 31.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.662 -0.866 . . . . 71.040000000000006 108.662 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 265' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 28.8 tt0 -103.2 -56.77 2.16 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 119.273 -0.971 . . . . 73.430000000000007 112.045 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' C' ' 230' ' ' ASP . 29.5 m -135.86 127.13 28.27 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.029 -1.068 . . . . 73.319999999999993 111.35 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 267' ' ' VAL . . . . . 0.42 ' CG2' HG23 ' B' ' 231' ' ' ILE . 21.6 m -123.62 134.3 66.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.138 -0.689 . . . . 70.310000000000002 109.138 171.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 29.3 m -127.69 134.6 65.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.99 -0.55 . . . . 74.120000000000005 110.514 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.57 131.58 5.57 Favored Glycine 0 CA--C 1.476 -2.405 0 C-N-CA 119.254 -1.451 . . . . 50.399999999999999 112.621 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 270' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 62.9 tttp -135.57 144.9 46.45 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.278 0.634 . . . . 72.120000000000005 110.864 176.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 271' ' ' GLY . . . . . 0.418 ' H ' ' HB3' ' B' ' 235' ' ' GLU . . . 81.02 52.73 4.19 Favored Glycine 0 CA--C 1.486 -1.78 0 C-N-CA 120.877 -0.677 . . . . 62.030000000000001 112.238 173.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 65.11 89.18 0.1 Allowed 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.548 1.139 . . . . 75.230000000000004 109.835 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 273' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 21.0 m -121.75 144.12 48.98 Favored 'General case' 0 N--CA 1.405 -2.695 0 C-N-CA 119.652 -0.819 . . . . 62.130000000000003 110.162 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 29.0 mmt-85 -117.22 126.8 53.35 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 104.48 -2.415 . . . . 75.140000000000001 104.48 171.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 275' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 62.0 t -132.63 123.94 50.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 108.772 -0.825 . . . . 70.129999999999995 108.772 -178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 8.7 tt -120.48 128.39 53.1 Favored 'General case' 0 C--N 1.268 -2.946 0 C-N-CA 117.595 -1.642 . . . . 74.409999999999997 110.693 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 277' ' ' ILE . . . . . 0.483 HG23 HD12 ' C' ' 241' ' ' LEU . 50.7 mt -112.58 102.63 14.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 106.467 -1.679 . . . . 75.319999999999993 106.467 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 278' ' ' GLY . . . . . 0.591 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 144.09 -136.02 6.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.69 -1.243 . . . . 73.349999999999994 114.245 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 279' ' ' ASN . . . . . 0.406 ' HB3' ' OD1' ' B' ' 243' ' ' ASN . 1.5 t30 -127.3 141.42 51.72 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.88 -1.156 . . . . 75.109999999999999 107.88 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.01 120.07 22.95 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.818 -0.808 . . . . 63.329999999999998 108.818 -177.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 281' ' ' TYR . . . . . 0.5 ' HB2' ' HA ' ' B' ' 245' ' ' VAL . 97.2 m-85 -103.31 122.38 44.68 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 106.713 -1.588 . . . . 74.129999999999995 106.713 174.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 282' ' ' GLY . . . . . 0.461 ' HA3' HG22 ' B' ' 246' ' ' THR . . . 110.71 -51.73 0.68 Allowed Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.828 -0.909 . . . . 63.219999999999999 110.828 -176.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 283' ' ' GLY . . . . . 0.446 ' C ' ' HD2' ' B' ' 284' ' ' LYS . . . 88.41 -8.4 78.93 Favored Glycine 0 C--N 1.314 -0.656 0 N-CA-C 111.618 -0.593 . . . . 54.240000000000002 111.618 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 284' ' ' LYS . . . . . 0.446 ' HD2' ' C ' ' B' ' 283' ' ' GLY . 4.0 mptp? -124.97 17.53 8.53 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 120.913 0.387 . . . . 74.439999999999998 110.681 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -81.49 -60.03 2.28 Favored Glycine 0 N--CA 1.418 -2.507 0 N-CA-C 109.098 -1.601 . . . . 71.140000000000001 109.098 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 286' ' ' PHE . . . . . 0.634 ' CD1' ' HB2' ' B' ' 240' ' ' GLN . 28.1 t80 -67.4 -39.4 85.55 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 124.393 0.702 . . . . 65.129999999999995 112.228 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 9.9 m-90 . . . . . 0 C--N 1.307 -1.27 0 N-CA-C 114.143 1.164 . . . . 72.099999999999994 114.143 -176.279 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 225' ' ' ARG . . . . . 0.553 ' HA ' HG23 ' B' ' 261' ' ' THR . 14.5 ptt-85 . . . . . 0 CA--C 1.492 -1.275 0 N-CA-C 110.106 -0.331 . . . . 72.409999999999997 110.106 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 226' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 7.0 t30 -116.81 114.22 23.64 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.451 -1.314 . . . . 62.020000000000003 107.451 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 227' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' C' ' 263' ' ' SER . 12.9 t -135.16 137.64 42.93 Favored 'General case' 0 N--CA 1.411 -2.408 0 CA-C-O 121.226 0.536 . . . . 70.040000000000006 109.931 -175.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 228' ' ' ALA . . . . . 0.664 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -132.44 135.01 45.78 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.24 -1.392 . . . . 72.409999999999997 107.24 177.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 229' ' ' LYS . . . . . 0.408 ' HD2' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -85.75 -57.12 3.17 Favored 'General case' 0 C--N 1.287 -2.145 0 C-N-CA 119.793 -0.763 . . . . 64.25 109.828 -178.163 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 230' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' C' ' 266' ' ' THR . 30.8 t70 -139.36 138.96 37.05 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.992 0.425 . . . . 75.109999999999999 110.651 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 231' ' ' ILE . . . . . 0.467 HG23 ' CG2' ' C' ' 267' ' ' VAL . 6.0 mt -137.28 117.64 16.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.18 -1.044 . . . . 73.450000000000003 108.18 -176.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -111.81 117.17 32.09 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.084 0.469 . . . . 71.319999999999993 111.233 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 233' ' ' THR . . . . . 0.463 ' HB ' ' CB ' ' C' ' 237' ' ' ALA . 15.7 p -110.53 128.32 55.58 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.56 -0.745 . . . . 63.200000000000003 109.569 176.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 234' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 28.6 tt0 -143.21 137.01 28.68 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.244 -1.021 . . . . 64.319999999999993 108.244 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 235' ' ' GLU . . . . . 0.432 ' HB2' ' H ' ' C' ' 271' ' ' GLY . 53.9 mt-10 57.81 106.18 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.14 1.533 . . . . 72.200000000000003 115.14 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 236' ' ' ARG . . . . . 0.559 ' HB2' ' HA ' ' C' ' 272' ' ' GLU . 5.5 mpt_? 59.34 33.07 22.31 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.242 -0.651 . . . . 53.43 109.242 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 237' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -96.38 138.14 34.42 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 113.755 1.02 . . . . 74.329999999999998 113.755 -168.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 238' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 5.0 mpt_? -133.45 134.73 43.93 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.022 -1.103 . . . . 71.140000000000001 108.022 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 239' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' C' ' 275' ' ' VAL . 17.3 m -138.01 145.81 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 CA-C-O 122.065 0.936 . . . . 72.030000000000001 111.02 171.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 240' ' ' GLN . . . . . 0.524 ' HB2' ' CD1' ' C' ' 286' ' ' PHE . 0.0 OUTLIER -126.06 122.86 37.02 Favored 'General case' 0 C--N 1.26 -3.284 0 N-CA-C 104.425 -2.435 . . . . 73.230000000000004 104.425 176.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 241' ' ' LEU . . . . . 0.483 HD12 HG23 ' B' ' 277' ' ' ILE . 0.8 OUTLIER -121.77 115.4 22.6 Favored 'General case' 0 C--N 1.26 -3.319 0 N-CA-C 106.992 -1.485 . . . . 55.340000000000003 106.992 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 242' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 131.14 -121.71 3.26 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 115.527 -0.76 . . . . 72.150000000000006 111.477 -174.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -145.1 141.34 28.73 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.035 0.917 . . . . 53.240000000000002 110.648 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 244' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' C' ' 280' ' ' GLU . 80.9 t -131.36 131.45 63.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 C-N-CA 123.334 0.654 . . . . 72.239999999999995 110.623 178.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 6.1 p -122.42 116.77 50.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.426 -1.694 . . . . 63.450000000000003 106.426 168.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 15.0 t -77.21 160.58 28.82 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.467 -1.293 . . . . 54.340000000000003 111.581 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 247' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.4 -39.17 93.33 Favored 'General case' 0 CA--C 1.492 -1.25 0 CA-C-N 115.715 -0.675 . . . . 75.109999999999999 109.525 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.67 -33.4 60.72 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.517 -1.674 . . . . 71.340000000000003 112.102 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.654 0 CA-C-N 116.382 -0.372 . . . . 72.349999999999994 111.268 179.286 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 261' ' ' THR . . . . . 0.542 ' HG1' ' N ' ' C' ' 225' ' ' ARG . 13.9 t . . . . . 0 N--CA 1.409 -2.502 0 N-CA-C 105.192 -2.151 . . . . 72.420000000000002 105.192 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -123.59 137.53 54.73 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.241 -0.89 . . . . 54.149999999999999 111.36 -166.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 263' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' C' ' 227' ' ' SER . 49.0 m -142.59 123.9 14.71 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.013 -0.736 . . . . 64.450000000000003 109.013 175.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.5 p -128.64 151.85 35.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.736 -0.468 . . . . 73.420000000000002 109.736 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.49 -80.21 0.19 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 109.421 -0.585 . . . . 71.239999999999995 109.421 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 266' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 8.1 t -139.22 129.29 25.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.751 -0.593 . . . . 75.420000000000002 109.995 -177.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 267' ' ' VAL . . . . . 0.467 ' CG2' HG23 ' C' ' 231' ' ' ILE . 27.0 m -120.78 135.3 61.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 116.254 -0.43 . . . . 72.340000000000003 110.033 177.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.25 140.98 45.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 116.357 -0.383 . . . . 72.310000000000002 110.604 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.43 131.53 6.11 Favored Glycine 0 CA--C 1.474 -2.483 0 N-CA-C 110.342 -1.103 . . . . 72.409999999999997 110.342 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -135.06 119.88 18.41 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.998 -1.112 . . . . 74.030000000000001 107.998 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 271' ' ' GLY . . . . . 0.432 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 80.95 76.95 1.02 Allowed Glycine 0 N--CA 1.465 0.608 0 C-N-CA 120.829 -0.7 . . . . 62.030000000000001 113.178 175.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 272' ' ' GLU . . . . . 0.559 ' HA ' ' HB2' ' C' ' 236' ' ' ARG . 45.8 mt-10 63.03 82.38 0.18 Allowed 'General case' 0 CA--C 1.48 -1.718 0 C-N-CA 124.689 1.196 . . . . 71.239999999999995 110.478 -178.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 273' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 51.7 m -125.48 143.71 50.87 Favored 'General case' 0 N--CA 1.399 -3.021 0 C-N-CA 119.036 -1.066 . . . . 64.230000000000004 109.9 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 274' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 79.0 mtt85 -136.61 126.05 25.07 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 104.148 -2.538 . . . . 74.519999999999996 104.148 174.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 275' ' ' VAL . . . . . 0.579 ' HB ' HG12 ' C' ' 239' ' ' VAL . 8.1 t -138.1 134.41 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 N-CA-C 108.012 -1.107 . . . . 54.210000000000001 108.012 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 8.9 tt -119.74 115.51 24.05 Favored 'General case' 0 N--CA 1.384 -3.767 0 C-N-CA 118.846 -1.141 . . . . 64.510000000000005 108.991 174.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.0 mp -93.59 102.43 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 104.52 -2.4 . . . . 73.200000000000003 104.52 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 278' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 139.21 -147.01 18.87 Favored Glycine 0 CA--C 1.49 -1.482 0 C-N-CA 119.317 -1.42 . . . . 72.319999999999993 113.888 -177.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -118.56 149.37 41.46 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.563 -1.273 . . . . 73.150000000000006 107.563 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 280' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' C' ' 244' ' ' VAL . 15.6 tm-20 -146.36 121.11 9.87 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.839 -1.911 . . . . 72.030000000000001 105.839 -176.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -104.12 125.05 50.13 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.58 -0.896 . . . . 75.239999999999995 108.58 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 119.46 -47.32 1.04 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 111.298 -0.721 . . . . 70.200000000000003 111.298 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 283' ' ' GLY . . . . . 0.508 ' C ' ' HD2' ' C' ' 284' ' ' LYS . . . 94.86 -9.71 70.58 Favored Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 111.022 -0.831 . . . . 53.409999999999997 111.022 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 284' ' ' LYS . . . . . 0.508 ' HD2' ' C ' ' C' ' 283' ' ' GLY . 13.4 mptt -126.92 6.35 6.61 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.766 -0.717 . . . . 73.140000000000001 112.69 -172.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -73.14 -57.96 4.94 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 119.802 -1.189 . . . . 50.310000000000002 112.182 -176.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 286' ' ' PHE . . . . . 0.524 ' CD1' ' HB2' ' C' ' 240' ' ' GLN . 23.0 t80 -75.67 -31.23 59.69 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.633 1.345 . . . . 74.439999999999998 114.633 -174.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 . . . . . 0 C--N 1.308 -1.218 0 N-CA-C 115.405 1.632 . . . . 64.510000000000005 115.405 -172.915 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.47 ' SD ' ' HG3' ' A' ' 218' ' ' LYS . 1.9 tmt? . . . . . 0 CA--C 1.518 -0.27 0 N-CA-C 107.031 -1.47 . . . . 75.129999999999995 107.031 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.47 ' HG3' ' SD ' ' A' ' 217' ' ' MET . 99.1 mttt -139.31 91.55 2.51 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.451 -1.314 . . . . 72.219999999999999 107.451 170.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.8 pt -122.88 136.5 59.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.756 0.789 . . . . 60.439999999999998 112.495 -174.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -121.21 -25.85 5.19 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.592 -1.185 . . . . 75.439999999999998 108.347 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -93.88 120.56 34.3 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.013 -1.106 . . . . 53.299999999999997 108.013 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 86.4 mt -83.61 138.64 18.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.685 0.755 . . . . 73.230000000000004 111.222 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.7 t -99.5 119.49 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.833 0 CA-C-N 114.963 -1.017 . . . . 63.109999999999999 108.369 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.462 ' HA2' ' HB ' ' A' ' 261' ' ' THR . . . 149.39 82.77 0.04 OUTLIER Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 109.637 -1.385 . . . . 72.230000000000004 109.637 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -106.4 139.59 40.64 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.21 0.448 . . . . 73.439999999999998 112.21 -174.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.536 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 9.2 t30 -104.39 120.56 41.49 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.055 -1.461 . . . . 75.439999999999998 107.055 167.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 42.5 m -121.59 146.18 47.23 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 120.838 0.352 . . . . 74.140000000000001 111.359 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 264' ' ' VAL . . . -138.66 144.58 39.72 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.548 -1.279 . . . . 72.420000000000002 107.548 175.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -97.71 -60.01 1.65 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.127 0.489 . . . . 72.420000000000002 110.176 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.95 139.45 50.05 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.892 -0.594 . . . . 74.120000000000005 110.812 -175.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 25.6 mt -136.15 131.82 49.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.002 -1.11 . . . . 53.340000000000003 108.002 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 31.2 ttm180 -129.09 116.52 19.4 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.666 -0.865 . . . . 65.219999999999999 108.666 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.449 HG21 ' HB ' ' A' ' 239' ' ' VAL . 12.4 p -119.57 127.42 52.96 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.171 -0.677 . . . . 43.409999999999997 109.171 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.41 ' HB2' ' HG3' ' A' ' 270' ' ' LYS . 43.9 mt-10 -135.86 144.24 45.51 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 116.592 -0.276 . . . . 72.129999999999995 111.063 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.551 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 41.6 mt-10 62.34 88.88 0.09 Allowed 'General case' 0 C--O 1.215 -0.715 0 O-C-N 124.908 1.38 . . . . 71.310000000000002 113.181 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.551 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.0 OUTLIER 59.45 21.72 10.17 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.868 0.867 . . . . 72.109999999999999 112.131 174.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.08 142.13 28.08 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.725 -0.472 . . . . 52.43 109.725 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -125.03 137.17 54.23 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.592 -0.521 . . . . 71.219999999999999 109.592 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 4.3 p -129.98 132.77 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 123.996 0.81 . . . . 73.25 111.285 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.511 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 57.9 tp60 -111.95 117.0 31.51 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 107.885 -1.154 . . . . 71.430000000000007 107.885 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.73 118.5 35.77 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.767 -0.827 . . . . 65.140000000000001 108.767 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.522 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 132.87 -114.23 1.38 Allowed Glycine 0 N--CA 1.439 -1.167 0 C-N-CA 120.679 -0.772 . . . . 73.120000000000005 113.203 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -145.4 139.19 26.76 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.452 -0.944 . . . . 73.340000000000003 108.452 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.445 HG11 ' HA3' ' A' ' 285' ' ' GLY . 27.0 t -123.57 114.56 42.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.965 -1.124 . . . . 64.329999999999998 107.965 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 80.4 t -111.13 119.79 60.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 109.367 -0.605 . . . . 70.349999999999994 109.367 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 28.5 m -88.44 158.01 18.49 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.211 -1.774 . . . . 64.439999999999998 106.211 172.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.42 87.58 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.392 0.515 . . . . 52.450000000000003 112.392 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.66 98.91 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.145 1.165 . . . . 72.530000000000001 114.145 -175.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -70.44 -45.51 65.67 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.877 0.37 . . . . 53.109999999999999 110.883 -175.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.5 pp -168.06 147.1 4.63 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 106.383 -1.71 . . . . 71.010000000000005 106.383 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -93.81 -63.53 1.19 Allowed 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.837 -0.745 . . . . 64.030000000000001 111.239 -173.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -133.14 50.35 0.88 Allowed Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 111.25 -0.74 . . . . 65.120000000000005 111.25 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 106.71 -109.78 3.16 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 120.642 -0.789 . . . . 62.219999999999999 113.384 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 254' ' ' ILE . 41.3 mm 70.85 82.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 124.637 1.175 . . . . 75.129999999999995 108.883 -172.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 63.92 179.06 0.17 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.723 -1.58 . . . . 72.120000000000005 109.581 -175.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.513 ' O ' ' HD2' ' B' ' 255' ' ' ARG . 22.8 pt -97.51 92.45 2.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 N-CA-C 107.038 -1.467 . . . . 74.299999999999997 107.038 168.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.3 t -64.92 -42.25 94.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.181 -0.918 . . . . 61.0 108.856 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.46 140.16 27.37 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.68 -1.146 . . . . 74.329999999999998 110.05 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -155.19 39.33 0.41 Allowed 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 125.571 1.548 . . . . 42.240000000000002 107.747 174.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 26.6 p -66.81 135.54 54.08 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.309 0.576 . . . . 74.230000000000004 110.749 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.462 ' HB ' ' HA2' ' A' ' 224' ' ' GLY . 6.0 t -92.87 127.13 38.26 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 121.566 0.698 . . . . 44.049999999999997 111.767 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 7.9 t30 -126.57 143.13 51.31 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.238 -1.023 . . . . 65.319999999999993 108.238 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.6 m -138.36 125.6 21.63 Favored 'General case' 0 C--N 1.29 -1.984 0 O-C-N 121.718 -0.614 . . . . 42.539999999999999 109.721 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.6 p -126.89 145.94 33.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.244 -0.65 . . . . 63.240000000000002 109.244 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 59.9 mt-10 -87.14 -79.11 0.28 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 119.755 -0.778 . . . . 73.420000000000002 110.364 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.2 t -116.65 132.02 56.8 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.641 0.734 . . . . 62.149999999999999 111.46 -174.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.88 124.77 47.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.151 -0.931 . . . . 62.520000000000003 110.405 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 4.0 p -127.25 129.06 70.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 116.056 -0.52 . . . . 74.030000000000001 111.421 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.09 131.06 8.04 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 109.469 -1.453 . . . . 61.329999999999998 109.469 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.41 ' HG3' ' HB2' ' A' ' 234' ' ' GLU . 45.4 tttm -134.19 120.67 20.34 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 120.142 -0.623 . . . . 52.240000000000002 111.583 -175.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.56 83.77 1.61 Allowed Glycine 0 C--N 1.306 -1.124 0 C-N-CA 120.33 -0.938 . . . . 53.420000000000002 112.974 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 55.19 28.26 10.84 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.68 1.592 . . . . 73.310000000000002 112.424 173.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 17.7 m -82.67 151.51 26.24 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.893 0.701 . . . . 72.129999999999995 112.893 -170.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -113.09 127.71 56.28 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.361 -0.836 . . . . 71.049999999999997 108.931 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.4 p -137.03 123.54 28.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.362 0.601 . . . . 73.0 110.572 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.1 tt -117.3 124.27 48.58 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.654 -1.239 . . . . 73.049999999999997 107.654 175.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.686 HG23 HD12 ' B' ' 241' ' ' LEU . 72.4 mt -113.17 103.7 15.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.14 -1.059 . . . . 70.109999999999999 108.14 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 141.65 -151.13 22.5 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 111.433 -0.667 . . . . 60.420000000000002 111.433 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -111.76 131.88 55.02 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 122.216 -0.579 . . . . 74.120000000000005 109.775 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 8.1 tp10 -113.97 118.57 34.53 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 124.401 1.08 . . . . 71.049999999999997 108.153 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -108.74 124.56 50.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.075 -1.083 . . . . 72.420000000000002 108.075 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.13 -52.71 0.64 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 111.323 -0.711 . . . . 60.420000000000002 111.323 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 88.13 18.37 55.87 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.335 -1.106 . . . . 61.020000000000003 110.335 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 284' ' ' LYS . 11.5 mmpt? -122.35 -2.35 9.03 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.598 -0.519 . . . . 72.140000000000001 109.598 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.445 ' HA3' HG11 ' A' ' 244' ' ' VAL . . . -78.56 -75.69 0.97 Allowed Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.269 -0.967 . . . . 32.310000000000002 113.507 -174.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.432 ' CB ' HD12 ' A' ' 276' ' ' LEU . 59.6 t80 -79.59 -35.02 40.29 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.797 -0.361 . . . . 63.140000000000001 111.634 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 30.0 p90 -127.55 -175.72 3.54 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.857 -0.794 . . . . 72.239999999999995 108.857 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -144.18 -177.85 5.66 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 103.512 -2.773 . . . . 71.150000000000006 103.512 171.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ASN . . . . . 0.485 ' HB3' ' OD2' ' B' ' 288' ' ' ASP . 21.6 m120 -78.58 153.86 30.81 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 118.405 0.548 . . . . 71.140000000000001 109.991 -175.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -120.01 -168.61 1.64 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.639 0.978 . . . . 62.200000000000003 113.639 -169.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -118.97 103.7 9.83 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 105.717 -1.957 . . . . 62.340000000000003 105.717 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' HIS . . . . . 0.536 ' CE1' ' HD2' ' C' ' 238' ' ' ARG . 54.3 t-80 -121.3 142.72 49.68 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.559 -0.904 . . . . 63.539999999999999 108.559 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -78.98 109.55 13.38 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.059 -1.089 . . . . 62.109999999999999 108.059 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . 0.284 29.3 m80 77.47 133.67 0.06 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 125.474 1.51 . . . . 72.420000000000002 112.841 -174.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' HIS . . . . . 0.449 ' C ' HH21 ' C' ' 238' ' ' ARG . 16.4 t60 . . . . . 0 C--N 1.293 -1.848 0 CA-C-N 113.376 -1.738 . . . . 45.140000000000001 108.431 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' MET . . . . . 0.412 ' HA ' ' OD1' ' C' ' 220' ' ' ASP . 25.4 ttt . . . . . 0 C--O 1.243 0.756 0 N-CA-C 108.584 -0.895 . . . . 63.450000000000003 108.584 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt 81.53 87.15 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.91 1.684 . . . . 73.310000000000002 110.034 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' ILE . . . . . 0.488 HG12 ' H ' ' B' ' 221' ' ' ALA . 13.1 tt -134.51 141.38 43.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.093 -0.958 . . . . 74.439999999999998 108.972 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 220' ' ' ASP . . . . . 0.539 ' CB ' ' HG2' ' C' ' 218' ' ' LYS . 6.9 p-10 -128.1 11.96 6.57 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.544 0.687 . . . . 74.140000000000001 110.433 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.488 ' H ' HG12 ' B' ' 219' ' ' ILE . . . -98.53 -159.93 0.77 Allowed 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.027 -0.988 . . . . 75.420000000000002 110.731 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 222' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' B' ' 257' ' ' SER . 75.5 mt -83.82 133.33 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.898 -0.592 . . . . 71.299999999999997 110.764 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 2.9 p -135.78 137.81 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.031 0 CA-C-N 115.316 -0.856 . . . . 74.209999999999994 108.72 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 135.27 99.09 0.59 Allowed Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 109.573 -1.411 . . . . 61.32 109.573 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -113.52 145.39 41.3 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.267 0.556 . . . . 71.129999999999995 112.238 -175.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 9.1 t30 -110.54 133.73 53.03 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.484 -2.043 . . . . 71.209999999999994 105.484 171.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 50.8 m -133.89 149.57 51.32 Favored 'General case' 0 C--N 1.281 -2.404 0 O-C-N 121.197 -0.939 . . . . 74.519999999999996 111.769 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.648 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -135.99 146.29 47.05 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.929 -1.137 . . . . 70.120000000000005 107.929 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 3.5 tmtm? -101.88 -57.93 1.98 Allowed 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.917 -0.771 . . . . 45.020000000000003 108.917 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -135.26 139.21 44.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.255 -0.43 . . . . 74.120000000000005 109.998 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.436 HD13 HD12 ' B' ' 277' ' ' ILE . 21.8 mt -135.9 127.62 44.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.254 -1.017 . . . . 73.549999999999997 108.254 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 38.1 ttm180 -125.95 115.61 20.2 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.636 -0.876 . . . . 73.010000000000005 108.636 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.418 HG21 ' CG1' ' B' ' 239' ' ' VAL . 81.7 p -110.75 126.49 54.64 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.173 -1.417 . . . . 64.430000000000007 107.173 176.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -133.29 138.86 46.6 Favored 'General case' 0 CA--C 1.493 -1.239 0 C-N-CA 120.34 -0.544 . . . . 73.340000000000003 109.753 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.588 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 43.1 mt-10 64.37 97.93 0.04 OUTLIER 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.758 1.392 . . . . 74.030000000000001 114.758 171.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.588 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.0 OUTLIER 57.71 29.25 17.04 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.57 0.748 . . . . 71.239999999999995 109.95 174.347 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.55 140.14 30.81 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-O 122.022 0.915 . . . . 75.349999999999994 110.984 -175.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.407 ' HD2' ' N ' ' B' ' 238' ' ' ARG . 0.5 OUTLIER -125.81 134.27 51.74 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 105.863 -1.903 . . . . 74.019999999999996 105.863 177.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.6 p -134.06 134.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.895 0.855 . . . . 42.0 111.097 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.548 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 35.4 tp60 -110.64 121.0 44.25 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 114.16 -1.382 . . . . 73.219999999999999 107.271 172.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.686 HD12 HG23 ' A' ' 277' ' ' ILE . 2.9 tm? -117.24 118.76 33.19 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 107.072 -1.455 . . . . 70.140000000000001 107.072 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.523 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 127.6 -109.51 1.06 Allowed Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.472 -0.871 . . . . 62.130000000000003 112.42 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.586 ' OD1' HG23 ' B' ' 245' ' ' VAL . 24.1 t-20 -144.4 146.58 32.59 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 122.286 -0.538 . . . . 71.439999999999998 110.699 -176.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.548 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 25.0 t -133.06 120.42 40.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.175 -1.046 . . . . 74.209999999999994 108.175 172.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.586 HG23 ' OD1' ' B' ' 243' ' ' ASN . 88.6 t -115.57 119.37 61.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.65 -0.5 . . . . 70.209999999999994 109.65 176.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 24.8 m -79.02 157.44 28.08 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 106.003 -1.851 . . . . 74.019999999999996 106.003 174.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -65.11 -46.36 81.36 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.99 0.9 . . . . 61.509999999999998 112.201 -176.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.29 74.33 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 113.831 -1.531 . . . . 72.049999999999997 113.576 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.711 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -70.48 -46.43 63.77 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.543 0.942 . . . . 71.430000000000007 113.543 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 44.2 tp -161.0 124.57 3.36 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.967 -0.693 . . . . 42.130000000000003 110.518 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -135.92 93.64 2.96 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.83 -0.623 . . . . 71.230000000000004 109.437 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 63.42 -138.94 43.39 Favored Glycine 0 C--O 1.243 0.699 0 CA-C-N 115.585 -0.734 . . . . 74.230000000000004 114.111 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 69.36 -166.16 48.69 Favored Glycine 0 C--O 1.244 0.762 0 CA-C-N 115.338 -0.431 . . . . 63.530000000000001 112.957 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 3.0 mp -91.29 74.74 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.277 -1.749 . . . . 74.450000000000003 106.277 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.513 ' HD2' ' O ' ' A' ' 256' ' ' ILE . 0.0 OUTLIER -94.0 -176.61 4.06 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.118 -1.401 . . . . 74.430000000000007 111.017 -175.341 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 256' ' ' ILE . . . . . 0.438 HG22 ' O ' ' C' ' 253' ' ' GLY . 22.0 pt -55.77 147.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 124.815 1.246 . . . . 74.109999999999999 111.669 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 257' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' B' ' 222' ' ' ILE . 68.7 m -141.79 21.39 2.15 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.603 -1.258 . . . . 74.430000000000007 107.603 174.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.424 ' OD1' ' HB2' ' C' ' 217' ' ' MET . 5.5 m-20 -144.16 133.31 22.95 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 105.026 -2.213 . . . . 62.049999999999997 105.026 -176.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 259' ' ' GLN . . . . . 0.471 ' NE2' HD11 ' C' ' 256' ' ' ILE . 23.1 mm-40 -143.26 167.15 22.82 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 123.344 0.403 . . . . 63.32 111.264 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 24.6 p -76.23 139.08 41.01 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.348 -0.842 . . . . 74.140000000000001 110.507 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 7.4 t -94.33 127.69 40.37 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-O 121.429 0.633 . . . . 34.539999999999999 110.857 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.513 ' HB3' ' OD1' ' B' ' 226' ' ' ASN . 54.5 t30 -126.66 143.56 51.19 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.127 -1.064 . . . . 74.510000000000005 108.127 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 263' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' C' ' 227' ' ' SER . 24.3 m -141.97 126.31 17.63 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 122.019 -0.426 . . . . 71.120000000000005 110.074 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.7 p -120.16 152.28 22.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 109.09 -0.708 . . . . 73.519999999999996 109.09 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.467 ' HA ' ' CB ' ' B' ' 229' ' ' LYS . 27.8 mt-10 -92.8 -86.42 0.25 Allowed 'General case' 0 N--CA 1.404 -2.768 0 C-N-CA 119.455 -0.898 . . . . 64.200000000000003 111.151 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 11.3 t -109.42 130.13 55.51 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.604 -0.839 . . . . 71.140000000000001 111.745 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.5 p -132.29 124.48 52.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.114 -0.948 . . . . 75.140000000000001 110.54 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 268' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 7.7 p -127.1 134.52 65.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 116.078 -0.51 . . . . 70.120000000000005 111.718 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.78 132.28 10.32 Favored Glycine 0 CA--C 1.479 -2.208 0 N-CA-C 110.062 -1.215 . . . . 41.439999999999998 110.062 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -133.59 116.66 16.15 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 120.778 0.323 . . . . 73.329999999999998 111.281 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.69 86.31 0.57 Allowed Glycine 0 C--O 1.25 1.123 0 C-N-CA 120.583 -0.818 . . . . 73.010000000000005 114.094 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 61.59 31.08 18.86 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.284 1.034 . . . . 73.019999999999996 111.961 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 24.5 m -83.25 145.64 29.01 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.575 0.702 . . . . 74.299999999999997 112.12 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.461 ' NH2' ' HA ' ' B' ' 287' ' ' TRP . 39.6 mtp180 -115.14 125.93 54.03 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.236 -2.135 . . . . 75.030000000000001 105.236 173.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 1.6 p -135.84 127.09 44.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-O 120.958 0.408 . . . . 64.409999999999997 110.498 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' B' ' 286' ' ' PHE . 5.5 tt -120.15 121.76 39.5 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.361 -1.348 . . . . 74.200000000000003 107.361 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.638 HG23 HD12 ' C' ' 241' ' ' LEU . 36.7 mt -113.06 103.72 15.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 N-CA-C 106.767 -1.568 . . . . 53.520000000000003 106.767 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 145.11 -147.54 18.76 Favored Glycine 0 N--CA 1.416 -2.637 0 C-N-CA 120.917 -0.658 . . . . 73.409999999999997 111.783 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -115.01 128.71 56.43 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 120.937 -0.305 . . . . 74.319999999999993 111.392 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.542 ' HG2' ' CZ2' ' B' ' 287' ' ' TRP . 9.7 tp10 -112.46 121.47 44.92 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.921 -1.14 . . . . 75.340000000000003 107.921 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.463 ' CD2' ' HB ' ' C' ' 245' ' ' VAL . 86.7 m-85 -111.53 124.03 51.45 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.378 -0.971 . . . . 73.230000000000004 108.378 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.29 -61.59 0.31 Allowed Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 111.014 -0.834 . . . . 74.319999999999993 111.014 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 283' ' ' GLY . . . . . 0.407 ' C ' ' HD2' ' B' ' 284' ' ' LYS . . . 94.53 26.02 14.44 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.314 -0.715 . . . . 74.450000000000003 111.314 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 284' ' ' LYS . . . . . 0.407 ' HD2' ' C ' ' B' ' 283' ' ' GLY . 3.2 mptp? -134.09 2.57 3.35 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 110.39 -0.226 . . . . 72.420000000000002 110.39 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 285' ' ' GLY . . . . . 0.495 ' HA3' HG11 ' B' ' 244' ' ' VAL . . . -78.53 -66.76 1.69 Allowed Glycine 0 N--CA 1.417 -2.633 0 C-N-CA 119.952 -1.118 . . . . 74.319999999999993 112.371 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.501 ' HB3' HD12 ' B' ' 276' ' ' LEU . 75.9 t80 -87.67 -37.84 16.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.914 0.709 . . . . 63.539999999999999 112.914 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.542 ' CZ2' ' HG2' ' B' ' 280' ' ' GLU . 20.8 p90 -109.2 152.91 24.53 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.86 0.689 . . . . 70.120000000000005 112.86 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 288' ' ' ASP . . . . . 0.485 ' OD2' ' HB3' ' A' ' 289' ' ' ASN . 5.2 p-10 -168.53 172.59 8.06 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.579 -1.192 . . . . 71.209999999999994 108.012 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -89.56 -67.3 0.85 Allowed 'General case' 0 C--N 1.31 -1.121 0 O-C-N 123.846 0.716 . . . . 64.420000000000002 111.589 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 290' ' ' HIS . . . . . 0.551 ' O ' ' HB3' ' C' ' 295' ' ' HIS . 14.5 t-80 -161.25 112.71 1.79 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.656 -0.498 . . . . 72.319999999999993 109.656 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -129.69 -168.91 2.02 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.629 0.252 . . . . 71.0 111.516 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -87.55 83.82 7.2 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 116.568 -0.287 . . . . 73.0 111.177 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 293' ' ' HIS . . . . . 0.417 ' HB3' ' O ' ' A' ' 289' ' ' ASN . 7.3 p80 -80.47 103.84 10.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.024 -1.102 . . . . 54.140000000000001 108.024 174.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -101.67 -10.26 20.17 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.476 -0.784 . . . . 65.109999999999999 112.366 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 40.0 m80 . . . . . 0 C--O 1.259 1.561 0 N-CA-C 107.562 -1.273 . . . . 71.109999999999999 107.562 173.466 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 217' ' ' MET . . . . . 0.569 ' HG3' ' H ' ' C' ' 218' ' ' LYS . 8.1 tpt . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.279 -1.378 . . . . 75.030000000000001 107.279 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 218' ' ' LYS . . . . . 0.569 ' H ' ' HG3' ' C' ' 217' ' ' MET . 87.3 mttt -84.81 15.23 4.05 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 113.764 1.024 . . . . 71.040000000000006 113.764 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 3.4 mp -83.17 122.74 37.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.856 -1.535 . . . . 75.120000000000005 106.856 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 220' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' B' ' 217' ' ' MET . 36.9 t70 -77.53 100.49 6.09 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.263 -0.426 . . . . 70.510000000000005 110.83 -176.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 78.84 132.29 0.05 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.929 1.691 . . . . 53.509999999999998 113.051 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 0.413 HG23 ' HA ' ' C' ' 257' ' ' SER . 45.1 mt -96.71 128.89 47.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.563 -0.744 . . . . 72.219999999999999 109.246 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 12.1 p -108.22 127.61 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.07 0 CA-C-N 115.733 -0.667 . . . . 75.019999999999996 109.229 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 135.2 89.64 0.31 Allowed Glycine 0 N--CA 1.434 -1.439 0 N-CA-C 109.447 -1.461 . . . . 75.129999999999995 109.447 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' C' ' 261' ' ' THR . 14.9 ptt180 -115.25 147.98 39.71 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.464 0.65 . . . . 73.530000000000001 111.102 -176.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 7.4 t30 -108.85 141.55 40.73 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.017 -2.216 . . . . 55.030000000000001 105.017 169.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' B' ' 263' ' ' SER . 54.0 m -139.8 139.48 36.41 Favored 'General case' 0 C--N 1.278 -2.542 0 O-C-N 121.818 -0.551 . . . . 62.109999999999999 110.889 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -127.45 143.19 51.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.782 -1.192 . . . . 62.140000000000001 107.782 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' C' ' 265' ' ' GLU . 9.3 tmtt? -102.77 -53.1 2.93 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.588 -0.523 . . . . 63.329999999999998 109.588 -174.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.21 137.96 43.14 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.248 -0.649 . . . . 64.200000000000003 109.248 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 33.5 mt -136.67 130.31 46.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.01 -1.107 . . . . 75.420000000000002 108.01 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -133.6 119.1 19.0 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.43 -0.952 . . . . 73.099999999999994 108.43 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 45.0 p -110.49 126.41 54.33 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.19 -1.411 . . . . 73.140000000000001 107.19 174.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -127.91 139.22 52.73 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 110.05 -0.352 . . . . 63.240000000000002 110.05 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.571 ' C ' ' HD3' ' C' ' 236' ' ' ARG . 62.5 mt-10 63.13 93.43 0.05 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.664 1.227 . . . . 74.140000000000001 114.218 170.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.571 ' HD3' ' C ' ' C' ' 235' ' ' GLU . 0.7 OUTLIER 56.37 26.91 11.22 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 123.889 0.875 . . . . 73.549999999999997 111.387 172.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -87.5 148.46 24.91 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.751 -0.659 . . . . 62.520000000000003 110.576 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.536 ' HD2' ' CE1' ' A' ' 292' ' ' HIS . 1.2 mpp_? -124.66 134.22 52.96 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.17 -1.418 . . . . 72.140000000000001 107.17 177.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 4.7 p -135.96 135.14 50.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.622 0.725 . . . . 71.239999999999995 111.188 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.501 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 36.4 tp60 -114.37 115.17 26.91 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-N 114.28 -1.327 . . . . 70.530000000000001 108.152 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.638 HD12 HG23 ' B' ' 277' ' ' ILE . 3.0 tm? -111.85 117.79 33.76 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 105.596 -2.002 . . . . 73.319999999999993 105.596 176.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.546 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 138.65 -130.62 4.99 Favored Glycine 0 CA--C 1.485 -1.837 0 C-N-CA 119.577 -1.297 . . . . 53.539999999999999 111.724 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -141.06 131.26 24.88 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 120.956 0.408 . . . . 70.340000000000003 109.911 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.501 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 21.4 t -114.52 129.87 69.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.668 -0.864 . . . . 73.310000000000002 108.668 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.463 ' HB ' ' CD2' ' B' ' 281' ' ' TYR . 95.8 t -122.11 118.53 55.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 109.195 -0.668 . . . . 64.219999999999999 109.195 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 21.4 m -79.43 159.42 27.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.949 -1.871 . . . . 74.109999999999999 105.949 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.711 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -62.63 -47.63 82.92 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-O 122.08 0.943 . . . . 64.230000000000004 110.772 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.88 -34.76 65.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 113.718 -1.583 . . . . 53.140000000000001 112.806 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -74.15 -45.31 49.57 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 113.74 1.015 . . . . 72.510000000000005 113.74 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 91.6 mt -150.11 107.71 3.66 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.671 0.619 . . . . 73.010000000000005 112.671 -174.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -108.93 -69.24 0.87 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.226 -1.027 . . . . 62.439999999999998 108.226 169.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -96.72 36.58 3.81 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.353 -0.84 . . . . 74.420000000000002 113.688 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 253' ' ' GLY . . . . . 0.438 ' O ' HG22 ' B' ' 256' ' ' ILE . . . -83.12 64.18 4.36 Favored Glycine 0 C--N 1.316 -0.564 0 N-CA-C 111.058 -0.817 . . . . 63.149999999999999 111.058 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 6.3 tp -80.41 66.58 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 113.367 0.877 . . . . 65.5 113.367 -175.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 154.94 108.91 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 127.605 2.362 . . . . 73.109999999999999 109.309 169.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 256' ' ' ILE . . . . . 0.471 HD11 ' NE2' ' B' ' 259' ' ' GLN . 9.8 pt -147.24 98.7 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.796 -1.187 . . . . 73.439999999999998 107.796 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 257' ' ' SER . . . . . 0.413 ' HA ' HG23 ' C' ' 222' ' ' ILE . 15.2 m -130.63 15.2 5.41 Favored 'General case' 0 C--O 1.254 1.294 0 C-N-CA 119.953 -0.699 . . . . 71.430000000000007 112.679 -171.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -147.25 94.49 2.4 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.169 0.985 . . . . 51.100000000000001 109.236 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -125.72 -178.05 4.13 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.827 -1.078 . . . . 62.240000000000002 111.719 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 5.6 m -77.07 138.98 39.87 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 123.768 0.827 . . . . 64.510000000000005 110.794 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 15.4 t -108.86 116.23 31.6 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-O 121.889 0.852 . . . . 63.439999999999998 110.169 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 9.0 t30 -127.77 126.7 42.25 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.808 -0.558 . . . . 62.119999999999997 111.661 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 68.4 m -121.43 134.39 55.09 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 122.126 -0.359 . . . . 33.240000000000002 110.731 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -128.32 150.55 34.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.166 -1.05 . . . . 53.219999999999999 108.166 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' C' ' 229' ' ' LYS . 49.1 mt-10 -91.11 -88.49 0.18 Allowed 'General case' 0 N--CA 1.419 -1.978 0 C-N-CA 119.374 -0.931 . . . . 71.5 111.045 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 5.8 t -107.78 132.65 53.17 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.652 -0.819 . . . . 72.25 111.914 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.02 131.34 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.162 -0.926 . . . . 73.400000000000006 109.119 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.79 135.76 62.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 116.104 -0.498 . . . . 74.209999999999994 110.652 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.04 9.86 Favored Glycine 0 CA--C 1.474 -2.511 0 N-CA-C 109.086 -1.605 . . . . 73.510000000000005 109.086 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -134.03 116.27 15.3 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 110.227 -0.286 . . . . 72.239999999999995 110.227 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.57 83.48 0.73 Allowed Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.513 -0.851 . . . . 75.129999999999995 114.217 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 60.44 33.88 20.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.409 1.084 . . . . 75.030000000000001 112.319 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 10.7 m -83.72 145.18 28.88 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.925 0.713 . . . . 52.240000000000002 112.925 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -105.87 128.13 53.56 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.486 -1.301 . . . . 74.439999999999998 107.486 168.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 7.5 p -139.22 127.59 27.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 120.974 0.416 . . . . 73.340000000000003 111.226 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.516 HD12 ' CB ' ' C' ' 286' ' ' PHE . 7.2 tt -117.19 120.35 38.02 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.41 -0.959 . . . . 74.310000000000002 108.41 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 28.2 mt -113.26 103.6 15.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 106.991 -1.485 . . . . 72.120000000000005 106.991 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 278' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 144.85 -146.04 16.02 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.764 -0.935 . . . . 44.399999999999999 110.764 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -115.45 133.25 56.21 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 110.1 -0.333 . . . . 74.140000000000001 110.1 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.416 ' HG2' ' CZ2' ' C' ' 287' ' ' TRP . 10.5 tp10 -113.35 118.21 33.93 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.869 -1.159 . . . . 75.409999999999997 107.869 177.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -108.86 124.94 51.42 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.325 0.583 . . . . 73.120000000000005 109.861 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 106.08 -38.59 3.23 Favored Glycine 0 N--CA 1.417 -2.602 0 CA-C-N 115.089 -0.96 . . . . 63.100000000000001 110.957 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 72.76 35.06 58.92 Favored Glycine 0 CA--C 1.489 -1.569 0 N-CA-C 109.507 -1.437 . . . . 53.350000000000001 109.507 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -146.88 -7.3 0.49 Allowed 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 114.851 -0.675 . . . . 71.519999999999996 109.906 -173.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 285' ' ' GLY . . . . . 0.457 ' HA3' HG11 ' C' ' 244' ' ' VAL . . . -76.45 -70.15 1.31 Allowed Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 120.789 -0.719 . . . . 72.150000000000006 112.843 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.516 ' CB ' HD12 ' C' ' 276' ' ' LEU . 70.9 t80 -77.07 -51.16 11.53 Favored 'General case' 0 CA--C 1.49 -1.355 0 C-N-CA 120.411 -0.516 . . . . 75.319999999999993 110.097 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.416 ' CZ2' ' HG2' ' C' ' 280' ' ' GLU 0.317 28.5 p90 -87.46 65.77 8.78 Favored 'General case' 0 N--CA 1.412 -2.348 0 C-N-CA 118.504 -1.278 . . . . 75.549999999999997 112.2 177.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.61 118.42 15.51 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 105.556 -2.016 . . . . 74.420000000000002 105.556 172.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -67.52 177.43 1.96 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.252 -0.885 . . . . 73.219999999999999 110.224 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -70.71 87.79 0.69 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.303 -0.628 . . . . 74.209999999999994 109.303 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -103.22 -28.69 11.74 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.908 -0.587 . . . . 72.040000000000006 110.215 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -114.37 86.59 2.46 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.214 -0.448 . . . . 72.420000000000002 111.179 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -88.25 -14.43 38.44 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.61 0.719 . . . . 51.310000000000002 109.88 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -81.01 0.28 36.41 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.021 -0.99 . . . . 70.329999999999998 112.052 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 295' ' ' HIS . . . . . 0.551 ' HB3' ' O ' ' B' ' 290' ' ' HIS . 25.6 m170 . . . . . 0 C--N 1.304 -1.374 0 CA-C-N 116.537 -0.301 . . . . 72.120000000000005 111.424 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 C--O 1.235 0.297 0 N-CA-C 109.867 -0.42 . . . . 72.409999999999997 109.867 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -147.58 83.56 1.54 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.518 -0.31 . . . . 60.140000000000001 111.066 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 13.7 tt -106.74 -9.05 10.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.351 -1.352 . . . . 64.239999999999995 107.351 172.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.49 111.66 4.24 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 113.639 -1.619 . . . . 73.239999999999995 108.738 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -158.29 165.17 35.46 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.54 -0.911 . . . . 45.549999999999997 108.54 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.475 HD13 HD22 ' A' ' 243' ' ' ASN . 7.1 tt -83.48 118.03 30.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.886 -0.783 . . . . 72.019999999999996 108.886 177.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.5 m -131.96 145.32 35.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.574 -0.739 . . . . 74.400000000000006 110.745 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 149.75 114.52 0.71 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 111.547 -0.621 . . . . 72.030000000000001 111.547 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 261' ' ' THR . 37.4 ttm180 -89.63 123.49 33.72 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.921 0.36 . . . . 73.430000000000007 110.235 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 34.1 t-20 -116.88 149.23 40.43 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.527 -0.916 . . . . 73.540000000000006 108.527 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.3 m -137.09 137.52 39.39 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.97 -0.752 . . . . 71.140000000000001 108.97 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 277' ' ' ILE . . . -137.17 132.06 33.42 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 110.109 -0.33 . . . . 53.240000000000002 110.109 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 5.2 tmmm? -90.87 -55.06 3.7 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.122 -0.49 . . . . 74.299999999999997 110.971 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -131.59 139.4 49.17 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.972 -0.381 . . . . 71.099999999999994 109.972 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 68.0 mt -137.29 121.03 22.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.546 -0.909 . . . . 74.239999999999995 108.546 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -131.27 129.21 41.25 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.325 0.583 . . . . 72.349999999999994 112.011 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.44 HG21 ' HB ' ' A' ' 239' ' ' VAL . 27.2 p -132.32 128.49 37.85 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.415 -0.811 . . . . 74.5 109.029 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -121.48 147.99 45.04 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 111.841 0.311 . . . . 72.530000000000001 111.841 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 67.07 -87.23 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.729 1.212 . . . . 73.310000000000002 113.859 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 25.0 mtm-85 -116.31 3.02 13.33 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.191 0.596 . . . . 72.129999999999995 110.487 -175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -69.64 136.71 51.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.308 -0.86 . . . . 75.450000000000003 111.33 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -125.45 135.38 52.28 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.36 -0.978 . . . . 74.200000000000003 108.36 -177.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.9 p -129.68 146.03 34.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.573 0.701 . . . . 62.329999999999998 110.809 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.53 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 51.1 tp60 -123.72 130.01 51.98 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 107.929 -1.137 . . . . 75.329999999999998 107.929 174.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -123.32 118.68 28.08 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.469 -0.937 . . . . 74.040000000000006 108.469 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.528 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 130.27 -114.12 1.58 Allowed Glycine 0 N--CA 1.433 -1.566 0 CA-C-N 115.825 -0.625 . . . . 75.219999999999999 111.618 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ASN . . . . . 0.475 HD22 HD13 ' A' ' 222' ' ' ILE . 28.8 p-10 -145.19 138.75 26.75 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 122.437 -0.449 . . . . 60.149999999999999 111.375 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 85.5 t -122.45 114.08 41.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.806 -1.553 . . . . 73.25 106.806 174.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.457 ' HA ' ' HB2' ' A' ' 281' ' ' TYR . 7.3 p -122.78 114.35 41.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 C-N-CA 120.334 -0.546 . . . . 72.239999999999995 110.607 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 22.8 m -79.92 158.9 26.54 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.826 -1.176 . . . . 74.230000000000004 107.826 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.97 -41.49 95.41 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.054 0.455 . . . . 34.229999999999997 111.368 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -35.9 67.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.408 -1.269 . . . . 70.099999999999994 113.895 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -64.95 -26.28 68.23 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 122.766 0.426 . . . . 54.130000000000003 112.126 -176.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 61.9 tp 81.04 114.53 0.06 Allowed 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 125.039 1.336 . . . . 72.0 112.09 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -132.23 150.8 52.07 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.257 -0.883 . . . . 64.549999999999997 109.179 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.91 44.87 1.17 Allowed Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 111.45 -0.66 . . . . 75.530000000000001 111.45 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.15 -162.11 21.76 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 121.159 -0.544 . . . . 71.140000000000001 112.398 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 42.1 mm -118.13 130.99 72.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.191 -1.04 . . . . 52.240000000000002 108.191 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -105.53 -83.92 0.51 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.975 0.417 . . . . 73.219999999999999 111.006 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.6 tt -159.38 135.47 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.053 -1.462 . . . . 74.439999999999998 107.053 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.454 ' HB3' ' N ' ' A' ' 225' ' ' ARG . 48.3 m -80.14 84.15 5.9 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.755 0.788 . . . . 70.519999999999996 109.887 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -126.12 156.41 40.11 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.299 -1.319 . . . . 73.420000000000002 108.878 -175.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.446 HE22 ' HB3' ' C' ' 217' ' ' MET . 78.0 mm-40 72.19 -49.79 0.69 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.594 1.558 . . . . 71.0 112.771 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' B' ' 224' ' ' GLY . 36.5 m -90.24 117.64 29.14 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.534 -1.284 . . . . 74.400000000000006 107.534 170.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.555 ' HB ' ' HD2' ' B' ' 225' ' ' ARG . 29.3 m -138.46 123.06 18.57 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.177 -1.046 . . . . 72.430000000000007 108.177 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.546 ' O ' ' HA ' ' A' ' 226' ' ' ASN . 38.9 t-20 -126.15 136.77 53.27 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.14 -1.43 . . . . 54.240000000000002 107.14 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.6 m -138.15 134.53 34.69 Favored 'General case' 0 C--N 1.285 -2.21 0 O-C-N 122.077 -0.389 . . . . 75.129999999999995 110.289 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 13.1 p -128.43 141.88 45.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.211 0.529 . . . . 75.010000000000005 111.118 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.608 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 6.4 mm-40 -78.58 -72.18 0.39 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.652 -0.703 . . . . 54.149999999999999 110.961 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -128.8 127.84 42.76 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.854 -0.738 . . . . 62.310000000000002 112.713 -175.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.425 HG12 HD12 ' B' ' 231' ' ' ILE . 35.5 m -119.97 126.9 75.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.975 -0.557 . . . . 54.420000000000002 110.07 175.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.55 136.88 59.53 Favored 'Isoleucine or valine' 0 C--O 1.257 1.473 0 CA-C-O 121.358 0.599 . . . . 73.310000000000002 112.115 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.09 131.34 8.38 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.725 -1.35 . . . . 72.120000000000005 109.725 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -124.24 117.57 24.88 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.412 0.625 . . . . 75.129999999999995 111.536 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.24 -118.87 5.41 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.106 -1.198 . . . . 74.329999999999998 110.106 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -102.63 90.66 3.9 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.449 -1.315 . . . . 62.109999999999999 107.449 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 31.5 m -130.7 145.35 51.91 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.607 -1.179 . . . . 71.120000000000005 108.643 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ARG . . . . . 0.529 ' HB2' ' HG3' ' B' ' 238' ' ' ARG . 94.0 mtt180 -130.45 127.51 39.39 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.445 -1.302 . . . . 74.120000000000005 108.225 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.5 p -132.76 130.38 59.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.961 0.886 . . . . 64.349999999999994 111.327 -173.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.6 tt -117.51 126.13 52.06 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.972 -1.122 . . . . 72.450000000000003 107.972 176.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.454 HG21 ' HB2' ' A' ' 228' ' ' ALA . 34.6 mm -112.68 103.51 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 107.075 -1.454 . . . . 61.420000000000002 107.075 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.625 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 150.44 -141.17 8.5 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.881 -1.152 . . . . 72.140000000000001 112.85 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -113.02 134.14 54.65 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.798 -1.186 . . . . 74.450000000000003 107.798 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.4 OUTLIER -129.74 120.36 24.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.966 0.889 . . . . 71.430000000000007 109.104 176.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.457 ' HB2' ' HA ' ' A' ' 245' ' ' VAL . 2.8 m-85 -113.97 124.65 52.67 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.858 -1.064 . . . . 73.010000000000005 108.951 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 129.72 -42.6 1.4 Allowed Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.841 -0.695 . . . . 74.0 112.407 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' B' ' 286' ' ' PHE . . . 100.61 -15.95 58.12 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.81 -0.916 . . . . 54.509999999999998 110.81 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.07 83.96 2.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.002 -0.74 . . . . 70.129999999999995 109.002 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -84.88 -121.75 1.02 Allowed Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.653 -0.703 . . . . 73.430000000000007 112.312 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -87.98 15.89 6.69 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.104 0.478 . . . . 75.010000000000005 110.223 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.428 ' CH2' ' HB2' ' A' ' 276' ' ' LEU . 78.0 m95 -65.96 -16.52 63.95 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 114.686 1.365 . . . . 74.420000000000002 114.686 -170.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.503 ' HB3' ' NH1' ' A' ' 274' ' ' ARG . 1.3 t70 70.73 132.18 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.006 0.816 . . . . 75.230000000000004 112.361 -177.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -130.91 34.88 4.02 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.13 -1.063 . . . . 71.230000000000004 108.13 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -82.56 -22.39 34.92 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.883 -1.155 . . . . 73.439999999999998 107.883 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -89.5 107.81 19.29 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.74 -1.118 . . . . 73.450000000000003 108.716 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -110.63 117.53 33.74 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 110.009 -0.367 . . . . 74.239999999999995 110.009 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -84.09 85.8 7.29 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.673 -0.811 . . . . 71.299999999999997 109.356 173.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -76.72 -69.98 0.48 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.739 -1.119 . . . . 74.340000000000003 108.57 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 30.6 m170 . . . . . 0 C--N 1.313 -1.015 0 N-CA-C 106.39 -1.708 . . . . 72.209999999999994 106.39 176.462 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 27.0 ptm . . . . . 0 CA--C 1.514 -0.425 0 N-CA-C 109.4 -0.593 . . . . 72.099999999999994 109.4 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -84.31 102.39 12.66 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.661 -1.237 . . . . 72.319999999999993 107.661 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 10.6 tt -123.19 -65.63 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 113.712 1.004 . . . . 62.450000000000003 113.712 -176.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' ASP . . . . . 0.537 ' HA ' ' HA3' ' B' ' 253' ' ' GLY . 33.3 t70 -108.29 133.07 53.03 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.303 0.482 . . . . 62.409999999999997 112.303 -171.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -175.32 -169.99 0.41 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.643 1.177 . . . . 65.030000000000001 108.517 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' ILE . . . . . 0.551 HG13 ' CZ ' ' B' ' 281' ' ' TYR . 8.4 tt -105.83 130.73 56.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.661 -0.866 . . . . 72.129999999999995 108.661 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 19.1 m -124.82 159.96 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 112.282 0.475 . . . . 61.310000000000002 112.282 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 260' ' ' THR . . . 145.83 127.87 1.93 Allowed Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.86 -0.496 . . . . 44.340000000000003 111.86 176.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.555 ' HD2' ' HB ' ' A' ' 261' ' ' THR . 8.1 tpt180 -106.64 117.6 34.48 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.524 -1.287 . . . . 74.409999999999997 107.524 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.594 HD21 HG22 ' B' ' 277' ' ' ILE . 7.3 t30 -120.95 144.56 48.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 120.747 0.308 . . . . 55.130000000000003 111.79 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 227' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' B' ' 263' ' ' SER . 50.5 m -136.33 136.96 40.14 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.179 -0.674 . . . . 70.420000000000002 109.179 173.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.03 142.94 49.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.537 -0.542 . . . . 61.009999999999998 109.537 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.608 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 2.3 tmmm? -100.69 -64.1 1.07 Allowed 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 120.393 -0.523 . . . . 73.299999999999997 110.267 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -127.85 138.33 52.66 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 108.959 -0.756 . . . . 73.430000000000007 108.959 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.425 HD12 HG12 ' A' ' 267' ' ' VAL . 16.9 mt -135.57 119.91 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.095 -0.705 . . . . 73.010000000000005 109.095 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -123.23 115.71 22.18 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.873 0.368 . . . . 73.299999999999997 110.651 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 52.6 p -111.69 127.66 55.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.625 -1.25 . . . . 73.099999999999994 107.625 175.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -130.18 149.68 51.77 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.457 -0.497 . . . . 73.450000000000003 111.028 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . 0.251 33.5 mt-10 75.87 -74.16 0.08 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 115.733 1.753 . . . . 64.129999999999995 115.733 170.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.26 24.72 2.3 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.334 -0.987 . . . . 75.209999999999994 108.334 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -84.91 142.93 29.34 Favored 'General case' 0 C--O 1.275 2.444 0 CA-C-O 122.954 1.359 . . . . 75.340000000000003 113.895 -172.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.529 ' HG3' ' HB2' ' A' ' 274' ' ' ARG . 3.7 mpt_? -125.93 135.21 51.61 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.487 -1.233 . . . . 62.039999999999999 110.845 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.515 HG13 HG23 ' A' ' 275' ' ' VAL . 14.1 p -134.29 143.4 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.201 1.001 . . . . 74.099999999999994 110.51 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.56 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 4.8 tp-100 -121.12 125.17 46.56 Favored 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 114.108 -1.405 . . . . 64.200000000000003 107.857 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.407 HD12 HG23 ' A' ' 277' ' ' ILE . 3.2 tm? -119.16 117.04 27.6 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.176 -1.787 . . . . 61.200000000000003 106.176 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 139.05 -121.33 2.08 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 110.487 -1.045 . . . . 61.200000000000003 110.487 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -145.34 139.1 26.79 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.932 0.366 . . . . 71.120000000000005 110.853 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.56 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 44.8 t -122.41 122.61 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 107.989 -1.115 . . . . 73.409999999999997 107.989 175.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.516 HG21 ' O ' ' B' ' 250' ' ' LEU . 7.0 p -123.67 125.67 71.68 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 C-N-CA 120.052 -0.659 . . . . 75.109999999999999 110.89 175.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 2.1 m -81.88 160.82 23.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.393 -1.336 . . . . 63.049999999999997 107.393 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -61.97 -35.94 79.97 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 120.986 0.422 . . . . 74.519999999999996 111.636 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.33 -52.28 64.0 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.698 -1.137 . . . . 72.030000000000001 112.566 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.16 -46.42 34.38 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.707 -0.397 . . . . 20.41 110.414 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.516 ' O ' HG21 ' B' ' 245' ' ' VAL . 52.1 tp 65.53 -79.97 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.916 1.286 . . . . 70.049999999999997 113.138 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -143.72 167.78 21.46 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.869 -0.789 . . . . 74.040000000000006 108.869 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -156.16 67.32 0.3 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.54 -1.024 . . . . 70.420000000000002 110.54 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' B' ' 220' ' ' ASP . . . -117.13 149.79 18.63 Favored Glycine 0 N--CA 1.424 -2.113 0 C-N-CA 119.206 -1.473 . . . . 54.030000000000001 114.433 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 10.7 pt -168.93 -156.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 101.97 -3.345 . . . . 63.43 101.97 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -138.55 144.12 39.76 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 120.24 1.382 . . . . 75.209999999999994 110.163 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 6.9 tp -127.01 -56.54 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 O-C-N 123.756 0.66 . . . . 73.329999999999998 110.858 176.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 58.1 m -169.06 -61.28 0.02 OUTLIER 'General case' 0 C--O 1.242 0.666 0 C-N-CA 122.918 0.487 . . . . 55.149999999999999 111.559 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -152.39 -172.03 4.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 106.365 -1.717 . . . . 73.439999999999998 106.365 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -115.6 177.5 4.64 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 119.196 0.907 . . . . 61.409999999999997 112.376 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.483 ' OG1' HG12 ' C' ' 222' ' ' ILE . 86.1 m -82.25 131.55 35.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.116 -0.947 . . . . 73.219999999999999 108.92 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 29.1 m -126.58 112.88 16.03 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.92 -0.77 . . . . 70.510000000000005 108.92 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -121.05 138.18 54.3 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.936 -1.135 . . . . 60.450000000000003 107.936 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 263' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' C' ' 227' ' ' SER . 43.6 m -138.6 138.88 38.31 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 120.739 0.304 . . . . 54.039999999999999 110.219 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' C' ' 228' ' ' ALA . 12.5 p -128.51 150.33 34.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 120.87 0.367 . . . . 52.310000000000002 110.527 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 44.0 mm-40 -86.01 -76.21 0.35 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.834 -0.621 . . . . 71.109999999999999 110.691 174.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 27.8 m -128.81 127.87 42.8 Favored 'General case' 0 C--O 1.249 1.034 0 C-N-CA 119.931 -0.707 . . . . 63.229999999999997 112.454 -176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.412 HG12 ' HB ' ' C' ' 231' ' ' ILE . 35.1 m -118.46 129.31 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.696 -0.684 . . . . 62.509999999999998 109.265 175.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 8.8 p -127.58 128.87 70.11 Favored 'Isoleucine or valine' 0 C--O 1.266 1.922 0 CA-C-O 121.716 0.769 . . . . 70.340000000000003 112.237 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.91 132.82 10.93 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 110.46 -1.056 . . . . 61.109999999999999 110.46 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -124.09 121.29 34.77 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 122.472 0.309 . . . . 72.439999999999998 111.127 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.24 -130.0 9.42 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.65 -1.38 . . . . 44.109999999999999 109.65 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.93 98.4 11.35 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.653 -1.98 . . . . 52.240000000000002 105.653 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.4 t -130.03 143.03 50.57 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.989 -1.005 . . . . 72.349999999999994 108.764 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.549 ' HB2' ' HG3' ' C' ' 238' ' ' ARG . 76.3 mtt180 -131.3 127.05 36.91 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 118.565 -1.254 . . . . 73.329999999999998 108.376 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.0 p -135.9 132.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 115.094 -0.957 . . . . 73.219999999999999 110.918 -175.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.521 ' HB3' ' OE1' ' C' ' 240' ' ' GLN . 5.9 tt -119.96 125.41 48.34 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 107.546 -1.279 . . . . 63.310000000000002 107.546 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.594 HG22 HD21 ' B' ' 226' ' ' ASN . 30.0 mm -112.54 103.56 15.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 N-CA-C 106.772 -1.566 . . . . 74.140000000000001 106.772 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.567 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 147.21 -143.77 11.73 Favored Glycine 0 N--CA 1.427 -1.951 0 C-N-CA 120.422 -0.894 . . . . 51.549999999999997 113.829 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -108.76 132.25 54.15 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.721 -0.844 . . . . 53.0 108.721 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' C' ' 244' ' ' VAL . 0.0 OUTLIER -127.8 122.49 32.85 Favored 'General case' 0 C--O 1.265 1.88 0 CA-C-O 122.324 1.059 . . . . 73.299999999999997 108.593 177.39 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.551 ' CZ ' HG13 ' B' ' 222' ' ' ILE . 2.3 m-85 -120.52 124.11 44.57 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.407 -1.27 . . . . 71.299999999999997 107.7 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 128.94 -40.05 1.76 Allowed Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.333 -0.937 . . . . 31.399999999999999 111.524 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 283' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' C' ' 286' ' ' PHE . . . 97.01 -16.54 60.77 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 110.576 -1.01 . . . . 61.329999999999998 110.576 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.29 77.56 1.68 Allowed 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.208 -0.496 . . . . 73.099999999999994 110.577 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -76.3 -128.86 0.3 Allowed Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 115.013 -0.994 . . . . 43.119999999999997 112.007 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 5.0 p90 -81.99 13.55 3.29 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.484 0.659 . . . . 71.209999999999994 111.391 -175.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.465 ' CH2' ' HB2' ' B' ' 276' ' ' LEU . 39.9 m95 -74.1 -57.18 4.13 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.037 -0.528 . . . . 71.430000000000007 109.647 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 35.1 t70 56.18 101.0 0.01 OUTLIER 'General case' 0 C--O 1.254 1.336 0 C-N-CA 126.091 1.756 . . . . 63.32 114.339 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -63.96 149.62 46.87 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.745 -0.661 . . . . 64.230000000000004 109.716 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -153.59 30.35 0.47 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.279 1.038 . . . . 75.430000000000007 108.963 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 291' ' ' HIS . . . . . 0.493 ' HB3' ' CE1' ' B' ' 293' ' ' HIS . 46.9 m-70 -80.27 93.34 5.88 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.325 -1.307 . . . . 72.310000000000002 110.461 -177.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -80.55 -24.88 38.96 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.975 -0.557 . . . . 75.439999999999998 110.038 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 293' ' ' HIS . . . . . 0.493 ' CE1' ' HB3' ' B' ' 291' ' ' HIS . 29.9 m170 53.81 58.62 4.93 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.171 1.545 . . . . 62.420000000000002 115.171 176.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -150.24 144.99 25.95 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 123.222 0.609 . . . . 73.140000000000001 109.497 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 C--N 1.3 -1.58 0 N-CA-C 107.977 -1.12 . . . . 74.319999999999993 107.977 177.214 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 217' ' ' MET . . . . . 0.618 ' SD ' ' HG3' ' C' ' 218' ' ' LYS . 1.4 tmt? . . . . . 0 C--O 1.241 0.658 0 N-CA-C 107.431 -1.322 . . . . 73.040000000000006 107.431 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 218' ' ' LYS . . . . . 0.618 ' HG3' ' SD ' ' C' ' 217' ' ' MET . 68.7 mttm -138.03 111.04 7.76 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 104.438 -2.43 . . . . 62.329999999999998 104.438 169.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 69.9 mt 89.75 97.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 O-C-N 125.683 1.865 . . . . 64.150000000000006 106.378 -162.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -167.61 161.7 13.75 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 124.48 1.112 . . . . 72.25 109.888 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -162.85 -45.9 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.995 -1.113 . . . . 72.530000000000001 107.995 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 0.521 HG13 ' CE1' ' C' ' 281' ' ' TYR . 12.6 tt -89.38 115.98 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-N 114.101 -1.409 . . . . 72.450000000000003 109.741 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 35.2 m -112.42 156.21 13.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.916 -0.584 . . . . 72.140000000000001 109.981 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 224' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' B' ' 260' ' ' THR . . . 149.55 154.23 6.32 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.418 -1.073 . . . . 54.340000000000003 110.418 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' C' ' 261' ' ' THR . 28.4 ttt180 -138.56 119.48 14.31 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.023 -0.732 . . . . 74.099999999999994 109.023 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.568 HD21 HG22 ' C' ' 277' ' ' ILE . 7.2 t30 -118.78 148.97 42.26 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 116.182 -0.463 . . . . 65.129999999999995 110.475 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' C' ' 263' ' ' SER . 31.9 m -136.68 136.53 39.15 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.195 -1.039 . . . . 63.200000000000003 108.195 172.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.472 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -130.7 138.23 49.91 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.469 -0.567 . . . . 75.430000000000007 109.469 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 2.9 tmmm? -93.38 -64.22 1.12 Allowed 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.556 -0.458 . . . . 74.120000000000005 110.943 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 230' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' C' ' 266' ' ' THR . 28.4 t70 -127.37 137.79 52.85 Favored 'General case' 0 C--O 1.253 1.243 0 C-N-CA 120.1 -0.64 . . . . 63.539999999999999 109.682 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.412 ' HB ' HG12 ' B' ' 267' ' ' VAL . 31.3 mt -133.95 118.94 30.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.889 -0.782 . . . . 62.539999999999999 108.889 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -118.99 122.38 42.07 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.792 -0.448 . . . . 73.200000000000003 109.792 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 31.7 p -122.24 127.9 50.49 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.865 -0.791 . . . . 75.530000000000001 108.865 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -129.35 150.28 50.78 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 120.985 0.421 . . . . 53.5 111.596 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 74.42 -73.05 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.951 1.834 . . . . 71.510000000000005 115.951 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -139.53 29.81 2.15 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 107.498 -1.297 . . . . 70.439999999999998 107.498 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -91.3 137.6 32.24 Favored 'General case' 0 C--O 1.277 2.524 0 CA-C-O 122.571 1.177 . . . . 51.210000000000001 113.102 -173.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' B' ' 274' ' ' ARG . 2.9 mpt_? -125.7 134.71 51.72 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.891 -1.504 . . . . 72.140000000000001 109.426 176.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.523 HG23 HG13 ' C' ' 275' ' ' VAL . 8.5 p -133.42 139.4 49.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.832 0.825 . . . . 75.430000000000007 110.887 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.611 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 49.0 tp60 -114.85 118.89 34.79 Favored 'General case' 0 N--CA 1.401 -2.91 0 CA-C-N 114.228 -1.351 . . . . 64.140000000000001 108.425 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.437 HD12 HG23 ' B' ' 277' ' ' ILE . 3.2 tm? -111.74 118.77 36.52 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 105.416 -2.068 . . . . 72.209999999999994 105.416 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 135.97 -120.0 2.15 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.898 -1.281 . . . . 72.400000000000006 109.898 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 7.8 p30 -144.75 144.25 31.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 116.542 0.171 . . . . 55.100000000000001 111.156 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.611 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 48.9 t -124.08 114.64 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.595 0 N-CA-C 107.075 -1.454 . . . . 70.510000000000005 107.075 172.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' C' ' 281' ' ' TYR . 7.1 p -123.87 129.17 74.47 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 C-N-CA 119.298 -0.961 . . . . 70.239999999999995 111.098 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.5 m -88.91 159.2 17.79 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.219 -1.4 . . . . 73.400000000000006 107.219 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.79 94.37 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.726 0.774 . . . . 61.509999999999998 110.702 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.98 -34.27 63.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.111 -1.404 . . . . 64.209999999999994 112.464 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 249' ' ' ALA . . . . . 0.419 ' HB2' ' HA2' ' C' ' 282' ' ' GLY . . . -68.42 -31.53 70.93 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.297 0.851 . . . . 73.420000000000002 113.297 -175.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 89.4 mt -88.53 70.26 8.93 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.044 0.926 . . . . 64.010000000000005 113.042 -172.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -144.18 -51.41 0.31 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.941 -1.481 . . . . 71.319999999999993 107.098 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -100.63 176.73 27.7 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 110.375 -1.09 . . . . 72.530000000000001 110.375 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 98.52 93.87 2.0 Favored Glycine 0 C--N 1.306 -1.107 0 N-CA-C 109.589 -1.404 . . . . 73.230000000000004 109.589 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 62.3 mt -87.12 -41.3 14.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 120.486 0.184 . . . . 64.109999999999999 110.868 -174.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 67.74 174.87 0.26 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.769 0.828 . . . . 64.409999999999997 110.597 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 3.5 mp -108.32 -54.11 5.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.403 -1.332 . . . . 72.140000000000001 107.403 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 23.1 t 172.42 -32.69 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 105.367 -2.086 . . . . 73.349999999999994 105.367 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -34.86 106.67 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 113.212 -1.813 . . . . 70.140000000000001 114.724 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -87.59 96.51 10.44 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 105.523 -2.028 . . . . 64.010000000000005 105.523 168.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 5.3 m -63.35 121.37 13.59 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.616 -1.174 . . . . 75.299999999999997 108.903 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 21.8 m -107.34 108.56 20.0 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 109.275 -0.639 . . . . 73.140000000000001 109.275 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -111.04 141.12 44.95 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.207 -1.034 . . . . 53.520000000000003 108.207 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 263' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' C' ' 227' ' ' SER . 21.7 m -140.01 140.25 36.19 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 122.035 -0.416 . . . . 53.229999999999997 110.163 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.459 HG21 HG13 ' C' ' 267' ' ' VAL . 7.2 p -129.18 142.87 42.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 121.195 -0.202 . . . . 71.0 111.086 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 9.7 mm-40 -80.91 -52.73 7.14 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 111.798 0.295 . . . . 73.230000000000004 111.798 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 266' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 37.5 m -150.18 133.05 16.03 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.162 -0.615 . . . . 71.530000000000001 111.063 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.459 HG13 HG21 ' C' ' 264' ' ' VAL . 17.1 m -126.05 135.08 64.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 109.178 -0.675 . . . . 62.32 109.178 171.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.08 129.15 71.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 109.746 -0.464 . . . . 72.129999999999995 109.746 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.65 132.8 11.25 Favored Glycine 0 N--CA 1.428 -1.884 0 N-CA-C 108.37 -1.892 . . . . 74.120000000000005 108.37 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -128.24 117.05 20.82 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 120.925 0.393 . . . . 71.319999999999993 110.094 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.85 -136.23 17.2 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 109.811 -1.316 . . . . 50.119999999999997 109.811 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.3 96.52 6.66 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.342 -1.355 . . . . 74.040000000000006 107.342 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 273' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 51.0 m -134.99 145.04 47.72 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 115.254 -0.884 . . . . 62.119999999999997 109.502 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -135.21 126.59 28.46 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 107.05 -1.463 . . . . 73.109999999999999 107.05 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.523 HG13 HG23 ' C' ' 239' ' ' VAL . 6.2 p -139.33 139.65 38.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.874 -0.603 . . . . 75.209999999999994 110.301 -176.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 7.0 tt -123.2 122.35 38.19 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 107.71 -1.218 . . . . 65.439999999999998 107.71 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.568 HG22 HD21 ' C' ' 226' ' ' ASN . 42.8 mm -110.65 103.79 16.04 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.843 0 N-CA-C 106.791 -1.559 . . . . 62.140000000000001 106.791 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.06 -133.67 5.05 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 119.918 -1.134 . . . . 71.409999999999997 113.548 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 279' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 17.9 m120 -115.07 134.07 55.49 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 120.816 0.341 . . . . 72.140000000000001 110.201 -177.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.64 119.58 19.58 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.61 -1.256 . . . . 75.540000000000006 107.61 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.521 ' CE1' HG13 ' C' ' 222' ' ' ILE . 3.4 m-85 -119.17 124.91 47.95 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.488 -0.931 . . . . 74.109999999999999 108.488 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 282' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' C' ' 249' ' ' ALA . . . 136.2 -36.91 1.95 Allowed Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.195 -0.762 . . . . 43.140000000000001 111.195 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 100.03 -27.29 20.98 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.264 -1.134 . . . . 72.140000000000001 110.264 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -132.84 87.34 2.4 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.845 -1.169 . . . . 74.219999999999999 107.845 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -84.44 -130.31 2.0 Allowed Glycine 0 C--N 1.308 -0.991 0 C-N-CA 120.944 -0.646 . . . . 71.239999999999995 112.291 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' B' ' 283' ' ' GLY . 1.4 p90 -73.67 18.32 0.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.336 0.589 . . . . 64.340000000000003 112.007 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 53.3 m95 -79.04 32.36 0.21 Allowed 'General case' 0 C--O 1.244 0.768 0 O-C-N 121.407 -0.808 . . . . 73.430000000000007 110.304 -175.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 288' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' C' ' 286' ' ' PHE . 39.2 t70 -61.63 117.48 5.83 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.791 1.236 . . . . 74.310000000000002 111.127 -175.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 177.16 -34.49 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 105.024 -2.213 . . . . 74.450000000000003 105.024 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -78.4 127.62 32.46 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 105.989 -1.856 . . . . 72.510000000000005 105.989 170.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 35.5 m80 59.15 61.07 2.18 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 124.188 0.93 . . . . 64.420000000000002 110.456 -172.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -80.88 119.62 23.66 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.378 0.609 . . . . 73.140000000000001 110.431 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -122.05 107.72 12.53 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.414 -0.812 . . . . 64.120000000000005 109.925 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -143.89 -69.77 0.31 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.872 -1.529 . . . . 71.140000000000001 106.872 176.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 126.929 2.092 . . . . 75.25 114.325 173.738 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.585 ' HA ' ' OD2' ' B' ' 220' ' ' ASP . 24.3 ptm . . . . . 0 CA--C 1.517 -0.322 0 CA-C-O 121.644 0.735 . . . . 74.099999999999994 111.263 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -89.25 -63.14 1.33 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 109.108 -0.701 . . . . 73.299999999999997 109.108 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.8 mt 53.63 84.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 1.0 0 O-C-N 124.275 0.985 . . . . 62.409999999999997 112.248 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -102.76 113.84 27.58 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 120.824 0.345 . . . . 65.409999999999997 110.773 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -86.11 67.26 9.92 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.687 0.756 . . . . 71.219999999999999 110.32 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 60.8 mt -116.19 133.34 63.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.12 -1.067 . . . . 45.219999999999999 108.12 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.9 119.06 48.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 120.291 -0.563 . . . . 71.420000000000002 111.82 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 45.68 67.91 1.15 Allowed Glycine 0 N--CA 1.469 0.852 0 N-CA-C 116.164 1.226 . . . . 54.229999999999997 116.164 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -109.83 134.16 52.35 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.069 -1.052 . . . . 70.25 110.637 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -104.3 141.0 37.07 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.132 -1.433 . . . . 71.140000000000001 107.132 172.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.6 m -121.52 137.1 54.87 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.982 -0.377 . . . . 74.329999999999998 109.982 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.74 119.65 32.35 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.075 -1.454 . . . . 43.009999999999998 107.075 176.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -88.69 -41.31 12.67 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 116.206 -0.452 . . . . 63.009999999999998 110.807 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -140.71 138.99 34.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.915 0.388 . . . . 65.140000000000001 110.352 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.6 mt -131.41 121.85 49.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 107.673 -1.232 . . . . 64.230000000000004 107.673 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 60.4 ttt180 -132.58 115.1 15.03 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.493 0.663 . . . . 73.349999999999994 109.369 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 22.6 p -125.88 128.77 48.11 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.988 -1.116 . . . . 73.329999999999998 107.988 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -125.47 162.14 25.54 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.679 -0.808 . . . . 71.420000000000002 111.469 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 65.27 -84.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.122 1.369 . . . . 61.409999999999997 113.979 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -140.2 26.14 2.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.126 -0.943 . . . . 73.150000000000006 109.011 -168.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -79.67 151.62 30.41 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.832 -1.076 . . . . 75.209999999999994 109.763 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -124.11 135.43 53.52 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.241 -1.763 . . . . 73.230000000000004 106.241 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.5 p -135.87 139.59 45.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.038 0.447 . . . . 53.409999999999997 110.175 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.455 ' HB3' HD13 ' A' ' 276' ' ' LEU . 62.3 tp60 -129.89 130.85 45.69 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.438 -0.949 . . . . 60.240000000000002 108.438 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.41 ' HA ' HG13 ' A' ' 277' ' ' ILE . 2.7 tm? -120.81 120.57 35.96 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.751 -1.203 . . . . 65.040000000000006 107.751 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.539 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 137.17 -140.09 11.09 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 120.22 -0.991 . . . . 61.210000000000001 112.127 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -123.85 128.32 49.32 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.906 -0.775 . . . . 73.310000000000002 108.906 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.4 118.71 57.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 107.897 -1.149 . . . . 53.030000000000001 107.897 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.39 112.75 41.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.835 -0.802 . . . . 72.120000000000005 108.835 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.409 ' OG1' ' HA3' ' A' ' 285' ' ' GLY . 29.6 m -101.53 159.6 15.15 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 108.128 -1.064 . . . . 73.430000000000007 108.128 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.59 74.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.637 0.977 . . . . 72.439999999999998 113.637 -175.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.02 -49.46 71.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 113.377 0.88 . . . . 63.140000000000001 113.377 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.609 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -76.2 -48.31 20.88 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 113.686 0.995 . . . . 53.119999999999997 113.686 -176.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 77.6 mt -151.98 105.63 3.11 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.767 -0.457 . . . . 61.32 109.767 -169.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -104.24 -19.28 14.17 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.256 -1.016 . . . . 75.340000000000003 108.256 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -86.91 -34.8 10.57 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.045 -0.98 . . . . 70.040000000000006 113.226 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -173.69 134.22 2.81 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.613 -0.803 . . . . 31.210000000000001 111.237 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.0 mp -76.16 -38.37 34.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.831 0.824 . . . . 52.109999999999999 108.877 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 69.03 -88.61 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 125.212 1.405 . . . . 75.450000000000003 113.527 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 15.0 pt -138.45 167.99 20.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.405 0.621 . . . . 75.109999999999999 112.316 -170.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 14.2 t -101.57 -163.8 1.04 Allowed 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.603 -1.258 . . . . 73.150000000000006 107.603 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -108.56 173.23 6.41 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.346 -0.388 . . . . 74.109999999999999 110.325 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -17.56 27.52 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 113.008 0.744 . . . . 72.219999999999999 113.008 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' B' ' 224' ' ' GLY . 94.7 m -69.54 123.47 21.39 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.611 0.72 . . . . 45.009999999999998 112.239 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.2 t -101.05 116.51 33.01 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.086 -0.961 . . . . 71.030000000000001 108.465 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -95.57 144.16 26.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.721 -0.672 . . . . 73.209999999999994 109.195 -176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' B' ' 227' ' ' SER . 20.3 m -140.42 123.24 16.41 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.484 -0.562 . . . . 51.229999999999997 109.484 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.9 p -128.51 140.14 50.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.418 0.152 . . . . 75.340000000000003 110.985 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.65 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 62.6 mm-40 -77.73 -78.4 0.14 Allowed 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 116.384 -0.371 . . . . 71.040000000000006 110.273 176.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.1 t -124.42 130.82 53.17 Favored 'General case' 0 C--O 1.261 1.672 0 N-CA-C 112.986 0.735 . . . . 74.019999999999996 112.986 -174.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.768 HG12 HD12 ' B' ' 231' ' ' ILE . 17.0 m -118.09 125.35 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 115.109 -0.951 . . . . 61.32 109.167 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 5.1 p -127.4 125.91 66.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.17 0.509 . . . . 74.299999999999997 111.99 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.85 133.03 11.07 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.561 -0.745 . . . . 54.210000000000001 111.498 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -123.66 141.51 51.95 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.27 0.628 . . . . 71.239999999999995 110.437 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.41 -127.58 29.35 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.919 -0.658 . . . . 44.509999999999998 111.938 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.431 ' HB3' ' NH1' ' A' ' 274' ' ' ARG . 60.9 mm-40 -93.35 57.55 2.67 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.817 0.847 . . . . 73.099999999999994 110.407 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 70.7 m -88.74 145.09 25.83 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 120.115 -0.634 . . . . 51.219999999999999 111.969 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ARG . . . . . 0.431 ' NH1' ' HB3' ' A' ' 272' ' ' GLU . 10.4 mpt_? -121.47 127.69 51.34 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.193 -1.41 . . . . 75.519999999999996 107.193 173.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.1 p -136.0 123.57 34.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-O 121.536 0.684 . . . . 74.299999999999997 110.852 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 240' ' ' GLN . 13.3 tp -121.97 124.3 43.7 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.542 0.687 . . . . 62.329999999999998 110.256 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.562 HG22 ' HB3' ' B' ' 241' ' ' LEU . 2.9 pt -112.7 104.55 17.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.402 -1.272 . . . . 73.420000000000002 110.056 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 146.0 -148.91 20.95 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 115.53 -0.759 . . . . 71.329999999999998 111.731 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 7.0 m-20 -101.94 149.58 24.07 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 122.752 -0.263 . . . . 74.129999999999995 110.709 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.1 125.94 24.09 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.776 -1.935 . . . . 62.020000000000003 105.776 175.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -109.29 122.81 48.15 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.493 -1.299 . . . . 64.519999999999996 107.493 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 134.11 -53.03 0.8 Allowed Glycine 0 C--N 1.283 -2.373 0 N-CA-C 108.939 -1.664 . . . . 60.32 108.939 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 103.32 -7.67 51.67 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.931 -1.268 . . . . 73.099999999999994 109.931 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -160.07 53.23 0.34 Allowed 'General case' 0 C--O 1.253 1.252 0 CA-C-N 114.755 -0.722 . . . . 74.019999999999996 111.15 -175.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.409 ' HA3' ' OG1' ' A' ' 246' ' ' THR . . . -95.22 -57.87 1.19 Allowed Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.57 -0.741 . . . . 62.240000000000002 113.99 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -78.66 -2.03 37.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.363 1.078 . . . . 64.239999999999995 110.788 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.447 ' CZ2' ' HD1' ' B' ' 286' ' ' PHE . 36.9 p90 -151.61 175.31 12.48 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 105.162 -2.162 . . . . 61.229999999999997 105.162 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -121.65 -62.66 1.39 Allowed 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 105.12 -2.178 . . . . 75.140000000000001 105.12 171.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 167.47 -177.17 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.13 1 N-CA-C 99.748 -4.167 . . . . 65.200000000000003 99.748 170.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -135.55 107.87 7.3 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 123.168 2.713 . . . . 73.530000000000001 116.466 -173.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 60.29 23.53 12.97 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 115.531 1.678 . . . . 63.439999999999998 115.531 169.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' HIS . . . . . 0.51 ' CD2' HH12 ' B' ' 274' ' ' ARG . 89.1 m-70 -94.79 85.47 4.44 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 121.549 -0.719 . . . . 71.400000000000006 109.47 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -81.1 -9.27 59.84 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.046 -0.524 . . . . 65.140000000000001 112.057 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -154.45 -61.88 0.13 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.068 -0.715 . . . . 73.510000000000005 109.068 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.481 0 N-CA-C 108.426 -0.953 . . . . 71.140000000000001 108.426 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 C--O 1.223 -0.302 0 CA-C-O 120.82 0.343 . . . . 73.409999999999997 111.0 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -150.59 131.76 14.45 Favored 'General case' 0 C--O 1.209 -1.055 0 N-CA-C 109.223 -0.658 . . . . 54.399999999999999 109.223 -176.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 219' ' ' ILE . . . . . 0.518 ' H ' HD13 ' B' ' 219' ' ' ILE . 0.1 OUTLIER -99.82 168.44 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.52 -0.548 . . . . 64.430000000000007 109.52 174.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 220' ' ' ASP . . . . . 0.585 ' OD2' ' HA ' ' A' ' 217' ' ' MET . 7.6 p-10 -73.24 147.19 44.87 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 113.245 0.832 . . . . 63.399999999999999 113.245 -171.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 72.03 35.38 1.31 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.331 1.452 . . . . 44.020000000000003 113.983 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 59.3 mt -100.94 132.49 46.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 108.39 -0.967 . . . . 73.329999999999998 108.39 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.475 ' HA ' ' HG3' ' B' ' 259' ' ' GLN . 7.4 p -107.24 124.55 63.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-O 119.752 -0.166 . . . . 51.310000000000002 111.119 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 224' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 260' ' ' THR . . . 48.79 87.82 0.01 OUTLIER Glycine 0 C--N 1.354 1.533 0 O-C-N 124.504 1.127 . . . . 54.020000000000003 114.29 174.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.06 134.4 42.32 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.215 -0.994 . . . . 64.230000000000004 111.326 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' B' ' 262' ' ' ASN . 20.1 p-10 -116.67 140.29 49.57 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.381 -0.97 . . . . 54.030000000000001 108.381 174.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 227' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 263' ' ' SER . 18.2 m -121.48 136.5 54.95 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 109.526 -0.546 . . . . 64.400000000000006 109.526 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -120.8 131.53 54.51 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 106.989 -1.486 . . . . 74.219999999999999 106.989 175.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.65 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 1.4 tmtp? -93.31 -62.3 1.4 Allowed 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.121 -0.696 . . . . 71.510000000000005 109.121 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -127.95 137.36 52.23 Favored 'General case' 0 C--N 1.3 -1.543 0 N-CA-C 109.575 -0.528 . . . . 63.100000000000001 109.575 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.768 HD12 HG12 ' A' ' 267' ' ' VAL . 18.7 mt -133.8 122.36 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 108.523 -0.917 . . . . 74.25 108.523 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 38.9 ttp180 -123.54 115.68 21.92 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.904 -0.776 . . . . 73.310000000000002 108.904 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 70.6 p -109.24 127.75 54.5 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 105.831 -1.915 . . . . 74.129999999999995 105.831 177.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.55 161.67 26.65 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.207 -0.597 . . . . 72.519999999999996 111.48 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 67.52 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.251 -1.34 . . . . 71.450000000000003 113.41 172.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.06 18.3 2.28 Favored 'General case' 0 C--O 1.195 -1.783 0 N-CA-C 108.248 -1.019 . . . . 74.540000000000006 108.248 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.52 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -68.69 149.17 49.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.903 0.859 . . . . 74.409999999999997 113.016 -172.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -125.54 135.35 52.16 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.149 -0.932 . . . . 74.219999999999999 108.628 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 8.4 p -132.38 138.7 51.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.665 0.745 . . . . 54.32 110.763 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.541 ' CG ' HD13 ' B' ' 276' ' ' LEU . 52.5 tp60 -117.5 125.83 51.55 Favored 'General case' 0 N--CA 1.401 -2.887 0 CA-C-N 114.495 -1.229 . . . . 64.450000000000003 108.398 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.562 ' HB3' HG22 ' A' ' 277' ' ' ILE . 2.4 tm? -118.15 119.14 33.82 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.9 -1.889 . . . . 54.439999999999998 105.9 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.668 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 136.12 -147.01 19.0 Favored Glycine 0 C--N 1.278 -2.646 0 C-N-CA 119.721 -1.228 . . . . 41.149999999999999 110.875 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 86.2 m-20 -124.93 129.13 49.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.157 0.503 . . . . 64.129999999999995 110.017 -174.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 93.7 t -111.04 129.26 66.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.758 -0.83 . . . . 73.239999999999995 108.758 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 61.1 t -118.4 111.79 35.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.229 -1.026 . . . . 64.209999999999994 108.229 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.404 ' OG1' ' HA3' ' B' ' 285' ' ' GLY . 28.2 m -96.67 161.1 14.03 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.785 -0.821 . . . . 63.240000000000002 108.785 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.609 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.69 -33.95 76.77 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.273 0.629 . . . . 73.530000000000001 112.331 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.53 -37.16 67.58 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 115.222 1.564 . . . . 55.549999999999997 115.222 -173.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.441 ' HB2' ' N ' ' B' ' 282' ' ' GLY . . . -74.78 -37.79 62.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.148 0.796 . . . . 72.299999999999997 113.148 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.8 mp 54.51 89.34 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.864 -0.791 . . . . 73.519999999999996 108.864 -167.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' HIS . . . . . 0.428 ' HB2' HG21 ' B' ' 254' ' ' ILE . 35.6 p-80 -60.97 118.5 6.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.132 -0.94 . . . . 73.430000000000007 113.465 -168.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -123.05 -70.61 0.24 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.172 -0.922 . . . . 73.150000000000006 111.167 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -82.46 72.38 2.82 Favored Glycine 0 C--O 1.218 -0.881 0 N-CA-C 111.256 -0.738 . . . . 53.130000000000003 111.256 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 254' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' B' ' 251' ' ' HIS . 12.2 tt -129.04 80.28 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 122.19 0.995 . . . . 71.439999999999998 111.83 -176.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -179.61 -50.19 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 124.986 1.314 . . . . 75.329999999999998 108.002 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 4.5 tp -122.61 87.96 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.142 0.972 . . . . 72.5 108.699 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 257' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' C' ' 252' ' ' GLY . 29.8 t -160.22 113.04 2.08 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 106.454 -1.684 . . . . 73.129999999999995 106.454 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 18.2 t70 69.48 166.82 0.28 Allowed 'General case' 0 N--CA 1.484 1.244 0 O-C-N 124.336 1.022 . . . . 73.349999999999994 112.039 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 259' ' ' GLN . . . . . 0.475 ' HG3' ' HA ' ' B' ' 223' ' ' VAL . 43.6 tt0 -161.24 29.21 0.14 Allowed 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 108.842 -0.799 . . . . 72.319999999999993 108.842 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 67.3 m -64.92 137.21 57.61 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.562 -0.744 . . . . 70.239999999999995 110.459 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 63.4 m -105.28 108.5 20.05 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.982 -0.747 . . . . 74.439999999999998 108.982 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' B' ' 226' ' ' ASN . 21.9 m-80 -100.98 138.61 37.8 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.109 -0.7 . . . . 62.329999999999998 109.109 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 263' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' C' ' 227' ' ' SER . 4.1 p -143.28 123.94 14.11 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 122.259 -0.276 . . . . 65.5 110.899 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 7.1 p -124.88 142.3 42.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 110.263 -0.273 . . . . 63.219999999999999 110.263 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 43.2 mm-40 -82.47 -78.81 0.2 Allowed 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 123.202 0.314 . . . . 65.140000000000001 110.282 175.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 10.2 t -120.86 130.43 53.93 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.992 -1.083 . . . . 65.310000000000002 112.54 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.533 HG21 HG21 ' B' ' 275' ' ' VAL . 1.5 p -125.05 124.8 68.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.711 -1.131 . . . . 64.230000000000004 110.182 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 268' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 14.8 p -127.01 140.57 48.71 Favored 'Isoleucine or valine' 0 C--O 1.267 2.013 0 CA-C-O 121.782 0.801 . . . . 75.099999999999994 111.395 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.78 133.08 9.53 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 110.609 -0.996 . . . . 74.010000000000005 110.609 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -127.59 116.51 20.45 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.154 0.582 . . . . 65.230000000000004 110.515 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.62 -131.03 10.57 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.126 -1.035 . . . . 71.140000000000001 110.87 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 272' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 67.5 mm-40 -91.85 52.1 1.95 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.324 0.583 . . . . 72.420000000000002 109.511 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 33.3 m -82.9 145.59 29.33 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.499 0.666 . . . . 72.109999999999999 111.558 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.51 HH12 ' CD2' ' A' ' 292' ' ' HIS . 16.8 mtm180 -132.4 126.35 32.94 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.754 -1.112 . . . . 74.349999999999994 108.724 176.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.533 HG21 HG21 ' B' ' 267' ' ' VAL . 0.8 OUTLIER -135.92 127.07 43.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.245 -0.889 . . . . 75.209999999999994 111.076 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.541 HD13 ' CG ' ' B' ' 240' ' ' GLN . 11.9 tp -122.43 121.87 37.64 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.154 0.978 . . . . 74.129999999999995 110.523 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.788 HG22 ' HB3' ' C' ' 241' ' ' LEU . 4.6 pt -112.62 104.33 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-N 114.175 -1.375 . . . . 74.150000000000006 109.131 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.668 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 160.7 -148.83 17.44 Favored Glycine 0 N--CA 1.42 -2.418 0 C-N-CA 120.887 -0.673 . . . . 53.130000000000003 111.691 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 279' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 54.7 t30 -120.63 130.01 53.97 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.161 -1.052 . . . . 71.129999999999995 108.161 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.406 ' HG3' ' CH2' ' B' ' 287' ' ' TRP . 0.3 OUTLIER -117.96 130.52 56.26 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.038 -1.097 . . . . 74.540000000000006 108.038 -174.68 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -108.32 122.93 47.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.304 0.574 . . . . 74.109999999999999 109.991 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.441 ' N ' ' HB2' ' B' ' 249' ' ' ALA . . . 129.05 -53.23 0.81 Allowed Glycine 0 N--CA 1.421 -2.31 0 N-CA-C 109.378 -1.489 . . . . 64.230000000000004 109.378 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 105.95 -7.77 41.75 Favored Glycine 0 N--CA 1.434 -1.459 0 C-N-CA 120.742 -0.742 . . . . 54.130000000000003 111.84 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 284' ' ' LYS . . . . . 0.555 ' HA ' ' NE1' ' B' ' 287' ' ' TRP . 11.0 ptmm? -155.95 36.73 0.35 Allowed 'General case' 0 C--O 1.251 1.183 0 N-CA-C 111.774 0.287 . . . . 75.340000000000003 111.774 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 285' ' ' GLY . . . . . 0.404 ' HA3' ' OG1' ' B' ' 246' ' ' THR . . . -74.43 -76.03 0.75 Allowed Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.252 -0.975 . . . . 70.319999999999993 112.809 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.447 ' HD1' ' CZ2' ' A' ' 287' ' ' TRP . 75.3 t80 -56.36 -26.48 52.95 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.987 0.898 . . . . 75.030000000000001 111.419 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.555 ' NE1' ' HA ' ' B' ' 284' ' ' LYS . 26.8 p90 -115.18 71.85 0.78 Allowed 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.383 -0.826 . . . . 73.450000000000003 109.426 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.35 -35.46 67.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.862 -0.608 . . . . 74.010000000000005 110.936 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 t30 61.75 34.06 17.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.9 0.88 . . . . 55.43 110.103 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 290' ' ' HIS . . . . . 0.438 ' HA ' ' HB3' ' B' ' 293' ' ' HIS . 31.5 t-80 71.26 85.99 0.12 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.184 -1.371 . . . . 74.230000000000004 113.114 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -145.6 -51.42 0.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.617 -1.174 . . . . 55.299999999999997 108.123 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -103.24 -29.61 11.17 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.167 -1.049 . . . . 73.120000000000005 108.167 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 293' ' ' HIS . . . . . 0.438 ' HB3' ' HA ' ' B' ' 290' ' ' HIS . 8.9 t60 -43.41 132.51 4.55 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.728 1.611 . . . . 72.049999999999997 114.326 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -149.0 100.65 3.09 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.292 -1.322 . . . . 74.329999999999998 109.35 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 78.0 t60 . . . . . 0 C--O 1.264 1.854 0 C-N-CA 125.486 1.515 . . . . 62.439999999999998 113.95 175.025 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 45.8 ttm . . . . . 0 CA--C 1.502 -0.873 0 N-CA-C 109.142 -0.688 . . . . 60.310000000000002 109.142 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -157.45 114.37 2.99 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.84 -1.17 . . . . 74.129999999999995 107.84 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.49 96.87 4.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.123 -1.806 . . . . 75.319999999999993 106.123 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.73 -166.14 1.48 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.15 -1.386 . . . . 61.450000000000003 110.963 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 70.14 79.66 0.18 Allowed 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 124.427 1.091 . . . . 74.349999999999994 109.23 -174.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 52.0 mt -116.1 138.26 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 CA-C-N 114.771 -1.104 . . . . 71.230000000000004 108.7 -175.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.74 119.87 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 CA-C-N 116.414 -0.357 . . . . 62.32 110.892 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 51.06 67.42 1.96 Allowed Glycine 0 CA--C 1.5 -0.854 0 CA-C-N 114.794 -1.094 . . . . 72.120000000000005 114.438 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' B' ' 261' ' ' THR . 1.5 ptp180 -95.88 138.03 34.11 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 118.203 -1.399 . . . . 74.019999999999996 112.814 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -116.46 115.02 25.03 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 106.695 -1.594 . . . . 72.129999999999995 106.695 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' B' ' 263' ' ' SER . 8.3 p -121.13 136.6 54.95 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 122.025 0.917 . . . . 74.530000000000001 112.402 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -121.2 135.83 55.08 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.358 -1.292 . . . . 74.019999999999996 107.639 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.578 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 1.1 tmtp? -93.62 -55.7 3.17 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 109.486 -0.561 . . . . 74.140000000000001 109.486 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -131.45 138.52 49.07 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.773 0.321 . . . . 75.420000000000002 110.403 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.438 HD12 ' HB ' ' B' ' 267' ' ' VAL . 28.3 mt -131.35 117.83 37.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 107.95 -1.13 . . . . 61.020000000000003 107.95 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 11.4 ttp180 -122.94 114.92 21.09 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.612 -0.514 . . . . 73.420000000000002 109.612 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 40.7 p -113.18 127.8 56.29 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.094 -1.076 . . . . 62.109999999999999 108.094 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -128.18 165.79 19.77 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.913 -0.715 . . . . 74.239999999999995 110.714 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 43.9 mt-10 68.52 -84.7 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 114.791 -1.095 . . . . 63.049999999999997 112.836 175.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.507 ' O ' ' HD2' ' C' ' 238' ' ' ARG . 0.3 OUTLIER -141.25 21.5 2.24 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 108.155 -1.054 . . . . 73.129999999999995 108.155 178.686 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.506 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -68.42 148.32 50.81 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.623 0.725 . . . . 73.430000000000007 112.174 -173.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' C' ' 236' ' ' ARG . 3.4 mpt_? -124.27 135.18 53.21 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.318 -1.364 . . . . 75.109999999999999 107.318 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.2 141.16 45.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.318 0.58 . . . . 71.129999999999995 111.183 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -122.82 123.3 40.7 Favored 'General case' 0 N--CA 1.408 -2.539 0 CA-C-N 114.545 -1.207 . . . . 51.240000000000002 108.808 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.788 ' HB3' HG22 ' B' ' 277' ' ' ILE . 2.1 tm? -120.48 119.16 32.2 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.586 -1.264 . . . . 55.520000000000003 107.586 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.54 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 134.7 -125.43 3.77 Favored Glycine 0 N--CA 1.411 -3.005 0 N-CA-C 110.158 -1.177 . . . . 51.409999999999997 110.158 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 92.7 m-20 -130.22 150.59 51.41 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 120.909 0.385 . . . . 55.109999999999999 110.49 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 83.1 t -128.8 118.38 46.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.449 -1.315 . . . . 62.240000000000002 107.449 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 47.5 t -114.56 112.3 39.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.784 -0.821 . . . . 74.230000000000004 108.784 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 15.4 m -100.37 160.91 13.96 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 115.561 -0.745 . . . . 62.520000000000003 109.503 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.06 -32.21 72.71 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.773 0.796 . . . . 55.210000000000001 110.508 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.97 -42.13 72.02 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.062 -1.427 . . . . 52.32 112.367 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 249' ' ' ALA . . . . . 0.474 ' HB2' ' N ' ' C' ' 282' ' ' GLY . . . -75.34 -40.31 58.43 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.009 0.433 . . . . 70.329999999999998 110.014 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 67.4 tp 72.72 -61.49 0.5 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.646 1.578 . . . . 65.439999999999998 113.114 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -130.01 129.13 43.32 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.255 0.55 . . . . 63.310000000000002 111.354 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 252' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' B' ' 257' ' ' SER . . . -118.92 39.38 2.56 Favored Glycine 0 C--N 1.299 -1.481 0 N-CA-C 107.891 -2.084 . . . . 64.219999999999999 107.891 172.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -74.93 81.95 0.88 Allowed Glycine 0 CA--C 1.496 -1.152 0 CA-C-N 114.216 -0.992 . . . . 72.109999999999999 113.35 -174.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 11.1 tt -168.29 137.8 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.934 -1.136 . . . . 75.310000000000002 107.934 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -79.58 96.06 6.05 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.676 -0.861 . . . . 74.319999999999993 108.676 174.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 18.1 pt -59.87 117.85 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 107.881 -1.155 . . . . 72.5 107.881 174.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 13.0 m -106.31 -31.26 8.69 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 116.185 -0.461 . . . . 73.239999999999995 111.735 -173.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -126.85 99.35 5.71 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.236 -1.024 . . . . 63.219999999999999 108.236 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -118.81 174.55 6.22 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.058 -0.519 . . . . 63.229999999999997 110.663 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 18.6 m -84.85 134.86 34.27 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.633 -0.877 . . . . 75.140000000000001 108.633 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 9.9 t -91.36 131.05 37.1 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.182 -1.414 . . . . 75.340000000000003 107.182 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -119.57 135.83 54.62 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.778 -0.453 . . . . 71.439999999999998 109.778 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 20.8 m -142.47 125.38 16.13 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.194 -0.669 . . . . 64.5 109.194 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.1 p -128.16 143.59 40.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 110.195 -0.298 . . . . 53.149999999999999 110.195 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 64.2 mm-40 -76.44 -69.74 0.49 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.531 -0.304 . . . . 65.010000000000005 110.762 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 8.8 t -136.95 133.91 36.16 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 119.004 -1.078 . . . . 64.150000000000006 112.061 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.98 133.49 65.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.503 -0.925 . . . . 62.140000000000001 108.503 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 268' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 11.6 p -127.32 138.99 53.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 116.387 -0.369 . . . . 65.310000000000002 110.256 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.92 132.98 9.95 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.685 -0.966 . . . . 64.219999999999999 110.685 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -132.85 129.74 38.85 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 123.66 0.784 . . . . 74.409999999999997 109.951 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.85 -122.32 9.09 Favored Glycine 0 C--N 1.304 -1.198 0 C-N-CA 121.051 -0.595 . . . . 33.100000000000001 112.043 -176.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -96.79 51.89 1.16 Allowed 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.511 0.724 . . . . 53.119999999999997 110.463 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 56.3 m -83.67 144.36 29.45 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.778 0.799 . . . . 72.329999999999998 112.179 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 274' ' ' ARG . . . . . 0.463 ' HB3' ' CE2' ' C' ' 286' ' ' PHE . 7.6 mpt_? -127.64 127.72 44.27 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.369 -2.085 . . . . 73.030000000000001 105.369 172.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 3.4 p -138.53 124.03 23.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.099 0.476 . . . . 75.420000000000002 111.309 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 20.1 tp -113.41 120.12 39.96 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.728 0.775 . . . . 74.120000000000005 110.479 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.444 HG13 ' HA ' ' C' ' 241' ' ' LEU . 3.9 pt -112.51 103.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 N-CA-C 107.769 -1.197 . . . . 74.439999999999998 107.769 174.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 278' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 152.1 -161.14 29.23 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.073 -1.06 . . . . 73.319999999999993 111.812 -176.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -109.0 136.07 49.14 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.319 -0.623 . . . . 73.319999999999993 109.319 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.95 144.64 45.32 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.204 -1.406 . . . . 74.439999999999998 107.204 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -124.06 122.9 39.12 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.33 -0.618 . . . . 73.230000000000004 109.33 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 282' ' ' GLY . . . . . 0.474 ' N ' ' HB2' ' C' ' 249' ' ' ALA . . . 127.14 -48.33 0.97 Allowed Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 108.738 -1.745 . . . . 54.340000000000003 108.738 -174.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 283' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' C' ' 293' ' ' HIS . . . 103.04 -8.01 53.26 Favored Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.907 -0.877 . . . . 54.329999999999998 110.907 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 284' ' ' LYS . . . . . 0.576 ' HA ' ' NE1' ' C' ' 287' ' ' TRP . 17.3 ptmt -154.46 36.2 0.42 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.25 0.62 . . . . 71.340000000000003 110.761 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -70.23 -78.0 0.42 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.359 -0.924 . . . . 73.239999999999995 112.423 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.539 ' HD1' ' CZ2' ' B' ' 287' ' ' TRP . 67.5 t80 -53.79 -19.64 4.59 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.583 1.153 . . . . 74.129999999999995 112.658 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.576 ' NE1' ' HA ' ' C' ' 284' ' ' LYS . 23.8 p90 -125.92 97.2 5.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.527 0.68 . . . . 72.319999999999993 111.679 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -97.93 19.7 13.43 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 123.518 1.628 . . . . 62.229999999999997 107.921 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -153.6 -176.75 5.96 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 102.788 -3.042 . . . . 54.039999999999999 102.788 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 68.49 -173.99 0.19 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.305 0.957 . . . . 74.420000000000002 110.26 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -128.26 138.06 52.27 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.655 -0.498 . . . . 70.239999999999995 109.655 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -179.5 -36.18 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 O-C-N 124.145 0.903 . . . . 71.319999999999993 108.616 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 293' ' ' HIS . . . . . 0.442 ' HB3' ' O ' ' C' ' 283' ' ' GLY . 9.3 p80 -69.29 101.79 1.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.551 0.691 . . . . 74.340000000000003 111.317 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -146.76 111.28 5.21 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 105.522 -2.029 . . . . 75.319999999999993 105.522 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 8.9 p80 . . . . . 0 C--N 1.295 -1.794 0 CA-C-O 117.977 -1.011 . . . . 75.219999999999999 112.825 -172.945 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.894 0 N-CA-C 109.152 -0.684 . . . . 72.230000000000004 109.152 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.441 ' HB2' ' H ' ' A' ' 219' ' ' ILE . 2.3 mptp? -156.12 -84.79 0.05 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 105.002 -2.222 . . . . 63.420000000000002 105.002 171.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.441 ' H ' ' HB2' ' A' ' 218' ' ' LYS . 46.8 mm -141.19 97.04 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 101.783 -3.414 . . . . 73.310000000000002 101.783 173.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -113.58 -22.21 10.41 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.719 -0.673 . . . . 75.099999999999994 111.672 -168.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . 57.15 61.73 2.46 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.018 0.927 . . . . 51.130000000000003 111.475 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 49.7 mm -116.92 138.71 46.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.301 -0.863 . . . . 74.420000000000002 110.213 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.79 148.85 18.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.805 -0.442 . . . . 54.039999999999999 109.805 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -99.12 109.88 3.87 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 109.837 -1.305 . . . . 51.530000000000001 109.837 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -103.83 135.02 46.15 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.175 0.512 . . . . 54.009999999999998 110.868 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.43 HD22 ' HA2' ' A' ' 278' ' ' GLY . 53.6 t30 -92.71 126.18 37.67 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.929 -1.508 . . . . 64.129999999999995 106.929 174.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 14.1 m -121.84 136.81 54.94 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.216 0.531 . . . . 73.219999999999999 110.23 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.81 124.06 16.63 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.897 -1.149 . . . . 62.509999999999998 107.897 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 265' ' ' GLU . 4.8 mmmm -76.76 -64.29 1.16 Allowed 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 114.431 1.271 . . . . 73.409999999999997 114.431 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -127.74 140.08 52.28 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.058 -1.057 . . . . 73.519999999999996 110.999 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 30.1 mm -121.15 118.21 55.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.902 -0.777 . . . . 75.329999999999998 108.902 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 80.2 mtt180 -124.76 116.74 22.79 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.921 0.391 . . . . 64.420000000000002 111.046 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 27.3 p -120.44 126.76 51.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.135 -0.691 . . . . 72.099999999999994 109.135 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 270' ' ' LYS . 47.4 mt-10 -139.94 139.47 36.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.596 -0.52 . . . . 53.420000000000002 109.596 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 51.71 97.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.824 1.25 . . . . 74.319999999999993 114.229 174.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? 64.59 20.94 12.31 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.373 1.069 . . . . 75.519999999999996 110.985 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.1 129.4 45.36 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.368 0.604 . . . . 71.420000000000002 110.292 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.85 140.15 52.2 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.455 -0.793 . . . . 71.019999999999996 109.343 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 5.9 p -129.35 146.72 33.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 121.001 0.429 . . . . 55.340000000000003 111.165 -174.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -119.15 124.1 45.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.089 -1.449 . . . . 75.519999999999996 107.089 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -118.58 122.76 43.39 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.686 -0.487 . . . . 74.310000000000002 109.686 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.481 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 120.45 -156.85 15.92 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.906 -0.664 . . . . 74.409999999999997 112.453 175.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -102.23 132.87 47.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.104 -0.702 . . . . 72.430000000000007 109.104 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.638 HG11 ' HA3' ' A' ' 285' ' ' GLY . 15.7 t -116.33 122.11 69.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.76 -0.83 . . . . 73.519999999999996 108.76 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 48.5 t -113.11 112.69 41.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.19 -1.041 . . . . 74.239999999999995 108.19 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.43 HG21 ' HB3' ' A' ' 284' ' ' LYS . 54.3 m -89.44 160.73 16.64 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.243 -0.435 . . . . 60.130000000000003 109.972 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.14 -37.2 86.26 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.33 0.652 . . . . 64.430000000000007 110.9 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.36 -35.04 64.81 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.238 1.015 . . . . 54.130000000000003 113.589 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -73.99 -36.75 64.56 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.79 0.663 . . . . 55.210000000000001 112.79 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 64.71 -172.2 0.18 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.227 0.611 . . . . 61.420000000000002 109.773 -171.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -82.9 82.8 8.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 122.227 1.013 . . . . 50.119999999999997 111.867 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -105.95 25.32 24.24 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.76 -1.109 . . . . 60.539999999999999 111.807 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -70.01 -14.85 71.28 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 111.87 -0.492 . . . . 35.229999999999997 111.87 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 28.6 pt -61.22 -29.59 46.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 123.289 0.636 . . . . 74.310000000000002 111.241 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.15 79.74 5.71 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 108.545 -0.909 . . . . 70.109999999999999 108.545 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 13.2 tt -102.22 111.93 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 CA-C-O 122.281 1.038 . . . . 73.120000000000005 109.972 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 46.5 m -134.08 25.99 3.9 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.596 -1.261 . . . . 61.229999999999997 107.596 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -113.45 122.78 48.35 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.542 -1.663 . . . . 73.329999999999998 111.19 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -139.17 22.2 2.59 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.302 -1.74 . . . . 65.219999999999999 106.302 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 4.1 m -76.52 121.59 23.36 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 114.306 -1.315 . . . . 64.549999999999997 110.438 -173.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.5 m -99.61 108.15 20.46 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.455 -1.313 . . . . 75.140000000000001 107.455 175.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -96.07 142.77 27.88 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.323 -0.991 . . . . 61.219999999999999 108.323 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.5 m -139.72 123.63 17.61 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.724 -0.391 . . . . 71.230000000000004 111.21 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 12.3 p -128.85 144.9 36.68 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.685 -0.487 . . . . 72.439999999999998 109.685 173.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.525 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 4.2 tp10 -84.34 -75.85 0.33 Allowed 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 109.572 -0.529 . . . . 73.120000000000005 109.572 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 14.6 m -123.28 134.5 54.07 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.227 -0.921 . . . . 71.140000000000001 111.3 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 32.5 m -119.3 124.33 72.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 107.972 -1.121 . . . . 74.109999999999999 107.972 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 10.4 p -127.6 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 110.221 -0.288 . . . . 64.540000000000006 110.221 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.591 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -134.19 131.48 5.98 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 119.969 -1.11 . . . . 72.430000000000007 111.94 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 234' ' ' GLU . 27.5 ttmt -135.77 144.87 46.03 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.867 0.692 . . . . 73.340000000000003 112.867 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.72 -54.37 1.43 Allowed Glycine 0 CA--C 1.5 -0.906 0 N-CA-C 111.827 -0.509 . . . . 64.239999999999995 111.827 173.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.635 ' HB3' ' H ' ' B' ' 236' ' ' ARG . 23.1 tt0 -176.76 102.98 0.06 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 105.485 -2.043 . . . . 61.310000000000002 105.485 174.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 59.8 m -135.05 145.18 47.75 Favored 'General case' 0 C--N 1.281 -2.41 0 C-N-CA 119.923 -0.711 . . . . 74.310000000000002 110.795 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -126.7 126.22 43.14 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 104.713 -2.329 . . . . 75.310000000000002 104.713 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 1.6 p -135.75 123.99 37.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 CA-C-O 121.06 0.457 . . . . 72.129999999999995 110.763 -176.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 6.7 tt -111.52 121.21 44.56 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.963 -1.125 . . . . 73.420000000000002 107.963 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.508 HG23 HD12 ' B' ' 241' ' ' LEU . 43.5 mm -112.1 104.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 107.967 -1.123 . . . . 72.420000000000002 107.967 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.512 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 149.99 -128.87 2.81 Favored Glycine 0 N--CA 1.427 -1.936 0 C-N-CA 119.241 -1.457 . . . . 30.039999999999999 113.627 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -128.71 128.88 44.93 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.205 -1.035 . . . . 62.109999999999999 108.205 -175.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -112.93 118.7 35.59 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.741 -0.837 . . . . 75.239999999999995 108.741 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 90.2 m-85 -114.79 123.85 50.27 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.969 -0.752 . . . . 74.340000000000003 108.969 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.447 ' CA ' ' HB2' ' A' ' 249' ' ' ALA . . . 105.94 -47.12 1.09 Allowed Glycine 0 C--N 1.297 -1.611 0 N-CA-C 110.905 -0.878 . . . . 61.119999999999997 110.905 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.536 ' HA2' ' H ' ' B' ' 286' ' ' PHE . . . 89.98 47.28 3.94 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.931 -0.652 . . . . 72.310000000000002 113.155 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.43 ' HB3' HG21 ' A' ' 246' ' ' THR . 0.9 OUTLIER -174.78 30.87 0.01 OUTLIER 'General case' 0 C--O 1.247 0.933 0 CA-C-O 122.151 0.977 . . . . 51.350000000000001 109.372 -177.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.638 ' HA3' HG11 ' A' ' 244' ' ' VAL . . . -86.73 128.08 8.73 Favored Glycine 0 N--CA 1.411 -3.007 0 C-N-CA 120.351 -0.928 . . . . 73.230000000000004 112.161 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 27.0 t80 73.86 -51.69 0.69 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.917 1.287 . . . . 62.350000000000001 112.396 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.54 -175.65 4.81 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.988 0.736 . . . . 73.200000000000003 112.988 -172.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.536 ' OD1' ' HA ' ' B' ' 287' ' ' TRP . 41.1 t0 171.97 155.18 0.08 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.369 2.267 . . . . 70.329999999999998 107.726 171.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -168.97 66.39 0.06 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.0 -1.482 . . . . 73.549999999999997 107.0 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -96.88 92.77 6.28 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 122.415 1.102 . . . . 65.129999999999995 111.523 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -122.86 133.19 54.43 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 104.969 -2.234 . . . . 74.510000000000005 104.969 174.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -71.76 -32.77 68.05 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.085 -1.046 . . . . 64.109999999999999 110.144 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -111.62 116.89 31.56 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 106.783 -1.562 . . . . 73.209999999999994 106.783 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -102.9 -57.0 2.12 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.203 0.525 . . . . 63.549999999999997 109.979 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 8.4 p80 . . . . . 0 N--CA 1.428 -1.563 0 N-CA-C 108.259 -1.015 . . . . 74.109999999999999 108.259 178.782 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 108.973 -0.751 . . . . 71.239999999999995 108.973 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt 73.43 -74.6 0.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.848 1.259 . . . . 75.420000000000002 108.69 -173.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 43.8 pt -116.56 144.0 25.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 104.289 -2.486 . . . . 75.140000000000001 104.289 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -101.27 80.82 2.14 Favored 'General case' 0 C--N 1.263 -3.186 0 C-N-CA 117.746 -1.581 . . . . 62.140000000000001 108.286 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -81.23 15.16 2.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.694 -1.594 . . . . 61.32 111.614 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 51.0 mm -83.85 115.12 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 105.648 -1.982 . . . . 63.420000000000002 105.648 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.417 ' HA ' ' OE1' ' B' ' 259' ' ' GLN . 26.9 m -123.35 152.72 28.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 116.212 -0.449 . . . . 60.200000000000003 110.497 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -86.26 121.38 5.71 Favored Glycine 0 N--CA 1.423 -2.219 0 N-CA-C 110.754 -0.938 . . . . 73.530000000000001 110.754 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -102.69 147.73 26.46 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.306 0.574 . . . . 75.430000000000007 109.798 176.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -112.67 130.52 56.02 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 105.191 -2.152 . . . . 74.519999999999996 105.191 171.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 14.5 m -132.53 135.81 46.22 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 118.356 -1.338 . . . . 62.420000000000002 110.977 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.92 134.5 42.71 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 107.178 -1.416 . . . . 71.409999999999997 107.178 175.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' B' ' 265' ' ' GLU . 24.6 mmtp -80.17 -71.23 0.47 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.659 -0.416 . . . . 75.209999999999994 112.058 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -127.11 138.59 53.21 Favored 'General case' 0 N--CA 1.414 -2.274 0 C-N-CA 118.555 -1.258 . . . . 72.310000000000002 109.597 -173.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 31.1 mm -123.41 116.98 50.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.791 -1.189 . . . . 72.450000000000003 107.791 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -117.4 115.23 24.8 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 120.299 -0.561 . . . . 75.310000000000002 109.52 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.591 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 40.8 p -110.8 126.43 54.62 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.206 -1.405 . . . . 73.099999999999994 107.206 176.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 234' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 51.0 mt-10 -143.43 138.83 29.6 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 109.811 -0.44 . . . . 73.349999999999994 109.811 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.481 ' HB2' ' H ' ' B' ' 271' ' ' GLY . 41.1 mt-10 56.49 98.22 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.868 0 O-C-N 125.292 1.62 . . . . 73.530000000000001 113.041 174.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.635 ' H ' ' HB3' ' A' ' 272' ' ' GLU . 1.1 mpt_? 60.89 35.66 19.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.857 0.863 . . . . 75.319999999999993 109.718 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -103.76 138.88 39.75 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.586 0.707 . . . . 72.209999999999994 111.106 -175.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 1.4 mpt_? -133.84 136.35 44.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.978 -1.119 . . . . 71.230000000000004 107.978 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 5.7 p -137.37 137.66 45.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-O 121.578 0.704 . . . . 64.530000000000001 112.059 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.423 ' HB3' ' HG ' ' B' ' 276' ' ' LEU . 47.4 tp60 -110.64 117.65 34.06 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.113 -1.44 . . . . 71.150000000000006 107.113 175.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.508 HD12 HG23 ' A' ' 277' ' ' ILE . 3.0 tm? -119.33 127.4 53.15 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.085 -0.709 . . . . 72.319999999999993 109.085 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 122.7 -121.3 4.59 Favored Glycine 0 CA--C 1.473 -2.542 0 N-CA-C 109.636 -1.385 . . . . 62.420000000000002 109.636 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 33.8 p30 -144.1 154.77 43.55 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 119.739 -0.784 . . . . 52.039999999999999 111.41 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.701 HG11 ' HA3' ' B' ' 285' ' ' GLY . 65.6 t -123.49 130.37 74.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.176 -0.92 . . . . 71.329999999999998 109.69 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 57.8 t -122.66 111.58 30.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.643 -1.243 . . . . 74.400000000000006 107.643 171.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.47 ' HB ' ' HA3' ' B' ' 282' ' ' GLY . 16.8 m -88.02 160.72 17.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.548 -0.908 . . . . 72.510000000000005 108.548 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.4 -43.85 96.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 122.056 0.932 . . . . 74.510000000000005 110.532 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.51 -35.63 65.83 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.65 -1.614 . . . . 74.439999999999998 112.282 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.451 ' HB2' ' CA ' ' B' ' 282' ' ' GLY . . . -63.52 -25.54 68.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.07 0.767 . . . . 71.439999999999998 113.07 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 tt -57.41 110.36 0.85 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.269 0.557 . . . . 75.340000000000003 110.215 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -150.07 167.78 25.78 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.785 -0.821 . . . . 73.530000000000001 108.785 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -71.21 91.71 0.46 Allowed Glycine 0 N--CA 1.442 -0.957 0 O-C-N 124.178 0.924 . . . . 63.409999999999997 112.256 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -174.22 64.64 0.11 Allowed Glycine 0 N--CA 1.428 -1.873 0 C-N-CA 120.797 -0.716 . . . . 64.430000000000007 111.936 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 49.9 mm -74.11 114.75 14.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.826 -0.805 . . . . 65.120000000000005 108.826 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 72.69 103.83 0.07 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.536 1.147 . . . . 73.340000000000003 110.558 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 38.7 pt -113.96 158.47 14.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.878 -1.156 . . . . 73.019999999999996 107.878 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 70.5 m -93.01 76.88 4.71 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 114.347 1.24 . . . . 71.010000000000005 114.347 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -143.11 103.99 4.23 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 106.569 -1.641 . . . . 75.530000000000001 106.569 168.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 259' ' ' GLN . . . . . 0.417 ' OE1' ' HA ' ' B' ' 223' ' ' VAL . 29.2 mt-30 -130.01 44.1 3.02 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.262 -1.384 . . . . 74.099999999999994 107.262 175.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 68.8 m -63.88 121.32 13.77 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 113.232 -1.804 . . . . 72.040000000000006 108.324 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 62.8 m -90.29 112.96 24.7 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.665 -0.865 . . . . 63.109999999999999 108.665 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -96.47 128.62 43.56 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-N 114.891 -1.05 . . . . 60.130000000000003 109.899 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 14.5 m -121.49 121.13 36.83 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.194 -1.039 . . . . 74.5 108.194 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.8 p -129.61 145.82 35.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.302 -0.999 . . . . 64.200000000000003 108.302 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 20.5 tt0 -93.0 -75.44 0.49 Allowed 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 119.03 -1.068 . . . . 74.409999999999997 112.033 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 32.8 m -124.95 134.54 52.59 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.806 -1.158 . . . . 73.019999999999996 111.478 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.47 HG12 ' HB ' ' C' ' 231' ' ' ILE . 10.0 m -118.4 134.33 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 108.018 -1.104 . . . . 71.129999999999995 108.018 173.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 85.1 t -123.97 128.49 74.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 115.636 -0.711 . . . . 72.400000000000006 110.036 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.22 131.69 9.89 Favored Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 110.293 -1.123 . . . . 71.439999999999998 110.293 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.495 ' HB3' ' HG2' ' C' ' 234' ' ' GLU . 2.2 tpmt? -135.53 137.85 42.47 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 122.943 0.497 . . . . 75.140000000000001 111.073 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 271' ' ' GLY . . . . . 0.481 ' H ' ' HB2' ' B' ' 235' ' ' GLU . . . 86.29 -52.74 4.54 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 114.746 0.658 . . . . 43.43 114.746 169.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 272' ' ' GLU . . . . . 0.721 ' HB3' ' H ' ' C' ' 236' ' ' ARG . 1.6 tm-20 -177.4 105.28 0.05 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 103.156 -2.905 . . . . 71.209999999999994 103.156 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 273' ' ' SER . . . . . 0.603 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 44.4 m -145.24 144.95 31.09 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-O 121.07 0.462 . . . . 55.329999999999998 110.764 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 60.4 mtt180 -135.68 127.28 28.89 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 106.373 -1.714 . . . . 73.040000000000006 106.373 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.2 p -132.68 129.61 58.64 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.824 0 O-C-N 123.695 0.622 . . . . 74.209999999999994 110.364 -175.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.423 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 6.6 tt -110.59 115.75 30.14 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.976 -1.12 . . . . 75.109999999999999 107.976 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.468 HG23 HD12 ' C' ' 241' ' ' LEU . 37.2 mm -106.9 103.82 16.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.031 -1.1 . . . . 71.030000000000001 108.031 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 144.04 -140.39 9.39 Favored Glycine 0 N--CA 1.424 -2.167 0 C-N-CA 119.53 -1.319 . . . . 63.32 113.285 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 279' ' ' ASN . . . . . 0.405 ' HB3' ' CE2' ' B' ' 281' ' ' TYR . 1.7 m-20 -111.76 129.48 56.11 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.55 -0.537 . . . . 72.530000000000001 109.55 -175.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -114.5 118.28 33.33 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.345 -0.983 . . . . 74.349999999999994 108.345 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.405 ' CE2' ' HB3' ' B' ' 279' ' ' ASN . 97.8 m-85 -117.22 124.52 49.27 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 109.227 -0.657 . . . . 74.439999999999998 109.227 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.47 ' HA3' ' HB ' ' B' ' 246' ' ' THR . . . 103.99 -46.86 1.14 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 110.139 -1.185 . . . . 71.150000000000006 110.139 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 283' ' ' GLY . . . . . 0.555 ' O ' ' HE2' ' B' ' 284' ' ' LYS . . . 95.5 37.31 5.09 Favored Glycine 0 N--CA 1.411 -3.016 0 C-N-CA 120.899 -0.667 . . . . 74.349999999999994 112.748 176.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 284' ' ' LYS . . . . . 0.555 ' HE2' ' O ' ' B' ' 283' ' ' GLY . 9.9 tppt? -161.64 35.24 0.13 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 119.21 -0.996 . . . . 74.25 112.34 -175.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 285' ' ' GLY . . . . . 0.701 ' HA3' HG11 ' B' ' 244' ' ' VAL . . . -89.61 144.78 17.99 Favored Glycine 0 CA--C 1.488 -1.595 0 C-N-CA 119.28 -1.438 . . . . 72.25 113.572 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.536 ' H ' ' HA2' ' A' ' 283' ' ' GLY . 0.2 OUTLIER 68.78 -71.31 0.12 Allowed 'General case' 0 C--O 1.245 0.854 0 C-N-CA 124.872 1.269 . . . . 74.0 110.18 178.669 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.536 ' HA ' ' OD1' ' A' ' 288' ' ' ASP . 0.0 OUTLIER -99.96 142.19 31.77 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.047 -0.979 . . . . 70.310000000000002 112.973 -173.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . 0.274 30.0 t70 88.27 169.55 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 126.835 2.054 . . . . 61.329999999999998 110.662 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 74.78 27.32 1.26 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 104.621 -2.363 . . . . 51.140000000000001 104.621 -165.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -85.27 -26.9 26.36 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 112.574 -2.103 . . . . 63.299999999999997 107.078 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -80.93 66.23 6.37 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.067 -1.456 . . . . 74.200000000000003 107.067 172.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -147.1 91.25 1.97 Allowed 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 103.057 -2.942 . . . . 73.120000000000005 103.057 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -80.81 71.83 7.75 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.041 0.924 . . . . 74.200000000000003 113.129 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -121.13 78.31 1.39 Allowed 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 106.838 -1.541 . . . . 64.439999999999998 106.838 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 . . . . . 0 C--N 1.298 -1.659 0 N-CA-C 107.588 -1.264 . . . . 52.32 107.588 -178.878 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 CA--C 1.51 -0.587 0 N-CA-C 110.067 -0.345 . . . . 74.329999999999998 110.067 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -143.45 97.93 3.16 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.068 -0.715 . . . . 72.540000000000006 109.068 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.29 160.17 10.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.702 -0.481 . . . . 63.32 109.702 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.77 146.96 30.72 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.222 -1.029 . . . . 75.439999999999998 108.222 172.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -150.28 22.18 0.84 Allowed 'General case' 0 N--CA 1.427 -1.604 0 O-C-N 123.351 0.407 . . . . 73.319999999999993 110.881 -175.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 49.2 mm -83.4 113.02 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 118.346 -1.341 . . . . 72.540000000000006 109.407 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 29.1 m -140.08 165.26 21.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 114.817 -1.083 . . . . 74.129999999999995 109.09 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -91.99 130.89 10.52 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 109.325 -1.51 . . . . 64.540000000000006 109.325 173.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -120.71 140.97 50.88 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 120.424 -0.511 . . . . 73.129999999999995 109.802 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -114.93 124.55 51.97 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.933 -1.506 . . . . 72.209999999999994 106.933 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 23.6 m -121.93 136.68 54.94 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 121.185 0.517 . . . . 60.450000000000003 110.35 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -139.51 129.72 25.29 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 107.878 -1.156 . . . . 74.25 107.878 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' C' ' 265' ' ' GLU . 17.5 mmtp -78.46 -71.46 0.43 Allowed 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.266 0.555 . . . . 74.209999999999994 112.361 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 230' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' C' ' 266' ' ' THR . 10.1 t0 -127.69 138.92 52.96 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.203 -0.908 . . . . 70.430000000000007 108.833 -170.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.47 ' HB ' HG12 ' B' ' 267' ' ' VAL . 23.5 mm -129.34 117.83 44.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.564 -1.272 . . . . 71.420000000000002 107.564 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 78.5 mtt180 -122.08 115.56 22.69 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.201 0.524 . . . . 71.239999999999995 109.612 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 20.0 p -110.21 126.46 54.15 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 106.843 -1.54 . . . . 74.019999999999996 106.843 177.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' B' ' 270' ' ' LYS . 48.0 mt-10 -137.59 138.38 39.48 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 108.74 -0.837 . . . . 74.209999999999994 108.74 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 50.65 92.01 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.661 1.356 . . . . 72.450000000000003 114.661 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.721 ' H ' ' HB3' ' B' ' 272' ' ' GLU . 3.5 mpt_? 66.85 34.59 5.36 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.23 1.412 . . . . 71.129999999999995 109.952 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.603 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -104.44 128.85 52.42 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.23 -0.895 . . . . 51.439999999999998 110.661 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.0 OUTLIER -124.98 135.3 52.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.504 -0.924 . . . . 73.019999999999996 108.504 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.6 p -139.65 142.68 32.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.862 0.839 . . . . 64.400000000000006 112.212 -176.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.407 ' HB3' ' HG ' ' C' ' 276' ' ' LEU . 48.2 tp60 -110.92 130.19 55.66 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.152 -1.425 . . . . 64.549999999999997 107.152 175.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.468 HD12 HG23 ' B' ' 277' ' ' ILE . 2.8 tm? -130.13 128.79 42.52 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.008 -0.738 . . . . 64.430000000000007 109.008 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 122.25 -121.9 4.87 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 109.919 -1.273 . . . . 72.450000000000003 109.919 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -139.39 153.28 47.6 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 120.508 -0.477 . . . . 73.329999999999998 111.087 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.793 HG11 ' HA3' ' C' ' 285' ' ' GLY . 63.8 t -127.58 124.23 63.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.663 -0.699 . . . . 53.119999999999997 109.61 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 59.2 t -122.15 110.76 28.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.429 -1.322 . . . . 63.240000000000002 107.429 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 246' ' ' THR . . . . . 0.417 ' HB ' ' HA3' ' C' ' 282' ' ' GLY . 37.7 m -87.78 161.92 17.31 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.154 -0.684 . . . . 72.400000000000006 109.154 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.93 -39.18 74.0 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.509 0.723 . . . . 72.140000000000001 110.83 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.41 -34.5 64.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.642 -1.617 . . . . 75.239999999999995 113.381 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -59.73 -34.78 73.38 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.255 0.465 . . . . 74.140000000000001 112.255 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 56.5 tp 47.92 78.46 0.08 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.392 1.077 . . . . 54.299999999999997 112.538 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 73.6 t60 70.92 -52.3 0.68 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.898 1.279 . . . . 74.120000000000005 112.838 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.01 -72.56 1.84 Allowed Glycine 0 C--N 1.308 -1.023 0 C-N-CA 121.309 -0.472 . . . . 52.450000000000003 111.973 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -174.94 146.52 8.49 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.961 -0.856 . . . . 50.229999999999997 110.961 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 9.1 tp -100.44 -23.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.748 0.785 . . . . 52.049999999999997 110.149 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -133.25 -37.26 0.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.765 -0.584 . . . . 74.140000000000001 111.323 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 16.1 tt -86.87 90.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 122.559 1.171 . . . . 53.229999999999997 110.723 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 25.5 t -135.4 141.94 45.56 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 105.584 -2.006 . . . . 64.019999999999996 105.584 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.17 -62.08 1.56 Allowed 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 112.271 0.471 . . . . 72.420000000000002 112.271 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 48.16 60.3 3.69 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 124.316 1.01 . . . . 74.430000000000007 111.069 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 29.1 m -77.99 140.07 39.17 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.681 -1.145 . . . . 72.420000000000002 108.656 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 85.0 m -89.11 117.25 27.97 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.976 0.894 . . . . 70.219999999999999 109.516 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -119.9 144.12 47.59 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.058 -1.428 . . . . 71.129999999999995 109.135 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -142.08 131.16 23.24 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 110.182 -0.303 . . . . 74.040000000000006 110.182 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 12.2 p -128.98 145.43 35.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.451 -0.944 . . . . 75.209999999999994 108.451 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' C' ' 229' ' ' LYS . 7.0 tp10 -79.76 -81.49 0.12 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 109.135 -0.691 . . . . 53.409999999999997 109.135 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 266' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 90.0 m -131.72 137.01 48.06 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.397 -0.815 . . . . 73.120000000000005 110.825 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.06 130.71 74.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.962 -0.755 . . . . 63.32 108.962 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 268' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.4 p -127.56 137.38 57.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 116.635 -0.257 . . . . 71.299999999999997 110.473 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.93 132.88 9.65 Favored Glycine 0 CA--C 1.483 -1.934 0 N-CA-C 110.352 -1.099 . . . . 70.219999999999999 110.352 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -134.6 147.73 50.28 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.145 -0.687 . . . . 65.25 109.145 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.26 -60.86 4.7 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 112.293 -0.323 . . . . 71.019999999999996 112.293 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 272' ' ' GLU . . . . . 0.533 ' HA ' ' HB2' ' C' ' 236' ' ' ARG . 36.4 tt0 -173.18 130.79 0.48 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.914 -2.254 . . . . 72.239999999999995 104.914 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 273' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 17.8 t -156.11 148.08 23.18 Favored 'General case' 0 N--CA 1.413 -2.324 0 C-N-CA 120.074 -0.65 . . . . 54.439999999999998 109.926 -176.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 274' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 46.2 mtm180 -138.12 125.43 21.76 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.212 -1.773 . . . . 74.140000000000001 106.212 172.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 5.1 p -139.57 135.44 39.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 123.548 0.53 . . . . 62.509999999999998 110.693 -176.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' C' ' 240' ' ' GLN . 7.0 tt -115.93 111.58 20.61 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.912 -0.773 . . . . 72.129999999999995 108.912 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 47.7 mm -102.28 104.21 16.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.871 -1.159 . . . . 73.209999999999994 107.871 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 278' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 147.84 -144.39 12.34 Favored Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.009 -1.636 . . . . 55.140000000000001 109.009 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -127.96 150.61 49.82 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 120.869 0.366 . . . . 73.200000000000003 110.405 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.531 ' HG2' ' ND2' ' C' ' 289' ' ' ASN . 6.2 tp10 -126.64 118.14 24.19 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.618 -0.719 . . . . 74.420000000000002 109.801 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -109.18 124.12 50.32 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.913 -0.773 . . . . 73.450000000000003 108.913 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 282' ' ' GLY . . . . . 0.417 ' HA3' ' HB ' ' C' ' 246' ' ' THR . . . 102.94 -53.17 0.76 Allowed Glycine 0 N--CA 1.434 -1.497 0 N-CA-C 110.502 -1.039 . . . . 62.32 110.502 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 283' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' C' ' 289' ' ' ASN . . . 95.14 54.64 1.46 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.416 -0.897 . . . . 21.550000000000001 113.207 176.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -164.2 21.65 0.07 Allowed 'General case' 0 C--O 1.238 0.47 0 C-N-CA 119.903 -0.719 . . . . 64.200000000000003 110.947 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 285' ' ' GLY . . . . . 0.793 ' HA3' HG11 ' C' ' 244' ' ' VAL . . . -74.92 138.75 24.14 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 115.011 0.764 . . . . 65.340000000000003 115.011 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.413 ' H ' ' HA2' ' B' ' 283' ' ' GLY . 0.1 OUTLIER 67.43 -79.37 0.04 OUTLIER 'General case' 0 C--O 1.252 1.196 0 C-N-CA 124.786 1.234 . . . . 73.310000000000002 110.934 174.543 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -93.51 -69.93 0.73 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 121.078 -0.249 . . . . 73.219999999999999 111.273 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 288' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' C' ' 289' ' ' ASN . 6.7 t70 -175.54 -168.86 0.33 Allowed 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 104.055 -2.572 . . . . 70.400000000000006 104.055 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 289' ' ' ASN . . . . . 0.531 ' ND2' ' HG2' ' C' ' 280' ' ' GLU . 33.1 t-20 177.16 -58.73 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.786 0.721 . . . . 72.239999999999995 109.506 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -143.47 155.24 44.31 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.552 -0.295 . . . . 73.349999999999994 110.853 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 33.4 t60 66.45 104.78 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.233 1.413 . . . . 73.310000000000002 112.385 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -70.64 122.15 19.25 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.138 0.792 . . . . 74.310000000000002 113.138 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 49.7 m80 60.53 105.41 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 116.456 2.021 . . . . 74.409999999999997 116.456 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -168.76 132.99 1.5 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.116 -1.809 . . . . 64.439999999999998 106.116 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 . . . . . 0 C--O 1.246 0.889 0 C-N-CA 123.993 0.917 . . . . 73.019999999999996 109.58 177.276 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 59.7 mtm . . . . . 0 CA--C 1.494 -1.195 0 N-CA-C 110.17 -0.307 . . . . 62.43 110.17 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -162.22 161.88 28.02 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.832 -1.914 . . . . 72.540000000000006 105.832 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.3 pt -74.58 106.08 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 N-CA-C 107.297 -1.372 . . . . 72.109999999999999 107.297 168.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.31 169.91 15.26 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.207 -0.906 . . . . 52.32 109.77 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -72.68 -33.71 66.7 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.715 -0.846 . . . . 64.150000000000006 108.715 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.24 117.58 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 CA-C-N 114.812 -1.086 . . . . 73.530000000000001 108.088 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.427 HG11 HG13 ' B' ' 222' ' ' ILE . 45.9 t -100.82 118.67 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 108.332 -0.988 . . . . 75.319999999999993 108.332 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 146.99 63.1 0.01 OUTLIER Glycine 0 C--N 1.287 -2.146 0 N-CA-C 107.016 -2.434 . . . . 53.5 107.016 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 23.1 ptt-85 -134.43 146.7 50.07 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 107.919 -1.141 . . . . 73.349999999999994 107.919 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.561 ' OD1' ' HA2' ' B' ' 242' ' ' GLY . 41.4 m-80 -109.96 135.32 50.99 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.094 -1.076 . . . . 74.239999999999995 108.094 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.9 m -121.55 136.5 54.95 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.578 0.704 . . . . 62.409999999999997 110.874 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.68 127.99 47.12 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.137 -1.431 . . . . 53.109999999999999 107.137 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -78.88 -60.42 2.39 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.913 -0.773 . . . . 74.129999999999995 108.913 -177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -137.5 139.3 40.46 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.538 0.685 . . . . 75.430000000000007 110.831 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 67.3 mt -128.78 122.47 57.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.257 -1.016 . . . . 33.200000000000003 108.257 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -130.69 115.01 16.1 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.721 0.772 . . . . 73.400000000000006 111.329 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.643 HG21 HG13 ' A' ' 239' ' ' VAL . 6.8 p -111.99 137.06 50.52 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.226 -0.897 . . . . 74.409999999999997 109.75 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.404 ' OE2' ' HE3' ' A' ' 270' ' ' LYS . 40.5 tt0 -133.97 147.17 51.0 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 116.066 -0.516 . . . . 64.109999999999999 110.989 -174.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.429 ' HG2' ' HE ' ' A' ' 236' ' ' ARG . 32.3 tt0 73.38 -79.0 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.589 1.156 . . . . 71.150000000000006 112.727 170.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.429 ' HE ' ' HG2' ' A' ' 235' ' ' GLU . 75.1 mtm180 -136.16 15.81 3.25 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.09 0.947 . . . . 74.510000000000005 109.077 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.08 133.37 34.23 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.65 -1.159 . . . . 64.530000000000001 109.791 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -132.11 144.02 50.42 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.621 0.724 . . . . 74.120000000000005 112.006 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.934 HG12 ' HB ' ' A' ' 275' ' ' VAL . 15.4 m -123.69 150.4 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 CA-C-N 114.832 -1.076 . . . . 70.230000000000004 111.804 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -116.85 120.83 39.7 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-N 114.259 -1.337 . . . . 74.129999999999995 108.148 175.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -111.26 118.2 35.26 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.049 -1.834 . . . . 74.209999999999994 106.049 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.02 -155.71 21.13 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 119.828 -1.177 . . . . 33.0 112.892 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -110.83 128.58 55.82 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.136 0.574 . . . . 71.109999999999999 110.658 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.421 ' CG1' ' HA3' ' A' ' 285' ' ' GLY . 48.6 t -116.34 115.05 47.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.369 -0.974 . . . . 74.409999999999997 108.369 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' A' ' 281' ' ' TYR . 7.3 p -114.42 124.82 71.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.277 0.56 . . . . 53.43 112.46 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 23.8 p -117.24 166.59 12.09 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 116.001 -0.545 . . . . 71.209999999999994 111.366 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.74 74.13 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.536 0.734 . . . . 71.239999999999995 112.757 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.37 66.29 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.634 0.975 . . . . 64.209999999999994 113.634 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.645 ' HB2' ' N ' ' A' ' 282' ' ' GLY . . . -75.52 -26.36 58.0 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 112.536 0.569 . . . . 73.319999999999993 112.536 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 6.9 mp 65.34 -170.48 0.19 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.795 -1.187 . . . . 64.310000000000002 107.795 -168.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -112.19 11.35 20.27 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.237 -0.914 . . . . 74.409999999999997 110.292 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -73.11 -24.74 75.1 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.391 -0.822 . . . . 71.430000000000007 112.381 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -79.81 -12.3 83.67 Favored Glycine 0 C--O 1.25 1.119 0 N-CA-C 111.385 -0.686 . . . . 61.439999999999998 111.385 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 55.6 mt -82.97 76.15 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 122.667 1.223 . . . . 75.340000000000003 109.12 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -155.32 -34.94 0.09 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 112.618 -2.083 . . . . 72.310000000000002 107.377 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.483 HD12 ' CD2' ' B' ' 281' ' ' TYR . 6.5 pt -94.79 -54.64 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.082 -0.963 . . . . 73.140000000000001 109.316 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 14.9 m 55.97 -157.8 0.24 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.773 0.829 . . . . 62.43 111.786 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.422 ' HA ' ' OD1' ' B' ' 243' ' ' ASN . 3.6 m-20 -68.97 122.2 18.18 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 109.493 -0.558 . . . . 62.409999999999997 109.493 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -135.46 -51.67 0.75 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.663 -0.698 . . . . 70.25 110.073 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 40.9 m -67.9 126.06 28.24 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.398 -0.964 . . . . 64.040000000000006 108.398 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 10.6 t -92.91 133.94 35.6 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-O 121.292 0.568 . . . . 73.150000000000006 109.617 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -126.33 142.2 51.62 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.12 -0.696 . . . . 73.530000000000001 109.12 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.637 ' HG ' ' N ' ' B' ' 217' ' ' MET . 22.7 t -127.69 130.71 49.34 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 108.721 -0.844 . . . . 74.230000000000004 108.721 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.02 139.73 51.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.967 -0.383 . . . . 73.349999999999994 109.967 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 15.3 mt-10 -79.1 -70.64 0.49 Allowed 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 119.823 -0.751 . . . . 71.439999999999998 111.525 176.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 13.6 m -119.44 126.86 52.33 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.889 -0.724 . . . . 40.340000000000003 111.949 -174.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.39 122.26 67.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 N-CA-C 109.118 -0.697 . . . . 51.539999999999999 109.118 171.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.56 146.67 29.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.643 0.735 . . . . 62.240000000000002 112.593 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.73 133.28 7.78 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.14 -0.936 . . . . 34.32 111.002 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.404 ' HE3' ' OE2' ' A' ' 234' ' ' GLU . 0.2 OUTLIER -130.27 116.0 17.75 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.074 -1.084 . . . . 54.43 108.074 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.16 -136.84 13.02 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.147 -1.581 . . . . 75.25 109.147 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -99.24 53.22 0.96 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.942 0.877 . . . . 73.019999999999996 109.701 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 7.1 m -83.02 148.22 27.69 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.167 -0.924 . . . . 61.5 111.209 -174.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 45.8 mtm180 -130.02 128.19 41.48 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.287 -0.415 . . . . 75.310000000000002 109.946 175.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.934 ' HB ' HG12 ' A' ' 239' ' ' VAL . 17.9 t -130.46 140.42 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 N-CA-C 108.095 -1.076 . . . . 55.340000000000003 108.095 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 286' ' ' PHE . 5.5 tt -126.17 121.1 31.83 Favored 'General case' 0 C--N 1.275 -2.655 0 C-N-CA 118.913 -1.115 . . . . 74.019999999999996 108.426 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.406 ' HA ' ' HB3' ' B' ' 241' ' ' LEU . 3.5 mp -107.92 104.61 17.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 106.316 -1.735 . . . . 62.329999999999998 106.316 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.13 -134.77 5.37 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.435 -1.066 . . . . 62.109999999999999 110.435 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 45.2 t-20 -130.15 134.58 47.42 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 117.103 0.451 . . . . 62.200000000000003 111.396 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 287' ' ' TRP . 10.3 tp10 -111.23 122.85 48.93 Favored 'General case' 0 C--O 1.269 2.084 0 N-CA-C 106.746 -1.576 . . . . 74.219999999999999 106.746 174.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.506 ' HB2' ' HA ' ' A' ' 245' ' ' VAL . 12.0 m-85 -109.24 122.81 48.14 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.751 -1.944 . . . . 73.140000000000001 105.751 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.645 ' N ' ' HB2' ' A' ' 249' ' ' ALA . . . 103.86 -51.85 0.79 Allowed Glycine 0 C--N 1.297 -1.617 0 C-N-CA 120.445 -0.883 . . . . 74.140000000000001 112.999 177.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.41 30.54 18.88 Favored Glycine 0 CA--C 1.498 -0.986 0 N-CA-C 109.9 -1.28 . . . . 60.520000000000003 109.9 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -129.81 -8.98 4.47 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.465 -0.867 . . . . 73.209999999999994 111.456 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.421 ' HA3' ' CG1' ' A' ' 244' ' ' VAL . . . -86.61 -80.27 1.19 Allowed Glycine 0 CA--C 1.487 -1.661 0 C-N-CA 119.386 -1.388 . . . . 72.25 112.415 -175.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.477 ' HB3' HD12 ' A' ' 276' ' ' LEU . 75.6 t80 -99.98 -22.74 15.14 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.504 -1.295 . . . . 75.450000000000003 107.504 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.576 ' HA ' ' CE3' ' A' ' 287' ' ' TRP . 0.2 OUTLIER -91.7 174.61 7.26 Favored 'General case' 0 N--CA 1.41 -2.469 0 N-CA-C 115.741 1.756 . . . . 74.230000000000004 115.741 178.18 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -164.17 163.83 22.85 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 111.599 -2.546 . . . . 71.040000000000006 105.394 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.76 42.91 3.22 Favored 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 106.861 -1.533 . . . . 73.310000000000002 106.861 171.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -86.71 171.54 10.86 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-N 112.614 -2.084 . . . . 72.040000000000006 108.82 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 79.87 85.52 0.05 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.44 1.496 . . . . 65.439999999999998 111.862 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -149.53 145.11 26.68 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 124.677 1.191 . . . . 63.509999999999998 107.878 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -129.78 -30.62 2.03 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.241 -1.022 . . . . 55.509999999999998 108.241 172.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.432 ' H ' ' CD ' ' C' ' 272' ' ' GLU . 2.1 t-80 67.24 24.75 9.07 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.038 1.735 . . . . 70.349999999999994 110.536 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 . . . . . 0 N--CA 1.435 -1.192 0 N-CA-C 106.671 -1.603 . . . . 74.329999999999998 106.671 178.538 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 217' ' ' MET . . . . . 0.637 ' N ' ' HG ' ' A' ' 263' ' ' SER . 1.5 mpt? . . . . . 0 CA--C 1.502 -0.894 0 N-CA-C 107.572 -1.27 . . . . 70.129999999999995 107.572 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.401 ' CD ' ' HB2' ' A' ' 263' ' ' SER . 1.7 mmmp? -113.21 107.5 15.99 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.661 -0.866 . . . . 73.140000000000001 108.661 177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 62.7 mt -95.46 83.01 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 106.9 -1.518 . . . . 63.219999999999999 106.9 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -138.25 172.95 12.15 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.596 -1.184 . . . . 73.409999999999997 107.887 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -92.08 6.28 47.07 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.612 0.72 . . . . 72.219999999999999 110.386 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' ILE . . . . . 0.427 HG13 HG11 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -99.29 121.02 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-N 115.739 -0.664 . . . . 71.540000000000006 109.272 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.89 126.17 55.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 106.711 -1.589 . . . . 61.340000000000003 106.711 174.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 140.96 60.38 0.03 OUTLIER Glycine 0 C--N 1.294 -1.799 0 N-CA-C 106.305 -2.718 . . . . 64.420000000000002 106.305 -174.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 261' ' ' THR . 30.3 ptt85 -140.11 139.95 35.93 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.007 -1.096 . . . . 70.230000000000004 110.859 -170.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.496 ' OD1' ' HA2' ' C' ' 242' ' ' GLY . 51.1 m-80 -108.18 148.52 29.78 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.919 -1.141 . . . . 72.230000000000004 107.919 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 227' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 263' ' ' SER . 31.2 m -135.95 137.44 41.3 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.572 0.701 . . . . 70.430000000000007 111.163 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.51 129.85 51.37 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.631 -1.168 . . . . 74.120000000000005 108.449 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 5.3 tmtt? -78.55 -66.49 0.85 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.384 -0.826 . . . . 72.400000000000006 108.816 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -134.82 139.05 44.78 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 116.524 -0.307 . . . . 51.399999999999999 110.347 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 10.8 mt -132.23 117.72 33.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.241 -1.022 . . . . 65.530000000000001 108.241 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.455 ' HB3' HG12 ' B' ' 268' ' ' VAL . 25.8 ttt180 -113.64 122.46 47.25 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.938 -0.574 . . . . 65.010000000000005 110.735 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 76.0 p -110.7 132.16 54.44 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.945 -1.131 . . . . 75.450000000000003 107.945 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -133.72 150.83 51.51 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.353 -0.539 . . . . 73.439999999999998 109.778 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.413 ' HB3' ' HD2' ' B' ' 236' ' ' ARG . 42.4 mt-10 70.13 -95.19 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 124.556 1.142 . . . . 73.209999999999994 113.455 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' B' ' 272' ' ' GLU . 0.0 OUTLIER -129.04 31.13 4.95 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.425 -1.324 . . . . 75.209999999999994 107.425 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -76.24 137.25 39.84 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.29 -0.868 . . . . 74.329999999999998 110.701 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 1.7 mpp_? -125.34 134.35 52.24 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.031 -0.986 . . . . 65.400000000000006 108.514 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.549 HG12 ' HB ' ' B' ' 275' ' ' VAL . 19.6 m -135.58 140.83 43.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.8 0.809 . . . . 52.409999999999997 111.265 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.441 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 38.8 tp60 -105.15 135.79 45.84 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 114.211 -1.359 . . . . 60.030000000000001 108.463 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.406 ' HB3' ' HA ' ' A' ' 277' ' ' ILE . 1.5 tm? -125.97 117.02 22.39 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 104.911 -2.255 . . . . 63.200000000000003 104.911 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.574 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 125.19 -146.12 16.0 Favored Glycine 0 N--CA 1.42 -2.407 0 C-N-CA 119.549 -1.31 . . . . 44.43 111.844 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 0.7 OUTLIER -113.81 146.17 40.34 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.442 -0.577 . . . . 74.430000000000007 109.442 -176.428 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.441 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 59.2 t -126.78 122.48 60.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.015 -1.476 . . . . 71.310000000000002 107.015 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.53 126.0 72.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.369 -1.333 . . . . 75.319999999999993 113.49 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 24.4 p -120.28 163.13 18.27 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.947 -0.569 . . . . 75.340000000000003 112.034 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.64 -31.82 58.06 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.723 1.209 . . . . 31.140000000000001 112.201 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.36 70.17 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.885 0.698 . . . . 75.430000000000007 112.885 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.48 ' HB2' ' N ' ' B' ' 282' ' ' GLY . . . -75.01 -44.37 48.44 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.484 -0.486 . . . . 34.229999999999997 109.988 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 63.8 tp 64.76 -72.49 0.06 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.131 1.372 . . . . 52.539999999999999 110.36 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -130.34 77.55 1.79 Allowed 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 107.147 -1.427 . . . . 73.310000000000002 107.147 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' GLY . . . . . 0.472 ' H ' HD13 ' A' ' 256' ' ' ILE . . . -85.31 73.59 2.58 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.57 -1.195 . . . . 73.510000000000005 111.198 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 253' ' ' GLY . . . . . 0.403 ' N ' HD21 ' C' ' 250' ' ' LEU . . . 137.62 -151.79 21.37 Favored Glycine 0 N--CA 1.42 -2.4 0 N-CA-C 109.93 -1.268 . . . . 11.539999999999999 109.93 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 64.4 mt -139.78 -66.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 105.85 -1.908 . . . . 41.409999999999997 105.85 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -147.84 -157.23 0.79 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 104.625 -2.361 . . . . 74.140000000000001 104.625 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 11.2 tt -71.28 89.26 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 122.469 1.128 . . . . 72.450000000000003 111.118 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 14.0 m -101.72 6.88 42.03 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.534 -1.212 . . . . 74.340000000000003 109.967 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -125.1 157.67 35.74 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.039 -0.528 . . . . 72.409999999999997 111.173 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.21 28.66 0.58 Allowed 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 124.307 1.043 . . . . 55.399999999999999 110.178 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 58.2 m -79.01 135.44 36.9 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.136 -0.69 . . . . 75.340000000000003 109.136 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 10.2 t -123.53 134.54 53.85 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 121.558 0.694 . . . . 75.099999999999994 110.182 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -125.16 138.15 54.15 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.582 -0.896 . . . . 71.530000000000001 108.582 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 263' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' C' ' 227' ' ' SER . 41.8 m -130.33 132.51 45.88 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.691 -0.485 . . . . 74.099999999999994 109.691 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 7.3 p -125.68 142.35 42.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 116.123 -0.489 . . . . 70.329999999999998 110.923 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.552 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 10.4 mm-40 -82.68 -69.02 0.66 Allowed 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 123.793 0.683 . . . . 75.109999999999999 109.703 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.5 m -126.06 127.21 45.48 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 119.572 -0.851 . . . . 73.510000000000005 112.252 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.46 HG11 HG11 ' B' ' 275' ' ' VAL . 48.0 t -118.66 120.76 65.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.359 -1.348 . . . . 53.409999999999997 107.359 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 268' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' B' ' 232' ' ' ARG . 27.4 m -125.6 137.46 57.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.69 0.757 . . . . 70.409999999999997 112.152 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.71 133.65 11.01 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 110.279 -1.128 . . . . 71.430000000000007 110.279 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -132.08 115.88 16.34 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.359 0.599 . . . . 75.040000000000006 109.566 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.75 -132.28 10.95 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 119.996 -1.097 . . . . 15.44 111.178 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 272' ' ' GLU . . . . . 0.415 ' HG3' HH11 ' B' ' 236' ' ' ARG . 21.5 mt-10 -96.14 48.28 1.1 Allowed 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.746 0.818 . . . . 72.329999999999998 110.437 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 15.5 m -81.46 150.27 28.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.156 -0.929 . . . . 72.329999999999998 112.93 -171.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 49.2 mtm180 -133.26 128.09 35.09 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.887 -0.597 . . . . 75.140000000000001 110.016 173.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.641 HG13 HG23 ' C' ' 239' ' ' VAL . 22.0 t -131.83 138.69 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.778 0 N-CA-C 108.366 -0.976 . . . . 61.310000000000002 108.366 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.414 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 5.9 tt -120.99 116.32 24.86 Favored 'General case' 0 C--N 1.277 -2.561 0 C-N-CA 118.849 -1.14 . . . . 63.439999999999998 108.148 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.479 ' HA ' ' HB3' ' C' ' 241' ' ' LEU . 4.0 mp -106.31 103.5 15.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 106.313 -1.736 . . . . 72.099999999999994 106.313 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 149.67 -135.02 5.13 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.729 -0.748 . . . . 74.420000000000002 112.501 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 279' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 48.5 t-20 -128.72 130.0 46.53 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.201 -0.666 . . . . 63.340000000000003 109.201 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -111.35 118.67 36.47 Favored 'General case' 0 C--O 1.268 2.034 0 N-CA-C 106.992 -1.484 . . . . 73.230000000000004 106.992 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.483 ' CD2' HD12 ' A' ' 256' ' ' ILE . 69.8 m-85 -105.04 122.31 45.6 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 106.919 -1.511 . . . . 72.409999999999997 106.919 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.48 ' N ' ' HB2' ' B' ' 249' ' ' ALA . . . 101.09 -52.29 0.91 Allowed Glycine 0 C--N 1.297 -1.638 0 C-N-CA 120.37 -0.919 . . . . 74.439999999999998 112.524 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.58 32.75 12.58 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.962 -1.113 . . . . 62.340000000000003 111.39 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -136.68 2.09 2.63 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.569 0.581 . . . . 65.219999999999999 112.569 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 285' ' ' GLY . . . . . 0.435 ' HA3' ' CG1' ' B' ' 244' ' ' VAL . . . -86.15 -77.86 1.21 Allowed Glycine 0 CA--C 1.487 -1.707 0 C-N-CA 118.712 -1.708 . . . . 40.420000000000002 110.739 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -97.01 -21.29 17.5 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.545 -1.28 . . . . 73.530000000000001 107.545 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.547 ' HA ' ' CE3' ' B' ' 287' ' ' TRP . 0.0 OUTLIER -93.6 173.31 7.76 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.309 -1.314 . . . . 72.239999999999995 114.374 177.545 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -140.87 149.38 41.88 Favored 'General case' 0 N--CA 1.407 -2.605 0 N-CA-C 103.952 -2.61 . . . . 74.230000000000004 103.952 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -80.14 -15.52 56.9 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.453 -0.499 . . . . 62.299999999999997 112.044 -174.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 290' ' ' HIS . . . . . 0.594 ' CE1' ' HA ' ' C' ' 291' ' ' HIS . 10.3 t60 -173.73 -54.54 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.934 -1.135 . . . . 72.030000000000001 107.934 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -159.66 145.98 16.17 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 106.198 -1.779 . . . . 73.239999999999995 106.198 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -154.2 130.05 10.14 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.466 -1.309 . . . . 70.219999999999999 107.466 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -82.96 94.39 7.73 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.935 0.874 . . . . 74.310000000000002 110.464 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -101.25 72.56 1.45 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.256 -1.386 . . . . 74.239999999999995 107.256 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 . . . . . 0 C--N 1.3 -1.571 0 N-CA-C 108.273 -1.01 . . . . 63.5 108.273 -176.026 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 217' ' ' MET . . . . . 0.547 ' HG2' ' H ' ' C' ' 218' ' ' LYS . 17.6 ttt . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 106.157 -1.794 . . . . 55.229999999999997 106.157 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 218' ' ' LYS . . . . . 0.547 ' H ' ' HG2' ' C' ' 217' ' ' MET . 0.0 OUTLIER 68.56 130.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 119.456 1.026 . . . . 74.200000000000003 111.569 -174.613 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 10.8 tt -90.27 132.46 34.84 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 CA-C-O 121.497 0.665 . . . . 75.209999999999994 112.594 -176.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -142.4 -174.86 4.25 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 104.518 -2.401 . . . . 70.129999999999995 104.518 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -79.91 96.82 6.49 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.428 -2.064 . . . . 45.409999999999997 105.428 168.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.96 114.96 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-O 122.003 0.906 . . . . 61.310000000000002 111.8 -171.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.4 t -100.99 119.34 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 107.305 -1.368 . . . . 71.040000000000006 107.305 175.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 145.54 56.23 0.02 OUTLIER Glycine 0 C--N 1.289 -2.06 0 N-CA-C 107.504 -2.238 . . . . 52.210000000000001 107.504 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -122.99 144.48 49.22 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-N 114.639 -0.781 . . . . 75.310000000000002 109.715 -174.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -102.22 142.18 33.88 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 106.64 -1.615 . . . . 75.420000000000002 106.64 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' B' ' 263' ' ' SER . 55.5 m -136.98 137.91 39.99 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.382 0.611 . . . . 71.450000000000003 111.19 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.19 130.23 50.55 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.417 -0.81 . . . . 71.230000000000004 109.262 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -84.07 -61.58 1.78 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.578 -0.527 . . . . 74.049999999999997 109.578 -177.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -129.14 138.18 51.63 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 122.152 -0.342 . . . . 70.540000000000006 110.538 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 18.4 mt -136.04 117.32 19.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 107.614 -1.254 . . . . 74.540000000000006 107.614 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -119.4 126.0 50.33 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.481 0.658 . . . . 63.329999999999998 110.82 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 24.5 p -110.17 135.44 50.95 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.431 -0.951 . . . . 62.450000000000003 108.431 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -134.89 149.83 50.35 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.757 -0.831 . . . . 63.530000000000001 108.757 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.518 ' HB3' ' HD3' ' C' ' 236' ' ' ARG . 36.6 mt-10 64.58 -99.02 0.07 Allowed 'General case' 0 C--O 1.203 -1.372 0 C-N-CA 124.556 1.142 . . . . 62.240000000000002 113.698 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.518 ' HD3' ' HB3' ' C' ' 235' ' ' GLU . 0.2 OUTLIER -122.62 35.52 4.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 108.221 -1.029 . . . . 74.510000000000005 108.221 -177.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -81.3 134.38 35.58 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 114.563 -1.198 . . . . 72.519999999999996 110.659 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 2.0 mpp_? -125.33 133.88 52.43 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.616 -1.174 . . . . 63.119999999999997 107.942 176.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.641 HG23 HG13 ' B' ' 275' ' ' VAL . 29.4 m -134.67 141.26 43.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.649 0.738 . . . . 73.030000000000001 110.922 177.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.422 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 45.1 tp60 -104.79 136.05 45.03 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 114.648 -1.16 . . . . 75.519999999999996 108.495 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.479 ' HB3' ' HA ' ' B' ' 277' ' ' ILE . 1.6 tm? -126.42 116.96 21.97 Favored 'General case' 0 N--CA 1.402 -2.848 0 N-CA-C 104.864 -2.273 . . . . 74.109999999999999 104.864 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.501 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 121.66 -131.42 8.52 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 119.618 -1.277 . . . . 75.540000000000006 113.31 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.626 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 13.1 m120 -122.23 139.7 53.46 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.884 -0.413 . . . . 63.009999999999998 109.884 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.422 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 48.4 t -126.34 117.46 48.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 106.545 -1.65 . . . . 74.209999999999994 106.545 172.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.03 127.85 74.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.797 -1.161 . . . . 71.439999999999998 113.104 -175.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 20.2 p -114.0 162.63 16.18 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.093 -0.503 . . . . 63.130000000000003 111.185 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.33 -32.04 69.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.445 0.698 . . . . 63.509999999999998 110.836 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.32 -33.61 59.26 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.505 1.122 . . . . 72.430000000000007 112.533 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -63.57 -26.7 68.81 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 112.244 0.461 . . . . 64.439999999999998 112.244 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 250' ' ' LEU . . . . . 0.403 HD21 ' N ' ' B' ' 253' ' ' GLY . 3.0 mm? -75.42 79.94 2.47 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.285 1.041 . . . . 73.129999999999995 110.082 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -167.81 -39.8 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 105.984 -1.858 . . . . 75.099999999999994 105.984 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 174.52 156.64 14.28 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 110.775 -0.93 . . . . 64.019999999999996 110.775 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 116.38 -2.36 20.45 Favored Glycine 0 C--N 1.31 -0.911 0 C-N-CA 120.529 -0.843 . . . . 73.299999999999997 112.617 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 30.0 pt -114.81 130.34 69.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 120.801 0.334 . . . . 54.32 110.437 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 255' ' ' ARG . . . . . 0.45 ' HG3' HD12 ' C' ' 256' ' ' ILE . 14.5 tpp180 -148.76 -73.66 0.18 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.341 -0.985 . . . . 74.109999999999999 108.341 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 256' ' ' ILE . . . . . 0.45 HD12 ' HG3' ' C' ' 255' ' ' ARG . 2.5 mp -135.83 -66.35 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 106.855 -1.535 . . . . 71.129999999999995 106.855 176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 14.4 t 166.9 -160.11 0.01 OUTLIER 'General case' 0 C--O 1.258 1.539 0 N-CA-C 102.267 -3.235 . . . . 74.530000000000001 102.267 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -134.2 141.31 47.0 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.234 -1.024 . . . . 72.409999999999997 108.234 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -74.8 18.18 0.18 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.466 0.913 . . . . 74.150000000000006 113.466 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 89.1 m -83.73 122.0 28.05 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 109.281 -0.637 . . . . 65.5 109.281 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 8.6 t -109.03 119.95 41.07 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.592 0.71 . . . . 53.439999999999998 109.34 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -114.68 125.63 53.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.749 -0.66 . . . . 71.219999999999999 109.513 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 263' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' C' ' 227' ' ' SER . 28.5 t -117.78 135.37 54.1 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 108.179 -1.045 . . . . 62.219999999999999 108.179 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.0 141.44 42.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 116.402 -0.363 . . . . 73.230000000000004 110.333 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -78.42 -66.45 0.85 Allowed 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 122.493 0.317 . . . . 73.340000000000003 111.047 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.8 m -129.03 132.37 47.48 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 120.523 -0.471 . . . . 72.239999999999995 111.441 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.75 123.95 72.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.074 -1.454 . . . . 65.030000000000001 107.074 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 20.1 m -124.99 143.59 38.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.3 0.571 . . . . 70.109999999999999 112.338 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.2 133.78 9.16 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.331 -1.108 . . . . 64.530000000000001 110.331 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -133.84 125.09 27.66 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 123.643 0.777 . . . . 60.509999999999998 109.708 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.24 -136.99 21.32 Favored Glycine 0 CA--C 1.506 -0.512 0 N-CA-C 110.108 -1.197 . . . . 45.210000000000001 110.108 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 272' ' ' GLU . . . . . 0.432 ' CD ' ' H ' ' A' ' 294' ' ' HIS . 10.2 mp0 -81.26 98.12 7.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.528 -0.916 . . . . 74.099999999999994 108.528 173.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 50.5 m -120.35 149.94 41.53 Favored 'General case' 0 C--N 1.278 -2.5 0 C-N-CA 120.121 -0.632 . . . . 70.349999999999994 110.845 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 274' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 75.6 mtm180 -140.1 127.49 21.36 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.022 -1.103 . . . . 70.140000000000001 108.022 174.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.416 ' HB ' HG12 ' C' ' 239' ' ' VAL . 7.8 t -135.29 140.06 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.678 0 N-CA-C 107.561 -1.274 . . . . 64.129999999999995 107.561 176.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 7.0 tt -120.65 111.74 18.01 Favored 'General case' 0 N--CA 1.403 -2.789 0 C-N-CA 118.894 -1.122 . . . . 63.509999999999998 108.871 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.66 103.18 14.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 105.272 -2.122 . . . . 74.140000000000001 105.272 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 278' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 149.11 -140.32 8.09 Favored Glycine 0 CA--C 1.492 -1.401 0 C-N-CA 120.286 -0.959 . . . . 64.150000000000006 111.852 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -128.45 133.89 48.63 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.417 -0.586 . . . . 72.310000000000002 109.417 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' C' ' 287' ' ' TRP . 10.2 tp10 -111.75 118.72 36.37 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.351 -1.351 . . . . 74.319999999999993 107.351 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -105.31 123.58 48.1 Favored 'General case' 0 C--O 1.253 1.282 0 N-CA-C 107.713 -1.218 . . . . 73.430000000000007 107.713 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.35 -42.03 2.04 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.958 -0.857 . . . . 73.099999999999994 110.958 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 73.06 43.4 40.36 Favored Glycine 0 CA--C 1.482 -1.996 0 N-CA-C 109.219 -1.552 . . . . 53.439999999999998 109.219 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -151.46 6.23 0.47 Allowed 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.236 -0.482 . . . . 72.010000000000005 110.027 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -92.01 -80.6 1.43 Allowed Glycine 0 CA--C 1.491 -1.442 0 C-N-CA 119.943 -1.122 . . . . 21.210000000000001 110.693 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -95.42 -27.7 15.29 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.136 -1.061 . . . . 74.510000000000005 108.136 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.529 ' HA ' ' CE3' ' C' ' 287' ' ' TRP . 0.0 OUTLIER -88.57 153.74 20.89 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.61 -1.177 . . . . 74.010000000000005 112.984 177.146 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -170.0 174.1 5.69 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 106.799 -1.556 . . . . 72.329999999999998 106.799 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -152.25 56.45 0.83 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 104.839 -2.282 . . . . 73.319999999999993 104.839 170.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -127.1 47.85 2.29 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.259 -1.792 . . . . 73.400000000000006 106.409 -176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 291' ' ' HIS . . . . . 0.594 ' HA ' ' CE1' ' B' ' 290' ' ' HIS . 83.2 m-70 -62.19 118.66 7.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.56 -1.655 . . . . 60.140000000000001 110.886 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -97.51 88.04 4.27 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.028 0.918 . . . . 74.319999999999993 111.769 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -94.46 93.08 7.44 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.018 -0.537 . . . . 73.310000000000002 110.915 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -73.88 104.21 4.68 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.74 -0.664 . . . . 74.030000000000001 109.507 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 . . . . . 0 C--N 1.3 -1.56 0 CA-C-O 118.157 -0.925 . . . . 74.349999999999994 109.729 -178.702 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 111.88 0.326 . . . . 65.549999999999997 111.88 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.41 ' HD3' HG23 ' A' ' 219' ' ' ILE . 7.8 tmtm? -106.61 -70.96 0.77 Allowed 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 108.094 -1.076 . . . . 75.439999999999998 108.094 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.41 HG23 ' HD3' ' A' ' 218' ' ' LYS . 2.5 pp -127.28 11.36 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 CA-C-O 122.08 0.943 . . . . 73.329999999999998 110.449 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.76 170.43 9.45 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.383 -1.281 . . . . 75.540000000000006 109.818 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.24 92.62 0.08 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 114.498 1.296 . . . . 72.140000000000001 114.498 -172.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 7.0 tp -117.05 132.28 67.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 106.026 -1.842 . . . . 71.219999999999999 106.026 170.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 6.0 m -139.24 161.98 27.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 111.886 0.328 . . . . 44.219999999999999 111.886 -174.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -77.33 -161.94 15.44 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.579 -0.737 . . . . 72.120000000000005 113.314 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 17.0 ptt85 -131.44 125.99 33.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.776 0.798 . . . . 74.099999999999994 112.588 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -98.41 147.55 24.6 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.714 -1.958 . . . . 65.150000000000006 105.714 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.5 m -121.8 136.37 54.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.531 0.681 . . . . 73.420000000000002 111.28 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.4 129.17 37.0 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.481 -1.303 . . . . 63.149999999999999 107.481 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -89.08 -43.93 10.72 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.292 -0.633 . . . . 74.120000000000005 109.292 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -139.86 138.93 36.13 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.693 0.283 . . . . 74.409999999999997 110.267 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 56.2 mt -137.09 123.48 28.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 106.497 -1.668 . . . . 70.430000000000007 106.497 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 60.4 ttt-85 -128.88 115.27 17.61 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.201 -1.037 . . . . 70.219999999999999 108.201 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 30.9 p -120.5 128.41 53.11 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.982 -0.448 . . . . 44.299999999999997 110.789 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -127.78 140.34 52.11 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 110.083 -0.34 . . . . 72.439999999999998 110.083 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.422 ' C ' ' HD2' ' A' ' 236' ' ' ARG . 40.1 mt-10 59.87 105.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.529 1.677 . . . . 53.439999999999998 115.529 169.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 272' ' ' GLU . 1.2 mpt_? 53.0 24.15 3.28 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.071 1.348 . . . . 72.319999999999993 111.526 176.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.97 151.67 23.07 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 120.981 0.42 . . . . 64.099999999999994 110.553 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.32 135.55 38.99 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.649 -0.705 . . . . 73.450000000000003 109.241 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 3.2 p -133.11 140.17 47.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.863 -0.608 . . . . 70.340000000000003 110.526 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -116.32 124.42 50.08 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.63 -1.248 . . . . 75.340000000000003 107.63 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tt -119.07 117.47 28.83 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 105.527 -2.027 . . . . 70.209999999999994 105.527 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.592 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 131.32 -162.28 23.65 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 109.662 -1.375 . . . . 44.25 109.662 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -117.43 134.74 54.49 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 109.172 -0.677 . . . . 71.409999999999997 109.172 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 30.8 t -107.0 121.61 60.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.29 -1.004 . . . . 74.439999999999998 108.29 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 56.2 t -113.58 114.95 48.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.502 -0.925 . . . . 72.230000000000004 108.502 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.437 HG21 ' HB2' ' A' ' 284' ' ' LYS . 12.3 m -96.96 160.37 14.39 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.259 -1.015 . . . . 74.349999999999994 108.259 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.19 75.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.176 0.59 . . . . 74.219999999999999 111.067 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.38 66.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.353 1.061 . . . . 72.430000000000007 113.399 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -75.16 -26.09 58.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.854 0.359 . . . . 61.329999999999998 110.954 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 9.5 mp 74.53 176.68 0.23 Allowed 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 125.203 1.401 . . . . 72.420000000000002 110.219 -172.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -127.35 93.07 3.63 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.931 0.872 . . . . 51.219999999999999 109.891 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -160.48 160.28 31.65 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 110.488 -1.045 . . . . 64.140000000000001 110.488 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' B' ' 219' ' ' ILE . . . -154.52 -165.26 13.71 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 110.044 -1.222 . . . . 34.109999999999999 110.044 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 47.2 mm -119.02 -55.61 3.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 120.886 0.374 . . . . 53.439999999999998 110.58 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -150.67 168.16 25.16 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.754 -0.462 . . . . 73.140000000000001 109.754 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.82 160.43 4.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 112.853 0.686 . . . . 63.32 112.853 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.535 ' HG ' ' N ' ' B' ' 217' ' ' MET . 17.2 p -154.23 -175.19 5.27 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.577 -0.897 . . . . 73.230000000000004 108.577 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 259' ' ' GLN . 12.5 t70 -95.13 -158.89 0.68 Allowed 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.673 -0.862 . . . . 70.530000000000001 108.673 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.416 ' H ' ' CG ' ' A' ' 258' ' ' ASP . 79.6 mt-30 -97.38 118.13 33.15 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.267 0.556 . . . . 75.230000000000004 111.337 -177.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' B' ' 222' ' ' ILE . 84.3 m -64.38 133.01 51.75 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.954 -1.021 . . . . 73.409999999999997 108.861 174.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 26.9 m -134.6 132.16 38.71 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 110.135 -0.32 . . . . 74.109999999999999 110.135 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -126.25 150.2 48.57 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 104.953 -2.239 . . . . 72.530000000000001 104.953 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 26.7 m -134.93 123.77 23.91 Favored 'General case' 0 C--O 1.263 1.797 0 N-CA-C 114.494 1.294 . . . . 74.140000000000001 114.494 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -121.76 134.5 64.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 CA-C-N 115.108 -0.951 . . . . 72.349999999999994 110.616 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -77.35 -73.19 0.31 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.611 -0.722 . . . . 73.209999999999994 110.804 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 32.3 m -126.12 126.82 44.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 120.882 -0.327 . . . . 53.020000000000003 110.227 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.458 HG11 HD11 ' A' ' 277' ' ' ILE . 3.4 p -129.64 120.85 51.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.848 0.832 . . . . 64.349999999999994 110.874 176.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 44.7 t -118.71 135.28 59.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.073 -0.967 . . . . 42.32 110.892 -175.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.472 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -121.37 131.12 8.45 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 108.411 -1.875 . . . . 71.120000000000005 108.411 172.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.493 ' HB3' ' HG2' ' B' ' 234' ' ' GLU . 7.1 tmtm? -134.91 115.02 13.12 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.437 -0.579 . . . . 72.319999999999993 109.437 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.37 82.71 0.68 Allowed Glycine 0 C--O 1.216 -0.977 0 C-N-CA 120.672 -0.775 . . . . 64.400000000000006 114.309 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 236' ' ' ARG . 41.5 mt-10 63.62 24.32 13.91 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.438 1.095 . . . . 64.510000000000005 112.414 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 48.8 m -82.46 145.12 30.0 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 121.715 0.769 . . . . 75.439999999999998 111.491 -176.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -109.09 127.86 54.5 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 106.42 -1.696 . . . . 75.439999999999998 106.42 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.4 p -129.23 123.55 58.48 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.665 0 N-CA-C 108.94 -0.763 . . . . 74.010000000000005 108.94 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.432 HD13 HE22 ' B' ' 240' ' ' GLN . 4.5 tt -113.53 120.21 40.2 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 107.88 -1.155 . . . . 64.400000000000006 107.88 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.458 HD11 HG11 ' A' ' 267' ' ' VAL . 41.7 mm -112.45 103.49 15.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.716 -1.216 . . . . 73.310000000000002 107.716 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.645 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 147.15 -145.06 13.38 Favored Glycine 0 C--N 1.301 -1.381 0 N-CA-C 110.452 -1.059 . . . . 34.399999999999999 110.452 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -127.53 143.3 51.2 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.628 -0.879 . . . . 74.329999999999998 108.628 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.75 120.23 37.94 Favored 'General case' 0 C--O 1.259 1.605 0 N-CA-C 106.849 -1.537 . . . . 73.239999999999995 106.849 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -107.12 123.11 47.77 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 106.854 -1.536 . . . . 75.450000000000003 106.854 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 98.96 -48.08 1.33 Allowed Glycine 0 C--N 1.295 -1.701 0 C-N-CA 120.54 -0.838 . . . . 72.530000000000001 111.356 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 82.93 15.04 73.72 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.829 -0.7 . . . . 63.219999999999999 113.036 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.437 ' HB2' HG21 ' A' ' 246' ' ' THR . 32.1 mmtp -127.47 5.91 6.27 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.264 -0.551 . . . . 74.349999999999994 111.755 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -85.71 -54.79 2.69 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 110.173 -1.171 . . . . 72.329999999999998 110.173 -178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -111.86 -30.68 7.2 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.143 -0.529 . . . . 72.340000000000003 109.674 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.481 ' CH2' ' HB2' ' B' ' 238' ' ' ARG 0.283 11.3 t-105 -68.03 120.75 14.78 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 118.441 -1.304 . . . . 74.010000000000005 113.684 -173.186 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -111.14 111.17 22.06 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 112.872 -1.967 . . . . 71.010000000000005 108.619 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -171.29 87.66 0.1 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.587 -1.264 . . . . 72.420000000000002 107.587 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -96.23 69.64 2.71 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.599 -0.728 . . . . 73.530000000000001 112.138 -172.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 69.47 144.43 0.05 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.464 1.105 . . . . 72.109999999999999 112.288 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -142.04 -61.67 0.45 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.993 -0.549 . . . . 75.040000000000006 110.081 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -145.31 -79.97 0.17 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.918 -0.313 . . . . 62.109999999999999 110.905 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.54 ' CD2' ' HA ' ' B' ' 291' ' ' HIS . 23.6 t-80 -160.36 -51.74 0.05 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.782 -1.192 . . . . 74.519999999999996 107.782 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 26.5 p80 . . . . . 0 CA--C 1.496 -1.106 0 N-CA-C 104.584 -2.376 . . . . 70.420000000000002 104.584 172.107 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 217' ' ' MET . . . . . 0.535 ' N ' ' HG ' ' A' ' 257' ' ' SER . 80.9 mtp . . . . . 0 C--O 1.238 0.463 0 CA-C-O 119.51 -0.281 . . . . 75.299999999999997 111.483 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -147.05 -70.95 0.23 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.57 0.623 . . . . 71.239999999999995 110.097 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 219' ' ' ILE . . . . . 0.406 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 38.8 pt -98.05 -21.44 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-O 121.525 0.678 . . . . 70.319999999999993 109.865 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -73.71 143.47 46.15 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.665 -1.152 . . . . 74.129999999999995 108.682 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -73.39 123.68 24.31 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 115.244 -0.889 . . . . 71.219999999999999 110.467 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' ILE . . . . . 0.537 ' H ' HG21 ' B' ' 254' ' ' ILE . 6.1 tp -82.92 114.74 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 105.471 -2.048 . . . . 74.340000000000003 105.471 173.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 10.5 m -136.17 164.49 31.55 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 115.093 -0.958 . . . . 71.340000000000003 110.806 -174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' GLY . . . . . 0.546 ' HA3' ' HB ' ' B' ' 260' ' ' THR . . . -67.93 176.14 26.12 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 117.069 1.587 . . . . 65.340000000000003 117.069 -173.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.66 ' O ' ' HA ' ' B' ' 261' ' ' THR . 8.7 ptm180 -105.24 121.09 43.12 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 112.757 -1.721 . . . . 75.030000000000001 110.621 -176.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -103.69 149.11 25.27 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 104.576 -2.379 . . . . 71.409999999999997 104.576 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 23.9 m -125.75 134.74 51.65 Favored 'General case' 0 N--CA 1.411 -2.386 0 C-N-CA 119.252 -0.979 . . . . 74.439999999999998 110.497 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.428 ' HB2' HG21 ' B' ' 277' ' ' ILE . . . -131.24 121.74 25.3 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.156 -1.384 . . . . 75.349999999999994 110.331 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -76.1 -67.14 0.71 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.156 -0.929 . . . . 72.319999999999993 112.164 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -127.16 137.07 52.87 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 118.327 -1.349 . . . . 74.230000000000004 108.752 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.475 HG21 HG21 ' B' ' 239' ' ' VAL . 43.3 mt -131.93 117.68 34.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.35 -1.352 . . . . 64.439999999999998 107.35 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -126.09 115.15 19.38 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.226 -0.657 . . . . 61.240000000000002 109.226 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.472 ' OG1' ' HA2' ' A' ' 269' ' ' GLY . 71.2 p -112.66 127.24 56.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.844 -1.169 . . . . 55.130000000000003 107.844 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 234' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' B' ' 270' ' ' LYS . 52.2 mt-10 -131.44 139.89 49.49 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 122.072 -0.392 . . . . 72.420000000000002 111.1 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.542 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 28.9 mt-10 60.56 93.62 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 O-C-N 124.711 1.257 . . . . 73.310000000000002 114.037 171.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.542 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 1.4 mpt_? 63.0 15.6 8.56 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 125.036 1.335 . . . . 73.239999999999995 111.06 175.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -78.15 156.57 29.82 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.197 0.522 . . . . 75.340000000000003 111.071 -176.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.481 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -139.75 135.15 32.8 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.362 -0.607 . . . . 60.009999999999998 109.362 177.093 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.4 p -133.32 142.45 41.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.632 0.73 . . . . 72.319999999999993 111.381 -178.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.692 ' HB2' ' CE2' ' B' ' 286' ' ' PHE . 5.8 tp-100 -109.35 131.99 54.55 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.382 -1.34 . . . . 65.129999999999995 107.382 173.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.409 ' HB3' HD13 ' A' ' 277' ' ' ILE . 3.3 tm? -129.72 115.58 17.53 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 104.801 -2.296 . . . . 75.040000000000006 104.801 171.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 135.96 -136.32 8.36 Favored Glycine 0 N--CA 1.417 -2.578 0 N-CA-C 109.057 -1.617 . . . . 61.240000000000002 109.057 -175.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -142.3 148.71 38.47 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 117.575 0.688 . . . . 74.239999999999995 109.682 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 17.2 t -114.8 124.11 71.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.538 -1.282 . . . . 72.219999999999999 107.538 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.15 113.37 38.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 120.178 -0.609 . . . . 73.200000000000003 109.494 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.475 HG21 ' HB2' ' B' ' 284' ' ' LYS . 7.4 m -95.09 159.5 14.99 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.353 -1.351 . . . . 70.200000000000003 107.353 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.497 ' HB1' ' CE1' ' B' ' 251' ' ' HIS . . . -64.15 -32.13 73.58 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.941 0.876 . . . . 72.430000000000007 110.241 177.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.89 -44.47 74.13 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.383 -1.735 . . . . 71.019999999999996 113.366 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -75.74 -47.7 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.273 -0.571 . . . . 71.030000000000001 111.16 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 94.1 mt -165.94 149.5 7.74 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.929 0.892 . . . . 71.140000000000001 109.296 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 251' ' ' HIS . . . . . 0.497 ' CE1' ' HB1' ' B' ' 247' ' ' ALA . 86.4 m-70 -102.32 84.84 2.53 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 105.358 -2.09 . . . . 75.430000000000007 105.358 168.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.26 -84.88 0.93 Allowed Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 108.603 -1.799 . . . . 51.240000000000002 108.603 -172.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 253' ' ' GLY . . . . . 0.464 ' CA ' ' HA ' ' C' ' 217' ' ' MET . . . 51.67 49.9 45.04 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 114.64 0.616 . . . . 53.520000000000003 114.64 175.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 254' ' ' ILE . . . . . 0.537 HG21 ' H ' ' B' ' 222' ' ' ILE . 17.5 pt -102.56 141.45 18.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 113.503 0.927 . . . . 63.530000000000001 113.503 -173.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.458 ' HB3' ' OD1' ' C' ' 220' ' ' ASP . 37.7 ttt180 -110.81 -20.82 12.34 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 124.731 1.212 . . . . 74.420000000000002 109.444 178.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . 0.481 14.4 tt 71.84 68.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.957 0 C-N-CA 128.338 2.655 . . . . 62.539999999999999 113.336 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 257' ' ' SER . . . . . 0.62 ' O ' ' HB ' ' C' ' 222' ' ' ILE . 1.6 m -124.3 98.71 5.88 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.025 -1.843 . . . . 41.439999999999998 106.025 173.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -149.06 137.18 20.77 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.969 1.47 . . . . 75.549999999999997 114.969 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -164.54 23.58 0.06 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.839 -1.911 . . . . 73.420000000000002 105.839 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.546 ' HB ' ' HA3' ' B' ' 224' ' ' GLY . 3.7 m -70.93 125.21 26.23 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.904 -1.044 . . . . 72.510000000000005 108.44 -175.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' B' ' 225' ' ' ARG . 25.3 m -132.96 135.18 45.36 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.639 -1.615 . . . . 62.039999999999999 106.639 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -126.67 146.05 50.34 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.192 -1.781 . . . . 72.530000000000001 106.192 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 263' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' C' ' 227' ' ' SER . 40.5 m -125.6 123.51 39.18 Favored 'General case' 0 C--O 1.256 1.434 0 C-N-CA 118.536 -1.266 . . . . 72.409999999999997 114.043 -170.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.439 HG21 HG13 ' B' ' 267' ' ' VAL . 11.3 p -128.63 137.31 57.67 Favored 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 120.088 -0.645 . . . . 75.239999999999995 111.212 172.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.562 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 10.4 tp10 -86.34 -63.36 1.33 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.025 -0.534 . . . . 73.439999999999998 110.01 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 25.1 m -137.15 127.56 26.58 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.346 -0.847 . . . . 70.040000000000006 112.408 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.465 HG12 HD12 ' C' ' 231' ' ' ILE . 30.4 m -118.56 128.41 75.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 115.882 -0.599 . . . . 63.109999999999999 109.815 173.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.41 130.63 74.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.61 -0.723 . . . . 65.219999999999999 109.98 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.44 132.95 9.28 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 110.585 -1.006 . . . . 70.519999999999996 110.585 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.528 ' HD2' ' HB2' ' B' ' 234' ' ' GLU . 31.2 mmmt -132.91 115.64 15.49 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 123.218 0.607 . . . . 70.140000000000001 111.108 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.61 80.67 0.61 Allowed Glycine 0 C--N 1.304 -1.196 0 C-N-CA 120.445 -0.883 . . . . 43.340000000000003 114.589 172.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 63.7 28.64 14.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.159 0.984 . . . . 54.219999999999999 112.509 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 273' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 50.1 m -81.97 145.19 30.41 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.351 0.596 . . . . 73.239999999999995 111.175 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.436 ' HD3' ' HB3' ' C' ' 238' ' ' ARG . 6.1 mpt_? -109.5 128.72 55.38 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 106.849 -1.537 . . . . 64.319999999999993 106.849 174.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.4 p -130.96 123.06 53.32 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 N-CA-C 108.17 -1.048 . . . . 74.400000000000006 108.17 172.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 6.1 tt -114.08 116.79 29.7 Favored 'General case' 0 C--N 1.277 -2.571 0 C-N-CA 119.36 -0.936 . . . . 55.119999999999997 108.599 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.465 HG23 HD12 ' C' ' 241' ' ' LEU . 34.0 mm -106.46 102.54 14.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 106.834 -1.543 . . . . 61.140000000000001 106.834 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 146.82 -164.36 28.53 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 110.856 -0.897 . . . . 10.109999999999999 110.856 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -109.54 139.66 44.28 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.159 -0.682 . . . . 72.140000000000001 109.159 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.95 118.89 36.73 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.256 -1.757 . . . . 74.120000000000005 106.256 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -105.91 122.95 47.17 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.891 -1.151 . . . . 73.439999999999998 107.891 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.44 -46.47 1.28 Allowed Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.669 -0.696 . . . . 73.549999999999997 111.682 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 74.59 29.25 61.86 Favored Glycine 0 CA--C 1.506 -0.486 0 N-CA-C 111.555 -0.618 . . . . 23.010000000000002 111.555 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 284' ' ' LYS . . . . . 0.475 ' HB2' HG21 ' B' ' 246' ' ' THR . 73.1 mmtt -137.25 11.41 3.03 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.528 -0.336 . . . . 72.319999999999993 110.624 -177.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -103.78 -47.05 1.31 Allowed Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 119.729 -1.224 . . . . 75.319999999999993 110.686 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.692 ' CE2' ' HB2' ' B' ' 240' ' ' GLN . 6.3 t80 -110.03 -42.11 4.29 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.996 0.427 . . . . 75.409999999999997 110.39 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.517 ' CZ2' ' HB2' ' C' ' 238' ' ' ARG . 11.2 t-105 -70.93 148.85 47.3 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 115.483 1.661 . . . . 75.150000000000006 115.483 -165.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.55 22.59 0.08 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.683 1.593 . . . . 62.32 111.222 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 289' ' ' ASN . . . . . 0.424 ' H ' ' C ' ' B' ' 287' ' ' TRP . 22.4 t30 -80.21 88.98 5.45 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 122.536 1.16 . . . . 74.230000000000004 110.233 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -133.3 71.38 1.47 Allowed 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 114.039 -1.437 . . . . 74.310000000000002 108.908 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 291' ' ' HIS . . . . . 0.54 ' HA ' ' CD2' ' A' ' 294' ' ' HIS . 20.5 p80 -76.35 133.46 39.96 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 113.917 -1.492 . . . . 72.319999999999993 110.772 -176.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 292' ' ' HIS . . . . . 0.412 ' H ' ' CD2' ' A' ' 294' ' ' HIS . 47.7 t60 -87.28 84.76 7.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.419 -0.81 . . . . 72.340000000000003 109.499 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -168.04 33.07 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 104.662 -2.347 . . . . 75.409999999999997 104.662 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -90.16 75.77 6.98 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.19 -1.368 . . . . 75.230000000000004 113.822 -173.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 . . . . . 0 C--N 1.312 -1.033 0 CA-C-N 113.506 -1.679 . . . . 71.319999999999993 107.2 177.109 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 217' ' ' MET . . . . . 0.464 ' HA ' ' CA ' ' B' ' 253' ' ' GLY . 65.7 mtt . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 111.585 0.217 . . . . 72.209999999999994 111.585 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 218' ' ' LYS . . . . . 0.47 ' HG3' HD12 ' C' ' 219' ' ' ILE . 22.1 pttp -77.15 -12.37 59.94 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.966 0.888 . . . . 75.010000000000005 109.857 174.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.47 HD12 ' HG3' ' C' ' 218' ' ' LYS . 3.1 mp -127.02 137.98 56.24 Favored 'Isoleucine or valine' 0 C--O 1.256 1.439 0 N-CA-C 105.438 -2.06 . . . . 63.350000000000001 105.438 169.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 220' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' B' ' 255' ' ' ARG . 28.8 p-10 -114.38 -167.88 1.28 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.649 -0.871 . . . . 45.140000000000001 108.649 176.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.8 111.44 14.21 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.939 1.088 . . . . 64.310000000000002 113.939 -173.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 0.62 ' HB ' ' O ' ' B' ' 257' ' ' SER . 0.0 OUTLIER -115.95 133.34 62.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 104.572 -2.381 . . . . 63.450000000000003 104.572 171.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 223' ' ' VAL . . . . . 0.47 ' N ' HD13 ' C' ' 222' ' ' ILE . 4.8 t -127.06 164.18 28.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 120.659 -0.417 . . . . 62.43 110.519 -172.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -74.62 -168.75 21.2 Favored Glycine 0 C--O 1.245 0.806 0 N-CA-C 111.303 -0.719 . . . . 75.519999999999996 111.303 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' B' ' 261' ' ' THR . 15.8 ptt-85 -121.92 147.52 45.92 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 118.7 -1.2 . . . . 70.439999999999998 114.115 -173.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -116.25 147.41 41.51 Favored 'General case' 0 N--CA 1.399 -2.985 0 N-CA-C 105.26 -2.126 . . . . 75.25 105.26 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' C' ' 263' ' ' SER . 24.1 m -130.03 136.55 49.52 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 121.269 0.557 . . . . 62.039999999999999 110.117 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.511 ' HB2' HG21 ' C' ' 277' ' ' ILE . . . -130.41 134.37 47.08 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 109.198 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.562 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -85.95 -61.32 1.78 Allowed 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 115.266 -0.879 . . . . 71.400000000000006 109.193 -178.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -129.56 137.97 51.05 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.953 -0.699 . . . . 71.239999999999995 110.345 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.465 HD12 HG12 ' B' ' 267' ' ' VAL . 34.5 mt -135.18 119.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.879 -0.785 . . . . 70.109999999999999 108.879 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.429 ' HB3' HG12 ' C' ' 268' ' ' VAL . 30.9 ttt180 -125.56 115.92 20.94 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.998 0.428 . . . . 72.129999999999995 110.078 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 38.9 p -112.61 127.5 56.11 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.452 -0.944 . . . . 74.129999999999995 108.452 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -131.55 139.43 49.23 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.437 -0.505 . . . . 71.010000000000005 110.691 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.459 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 38.2 mt-10 62.81 92.16 0.06 Allowed 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 124.926 1.391 . . . . 45.399999999999999 114.133 170.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.459 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 2.8 mpt_? 63.55 12.04 6.14 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.859 1.264 . . . . 55.32 111.21 175.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -77.97 149.01 34.18 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.204 0.526 . . . . 62.509999999999998 111.64 -174.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.517 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.0 OUTLIER -133.65 134.96 43.8 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.943 -0.572 . . . . 72.329999999999998 111.511 176.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.6 p -132.97 137.86 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 115.276 -0.875 . . . . 70.319999999999993 111.534 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -106.03 129.79 54.07 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 114.127 -1.397 . . . . 63.539999999999999 107.863 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.465 HD12 HG23 ' B' ' 277' ' ' ILE . 3.2 tm? -125.15 116.32 21.85 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.069 -1.826 . . . . 71.129999999999995 106.069 173.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.653 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 126.98 -148.18 17.21 Favored Glycine 0 C--N 1.284 -2.348 0 N-CA-C 108.278 -1.929 . . . . 65.409999999999997 108.278 -176.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -126.96 150.16 49.51 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 118.336 1.068 . . . . 72.409999999999997 110.621 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.78 126.56 74.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.614 -1.254 . . . . 73.340000000000003 107.614 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 65.4 t -122.52 118.59 55.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 120.439 -0.504 . . . . 63.43 109.98 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 9.4 m -95.27 159.42 15.02 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 108.114 -1.069 . . . . 71.409999999999997 108.114 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -64.05 -33.76 76.48 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.354 0.597 . . . . 55.329999999999998 110.776 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.14 -47.76 74.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.405 -1.271 . . . . 71.409999999999997 111.464 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.32 -42.51 44.9 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.941 0.4 . . . . 54.229999999999997 111.367 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 52.5 tp 76.7 -61.67 0.43 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.619 1.567 . . . . 75.209999999999994 113.248 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -155.03 170.34 22.0 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.379 0.536 . . . . 74.0 111.459 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 179.83 100.33 0.14 Allowed Glycine 0 CA--C 1.527 0.811 0 O-C-N 123.435 0.459 . . . . 72.0 112.312 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.07 33.55 2.16 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.286 -0.483 . . . . 54.240000000000002 112.816 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 254' ' ' ILE . . . . . 0.513 ' HA ' ' CG2' ' C' ' 222' ' ' ILE . 44.1 pt -75.44 0.77 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 113.845 1.054 . . . . 74.140000000000001 113.845 -174.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -85.75 -2.3 58.08 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.782 -0.821 . . . . 74.400000000000006 108.782 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 256' ' ' ILE . . . . . 0.59 ' HA ' HD12 ' C' ' 222' ' ' ILE . 1.9 mp 77.7 91.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 CA-C-O 122.611 1.196 . . . . 73.239999999999995 108.575 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 22.9 m -99.36 29.73 3.85 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.984 -1.462 . . . . 73.340000000000003 110.831 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -75.81 72.26 2.7 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 122.205 1.002 . . . . 35.329999999999998 111.07 176.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -164.77 -19.25 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 128.618 2.767 . . . . 73.019999999999996 107.837 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 22.2 m -64.35 121.34 14.09 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 104.527 -2.397 . . . . 72.450000000000003 104.527 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 22.0 m -133.52 112.44 11.52 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 109.584 -0.524 . . . . 75.319999999999993 109.584 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -112.51 124.48 52.61 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.064 -1.828 . . . . 70.409999999999997 106.064 173.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 263' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' C' ' 227' ' ' SER . 10.7 p -130.37 144.79 51.6 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 113.735 1.013 . . . . 71.209999999999994 113.735 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 10.0 p -128.51 149.58 33.43 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.494 -0.775 . . . . 64.450000000000003 110.296 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -81.03 -68.28 0.7 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.626 0.25 . . . . 74.099999999999994 111.284 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 61.8 m -138.59 127.6 23.94 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 120.367 -0.533 . . . . 75.120000000000005 110.646 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.1 m -118.68 134.6 61.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.466 -0.568 . . . . 63.439999999999998 109.466 172.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 268' ' ' VAL . . . . . 0.429 HG12 ' HB3' ' C' ' 232' ' ' ARG . 13.6 m -127.1 135.53 63.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-N 115.634 -0.712 . . . . 53.119999999999997 110.485 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.15 132.35 9.08 Favored Glycine 0 CA--C 1.47 -2.739 0 N-CA-C 109.089 -1.604 . . . . 44.299999999999997 109.089 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -134.4 115.21 13.75 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.603 -0.888 . . . . 75.120000000000005 108.603 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.39 91.61 0.19 Allowed Glycine 0 C--O 1.242 0.653 0 C-N-CA 121.139 -0.553 . . . . 71.150000000000006 113.427 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 56.5 29.65 15.77 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.638 1.175 . . . . 72.519999999999996 112.158 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 23.2 m -82.8 145.24 29.62 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 119.561 -0.856 . . . . 63.200000000000003 111.547 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 274' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' C' ' 274' ' ' ARG . 6.5 mtm180 -118.72 127.65 53.76 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 107.908 -1.145 . . . . 71.409999999999997 107.908 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 4.0 p -138.25 128.5 35.06 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-N 115.592 -0.731 . . . . 64.0 109.292 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.7 tt -116.62 115.3 25.45 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.485 -0.931 . . . . 72.420000000000002 108.485 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' C' ' 228' ' ' ALA . 43.1 mm -105.9 102.97 14.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 106.509 -1.663 . . . . 73.120000000000005 106.509 178.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 278' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 141.42 -163.2 26.84 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 111.028 -0.829 . . . . 53.399999999999999 111.028 -174.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -114.08 135.87 53.55 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.818 -0.808 . . . . 75.239999999999995 108.818 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.69 118.68 36.31 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.169 -1.789 . . . . 75.310000000000002 106.169 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -105.26 123.39 47.76 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 109.097 -0.705 . . . . 75.239999999999995 109.097 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.19 -43.65 1.66 Allowed Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 109.957 -1.257 . . . . 64.430000000000007 109.957 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 80.1 21.68 64.84 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.359 -0.697 . . . . 70.409999999999997 111.359 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 284' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' C' ' 287' ' ' TRP . 33.3 mttm -145.68 20.5 1.49 Allowed 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 113.987 1.106 . . . . 61.119999999999997 113.987 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -94.58 -45.5 3.18 Favored Glycine 0 N--CA 1.427 -1.922 0 N-CA-C 107.794 -2.123 . . . . 64.420000000000002 107.794 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.53 -50.91 3.11 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.578 -1.267 . . . . 74.25 107.578 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.574 ' O ' ' HA ' ' C' ' 284' ' ' LYS . 0.8 OUTLIER -88.23 161.91 16.95 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.268 -0.878 . . . . 71.450000000000003 112.097 -169.287 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -122.68 105.54 10.17 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.549 0.69 . . . . 74.329999999999998 112.222 176.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -92.82 149.34 21.35 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 105.802 -1.925 . . . . 71.030000000000001 105.802 167.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -68.44 98.46 0.85 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.771 0.796 . . . . 75.409999999999997 111.365 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -171.86 169.86 5.65 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 104.224 -2.51 . . . . 71.129999999999995 104.224 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -94.86 149.88 20.78 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 119.37 0.986 . . . . 72.5 110.569 178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 293' ' ' HIS . . . . . 0.486 ' HB2' ' HD3' ' C' ' 284' ' ' LYS . 11.7 t-160 -166.26 76.26 0.21 Allowed 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.987 0.915 . . . . 64.549999999999997 110.274 173.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 56.5 -171.75 0.08 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.066 1.136 . . . . 75.25 114.066 176.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 5.8 p80 . . . . . 0 N--CA 1.427 -1.62 0 CA-C-N 114.621 -1.172 . . . . 75.230000000000004 110.013 177.785 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 66.3 mtm . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.675 0.274 . . . . 63.399999999999999 110.875 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -132.7 -42.4 0.92 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.96 -0.385 . . . . 64.430000000000007 109.96 173.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.0 mp -102.66 127.69 56.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 120.836 0.35 . . . . 74.340000000000003 110.152 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -136.09 102.46 5.03 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.975 -1.12 . . . . 73.010000000000005 107.975 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -134.41 135.7 42.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.706 -0.85 . . . . 71.120000000000005 108.706 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 63.1 mt -113.95 114.67 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 108.116 -1.068 . . . . 62.140000000000001 108.116 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.51 124.71 29.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.743 -0.662 . . . . 74.129999999999995 110.163 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -113.82 58.86 0.41 Allowed Glycine 0 C--N 1.294 -1.783 0 N-CA-C 107.458 -2.257 . . . . 61.109999999999999 107.458 175.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -100.59 132.17 46.12 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.695 0.759 . . . . 75.310000000000002 112.053 -172.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -110.28 134.96 51.74 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.301 -1.318 . . . . 62.229999999999997 108.677 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.6 m -126.19 136.71 53.17 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 109.326 -0.62 . . . . 74.099999999999994 109.326 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.18 132.19 27.83 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.453 -1.684 . . . . 70.129999999999995 106.453 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.17 -56.85 2.5 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.873 -0.731 . . . . 71.109999999999999 111.656 -174.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.81 139.57 52.57 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.129 -0.693 . . . . 64.019999999999996 109.129 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.2 mm -131.92 118.72 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.884 -0.784 . . . . 73.209999999999994 108.884 -174.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -120.56 127.01 51.75 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.846 -0.428 . . . . 72.439999999999998 109.846 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 45.1 p -133.46 128.64 35.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.684 -0.487 . . . . 65.230000000000004 109.684 -176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.424 ' HB2' ' HD3' ' A' ' 270' ' ' LYS . 42.7 mt-10 -142.8 139.71 31.07 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 121.059 -0.256 . . . . 74.319999999999993 110.773 176.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.606 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 38.7 mt-10 64.18 95.64 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 114.748 1.388 . . . . 50.140000000000001 114.748 170.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.606 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.1 mpp_? 60.31 26.85 16.37 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.674 1.19 . . . . 74.340000000000003 110.435 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -92.35 125.95 37.23 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 115.252 -0.886 . . . . 75.140000000000001 110.614 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.539 ' HD3' ' HG2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -128.05 134.94 49.25 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.621 -0.881 . . . . 70.299999999999997 108.621 176.665 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.657 HG12 ' HB ' ' A' ' 275' ' ' VAL . 33.1 m -134.32 150.12 30.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 116.116 -0.493 . . . . 72.040000000000006 110.711 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 15.7 tm0? -123.14 125.34 44.96 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.336 -1.357 . . . . 71.219999999999999 107.336 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -116.12 117.75 30.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.65 -1.241 . . . . 75.230000000000004 107.65 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.452 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 126.59 -159.57 20.86 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 111.337 -0.705 . . . . 73.140000000000001 111.337 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' A' ' 279' ' ' ASN . 39.3 t30 -107.0 137.86 44.27 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 122.935 0.494 . . . . 72.430000000000007 110.383 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 99.9 t -113.27 114.33 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.249 -0.649 . . . . 45.420000000000002 109.249 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.513 ' HA ' ' HB3' ' A' ' 281' ' ' TYR . 27.4 m -99.32 118.39 45.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 119.844 -0.742 . . . . 65.129999999999995 110.711 176.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 17.6 m -102.0 158.95 15.78 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.562 -0.533 . . . . 73.150000000000006 109.562 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.79 -35.27 80.24 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.639 0.977 . . . . 50.109999999999999 113.639 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -39.03 68.01 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.476 1.288 . . . . 62.439999999999998 114.476 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.571 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . -74.6 -23.72 58.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.217 0.451 . . . . 74.420000000000002 112.217 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.41 ' HB3' ' H ' ' A' ' 251' ' ' HIS . 6.7 mp 72.91 -162.26 0.1 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.066 0.947 . . . . 72.340000000000003 108.509 -172.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.41 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 72.5 m80 69.38 177.81 0.26 Allowed 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.743 0.817 . . . . 72.239999999999995 111.142 177.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -167.0 41.51 0.25 Allowed Glycine 0 CA--C 1.483 -1.965 0 C-N-CA 120.268 -0.968 . . . . 53.130000000000003 111.127 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -168.14 161.25 35.0 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 109.949 -1.26 . . . . 43.530000000000001 109.949 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 33.0 pt -96.33 113.89 31.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.61 0.719 . . . . 74.0 109.933 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.408 ' HB3' ' CD2' ' B' ' 251' ' ' HIS . 14.6 ttm180 -95.36 179.85 5.03 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.277 -1.749 . . . . 75.019999999999996 106.277 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 42.6 mm -76.66 92.86 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 119.568 1.076 . . . . 70.120000000000005 111.933 -174.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 47.7 m -139.27 -45.06 0.46 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.256 -0.884 . . . . 64.430000000000007 110.706 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.08 89.09 5.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.668 0.747 . . . . 75.219999999999999 112.265 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -103.05 9.09 38.71 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.984 -1.487 . . . . 73.329999999999998 106.984 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 6.1 m -75.6 122.88 24.58 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 112.984 -1.916 . . . . 43.539999999999999 111.127 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 m -107.56 108.6 19.97 Favored 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 106.204 -1.776 . . . . 74.349999999999994 106.204 174.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 17.2 m120 -104.91 130.8 53.0 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.797 -0.816 . . . . 63.200000000000003 108.797 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 59.5 m -138.96 123.43 18.34 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.53 -0.545 . . . . 54.210000000000001 109.53 174.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 12.7 p -128.19 149.18 32.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.844 -1.169 . . . . 73.109999999999999 107.844 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 32.1 tt0 -92.91 -67.6 0.85 Allowed 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 120.005 -0.678 . . . . 73.420000000000002 110.339 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 20.7 m -123.74 133.08 53.91 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.235 -0.586 . . . . 74.439999999999998 111.429 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.84 131.71 72.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 108.492 -0.929 . . . . 72.319999999999993 108.492 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 6.4 p -127.26 131.51 70.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 110.207 -0.294 . . . . 62.439999999999998 110.207 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.486 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -122.71 131.49 8.31 Favored Glycine 0 CA--C 1.485 -1.837 0 C-N-CA 120.34 -0.933 . . . . 34.409999999999997 111.347 176.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 234' ' ' GLU . 15.9 tptm -134.41 115.84 14.48 Favored 'General case' 0 N--CA 1.428 -1.531 0 O-C-N 123.679 0.282 . . . . 70.430000000000007 110.828 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.63 99.7 0.49 Allowed Glycine 0 C--O 1.245 0.801 0 C-N-CA 120.717 -0.754 . . . . 73.25 113.878 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' B' ' 236' ' ' ARG . 51.8 mm-40 60.55 24.18 13.87 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.432 1.093 . . . . 63.240000000000002 110.597 175.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 18.9 m -82.57 144.63 30.22 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.987 0.899 . . . . 74.239999999999995 112.784 -169.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' ARG . . . . . 0.539 ' HG2' ' HD3' ' A' ' 238' ' ' ARG . 82.9 mtt180 -135.31 126.21 27.57 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.124 -1.436 . . . . 75.239999999999995 107.124 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.657 ' HB ' HG12 ' A' ' 239' ' ' VAL . 46.4 t -136.19 133.67 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.989 0 N-CA-C 109.691 -0.485 . . . . 65.030000000000001 109.691 -176.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 6.3 tt -119.45 117.98 29.89 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.507 -1.277 . . . . 74.340000000000003 108.849 171.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.432 HG22 ' HB3' ' B' ' 241' ' ' LEU . 2.7 pt -112.54 104.38 16.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-O 121.622 0.725 . . . . 74.430000000000007 109.508 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.687 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 148.21 -133.45 4.62 Favored Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 115.843 -0.617 . . . . 63.539999999999999 111.568 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 243' ' ' ASN . 14.3 m120 -128.29 153.5 46.92 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.507 -0.923 . . . . 74.109999999999999 108.507 -176.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.17 143.45 34.25 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.945 0.878 . . . . 73.420000000000002 110.475 170.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.513 ' HB3' ' HA ' ' A' ' 245' ' ' VAL 0.252 5.3 t80 -119.45 124.63 46.98 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 105.801 -1.926 . . . . 74.319999999999993 105.801 -175.277 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 144.2 -52.13 0.62 Allowed Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.003 -1.094 . . . . 61.329999999999998 112.974 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.453 ' HA3' HG23 ' B' ' 246' ' ' THR . . . 119.87 -34.74 4.08 Favored Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 108.816 -1.714 . . . . 40.130000000000003 108.816 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -135.89 87.47 2.31 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.609 -1.626 . . . . 72.099999999999994 106.609 170.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -95.97 -132.81 7.26 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.812 -0.915 . . . . 45.420000000000002 110.812 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 26.0 t80 52.07 -130.1 2.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 107.819 -1.178 . . . . 75.310000000000002 107.819 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -124.22 14.8 9.05 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.318 -1.364 . . . . 70.25 107.318 172.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.533 ' C ' HD22 ' A' ' 289' ' ' ASN . 23.1 t70 51.21 -163.64 0.06 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.231 -1.35 . . . . 72.430000000000007 108.35 -172.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ASN . . . . . 0.533 HD22 ' C ' ' A' ' 288' ' ' ASP . 0.9 OUTLIER -124.94 -2.42 7.74 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.727 -1.233 . . . . 74.239999999999995 109.428 178.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 75.62 84.79 0.09 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 126.065 1.746 . . . . 72.030000000000001 108.969 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 67.0 t60 63.79 82.34 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.632 -1.622 . . . . 65.329999999999998 109.562 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -78.85 79.21 5.27 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.879 -1.055 . . . . 73.409999999999997 109.891 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -157.45 141.64 16.21 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.677 -0.86 . . . . 61.240000000000002 108.677 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.576 ' H ' ' CD2' ' B' ' 291' ' ' HIS . 30.8 t-80 74.01 1.44 3.9 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.249 1.82 . . . . 75.230000000000004 112.117 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' HIS . . . . . 0.433 ' C ' HH22 ' B' ' 238' ' ' ARG . 48.8 p-80 . . . . . 0 C--N 1.303 -1.428 0 N-CA-C 106.792 -1.559 . . . . 74.310000000000002 106.792 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 13.8 tpt . . . . . 0 CA--C 1.507 -0.681 0 CA-C-O 120.898 0.38 . . . . 74.019999999999996 110.788 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -96.2 140.66 30.58 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.454 -0.943 . . . . 31.140000000000001 108.454 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 219' ' ' ILE . . . . . 0.463 HG13 ' O ' ' C' ' 219' ' ' ILE . 18.3 pt -93.65 -164.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 112.796 0.665 . . . . 61.340000000000003 112.796 -174.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -141.53 127.09 18.93 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.822 -0.807 . . . . 61.439999999999998 108.822 -173.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 178.57 136.63 0.09 Allowed 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.743 0.652 . . . . 53.130000000000003 111.77 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 63.5 mt -94.6 114.9 32.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 106.096 -1.816 . . . . 75.319999999999993 106.096 171.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.22 136.07 41.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 120.976 0.417 . . . . 74.230000000000004 111.944 -175.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -105.42 84.13 0.4 Allowed Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 107.948 -2.061 . . . . 55.509999999999998 107.948 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -90.06 121.1 31.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.255 0.465 . . . . 73.420000000000002 112.255 -174.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 6.9 t30 -118.58 113.39 21.18 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.654 -0.869 . . . . 74.409999999999997 108.654 169.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 46.7 m -121.26 136.61 54.94 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-O 121.725 0.774 . . . . 61.520000000000003 110.124 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.21 147.58 52.0 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.999 -1.482 . . . . 55.539999999999999 106.999 178.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 10.0 tmtt? -104.51 -67.76 0.89 Allowed 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.677 -0.809 . . . . 75.420000000000002 109.299 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 230' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' B' ' 266' ' ' THR . 33.3 t70 -128.01 138.7 52.69 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.435 -0.58 . . . . 73.400000000000006 109.435 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.48 HD11 ' HB1' ' B' ' 228' ' ' ALA . 39.9 mm -128.88 117.57 44.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.637 -0.875 . . . . 71.400000000000006 108.637 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -114.31 114.51 26.02 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.895 -0.78 . . . . 72.420000000000002 108.895 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.486 ' OG1' ' HA2' ' A' ' 269' ' ' GLY . 78.2 p -111.53 127.24 55.65 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 107.664 -1.235 . . . . 54.539999999999999 107.664 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -139.34 138.93 37.07 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 120.842 -0.343 . . . . 73.129999999999995 111.019 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.6 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 44.5 mt-10 57.99 98.4 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 125.098 1.499 . . . . 70.299999999999997 114.908 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.6 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.2 OUTLIER 60.75 26.21 16.02 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.859 -1.064 . . . . 71.219999999999999 110.198 174.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -91.35 136.03 33.4 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.121 -0.945 . . . . 62.219999999999999 111.882 -175.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 3.5 mpt_? -125.94 134.41 51.55 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.711 -1.218 . . . . 74.230000000000004 107.711 176.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.629 HG12 ' HB ' ' B' ' 275' ' ' VAL . 19.7 m -138.97 147.41 24.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.234 0.54 . . . . 61.240000000000002 110.945 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -122.06 127.93 50.78 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.66 -1.608 . . . . 74.219999999999999 106.66 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' B' ' 277' ' ' ILE . 2.3 tm? -122.5 117.67 26.49 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.892 -1.522 . . . . 53.439999999999998 106.892 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 136.92 -126.39 3.7 Favored Glycine 0 N--CA 1.428 -1.861 0 C-N-CA 120.804 -0.713 . . . . 52.340000000000003 111.761 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' B' ' 279' ' ' ASN . 43.9 t30 -142.78 134.86 27.23 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 110.286 -0.264 . . . . 73.430000000000007 110.286 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.55 HG11 ' H ' ' B' ' 286' ' ' PHE . 68.7 t -114.94 114.91 47.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 109.539 -0.541 . . . . 64.129999999999995 109.539 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.499 ' HA ' ' HB3' ' B' ' 281' ' ' TYR . 28.5 m -104.15 112.72 38.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.69 -0.804 . . . . 61.140000000000001 111.192 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.484 HG22 ' H ' ' B' ' 248' ' ' ALA . 42.0 m -81.72 158.19 24.29 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 121.047 0.451 . . . . 75.010000000000005 110.914 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.23 93.24 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.322 1.049 . . . . 63.310000000000002 112.342 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' ALA . . . . . 0.484 ' H ' HG22 ' B' ' 246' ' ' THR . . . -55.31 -44.29 75.65 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.068 -1.424 . . . . 33.299999999999997 114.065 -173.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.71 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -74.95 -25.76 59.12 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 120.9 0.381 . . . . 62.530000000000001 110.744 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 8.8 mp 75.85 157.8 0.19 Allowed 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 125.186 1.395 . . . . 74.230000000000004 109.458 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 251' ' ' HIS . . . . . 0.408 ' CD2' ' HB3' ' A' ' 255' ' ' ARG . 76.9 t60 -83.86 91.54 7.58 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.4 -0.963 . . . . 73.439999999999998 108.4 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -92.14 111.69 4.08 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.038 -0.983 . . . . 75.340000000000003 112.374 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.06 62.19 4.26 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.995 -0.842 . . . . 62.439999999999998 110.995 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 9.2 tp -98.34 -15.37 7.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.121 -0.539 . . . . 72.010000000000005 109.981 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 69.73 135.08 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.486 1.114 . . . . 74.340000000000003 113.123 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 50.1 mm -71.72 113.94 9.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 105.259 -2.126 . . . . 71.510000000000005 105.259 172.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 15.1 m -113.92 25.25 11.33 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.295 -0.562 . . . . 63.119999999999997 112.266 -171.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.515 ' OD2' ' HD2' ' C' ' 255' ' ' ARG . 4.5 p30 -111.17 -164.63 0.93 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.083 -0.508 . . . . 72.439999999999998 110.552 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -124.66 33.59 5.19 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.18 -0.464 . . . . 71.519999999999996 110.475 -175.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' C' ' 224' ' ' GLY . 16.7 m -64.51 120.97 13.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.936 0.874 . . . . 64.129999999999995 111.254 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 33.9 m -124.11 108.91 12.83 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 115.039 -0.982 . . . . 71.219999999999999 108.565 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -108.49 132.59 53.66 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 109.65 -0.5 . . . . 63.409999999999997 109.65 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 263' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' C' ' 227' ' ' SER . 37.3 t -142.19 123.86 15.06 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.418 -0.586 . . . . 75.239999999999995 109.418 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.9 p -123.7 148.64 27.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.535 -0.913 . . . . 73.329999999999998 108.535 177.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 37.4 tt0 -89.21 -72.79 0.53 Allowed 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 119.576 -0.85 . . . . 73.430000000000007 110.529 175.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 25.1 m -127.81 133.97 49.44 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.917 -1.114 . . . . 73.329999999999998 112.471 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.82 135.27 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.793 -1.188 . . . . 72.530000000000001 107.793 173.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 5.3 p -127.48 125.43 65.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 121.024 0.44 . . . . 74.209999999999994 110.677 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.57 132.52 10.5 Favored Glycine 0 CA--C 1.476 -2.406 0 N-CA-C 111.137 -0.785 . . . . 53.520000000000003 111.137 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.502 ' HB3' ' HG2' ' C' ' 234' ' ' GLU . 40.6 tptt -134.12 115.83 14.7 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 109.987 -0.375 . . . . 70.230000000000004 109.987 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.97 99.74 0.06 OUTLIER Glycine 0 CA--C 1.527 0.782 0 N-CA-C 114.159 0.424 . . . . 61.32 114.159 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 63.91 26.83 14.33 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.161 0.984 . . . . 74.540000000000006 112.421 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 273' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 37.4 m -83.41 144.79 29.38 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.444 -0.902 . . . . 64.120000000000005 113.066 -171.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 4.8 mtt-85 -135.55 127.23 29.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.001 -1.111 . . . . 72.439999999999998 108.001 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.629 ' HB ' HG12 ' B' ' 239' ' ' VAL . 55.6 t -136.49 138.44 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.594 0 N-CA-C 109.165 -0.68 . . . . 75.010000000000005 109.165 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 6.1 tt -123.44 120.88 34.25 Favored 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 119.095 -1.042 . . . . 72.340000000000003 108.434 169.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.496 HG22 ' HB3' ' C' ' 241' ' ' LEU . 1.5 pt -112.43 104.28 16.79 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 C-N-CA 123.991 0.916 . . . . 74.310000000000002 109.502 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.504 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 145.45 -133.63 5.14 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.804 -0.635 . . . . 60.109999999999999 111.699 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 279' ' ' ASN . . . . . 0.562 ' O ' ' HA ' ' B' ' 243' ' ' ASN . 12.5 m120 -127.28 152.29 47.63 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-O 121.218 0.532 . . . . 70.5 109.978 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -137.68 150.01 47.0 Favored 'General case' 0 N--CA 1.409 -2.52 0 N-CA-C 107.962 -1.125 . . . . 72.140000000000001 107.962 170.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.499 ' HB3' ' HA ' ' B' ' 245' ' ' VAL . 11.2 t80 -125.51 124.34 41.12 Favored 'General case' 0 N--CA 1.395 -3.175 0 N-CA-C 107.623 -1.251 . . . . 61.509999999999998 107.623 -174.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.71 ' HA2' ' HB2' ' B' ' 249' ' ' ALA . . . 143.6 -48.03 0.77 Allowed Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.653 -0.784 . . . . 75.209999999999994 111.747 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 283' ' ' GLY . . . . . 0.446 ' HA3' HG23 ' C' ' 246' ' ' THR . . . 111.59 -23.72 17.03 Favored Glycine 0 C--O 1.206 -1.62 0 N-CA-C 108.578 -1.809 . . . . 60.409999999999997 108.578 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -141.92 81.88 1.78 Allowed 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 106.886 -1.524 . . . . 75.409999999999997 106.886 173.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -103.88 -159.93 24.61 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.492 -1.443 . . . . 64.439999999999998 109.492 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.55 ' H ' HG11 ' B' ' 244' ' ' VAL . 71.3 t80 63.3 -175.04 0.15 Allowed 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 122.912 0.485 . . . . 71.540000000000006 110.54 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -96.5 -16.77 20.95 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.528 -1.357 . . . . 74.200000000000003 112.292 -174.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.34 6.89 47.79 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.379 0.609 . . . . 72.439999999999998 112.227 -172.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -70.89 -4.32 23.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.933 . . . . 71.519999999999996 112.014 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -102.53 5.79 39.57 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.325 1.06 . . . . 64.239999999999995 108.709 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 291' ' ' HIS . . . . . 0.576 ' CD2' ' H ' ' A' ' 294' ' ' HIS . 17.9 t-160 -124.37 26.61 7.29 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 122.221 1.01 . . . . 63.32 109.333 -176.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 292' ' ' HIS . . . . . 0.426 ' HB2' ' HA ' ' C' ' 288' ' ' ASP . 9.2 p80 -75.98 164.78 25.83 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-N 114.99 -1.004 . . . . 72.230000000000004 110.458 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -111.72 -39.02 4.7 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 111.926 0.343 . . . . 72.329999999999998 111.926 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -89.47 127.55 35.86 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.123 -1.066 . . . . 74.209999999999994 108.123 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 . . . . . 0 C--N 1.288 -2.101 0 N-CA-C 108.149 -1.056 . . . . 73.239999999999995 108.149 178.108 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.245 0 N-CA-C 109.779 -0.452 . . . . 72.310000000000002 109.779 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.67 128.96 34.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.908 0.385 . . . . 70.200000000000003 110.936 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.463 ' O ' HG13 ' B' ' 219' ' ' ILE . 21.7 pt -141.29 -174.01 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 106.405 -1.702 . . . . 63.43 106.405 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -119.62 -170.96 2.04 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.812 -1.181 . . . . 51.439999999999998 107.812 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.93 -20.03 31.29 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.524 -0.917 . . . . 72.109999999999999 108.524 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 56.8 mt -107.21 126.75 63.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 105.811 -1.922 . . . . 23.34 105.811 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.89 120.62 52.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 113.559 0.948 . . . . 73.099999999999994 113.559 -174.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 224' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' B' ' 260' ' ' THR . . . -104.34 82.75 0.37 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 107.356 -2.298 . . . . 65.230000000000004 107.356 173.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -118.47 133.45 55.86 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 113.707 1.003 . . . . 72.019999999999996 113.707 -169.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -117.24 120.58 38.68 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.03 -1.441 . . . . 74.239999999999995 108.706 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' C' ' 263' ' ' SER . 42.7 m -121.17 137.08 54.84 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.706 -0.479 . . . . 74.200000000000003 109.706 177.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -133.3 144.38 49.66 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.458 -0.942 . . . . 72.420000000000002 108.458 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -58.78 1.82 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.544 -0.862 . . . . 73.230000000000004 110.883 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 230' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' C' ' 266' ' ' THR . 1.2 m-20 -127.23 139.47 52.9 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.295 0.569 . . . . 75.150000000000006 110.734 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.428 HD11 ' HB1' ' C' ' 228' ' ' ALA . 32.6 mm -128.87 118.05 46.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 106.454 -1.684 . . . . 74.0 106.454 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -118.91 115.1 23.67 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.841 -0.429 . . . . 71.329999999999998 109.841 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 80.5 p -112.19 127.4 55.93 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 108.326 -0.99 . . . . 73.230000000000004 108.326 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.502 ' HG2' ' HB3' ' B' ' 270' ' ' LYS . 43.8 mt-10 -138.9 139.34 38.02 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 121.119 -0.232 . . . . 71.510000000000005 110.41 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.559 ' HB3' ' NH1' ' C' ' 236' ' ' ARG . 49.2 mt-10 56.76 95.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 115.539 1.681 . . . . 62.200000000000003 115.539 174.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.559 ' NH1' ' HB3' ' C' ' 235' ' ' GLU . 0.5 OUTLIER 61.06 24.14 14.26 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.164 0.986 . . . . 61.030000000000001 111.712 175.08 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -91.8 139.57 30.54 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.958 0.885 . . . . 75.5 112.774 -175.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.618 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 8.8 mpt_? -125.65 135.45 52.16 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.17 -1.377 . . . . 72.109999999999999 108.309 177.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.497 HG23 HG13 ' B' ' 275' ' ' VAL . 30.5 m -138.13 147.34 25.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.313 0.578 . . . . 64.450000000000003 110.66 172.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -121.1 129.53 53.35 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.089 -1.819 . . . . 75.349999999999994 106.089 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.496 ' HB3' HG22 ' B' ' 277' ' ' ILE . 2.8 tm? -122.0 118.58 29.16 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 106.162 -1.792 . . . . 74.200000000000003 106.162 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 135.54 -127.77 4.42 Favored Glycine 0 N--CA 1.416 -2.7 0 C-N-CA 120.179 -1.01 . . . . 53.240000000000002 111.421 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.596 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 45.9 t30 -144.34 130.36 19.47 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.525 0.202 . . . . 63.229999999999997 110.783 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.408 HG11 ' H ' ' C' ' 286' ' ' PHE . 85.2 t -110.92 117.88 56.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 123.713 0.805 . . . . 70.129999999999995 109.258 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 18.3 m -107.82 119.26 57.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 120.147 -0.621 . . . . 71.239999999999995 110.479 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 246' ' ' THR . . . . . 0.446 HG23 ' HA3' ' B' ' 283' ' ' GLY . 29.7 m -84.6 158.66 20.82 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 120.943 -0.303 . . . . 54.149999999999999 111.223 -176.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.15 -47.83 78.4 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 122.159 0.98 . . . . 55.240000000000002 110.871 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.38 -35.98 65.87 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.265 -1.789 . . . . 72.109999999999999 112.807 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 249' ' ' ALA . . . . . 0.666 ' HB2' ' HA2' ' C' ' 282' ' ' GLY . . . -74.11 -29.91 62.07 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.166 -0.47 . . . . 41.420000000000002 111.967 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.22 98.24 7.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 122.272 1.034 . . . . 62.399999999999999 110.912 -174.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -98.32 -50.62 4.26 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.018 -1.447 . . . . 73.120000000000005 107.655 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -175.58 45.24 0.12 Allowed Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.689 -0.767 . . . . 55.210000000000001 112.778 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 164.19 136.33 1.98 Allowed Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.058 -1.068 . . . . 71.430000000000007 112.482 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 46.0 mm -106.87 89.2 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.896 -1.15 . . . . 63.549999999999997 107.896 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 255' ' ' ARG . . . . . 0.515 ' HD2' ' OD2' ' B' ' 258' ' ' ASP . 86.0 mtt180 58.77 -168.08 0.14 Allowed 'General case' 0 C--O 1.239 0.544 0 O-C-N 124.2 0.938 . . . . 71.140000000000001 113.259 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 12.8 tt -151.91 -38.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.994 -1.003 . . . . 64.420000000000002 109.5 174.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 26.9 t -162.48 121.37 2.23 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 109.888 -0.412 . . . . 72.519999999999996 109.888 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -125.95 138.3 53.76 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.032 -1.099 . . . . 74.129999999999995 108.032 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -130.93 36.19 3.89 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.352 1.072 . . . . 72.340000000000003 109.975 -175.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 10.3 m -82.88 138.49 33.88 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.614 -0.721 . . . . 71.129999999999995 109.704 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 38.4 m -126.86 111.55 14.29 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.651 -0.656 . . . . 73.239999999999995 110.048 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -123.71 136.02 54.21 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 120.989 0.423 . . . . 71.230000000000004 109.862 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 263' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' C' ' 227' ' ' SER . 33.2 m -142.83 130.41 21.3 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.133 -0.692 . . . . 73.329999999999998 109.133 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.38 153.42 34.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.507 -0.553 . . . . 61.119999999999997 109.507 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -85.35 -74.76 0.39 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.477 -0.564 . . . . 75.219999999999999 109.477 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 266' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 60.4 m -138.41 134.11 33.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.687 -0.633 . . . . 72.349999999999994 110.693 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.54 136.04 57.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 108.374 -0.973 . . . . 72.519999999999996 108.374 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.18 137.16 58.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 116.514 -0.312 . . . . 70.439999999999998 110.308 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.48 133.02 7.51 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 110.933 -0.867 . . . . 71.219999999999999 110.933 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -133.91 115.03 13.95 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.847 -0.797 . . . . 73.129999999999995 108.847 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 74.47 108.75 0.08 OUTLIER Glycine 0 CA--C 1.527 0.834 0 O-C-N 123.843 0.714 . . . . 74.019999999999996 114.42 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 58.64 20.32 7.61 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 123.716 0.807 . . . . 72.519999999999996 112.282 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 273' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 24.4 m -83.76 144.2 29.48 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-O 121.233 0.539 . . . . 72.310000000000002 110.504 -173.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 274' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 0.0 OUTLIER -150.32 128.34 11.87 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.907 -0.588 . . . . 73.230000000000004 109.677 174.064 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 10.1 t -136.75 140.93 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 O-C-N 123.78 0.675 . . . . 60.420000000000002 109.232 -173.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.9 tt -112.03 116.67 30.93 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 107.939 -1.134 . . . . 61.219999999999999 107.939 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 3.2 mp -101.27 104.45 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 106.555 -1.646 . . . . 71.030000000000001 106.555 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 278' ' ' GLY . . . . . 0.482 ' C ' HD22 ' C' ' 279' ' ' ASN . . . 138.13 -128.48 4.22 Favored Glycine 0 N--CA 1.409 -3.152 0 C-N-CA 119.446 -1.359 . . . . 32.039999999999999 112.092 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 279' ' ' ASN . . . . . 0.596 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 1.0 OUTLIER -128.04 138.96 52.77 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.057 0.456 . . . . 73.420000000000002 111.822 -173.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -126.62 145.79 50.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.325 -1.361 . . . . 71.519999999999996 107.325 168.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -125.85 123.35 38.49 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 108.305 -0.998 . . . . 75.120000000000005 108.305 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 282' ' ' GLY . . . . . 0.666 ' HA2' ' HB2' ' C' ' 249' ' ' ALA . . . 134.03 9.77 1.87 Allowed Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.59 -0.732 . . . . 72.109999999999999 113.989 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 80.99 -47.93 3.66 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-N 117.92 0.86 . . . . 35.329999999999998 111.771 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 284' ' ' LYS . . . . . 0.517 ' HD3' ' OD1' ' C' ' 289' ' ' ASN . 96.0 mttt -136.65 96.61 3.37 Favored 'General case' 0 N--CA 1.413 -2.302 0 N-CA-C 107.473 -1.306 . . . . 73.409999999999997 107.473 174.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -110.06 -159.74 17.73 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 108.666 -1.773 . . . . 44.329999999999998 108.666 173.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.408 ' H ' HG11 ' C' ' 244' ' ' VAL . 60.6 t80 73.87 169.97 0.3 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.803 0.841 . . . . 75.310000000000002 110.993 176.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -71.01 -27.54 63.77 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 116.81 2.152 . . . . 74.219999999999999 116.81 -167.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 288' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' B' ' 292' ' ' HIS . 27.0 t0 -78.11 -78.53 0.14 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 119.824 -0.75 . . . . 74.209999999999994 112.277 -171.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 289' ' ' ASN . . . . . 0.517 ' OD1' ' HD3' ' C' ' 284' ' ' LYS . 17.3 t-20 -120.13 130.87 54.82 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.361 -0.607 . . . . 74.450000000000003 109.361 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.57 -171.0 2.6 Favored 'General case' 0 C--O 1.25 1.1 0 C-N-CA 120.798 -0.361 . . . . 73.219999999999999 110.782 -174.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 80.32 105.26 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.006 1.323 . . . . 71.030000000000001 112.567 175.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -170.05 172.9 6.22 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 105.665 -1.976 . . . . 75.140000000000001 105.665 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -123.36 98.87 6.05 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.531 -0.914 . . . . 70.349999999999994 108.531 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -177.61 -179.96 0.86 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 104.402 -2.444 . . . . 62.409999999999997 104.402 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 56.4 m170 . . . . . 0 C--N 1.304 -1.403 0 N-CA-C 108.335 -0.987 . . . . 72.150000000000006 108.335 174.473 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.66 ' HB3' ' HB2' ' B' ' 258' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.49 0 N-CA-C 109.617 -0.512 . . . . 73.209999999999994 109.617 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -138.49 148.68 44.59 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.362 -2.088 . . . . 75.329999999999998 105.362 171.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.5 pt -92.77 147.94 5.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.424 -0.511 . . . . 74.450000000000003 111.827 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 221' ' ' ALA . 10.5 t70 64.31 -169.64 0.2 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.546 1.538 . . . . 74.349999999999994 111.812 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.489 ' H ' ' CG ' ' A' ' 220' ' ' ASP . . . 70.79 163.14 0.25 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 125.805 1.642 . . . . 72.519999999999996 108.549 -170.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 3.1 mp -83.9 112.32 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 116.495 -2.082 . . . . 72.329999999999998 107.523 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 24.2 m -140.11 165.54 21.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 107.743 -1.206 . . . . 71.219999999999999 107.743 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 96.06 34.78 5.78 Favored Glycine 0 C--N 1.289 -2.028 0 C-N-CA 119.16 -1.495 . . . . 50.219999999999999 112.225 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 154.52 44.92 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.43 -0.952 . . . . 75.319999999999993 108.43 175.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -86.34 133.89 33.77 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.479 -1.304 . . . . 71.349999999999994 107.479 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 32.9 m -133.63 141.79 47.79 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.318 0.58 . . . . 75.299999999999997 112.386 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.34 137.88 37.79 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.003 -1.851 . . . . 74.099999999999994 106.003 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.41 -48.04 10.06 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.684 -0.858 . . . . 73.230000000000004 108.684 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -140.15 140.64 36.0 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 119.76 -0.776 . . . . 71.019999999999996 111.646 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 62.6 mt -126.49 117.17 47.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 106.806 -1.553 . . . . 71.439999999999998 106.806 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -118.92 115.96 25.47 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.619 -0.833 . . . . 63.539999999999999 110.127 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.1 t -113.11 128.69 56.56 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.602 -0.726 . . . . 65.239999999999995 109.276 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.425 ' HG2' ' HG3' ' A' ' 235' ' ' GLU . 40.3 tt0 -150.23 139.81 21.58 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 108.435 -0.95 . . . . 73.540000000000006 108.435 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.425 ' HG3' ' HG2' ' A' ' 234' ' ' GLU . 43.9 mt-10 65.6 89.14 0.1 Allowed 'General case' 0 C--O 1.22 -0.48 0 O-C-N 124.409 1.068 . . . . 73.120000000000005 113.075 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 271' ' ' GLY . 36.2 mtt85 66.33 -4.82 0.65 Allowed 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 124.448 1.099 . . . . 62.210000000000001 113.136 171.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.431 ' HA ' ' H ' ' A' ' 273' ' ' SER . . . -70.61 143.44 51.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 123.352 0.661 . . . . 74.439999999999998 111.2 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -126.37 135.81 51.92 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.979 -1.119 . . . . 71.540000000000006 107.979 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.431 HG12 ' HB ' ' A' ' 275' ' ' VAL . 34.7 m -128.73 150.82 34.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 120.844 0.354 . . . . 70.329999999999998 111.666 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.409 ' HG2' ' CG2' ' A' ' 244' ' ' VAL . 55.0 tp60 -134.05 134.55 42.5 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.137 -0.938 . . . . 75.129999999999995 108.831 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -128.14 119.28 24.97 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.583 -1.266 . . . . 74.310000000000002 107.583 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.501 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 132.35 -115.67 1.67 Allowed Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 119.991 -1.1 . . . . 63.149999999999999 112.689 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -143.51 135.86 27.05 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.301 -0.629 . . . . 53.25 109.301 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.409 ' CG2' ' HG2' ' A' ' 240' ' ' GLN . 99.0 t -116.94 120.63 65.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.46 -1.311 . . . . 73.129999999999995 107.46 175.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.73 117.19 51.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 108.996 -0.742 . . . . 64.209999999999994 108.996 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 90.5 m -77.48 159.72 29.17 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.064 -0.717 . . . . 75.019999999999996 109.064 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.38 -38.83 91.1 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.538 0.735 . . . . 64.310000000000002 112.122 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.13 -33.74 72.57 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.861 0.864 . . . . 72.120000000000005 111.551 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.56 -26.86 64.69 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.642 -0.708 . . . . 61.340000000000003 112.223 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.09 122.73 18.42 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.869 -0.419 . . . . 74.010000000000005 109.869 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 6.4 t60 69.98 86.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.828 1.251 . . . . 62.549999999999997 108.275 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -162.33 103.13 0.21 Allowed Glycine 0 N--CA 1.42 -2.376 0 N-CA-C 108.779 -1.729 . . . . 75.140000000000001 108.779 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 84.75 172.37 49.05 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.503 -0.856 . . . . 72.439999999999998 111.644 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 13.8 tt -109.57 -20.75 6.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.065 0.459 . . . . 74.540000000000006 111.29 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.455 ' HB2' ' HA2' ' B' ' 252' ' ' GLY . 99.5 mtt180 -129.63 147.58 51.43 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.024 0.75 . . . . 74.5 113.024 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 8.0 tt -108.07 91.3 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 107.144 -1.428 . . . . 64.140000000000001 107.144 172.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 16.1 m -80.48 -44.75 18.66 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.705 -1.134 . . . . 53.25 113.824 -172.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.408 ' OD2' HG23 ' A' ' 260' ' ' THR . 16.3 t70 -86.04 127.19 34.61 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.873 -0.731 . . . . 52.329999999999998 111.486 -175.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -135.31 66.57 1.52 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.831 -1.174 . . . . 65.450000000000003 107.831 174.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.408 HG23 ' OD2' ' A' ' 258' ' ' ASP . 0.8 OUTLIER -64.68 138.42 58.38 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 114.367 1.247 . . . . 71.329999999999998 114.367 -177.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.1 m -101.75 115.68 31.07 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 106.701 -1.592 . . . . 75.140000000000001 106.701 172.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -121.15 141.43 50.83 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.213 -1.032 . . . . 73.329999999999998 108.213 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.7 p -136.23 123.4 21.71 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.056 -0.52 . . . . 74.430000000000007 111.588 -172.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 13.4 p -129.0 148.28 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 108.917 -0.772 . . . . 72.439999999999998 108.917 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 34.5 tt0 -85.89 -69.16 0.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.686 -0.487 . . . . 74.230000000000004 109.686 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 28.6 m -126.09 128.06 46.77 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.315 -0.554 . . . . 72.400000000000006 111.404 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 36.0 m -119.77 125.67 74.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.049 0 N-CA-C 109.101 -0.704 . . . . 71.109999999999999 109.101 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.14 134.9 64.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 116.078 -0.51 . . . . 55.329999999999998 112.063 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -123.96 132.27 8.31 Favored Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 111.298 -0.721 . . . . 60.439999999999998 111.298 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 26.3 mmmt -133.76 147.6 51.31 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.117 0.967 . . . . 71.209999999999994 112.175 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.439 ' O ' ' HD2' ' A' ' 236' ' ' ARG . . . 84.53 -57.82 5.01 Favored Glycine 0 CA--C 1.502 -0.732 0 CA-C-N 115.981 -0.554 . . . . 75.530000000000001 112.453 174.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.493 ' HG3' ' CE1' ' A' ' 292' ' ' HIS . 0.7 OUTLIER 179.6 121.3 0.06 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 103.468 -2.79 . . . . 63.509999999999998 103.468 176.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 68.6 m -151.28 155.88 39.67 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.902 0.382 . . . . 52.210000000000001 110.685 -175.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' B' ' 238' ' ' ARG . 2.2 mpt_? -127.75 127.92 44.45 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.206 -1.776 . . . . 74.030000000000001 106.206 174.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.431 ' HB ' HG12 ' A' ' 239' ' ' VAL . 33.5 t -129.1 129.79 67.92 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 109.583 -0.525 . . . . 74.420000000000002 109.583 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.502 ' HB3' ' OE1' ' B' ' 240' ' ' GLN . 4.8 tt -125.32 118.94 27.04 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.197 -1.038 . . . . 63.009999999999998 108.197 172.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 43.5 mm -107.99 104.86 17.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.957 -1.127 . . . . 71.040000000000006 107.957 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 144.77 -140.04 8.91 Favored Glycine 0 N--CA 1.419 -2.464 0 C-N-CA 120.66 -0.781 . . . . 71.219999999999999 111.794 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -115.18 140.36 49.14 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 109.72 -0.474 . . . . 73.230000000000004 109.72 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.43 129.52 53.93 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.193 -2.151 . . . . 63.109999999999999 105.193 174.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 2.0 t80 -127.49 122.81 34.4 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 107.228 -1.397 . . . . 72.319999999999993 107.228 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.72 -52.95 0.63 Allowed Glycine 0 N--CA 1.412 -2.93 0 N-CA-C 108.624 -1.79 . . . . 61.25 108.624 -175.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 139.02 -57.84 0.62 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 111.17 -0.772 . . . . 64.140000000000001 111.17 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.557 ' HA ' ' NE1' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -132.18 35.2 3.72 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.948 0.88 . . . . 74.040000000000006 110.617 -176.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -57.29 -31.26 62.29 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 116.002 1.161 . . . . 70.019999999999996 116.002 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.455 ' CB ' HD12 ' A' ' 276' ' ' LEU . 71.0 t80 -114.72 0.22 13.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.908 0.861 . . . . 72.530000000000001 110.535 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.557 ' NE1' ' HA ' ' A' ' 284' ' ' LYS . 10.5 p90 -137.66 87.41 2.26 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.888 0.852 . . . . 73.340000000000003 111.291 -177.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -86.86 -45.57 10.74 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.415 -0.811 . . . . 75.109999999999999 109.698 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -156.62 165.15 37.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.591 -0.731 . . . . 74.030000000000001 111.474 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -103.68 74.55 1.25 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.861 0.839 . . . . 62.350000000000001 110.9 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -68.57 80.41 0.27 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.667 -1.151 . . . . 72.340000000000003 110.175 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' HIS . . . . . 0.493 ' CE1' ' HG3' ' A' ' 272' ' ' GLU . 3.6 m170 169.51 84.92 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 127.961 2.504 . . . . 74.200000000000003 109.91 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -94.75 -22.09 18.31 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.98 -1.119 . . . . 73.549999999999997 107.98 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 64.78 22.11 12.49 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.366 1.466 . . . . 73.329999999999998 112.155 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 16.7 t60 . . . . . 0 C--N 1.313 -0.979 0 N-CA-C 107.353 -1.351 . . . . 65.409999999999997 107.353 176.271 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 110.093 -0.336 . . . . 71.409999999999997 110.093 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -72.93 104.54 4.1 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.294 0.638 . . . . 73.510000000000005 110.978 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 219' ' ' ILE . . . . . 0.606 ' H ' HD13 ' B' ' 219' ' ' ILE . 0.2 OUTLIER -89.16 -17.16 8.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.295 -0.412 . . . . 73.349999999999994 110.593 176.597 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 2.2 t0 75.28 -173.99 0.12 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.719 1.608 . . . . 60.009999999999998 110.832 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -114.89 19.9 15.52 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.765 0.654 . . . . 72.140000000000001 112.765 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 2.1 mp -84.06 125.14 40.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 109.195 -0.669 . . . . 62.310000000000002 109.195 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 217' ' ' MET . 27.7 m -100.03 163.82 2.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.306 -0.406 . . . . 72.150000000000006 110.277 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 98.47 43.43 2.73 Favored Glycine 0 CA--C 1.49 -1.524 0 N-CA-C 110.253 -1.139 . . . . 31.43 110.253 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -142.13 154.23 44.72 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 121.019 0.438 . . . . 72.329999999999998 110.077 -175.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -94.03 129.86 40.39 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 103.865 -2.643 . . . . 54.25 103.865 167.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 23.9 m -131.69 137.08 48.14 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.104 -1.038 . . . . 72.530000000000001 111.63 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.501 ' HB2' HG21 ' B' ' 277' ' ' ILE . . . -132.2 135.82 46.6 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.611 -1.255 . . . . 74.450000000000003 107.611 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 0.1 OUTLIER -82.77 -61.47 1.86 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.747 -0.835 . . . . 70.209999999999994 108.747 -178.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -134.24 139.46 45.78 Favored 'General case' 0 C--O 1.254 1.318 0 C-N-CA 120.036 -0.666 . . . . 75.540000000000006 109.409 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 10.9 mt -128.43 116.77 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.199 -1.408 . . . . 72.25 107.199 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.412 ' HB3' HG12 ' B' ' 268' ' ' VAL . 56.1 ttt180 -113.3 118.83 35.71 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.216 -0.447 . . . . 72.349999999999994 110.286 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.46 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 0.0 OUTLIER -110.82 128.65 55.85 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 108.713 -0.847 . . . . 75.219999999999999 108.713 175.025 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 234' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 33.9 tt0 -147.46 138.88 23.84 Favored 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 108.543 -0.91 . . . . 74.030000000000001 108.543 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.556 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 52.5 mt-10 65.09 94.85 0.06 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 124.675 1.235 . . . . 60.549999999999997 113.273 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.556 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 58.6 15.78 3.88 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 125.459 1.503 . . . . 70.540000000000006 112.711 171.102 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -92.33 149.05 21.66 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 121.526 0.679 . . . . 74.400000000000006 111.911 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -129.45 135.75 49.05 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 115.612 -0.722 . . . . 72.430000000000007 110.183 175.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.518 HG12 ' HB ' ' B' ' 275' ' ' VAL . 30.4 m -125.87 136.8 59.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 124.089 0.868 . . . . 65.239999999999995 109.987 -177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.502 ' OE1' ' HB3' ' A' ' 276' ' ' LEU . 38.8 tp60 -115.92 132.94 56.5 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.866 -1.061 . . . . 73.140000000000001 108.693 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.28 118.36 24.94 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.348 -1.353 . . . . 75.0 107.348 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 134.04 -114.12 1.28 Allowed Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 120.044 -1.074 . . . . 72.349999999999994 111.924 177.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -144.31 140.32 29.08 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.796 -0.446 . . . . 73.109999999999999 109.796 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.499 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 97.7 t -122.11 114.87 44.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.239 -1.393 . . . . 71.200000000000003 107.239 175.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' B' ' 250' ' ' LEU . 4.2 p -122.13 118.5 55.66 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-O 121.21 0.529 . . . . 65.340000000000003 109.803 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 28.7 m -71.09 158.85 35.76 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 109.05 -0.722 . . . . 72.140000000000001 109.05 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.98 -47.41 80.47 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.038 0.923 . . . . 65.349999999999994 111.291 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.77 79.17 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.896 -1.502 . . . . 64.200000000000003 111.847 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.497 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -67.88 -40.31 83.55 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.506 0.928 . . . . 72.25 113.506 -173.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.453 ' HB2' ' CG2' ' B' ' 245' ' ' VAL . 26.6 tp -83.7 75.4 10.07 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.043 -0.663 . . . . 64.209999999999994 111.93 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -84.8 -54.5 4.64 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.42 -0.809 . . . . 74.510000000000005 110.373 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 255' ' ' ARG . . . 176.47 -160.1 27.46 Favored Glycine 0 N--CA 1.417 -2.627 0 C-N-CA 120.314 -0.946 . . . . 64.219999999999999 111.788 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 138.94 -147.21 19.06 Favored Glycine 0 N--CA 1.423 -2.193 0 N-CA-C 109.358 -1.497 . . . . 64.209999999999994 109.358 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 49.9 mm -117.27 136.02 55.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.627 -1.249 . . . . 75.439999999999998 107.627 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -60.62 125.21 22.83 Favored 'General case' 0 C--O 1.245 0.854 0 O-C-N 123.527 0.517 . . . . 72.310000000000002 109.683 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.5 pp -111.39 154.24 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.006 0 CA-C-O 121.045 0.45 . . . . 73.510000000000005 110.549 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 13.0 m -128.44 13.96 6.57 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.404 -1.332 . . . . 61.420000000000002 107.404 174.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.66 ' HB2' ' HB3' ' A' ' 217' ' ' MET . 15.6 t70 -173.27 130.78 0.47 Allowed 'General case' 0 CA--C 1.493 -1.225 0 CA-C-N 114.081 -1.418 . . . . 73.400000000000006 108.14 -175.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . 0.289 1.1 pt20 -144.03 -97.44 0.11 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 123.624 0.578 . . . . 61.229999999999997 111.193 173.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.408 ' HA ' ' OD2' ' C' ' 258' ' ' ASP . 16.2 p -94.3 131.84 39.5 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 118.757 0.708 . . . . 71.200000000000003 111.379 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 53.9 m -106.11 108.16 19.53 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 107.459 -1.312 . . . . 60.32 107.459 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -124.65 131.83 53.45 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.641 -1.244 . . . . 64.409999999999997 107.641 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 15.7 m -121.54 123.79 42.85 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.835 -0.62 . . . . 40.149999999999999 110.521 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 8.4 p -126.29 149.86 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 108.024 -1.102 . . . . 63.409999999999997 108.024 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 12.8 tt0 -93.95 -77.94 0.44 Allowed 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.97 -0.752 . . . . 75.420000000000002 108.97 175.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 28.8 m -113.26 127.54 56.19 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 120.25 -0.58 . . . . 62.100000000000001 110.854 -175.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.83 120.68 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-O 121.695 0.759 . . . . 61.32 109.512 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 268' ' ' VAL . . . . . 0.412 HG12 ' HB3' ' B' ' 232' ' ' ARG . 27.0 m -126.92 141.55 45.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.623 -0.717 . . . . 72.120000000000005 112.199 -174.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 269' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.72 132.41 7.92 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.982 -0.847 . . . . 61.420000000000002 110.982 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 25.4 mmmt -133.87 148.83 51.3 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 124.205 1.002 . . . . 52.020000000000003 112.541 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 271' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' B' ' 236' ' ' ARG . . . 85.57 -57.99 4.88 Favored Glycine 0 CA--C 1.499 -0.945 0 C-N-CA 121.362 -0.447 . . . . 71.349999999999994 112.954 174.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 176.24 114.17 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 103.279 -2.86 . . . . 72.25 103.279 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 273' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 67.1 m -146.79 160.22 42.53 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.734 0.778 . . . . 72.540000000000006 112.448 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.532 ' HD3' ' HB3' ' C' ' 238' ' ' ARG . 0.7 OUTLIER -129.48 127.58 41.14 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 105.799 -1.926 . . . . 70.099999999999994 105.799 176.354 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.518 ' HB ' HG12 ' B' ' 239' ' ' VAL . 41.5 t -132.02 126.31 56.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.658 -0.497 . . . . 71.340000000000003 109.658 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.495 HD12 ' CB ' ' B' ' 286' ' ' PHE . 4.7 tt -121.78 118.7 29.69 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.752 -1.179 . . . . 74.310000000000002 108.029 173.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.501 HG21 ' HB2' ' B' ' 228' ' ' ALA . 44.6 mm -108.18 104.23 16.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 106.952 -1.499 . . . . 75.319999999999993 106.952 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 146.36 -158.02 27.57 Favored Glycine 0 CA--C 1.476 -2.39 0 C-N-CA 120.358 -0.925 . . . . 61.130000000000003 113.204 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -96.38 138.86 33.35 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.293 -0.632 . . . . 73.030000000000001 109.293 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -121.32 126.8 50.37 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 105.801 -1.925 . . . . 73.239999999999995 105.801 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.543 ' CD1' HG13 ' C' ' 245' ' ' VAL . 1.3 t80 -123.63 123.56 40.83 Favored 'General case' 0 N--CA 1.405 -2.716 0 N-CA-C 107.304 -1.369 . . . . 60.219999999999999 107.304 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' B' ' 249' ' ' ALA . . . 142.59 -43.98 1.01 Allowed Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 108.809 -1.716 . . . . 72.129999999999995 108.809 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.24 -29.0 8.26 Favored Glycine 0 N--CA 1.423 -2.215 0 N-CA-C 111.678 -0.569 . . . . 44.219999999999999 111.678 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 284' ' ' LYS . . . . . 0.533 ' HA ' ' CD1' ' B' ' 287' ' ' TRP . 42.6 pttt -149.04 19.84 0.98 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.679 -0.409 . . . . 73.299999999999997 111.974 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -53.97 -43.49 71.96 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.117 -0.563 . . . . 75.319999999999993 114.226 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.495 ' CB ' HD12 ' B' ' 276' ' ' LEU . 62.1 t80 -97.69 -1.09 44.31 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.685 0.755 . . . . 73.450000000000003 111.202 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.533 ' CD1' ' HA ' ' B' ' 284' ' ' LYS . 13.6 p90 -145.74 95.09 2.59 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.329 0.585 . . . . 75.430000000000007 110.926 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 288' ' ' ASP . . . . . 0.473 ' OD2' ' HA ' ' B' ' 291' ' ' HIS . 37.4 t70 -77.51 81.95 3.95 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 122.004 0.907 . . . . 74.140000000000001 110.096 -177.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -80.14 -53.59 6.54 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.464 -1.244 . . . . 72.329999999999998 108.773 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -82.18 101.64 10.59 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 103.409 -2.811 . . . . 74.299999999999997 103.409 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 291' ' ' HIS . . . . . 0.473 ' HA ' ' OD2' ' B' ' 288' ' ' ASP . 51.9 t-80 -53.29 127.26 23.96 Favored 'General case' 0 C--O 1.248 0.982 0 O-C-N 124.154 0.909 . . . . 75.340000000000003 112.278 -169.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -60.45 152.58 25.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.197 -0.91 . . . . 73.540000000000006 111.47 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -94.65 -86.38 0.28 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.637 -1.616 . . . . 71.430000000000007 106.637 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -146.1 -177.6 5.69 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 105.965 -1.865 . . . . 74.310000000000002 105.965 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 . . . . . 0 C--N 1.294 -1.841 0 C-N-CA 120.538 -0.465 . . . . 72.420000000000002 109.822 178.44 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 217' ' ' MET . . . . . 0.439 ' SD ' ' N ' ' C' ' 218' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 105.715 -1.957 . . . . 72.25 105.715 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 218' ' ' LYS . . . . . 0.439 ' N ' ' SD ' ' C' ' 217' ' ' MET . 7.1 tmtm? -78.7 -40.99 32.23 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.924 -1.51 . . . . 53.229999999999997 106.924 177.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 15.8 tt -144.8 136.34 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 108.927 -0.768 . . . . 51.520000000000003 108.927 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -150.31 141.2 22.85 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 122.846 0.458 . . . . 70.540000000000006 110.438 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 60.79 88.47 0.08 Allowed 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.602 1.161 . . . . 63.0 112.858 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 0.554 ' HB ' HH21 ' C' ' 225' ' ' ARG . 3.5 mp -106.67 114.49 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 107.563 -1.273 . . . . 41.399999999999999 107.563 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.92 165.34 9.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.102 -0.954 . . . . 73.140000000000001 109.938 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.13 51.84 4.03 Favored Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 109.674 -1.37 . . . . 61.350000000000001 109.674 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.554 HH21 ' HB ' ' C' ' 222' ' ' ILE . 8.5 ptp180 -143.3 154.44 43.78 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.955 -1.128 . . . . 62.329999999999998 107.955 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -93.29 133.2 36.76 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.569 -1.271 . . . . 73.310000000000002 107.569 172.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 48.8 m -140.67 141.8 34.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.549 0.944 . . . . 64.409999999999997 113.549 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -137.37 133.03 34.38 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.222 -1.029 . . . . 52.439999999999998 108.222 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -76.67 -57.98 3.54 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.24 -0.652 . . . . 61.32 109.24 -178.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.14 140.0 41.56 Favored 'General case' 0 C--O 1.265 1.881 0 C-N-CA 120.041 -0.663 . . . . 74.400000000000006 110.84 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.442 HG23 HG23 ' C' ' 267' ' ' VAL . 11.9 mt -130.22 116.97 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 107.898 -1.149 . . . . 63.340000000000003 107.898 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.45 ' HB3' HG12 ' C' ' 268' ' ' VAL . 38.1 ttt180 -118.02 118.1 31.02 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.263 0.554 . . . . 73.329999999999998 110.625 177.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.469 ' HB ' HG13 ' C' ' 239' ' ' VAL . 0.0 OUTLIER -110.53 129.88 55.69 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 108.707 -0.849 . . . . 65.219999999999999 108.707 175.389 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 33.6 tt0 -144.13 138.56 28.28 Favored 'General case' 0 N--CA 1.415 -2.204 0 C-N-CA 120.317 -0.553 . . . . 73.109999999999999 109.515 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.571 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 51.0 mt-10 59.72 97.76 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.617 1.167 . . . . 63.439999999999998 114.018 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.571 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 0.2 OUTLIER 61.87 13.59 5.63 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.426 1.49 . . . . 73.340000000000003 112.333 172.315 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.38 151.46 19.38 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.443 0.64 . . . . 71.040000000000006 111.964 -174.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.532 ' HB3' ' HD3' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -132.91 135.47 45.58 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-N 115.44 -0.8 . . . . 73.319999999999993 110.823 178.191 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.475 HG12 ' HB ' ' C' ' 275' ' ' VAL . 33.1 m -127.85 138.32 55.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.228 -0.897 . . . . 71.329999999999998 110.234 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.489 ' OE1' ' HB3' ' B' ' 276' ' ' LEU . 38.4 tp60 -116.19 133.35 56.12 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.799 -1.091 . . . . 71.319999999999993 108.873 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.27 118.41 24.17 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.802 -1.555 . . . . 63.5 106.802 175.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.474 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 133.68 -117.94 1.98 Allowed Glycine 0 N--CA 1.422 -2.269 0 C-N-CA 119.918 -1.134 . . . . 75.319999999999993 111.007 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -144.67 140.01 28.36 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 123.582 0.224 . . . . 64.299999999999997 111.066 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.485 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 86.2 t -121.58 116.19 48.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 108.408 -0.96 . . . . 64.329999999999998 108.408 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.543 HG13 ' CD1' ' B' ' 281' ' ' TYR . 2.7 p -122.62 123.48 68.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 109.46 -0.571 . . . . 74.109999999999999 109.46 176.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 24.9 m -77.84 159.29 29.06 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 109.561 -0.533 . . . . 62.049999999999997 109.561 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.96 -46.53 81.18 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.308 1.052 . . . . 65.409999999999997 110.739 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.81 67.85 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.215 -1.811 . . . . 72.439999999999998 112.245 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 249' ' ' ALA . . . . . 0.555 ' HB2' ' HA2' ' C' ' 282' ' ' GLY . . . -69.14 -26.6 64.96 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 113.085 0.772 . . . . 73.409999999999997 113.085 -176.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 9.5 mp 69.82 110.48 0.05 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.401 1.08 . . . . 75.230000000000004 112.236 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -61.27 -52.38 64.96 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.779 -0.823 . . . . 75.319999999999993 108.779 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 69.28 -126.84 20.19 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 115.081 -0.963 . . . . 73.150000000000006 111.014 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.45 170.87 15.84 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 120.624 -0.798 . . . . 64.349999999999994 112.066 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 6.1 tt -64.29 124.57 19.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 123.537 0.735 . . . . 63.149999999999999 111.484 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 60.6 ttp85 -147.43 83.64 1.55 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 108.824 -0.806 . . . . 75.420000000000002 108.824 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 48.8 mm 69.25 -51.63 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 125.27 1.428 . . . . 63.119999999999997 113.213 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 11.1 m 69.22 -73.28 0.09 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 126.204 1.802 . . . . 71.519999999999996 111.863 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 258' ' ' ASP . . . . . 0.408 ' OD2' ' HA ' ' B' ' 260' ' ' THR . 12.0 m-20 -85.99 75.37 9.97 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.734 0.778 . . . . 74.430000000000007 109.409 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -90.48 -20.73 22.38 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.591 -0.731 . . . . 60.350000000000001 109.755 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 3.1 p -100.83 121.2 41.29 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.043 -1.095 . . . . 62.539999999999999 108.043 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 55.9 m -105.01 108.48 20.02 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.654 -0.869 . . . . 71.120000000000005 108.654 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -119.45 131.93 55.71 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.867 -0.606 . . . . 75.209999999999994 109.39 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 14.9 m -117.76 122.98 44.88 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.439 0.638 . . . . 52.119999999999997 110.014 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.25 129.86 65.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.163 -0.926 . . . . 73.400000000000006 111.79 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -72.49 -75.68 0.13 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.488 -0.93 . . . . 64.310000000000002 108.488 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 86.9 m -148.94 136.56 20.42 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.22 -0.925 . . . . 73.540000000000006 110.006 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.442 HG23 HG23 ' C' ' 231' ' ' ILE . 15.9 m -124.05 129.96 73.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 116.012 -0.54 . . . . 71.209999999999994 109.758 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 268' ' ' VAL . . . . . 0.45 HG12 ' HB3' ' C' ' 232' ' ' ARG . 31.0 m -123.66 140.02 48.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 120.926 0.393 . . . . 71.310000000000002 110.602 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.31 132.58 9.64 Favored Glycine 0 C--N 1.299 -1.495 0 N-CA-C 110.879 -0.888 . . . . 65.439999999999998 110.879 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -134.54 128.92 34.25 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 123.432 0.693 . . . . 74.25 111.624 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 64.23 56.28 18.87 Favored Glycine 0 C--N 1.318 -0.462 0 O-C-N 123.553 0.533 . . . . 75.549999999999997 113.046 175.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 71.48 102.85 0.07 Allowed 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.467 1.507 . . . . 71.310000000000002 109.601 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.1 m -139.4 148.79 43.3 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.935 -1.029 . . . . 60.509999999999998 108.771 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -121.54 126.34 48.94 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.067 -1.827 . . . . 54.32 106.067 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.475 ' HB ' HG12 ' C' ' 239' ' ' VAL . 31.0 t -138.13 128.79 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 110.042 -0.355 . . . . 65.319999999999993 110.042 -175.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.72 117.91 25.27 Favored 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 107.97 -1.122 . . . . 53.43 107.97 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.438 HG21 ' HB2' ' C' ' 228' ' ' ALA . 50.1 mm -109.34 104.43 17.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.059 -1.089 . . . . 72.239999999999995 108.059 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 278' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 146.06 -154.85 26.21 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 120.565 -0.826 . . . . 25.050000000000001 111.978 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.41 128.17 44.67 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.7 -0.482 . . . . 74.299999999999997 109.7 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -111.93 125.46 54.08 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.876 -1.527 . . . . 75.519999999999996 106.876 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -130.18 123.9 31.34 Favored 'General case' 0 N--CA 1.404 -2.765 0 CA-C-O 121.663 0.744 . . . . 64.319999999999993 109.432 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 282' ' ' GLY . . . . . 0.555 ' HA2' ' HB2' ' C' ' 249' ' ' ALA . . . 151.58 -46.92 0.59 Allowed Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 108.873 -1.691 . . . . 43.240000000000002 108.873 -176.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 128.4 -25.02 4.88 Favored Glycine 0 CA--C 1.481 -2.077 0 C-N-CA 120.07 -1.062 . . . . 63.130000000000003 111.255 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 284' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' C' ' 287' ' ' TRP . 56.3 pttt -151.93 -62.09 0.17 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.177 -0.511 . . . . 74.420000000000002 110.486 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 285' ' ' GLY . . . . . 0.437 ' H ' ' HG3' ' C' ' 284' ' ' LYS . . . 50.5 -86.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.114 0 N-CA-C 115.503 0.961 . . . . 74.129999999999995 115.503 176.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.408 ' HA ' ' NE1' ' B' ' 287' ' ' TRP . 42.6 t80 -65.79 -29.72 70.25 Favored 'General case' 0 C--O 1.255 1.379 0 C-N-CA 125.192 1.397 . . . . 73.25 110.62 -176.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.579 ' O ' ' HB2' ' C' ' 284' ' ' LYS . 20.1 p90 -125.25 151.57 45.75 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.669 -0.696 . . . . 73.209999999999994 109.884 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -97.67 126.67 43.12 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.668 -0.864 . . . . 73.420000000000002 108.668 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -156.28 -152.65 0.39 Allowed 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 103.339 -2.837 . . . . 72.140000000000001 103.339 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -55.99 143.5 32.05 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 119.323 0.965 . . . . 72.430000000000007 110.413 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -58.53 -82.85 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 114.807 1.41 . . . . 74.150000000000006 114.807 -172.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 60.15 97.91 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 O-C-N 124.127 0.892 . . . . 71.299999999999997 109.865 -175.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -99.12 -43.63 6.58 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 113.176 0.806 . . . . 73.329999999999998 113.176 -171.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 7.8 m170 75.5 149.31 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.122 0.969 . . . . 74.430000000000007 111.982 -171.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 80.9 t60 . . . . . 0 C--O 1.256 1.443 0 C-N-CA 124.869 1.267 . . . . 74.109999999999999 111.21 179.475 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 108.949 -0.76 . . . . 61.240000000000002 108.949 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? 50.89 64.21 1.92 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.723 1.209 . . . . 61.409999999999997 113.352 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 21.4 pt -75.62 138.97 19.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.863 -0.608 . . . . 74.040000000000006 110.421 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -98.44 -25.27 14.85 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.674 -0.694 . . . . 72.439999999999998 110.282 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -90.73 77.1 6.35 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 116.012 -0.54 . . . . 74.430000000000007 109.696 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 67.3 mt -99.39 132.56 44.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 115.648 -0.706 . . . . 50.119999999999997 109.315 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 10.3 p -139.21 164.29 25.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 106.16 -1.793 . . . . 75.209999999999994 106.16 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -75.37 77.86 1.18 Allowed Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.856 -0.687 . . . . 73.239999999999995 111.645 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -122.0 151.69 40.55 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.569 -0.901 . . . . 72.120000000000005 108.569 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.467 HD22 ' HA2' ' A' ' 278' ' ' GLY . 62.9 t30 -99.01 136.9 38.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.757 -1.201 . . . . 71.109999999999999 107.757 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 43.4 m -126.59 136.87 53.1 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.854 0.835 . . . . 30.309999999999999 112.478 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 277' ' ' ILE . . . -133.72 138.93 46.08 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.208 -1.775 . . . . 73.450000000000003 106.208 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -92.75 -60.91 1.7 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.359 -0.978 . . . . 75.310000000000002 108.359 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -129.78 140.55 51.03 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.49 0.662 . . . . 73.409999999999997 110.921 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 70.7 mt -125.43 123.26 64.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.408 -1.33 . . . . 74.219999999999999 107.408 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 57.1 ttt180 -130.01 115.89 17.78 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.491 -0.484 . . . . 74.420000000000002 109.975 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.563 HG21 HG22 ' A' ' 239' ' ' VAL . 31.4 p -126.65 128.58 46.98 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.045 0.45 . . . . 55.310000000000002 110.064 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -131.8 143.31 50.12 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 109.649 -0.5 . . . . 75.299999999999997 109.649 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.52 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 41.2 mt-10 66.11 96.88 0.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.275 1.583 . . . . 73.310000000000002 115.275 172.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.52 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.1 mpt_? 60.93 11.78 3.5 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 124.961 1.304 . . . . 73.549999999999997 111.926 175.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -88.37 140.72 29.18 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 110.096 -0.335 . . . . 63.140000000000001 110.096 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.05 142.21 51.62 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.051 -0.522 . . . . 65.140000000000001 110.601 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.563 HG22 HG21 ' A' ' 233' ' ' THR . 12.6 t -122.27 149.58 25.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 O-C-N 123.396 0.435 . . . . 73.329999999999998 110.928 -170.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -138.0 120.63 16.21 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.423 -0.955 . . . . 63.009999999999998 108.423 168.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -117.64 122.55 43.88 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.106 -1.072 . . . . 72.25 108.106 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.77 -114.08 1.11 Allowed Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.008 -1.091 . . . . 62.420000000000002 112.599 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -145.48 133.99 22.01 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.883 -0.414 . . . . 73.310000000000002 109.883 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 92.3 t -107.51 115.47 48.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.947 -0.76 . . . . 64.329999999999998 108.947 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.5 112.24 39.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.75 -0.833 . . . . 62.130000000000003 108.75 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 24.6 m -91.11 159.3 16.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.516 -0.92 . . . . 73.239999999999995 108.516 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.57 -33.72 76.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.062 0.764 . . . . 64.219999999999999 113.062 -176.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.78 -39.98 94.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.087 0.773 . . . . 61.020000000000003 113.087 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -74.95 -35.95 62.11 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.418 0.155 . . . . 64.510000000000005 111.418 -177.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.0 mp 68.43 -80.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.306 1.042 . . . . 74.019999999999996 109.465 -171.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -174.28 174.53 2.83 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 126.305 1.842 . . . . 73.219999999999999 108.358 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -148.07 132.74 4.34 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.677 -0.773 . . . . 61.219999999999999 111.381 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -170.91 -174.65 38.93 Favored Glycine 0 N--CA 1.437 -1.259 0 N-CA-C 111.027 -0.829 . . . . 61.030000000000001 111.027 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 6.6 tt -167.52 -53.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 123.894 0.878 . . . . 64.209999999999994 109.01 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.552 ' O ' ' HB ' ' A' ' 256' ' ' ILE . 37.8 ttm180 -165.67 102.36 0.69 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 103.088 -2.93 . . . . 73.450000000000003 103.088 176.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 255' ' ' ARG . 29.9 mm 78.11 137.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 124.395 1.059 . . . . 65.340000000000003 108.65 -170.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 19.2 m -90.98 -175.59 4.37 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.288 -0.634 . . . . 63.329999999999998 109.288 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -59.5 136.83 58.1 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.891 0.376 . . . . 74.340000000000003 111.141 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -128.18 30.55 5.2 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.121 -0.49 . . . . 75.329999999999998 110.85 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 58.2 m -65.37 121.25 14.4 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 120.401 -0.52 . . . . 71.200000000000003 109.693 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -105.88 126.15 51.83 Favored 'General case' 0 N--CA 1.405 -2.723 0 N-CA-C 108.417 -0.957 . . . . 61.0 108.417 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.437 ' HB3' ' OD1' ' A' ' 226' ' ' ASN . 45.3 t-20 -126.38 146.83 49.9 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.7 -1.963 . . . . 64.439999999999998 105.7 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 29.6 m -142.22 125.12 16.09 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 121.122 0.487 . . . . 71.129999999999995 110.501 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 14.7 p -128.18 150.51 33.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.677 -1.231 . . . . 62.119999999999997 107.677 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . 0.351 9.1 pt-20 -98.81 -50.66 4.14 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 117.794 -1.562 . . . . 74.409999999999997 113.298 174.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 61.8 m -127.19 126.97 43.76 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 117.958 -1.497 . . . . 74.510000000000005 112.439 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.75 126.83 75.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.687 -0.857 . . . . 62.399999999999999 108.687 173.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 7.9 p -127.76 133.65 67.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-O 121.005 0.431 . . . . 65.230000000000004 111.6 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -126.26 133.11 8.04 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 111.355 -0.698 . . . . 43.140000000000001 111.355 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.53 ' HB2' ' HG2' ' B' ' 234' ' ' GLU . 29.6 mmmt -130.04 116.65 18.85 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 122.587 0.355 . . . . 75.140000000000001 111.25 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.2 100.76 0.24 Allowed Glycine 0 C--N 1.308 -0.992 0 N-CA-C 115.361 0.905 . . . . 62.420000000000002 115.361 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.435 ' H ' ' HB2' ' A' ' 236' ' ' ARG . 34.9 mt-10 61.57 20.82 11.59 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.601 0.761 . . . . 74.420000000000002 112.855 169.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 19.4 m -92.79 145.18 24.6 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.464 0.65 . . . . 52.049999999999997 112.264 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' ARG . . . . . 0.457 ' O ' HG23 ' B' ' 239' ' ' VAL . 66.0 mtt180 -108.3 127.17 53.63 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.147 -2.168 . . . . 74.109999999999999 105.147 173.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 6.1 t -121.45 123.22 69.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 120.179 -0.608 . . . . 72.409999999999997 109.37 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.626 ' HG ' ' OE1' ' B' ' 240' ' ' GLN . 26.8 tp -120.24 120.3 35.72 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.028 -1.069 . . . . 74.140000000000001 111.344 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 228' ' ' ALA . 3.6 mp -113.71 104.79 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 107.627 -1.249 . . . . 61.409999999999997 107.627 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.467 ' HA2' HD22 ' A' ' 226' ' ' ASN . . . 158.28 -145.2 11.35 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.227 -0.987 . . . . 74.200000000000003 111.858 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 45.4 t-20 -120.13 146.85 45.57 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 106.047 -1.834 . . . . 62.219999999999999 106.047 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -123.22 117.45 25.35 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.163 -1.051 . . . . 75.200000000000003 108.163 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -109.71 124.41 51.17 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.8 -1.185 . . . . 73.109999999999999 107.8 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 146.18 -46.55 0.75 Allowed Glycine 0 CA--C 1.473 -2.555 0 N-CA-C 109.896 -1.282 . . . . 45.0 109.896 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.533 ' O ' ' HG2' ' A' ' 284' ' ' LYS . . . 103.36 72.57 0.92 Allowed Glycine 0 N--CA 1.417 -2.575 0 N-CA-C 109.451 -1.46 . . . . 73.310000000000002 109.451 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 283' ' ' GLY . 4.6 ptpp? 82.09 19.4 0.33 Allowed 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 127.706 2.402 . . . . 71.540000000000006 111.419 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -47.82 -38.22 15.94 Favored Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.267 1.267 . . . . 73.510000000000005 116.267 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.458 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 80.1 t80 -83.56 -3.13 57.4 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 117.378 0.589 . . . . 73.349999999999994 112.453 -175.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.458 ' CE3' ' HB3' ' A' ' 286' ' ' PHE . 32.8 p90 -151.59 -170.23 3.59 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 121.473 -0.767 . . . . 74.299999999999997 111.592 -177.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.01 -71.67 0.25 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.618 0.767 . . . . 73.329999999999998 110.514 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ASN . . . . . 0.406 ' HB3' ' CZ ' ' B' ' 274' ' ' ARG . 2.8 t-20 52.97 63.46 2.23 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.829 1.252 . . . . 62.539999999999999 112.158 -174.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.51 ' HB2' ' ND2' ' B' ' 289' ' ' ASN . 78.3 t60 -147.01 -38.5 0.21 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.415 -1.266 . . . . 75.400000000000006 109.2 172.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -60.49 21.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.033 1.864 . . . . 71.230000000000004 116.033 -174.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -153.41 -52.98 0.1 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 123.526 0.73 . . . . 75.310000000000002 109.452 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -171.13 128.05 0.71 Allowed 'General case' 0 C--O 1.242 0.704 0 C-N-CA 122.869 0.467 . . . . 74.120000000000005 110.027 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.438 ' CD2' HH21 ' B' ' 274' ' ' ARG . 43.6 t-80 -161.0 172.58 16.64 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.204 -1.406 . . . . 73.030000000000001 107.204 174.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' HIS . . . . . 0.418 ' HB3' HH22 ' C' ' 238' ' ' ARG . 56.3 t-80 . . . . . 0 N--CA 1.432 -1.339 0 N-CA-C 107.497 -1.297 . . . . 74.120000000000005 107.497 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 11.7 tpt . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 109.705 -0.48 . . . . 53.310000000000002 109.705 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.408 ' HD2' ' HB2' ' C' ' 220' ' ' ASP . 62.2 mttp -136.28 149.44 48.46 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.804 -0.813 . . . . 74.099999999999994 108.804 176.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 46.3 pt -82.55 167.78 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.289 0.566 . . . . 52.310000000000002 111.702 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -85.74 106.66 17.16 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.007 -1.109 . . . . 63.43 108.007 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -119.29 31.23 6.71 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.823 -1.547 . . . . 60.32 106.823 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 64.6 mt -105.91 115.47 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-N 114.507 -1.224 . . . . 70.519999999999996 110.937 -173.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 11.8 p -105.86 164.91 4.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 N-CA-C 106.402 -1.703 . . . . 71.040000000000006 106.402 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' B' ' 259' ' ' GLN . . . -73.57 73.78 1.14 Allowed Glycine 0 CA--C 1.503 -0.702 0 C-N-CA 121.011 -0.614 . . . . 64.099999999999994 111.982 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -108.11 145.0 34.72 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 115.025 -0.588 . . . . 52.329999999999998 110.086 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -98.08 136.7 37.94 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 104.536 -2.394 . . . . 70.430000000000007 104.536 171.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 20.1 m -131.85 136.39 47.43 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 120.109 -0.636 . . . . 70.400000000000006 111.255 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -129.2 134.84 48.18 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.689 -1.226 . . . . 54.329999999999998 107.689 175.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -82.2 -65.98 0.95 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.017 -0.734 . . . . 72.299999999999997 109.017 178.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -128.46 140.07 52.01 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-O 121.022 0.439 . . . . 73.120000000000005 109.988 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 27.7 mt -124.72 122.64 64.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.245 -1.391 . . . . 64.310000000000002 107.245 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 22.1 ttt180 -122.84 114.55 20.65 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.746 -0.835 . . . . 64.329999999999998 108.746 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.73 HG21 HG22 ' B' ' 239' ' ' VAL . 72.4 p -117.88 127.2 53.63 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.021 -1.103 . . . . 74.340000000000003 108.021 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 234' ' ' GLU . . . . . 0.53 ' HG2' ' HB2' ' A' ' 270' ' ' LYS . 34.0 mt-10 -137.61 139.79 40.55 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.201 -0.599 . . . . 62.399999999999999 110.322 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.497 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 46.8 mt-10 67.5 96.71 0.06 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.542 1.312 . . . . 73.099999999999994 114.542 173.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.497 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.0 OUTLIER 58.14 27.98 15.78 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.474 1.11 . . . . 73.209999999999994 110.897 175.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.425 ' CB ' ' HB ' ' B' ' 233' ' ' THR . . . -84.77 150.89 24.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.163 0.506 . . . . 74.299999999999997 110.6 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.502 ' HD3' ' HG2' ' B' ' 274' ' ' ARG . 4.4 mpt_? -125.66 134.5 51.83 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.647 -1.983 . . . . 75.400000000000006 105.647 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.73 HG22 HG21 ' B' ' 233' ' ' THR . 2.4 t -125.41 139.67 50.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 123.404 0.44 . . . . 65.109999999999999 110.02 -172.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.626 ' OE1' ' HG ' ' A' ' 276' ' ' LEU . 24.5 tp60 -138.48 114.84 10.38 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.864 0.728 . . . . 73.349999999999994 109.8 170.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.464 HD12 HG23 ' A' ' 277' ' ' ILE . 3.4 tm? -115.0 118.73 34.24 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.431 -1.322 . . . . 65.230000000000004 107.431 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 141.19 -114.06 0.9 Allowed Glycine 0 N--CA 1.422 -2.268 0 C-N-CA 120.276 -0.964 . . . . 53.439999999999998 111.07 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 55.0 t30 -145.46 149.54 34.87 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.981 -0.748 . . . . 61.549999999999997 108.981 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 98.1 t -121.61 122.66 67.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.429 -0.952 . . . . 74.200000000000003 108.429 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 48.7 t -122.19 111.84 32.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.975 -0.75 . . . . 64.209999999999994 108.975 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 23.8 m -83.15 159.28 22.08 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.195 -1.039 . . . . 75.129999999999995 108.195 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -64.6 -42.48 95.53 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 123.207 1.48 . . . . 52.229999999999997 109.749 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.68 -34.01 61.67 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 111.762 -2.472 . . . . 74.129999999999995 112.827 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.671 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -62.9 -26.81 68.97 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.678 0.791 . . . . 65.530000000000001 112.482 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -79.65 76.13 6.3 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.981 0.896 . . . . 74.319999999999993 108.867 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -103.55 -44.69 5.04 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.179 -1.373 . . . . 73.349999999999994 108.109 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 152.68 -172.75 31.77 Favored Glycine 0 N--CA 1.42 -2.376 0 N-CA-C 107.226 -2.35 . . . . 65.319999999999993 107.226 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 80.41 -49.97 3.93 Favored Glycine 0 C--N 1.304 -1.21 0 CA-C-N 118.119 0.959 . . . . 74.319999999999993 113.161 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.74 109.45 9.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.151 -0.685 . . . . 60.149999999999999 109.151 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -116.62 -14.74 10.85 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.263 -1.014 . . . . 65.109999999999999 108.263 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 12.4 pt -155.53 177.75 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.153 0 N-CA-C 105.887 -1.894 . . . . 70.109999999999999 105.887 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 23.9 t -96.64 146.4 24.88 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.154 -1.054 . . . . 53.130000000000003 108.154 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -74.04 119.08 17.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.423 0.63 . . . . 64.230000000000004 109.431 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 259' ' ' GLN . . . . . 0.488 ' HB3' ' HA3' ' B' ' 224' ' ' GLY . 88.9 mt-30 -83.5 57.31 3.97 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 114.289 1.218 . . . . 51.43 114.289 -173.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.512 ' OG1' ' HA ' ' C' ' 257' ' ' SER . 55.1 m -87.03 123.17 31.82 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.338 -0.986 . . . . 62.43 108.338 172.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -91.55 127.93 37.18 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 121.799 0.809 . . . . 73.340000000000003 110.405 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -126.82 142.23 51.6 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.946 -1.872 . . . . 74.299999999999997 105.946 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 47.4 m -139.64 133.01 30.05 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 118.313 0.506 . . . . 70.530000000000001 111.655 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.1 p -128.22 144.17 38.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 116.056 -0.52 . . . . 72.239999999999995 110.658 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 38.2 mm-40 -81.05 -63.73 1.34 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.193 0.521 . . . . 75.439999999999998 110.801 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 38.2 m -137.59 127.13 25.08 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 118.138 -1.425 . . . . 75.450000000000003 111.915 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.05 121.13 66.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.891 -1.05 . . . . 72.129999999999995 108.704 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 268' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 5.4 p -127.38 138.79 53.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.721 -0.672 . . . . 72.510000000000005 112.266 -176.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.7 133.97 8.81 Favored Glycine 0 CA--C 1.485 -1.8 0 CA-C-N 115.793 -0.64 . . . . 61.450000000000003 112.134 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.47 ' HB2' ' HG2' ' C' ' 234' ' ' GLU . 30.9 mmmt -128.96 115.95 18.6 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 123.748 0.322 . . . . 73.340000000000003 110.689 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 81.58 93.31 0.51 Allowed Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.46 -0.876 . . . . 71.430000000000007 114.626 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 64.01 17.25 10.49 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.341 1.056 . . . . 75.400000000000006 111.89 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 273' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 19.8 m -82.88 145.19 29.58 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.743 0.783 . . . . 63.25 111.383 -172.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.539 ' HB3' ' CE1' ' B' ' 286' ' ' PHE . 51.1 mtm180 -116.84 127.44 54.3 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 108.739 -0.837 . . . . 73.439999999999998 108.739 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.44 HG12 ' CG1' ' C' ' 239' ' ' VAL . 29.2 m -120.64 123.58 70.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-O 121.394 0.616 . . . . 74.519999999999996 110.547 -176.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.583 ' HG ' ' OE1' ' C' ' 240' ' ' GLN . 26.4 tp -115.06 114.78 25.81 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.989 -0.745 . . . . 54.340000000000003 108.989 173.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.521 HG23 HD12 ' C' ' 241' ' ' LEU . 3.4 mp -112.78 103.63 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.609 0 N-CA-C 106.025 -1.843 . . . . 53.219999999999999 106.025 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.434 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 161.3 -150.83 20.86 Favored Glycine 0 N--CA 1.416 -2.662 0 C-N-CA 119.798 -1.192 . . . . 72.140000000000001 112.835 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -113.77 151.81 31.47 Favored 'General case' 0 C--N 1.273 -2.753 0 N-CA-C 104.791 -2.3 . . . . 63.43 104.791 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.4 ' OE1' HG13 ' C' ' 244' ' ' VAL . 1.5 tm-20 -130.06 118.87 22.2 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.94 -1.133 . . . . 62.350000000000001 107.94 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -113.1 124.28 52.21 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.911 0.862 . . . . 75.340000000000003 110.927 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' B' ' 249' ' ' ALA . . . 138.01 -47.32 0.94 Allowed Glycine 0 N--CA 1.417 -2.619 0 CA-C-N 114.37 -1.286 . . . . 73.040000000000006 110.442 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 283' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' B' ' 284' ' ' LYS . . . 108.25 90.92 2.15 Favored Glycine 0 N--CA 1.414 -2.79 0 N-CA-C 108.363 -1.895 . . . . 72.140000000000001 108.363 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 284' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' B' ' 287' ' ' TRP . 50.0 mtmt 90.95 -59.45 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 126.408 1.883 . . . . 75.049999999999997 109.681 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 49.87 -84.27 0.01 OUTLIER Glycine 0 N--CA 1.478 1.459 0 O-C-N 124.279 0.987 . . . . 55.219999999999999 115.101 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' B' ' 274' ' ' ARG . 1.3 t80 -52.0 -45.95 64.72 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.466 1.906 . . . . 75.519999999999996 109.908 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.581 ' O ' ' HB3' ' B' ' 284' ' ' LYS . 48.9 p90 -116.93 152.38 34.67 Favored 'General case' 0 C--O 1.201 -1.484 0 N-CA-C 106.741 -1.578 . . . . 70.230000000000004 106.741 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 11.5 t70 169.87 -78.34 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 106.802 -1.555 . . . . 73.109999999999999 106.802 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 289' ' ' ASN . . . . . 0.566 ' HA ' ' HB2' ' B' ' 292' ' ' HIS . 15.0 m120 62.56 19.96 11.63 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 114.116 -1.402 . . . . 50.229999999999997 112.417 173.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -87.96 109.39 19.78 Favored 'General case' 0 C--O 1.248 1.016 0 N-CA-C 108.01 -1.107 . . . . 73.510000000000005 108.01 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.61 22.34 13.26 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.336 1.055 . . . . 74.430000000000007 110.066 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 292' ' ' HIS . . . . . 0.566 ' HB2' ' HA ' ' B' ' 289' ' ' ASN . 17.0 m80 -111.19 117.04 32.14 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.899 -1.046 . . . . 72.150000000000006 109.331 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 72.26 -63.26 0.44 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.243 1.417 . . . . 71.349999999999994 111.588 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 6.9 m170 55.49 100.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.918 1.821 . . . . 52.399999999999999 115.918 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--N 1.296 -1.746 0 N-CA-C 105.587 -2.005 . . . . 72.040000000000006 105.587 176.492 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.516 -0.356 0 N-CA-C 109.353 -0.61 . . . . 74.420000000000002 109.353 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.23 167.24 11.15 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.188 0.81 . . . . 54.240000000000002 113.188 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.45 174.12 4.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 114.885 -1.052 . . . . 72.450000000000003 111.704 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 220' ' ' ASP . . . . . 0.408 ' HB2' ' HD2' ' B' ' 218' ' ' LYS . 12.3 t70 -93.04 -65.87 0.97 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.378 -0.971 . . . . 63.219999999999999 108.378 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -77.06 127.84 33.4 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 107.859 -1.163 . . . . 71.219999999999999 107.859 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 78.6 mt -82.73 115.55 25.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.579 0.704 . . . . 71.109999999999999 111.324 -174.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 12.2 p -104.74 164.03 4.0 Favored 'Isoleucine or valine' 0 C--O 1.257 1.481 0 N-CA-C 106.699 -1.593 . . . . 70.400000000000006 106.699 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -74.34 76.56 1.1 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.95 -0.643 . . . . 74.25 111.649 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' C' ' 261' ' ' THR . 4.9 ptp180 -111.68 154.22 25.27 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.085 0.469 . . . . 60.420000000000002 110.731 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -109.98 140.74 43.65 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.248 -2.131 . . . . 73.519999999999996 105.248 173.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' C' ' 263' ' ' SER . 45.0 m -139.74 137.95 35.53 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.892 -0.505 . . . . 74.439999999999998 111.399 -176.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.65 128.92 45.09 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.421 -0.955 . . . . 74.209999999999994 108.421 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.58 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 27.9 tptp -75.31 -62.17 1.65 Allowed 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.395 -0.594 . . . . 64.310000000000002 109.395 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 230' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' C' ' 266' ' ' THR . 16.5 m-20 -134.85 139.86 45.38 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.066 0.46 . . . . 73.549999999999997 110.719 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.493 HG21 HG21 ' C' ' 239' ' ' VAL . 35.6 mt -127.53 123.52 61.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 106.96 -1.496 . . . . 65.109999999999999 106.96 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.491 ' HG3' HG13 ' B' ' 268' ' ' VAL . 31.6 ttt180 -126.9 114.98 18.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.755 -0.832 . . . . 71.230000000000004 108.755 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.412 HG21 ' HB ' ' C' ' 239' ' ' VAL . 39.4 p -110.62 127.36 55.22 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.71 -1.219 . . . . 64.540000000000006 107.71 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' B' ' 270' ' ' LYS . 40.5 mt-10 -135.07 139.62 44.89 Favored 'General case' 0 N--CA 1.42 -1.943 0 C-N-CA 120.396 -0.522 . . . . 75.209999999999994 110.31 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 64.43 101.29 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 O-C-N 124.621 1.201 . . . . 71.030000000000001 114.117 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 59.6 13.88 3.63 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.669 1.188 . . . . 75.340000000000003 111.27 173.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.38 151.58 22.97 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.619 0.6 . . . . 73.430000000000007 112.619 -172.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.418 HH22 ' HB3' ' A' ' 295' ' ' HIS . 0.1 OUTLIER -135.05 135.24 41.15 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.02 -1.474 . . . . 73.549999999999997 107.02 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.493 HG21 HG21 ' C' ' 231' ' ' ILE . 6.9 p -132.38 146.08 33.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.058 0.456 . . . . 70.349999999999994 111.437 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.583 ' OE1' ' HG ' ' B' ' 276' ' ' LEU . 23.2 tp60 -124.6 120.16 31.12 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.67 -1.15 . . . . 72.540000000000006 108.829 172.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.521 HD12 HG23 ' B' ' 277' ' ' ILE . 3.4 tm? -113.66 117.78 32.54 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.966 -1.494 . . . . 44.530000000000001 106.966 177.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 139.14 -114.36 1.01 Allowed Glycine 0 N--CA 1.424 -2.116 0 C-N-CA 119.972 -1.109 . . . . 44.219999999999999 112.02 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -145.39 143.79 30.29 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.571 -0.529 . . . . 73.239999999999995 109.571 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.4 HG13 ' OE1' ' B' ' 280' ' ' GLU . 69.5 t -117.44 118.43 58.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.432 -0.581 . . . . 74.340000000000003 109.432 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' C' ' 281' ' ' TYR . 47.9 t -121.8 111.99 33.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.452 -0.573 . . . . 74.340000000000003 109.452 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 31.4 m -78.07 159.47 28.68 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.239 -1.023 . . . . 61.030000000000001 108.239 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.671 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -63.46 -43.38 97.53 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.482 1.134 . . . . 72.420000000000002 109.48 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.29 65.6 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.891 -1.959 . . . . 74.099999999999994 112.776 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.14 -37.21 80.83 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 111.995 0.368 . . . . 73.409999999999997 111.995 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 79.2 mt 69.39 -163.96 0.18 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 124.35 1.031 . . . . 63.049999999999997 110.677 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 251' ' ' HIS . . . . . 0.428 ' CD2' ' H ' ' C' ' 253' ' ' GLY . 83.6 t60 -152.65 -54.65 0.12 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.937 0.398 . . . . 65.299999999999997 110.056 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 107.08 -17.51 37.78 Favored Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 120.742 -0.742 . . . . 45.039999999999999 112.602 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 253' ' ' GLY . . . . . 0.428 ' H ' ' CD2' ' C' ' 251' ' ' HIS . . . 89.93 21.17 40.28 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 110.795 -0.922 . . . . 50.109999999999999 110.795 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 10.1 tt -139.88 136.82 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 108.22 -1.03 . . . . 75.129999999999995 108.22 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -59.8 115.45 3.38 Favored 'General case' 0 C--O 1.248 1.001 0 O-C-N 123.697 0.623 . . . . 71.340000000000003 110.154 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 62.5 mt -90.14 -56.79 4.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 107.48 -1.304 . . . . 72.519999999999996 107.48 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 257' ' ' SER . . . . . 0.512 ' HA ' ' OG1' ' B' ' 260' ' ' THR . 14.9 m 65.82 146.08 0.03 OUTLIER 'General case' 0 C--O 1.243 0.742 0 C-N-CA 125.867 1.667 . . . . 65.239999999999995 114.088 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 258' ' ' ASP . . . . . 0.457 ' OD1' ' HB ' ' C' ' 260' ' ' THR . 10.9 t0 -51.22 -50.61 58.78 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.024 -1.102 . . . . 70.219999999999999 108.024 176.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 76.12 -24.19 0.23 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.721 1.608 . . . . 72.010000000000005 111.852 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 260' ' ' THR . . . . . 0.457 ' HB ' ' OD1' ' C' ' 258' ' ' ASP . 88.2 m -85.11 133.73 34.21 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 108.687 -0.857 . . . . 24.420000000000002 108.687 176.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 39.2 m -92.33 108.69 20.14 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 108.173 -1.047 . . . . 41.240000000000002 108.173 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -124.26 127.85 48.29 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.733 -0.84 . . . . 70.239999999999995 108.733 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 263' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' C' ' 227' ' ' SER . 41.4 m -133.43 136.22 45.08 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 110.069 -0.345 . . . . 51.299999999999997 110.069 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.22 153.5 37.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.295 -0.632 . . . . 71.420000000000002 109.295 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.58 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 35.2 mm-40 -81.13 -88.5 0.08 Allowed 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 110.197 -0.297 . . . . 75.230000000000004 110.197 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 266' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 51.4 m -121.85 131.33 53.98 Favored 'General case' 0 N--CA 1.417 -2.09 0 C-N-CA 119.581 -0.848 . . . . 54.130000000000003 111.061 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 26.2 m -117.87 132.53 67.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.33 -0.989 . . . . 71.439999999999998 108.33 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 268' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.8 p -127.38 139.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 116.206 -0.452 . . . . 70.109999999999999 110.4 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.99 133.66 9.47 Favored Glycine 0 CA--C 1.476 -2.362 0 N-CA-C 110.155 -1.178 . . . . 75.310000000000002 110.155 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -131.36 115.55 16.39 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 111.988 0.366 . . . . 74.329999999999998 111.988 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 70.05 97.39 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.859 -1.064 . . . . 73.319999999999993 114.415 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 68.09 21.66 8.64 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.782 0.833 . . . . 50.409999999999997 111.955 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.5 m -83.77 144.7 29.14 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.027 0.751 . . . . 40.520000000000003 113.027 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -110.07 128.36 55.39 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.207 -1.775 . . . . 64.530000000000001 106.207 171.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 1.5 t -128.08 123.9 61.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 119.726 -0.79 . . . . 70.120000000000005 109.199 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.41 ' CD1' ' HG3' ' C' ' 240' ' ' GLN . 30.8 tp -117.62 117.96 30.82 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.902 -0.719 . . . . 74.540000000000006 110.3 174.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.503 HG21 ' HB2' ' C' ' 228' ' ' ALA . 3.7 mp -112.48 103.47 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.893 0 N-CA-C 105.902 -1.888 . . . . 75.510000000000005 105.902 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.35 -168.24 30.27 Favored Glycine 0 CA--C 1.478 -2.223 0 C-N-CA 120.546 -0.835 . . . . 74.420000000000002 111.456 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -96.7 156.8 16.19 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.46 -0.941 . . . . 74.120000000000005 108.46 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.481 ' HB3' ' ND1' ' C' ' 294' ' ' HIS . 2.9 tm-20 -129.12 121.3 27.5 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.944 -1.132 . . . . 74.430000000000007 107.944 -175.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.407 ' HB2' ' HA ' ' C' ' 245' ' ' VAL . 96.6 m-85 -116.54 125.12 51.44 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.945 0.403 . . . . 72.239999999999995 110.078 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.47 -37.74 1.84 Allowed Glycine 0 N--CA 1.437 -1.3 0 N-CA-C 111.668 -0.573 . . . . 71.230000000000004 111.668 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 104.4 103.04 2.8 Favored Glycine 0 CA--C 1.48 -2.137 0 N-CA-C 107.304 -2.319 . . . . 45.119999999999997 107.304 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 284' ' ' LYS . . . . . 0.491 ' HD3' ' HA ' ' C' ' 288' ' ' ASP . 94.8 mttt 75.07 -57.78 0.59 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.785 1.234 . . . . 73.129999999999995 109.169 -172.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 57.63 -86.22 0.01 OUTLIER Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.307 0.956 . . . . 61.140000000000001 113.961 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.571 ' HB3' ' CE3' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -56.67 -39.57 73.99 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.023 1.729 . . . . 73.040000000000006 110.642 -178.635 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.571 ' CE3' ' HB3' ' C' ' 286' ' ' PHE . 24.6 p90 -129.99 -171.66 2.58 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.067 0.46 . . . . 61.439999999999998 111.622 -171.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 288' ' ' ASP . . . . . 0.491 ' HA ' ' HD3' ' C' ' 284' ' ' LYS . 21.0 t70 -131.11 -36.27 1.33 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.981 -1.009 . . . . 63.329999999999998 109.692 169.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 289' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' C' ' 290' ' ' HIS . 26.5 t-20 -81.91 72.95 8.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.876 -0.602 . . . . 73.120000000000005 111.25 -177.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 290' ' ' HIS . . . . . 0.548 ' HB3' ' CD1' ' C' ' 287' ' ' TRP . 9.2 t60 163.9 116.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.887 2.075 . . . . 73.140000000000001 105.936 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -99.52 95.28 6.89 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 113.406 0.891 . . . . 72.010000000000005 113.406 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -152.37 135.66 15.87 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.75 -1.113 . . . . 61.420000000000002 110.512 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -124.24 133.68 53.45 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.745 -1.205 . . . . 73.140000000000001 107.745 173.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 294' ' ' HIS . . . . . 0.481 ' ND1' ' HB3' ' C' ' 280' ' ' GLU . 76.8 m80 -95.85 -46.61 6.49 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 112.935 0.717 . . . . 65.25 112.935 -173.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 . . . . . 0 C--N 1.303 -1.414 0 CA-C-O 118.528 -0.748 . . . . 51.32 109.509 -177.616 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 CA--C 1.51 -0.593 0 CA-C-O 121.591 0.71 . . . . 52.329999999999998 109.41 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -164.01 77.12 0.37 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.841 -1.072 . . . . 70.409999999999997 110.272 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 64.3 mt -78.61 88.22 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 122.129 0.966 . . . . 72.329999999999998 108.534 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -151.97 -36.08 0.12 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.48 -1.691 . . . . 73.319999999999993 107.594 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.04 146.93 10.27 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 114.553 -1.203 . . . . 31.129999999999999 110.748 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.9 mp -83.35 124.31 39.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.138 -0.69 . . . . 64.120000000000005 109.138 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.533 HG21 HG21 ' B' ' 222' ' ' ILE . 14.9 p -100.1 148.91 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 109.501 -0.555 . . . . 71.010000000000005 109.501 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 103.6 15.07 23.81 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 109.149 -1.58 . . . . 52.439999999999998 109.149 -174.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -90.01 141.89 28.23 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.685 -0.757 . . . . 74.549999999999997 109.948 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 48.1 t-20 -116.75 123.97 48.48 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.644 -1.614 . . . . 53.119999999999997 106.644 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.1 m -121.65 137.42 54.75 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 120.342 -0.543 . . . . 73.530000000000001 111.239 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.4 134.06 46.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.052 -0.722 . . . . 65.329999999999998 109.052 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -91.49 -46.87 7.74 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.643 -0.253 . . . . 55.329999999999998 110.836 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -136.9 139.71 41.8 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.372 -0.603 . . . . 53.520000000000003 109.372 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 66.1 mt -137.28 119.34 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.388 -1.338 . . . . 75.239999999999995 107.388 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -134.22 122.81 23.3 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.909 0.385 . . . . 74.549999999999997 110.834 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 33.4 p -129.43 128.65 43.39 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.053 -0.351 . . . . 71.409999999999997 110.053 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.423 ' HB2' ' HD3' ' A' ' 270' ' ' LYS . 45.0 mt-10 -125.67 166.16 17.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.141 0.496 . . . . 74.409999999999997 111.91 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.426 ' HB3' ' HD2' ' A' ' 236' ' ' ARG . 41.1 mt-10 64.9 -85.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.73 1.612 . . . . 72.140000000000001 113.961 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.426 ' HD2' ' HB3' ' A' ' 235' ' ' GLU . 0.6 OUTLIER -130.65 11.7 5.28 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 109.373 -0.602 . . . . 72.540000000000006 109.373 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -73.14 134.25 44.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.495 -0.775 . . . . 71.299999999999997 110.563 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.1 145.25 50.56 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.839 -0.8 . . . . 72.040000000000006 108.839 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.7 p -132.3 141.8 44.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.719 0.771 . . . . 52.240000000000002 111.438 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -105.14 128.25 53.29 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.678 -1.23 . . . . 71.129999999999995 107.678 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -122.32 117.85 27.07 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.281 -1.377 . . . . 34.229999999999997 107.281 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 113.25 -159.79 13.48 Favored Glycine 0 C--N 1.306 -1.113 0 C-N-CA 121.23 -0.51 . . . . 61.43 111.925 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -98.78 137.39 37.44 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 122.628 0.371 . . . . 73.549999999999997 110.916 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 61.7 t -114.73 116.32 52.21 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 N-CA-C 107.22 -1.4 . . . . 74.329999999999998 107.22 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.2 p -122.44 114.37 42.23 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 N-CA-C 108.46 -0.941 . . . . 42.5 108.46 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 15.0 m -84.22 157.18 21.69 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 118.406 -1.318 . . . . 64.409999999999997 110.045 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.01 -47.09 72.51 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.41 0.624 . . . . 63.450000000000003 111.552 176.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.38 -34.42 68.85 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.561 1.545 . . . . 72.140000000000001 112.649 -175.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.608 ' HB2' ' HA3' ' A' ' 282' ' ' GLY . . . -59.42 -26.52 65.24 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.145 0.978 . . . . 72.430000000000007 111.548 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 33.9 tp 67.07 73.61 0.34 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.662 1.185 . . . . 63.200000000000003 111.456 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -82.69 103.16 11.99 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.7 -1.222 . . . . 72.430000000000007 107.7 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.42 73.72 0.46 Allowed Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 110.475 -1.05 . . . . 62.109999999999999 110.475 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 174.05 -174.42 46.33 Favored Glycine 0 N--CA 1.422 -2.279 0 N-CA-C 110.341 -1.104 . . . . 71.340000000000003 110.341 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 3.4 mp -90.23 124.78 43.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.289 -1.004 . . . . 71.129999999999995 108.289 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.67 84.87 5.44 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.995 -1.113 . . . . 51.009999999999998 107.995 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 15.1 tt -114.87 -13.14 11.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.791 -1.559 . . . . 72.430000000000007 106.791 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 16.3 m -68.66 148.36 50.53 Favored 'General case' 0 C--O 1.256 1.396 0 CA-C-N 113.993 -1.458 . . . . 73.209999999999994 108.138 175.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 27.6 t70 70.45 120.55 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.689 1.196 . . . . 64.140000000000001 110.655 -174.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -129.14 23.95 5.6 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.659 -0.867 . . . . 63.240000000000002 108.659 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' B' ' 224' ' ' GLY . 23.6 m -74.57 124.21 26.23 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.925 -1.034 . . . . 73.519999999999996 110.102 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.9 t -110.83 130.45 55.57 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 106.044 -1.836 . . . . 60.340000000000003 106.044 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 38.3 t-20 -126.38 140.35 52.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.911 -0.716 . . . . 73.409999999999997 109.151 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.9 m -133.76 123.1 24.31 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 120.809 -0.356 . . . . 43.409999999999997 110.392 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 8.7 p -128.92 145.1 36.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 110.128 -0.323 . . . . 72.099999999999994 110.128 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.591 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 76.9 mm-40 -85.38 -79.09 0.24 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 121.0 -0.28 . . . . 74.420000000000002 110.747 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 25.9 m -116.29 127.65 54.89 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.182 0.438 . . . . 74.140000000000001 112.182 -172.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.528 HG21 HD11 ' A' ' 277' ' ' ILE . 17.4 m -120.69 132.78 69.34 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.276 0.56 . . . . 63.310000000000002 109.583 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' B' ' 232' ' ' ARG . 3.3 p -127.98 131.81 69.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 116.358 -0.383 . . . . 73.409999999999997 111.637 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.86 131.06 7.65 Favored Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 109.3 -1.52 . . . . 32.109999999999999 109.3 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 234' ' ' GLU . 18.9 tptm -134.17 140.55 46.6 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.6 -0.518 . . . . 72.310000000000002 109.6 -177.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 81.56 -136.71 16.41 Favored Glycine 0 CA--C 1.487 -1.672 0 N-CA-C 107.78 -2.128 . . . . 73.230000000000004 107.78 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -101.36 85.41 2.79 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 118.443 1.122 . . . . 73.519999999999996 109.356 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 21.6 m -104.39 144.98 30.92 Favored 'General case' 0 N--CA 1.408 -2.562 0 CA-C-N 114.923 -1.035 . . . . 71.439999999999998 108.934 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' ARG . . . . . 0.537 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 98.8 mtt180 -122.73 125.93 46.51 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 106.138 -1.801 . . . . 72.129999999999995 106.138 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 26.9 t -131.62 131.63 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 N-CA-C 108.973 -0.751 . . . . 71.129999999999995 108.973 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 5.4 tt -125.88 114.77 18.97 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 118.429 -1.308 . . . . 72.030000000000001 108.444 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.579 HG23 HD12 ' B' ' 241' ' ' LEU . 68.5 mt -111.02 104.33 16.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.098 -0.704 . . . . 64.209999999999994 109.098 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.514 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 144.27 -143.93 12.76 Favored Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 110.969 -0.852 . . . . 73.420000000000002 110.969 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -124.29 143.53 50.5 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.213 -1.032 . . . . 45.439999999999998 108.213 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.96 130.01 46.17 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.502 0.668 . . . . 71.439999999999998 109.314 174.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -113.55 121.56 44.58 Favored 'General case' 0 N--CA 1.409 -2.493 0 N-CA-C 107.383 -1.34 . . . . 72.019999999999996 107.383 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.608 ' HA3' ' HB2' ' A' ' 249' ' ' ALA . . . 62.81 24.82 66.95 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.407 -1.269 . . . . 73.010000000000005 113.903 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -86.69 -47.63 4.76 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.037 -1.225 . . . . 62.329999999999998 110.037 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.425 ' HB2' ' NZ ' ' A' ' 284' ' ' LYS . 0.1 OUTLIER 68.28 23.51 7.72 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.043 1.337 . . . . 74.299999999999997 110.03 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 287' ' ' TRP . . . 115.02 92.91 1.88 Allowed Glycine 0 N--CA 1.407 -3.249 0 C-N-CA 120.129 -1.034 . . . . 55.439999999999998 110.768 -176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -73.1 33.78 0.07 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-O 122.54 1.162 . . . . 75.239999999999995 109.398 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.537 ' CE3' ' HB3' ' A' ' 274' ' ' ARG . 2.5 m95 -97.03 -49.76 4.88 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.407 -0.815 . . . . 72.430000000000007 111.979 -174.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -113.57 -97.26 0.44 Allowed 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 118.645 -1.222 . . . . 62.329999999999998 113.203 -169.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -149.29 178.27 8.92 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.201 -1.407 . . . . 75.310000000000002 107.201 -176.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -100.47 56.58 0.91 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 122.24 1.019 . . . . 75.329999999999998 110.907 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -112.35 -46.0 3.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.529 -1.214 . . . . 74.319999999999993 108.199 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 64.03 37.87 8.94 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 122.271 1.034 . . . . 74.430000000000007 112.143 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -79.5 152.98 29.9 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.025 -1.443 . . . . 63.219999999999999 107.383 175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.514 ' CE1' ' HA ' ' B' ' 290' ' ' HIS . 10.1 t60 -47.15 111.06 0.36 Allowed 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.601 0.715 . . . . 72.310000000000002 112.405 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 . . . . . 0 N--CA 1.417 -2.08 0 N-CA-C 103.945 -2.613 . . . . 74.030000000000001 103.945 176.406 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 CA--C 1.506 -0.719 0 CA-C-O 121.412 0.625 . . . . 74.329999999999998 111.238 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -144.66 49.45 1.31 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.917 -1.142 . . . . 70.040000000000006 107.917 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.71 84.44 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 114.379 -1.282 . . . . 70.010000000000005 108.92 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -91.62 -28.78 17.28 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.246 -1.343 . . . . 52.43 110.12 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -70.78 137.73 49.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.075 -0.966 . . . . 71.530000000000001 109.757 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' ILE . . . . . 0.533 HG21 HG21 ' A' ' 223' ' ' VAL . 3.5 mp -83.51 139.27 17.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.333 -0.988 . . . . 70.140000000000001 108.333 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 13.6 p -98.27 153.93 3.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.693 -1.225 . . . . 63.329999999999998 107.693 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 260' ' ' THR . . . 93.31 48.92 2.71 Favored Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 107.629 -2.189 . . . . 75.25 107.629 -171.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -134.14 141.49 47.13 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.792 -0.704 . . . . 73.430000000000007 109.637 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 39.1 t-20 -118.06 141.7 48.19 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.545 -1.28 . . . . 54.149999999999999 107.545 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 52.5 m -133.81 137.38 45.05 Favored 'General case' 0 C--N 1.275 -2.663 0 O-C-N 122.075 -0.39 . . . . 54.219999999999999 110.172 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -127.72 160.77 30.67 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.21 -1.404 . . . . 73.099999999999994 107.21 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 4.6 tmmm? -121.67 -54.63 1.95 Allowed 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 119.599 -0.841 . . . . 74.340000000000003 109.045 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -131.76 138.03 48.43 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.81 -1.552 . . . . 73.340000000000003 106.81 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 12.5 mt -133.85 120.04 34.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 106.795 -1.557 . . . . 70.109999999999999 106.795 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.631 ' NH1' ' HB2' ' B' ' 232' ' ' ARG . 0.0 OUTLIER -115.39 119.9 37.8 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 109.191 -0.67 . . . . 75.120000000000005 109.191 -176.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 38.4 p -121.88 129.16 52.36 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.613 -1.254 . . . . 62.020000000000003 107.613 175.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 234' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 27.5 tt0 -144.69 150.51 37.45 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 120.12 -0.632 . . . . 71.129999999999995 110.398 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 77.82 -79.19 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 125.798 1.639 . . . . 75.099999999999994 113.021 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -140.57 27.1 2.08 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.569 -0.9 . . . . 65.219999999999999 108.569 -172.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -86.71 143.65 27.47 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 112.9 0.704 . . . . 64.010000000000005 112.9 -173.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -124.4 136.46 54.08 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.311 -1.366 . . . . 61.530000000000001 107.311 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.5 p -134.14 136.14 53.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.996 0.903 . . . . 74.019999999999996 111.396 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.428 ' HB2' ' CE2' ' B' ' 286' ' ' PHE . 44.1 tp60 -104.57 130.99 52.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 106.884 -1.524 . . . . 64.230000000000004 106.884 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.579 HD12 HG23 ' A' ' 277' ' ' ILE . 2.7 tm? -130.27 116.28 18.14 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 106.561 -1.644 . . . . 72.430000000000007 106.561 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 123.05 -129.39 7.41 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.634 -0.793 . . . . 53.049999999999997 112.05 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' B' ' 279' ' ' ASN . 53.3 t-20 -132.53 137.38 47.13 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.17 0.485 . . . . 75.349999999999994 109.862 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 54.4 t -114.63 114.87 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.595 -1.261 . . . . 73.150000000000006 107.595 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 3.6 p -122.42 114.3 41.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 C-N-CA 119.492 -0.883 . . . . 63.130000000000003 110.165 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 42.3 m -80.34 155.0 27.42 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 117.419 -1.713 . . . . 72.510000000000005 109.92 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.56 66.03 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.254 1.026 . . . . 74.409999999999997 111.249 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.31 -35.13 67.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.195 -1.82 . . . . 64.120000000000005 112.246 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.503 ' HB2' ' HA3' ' B' ' 282' ' ' GLY . . . -60.56 -47.03 88.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.989 -0.55 . . . . 45.219999999999999 110.381 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 18.1 tp 165.8 161.34 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 105.316 -2.105 . . . . 73.230000000000004 105.316 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -76.63 83.03 3.28 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 118.397 0.544 . . . . 75.109999999999999 111.394 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.96 13.34 83.25 Favored Glycine 0 CA--C 1.51 -0.228 0 N-CA-C 111.551 -0.62 . . . . 63.25 111.551 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 70.66 -160.96 53.81 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 110.813 -0.915 . . . . 52.130000000000003 110.813 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 70.7 mt -89.52 -34.92 7.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 108.763 -0.829 . . . . 72.030000000000001 108.763 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -159.97 -46.27 0.05 Allowed 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 124.281 1.032 . . . . 73.450000000000003 109.612 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 60.3 mt 62.76 81.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.38 1.086 . . . . 64.439999999999998 110.112 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 23.7 m -156.13 134.7 11.67 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.943 -1.503 . . . . 41.439999999999998 106.943 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -145.24 -171.83 3.74 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.785 -1.191 . . . . 73.120000000000005 107.785 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -106.34 9.3 31.93 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.168 -0.613 . . . . 70.120000000000005 111.64 -173.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 12.0 m -77.78 120.78 23.17 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 121.915 0.864 . . . . 51.200000000000003 110.171 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.495 HG23 ' HB3' ' C' ' 225' ' ' ARG . 5.1 t -115.82 120.51 39.49 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 105.687 -1.968 . . . . 72.099999999999994 105.687 171.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' B' ' 226' ' ' ASN . 37.0 t-20 -126.39 138.35 53.54 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.072 -0.651 . . . . 65.420000000000002 109.268 -172.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 263' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' C' ' 227' ' ' SER . 51.9 m -142.08 129.54 21.29 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.152 0.501 . . . . 63.140000000000001 111.336 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 14.1 p -121.11 153.16 24.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.831 -0.803 . . . . 64.450000000000003 108.831 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 75.8 mm-40 -91.94 -78.34 0.41 Allowed 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 109.583 -0.525 . . . . 63.210000000000001 109.583 171.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.6 m -114.35 127.97 56.12 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.944 -0.473 . . . . 61.329999999999998 111.192 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.27 120.74 47.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 109.162 -0.681 . . . . 71.209999999999994 109.162 176.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 5.4 m -124.76 148.33 29.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 121.246 0.546 . . . . 74.219999999999999 111.301 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 269' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -137.34 132.43 5.95 Favored Glycine 0 N--CA 1.415 -2.755 0 N-CA-C 109.489 -1.444 . . . . 61.119999999999997 109.489 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -132.51 116.19 16.44 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.524 0.678 . . . . 73.010000000000005 110.057 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 104.08 -139.19 14.45 Favored Glycine 0 CA--C 1.471 -2.715 0 N-CA-C 109.213 -1.555 . . . . 73.25 109.213 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 272' ' ' GLU . . . . . 0.517 ' HB3' ' O ' ' C' ' 235' ' ' GLU . 11.1 tp10 -86.42 80.65 8.6 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.133 -1.432 . . . . 74.430000000000007 107.133 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 273' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 20.6 m -113.96 144.29 43.32 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.429 -1.26 . . . . 63.219999999999999 109.061 -177.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' C' ' 238' ' ' ARG . 76.3 mtt180 -134.4 127.35 31.41 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.013 -1.106 . . . . 73.420000000000002 108.013 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 10.9 t -131.2 137.77 54.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 116.101 -0.5 . . . . 73.010000000000005 109.714 -173.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 4.5 tt -126.56 113.87 17.35 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 106.872 -1.529 . . . . 74.230000000000004 106.872 173.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.536 HG23 HD12 ' C' ' 241' ' ' LEU . 58.2 mt -112.72 103.19 15.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.509 -0.923 . . . . 73.420000000000002 108.509 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' B' ' 226' ' ' ASN . . . 140.98 -146.11 17.18 Favored Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 111.141 -0.784 . . . . 70.409999999999997 111.141 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 279' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 5.5 m-20 -123.58 138.24 54.59 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.316 -0.624 . . . . 73.530000000000001 109.316 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.81 137.85 54.29 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.075 -0.713 . . . . 72.420000000000002 109.075 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 87.4 t80 -124.03 121.92 36.52 Favored 'General case' 0 C--O 1.271 2.226 0 N-CA-C 108.493 -0.929 . . . . 71.150000000000006 108.493 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' B' ' 249' ' ' ALA . . . 81.65 -1.17 86.82 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 114.311 -1.313 . . . . 72.129999999999995 113.979 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -71.33 -60.11 4.58 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.922 -0.871 . . . . 75.519999999999996 110.922 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm 74.24 21.64 2.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.283 1.433 . . . . 73.030000000000001 109.1 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.9 90.07 0.83 Allowed Glycine 0 N--CA 1.409 -3.109 0 N-CA-C 109.48 -1.448 . . . . 75.439999999999998 109.48 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' B' ' 240' ' ' GLN . 44.5 t80 -72.73 40.54 0.09 Allowed 'General case' 0 CA--C 1.573 1.857 0 C-N-CA 124.689 1.195 . . . . 73.219999999999999 110.118 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.534 ' CE3' ' HB3' ' B' ' 274' ' ' ARG . 8.0 m95 -117.3 123.45 46.58 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.347 -0.982 . . . . 73.400000000000006 108.347 -176.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.44 115.83 10.07 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.725 -1.583 . . . . 65.430000000000007 106.725 172.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 289' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' B' ' 292' ' ' HIS . 5.6 p30 -155.76 -172.67 4.22 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.363 -0.535 . . . . 64.230000000000004 111.114 -171.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 290' ' ' HIS . . . . . 0.514 ' HA ' ' CE1' ' A' ' 294' ' ' HIS . 62.6 m-70 -57.49 -37.23 72.59 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.86 0.864 . . . . 52.520000000000003 112.447 -178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -88.06 44.96 1.23 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.041 -0.726 . . . . 71.430000000000007 109.041 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 292' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' B' ' 289' ' ' ASN . 1.9 t60 -78.49 87.4 4.48 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.566 -1.272 . . . . 74.340000000000003 107.566 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -85.21 88.78 7.51 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.883 1.068 . . . . 72.420000000000002 113.883 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -96.36 -30.52 13.35 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.857 -1.905 . . . . 74.219999999999999 105.857 167.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 79.9 t60 . . . . . 0 N--CA 1.427 -1.594 0 N-CA-C 104.284 -2.487 . . . . 73.420000000000002 104.284 174.584 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 55.6 ttp . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 108.06 -1.089 . . . . 62.210000000000001 108.06 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -104.03 148.99 25.59 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.794 -1.187 . . . . 61.509999999999998 107.794 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.73 130.27 20.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.27 0 CA-C-O 122.15 0.976 . . . . 74.230000000000004 112.084 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -108.17 154.47 21.68 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 113.982 -1.463 . . . . 74.409999999999997 108.453 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.23 16.49 4.11 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.043 0.449 . . . . 53.009999999999998 110.473 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 3.1 mp -105.55 140.62 23.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 123.143 0.577 . . . . 74.230000000000004 109.579 -175.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 13.1 p -98.66 136.83 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.328 -0.99 . . . . 61.409999999999997 108.328 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 109.97 48.29 0.78 Allowed Glycine 0 C--N 1.307 -1.073 0 N-CA-C 108.1 -2.0 . . . . 52.109999999999999 108.1 -172.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.495 ' HB3' HG23 ' B' ' 261' ' ' THR . 26.8 ptt180 -131.36 143.15 50.28 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.671 -0.765 . . . . 75.109999999999999 110.553 -173.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 37.9 t-20 -117.81 136.96 53.07 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.877 -1.527 . . . . 62.149999999999999 106.877 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' B' ' 263' ' ' SER . 32.8 m -134.34 137.28 44.04 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-O 121.041 0.448 . . . . 73.299999999999997 110.622 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -125.18 150.75 46.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.52 -0.919 . . . . 72.120000000000005 108.52 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 1.0 OUTLIER -108.26 -54.21 2.53 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 109.131 -0.692 . . . . 73.030000000000001 109.131 -177.05 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 230' ' ' ASP . . . . . 0.416 ' CG ' HH21 ' C' ' 232' ' ' ARG . 11.8 t70 -132.8 137.62 46.85 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.495 -1.298 . . . . 63.219999999999999 107.495 176.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.424 ' HA ' HG13 ' C' ' 267' ' ' VAL . 19.1 mt -137.25 120.48 21.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.454 -2.054 . . . . 62.340000000000003 105.454 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.416 HH21 ' CG ' ' C' ' 230' ' ' ASP . 19.0 ptp180 -126.11 120.4 30.06 Favored 'General case' 0 C--N 1.274 -2.678 0 C-N-CA 119.815 -0.754 . . . . 45.109999999999999 111.42 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.436 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 33.0 p -111.0 134.76 52.35 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.892 -1.049 . . . . 55.350000000000001 108.854 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -144.93 148.03 33.39 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.561 -0.456 . . . . 65.439999999999998 110.062 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' B' ' 272' ' ' GLU . 64.7 mt-10 73.93 -74.02 0.09 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.231 1.567 . . . . 72.239999999999995 115.231 176.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.44 ' HD2' ' HB3' ' C' ' 235' ' ' GLU . 8.0 mpt_? -136.48 17.0 3.14 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.206 -0.665 . . . . 71.239999999999995 109.206 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -78.71 131.11 36.48 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.998 0.904 . . . . 72.439999999999998 113.293 -173.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.575 ' HB3' ' HB2' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -128.5 135.74 49.84 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 114.887 -1.051 . . . . 61.219999999999999 111.157 174.588 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.474 HG23 ' HB ' ' C' ' 275' ' ' VAL . 7.2 p -130.99 142.59 43.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.375 -0.829 . . . . 53.130000000000003 111.529 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -104.7 132.25 51.17 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 114.363 -1.29 . . . . 75.310000000000002 107.698 171.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.536 HD12 HG23 ' B' ' 277' ' ' ILE . 2.7 tm? -130.13 116.03 17.89 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 105.303 -2.11 . . . . 72.409999999999997 105.303 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 129.63 -132.4 7.06 Favored Glycine 0 C--N 1.3 -1.462 0 C-N-CA 120.147 -1.025 . . . . 63.229999999999997 111.416 -178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 44.2 t30 -137.2 135.56 37.39 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.047 0.451 . . . . 73.439999999999998 110.492 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.07 117.46 51.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.283 0 N-CA-C 107.863 -1.162 . . . . 71.099999999999994 107.863 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 2.8 p -123.56 112.83 34.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 118.691 0.678 . . . . 72.099999999999994 110.455 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.4 m -81.98 156.05 24.89 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 117.444 -1.702 . . . . 73.209999999999994 110.298 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.445 ' HB2' ' HB1' ' B' ' 249' ' ' ALA . . . -67.64 -48.79 65.71 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.744 0.783 . . . . 73.040000000000006 112.042 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.17 75.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.116 -1.402 . . . . 65.109999999999999 112.253 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -74.93 -27.95 60.4 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.929 -0.578 . . . . 64.340000000000003 111.561 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -77.59 93.94 4.28 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.6 0.714 . . . . 70.329999999999998 109.62 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -168.28 98.05 0.43 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.423 -1.262 . . . . 72.140000000000001 107.889 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 158.67 -49.43 0.41 Allowed Glycine 0 C--N 1.293 -1.832 0 N-CA-C 109.99 -1.244 . . . . 43.350000000000001 109.99 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 179.42 145.87 6.5 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 110.845 -0.902 . . . . 71.349999999999994 110.845 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 40.4 pt -94.61 -171.74 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 108.6 -0.889 . . . . 55.109999999999999 108.6 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 66.89 87.57 0.12 Allowed 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 123.313 0.645 . . . . 61.549999999999997 110.385 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 46.4 mm -85.48 88.7 2.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.228 -1.397 . . . . 61.450000000000003 107.228 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 21.5 m -89.88 89.57 7.8 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.334 -0.848 . . . . 65.219999999999999 110.673 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -106.96 139.69 40.96 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.819 -1.178 . . . . 72.140000000000001 107.819 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.55 28.93 8.19 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.151 0.797 . . . . 72.129999999999995 113.151 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 30.6 m -87.59 121.73 30.4 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.347 -0.612 . . . . 71.409999999999997 109.347 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 10.5 t -99.91 122.78 43.36 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 108.334 -0.987 . . . . 34.420000000000002 108.334 174.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 53.1 t-20 -123.7 137.1 54.77 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.876 -1.157 . . . . 54.43 107.876 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 32.2 t -142.2 125.72 16.75 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.272 -0.64 . . . . 74.310000000000002 109.272 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.15 147.0 32.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.161 -0.681 . . . . 61.439999999999998 109.161 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 27.0 mm-40 -90.03 -76.04 0.44 Allowed 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 110.18 -0.304 . . . . 72.299999999999997 110.18 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 11.2 m -114.31 127.85 56.07 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.211 -0.996 . . . . 74.530000000000001 111.707 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' C' ' 231' ' ' ILE . 1.3 p -128.52 122.46 57.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.511 0.672 . . . . 74.319999999999993 110.028 175.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.7 133.73 68.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.547 -0.751 . . . . 75.109999999999999 112.13 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.34 130.57 6.64 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 108.404 -1.878 . . . . 35.43 108.404 170.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -134.41 116.51 15.26 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.667 -1.234 . . . . 74.120000000000005 107.667 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.9 -139.81 14.7 Favored Glycine 0 C--N 1.291 -1.939 0 N-CA-C 109.685 -1.366 . . . . 73.340000000000003 109.685 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.52 91.85 2.32 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.18 -1.045 . . . . 52.450000000000003 108.18 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 273' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 23.2 m -131.37 144.67 51.4 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 121.66 0.743 . . . . 75.340000000000003 110.893 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 274' ' ' ARG . . . . . 0.462 ' HD3' ' HB2' ' C' ' 287' ' ' TRP . 55.2 mtt85 -136.26 127.6 28.35 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 105.723 -1.954 . . . . 74.099999999999994 105.723 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.474 ' HB ' HG23 ' C' ' 239' ' ' VAL . 6.9 t -138.19 140.1 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 109.486 -0.561 . . . . 71.25 109.486 -175.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.3 tt -128.71 111.93 13.68 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.074 -1.084 . . . . 74.239999999999995 108.074 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 58.1 mt -111.82 103.96 16.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.575 -0.898 . . . . 74.040000000000006 108.575 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.67 -136.02 7.57 Favored Glycine 0 N--CA 1.424 -2.131 0 N-CA-C 110.992 -0.843 . . . . 44.530000000000001 110.992 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 279' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 94.3 m-20 -127.88 156.34 42.74 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 110.111 -0.329 . . . . 75.040000000000006 110.111 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.88 138.25 24.18 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.013 -0.539 . . . . 72.0 110.049 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -130.12 122.33 28.05 Favored 'General case' 0 N--CA 1.415 -2.204 0 N-CA-C 107.37 -1.344 . . . . 73.299999999999997 107.37 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.57 -14.14 58.84 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.309 -0.859 . . . . 70.219999999999999 112.447 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -64.78 -58.18 10.6 Favored Glycine 0 CA--C 1.497 -1.038 0 N-CA-C 111.613 -0.595 . . . . 73.329999999999998 111.613 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 284' ' ' LYS . . . . . 0.534 ' NZ ' ' HB2' ' C' ' 284' ' ' LYS . 6.7 mtmp? 65.84 31.37 9.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.561 1.144 . . . . 62.329999999999998 108.344 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.19 97.15 2.38 Favored Glycine 0 N--CA 1.417 -2.567 0 N-CA-C 108.493 -1.843 . . . . 43.350000000000001 108.493 -172.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -76.22 41.64 0.24 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.262 1.03 . . . . 74.239999999999995 110.844 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.462 ' HB2' ' HD3' ' C' ' 274' ' ' ARG . 1.3 p90 -148.93 156.39 42.22 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-O 122.318 1.056 . . . . 72.510000000000005 113.254 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.36 24.41 0.19 Allowed 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 127.072 2.149 . . . . 71.420000000000002 112.371 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -135.78 5.59 3.13 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.986 -0.686 . . . . 63.509999999999998 110.857 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -147.99 108.4 4.12 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.914 -0.714 . . . . 74.239999999999995 111.359 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -146.04 97.65 2.98 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.191 -1.411 . . . . 53.399999999999999 107.191 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -109.36 -61.91 1.56 Allowed 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.304 -0.862 . . . . 74.430000000000007 110.282 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -174.43 179.26 1.82 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 103.801 -2.666 . . . . 73.129999999999995 103.801 -172.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -79.33 88.17 4.97 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.758 -2.312 . . . . 74.439999999999998 104.758 171.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 . . . . . 0 C--O 1.249 1.048 0 O-C-N 124.886 1.366 . . . . 73.409999999999997 107.811 -169.364 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 C--O 1.244 0.79 0 N-CA-C 109.143 -0.688 . . . . 63.32 109.143 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp 64.3 -92.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 114.611 1.337 . . . . 52.299999999999997 114.611 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.517 ' H ' HG12 ' B' ' 222' ' ' ILE . 41.8 mt 57.92 28.84 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.382 0 N-CA-C 106.524 -1.658 . . . . 64.400000000000006 106.524 -168.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -95.3 -39.92 9.8 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 113.988 -1.46 . . . . 71.540000000000006 109.968 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -70.59 158.94 35.28 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.695 -1.224 . . . . 61.420000000000002 107.695 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 64.2 mt -83.05 114.92 24.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 122.167 0.984 . . . . 53.340000000000003 111.097 -170.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 22.4 m -114.88 164.28 11.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 114.575 -1.193 . . . . 74.319999999999993 108.018 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 259' ' ' GLN . . . 114.73 52.28 0.43 Allowed Glycine 0 C--N 1.288 -2.099 0 C-N-CA 119.941 -1.123 . . . . 62.219999999999999 110.493 -174.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.616 ' HG2' HH11 ' A' ' 225' ' ' ARG . 0.0 OUTLIER -114.93 121.73 44.08 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.839 -0.43 . . . . 74.310000000000002 109.839 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -106.62 123.89 48.8 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.945 -1.131 . . . . 72.25 107.945 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 12.2 m -123.91 136.83 54.59 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 116.109 -0.496 . . . . 62.140000000000001 110.393 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.31 138.16 44.76 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.68 -1.23 . . . . 62.130000000000003 107.68 175.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -93.43 -53.86 3.9 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.676 -0.49 . . . . 62.539999999999999 109.676 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.83 139.23 52.77 Favored 'General case' 0 C--O 1.252 1.191 0 N-CA-C 109.835 -0.432 . . . . 74.310000000000002 109.835 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 28.4 mm -128.08 116.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 106.279 -1.749 . . . . 63.409999999999997 106.279 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 31.5 ttp-105 -134.43 115.87 14.49 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.606 0.717 . . . . 73.140000000000001 111.489 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.64 ' HB ' ' CB ' ' A' ' 237' ' ' ALA . 4.8 p -129.1 140.47 51.55 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.493 -0.776 . . . . 51.130000000000003 111.227 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -121.04 143.16 49.2 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.542 0.687 . . . . 70.230000000000004 112.573 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 68.79 -100.66 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.394 1.627 . . . . 55.420000000000002 115.394 171.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.622 ' HD2' ' OE2' ' A' ' 272' ' ' GLU . 16.8 mtm180 -99.08 23.39 9.1 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.476 1.131 . . . . 73.310000000000002 110.128 -171.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.64 ' CB ' ' HB ' ' A' ' 233' ' ' THR . . . -84.13 156.17 22.25 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.591 -1.64 . . . . 73.040000000000006 111.835 -176.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ARG . . . . . 0.474 ' HD3' ' HG2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -146.18 137.85 24.86 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.502 -0.772 . . . . 62.439999999999998 110.202 174.201 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.53 HG12 ' HB ' ' A' ' 275' ' ' VAL . 29.7 m -132.21 142.49 42.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.394 0.616 . . . . 61.340000000000003 111.892 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.463 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 56.5 tp60 -123.48 135.38 54.03 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.535 -0.757 . . . . 43.530000000000001 109.003 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -123.19 118.17 27.01 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.735 -1.58 . . . . 75.439999999999998 106.735 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.424 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 126.8 -113.0 1.67 Allowed Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 119.756 -1.211 . . . . 62.030000000000001 114.572 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -143.98 131.92 21.57 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 110.114 -0.328 . . . . 73.420000000000002 110.114 -172.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.539 HG11 ' H ' ' A' ' 286' ' ' PHE . 48.9 t -122.14 123.63 69.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.324 -0.621 . . . . 65.219999999999999 109.324 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.406 ' HA ' ' HB2' ' A' ' 281' ' ' TYR . 12.3 m -113.59 114.62 47.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.176 0.513 . . . . 75.230000000000004 110.364 174.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 24.4 m -96.97 159.76 14.73 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.842 -0.799 . . . . 52.119999999999997 108.842 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.47 75.73 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 123.249 0.62 . . . . 70.129999999999995 111.567 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.25 -42.84 78.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.06 -0.973 . . . . 50.409999999999997 111.985 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.435 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -74.38 -45.56 46.06 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.368 -0.378 . . . . 71.329999999999998 110.545 -178.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 59.6 tp 48.34 -95.04 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.19 1.396 . . . . 74.109999999999999 112.622 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -131.49 78.29 1.82 Allowed 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.212 -0.662 . . . . 75.219999999999999 109.212 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -99.02 -55.48 1.05 Allowed Glycine 0 C--N 1.298 -1.565 0 N-CA-C 108.247 -1.941 . . . . 42.409999999999997 108.247 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -162.89 121.96 1.06 Allowed Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 108.428 -1.869 . . . . 54.399999999999999 108.428 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 22.7 pt -128.67 108.06 16.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 117.273 0.537 . . . . 53.140000000000001 110.902 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 60.34 54.68 3.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 122.917 1.341 . . . . 74.219999999999999 110.644 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 69.7 mt -124.16 -52.29 2.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 114.154 -1.385 . . . . 73.040000000000006 109.322 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' B' ' 253' ' ' GLY . 8.6 t -135.22 -4.92 2.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 122.552 1.168 . . . . 53.329999999999998 109.374 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -88.31 19.5 3.75 Favored 'General case' 0 C--N 1.281 -2.377 0 C-N-CA 125.979 1.712 . . . . 61.439999999999998 112.914 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.421 ' HB3' ' HA3' ' A' ' 224' ' ' GLY . 36.5 mt-30 -101.18 86.25 2.98 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.727 0.775 . . . . 54.409999999999997 110.847 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 87.2 m -91.14 138.36 31.66 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.594 -1.185 . . . . 55.020000000000003 109.926 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 52.9 m -102.85 108.12 19.22 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.529 -1.285 . . . . 74.319999999999993 107.529 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 37.2 t-20 -127.11 138.32 53.16 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.197 -0.668 . . . . 65.400000000000006 109.197 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.5 m -128.62 123.14 32.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.737 -0.468 . . . . 75.25 109.737 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.92 150.12 34.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 N-CA-C 110.455 -0.202 . . . . 72.420000000000002 110.455 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.694 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 3.7 tp10 -85.46 -74.91 0.39 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.096 0.559 . . . . 74.319999999999993 110.097 178.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 32.2 m -128.59 134.71 48.68 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 122.146 -0.346 . . . . 71.019999999999996 111.234 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.59 127.07 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.659 -1.237 . . . . 74.239999999999995 107.659 172.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 10.1 p -127.23 134.84 65.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 116.439 -0.346 . . . . 73.349999999999994 110.897 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.92 132.75 7.32 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.669 -0.776 . . . . 41.140000000000001 111.999 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -132.09 116.64 17.3 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.748 -0.464 . . . . 74.219999999999999 109.748 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 109.93 -131.56 10.53 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.882 -0.887 . . . . 61.149999999999999 110.882 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.622 ' OE2' ' HD2' ' A' ' 236' ' ' ARG . 10.0 mp0 -92.5 32.3 1.23 Allowed 'General case' 0 C--O 1.252 1.22 0 C-N-CA 125.133 1.373 . . . . 51.299999999999997 110.087 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 16.7 m -81.77 145.22 30.57 Favored 'General case' 0 C--O 1.287 3.077 0 CA-C-O 122.927 1.346 . . . . 54.200000000000003 112.708 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' ARG . . . . . 0.474 ' HG2' ' HD3' ' A' ' 238' ' ' ARG . 72.1 mtm-85 -127.08 127.79 45.23 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.697 -1.592 . . . . 74.219999999999999 109.27 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.53 ' HB ' HG12 ' A' ' 239' ' ' VAL . 48.9 t -127.81 132.29 69.01 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 CA-C-N 115.957 -0.565 . . . . 52.020000000000003 109.947 -175.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.8 tt -125.01 128.41 48.52 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 118.151 -1.42 . . . . 65.540000000000006 109.677 173.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.445 HG23 HD12 ' B' ' 241' ' ' LEU . 35.0 mm -112.56 105.62 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.657 -0.868 . . . . 63.119999999999997 108.657 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 138.78 -134.02 6.56 Favored Glycine 0 C--N 1.31 -0.883 0 C-N-CA 120.648 -0.787 . . . . 61.43 113.297 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' B' ' 243' ' ' ASN . 15.1 m120 -115.87 128.27 55.67 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 122.574 0.35 . . . . 71.340000000000003 110.816 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.06 118.67 34.05 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.657 -1.609 . . . . 73.010000000000005 106.657 176.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.406 ' HB2' ' HA ' ' A' ' 245' ' ' VAL . 22.4 m-85 -106.38 123.33 47.89 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.369 -1.345 . . . . 74.329999999999998 107.369 176.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.56 -50.66 0.79 Allowed Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.391 -1.083 . . . . 70.299999999999997 110.391 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.64 53.3 Favored Glycine 0 C--N 1.308 -1.02 0 N-CA-C 110.747 -0.941 . . . . 34.420000000000002 110.747 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' B' ' 287' ' ' TRP . 17.8 ptpt -179.85 27.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.286 1.034 . . . . 74.099999999999994 110.562 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -85.61 -120.72 1.08 Allowed Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 119.944 -1.122 . . . . 54.109999999999999 111.642 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.539 ' H ' HG11 ' A' ' 244' ' ' VAL . 86.8 t80 62.53 -89.07 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.106 0.562 . . . . 73.0 111.362 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -166.89 15.84 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 127.35 2.26 . . . . 61.119999999999997 107.206 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -85.2 104.71 15.32 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 104.707 -2.331 . . . . 71.129999999999995 104.707 -176.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.16 135.22 57.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.805 -0.634 . . . . 71.140000000000001 112.183 -171.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -52.11 113.25 0.96 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.054 -0.975 . . . . 74.439999999999998 111.327 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.478 ' H ' ' CD2' ' A' ' 293' ' ' HIS . 58.6 m-70 78.72 6.32 2.34 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.284 1.433 . . . . 73.129999999999995 113.709 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -96.74 7.31 46.88 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.274 -1.38 . . . . 72.420000000000002 107.274 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' HIS . . . . . 0.478 ' CD2' ' H ' ' A' ' 291' ' ' HIS . 13.3 m-70 -80.28 14.56 1.89 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.287 -1.324 . . . . 75.340000000000003 109.601 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -77.13 62.65 2.26 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.868 1.432 . . . . 75.310000000000002 114.868 -170.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 . . . . . 0 C--N 1.301 -1.537 0 N-CA-C 106.394 -1.706 . . . . 74.450000000000003 106.394 172.175 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 54.1 ttm . . . . . 0 CA--C 1.508 -0.654 0 N-CA-C 109.578 -0.527 . . . . 72.209999999999994 109.578 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.492 ' H ' ' HB2' ' C' ' 218' ' ' LYS . 86.6 tttt 75.51 -72.26 0.11 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.429 1.091 . . . . 72.420000000000002 109.799 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 14.8 tt -167.63 13.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 107.52 -1.289 . . . . 73.140000000000001 107.52 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -140.03 150.4 44.35 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.561 -0.745 . . . . 72.439999999999998 109.102 -173.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -96.84 -12.23 23.82 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 112.501 0.556 . . . . 51.310000000000002 112.501 -175.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 222' ' ' ILE . . . . . 0.517 HG12 ' H ' ' A' ' 219' ' ' ILE . 58.6 mt -90.76 116.09 31.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 120.68 0.276 . . . . 54.43 110.372 -174.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.482 HG11 HG21 ' C' ' 222' ' ' ILE . 31.0 m -106.22 146.47 12.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 120.815 0.341 . . . . 72.319999999999993 110.639 176.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 224' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' B' ' 258' ' ' ASP . . . 134.3 81.43 0.16 Allowed Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 109.719 -1.352 . . . . 55.020000000000003 109.719 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.417 ' HD2' ' H ' ' B' ' 224' ' ' GLY . 0.2 OUTLIER -142.72 129.5 20.46 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 107.132 -1.433 . . . . 73.420000000000002 107.132 178.769 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.537 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 29.6 m-80 -103.87 130.18 51.44 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 107.991 -1.115 . . . . 50.350000000000001 107.991 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 28.6 m -128.61 137.04 51.48 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-O 121.197 0.523 . . . . 71.140000000000001 110.615 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.498 ' HB1' HD11 ' B' ' 231' ' ' ILE . . . -131.59 155.55 47.33 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.791 -1.188 . . . . 75.530000000000001 107.791 177.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.694 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 0.1 OUTLIER -109.0 -61.72 1.58 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 119.51 -0.876 . . . . 71.409999999999997 108.854 -178.435 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -126.63 137.8 53.35 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.84 -0.8 . . . . 75.420000000000002 108.84 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.498 HD11 ' HB1' ' B' ' 228' ' ' ALA . 18.5 mm -131.66 117.55 35.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 106.874 -1.528 . . . . 72.340000000000003 106.874 -178.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.444 ' HG3' HG23 ' B' ' 268' ' ' VAL . 7.0 ptm180 -130.38 118.81 21.78 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.345 0.593 . . . . 72.439999999999998 111.492 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 34.5 p -110.72 128.14 55.61 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.352 -0.84 . . . . 61.229999999999997 109.31 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -125.01 142.38 51.52 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.035 0.445 . . . . 73.319999999999993 111.04 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.461 ' HB3' ' HD3' ' B' ' 236' ' ' ARG . 45.0 mt-10 74.76 -102.37 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.388 0 C-N-CA 125.011 1.324 . . . . 72.030000000000001 113.084 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.565 ' HD3' ' N ' ' B' ' 236' ' ' ARG . 0.7 OUTLIER -110.37 25.49 11.73 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.723 0.773 . . . . 64.319999999999993 109.448 -175.293 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -82.99 142.45 31.36 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 122.568 1.175 . . . . 55.32 112.759 -175.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -131.65 135.86 47.25 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.542 -1.208 . . . . 63.340000000000003 109.506 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.832 HG12 ' HB ' ' B' ' 275' ' ' VAL . 2.6 m -125.31 141.27 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 CA-C-O 121.869 0.843 . . . . 71.530000000000001 111.538 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.492 ' HB3' ' HG ' ' B' ' 276' ' ' LEU . 5.9 tp-100 -116.41 128.38 55.45 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 114.074 -1.421 . . . . 65.329999999999998 107.643 174.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.445 HD12 HG23 ' A' ' 277' ' ' ILE . 3.0 tm? -120.38 117.31 27.41 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.927 -1.509 . . . . 72.439999999999998 106.927 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.417 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 125.92 -112.23 1.61 Allowed Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.554 -1.308 . . . . 73.140000000000001 113.143 176.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.466 ' HB3' ' ND2' ' A' ' 279' ' ' ASN . 25.7 t-20 -144.97 138.36 26.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 111.556 0.206 . . . . 72.349999999999994 111.556 -174.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.515 HG11 ' H ' ' B' ' 286' ' ' PHE . 45.2 t -119.9 133.7 65.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.605 -0.887 . . . . 51.420000000000002 108.605 175.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 19.3 t -122.28 112.11 33.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 108.943 -0.762 . . . . 63.310000000000002 108.943 177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 23.5 m -95.49 158.95 15.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.97 -1.122 . . . . 62.329999999999998 107.97 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.435 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -64.39 -39.7 94.37 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.792 0.806 . . . . 74.400000000000006 110.553 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.89 -34.47 65.57 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.425 -1.716 . . . . 53.409999999999997 114.157 -175.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.439 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -68.03 -33.27 74.27 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.313 0.486 . . . . 63.25 112.313 -176.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 90.8 mt 68.23 165.05 0.24 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.182 0.993 . . . . 75.010000000000005 111.135 -175.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -86.61 66.74 9.62 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.669 1.224 . . . . 72.439999999999998 110.783 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 252' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' C' ' 252' ' ' GLY . . . -91.11 -15.85 55.12 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 109.499 -1.44 . . . . 71.439999999999998 109.499 176.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 253' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 257' ' ' SER . . . -85.76 119.49 5.11 Favored Glycine 0 N--CA 1.419 -2.471 0 CA-C-N 114.857 -0.672 . . . . 64.439999999999998 111.702 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 10.0 tt -125.73 -36.9 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.171 0.51 . . . . 63.219999999999999 110.523 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -112.76 -14.49 13.1 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.929 -0.482 . . . . 64.120000000000005 110.696 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 256' ' ' ILE . . . . . 0.479 HG13 ' NE2' ' B' ' 259' ' ' GLN . 17.0 tt -78.95 3.28 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 CA-C-O 121.383 0.611 . . . . 73.519999999999996 111.119 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.8 m -58.01 98.3 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.301 1.44 . . . . 65.129999999999995 111.454 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.516 ' O ' ' HA3' ' B' ' 224' ' ' GLY . 34.5 t0 37.54 85.3 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.871 2.068 . . . . 73.409999999999997 113.488 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 259' ' ' GLN . . . . . 0.479 ' NE2' HG13 ' B' ' 256' ' ' ILE . 42.0 mt-30 -87.25 -36.18 18.08 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.278 -1.328 . . . . 74.530000000000001 109.414 -178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' C' ' 243' ' ' ASN . 0.1 OUTLIER -65.02 120.65 13.02 Favored 'General case' 0 N--CA 1.396 -3.142 0 CA-C-N 113.33 -1.759 . . . . 63.210000000000001 113.665 -172.801 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 63.9 m -100.74 105.95 17.33 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 104.139 -2.541 . . . . 65.409999999999997 104.139 167.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 1.8 t-20 -128.44 142.02 51.22 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.097 -0.956 . . . . 73.209999999999994 109.886 -171.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 39.6 m -137.2 128.07 27.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.807 0.337 . . . . 53.140000000000001 110.948 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.2 p -128.39 153.72 38.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.795 -0.817 . . . . 74.409999999999997 108.795 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 38.4 tt0 -96.2 -76.35 0.51 Allowed 'General case' 0 N--CA 1.418 -2.029 0 C-N-CA 120.156 -0.617 . . . . 64.310000000000002 111.452 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -116.37 128.43 55.52 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.765 -0.774 . . . . 72.019999999999996 112.635 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 11.8 m -118.45 129.08 75.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.197 0 N-CA-C 107.793 -1.188 . . . . 62.039999999999999 107.793 171.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 268' ' ' VAL . . . . . 0.444 HG23 ' HG3' ' B' ' 232' ' ' ARG . 4.1 p -126.83 128.25 70.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.978 -0.555 . . . . 63.210000000000001 111.126 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 269' ' ' GLY . . . . . 0.407 ' HA2' ' OG1' ' C' ' 233' ' ' THR . . . -116.06 132.01 9.95 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.361 -1.096 . . . . 21.420000000000002 110.361 175.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -131.99 116.4 17.06 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.491 -0.559 . . . . 72.219999999999999 109.491 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 100.56 -137.66 13.39 Favored Glycine 0 C--N 1.309 -0.92 0 N-CA-C 111.139 -0.784 . . . . 71.239999999999995 111.139 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 272' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 2.4 mp0 -77.22 40.43 0.27 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.993 1.317 . . . . 55.140000000000001 110.177 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 273' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 39.0 m -82.92 144.66 29.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.979 0.895 . . . . 73.310000000000002 112.503 -169.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 32.5 mtt180 -130.75 127.21 38.3 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.58 -1.637 . . . . 73.530000000000001 106.58 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.832 ' HB ' HG12 ' B' ' 239' ' ' VAL . 89.4 t -135.06 130.34 51.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.377 -0.601 . . . . 70.140000000000001 109.377 -176.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 7.0 tt -122.09 125.41 46.14 Favored 'General case' 0 C--N 1.277 -2.553 0 C-N-CA 117.7 -1.6 . . . . 73.319999999999993 110.144 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.43 HG23 HD12 ' C' ' 241' ' ' LEU . 29.1 mm -110.51 103.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.043 -1.465 . . . . 71.349999999999994 107.043 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 139.76 -147.65 19.35 Favored Glycine 0 C--N 1.308 -0.976 0 C-N-CA 120.197 -1.002 . . . . 62.43 113.694 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 279' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 0.9 OUTLIER -106.64 129.8 54.49 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.957 -0.386 . . . . 55.25 109.957 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.94 118.69 36.17 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.511 -1.663 . . . . 71.109999999999999 106.511 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -107.62 123.15 48.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.694 -0.854 . . . . 75.349999999999994 108.694 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 139.46 -50.17 0.79 Allowed Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 109.79 -1.324 . . . . 50.43 109.79 -176.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 94.53 17.05 40.48 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.738 -0.945 . . . . 62.210000000000001 110.738 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt 174.05 27.77 0.0 OUTLIER 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.784 1.234 . . . . 70.120000000000005 109.726 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.22 -113.36 0.23 Allowed Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.011 -0.836 . . . . 75.420000000000002 111.011 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.515 ' H ' HG11 ' B' ' 244' ' ' VAL . 92.7 t80 60.61 -83.53 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.39 0.676 . . . . 73.329999999999998 111.646 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.508 ' HE1' ' HB3' ' A' ' 286' ' ' PHE . 3.5 m-90 -162.63 48.86 0.17 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 126.477 1.911 . . . . 74.230000000000004 108.672 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 9.0 t70 67.2 -166.38 0.21 Allowed 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 114.562 -1.199 . . . . 71.129999999999995 109.392 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -153.33 127.37 9.01 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 121.505 -0.747 . . . . 53.200000000000003 112.138 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -121.57 178.6 4.76 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.003 -0.74 . . . . 72.340000000000003 109.003 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -100.18 -75.64 0.57 Allowed 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 114.174 1.176 . . . . 73.200000000000003 114.174 -173.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -135.73 129.35 32.49 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.803 -0.359 . . . . 62.219999999999999 110.999 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -144.14 165.87 26.61 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 105.704 -1.961 . . . . 73.120000000000005 105.704 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 294' ' ' HIS . . . . . 0.439 ' CD2' HH21 ' C' ' 236' ' ' ARG . 27.2 t-80 -165.88 151.24 8.75 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.075 -0.713 . . . . 75.409999999999997 109.075 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 295' ' ' HIS . . . . . 0.414 ' HB3' ' CZ ' ' B' ' 236' ' ' ARG . 73.2 t60 . . . . . 0 C--N 1.299 -1.618 0 N-CA-C 107.807 -1.182 . . . . 74.230000000000004 107.807 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 CA--C 1.508 -0.637 0 N-CA-C 110.063 -0.347 . . . . 52.229999999999997 110.063 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 218' ' ' LYS . . . . . 0.492 ' HB2' ' H ' ' B' ' 218' ' ' LYS . 53.3 tptt -126.47 114.94 18.82 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.692 -0.484 . . . . 63.219999999999999 109.692 -172.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.581 ' H ' HD13 ' C' ' 219' ' ' ILE . 0.2 OUTLIER -96.56 68.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-O 122.221 1.01 . . . . 73.109999999999999 110.295 178.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -155.11 144.49 21.17 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 114.25 -1.341 . . . . 72.319999999999993 108.831 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 68.77 -72.21 0.1 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.411 1.484 . . . . 61.229999999999997 114.076 173.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 0.482 HG21 HG11 ' B' ' 223' ' ' VAL . 66.9 mt -83.91 114.66 24.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.364 0.602 . . . . 75.420000000000002 110.324 -175.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 223' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' C' ' 258' ' ' ASP . 26.8 m -112.05 143.05 22.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.522 -0.918 . . . . 75.030000000000001 108.522 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 224' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' C' ' 260' ' ' THR . . . 137.64 52.39 0.06 OUTLIER Glycine 0 C--N 1.297 -1.602 0 C-N-CA 119.798 -1.192 . . . . 52.210000000000001 111.513 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.24 138.58 52.24 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.756 -0.831 . . . . 72.409999999999997 108.756 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 40.8 m-80 -110.25 132.63 54.0 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 108.028 -1.101 . . . . 62.100000000000001 108.028 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 17.2 m -129.38 136.72 50.33 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 116.318 -0.401 . . . . 73.400000000000006 110.019 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.527 ' HB1' HD11 ' C' ' 231' ' ' ILE . . . -137.4 147.08 45.18 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.565 -0.902 . . . . 63.240000000000002 108.565 178.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -100.86 -64.65 1.03 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.936 -0.394 . . . . 71.040000000000006 109.936 -177.158 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.59 138.03 52.75 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 108.928 -0.767 . . . . 70.129999999999995 108.928 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.527 HD11 ' HB1' ' C' ' 228' ' ' ALA . 10.9 mm -132.0 117.46 33.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 106.552 -1.648 . . . . 74.150000000000006 106.552 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -126.03 122.12 34.96 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.585 -0.846 . . . . 74.409999999999997 112.413 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.431 ' CG2' HG13 ' C' ' 239' ' ' VAL . 17.3 p -110.47 126.99 54.92 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.051 -0.977 . . . . 70.230000000000004 109.19 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -128.93 142.77 50.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.036 0.446 . . . . 65.140000000000001 111.087 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 51.9 mt-10 78.75 -90.01 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 125.571 1.548 . . . . 72.400000000000006 113.971 173.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.474 ' HD3' ' OE2' ' C' ' 272' ' ' GLU . 0.0 OUTLIER -126.25 28.67 5.98 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.043 -1.095 . . . . 73.439999999999998 108.043 -177.251 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -82.58 146.42 29.17 Favored 'General case' 0 C--O 1.265 1.882 0 CA-C-O 122.794 1.283 . . . . 63.009999999999998 113.844 -174.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.1 OUTLIER -131.84 135.53 46.78 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.23 -1.35 . . . . 72.049999999999997 109.541 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.694 HG12 ' HB ' ' C' ' 275' ' ' VAL . 25.8 m -134.91 141.74 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 CA-C-O 121.936 0.874 . . . . 72.310000000000002 111.94 176.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.455 HE22 HD22 ' B' ' 276' ' ' LEU . 48.7 tp60 -110.83 133.19 53.57 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 113.985 -1.461 . . . . 73.140000000000001 108.304 176.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.43 HD12 HG23 ' B' ' 277' ' ' ILE . 3.1 tm? -125.26 117.01 22.87 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 106.249 -1.76 . . . . 55.109999999999999 106.249 177.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.409 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 125.88 -115.14 2.26 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 119.407 -1.378 . . . . 51.240000000000002 113.624 176.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 1.8 t30 -144.34 137.54 27.22 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 110.008 -0.367 . . . . 64.439999999999998 110.008 -173.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.544 HG11 ' H ' ' C' ' 286' ' ' PHE . 60.1 t -124.26 124.84 69.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.377 -0.601 . . . . 74.140000000000001 109.377 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 32.4 t -116.21 111.85 37.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.853 -0.795 . . . . 54.43 108.853 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.8 m -94.93 159.68 14.92 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.226 -1.028 . . . . 63.340000000000003 108.226 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -64.45 -39.96 94.82 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.685 0.755 . . . . 74.319999999999993 110.418 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -33.23 61.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.608 -1.633 . . . . 75.340000000000003 112.155 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.77 -45.96 63.79 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.15 -0.477 . . . . 34.310000000000002 112.132 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . 0.25 1.2 pt? 49.4 28.17 2.28 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.745 1.387 . . . . 72.349999999999994 114.745 -175.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -80.45 28.87 0.31 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.762 -0.586 . . . . 72.519999999999996 110.085 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 252' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' B' ' 252' ' ' GLY . . . -75.5 -27.06 64.12 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 114.55 0.58 . . . . 42.32 114.55 -172.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -97.68 22.64 39.76 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 121.242 -0.504 . . . . 73.219999999999999 113.05 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 9.0 tp -149.93 158.82 5.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.357 -0.979 . . . . 75.450000000000003 108.357 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -119.04 141.29 48.85 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.4 0.619 . . . . 74.010000000000005 111.734 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 6.7 tt -136.79 68.05 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 106.567 -1.642 . . . . 55.030000000000001 106.567 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 257' ' ' SER . . . . . 0.477 ' HB2' ' HB3' ' B' ' 259' ' ' GLN . 47.4 t -103.56 15.49 28.81 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 112.695 -2.048 . . . . 63.32 107.275 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 258' ' ' ASP . . . . . 0.457 ' OD2' ' HG3' ' C' ' 259' ' ' GLN . 8.1 p-10 -128.5 -177.22 4.08 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 113.754 -1.566 . . . . 71.219999999999999 107.573 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 259' ' ' GLN . . . . . 0.457 ' HG3' ' OD2' ' C' ' 258' ' ' ASP . 96.7 mt-30 72.37 -65.96 0.33 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.15 0.98 . . . . 70.540000000000006 111.999 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 260' ' ' THR . . . . . 0.507 ' O ' ' HA2' ' C' ' 224' ' ' GLY . 23.6 m -86.84 118.36 26.18 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.855 -0.738 . . . . 75.340000000000003 110.358 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 7.7 t -136.05 108.28 7.27 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 104.771 -2.307 . . . . 72.319999999999993 104.771 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 262' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 49.6 t30 -125.82 139.24 53.66 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.086 -0.506 . . . . 64.310000000000002 111.095 -168.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 13.1 t -129.38 123.5 31.87 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.438 -0.949 . . . . 54.509999999999998 108.438 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.01 153.92 34.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.165 -1.05 . . . . 73.120000000000005 108.165 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -97.56 -79.87 0.46 Allowed 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 120.028 -0.669 . . . . 72.409999999999997 111.403 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 29.2 m -120.07 127.73 52.82 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.145 -0.622 . . . . 71.239999999999995 111.812 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.9 m -118.7 127.3 75.66 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-O 121.621 0.724 . . . . 73.319999999999993 109.292 174.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.05 120.22 63.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.406 -0.815 . . . . 55.119999999999997 109.23 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.83 131.67 9.93 Favored Glycine 0 N--CA 1.416 -2.682 0 C-N-CA 119.635 -1.269 . . . . 53.149999999999999 111.114 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -133.33 133.84 43.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.491 -0.929 . . . . 55.539999999999999 108.491 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.77 -132.84 11.43 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.264 -0.969 . . . . 61.409999999999997 111.469 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 272' ' ' GLU . . . . . 0.474 ' OE2' ' HD3' ' C' ' 236' ' ' ARG . 4.5 mp0 -91.37 52.83 2.16 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.945 -1.131 . . . . 74.129999999999995 107.945 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 273' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 21.7 t -83.71 145.63 28.64 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 115.141 -0.936 . . . . 62.32 110.974 -174.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 274' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 17.2 mtm180 -141.12 127.5 19.87 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.785 -1.191 . . . . 73.439999999999998 107.785 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.694 ' HB ' HG12 ' C' ' 239' ' ' VAL . 13.6 t -137.2 138.95 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.14 -1.059 . . . . 63.32 108.14 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 8.8 tt -123.99 114.75 20.19 Favored 'General case' 0 N--CA 1.404 -2.768 0 C-N-CA 118.875 -1.13 . . . . 73.019999999999996 109.916 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 47.5 mm -102.51 103.04 14.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 106.674 -1.602 . . . . 74.040000000000006 106.674 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 278' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 145.54 -145.67 15.09 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.014 -1.089 . . . . 71.109999999999999 113.232 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -113.46 131.83 55.89 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 122.868 0.467 . . . . 64.030000000000001 109.764 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.64 118.54 32.39 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.702 -1.592 . . . . 64.150000000000006 106.702 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.29 123.34 49.92 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.63 -0.878 . . . . 72.120000000000005 108.63 176.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.98 -45.06 0.96 Allowed Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 110.632 -0.987 . . . . 62.210000000000001 110.632 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 94.28 4.36 62.75 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.61 -0.996 . . . . 55.119999999999997 110.61 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -170.71 28.75 0.02 OUTLIER 'General case' 0 C--O 1.247 0.948 0 C-N-CA 123.756 0.822 . . . . 64.340000000000003 109.671 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.37 -124.45 0.44 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.766 -0.933 . . . . 63.119999999999997 110.766 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.544 ' H ' HG11 ' C' ' 244' ' ' VAL . 88.1 t80 65.91 -78.67 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.351 0.66 . . . . 63.539999999999999 111.187 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -157.34 23.24 0.3 Allowed 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.574 1.15 . . . . 75.200000000000003 109.045 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 10.4 t70 61.57 -150.6 0.39 Allowed 'General case' 0 C--O 1.254 1.298 0 N-CA-C 105.096 -2.187 . . . . 72.519999999999996 105.096 -173.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 m120 68.41 149.82 0.07 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.644 1.177 . . . . 64.299999999999997 111.719 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 69.08 148.7 0.07 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.985 0.897 . . . . 74.340000000000003 112.407 173.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -79.1 96.77 5.92 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.145 -1.428 . . . . 75.319999999999993 107.145 172.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -58.98 119.07 6.56 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.986 -1.461 . . . . 53.119999999999997 111.213 -170.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -87.55 128.68 35.25 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.043 -1.465 . . . . 75.439999999999998 107.043 176.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -78.94 139.78 38.19 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.81 0.815 . . . . 74.230000000000004 112.27 -175.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 . . . . . 0 C--N 1.288 -2.083 0 N-CA-C 106.858 -1.534 . . . . 52.409999999999997 106.858 175.163 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 16.0 tmm? . . . . . 0 C--O 1.24 0.567 0 N-CA-C 107.963 -1.125 . . . . 55.240000000000002 107.963 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -73.61 95.67 2.34 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 123.398 0.679 . . . . 73.109999999999999 111.883 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 43.4 pt -87.69 149.17 4.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.812 -0.631 . . . . 75.099999999999994 109.516 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -92.27 80.27 5.0 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.097 0.951 . . . . 65.439999999999998 110.62 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -144.54 81.95 1.67 Allowed 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.03 -1.441 . . . . 73.319999999999993 107.617 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.497 HG21 HG21 ' B' ' 223' ' ' VAL . 3.3 mp -111.81 124.62 68.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.312 -0.858 . . . . 73.049999999999997 110.355 -177.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.8 m -107.25 164.99 4.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.367 -1.345 . . . . 72.219999999999999 107.367 173.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -65.73 87.49 0.1 Allowed Glycine 0 C--N 1.316 -0.578 0 C-N-CA 121.132 -0.556 . . . . 43.219999999999999 111.999 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -94.63 123.62 38.18 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.904 0.383 . . . . 64.25 110.041 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -112.53 130.87 55.86 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.295 -1.372 . . . . 75.0 107.295 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.7 m -135.62 136.77 41.28 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.146 0.498 . . . . 32.420000000000002 111.044 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 277' ' ' ILE . . . -116.2 131.17 57.02 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.334 -0.988 . . . . 62.310000000000002 108.334 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 4.1 tmmm? -81.39 -62.08 1.76 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.701 -0.481 . . . . 75.209999999999994 109.701 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -130.17 140.25 50.77 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.57 0.224 . . . . 75.219999999999999 111.401 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 48.7 mt -131.84 119.47 41.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.857 -0.794 . . . . 72.019999999999996 108.857 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.421 ' HB3' HG23 ' A' ' 268' ' ' VAL . 2.5 mpt_? -112.04 126.1 54.8 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.835 -0.431 . . . . 71.010000000000005 109.835 176.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.48 128.2 30.97 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 120.979 0.419 . . . . 52.329999999999998 110.395 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.25 159.73 39.15 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.416 -0.811 . . . . 73.030000000000001 109.956 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.494 ' HB2' ' H ' ' A' ' 271' ' ' GLY . 28.2 mm-40 63.3 72.2 0.49 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.551 0.741 . . . . 70.129999999999995 112.634 177.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.31 22.71 8.04 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.177 0.991 . . . . 73.200000000000003 113.031 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.41 145.76 28.82 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.107 0.48 . . . . 65.129999999999995 111.077 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -127.63 134.94 49.64 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.787 -0.642 . . . . 74.319999999999993 110.382 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 77.8 t -123.44 132.32 71.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.566 -0.743 . . . . 74.25 110.493 -174.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.524 ' HG3' HD13 ' A' ' 276' ' ' LEU . 55.5 tp60 -118.23 114.81 23.58 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.252 -1.018 . . . . 74.329999999999998 108.252 174.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -115.69 121.97 44.12 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.275 -1.379 . . . . 73.329999999999998 107.275 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.49 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 136.48 -119.74 2.04 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 119.946 -1.121 . . . . 61.240000000000002 112.525 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -144.18 129.04 18.4 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 110.09 -0.337 . . . . 70.519999999999996 110.09 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.0 t -112.57 120.98 64.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.452 -0.573 . . . . 72.530000000000001 109.452 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 25.8 m -117.99 112.17 37.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.594 0.711 . . . . 61.43 109.665 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 17.1 m -77.8 159.65 28.87 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.755 -0.657 . . . . 73.420000000000002 109.665 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.14 90.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.206 0.527 . . . . 73.510000000000005 110.654 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.64 -33.33 63.95 Favored 'General case' 0 C--O 1.211 -0.973 0 C-N-CA 124.891 1.276 . . . . 73.329999999999998 112.325 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -67.24 -32.48 73.55 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.366 -0.834 . . . . 73.430000000000007 112.865 -176.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 60.85 99.8 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 O-C-N 123.855 0.722 . . . . 64.200000000000003 109.747 -170.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -72.59 86.46 1.19 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.213 0.82 . . . . 70.439999999999998 113.213 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -156.89 81.31 0.16 Allowed Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 109.124 -1.591 . . . . 74.239999999999995 109.124 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -71.03 154.89 52.46 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 112.493 -0.243 . . . . 44.229999999999997 112.493 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 62.6 mt -113.47 94.73 3.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.388 -0.597 . . . . 72.230000000000004 109.388 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 51.3 94.78 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.6 1.333 . . . . 74.340000000000003 114.6 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 49.9 mt -84.04 83.81 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 106.861 -1.533 . . . . 51.450000000000003 106.861 174.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 39.8 m -85.82 -53.91 4.84 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.037 -0.983 . . . . 73.319999999999993 112.808 -173.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.431 ' CG ' HH22 ' C' ' 255' ' ' ARG . 8.5 t70 -130.0 101.01 5.65 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.207 -1.034 . . . . 40.409999999999997 108.207 -174.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.13 161.1 18.86 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.633 -0.712 . . . . 55.420000000000002 109.912 -174.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 51.9 m -87.08 138.44 31.49 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 124.646 1.178 . . . . 73.200000000000003 110.995 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -97.0 136.2 37.91 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 108.118 -1.067 . . . . 71.409999999999997 108.118 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.434 ' CG ' ' HA2' ' B' ' 242' ' ' GLY . 18.2 m-80 -120.87 140.4 51.84 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.999 0.428 . . . . 54.32 110.162 -176.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 42.6 m -142.13 123.8 15.06 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.846 -0.427 . . . . 71.310000000000002 109.846 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.3 p -122.53 138.48 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 109.971 -0.381 . . . . 64.340000000000003 109.971 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 65.1 mm-40 -81.17 -68.67 0.67 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.406 -0.361 . . . . 71.099999999999994 111.387 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 99.1 m -125.56 128.33 47.78 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.432 -0.507 . . . . 75.319999999999993 112.296 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.415 ' HB ' HD12 ' B' ' 231' ' ' ILE . 3.3 p -125.02 123.77 66.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.685 -0.857 . . . . 72.299999999999997 108.685 173.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 232' ' ' ARG . 7.3 p -127.07 139.54 51.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.888 0.375 . . . . 75.200000000000003 111.077 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.76 132.34 8.13 Favored Glycine 0 N--CA 1.423 -2.18 0 C-N-CA 121.019 -0.61 . . . . 71.5 111.756 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -133.23 116.46 16.24 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.431 -0.581 . . . . 73.450000000000003 109.431 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.494 ' H ' ' HB2' ' A' ' 235' ' ' GLU . . . 80.59 73.78 1.15 Allowed Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.386 -0.911 . . . . 74.200000000000003 113.322 173.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 56.35 53.65 8.53 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 113.788 1.033 . . . . 75.450000000000003 113.788 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 50.3 m -88.09 144.4 26.52 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 107.352 -1.351 . . . . 75.129999999999995 107.352 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 2.3 mpt_? -128.1 125.31 38.97 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 105.479 -2.045 . . . . 72.230000000000004 105.479 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.481 HG12 HG22 ' B' ' 239' ' ' VAL . 4.4 m -130.54 140.19 49.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 C-N-CA 119.936 -0.706 . . . . 72.530000000000001 110.122 -174.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.524 HD13 ' HG3' ' A' ' 240' ' ' GLN . 11.1 tp -125.11 118.64 26.58 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.649 0.738 . . . . 74.420000000000002 109.62 175.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.534 HG23 HD12 ' B' ' 241' ' ' LEU . 14.4 mt -113.18 104.43 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.936 0 CA-C-N 113.942 -1.481 . . . . 64.409999999999997 107.229 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.516 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 151.8 -129.08 2.71 Favored Glycine 0 N--CA 1.423 -2.206 0 C-N-CA 120.278 -0.963 . . . . 51.210000000000001 112.658 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -123.92 141.76 51.75 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.181 -0.674 . . . . 74.049999999999997 109.181 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.491 ' HB2' HE22 ' B' ' 240' ' ' GLN . 5.6 tm-20 -130.72 123.05 28.39 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.257 -1.016 . . . . 72.430000000000007 108.257 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.482 ' HD1' ' O ' ' B' ' 245' ' ' VAL . 7.4 t80 -116.01 124.01 49.43 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 107.96 -1.126 . . . . 72.219999999999999 107.96 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.592 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 144.68 -64.34 0.46 Allowed Glycine 0 N--CA 1.424 -2.139 0 CA-C-N 115.323 -0.853 . . . . 74.019999999999996 111.434 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 124.51 25.1 1.65 Allowed Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 120.44 -0.886 . . . . 42.539999999999999 113.018 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.403 ' HG3' ' HA ' ' A' ' 288' ' ' ASP . 0.2 OUTLIER -176.91 -5.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.159 0.8 . . . . 73.120000000000005 113.159 174.205 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.28 -132.26 38.23 Favored Glycine 0 CA--C 1.505 -0.588 0 N-CA-C 115.157 0.823 . . . . 63.109999999999999 115.157 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -98.77 -3.25 36.06 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.4 -0.593 . . . . 74.310000000000002 109.4 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.505 ' CZ2' ' HB3' ' A' ' 276' ' ' LEU . 10.9 m-90 -80.55 -48.02 13.36 Favored 'General case' 0 CA--C 1.49 -1.34 0 CA-C-N 115.711 -0.677 . . . . 73.439999999999998 110.506 -176.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.403 ' HA ' ' HG3' ' A' ' 284' ' ' LYS . 30.5 t70 62.6 92.94 0.05 Allowed 'General case' 0 CA--C 1.508 -0.636 0 O-C-N 125.589 1.805 . . . . 54.020000000000003 108.112 -169.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.86 119.85 39.28 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.224 -0.898 . . . . 73.019999999999996 111.908 -171.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -77.85 114.62 16.88 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.974 -1.121 . . . . 75.530000000000001 107.974 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -76.61 122.4 24.58 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 106.553 -1.647 . . . . 75.420000000000002 106.553 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -63.24 106.24 0.85 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.626 0.727 . . . . 64.329999999999998 109.472 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -53.04 -54.65 32.28 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.76 -1.564 . . . . 75.109999999999999 113.362 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -154.78 163.72 39.85 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.355 -0.609 . . . . 72.25 109.355 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 . . . . . 0 C--N 1.307 -1.246 0 N-CA-C 108.102 -1.073 . . . . 65.430000000000007 108.102 -177.195 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.519 -0.223 0 N-CA-C 107.382 -1.34 . . . . 73.230000000000004 107.382 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -125.58 56.75 1.36 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.753 -0.832 . . . . 73.109999999999999 108.753 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 82.6 mt -76.48 115.69 18.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 114.945 -1.025 . . . . 61.43 110.203 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' ASP . . . . . 0.475 ' O ' HD12 ' B' ' 222' ' ' ILE . 12.9 t70 -85.39 104.33 15.1 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 105.604 -1.999 . . . . 70.230000000000004 105.604 176.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.54 113.7 3.47 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 123.465 0.478 . . . . 72.0 111.121 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 222' ' ' ILE . . . . . 0.475 HD12 ' O ' ' B' ' 220' ' ' ASP . 3.5 mp -82.92 114.82 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 108.602 -0.888 . . . . 74.510000000000005 108.602 178.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.504 ' O ' ' HG3' ' B' ' 225' ' ' ARG . 26.9 m -106.52 166.62 3.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 107.004 -1.48 . . . . 74.120000000000005 107.004 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 224' ' ' GLY . . . . . 0.417 ' N ' ' HB3' ' B' ' 259' ' ' GLN . . . -54.36 115.45 5.27 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.228 -1.149 . . . . 70.030000000000001 110.228 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' B' ' 223' ' ' VAL . 97.5 mtt180 -116.75 122.42 44.42 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.673 -0.862 . . . . 52.240000000000002 108.673 -177.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 4.2 t30 -116.46 115.95 26.76 Favored 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 108.01 -1.107 . . . . 62.5 108.01 175.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 16.3 m -121.25 136.8 54.91 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-O 121.377 0.608 . . . . 71.120000000000005 110.799 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -124.66 124.09 41.45 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.649 -1.16 . . . . 71.439999999999998 108.357 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 0.3 OUTLIER -81.04 -57.5 3.5 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.658 -0.497 . . . . 74.400000000000006 109.658 -178.412 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -136.36 138.4 41.58 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.126 -0.63 . . . . 63.119999999999997 110.568 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.415 HD12 ' HB ' ' A' ' 267' ' ' VAL . 18.5 mt -130.36 119.19 45.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.419 -1.326 . . . . 53.420000000000002 107.419 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 69.8 mtt180 -117.16 115.53 25.51 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.733 -0.84 . . . . 64.219999999999999 108.733 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 69.4 p -112.84 127.29 56.14 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.303 -0.999 . . . . 63.119999999999997 108.303 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -134.55 139.25 45.27 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 120.07 -0.652 . . . . 73.129999999999995 109.398 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.463 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 44.8 mt-10 59.82 93.62 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 115.717 1.747 . . . . 75.310000000000002 115.717 170.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.463 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 2.8 mpt_? 62.75 20.12 11.9 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.1 -0.955 . . . . 72.109999999999999 110.954 172.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -84.1 141.83 30.83 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.935 -0.575 . . . . 43.350000000000001 110.48 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 7.9 mpt_? -124.69 133.93 53.04 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.788 -1.56 . . . . 62.310000000000002 106.788 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.55 HG12 HG22 ' B' ' 275' ' ' VAL . 23.4 m -135.84 147.56 28.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.559 -0.856 . . . . 62.109999999999999 111.467 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.606 ' CG ' HD13 ' B' ' 276' ' ' LEU . 5.5 tp-100 -124.01 120.33 32.12 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.226 -1.352 . . . . 75.120000000000005 108.425 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.534 HD12 HG23 ' A' ' 277' ' ' ILE . 2.9 tm? -118.09 117.71 29.93 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.133 -1.803 . . . . 75.120000000000005 106.133 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.524 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 139.82 -121.39 2.02 Favored Glycine 0 N--CA 1.412 -2.909 0 C-N-CA 119.398 -1.382 . . . . 61.43 112.902 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.558 HD21 HG13 ' B' ' 245' ' ' VAL . 8.2 t30 -143.27 130.35 20.71 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.083 0.468 . . . . 72.140000000000001 111.528 -174.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 98.5 t -112.58 126.7 70.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.382 -0.826 . . . . 73.040000000000006 109.254 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.558 HG13 HD21 ' B' ' 243' ' ' ASN . 4.1 m -122.03 113.7 39.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 108.134 -1.061 . . . . 73.140000000000001 108.134 173.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.474 HG21 ' HD3' ' B' ' 284' ' ' LYS . 17.3 m -77.43 160.7 28.53 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.708 -0.849 . . . . 74.319999999999993 108.708 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -61.74 -46.26 90.4 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 122.406 1.098 . . . . 51.43 109.807 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.39 -34.29 68.71 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 112.843 -1.98 . . . . 74.129999999999995 112.991 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.61 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -59.86 -26.86 66.18 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.224 0.61 . . . . 74.140000000000001 112.563 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 9.3 mp -75.7 80.96 2.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.286 1.041 . . . . 73.319999999999993 112.248 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -122.89 6.82 9.31 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.237 -1.764 . . . . 63.520000000000003 106.237 174.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -163.48 -153.77 7.43 Favored Glycine 0 N--CA 1.428 -1.847 0 N-CA-C 109.155 -1.578 . . . . 62.32 109.155 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -98.61 158.04 20.33 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.757 -0.735 . . . . 73.549999999999997 111.542 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 64.3 mt -82.74 91.86 2.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 122.203 1.002 . . . . 73.329999999999998 110.029 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -155.19 144.69 21.22 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.653 -1.158 . . . . 73.349999999999994 107.958 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 30.5 pt -88.44 163.83 2.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 120.584 -0.446 . . . . 71.230000000000004 110.864 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.3 p -67.58 -69.9 0.29 Allowed 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 122.545 0.338 . . . . 62.299999999999997 110.631 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -129.22 159.48 35.95 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.768 -1.197 . . . . 74.299999999999997 107.768 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 259' ' ' GLN . . . . . 0.417 ' HB3' ' N ' ' B' ' 224' ' ' GLY . 22.4 mt-30 -94.17 90.86 6.52 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.193 0.521 . . . . 71.140000000000001 110.605 -172.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 29.8 m -90.49 139.13 30.98 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.419 -0.81 . . . . 74.329999999999998 109.432 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.563 ' CG2' ' HG2' ' C' ' 225' ' ' ARG . 9.0 t -107.18 132.47 53.01 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.537 0.684 . . . . 74.150000000000006 109.373 177.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 16.5 m-80 -123.23 137.61 54.84 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.458 -0.792 . . . . 70.030000000000001 108.95 -177.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.3 m -139.24 123.62 18.2 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.667 -0.494 . . . . 74.299999999999997 109.667 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 9.2 p -117.77 141.14 38.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 120.866 0.365 . . . . 75.040000000000006 110.559 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 21.8 mm-40 -81.7 -69.03 0.64 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.595 -0.73 . . . . 62.530000000000001 110.745 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 29.2 m -133.1 127.44 33.99 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.796 -0.762 . . . . 52.310000000000002 112.183 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 3.6 p -123.51 124.18 69.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.972 -0.751 . . . . 74.25 108.972 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 268' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 8.5 p -127.32 136.97 59.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.131 0.491 . . . . 70.540000000000006 111.766 -176.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.99 133.07 10.6 Favored Glycine 0 CA--C 1.471 -2.686 0 CA-C-N 115.514 -0.766 . . . . 73.109999999999999 111.283 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -133.19 115.13 14.65 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 109.358 -0.608 . . . . 75.019999999999996 109.358 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.16 95.28 0.03 OUTLIER Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.924 -0.58 . . . . 75.040000000000006 114.532 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 63.36 31.54 15.13 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.502 0.556 . . . . 64.329999999999998 112.502 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.9 m -84.99 145.06 27.91 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.352 -0.386 . . . . 72.540000000000006 110.638 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 9.7 mpt_? -132.28 126.41 33.32 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.268 -1.382 . . . . 75.140000000000001 107.268 172.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.55 HG22 HG12 ' B' ' 239' ' ' VAL . 1.1 m -132.65 140.61 47.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 118.958 -1.097 . . . . 71.109999999999999 110.362 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.606 HD13 ' CG ' ' B' ' 240' ' ' GLN . 8.1 tp -122.86 117.17 24.98 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.024 0.916 . . . . 53.5 110.036 173.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.69 HG22 ' HB3' ' C' ' 241' ' ' LEU . 1.3 pt -112.13 103.89 16.17 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.026 0 CA-C-N 113.79 -1.55 . . . . 73.120000000000005 107.279 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 154.22 -147.18 16.09 Favored Glycine 0 N--CA 1.417 -2.598 0 CA-C-N 115.219 -0.9 . . . . 62.020000000000003 112.823 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -104.9 138.28 41.39 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.064 -1.088 . . . . 63.229999999999997 108.064 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -127.41 118.2 23.63 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.796 -1.557 . . . . 73.430000000000007 106.796 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.458 ' HB3' HG12 ' B' ' 245' ' ' VAL . 20.5 t80 -115.6 123.73 49.16 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 108.565 -0.902 . . . . 74.030000000000001 108.565 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.07 -55.32 0.68 Allowed Glycine 0 N--CA 1.416 -2.679 0 N-CA-C 109.328 -1.509 . . . . 74.230000000000004 109.328 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 102.2 44.02 1.94 Allowed Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.576 -1.009 . . . . 54.219999999999999 110.576 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 284' ' ' LYS . . . . . 0.474 ' HD3' HG21 ' B' ' 246' ' ' THR . 11.8 ptmm? -174.9 -18.14 0.01 OUTLIER 'General case' 0 C--O 1.253 1.278 0 O-C-N 123.713 0.302 . . . . 74.010000000000005 111.522 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 54.02 -141.99 32.23 Favored Glycine 0 CA--C 1.5 -0.898 0 CA-C-N 115.574 -0.739 . . . . 72.319999999999993 114.251 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -96.39 4.57 52.11 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.172 -0.677 . . . . 54.299999999999997 109.172 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.455 ' CH2' ' HB3' ' B' ' 276' ' ' LEU . 8.5 m-90 -83.32 -45.92 13.21 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.441 -0.8 . . . . 73.230000000000004 112.023 -174.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 288' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' B' ' 284' ' ' LYS . 35.3 t70 -89.27 103.45 16.08 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.726 1.01 . . . . 72.5 113.726 -173.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -168.34 174.38 7.05 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 103.698 -2.704 . . . . 74.430000000000007 103.698 173.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -115.32 -73.76 0.64 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 119.8 1.182 . . . . 72.299999999999997 112.588 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -151.97 131.16 12.74 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.281 -0.968 . . . . 74.010000000000005 112.345 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 22.4 t60 68.72 -74.02 0.08 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.79 1.636 . . . . 72.319999999999993 111.751 171.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -156.55 -54.28 0.08 Allowed 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.71 -1.589 . . . . 75.439999999999998 106.71 -176.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -147.1 83.57 1.57 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.658 -1.156 . . . . 72.409999999999997 108.757 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 34.1 t60 . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 124.826 1.25 . . . . 72.519999999999996 112.645 175.308 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 89.0 mtp . . . . . 0 CA--C 1.502 -0.889 0 N-CA-C 107.808 -1.182 . . . . 73.299999999999997 107.808 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -133.33 154.73 50.46 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 119.825 -0.75 . . . . 73.409999999999997 110.031 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 10.1 tt -154.29 96.27 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-O 121.728 0.775 . . . . 73.510000000000005 110.351 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -95.32 166.26 11.97 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.446 -0.946 . . . . 64.239999999999995 108.446 175.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 73.53 146.37 0.08 Allowed 'General case' 0 C--O 1.243 0.735 0 O-C-N 124.639 1.212 . . . . 54.030000000000001 110.44 -172.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.3 mp -94.61 115.82 34.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 121.723 0.773 . . . . 42.009999999999998 109.914 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 223' ' ' VAL . . . . . 0.506 ' O ' ' HG3' ' C' ' 225' ' ' ARG . 30.5 m -117.28 166.41 11.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 107.076 -1.453 . . . . 73.230000000000004 107.076 177.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -58.24 116.59 8.63 Favored Glycine 0 C--O 1.245 0.799 0 N-CA-C 110.625 -0.99 . . . . 43.219999999999999 110.625 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.563 ' HG2' ' CG2' ' B' ' 261' ' ' THR . 82.8 mtm180 -122.76 121.9 37.41 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.015 0.436 . . . . 73.349999999999994 110.163 -176.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 4.4 t30 -116.4 123.25 47.1 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.525 -0.917 . . . . 75.239999999999995 108.525 178.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' C' ' 263' ' ' SER . 46.7 t -121.94 137.52 54.76 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.854 -0.612 . . . . 73.030000000000001 109.955 -175.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -126.08 124.38 40.48 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.488 -0.93 . . . . 70.209999999999994 108.488 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -83.74 -64.84 1.09 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.554 -0.535 . . . . 73.319999999999993 109.554 -177.201 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -127.49 138.12 52.85 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 109.617 -0.512 . . . . 70.120000000000005 109.617 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.531 HG23 HG13 ' C' ' 267' ' ' VAL . 13.7 mt -133.48 117.44 27.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.15 -1.796 . . . . 64.409999999999997 106.15 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 17.0 ptp180 -124.88 115.65 20.96 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.634 0.731 . . . . 75.409999999999997 110.052 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 49.2 p -110.64 128.34 55.65 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.949 -0.76 . . . . 71.209999999999994 108.949 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -132.33 139.45 48.16 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.23 -0.655 . . . . 52.310000000000002 109.23 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.501 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 44.3 mt-10 59.07 93.05 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.283 1.586 . . . . 70.439999999999998 115.283 171.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.501 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 1.3 mpt_? 61.35 17.17 8.07 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.164 0.985 . . . . 60.32 111.772 175.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -80.15 136.59 36.54 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.082 0.468 . . . . 64.230000000000004 110.525 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.6 OUTLIER -124.95 133.07 53.17 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.385 -1.339 . . . . 72.0 107.385 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.529 HG12 HG22 ' C' ' 275' ' ' VAL . 19.2 m -136.52 149.69 27.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.563 -0.855 . . . . 74.019999999999996 111.772 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.59 ' HG3' HD13 ' C' ' 276' ' ' LEU . 47.7 tp60 -126.07 120.74 31.0 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 114.043 -1.435 . . . . 70.030000000000001 109.079 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.69 ' HB3' HG22 ' B' ' 277' ' ' ILE . 2.1 tm? -120.99 118.55 30.13 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.744 -1.576 . . . . 65.239999999999995 106.744 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.463 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 139.66 -122.91 2.35 Favored Glycine 0 N--CA 1.417 -2.63 0 C-N-CA 119.619 -1.277 . . . . 60.130000000000003 111.91 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -137.76 129.47 28.39 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 110.274 -0.269 . . . . 44.399999999999999 110.274 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.454 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 86.0 t -112.56 123.21 68.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.0 -0.741 . . . . 73.230000000000004 109.0 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 1.6 p -122.67 111.93 32.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 N-CA-C 108.236 -1.024 . . . . 63.409999999999997 108.236 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 20.0 m -70.59 160.53 32.34 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 116.163 -0.472 . . . . 54.229999999999997 109.894 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.61 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -59.28 -46.29 88.93 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.172 0.987 . . . . 50.420000000000002 110.14 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.49 73.48 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 113.633 -1.622 . . . . 72.230000000000004 112.567 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 249' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' C' ' 281' ' ' TYR . . . -64.0 -45.3 89.61 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.441 -0.799 . . . . 54.140000000000001 111.537 -175.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -83.87 70.57 10.43 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 122.825 1.298 . . . . 71.549999999999997 107.887 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -99.53 -21.99 15.68 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.061 -1.427 . . . . 62.009999999999998 107.377 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -150.22 169.11 30.23 Favored Glycine 0 N--CA 1.421 -2.323 0 N-CA-C 109.355 -1.498 . . . . 53.439999999999998 109.355 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -86.66 69.25 3.14 Favored Glycine 0 C--N 1.302 -1.34 0 C-N-CA 120.88 -0.676 . . . . 54.450000000000003 111.868 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.28 126.48 43.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.497 -0.927 . . . . 71.219999999999999 108.497 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 255' ' ' ARG . . . . . 0.431 HH22 ' CG ' ' A' ' 258' ' ' ASP . 19.1 ttm180 -131.26 86.31 2.35 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.564 0.697 . . . . 73.439999999999998 111.671 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 16.2 pt -159.12 167.77 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 106.309 -1.738 . . . . 62.439999999999998 106.309 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 55.9 p -162.73 177.01 9.71 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.582 -0.896 . . . . 55.229999999999997 108.582 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -96.6 94.24 7.22 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.413 -1.699 . . . . 55.25 106.413 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . 0.256 15.8 pm0 -75.42 73.75 2.48 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 122.209 1.005 . . . . 75.340000000000003 113.544 -174.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 99.5 m -102.81 139.27 38.6 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 114.126 -1.397 . . . . 71.219999999999999 108.931 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 7.1 t -91.4 110.04 21.34 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.578 -0.897 . . . . 54.240000000000002 108.578 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -109.9 123.25 49.28 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.265 -0.643 . . . . 73.310000000000002 109.265 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 263' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' C' ' 227' ' ' SER . 13.0 p -125.37 127.64 46.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 110.185 -0.302 . . . . 53.219999999999999 110.185 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.05 137.04 46.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.573 -0.528 . . . . 61.509999999999998 109.573 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 62.3 mm-40 -80.5 -64.61 1.15 Allowed 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 123.043 0.215 . . . . 51.310000000000002 110.759 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 19.0 m -131.98 127.36 36.12 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 119.644 -0.822 . . . . 75.530000000000001 110.299 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.531 HG13 HG23 ' C' ' 231' ' ' ILE . 2.6 p -126.44 122.89 62.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.927 -0.768 . . . . 74.329999999999998 108.927 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 268' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 6.0 p -124.0 142.78 39.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.885 -0.598 . . . . 60.240000000000002 110.762 -175.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.92 132.16 9.27 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 110.315 -1.114 . . . . 65.230000000000004 110.315 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -134.28 115.74 14.46 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 109.009 -0.737 . . . . 71.319999999999993 109.009 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.68 94.19 0.04 OUTLIER Glycine 0 CA--C 1.523 0.542 0 O-C-N 123.506 0.504 . . . . 42.539999999999999 114.249 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 272' ' ' GLU . . . . . 0.491 ' CD ' HH12 ' C' ' 238' ' ' ARG . 43.6 mm-40 62.2 25.64 15.35 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.506 0.928 . . . . 62.43 113.506 176.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 25.0 m -82.28 144.42 30.63 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.679 -0.808 . . . . 64.099999999999994 110.303 -176.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 274' ' ' ARG . . . . . 0.628 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 63.3 mtt180 -135.86 126.11 26.45 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 105.831 -1.914 . . . . 71.140000000000001 105.831 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.529 HG22 HG12 ' C' ' 239' ' ' VAL . 1.5 m -137.88 142.0 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 119.573 -0.851 . . . . 52.229999999999997 111.496 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.59 HD13 ' HG3' ' C' ' 240' ' ' GLN . 7.5 tp -122.46 112.59 18.24 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.037 0.922 . . . . 63.240000000000002 110.798 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.422 HD11 HD13 ' C' ' 231' ' ' ILE . 1.9 pt -108.67 104.98 17.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-N 114.054 -1.43 . . . . 72.129999999999995 108.544 175.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 278' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 149.97 -149.44 21.35 Favored Glycine 0 N--CA 1.419 -2.454 0 CA-C-N 115.408 -0.815 . . . . 54.32 111.533 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -98.1 145.67 26.32 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.499 -0.926 . . . . 75.310000000000002 108.499 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.488 ' HB2' HD21 ' C' ' 276' ' ' LEU . 2.9 tm-20 -137.12 117.91 14.09 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.857 -1.535 . . . . 54.439999999999998 106.857 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.509 ' CD2' ' HB1' ' C' ' 249' ' ' ALA . 42.9 t80 -118.47 124.57 47.92 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 108.882 -0.785 . . . . 61.100000000000001 108.882 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 140.49 -52.95 0.68 Allowed Glycine 0 N--CA 1.416 -2.66 0 N-CA-C 109.371 -1.492 . . . . 73.540000000000006 109.371 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 115.27 -11.31 19.7 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.664 -0.779 . . . . 73.299999999999997 111.787 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -125.12 -5.33 7.33 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 112.581 0.586 . . . . 60.43 112.581 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.33 -121.96 19.25 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 115.777 -0.647 . . . . 72.230000000000004 113.178 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -125.47 13.16 8.15 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.296 -1.001 . . . . 75.340000000000003 108.296 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' C' ' 276' ' ' LEU . 18.0 m-90 -77.6 -57.04 4.03 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 114.452 1.279 . . . . 72.340000000000003 114.452 -171.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -165.88 -167.55 1.11 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.548 -0.908 . . . . 71.040000000000006 108.548 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 72.78 105.94 0.07 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 126.217 1.807 . . . . 73.540000000000006 111.559 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 62.4 m170 75.79 -57.85 0.56 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.288 1.435 . . . . 74.400000000000006 113.096 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . 0.372 5.1 p80 50.61 -73.32 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.637 1.975 . . . . 71.25 114.168 -174.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -87.85 80.91 7.7 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.33 -0.856 . . . . 74.049999999999997 110.765 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -162.37 151.93 15.92 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.908 -2.256 . . . . 71.340000000000003 104.908 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -84.2 23.92 1.01 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 120.874 0.369 . . . . 72.319999999999993 111.27 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 . . . . . 0 N--CA 1.438 -1.059 0 CA-C-O 118.007 -0.997 . . . . 72.239999999999995 108.532 -177.134 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 112.763 0.653 . . . . 73.239999999999995 112.763 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -103.57 90.88 3.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.754 -0.832 . . . . 73.239999999999995 108.754 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.1 pt -130.48 150.56 34.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 116.224 -0.444 . . . . 71.239999999999995 111.242 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -112.59 89.45 3.08 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 103.65 -2.722 . . . . 74.519999999999996 103.65 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.97 16.02 4.51 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 114.985 1.476 . . . . 72.230000000000004 114.985 -165.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 222' ' ' ILE . 0.1 OUTLIER -90.0 114.34 27.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 118.496 -1.282 . . . . 75.5 109.454 173.804 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.415 HG23 ' HG2' ' A' ' 225' ' ' ARG . 12.3 m -134.54 144.9 33.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 114.313 -1.312 . . . . 75.140000000000001 108.406 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -82.57 51.33 4.51 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 121.141 -0.552 . . . . 52.340000000000003 113.532 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.415 ' HG2' HG23 ' A' ' 223' ' ' VAL . 33.9 ptt180 -120.86 140.25 52.03 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.355 -0.609 . . . . 72.329999999999998 109.355 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -116.55 137.96 51.77 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.423 -1.695 . . . . 43.409999999999997 106.423 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 7.9 p -128.4 137.43 51.86 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 113.474 0.916 . . . . 63.149999999999999 113.474 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.77 150.44 51.08 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.523 -1.288 . . . . 71.010000000000005 107.523 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -103.3 -50.95 3.34 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.763 -0.829 . . . . 70.129999999999995 108.763 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.441 ' HB2' HG23 ' A' ' 266' ' ' THR . 18.2 m-20 -127.36 140.71 52.0 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 109.577 -0.527 . . . . 65.239999999999995 109.577 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 55.0 mt -136.64 117.09 17.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 105.817 -1.92 . . . . 75.409999999999997 105.817 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.407 ' HB3' HG12 ' A' ' 268' ' ' VAL . 36.7 ttt180 -128.5 128.91 45.24 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.702 -0.481 . . . . 71.510000000000005 109.702 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 36.2 p -121.53 137.5 54.7 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 116.535 -0.302 . . . . 72.319999999999993 110.752 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -131.11 157.22 43.7 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 120.55 -0.46 . . . . 71.040000000000006 110.878 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 63.82 -85.77 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.942 1.297 . . . . 63.109999999999999 113.504 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.76 20.31 4.21 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 121.683 0.754 . . . . 53.210000000000001 109.331 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.523 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -69.86 130.98 43.72 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.792 -0.64 . . . . 75.540000000000006 109.989 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -125.42 135.15 52.07 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 108.075 -1.083 . . . . 74.340000000000003 108.075 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.557 HG22 ' CG2' ' A' ' 275' ' ' VAL . 96.2 t -132.42 145.37 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 121.037 0.446 . . . . 65.420000000000002 110.504 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.455 ' CG ' HD13 ' A' ' 276' ' ' LEU . 6.4 tp-100 -120.21 122.77 41.67 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.204 -1.406 . . . . 71.540000000000006 107.204 172.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.82 119.31 38.15 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.075 -1.083 . . . . 72.219999999999999 108.075 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.642 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 125.55 -132.92 8.15 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 111.305 -0.718 . . . . 52.32 111.305 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -125.1 143.82 50.73 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 117.198 0.499 . . . . 41.32 110.654 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.414 ' CG2' ' HG2' ' A' ' 240' ' ' GLN . 95.7 t -110.74 116.7 53.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.645 -1.243 . . . . 71.530000000000001 107.645 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.4 t -113.94 111.79 37.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 107.914 -1.143 . . . . 73.109999999999999 107.914 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.9 m -101.05 160.62 14.23 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 109.339 -0.615 . . . . 74.109999999999999 109.339 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.11 -32.76 66.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.89 1.276 . . . . 61.409999999999997 111.609 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.32 -48.19 74.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.685 0.794 . . . . 63.32 113.047 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.57 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . -74.17 -26.71 60.45 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.294 -0.632 . . . . 63.32 109.294 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 55.4 tp 76.61 -62.17 0.42 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 126.102 1.761 . . . . 64.140000000000001 110.583 -175.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -129.52 140.59 51.2 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.367 -0.975 . . . . 75.430000000000007 108.367 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -85.24 70.62 3.07 Favored Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 120.8 -0.714 . . . . 43.350000000000001 112.678 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.37 166.56 18.45 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 121.251 -0.5 . . . . 72.530000000000001 112.426 177.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 38.7 pt -130.3 -166.39 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.647 -1.242 . . . . 71.200000000000003 107.647 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -49.66 110.62 0.4 Allowed 'General case' 0 C--O 1.24 0.557 0 O-C-N 124.091 0.87 . . . . 73.319999999999993 111.025 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 50.6 mm 66.51 84.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 124.684 1.194 . . . . 74.239999999999995 110.055 -176.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 18.5 t -85.97 162.56 18.47 Favored 'General case' 0 C--O 1.256 1.434 0 CA-C-N 114.594 -1.185 . . . . 75.409999999999997 109.102 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -97.0 112.79 24.39 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.99 -1.115 . . . . 71.010000000000005 107.99 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -114.51 111.32 21.21 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.412 -0.813 . . . . 54.32 109.355 -177.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 20.9 m -101.31 137.23 39.93 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.292 -1.373 . . . . 54.140000000000001 107.292 175.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 10.0 t -98.74 136.86 38.18 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.662 -0.866 . . . . 72.319999999999993 108.662 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.56 ' OD1' ' HB3' ' B' ' 226' ' ' ASN . 3.8 t30 -126.54 133.0 51.22 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.018 -0.734 . . . . 74.420000000000002 109.018 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' B' ' 227' ' ' SER . 19.6 m -117.93 123.5 45.94 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.587 0.555 . . . . 65.120000000000005 109.706 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 10.2 p -126.92 143.42 40.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.248 -0.649 . . . . 63.310000000000002 109.248 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.594 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 36.8 tt0 -83.6 -82.61 0.15 Allowed 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 120.677 -0.409 . . . . 72.120000000000005 111.004 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 230' ' ' ASP . 81.0 m -115.45 126.69 54.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.663 -0.648 . . . . 71.120000000000005 111.897 -174.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 11.5 t -118.68 120.95 65.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 107.278 -1.379 . . . . 72.150000000000006 107.278 177.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.425 HG23 ' HG3' ' B' ' 232' ' ' ARG . 20.9 m -123.83 136.52 59.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 120.216 -0.594 . . . . 72.140000000000001 111.102 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.408 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -117.48 133.17 10.38 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.92 -0.582 . . . . 75.310000000000002 111.943 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -129.6 147.2 51.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.158 -1.052 . . . . 61.520000000000003 108.158 -177.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.27 -133.39 42.45 Favored Glycine 0 C--O 1.239 0.436 0 C-N-CA 120.972 -0.632 . . . . 75.140000000000001 112.226 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -90.69 83.56 5.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.769 -0.826 . . . . 74.0 108.769 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 75.3 m -104.62 144.07 32.21 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.555 -0.858 . . . . 73.230000000000004 110.693 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 28.0 mmm-85 -133.39 123.05 24.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.05 -2.204 . . . . 73.439999999999998 105.05 171.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.58 HG12 ' HB ' ' B' ' 239' ' ' VAL . 30.6 m -140.0 140.58 35.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.239 0.542 . . . . 61.539999999999999 111.627 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.594 ' HB3' ' CH2' ' A' ' 287' ' ' TRP . 9.4 tp -122.37 124.58 44.0 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 115.663 -0.699 . . . . 64.310000000000002 109.687 175.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.728 HG23 HD12 ' B' ' 241' ' ' LEU . 71.6 mt -110.72 103.45 15.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 107.642 -1.244 . . . . 74.420000000000002 107.642 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 145.52 -135.77 6.13 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.283 -0.871 . . . . 70.329999999999998 111.504 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 46.1 t-20 -129.59 137.64 50.83 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 122.17 -0.606 . . . . 72.329999999999998 109.509 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 285' ' ' GLY . 34.4 tt0 -111.17 127.28 55.54 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.396 -0.964 . . . . 65.019999999999996 108.396 177.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 99.7 m-85 -113.73 124.52 52.47 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.681 -0.859 . . . . 73.310000000000002 108.681 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.57 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 138.99 -87.09 0.21 Allowed Glycine 0 CA--C 1.467 -2.916 0 C-N-CA 120.397 -0.906 . . . . 74.310000000000002 112.211 177.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 141.9 96.94 0.27 Allowed Glycine 0 N--CA 1.406 -3.314 0 N-CA-C 108.555 -1.818 . . . . 72.420000000000002 108.555 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.477 ' HE3' ' HB3' ' B' ' 288' ' ' ASP . 35.4 mmtp 80.24 45.25 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 O-C-N 125.106 1.121 . . . . 72.120000000000005 110.296 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.464 ' H ' ' CD ' ' A' ' 280' ' ' GLU . . . -78.17 -54.87 4.24 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 115.431 -0.804 . . . . 54.140000000000001 111.683 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -89.62 -33.83 16.53 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.146 0.498 . . . . 73.010000000000005 110.708 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.594 ' CH2' ' HB3' ' A' ' 276' ' ' LEU . 29.6 m-90 -102.19 117.62 35.17 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.334 -0.393 . . . . 55.329999999999998 110.466 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -97.86 158.06 15.73 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.926 -0.768 . . . . 74.349999999999994 108.926 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' ASN . . . . . 0.551 HD22 ' HB2' ' A' ' 292' ' ' HIS . 56.8 t30 71.05 173.49 0.31 Allowed 'General case' 0 CA--C 1.558 1.265 0 O-C-N 124.404 1.065 . . . . 64.310000000000002 110.925 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -79.78 -40.47 28.6 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.303 -0.873 . . . . 64.219999999999999 111.202 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -140.83 -68.48 0.4 Allowed 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 120.035 -0.666 . . . . 64.129999999999995 110.517 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' HIS . . . . . 0.551 ' HB2' HD22 ' A' ' 289' ' ' ASN . 7.8 t60 79.47 93.19 0.05 Allowed 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 125.885 1.674 . . . . 63.409999999999997 108.963 -177.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 76.74 140.05 0.07 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.537 1.135 . . . . 74.319999999999993 108.598 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -157.81 81.48 0.87 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.607 0.718 . . . . 51.299999999999997 111.935 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 58.0 m80 . . . . . 0 C--O 1.258 1.532 0 CA-C-O 117.653 -1.165 . . . . 74.519999999999996 112.437 -178.939 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 20.1 ptp . . . . . 0 N--CA 1.467 0.405 0 N-CA-C 112.8 0.667 . . . . 61.549999999999997 112.8 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -141.9 94.03 2.62 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 118.604 0.638 . . . . 64.239999999999995 110.903 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 2.5 mp -134.25 -70.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.454 0.645 . . . . 75.109999999999999 109.463 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -156.53 173.97 16.13 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 106.511 -1.663 . . . . 70.409999999999997 106.511 -176.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -142.55 -172.55 3.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.103 -0.703 . . . . 73.120000000000005 109.103 -177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' ILE . . . . . 0.638 ' H ' HD13 ' B' ' 222' ' ' ILE . 0.2 OUTLIER -82.67 115.45 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 122.161 0.981 . . . . 74.209999999999994 109.21 177.065 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.422 HG23 ' HG2' ' B' ' 225' ' ' ARG . 27.1 m -100.84 135.27 37.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 114.248 -1.342 . . . . 74.510000000000005 110.229 -177.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -83.44 73.65 2.64 Favored Glycine 0 N--CA 1.428 -1.866 0 C-N-CA 120.611 -0.804 . . . . 62.329999999999998 113.047 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.632 ' HA ' ' O ' ' A' ' 261' ' ' THR . 40.6 ptt180 -138.17 142.74 40.06 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.059 0.457 . . . . 75.209999999999994 110.543 178.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.56 ' HB3' ' OD1' ' A' ' 262' ' ' ASN . 51.0 t-20 -116.18 148.43 40.38 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 105.285 -2.117 . . . . 74.140000000000001 105.285 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 227' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 263' ' ' SER . 3.2 p -139.01 136.78 35.69 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 121.515 0.674 . . . . 73.5 111.829 -175.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -132.13 144.25 50.57 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.726 -1.125 . . . . 54.229999999999997 108.571 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 5.9 tmtm? -96.74 -61.32 1.43 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.948 -0.76 . . . . 62.310000000000002 108.948 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -127.18 139.38 52.98 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 121.807 -0.558 . . . . 61.399999999999999 110.089 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.437 HG21 HG11 ' B' ' 239' ' ' VAL . 6.9 mt -134.96 120.65 31.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.713 -1.588 . . . . 72.140000000000001 106.713 175.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.425 ' HG3' HG23 ' A' ' 268' ' ' VAL . 78.8 ttt-85 -123.36 120.44 33.03 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.408 -0.59 . . . . 74.530000000000001 109.408 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 81.0 p -109.99 128.87 55.66 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.139 -1.059 . . . . 64.519999999999996 108.139 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -137.25 157.17 47.24 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.598 -0.519 . . . . 73.129999999999995 109.598 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.593 ' HB3' ' HD2' ' B' ' 236' ' ' ARG . 6.2 mp0 63.09 -89.09 0.03 OUTLIER 'General case' 0 C--O 1.21 -1.01 0 C-N-CA 124.425 1.09 . . . . 71.409999999999997 113.496 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.593 ' HD2' ' HB3' ' B' ' 235' ' ' GLU . 0.0 OUTLIER -137.2 59.27 1.69 Allowed 'General case' 0 C--O 1.245 0.843 0 N-CA-C 107.701 -1.222 . . . . 73.439999999999998 107.701 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.66 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -99.61 135.19 41.4 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-O 122.353 1.073 . . . . 74.439999999999998 110.399 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 6.1 mpt_? -124.28 133.21 53.54 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 105.691 -1.966 . . . . 73.519999999999996 105.691 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.58 ' HB ' HG12 ' A' ' 275' ' ' VAL . 69.7 t -142.48 133.08 24.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.847 0.832 . . . . 63.420000000000002 111.239 -175.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.584 ' CG ' HD13 ' B' ' 276' ' ' LEU . 44.0 tp60 -105.23 132.51 51.35 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.678 -1.23 . . . . 75.530000000000001 107.678 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.728 HD12 HG23 ' A' ' 277' ' ' ILE . 3.4 tm? -121.85 117.01 25.46 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 106.354 -1.721 . . . . 51.240000000000002 106.354 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.695 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 117.84 -130.05 8.58 Favored Glycine 0 C--O 1.206 -1.632 0 N-CA-C 111.189 -0.764 . . . . 72.209999999999994 111.189 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 5.8 m-20 -124.41 148.4 47.61 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 122.0 -0.706 . . . . 62.340000000000003 112.255 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.551 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 98.5 t -118.3 114.69 45.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.647 -1.242 . . . . 32.299999999999997 107.647 175.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 58.9 t -117.86 111.98 36.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 108.698 -0.853 . . . . 74.430000000000007 108.698 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.492 ' OG1' ' HA3' ' B' ' 282' ' ' GLY . 13.6 p -93.69 161.98 14.12 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 119.895 -0.722 . . . . 54.130000000000003 109.57 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -59.25 -32.54 70.09 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.475 1.131 . . . . 43.439999999999998 109.636 176.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.57 -35.16 65.46 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 112.655 -2.066 . . . . 53.140000000000001 113.5 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -62.31 -26.42 68.41 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.069 0.461 . . . . 71.530000000000001 110.406 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.8 mp -86.08 75.52 9.92 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.807 0.813 . . . . 72.030000000000001 109.022 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -92.85 -44.41 8.49 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.459 -1.312 . . . . 64.299999999999997 107.459 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -125.11 21.29 6.53 Favored Glycine 0 C--N 1.311 -0.858 0 N-CA-C 108.94 -1.664 . . . . 51.399999999999999 108.94 173.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 102.82 147.78 19.44 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.273 -1.131 . . . . 51.119999999999997 110.273 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.5 139.17 18.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.975 -0.75 . . . . 63.329999999999998 108.975 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -136.3 154.89 50.74 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.152 -1.796 . . . . 65.239999999999995 106.152 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 30.1 pt -70.32 134.76 29.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.593 0.711 . . . . 72.299999999999997 111.828 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 71.9 p -98.44 -163.3 1.03 Allowed 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.903 -1.044 . . . . 75.040000000000006 111.031 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -97.8 119.54 36.59 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.1 -1.444 . . . . 73.340000000000003 107.1 174.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 20.5 mp0 -98.44 82.76 2.92 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.296 -0.561 . . . . 74.540000000000006 110.8 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.2 m -64.76 135.5 55.9 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 108.805 -0.813 . . . . 60.530000000000001 108.805 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 9.0 t -91.99 132.86 36.22 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.082 0.468 . . . . 73.109999999999999 109.78 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 39.9 t-20 -126.56 146.66 50.05 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.695 -0.854 . . . . 74.329999999999998 108.695 -178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 49.3 m -135.65 123.48 22.56 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.023 0.439 . . . . 63.539999999999999 110.207 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.7 p -123.38 150.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.183 -0.673 . . . . 71.340000000000003 109.183 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 39.3 tt0 -93.5 -69.27 0.76 Allowed 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.539 -0.864 . . . . 72.420000000000002 110.409 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 15.6 m -119.53 127.63 53.2 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.104 -1.039 . . . . 65.099999999999994 112.301 -176.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 25.7 t -119.08 120.59 64.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.652 -1.24 . . . . 73.439999999999998 107.652 174.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.83 131.59 69.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 112.248 0.462 . . . . 72.25 112.248 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 269' ' ' GLY . . . . . 0.409 ' HA2' ' OG1' ' C' ' 233' ' ' THR . . . -109.66 133.89 11.89 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.608 -0.724 . . . . 62.409999999999997 111.886 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.428 ' HB3' ' HG2' ' C' ' 234' ' ' GLU . 16.3 tppt? -131.8 130.23 41.52 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 124.826 1.25 . . . . 71.310000000000002 109.546 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.28 -133.47 14.06 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 110.551 -1.019 . . . . 43.240000000000002 110.551 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 272' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 77.1 mm-40 -87.25 97.9 11.03 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 107.849 -1.167 . . . . 74.519999999999996 107.849 176.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 66.1 m -117.86 143.42 46.32 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 119.342 -0.943 . . . . 55.0 110.417 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 18.9 mmm-85 -133.99 123.83 25.26 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 104.259 -2.497 . . . . 65.530000000000001 104.259 172.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.3 t -139.22 140.73 37.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.515 -0.921 . . . . 75.219999999999999 108.515 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.723 ' HB3' ' CH2' ' B' ' 287' ' ' TRP . 3.0 tp -126.79 122.06 33.71 Favored 'General case' 0 C--N 1.26 -3.299 0 N-CA-C 109.651 -0.5 . . . . 72.5 109.651 173.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.493 HG23 HD12 ' C' ' 241' ' ' LEU . 3.2 mp -107.01 103.72 15.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 106.386 -1.709 . . . . 73.239999999999995 106.386 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.695 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 152.48 -140.9 8.01 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 121.061 -0.59 . . . . 25.109999999999999 112.245 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -128.86 135.29 48.89 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.621 -0.881 . . . . 55.450000000000003 108.621 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.426 ' HB2' HD21 ' B' ' 276' ' ' LEU . 41.5 tt0 -111.77 133.69 53.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.814 0.34 . . . . 61.240000000000002 110.225 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -121.87 125.65 46.91 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 115.885 -0.598 . . . . 72.239999999999995 110.988 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.492 ' HA3' ' OG1' ' B' ' 246' ' ' THR . . . 133.37 -99.55 0.37 Allowed Glycine 0 CA--C 1.48 -2.156 0 C-N-CA 120.559 -0.829 . . . . 71.549999999999997 112.725 174.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 178.34 112.32 0.33 Allowed Glycine 0 C--N 1.277 -2.706 0 N-CA-C 108.106 -1.997 . . . . 60.240000000000002 108.106 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 284' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' B' ' 288' ' ' ASP . 1.1 mptm? 78.01 -50.88 0.5 Allowed 'General case' 0 C--O 1.197 -1.677 0 C-N-CA 124.217 1.007 . . . . 71.019999999999996 112.537 -178.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 285' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' B' ' 246' ' ' THR . . . 46.5 -102.31 0.04 OUTLIER Glycine 0 C--O 1.244 0.779 0 O-C-N 124.439 1.087 . . . . 12.210000000000001 114.983 175.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -70.75 -28.42 64.68 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 123.959 0.904 . . . . 75.430000000000007 111.382 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.723 ' CH2' ' HB3' ' B' ' 276' ' ' LEU . 22.8 m-90 -105.82 23.44 13.92 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 122.052 -0.405 . . . . 74.540000000000006 111.645 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 288' ' ' ASP . . . . . 0.528 ' HA ' ' HB3' ' B' ' 284' ' ' LYS . 30.0 t70 -65.95 101.18 0.64 Allowed 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 119.738 -0.785 . . . . 74.120000000000005 110.123 174.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -117.21 97.74 6.07 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-N 114.594 -1.185 . . . . 72.040000000000006 109.07 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -124.21 127.22 47.39 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.121 -1.437 . . . . 72.530000000000001 107.121 173.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -69.67 80.27 0.43 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 114.873 1.434 . . . . 71.209999999999994 114.873 -173.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -89.1 -16.48 31.4 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.133 0.968 . . . . 75.230000000000004 108.502 170.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -126.56 -170.64 2.24 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 105.236 -2.135 . . . . 74.519999999999996 105.236 171.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -136.93 27.78 2.93 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.672 -1.233 . . . . 71.019999999999996 107.672 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 69.3 t60 . . . . . 0 C--N 1.307 -1.249 0 N-CA-C 108.298 -1.001 . . . . 73.420000000000002 108.298 -176.853 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 110.472 -0.196 . . . . 63.25 110.472 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt 56.18 81.36 0.13 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.825 1.25 . . . . 55.140000000000001 113.252 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 41.6 pt -141.36 147.97 21.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.299 -0.63 . . . . 54.229999999999997 109.299 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -141.67 167.81 21.27 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.931 -1.507 . . . . 61.350000000000001 106.931 175.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 61.39 -154.5 0.36 Allowed 'General case' 0 C--O 1.243 0.747 0 O-C-N 124.345 1.028 . . . . 71.200000000000003 109.279 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 0.596 ' H ' HD13 ' C' ' 222' ' ' ILE . 0.2 OUTLIER -116.11 138.05 47.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 121.265 0.555 . . . . 70.5 110.901 -178.779 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 28.8 m -121.7 148.59 25.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.615 -0.883 . . . . 55.25 108.615 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 224' ' ' GLY . . . . . 0.454 ' HA2' ' HB2' ' C' ' 259' ' ' GLN . . . -81.36 63.89 4.26 Favored Glycine 0 CA--C 1.495 -1.169 0 C-N-CA 121.228 -0.51 . . . . 54.340000000000003 111.89 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.577 ' HA ' ' O ' ' B' ' 261' ' ' THR . 56.4 ttp180 -126.07 122.69 36.51 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 120.904 0.383 . . . . 73.019999999999996 110.304 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 23.2 t-20 -106.95 142.76 36.06 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.72 -1.956 . . . . 62.030000000000001 105.72 175.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 9.1 p -139.98 137.31 34.6 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.216 -0.994 . . . . 74.310000000000002 113.101 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -127.45 142.02 51.52 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.101 -0.954 . . . . 60.43 109.435 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 49.0 tptt -87.81 -66.61 0.89 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.964 -0.562 . . . . 70.409999999999997 110.537 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -133.68 138.93 46.13 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.959 -0.756 . . . . 71.400000000000006 108.959 -175.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.413 HG23 ' HB ' ' C' ' 267' ' ' VAL . 10.7 mt -135.38 120.52 28.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.721 -1.214 . . . . 62.310000000000002 107.721 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 77.7 ttt180 -122.85 121.64 36.73 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 109.351 -0.611 . . . . 74.450000000000003 109.351 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 68.5 p -110.46 127.92 55.36 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.466 -0.939 . . . . 30.510000000000002 108.466 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' B' ' 270' ' ' LYS . 34.5 mt-10 -130.13 152.27 49.75 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 119.99 -0.684 . . . . 50.329999999999998 112.0 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 48.8 mt-10 69.8 -77.81 0.05 Allowed 'General case' 0 C--O 1.194 -1.84 0 CA-C-N 113.84 -1.527 . . . . 71.409999999999997 113.854 172.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.1 56.8 1.47 Allowed 'General case' 0 C--O 1.245 0.819 0 N-CA-C 107.134 -1.432 . . . . 74.140000000000001 107.134 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -104.12 135.11 46.23 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 122.492 1.139 . . . . 65.530000000000001 111.292 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 4.8 mpt_? -124.86 133.16 53.19 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 106.071 -1.825 . . . . 75.109999999999999 106.071 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.492 HG22 ' HB ' ' C' ' 275' ' ' VAL . 94.9 t -141.52 134.68 30.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.418 0.628 . . . . 74.209999999999994 110.766 -176.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.566 ' CG ' HD13 ' C' ' 276' ' ' LEU . 5.1 tp-100 -105.3 129.5 53.63 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.646 -1.242 . . . . 72.439999999999998 107.646 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.493 HD12 HG23 ' B' ' 277' ' ' ILE . 3.4 tm? -122.42 116.01 23.24 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.048 -1.834 . . . . 72.400000000000006 106.048 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.447 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 130.0 -111.07 1.11 Allowed Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 119.668 -1.253 . . . . 64.439999999999998 112.859 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.01 148.91 34.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.738 -0.467 . . . . 72.519999999999996 109.738 -174.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.515 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 91.6 t -126.94 114.94 39.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.852 -0.795 . . . . 75.120000000000005 108.852 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.87 111.77 37.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.859 -0.793 . . . . 74.340000000000003 108.859 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.3 m -85.56 160.97 19.52 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.548 -0.908 . . . . 60.5 108.548 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -63.09 -34.24 77.17 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 122.444 1.116 . . . . 63.119999999999997 109.294 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.92 -35.62 66.81 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 113.14 -1.846 . . . . 72.109999999999999 111.671 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.0 -26.19 62.13 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 116.383 -0.371 . . . . 54.009999999999998 111.387 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 90.2 mt -76.54 62.4 1.9 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.628 0.728 . . . . 72.200000000000003 112.012 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -96.21 -46.81 6.3 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.114 -1.81 . . . . 73.200000000000003 106.114 173.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -113.47 -142.99 8.41 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 110.558 -1.017 . . . . 65.25 110.558 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -170.27 102.43 0.18 Allowed Glycine 0 C--N 1.299 -1.479 0 N-CA-C 110.084 -1.207 . . . . 65.439999999999998 110.084 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 34.4 pt -122.94 164.09 20.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 112.165 0.431 . . . . 63.509999999999998 112.165 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -150.12 107.14 3.57 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 105.923 -1.88 . . . . 74.420000000000002 105.923 173.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 25.4 pt -124.61 149.28 28.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-O 121.563 0.696 . . . . 64.129999999999995 112.484 -173.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 22.8 t -95.42 -16.19 22.47 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.399 -0.963 . . . . 55.200000000000003 108.399 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 258' ' ' ASP . . . . . 0.443 ' HA ' ' CG1' ' C' ' 222' ' ' ILE . 12.0 t70 -78.89 80.01 5.26 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.299 1.047 . . . . 72.540000000000006 108.672 177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 259' ' ' GLN . . . . . 0.454 ' HB2' ' HA2' ' C' ' 224' ' ' GLY . 18.3 mm-40 -122.69 172.79 8.16 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 114.32 -1.309 . . . . 70.150000000000006 107.614 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 10.4 m -101.24 121.85 42.61 Favored 'General case' 0 N--CA 1.405 -2.676 0 N-CA-C 107.408 -1.33 . . . . 62.310000000000002 107.408 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -91.21 110.2 21.48 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 119.206 -0.998 . . . . 73.099999999999994 108.369 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -113.52 128.07 56.31 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.317 -0.856 . . . . 65.329999999999998 109.58 -176.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.2 m -117.61 123.25 45.73 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.033 -0.728 . . . . 75.319999999999993 109.033 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -117.67 148.74 20.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.178 -1.045 . . . . 74.329999999999998 108.178 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 43.0 tt0 -90.44 -84.66 0.23 Allowed 'General case' 0 N--CA 1.415 -2.184 0 C-N-CA 120.355 -0.538 . . . . 54.409999999999997 110.269 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 20.0 m -110.59 130.31 55.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.774 -0.77 . . . . 74.150000000000006 110.477 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.413 ' HB ' HG23 ' C' ' 231' ' ' ILE . 40.6 t -117.85 120.77 65.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.72 -1.215 . . . . 74.219999999999999 107.72 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 268' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.1 p -127.61 131.96 69.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 120.411 -0.515 . . . . 73.109999999999999 110.987 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.14 133.61 11.7 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 108.912 -1.675 . . . . 71.310000000000002 108.912 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -132.33 132.95 43.45 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.716 -0.846 . . . . 73.219999999999999 108.716 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.5 -125.23 10.21 Favored Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 120.428 -0.891 . . . . 41.409999999999997 111.346 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -91.84 97.55 11.05 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.521 -1.288 . . . . 74.319999999999993 107.521 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 33.4 m -127.61 145.07 51.0 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 113.45 0.907 . . . . 43.509999999999998 113.45 -175.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 34.5 mmm-85 -133.46 124.79 27.69 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 104.919 -2.252 . . . . 70.420000000000002 104.919 173.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.492 ' HB ' HG22 ' C' ' 239' ' ' VAL . 4.2 t -139.4 140.55 37.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 118.634 0.652 . . . . 61.32 109.729 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.685 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 5.1 tp -126.94 119.73 27.42 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-O 121.374 0.606 . . . . 72.209999999999994 109.397 172.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.405 HD12 HD13 ' C' ' 231' ' ' ILE . 54.9 mt -108.45 103.4 15.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 105.719 -1.956 . . . . 75.120000000000005 105.719 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 278' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 146.24 -146.71 17.05 Favored Glycine 0 N--CA 1.427 -1.944 0 C-N-CA 120.721 -0.752 . . . . 54.039999999999999 111.352 -175.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -121.72 140.33 52.45 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.577 -0.897 . . . . 62.049999999999997 108.577 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.527 ' HB2' HD21 ' C' ' 276' ' ' LEU . 36.0 tt0 -118.63 118.35 31.41 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.973 -0.751 . . . . 74.329999999999998 108.973 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -107.72 125.82 51.85 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 109.92 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 131.28 -129.25 5.66 Favored Glycine 0 N--CA 1.427 -1.935 0 C-N-CA 120.749 -0.738 . . . . 52.229999999999997 112.332 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -157.02 111.58 0.49 Allowed Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.52 -1.432 . . . . 62.450000000000003 109.52 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 63.56 38.14 9.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.957 0.903 . . . . 62.030000000000001 109.785 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -60.93 -68.15 1.8 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.355 -0.839 . . . . 65.420000000000002 113.53 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -89.72 -46.17 8.8 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.661 -0.496 . . . . 74.530000000000001 109.661 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.685 ' CH2' ' HB3' ' C' ' 276' ' ' LEU . 24.4 m-90 -94.22 105.25 17.24 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 116.101 -0.5 . . . . 71.109999999999999 109.892 177.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -99.91 102.63 14.08 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.37 1.081 . . . . 64.230000000000004 112.163 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -97.23 138.88 34.03 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 104.107 -2.553 . . . . 64.25 104.107 172.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -62.86 99.04 0.14 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.536 1.16 . . . . 65.540000000000006 111.736 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -138.13 -49.66 0.56 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.242 -1.762 . . . . 73.400000000000006 106.242 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 34.0 t60 54.92 67.37 1.03 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.471 -1.24 . . . . 52.219999999999999 111.077 176.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -143.82 -176.85 5.14 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.587 -0.894 . . . . 62.329999999999998 108.587 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -77.96 -7.33 56.66 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.72 0.772 . . . . 73.209999999999994 109.325 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 . . . . . 0 N--CA 1.423 -1.808 0 CA-C-N 115.291 -0.868 . . . . 61.409999999999997 110.46 179.874 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.584 0 CA-C-O 120.681 0.277 . . . . 65.209999999999994 110.308 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.433 ' HD2' ' H ' ' A' ' 218' ' ' LYS . 8.3 mptt -82.15 99.62 9.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.322 -1.732 . . . . 74.200000000000003 106.322 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.427 ' O ' HD12 ' A' ' 219' ' ' ILE 0.274 2.6 pp -78.68 124.85 37.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 113.31 0.855 . . . . 72.209999999999994 113.31 -174.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -142.77 169.48 17.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.647 -1.612 . . . . 75.200000000000003 106.647 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -102.84 -0.56 31.12 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 122.949 0.5 . . . . 43.140000000000001 111.301 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.6 tt -81.72 115.7 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.55 -0.907 . . . . 71.230000000000004 108.55 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 26.9 m -116.02 149.17 18.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.561 -0.745 . . . . 54.020000000000003 111.613 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 53.84 57.71 15.19 Favored Glycine 0 CA--C 1.507 -0.422 0 O-C-N 124.817 1.323 . . . . 63.240000000000002 113.486 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.74 124.47 43.61 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.618 -0.833 . . . . 74.299999999999997 110.877 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -80.84 131.86 35.42 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.017 -1.846 . . . . 73.049999999999997 106.017 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 10.6 m -120.98 137.88 54.42 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 120.061 -0.656 . . . . 73.109999999999999 111.484 -171.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.76 118.46 19.07 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.584 -1.636 . . . . 64.409999999999997 106.584 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.523 ' HE2' ' O ' ' A' ' 265' ' ' GLU . 5.7 tmmm? -86.36 -38.58 17.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.832 -0.433 . . . . 73.019999999999996 109.832 -176.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -143.82 138.77 28.93 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.142 -0.688 . . . . 61.409999999999997 109.142 174.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 60.7 mt -130.77 126.7 60.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 105.149 -2.167 . . . . 74.349999999999994 105.149 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.413 ' HE ' ' HB2' ' A' ' 232' ' ' ARG . 10.1 ttm180 -134.44 116.21 14.89 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.954 -0.758 . . . . 61.200000000000003 108.954 -177.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 31.3 p -123.42 127.74 48.86 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 110.121 -0.325 . . . . 74.230000000000004 110.121 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -144.65 145.97 32.02 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 120.86 0.362 . . . . 74.409999999999997 111.304 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 63.49 86.68 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.968 1.307 . . . . 75.439999999999998 113.989 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.51 26.43 16.06 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.014 -0.994 . . . . 74.219999999999999 111.865 177.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.49 144.64 27.16 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.825 -0.625 . . . . 63.109999999999999 109.855 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -127.24 135.49 50.69 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.932 -0.766 . . . . 74.420000000000002 108.932 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 3.3 p -132.98 145.21 34.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.952 0.882 . . . . 72.049999999999997 112.738 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -124.84 130.42 52.35 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.062 -1.458 . . . . 64.120000000000005 107.062 170.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -128.43 118.56 23.33 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.533 -1.284 . . . . 54.350000000000001 107.533 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.19 -116.79 1.8 Allowed Glycine 0 N--CA 1.427 -1.945 0 C-N-CA 119.603 -1.284 . . . . 31.539999999999999 114.123 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ASN . . . . . 0.426 ' OD1' HG13 ' A' ' 245' ' ' VAL . 15.6 t-20 -144.48 128.69 17.73 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 122.968 0.507 . . . . 75.049999999999997 110.178 -175.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 50.2 t -108.77 114.01 45.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.376 -0.602 . . . . 75.230000000000004 109.376 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' VAL . . . . . 0.43 HG12 ' HD2' ' A' ' 281' ' ' TYR . 15.7 m -103.33 121.82 55.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.885 -0.783 . . . . 71.209999999999994 108.885 175.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.587 ' OG1' ' HA3' ' A' ' 282' ' ' GLY . 24.0 p -92.64 160.63 14.92 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.591 -1.244 . . . . 51.520000000000003 111.18 176.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.27 -34.5 78.26 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 123.78 0.832 . . . . 71.140000000000001 112.564 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -70.14 -35.37 74.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.079 0.466 . . . . 65.219999999999999 111.959 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.612 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . -73.84 -39.15 64.21 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.704 -0.68 . . . . 64.109999999999999 111.201 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 5.0 mp 54.3 -98.27 0.08 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.18 1.392 . . . . 71.299999999999997 111.427 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -145.34 29.62 1.15 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.725 -1.213 . . . . 73.310000000000002 107.725 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -67.66 -27.21 73.6 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.708 -1.133 . . . . 74.329999999999998 111.633 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -78.77 73.56 2.26 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.578 -1.409 . . . . 73.439999999999998 109.578 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 13.6 tt -75.67 -33.99 27.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 124.273 1.029 . . . . 62.420000000000002 112.86 -173.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 255' ' ' ARG . 9.7 mmt85 -117.28 89.81 3.2 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.938 0.875 . . . . 73.109999999999999 112.37 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 9.3 tp -137.76 28.63 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 123.339 1.542 . . . . 43.340000000000003 107.365 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 13.2 m -98.83 36.17 1.72 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.259 -1.337 . . . . 74.109999999999999 110.038 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.559 ' HA ' ' O ' ' B' ' 254' ' ' ILE . 5.7 t70 -79.14 -178.33 6.1 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.288 -0.634 . . . . 65.450000000000003 109.288 -174.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -101.43 23.56 10.89 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.835 -0.541 . . . . 64.530000000000001 111.091 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.2 m -65.16 120.76 13.29 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.954 -0.758 . . . . 74.120000000000005 108.954 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 8.0 m -118.55 122.88 43.7 Favored 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 119.55 -0.86 . . . . 63.32 109.285 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -120.26 133.61 55.44 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.046 -1.094 . . . . 73.219999999999999 108.046 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 18.2 m -142.31 130.4 22.0 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.974 -0.454 . . . . 50.119999999999997 112.218 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -114.1 133.35 60.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 109.529 -0.545 . . . . 73.230000000000004 109.529 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.523 ' O ' ' HE2' ' A' ' 229' ' ' LYS . 71.5 mm-40 -78.4 -50.87 10.94 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 116.331 -0.395 . . . . 72.430000000000007 110.09 177.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 90.5 m -145.92 127.24 14.88 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.34 -0.85 . . . . 62.149999999999999 111.275 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.0 p -120.81 120.39 62.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.566 -0.743 . . . . 74.420000000000002 109.053 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.7 130.48 72.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.58 -0.737 . . . . 72.239999999999995 109.447 -175.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.42 131.92 8.56 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.293 -1.123 . . . . 72.519999999999996 110.293 174.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 22.8 tptt -134.01 116.7 15.83 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 110.057 -0.349 . . . . 73.549999999999997 110.057 -177.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.33 90.47 0.21 Allowed Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.33 -0.938 . . . . 70.200000000000003 113.303 174.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.498 ' HB3' ' NH1' ' A' ' 274' ' ' ARG . 19.5 mt-10 58.58 37.89 25.34 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.598 0.962 . . . . 72.219999999999999 113.598 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 15.5 m -88.43 143.7 26.83 Favored 'General case' 0 C--N 1.274 -2.682 0 C-N-CA 118.639 -1.224 . . . . 72.420000000000002 109.386 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' ARG . . . . . 0.498 ' NH1' ' HB3' ' A' ' 272' ' ' GLU . 9.2 mpt_? -116.6 127.03 54.11 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.369 -1.715 . . . . 71.439999999999998 106.369 174.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.551 HG12 ' CG1' ' B' ' 239' ' ' VAL . 17.2 m -126.41 123.42 63.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-O 121.458 0.647 . . . . 72.209999999999994 109.952 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 5.4 tt -113.57 111.77 22.43 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.744 -1.576 . . . . 55.210000000000001 106.744 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.623 HG23 HD12 ' B' ' 241' ' ' LEU . 60.0 mt -112.36 107.33 22.7 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 CA-C-O 121.612 0.72 . . . . 63.340000000000003 110.122 -177.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 137.61 -135.27 7.47 Favored Glycine 0 N--CA 1.426 -1.993 0 CA-C-N 115.533 -0.758 . . . . 61.219999999999999 112.139 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 3.1 m120 -104.09 134.34 47.51 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 112.06 0.392 . . . . 73.319999999999993 112.06 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -113.2 117.92 33.25 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 103.401 -2.814 . . . . 74.010000000000005 103.401 167.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 16.0 t80 -130.13 123.61 30.76 Favored 'General case' 0 C--O 1.264 1.818 0 CA-C-O 122.54 1.162 . . . . 73.120000000000005 113.514 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.612 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 129.98 -77.27 0.4 Allowed Glycine 0 N--CA 1.415 -2.734 0 CA-C-N 113.475 -1.693 . . . . 42.539999999999999 114.938 175.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -61.27 -81.74 0.08 OUTLIER Glycine 0 C--N 1.317 -0.508 0 N-CA-C 115.708 1.043 . . . . 72.430000000000007 115.708 -170.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -178.67 -35.95 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.122 -1.807 . . . . 73.019999999999996 106.122 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' B' ' 287' ' ' TRP . . . -158.35 -167.41 19.16 Favored Glycine 0 N--CA 1.401 -3.652 0 CA-C-N 113.73 -1.577 . . . . 74.239999999999995 109.541 176.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.416 ' HE1' ' CZ2' ' B' ' 287' ' ' TRP . 41.7 p90 -104.25 -169.66 1.66 Allowed 'General case' 0 C--N 1.294 -1.825 0 O-C-N 124.105 0.532 . . . . 72.129999999999995 110.468 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 27.8 p90 -53.02 104.2 0.09 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 124.455 1.102 . . . . 70.109999999999999 113.02 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -140.01 152.88 46.61 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.622 -1.622 . . . . 34.409999999999997 106.622 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.79 -29.91 63.66 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 123.143 0.277 . . . . 73.340000000000003 110.287 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.454 ' NE2' ' HA ' ' B' ' 289' ' ' ASN . 42.1 t-80 58.46 75.43 0.39 Allowed 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.003 1.321 . . . . 71.239999999999995 108.665 -175.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -82.12 155.2 25.15 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.868 -1.06 . . . . 74.120000000000005 110.16 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -77.19 105.6 8.39 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.339 -0.846 . . . . 75.439999999999998 109.688 -176.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -124.54 102.6 7.71 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.253 -0.647 . . . . 72.319999999999993 109.253 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -171.66 17.72 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.41 0.893 . . . . 75.409999999999997 113.41 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 . . . . . 0 C--O 1.261 1.685 0 N-CA-C 107.979 -1.119 . . . . 74.420000000000002 107.979 175.641 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.469 0.495 0 CA-C-O 120.742 0.306 . . . . 73.319999999999993 111.083 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -124.81 134.46 52.75 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 122.331 0.252 . . . . 65.019999999999996 110.359 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 7.2 tp -128.36 -40.39 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.603 -0.888 . . . . 73.230000000000004 108.603 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 219' ' ' ILE . 16.5 t70 57.23 -92.73 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.845 1.258 . . . . 72.010000000000005 111.542 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -180.0 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.242 -1.762 . . . . 73.019999999999996 106.242 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' ILE . . . . . 0.502 HD11 ' HD2' ' B' ' 225' ' ' ARG . 17.7 tt -107.32 113.05 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 CA-C-O 122.204 1.002 . . . . 51.329999999999998 111.085 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.476 ' CG2' HH12 ' C' ' 255' ' ' ARG . 1.9 m -140.93 119.62 10.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 114.568 -1.196 . . . . 71.450000000000003 110.075 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.15 72.18 1.29 Allowed Glycine 0 C--N 1.308 -0.994 0 N-CA-C 109.674 -1.37 . . . . 75.409999999999997 109.674 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 261' ' ' THR . 14.7 ttt180 -108.94 121.81 45.91 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.128 -0.536 . . . . 71.409999999999997 111.707 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -85.92 126.34 34.02 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.213 -2.143 . . . . 40.439999999999998 105.213 171.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 227' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' B' ' 263' ' ' SER . 18.7 m -121.25 136.61 54.94 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.789 -0.765 . . . . 74.010000000000005 111.746 -174.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.62 119.19 26.43 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.474 -1.306 . . . . 74.409999999999997 107.474 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.582 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 33.5 ttmt -75.74 -61.73 1.82 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.059 -0.719 . . . . 73.209999999999994 109.059 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -128.32 137.7 52.05 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 109.373 -0.602 . . . . 74.230000000000004 109.373 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.451 ' HA ' HG13 ' B' ' 267' ' ' VAL . 40.0 mt -128.6 128.16 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.791 0 N-CA-C 104.956 -2.238 . . . . 44.039999999999999 104.956 174.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.513 ' HB3' HG12 ' B' ' 268' ' ' VAL . 16.0 ttm180 -132.25 114.09 14.03 Favored 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 108.537 -0.912 . . . . 73.030000000000001 108.537 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 45.7 p -110.04 127.89 55.1 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.243 -1.762 . . . . 72.230000000000004 106.243 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 234' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' B' ' 270' ' ' LYS . 48.4 mt-10 -143.31 140.5 30.61 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.007 -0.738 . . . . 74.040000000000006 109.007 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 60.89 97.66 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 O-C-N 124.032 0.833 . . . . 61.450000000000003 113.212 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.535 ' HB2' ' H ' ' B' ' 272' ' ' GLU . 2.0 mpt_? 60.37 22.61 12.15 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.031 0.533 . . . . 61.399999999999999 111.533 173.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.58 140.53 33.63 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.189 0.519 . . . . 54.25 110.895 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.94 134.76 46.01 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.685 -0.688 . . . . 74.549999999999997 109.498 178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.582 HG23 ' HB ' ' B' ' 275' ' ' VAL . 7.2 p -137.53 150.01 25.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.271 0.558 . . . . 31.309999999999999 110.204 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.485 HE22 ' N ' ' B' ' 243' ' ' ASN . 22.5 tm0? -122.63 128.13 50.26 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 105.663 -1.977 . . . . 54.140000000000001 105.663 170.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.623 HD12 HG23 ' A' ' 277' ' ' ILE . 3.3 tm? -118.33 117.91 30.37 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.16 -2.163 . . . . 74.540000000000006 105.16 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.437 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 143.19 -125.56 2.6 Favored Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 118.695 -1.717 . . . . 43.439999999999998 112.852 -178.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.533 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 2.8 t-20 -144.44 128.22 17.28 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 110.292 -0.262 . . . . 74.019999999999996 110.292 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.418 HG21 ' HZ3' ' B' ' 287' ' ' TRP . 30.0 t -99.54 128.0 51.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.105 -1.442 . . . . 74.340000000000003 107.105 177.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 10.5 t -122.51 116.07 47.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 107.381 -1.34 . . . . 74.230000000000004 107.381 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.9 p -85.02 158.07 20.57 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 117.1 -1.84 . . . . 72.25 111.065 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -66.57 -47.1 73.85 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.61 1.195 . . . . 71.310000000000002 110.035 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.81 -33.49 61.6 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.243 -2.253 . . . . 51.219999999999999 113.795 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.532 ' HB2' ' HA3' ' B' ' 282' ' ' GLY . . . -58.7 -42.84 89.54 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.078 0.551 . . . . 53.240000000000002 111.171 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 90.7 mt 65.68 -69.05 0.11 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.807 1.243 . . . . 72.340000000000003 112.549 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -154.18 166.67 32.38 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.067 -0.515 . . . . 71.310000000000002 110.12 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 171.83 -63.37 0.15 Allowed Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 109.771 -1.331 . . . . 71.450000000000003 109.771 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -95.15 147.61 18.67 Favored Glycine 0 C--N 1.303 -1.284 0 CA-C-N 115.362 -0.419 . . . . 73.200000000000003 112.063 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 254' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 258' ' ' ASP . 54.1 mt -138.8 -45.66 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 107.396 -1.335 . . . . 45.43 107.396 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.96 62.4 0.35 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.358 1.075 . . . . 73.340000000000003 108.323 169.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 10.5 tp -128.18 5.77 3.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.22 -0.9 . . . . 73.430000000000007 112.233 -174.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 24.6 m -65.9 98.41 0.41 Allowed 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 107.848 -1.167 . . . . 71.340000000000003 107.848 173.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.28 146.73 46.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.187 -0.461 . . . . 42.43 110.634 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -76.29 71.77 3.01 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.83 0.824 . . . . 70.120000000000005 112.025 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 15.4 m -101.29 120.64 40.56 Favored 'General case' 0 N--CA 1.399 -2.996 0 N-CA-C 103.618 -2.734 . . . . 63.32 103.618 170.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 13.9 m -94.47 108.44 20.38 Favored 'General case' 0 N--CA 1.417 -2.114 0 C-N-CA 119.208 -0.997 . . . . 74.099999999999994 109.446 -175.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -104.19 128.54 51.92 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.147 -1.057 . . . . 72.010000000000005 108.147 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 263' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' B' ' 227' ' ' SER . 38.6 t -142.78 136.09 28.51 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-O 121.074 0.464 . . . . 73.109999999999999 111.747 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 9.4 p -116.39 137.25 50.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.982 -0.554 . . . . 74.510000000000005 110.076 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.582 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 31.7 mm-40 -78.02 -57.44 3.79 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.866 -0.79 . . . . 75.200000000000003 108.866 176.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 88.0 m -146.96 126.98 13.65 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.661 0.743 . . . . 73.010000000000005 111.387 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' B' ' 231' ' ' ILE . 1.3 p -121.91 120.51 61.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.271 -0.877 . . . . 73.430000000000007 109.603 176.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 268' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' B' ' 232' ' ' ARG . 34.2 m -121.06 145.59 27.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 116.044 -0.526 . . . . 73.219999999999999 110.194 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 269' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -143.82 132.79 5.06 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 120.097 -1.049 . . . . 43.520000000000003 112.4 176.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' B' ' 234' ' ' GLU . 65.0 mttm -133.92 131.01 38.56 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.724 0.81 . . . . 73.319999999999993 112.319 176.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.03 86.57 0.59 Allowed Glycine 0 C--N 1.296 -1.679 0 N-CA-C 114.476 0.551 . . . . 54.219999999999999 114.476 172.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 272' ' ' GLU . . . . . 0.535 ' H ' ' HB2' ' B' ' 236' ' ' ARG . 65.3 mm-40 65.95 27.65 10.76 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 112.193 0.442 . . . . 74.439999999999998 112.193 173.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 12.9 m -83.54 143.15 30.37 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.29 0.567 . . . . 74.109999999999999 110.149 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.539 ' HB2' ' HG3' ' C' ' 238' ' ' ARG . 10.9 mpt_? -123.47 127.63 48.66 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.521 -1.659 . . . . 64.5 106.521 174.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.582 ' HB ' HG23 ' B' ' 239' ' ' VAL . 5.9 t -127.41 133.9 66.91 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 108.45 -0.945 . . . . 65.439999999999998 108.45 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 4.4 tt -121.99 112.82 18.75 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.011 -1.477 . . . . 73.129999999999995 107.011 171.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.675 HG23 HD12 ' C' ' 241' ' ' LEU . 39.4 mt -112.83 107.0 21.87 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 109.131 -0.692 . . . . 62.520000000000003 109.131 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 149.95 -137.58 6.28 Favored Glycine 0 N--CA 1.405 -3.38 0 C-N-CA 119.948 -1.12 . . . . 41.229999999999997 112.188 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 279' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 27.7 t-20 -119.03 133.18 55.97 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.998 -0.601 . . . . 44.420000000000002 110.133 -178.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -109.89 118.64 37.01 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 104.603 -2.369 . . . . 74.239999999999995 104.603 177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -120.05 123.43 43.39 Favored 'General case' 0 C--O 1.274 2.369 0 CA-C-O 122.535 1.16 . . . . 73.5 110.379 -172.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' B' ' 249' ' ' ALA . . . 111.91 -55.66 0.5 Allowed Glycine 0 N--CA 1.398 -3.9 0 CA-C-N 114.064 -1.425 . . . . 53.130000000000003 115.385 172.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.43 -97.91 0.03 OUTLIER Glycine 0 C--N 1.313 -0.737 0 N-CA-C 115.655 1.022 . . . . 72.299999999999997 115.655 -171.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 42.8 tptt 173.92 -42.06 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 103.94 -2.615 . . . . 72.319999999999993 103.94 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -147.09 161.68 28.49 Favored Glycine 1 N--CA 1.387 -4.591 0 N-CA-C 106.215 -2.754 . . . . 62.240000000000002 106.215 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -83.4 -153.63 0.14 Allowed 'General case' 0 C--N 1.278 -2.509 0 O-C-N 124.358 0.681 . . . . 75.150000000000006 110.56 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.5 ' HE1' ' HB3' ' B' ' 274' ' ' ARG . 34.4 p90 -64.66 43.5 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.756 1.623 . . . . 65.140000000000001 113.629 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -76.34 170.18 16.83 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.031 -1.1 . . . . 62.340000000000003 108.031 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 289' ' ' ASN . . . . . 0.454 ' HA ' ' NE2' ' A' ' 290' ' ' HIS . 16.0 m120 -86.24 26.95 0.97 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 114.616 1.339 . . . . 73.439999999999998 114.616 -165.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 32.6 m170 62.99 80.42 0.23 Allowed 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 124.653 1.181 . . . . 71.439999999999998 113.431 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -111.0 -32.42 6.81 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.074 -1.824 . . . . 64.349999999999994 106.074 171.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 19.7 t60 59.46 -88.9 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.965 1.706 . . . . 74.230000000000004 112.525 171.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -115.53 40.09 2.82 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.384 0.612 . . . . 72.120000000000005 109.576 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 51.0 t60 -76.04 82.86 2.9 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.723 -1.214 . . . . 70.299999999999997 107.723 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 . . . . . 0 C--N 1.295 -1.793 0 CA-C-N 114.885 -1.052 . . . . 72.310000000000002 108.55 -174.063 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 46.7 ttm . . . . . 0 C--O 1.218 -0.562 0 N-CA-C 109.765 -0.457 . . . . 73.040000000000006 109.765 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -145.48 113.13 6.33 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.413 -0.958 . . . . 71.219999999999999 108.413 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 65.1 mt -148.36 144.01 18.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.842 -1.54 . . . . 72.129999999999995 106.842 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -86.35 -56.62 3.35 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.243 0.474 . . . . 53.240000000000002 109.99 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -141.18 137.19 32.49 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.09 -1.078 . . . . 43.530000000000001 108.09 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 13.9 tt -116.81 118.86 60.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.102 0.477 . . . . 71.439999999999998 111.91 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 22.0 m -134.11 151.52 32.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.935 -0.765 . . . . 65.349999999999994 108.935 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 57.26 65.81 3.3 Favored Glycine 0 C--N 1.335 0.526 0 O-C-N 124.095 0.872 . . . . 62.509999999999998 112.071 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' B' ' 261' ' ' THR . 47.5 ttt180 -97.72 121.48 39.68 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.513 -0.475 . . . . 71.329999999999998 111.301 -177.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -93.23 124.93 37.56 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 104.962 -2.236 . . . . 75.120000000000005 104.962 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' B' ' 263' ' ' SER . 8.1 m -121.69 136.22 54.95 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.976 -0.689 . . . . 71.120000000000005 110.856 -174.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.38 119.02 30.92 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.829 -1.545 . . . . 70.430000000000007 106.829 174.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.543 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.8 OUTLIER -82.17 -54.72 5.04 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 116.301 -0.409 . . . . 74.140000000000001 109.958 -174.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -131.46 137.41 48.58 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.462 -1.31 . . . . 71.200000000000003 107.462 173.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.433 ' HA ' HG13 ' C' ' 267' ' ' VAL . 30.8 mt -130.73 128.79 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 104.983 -2.228 . . . . 73.319999999999993 104.983 174.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.491 ' HB3' HG12 ' C' ' 268' ' ' VAL . 10.7 ttm180 -133.05 113.85 13.26 Favored 'General case' 0 N--CA 1.401 -2.896 0 N-CA-C 108.758 -0.831 . . . . 72.319999999999993 108.758 -176.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.44 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 40.9 p -110.79 126.22 54.39 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.856 -1.164 . . . . 63.530000000000001 107.856 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 48.4 mt-10 -145.14 142.24 29.45 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 110.271 -0.27 . . . . 75.340000000000003 110.271 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 64.49 89.59 0.09 Allowed 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.437 1.085 . . . . 61.350000000000001 113.113 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.459 ' HB2' ' H ' ' C' ' 272' ' ' GLU . 4.8 mpt_? 64.75 15.99 10.13 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.993 -1.003 . . . . 71.430000000000007 112.026 174.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.47 140.97 28.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.289 0.566 . . . . 64.219999999999999 112.481 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.539 ' HG3' ' HB2' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -128.47 135.75 49.89 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.021 -0.733 . . . . 70.519999999999996 109.021 178.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' C' ' 275' ' ' VAL . 7.1 p -138.85 147.53 24.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.452 0.644 . . . . 72.530000000000001 111.469 -177.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.35 132.54 56.57 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 104.506 -2.405 . . . . 74.120000000000005 104.506 172.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.675 HD12 HG23 ' B' ' 277' ' ' ILE . 3.4 tm? -129.68 117.79 20.88 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 106.319 -1.734 . . . . 72.120000000000005 106.319 177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.31 -117.65 1.66 Allowed Glycine 0 N--CA 1.426 -1.999 0 C-N-CA 119.912 -1.137 . . . . 64.049999999999997 112.474 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.6 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 18.1 t-20 -144.4 134.33 23.91 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.798 0.333 . . . . 65.430000000000007 111.435 -176.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.31 123.61 68.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.49 -0.93 . . . . 74.310000000000002 108.49 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.456 HG13 ' OD1' ' C' ' 243' ' ' ASN . 31.5 m -121.43 117.2 51.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-O 121.625 0.726 . . . . 72.109999999999999 109.143 177.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 246' ' ' THR . . . . . 0.526 ' OG1' ' HA3' ' C' ' 282' ' ' GLY . 12.4 p -83.76 158.55 21.7 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 117.871 -1.532 . . . . 63.130000000000003 109.969 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.93 89.73 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.934 1.35 . . . . 71.109999999999999 108.632 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.19 62.36 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 112.374 -2.193 . . . . 34.100000000000001 112.826 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -59.4 -35.0 73.15 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 112.908 0.707 . . . . 74.329999999999998 112.908 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 96.5 mt 64.53 -178.92 0.17 Allowed 'General case' 0 C--O 1.247 0.964 0 O-C-N 124.235 0.959 . . . . 73.25 110.842 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -104.3 140.5 37.78 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 120.54 -0.464 . . . . 74.329999999999998 110.206 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -87.39 -162.2 37.5 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 111.314 -0.714 . . . . 63.340000000000003 111.314 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -100.45 83.69 0.55 Allowed Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 121.019 -0.61 . . . . 72.310000000000002 111.991 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 66.2 mt 72.04 148.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 C-N-CA 123.871 0.868 . . . . 74.319999999999993 111.145 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 255' ' ' ARG . . . . . 0.476 HH12 ' CG2' ' B' ' 223' ' ' VAL . 59.5 mtp180 -66.74 149.74 50.09 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.89 0.876 . . . . 75.140000000000001 109.703 -175.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 29.5 pt -121.23 -37.73 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 113.837 1.051 . . . . 71.030000000000001 113.837 -173.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 87.2 p 68.91 130.53 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 127.121 2.168 . . . . 74.099999999999994 113.018 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -97.69 148.87 22.89 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.026 -1.472 . . . . 74.150000000000006 107.026 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -109.26 5.21 23.51 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.032 0.753 . . . . 73.450000000000003 113.032 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 37.8 p -82.26 131.55 35.23 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 119.855 -0.738 . . . . 75.349999999999994 111.383 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 261' ' ' THR . . . . . 0.457 HG22 ' H ' ' C' ' 225' ' ' ARG . 11.2 p -102.46 108.74 20.16 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.861 -0.609 . . . . 72.409999999999997 110.706 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -97.89 138.81 34.68 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.213 -1.402 . . . . 73.129999999999995 107.213 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 45.6 m -142.58 136.12 28.91 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.639 -0.663 . . . . 54.030000000000001 111.11 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.96 130.56 74.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.101 -0.703 . . . . 64.329999999999998 109.101 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 5.5 mm-40 -75.09 -47.14 30.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.051 0.453 . . . . 65.540000000000006 110.904 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 69.8 m -150.41 127.88 11.47 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 122.005 -0.434 . . . . 74.109999999999999 110.623 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' C' ' 231' ' ' ILE . 1.1 p -126.1 119.8 55.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.983 -0.747 . . . . 75.109999999999999 108.983 174.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 268' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' C' ' 232' ' ' ARG . 25.8 m -121.04 144.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.262 -0.644 . . . . 75.340000000000003 109.262 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.33 132.42 6.65 Favored Glycine 0 CA--C 1.473 -2.558 0 N-CA-C 110.705 -0.958 . . . . 52.530000000000001 110.705 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.59 128.83 36.0 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 109.499 -0.556 . . . . 75.310000000000002 109.499 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.6 75.49 1.15 Allowed Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.357 -0.925 . . . . 44.450000000000003 113.718 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 272' ' ' GLU . . . . . 0.459 ' H ' ' HB2' ' C' ' 236' ' ' ARG . 53.1 mt-10 60.52 40.81 16.53 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.389 0.676 . . . . 61.219999999999999 112.269 175.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.4 m -81.98 143.81 31.33 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 119.221 -0.992 . . . . 73.0 109.482 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 274' ' ' ARG . . . . . 0.445 ' HB3' ' HE1' ' C' ' 287' ' ' TRP . 1.3 mpp_? -120.2 127.0 52.04 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.545 -1.65 . . . . 73.129999999999995 106.545 173.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' C' ' 239' ' ' VAL . 3.0 t -135.54 140.18 45.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 109.315 -0.624 . . . . 62.509999999999998 109.315 -175.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.534 HD12 ' CZ3' ' C' ' 287' ' ' TRP . 4.0 tt -128.17 115.6 18.64 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.145 -1.798 . . . . 64.400000000000006 106.145 170.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.416 HD12 HD13 ' C' ' 231' ' ' ILE . 56.7 mt -112.73 104.31 16.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.047 -1.464 . . . . 74.540000000000006 107.047 176.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.12 -139.5 6.72 Favored Glycine 0 N--CA 1.403 -3.507 0 C-N-CA 119.89 -1.147 . . . . 71.109999999999999 111.476 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 279' ' ' ASN . . . . . 0.456 ' HB3' HD22 ' C' ' 243' ' ' ASN . 28.5 t-20 -122.87 130.29 52.69 Favored 'General case' 0 C--N 1.279 -2.466 0 O-C-N 123.807 0.357 . . . . 64.519999999999996 110.237 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.88 117.9 34.64 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.618 -1.623 . . . . 75.040000000000006 106.618 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -124.77 123.94 41.06 Favored 'General case' 0 C--O 1.272 2.245 0 CA-C-O 122.394 1.092 . . . . 72.319999999999993 111.794 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 282' ' ' GLY . . . . . 0.526 ' HA3' ' OG1' ' C' ' 246' ' ' THR . . . 128.2 -53.91 0.79 Allowed Glycine 0 N--CA 1.419 -2.459 0 CA-C-N 114.193 -1.367 . . . . 63.409999999999997 113.515 178.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -80.48 -97.62 0.35 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.493 -0.86 . . . . 74.519999999999996 114.104 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 52.5 tttp 170.43 -34.11 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 104.877 -2.268 . . . . 74.109999999999999 104.877 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -143.05 156.31 26.4 Favored Glycine 0 N--CA 1.404 -3.442 0 N-CA-C 106.479 -2.649 . . . . 52.039999999999999 106.479 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -89.08 -166.09 1.51 Allowed 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 117.258 0.529 . . . . 70.340000000000003 109.719 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.534 ' CZ3' HD12 ' C' ' 276' ' ' LEU . 43.4 p90 -53.97 144.9 17.8 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 123.409 0.684 . . . . 64.409999999999997 110.756 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 288' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' C' ' 287' ' ' TRP . 2.4 m-20 75.01 -81.35 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.508 0.723 . . . . 74.209999999999994 111.527 -176.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -161.77 159.67 27.39 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.489 -0.93 . . . . 72.219999999999999 108.489 -173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -78.53 94.89 5.05 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.229 -1.026 . . . . 75.230000000000004 108.229 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -86.32 -57.67 2.92 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.606 -0.725 . . . . 74.239999999999995 109.831 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -143.63 165.26 28.12 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.16 -0.681 . . . . 74.519999999999996 109.16 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -162.09 -69.89 0.05 Allowed 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.928 -1.138 . . . . 75.129999999999995 107.928 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -131.1 145.87 52.15 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.587 -0.894 . . . . 63.219999999999999 108.587 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 C--N 1.285 -2.206 0 N-CA-C 106.462 -1.681 . . . . 73.510000000000005 106.462 175.267 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 83.0 mtp . . . . . 0 CA--C 1.5 -0.945 0 N-CA-C 108.11 -1.07 . . . . 52.329999999999998 108.11 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -130.76 -65.38 0.79 Allowed 'General case' 0 C--N 1.316 -0.89 0 O-C-N 123.234 0.334 . . . . 72.310000000000002 110.638 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.9 mt 68.84 104.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.06 0.944 . . . . 73.549999999999997 111.937 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 7.0 t70 66.97 -156.7 0.23 Allowed 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.22 -1.355 . . . . 74.019999999999996 108.407 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -125.41 30.34 5.81 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.935 -0.765 . . . . 74.510000000000005 108.935 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 50.2 mm -83.56 121.71 36.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.639 -0.71 . . . . 70.510000000000005 110.627 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.95 119.59 57.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.1 0.476 . . . . 62.509999999999998 111.239 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 52.07 52.48 35.4 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 114.487 -1.233 . . . . 51.310000000000002 115.738 174.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 225' ' ' ARG . 24.5 mmt180 -100.57 134.3 43.74 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.616 0.722 . . . . 72.409999999999997 111.318 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.484 ' HB2' ' OD1' ' A' ' 262' ' ' ASN . 23.4 p-10 -116.88 156.0 28.09 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 125.23 1.412 . . . . 71.120000000000005 111.675 -173.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 263' ' ' SER . 23.4 m -116.99 136.53 52.87 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 108.813 -0.81 . . . . 63.030000000000001 108.813 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.7 135.34 43.98 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.267 -0.879 . . . . 70.409999999999997 110.285 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 1.9 tmtp? -87.84 -63.93 1.23 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.723 -0.671 . . . . 63.130000000000003 110.367 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -131.03 139.03 49.89 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.166 -0.334 . . . . 61.509999999999998 110.52 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.6 mt -137.8 128.15 36.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.029 -1.471 . . . . 73.319999999999993 107.029 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.467 ' HB2' HG12 ' A' ' 268' ' ' VAL . 65.0 mtt180 -134.41 115.14 13.67 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.437 -0.505 . . . . 71.430000000000007 109.706 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.505 HG21 ' HB ' ' A' ' 239' ' ' VAL . 28.9 p -118.95 128.31 54.29 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.415 -0.514 . . . . 74.349999999999994 109.868 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.3 153.29 46.42 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.904 -0.406 . . . . 55.32 109.904 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 63.46 83.44 0.16 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.603 1.161 . . . . 71.5 113.036 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 236' ' ' ARG . 6.1 mpt_? 58.83 22.79 10.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.913 1.285 . . . . 73.109999999999999 112.436 176.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.6 142.03 27.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 122.173 -0.329 . . . . 34.149999999999999 110.445 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.75 137.16 53.8 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.825 -0.435 . . . . 72.040000000000006 109.825 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.505 ' HB ' HG21 ' A' ' 233' ' ' THR . 3.1 p -129.16 142.59 43.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.453 0.644 . . . . 44.439999999999998 111.777 -176.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -125.99 125.38 42.6 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 108.496 -0.928 . . . . 72.439999999999998 108.496 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.422 ' HA ' HG13 ' A' ' 277' ' ' ILE . 59.7 tp -115.88 123.87 49.22 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.454 -0.943 . . . . 74.239999999999995 108.454 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.564 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 121.09 -123.54 5.57 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.382 -0.913 . . . . 71.299999999999997 112.166 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 279' ' ' ASN . 20.8 t30 -141.76 128.57 20.51 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 122.196 -0.591 . . . . 61.43 111.524 -174.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 51.3 t -104.11 122.45 56.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.201 -1.407 . . . . 73.430000000000007 107.201 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.7 t -118.17 116.26 50.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.401 -0.592 . . . . 60.439999999999998 109.401 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.3 t -114.34 162.1 17.05 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 119.977 -0.689 . . . . 71.5 109.393 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.37 -32.0 62.24 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 114.862 1.43 . . . . 75.430000000000007 114.862 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.41 -37.54 65.19 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.823 1.416 . . . . 71.340000000000003 114.823 -173.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.11 -25.93 55.9 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.542 0.571 . . . . 62.219999999999999 112.542 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 69.26 -94.22 0.03 OUTLIER 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.232 1.013 . . . . 75.099999999999994 109.131 -170.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 171.33 139.04 0.03 OUTLIER 'General case' 0 C--O 1.247 0.967 0 C-N-CA 124.638 1.175 . . . . 72.230000000000004 108.674 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -159.28 171.74 35.83 Favored Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 110.77 -0.932 . . . . 64.340000000000003 110.77 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -70.91 124.0 11.33 Favored Glycine 0 CA--C 1.498 -0.985 0 N-CA-C 109.705 -1.358 . . . . 72.140000000000001 109.705 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 8.8 tp -134.59 118.33 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 121.773 0.797 . . . . 64.340000000000003 112.719 -172.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.43 149.74 33.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.26 -0.882 . . . . 73.140000000000001 109.837 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.471 ' HB ' HG23 ' B' ' 223' ' ' VAL . 4.0 mm -156.27 -36.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 112.515 0.561 . . . . 72.129999999999995 112.515 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 25.2 t -151.54 96.0 2.2 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.063 -1.458 . . . . 45.32 107.063 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.42 ' HB3' ' HA ' ' B' ' 220' ' ' ASP . 11.0 m-20 -84.41 -1.07 54.99 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.745 -1.116 . . . . 75.150000000000006 113.722 -166.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -104.59 -21.93 13.34 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.587 0.708 . . . . 73.299999999999997 110.289 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' B' ' 225' ' ' ARG . 29.6 p -91.72 138.55 31.47 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 113.943 1.09 . . . . 74.310000000000002 113.943 -169.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.4 t -120.19 143.28 48.33 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.543 -1.28 . . . . 73.109999999999999 107.543 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 25.0 t-20 -86.45 121.45 29.01 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 119.847 -0.741 . . . . 73.349999999999994 109.378 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 227' ' ' SER . 50.8 m -142.32 132.77 25.09 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.554 -0.748 . . . . 72.540000000000006 111.079 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.4 p -126.82 138.22 55.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.603 -0.272 . . . . 73.340000000000003 111.6 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 55.3 mm-40 -78.11 -66.48 0.84 Allowed 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 116.031 -0.532 . . . . 74.230000000000004 110.825 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 30.1 m -133.63 126.97 32.01 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.23 -0.588 . . . . 73.519999999999996 110.41 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.72 121.68 55.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.637 -0.711 . . . . 75.099999999999994 109.601 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 232' ' ' ARG . 15.9 m -126.05 146.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-O 121.112 0.482 . . . . 74.430000000000007 111.568 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -130.02 131.26 6.54 Favored Glycine 0 N--CA 1.425 -2.073 0 N-CA-C 109.096 -1.601 . . . . 61.119999999999997 109.096 174.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.498 ' HB2' ' HG2' ' B' ' 234' ' ' GLU . 29.8 mmmt -133.25 116.14 15.82 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 120.565 0.221 . . . . 44.32 110.946 -176.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 83.68 84.05 0.91 Allowed Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 119.314 -1.422 . . . . 42.420000000000002 113.657 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 60.2 27.27 16.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.88 0.872 . . . . 73.530000000000001 111.74 171.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 17.4 m -84.11 145.49 28.4 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.281 0.563 . . . . 63.439999999999998 110.85 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -113.2 127.44 56.18 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.989 -1.856 . . . . 74.099999999999994 105.989 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 1.2 p -133.66 123.1 44.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-O 121.379 0.609 . . . . 70.129999999999995 111.418 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.529 HD23 ' CH2' ' A' ' 287' ' ' TRP . 18.3 tp -117.03 119.37 35.06 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.489 -0.93 . . . . 73.209999999999994 108.489 174.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.51 HG22 ' HB3' ' B' ' 241' ' ' LEU . 2.7 pt -113.67 104.91 17.73 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.146 0 CA-C-N 114.194 -1.367 . . . . 62.409999999999997 109.505 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 149.09 -122.78 1.51 Allowed Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.941 -0.572 . . . . 71.239999999999995 113.036 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 243' ' ' ASN . 9.8 t30 -129.75 135.31 48.31 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 122.232 -0.569 . . . . 62.240000000000002 111.673 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.493 ' HG2' ' NE1' ' A' ' 287' ' ' TRP . 7.2 tp10 -111.75 118.27 35.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 105.854 -1.906 . . . . 75.530000000000001 105.854 174.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -117.8 123.13 45.2 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 105.721 -1.955 . . . . 75.430000000000007 105.721 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 121.82 -48.51 0.94 Allowed Glycine 0 C--N 1.284 -2.335 0 N-CA-C 108.192 -1.963 . . . . 50.409999999999997 108.192 -172.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 99.52 16.39 29.41 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 120.809 -0.71 . . . . 73.239999999999995 112.112 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.454 ' HB3' ' NZ ' ' A' ' 284' ' ' LYS . 0.1 OUTLIER 176.82 66.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.849 0.859 . . . . 63.520000000000003 112.728 178.302 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -109.72 -51.22 0.66 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 109.633 -1.387 . . . . 70.109999999999999 109.633 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -96.73 -5.82 37.76 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.243 0.544 . . . . 71.150000000000006 110.591 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.603 ' CH2' ' HB2' ' B' ' 240' ' ' GLN . 2.5 m95 -69.06 152.16 45.55 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 114.526 1.306 . . . . 75.299999999999997 114.526 -174.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -138.14 140.72 40.0 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 113.611 -1.631 . . . . 64.409999999999997 107.342 -174.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -140.09 155.14 47.15 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.164 -0.31 . . . . 50.43 110.164 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -147.72 3.6 0.74 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.705 0.402 . . . . 75.129999999999995 110.289 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -106.25 149.76 26.56 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.963 0.411 . . . . 74.120000000000005 111.591 -172.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -143.2 167.94 20.95 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.395 -1.335 . . . . 74.329999999999998 107.395 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -146.61 -42.2 0.19 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.224 0.535 . . . . 74.519999999999996 110.806 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -107.81 -53.02 2.68 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.459 -0.941 . . . . 54.210000000000001 108.459 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 34.4 m170 . . . . . 0 C--N 1.304 -1.378 0 N-CA-C 107.199 -1.408 . . . . 60.439999999999998 107.199 176.498 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 N-CA-C 109.649 -0.5 . . . . 50.439999999999998 109.649 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 40.6 tttm 75.0 124.45 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.921 1.289 . . . . 70.239999999999995 111.713 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 52.0 mt -129.69 -74.85 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 105.799 -1.926 . . . . 64.310000000000002 105.799 174.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' ASP . . . . . 0.42 ' HA ' ' HB3' ' A' ' 258' ' ' ASP . 25.1 m-20 66.88 -173.71 0.19 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.83 -1.532 . . . . 63.340000000000003 108.65 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 64.29 27.19 13.79 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.966 0.906 . . . . 75.549999999999997 111.339 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 59.4 mt -94.82 138.48 20.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.756 0.789 . . . . 75.519999999999996 109.903 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.592 HG22 ' ND2' ' B' ' 243' ' ' ASN . 14.1 p -101.0 119.32 48.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 121.244 -0.91 . . . . 72.209999999999994 112.143 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 31.78 83.85 0.01 OUTLIER Glycine 0 N--CA 1.48 1.608 0 C-N-CA 126.164 1.84 . . . . 31.420000000000002 117.472 171.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.558 ' O ' ' HB ' ' A' ' 260' ' ' THR . 17.6 mmt180 -118.35 138.77 52.19 Favored 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 118.025 0.912 . . . . 75.200000000000003 111.564 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.612 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 21.2 p-10 -118.23 155.34 30.71 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 125.328 1.451 . . . . 75.209999999999994 114.27 -174.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 227' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' B' ' 263' ' ' SER . 20.7 m -117.38 135.93 53.52 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 122.362 1.077 . . . . 72.120000000000005 108.149 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -134.06 139.21 45.83 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.004 -0.998 . . . . 62.450000000000003 109.695 -174.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 37.2 ttmt -86.58 -65.53 1.0 Allowed 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.832 -0.622 . . . . 71.239999999999995 110.747 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -126.24 137.83 53.56 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.148 -1.021 . . . . 73.239999999999995 110.489 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 44.9 mt -135.39 121.74 32.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.425 -1.324 . . . . 71.310000000000002 107.425 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 58.4 mtt180 -128.17 114.85 17.52 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.804 -0.813 . . . . 75.430000000000007 108.804 177.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 45.3 p -116.37 126.59 53.69 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.778 -1.564 . . . . 71.129999999999995 106.778 175.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 234' ' ' GLU . . . . . 0.561 ' HB2' ' HE3' ' B' ' 270' ' ' LYS . 32.7 mt-10 -141.67 151.91 43.44 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.88 -0.785 . . . . 63.399999999999999 108.88 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 61.38 80.38 0.22 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.536 1.134 . . . . 71.340000000000003 112.466 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.523 ' HD3' ' N ' ' B' ' 236' ' ' ARG . 0.0 OUTLIER 62.78 25.16 14.95 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.821 0.674 . . . . 72.040000000000006 112.821 173.4 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -84.86 150.66 24.84 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.323 0.583 . . . . 65.129999999999995 110.802 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -125.54 135.14 51.94 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.122 -1.436 . . . . 72.420000000000002 107.122 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.464 ' HB ' HG21 ' B' ' 233' ' ' THR . 5.8 p -136.76 141.95 39.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.304 0.573 . . . . 73.209999999999994 111.635 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.603 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 4.4 tp60 -122.26 125.87 46.95 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-N 114.306 -1.315 . . . . 74.140000000000001 107.867 171.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.577 ' HG ' HD21 ' A' ' 262' ' ' ASN . 52.5 tp -117.3 118.54 32.55 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 107.934 -1.135 . . . . 72.329999999999998 107.934 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.567 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 128.33 -117.12 2.46 Favored Glycine 0 N--CA 1.421 -2.347 0 C-N-CA 120.389 -0.91 . . . . 70.409999999999997 111.644 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.592 ' ND2' HG22 ' B' ' 223' ' ' VAL . 42.0 t-20 -144.57 136.41 25.87 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 120.022 -0.671 . . . . 74.319999999999993 110.243 -176.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.489 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 48.1 t -108.54 120.28 59.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.258 -1.386 . . . . 33.200000000000003 107.258 174.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.16 115.23 46.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 120.894 -0.323 . . . . 72.439999999999998 110.598 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.439 HG22 ' HA3' ' B' ' 282' ' ' GLY . 14.9 t -113.93 162.25 16.63 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.626 -0.879 . . . . 73.109999999999999 108.626 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.03 -32.19 70.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.657 1.183 . . . . 62.509999999999998 114.017 -173.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.91 -41.07 67.26 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 114.417 1.266 . . . . 53.109999999999999 114.417 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.464 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -74.27 -25.98 59.94 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 114.273 1.212 . . . . 70.150000000000006 114.273 -175.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 41.6 tp -65.19 91.83 0.11 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.312 0.577 . . . . 50.009999999999998 111.896 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -161.75 -38.81 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 126.57 1.948 . . . . 65.140000000000001 108.965 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -156.9 -160.06 9.86 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.496 -1.042 . . . . 71.129999999999995 110.496 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 128.48 67.92 0.13 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 111.212 -0.755 . . . . 73.239999999999995 111.212 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 46.9 mm -73.44 126.17 33.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 109.971 -0.381 . . . . 74.120000000000005 109.971 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -113.49 116.16 29.15 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.576 -0.738 . . . . 75.219999999999999 112.337 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 71.3 mt -145.26 135.08 18.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 106.895 -1.52 . . . . 62.049999999999997 106.895 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 20.6 t -178.14 -169.11 0.18 Allowed 'General case' 0 C--O 1.247 0.953 0 N-CA-C 107.459 -1.311 . . . . 62.25 107.459 174.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -93.11 -159.66 0.7 Allowed 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.473 -1.677 . . . . 63.509999999999998 106.473 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -84.09 75.15 10.19 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.382 -0.97 . . . . 74.129999999999995 108.382 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.584 ' O ' HG21 ' C' ' 222' ' ' ILE . 18.0 p -96.49 131.51 43.01 Favored 'General case' 0 N--CA 1.397 -3.079 0 CA-C-N 115.579 -0.737 . . . . 72.099999999999994 109.249 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 8.2 t -127.75 141.65 51.53 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.798 -1.186 . . . . 55.210000000000001 107.798 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.663 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 25.7 t-20 -87.06 119.13 26.95 Favored 'General case' 0 CA--C 1.479 -1.768 0 N-CA-C 107.846 -1.168 . . . . 65.140000000000001 107.846 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 263' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' B' ' 227' ' ' SER . 49.7 m -142.56 128.03 18.98 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.394 -0.821 . . . . 73.219999999999999 110.889 -177.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.4 p -125.82 141.42 45.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.277 -0.569 . . . . 62.229999999999997 112.462 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 16.6 mm-40 -79.33 -59.3 2.82 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.568 -0.742 . . . . 72.109999999999999 110.938 177.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 97.0 m -143.6 127.37 17.18 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.023 -0.671 . . . . 72.25 112.694 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.519 HG12 HD12 ' C' ' 231' ' ' ILE . 24.0 m -121.07 127.81 75.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 109.056 -0.72 . . . . 72.019999999999996 109.056 172.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 268' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 5.5 p -128.64 135.37 62.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-N 116.16 -0.473 . . . . 62.100000000000001 111.877 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 269' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.7 132.58 7.99 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 110.494 -1.043 . . . . 43.009999999999998 110.494 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.561 ' HE3' ' HB2' ' B' ' 234' ' ' GLU . 13.9 mmmm -132.84 117.71 18.08 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 122.451 0.3 . . . . 74.420000000000002 111.648 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.87 87.32 0.9 Allowed Glycine 0 C--N 1.307 -1.069 0 C-N-CA 120.379 -0.915 . . . . 74.140000000000001 113.171 173.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 55.16 30.35 14.31 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.953 0.901 . . . . 55.399999999999999 111.899 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.8 m -83.06 145.08 29.48 Favored 'General case' 0 N--CA 1.422 -1.863 0 C-N-CA 120.489 -0.484 . . . . 65.219999999999999 110.355 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -116.84 127.62 54.47 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.088 -1.819 . . . . 73.409999999999997 106.088 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 1.5 p -133.03 123.14 47.57 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 121.517 0.675 . . . . 71.209999999999994 111.252 178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.54 ' HG ' ' OE1' ' C' ' 240' ' ' GLN . 8.0 tp -113.85 119.86 38.77 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.18 -1.045 . . . . 73.019999999999996 108.18 174.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.517 HG23 HD23 ' C' ' 241' ' ' LEU . 2.0 mt -112.14 103.56 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.887 0 N-CA-C 105.192 -2.151 . . . . 75.310000000000002 105.192 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 147.85 -126.96 2.48 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 119.136 -1.507 . . . . 24.25 114.635 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -128.91 135.42 49.02 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.159 0.504 . . . . 65.5 111.04 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.431 ' HG2' ' NE1' ' B' ' 287' ' ' TRP . 13.9 tp10 -113.45 118.5 34.7 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.776 -1.564 . . . . 74.430000000000007 106.776 177.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.443 ' CD2' ' HB3' ' B' ' 249' ' ' ALA . 4.6 t80 -115.25 122.75 46.94 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 106.144 -1.799 . . . . 62.109999999999999 106.144 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' B' ' 249' ' ' ALA . . . 114.72 -51.37 0.72 Allowed Glycine 0 C--N 1.288 -2.094 0 N-CA-C 108.226 -1.95 . . . . 71.439999999999998 108.226 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 89.97 15.17 58.2 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 111.204 -0.758 . . . . 63.100000000000001 111.204 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 284' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' B' ' 290' ' ' HIS . 41.4 mmtm -145.75 19.92 1.47 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.157 0.503 . . . . 75.430000000000007 109.992 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 285' ' ' GLY . . . . . 0.406 ' HA3' HG11 ' B' ' 244' ' ' VAL . . . -81.93 -79.81 0.95 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.393 -0.908 . . . . 60.530000000000001 113.116 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.447 ' HB2' HG21 ' B' ' 244' ' ' VAL . 86.9 t80 -76.95 -13.36 59.98 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.812 0.671 . . . . 72.310000000000002 112.812 -176.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.609 ' CH2' ' HB2' ' C' ' 240' ' ' GLN . 6.4 m95 -74.0 135.34 43.12 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.107 0.48 . . . . 64.120000000000005 112.177 -173.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -86.94 -0.25 56.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.234 1.016 . . . . 50.409999999999997 108.7 174.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -82.41 151.31 26.67 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 106.959 -1.497 . . . . 74.349999999999994 106.959 172.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 290' ' ' HIS . . . . . 0.508 ' NE2' ' HA ' ' B' ' 294' ' ' HIS . 2.5 p80 -104.55 -160.78 0.78 Allowed 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.681 -0.489 . . . . 74.230000000000004 109.681 -174.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -65.65 169.6 6.1 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.468 0.307 . . . . 73.439999999999998 111.309 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 292' ' ' HIS . . . . . 0.444 ' NE2' ' HA ' ' C' ' 289' ' ' ASN . 65.3 t-80 -83.67 64.99 8.27 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 122.558 1.171 . . . . 70.439999999999998 108.347 -176.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -143.95 35.7 1.26 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 113.302 -1.772 . . . . 75.329999999999998 106.917 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 294' ' ' HIS . . . . . 0.508 ' HA ' ' NE2' ' B' ' 290' ' ' HIS . 8.3 p-80 -47.54 -47.65 27.99 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 114.357 -1.292 . . . . 75.319999999999993 113.227 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 3.3 t60 . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 107.259 -1.386 . . . . 73.010000000000005 107.259 177.484 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 121.161 0.505 . . . . 64.329999999999998 110.529 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -101.97 -33.29 9.8 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.718 -1.216 . . . . 60.149999999999999 107.718 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 49.3 mm -102.59 109.25 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 105.137 -2.172 . . . . 74.140000000000001 105.137 169.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -115.16 27.94 9.04 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.32 0.581 . . . . 64.219999999999999 109.852 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -72.57 101.3 2.97 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.167 -0.924 . . . . 71.420000000000002 108.985 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 0.584 HG21 ' O ' ' B' ' 260' ' ' THR . 66.5 mt -116.25 139.19 44.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 115.135 -0.939 . . . . 74.230000000000004 108.532 -177.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.06 122.4 68.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 120.885 -0.326 . . . . 62.109999999999999 111.508 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 44.06 74.18 0.22 Allowed Glycine 0 N--CA 1.469 0.885 0 O-C-N 125.15 1.531 . . . . 52.140000000000001 116.684 172.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' B' ' 260' ' ' THR . 24.9 mmt180 -115.92 131.54 56.91 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 122.079 0.942 . . . . 73.310000000000002 111.99 177.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.663 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 28.3 p-10 -117.49 155.67 29.32 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 113.419 -1.719 . . . . 72.420000000000002 114.242 -171.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' C' ' 263' ' ' SER . 23.9 t -117.75 136.37 53.42 Favored 'General case' 0 N--CA 1.409 -2.487 0 N-CA-C 107.671 -1.233 . . . . 73.010000000000005 107.671 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.43 137.92 52.07 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.872 -1.058 . . . . 74.430000000000007 108.842 -175.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 5.2 tmmm? -90.83 -62.0 1.55 Allowed 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 120.062 -0.655 . . . . 73.230000000000004 110.527 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -127.56 137.09 52.5 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 108.392 -0.966 . . . . 55.049999999999997 108.392 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.519 HD12 HG12 ' B' ' 267' ' ' VAL . 17.4 mt -137.82 123.59 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.145 -1.057 . . . . 73.25 108.145 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 81.5 mtt180 -128.32 115.1 17.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.418 -0.586 . . . . 74.040000000000006 109.418 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.469 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 33.1 p -112.31 126.87 55.72 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.342 -1.355 . . . . 74.129999999999995 107.342 175.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.526 ' HG2' ' HB2' ' B' ' 270' ' ' LYS . 43.1 mt-10 -138.87 145.78 40.38 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 120.328 -0.549 . . . . 73.030000000000001 110.508 -178.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 65.52 84.26 0.16 Allowed 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.637 1.175 . . . . 73.439999999999998 112.506 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? 61.3 23.31 13.56 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.345 1.058 . . . . 73.299999999999997 111.752 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -87.18 151.2 23.39 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.031 0.443 . . . . 71.549999999999997 111.423 -176.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -125.53 135.24 52.06 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.686 -1.227 . . . . 62.219999999999999 107.686 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 2.5 p -130.83 136.31 58.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.459 0.647 . . . . 72.439999999999998 110.929 176.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.609 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 3.9 tp60 -114.56 121.35 43.2 Favored 'General case' 0 N--CA 1.4 -2.967 0 CA-C-N 114.247 -1.342 . . . . 53.229999999999997 107.479 170.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.635 ' HG ' HD21 ' B' ' 262' ' ' ASN . 64.7 tp -115.53 118.16 32.36 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 108.32 -0.992 . . . . 72.209999999999994 108.32 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.549 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 129.5 -115.08 1.84 Allowed Glycine 0 N--CA 1.416 -2.657 0 C-N-CA 120.347 -0.93 . . . . 33.450000000000003 112.47 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.479 ' ND2' HG23 ' C' ' 245' ' ' VAL . 5.9 t30 -144.94 136.28 25.16 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 122.651 -0.323 . . . . 75.230000000000004 110.934 -173.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.453 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 61.0 t -114.79 125.85 72.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.195 0 N-CA-C 108.244 -1.021 . . . . 73.140000000000001 108.244 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.479 HG23 ' ND2' ' C' ' 243' ' ' ASN . 85.5 t -122.06 118.58 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 118.104 0.411 . . . . 72.310000000000002 110.294 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 246' ' ' THR . . . . . 0.41 HG22 ' HA3' ' C' ' 282' ' ' GLY . 14.8 t -114.07 162.28 16.67 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 108.242 -1.021 . . . . 74.319999999999993 108.242 170.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.68 -31.86 73.16 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 114.229 1.196 . . . . 55.509999999999998 114.229 -172.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.41 -34.29 57.2 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.749 1.388 . . . . 63.530000000000001 114.749 -169.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 249' ' ' ALA . . . . . 0.514 ' HB2' ' HA2' ' C' ' 282' ' ' GLY . . . -73.26 -43.34 61.27 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.194 -0.602 . . . . 34.030000000000001 112.128 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 64.52 -65.89 0.13 Allowed 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 124.231 1.013 . . . . 64.430000000000007 109.065 -168.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -136.62 114.54 11.34 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 126.319 1.848 . . . . 74.439999999999998 106.246 173.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -87.78 -124.89 2.1 Favored Glycine 0 C--N 1.304 -1.245 0 C-N-CA 120.551 -0.833 . . . . 35.539999999999999 113.156 -173.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -134.49 66.96 0.56 Allowed Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 110.113 -1.195 . . . . 75.430000000000007 110.113 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.5 tp -75.53 124.27 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-O 121.558 0.694 . . . . 74.430000000000007 109.532 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -93.73 -173.67 3.23 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.644 -1.243 . . . . 74.129999999999995 107.644 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 12.8 tt -73.87 130.84 35.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.109 0.48 . . . . 74.329999999999998 110.185 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 25.1 m -128.79 101.38 6.09 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 107.682 -1.229 . . . . 62.409999999999997 107.682 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -133.7 -52.1 0.86 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.527 0.679 . . . . 74.239999999999995 110.164 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -111.92 -21.06 11.78 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.789 -0.641 . . . . 72.430000000000007 110.481 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 7.4 m -84.52 121.64 27.87 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.756 -0.461 . . . . 72.530000000000001 109.756 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 10.9 t -134.34 142.68 47.32 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.588 -0.893 . . . . 15.35 108.588 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -87.99 120.38 29.28 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.297 0.57 . . . . 64.310000000000002 110.177 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 263' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' C' ' 227' ' ' SER . 46.8 m -139.6 132.77 29.74 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.601 -0.727 . . . . 74.25 109.047 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 12.3 p -123.91 139.52 50.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.964 0.411 . . . . 64.310000000000002 111.129 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 9.1 mm-40 -75.88 -64.12 1.16 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.913 -0.585 . . . . 75.230000000000004 111.794 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 87.4 m -144.85 127.91 16.56 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 122.058 -0.402 . . . . 72.420000000000002 109.966 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.402 HG11 HD13 ' C' ' 277' ' ' ILE . 0.9 OUTLIER -126.86 123.67 63.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 115.323 -0.853 . . . . 70.129999999999995 109.638 178.488 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 268' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 26.5 m -124.65 146.61 29.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.179 -0.464 . . . . 65.25 110.337 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -130.85 132.52 6.9 Favored Glycine 0 CA--C 1.481 -2.062 0 N-CA-C 109.348 -1.501 . . . . 70.450000000000003 109.348 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -132.78 116.55 16.7 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.735 0.268 . . . . 72.209999999999994 111.592 -175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.95 84.42 0.85 Allowed Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.022 -1.085 . . . . 73.209999999999994 113.868 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 59.19 29.07 18.56 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.267 1.027 . . . . 74.140000000000001 111.629 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 15.8 m -82.87 145.55 29.38 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.102 -0.499 . . . . 75.319999999999993 111.102 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -113.43 128.4 56.44 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.06 -1.83 . . . . 64.150000000000006 106.06 174.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 6.6 p -137.95 123.57 25.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.533 0.682 . . . . 74.340000000000003 111.317 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.572 HD13 ' CG ' ' C' ' 240' ' ' GLN . 5.3 tp -113.88 112.17 22.9 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.866 -0.79 . . . . 61.039999999999999 108.866 175.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.402 HD13 HG11 ' C' ' 267' ' ' VAL . 5.4 mt -103.9 103.71 15.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 105.256 -2.127 . . . . 73.400000000000006 105.256 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 278' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 143.51 -144.83 14.18 Favored Glycine 0 N--CA 1.421 -2.314 0 C-N-CA 119.869 -1.158 . . . . 74.0 112.809 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -110.18 139.81 44.94 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.114 0.483 . . . . 71.200000000000003 110.342 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.583 ' HG2' ' NE1' ' C' ' 287' ' ' TRP . 12.9 tp10 -118.06 117.46 29.26 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 105.933 -1.877 . . . . 72.540000000000006 105.933 175.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 281' ' ' TYR . . . . . 0.42 ' HB3' ' HA ' ' C' ' 245' ' ' VAL . 6.5 t80 -111.51 123.39 50.13 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.01 -1.848 . . . . 74.409999999999997 106.01 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 282' ' ' GLY . . . . . 0.514 ' HA2' ' HB2' ' C' ' 249' ' ' ALA . . . 109.58 -51.29 0.71 Allowed Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 109.548 -1.421 . . . . 44.420000000000002 109.548 -173.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 86.13 24.35 41.13 Favored Glycine 0 CA--C 1.496 -1.156 0 C-N-CA 120.94 -0.648 . . . . 62.210000000000001 111.634 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -148.53 13.89 0.95 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 122.979 0.512 . . . . 64.340000000000003 110.247 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.43 -79.63 0.81 Allowed Glycine 0 N--CA 1.422 -2.263 0 C-N-CA 120.096 -1.049 . . . . 21.420000000000002 112.82 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -80.23 -19.78 46.11 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.126 0.787 . . . . 74.129999999999995 113.126 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.583 ' NE1' ' HG2' ' C' ' 280' ' ' GLU . 9.2 m95 -73.87 139.83 45.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 114.261 1.208 . . . . 71.439999999999998 114.261 -171.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.25 -44.86 71.1 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.446 -0.946 . . . . 60.439999999999998 108.446 170.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 289' ' ' ASN . . . . . 0.444 ' HA ' ' NE2' ' B' ' 292' ' ' HIS . 54.2 t-20 -145.57 133.99 21.91 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.784 -1.191 . . . . 62.409999999999997 107.784 -176.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -153.9 101.23 2.42 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 123.036 0.21 . . . . 63.25 110.594 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 50.8 t60 71.06 -22.75 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 125.105 1.362 . . . . 72.129999999999995 114.411 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . 0.313 14.5 m80 81.88 99.21 0.05 Allowed 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 114.69 1.367 . . . . 75.340000000000003 114.69 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -160.07 142.56 13.35 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 104.377 -2.453 . . . . 74.310000000000002 104.377 173.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -82.27 134.86 35.3 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 121.609 0.719 . . . . 75.409999999999997 112.047 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 73.8 t60 . . . . . 0 C--N 1.296 -1.72 0 N-CA-C 106.931 -1.507 . . . . 70.310000000000002 106.931 -179.85 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 107.985 -1.117 . . . . 63.009999999999998 107.985 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -126.83 12.26 7.28 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.11 0.481 . . . . 73.150000000000006 109.751 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 8.5 tp -117.91 150.58 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 115.238 -0.892 . . . . 72.439999999999998 109.935 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -121.44 -165.66 1.27 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 106.675 -1.602 . . . . 73.519999999999996 106.675 175.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.96 81.62 8.82 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 119.222 0.919 . . . . 52.420000000000002 112.424 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.456 ' O ' ' HB3' ' A' ' 259' ' ' GLN . 47.1 mm -116.12 114.41 46.05 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 N-CA-C 107.387 -1.338 . . . . 71.329999999999998 107.387 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 15.4 m -138.08 119.21 16.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 117.747 0.249 . . . . 74.019999999999996 110.353 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 45.46 53.78 7.94 Favored Glycine 0 C--N 1.337 0.629 0 O-C-N 124.332 1.02 . . . . 62.299999999999997 113.166 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -89.93 124.87 35.09 Favored 'General case' 0 CA--C 1.49 -1.348 0 C-N-CA 119.792 -0.763 . . . . 73.239999999999995 111.504 -176.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -115.62 114.35 24.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.038 -1.467 . . . . 61.229999999999997 107.038 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 10.1 p -129.07 137.64 51.39 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.457 0.646 . . . . 74.349999999999994 112.385 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 231' ' ' ILE . . . -133.22 129.51 37.82 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.073 -1.084 . . . . 64.329999999999998 108.073 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -82.31 -55.84 4.27 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.798 -0.445 . . . . 74.430000000000007 109.798 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 266' ' ' THR . 26.3 t0 -138.55 139.46 38.69 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 119.95 -0.7 . . . . 73.340000000000003 111.985 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.484 HD11 ' HB1' ' A' ' 228' ' ' ALA . 30.8 mm -128.33 127.79 67.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 106.889 -1.523 . . . . 73.299999999999997 106.889 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 31.0 ttt180 -134.14 115.42 14.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.283 -0.567 . . . . 72.109999999999999 110.079 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 40.8 p -110.66 127.59 55.35 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.335 -0.987 . . . . 54.310000000000002 108.335 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -128.08 148.96 50.58 Favored 'General case' 0 CA--C 1.482 -1.67 0 C-N-CA 120.089 -0.644 . . . . 52.229999999999997 109.865 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.589 ' C ' ' HD2' ' A' ' 236' ' ' ARG . 44.4 mt-10 59.27 91.24 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 O-C-N 125.12 1.512 . . . . 64.230000000000004 114.029 173.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.589 ' HD2' ' C ' ' A' ' 235' ' ' GLU . 0.1 OUTLIER 61.33 2.23 0.61 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.345 1.458 . . . . 71.310000000000002 113.401 174.065 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -69.92 149.58 47.66 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.398 0.679 . . . . 44.140000000000001 112.156 -175.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.34 139.01 54.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.701 -0.681 . . . . 51.399999999999999 109.805 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 6.0 p -124.85 141.93 43.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 116.052 -0.522 . . . . 60.25 110.018 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -123.26 117.7 25.9 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.739 -0.664 . . . . 63.420000000000002 109.361 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 277' ' ' ILE . 2.9 tm? -111.63 118.76 36.56 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.64 -1.615 . . . . 73.040000000000006 106.64 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.468 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 136.66 -140.2 11.28 Favored Glycine 0 N--CA 1.422 -2.278 0 C-N-CA 119.707 -1.235 . . . . 54.299999999999997 112.061 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -124.52 133.73 53.23 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 120.972 0.415 . . . . 62.030000000000001 111.411 -173.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.7 t -119.01 121.02 65.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.387 -1.338 . . . . 54.340000000000003 107.387 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.28 129.65 74.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.262 0.553 . . . . 54.119999999999997 112.366 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 5.3 m -109.79 160.53 16.26 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.808 -1.182 . . . . 75.209999999999994 107.808 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.99 76.8 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 122.918 0.487 . . . . 73.409999999999997 111.941 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.18 -34.08 63.54 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.926 1.29 . . . . 63.450000000000003 113.741 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 281' ' ' TYR . . . -66.54 -38.95 88.26 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.106 0.78 . . . . 71.409999999999997 113.106 -175.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 61.5 tp 72.26 -35.29 0.32 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.459 0.703 . . . . 72.430000000000007 112.706 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.41 ' H ' ' C ' ' A' ' 249' ' ' ALA . 80.5 m80 79.78 113.69 0.07 Allowed 'General case' 0 C--O 1.247 0.933 0 C-N-CA 125.887 1.675 . . . . 75.030000000000001 110.617 -177.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -89.67 134.17 12.22 Favored Glycine 0 N--CA 1.431 -1.663 0 CA-C-N 115.043 -0.981 . . . . 73.129999999999995 112.288 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -143.14 122.93 1.99 Allowed Glycine 0 N--CA 1.425 -2.072 0 C-N-CA 121.069 -0.586 . . . . 74.349999999999994 111.977 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 10.1 tt -175.49 -48.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 124.589 1.155 . . . . 72.230000000000004 108.366 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -138.64 164.64 28.99 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.174 -1.417 . . . . 72.239999999999995 107.174 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 257' ' ' SER . 13.2 tt -79.89 156.34 4.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 O-C-N 123.703 0.627 . . . . 65.430000000000007 109.806 -176.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.403 ' O ' HG12 ' A' ' 256' ' ' ILE . 28.8 m -79.19 147.31 32.68 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 105.635 -1.987 . . . . 75.120000000000005 105.635 170.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.467 ' N ' ' HA3' ' B' ' 253' ' ' GLY . 1.0 OUTLIER -66.55 171.09 5.36 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.058 0.762 . . . . 63.439999999999998 113.058 -169.304 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 222' ' ' ILE . 49.7 mt-30 -87.47 84.1 7.2 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.091 0.948 . . . . 75.430000000000007 110.892 -170.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 16.7 p -97.42 139.66 33.03 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 113.816 -1.538 . . . . 72.409999999999997 111.751 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.9 m -115.28 108.78 17.02 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.874 -0.787 . . . . 75.129999999999995 108.874 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.547 HD21 HD22 ' B' ' 241' ' ' LEU . 64.9 t30 -106.29 121.63 44.61 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.801 -0.814 . . . . 74.450000000000003 108.801 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' B' ' 227' ' ' SER . 46.9 m -137.86 123.97 20.34 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.878 0.37 . . . . 73.340000000000003 111.726 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' B' ' 228' ' ' ALA . 11.2 p -119.76 135.27 60.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.855 0.36 . . . . 74.219999999999999 111.102 176.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -69.36 -65.05 0.76 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.883 -0.599 . . . . 73.299999999999997 111.469 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 29.5 m -144.58 132.76 21.68 Favored 'General case' 0 C--O 1.25 1.117 0 C-N-CA 120.184 -0.607 . . . . 74.209999999999994 112.501 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.415 HG12 ' HB ' ' B' ' 231' ' ' ILE . 27.4 m -118.03 129.56 74.21 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 107.932 -1.136 . . . . 74.329999999999998 107.932 172.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 7.8 p -127.59 130.86 70.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-O 121.186 0.517 . . . . 72.340000000000003 111.677 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.06 133.32 11.53 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 109.719 -1.352 . . . . 74.510000000000005 109.719 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -132.56 144.69 50.58 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 117.121 0.46 . . . . 74.400000000000006 111.131 -175.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.65 -65.76 3.89 Favored Glycine 0 C--O 1.244 0.755 0 N-CA-C 110.768 -0.933 . . . . 63.439999999999998 110.768 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -176.96 125.86 0.15 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.999 -2.223 . . . . 73.019999999999996 104.999 172.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 25.0 m -149.94 160.13 43.84 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.531 -0.544 . . . . 64.140000000000001 109.531 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 54.3 mtm180 -122.72 127.36 49.12 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.142 -1.059 . . . . 73.349999999999994 108.142 172.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 1.4 p -128.18 129.17 69.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 116.154 -0.475 . . . . 63.100000000000001 109.942 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 4.1 tt -121.0 121.24 37.54 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.854 -1.165 . . . . 74.040000000000006 107.854 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.584 HG22 ' HB3' ' B' ' 241' ' ' LEU . 3.2 pt -113.03 104.59 17.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 C-N-CA 124.063 0.945 . . . . 63.310000000000002 109.107 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 155.18 -122.84 1.26 Allowed Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.554 -0.832 . . . . 74.239999999999995 113.156 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 42.4 m-80 -128.3 148.96 50.68 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.62 0.247 . . . . 65.319999999999993 110.585 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.0 OUTLIER -136.6 121.6 18.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.172 -2.159 . . . . 54.140000000000001 105.172 173.587 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.469 ' HB3' ' CB ' ' A' ' 249' ' ' ALA . 57.0 m-85 -107.81 123.59 48.8 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 109.37 -0.604 . . . . 71.030000000000001 109.37 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.442 ' N ' ' HB2' ' A' ' 249' ' ' ALA . . . 104.91 -43.73 1.61 Allowed Glycine 0 N--CA 1.42 -2.387 0 CA-C-N 115.178 -0.919 . . . . 70.329999999999998 111.209 -177.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 76.29 14.42 82.36 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.916 -0.874 . . . . 73.439999999999998 110.916 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -126.43 13.6 7.63 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.899 0.857 . . . . 75.319999999999993 109.377 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -101.48 -55.44 0.9 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.156 -1.021 . . . . 73.519999999999996 110.92 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.473 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 31.1 t80 -93.04 -18.04 23.13 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.904 -0.406 . . . . 74.319999999999993 109.904 -177.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.639 ' CH2' ' HB2' ' B' ' 240' ' ' GLN . 12.6 m-90 -115.12 157.84 23.02 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 115.893 1.812 . . . . 64.010000000000005 115.893 -176.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 289' ' ' ASN . 8.2 p-10 -73.75 -72.45 0.27 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 126.282 1.833 . . . . 73.439999999999998 112.439 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' ASN . . . . . 0.465 ' H ' ' CG ' ' A' ' 288' ' ' ASP 0.398 6.9 m-20 103.33 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 117.515 2.413 . . . . 72.519999999999996 117.515 171.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 46.4 m80 71.41 148.04 0.08 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 116.716 2.117 . . . . 73.25 116.716 169.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -166.8 33.46 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 103.927 -2.62 . . . . 74.319999999999993 103.927 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -86.89 145.5 26.54 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.231 -1.35 . . . . 70.219999999999999 113.003 -169.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -120.94 117.37 27.14 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.687 -1.597 . . . . 72.010000000000005 106.687 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -89.14 140.74 29.15 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.025 0.44 . . . . 65.510000000000005 110.253 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--N 1.299 -1.625 0 N-CA-C 107.324 -1.362 . . . . 73.340000000000003 107.324 177.986 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 CA--C 1.512 -0.487 0 N-CA-C 108.353 -0.98 . . . . 30.41 108.353 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -89.85 -58.89 2.36 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 106.898 -1.519 . . . . 73.209999999999994 106.898 174.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 33.9 pt -138.1 157.43 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.086 -0.961 . . . . 73.209999999999994 109.512 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -173.95 -56.38 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 106.152 -1.796 . . . . 61.509999999999998 106.152 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 68.18 164.38 0.23 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 113.805 -1.543 . . . . 65.340000000000003 112.703 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 222' ' ' ILE . . . . . 0.424 HG21 ' OG1' ' B' ' 261' ' ' THR . 42.2 mm -98.52 113.77 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 N-CA-C 106.55 -1.648 . . . . 71.019999999999996 106.55 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 23.9 m -132.5 118.32 34.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 109.451 -0.574 . . . . 72.239999999999995 109.451 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 43.39 50.97 6.59 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 114.522 -1.217 . . . . 63.329999999999998 112.937 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -89.3 121.74 31.87 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 119.729 -0.788 . . . . 75.010000000000005 111.281 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.486 ' OD1' ' HA2' ' C' ' 242' ' ' GLY . 63.3 t30 -113.5 114.62 26.79 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 106.181 -1.785 . . . . 51.140000000000001 106.181 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 227' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' B' ' 263' ' ' SER . 20.1 m -125.4 137.06 54.0 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.513 0.673 . . . . 74.420000000000002 111.351 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.423 ' HB1' HD11 ' B' ' 231' ' ' ILE . . . -128.33 132.85 48.61 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.236 -0.893 . . . . 75.319999999999993 108.74 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.554 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -88.72 -68.12 0.79 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.976 -0.379 . . . . 74.219999999999999 109.976 -177.484 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.91 138.6 53.33 Favored 'General case' 0 CA--C 1.481 -1.673 0 C-N-CA 119.355 -0.938 . . . . 71.409999999999997 111.327 177.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.423 HD11 ' HB1' ' B' ' 228' ' ' ALA . 29.4 mm -130.91 118.4 41.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.576 -1.268 . . . . 64.519999999999996 107.576 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -118.77 117.76 29.76 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.483 -0.562 . . . . 43.420000000000002 109.483 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 49.7 p -109.5 127.2 54.26 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.903 -1.517 . . . . 75.219999999999999 106.903 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.28 155.75 46.61 Favored 'General case' 0 CA--C 1.471 -2.083 0 N-CA-C 108.759 -0.83 . . . . 73.25 108.759 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.572 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 83.8 mt-10 55.16 84.49 0.07 Allowed 'General case' 0 C--N 1.311 -1.065 0 O-C-N 125.016 1.447 . . . . 65.230000000000004 114.055 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.572 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 60.91 6.93 1.31 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.07 1.348 . . . . 74.409999999999997 113.151 173.437 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -69.9 148.43 49.0 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.201 0.524 . . . . 64.319999999999993 112.138 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 1.0 OUTLIER -127.87 136.09 50.92 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 108.806 -0.812 . . . . 73.340000000000003 108.806 179.216 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.437 ' HB ' HG13 ' B' ' 275' ' ' VAL . 5.4 p -127.65 142.23 44.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 116.335 -0.393 . . . . 61.5 110.853 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.639 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 5.8 tp-100 -112.89 134.62 54.31 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.918 -1.512 . . . . 71.120000000000005 106.918 173.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.584 ' HB3' HG22 ' A' ' 277' ' ' ILE . 2.8 tm? -129.28 117.44 20.69 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 105.953 -1.869 . . . . 73.319999999999993 105.953 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.466 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 137.67 -115.29 1.19 Allowed Glycine 0 N--CA 1.404 -3.489 0 C-N-CA 119.006 -1.568 . . . . 72.209999999999994 113.292 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 6.4 t30 -145.35 129.15 17.28 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 113.275 0.843 . . . . 50.219999999999999 113.275 -171.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 280' ' ' GLU . 99.2 t -119.64 125.56 74.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.339 -0.986 . . . . 63.149999999999999 108.339 176.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.449 ' HB ' ' CD2' ' A' ' 281' ' ' TYR . 57.7 t -122.29 129.66 75.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 120.843 -0.343 . . . . 75.230000000000004 111.285 -177.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.557 HG21 ' HB3' ' B' ' 284' ' ' LYS . 2.2 m -104.48 161.41 14.12 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.439 -0.948 . . . . 72.109999999999999 108.439 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.33 -32.57 74.02 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.756 0.788 . . . . 73.519999999999996 110.486 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.18 -36.06 65.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.026 -1.443 . . . . 73.099999999999994 113.805 -176.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.495 ' HB2' ' N ' ' B' ' 282' ' ' GLY . . . -74.67 -38.74 62.34 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 121.201 -0.2 . . . . 73.540000000000006 110.886 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 60.2 tp 73.34 -37.25 0.37 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.732 1.213 . . . . 71.200000000000003 112.002 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -169.01 179.06 4.21 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.517 -1.66 . . . . 74.25 106.517 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 252' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' B' ' 281' ' ' TYR . . . -166.43 56.68 0.24 Allowed Glycine 0 N--CA 1.429 -1.81 0 C-N-CA 118.437 -1.84 . . . . 74.310000000000002 113.146 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 253' ' ' GLY . . . . . 0.467 ' HA3' ' N ' ' A' ' 258' ' ' ASP . . . 170.74 179.15 41.86 Favored Glycine 0 N--CA 1.419 -2.436 0 C-N-CA 119.746 -1.216 . . . . 71.129999999999995 112.26 177.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 254' ' ' ILE . . . . . 0.571 HD12 ' H ' ' B' ' 255' ' ' ARG . 0.8 OUTLIER -147.43 -61.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 124.429 0.723 . . . . 72.450000000000003 111.492 179.089 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 255' ' ' ARG . . . . . 0.571 ' H ' HD12 ' B' ' 254' ' ' ILE . 10.6 ptm180 177.44 81.9 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.852 1.661 . . . . 74.310000000000002 109.648 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 48.1 mm 73.32 89.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 C-N-CA 124.317 1.047 . . . . 55.130000000000003 110.332 178.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 40.3 t -54.43 -73.71 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.754 -1.112 . . . . 43.219999999999999 109.438 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -155.5 -179.79 8.43 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.973 -1.121 . . . . 72.349999999999994 107.973 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -114.03 78.56 1.16 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.593 0.711 . . . . 74.450000000000003 111.009 -176.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.24 139.73 36.51 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.646 -1.161 . . . . 73.420000000000002 111.9 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.535 ' HB ' ' HG2' ' C' ' 225' ' ' ARG . 4.7 m -116.23 108.24 15.87 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.18 -1.415 . . . . 73.310000000000002 107.18 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.572 HD21 HD22 ' C' ' 241' ' ' LEU . 64.2 t30 -108.7 126.17 52.7 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.215 -1.032 . . . . 71.319999999999993 108.215 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 263' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' C' ' 227' ' ' SER . 31.9 m -142.42 123.75 14.74 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.237 0.542 . . . . 61.43 111.813 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' C' ' 228' ' ' ALA . 14.5 p -110.31 140.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.459 -0.571 . . . . 70.239999999999995 109.459 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 3.4 tm-20 -80.45 -69.26 0.61 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.423 -0.954 . . . . 71.150000000000006 108.423 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 90.7 m -137.3 128.85 28.45 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 121.629 -0.669 . . . . 72.329999999999998 112.683 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 48.9 t -118.49 128.83 75.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.08 -1.082 . . . . 52.210000000000001 108.08 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 8.6 p -127.4 134.44 65.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.131 0.491 . . . . 72.010000000000005 111.295 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.09 133.25 11.18 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.723 -1.351 . . . . 65.129999999999995 109.723 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -133.18 147.22 52.04 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 117.059 0.43 . . . . 75.200000000000003 111.349 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.58 -63.96 4.04 Favored Glycine 0 CA--C 1.498 -1.014 0 N-CA-C 110.812 -0.915 . . . . 73.25 110.812 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -178.99 126.72 0.1 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 103.624 -2.732 . . . . 72.319999999999993 103.624 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 45.7 m -147.61 161.29 41.45 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 120.949 0.404 . . . . 73.030000000000001 110.809 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.706 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 14.7 mtp180 -127.7 127.33 43.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.436 -1.32 . . . . 71.310000000000002 107.436 174.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' B' ' 239' ' ' VAL . 0.7 OUTLIER -134.8 137.31 51.13 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.109 0 N-CA-C 109.716 -0.476 . . . . 44.520000000000003 109.716 179.196 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.456 HD12 ' CG ' ' B' ' 286' ' ' PHE . 5.4 tt -124.15 124.23 42.04 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.059 -1.459 . . . . 61.009999999999998 107.059 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.464 HG23 HD12 ' C' ' 241' ' ' LEU . 6.7 mt -113.0 103.81 16.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 106.334 -1.728 . . . . 71.340000000000003 106.334 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 152.0 -141.31 8.41 Favored Glycine 0 CA--C 1.474 -2.53 0 C-N-CA 119.164 -1.493 . . . . 71.430000000000007 113.751 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 279' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 45.3 m-80 -111.57 136.93 50.09 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.109 -0.545 . . . . 71.5 109.625 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.506 ' HB2' ' NE2' ' C' ' 240' ' ' GLN . 0.1 OUTLIER -125.67 118.39 25.53 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 104.931 -2.248 . . . . 71.450000000000003 104.931 175.83 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.409 ' CE1' ' HA3' ' B' ' 252' ' ' GLY . 87.1 m-85 -105.58 124.07 48.95 Favored 'General case' 0 N--CA 1.401 -2.885 0 CA-C-O 121.564 0.697 . . . . 54.439999999999998 110.239 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.495 ' N ' ' HB2' ' B' ' 249' ' ' ALA . . . 108.14 -45.55 1.29 Allowed Glycine 0 N--CA 1.416 -2.638 0 CA-C-N 114.991 -1.004 . . . . 62.009999999999998 110.971 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 70.79 26.26 74.33 Favored Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 109.845 -1.302 . . . . 75.400000000000006 109.845 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 284' ' ' LYS . . . . . 0.557 ' HB3' HG21 ' B' ' 246' ' ' THR . 24.8 tptp -136.73 14.21 3.15 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.423 -0.954 . . . . 74.349999999999994 108.423 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -112.23 -59.11 0.44 Allowed Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.569 -0.741 . . . . 61.350000000000001 111.429 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.456 ' CG ' HD12 ' B' ' 276' ' ' LEU . 19.0 t80 -90.41 -20.66 22.53 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.185 -1.043 . . . . 63.299999999999997 108.185 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.507 ' HE1' ' HB2' ' C' ' 238' ' ' ARG . 14.3 m-90 -132.33 -166.68 1.77 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.002 -0.999 . . . . 73.209999999999994 108.79 176.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -146.85 145.07 29.74 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.156 -1.053 . . . . 74.150000000000006 108.156 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -71.03 -26.94 63.32 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 123.96 0.788 . . . . 71.319999999999993 110.563 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -123.27 -173.44 2.72 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.325 -0.991 . . . . 74.310000000000002 108.325 -176.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -66.51 124.1 21.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.063 -1.458 . . . . 75.450000000000003 107.063 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -103.89 110.05 22.03 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.373 0.606 . . . . 63.109999999999999 111.696 -174.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -163.26 96.95 0.89 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.469 -1.678 . . . . 75.010000000000005 106.469 171.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -86.84 138.69 31.36 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.43 -0.952 . . . . 71.219999999999999 108.43 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 . . . . . 0 C--N 1.293 -1.882 0 N-CA-C 107.895 -1.15 . . . . 74.219999999999999 107.895 -178.981 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 CA--C 1.505 -0.783 0 N-CA-C 109.633 -0.506 . . . . 75.239999999999995 109.633 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -70.83 105.94 3.41 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.523 -0.547 . . . . 74.340000000000003 109.523 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 12.9 pt -85.76 80.92 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 121.583 0.706 . . . . 71.329999999999998 110.24 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -93.36 92.79 7.83 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-N 115.534 -0.757 . . . . 70.420000000000002 109.766 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 67.91 164.23 0.22 Allowed 'General case' 0 C--O 1.241 0.65 0 O-C-N 125.125 1.515 . . . . 72.230000000000004 113.402 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 34.8 mm -88.94 131.83 35.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.713 -1.588 . . . . 71.099999999999994 106.713 174.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 29.8 m -100.55 118.22 46.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 119.282 -0.967 . . . . 62.100000000000001 112.911 -175.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 39.73 55.08 2.78 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 113.642 -1.617 . . . . 74.530000000000001 115.646 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.535 ' HG2' ' HB ' ' B' ' 261' ' ' THR . 70.5 mtt180 -92.23 121.07 33.4 Favored 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 118.62 -1.232 . . . . 70.409999999999997 112.691 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -116.57 116.92 28.51 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.367 -1.345 . . . . 74.239999999999995 107.367 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' B' ' 263' ' ' SER . 15.7 p -128.72 139.39 52.24 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 121.569 0.699 . . . . 53.439999999999998 111.423 -176.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.5 ' HB1' HD11 ' C' ' 231' ' ' ILE . . . -126.91 129.49 48.29 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.015 -0.993 . . . . 52.420000000000002 108.469 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 13.8 tmtt? -87.48 -60.35 2.0 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.288 0.368 . . . . 74.439999999999998 111.614 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.32 138.04 53.54 Favored 'General case' 0 CA--C 1.484 -1.565 0 O-C-N 121.741 -0.599 . . . . 72.319999999999993 110.074 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.5 HD11 ' HB1' ' C' ' 228' ' ' ALA . 41.5 mm -133.13 119.12 35.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.777 -1.194 . . . . 72.409999999999997 107.777 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 44.9 ttt180 -122.65 115.22 21.73 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 109.479 -0.563 . . . . 71.439999999999998 109.479 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 42.5 p -110.61 127.39 55.23 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.725 -1.583 . . . . 63.340000000000003 106.725 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -141.58 153.62 44.93 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 120.143 -0.623 . . . . 74.530000000000001 110.107 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.511 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 43.4 mt-10 61.31 85.41 0.12 Allowed 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.889 1.368 . . . . 71.319999999999993 113.156 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.511 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 1.4 mpt_? 59.18 5.17 0.53 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.813 1.645 . . . . 72.340000000000003 113.393 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -69.6 147.5 50.61 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.461 0.648 . . . . 41.100000000000001 112.073 -174.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.706 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 1.5 mpt_? -126.98 135.02 50.29 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.273 -0.876 . . . . 75.030000000000001 108.959 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.2 p -128.32 139.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.066 0.46 . . . . 72.209999999999994 111.326 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.506 ' NE2' ' HB2' ' B' ' 280' ' ' GLU . 5.4 tp-100 -110.47 120.02 41.07 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.053 -0.976 . . . . 61.399999999999999 108.815 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.572 HD22 HD21 ' B' ' 262' ' ' ASN . 3.1 tm? -115.16 116.52 28.5 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 105.339 -2.097 . . . . 73.209999999999994 105.339 172.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.486 ' HA2' ' OD1' ' B' ' 226' ' ' ASN . . . 142.45 -121.88 1.86 Allowed Glycine 0 N--CA 1.41 -3.073 0 C-N-CA 118.56 -1.781 . . . . 42.200000000000003 113.174 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 35.8 t30 -144.63 128.48 17.36 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 123.621 0.248 . . . . 74.439999999999998 111.608 -171.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' B' ' 280' ' ' GLU . 92.0 t -118.52 122.98 70.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.221 -1.029 . . . . 64.400000000000006 108.221 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.94 128.85 75.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 120.533 -0.467 . . . . 73.439999999999998 110.454 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 246' ' ' THR . . . . . 0.432 HG21 ' HB3' ' C' ' 284' ' ' LYS . 2.6 m -99.33 161.05 13.84 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.196 -1.038 . . . . 65.409999999999997 108.196 174.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.3 -32.29 69.91 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.832 0.853 . . . . 74.109999999999999 110.959 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.48 -35.49 63.11 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.21 -1.359 . . . . 64.140000000000001 112.522 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.95 -26.45 61.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.012 0.434 . . . . 53.520000000000003 111.686 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.96 28.0 0.62 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.047 0.758 . . . . 71.120000000000005 113.047 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -66.04 -24.63 66.78 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.811 0.815 . . . . 73.340000000000003 109.767 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -168.48 -48.91 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 109.178 -1.569 . . . . 43.049999999999997 109.178 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 148.27 172.58 18.35 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 109.426 -1.47 . . . . 73.010000000000005 109.426 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 10.2 tt -147.3 114.07 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.576 -0.528 . . . . 60.0 109.576 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -115.59 16.12 16.54 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.288 -0.415 . . . . 65.310000000000002 110.881 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 50.2 mm -61.59 99.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.158 -0.682 . . . . 53.439999999999998 109.158 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 14.7 m -102.63 173.85 6.15 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.493 -0.776 . . . . 71.349999999999994 109.436 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -158.11 159.82 36.65 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.233 -1.025 . . . . 63.009999999999998 108.233 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -71.29 71.04 0.61 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 122.52 1.153 . . . . 70.239999999999995 109.361 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 2.8 p -102.31 123.13 45.58 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 115.685 1.735 . . . . 72.319999999999993 115.685 -171.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 32.0 m -133.54 107.09 7.8 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 104.706 -2.331 . . . . 64.019999999999996 104.706 167.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -113.86 123.95 51.03 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.228 -1.027 . . . . 74.209999999999994 108.228 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 34.8 m -134.86 122.81 22.54 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.789 -0.819 . . . . 51.210000000000001 108.789 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 264' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' C' ' 228' ' ' ALA . 12.1 p -108.94 144.27 17.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.012 -0.736 . . . . 72.219999999999999 109.012 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -78.79 -77.17 0.17 Allowed 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 108.625 -0.88 . . . . 64.209999999999994 108.625 -176.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 85.8 m -132.82 134.12 44.25 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.133 -0.354 . . . . 65.310000000000002 110.357 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 25.6 t -118.43 129.17 75.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.245 -1.391 . . . . 65.0 107.245 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 268' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.4 p -127.79 132.35 68.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 120.919 -0.313 . . . . 42.409999999999997 111.159 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.16 132.86 11.24 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 108.869 -1.692 . . . . 74.230000000000004 108.869 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -133.86 145.55 49.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.978 0.389 . . . . 62.520000000000003 110.569 -174.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.41 -65.83 3.92 Favored Glycine 0 CA--C 1.5 -0.865 0 N-CA-C 110.631 -0.988 . . . . 63.229999999999997 110.631 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 179.89 118.94 0.06 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 126.614 1.966 . . . . 72.140000000000001 105.738 174.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 35.7 m -141.02 154.14 45.86 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.311 0.485 . . . . 70.340000000000003 112.311 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -118.89 126.76 52.52 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.366 -1.346 . . . . 74.340000000000003 107.366 171.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 2.1 p -139.08 138.51 41.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 123.044 0.215 . . . . 74.510000000000005 110.776 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.9 tt -128.6 122.63 31.39 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.385 -0.598 . . . . 62.219999999999999 109.385 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.506 HD12 HD23 ' C' ' 241' ' ' LEU . 1.3 pt -113.4 104.47 17.04 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 C-N-CA 123.915 0.886 . . . . 74.430000000000007 109.772 173.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.9 -140.43 7.9 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 119.655 -1.26 . . . . 51.229999999999997 113.123 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -100.15 139.75 35.37 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.623 -0.788 . . . . 74.200000000000003 109.521 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -142.08 118.46 10.86 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 103.324 -2.843 . . . . 74.239999999999995 103.324 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -116.84 124.99 50.87 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.329 0.585 . . . . 75.340000000000003 111.508 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 116.44 -41.52 2.1 Favored Glycine 0 N--CA 1.407 -3.277 0 CA-C-N 114.596 -1.184 . . . . 61.399999999999999 110.612 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 67.07 30.08 75.38 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 109.361 -1.496 . . . . 74.430000000000007 109.361 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 284' ' ' LYS . . . . . 0.432 ' HB3' HG21 ' C' ' 246' ' ' THR . 52.9 tptt -141.92 17.39 2.13 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 108.461 -0.941 . . . . 74.040000000000006 108.461 -174.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -114.32 -72.85 0.57 Allowed Glycine 0 N--CA 1.424 -2.11 0 C-N-CA 120.218 -0.991 . . . . 73.310000000000002 110.725 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -79.64 -25.91 41.24 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.049 0.452 . . . . 72.109999999999999 110.049 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -137.41 167.41 21.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.6 -0.889 . . . . 73.239999999999995 108.6 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -112.55 114.48 27.16 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 105.964 -1.865 . . . . 71.450000000000003 105.964 171.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -76.2 5.17 7.28 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 113.625 0.972 . . . . 63.200000000000003 113.625 -175.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -117.39 -70.12 0.81 Allowed 'General case' 0 C--N 1.307 -1.282 0 O-C-N 122.496 -0.127 . . . . 73.140000000000001 111.021 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -178.81 137.82 0.15 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.122 -1.066 . . . . 73.530000000000001 108.122 -172.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -63.31 116.99 5.99 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.411 0.624 . . . . 70.219999999999999 110.643 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 293' ' ' HIS . . . . . 0.416 ' CG ' ' H ' ' C' ' 294' ' ' HIS . 7.4 p80 -80.16 -92.1 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.675 -0.693 . . . . 73.530000000000001 112.482 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 294' ' ' HIS . . . . . 0.416 ' H ' ' CG ' ' C' ' 293' ' ' HIS . 4.9 p80 -177.22 152.91 0.91 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.597 -1.26 . . . . 55.439999999999998 107.597 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 . . . . . 0 C--N 1.296 -1.731 0 CA-C-O 118.545 -0.741 . . . . 72.040000000000006 109.675 -176.439 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 CA--C 1.499 -0.986 0 N-CA-C 110.083 -0.34 . . . . 62.240000000000002 110.083 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -139.7 78.01 1.64 Allowed 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.361 -0.978 . . . . 60.5 108.361 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.35 -64.48 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.108 -1.442 . . . . 75.549999999999997 107.108 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 55.3 82.65 0.1 Allowed 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 124.712 1.205 . . . . 63.350000000000001 112.998 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -143.23 -178.81 6.04 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.407 -1.331 . . . . 32.140000000000001 107.407 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 7.9 tp -83.03 130.2 36.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.512 -0.551 . . . . 75.439999999999998 109.512 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.0 m -99.58 161.96 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 109.16 -0.682 . . . . 74.209999999999994 109.16 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.481 ' H ' HG22 ' A' ' 261' ' ' THR . . . 78.77 28.95 53.74 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 109.734 -1.346 . . . . 50.039999999999999 109.734 -170.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -113.7 138.5 50.14 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.614 -0.513 . . . . 52.030000000000001 109.614 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.403 ' ND2' ' HA2' ' A' ' 278' ' ' GLY . 44.9 t-20 -117.82 114.83 23.85 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 106.147 -1.797 . . . . 74.299999999999997 106.147 168.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 33.6 m -120.59 137.01 54.64 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.388 0.613 . . . . 54.310000000000002 111.149 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.77 130.31 51.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.851 -1.166 . . . . 64.310000000000002 107.851 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 39.4 ttmt -79.04 -63.97 1.29 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.816 -0.354 . . . . 74.140000000000001 111.911 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -126.51 139.25 53.37 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 118.914 -1.114 . . . . 75.140000000000001 110.261 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.3 mt -130.75 119.57 45.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.634 -0.876 . . . . 72.329999999999998 108.634 -175.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 87.2 mtt180 -125.08 115.05 19.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.755 -1.202 . . . . 71.409999999999997 107.755 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.474 HG21 HG22 ' A' ' 239' ' ' VAL . 40.4 p -128.24 128.66 45.1 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 120.567 -0.453 . . . . 72.340000000000003 109.838 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -126.6 166.07 18.0 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 119.751 -0.78 . . . . 73.0 112.608 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 71.42 -88.09 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.603 -1.635 . . . . 54.130000000000003 114.311 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.494 ' HD3' ' OE2' ' A' ' 272' ' ' GLU . 0.0 OUTLIER -135.48 26.66 3.43 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.162 -1.051 . . . . 70.329999999999998 108.162 -176.324 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -69.04 149.45 48.74 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.598 -0.728 . . . . 64.439999999999998 111.245 -174.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.83 134.9 53.52 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 105.932 -1.877 . . . . 70.510000000000005 105.932 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.474 HG22 HG21 ' A' ' 233' ' ' THR . 9.8 t -135.17 139.0 47.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.981 0.419 . . . . 53.399999999999999 110.659 -170.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.479 ' HB3' HD13 ' A' ' 276' ' ' LEU . 6.3 tp-100 -131.2 135.28 47.26 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.595 -1.261 . . . . 71.200000000000003 107.595 172.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.1 tt -130.42 120.2 23.85 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.947 -1.501 . . . . 64.120000000000005 106.947 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.608 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 128.93 -113.91 1.65 Allowed Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.7 -0.762 . . . . 61.340000000000003 111.386 177.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -144.39 144.33 31.37 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.613 -0.345 . . . . 71.140000000000001 110.087 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.441 ' CG2' ' HG2' ' A' ' 240' ' ' GLN . 83.6 t -118.75 118.3 57.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.811 -1.181 . . . . 63.439999999999998 107.811 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.57 112.8 35.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 N-CA-C 109.135 -0.691 . . . . 55.549999999999997 109.135 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.474 HG22 ' HA3' ' A' ' 282' ' ' GLY . 8.9 t -94.92 161.0 14.33 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.034 -1.066 . . . . 74.299999999999997 109.863 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.45 -33.61 75.94 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.42 0.688 . . . . 33.200000000000003 111.778 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.83 65.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.399 -0.819 . . . . 75.340000000000003 111.579 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.703 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -66.72 -29.27 69.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.028 -0.533 . . . . 73.430000000000007 111.706 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.93 82.81 7.43 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 113.578 0.955 . . . . 73.230000000000004 113.578 -174.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -116.88 1.59 12.7 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.521 -1.218 . . . . 43.350000000000001 108.304 171.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 161.69 -172.13 37.8 Favored Glycine 0 N--CA 1.419 -2.446 0 N-CA-C 107.633 -2.187 . . . . 73.209999999999994 107.633 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.45 74.46 0.69 Allowed Glycine 0 N--CA 1.428 -1.868 0 C-N-CA 120.141 -1.028 . . . . 52.210000000000001 112.011 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 7.9 tp -74.64 -47.76 37.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-O 120.658 0.266 . . . . 71.030000000000001 111.226 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.437 ' O ' ' HA3' ' B' ' 253' ' ' GLY . 37.0 ttm180 -90.34 83.82 5.98 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 121.28 0.562 . . . . 64.230000000000004 109.527 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 12.6 tt -89.8 117.94 34.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.606 -0.887 . . . . 72.040000000000006 108.606 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 50.1 m -147.85 153.96 39.81 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.533 -0.758 . . . . 74.049999999999997 108.968 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -88.2 100.17 12.77 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.915 -1.513 . . . . 61.409999999999997 106.915 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.78 -22.6 49.9 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.325 -0.398 . . . . 44.409999999999997 111.641 -177.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 10.3 m -101.12 121.71 42.31 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 115.962 -0.563 . . . . 72.439999999999998 109.939 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 224' ' ' GLY . 25.8 p -93.88 117.14 29.7 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.554 -0.906 . . . . 54.009999999999998 108.554 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 7.9 t30 -117.99 138.46 52.18 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.419 -0.912 . . . . 75.25 111.065 -176.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 39.8 m -138.59 123.33 18.69 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.147 -0.479 . . . . 55.130000000000003 109.935 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 10.7 p -128.89 145.59 35.5 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-N 116.259 -0.428 . . . . 74.140000000000001 110.939 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 12.0 mm-40 -84.66 -75.68 0.34 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.429 -0.351 . . . . 62.240000000000002 110.945 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.7 p -118.36 127.91 54.14 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.659 0.614 . . . . 64.219999999999999 112.659 -175.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 277' ' ' ILE . 26.7 m -124.87 127.11 72.33 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 109.396 -0.594 . . . . 74.219999999999999 109.396 174.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 7.3 p -127.14 132.18 70.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 121.205 0.526 . . . . 63.100000000000001 111.863 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.541 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -113.66 131.67 10.11 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 109.919 -1.272 . . . . 75.420000000000002 109.919 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -132.12 116.42 17.01 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 111.99 0.367 . . . . 74.530000000000001 111.99 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 92.96 -123.39 7.32 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 120.747 -0.74 . . . . 65.430000000000007 112.386 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.494 ' OE2' ' HD3' ' A' ' 236' ' ' ARG . 40.9 mm-40 -92.39 35.48 1.01 Allowed 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.333 1.053 . . . . 63.439999999999998 109.335 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 50.1 m -81.68 144.36 31.22 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.069 0.938 . . . . 51.32 111.04 -174.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -130.5 126.73 37.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 104.809 -2.293 . . . . 71.409999999999997 104.809 176.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.94 134.0 41.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 121.565 0.697 . . . . 73.25 111.509 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.479 HD13 ' HB3' ' A' ' 240' ' ' GLN . 11.0 tp -120.23 121.64 39.17 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.228 -0.896 . . . . 74.099999999999994 110.671 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 267' ' ' VAL . 81.6 mt -104.39 104.27 16.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 114.107 -1.406 . . . . 75.099999999999994 108.073 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 140.22 -153.86 23.66 Favored Glycine 0 N--CA 1.427 -1.918 0 C-N-CA 120.181 -1.009 . . . . 45.219999999999999 113.866 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -91.96 128.48 37.82 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.828 0.851 . . . . 74.420000000000002 110.295 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -111.1 118.69 36.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.838 -2.282 . . . . 71.439999999999998 104.838 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.496 ' OH ' ' HA3' ' B' ' 252' ' ' GLY . 1.7 t80 -120.02 122.23 40.67 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.473 -1.306 . . . . 64.150000000000006 107.473 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.474 ' HA3' HG22 ' A' ' 246' ' ' THR . . . 125.24 -41.38 1.7 Allowed Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.351 -1.295 . . . . 71.340000000000003 110.744 -175.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 125.05 -57.96 0.67 Allowed Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 110.46 -1.056 . . . . 64.219999999999999 110.46 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -145.08 80.6 1.62 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.084 0.945 . . . . 72.430000000000007 112.517 177.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -100.86 -40.35 2.91 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 114.748 -1.115 . . . . 52.329999999999998 110.467 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -69.81 -36.53 75.71 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.17 0.51 . . . . 70.510000000000005 110.477 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.44 ' CZ2' ' HE1' ' B' ' 286' ' ' PHE . 27.8 m-90 -92.45 131.17 37.83 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.481 -0.933 . . . . 74.329999999999998 108.481 175.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -50.93 -39.62 55.23 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.455 1.097 . . . . 73.530000000000001 110.692 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.7 t30 173.09 176.33 0.1 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 102.397 -3.186 . . . . 74.219999999999999 102.397 174.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.456 ' CE1' ' HD3' ' B' ' 274' ' ' ARG . 63.5 t60 -129.57 120.35 25.17 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 107.411 -1.329 . . . . 75.549999999999997 107.411 174.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -65.17 138.21 58.12 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.44 -0.578 . . . . 53.340000000000003 109.44 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' HIS . . . . . 0.441 ' CD2' ' H ' ' A' ' 292' ' ' HIS . 4.9 p80 -69.85 80.52 0.46 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.462 1.125 . . . . 55.399999999999999 113.604 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -86.84 80.85 8.35 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.291 -1.744 . . . . 74.319999999999993 106.291 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -139.48 171.37 14.35 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.735 -1.121 . . . . 65.230000000000004 111.039 -173.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 70.2 t60 . . . . . 0 C--N 1.324 -0.527 0 C-N-CA 126.147 1.779 . . . . 70.299999999999997 106.55 175.785 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.505 -0.779 0 N-CA-C 107.553 -1.277 . . . . 73.430000000000007 107.553 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -70.17 -39.18 75.45 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.46 -0.496 . . . . 60.229999999999997 109.943 177.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 219' ' ' ILE . . . . . 0.461 HG22 ' H ' ' C' ' 223' ' ' VAL . 41.5 pt -68.76 134.18 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.539 -0.755 . . . . 55.439999999999998 110.078 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -148.34 -167.69 2.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.193 -1.41 . . . . 73.140000000000001 107.193 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 65.71 -178.78 0.19 Allowed 'General case' 0 C--O 1.252 1.213 0 C-N-CA 124.358 1.063 . . . . 53.130000000000003 111.782 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 6.2 tp -86.7 131.97 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 107.893 -1.151 . . . . 55.450000000000003 107.893 173.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.34 147.63 7.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.051 -1.092 . . . . 62.299999999999997 108.051 -177.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 85.0 36.82 10.68 Favored Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 107.554 -2.219 . . . . 52.030000000000001 107.554 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 261' ' ' THR . 36.1 ttt180 -123.45 128.7 50.19 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 113.63 -1.285 . . . . 73.019999999999996 110.893 -173.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.487 HD22 ' HA2' ' B' ' 278' ' ' GLY . 38.3 t-20 -117.17 127.79 54.47 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.615 -1.624 . . . . 63.43 106.615 169.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 58.0 m -129.98 137.25 50.21 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-O 121.625 0.726 . . . . 73.109999999999999 111.078 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -125.63 137.42 53.88 Favored 'General case' 0 N--CA 1.404 -2.756 0 CA-C-N 114.146 -1.388 . . . . 74.010000000000005 107.56 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 3.5 ttmp? -84.28 -70.77 0.55 Allowed 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.309 -0.956 . . . . 70.5 110.467 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -127.25 137.71 52.93 Favored 'General case' 0 N--CA 1.428 -1.557 0 C-N-CA 119.684 -0.807 . . . . 63.530000000000001 109.736 -174.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 6.3 mt -134.16 117.97 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.207 -1.034 . . . . 64.430000000000007 108.207 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -113.42 119.31 37.18 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.018 -1.104 . . . . 74.010000000000005 108.018 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.551 HG22 HG21 ' B' ' 239' ' ' VAL . 22.2 p -116.72 126.95 53.9 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 106.05 -1.833 . . . . 73.329999999999998 106.05 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 234' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' B' ' 270' ' ' LYS . 52.1 mt-10 -134.22 153.93 51.56 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.476 0.655 . . . . 71.439999999999998 112.366 -176.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.522 ' HB3' ' HD3' ' B' ' 236' ' ' ARG . 45.0 mt-10 71.88 -83.64 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 113.642 -1.617 . . . . 73.409999999999997 114.016 171.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.522 ' HD3' ' HB3' ' B' ' 235' ' ' GLU . 0.4 OUTLIER -136.61 42.28 2.51 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 107.964 -1.124 . . . . 73.239999999999995 107.964 -178.4 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -82.81 139.56 33.45 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.886 -1.052 . . . . 73.519999999999996 111.773 -177.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 5.8 mpt_? -123.74 132.52 53.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 103.751 -2.685 . . . . 72.129999999999995 103.751 173.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.551 HG21 HG22 ' B' ' 233' ' ' THR . 86.7 t -142.93 132.62 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-O 121.604 0.716 . . . . 61.149999999999999 112.006 -172.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.562 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 55.1 tp60 -112.43 132.02 55.26 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 106.901 -1.518 . . . . 74.230000000000004 106.901 173.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.475 HD12 HG23 ' A' ' 277' ' ' ILE . 1.7 tm? -130.04 117.44 20.03 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.856 -1.164 . . . . 75.219999999999999 107.856 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.59 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 129.08 -114.1 1.68 Allowed Glycine 0 C--N 1.309 -0.935 0 N-CA-C 110.817 -0.913 . . . . 74.540000000000006 110.817 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -145.38 153.66 41.45 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 122.048 -0.678 . . . . 71.25 110.467 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.562 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 61.7 t -129.53 120.26 50.2 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 108.566 -0.902 . . . . 74.200000000000003 108.566 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.14 112.37 33.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 109.528 -0.545 . . . . 74.340000000000003 109.528 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.543 HG22 ' HA3' ' B' ' 282' ' ' GLY . 6.7 t -86.82 161.31 18.41 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.577 -0.849 . . . . 54.32 111.382 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.703 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.4 -33.62 75.94 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 122.434 1.111 . . . . 53.299999999999997 109.727 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.64 78.53 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 112.708 -2.042 . . . . 72.219999999999999 113.104 -177.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -60.12 -46.66 88.87 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.186 0.595 . . . . 61.149999999999999 112.031 -174.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.51 157.75 1.31 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 101.45 -3.537 . . . . 75.349999999999994 101.45 -176.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -79.33 70.42 5.74 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 119.611 1.096 . . . . 44.409999999999997 113.164 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 252' ' ' GLY . . . . . 0.496 ' HA3' ' OH ' ' A' ' 281' ' ' TYR . . . 62.09 -144.63 49.17 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.085 -1.416 . . . . 72.219999999999999 115.539 174.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 253' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 255' ' ' ARG . . . -74.01 60.78 2.19 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 114.514 -0.843 . . . . 65.209999999999994 114.849 -175.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.23 3.78 4.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 106.861 -1.533 . . . . 63.420000000000002 106.861 170.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -160.03 138.81 10.6 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.124 -2.547 . . . . 73.0 104.124 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 39.0 pt -127.81 140.73 48.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 118.814 0.734 . . . . 75.209999999999994 110.151 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.9 t -149.06 119.65 7.46 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 120.402 -0.519 . . . . 64.239999999999995 110.396 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -152.06 146.09 25.28 Favored 'General case' 0 C--O 1.253 1.257 0 N-CA-C 103.03 -2.952 . . . . 74.420000000000002 103.03 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 259' ' ' GLN . . . . . 0.418 ' HA ' HG12 ' C' ' 256' ' ' ILE . 55.7 mt-30 -146.61 -63.96 0.3 Allowed 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 113.649 0.981 . . . . 71.239999999999995 113.649 -172.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 31.5 m -83.48 127.11 33.45 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.243 -0.889 . . . . 65.329999999999998 112.764 -169.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 61.8 m -91.19 108.85 20.15 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 106.653 -1.61 . . . . 74.129999999999995 106.653 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.519 HD21 HD11 ' C' ' 241' ' ' LEU . 7.5 t30 -106.25 145.67 31.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.199 0.523 . . . . 72.400000000000006 112.123 -171.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.9 m -138.57 123.86 19.29 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.218 -0.66 . . . . 72.120000000000005 109.218 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 15.0 p -127.37 143.84 39.3 Favored 'Isoleucine or valine' 0 C--O 1.249 1.027 0 N-CA-C 109.802 -0.444 . . . . 54.119999999999997 109.802 178.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 48.7 mm-40 -90.48 -71.71 0.61 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.559 -0.291 . . . . 64.239999999999995 110.437 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 26.9 m -121.66 127.06 50.39 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.086 -0.646 . . . . 73.400000000000006 110.816 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.87 123.54 56.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 116.086 -0.506 . . . . 71.319999999999993 110.163 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.17 133.92 67.12 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 CA-C-O 121.491 0.662 . . . . 71.200000000000003 112.425 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 269' ' ' GLY . . . . . 0.524 ' HA2' ' OG1' ' C' ' 233' ' ' THR . . . -111.23 131.64 10.44 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 110.415 -1.074 . . . . 63.25 110.415 175.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.416 ' HD2' ' HB2' ' B' ' 234' ' ' GLU . 29.1 mmmt -132.89 116.71 16.82 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 123.665 0.786 . . . . 75.019999999999996 111.761 -176.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.42 -133.81 11.75 Favored Glycine 0 C--N 1.299 -1.486 0 N-CA-C 110.711 -0.955 . . . . 54.520000000000003 110.711 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 272' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 77.8 mm-40 -85.31 48.14 1.53 Allowed 'General case' 0 C--O 1.258 1.527 0 C-N-CA 123.3 0.64 . . . . 73.010000000000005 109.939 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 273' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 74.7 m -82.09 144.68 30.63 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 122.386 1.089 . . . . 44.520000000000003 111.826 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 7.5 mtm180 -135.66 124.72 24.34 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 106.559 -1.645 . . . . 74.219999999999999 106.559 172.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' C' ' 239' ' ' VAL . 7.4 p -140.5 138.17 36.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-O 121.216 0.532 . . . . 55.43 111.303 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.561 HD13 ' CG ' ' B' ' 240' ' ' GLN . 4.5 tp -119.43 115.82 24.86 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.463 -0.79 . . . . 64.129999999999995 109.881 175.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.463 HG23 HD12 ' C' ' 241' ' ' LEU . 3.9 mp -98.9 103.37 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 N-CA-C 106.332 -1.729 . . . . 71.430000000000007 106.332 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.59 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 147.74 -157.21 27.28 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 119.563 -1.304 . . . . 52.450000000000003 114.436 178.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -96.44 124.64 40.5 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 124.084 0.954 . . . . 62.200000000000003 109.964 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -111.1 118.98 37.47 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.891 -1.892 . . . . 72.109999999999999 105.891 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.409 ' CD1' HG13 ' C' ' 245' ' ' VAL . 0.9 OUTLIER -119.4 122.52 41.96 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 107.129 -1.434 . . . . 64.319999999999993 107.129 178.284 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.543 ' HA3' HG22 ' B' ' 246' ' ' THR . . . 130.16 -38.44 1.97 Allowed Glycine 0 N--CA 1.417 -2.61 0 CA-C-N 114.612 -1.177 . . . . 71.319999999999993 111.332 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 116.95 -52.21 0.69 Allowed Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.02 -1.232 . . . . 72.010000000000005 110.02 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 284' ' ' LYS . . . . . 0.647 ' HD2' ' O ' ' B' ' 284' ' ' LYS . 0.1 OUTLIER -148.5 72.77 1.21 Allowed 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 122.403 1.097 . . . . 73.530000000000001 111.315 -178.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -90.17 -51.86 2.68 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.115 -1.194 . . . . 63.520000000000003 110.115 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.44 ' HE1' ' CZ2' ' A' ' 287' ' ' TRP . 56.3 t80 -65.52 -35.22 80.22 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.416 0.627 . . . . 75.420000000000002 110.561 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.567 ' O ' ' HB2' ' B' ' 284' ' ' LYS . 29.0 m-90 -110.36 88.4 2.76 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.151 -1.055 . . . . 74.430000000000007 108.151 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -77.48 86.35 3.84 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.911 -1.116 . . . . 75.120000000000005 111.857 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 289' ' ' ASN . . . . . 0.499 ' H ' ' HD3' ' B' ' 284' ' ' LYS . 45.1 t-20 -72.4 93.88 1.58 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.078 -1.453 . . . . 72.430000000000007 107.078 175.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -156.16 163.01 40.13 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.582 -1.636 . . . . 73.010000000000005 106.582 -176.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -85.41 90.43 7.94 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.449 0.642 . . . . 74.400000000000006 110.553 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -92.1 -42.68 9.8 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.977 -1.01 . . . . 73.439999999999998 111.454 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 57.39 103.86 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.675 1.19 . . . . 61.210000000000001 112.151 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -129.59 135.38 48.5 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.009 -0.737 . . . . 63.109999999999999 109.009 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 40.5 m80 . . . . . 0 C--N 1.308 -1.2 0 CA-C-O 118.325 -0.845 . . . . 71.340000000000003 108.956 179.888 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 CA--C 1.511 -0.543 0 CA-C-O 120.71 0.291 . . . . 74.129999999999995 110.57 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -105.73 -11.0 16.45 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.023 -0.732 . . . . 74.120000000000005 109.023 175.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 11.5 tt -71.75 155.34 7.39 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-N 114.94 -1.027 . . . . 53.210000000000001 108.422 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 220' ' ' ASP . . . . . 0.563 ' HA ' ' NH2' ' C' ' 225' ' ' ARG . 21.3 t70 -99.88 -61.26 1.39 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.206 -0.665 . . . . 70.420000000000002 109.206 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 65.55 -71.63 0.08 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.562 1.545 . . . . 71.010000000000005 113.923 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 222' ' ' ILE . . . . . 0.483 HG23 ' HD3' ' C' ' 225' ' ' ARG . 6.3 tp -83.69 130.19 36.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.174 0.512 . . . . 61.530000000000001 110.207 -175.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 223' ' ' VAL . . . . . 0.461 ' H ' HG22 ' B' ' 219' ' ' ILE . 49.1 t -99.81 140.23 19.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 106.955 -1.498 . . . . 63.200000000000003 106.955 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 91.02 28.21 16.18 Favored Glycine 0 N--CA 1.431 -1.637 0 N-CA-C 109.743 -1.343 . . . . 54.43 109.743 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.563 ' NH2' ' HA ' ' C' ' 220' ' ' ASP . 17.8 ptt180 -112.35 144.01 42.49 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 115.108 -0.546 . . . . 74.430000000000007 109.69 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.484 HD22 ' HA2' ' C' ' 278' ' ' GLY . 37.3 t-20 -117.75 128.69 55.13 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 105.906 -1.887 . . . . 52.329999999999998 105.906 170.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.1 m -128.77 136.51 50.63 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-O 121.457 0.646 . . . . 63.130000000000003 110.264 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.92 127.47 41.82 Favored 'General case' 0 N--CA 1.417 -2.103 0 N-CA-C 107.92 -1.141 . . . . 74.450000000000003 107.92 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 37.7 ttmt -80.26 -60.68 2.23 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.996 -0.682 . . . . 70.120000000000005 112.097 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -126.21 137.49 53.55 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.076 -1.083 . . . . 74.109999999999999 108.076 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 24.8 mt -136.19 117.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.202 -1.036 . . . . 74.109999999999999 108.202 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 92.5 mtt180 -120.11 119.45 33.34 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.19 -1.041 . . . . 73.549999999999997 108.19 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.566 HG22 HG21 ' C' ' 239' ' ' VAL . 28.9 p -119.75 127.83 53.19 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.462 -1.681 . . . . 64.299999999999997 106.462 -177.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.425 ' HB2' ' HD2' ' C' ' 270' ' ' LYS . 54.2 mt-10 -133.58 155.31 49.86 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.454 0.645 . . . . 61.310000000000002 112.075 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.518 ' HB3' ' HD3' ' C' ' 236' ' ' ARG . 46.6 mt-10 72.26 -86.54 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.199 0 CA-C-N 113.896 -1.502 . . . . 71.030000000000001 114.693 170.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.518 ' HD3' ' HB3' ' C' ' 235' ' ' GLU . 0.3 OUTLIER -131.11 31.32 4.44 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.654 -0.869 . . . . 71.209999999999994 108.654 -177.487 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -75.11 138.39 42.04 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 122.333 1.063 . . . . 71.540000000000006 113.547 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 4.3 mpt_? -123.91 133.37 53.75 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 103.765 -2.68 . . . . 72.519999999999996 103.765 172.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.566 HG21 HG22 ' C' ' 233' ' ' THR . 85.8 t -141.16 132.31 27.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.252 0.549 . . . . 70.120000000000005 111.218 -174.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.603 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 51.8 tp60 -111.68 128.71 56.15 Favored 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 107.05 -1.463 . . . . 64.540000000000006 107.05 174.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.519 HD11 HD21 ' B' ' 262' ' ' ASN . 1.7 tm? -128.62 117.54 21.4 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.411 -0.959 . . . . 62.310000000000002 108.411 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.545 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 131.4 -111.68 1.11 Allowed Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 110.333 -1.107 . . . . 73.450000000000003 110.333 -177.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -145.71 155.19 42.81 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 122.109 -0.642 . . . . 64.200000000000003 110.371 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.603 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 58.8 t -131.22 122.02 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 108.635 -0.876 . . . . 75.129999999999995 108.635 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.409 HG13 ' CD1' ' B' ' 281' ' ' TYR . 2.7 p -122.18 112.01 32.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.54 -0.911 . . . . 54.539999999999999 108.54 173.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 246' ' ' THR . . . . . 0.485 HG22 ' HA3' ' C' ' 282' ' ' GLY . 5.0 t -81.39 162.38 23.39 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.225 0.824 . . . . 72.219999999999999 113.225 -174.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.54 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -60.36 -35.17 75.05 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 124.693 1.197 . . . . 73.329999999999998 109.678 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.49 -34.77 69.41 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.345 -1.298 . . . . 62.200000000000003 111.584 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.59 -36.48 76.27 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.129 -0.487 . . . . 51.039999999999999 110.85 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 97.4 mt 55.97 27.97 11.99 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.585 0.754 . . . . 75.140000000000001 111.302 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -102.74 145.99 28.9 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.114 -0.494 . . . . 74.010000000000005 110.946 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -171.07 60.05 0.17 Allowed Glycine 0 N--CA 1.423 -2.181 0 N-CA-C 109.685 -1.366 . . . . 72.010000000000005 109.685 175.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.77 27.46 6.82 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.528 -0.844 . . . . 72.340000000000003 112.085 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 45.7 mm 43.77 81.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.112 1.365 . . . . 73.409999999999997 113.231 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.82 89.39 3.85 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.398 -0.814 . . . . 73.040000000000006 111.218 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 256' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' B' ' 259' ' ' GLN . 25.4 mt -123.13 13.55 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 107.823 -1.177 . . . . 64.349999999999994 107.823 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 5.9 m -62.55 -42.34 99.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.92 -1.036 . . . . 60.350000000000001 109.207 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -161.25 126.35 3.61 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.993 -1.484 . . . . 71.219999999999999 106.993 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -143.39 154.3 43.57 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.039 -1.837 . . . . 71.439999999999998 106.039 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 26.0 m -64.57 120.24 11.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.404 0.621 . . . . 71.209999999999994 110.58 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 31.2 m -94.56 108.88 20.82 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 115.272 -0.876 . . . . 73.25 108.704 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -111.86 141.44 45.48 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.576 -0.738 . . . . 64.420000000000002 111.497 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 22.0 m -134.74 124.09 24.67 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.073 -1.084 . . . . 75.230000000000004 108.073 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.23 143.8 39.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.863 0.363 . . . . 71.510000000000005 110.613 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 53.9 mm-40 -80.42 -65.43 1.01 Allowed 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 115.955 -0.566 . . . . 61.119999999999997 111.459 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 59.2 m -140.8 130.79 24.61 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.107 -0.637 . . . . 62.25 110.906 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.0 m -123.51 133.88 67.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.852 -0.613 . . . . 73.129999999999995 109.393 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 268' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 8.3 p -128.02 140.23 49.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 116.181 -0.463 . . . . 45.329999999999998 109.945 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.03 132.87 9.61 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.988 -1.245 . . . . 73.5 109.988 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.425 ' HD2' ' HB2' ' C' ' 234' ' ' GLU . 29.8 mmmt -131.36 141.19 49.85 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.25 0.62 . . . . 72.310000000000002 110.177 -177.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 70.64 -132.02 22.05 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.883 -0.675 . . . . 64.439999999999998 112.166 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -85.94 49.35 1.76 Allowed 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 123.582 0.753 . . . . 74.349999999999994 110.502 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 273' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 67.9 m -83.22 145.07 29.36 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.602 0.964 . . . . 72.239999999999995 113.602 -174.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 274' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 41.7 mtt180 -138.68 125.68 21.23 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 103.586 -2.746 . . . . 71.420000000000002 103.586 172.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.481 ' CG1' HG22 ' C' ' 239' ' ' VAL . 4.6 p -140.28 137.78 37.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 C-N-CA 120.297 -0.561 . . . . 63.340000000000003 111.827 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.419 HD13 ' CG ' ' C' ' 240' ' ' GLN . 13.0 tp -113.15 112.43 23.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.644 0.735 . . . . 73.340000000000003 109.74 175.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 30.7 mt -101.21 103.29 14.66 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 104.996 -2.224 . . . . 63.439999999999998 104.996 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 278' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 144.26 -159.63 27.73 Favored Glycine 0 N--CA 1.42 -2.384 0 C-N-CA 118.916 -1.611 . . . . 53.039999999999999 113.863 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -92.6 129.41 38.54 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.793 -0.703 . . . . 74.400000000000006 109.848 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -111.99 122.35 47.51 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 105.435 -2.061 . . . . 71.349999999999994 105.435 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.75 124.26 40.62 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 108.517 -0.92 . . . . 65.400000000000006 108.517 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 282' ' ' GLY . . . . . 0.485 ' HA3' HG22 ' C' ' 246' ' ' THR . . . 122.42 -34.65 3.73 Favored Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.628 -0.715 . . . . 51.130000000000003 112.087 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 122.88 -62.63 0.55 Allowed Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.886 -0.673 . . . . 72.519999999999996 111.645 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 284' ' ' LYS . . . . . 0.622 ' HD2' ' O ' ' C' ' 284' ' ' LYS 0.255 0.1 OUTLIER -136.0 70.02 1.42 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.855 0.836 . . . . 74.450000000000003 112.171 178.525 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.29 -64.06 1.96 Allowed Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.66 -1.257 . . . . 70.430000000000007 110.749 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -65.03 -24.32 67.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.637 0.732 . . . . 54.219999999999999 110.911 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -115.51 45.86 1.6 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.804 -0.634 . . . . 75.040000000000006 110.354 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.25 179.79 2.73 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 120.106 -0.638 . . . . 54.210000000000001 109.749 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -93.34 166.03 12.5 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 114.139 1.163 . . . . 72.519999999999996 114.139 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -56.76 -27.63 59.81 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.895 1.678 . . . . 72.510000000000005 114.44 -170.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -138.78 84.46 2.02 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.284 0.564 . . . . 74.319999999999993 109.556 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -77.01 133.81 39.02 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.532 -0.914 . . . . 62.130000000000003 108.532 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -97.09 171.12 8.67 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.746 -0.464 . . . . 75.120000000000005 109.746 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -95.78 150.6 20.22 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 120.015 -0.674 . . . . 72.239999999999995 109.448 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 . . . . . 0 C--N 1.297 -1.717 0 N-CA-C 107.766 -1.198 . . . . 65.450000000000003 107.766 -178.389 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 C--O 1.24 0.586 0 N-CA-C 109.8 -0.444 . . . . 74.200000000000003 109.8 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 45.8 mttp 70.12 140.44 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.212 1.19 . . . . 74.349999999999994 114.212 174.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 9.6 tt -76.94 116.18 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 105.796 -1.927 . . . . 72.150000000000006 105.796 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -73.31 102.81 3.8 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.503 0.668 . . . . 72.129999999999995 112.145 -173.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -109.33 126.62 53.58 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.703 -1.135 . . . . 64.310000000000002 108.396 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 75.9 mt -101.18 126.99 54.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-O 121.146 0.498 . . . . 71.319999999999993 111.292 -175.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 39.9 t -138.15 119.28 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 105.616 -1.994 . . . . 71.219999999999999 105.616 172.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -129.82 112.46 1.32 Allowed Glycine 0 C--N 1.297 -1.611 0 C-N-CA 120.17 -1.014 . . . . 70.129999999999995 111.18 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 23.6 ptt85 -137.97 142.24 40.49 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.135 0.493 . . . . 71.510000000000005 111.984 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.445 HD22 ' HA2' ' A' ' 278' ' ' GLY . 34.5 t30 -99.3 114.25 27.0 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.201 -1.777 . . . . 60.119999999999997 106.201 173.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.4 m -126.15 136.66 53.13 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.667 -0.813 . . . . 75.120000000000005 111.756 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -120.71 119.41 32.7 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.171 -1.418 . . . . 64.349999999999994 107.171 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -75.8 -58.2 3.42 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 123.803 0.69 . . . . 74.329999999999998 110.165 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -126.57 140.48 52.4 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.137 0.494 . . . . 73.140000000000001 111.345 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.0 mt -134.16 124.95 47.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.162 -1.051 . . . . 65.129999999999995 108.162 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -128.76 122.74 31.27 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.613 -0.514 . . . . 72.239999999999995 109.613 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 20.2 p -112.31 128.23 56.22 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.269 -1.382 . . . . 75.129999999999995 107.269 171.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -147.37 146.4 29.62 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.815 -1.18 . . . . 73.129999999999995 107.815 -175.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 60.14 72.96 0.5 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.248 0.619 . . . . 65.540000000000006 112.634 -175.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 65.28 22.87 12.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.054 0.541 . . . . 65.450000000000003 112.264 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.41 134.97 36.36 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.274 -0.421 . . . . 73.310000000000002 109.893 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.93 139.99 53.0 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.126 -0.488 . . . . 71.420000000000002 111.636 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 p -124.18 138.49 53.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.545 -0.752 . . . . 64.140000000000001 111.513 -176.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.576 ' HB3' HD22 ' A' ' 276' ' ' LEU . 55.0 tp60 -111.15 118.64 36.53 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.688 -1.227 . . . . 63.32 107.688 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.87 118.87 36.7 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.257 -1.016 . . . . 63.020000000000003 108.257 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.572 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 134.89 -136.72 8.73 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.437 -0.887 . . . . 61.399999999999999 111.843 177.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -130.12 128.58 42.11 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.568 -0.901 . . . . 73.510000000000005 108.568 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.4 115.38 43.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.025 -1.102 . . . . 71.230000000000004 108.025 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 45.5 t -113.87 114.39 46.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.701 -0.851 . . . . 63.409999999999997 108.701 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.497 ' HB ' ' HA3' ' A' ' 282' ' ' GLY . 10.7 m -105.06 161.15 14.48 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.895 -1.15 . . . . 62.219999999999999 107.895 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.73 72.34 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.991 0.916 . . . . 75.140000000000001 113.087 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.59 -34.49 64.88 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.899 1.444 . . . . 51.200000000000003 114.899 -174.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' B' ' 247' ' ' ALA . . . -73.81 -45.8 49.21 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.801 1.038 . . . . 53.299999999999997 113.801 -174.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.425 ' HB3' ' H ' ' A' ' 251' ' ' HIS . 3.3 mm? 58.88 -151.39 0.42 Allowed 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.256 -1.016 . . . . 71.120000000000005 108.256 -172.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.425 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 5.8 t-80 -153.68 -161.98 1.36 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.116 -1.439 . . . . 75.049999999999997 107.116 177.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 167.58 -158.39 31.23 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 110.818 -0.913 . . . . 51.130000000000003 110.818 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -72.72 118.24 6.44 Favored Glycine 0 N--CA 1.441 -0.997 0 O-C-N 124.015 0.479 . . . . 61.240000000000002 111.956 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 43.2 mm -96.78 -55.72 5.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 122.879 -0.189 . . . . 73.540000000000006 110.675 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 65.31 -86.75 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.884 1.274 . . . . 70.239999999999995 111.777 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.415 HD12 ' O ' ' A' ' 256' ' ' ILE 0.338 2.7 pp -121.48 109.49 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-O 122.681 1.229 . . . . 74.25 113.6 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 49.6 m -146.84 137.28 23.68 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.754 -1.573 . . . . 63.130000000000003 106.754 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -98.22 -171.31 2.12 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.817 -0.809 . . . . 54.109999999999999 108.817 -173.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -125.42 103.87 8.14 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.265 -0.643 . . . . 70.150000000000006 109.265 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.408 HG21 ' OD1' ' B' ' 279' ' ' ASN . 8.3 m -64.78 125.65 25.47 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.442 -0.799 . . . . 71.109999999999999 110.284 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.5 t -91.89 129.04 37.93 Favored 'General case' 0 N--CA 1.415 -2.189 0 C-N-CA 119.653 -0.819 . . . . 71.049999999999997 108.863 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -124.69 138.37 54.3 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.372 -1.344 . . . . 73.430000000000007 107.372 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.6 m -137.63 123.83 20.48 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.935 -0.706 . . . . 74.129999999999995 111.953 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 11.7 p -122.46 137.76 54.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 115.864 -0.607 . . . . 62.25 109.721 175.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 3.7 tp10 -79.0 -65.34 1.01 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.055 -0.52 . . . . 72.230000000000004 109.937 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 30.8 m -136.97 129.78 30.53 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 121.77 -0.581 . . . . 74.420000000000002 111.973 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.445 HG12 HD12 ' B' ' 231' ' ' ILE . 35.3 m -117.79 126.45 74.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 N-CA-C 108.368 -0.975 . . . . 74.140000000000001 108.368 174.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.93 126.68 66.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 121.38 0.61 . . . . 74.420000000000002 111.518 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.57 132.49 11.0 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 109.937 -1.265 . . . . 54.32 109.937 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' LYS . . . . . 0.644 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 30.5 mmmt -133.13 116.43 16.29 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.514 0.726 . . . . 73.530000000000001 110.284 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.43 86.29 0.9 Allowed Glycine 0 C--N 1.296 -1.67 0 C-N-CA 119.483 -1.342 . . . . 64.340000000000003 113.734 174.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 55.23 31.01 15.65 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.635 1.174 . . . . 71.239999999999995 111.618 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 23.6 m -83.04 149.18 27.1 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.485 0.66 . . . . 32.350000000000001 112.169 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -119.49 128.15 53.71 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.69 -0.856 . . . . 73.209999999999994 108.69 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 24.7 t -122.54 129.99 74.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.999 -0.741 . . . . 74.099999999999994 108.999 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.576 HD22 ' HB3' ' A' ' 240' ' ' GLN . 0.9 OUTLIER -119.78 117.36 27.99 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.556 -1.646 . . . . 73.230000000000004 106.556 173.321 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.496 HD13 ' HB3' ' B' ' 241' ' ' LEU . 42.7 mm -112.89 104.89 17.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.411 -0.959 . . . . 74.140000000000001 108.411 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 144.31 -127.7 3.05 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 119.746 -1.216 . . . . 71.209999999999994 113.007 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -128.36 150.76 49.95 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 120.711 0.291 . . . . 65.010000000000005 110.404 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -129.15 123.62 32.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.803 -1.925 . . . . 74.340000000000003 105.803 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -120.45 123.54 43.23 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.016 -1.475 . . . . 74.200000000000003 107.016 174.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.497 ' HA3' ' HB ' ' A' ' 246' ' ' THR . . . 145.36 -82.49 0.2 Allowed Glycine 0 N--CA 1.412 -2.923 0 C-N-CA 118.905 -1.617 . . . . 72.439999999999998 112.692 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -142.02 16.97 2.56 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.71 -1.233 . . . . 73.030000000000001 113.317 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.505 ' HD3' ' HA ' ' B' ' 286' ' ' PHE . 62.7 mttm 71.57 -38.28 0.42 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.887 1.675 . . . . 71.239999999999995 113.843 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.537 ' HA2' ' CD1' ' B' ' 287' ' ' TRP . . . -72.0 -28.84 67.84 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 117.391 1.717 . . . . 61.509999999999998 117.391 -170.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 276' ' ' LEU 0.325 51.9 p90 53.33 -78.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.468 1.107 . . . . 63.43 113.917 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.3 m0 -95.47 -34.09 12.21 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.677 -0.639 . . . . 73.019999999999996 110.051 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -92.9 175.56 6.75 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.668 -1.234 . . . . 73.0 107.668 175.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' ASN . . . . . 0.467 ' O ' ' HB3' ' B' ' 289' ' ' ASN . 26.7 t-20 -176.79 -67.23 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.957 0.798 . . . . 72.420000000000002 111.419 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.3 t60 167.85 -43.22 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 104.557 -2.386 . . . . 75.230000000000004 104.557 -169.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -69.34 -58.26 4.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 113.313 -1.767 . . . . 75.040000000000006 107.478 175.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -89.07 124.49 34.35 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.964 -1.495 . . . . 72.329999999999998 106.964 172.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -154.49 -27.56 0.12 Allowed 'General case' 0 C--N 1.311 -1.066 0 O-C-N 123.791 0.682 . . . . 73.340000000000003 111.707 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -93.39 78.07 4.44 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.401 0.619 . . . . 64.420000000000002 111.695 -174.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 C--N 1.305 -1.326 0 N-CA-C 105.605 -1.998 . . . . 70.420000000000002 105.605 175.528 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 108.902 -0.777 . . . . 61.340000000000003 108.902 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 218' ' ' LYS . . . . . 0.531 ' O ' ' HD2' ' B' ' 218' ' ' LYS . 0.1 OUTLIER -87.8 132.92 33.99 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.999 -0.681 . . . . 73.230000000000004 111.425 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 13.5 tt -178.84 108.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 124.693 1.197 . . . . 43.520000000000003 108.409 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -135.07 132.97 38.84 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.5 1.143 . . . . 73.109999999999999 113.017 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -156.68 47.16 0.44 Allowed 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 102.765 -3.05 . . . . 63.539999999999999 102.765 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 75.4 mt -81.87 112.85 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 CA-C-N 113.721 -1.581 . . . . 73.239999999999995 112.678 -166.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 223' ' ' VAL . . . . . 0.439 HG12 ' HG3' ' B' ' 225' ' ' ARG . 46.9 t -141.32 119.79 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.28 0 N-CA-C 105.433 -2.062 . . . . 72.310000000000002 105.433 169.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 224' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' B' ' 259' ' ' GLN . . . -98.15 125.89 8.69 Favored Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 109.398 -1.481 . . . . 50.329999999999998 109.398 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.439 ' HG3' HG12 ' B' ' 223' ' ' VAL . 72.1 mtp180 -141.93 121.73 13.53 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 118.146 0.973 . . . . 72.430000000000007 113.561 -175.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -101.04 114.38 28.27 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 104.408 -2.442 . . . . 63.530000000000001 104.408 167.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 55.6 m -130.2 136.01 48.77 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 118.875 -1.13 . . . . 75.409999999999997 112.885 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -120.53 126.0 49.26 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.559 -1.655 . . . . 60.240000000000002 107.443 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 13.2 tmtt? -86.29 -59.34 2.31 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 116.137 -0.483 . . . . 74.540000000000006 110.747 -176.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -126.24 138.26 53.61 Favored 'General case' 0 C--O 1.25 1.12 0 C-N-CA 119.524 -0.87 . . . . 63.229999999999997 109.352 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.449 HG21 HG21 ' B' ' 239' ' ' VAL . 28.1 mt -130.54 121.59 51.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.803 -1.184 . . . . 74.120000000000005 107.803 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 29.3 ttt180 -127.03 118.45 24.47 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-O 121.049 0.452 . . . . 75.230000000000004 109.987 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 24.9 p -109.57 127.55 54.57 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.635 -1.987 . . . . 74.409999999999997 105.635 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 234' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 33.5 tt0 -139.81 138.54 35.9 Favored 'General case' 0 N--CA 1.406 -2.674 0 C-N-CA 119.977 -0.689 . . . . 65.439999999999998 109.564 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.559 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 46.8 mt-10 60.69 91.39 0.06 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.961 1.097 . . . . 75.519999999999996 113.961 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.559 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 61.35 23.79 13.98 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.999 0.92 . . . . 74.409999999999997 110.598 175.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -94.57 144.52 25.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.84 -0.618 . . . . 65.040000000000006 110.973 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -125.16 142.27 51.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.549 -1.278 . . . . 72.340000000000003 107.549 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.449 HG21 HG21 ' B' ' 231' ' ' ILE . 7.5 p -130.75 131.98 64.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 121.479 0.657 . . . . 73.209999999999994 110.699 174.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.549 ' HG3' HD13 ' B' ' 276' ' ' LEU . 5.8 tp-100 -108.15 120.71 43.11 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 105.807 -1.923 . . . . 74.430000000000007 105.807 173.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.496 ' HB3' HD13 ' A' ' 277' ' ' ILE . 3.1 tm? -125.86 117.68 23.88 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.332 -0.988 . . . . 61.240000000000002 108.332 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.27 -122.49 2.55 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.768 -0.73 . . . . 72.439999999999998 111.423 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -144.32 128.1 17.28 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.094 -0.706 . . . . 71.510000000000005 109.094 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 73.8 t -102.91 117.99 49.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.473 -0.936 . . . . 70.209999999999994 108.473 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.16 112.72 35.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.426 0.631 . . . . 73.540000000000006 109.565 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.2 m -105.49 161.66 14.15 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.555 -0.906 . . . . 54.310000000000002 108.555 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 249' ' ' ALA . . . -56.8 -33.33 66.59 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.848 0.859 . . . . 64.230000000000004 111.919 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.04 -34.14 59.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.453 -1.249 . . . . 73.319999999999993 113.14 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -68.43 -25.45 65.03 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 122.773 0.429 . . . . 74.430000000000007 112.092 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 tt -68.7 104.07 1.9 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.594 -0.891 . . . . 65.109999999999999 108.594 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 251' ' ' HIS . . . . . 0.452 ' CB ' ' HB1' ' C' ' 247' ' ' ALA . 14.4 t-80 -153.69 137.53 16.2 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.157 -1.053 . . . . 64.319999999999993 108.157 -177.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 53.01 -106.57 0.42 Allowed Glycine 0 C--O 1.243 0.703 0 O-C-N 124.293 0.995 . . . . 71.519999999999996 113.766 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -165.04 171.33 40.39 Favored Glycine 0 N--CA 1.419 -2.462 0 N-CA-C 107.867 -2.093 . . . . 74.430000000000007 107.867 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 66.9 mt 69.85 92.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 123.692 0.797 . . . . 75.310000000000002 110.757 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -154.37 151.64 29.28 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.181 -0.674 . . . . 71.150000000000006 109.181 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 256' ' ' ILE . . . . . 0.552 ' HA ' ' OH ' ' B' ' 281' ' ' TYR . 44.7 mt 59.97 79.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 C-N-CA 124.315 1.046 . . . . 73.549999999999997 112.043 176.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 72.6 m -163.07 115.6 1.56 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.632 -1.247 . . . . 51.009999999999998 107.632 175.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -134.88 159.93 39.85 Favored 'General case' 0 C--O 1.257 1.452 0 C-N-CA 120.99 -0.284 . . . . 72.420000000000002 110.932 -173.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 259' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' B' ' 259' ' ' GLN . 45.0 tt0 -149.32 18.53 0.95 Allowed 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.063 -1.088 . . . . 74.329999999999998 108.063 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 19.9 m -75.3 121.85 22.82 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.688 -1.227 . . . . 63.399999999999999 107.688 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 91.1 m -91.25 107.87 19.49 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 107.884 -1.154 . . . . 53.310000000000002 107.884 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -120.9 131.31 54.31 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.388 -1.278 . . . . 61.240000000000002 107.559 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 51.5 m -138.86 126.49 21.96 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 120.937 0.399 . . . . 73.120000000000005 110.897 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.3 138.0 53.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.798 -0.761 . . . . 74.109999999999999 110.349 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.613 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 19.8 tp10 -79.24 -59.29 2.83 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.9 -0.591 . . . . 73.109999999999999 109.686 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 39.7 m -145.4 128.11 16.22 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.62 -0.675 . . . . 54.450000000000003 111.924 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.404 HG12 ' HB ' ' C' ' 231' ' ' ILE . 35.7 m -117.54 128.22 74.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.18 -1.044 . . . . 71.140000000000001 108.18 173.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 268' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 6.5 p -128.02 129.77 69.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-N 116.062 -0.517 . . . . 61.329999999999998 112.139 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.6 132.98 11.35 Favored Glycine 0 CA--C 1.475 -2.412 0 N-CA-C 110.037 -1.225 . . . . 73.120000000000005 110.037 176.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.591 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 27.3 mmmt -133.9 115.99 15.09 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 123.184 0.594 . . . . 74.340000000000003 111.621 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 77.54 92.29 0.27 Allowed Glycine 0 C--N 1.299 -1.5 0 C-N-CA 119.872 -1.156 . . . . 72.140000000000001 113.588 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 272' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' B' ' 236' ' ' ARG . 16.0 mp0 61.59 24.82 14.86 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.886 0.875 . . . . 71.219999999999999 111.638 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 273' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 41.6 m -83.04 152.39 25.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.476 0.917 . . . . 74.120000000000005 113.476 -171.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.452 ' HB3' ' CE3' ' B' ' 287' ' ' TRP . 94.9 mtt180 -128.34 127.96 43.66 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.467 -0.938 . . . . 75.510000000000005 108.467 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 47.2 t -126.28 128.17 71.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 122.41 0.284 . . . . 72.049999999999997 110.304 -175.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.549 HD13 ' HG3' ' B' ' 240' ' ' GLN . 5.8 tp -122.43 114.62 20.97 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.569 -0.852 . . . . 64.310000000000002 110.597 169.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.614 HG23 HD12 ' C' ' 241' ' ' LEU . 40.1 mm -108.01 104.55 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 N-CA-C 106.997 -1.483 . . . . 74.519999999999996 106.997 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.84 -148.95 20.75 Favored Glycine 0 CA--C 1.476 -2.389 0 C-N-CA 119.267 -1.444 . . . . 25.329999999999998 112.98 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 279' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 18.4 m120 -112.38 136.59 51.67 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.089 -0.708 . . . . 63.530000000000001 109.089 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.88 118.81 36.54 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.167 -1.79 . . . . 71.109999999999999 106.167 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.552 ' OH ' ' HA ' ' B' ' 256' ' ' ILE . 77.7 m-85 -118.98 124.01 45.95 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.012 0.911 . . . . 65.120000000000005 109.921 175.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 139.29 -64.92 0.54 Allowed Glycine 0 N--CA 1.412 -2.928 0 C-N-CA 119.745 -1.217 . . . . 75.409999999999997 113.5 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -169.73 37.01 0.19 Allowed Glycine 0 C--O 1.21 -1.381 0 C-N-CA 117.371 -2.347 . . . . 74.519999999999996 115.367 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt 70.87 -66.37 0.3 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.637 1.175 . . . . 61.539999999999999 113.188 170.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -81.7 89.84 1.43 Allowed Glycine 0 CA--C 1.494 -1.265 0 CA-C-N 115.458 -0.792 . . . . 33.32 114.033 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.505 ' HA ' ' HD3' ' A' ' 284' ' ' LYS . 6.6 p90 -60.49 -66.45 0.53 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.815 0.846 . . . . 52.210000000000001 112.437 176.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.537 ' CD1' ' HA2' ' A' ' 285' ' ' GLY . 5.0 m-90 -102.56 80.29 1.91 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.739 -1.208 . . . . 72.409999999999997 107.739 176.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -150.07 -59.43 0.2 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.745 -1.205 . . . . 73.349999999999994 107.745 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 289' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 289' ' ' ASN . 59.2 t30 38.02 79.95 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 O-C-N 125.418 1.699 . . . . 75.540000000000006 115.053 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -118.23 25.38 10.36 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 105.175 -2.158 . . . . 73.329999999999998 105.175 171.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 27.7 m80 61.71 73.67 0.47 Allowed 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.187 -2.153 . . . . 73.510000000000005 105.187 -170.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -71.54 148.02 47.11 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.515 -1.675 . . . . 72.140000000000001 111.631 -167.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -76.77 156.56 32.28 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.722 -1.126 . . . . 75.319999999999993 110.105 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -89.41 -23.92 22.03 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.782 -1.192 . . . . 75.510000000000005 107.782 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 . . . . . 0 C--O 1.251 1.156 0 CA-C-N 113.182 -1.826 . . . . 72.219999999999999 109.142 -175.645 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 17.0 mmt . . . . . 0 CA--C 1.496 -1.105 0 CA-C-O 120.784 0.326 . . . . 70.239999999999995 111.49 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -106.67 84.93 2.08 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.575 -1.269 . . . . 72.239999999999995 107.575 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 14.3 tt -125.18 149.83 29.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 115.172 -0.922 . . . . 53.340000000000003 108.901 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -81.74 93.14 6.75 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.35 0.595 . . . . 71.5 112.009 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -164.46 -100.22 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.839 -1.073 . . . . 73.310000000000002 108.439 174.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 47.0 mm -116.53 115.44 49.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 106.949 -1.5 . . . . 71.439999999999998 106.949 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.07 118.15 35.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.685 0.755 . . . . 73.430000000000007 111.095 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -121.79 120.29 4.33 Favored Glycine 0 N--CA 1.42 -2.37 0 N-CA-C 108.779 -1.729 . . . . 75.239999999999995 108.779 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -142.83 148.25 36.77 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-O 121.276 0.56 . . . . 71.310000000000002 111.146 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -101.17 116.32 32.55 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.674 -1.972 . . . . 63.329999999999998 105.674 173.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 50.0 m -131.58 136.98 48.23 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.542 -0.863 . . . . 73.510000000000005 111.887 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.12 130.93 52.03 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.8 -1.091 . . . . 74.439999999999998 108.308 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.629 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.1 OUTLIER -80.27 -67.83 0.73 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.613 -0.884 . . . . 60.219999999999999 108.613 -178.364 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -125.54 139.19 53.82 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 119.869 -0.732 . . . . 74.239999999999995 109.258 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.417 HG23 HG23 ' C' ' 267' ' ' VAL . 20.3 mt -133.42 118.76 32.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.242 -1.392 . . . . 62.299999999999997 107.242 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -120.0 124.52 46.13 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.601 -0.44 . . . . 74.400000000000006 110.222 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 27.8 p -109.58 126.52 53.68 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 104.599 -2.371 . . . . 75.409999999999997 104.599 173.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 32.6 tt0 -140.86 138.81 34.22 Favored 'General case' 0 N--CA 1.415 -2.193 0 C-N-CA 119.804 -0.758 . . . . 63.420000000000002 109.132 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.531 ' C ' ' HD3' ' C' ' 236' ' ' ARG . 56.4 mt-10 62.91 85.74 0.13 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.303 1.002 . . . . 74.519999999999996 112.939 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.579 ' HD3' ' N ' ' C' ' 236' ' ' ARG . 0.1 OUTLIER 64.9 21.82 12.39 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.882 0.873 . . . . 75.25 111.473 174.162 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -91.68 147.48 22.97 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.294 0.569 . . . . 54.049999999999997 111.447 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.418 ' HG3' ' HB2' ' B' ' 274' ' ' ARG . 5.2 mpt_? -125.1 144.41 50.43 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.863 -1.162 . . . . 73.329999999999998 107.863 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.41 HG21 HG21 ' C' ' 231' ' ' ILE . 5.7 p -133.85 135.52 55.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.351 0.596 . . . . 64.209999999999994 111.377 175.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -110.41 117.81 34.59 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 106.913 -1.514 . . . . 72.0 106.913 172.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.614 HD12 HG23 ' B' ' 277' ' ' ILE . 3.2 tm? -121.88 117.69 27.11 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.947 -1.501 . . . . 74.030000000000001 106.947 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.65 -128.38 4.1 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.551 -0.833 . . . . 70.439999999999998 111.024 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 51.5 t-20 -140.14 128.83 23.08 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.426 -0.953 . . . . 71.219999999999999 108.426 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.23 115.12 44.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.637 -1.246 . . . . 71.420000000000002 107.637 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 245' ' ' VAL . . . . . 0.476 ' HB ' ' CE2' ' B' ' 281' ' ' TYR . 43.4 t -120.51 112.57 36.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.949 -0.76 . . . . 63.32 108.949 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.1 m -101.57 160.91 14.04 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.069 -0.715 . . . . 65.200000000000003 109.069 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.452 ' HB1' ' CB ' ' B' ' 251' ' ' HIS . . . -58.91 -31.77 68.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.957 1.303 . . . . 74.109999999999999 110.519 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.31 59.24 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.043 -1.89 . . . . 60.310000000000002 113.616 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.49 -46.5 69.53 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.426 -0.51 . . . . 70.239999999999995 111.412 -176.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 25.3 tp 46.15 35.8 2.8 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.636 1.174 . . . . 74.230000000000004 111.318 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -86.58 121.94 29.82 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.945 -0.57 . . . . 74.109999999999999 111.615 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -82.1 63.55 4.38 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.137 -0.785 . . . . 45.340000000000003 111.137 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -154.57 82.27 0.17 Allowed Glycine 0 C--N 1.293 -1.831 0 N-CA-C 108.947 -1.661 . . . . 64.349999999999994 108.947 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 20.3 pt -117.86 142.53 31.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 115.516 -0.342 . . . . 73.129999999999995 111.536 -175.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 255' ' ' ARG . . . . . 0.453 ' HG3' ' HB2' ' B' ' 259' ' ' GLN . 39.0 ttm180 56.92 78.71 0.21 Allowed 'General case' 0 CA--C 1.534 0.346 0 O-C-N 124.432 1.082 . . . . 74.540000000000006 112.988 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 29.6 pt -132.78 152.39 36.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 114.766 -1.106 . . . . 62.240000000000002 108.145 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 19.4 m -79.84 112.32 17.02 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 120.756 0.313 . . . . 43.229999999999997 110.654 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -81.32 155.04 26.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.759 -0.655 . . . . 62.439999999999998 110.429 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -120.12 -4.05 10.06 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.814 -0.63 . . . . 64.329999999999998 109.574 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 9.4 m -78.02 121.2 23.91 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.192 0.52 . . . . 62.450000000000003 109.772 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -111.78 124.55 52.59 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.561 0.696 . . . . 73.510000000000005 109.259 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -121.24 137.21 54.79 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.803 -1.184 . . . . 75.5 107.803 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 18.1 t -135.95 123.3 21.92 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 108.929 -0.767 . . . . 70.209999999999994 108.929 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.02 131.34 72.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.26 -0.882 . . . . 72.349999999999994 109.119 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.629 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 17.2 tp10 -88.36 -54.76 4.03 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.534 -0.543 . . . . 70.519999999999996 109.534 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 55.0 m -150.22 127.44 11.31 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.349 -0.845 . . . . 50.340000000000003 110.842 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.417 HG23 HG23 ' C' ' 231' ' ' ILE . 5.1 m -121.21 128.42 75.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.706 -0.849 . . . . 45.32 108.706 171.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.09 135.53 63.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 116.34 -0.391 . . . . 74.549999999999997 110.352 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.53 133.49 11.4 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 109.866 -1.294 . . . . 51.240000000000002 109.866 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -132.31 116.24 16.64 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.801 -0.444 . . . . 74.430000000000007 109.801 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.32 93.16 0.56 Allowed Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.345 -0.931 . . . . 64.099999999999994 113.309 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 55.38 28.4 11.42 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.696 1.198 . . . . 75.219999999999999 111.653 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 273' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 46.3 m -82.37 154.89 25.01 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.953 1.094 . . . . 61.409999999999997 113.953 -169.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -122.85 128.26 50.14 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.871 -1.059 . . . . 71.140000000000001 108.254 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 11.0 t -125.64 130.53 72.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.073 -0.714 . . . . 74.519999999999996 109.073 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -123.55 110.59 15.23 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.284 -1.376 . . . . 75.150000000000006 107.284 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 40.8 mm -113.53 103.95 16.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.072 -1.455 . . . . 62.140000000000001 107.072 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.05 -152.65 24.53 Favored Glycine 0 CA--C 1.471 -2.676 0 C-N-CA 120.034 -1.079 . . . . 54.310000000000002 111.216 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.56 141.15 48.44 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 109.213 -0.662 . . . . 73.239999999999995 109.213 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.69 118.37 34.84 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.143 -1.428 . . . . 74.299999999999997 107.143 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -119.08 124.29 46.55 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.76 0.791 . . . . 71.439999999999998 110.828 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.51 -52.92 0.74 Allowed Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 120.072 -1.061 . . . . 22.420000000000002 113.151 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -151.59 -4.16 0.18 Allowed Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 117.434 -2.317 . . . . 64.409999999999997 115.207 -173.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm 78.47 -40.65 0.28 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.832 1.253 . . . . 71.430000000000007 109.616 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 285' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' C' ' 289' ' ' ASN . . . -86.03 110.38 3.47 Favored Glycine 0 N--CA 1.41 -3.067 0 N-CA-C 109.823 -1.311 . . . . 61.299999999999997 109.823 174.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -79.97 -85.84 0.08 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 112.88 0.696 . . . . 61.25 112.88 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -85.12 3.14 40.37 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 120.91 -1.119 . . . . 74.040000000000006 111.486 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 38.4 t70 179.62 145.26 0.18 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.842 -1.91 . . . . 74.310000000000002 105.842 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 289' ' ' ASN . . . . . 0.605 ' HA ' ' HA3' ' C' ' 285' ' ' GLY . 33.4 t-20 -88.89 98.95 12.02 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.176 -1.01 . . . . 74.310000000000002 109.497 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -78.21 -11.09 59.9 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.27 -0.877 . . . . 74.409999999999997 110.459 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 67.9 m80 69.2 -61.36 0.43 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.568 1.547 . . . . 71.349999999999994 112.173 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -90.83 90.37 7.89 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.376 0.608 . . . . 71.129999999999995 109.452 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -135.23 149.57 49.9 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.632 -1.248 . . . . 61.0 107.632 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -83.57 85.26 7.29 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.983 -0.287 . . . . 73.329999999999998 110.919 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 . . . . . 0 C--O 1.25 1.102 0 N-CA-C 105.674 -1.973 . . . . 72.040000000000006 105.674 172.972 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 217' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' B' ' 221' ' ' ALA . 82.6 mtp . . . . . 0 CA--C 1.512 -0.496 0 N-CA-C 108.528 -0.916 . . . . 72.439999999999998 108.528 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.405 ' HB2' ' HE3' ' A' ' 218' ' ' LYS . 37.3 ttmt 59.6 36.03 22.63 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.174 0.99 . . . . 71.109999999999999 109.299 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.2 mp 60.51 71.17 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.052 -1.431 . . . . 71.450000000000003 110.741 -177.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -111.11 1.61 17.41 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.799 -1.091 . . . . 73.420000000000002 109.189 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -86.29 175.4 8.47 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.08 -0.964 . . . . 51.140000000000001 109.529 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 4.7 tp -82.32 119.17 31.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 121.691 0.758 . . . . 52.229999999999997 109.11 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 11.8 p -100.75 147.87 7.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.105 -0.952 . . . . 71.140000000000001 108.611 -176.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.21 59.04 2.1 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.1 -1.2 . . . . 64.430000000000007 110.1 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -142.43 135.33 28.4 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 123.301 0.64 . . . . 72.310000000000002 110.475 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -113.83 127.83 56.16 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.606 -1.257 . . . . 74.140000000000001 107.606 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 28.0 m -123.41 137.66 54.76 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.93 -0.396 . . . . 71.450000000000003 109.93 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.62 125.38 28.63 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.25 -0.432 . . . . 70.540000000000006 110.284 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 12.9 tmtt? -76.3 -62.72 1.52 Allowed 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.723 0.639 . . . . 73.409999999999997 109.749 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -133.72 139.14 46.21 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-O 121.319 0.581 . . . . 53.200000000000003 112.543 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 34.5 mm -123.39 117.12 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 106.774 -1.565 . . . . 71.140000000000001 106.774 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -118.75 115.89 25.41 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.328 0.585 . . . . 71.230000000000004 110.201 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.4 128.27 50.73 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.597 -0.89 . . . . 74.140000000000001 108.597 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -137.1 164.1 29.24 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.258 0.349 . . . . 73.430000000000007 110.607 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 236' ' ' ARG . 34.7 mt-10 66.99 -88.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.777 1.231 . . . . 64.5 113.443 174.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.435 ' HD2' ' HB3' ' A' ' 235' ' ' GLU . 0.2 OUTLIER -138.18 27.25 2.62 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 108.174 -1.047 . . . . 71.409999999999997 108.174 -177.494 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -75.13 149.19 39.13 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.166 -0.925 . . . . 61.509999999999998 110.107 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -125.57 135.06 51.82 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 104.861 -2.274 . . . . 75.099999999999994 104.861 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.14 148.47 30.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.7 0.762 . . . . 71.209999999999994 111.924 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.461 ' CG ' ' HG ' ' A' ' 276' ' ' LEU . 49.9 tp60 -126.87 128.58 46.72 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.96 -1.018 . . . . 72.219999999999999 108.878 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -126.48 118.72 25.51 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.66 -1.607 . . . . 53.119999999999997 106.66 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.499 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 135.86 -135.17 7.64 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.197 -1.001 . . . . 61.43 112.409 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -128.82 128.43 43.9 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 122.687 -0.302 . . . . 74.239999999999995 110.272 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 91.3 t -118.29 127.17 75.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.718 -0.845 . . . . 74.209999999999994 108.718 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.11 112.76 39.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.563 -0.902 . . . . 71.409999999999997 108.563 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 50.6 m -81.14 160.08 24.49 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.554 -1.276 . . . . 72.0 107.554 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.49 84.33 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.543 0.571 . . . . 74.450000000000003 112.543 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.54 -34.89 65.11 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 114.32 1.23 . . . . 73.120000000000005 114.32 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -63.27 -46.06 88.59 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.75 1.019 . . . . 62.210000000000001 113.75 -173.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 66.4 tp 57.86 71.54 0.57 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.352 1.072 . . . . 62.310000000000002 109.953 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -86.32 155.18 20.74 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.825 -1.079 . . . . 72.049999999999997 108.691 -177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -147.35 -127.35 1.75 Allowed Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 110.611 -0.996 . . . . 65.310000000000002 110.611 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -149.64 43.05 0.77 Allowed Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 120.513 -0.851 . . . . 74.310000000000002 112.445 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 6.4 pt -107.86 121.15 60.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 120.696 0.284 . . . . 72.409999999999997 110.24 176.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.81 -178.04 0.21 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.57 1.148 . . . . 72.430000000000007 110.219 -172.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.3 tt -107.64 108.37 25.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.346 -1.353 . . . . 75.439999999999998 107.346 173.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.1 m -83.35 -34.8 25.54 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.12 -0.491 . . . . 62.399999999999999 111.397 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -102.24 106.64 17.49 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.375 -0.93 . . . . 63.020000000000003 111.719 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -119.8 20.57 12.23 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.213 -1.358 . . . . 75.209999999999994 108.078 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 11.0 m -81.23 124.77 29.58 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 115.783 -0.644 . . . . 71.030000000000001 110.957 -175.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 36.2 p -107.92 108.18 19.22 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 106.539 -1.652 . . . . 71.340000000000003 106.539 168.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 31.8 t-20 -126.52 122.21 34.51 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.102 -0.703 . . . . 72.329999999999998 109.102 -174.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 35.3 m -122.92 123.15 40.29 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.697 -0.483 . . . . 74.420000000000002 109.697 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.1 p -115.74 140.52 37.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.01 0.433 . . . . 65.209999999999994 110.629 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.597 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 22.7 tp10 -82.78 -69.2 0.64 Allowed 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.165 -0.925 . . . . 71.540000000000006 110.548 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 13.5 m -133.73 129.22 36.4 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 121.535 -0.728 . . . . 62.310000000000002 111.814 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 24.0 m -118.1 127.28 75.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.814 -1.18 . . . . 72.209999999999994 107.814 170.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.72 127.07 73.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-O 121.116 0.484 . . . . 74.439999999999998 111.533 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.84 133.57 11.53 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.623 -0.717 . . . . 64.510000000000005 111.762 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -125.06 144.17 50.54 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 124.179 0.992 . . . . 61.310000000000002 109.28 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 65.21 -132.06 35.99 Favored Glycine 0 C--N 1.305 -1.149 0 C-N-CA 121.212 -0.518 . . . . 63.409999999999997 112.931 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' B' ' 235' ' ' GLU . 8.7 mm-40 -92.79 53.65 2.07 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 125.201 1.4 . . . . 75.099999999999994 111.413 -177.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 73.5 m -83.1 150.03 26.53 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.166 0.508 . . . . 72.340000000000003 112.113 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -128.61 127.47 42.32 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.183 -1.414 . . . . 64.409999999999997 107.183 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.463 HG13 HG23 ' B' ' 239' ' ' VAL . 16.4 t -132.71 130.09 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 109.094 -0.706 . . . . 73.120000000000005 109.094 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.461 ' HG ' ' CG ' ' A' ' 240' ' ' GLN . 5.8 tt -118.31 121.55 40.67 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.879 -1.156 . . . . 72.409999999999997 107.879 174.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.448 HG23 HD12 ' B' ' 241' ' ' LEU . 3.5 mp -112.23 104.36 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.982 0 N-CA-C 107.303 -1.369 . . . . 55.140000000000001 107.303 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 151.54 -145.27 12.88 Favored Glycine 0 N--CA 1.421 -2.309 0 N-CA-C 111.064 -0.814 . . . . 25.530000000000001 111.064 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' B' ' 243' ' ' ASN . 95.7 m-20 -114.3 140.2 48.81 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 116.735 0.267 . . . . 72.409999999999997 110.594 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.8 OUTLIER -128.16 129.54 46.68 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.796 -1.557 . . . . 73.209999999999994 106.796 178.486 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -119.4 124.62 47.0 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 109.349 -0.612 . . . . 71.519999999999996 109.349 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' GLY . . . . . 0.417 ' CA ' ' HB2' ' A' ' 249' ' ' ALA . . . 136.42 -50.65 0.83 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 111.254 -0.739 . . . . 72.239999999999995 111.254 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 98.12 39.21 3.84 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 109.546 -1.422 . . . . 73.049999999999997 109.546 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -141.04 -56.37 0.5 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.318 -0.553 . . . . 75.129999999999995 109.641 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.612 ' HA3' ' CZ3' ' A' ' 287' ' ' TRP . . . 72.21 -159.53 53.74 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.494 -0.776 . . . . 65.030000000000001 114.907 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -105.24 -0.18 26.62 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.351 -0.425 . . . . 71.209999999999994 109.92 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' TRP . . . . . 0.612 ' CZ3' ' HA3' ' A' ' 285' ' ' GLY . 24.2 m-90 -58.9 -27.18 64.99 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.54 -0.755 . . . . 63.549999999999997 111.944 -174.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -167.2 140.94 3.66 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.288 -1.005 . . . . 73.439999999999998 108.288 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -109.04 24.34 13.26 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 121.641 0.734 . . . . 62.329999999999998 110.405 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -125.05 163.9 21.36 Favored 'General case' 0 C--O 1.252 1.194 0 O-C-N 121.026 -1.046 . . . . 63.450000000000003 109.976 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -81.77 87.68 6.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 104.682 -2.34 . . . . 74.420000000000002 104.682 165.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' HIS . . . . . 0.443 ' CD2' ' H ' ' A' ' 292' ' ' HIS . 2.7 p80 -94.41 -82.18 0.37 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 114.59 1.33 . . . . 71.030000000000001 114.59 -169.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' HIS . . . . . 0.427 ' H ' ' CG ' ' A' ' 292' ' ' HIS . 75.9 m-70 -133.69 87.67 2.4 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.603 0.716 . . . . 74.040000000000006 112.783 -175.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -122.62 76.06 1.31 Allowed 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 104.407 -2.442 . . . . 73.409999999999997 104.407 171.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 107.835 -1.172 . . . . 50.130000000000003 107.835 -171.127 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 67.7 mtm . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 111.665 0.246 . . . . 74.239999999999995 111.665 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -81.52 16.41 1.72 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.824 -0.547 . . . . 61.340000000000003 111.474 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 11.5 tt -163.22 137.82 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.919 0 C-N-CA 124.018 0.927 . . . . 73.099999999999994 108.852 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.42 117.23 19.38 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.952 -1.499 . . . . 40.140000000000001 106.952 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.422 ' HA ' ' SD ' ' A' ' 217' ' ' MET . . . -162.66 -171.75 2.85 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.373 -0.973 . . . . 74.349999999999994 108.373 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 7.0 tp -83.84 129.35 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 108.462 -0.94 . . . . 73.219999999999999 108.462 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 5.5 p -124.41 151.85 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.239 0 N-CA-C 107.08 -1.452 . . . . 72.120000000000005 107.08 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 92.86 39.01 5.33 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 108.866 -1.693 . . . . 72.420000000000002 108.866 -173.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 261' ' ' THR . 13.9 ptt180 -124.38 141.34 52.16 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 121.589 0.709 . . . . 75.109999999999999 111.527 -176.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 48.0 t-20 -116.85 127.63 54.48 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.342 -1.725 . . . . 72.420000000000002 106.342 172.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 19.5 m -125.75 136.37 53.09 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 109.11 -0.7 . . . . 74.25 109.11 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.502 ' HB1' HD11 ' B' ' 231' ' ' ILE . . . -131.39 127.66 37.97 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.808 -0.633 . . . . 62.420000000000002 110.447 -175.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.597 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 12.1 tmtt? -81.73 -68.12 0.72 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.686 -0.688 . . . . 44.420000000000002 109.656 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -127.38 137.48 52.77 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 119.374 -0.93 . . . . 71.230000000000004 110.961 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.502 HD11 ' HB1' ' B' ' 228' ' ' ALA . 35.9 mm -129.77 117.13 40.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 106.544 -1.65 . . . . 72.230000000000004 106.544 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 232' ' ' ARG . . . . . 0.585 ' HD3' ' OE2' ' B' ' 234' ' ' GLU . 18.2 ttm180 -118.47 124.31 47.29 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 120.696 0.284 . . . . 71.109999999999999 110.59 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 73.1 p -115.46 128.23 55.87 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.252 -1.018 . . . . 72.420000000000002 108.252 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 234' ' ' GLU . . . . . 0.585 ' OE2' ' HD3' ' B' ' 232' ' ' ARG . 59.3 mt-10 -127.01 156.24 41.94 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.132 0.491 . . . . 74.340000000000003 111.043 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' B' ' 236' ' ' ARG . 49.3 mt-10 66.68 -86.85 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.443 0 N-CA-C 114.38 1.252 . . . . 75.329999999999998 114.38 172.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 236' ' ' ARG . . . . . 0.462 ' HD2' ' HB3' ' B' ' 235' ' ' GLU . 0.8 OUTLIER -135.59 31.84 3.08 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.31 -0.996 . . . . 60.119999999999997 108.31 -178.297 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -76.56 141.91 40.99 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.106 -0.952 . . . . 74.5 111.745 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 7.1 mpt_? -125.12 133.86 52.68 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.895 -1.52 . . . . 70.549999999999997 106.895 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.573 HG12 ' HB ' ' B' ' 275' ' ' VAL . 21.7 m -140.97 151.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.419 0.628 . . . . 54.229999999999997 112.331 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.502 ' CG ' ' HG ' ' B' ' 276' ' ' LEU . 38.3 tp60 -119.43 137.31 53.85 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.019 -1.446 . . . . 71.340000000000003 108.728 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.448 HD12 HG23 ' A' ' 277' ' ' ILE . 2.7 tm? -129.39 117.96 21.43 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.212 -1.773 . . . . 75.420000000000002 106.212 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.564 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 131.33 -131.8 6.53 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.504 -0.855 . . . . 40.219999999999999 112.886 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.515 ' HB3' ' OD1' ' A' ' 279' ' ' ASN . 23.8 t-20 -125.38 136.3 53.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 122.491 -0.417 . . . . 70.150000000000006 110.912 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 280' ' ' GLU . 93.8 t -126.77 128.36 70.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.366 -0.975 . . . . 74.209999999999994 108.366 175.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 61.9 t -120.38 112.83 38.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.182 -1.044 . . . . 72.549999999999997 108.182 174.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.45 HG21 ' HB3' ' B' ' 284' ' ' LYS . 28.4 m -76.68 160.74 29.11 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 106.776 -1.564 . . . . 73.430000000000007 106.776 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.08 -33.87 76.38 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.109 0.956 . . . . 51.329999999999998 110.74 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.5 -34.4 64.58 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.404 -1.725 . . . . 71.5 114.117 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' B' ' 250' ' ' LEU . . . -59.83 -26.09 65.52 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.562 0.949 . . . . 73.349999999999994 113.562 -174.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' B' ' 249' ' ' ALA . 53.6 tp 78.92 86.76 0.06 Allowed 'General case' 0 C--O 1.246 0.895 0 O-C-N 124.473 1.108 . . . . 70.420000000000002 110.781 -174.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -59.96 114.45 2.83 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.408 -1.269 . . . . 53.32 110.346 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 82.44 17.39 68.88 Favored Glycine 0 N--CA 1.435 -1.37 0 CA-C-N 115.563 -0.744 . . . . 53.240000000000002 113.586 176.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -69.88 -48.91 38.37 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.5 -0.857 . . . . 62.140000000000001 112.02 177.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 10.4 tp -165.91 160.99 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 105.957 -1.868 . . . . 55.140000000000001 105.957 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -87.28 136.55 32.89 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 118.695 0.68 . . . . 64.409999999999997 109.615 176.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.2 mp -129.17 79.06 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.135 -1.432 . . . . 61.509999999999998 107.135 172.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 4.7 p -92.21 102.94 15.46 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.534 -0.757 . . . . 52.409999999999997 110.849 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.04 165.58 13.94 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.627 -0.715 . . . . 72.430000000000007 109.933 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 259' ' ' GLN . . . . . 0.514 ' HG3' HD11 ' C' ' 254' ' ' ILE . 97.9 mt-30 -100.99 40.56 1.26 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 122.907 0.483 . . . . 75.230000000000004 109.977 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 260' ' ' THR . . . . . 0.401 HG21 ' HB2' ' C' ' 243' ' ' ASN . 2.4 m -64.78 121.53 14.78 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.62 -0.718 . . . . 75.519999999999996 110.831 -178.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -126.77 108.75 11.32 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.356 -1.72 . . . . 54.109999999999999 106.356 166.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 18.3 t-20 -124.42 128.25 48.75 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.279 -1.008 . . . . 61.299999999999997 108.279 -172.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 33.1 m -129.27 123.66 32.47 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.889 -0.411 . . . . 73.430000000000007 109.889 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.51 141.22 28.77 Favored 'Isoleucine or valine' 0 C--O 1.25 1.121 0 CA-C-N 115.977 -0.556 . . . . 70.25 109.749 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 20.7 tp10 -83.37 -58.04 3.0 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.582 -0.735 . . . . 74.040000000000006 110.315 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' C' ' 230' ' ' ASP . 80.4 m -149.75 133.16 16.55 Favored 'General case' 0 C--N 1.31 -1.125 0 O-C-N 121.372 -0.83 . . . . 61.119999999999997 112.428 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 12.2 m -118.5 134.68 61.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.767 -1.197 . . . . 74.329999999999998 107.767 171.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 m -125.88 122.82 62.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.033 0.444 . . . . 75.230000000000004 110.629 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.99 132.86 11.26 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.466 -0.873 . . . . 74.150000000000006 111.893 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' C' ' 234' ' ' GLU . 29.3 mmmt -126.39 147.12 49.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 124.213 1.005 . . . . 72.230000000000004 109.236 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.41 -136.25 34.23 Favored Glycine 0 C--O 1.228 -0.259 0 C-N-CA 120.009 -1.091 . . . . 62.140000000000001 110.516 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -97.35 69.55 2.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.866 0.841 . . . . 72.25 111.277 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 72.3 m -85.67 146.46 26.83 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.12 -0.945 . . . . 74.140000000000001 111.366 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 8.8 mpt_? -127.49 127.11 43.47 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.706 -1.59 . . . . 74.519999999999996 106.706 169.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.573 ' HB ' HG12 ' B' ' 239' ' ' VAL . 21.7 t -134.16 139.13 48.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 108.282 -1.007 . . . . 52.43 108.282 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 276' ' ' LEU . . . . . 0.502 ' HG ' ' CG ' ' B' ' 240' ' ' GLN . 6.5 tt -123.56 125.44 44.87 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 106.706 -1.59 . . . . 65.219999999999999 106.706 173.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.411 HG23 HD12 ' C' ' 241' ' ' LEU . 4.0 mp -112.57 104.06 16.44 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 105.903 -1.888 . . . . 73.439999999999998 105.903 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 153.35 -149.24 20.74 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.164 -1.017 . . . . 60.210000000000001 113.26 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -110.04 133.56 53.07 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.019 -0.734 . . . . 64.219999999999999 109.019 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 280' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' C' ' 244' ' ' VAL . 2.2 tm-20 -126.65 128.08 46.2 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 106.507 -1.664 . . . . 70.420000000000002 106.507 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -118.58 125.06 49.0 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 109.143 -0.688 . . . . 64.349999999999994 109.143 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.02 -43.29 1.24 Allowed Glycine 0 N--CA 1.417 -2.621 0 N-CA-C 110.498 -1.041 . . . . 43.210000000000001 110.498 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.39 36.14 9.0 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.319 -1.512 . . . . 73.109999999999999 109.319 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 284' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' B' ' 289' ' ' ASN . 49.4 tptt -142.56 -62.27 0.43 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.873 -0.417 . . . . 71.319999999999993 109.873 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 285' ' ' GLY . . . . . 0.438 ' HA3' ' CZ3' ' B' ' 287' ' ' TRP . . . 68.95 -159.67 52.66 Favored Glycine 0 N--CA 1.44 -1.079 0 O-C-N 123.408 0.443 . . . . 63.149999999999999 113.821 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -102.26 -6.8 22.72 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 121.086 -0.246 . . . . 75.430000000000007 111.223 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 287' ' ' TRP . . . . . 0.477 ' HB3' ' HG2' ' C' ' 238' ' ' ARG . 26.6 m-90 -57.88 -64.97 0.72 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.907 0.86 . . . . 74.430000000000007 110.169 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -118.65 79.74 1.43 Allowed 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 101.947 -3.353 . . . . 72.209999999999994 101.947 173.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 289' ' ' ASN . . . . . 0.487 ' O ' ' HE3' ' B' ' 284' ' ' LYS 0.279 18.0 p30 -49.47 -76.21 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 118.731 2.863 . . . . 75.519999999999996 118.731 -164.85 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -155.5 151.13 27.33 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 118.234 -1.386 . . . . 64.340000000000003 112.925 -171.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -67.67 158.89 31.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.97 -1.863 . . . . 65.209999999999994 105.97 170.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -68.14 86.27 0.26 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.405 1.098 . . . . 75.510000000000005 113.248 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -93.75 109.99 21.64 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 105.331 -2.1 . . . . 72.450000000000003 105.331 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -82.4 68.85 9.0 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.384 1.088 . . . . 62.329999999999998 111.821 -176.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 N--CA 1.422 -1.836 0 N-CA-C 104.349 -2.463 . . . . 75.439999999999998 104.349 -179.867 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 56.9 ttp . . . . . 0 CA--C 1.517 -0.323 0 N-CA-C 109.888 -0.412 . . . . 74.239999999999995 109.888 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt 77.9 -30.71 0.16 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.861 1.264 . . . . 65.430000000000007 113.553 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 39.3 mm -61.51 -39.74 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 106.201 -1.778 . . . . 62.030000000000001 106.201 169.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.05 -73.19 0.15 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 112.905 -1.952 . . . . 74.409999999999997 109.479 170.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 65.09 -71.92 0.07 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.962 1.705 . . . . 74.510000000000005 113.224 176.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 7.7 tp -84.59 115.75 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-O 121.803 0.811 . . . . 74.099999999999994 110.889 -176.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 10.3 p -115.92 142.39 29.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.766 -1.198 . . . . 61.200000000000003 107.766 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 95.96 44.78 3.01 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 109.51 -1.436 . . . . 54.240000000000002 109.51 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -128.98 145.71 51.17 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.097 -0.641 . . . . 71.349999999999994 111.753 -175.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 26.5 t-20 -117.28 127.0 53.64 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.743 -1.206 . . . . 72.349999999999994 107.743 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' C' ' 263' ' ' SER . 19.5 m -126.37 137.22 53.43 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 108.785 -0.82 . . . . 74.5 108.785 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.41 ' HB1' HD11 ' C' ' 231' ' ' ILE . . . -136.29 132.39 35.66 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.887 -0.325 . . . . 64.150000000000006 110.639 -176.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.613 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.0 OUTLIER -80.14 -76.34 0.23 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.274 -0.639 . . . . 75.510000000000005 109.274 178.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 230' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' B' ' 266' ' ' THR . 2.1 p-10 -129.09 140.51 51.54 Favored 'General case' 0 C--O 1.264 1.848 0 C-N-CA 118.062 -1.455 . . . . 70.230000000000004 112.216 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.41 HD11 ' HB1' ' C' ' 228' ' ' ALA . 28.0 mm -119.27 117.07 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 113.055 -1.884 . . . . 63.299999999999997 106.26 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 232' ' ' ARG . . . . . 0.47 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 17.9 ttm180 -111.75 123.67 50.73 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.907 -0.405 . . . . 73.430000000000007 109.907 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 72.0 p -116.96 128.37 55.13 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.003 -1.11 . . . . 71.239999999999995 108.003 175.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.47 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 49.2 mt-10 -127.31 160.74 30.42 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 120.586 -0.446 . . . . 73.319999999999993 111.361 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 63.43 -82.02 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.908 0 C-N-CA 124.94 1.296 . . . . 71.540000000000006 114.343 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.45 ' O ' ' HD2' ' C' ' 238' ' ' ARG . 0.2 OUTLIER -139.44 25.95 2.39 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.595 -0.891 . . . . 71.430000000000007 108.595 -178.433 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.53 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -71.23 141.83 50.59 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.826 0.822 . . . . 74.439999999999998 112.106 -177.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 9.1 mpt_? -124.55 133.43 53.3 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 106.454 -1.684 . . . . 75.030000000000001 106.454 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.503 HG23 HG13 ' B' ' 275' ' ' VAL . 21.2 m -142.94 150.18 18.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.707 0.765 . . . . 65.409999999999997 112.397 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.415 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 5.2 tp60 -112.33 137.42 50.5 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.248 -1.342 . . . . 73.200000000000003 109.062 176.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' C' ' 277' ' ' ILE . 2.8 tm? -128.13 117.53 21.78 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.278 -2.119 . . . . 72.450000000000003 105.278 172.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.485 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 130.93 -133.07 7.11 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.191 -1.004 . . . . 43.219999999999999 112.721 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.401 ' HB2' HG21 ' B' ' 260' ' ' THR . 40.8 t30 -128.99 138.56 52.02 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 122.233 -0.569 . . . . 73.109999999999999 110.716 -176.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' B' ' 280' ' ' GLU . 96.7 t -126.09 118.48 51.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.213 -0.662 . . . . 63.140000000000001 109.213 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.12 112.72 41.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.347 -0.983 . . . . 71.0 108.347 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 19.4 m -79.52 160.38 26.53 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.054 -1.461 . . . . 54.43 107.054 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.86 -33.07 72.52 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.1 0.952 . . . . 75.319999999999993 110.644 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.48 -33.33 63.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.236 -1.802 . . . . 75.340000000000003 113.848 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -62.62 -46.72 86.95 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.536 1.31 . . . . 64.430000000000007 114.536 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 54.44 -86.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.835 0.854 . . . . 71.349999999999994 112.158 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 251' ' ' HIS . . . . . 0.437 ' CD2' ' HA ' ' C' ' 254' ' ' ILE . 3.7 t60 67.96 -54.85 0.5 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.456 1.902 . . . . 63.149999999999999 112.696 176.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.56 65.64 1.15 Allowed Glycine 0 CA--C 1.501 -0.809 0 N-CA-C 109.873 -1.291 . . . . 75.439999999999998 109.873 -177.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 79.03 -140.27 22.92 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 107.24 -2.344 . . . . 53.5 107.24 -171.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 254' ' ' ILE . . . . . 0.514 HD11 ' HG3' ' B' ' 259' ' ' GLN . 41.6 pt -138.27 133.7 43.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 117.799 0.799 . . . . 63.329999999999998 109.606 172.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -81.11 -27.27 35.65 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.66 -1.607 . . . . 72.430000000000007 106.66 173.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 13.2 tt 176.9 145.4 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 105.105 -2.183 . . . . 71.319999999999993 105.105 174.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 6.7 m -74.82 -68.93 0.5 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.053 -1.462 . . . . 75.120000000000005 107.053 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 31.0 t70 168.17 161.74 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 103.57 -2.752 . . . . 71.299999999999997 103.57 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -88.18 39.72 0.91 Allowed 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 118.683 0.674 . . . . 75.299999999999997 110.103 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 18.4 m -70.57 121.9 18.71 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.194 -0.912 . . . . 74.030000000000001 111.031 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 10.3 t -129.03 107.87 9.94 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 105.236 -2.135 . . . . 64.120000000000005 105.236 168.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -126.72 139.0 53.47 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.497 -0.774 . . . . 63.329999999999998 110.922 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 263' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' C' ' 227' ' ' SER . 42.3 m -139.89 123.56 17.33 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 107.863 -1.162 . . . . 74.299999999999997 107.863 176.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.6 p -109.87 152.88 11.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.819 -0.352 . . . . 65.129999999999995 110.104 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 265' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 10.1 tp10 -88.25 -69.72 0.68 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.154 -0.475 . . . . 61.140000000000001 109.989 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 90.5 m -140.46 130.73 25.08 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.897 -0.409 . . . . 73.340000000000003 109.897 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.21 133.6 67.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.804 -0.813 . . . . 74.340000000000003 108.804 171.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 29.7 m -121.5 129.05 75.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.166 0.508 . . . . 64.510000000000005 111.154 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.54 133.47 11.5 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.433 -1.067 . . . . 53.32 110.433 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 270' ' ' LYS . . . . . 0.427 ' HD2' ' HB2' ' C' ' 234' ' ' GLU . 28.4 mmmt -132.07 131.52 42.48 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.124 0.569 . . . . 52.240000000000002 109.852 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 68.56 -133.02 27.51 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.782 -0.645 . . . . 43.420000000000002 112.263 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -79.35 47.39 0.8 Allowed 'General case' 0 C--N 1.305 -1.37 0 C-N-CA 125.063 1.345 . . . . 71.420000000000002 113.127 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 50.7 m -83.4 145.44 29.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.555 0.693 . . . . 74.519999999999996 112.853 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 274' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 10.2 mpt_? -130.6 127.04 38.2 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 106.537 -1.653 . . . . 62.310000000000002 106.537 170.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.439 ' HB ' HG12 ' C' ' 239' ' ' VAL . 10.0 t -137.83 140.73 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 108.771 -0.826 . . . . 61.049999999999997 108.771 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 276' ' ' LEU . . . . . 0.456 ' HB3' ' CZ2' ' C' ' 287' ' ' TRP . 6.8 tt -123.32 114.14 19.8 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.815 -1.18 . . . . 72.310000000000002 107.815 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 277' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 3.4 mp -104.57 104.19 16.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 105.532 -2.025 . . . . 64.420000000000002 105.532 176.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 278' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 159.26 -139.67 6.36 Favored Glycine 0 N--CA 1.41 -3.059 0 C-N-CA 119.4 -1.381 . . . . 73.230000000000004 112.402 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -127.79 142.97 51.15 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.165 -1.42 . . . . 73.209999999999994 107.165 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -141.93 132.62 25.56 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.218 -0.66 . . . . 60.310000000000002 109.218 -174.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.48 133.58 55.05 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.221 0.534 . . . . 74.129999999999995 111.023 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 122.86 -36.39 3.12 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 110.002 -1.239 . . . . 73.239999999999995 110.002 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 86.28 32.87 15.53 Favored Glycine 0 N--CA 1.419 -2.436 0 N-CA-C 111.422 -0.671 . . . . 54.219999999999999 111.422 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -131.92 -54.78 0.99 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.837 -0.801 . . . . 74.299999999999997 108.837 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 285' ' ' GLY . . . . . 0.414 ' HA3' ' CE3' ' C' ' 287' ' ' TRP . . . 69.21 -172.28 38.07 Favored Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 115.244 -0.889 . . . . 75.549999999999997 112.45 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -91.2 -5.73 54.47 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 110.429 -0.212 . . . . 73.409999999999997 110.429 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 287' ' ' TRP . . . . . 0.456 ' CZ2' ' HB3' ' C' ' 276' ' ' LEU . 27.6 m-90 -51.75 -50.13 61.25 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.55 0.69 . . . . 75.150000000000006 110.518 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -143.89 112.28 6.42 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.563 -1.198 . . . . 75.25 108.844 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 289' ' ' ASN . . . . . 0.439 ' HB3' ' HD3' ' B' ' 284' ' ' LYS . 48.0 t-20 -135.46 86.45 2.24 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 107.462 -1.31 . . . . 70.230000000000004 107.462 173.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -136.11 129.92 32.55 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.815 -1.539 . . . . 74.409999999999997 106.912 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -83.45 -34.83 25.35 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.816 -0.354 . . . . 75.319999999999993 110.801 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 33.7 m170 67.87 27.82 7.2 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.095 0.958 . . . . 74.099999999999994 110.453 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -94.57 98.85 11.12 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 114.625 -1.171 . . . . 62.450000000000003 108.145 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -75.8 125.73 29.64 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.171 -0.922 . . . . 71.510000000000005 109.788 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 . . . . . 0 C--O 1.24 0.58 0 O-C-N 124.396 1.06 . . . . 45.109999999999999 111.651 174.416 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 121.328 0.585 . . . . 52.329999999999998 109.96 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -133.6 131.1 39.25 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.605 -0.887 . . . . 74.329999999999998 108.605 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.518 ' HB ' ' CB ' ' B' ' 221' ' ' ALA . 2.5 mp -107.15 74.11 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 105.545 -2.02 . . . . 74.239999999999995 105.545 170.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -123.42 85.37 2.41 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 112.95 -1.932 . . . . 51.509999999999998 108.286 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -161.46 -178.45 6.63 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 105.413 -2.069 . . . . 73.310000000000002 105.413 -176.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.4 mp -83.15 114.81 24.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.346 -0.983 . . . . 64.329999999999998 108.346 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.0 122.41 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.934 0 N-CA-C 108.904 -0.776 . . . . 64.120000000000005 108.904 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 169.76 55.12 0.04 OUTLIER Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 110.048 -1.221 . . . . 51.200000000000003 110.048 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.484 ' HG2' ' OG1' ' A' ' 261' ' ' THR . 14.0 ptt180 -92.24 139.34 30.71 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.19 -0.671 . . . . 74.319999999999993 109.19 -177.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ASN . . . . . 0.401 HD21 HG22 ' A' ' 277' ' ' ILE . 24.2 t-20 -116.19 114.72 24.83 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.063 -0.717 . . . . 63.5 109.063 178.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 26.9 m -134.83 137.91 43.74 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.453 0.538 . . . . 62.119999999999997 112.453 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.9 135.33 45.51 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.418 -1.327 . . . . 70.530000000000001 107.418 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -55.25 3.36 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.578 -0.849 . . . . 74.420000000000002 110.493 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -139.63 139.05 36.62 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 122.279 -0.263 . . . . 61.130000000000003 110.491 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.483 HG21 HG21 ' A' ' 239' ' ' VAL . 30.0 mt -137.82 125.8 31.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 108.822 -0.807 . . . . 62.229999999999997 108.822 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ARG . . . . . 0.494 ' HB3' HG12 ' A' ' 268' ' ' VAL . 35.2 ttt180 -126.05 122.34 35.55 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.151 -1.055 . . . . 72.329999999999998 108.151 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.509 ' OG1' ' HB1' ' A' ' 237' ' ' ALA . 14.3 t -135.27 130.78 35.69 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 120.014 -0.674 . . . . 41.310000000000002 109.396 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -135.2 140.75 45.56 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 112.177 0.436 . . . . 71.420000000000002 112.177 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 66.68 106.53 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.02 1.328 . . . . 54.329999999999998 113.361 174.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 272' ' ' GLU . 47.6 mtt85 57.46 35.01 25.41 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.807 1.289 . . . . 74.549999999999997 107.564 176.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.509 ' HB1' ' OG1' ' A' ' 233' ' ' THR . . . -83.7 128.71 34.73 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 112.81 -1.996 . . . . 70.450000000000003 112.633 -170.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -129.86 135.06 47.94 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 106.878 -1.527 . . . . 72.409999999999997 106.878 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.483 HG21 HG21 ' A' ' 231' ' ' ILE . 6.7 p -143.68 140.1 25.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.646 -0.501 . . . . 74.519999999999996 109.646 175.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLN . . . . . 0.55 ' HB2' ' CD1' ' A' ' 286' ' ' PHE . 11.7 tm0? -125.82 136.99 53.74 Favored 'General case' 0 N--CA 1.405 -2.68 0 N-CA-C 106.431 -1.692 . . . . 70.109999999999999 106.431 177.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 tt -128.73 117.22 20.76 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 105.704 -1.962 . . . . 74.430000000000007 105.704 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.513 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 135.26 -119.23 2.06 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.367 -0.92 . . . . 53.119999999999997 113.338 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -144.43 139.53 28.42 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.032 -1.099 . . . . 73.549999999999997 108.032 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.435 ' HB ' ' HG2' ' A' ' 280' ' ' GLU . 22.5 t -125.79 121.44 59.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 109.465 -0.568 . . . . 42.549999999999997 109.465 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.76 112.64 34.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.996 -1.113 . . . . 52.219999999999999 107.996 170.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 281' ' ' TYR . 6.4 t -89.35 160.55 16.79 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.7 -1.2 . . . . 73.409999999999997 109.588 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.67 74.38 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 123.156 0.582 . . . . 74.230000000000004 110.15 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -35.5 66.82 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.167 -0.924 . . . . 53.43 112.138 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -70.71 -37.49 73.55 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.543 -0.299 . . . . 73.109999999999999 110.614 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 24.0 tp 65.65 33.31 8.51 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.447 1.099 . . . . 61.039999999999999 110.011 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 32.6 m80 69.19 119.41 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.363 1.465 . . . . 73.409999999999997 113.579 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.446 ' O ' HG13 ' B' ' 254' ' ' ILE . . . -79.83 70.95 2.8 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 109.563 -1.415 . . . . 74.409999999999997 109.563 175.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 135.36 -141.32 12.52 Favored Glycine 0 N--CA 1.425 -2.056 0 N-CA-C 108.962 -1.655 . . . . 45.439999999999998 108.962 -176.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 33.3 pt -91.11 -32.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.905 0.86 . . . . 72.329999999999998 109.231 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -146.46 -156.73 0.74 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 103.572 -2.751 . . . . 75.230000000000004 103.572 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 35.0 pt -75.62 148.85 7.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 106.306 -1.738 . . . . 64.219999999999999 106.306 170.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 10.8 p -93.7 -68.59 0.79 Allowed 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 119.688 -0.805 . . . . 72.439999999999998 109.72 -178.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . 0.383 4.2 m-20 59.67 170.61 0.08 Allowed 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 117.111 2.263 . . . . 32.32 117.111 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.456 ' NE2' ' HA3' ' B' ' 224' ' ' GLY . 0.4 OUTLIER 167.31 -21.51 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.105 -2.183 . . . . 71.120000000000005 105.105 -169.197 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 260' ' ' THR . . . . . 0.409 ' H ' ' H ' ' A' ' 259' ' ' GLN . 0.4 OUTLIER -63.16 119.71 10.08 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 113.558 -1.656 . . . . 65.540000000000006 110.36 -174.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 261' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' A' ' 225' ' ' ARG . 10.8 t -112.65 115.33 28.41 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 105.138 -2.171 . . . . 70.319999999999993 105.138 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' ASN . . . . . 0.588 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 7.2 t30 -122.1 127.07 49.71 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.564 -0.744 . . . . 63.32 111.786 -168.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.3 t -135.68 123.75 22.91 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 109.046 -0.724 . . . . 63.119999999999997 109.046 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.5 p -126.55 147.42 31.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 109.044 -0.725 . . . . 63.229999999999997 109.044 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -96.91 -75.86 0.53 Allowed 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 119.612 -0.835 . . . . 62.119999999999997 111.208 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 63.3 m -117.33 127.27 53.89 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.336 0.588 . . . . 62.450000000000003 110.831 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.449 HG11 HD11 ' A' ' 277' ' ' ILE . 1.4 p -134.0 123.99 45.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.876 -0.602 . . . . 70.409999999999997 110.903 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 232' ' ' ARG . 21.6 m -124.4 138.27 54.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.536 -0.756 . . . . 61.140000000000001 111.517 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.2 131.38 7.68 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 109.508 -1.437 . . . . 70.5 109.508 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.31 116.18 14.95 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 122.66 0.384 . . . . 60.119999999999997 110.976 -174.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.47 74.12 1.06 Allowed Glycine 0 N--CA 1.465 0.614 0 C-N-CA 120.079 -1.058 . . . . 50.420000000000002 112.868 172.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' GLU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 236' ' ' ARG . 35.4 tt0 58.37 77.01 0.31 Allowed 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 125.753 1.621 . . . . 54.140000000000001 110.465 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 25.7 m -121.91 143.76 49.26 Favored 'General case' 0 N--CA 1.39 -3.426 0 CA-C-N 114.977 -1.01 . . . . 70.5 109.049 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -122.51 126.15 47.23 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.001 -1.481 . . . . 70.430000000000007 107.001 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 53.2 t -124.13 126.23 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.018 0 O-C-N 123.878 0.736 . . . . 73.239999999999995 109.389 -174.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' LEU . . . . . 0.491 HD23 ' HG2' ' B' ' 240' ' ' GLN . 17.7 tp -122.31 121.47 36.81 Favored 'General case' 0 C--N 1.267 -3.008 0 C-N-CA 118.758 -1.177 . . . . 70.430000000000007 110.749 174.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.449 HD11 HG11 ' A' ' 267' ' ' VAL . 74.6 mt -109.75 103.93 16.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.489 -0.93 . . . . 75.200000000000003 108.489 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLY . . . . . 0.519 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 139.64 -141.04 11.29 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.614 -0.803 . . . . 54.020000000000003 112.717 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 44.8 t-20 -123.69 140.08 53.35 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.363 -0.977 . . . . 55.520000000000003 108.363 -176.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.435 ' HG2' ' HB ' ' A' ' 244' ' ' VAL . 0.0 OUTLIER -123.72 119.91 31.16 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.487 -0.931 . . . . 70.530000000000001 108.487 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 281' ' ' TYR . . . . . 0.483 ' O ' HG22 ' A' ' 246' ' ' THR . 22.1 m-85 -103.72 121.78 43.71 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.037 -1.838 . . . . 62.329999999999998 106.037 174.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 110.98 -51.7 0.68 Allowed Glycine 0 N--CA 1.423 -2.193 0 N-CA-C 110.077 -1.209 . . . . 61.420000000000002 110.077 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.525 ' C ' ' HD2' ' A' ' 284' ' ' LYS . . . 84.04 3.45 89.06 Favored Glycine 0 C--O 1.223 -0.567 0 CA-C-O 121.241 0.356 . . . . 62.509999999999998 112.269 177.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.525 ' HD2' ' C ' ' A' ' 283' ' ' GLY . 3.6 mptp? -135.52 18.12 3.35 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.148 0.499 . . . . 75.409999999999997 110.27 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -90.51 -39.72 5.87 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.615 -0.994 . . . . 55.340000000000003 110.615 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 240' ' ' GLN . 29.1 t80 -79.95 -37.49 34.35 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 112.134 0.42 . . . . 73.200000000000003 112.134 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -73.24 123.14 23.11 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 113.675 0.991 . . . . 74.129999999999995 113.675 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.54 136.01 36.2 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.722 -1.126 . . . . 64.540000000000006 109.199 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -82.76 72.37 9.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.686 1.365 . . . . 72.230000000000004 114.686 -171.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 173.37 111.34 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 126.074 1.749 . . . . 71.040000000000006 106.857 170.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' HIS . . . . . 0.503 ' HB2' ' NH2' ' B' ' 238' ' ' ARG . 0.4 OUTLIER -138.0 160.81 38.36 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.459 -0.791 . . . . 73.439999999999998 109.826 -175.887 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -125.2 104.44 8.51 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 121.552 0.692 . . . . 62.509999999999998 110.753 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -126.27 135.36 51.46 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.079 -1.452 . . . . 65.219999999999999 107.079 174.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' HIS . . . . . 0.497 ' CE1' ' HB3' ' C' ' 294' ' ' HIS . 57.1 t-80 -151.41 135.04 16.29 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.15 -1.426 . . . . 71.400000000000006 107.15 -165.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' HIS . . . . . 0.474 ' HB2' ' HG3' ' C' ' 236' ' ' ARG . 1.2 p-80 . . . . . 0 CA--C 1.551 1.0 0 N-CA-C 113.545 0.943 . . . . 71.319999999999993 113.545 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 119.416 -0.326 . . . . 62.439999999999998 110.123 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.23 106.7 0.77 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.799 0.809 . . . . 54.439999999999998 109.387 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 2.3 pp -101.94 174.61 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 113.857 1.058 . . . . 73.239999999999995 113.857 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -129.65 121.69 27.53 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 103.97 -2.604 . . . . 74.430000000000007 103.97 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 221' ' ' ALA . . . . . 0.518 ' CB ' ' HB ' ' A' ' 219' ' ' ILE . . . -154.25 157.71 39.15 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.633 -0.827 . . . . 73.519999999999996 112.3 -169.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 2.4 mp -83.95 115.81 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 105.111 -2.181 . . . . 71.510000000000005 105.111 167.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 8.7 p -100.67 122.87 53.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.057 0.456 . . . . 63.109999999999999 111.489 -174.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 224' ' ' GLY . . . . . 0.456 ' HA3' ' NE2' ' A' ' 259' ' ' GLN . . . 174.63 57.45 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.487 -0.778 . . . . 54.25 111.242 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 225' ' ' ARG . . . . . 0.422 ' HA ' ' CG2' ' A' ' 261' ' ' THR . 13.8 ptt180 -100.0 128.09 46.13 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.208 -0.597 . . . . 73.439999999999998 109.762 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 226' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 6.4 t30 -116.55 114.65 24.45 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.08 -0.711 . . . . 64.239999999999995 109.08 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 11.1 p -139.48 137.62 35.7 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 112.644 0.609 . . . . 74.510000000000005 112.644 -177.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 228' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -126.53 137.24 53.34 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.819 -1.082 . . . . 73.109999999999999 108.49 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -87.19 -66.67 0.89 Allowed 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.154 -0.619 . . . . 73.540000000000006 110.418 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -127.0 138.61 53.28 Favored 'General case' 0 C--O 1.264 1.822 0 CA-C-O 121.401 0.619 . . . . 63.25 109.561 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 231' ' ' ILE . . . . . 0.49 HG21 HG21 ' B' ' 239' ' ' VAL . 8.7 mt -131.48 117.39 35.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.495 -1.298 . . . . 75.209999999999994 107.495 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -116.46 115.65 26.2 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 110.01 -0.367 . . . . 72.540000000000006 110.01 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 233' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 22.3 p -114.31 127.54 55.91 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.167 -1.42 . . . . 62.409999999999997 107.167 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -143.31 138.66 29.68 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 109.434 -0.58 . . . . 43.149999999999999 109.434 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 235' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' B' ' 271' ' ' GLY . 33.2 tt0 62.59 91.32 0.07 Allowed 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 124.778 1.299 . . . . 64.420000000000002 112.569 171.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 65.59 34.85 7.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.22 -0.659 . . . . 64.540000000000006 109.22 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 237' ' ' ALA . . . . . 0.619 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -101.54 149.26 24.28 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 122.696 1.236 . . . . 73.420000000000002 113.744 -172.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 238' ' ' ARG . . . . . 0.503 ' NH2' ' HB2' ' A' ' 291' ' ' HIS . 3.7 mpt_? -134.35 136.37 43.37 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.12 -1.437 . . . . 62.149999999999999 107.12 175.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.49 HG21 HG21 ' B' ' 231' ' ' ILE . 12.1 p -137.17 137.83 46.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-O 121.696 0.76 . . . . 62.020000000000003 109.882 176.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.634 ' HB2' ' CD1' ' B' ' 286' ' ' PHE . 16.5 tm0? -118.29 132.49 56.29 Favored 'General case' 0 N--CA 1.39 -3.469 0 N-CA-C 105.068 -2.197 . . . . 62.409999999999997 105.068 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.42 ' CD1' HD22 ' A' ' 262' ' ' ASN . 0.8 OUTLIER -130.32 116.3 18.13 Favored 'General case' 0 C--N 1.263 -3.195 0 N-CA-C 106.957 -1.497 . . . . 74.450000000000003 106.957 178.21 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 242' ' ' GLY . . . . . 0.522 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 130.91 -114.15 1.53 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 115.882 -0.599 . . . . 73.099999999999994 112.165 -176.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 243' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 6.8 t30 -144.74 145.75 31.85 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.379 0.59 . . . . 74.099999999999994 110.635 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 244' ' ' VAL . . . . . 0.461 ' CG2' ' HG3' ' B' ' 240' ' ' GLN . 69.0 t -132.69 126.71 54.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 N-CA-C 109.571 -0.529 . . . . 71.140000000000001 109.571 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 245' ' ' VAL . . . . . 0.5 ' HA ' ' HB2' ' B' ' 281' ' ' TYR . 2.7 p -123.86 111.74 30.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.967 -1.123 . . . . 75.209999999999994 107.967 169.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 246' ' ' THR . . . . . 0.461 HG22 ' HA3' ' B' ' 282' ' ' GLY . 8.8 t -83.12 160.77 21.8 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.069 -1.052 . . . . 75.200000000000003 111.459 -176.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 247' ' ' ALA . . . . . 0.53 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.71 -36.12 82.81 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 122.386 1.089 . . . . 54.119999999999997 109.699 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.3 -35.55 73.97 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 113.243 -1.799 . . . . 75.150000000000006 111.6 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 249' ' ' ALA . . . . . 0.46 ' HA ' ' CB ' ' C' ' 247' ' ' ALA . . . -74.7 -26.84 60.1 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.387 -0.37 . . . . 45.409999999999997 110.863 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 52.8 tp -74.62 75.95 2.01 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 122.062 0.934 . . . . 73.109999999999999 111.976 -175.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 251' ' ' HIS . . . . . 0.427 ' CG ' HD22 ' C' ' 250' ' ' LEU . 21.0 t60 -100.21 -36.27 9.36 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.457 -2.053 . . . . 64.310000000000002 105.457 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -170.24 157.52 28.9 Favored Glycine 0 N--CA 1.418 -2.531 0 N-CA-C 107.339 -2.305 . . . . 45.409999999999997 107.339 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 104.74 -176.07 22.79 Favored Glycine 0 C--N 1.294 -1.759 0 C-N-CA 120.584 -0.817 . . . . 33.240000000000002 111.545 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 254' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 252' ' ' GLY . 9.2 tt -164.15 -41.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-O 121.145 0.498 . . . . 53.109999999999999 110.853 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -167.25 113.05 0.75 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.612 -1.996 . . . . 74.430000000000007 105.612 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.58 -54.96 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 119.51 -0.876 . . . . 71.030000000000001 112.562 -174.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 11.4 p -84.95 28.7 0.68 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 122.805 0.442 . . . . 71.129999999999995 111.028 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -131.0 102.78 6.18 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 114.065 1.135 . . . . 60.329999999999998 114.065 -176.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -137.87 23.35 2.85 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 102.97 -2.974 . . . . 74.400000000000006 102.97 170.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 2.4 m -76.79 120.58 22.14 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 113.415 -1.72 . . . . 51.32 112.2 -167.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 261' ' ' THR . . . . . 0.553 HG23 ' HA ' ' C' ' 225' ' ' ARG . 5.1 t -104.7 108.13 19.43 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 105.798 -1.927 . . . . 63.420000000000002 105.798 167.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 262' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 6.4 t30 -116.09 131.18 57.01 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.328 -0.851 . . . . 63.210000000000001 110.902 -172.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -140.97 123.2 15.71 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.163 0.506 . . . . 62.409999999999997 110.529 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 264' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 11.7 p -124.95 152.11 31.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.662 -0.866 . . . . 71.040000000000006 108.662 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 265' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 28.8 tt0 -103.2 -56.77 2.16 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 119.273 -0.971 . . . . 73.430000000000007 112.045 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' C' ' 230' ' ' ASP . 29.5 m -135.86 127.13 28.27 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.029 -1.068 . . . . 73.319999999999993 111.35 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 267' ' ' VAL . . . . . 0.42 ' CG2' HG23 ' B' ' 231' ' ' ILE . 21.6 m -123.62 134.3 66.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.138 -0.689 . . . . 70.310000000000002 109.138 171.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 29.3 m -127.69 134.6 65.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.99 -0.55 . . . . 74.120000000000005 110.514 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.57 131.58 5.57 Favored Glycine 0 CA--C 1.476 -2.405 0 C-N-CA 119.254 -1.451 . . . . 50.399999999999999 112.621 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 270' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 62.9 tttp -135.57 144.9 46.45 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.278 0.634 . . . . 72.120000000000005 110.864 176.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 271' ' ' GLY . . . . . 0.418 ' H ' ' HB3' ' B' ' 235' ' ' GLU . . . 81.02 52.73 4.19 Favored Glycine 0 CA--C 1.486 -1.78 0 C-N-CA 120.877 -0.677 . . . . 62.030000000000001 112.238 173.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 65.11 89.18 0.1 Allowed 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.548 1.139 . . . . 75.230000000000004 109.835 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 273' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 21.0 m -121.75 144.12 48.98 Favored 'General case' 0 N--CA 1.405 -2.695 0 C-N-CA 119.652 -0.819 . . . . 62.130000000000003 110.162 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 29.0 mmt-85 -117.22 126.8 53.35 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 104.48 -2.415 . . . . 75.140000000000001 104.48 171.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 275' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 62.0 t -132.63 123.94 50.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 108.772 -0.825 . . . . 70.129999999999995 108.772 -178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 8.7 tt -120.48 128.39 53.1 Favored 'General case' 0 C--N 1.268 -2.946 0 C-N-CA 117.595 -1.642 . . . . 74.409999999999997 110.693 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 277' ' ' ILE . . . . . 0.483 HG23 HD12 ' C' ' 241' ' ' LEU . 50.7 mt -112.58 102.63 14.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 106.467 -1.679 . . . . 75.319999999999993 106.467 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 278' ' ' GLY . . . . . 0.591 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 144.09 -136.02 6.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.69 -1.243 . . . . 73.349999999999994 114.245 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 279' ' ' ASN . . . . . 0.495 ' ND2' ' HB3' ' C' ' 243' ' ' ASN . 9.0 t-20 -127.3 141.42 51.72 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.88 -1.156 . . . . 75.109999999999999 107.88 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.01 120.07 22.95 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.818 -0.808 . . . . 63.329999999999998 108.818 -177.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 281' ' ' TYR . . . . . 0.5 ' HB2' ' HA ' ' B' ' 245' ' ' VAL . 97.2 m-85 -103.31 122.38 44.68 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 106.713 -1.588 . . . . 74.129999999999995 106.713 174.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 282' ' ' GLY . . . . . 0.461 ' HA3' HG22 ' B' ' 246' ' ' THR . . . 110.71 -51.73 0.68 Allowed Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.828 -0.909 . . . . 63.219999999999999 110.828 -176.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 283' ' ' GLY . . . . . 0.446 ' C ' ' HD2' ' B' ' 284' ' ' LYS . . . 88.41 -8.4 78.93 Favored Glycine 0 C--N 1.314 -0.656 0 N-CA-C 111.618 -0.593 . . . . 54.240000000000002 111.618 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 284' ' ' LYS . . . . . 0.446 ' HD2' ' C ' ' B' ' 283' ' ' GLY . 4.0 mptp? -124.97 17.53 8.53 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 120.913 0.387 . . . . 74.439999999999998 110.681 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -81.49 -60.03 2.28 Favored Glycine 0 N--CA 1.418 -2.507 0 N-CA-C 109.098 -1.601 . . . . 71.140000000000001 109.098 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 286' ' ' PHE . . . . . 0.634 ' CD1' ' HB2' ' B' ' 240' ' ' GLN . 28.1 t80 -67.4 -39.4 85.55 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 124.393 0.702 . . . . 65.129999999999995 112.228 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 9.9 m-90 -68.36 102.52 1.42 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 114.143 1.164 . . . . 72.099999999999994 114.143 -176.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -85.93 106.84 17.41 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.845 -1.525 . . . . 54.439999999999998 109.426 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -144.18 84.93 1.78 Allowed 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.525 -0.734 . . . . 74.209999999999994 110.281 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -144.65 72.04 1.32 Allowed 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.774 -1.195 . . . . 75.319999999999993 107.774 176.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -66.91 110.59 3.39 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.517 -0.765 . . . . 74.219999999999999 109.648 -176.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -75.3 -73.89 0.23 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.82 -0.627 . . . . 70.129999999999995 109.831 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -164.85 168.89 17.26 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.383 -1.71 . . . . 74.299999999999997 106.383 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -95.65 -81.78 0.4 Allowed 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.404 -1.332 . . . . 73.420000000000002 107.404 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 . . . . . 0 CA--C 1.502 -0.902 0 C-N-CA 124.541 1.136 . . . . 74.120000000000005 108.535 175.537 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 56.0 ttp . . . . . 0 C--O 1.241 0.64 0 CA-C-O 121.783 0.801 . . . . 74.329999999999998 110.111 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -147.5 -56.82 0.24 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.55 -1.278 . . . . 74.129999999999995 107.55 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 12.5 pt -99.02 77.43 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-O 122.297 1.046 . . . . 75.319999999999993 109.286 175.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -91.19 154.63 19.17 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.505 -1.225 . . . . 73.450000000000003 108.392 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -51.83 -67.07 0.28 Allowed 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.87 0.731 . . . . 62.530000000000001 111.374 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 3.0 mp -103.81 115.38 45.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 105.38 -2.082 . . . . 75.310000000000002 105.38 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 12.2 p -113.32 119.72 61.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 C-N-CA 119.733 -0.787 . . . . 25.440000000000001 110.494 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -174.77 55.9 0.13 Allowed Glycine 0 C--N 1.297 -1.587 0 N-CA-C 109.174 -1.571 . . . . 73.049999999999997 109.174 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 225' ' ' ARG . . . . . 0.553 ' HA ' HG23 ' B' ' 261' ' ' THR . 14.5 ptt-85 -98.1 132.56 43.53 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 120.737 -0.385 . . . . 72.409999999999997 110.106 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 226' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 7.0 t30 -116.81 114.22 23.64 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.451 -1.314 . . . . 62.020000000000003 107.451 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 227' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' C' ' 263' ' ' SER . 12.9 t -135.16 137.64 42.93 Favored 'General case' 0 N--CA 1.411 -2.408 0 CA-C-O 121.226 0.536 . . . . 70.040000000000006 109.931 -175.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 228' ' ' ALA . . . . . 0.664 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -132.44 135.01 45.78 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.24 -1.392 . . . . 72.409999999999997 107.24 177.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 229' ' ' LYS . . . . . 0.408 ' HD2' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -85.75 -57.12 3.17 Favored 'General case' 0 C--N 1.287 -2.145 0 C-N-CA 119.793 -0.763 . . . . 64.25 109.828 -178.163 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 230' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' C' ' 266' ' ' THR . 30.8 t70 -139.36 138.96 37.05 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.992 0.425 . . . . 75.109999999999999 110.651 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 231' ' ' ILE . . . . . 0.467 HG23 ' CG2' ' C' ' 267' ' ' VAL . 6.0 mt -137.28 117.64 16.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.18 -1.044 . . . . 73.450000000000003 108.18 -176.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -111.81 117.17 32.09 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.084 0.469 . . . . 71.319999999999993 111.233 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 233' ' ' THR . . . . . 0.463 ' HB ' ' CB ' ' C' ' 237' ' ' ALA . 15.7 p -110.53 128.32 55.58 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.56 -0.745 . . . . 63.200000000000003 109.569 176.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 234' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 28.6 tt0 -143.21 137.01 28.68 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.244 -1.021 . . . . 64.319999999999993 108.244 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 235' ' ' GLU . . . . . 0.432 ' HB2' ' H ' ' C' ' 271' ' ' GLY . 53.9 mt-10 57.81 106.18 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.14 1.533 . . . . 72.200000000000003 115.14 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 236' ' ' ARG . . . . . 0.559 ' HB2' ' HA ' ' C' ' 272' ' ' GLU . 5.5 mpt_? 59.34 33.07 22.31 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.242 -0.651 . . . . 53.43 109.242 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 237' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -96.38 138.14 34.42 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 113.755 1.02 . . . . 74.329999999999998 113.755 -168.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 238' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 5.0 mpt_? -133.45 134.73 43.93 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.022 -1.103 . . . . 71.140000000000001 108.022 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 239' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' C' ' 275' ' ' VAL . 17.3 m -138.01 145.81 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 CA-C-O 122.065 0.936 . . . . 72.030000000000001 111.02 171.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 240' ' ' GLN . . . . . 0.524 ' HB2' ' CD1' ' C' ' 286' ' ' PHE . 0.0 OUTLIER -126.06 122.86 37.02 Favored 'General case' 0 C--N 1.26 -3.284 0 N-CA-C 104.425 -2.435 . . . . 73.230000000000004 104.425 176.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.483 HD12 HG23 ' B' ' 277' ' ' ILE . 0.8 OUTLIER -121.77 115.4 22.6 Favored 'General case' 0 C--N 1.26 -3.319 0 N-CA-C 106.992 -1.485 . . . . 55.340000000000003 106.992 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 242' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 131.14 -121.71 3.26 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 115.527 -0.76 . . . . 72.150000000000006 111.477 -174.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 243' ' ' ASN . . . . . 0.495 ' HB3' ' ND2' ' B' ' 279' ' ' ASN . 48.9 t-20 -145.1 141.34 28.73 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.035 0.917 . . . . 53.240000000000002 110.648 -177.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 244' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' C' ' 280' ' ' GLU . 80.9 t -131.36 131.45 63.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 C-N-CA 123.334 0.654 . . . . 72.239999999999995 110.623 178.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 6.1 p -122.42 116.77 50.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.426 -1.694 . . . . 63.450000000000003 106.426 168.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 15.0 t -77.21 160.58 28.82 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.467 -1.293 . . . . 54.340000000000003 111.581 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 247' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.4 -39.17 93.33 Favored 'General case' 0 CA--C 1.492 -1.25 0 CA-C-N 115.715 -0.675 . . . . 75.109999999999999 109.525 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.67 -33.4 60.72 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.517 -1.674 . . . . 71.340000000000003 112.102 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -65.39 -26.72 68.12 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.382 -0.372 . . . . 72.349999999999994 111.268 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 250' ' ' LEU . . . . . 0.427 HD22 ' CG ' ' B' ' 251' ' ' HIS . 84.9 mt 47.98 75.72 0.13 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.647 1.179 . . . . 73.530000000000001 111.048 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 251' ' ' HIS . . . . . 0.404 ' NE2' ' HB2' ' C' ' 255' ' ' ARG . 24.0 t-80 -85.47 136.52 33.4 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 119.517 -0.873 . . . . 73.140000000000001 111.676 -172.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.14 119.44 1.91 Allowed Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.855 -1.298 . . . . 64.540000000000006 109.855 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.15 -158.92 21.24 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 109.931 -1.267 . . . . 51.149999999999999 109.931 -177.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 35.4 pt -124.48 110.03 24.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 117.675 0.737 . . . . 52.329999999999998 110.769 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 255' ' ' ARG . . . . . 0.404 ' HB2' ' NE2' ' C' ' 251' ' ' HIS . 57.5 mtm180 -131.34 92.51 3.2 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.792 -0.447 . . . . 73.519999999999996 109.792 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 3.0 mp -94.97 78.79 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 106.272 -1.751 . . . . 74.209999999999994 106.272 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 12.5 p -58.74 -61.53 2.55 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.273 -1.33 . . . . 70.420000000000002 111.723 -175.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 258' ' ' ASP . . . . . 0.438 ' HB3' HD21 ' C' ' 279' ' ' ASN . 13.9 t70 -94.41 116.72 29.13 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.613 -0.884 . . . . 73.25 108.613 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -81.77 89.27 6.28 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.535 -1.283 . . . . 71.140000000000001 107.535 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 5.0 m -86.52 121.84 29.62 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 113.158 0.799 . . . . 74.430000000000007 113.158 -171.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 13.9 t -133.34 109.33 9.29 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 105.192 -2.151 . . . . 72.420000000000002 105.192 168.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -123.59 137.53 54.73 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.241 -0.89 . . . . 54.149999999999999 111.36 -166.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 263' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' C' ' 227' ' ' SER . 49.0 m -142.59 123.9 14.71 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.013 -0.736 . . . . 64.450000000000003 109.013 175.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.5 p -128.64 151.85 35.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.736 -0.468 . . . . 73.420000000000002 109.736 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.49 -80.21 0.19 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 109.421 -0.585 . . . . 71.239999999999995 109.421 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 266' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 8.1 t -139.22 129.29 25.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.751 -0.593 . . . . 75.420000000000002 109.995 -177.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 267' ' ' VAL . . . . . 0.467 ' CG2' HG23 ' C' ' 231' ' ' ILE . 27.0 m -120.78 135.3 61.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 116.254 -0.43 . . . . 72.340000000000003 110.033 177.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.25 140.98 45.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 116.357 -0.383 . . . . 72.310000000000002 110.604 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.43 131.53 6.11 Favored Glycine 0 CA--C 1.474 -2.483 0 N-CA-C 110.342 -1.103 . . . . 72.409999999999997 110.342 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -135.06 119.88 18.41 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.998 -1.112 . . . . 74.030000000000001 107.998 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 271' ' ' GLY . . . . . 0.432 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 80.95 76.95 1.02 Allowed Glycine 0 N--CA 1.465 0.608 0 C-N-CA 120.829 -0.7 . . . . 62.030000000000001 113.178 175.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 272' ' ' GLU . . . . . 0.559 ' HA ' ' HB2' ' C' ' 236' ' ' ARG . 45.8 mt-10 63.03 82.38 0.18 Allowed 'General case' 0 CA--C 1.48 -1.718 0 C-N-CA 124.689 1.196 . . . . 71.239999999999995 110.478 -178.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 273' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 51.7 m -125.48 143.71 50.87 Favored 'General case' 0 N--CA 1.399 -3.021 0 C-N-CA 119.036 -1.066 . . . . 64.230000000000004 109.9 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 274' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 79.0 mtt85 -136.61 126.05 25.07 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 104.148 -2.538 . . . . 74.519999999999996 104.148 174.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 275' ' ' VAL . . . . . 0.579 ' HB ' HG12 ' C' ' 239' ' ' VAL . 8.1 t -138.1 134.41 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 N-CA-C 108.012 -1.107 . . . . 54.210000000000001 108.012 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 8.9 tt -119.74 115.51 24.05 Favored 'General case' 0 N--CA 1.384 -3.767 0 C-N-CA 118.846 -1.141 . . . . 64.510000000000005 108.991 174.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.0 mp -93.59 102.43 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 104.52 -2.4 . . . . 73.200000000000003 104.52 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 278' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 139.21 -147.01 18.87 Favored Glycine 0 CA--C 1.49 -1.482 0 C-N-CA 119.317 -1.42 . . . . 72.319999999999993 113.888 -177.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 279' ' ' ASN . . . . . 0.438 HD21 ' HB3' ' C' ' 258' ' ' ASP . 42.9 t-20 -118.56 149.37 41.46 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.563 -1.273 . . . . 73.150000000000006 107.563 -178.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 280' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' C' ' 244' ' ' VAL . 15.6 tm-20 -146.36 121.11 9.87 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.839 -1.911 . . . . 72.030000000000001 105.839 -176.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -104.12 125.05 50.13 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.58 -0.896 . . . . 75.239999999999995 108.58 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 119.46 -47.32 1.04 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 111.298 -0.721 . . . . 70.200000000000003 111.298 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 283' ' ' GLY . . . . . 0.508 ' C ' ' HD2' ' C' ' 284' ' ' LYS . . . 94.86 -9.71 70.58 Favored Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 111.022 -0.831 . . . . 53.409999999999997 111.022 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 284' ' ' LYS . . . . . 0.508 ' HD2' ' C ' ' C' ' 283' ' ' GLY . 13.4 mptt -126.92 6.35 6.61 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.766 -0.717 . . . . 73.140000000000001 112.69 -172.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -73.14 -57.96 4.94 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 119.802 -1.189 . . . . 50.310000000000002 112.182 -176.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 286' ' ' PHE . . . . . 0.524 ' CD1' ' HB2' ' C' ' 240' ' ' GLN . 23.0 t80 -75.67 -31.23 59.69 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.633 1.345 . . . . 74.439999999999998 114.633 -174.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -68.45 89.3 0.35 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 115.405 1.632 . . . . 64.510000000000005 115.405 -172.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -72.35 151.42 42.7 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 124.904 1.282 . . . . 61.119999999999997 111.488 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -105.45 -86.59 0.47 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.609 0.596 . . . . 73.140000000000001 112.609 -173.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 290' ' ' HIS . . . . . 0.44 ' CE1' ' HB3' ' C' ' 292' ' ' HIS . 24.3 t-80 67.2 132.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.833 1.653 . . . . 74.340000000000003 111.903 -174.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -135.23 87.11 2.3 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.295 -0.412 . . . . 63.229999999999997 110.352 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 292' ' ' HIS . . . . . 0.44 ' HB3' ' CE1' ' C' ' 290' ' ' HIS . 17.9 t60 -169.94 117.37 0.57 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.729 -1.212 . . . . 74.299999999999997 107.729 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -128.25 132.36 48.74 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.816 -0.354 . . . . 62.409999999999997 111.514 -174.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 294' ' ' HIS . . . . . 0.497 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 37.3 t-80 -172.23 -6.81 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 123.359 0.664 . . . . 72.120000000000005 111.311 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 295' ' ' HIS . . . . . 0.421 ' H ' ' H ' ' C' ' 294' ' ' HIS . 67.4 m80 . . . . . 0 N--CA 1.494 1.741 0 C-N-CA 125.748 1.619 . . . . 71.25 112.707 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 112.21 0.448 . . . . 73.439999999999998 112.21 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.536 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 9.2 t30 -104.39 120.56 41.49 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.055 -1.461 . . . . 75.439999999999998 107.055 167.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 42.5 m -121.59 146.18 47.23 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 120.838 0.352 . . . . 74.140000000000001 111.359 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 264' ' ' VAL . . . -138.66 144.58 39.72 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.548 -1.279 . . . . 72.420000000000002 107.548 175.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -97.71 -60.01 1.65 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.127 0.489 . . . . 72.420000000000002 110.176 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.95 139.45 50.05 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.892 -0.594 . . . . 74.120000000000005 110.812 -175.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 25.6 mt -136.15 131.82 49.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.002 -1.11 . . . . 53.340000000000003 108.002 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 31.2 ttm180 -129.09 116.52 19.4 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.666 -0.865 . . . . 65.219999999999999 108.666 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.449 HG21 ' HB ' ' A' ' 239' ' ' VAL . 12.4 p -119.57 127.42 52.96 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.171 -0.677 . . . . 43.409999999999997 109.171 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.41 ' HB2' ' HG3' ' A' ' 270' ' ' LYS . 43.9 mt-10 -135.86 144.24 45.51 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 116.592 -0.276 . . . . 72.129999999999995 111.063 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.551 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 41.6 mt-10 62.34 88.88 0.09 Allowed 'General case' 0 C--O 1.215 -0.715 0 O-C-N 124.908 1.38 . . . . 71.310000000000002 113.181 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.551 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.0 OUTLIER 59.45 21.72 10.17 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.868 0.867 . . . . 72.109999999999999 112.131 174.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.08 142.13 28.08 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.725 -0.472 . . . . 52.43 109.725 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -125.03 137.17 54.23 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.592 -0.521 . . . . 71.219999999999999 109.592 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 4.3 p -129.98 132.77 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 123.996 0.81 . . . . 73.25 111.285 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.511 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 57.9 tp60 -111.95 117.0 31.51 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 107.885 -1.154 . . . . 71.430000000000007 107.885 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.73 118.5 35.77 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.767 -0.827 . . . . 65.140000000000001 108.767 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.522 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 132.87 -114.23 1.38 Allowed Glycine 0 N--CA 1.439 -1.167 0 C-N-CA 120.679 -0.772 . . . . 73.120000000000005 113.203 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -145.4 139.19 26.76 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.452 -0.944 . . . . 73.340000000000003 108.452 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.445 HG11 ' HA3' ' A' ' 285' ' ' GLY . 27.0 t -123.57 114.56 42.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.965 -1.124 . . . . 64.329999999999998 107.965 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 80.4 t -111.13 119.79 60.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 109.367 -0.605 . . . . 70.349999999999994 109.367 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 28.5 m -88.44 158.01 18.49 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.211 -1.774 . . . . 64.439999999999998 106.211 172.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.42 87.58 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.392 0.515 . . . . 52.450000000000003 112.392 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.66 98.91 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.145 1.165 . . . . 72.530000000000001 114.145 -175.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 120.877 0.37 . . . . 53.109999999999999 110.883 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.425 -1.686 0 CA-C-O 121.566 0.698 . . . . 44.049999999999997 111.767 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 7.9 t30 -126.57 143.13 51.31 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.238 -1.023 . . . . 65.319999999999993 108.238 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.6 m -138.36 125.6 21.63 Favored 'General case' 0 C--N 1.29 -1.984 0 O-C-N 121.718 -0.614 . . . . 42.539999999999999 109.721 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.6 p -126.89 145.94 33.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.244 -0.65 . . . . 63.240000000000002 109.244 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 59.9 mt-10 -87.14 -79.11 0.28 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 119.755 -0.778 . . . . 73.420000000000002 110.364 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.2 t -116.65 132.02 56.8 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.641 0.734 . . . . 62.149999999999999 111.46 -174.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.88 124.77 47.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.151 -0.931 . . . . 62.520000000000003 110.405 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 4.0 p -127.25 129.06 70.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 116.056 -0.52 . . . . 74.030000000000001 111.421 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.09 131.06 8.04 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 109.469 -1.453 . . . . 61.329999999999998 109.469 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.41 ' HG3' ' HB2' ' A' ' 234' ' ' GLU . 45.4 tttm -134.19 120.67 20.34 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 120.142 -0.623 . . . . 52.240000000000002 111.583 -175.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.56 83.77 1.61 Allowed Glycine 0 C--N 1.306 -1.124 0 C-N-CA 120.33 -0.938 . . . . 53.420000000000002 112.974 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 55.19 28.26 10.84 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.68 1.592 . . . . 73.310000000000002 112.424 173.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 17.7 m -82.67 151.51 26.24 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.893 0.701 . . . . 72.129999999999995 112.893 -170.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -113.09 127.71 56.28 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.361 -0.836 . . . . 71.049999999999997 108.931 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.4 p -137.03 123.54 28.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.362 0.601 . . . . 73.0 110.572 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.1 tt -117.3 124.27 48.58 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.654 -1.239 . . . . 73.049999999999997 107.654 175.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.686 HG23 HD12 ' B' ' 241' ' ' LEU . 72.4 mt -113.17 103.7 15.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.14 -1.059 . . . . 70.109999999999999 108.14 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 141.65 -151.13 22.5 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 111.433 -0.667 . . . . 60.420000000000002 111.433 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -111.76 131.88 55.02 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 122.216 -0.579 . . . . 74.120000000000005 109.775 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 8.1 tp10 -113.97 118.57 34.53 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 124.401 1.08 . . . . 71.049999999999997 108.153 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -108.74 124.56 50.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.075 -1.083 . . . . 72.420000000000002 108.075 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.13 -52.71 0.64 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 111.323 -0.711 . . . . 60.420000000000002 111.323 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 88.13 18.37 55.87 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.335 -1.106 . . . . 61.020000000000003 110.335 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 284' ' ' LYS . 11.5 mmpt? -122.35 -2.35 9.03 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.598 -0.519 . . . . 72.140000000000001 109.598 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.445 ' HA3' HG11 ' A' ' 244' ' ' VAL . . . -78.56 -75.69 0.97 Allowed Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.269 -0.967 . . . . 32.310000000000002 113.507 -174.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.432 ' CB ' HD12 ' A' ' 276' ' ' LEU . 59.6 t80 -79.59 -35.02 40.29 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.797 -0.361 . . . . 63.140000000000001 111.634 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 30.0 p90 . . . . . 0 C--N 1.298 -1.65 0 N-CA-C 108.857 -0.794 . . . . 72.239999999999995 108.857 178.798 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 . . . . . 0 CA--C 1.511 -0.55 0 CA-C-O 121.267 0.556 . . . . 71.129999999999995 112.238 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 9.1 t30 -110.54 133.73 53.03 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.484 -2.043 . . . . 71.209999999999994 105.484 171.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 50.8 m -133.89 149.57 51.32 Favored 'General case' 0 C--N 1.281 -2.404 0 O-C-N 121.197 -0.939 . . . . 74.519999999999996 111.769 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.648 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -135.99 146.29 47.05 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.929 -1.137 . . . . 70.120000000000005 107.929 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 3.5 tmtm? -101.88 -57.93 1.98 Allowed 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.917 -0.771 . . . . 45.020000000000003 108.917 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -135.26 139.21 44.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.255 -0.43 . . . . 74.120000000000005 109.998 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.436 HD13 HD12 ' B' ' 277' ' ' ILE . 21.8 mt -135.9 127.62 44.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.254 -1.017 . . . . 73.549999999999997 108.254 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 38.1 ttm180 -125.95 115.61 20.2 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.636 -0.876 . . . . 73.010000000000005 108.636 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.418 HG21 ' CG1' ' B' ' 239' ' ' VAL . 81.7 p -110.75 126.49 54.64 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.173 -1.417 . . . . 64.430000000000007 107.173 176.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -133.29 138.86 46.6 Favored 'General case' 0 CA--C 1.493 -1.239 0 C-N-CA 120.34 -0.544 . . . . 73.340000000000003 109.753 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.588 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 43.1 mt-10 64.37 97.93 0.04 OUTLIER 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.758 1.392 . . . . 74.030000000000001 114.758 171.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.588 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.0 OUTLIER 57.71 29.25 17.04 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.57 0.748 . . . . 71.239999999999995 109.95 174.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.55 140.14 30.81 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-O 122.022 0.915 . . . . 75.349999999999994 110.984 -175.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.407 ' HD2' ' N ' ' B' ' 238' ' ' ARG . 0.5 OUTLIER -125.81 134.27 51.74 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 105.863 -1.903 . . . . 74.019999999999996 105.863 177.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.6 p -134.06 134.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.895 0.855 . . . . 42.0 111.097 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.548 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 35.4 tp60 -110.64 121.0 44.25 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 114.16 -1.382 . . . . 73.219999999999999 107.271 172.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.686 HD12 HG23 ' A' ' 277' ' ' ILE . 2.9 tm? -117.24 118.76 33.19 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 107.072 -1.455 . . . . 70.140000000000001 107.072 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.523 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 127.6 -109.51 1.06 Allowed Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.472 -0.871 . . . . 62.130000000000003 112.42 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.586 ' OD1' HG23 ' B' ' 245' ' ' VAL . 24.1 t-20 -144.4 146.58 32.59 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 122.286 -0.538 . . . . 71.439999999999998 110.699 -176.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.548 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 25.0 t -133.06 120.42 40.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.175 -1.046 . . . . 74.209999999999994 108.175 172.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.586 HG23 ' OD1' ' B' ' 243' ' ' ASN . 88.6 t -115.57 119.37 61.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.65 -0.5 . . . . 70.209999999999994 109.65 176.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 24.8 m -79.02 157.44 28.08 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 106.003 -1.851 . . . . 74.019999999999996 106.003 174.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -65.11 -46.36 81.36 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.99 0.9 . . . . 61.509999999999998 112.201 -176.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.29 74.33 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 113.831 -1.531 . . . . 72.049999999999997 113.576 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.711 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -70.48 -46.43 63.77 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.543 0.942 . . . . 71.430000000000007 113.543 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 44.2 tp . . . . . 0 C--N 1.313 -1.017 0 C-N-CA 119.967 -0.693 . . . . 42.130000000000003 110.518 -175.556 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 24.6 p . . . . . 0 N--CA 1.428 -1.566 0 CA-C-O 120.953 0.406 . . . . 74.140000000000001 110.507 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 7.4 t -94.33 127.69 40.37 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-O 121.429 0.633 . . . . 34.539999999999999 110.857 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.513 ' HB3' ' OD1' ' B' ' 226' ' ' ASN . 54.5 t30 -126.66 143.56 51.19 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.127 -1.064 . . . . 74.510000000000005 108.127 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' C' ' 227' ' ' SER . 24.3 m -141.97 126.31 17.63 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 122.019 -0.426 . . . . 71.120000000000005 110.074 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.7 p -120.16 152.28 22.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 109.09 -0.708 . . . . 73.519999999999996 109.09 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.467 ' HA ' ' CB ' ' B' ' 229' ' ' LYS . 27.8 mt-10 -92.8 -86.42 0.25 Allowed 'General case' 0 N--CA 1.404 -2.768 0 C-N-CA 119.455 -0.898 . . . . 64.200000000000003 111.151 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 11.3 t -109.42 130.13 55.51 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.604 -0.839 . . . . 71.140000000000001 111.745 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.5 p -132.29 124.48 52.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.114 -0.948 . . . . 75.140000000000001 110.54 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 7.7 p -127.1 134.52 65.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 116.078 -0.51 . . . . 70.120000000000005 111.718 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.78 132.28 10.32 Favored Glycine 0 CA--C 1.479 -2.208 0 N-CA-C 110.062 -1.215 . . . . 41.439999999999998 110.062 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -133.59 116.66 16.15 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 120.778 0.323 . . . . 73.329999999999998 111.281 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.69 86.31 0.57 Allowed Glycine 0 C--O 1.25 1.123 0 C-N-CA 120.583 -0.818 . . . . 73.010000000000005 114.094 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 61.59 31.08 18.86 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.284 1.034 . . . . 73.019999999999996 111.961 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 24.5 m -83.25 145.64 29.01 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.575 0.702 . . . . 74.299999999999997 112.12 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.461 ' NH2' ' HA ' ' B' ' 287' ' ' TRP . 39.6 mtp180 -115.14 125.93 54.03 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.236 -2.135 . . . . 75.030000000000001 105.236 173.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 1.6 p -135.84 127.09 44.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-O 120.958 0.408 . . . . 64.409999999999997 110.498 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' B' ' 286' ' ' PHE . 5.5 tt -120.15 121.76 39.5 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.361 -1.348 . . . . 74.200000000000003 107.361 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.638 HG23 HD12 ' C' ' 241' ' ' LEU . 36.7 mt -113.06 103.72 15.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 N-CA-C 106.767 -1.568 . . . . 53.520000000000003 106.767 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 145.11 -147.54 18.76 Favored Glycine 0 N--CA 1.416 -2.637 0 C-N-CA 120.917 -0.658 . . . . 73.409999999999997 111.783 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -115.01 128.71 56.43 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 120.937 -0.305 . . . . 74.319999999999993 111.392 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.542 ' HG2' ' CZ2' ' B' ' 287' ' ' TRP . 9.7 tp10 -112.46 121.47 44.92 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.921 -1.14 . . . . 75.340000000000003 107.921 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.463 ' CD2' ' HB ' ' C' ' 245' ' ' VAL . 86.7 m-85 -111.53 124.03 51.45 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.378 -0.971 . . . . 73.230000000000004 108.378 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.29 -61.59 0.31 Allowed Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 111.014 -0.834 . . . . 74.319999999999993 111.014 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . 0.407 ' C ' ' HD2' ' B' ' 284' ' ' LYS . . . 94.53 26.02 14.44 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.314 -0.715 . . . . 74.450000000000003 111.314 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . 0.407 ' HD2' ' C ' ' B' ' 283' ' ' GLY . 3.2 mptp? -134.09 2.57 3.35 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 110.39 -0.226 . . . . 72.420000000000002 110.39 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . 0.495 ' HA3' HG11 ' B' ' 244' ' ' VAL . . . -78.53 -66.76 1.69 Allowed Glycine 0 N--CA 1.417 -2.633 0 C-N-CA 119.952 -1.118 . . . . 74.319999999999993 112.371 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.501 ' HB3' HD12 ' B' ' 276' ' ' LEU . 75.9 t80 -87.67 -37.84 16.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.914 0.709 . . . . 63.539999999999999 112.914 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.542 ' CZ2' ' HG2' ' B' ' 280' ' ' GLU . 20.8 p90 . . . . . 0 C--N 1.312 -1.064 0 N-CA-C 112.86 0.689 . . . . 70.120000000000005 112.86 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' C' ' 261' ' ' THR . 14.9 ptt180 . . . . . 0 N--CA 1.437 -1.109 0 CA-C-O 121.464 0.65 . . . . 73.530000000000001 111.102 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 7.4 t30 -108.85 141.55 40.73 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.017 -2.216 . . . . 55.030000000000001 105.017 169.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' B' ' 263' ' ' SER . 54.0 m -139.8 139.48 36.41 Favored 'General case' 0 C--N 1.278 -2.542 0 O-C-N 121.818 -0.551 . . . . 62.109999999999999 110.889 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -127.45 143.19 51.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.782 -1.192 . . . . 62.140000000000001 107.782 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' C' ' 265' ' ' GLU . 9.3 tmtt? -102.77 -53.1 2.93 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.588 -0.523 . . . . 63.329999999999998 109.588 -174.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.21 137.96 43.14 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.248 -0.649 . . . . 64.200000000000003 109.248 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 33.5 mt -136.67 130.31 46.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.01 -1.107 . . . . 75.420000000000002 108.01 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -133.6 119.1 19.0 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.43 -0.952 . . . . 73.099999999999994 108.43 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 45.0 p -110.49 126.41 54.33 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.19 -1.411 . . . . 73.140000000000001 107.19 174.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -127.91 139.22 52.73 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 110.05 -0.352 . . . . 63.240000000000002 110.05 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.571 ' C ' ' HD3' ' C' ' 236' ' ' ARG . 62.5 mt-10 63.13 93.43 0.05 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.664 1.227 . . . . 74.140000000000001 114.218 170.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.571 ' HD3' ' C ' ' C' ' 235' ' ' GLU . 0.7 OUTLIER 56.37 26.91 11.22 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 123.889 0.875 . . . . 73.549999999999997 111.387 172.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -87.5 148.46 24.91 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.751 -0.659 . . . . 62.520000000000003 110.576 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -124.66 134.22 52.96 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.17 -1.418 . . . . 72.140000000000001 107.17 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 4.7 p -135.96 135.14 50.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.622 0.725 . . . . 71.239999999999995 111.188 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.501 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 36.4 tp60 -114.37 115.17 26.91 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-N 114.28 -1.327 . . . . 70.530000000000001 108.152 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.638 HD12 HG23 ' B' ' 277' ' ' ILE . 3.0 tm? -111.85 117.79 33.76 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 105.596 -2.002 . . . . 73.319999999999993 105.596 176.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.546 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 138.65 -130.62 4.99 Favored Glycine 0 CA--C 1.485 -1.837 0 C-N-CA 119.577 -1.297 . . . . 53.539999999999999 111.724 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -141.06 131.26 24.88 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 120.956 0.408 . . . . 70.340000000000003 109.911 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.501 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 21.4 t -114.52 129.87 69.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.668 -0.864 . . . . 73.310000000000002 108.668 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.463 ' HB ' ' CD2' ' B' ' 281' ' ' TYR . 95.8 t -122.11 118.53 55.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 109.195 -0.668 . . . . 64.219999999999999 109.195 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 21.4 m -79.43 159.42 27.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.949 -1.871 . . . . 74.109999999999999 105.949 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.711 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -62.63 -47.63 82.92 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-O 122.08 0.943 . . . . 64.230000000000004 110.772 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.88 -34.76 65.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 113.718 -1.583 . . . . 53.140000000000001 112.806 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.023 0 N-CA-C 113.74 1.015 . . . . 72.510000000000005 113.74 -174.028 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 15.4 t . . . . . 0 CA--C 1.56 1.342 0 CA-C-O 121.889 0.852 . . . . 63.439999999999998 110.169 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 9.0 t30 -127.77 126.7 42.25 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.808 -0.558 . . . . 62.119999999999997 111.661 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 68.4 m -121.43 134.39 55.09 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 122.126 -0.359 . . . . 33.240000000000002 110.731 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -128.32 150.55 34.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.166 -1.05 . . . . 53.219999999999999 108.166 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' C' ' 229' ' ' LYS . 49.1 mt-10 -91.11 -88.49 0.18 Allowed 'General case' 0 N--CA 1.419 -1.978 0 C-N-CA 119.374 -0.931 . . . . 71.5 111.045 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 5.8 t -107.78 132.65 53.17 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.652 -0.819 . . . . 72.25 111.914 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.02 131.34 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.162 -0.926 . . . . 73.400000000000006 109.119 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.79 135.76 62.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 116.104 -0.498 . . . . 74.209999999999994 110.652 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.04 9.86 Favored Glycine 0 CA--C 1.474 -2.511 0 N-CA-C 109.086 -1.605 . . . . 73.510000000000005 109.086 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -134.03 116.27 15.3 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 110.227 -0.286 . . . . 72.239999999999995 110.227 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.57 83.48 0.73 Allowed Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.513 -0.851 . . . . 75.129999999999995 114.217 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 60.44 33.88 20.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.409 1.084 . . . . 75.030000000000001 112.319 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 10.7 m -83.72 145.18 28.88 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.925 0.713 . . . . 52.240000000000002 112.925 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -105.87 128.13 53.56 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.486 -1.301 . . . . 74.439999999999998 107.486 168.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 7.5 p -139.22 127.59 27.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 120.974 0.416 . . . . 73.340000000000003 111.226 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.516 HD12 ' CB ' ' C' ' 286' ' ' PHE . 7.2 tt -117.19 120.35 38.02 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.41 -0.959 . . . . 74.310000000000002 108.41 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 28.2 mt -113.26 103.6 15.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 106.991 -1.485 . . . . 72.120000000000005 106.991 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 144.85 -146.04 16.02 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.764 -0.935 . . . . 44.399999999999999 110.764 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -115.45 133.25 56.21 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 110.1 -0.333 . . . . 74.140000000000001 110.1 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.416 ' HG2' ' CZ2' ' C' ' 287' ' ' TRP . 10.5 tp10 -113.35 118.21 33.93 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.869 -1.159 . . . . 75.409999999999997 107.869 177.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -108.86 124.94 51.42 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.325 0.583 . . . . 73.120000000000005 109.861 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 106.08 -38.59 3.23 Favored Glycine 0 N--CA 1.417 -2.602 0 CA-C-N 115.089 -0.96 . . . . 63.100000000000001 110.957 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 72.76 35.06 58.92 Favored Glycine 0 CA--C 1.489 -1.569 0 N-CA-C 109.507 -1.437 . . . . 53.350000000000001 109.507 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -146.88 -7.3 0.49 Allowed 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 114.851 -0.675 . . . . 71.519999999999996 109.906 -173.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . 0.457 ' HA3' HG11 ' C' ' 244' ' ' VAL . . . -76.45 -70.15 1.31 Allowed Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 120.789 -0.719 . . . . 72.150000000000006 112.843 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.516 ' CB ' HD12 ' C' ' 276' ' ' LEU . 70.9 t80 -77.07 -51.16 11.53 Favored 'General case' 0 CA--C 1.49 -1.355 0 C-N-CA 120.411 -0.516 . . . . 75.319999999999993 110.097 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.416 ' CZ2' ' HG2' ' C' ' 280' ' ' GLU 0.317 28.5 p90 . . . . . 0 N--CA 1.412 -2.348 0 C-N-CA 118.504 -1.278 . . . . 75.549999999999997 112.2 177.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 261' ' ' THR . 37.4 ttm180 . . . . . 0 CA--C 1.507 -0.693 0 N-CA-C 110.235 -0.283 . . . . 73.430000000000007 110.235 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 34.1 t-20 -116.88 149.23 40.43 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.527 -0.916 . . . . 73.540000000000006 108.527 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.3 m -137.09 137.52 39.39 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.97 -0.752 . . . . 71.140000000000001 108.97 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 277' ' ' ILE . . . -137.17 132.06 33.42 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 110.109 -0.33 . . . . 53.240000000000002 110.109 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 5.2 tmmm? -90.87 -55.06 3.7 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.122 -0.49 . . . . 74.299999999999997 110.971 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -131.59 139.4 49.17 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.972 -0.381 . . . . 71.099999999999994 109.972 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 68.0 mt -137.29 121.03 22.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.546 -0.909 . . . . 74.239999999999995 108.546 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -131.27 129.21 41.25 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.325 0.583 . . . . 72.349999999999994 112.011 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.44 HG21 ' HB ' ' A' ' 239' ' ' VAL . 27.2 p -132.32 128.49 37.85 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.415 -0.811 . . . . 74.5 109.029 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -121.48 147.99 45.04 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 111.841 0.311 . . . . 72.530000000000001 111.841 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 67.07 -87.23 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.729 1.212 . . . . 73.310000000000002 113.859 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 25.0 mtm-85 -116.31 3.02 13.33 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.191 0.596 . . . . 72.129999999999995 110.487 -175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -69.64 136.71 51.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.308 -0.86 . . . . 75.450000000000003 111.33 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -125.45 135.38 52.28 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.36 -0.978 . . . . 74.200000000000003 108.36 -177.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.9 p -129.68 146.03 34.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.573 0.701 . . . . 62.329999999999998 110.809 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.53 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 6.1 tp-100 -123.72 130.01 51.98 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 107.929 -1.137 . . . . 75.329999999999998 107.929 174.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -123.32 118.68 28.08 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.469 -0.937 . . . . 74.040000000000006 108.469 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.528 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 130.27 -114.12 1.58 Allowed Glycine 0 N--CA 1.433 -1.566 0 CA-C-N 115.825 -0.625 . . . . 75.219999999999999 111.618 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -145.19 138.75 26.75 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 122.437 -0.449 . . . . 60.149999999999999 111.375 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 85.5 t -122.45 114.08 41.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.806 -1.553 . . . . 73.25 106.806 174.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.457 ' HA ' ' HB2' ' A' ' 281' ' ' TYR . 7.3 p -122.78 114.35 41.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 C-N-CA 120.334 -0.546 . . . . 72.239999999999995 110.607 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 22.8 m -79.92 158.9 26.54 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.826 -1.176 . . . . 74.230000000000004 107.826 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.97 -41.49 95.41 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.054 0.455 . . . . 34.229999999999997 111.368 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -35.9 67.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.408 -1.269 . . . . 70.099999999999994 113.895 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.324 -0.51 0 C-N-CA 122.766 0.426 . . . . 54.130000000000003 112.126 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.555 ' HB ' ' HD2' ' B' ' 225' ' ' ARG . 29.3 m . . . . . 0 N--CA 1.419 -1.985 0 N-CA-C 108.177 -1.046 . . . . 72.430000000000007 108.177 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.546 ' O ' ' HA ' ' A' ' 226' ' ' ASN . 38.9 t-20 -126.15 136.77 53.27 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.14 -1.43 . . . . 54.240000000000002 107.14 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.6 m -138.15 134.53 34.69 Favored 'General case' 0 C--N 1.285 -2.21 0 O-C-N 122.077 -0.389 . . . . 75.129999999999995 110.289 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 13.1 p -128.43 141.88 45.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.211 0.529 . . . . 75.010000000000005 111.118 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.608 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 6.4 mm-40 -78.58 -72.18 0.39 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.652 -0.703 . . . . 54.149999999999999 110.961 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -128.8 127.84 42.76 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.854 -0.738 . . . . 62.310000000000002 112.713 -175.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.425 HG12 HD12 ' B' ' 231' ' ' ILE . 35.5 m -119.97 126.9 75.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.975 -0.557 . . . . 54.420000000000002 110.07 175.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.55 136.88 59.53 Favored 'Isoleucine or valine' 0 C--O 1.257 1.473 0 CA-C-O 121.358 0.599 . . . . 73.310000000000002 112.115 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.09 131.34 8.38 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.725 -1.35 . . . . 72.120000000000005 109.725 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -124.24 117.57 24.88 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.412 0.625 . . . . 75.129999999999995 111.536 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.24 -118.87 5.41 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.106 -1.198 . . . . 74.329999999999998 110.106 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -102.63 90.66 3.9 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.449 -1.315 . . . . 62.109999999999999 107.449 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 31.5 m -130.7 145.35 51.91 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.607 -1.179 . . . . 71.120000000000005 108.643 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . 0.529 ' HB2' ' HG3' ' B' ' 238' ' ' ARG . 94.0 mtt180 -130.45 127.51 39.39 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.445 -1.302 . . . . 74.120000000000005 108.225 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.5 p -132.76 130.38 59.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.961 0.886 . . . . 64.349999999999994 111.327 -173.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.6 tt -117.51 126.13 52.06 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.972 -1.122 . . . . 72.450000000000003 107.972 176.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.454 HG21 ' HB2' ' A' ' 228' ' ' ALA . 34.6 mm -112.68 103.51 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 107.075 -1.454 . . . . 61.420000000000002 107.075 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.625 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 150.44 -141.17 8.5 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.881 -1.152 . . . . 72.140000000000001 112.85 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -113.02 134.14 54.65 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.798 -1.186 . . . . 74.450000000000003 107.798 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.4 OUTLIER -129.74 120.36 24.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.966 0.889 . . . . 71.430000000000007 109.104 176.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.457 ' HB2' ' HA ' ' A' ' 245' ' ' VAL . 2.8 m-85 -113.97 124.65 52.67 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.858 -1.064 . . . . 73.010000000000005 108.951 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 129.72 -42.6 1.4 Allowed Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.841 -0.695 . . . . 74.0 112.407 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' B' ' 286' ' ' PHE . . . 100.61 -15.95 58.12 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.81 -0.916 . . . . 54.509999999999998 110.81 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.07 83.96 2.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.002 -0.74 . . . . 70.129999999999995 109.002 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -84.88 -121.75 1.02 Allowed Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.653 -0.703 . . . . 73.430000000000007 112.312 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -87.98 15.89 6.69 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.104 0.478 . . . . 75.010000000000005 110.223 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.428 ' CH2' ' HB2' ' A' ' 276' ' ' LEU . 78.0 m95 . . . . . 0 C--N 1.316 -0.866 0 N-CA-C 114.686 1.365 . . . . 74.420000000000002 114.686 -170.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.555 ' HD2' ' HB ' ' A' ' 261' ' ' THR . 8.1 tpt180 . . . . . 0 N--CA 1.443 -0.776 0 N-CA-C 107.524 -1.287 . . . . 74.409999999999997 107.524 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.594 HD21 HG22 ' B' ' 277' ' ' ILE . 7.3 t30 -120.95 144.56 48.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 120.747 0.308 . . . . 55.130000000000003 111.79 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' B' ' 263' ' ' SER . 50.5 m -136.33 136.96 40.14 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.179 -0.674 . . . . 70.420000000000002 109.179 173.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.03 142.94 49.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.537 -0.542 . . . . 61.009999999999998 109.537 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.608 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 2.3 tmmm? -100.69 -64.1 1.07 Allowed 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 120.393 -0.523 . . . . 73.299999999999997 110.267 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -127.85 138.33 52.66 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 108.959 -0.756 . . . . 73.430000000000007 108.959 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.425 HD12 HG12 ' A' ' 267' ' ' VAL . 16.9 mt -135.57 119.91 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.095 -0.705 . . . . 73.010000000000005 109.095 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -123.23 115.71 22.18 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.873 0.368 . . . . 73.299999999999997 110.651 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 52.6 p -111.69 127.66 55.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.625 -1.25 . . . . 73.099999999999994 107.625 175.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -130.18 149.68 51.77 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.457 -0.497 . . . . 73.450000000000003 111.028 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . 0.251 33.5 mt-10 75.87 -74.16 0.08 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 115.733 1.753 . . . . 64.129999999999995 115.733 170.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.26 24.72 2.3 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.334 -0.987 . . . . 75.209999999999994 108.334 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -84.91 142.93 29.34 Favored 'General case' 0 C--O 1.275 2.444 0 CA-C-O 122.954 1.359 . . . . 75.340000000000003 113.895 -172.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.529 ' HG3' ' HB2' ' A' ' 274' ' ' ARG . 3.7 mpt_? -125.93 135.21 51.61 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.487 -1.233 . . . . 62.039999999999999 110.845 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.515 HG13 HG23 ' A' ' 275' ' ' VAL . 14.1 p -134.29 143.4 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.201 1.001 . . . . 74.099999999999994 110.51 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.56 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 4.8 tp-100 -121.12 125.17 46.56 Favored 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 114.108 -1.405 . . . . 64.200000000000003 107.857 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.407 HD12 HG23 ' A' ' 277' ' ' ILE . 3.2 tm? -119.16 117.04 27.6 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.176 -1.787 . . . . 61.200000000000003 106.176 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 139.05 -121.33 2.08 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 110.487 -1.045 . . . . 61.200000000000003 110.487 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -145.34 139.1 26.79 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.932 0.366 . . . . 71.120000000000005 110.853 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.56 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 44.8 t -122.41 122.61 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 107.989 -1.115 . . . . 73.409999999999997 107.989 175.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.516 HG21 ' O ' ' B' ' 250' ' ' LEU . 7.0 p -123.67 125.67 71.68 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 C-N-CA 120.052 -0.659 . . . . 75.109999999999999 110.89 175.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 2.1 m -81.88 160.82 23.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.393 -1.336 . . . . 63.049999999999997 107.393 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -61.97 -35.94 79.97 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 120.986 0.422 . . . . 74.519999999999996 111.636 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.33 -52.28 64.0 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.698 -1.137 . . . . 72.030000000000001 112.566 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.16 -46.42 34.38 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.707 -0.397 . . . . 20.41 110.414 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.516 ' O ' HG21 ' B' ' 245' ' ' VAL . 52.1 tp . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 124.916 1.286 . . . . 70.049999999999997 113.138 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 86.1 m . . . . . 0 N--CA 1.431 -1.397 0 N-CA-C 108.92 -0.771 . . . . 73.219999999999999 108.92 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 29.1 m -126.58 112.88 16.03 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.92 -0.77 . . . . 70.510000000000005 108.92 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -121.05 138.18 54.3 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.936 -1.135 . . . . 60.450000000000003 107.936 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' C' ' 227' ' ' SER . 43.6 m -138.6 138.88 38.31 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 120.739 0.304 . . . . 54.039999999999999 110.219 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' C' ' 228' ' ' ALA . 12.5 p -128.51 150.33 34.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 120.87 0.367 . . . . 52.310000000000002 110.527 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 44.0 mm-40 -86.01 -76.21 0.35 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.834 -0.621 . . . . 71.109999999999999 110.691 174.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 27.8 m -128.81 127.87 42.8 Favored 'General case' 0 C--O 1.249 1.034 0 C-N-CA 119.931 -0.707 . . . . 63.229999999999997 112.454 -176.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.412 HG12 ' HB ' ' C' ' 231' ' ' ILE . 35.1 m -118.46 129.31 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.696 -0.684 . . . . 62.509999999999998 109.265 175.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 8.8 p -127.58 128.87 70.11 Favored 'Isoleucine or valine' 0 C--O 1.266 1.922 0 CA-C-O 121.716 0.769 . . . . 70.340000000000003 112.237 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.91 132.82 10.93 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 110.46 -1.056 . . . . 61.109999999999999 110.46 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -124.09 121.29 34.77 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 122.472 0.309 . . . . 72.439999999999998 111.127 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.24 -130.0 9.42 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.65 -1.38 . . . . 44.109999999999999 109.65 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.93 98.4 11.35 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.653 -1.98 . . . . 52.240000000000002 105.653 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.4 t -130.03 143.03 50.57 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.989 -1.005 . . . . 72.349999999999994 108.764 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.549 ' HB2' ' HG3' ' C' ' 238' ' ' ARG . 76.3 mtt180 -131.3 127.05 36.91 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 118.565 -1.254 . . . . 73.329999999999998 108.376 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.0 p -135.9 132.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 115.094 -0.957 . . . . 73.219999999999999 110.918 -175.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.521 ' HB3' ' OE1' ' C' ' 240' ' ' GLN . 5.9 tt -119.96 125.41 48.34 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 107.546 -1.279 . . . . 63.310000000000002 107.546 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.594 HG22 HD21 ' B' ' 226' ' ' ASN . 30.0 mm -112.54 103.56 15.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 N-CA-C 106.772 -1.566 . . . . 74.140000000000001 106.772 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.567 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 147.21 -143.77 11.73 Favored Glycine 0 N--CA 1.427 -1.951 0 C-N-CA 120.422 -0.894 . . . . 51.549999999999997 113.829 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -108.76 132.25 54.15 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.721 -0.844 . . . . 53.0 108.721 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' C' ' 244' ' ' VAL . 0.0 OUTLIER -127.8 122.49 32.85 Favored 'General case' 0 C--O 1.265 1.88 0 CA-C-O 122.324 1.059 . . . . 73.299999999999997 108.593 177.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -120.52 124.11 44.57 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.407 -1.27 . . . . 71.299999999999997 107.7 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 128.94 -40.05 1.76 Allowed Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.333 -0.937 . . . . 31.399999999999999 111.524 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' C' ' 286' ' ' PHE . . . 97.01 -16.54 60.77 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 110.576 -1.01 . . . . 61.329999999999998 110.576 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.29 77.56 1.68 Allowed 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.208 -0.496 . . . . 73.099999999999994 110.577 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -76.3 -128.86 0.3 Allowed Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 115.013 -0.994 . . . . 43.119999999999997 112.007 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 5.0 p90 -81.99 13.55 3.29 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.484 0.659 . . . . 71.209999999999994 111.391 -175.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.465 ' CH2' ' HB2' ' B' ' 276' ' ' LEU . 39.9 m95 . . . . . 0 C--N 1.315 -0.92 0 CA-C-N 116.037 -0.528 . . . . 71.430000000000007 109.647 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' C' ' 261' ' ' THR . 28.4 ttt180 . . . . . 0 N--CA 1.42 -1.931 0 N-CA-C 109.023 -0.732 . . . . 74.099999999999994 109.023 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.568 HD21 HG22 ' C' ' 277' ' ' ILE . 7.2 t30 -118.78 148.97 42.26 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 116.182 -0.463 . . . . 65.129999999999995 110.475 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' C' ' 263' ' ' SER . 31.9 m -136.68 136.53 39.15 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.195 -1.039 . . . . 63.200000000000003 108.195 172.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.472 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -130.7 138.23 49.91 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.469 -0.567 . . . . 75.430000000000007 109.469 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 2.9 tmmm? -93.38 -64.22 1.12 Allowed 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.556 -0.458 . . . . 74.120000000000005 110.943 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' C' ' 266' ' ' THR . 28.4 t70 -127.37 137.79 52.85 Favored 'General case' 0 C--O 1.253 1.243 0 C-N-CA 120.1 -0.64 . . . . 63.539999999999999 109.682 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.412 ' HB ' HG12 ' B' ' 267' ' ' VAL . 31.3 mt -133.95 118.94 30.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.889 -0.782 . . . . 62.539999999999999 108.889 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -118.99 122.38 42.07 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.792 -0.448 . . . . 73.200000000000003 109.792 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 31.7 p -122.24 127.9 50.49 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.865 -0.791 . . . . 75.530000000000001 108.865 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -129.35 150.28 50.78 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 120.985 0.421 . . . . 53.5 111.596 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 74.42 -73.05 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.951 1.834 . . . . 71.510000000000005 115.951 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -139.53 29.81 2.15 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 107.498 -1.297 . . . . 70.439999999999998 107.498 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -91.3 137.6 32.24 Favored 'General case' 0 C--O 1.277 2.524 0 CA-C-O 122.571 1.177 . . . . 51.210000000000001 113.102 -173.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' B' ' 274' ' ' ARG . 2.9 mpt_? -125.7 134.71 51.72 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.891 -1.504 . . . . 72.140000000000001 109.426 176.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.523 HG23 HG13 ' C' ' 275' ' ' VAL . 8.5 p -133.42 139.4 49.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.832 0.825 . . . . 75.430000000000007 110.887 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.611 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 49.0 tp60 -114.85 118.89 34.79 Favored 'General case' 0 N--CA 1.401 -2.91 0 CA-C-N 114.228 -1.351 . . . . 64.140000000000001 108.425 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.437 HD12 HG23 ' B' ' 277' ' ' ILE . 3.2 tm? -111.74 118.77 36.52 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 105.416 -2.068 . . . . 72.209999999999994 105.416 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 135.97 -120.0 2.15 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.898 -1.281 . . . . 72.400000000000006 109.898 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 7.8 p30 -144.75 144.25 31.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 116.542 0.171 . . . . 55.100000000000001 111.156 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.611 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 48.9 t -124.08 114.64 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.595 0 N-CA-C 107.075 -1.454 . . . . 70.510000000000005 107.075 172.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' C' ' 281' ' ' TYR . 7.1 p -123.87 129.17 74.47 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 C-N-CA 119.298 -0.961 . . . . 70.239999999999995 111.098 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.5 m -88.91 159.2 17.79 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.219 -1.4 . . . . 73.400000000000006 107.219 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.79 94.37 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.726 0.774 . . . . 61.509999999999998 110.702 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.98 -34.27 63.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.111 -1.404 . . . . 64.209999999999994 112.464 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . 0.419 ' HB2' ' HA2' ' C' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.313 -1.017 0 N-CA-C 113.297 0.851 . . . . 73.420000000000002 113.297 -175.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 21.8 m . . . . . 0 N--CA 1.425 -1.702 0 N-CA-C 109.275 -0.639 . . . . 73.140000000000001 109.275 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -111.04 141.12 44.95 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.207 -1.034 . . . . 53.520000000000003 108.207 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' C' ' 227' ' ' SER . 21.7 m -140.01 140.25 36.19 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 122.035 -0.416 . . . . 53.229999999999997 110.163 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.459 HG21 HG13 ' C' ' 267' ' ' VAL . 7.2 p -129.18 142.87 42.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 121.195 -0.202 . . . . 71.0 111.086 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 9.7 mm-40 -80.91 -52.73 7.14 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 111.798 0.295 . . . . 73.230000000000004 111.798 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 37.5 m -150.18 133.05 16.03 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.162 -0.615 . . . . 71.530000000000001 111.063 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.459 HG13 HG21 ' C' ' 264' ' ' VAL . 17.1 m -126.05 135.08 64.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 109.178 -0.675 . . . . 62.32 109.178 171.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.08 129.15 71.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 109.746 -0.464 . . . . 72.129999999999995 109.746 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.65 132.8 11.25 Favored Glycine 0 N--CA 1.428 -1.884 0 N-CA-C 108.37 -1.892 . . . . 74.120000000000005 108.37 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -128.24 117.05 20.82 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 120.925 0.393 . . . . 71.319999999999993 110.094 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.85 -136.23 17.2 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 109.811 -1.316 . . . . 50.119999999999997 109.811 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.3 96.52 6.66 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.342 -1.355 . . . . 74.040000000000006 107.342 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 51.0 m -134.99 145.04 47.72 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 115.254 -0.884 . . . . 62.119999999999997 109.502 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -135.21 126.59 28.46 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 107.05 -1.463 . . . . 73.109999999999999 107.05 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.523 HG13 HG23 ' C' ' 239' ' ' VAL . 6.2 p -139.33 139.65 38.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.874 -0.603 . . . . 75.209999999999994 110.301 -176.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 7.0 tt -123.2 122.35 38.19 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 107.71 -1.218 . . . . 65.439999999999998 107.71 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.568 HG22 HD21 ' C' ' 226' ' ' ASN . 42.8 mm -110.65 103.79 16.04 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.843 0 N-CA-C 106.791 -1.559 . . . . 62.140000000000001 106.791 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.06 -133.67 5.05 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 119.918 -1.134 . . . . 71.409999999999997 113.548 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 17.9 m120 -115.07 134.07 55.49 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 120.816 0.341 . . . . 72.140000000000001 110.201 -177.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.64 119.58 19.58 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.61 -1.256 . . . . 75.540000000000006 107.61 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.445 ' HB2' HG23 ' C' ' 245' ' ' VAL . 3.4 m-85 -119.17 124.91 47.95 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.488 -0.931 . . . . 74.109999999999999 108.488 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' C' ' 249' ' ' ALA . . . 136.2 -36.91 1.95 Allowed Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.195 -0.762 . . . . 43.140000000000001 111.195 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 100.03 -27.29 20.98 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.264 -1.134 . . . . 72.140000000000001 110.264 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -132.84 87.34 2.4 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.845 -1.169 . . . . 74.219999999999999 107.845 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -84.44 -130.31 2.0 Allowed Glycine 0 C--N 1.308 -0.991 0 C-N-CA 120.944 -0.646 . . . . 71.239999999999995 112.291 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' B' ' 283' ' ' GLY . 1.4 p90 -73.67 18.32 0.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.336 0.589 . . . . 64.340000000000003 112.007 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 53.3 m95 . . . . . 0 C--O 1.244 0.768 0 O-C-N 121.407 -0.808 . . . . 73.430000000000007 110.304 -175.63 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 . . . . . 0 CA--C 1.508 -0.66 0 CA-C-O 120.591 0.234 . . . . 70.25 110.637 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.498 ' ND2' ' HA2' ' A' ' 278' ' ' GLY . 8.7 p30 -104.3 141.0 37.07 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.132 -1.433 . . . . 71.140000000000001 107.132 172.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.6 m -121.52 137.1 54.87 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.982 -0.377 . . . . 74.329999999999998 109.982 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.74 119.65 32.35 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.075 -1.454 . . . . 43.009999999999998 107.075 176.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -88.69 -41.31 12.67 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 116.206 -0.452 . . . . 63.009999999999998 110.807 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -140.71 138.99 34.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.915 0.388 . . . . 65.140000000000001 110.352 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.6 mt -131.41 121.85 49.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 107.673 -1.232 . . . . 64.230000000000004 107.673 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 60.4 ttt180 -132.58 115.1 15.03 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.493 0.663 . . . . 73.349999999999994 109.369 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 22.6 p -125.88 128.77 48.11 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.988 -1.116 . . . . 73.329999999999998 107.988 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -125.47 162.14 25.54 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.679 -0.808 . . . . 71.420000000000002 111.469 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 65.27 -84.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.122 1.369 . . . . 61.409999999999997 113.979 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -140.2 26.14 2.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.126 -0.943 . . . . 73.150000000000006 109.011 -168.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -79.67 151.62 30.41 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.832 -1.076 . . . . 75.209999999999994 109.763 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -124.11 135.43 53.52 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.241 -1.763 . . . . 73.230000000000004 106.241 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.5 p -135.87 139.59 45.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.038 0.447 . . . . 53.409999999999997 110.175 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.455 ' HB3' HD13 ' A' ' 276' ' ' LEU . 8.4 tp-100 -129.89 130.85 45.69 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.438 -0.949 . . . . 60.240000000000002 108.438 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.41 ' HA ' HG13 ' A' ' 277' ' ' ILE . 2.7 tm? -120.81 120.57 35.96 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.751 -1.203 . . . . 65.040000000000006 107.751 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.539 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 137.17 -140.09 11.09 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 120.22 -0.991 . . . . 61.210000000000001 112.127 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -123.85 128.32 49.32 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.906 -0.775 . . . . 73.310000000000002 108.906 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.4 118.71 57.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 107.897 -1.149 . . . . 53.030000000000001 107.897 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.39 112.75 41.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.835 -0.802 . . . . 72.120000000000005 108.835 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.409 ' OG1' ' HA3' ' A' ' 285' ' ' GLY . 29.6 m -101.53 159.6 15.15 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 108.128 -1.064 . . . . 73.430000000000007 108.128 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.59 74.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.637 0.977 . . . . 72.439999999999998 113.637 -175.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.02 -49.46 71.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 113.377 0.88 . . . . 63.140000000000001 113.377 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.609 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 CA--C 1.502 -0.874 0 N-CA-C 113.686 0.995 . . . . 53.119999999999997 113.686 -176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.416 -2.13 0 N-CA-C 108.465 -0.939 . . . . 71.030000000000001 108.465 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -95.57 144.16 26.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.721 -0.672 . . . . 73.209999999999994 109.195 -176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' B' ' 227' ' ' SER . 20.3 m -140.42 123.24 16.41 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.484 -0.562 . . . . 51.229999999999997 109.484 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.9 p -128.51 140.14 50.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.418 0.152 . . . . 75.340000000000003 110.985 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.65 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 62.6 mm-40 -77.73 -78.4 0.14 Allowed 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 116.384 -0.371 . . . . 71.040000000000006 110.273 176.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.1 t -124.42 130.82 53.17 Favored 'General case' 0 C--O 1.261 1.672 0 N-CA-C 112.986 0.735 . . . . 74.019999999999996 112.986 -174.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.768 HG12 HD12 ' B' ' 231' ' ' ILE . 17.0 m -118.09 125.35 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 115.109 -0.951 . . . . 61.32 109.167 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 5.1 p -127.4 125.91 66.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.17 0.509 . . . . 74.299999999999997 111.99 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.85 133.03 11.07 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.561 -0.745 . . . . 54.210000000000001 111.498 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -123.66 141.51 51.95 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.27 0.628 . . . . 71.239999999999995 110.437 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.41 -127.58 29.35 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.919 -0.658 . . . . 44.509999999999998 111.938 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.431 ' HB3' ' NH1' ' A' ' 274' ' ' ARG . 60.9 mm-40 -93.35 57.55 2.67 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.817 0.847 . . . . 73.099999999999994 110.407 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 70.7 m -88.74 145.09 25.83 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 120.115 -0.634 . . . . 51.219999999999999 111.969 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . 0.431 ' NH1' ' HB3' ' A' ' 272' ' ' GLU . 10.4 mpt_? -121.47 127.69 51.34 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.193 -1.41 . . . . 75.519999999999996 107.193 173.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.1 p -136.0 123.57 34.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-O 121.536 0.684 . . . . 74.299999999999997 110.852 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 240' ' ' GLN . 13.3 tp -121.97 124.3 43.7 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.542 0.687 . . . . 62.329999999999998 110.256 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.562 HG22 ' HB3' ' B' ' 241' ' ' LEU . 2.9 pt -112.7 104.55 17.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.402 -1.272 . . . . 73.420000000000002 110.056 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 146.0 -148.91 20.95 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 115.53 -0.759 . . . . 71.329999999999998 111.731 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 7.0 m-20 -101.94 149.58 24.07 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 122.752 -0.263 . . . . 74.129999999999995 110.709 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.1 125.94 24.09 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.776 -1.935 . . . . 62.020000000000003 105.776 175.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -109.29 122.81 48.15 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.493 -1.299 . . . . 64.519999999999996 107.493 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 134.11 -53.03 0.8 Allowed Glycine 0 C--N 1.283 -2.373 0 N-CA-C 108.939 -1.664 . . . . 60.32 108.939 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 103.32 -7.67 51.67 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.931 -1.268 . . . . 73.099999999999994 109.931 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -160.07 53.23 0.34 Allowed 'General case' 0 C--O 1.253 1.252 0 CA-C-N 114.755 -0.722 . . . . 74.019999999999996 111.15 -175.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.409 ' HA3' ' OG1' ' A' ' 246' ' ' THR . . . -95.22 -57.87 1.19 Allowed Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.57 -0.741 . . . . 62.240000000000002 113.99 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -78.66 -2.03 37.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.363 1.078 . . . . 64.239999999999995 110.788 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.447 ' CZ2' ' HD1' ' B' ' 286' ' ' PHE . 36.9 p90 . . . . . 0 C--N 1.292 -1.935 0 N-CA-C 105.162 -2.162 . . . . 61.229999999999997 105.162 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.492 -1.28 0 CA-C-O 120.839 0.352 . . . . 64.230000000000004 111.326 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' B' ' 262' ' ' ASN . 20.1 p-10 -116.67 140.29 49.57 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.381 -0.97 . . . . 54.030000000000001 108.381 174.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 263' ' ' SER . 18.2 m -121.48 136.5 54.95 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 109.526 -0.546 . . . . 64.400000000000006 109.526 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -120.8 131.53 54.51 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 106.989 -1.486 . . . . 74.219999999999999 106.989 175.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.65 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 1.4 tmtp? -93.31 -62.3 1.4 Allowed 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.121 -0.696 . . . . 71.510000000000005 109.121 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -127.95 137.36 52.23 Favored 'General case' 0 C--N 1.3 -1.543 0 N-CA-C 109.575 -0.528 . . . . 63.100000000000001 109.575 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.768 HD12 HG12 ' A' ' 267' ' ' VAL . 18.7 mt -133.8 122.36 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 108.523 -0.917 . . . . 74.25 108.523 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 38.9 ttp180 -123.54 115.68 21.92 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.904 -0.776 . . . . 73.310000000000002 108.904 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 70.6 p -109.24 127.75 54.5 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 105.831 -1.915 . . . . 74.129999999999995 105.831 177.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.55 161.67 26.65 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.207 -0.597 . . . . 72.519999999999996 111.48 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 67.52 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.251 -1.34 . . . . 71.450000000000003 113.41 172.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.06 18.3 2.28 Favored 'General case' 0 C--O 1.195 -1.783 0 N-CA-C 108.248 -1.019 . . . . 74.540000000000006 108.248 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.52 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -68.69 149.17 49.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.903 0.859 . . . . 74.409999999999997 113.016 -172.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -125.54 135.35 52.16 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.149 -0.932 . . . . 74.219999999999999 108.628 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 8.4 p -132.38 138.7 51.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.665 0.745 . . . . 54.32 110.763 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.541 ' CG ' HD13 ' B' ' 276' ' ' LEU . 52.5 tp60 -117.5 125.83 51.55 Favored 'General case' 0 N--CA 1.401 -2.887 0 CA-C-N 114.495 -1.229 . . . . 64.450000000000003 108.398 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.562 ' HB3' HG22 ' A' ' 277' ' ' ILE . 2.4 tm? -118.15 119.14 33.82 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.9 -1.889 . . . . 54.439999999999998 105.9 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.668 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 136.12 -147.01 19.0 Favored Glycine 0 C--N 1.278 -2.646 0 C-N-CA 119.721 -1.228 . . . . 41.149999999999999 110.875 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 86.2 m-20 -124.93 129.13 49.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.157 0.503 . . . . 64.129999999999995 110.017 -174.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 93.7 t -111.04 129.26 66.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.758 -0.83 . . . . 73.239999999999995 108.758 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 61.1 t -118.4 111.79 35.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.229 -1.026 . . . . 64.209999999999994 108.229 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.404 ' OG1' ' HA3' ' B' ' 285' ' ' GLY . 28.2 m -96.67 161.1 14.03 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.785 -0.821 . . . . 63.240000000000002 108.785 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.609 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.69 -33.95 76.77 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.273 0.629 . . . . 73.530000000000001 112.331 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.53 -37.16 67.58 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 115.222 1.564 . . . . 55.549999999999997 115.222 -173.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.441 ' HB2' ' N ' ' B' ' 282' ' ' GLY . . . -74.78 -37.79 62.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.148 0.796 . . . . 72.299999999999997 113.148 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 108.864 -0.791 . . . . 73.519999999999996 108.864 -167.978 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 67.3 m . . . . . 0 C--O 1.244 0.775 0 CA-C-O 121.454 0.645 . . . . 70.239999999999995 110.459 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 63.4 m -105.28 108.5 20.05 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.982 -0.747 . . . . 74.439999999999998 108.982 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' B' ' 226' ' ' ASN . 15.8 m120 -100.98 138.61 37.8 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.109 -0.7 . . . . 62.329999999999998 109.109 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' C' ' 227' ' ' SER . 4.1 p -143.28 123.94 14.11 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 122.259 -0.276 . . . . 65.5 110.899 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 7.1 p -124.88 142.3 42.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 110.263 -0.273 . . . . 63.219999999999999 110.263 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 43.2 mm-40 -82.47 -78.81 0.2 Allowed 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 123.202 0.314 . . . . 65.140000000000001 110.282 175.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 10.2 t -120.86 130.43 53.93 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.992 -1.083 . . . . 65.310000000000002 112.54 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.533 HG21 HG21 ' B' ' 275' ' ' VAL . 1.5 p -125.05 124.8 68.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.711 -1.131 . . . . 64.230000000000004 110.182 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 14.8 p -127.01 140.57 48.71 Favored 'Isoleucine or valine' 0 C--O 1.267 2.013 0 CA-C-O 121.782 0.801 . . . . 75.099999999999994 111.395 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.78 133.08 9.53 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 110.609 -0.996 . . . . 74.010000000000005 110.609 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -127.59 116.51 20.45 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.154 0.582 . . . . 65.230000000000004 110.515 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.62 -131.03 10.57 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.126 -1.035 . . . . 71.140000000000001 110.87 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 67.5 mm-40 -91.85 52.1 1.95 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.324 0.583 . . . . 72.420000000000002 109.511 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 33.3 m -82.9 145.59 29.33 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.499 0.666 . . . . 72.109999999999999 111.558 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -132.4 126.35 32.94 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.754 -1.112 . . . . 74.349999999999994 108.724 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.533 HG21 HG21 ' B' ' 267' ' ' VAL . 0.8 OUTLIER -135.92 127.07 43.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.245 -0.889 . . . . 75.209999999999994 111.076 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.541 HD13 ' CG ' ' B' ' 240' ' ' GLN . 11.9 tp -122.43 121.87 37.64 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.154 0.978 . . . . 74.129999999999995 110.523 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.788 HG22 ' HB3' ' C' ' 241' ' ' LEU . 4.6 pt -112.62 104.33 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-N 114.175 -1.375 . . . . 74.150000000000006 109.131 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.668 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 160.7 -148.83 17.44 Favored Glycine 0 N--CA 1.42 -2.418 0 C-N-CA 120.887 -0.673 . . . . 53.130000000000003 111.691 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 54.7 t30 -120.63 130.01 53.97 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.161 -1.052 . . . . 71.129999999999995 108.161 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.406 ' HG3' ' CH2' ' B' ' 287' ' ' TRP . 0.3 OUTLIER -117.96 130.52 56.26 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.038 -1.097 . . . . 74.540000000000006 108.038 -174.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -108.32 122.93 47.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.304 0.574 . . . . 74.109999999999999 109.991 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.441 ' N ' ' HB2' ' B' ' 249' ' ' ALA . . . 129.05 -53.23 0.81 Allowed Glycine 0 N--CA 1.421 -2.31 0 N-CA-C 109.378 -1.489 . . . . 64.230000000000004 109.378 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 105.95 -7.77 41.75 Favored Glycine 0 N--CA 1.434 -1.459 0 C-N-CA 120.742 -0.742 . . . . 54.130000000000003 111.84 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . 0.555 ' HA ' ' NE1' ' B' ' 287' ' ' TRP . 11.0 ptmm? -155.95 36.73 0.35 Allowed 'General case' 0 C--O 1.251 1.183 0 N-CA-C 111.774 0.287 . . . . 75.340000000000003 111.774 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . 0.404 ' HA3' ' OG1' ' B' ' 246' ' ' THR . . . -74.43 -76.03 0.75 Allowed Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.252 -0.975 . . . . 70.319999999999993 112.809 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.447 ' HD1' ' CZ2' ' A' ' 287' ' ' TRP . 75.3 t80 -56.36 -26.48 52.95 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.987 0.898 . . . . 75.030000000000001 111.419 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.555 ' NE1' ' HA ' ' B' ' 284' ' ' LYS . 26.8 p90 . . . . . 0 C--N 1.301 -1.5 0 CA-C-N 115.383 -0.826 . . . . 73.450000000000003 109.426 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' B' ' 261' ' ' THR . 1.5 ptp180 . . . . . 0 N--CA 1.429 -1.479 0 CA-C-O 121.968 0.89 . . . . 74.019999999999996 112.814 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -116.46 115.02 25.03 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 106.695 -1.594 . . . . 72.129999999999995 106.695 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' B' ' 263' ' ' SER . 8.3 p -121.13 136.6 54.95 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 122.025 0.917 . . . . 74.530000000000001 112.402 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -121.2 135.83 55.08 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.358 -1.292 . . . . 74.019999999999996 107.639 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.578 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 1.1 tmtp? -93.62 -55.7 3.17 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 109.486 -0.561 . . . . 74.140000000000001 109.486 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -131.45 138.52 49.07 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.773 0.321 . . . . 75.420000000000002 110.403 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.438 HD12 ' HB ' ' B' ' 267' ' ' VAL . 28.3 mt -131.35 117.83 37.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 107.95 -1.13 . . . . 61.020000000000003 107.95 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 11.4 ttp180 -122.94 114.92 21.09 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.612 -0.514 . . . . 73.420000000000002 109.612 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 40.7 p -113.18 127.8 56.29 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.094 -1.076 . . . . 62.109999999999999 108.094 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -128.18 165.79 19.77 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.913 -0.715 . . . . 74.239999999999995 110.714 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 43.9 mt-10 68.52 -84.7 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 114.791 -1.095 . . . . 63.049999999999997 112.836 175.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.507 ' O ' ' HD2' ' C' ' 238' ' ' ARG . 0.3 OUTLIER -141.25 21.5 2.24 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 108.155 -1.054 . . . . 73.129999999999995 108.155 178.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.506 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -68.42 148.32 50.81 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.623 0.725 . . . . 73.430000000000007 112.174 -173.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' C' ' 236' ' ' ARG . 3.4 mpt_? -124.27 135.18 53.21 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.318 -1.364 . . . . 75.109999999999999 107.318 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.2 141.16 45.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.318 0.58 . . . . 71.129999999999995 111.183 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -122.82 123.3 40.7 Favored 'General case' 0 N--CA 1.408 -2.539 0 CA-C-N 114.545 -1.207 . . . . 51.240000000000002 108.808 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.788 ' HB3' HG22 ' B' ' 277' ' ' ILE . 2.1 tm? -120.48 119.16 32.2 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.586 -1.264 . . . . 55.520000000000003 107.586 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.54 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 134.7 -125.43 3.77 Favored Glycine 0 N--CA 1.411 -3.005 0 N-CA-C 110.158 -1.177 . . . . 51.409999999999997 110.158 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 92.7 m-20 -130.22 150.59 51.41 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 120.909 0.385 . . . . 55.109999999999999 110.49 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 83.1 t -128.8 118.38 46.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.449 -1.315 . . . . 62.240000000000002 107.449 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 47.5 t -114.56 112.3 39.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.784 -0.821 . . . . 74.230000000000004 108.784 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 15.4 m -100.37 160.91 13.96 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 115.561 -0.745 . . . . 62.520000000000003 109.503 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.06 -32.21 72.71 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.773 0.796 . . . . 55.210000000000001 110.508 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.97 -42.13 72.02 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.062 -1.427 . . . . 52.32 112.367 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . 0.474 ' HB2' ' N ' ' C' ' 282' ' ' GLY . . . . . . . . 0 CA--C 1.507 -0.698 0 CA-C-O 121.009 0.433 . . . . 70.329999999999998 110.014 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 107.182 -1.414 . . . . 75.340000000000003 107.182 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -119.57 135.83 54.62 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.778 -0.453 . . . . 71.439999999999998 109.778 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 20.8 m -142.47 125.38 16.13 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.194 -0.669 . . . . 64.5 109.194 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.1 p -128.16 143.59 40.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 110.195 -0.298 . . . . 53.149999999999999 110.195 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 64.2 mm-40 -76.44 -69.74 0.49 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.531 -0.304 . . . . 65.010000000000005 110.762 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 8.8 t -136.95 133.91 36.16 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 119.004 -1.078 . . . . 64.150000000000006 112.061 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.98 133.49 65.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.503 -0.925 . . . . 62.140000000000001 108.503 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 11.6 p -127.32 138.99 53.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 116.387 -0.369 . . . . 65.310000000000002 110.256 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.92 132.98 9.95 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.685 -0.966 . . . . 64.219999999999999 110.685 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -132.85 129.74 38.85 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 123.66 0.784 . . . . 74.409999999999997 109.951 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.85 -122.32 9.09 Favored Glycine 0 C--N 1.304 -1.198 0 C-N-CA 121.051 -0.595 . . . . 33.100000000000001 112.043 -176.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -96.79 51.89 1.16 Allowed 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.511 0.724 . . . . 53.119999999999997 110.463 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 56.3 m -83.67 144.36 29.45 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.778 0.799 . . . . 72.329999999999998 112.179 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . 0.463 ' HB3' ' CE2' ' C' ' 286' ' ' PHE . 7.6 mpt_? -127.64 127.72 44.27 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.369 -2.085 . . . . 73.030000000000001 105.369 172.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 3.4 p -138.53 124.03 23.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.099 0.476 . . . . 75.420000000000002 111.309 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 20.1 tp -113.41 120.12 39.96 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.728 0.775 . . . . 74.120000000000005 110.479 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.444 HG13 ' HA ' ' C' ' 241' ' ' LEU . 3.9 pt -112.51 103.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 N-CA-C 107.769 -1.197 . . . . 74.439999999999998 107.769 174.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 152.1 -161.14 29.23 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.073 -1.06 . . . . 73.319999999999993 111.812 -176.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -109.0 136.07 49.14 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.319 -0.623 . . . . 73.319999999999993 109.319 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.95 144.64 45.32 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.204 -1.406 . . . . 74.439999999999998 107.204 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -124.06 122.9 39.12 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.33 -0.618 . . . . 73.230000000000004 109.33 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . 0.474 ' N ' ' HB2' ' C' ' 249' ' ' ALA . . . 127.14 -48.33 0.97 Allowed Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 108.738 -1.745 . . . . 54.340000000000003 108.738 -174.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 103.04 -8.01 53.26 Favored Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.907 -0.877 . . . . 54.329999999999998 110.907 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . 0.576 ' HA ' ' NE1' ' C' ' 287' ' ' TRP . 17.3 ptmt -154.46 36.2 0.42 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.25 0.62 . . . . 71.340000000000003 110.761 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -70.23 -78.0 0.42 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.359 -0.924 . . . . 73.239999999999995 112.423 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.539 ' HD1' ' CZ2' ' B' ' 287' ' ' TRP . 67.5 t80 -53.79 -19.64 4.59 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.583 1.153 . . . . 74.129999999999995 112.658 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.576 ' NE1' ' HA ' ' C' ' 284' ' ' LYS . 23.8 p90 . . . . . 0 C--N 1.315 -0.894 0 CA-C-O 121.527 0.68 . . . . 72.319999999999993 111.679 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 . . . . . 0 N--CA 1.441 -0.885 0 CA-C-O 121.175 0.512 . . . . 54.009999999999998 110.868 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.43 HD22 ' HA2' ' A' ' 278' ' ' GLY . 53.6 t30 -92.71 126.18 37.67 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.929 -1.508 . . . . 64.129999999999995 106.929 174.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 14.1 m -121.84 136.81 54.94 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.216 0.531 . . . . 73.219999999999999 110.23 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.81 124.06 16.63 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.897 -1.149 . . . . 62.509999999999998 107.897 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 265' ' ' GLU . 4.8 mmmm -76.76 -64.29 1.16 Allowed 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 114.431 1.271 . . . . 73.409999999999997 114.431 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -127.74 140.08 52.28 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.058 -1.057 . . . . 73.519999999999996 110.999 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 30.1 mm -121.15 118.21 55.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.902 -0.777 . . . . 75.329999999999998 108.902 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 80.2 mtt180 -124.76 116.74 22.79 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.921 0.391 . . . . 64.420000000000002 111.046 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 27.3 p -120.44 126.76 51.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.135 -0.691 . . . . 72.099999999999994 109.135 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 270' ' ' LYS . 47.4 mt-10 -139.94 139.47 36.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.596 -0.52 . . . . 53.420000000000002 109.596 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 51.71 97.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.824 1.25 . . . . 74.319999999999993 114.229 174.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? 64.59 20.94 12.31 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.373 1.069 . . . . 75.519999999999996 110.985 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.1 129.4 45.36 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.368 0.604 . . . . 71.420000000000002 110.292 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.85 140.15 52.2 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.455 -0.793 . . . . 71.019999999999996 109.343 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 5.9 p -129.35 146.72 33.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 121.001 0.429 . . . . 55.340000000000003 111.165 -174.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -119.15 124.1 45.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.089 -1.449 . . . . 75.519999999999996 107.089 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -118.58 122.76 43.39 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.686 -0.487 . . . . 74.310000000000002 109.686 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.481 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 120.45 -156.85 15.92 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.906 -0.664 . . . . 74.409999999999997 112.453 175.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -102.23 132.87 47.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.104 -0.702 . . . . 72.430000000000007 109.104 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.638 HG11 ' HA3' ' A' ' 285' ' ' GLY . 15.7 t -116.33 122.11 69.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.76 -0.83 . . . . 73.519999999999996 108.76 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 48.5 t -113.11 112.69 41.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.19 -1.041 . . . . 74.239999999999995 108.19 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.43 HG21 ' HB3' ' A' ' 284' ' ' LYS . 54.3 m -89.44 160.73 16.64 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.243 -0.435 . . . . 60.130000000000003 109.972 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.14 -37.2 86.26 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.33 0.652 . . . . 64.430000000000007 110.9 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.36 -35.04 64.81 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.238 1.015 . . . . 54.130000000000003 113.589 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 112.79 0.663 . . . . 55.210000000000001 112.79 -175.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.5 m . . . . . 0 N--CA 1.407 -2.583 0 N-CA-C 107.455 -1.313 . . . . 75.140000000000001 107.455 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -96.07 142.77 27.88 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.323 -0.991 . . . . 61.219999999999999 108.323 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.5 m -139.72 123.63 17.61 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.724 -0.391 . . . . 71.230000000000004 111.21 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 12.3 p -128.85 144.9 36.68 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.685 -0.487 . . . . 72.439999999999998 109.685 173.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.525 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 4.2 tp10 -84.34 -75.85 0.33 Allowed 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 109.572 -0.529 . . . . 73.120000000000005 109.572 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 14.6 m -123.28 134.5 54.07 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.227 -0.921 . . . . 71.140000000000001 111.3 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 32.5 m -119.3 124.33 72.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 107.972 -1.121 . . . . 74.109999999999999 107.972 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 10.4 p -127.6 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 110.221 -0.288 . . . . 64.540000000000006 110.221 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.591 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -134.19 131.48 5.98 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 119.969 -1.11 . . . . 72.430000000000007 111.94 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 234' ' ' GLU . 27.5 ttmt -135.77 144.87 46.03 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.867 0.692 . . . . 73.340000000000003 112.867 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.72 -54.37 1.43 Allowed Glycine 0 CA--C 1.5 -0.906 0 N-CA-C 111.827 -0.509 . . . . 64.239999999999995 111.827 173.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.635 ' HB3' ' H ' ' B' ' 236' ' ' ARG . 23.1 tt0 -176.76 102.98 0.06 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 105.485 -2.043 . . . . 61.310000000000002 105.485 174.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 59.8 m -135.05 145.18 47.75 Favored 'General case' 0 C--N 1.281 -2.41 0 C-N-CA 119.923 -0.711 . . . . 74.310000000000002 110.795 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -126.7 126.22 43.14 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 104.713 -2.329 . . . . 75.310000000000002 104.713 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 1.6 p -135.75 123.99 37.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 CA-C-O 121.06 0.457 . . . . 72.129999999999995 110.763 -176.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 6.7 tt -111.52 121.21 44.56 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.963 -1.125 . . . . 73.420000000000002 107.963 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.508 HG23 HD12 ' B' ' 241' ' ' LEU . 43.5 mm -112.1 104.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 107.967 -1.123 . . . . 72.420000000000002 107.967 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.512 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 149.99 -128.87 2.81 Favored Glycine 0 N--CA 1.427 -1.936 0 C-N-CA 119.241 -1.457 . . . . 30.039999999999999 113.627 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -128.71 128.88 44.93 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.205 -1.035 . . . . 62.109999999999999 108.205 -175.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -112.93 118.7 35.59 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.741 -0.837 . . . . 75.239999999999995 108.741 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 90.2 m-85 -114.79 123.85 50.27 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.969 -0.752 . . . . 74.340000000000003 108.969 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.447 ' CA ' ' HB2' ' A' ' 249' ' ' ALA . . . 105.94 -47.12 1.09 Allowed Glycine 0 C--N 1.297 -1.611 0 N-CA-C 110.905 -0.878 . . . . 61.119999999999997 110.905 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.536 ' HA2' ' H ' ' B' ' 286' ' ' PHE . . . 89.98 47.28 3.94 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.931 -0.652 . . . . 72.310000000000002 113.155 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.43 ' HB3' HG21 ' A' ' 246' ' ' THR . 0.9 OUTLIER -174.78 30.87 0.01 OUTLIER 'General case' 0 C--O 1.247 0.933 0 CA-C-O 122.151 0.977 . . . . 51.350000000000001 109.372 -177.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.638 ' HA3' HG11 ' A' ' 244' ' ' VAL . . . -86.73 128.08 8.73 Favored Glycine 0 N--CA 1.411 -3.007 0 C-N-CA 120.351 -0.928 . . . . 73.230000000000004 112.161 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 27.0 t80 73.86 -51.69 0.69 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.917 1.287 . . . . 62.350000000000001 112.396 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.309 -1.154 0 N-CA-C 112.988 0.736 . . . . 73.200000000000003 112.988 -172.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 . . . . . 0 N--CA 1.429 -1.503 0 CA-C-O 121.306 0.574 . . . . 75.430000000000007 109.798 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -112.67 130.52 56.02 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 105.191 -2.152 . . . . 74.519999999999996 105.191 171.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 14.5 m -132.53 135.81 46.22 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 118.356 -1.338 . . . . 62.420000000000002 110.977 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.92 134.5 42.71 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 107.178 -1.416 . . . . 71.409999999999997 107.178 175.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' B' ' 265' ' ' GLU . 24.6 mmtp -80.17 -71.23 0.47 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.659 -0.416 . . . . 75.209999999999994 112.058 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -127.11 138.59 53.21 Favored 'General case' 0 N--CA 1.414 -2.274 0 C-N-CA 118.555 -1.258 . . . . 72.310000000000002 109.597 -173.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 31.1 mm -123.41 116.98 50.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.791 -1.189 . . . . 72.450000000000003 107.791 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -117.4 115.23 24.8 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 120.299 -0.561 . . . . 75.310000000000002 109.52 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.591 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 40.8 p -110.8 126.43 54.62 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.206 -1.405 . . . . 73.099999999999994 107.206 176.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 51.0 mt-10 -143.43 138.83 29.6 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 109.811 -0.44 . . . . 73.349999999999994 109.811 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.481 ' HB2' ' H ' ' B' ' 271' ' ' GLY . 41.1 mt-10 56.49 98.22 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.868 0 O-C-N 125.292 1.62 . . . . 73.530000000000001 113.041 174.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.635 ' H ' ' HB3' ' A' ' 272' ' ' GLU . 1.1 mpt_? 60.89 35.66 19.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.857 0.863 . . . . 75.319999999999993 109.718 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -103.76 138.88 39.75 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.586 0.707 . . . . 72.209999999999994 111.106 -175.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 1.4 mpt_? -133.84 136.35 44.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.978 -1.119 . . . . 71.230000000000004 107.978 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 5.7 p -137.37 137.66 45.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-O 121.578 0.704 . . . . 64.530000000000001 112.059 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.423 ' HB3' ' HG ' ' B' ' 276' ' ' LEU . 47.4 tp60 -110.64 117.65 34.06 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.113 -1.44 . . . . 71.150000000000006 107.113 175.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.508 HD12 HG23 ' A' ' 277' ' ' ILE . 3.0 tm? -119.33 127.4 53.15 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.085 -0.709 . . . . 72.319999999999993 109.085 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 122.7 -121.3 4.59 Favored Glycine 0 CA--C 1.473 -2.542 0 N-CA-C 109.636 -1.385 . . . . 62.420000000000002 109.636 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 33.8 p30 -144.1 154.77 43.55 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 119.739 -0.784 . . . . 52.039999999999999 111.41 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.701 HG11 ' HA3' ' B' ' 285' ' ' GLY . 65.6 t -123.49 130.37 74.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.176 -0.92 . . . . 71.329999999999998 109.69 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 57.8 t -122.66 111.58 30.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.643 -1.243 . . . . 74.400000000000006 107.643 171.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.47 ' HB ' ' HA3' ' B' ' 282' ' ' GLY . 16.8 m -88.02 160.72 17.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.548 -0.908 . . . . 72.510000000000005 108.548 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.4 -43.85 96.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 122.056 0.932 . . . . 74.510000000000005 110.532 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.51 -35.63 65.83 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.65 -1.614 . . . . 74.439999999999998 112.282 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.451 ' HB2' ' CA ' ' B' ' 282' ' ' GLY . . . -63.52 -25.54 68.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.07 0.767 . . . . 71.439999999999998 113.07 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 tt . . . . . 0 CA--C 1.541 0.633 0 CA-C-O 121.269 0.557 . . . . 75.340000000000003 110.215 -177.321 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.41 -2.434 0 N-CA-C 108.324 -0.991 . . . . 72.040000000000006 108.324 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 62.8 m -90.29 112.96 24.7 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.665 -0.865 . . . . 63.109999999999999 108.665 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -96.47 128.62 43.56 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-N 114.891 -1.05 . . . . 60.130000000000003 109.899 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 14.5 m -121.49 121.13 36.83 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.194 -1.039 . . . . 74.5 108.194 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.8 p -129.61 145.82 35.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.302 -0.999 . . . . 64.200000000000003 108.302 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 20.5 tt0 -93.0 -75.44 0.49 Allowed 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 119.03 -1.068 . . . . 74.409999999999997 112.033 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 32.8 m -124.95 134.54 52.59 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.806 -1.158 . . . . 73.019999999999996 111.478 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.47 HG12 ' HB ' ' C' ' 231' ' ' ILE . 10.0 m -118.4 134.33 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 108.018 -1.104 . . . . 71.129999999999995 108.018 173.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 85.1 t -123.97 128.49 74.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 115.636 -0.711 . . . . 72.400000000000006 110.036 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.22 131.69 9.89 Favored Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 110.293 -1.123 . . . . 71.439999999999998 110.293 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.495 ' HB3' ' HG2' ' C' ' 234' ' ' GLU . 2.2 tpmt? -135.53 137.85 42.47 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 122.943 0.497 . . . . 75.140000000000001 111.073 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . 0.481 ' H ' ' HB2' ' B' ' 235' ' ' GLU . . . 86.29 -52.74 4.54 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 114.746 0.658 . . . . 43.43 114.746 169.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . 0.721 ' HB3' ' H ' ' C' ' 236' ' ' ARG . 1.6 tm-20 -177.4 105.28 0.05 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 103.156 -2.905 . . . . 71.209999999999994 103.156 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . 0.603 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 44.4 m -145.24 144.95 31.09 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-O 121.07 0.462 . . . . 55.329999999999998 110.764 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 60.4 mtt180 -135.68 127.28 28.89 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 106.373 -1.714 . . . . 73.040000000000006 106.373 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.2 p -132.68 129.61 58.64 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.824 0 O-C-N 123.695 0.622 . . . . 74.209999999999994 110.364 -175.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.423 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 6.6 tt -110.59 115.75 30.14 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.976 -1.12 . . . . 75.109999999999999 107.976 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.468 HG23 HD12 ' C' ' 241' ' ' LEU . 37.2 mm -106.9 103.82 16.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.031 -1.1 . . . . 71.030000000000001 108.031 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 144.04 -140.39 9.39 Favored Glycine 0 N--CA 1.424 -2.167 0 C-N-CA 119.53 -1.319 . . . . 63.32 113.285 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . 0.405 ' HB3' ' CE2' ' B' ' 281' ' ' TYR . 1.7 m-20 -111.76 129.48 56.11 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.55 -0.537 . . . . 72.530000000000001 109.55 -175.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -114.5 118.28 33.33 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.345 -0.983 . . . . 74.349999999999994 108.345 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.405 ' CE2' ' HB3' ' B' ' 279' ' ' ASN . 97.8 m-85 -117.22 124.52 49.27 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 109.227 -0.657 . . . . 74.439999999999998 109.227 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.47 ' HA3' ' HB ' ' B' ' 246' ' ' THR . . . 103.99 -46.86 1.14 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 110.139 -1.185 . . . . 71.150000000000006 110.139 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . 0.555 ' O ' ' HE2' ' B' ' 284' ' ' LYS . . . 95.5 37.31 5.09 Favored Glycine 0 N--CA 1.411 -3.016 0 C-N-CA 120.899 -0.667 . . . . 74.349999999999994 112.748 176.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . 0.555 ' HE2' ' O ' ' B' ' 283' ' ' GLY . 9.9 tppt? -161.64 35.24 0.13 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 119.21 -0.996 . . . . 74.25 112.34 -175.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . 0.701 ' HA3' HG11 ' B' ' 244' ' ' VAL . . . -89.61 144.78 17.99 Favored Glycine 0 CA--C 1.488 -1.595 0 C-N-CA 119.28 -1.438 . . . . 72.25 113.572 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.536 ' H ' ' HA2' ' A' ' 283' ' ' GLY . 0.2 OUTLIER 68.78 -71.31 0.12 Allowed 'General case' 0 C--O 1.245 0.854 0 C-N-CA 124.872 1.269 . . . . 74.0 110.18 178.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.755 0 CA-C-N 115.047 -0.979 . . . . 70.310000000000002 112.973 -173.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 109.802 -0.444 . . . . 73.129999999999995 109.802 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -114.93 124.55 51.97 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.933 -1.506 . . . . 72.209999999999994 106.933 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 23.6 m -121.93 136.68 54.94 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 121.185 0.517 . . . . 60.450000000000003 110.35 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -139.51 129.72 25.29 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 107.878 -1.156 . . . . 74.25 107.878 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' C' ' 265' ' ' GLU . 17.5 mmtp -78.46 -71.46 0.43 Allowed 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.266 0.555 . . . . 74.209999999999994 112.361 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' C' ' 266' ' ' THR . 10.1 t0 -127.69 138.92 52.96 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.203 -0.908 . . . . 70.430000000000007 108.833 -170.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.47 ' HB ' HG12 ' B' ' 267' ' ' VAL . 23.5 mm -129.34 117.83 44.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.564 -1.272 . . . . 71.420000000000002 107.564 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 78.5 mtt180 -122.08 115.56 22.69 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.201 0.524 . . . . 71.239999999999995 109.612 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 20.0 p -110.21 126.46 54.15 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 106.843 -1.54 . . . . 74.019999999999996 106.843 177.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' B' ' 270' ' ' LYS . 48.0 mt-10 -137.59 138.38 39.48 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 108.74 -0.837 . . . . 74.209999999999994 108.74 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 50.65 92.01 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.661 1.356 . . . . 72.450000000000003 114.661 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.721 ' H ' ' HB3' ' B' ' 272' ' ' GLU . 3.5 mpt_? 66.85 34.59 5.36 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.23 1.412 . . . . 71.129999999999995 109.952 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.603 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -104.44 128.85 52.42 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.23 -0.895 . . . . 51.439999999999998 110.661 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.0 OUTLIER -124.98 135.3 52.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.504 -0.924 . . . . 73.019999999999996 108.504 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.6 p -139.65 142.68 32.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.862 0.839 . . . . 64.400000000000006 112.212 -176.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.407 ' HB3' ' HG ' ' C' ' 276' ' ' LEU . 48.2 tp60 -110.92 130.19 55.66 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.152 -1.425 . . . . 64.549999999999997 107.152 175.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.468 HD12 HG23 ' B' ' 277' ' ' ILE . 2.8 tm? -130.13 128.79 42.52 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.008 -0.738 . . . . 64.430000000000007 109.008 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 122.25 -121.9 4.87 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 109.919 -1.273 . . . . 72.450000000000003 109.919 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -139.39 153.28 47.6 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 120.508 -0.477 . . . . 73.329999999999998 111.087 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.793 HG11 ' HA3' ' C' ' 285' ' ' GLY . 63.8 t -127.58 124.23 63.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.663 -0.699 . . . . 53.119999999999997 109.61 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 59.2 t -122.15 110.76 28.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.429 -1.322 . . . . 63.240000000000002 107.429 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . 0.417 ' HB ' ' HA3' ' C' ' 282' ' ' GLY . 37.7 m -87.78 161.92 17.31 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.154 -0.684 . . . . 72.400000000000006 109.154 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.93 -39.18 74.0 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.509 0.723 . . . . 72.140000000000001 110.83 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.41 -34.5 64.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.642 -1.617 . . . . 75.239999999999995 113.381 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.327 0 N-CA-C 112.255 0.465 . . . . 74.140000000000001 112.255 -175.445 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.433 -1.295 0 CA-C-O 121.976 0.894 . . . . 70.219999999999999 109.516 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -119.9 144.12 47.59 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.058 -1.428 . . . . 71.129999999999995 109.135 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -142.08 131.16 23.24 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 110.182 -0.303 . . . . 74.040000000000006 110.182 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 12.2 p -128.98 145.43 35.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.451 -0.944 . . . . 75.209999999999994 108.451 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' C' ' 229' ' ' LYS . 7.0 tp10 -79.76 -81.49 0.12 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 109.135 -0.691 . . . . 53.409999999999997 109.135 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 90.0 m -131.72 137.01 48.06 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.397 -0.815 . . . . 73.120000000000005 110.825 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.06 130.71 74.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.962 -0.755 . . . . 63.32 108.962 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.4 p -127.56 137.38 57.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 116.635 -0.257 . . . . 71.299999999999997 110.473 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.93 132.88 9.65 Favored Glycine 0 CA--C 1.483 -1.934 0 N-CA-C 110.352 -1.099 . . . . 70.219999999999999 110.352 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -134.6 147.73 50.28 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.145 -0.687 . . . . 65.25 109.145 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.26 -60.86 4.7 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 112.293 -0.323 . . . . 71.019999999999996 112.293 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . 0.533 ' HA ' ' HB2' ' C' ' 236' ' ' ARG . 36.4 tt0 -173.18 130.79 0.48 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.914 -2.254 . . . . 72.239999999999995 104.914 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 17.8 t -156.11 148.08 23.18 Favored 'General case' 0 N--CA 1.413 -2.324 0 C-N-CA 120.074 -0.65 . . . . 54.439999999999998 109.926 -176.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 46.2 mtm180 -138.12 125.43 21.76 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.212 -1.773 . . . . 74.140000000000001 106.212 172.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 5.1 p -139.57 135.44 39.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 123.548 0.53 . . . . 62.509999999999998 110.693 -176.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' C' ' 240' ' ' GLN . 7.0 tt -115.93 111.58 20.61 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.912 -0.773 . . . . 72.129999999999995 108.912 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 47.7 mm -102.28 104.21 16.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.871 -1.159 . . . . 73.209999999999994 107.871 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 147.84 -144.39 12.34 Favored Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.009 -1.636 . . . . 55.140000000000001 109.009 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -127.96 150.61 49.82 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 120.869 0.366 . . . . 73.200000000000003 110.405 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.424 ' HA ' ' HB ' ' C' ' 244' ' ' VAL . 6.2 tp10 -126.64 118.14 24.19 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.618 -0.719 . . . . 74.420000000000002 109.801 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -109.18 124.12 50.32 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.913 -0.773 . . . . 73.450000000000003 108.913 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . 0.417 ' HA3' ' HB ' ' C' ' 246' ' ' THR . . . 102.94 -53.17 0.76 Allowed Glycine 0 N--CA 1.434 -1.497 0 N-CA-C 110.502 -1.039 . . . . 62.32 110.502 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 95.14 54.64 1.46 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.416 -0.897 . . . . 21.550000000000001 113.207 176.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -164.2 21.65 0.07 Allowed 'General case' 0 C--O 1.238 0.47 0 C-N-CA 119.903 -0.719 . . . . 64.200000000000003 110.947 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . 0.793 ' HA3' HG11 ' C' ' 244' ' ' VAL . . . -74.92 138.75 24.14 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 115.011 0.764 . . . . 65.340000000000003 115.011 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.413 ' H ' ' HA2' ' B' ' 283' ' ' GLY . 0.1 OUTLIER 67.43 -79.37 0.04 OUTLIER 'General case' 0 C--O 1.252 1.196 0 C-N-CA 124.786 1.234 . . . . 73.310000000000002 110.934 174.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 17.7 p90 . . . . . 0 N--CA 1.427 -1.623 0 C-N-CA 121.078 -0.249 . . . . 73.219999999999999 111.273 -177.221 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 23.1 ptt-85 . . . . . 0 N--CA 1.425 -1.681 0 N-CA-C 107.919 -1.141 . . . . 73.349999999999994 107.919 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.561 ' OD1' ' HA2' ' B' ' 242' ' ' GLY . 41.4 m-80 -109.96 135.32 50.99 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.094 -1.076 . . . . 74.239999999999995 108.094 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.9 m -121.55 136.5 54.95 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.578 0.704 . . . . 62.409999999999997 110.874 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.68 127.99 47.12 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.137 -1.431 . . . . 53.109999999999999 107.137 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -78.88 -60.42 2.39 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.913 -0.773 . . . . 74.129999999999995 108.913 -177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -137.5 139.3 40.46 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.538 0.685 . . . . 75.430000000000007 110.831 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 67.3 mt -128.78 122.47 57.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.257 -1.016 . . . . 33.200000000000003 108.257 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -130.69 115.01 16.1 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.721 0.772 . . . . 73.400000000000006 111.329 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.643 HG21 HG13 ' A' ' 239' ' ' VAL . 6.8 p -111.99 137.06 50.52 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.226 -0.897 . . . . 74.409999999999997 109.75 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.404 ' OE2' ' HE3' ' A' ' 270' ' ' LYS . 40.5 tt0 -133.97 147.17 51.0 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 116.066 -0.516 . . . . 64.109999999999999 110.989 -174.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.429 ' HG2' ' HE ' ' A' ' 236' ' ' ARG . 32.3 tt0 73.38 -79.0 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.589 1.156 . . . . 71.150000000000006 112.727 170.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.429 ' HE ' ' HG2' ' A' ' 235' ' ' GLU . 75.1 mtm180 -136.16 15.81 3.25 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.09 0.947 . . . . 74.510000000000005 109.077 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.08 133.37 34.23 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.65 -1.159 . . . . 64.530000000000001 109.791 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -132.11 144.02 50.42 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.621 0.724 . . . . 74.120000000000005 112.006 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.934 HG12 ' HB ' ' A' ' 275' ' ' VAL . 15.4 m -123.69 150.4 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 CA-C-N 114.832 -1.076 . . . . 70.230000000000004 111.804 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -116.85 120.83 39.7 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-N 114.259 -1.337 . . . . 74.129999999999995 108.148 175.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -111.26 118.2 35.26 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.049 -1.834 . . . . 74.209999999999994 106.049 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.02 -155.71 21.13 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 119.828 -1.177 . . . . 33.0 112.892 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -110.83 128.58 55.82 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.136 0.574 . . . . 71.109999999999999 110.658 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.421 ' CG1' ' HA3' ' A' ' 285' ' ' GLY . 48.6 t -116.34 115.05 47.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.369 -0.974 . . . . 74.409999999999997 108.369 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' A' ' 281' ' ' TYR . 7.3 p -114.42 124.82 71.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.277 0.56 . . . . 53.43 112.46 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 23.8 p -117.24 166.59 12.09 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 116.001 -0.545 . . . . 71.209999999999994 111.366 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.74 74.13 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.536 0.734 . . . . 71.239999999999995 112.757 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.37 66.29 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.634 0.975 . . . . 64.209999999999994 113.634 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.645 ' HB2' ' N ' ' A' ' 282' ' ' GLY . . . . . . . . 0 CA--C 1.503 -0.854 0 N-CA-C 112.536 0.569 . . . . 73.319999999999993 112.536 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 10.6 t . . . . . 0 N--CA 1.427 -1.595 0 CA-C-O 121.292 0.568 . . . . 73.150000000000006 109.617 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -126.33 142.2 51.62 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.12 -0.696 . . . . 73.530000000000001 109.12 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' B' ' 227' ' ' SER . 22.7 t -127.69 130.71 49.34 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 108.721 -0.844 . . . . 74.230000000000004 108.721 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.02 139.73 51.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.967 -0.383 . . . . 73.349999999999994 109.967 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 15.3 mt-10 -79.1 -70.64 0.49 Allowed 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 119.823 -0.751 . . . . 71.439999999999998 111.525 176.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 13.6 m -119.44 126.86 52.33 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.889 -0.724 . . . . 40.340000000000003 111.949 -174.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.39 122.26 67.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 N-CA-C 109.118 -0.697 . . . . 51.539999999999999 109.118 171.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.56 146.67 29.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.643 0.735 . . . . 62.240000000000002 112.593 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.73 133.28 7.78 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.14 -0.936 . . . . 34.32 111.002 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.404 ' HE3' ' OE2' ' A' ' 234' ' ' GLU . 0.2 OUTLIER -130.27 116.0 17.75 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.074 -1.084 . . . . 54.43 108.074 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.16 -136.84 13.02 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.147 -1.581 . . . . 75.25 109.147 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -99.24 53.22 0.96 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.942 0.877 . . . . 73.019999999999996 109.701 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 7.1 m -83.02 148.22 27.69 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.167 -0.924 . . . . 61.5 111.209 -174.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 45.8 mtm180 -130.02 128.19 41.48 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.287 -0.415 . . . . 75.310000000000002 109.946 175.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.934 ' HB ' HG12 ' A' ' 239' ' ' VAL . 17.9 t -130.46 140.42 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 N-CA-C 108.095 -1.076 . . . . 55.340000000000003 108.095 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 286' ' ' PHE . 5.5 tt -126.17 121.1 31.83 Favored 'General case' 0 C--N 1.275 -2.655 0 C-N-CA 118.913 -1.115 . . . . 74.019999999999996 108.426 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.406 ' HA ' ' HB3' ' B' ' 241' ' ' LEU . 3.5 mp -107.92 104.61 17.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 106.316 -1.735 . . . . 62.329999999999998 106.316 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.13 -134.77 5.37 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.435 -1.066 . . . . 62.109999999999999 110.435 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 45.2 t-20 -130.15 134.58 47.42 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 117.103 0.451 . . . . 62.200000000000003 111.396 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 287' ' ' TRP . 10.3 tp10 -111.23 122.85 48.93 Favored 'General case' 0 C--O 1.269 2.084 0 N-CA-C 106.746 -1.576 . . . . 74.219999999999999 106.746 174.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.506 ' HB2' ' HA ' ' A' ' 245' ' ' VAL . 12.0 m-85 -109.24 122.81 48.14 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.751 -1.944 . . . . 73.140000000000001 105.751 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.645 ' N ' ' HB2' ' A' ' 249' ' ' ALA . . . 103.86 -51.85 0.79 Allowed Glycine 0 C--N 1.297 -1.617 0 C-N-CA 120.445 -0.883 . . . . 74.140000000000001 112.999 177.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.41 30.54 18.88 Favored Glycine 0 CA--C 1.498 -0.986 0 N-CA-C 109.9 -1.28 . . . . 60.520000000000003 109.9 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -129.81 -8.98 4.47 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.465 -0.867 . . . . 73.209999999999994 111.456 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.421 ' HA3' ' CG1' ' A' ' 244' ' ' VAL . . . -86.61 -80.27 1.19 Allowed Glycine 0 CA--C 1.487 -1.661 0 C-N-CA 119.386 -1.388 . . . . 72.25 112.415 -175.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.477 ' HB3' HD12 ' A' ' 276' ' ' LEU . 75.6 t80 -99.98 -22.74 15.14 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.504 -1.295 . . . . 75.450000000000003 107.504 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.576 ' HA ' ' CE3' ' A' ' 287' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.41 -2.469 0 N-CA-C 115.741 1.756 . . . . 74.230000000000004 115.741 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 261' ' ' THR . 30.3 ptt85 . . . . . 0 N--CA 1.422 -1.847 0 CA-C-O 121.025 0.441 . . . . 70.230000000000004 110.859 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.496 ' OD1' ' HA2' ' C' ' 242' ' ' GLY . 51.1 m-80 -108.18 148.52 29.78 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.919 -1.141 . . . . 72.230000000000004 107.919 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 263' ' ' SER . 31.2 m -135.95 137.44 41.3 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.572 0.701 . . . . 70.430000000000007 111.163 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.51 129.85 51.37 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.631 -1.168 . . . . 74.120000000000005 108.449 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 5.3 tmtt? -78.55 -66.49 0.85 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.384 -0.826 . . . . 72.400000000000006 108.816 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -134.82 139.05 44.78 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 116.524 -0.307 . . . . 51.399999999999999 110.347 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 10.8 mt -132.23 117.72 33.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.241 -1.022 . . . . 65.530000000000001 108.241 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.455 ' HB3' HG12 ' B' ' 268' ' ' VAL . 25.8 ttt180 -113.64 122.46 47.25 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.938 -0.574 . . . . 65.010000000000005 110.735 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 76.0 p -110.7 132.16 54.44 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.945 -1.131 . . . . 75.450000000000003 107.945 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -133.72 150.83 51.51 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.353 -0.539 . . . . 73.439999999999998 109.778 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.413 ' HB3' ' HD2' ' B' ' 236' ' ' ARG . 42.4 mt-10 70.13 -95.19 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 124.556 1.142 . . . . 73.209999999999994 113.455 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' B' ' 272' ' ' GLU . 0.0 OUTLIER -129.04 31.13 4.95 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.425 -1.324 . . . . 75.209999999999994 107.425 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -76.24 137.25 39.84 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.29 -0.868 . . . . 74.329999999999998 110.701 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 1.7 mpp_? -125.34 134.35 52.24 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.031 -0.986 . . . . 65.400000000000006 108.514 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.549 HG12 ' HB ' ' B' ' 275' ' ' VAL . 19.6 m -135.58 140.83 43.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.8 0.809 . . . . 52.409999999999997 111.265 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.441 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 38.8 tp60 -105.15 135.79 45.84 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 114.211 -1.359 . . . . 60.030000000000001 108.463 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.406 ' HB3' ' HA ' ' A' ' 277' ' ' ILE . 1.5 tm? -125.97 117.02 22.39 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 104.911 -2.255 . . . . 63.200000000000003 104.911 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.574 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 125.19 -146.12 16.0 Favored Glycine 0 N--CA 1.42 -2.407 0 C-N-CA 119.549 -1.31 . . . . 44.43 111.844 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 0.7 OUTLIER -113.81 146.17 40.34 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.442 -0.577 . . . . 74.430000000000007 109.442 -176.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.441 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 59.2 t -126.78 122.48 60.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.015 -1.476 . . . . 71.310000000000002 107.015 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.53 126.0 72.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.369 -1.333 . . . . 75.319999999999993 113.49 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 24.4 p -120.28 163.13 18.27 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.947 -0.569 . . . . 75.340000000000003 112.034 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.64 -31.82 58.06 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.723 1.209 . . . . 31.140000000000001 112.201 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.36 70.17 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.885 0.698 . . . . 75.430000000000007 112.885 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.48 ' HB2' ' N ' ' B' ' 282' ' ' GLY . . . -75.01 -44.37 48.44 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.484 -0.486 . . . . 34.229999999999997 109.988 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 63.8 tp . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 125.131 1.372 . . . . 52.539999999999999 110.36 -176.502 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 58.2 m . . . . . 0 N--CA 1.437 -1.082 0 N-CA-C 109.136 -0.69 . . . . 75.340000000000003 109.136 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 10.2 t -123.53 134.54 53.85 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 121.558 0.694 . . . . 75.099999999999994 110.182 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -125.16 138.15 54.15 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.582 -0.896 . . . . 71.530000000000001 108.582 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' C' ' 227' ' ' SER . 41.8 m -130.33 132.51 45.88 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.691 -0.485 . . . . 74.099999999999994 109.691 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 7.3 p -125.68 142.35 42.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 116.123 -0.489 . . . . 70.329999999999998 110.923 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.552 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 10.4 mm-40 -82.68 -69.02 0.66 Allowed 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 123.793 0.683 . . . . 75.109999999999999 109.703 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.5 m -126.06 127.21 45.48 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 119.572 -0.851 . . . . 73.510000000000005 112.252 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.46 HG11 HG11 ' B' ' 275' ' ' VAL . 48.0 t -118.66 120.76 65.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.359 -1.348 . . . . 53.409999999999997 107.359 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' B' ' 232' ' ' ARG . 27.4 m -125.6 137.46 57.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.69 0.757 . . . . 70.409999999999997 112.152 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.71 133.65 11.01 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 110.279 -1.128 . . . . 71.430000000000007 110.279 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -132.08 115.88 16.34 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.359 0.599 . . . . 75.040000000000006 109.566 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.75 -132.28 10.95 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 119.996 -1.097 . . . . 15.44 111.178 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . 0.415 ' HG3' HH11 ' B' ' 236' ' ' ARG . 21.5 mt-10 -96.14 48.28 1.1 Allowed 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.746 0.818 . . . . 72.329999999999998 110.437 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 15.5 m -81.46 150.27 28.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.156 -0.929 . . . . 72.329999999999998 112.93 -171.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 49.2 mtm180 -133.26 128.09 35.09 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.887 -0.597 . . . . 75.140000000000001 110.016 173.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.641 HG13 HG23 ' C' ' 239' ' ' VAL . 22.0 t -131.83 138.69 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.778 0 N-CA-C 108.366 -0.976 . . . . 61.310000000000002 108.366 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.414 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 5.9 tt -120.99 116.32 24.86 Favored 'General case' 0 C--N 1.277 -2.561 0 C-N-CA 118.849 -1.14 . . . . 63.439999999999998 108.148 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.479 ' HA ' ' HB3' ' C' ' 241' ' ' LEU . 4.0 mp -106.31 103.5 15.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 106.313 -1.736 . . . . 72.099999999999994 106.313 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 149.67 -135.02 5.13 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.729 -0.748 . . . . 74.420000000000002 112.501 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 48.5 t-20 -128.72 130.0 46.53 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.201 -0.666 . . . . 63.340000000000003 109.201 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -111.35 118.67 36.47 Favored 'General case' 0 C--O 1.268 2.034 0 N-CA-C 106.992 -1.484 . . . . 73.230000000000004 106.992 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -105.04 122.31 45.6 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 106.919 -1.511 . . . . 72.409999999999997 106.919 177.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.48 ' N ' ' HB2' ' B' ' 249' ' ' ALA . . . 101.09 -52.29 0.91 Allowed Glycine 0 C--N 1.297 -1.638 0 C-N-CA 120.37 -0.919 . . . . 74.439999999999998 112.524 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.58 32.75 12.58 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.962 -1.113 . . . . 62.340000000000003 111.39 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -136.68 2.09 2.63 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.569 0.581 . . . . 65.219999999999999 112.569 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . 0.435 ' HA3' ' CG1' ' B' ' 244' ' ' VAL . . . -86.15 -77.86 1.21 Allowed Glycine 0 CA--C 1.487 -1.707 0 C-N-CA 118.712 -1.708 . . . . 40.420000000000002 110.739 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -97.01 -21.29 17.5 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.545 -1.28 . . . . 73.530000000000001 107.545 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.547 ' HA ' ' CE3' ' B' ' 287' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.418 -2.05 0 CA-C-N 114.309 -1.314 . . . . 72.239999999999995 114.374 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 . . . . . 0 N--CA 1.412 -2.365 0 N-CA-C 109.715 -0.476 . . . . 75.310000000000002 109.715 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -102.22 142.18 33.88 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 106.64 -1.615 . . . . 75.420000000000002 106.64 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' B' ' 263' ' ' SER . 55.5 m -136.98 137.91 39.99 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.382 0.611 . . . . 71.450000000000003 111.19 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.19 130.23 50.55 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.417 -0.81 . . . . 71.230000000000004 109.262 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -84.07 -61.58 1.78 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.578 -0.527 . . . . 74.049999999999997 109.578 -177.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -129.14 138.18 51.63 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 122.152 -0.342 . . . . 70.540000000000006 110.538 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 18.4 mt -136.04 117.32 19.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 107.614 -1.254 . . . . 74.540000000000006 107.614 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -119.4 126.0 50.33 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.481 0.658 . . . . 63.329999999999998 110.82 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 24.5 p -110.17 135.44 50.95 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.431 -0.951 . . . . 62.450000000000003 108.431 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -134.89 149.83 50.35 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.757 -0.831 . . . . 63.530000000000001 108.757 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.518 ' HB3' ' HD3' ' C' ' 236' ' ' ARG . 36.6 mt-10 64.58 -99.02 0.07 Allowed 'General case' 0 C--O 1.203 -1.372 0 C-N-CA 124.556 1.142 . . . . 62.240000000000002 113.698 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.518 ' HD3' ' HB3' ' C' ' 235' ' ' GLU . 0.2 OUTLIER -122.62 35.52 4.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 108.221 -1.029 . . . . 74.510000000000005 108.221 -177.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -81.3 134.38 35.58 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 114.563 -1.198 . . . . 72.519999999999996 110.659 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 2.0 mpp_? -125.33 133.88 52.43 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.616 -1.174 . . . . 63.119999999999997 107.942 176.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.641 HG23 HG13 ' B' ' 275' ' ' VAL . 29.4 m -134.67 141.26 43.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.649 0.738 . . . . 73.030000000000001 110.922 177.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.422 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 45.1 tp60 -104.79 136.05 45.03 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 114.648 -1.16 . . . . 75.519999999999996 108.495 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.479 ' HB3' ' HA ' ' B' ' 277' ' ' ILE . 1.6 tm? -126.42 116.96 21.97 Favored 'General case' 0 N--CA 1.402 -2.848 0 N-CA-C 104.864 -2.273 . . . . 74.109999999999999 104.864 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.501 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 121.66 -131.42 8.52 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 119.618 -1.277 . . . . 75.540000000000006 113.31 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.626 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 13.1 m120 -122.23 139.7 53.46 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.884 -0.413 . . . . 63.009999999999998 109.884 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.422 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 48.4 t -126.34 117.46 48.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 106.545 -1.65 . . . . 74.209999999999994 106.545 172.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.03 127.85 74.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.797 -1.161 . . . . 71.439999999999998 113.104 -175.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 20.2 p -114.0 162.63 16.18 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.093 -0.503 . . . . 63.130000000000003 111.185 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.33 -32.04 69.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.445 0.698 . . . . 63.509999999999998 110.836 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.32 -33.61 59.26 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.505 1.122 . . . . 72.430000000000007 112.533 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.654 0 N-CA-C 112.244 0.461 . . . . 64.439999999999998 112.244 -179.566 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.415 -2.203 0 CA-C-O 121.592 0.71 . . . . 53.439999999999998 109.34 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -114.68 125.63 53.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.749 -0.66 . . . . 71.219999999999999 109.513 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' C' ' 227' ' ' SER . 28.5 t -117.78 135.37 54.1 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 108.179 -1.045 . . . . 62.219999999999999 108.179 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.0 141.44 42.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 116.402 -0.363 . . . . 73.230000000000004 110.333 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -78.42 -66.45 0.85 Allowed 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 122.493 0.317 . . . . 73.340000000000003 111.047 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.8 m -129.03 132.37 47.48 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 120.523 -0.471 . . . . 72.239999999999995 111.441 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.75 123.95 72.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.074 -1.454 . . . . 65.030000000000001 107.074 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 20.1 m -124.99 143.59 38.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.3 0.571 . . . . 70.109999999999999 112.338 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.2 133.78 9.16 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.331 -1.108 . . . . 64.530000000000001 110.331 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -133.84 125.09 27.66 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 123.643 0.777 . . . . 60.509999999999998 109.708 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.24 -136.99 21.32 Favored Glycine 0 CA--C 1.506 -0.512 0 N-CA-C 110.108 -1.197 . . . . 45.210000000000001 110.108 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 10.2 mp0 -81.26 98.12 7.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.528 -0.916 . . . . 74.099999999999994 108.528 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 50.5 m -120.35 149.94 41.53 Favored 'General case' 0 C--N 1.278 -2.5 0 C-N-CA 120.121 -0.632 . . . . 70.349999999999994 110.845 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 75.6 mtm180 -140.1 127.49 21.36 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.022 -1.103 . . . . 70.140000000000001 108.022 174.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.416 ' HB ' HG12 ' C' ' 239' ' ' VAL . 7.8 t -135.29 140.06 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.678 0 N-CA-C 107.561 -1.274 . . . . 64.129999999999995 107.561 176.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 7.0 tt -120.65 111.74 18.01 Favored 'General case' 0 N--CA 1.403 -2.789 0 C-N-CA 118.894 -1.122 . . . . 63.509999999999998 108.871 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.66 103.18 14.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 105.272 -2.122 . . . . 74.140000000000001 105.272 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 149.11 -140.32 8.09 Favored Glycine 0 CA--C 1.492 -1.401 0 C-N-CA 120.286 -0.959 . . . . 64.150000000000006 111.852 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -128.45 133.89 48.63 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.417 -0.586 . . . . 72.310000000000002 109.417 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' C' ' 287' ' ' TRP . 10.2 tp10 -111.75 118.72 36.37 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.351 -1.351 . . . . 74.319999999999993 107.351 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -105.31 123.58 48.1 Favored 'General case' 0 C--O 1.253 1.282 0 N-CA-C 107.713 -1.218 . . . . 73.430000000000007 107.713 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.35 -42.03 2.04 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.958 -0.857 . . . . 73.099999999999994 110.958 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 73.06 43.4 40.36 Favored Glycine 0 CA--C 1.482 -1.996 0 N-CA-C 109.219 -1.552 . . . . 53.439999999999998 109.219 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -151.46 6.23 0.47 Allowed 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.236 -0.482 . . . . 72.010000000000005 110.027 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -92.01 -80.6 1.43 Allowed Glycine 0 CA--C 1.491 -1.442 0 C-N-CA 119.943 -1.122 . . . . 21.210000000000001 110.693 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -95.42 -27.7 15.29 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.136 -1.061 . . . . 74.510000000000005 108.136 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.529 ' HA ' ' CE3' ' C' ' 287' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.168 0 CA-C-N 114.61 -1.177 . . . . 74.010000000000005 112.984 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 17.0 ptt85 . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 121.776 0.798 . . . . 74.099999999999994 112.588 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -98.41 147.55 24.6 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.714 -1.958 . . . . 65.150000000000006 105.714 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.5 m -121.8 136.37 54.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.531 0.681 . . . . 73.420000000000002 111.28 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.4 129.17 37.0 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.481 -1.303 . . . . 63.149999999999999 107.481 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -89.08 -43.93 10.72 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.292 -0.633 . . . . 74.120000000000005 109.292 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -139.86 138.93 36.13 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.693 0.283 . . . . 74.409999999999997 110.267 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 56.2 mt -137.09 123.48 28.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 106.497 -1.668 . . . . 70.430000000000007 106.497 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 60.4 ttt-85 -128.88 115.27 17.61 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.201 -1.037 . . . . 70.219999999999999 108.201 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 30.9 p -120.5 128.41 53.11 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.982 -0.448 . . . . 44.299999999999997 110.789 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -127.78 140.34 52.11 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 110.083 -0.34 . . . . 72.439999999999998 110.083 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.422 ' C ' ' HD2' ' A' ' 236' ' ' ARG . 40.1 mt-10 59.87 105.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.529 1.677 . . . . 53.439999999999998 115.529 169.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 272' ' ' GLU . 1.2 mpt_? 53.0 24.15 3.28 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.071 1.348 . . . . 72.319999999999993 111.526 176.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.97 151.67 23.07 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 120.981 0.42 . . . . 64.099999999999994 110.553 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.32 135.55 38.99 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.649 -0.705 . . . . 73.450000000000003 109.241 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 3.2 p -133.11 140.17 47.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.863 -0.608 . . . . 70.340000000000003 110.526 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -116.32 124.42 50.08 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.63 -1.248 . . . . 75.340000000000003 107.63 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tt -119.07 117.47 28.83 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 105.527 -2.027 . . . . 70.209999999999994 105.527 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.592 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 131.32 -162.28 23.65 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 109.662 -1.375 . . . . 44.25 109.662 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -117.43 134.74 54.49 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 109.172 -0.677 . . . . 71.409999999999997 109.172 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 30.8 t -107.0 121.61 60.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.29 -1.004 . . . . 74.439999999999998 108.29 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 56.2 t -113.58 114.95 48.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.502 -0.925 . . . . 72.230000000000004 108.502 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.437 HG21 ' HB2' ' A' ' 284' ' ' LYS . 12.3 m -96.96 160.37 14.39 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.259 -1.015 . . . . 74.349999999999994 108.259 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.19 75.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.176 0.59 . . . . 74.219999999999999 111.067 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.38 66.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.353 1.061 . . . . 72.430000000000007 113.399 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.316 -0.862 0 CA-C-O 120.854 0.359 . . . . 61.329999999999998 110.954 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 C--O 1.213 -0.827 0 N-CA-C 110.135 -0.32 . . . . 74.109999999999999 110.135 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -126.25 150.2 48.57 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 104.953 -2.239 . . . . 72.530000000000001 104.953 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 26.7 m -134.93 123.77 23.91 Favored 'General case' 0 C--O 1.263 1.797 0 N-CA-C 114.494 1.294 . . . . 74.140000000000001 114.494 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -121.76 134.5 64.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 CA-C-N 115.108 -0.951 . . . . 72.349999999999994 110.616 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -77.35 -73.19 0.31 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.611 -0.722 . . . . 73.209999999999994 110.804 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 32.3 m -126.12 126.82 44.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 120.882 -0.327 . . . . 53.020000000000003 110.227 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.458 HG11 HD11 ' A' ' 277' ' ' ILE . 3.4 p -129.64 120.85 51.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.848 0.832 . . . . 64.349999999999994 110.874 176.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 44.7 t -118.71 135.28 59.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.073 -0.967 . . . . 42.32 110.892 -175.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.472 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -121.37 131.12 8.45 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 108.411 -1.875 . . . . 71.120000000000005 108.411 172.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.493 ' HB3' ' HG2' ' B' ' 234' ' ' GLU . 7.1 tmtm? -134.91 115.02 13.12 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.437 -0.579 . . . . 72.319999999999993 109.437 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.37 82.71 0.68 Allowed Glycine 0 C--O 1.216 -0.977 0 C-N-CA 120.672 -0.775 . . . . 64.400000000000006 114.309 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 236' ' ' ARG . 41.5 mt-10 63.62 24.32 13.91 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.438 1.095 . . . . 64.510000000000005 112.414 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 48.8 m -82.46 145.12 30.0 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 121.715 0.769 . . . . 75.439999999999998 111.491 -176.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -109.09 127.86 54.5 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 106.42 -1.696 . . . . 75.439999999999998 106.42 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.4 p -129.23 123.55 58.48 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.665 0 N-CA-C 108.94 -0.763 . . . . 74.010000000000005 108.94 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.432 HD13 HE22 ' B' ' 240' ' ' GLN . 4.5 tt -113.53 120.21 40.2 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 107.88 -1.155 . . . . 64.400000000000006 107.88 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.458 HD11 HG11 ' A' ' 267' ' ' VAL . 41.7 mm -112.45 103.49 15.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.716 -1.216 . . . . 73.310000000000002 107.716 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.645 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 147.15 -145.06 13.38 Favored Glycine 0 C--N 1.301 -1.381 0 N-CA-C 110.452 -1.059 . . . . 34.399999999999999 110.452 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -127.53 143.3 51.2 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.628 -0.879 . . . . 74.329999999999998 108.628 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.75 120.23 37.94 Favored 'General case' 0 C--O 1.259 1.605 0 N-CA-C 106.849 -1.537 . . . . 73.239999999999995 106.849 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -107.12 123.11 47.77 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 106.854 -1.536 . . . . 75.450000000000003 106.854 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 98.96 -48.08 1.33 Allowed Glycine 0 C--N 1.295 -1.701 0 C-N-CA 120.54 -0.838 . . . . 72.530000000000001 111.356 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 82.93 15.04 73.72 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.829 -0.7 . . . . 63.219999999999999 113.036 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.437 ' HB2' HG21 ' A' ' 246' ' ' THR . 32.1 mmtp -127.47 5.91 6.27 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.264 -0.551 . . . . 74.349999999999994 111.755 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -85.71 -54.79 2.69 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 110.173 -1.171 . . . . 72.329999999999998 110.173 -178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -111.86 -30.68 7.2 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.143 -0.529 . . . . 72.340000000000003 109.674 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.481 ' CH2' ' HB2' ' B' ' 238' ' ' ARG 0.283 11.3 t-105 . . . . . 0 N--CA 1.413 -2.285 0 C-N-CA 118.441 -1.304 . . . . 74.010000000000005 113.684 -173.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.66 ' O ' ' HA ' ' B' ' 261' ' ' THR . 8.7 ptm180 . . . . . 0 N--CA 1.425 -1.724 0 CA-C-O 121.711 0.767 . . . . 75.030000000000001 110.621 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -103.69 149.11 25.27 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 104.576 -2.379 . . . . 71.409999999999997 104.576 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 23.9 m -125.75 134.74 51.65 Favored 'General case' 0 N--CA 1.411 -2.386 0 C-N-CA 119.252 -0.979 . . . . 74.439999999999998 110.497 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.428 ' HB2' HG21 ' B' ' 277' ' ' ILE . . . -131.24 121.74 25.3 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.156 -1.384 . . . . 75.349999999999994 110.331 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -76.1 -67.14 0.71 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.156 -0.929 . . . . 72.319999999999993 112.164 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -127.16 137.07 52.87 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 118.327 -1.349 . . . . 74.230000000000004 108.752 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.475 HG21 HG21 ' B' ' 239' ' ' VAL . 43.3 mt -131.93 117.68 34.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.35 -1.352 . . . . 64.439999999999998 107.35 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -126.09 115.15 19.38 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.226 -0.657 . . . . 61.240000000000002 109.226 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.472 ' OG1' ' HA2' ' A' ' 269' ' ' GLY . 71.2 p -112.66 127.24 56.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.844 -1.169 . . . . 55.130000000000003 107.844 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' B' ' 270' ' ' LYS . 52.2 mt-10 -131.44 139.89 49.49 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 122.072 -0.392 . . . . 72.420000000000002 111.1 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.542 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 28.9 mt-10 60.56 93.62 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 O-C-N 124.711 1.257 . . . . 73.310000000000002 114.037 171.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.542 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 1.4 mpt_? 63.0 15.6 8.56 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 125.036 1.335 . . . . 73.239999999999995 111.06 175.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -78.15 156.57 29.82 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.197 0.522 . . . . 75.340000000000003 111.071 -176.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.481 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -139.75 135.15 32.8 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.362 -0.607 . . . . 60.009999999999998 109.362 177.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.4 p -133.32 142.45 41.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.632 0.73 . . . . 72.319999999999993 111.381 -178.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.692 ' HB2' ' CE2' ' B' ' 286' ' ' PHE . 5.8 tp-100 -109.35 131.99 54.55 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.382 -1.34 . . . . 65.129999999999995 107.382 173.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.409 ' HB3' HD13 ' A' ' 277' ' ' ILE . 3.3 tm? -129.72 115.58 17.53 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 104.801 -2.296 . . . . 75.040000000000006 104.801 171.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 135.96 -136.32 8.36 Favored Glycine 0 N--CA 1.417 -2.578 0 N-CA-C 109.057 -1.617 . . . . 61.240000000000002 109.057 -175.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -142.3 148.71 38.47 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 117.575 0.688 . . . . 74.239999999999995 109.682 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 17.2 t -114.8 124.11 71.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.538 -1.282 . . . . 72.219999999999999 107.538 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.15 113.37 38.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 120.178 -0.609 . . . . 73.200000000000003 109.494 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.475 HG21 ' HB2' ' B' ' 284' ' ' LYS . 7.4 m -95.09 159.5 14.99 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.353 -1.351 . . . . 70.200000000000003 107.353 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -64.15 -32.13 73.58 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.941 0.876 . . . . 72.430000000000007 110.241 177.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.89 -44.47 74.13 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.383 -1.735 . . . . 71.019999999999996 113.366 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -75.74 -47.7 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.273 -0.571 . . . . 71.030000000000001 111.16 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 N--CA 1.467 0.423 0 C-N-CA 123.929 0.892 . . . . 71.140000000000001 109.296 -175.448 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 3.7 m . . . . . 0 CA--C 1.506 -0.719 0 N-CA-C 108.44 -0.948 . . . . 72.510000000000005 108.44 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' B' ' 225' ' ' ARG . 25.3 m -132.96 135.18 45.36 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.639 -1.615 . . . . 62.039999999999999 106.639 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -126.67 146.05 50.34 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.192 -1.781 . . . . 72.530000000000001 106.192 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' C' ' 227' ' ' SER . 40.5 m -125.6 123.51 39.18 Favored 'General case' 0 C--O 1.256 1.434 0 C-N-CA 118.536 -1.266 . . . . 72.409999999999997 114.043 -170.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.439 HG21 HG13 ' B' ' 267' ' ' VAL . 11.3 p -128.63 137.31 57.67 Favored 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 120.088 -0.645 . . . . 75.239999999999995 111.212 172.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.562 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 10.4 tp10 -86.34 -63.36 1.33 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.025 -0.534 . . . . 73.439999999999998 110.01 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 25.1 m -137.15 127.56 26.58 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.346 -0.847 . . . . 70.040000000000006 112.408 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.465 HG12 HD12 ' C' ' 231' ' ' ILE . 30.4 m -118.56 128.41 75.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 115.882 -0.599 . . . . 63.109999999999999 109.815 173.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.41 130.63 74.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.61 -0.723 . . . . 65.219999999999999 109.98 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.44 132.95 9.28 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 110.585 -1.006 . . . . 70.519999999999996 110.585 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.528 ' HD2' ' HB2' ' B' ' 234' ' ' GLU . 31.2 mmmt -132.91 115.64 15.49 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 123.218 0.607 . . . . 70.140000000000001 111.108 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.61 80.67 0.61 Allowed Glycine 0 C--N 1.304 -1.196 0 C-N-CA 120.445 -0.883 . . . . 43.340000000000003 114.589 172.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 63.7 28.64 14.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.159 0.984 . . . . 54.219999999999999 112.509 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 50.1 m -81.97 145.19 30.41 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.351 0.596 . . . . 73.239999999999995 111.175 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.436 ' HD3' ' HB3' ' C' ' 238' ' ' ARG . 6.1 mpt_? -109.5 128.72 55.38 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 106.849 -1.537 . . . . 64.319999999999993 106.849 174.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.4 p -130.96 123.06 53.32 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 N-CA-C 108.17 -1.048 . . . . 74.400000000000006 108.17 172.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 6.1 tt -114.08 116.79 29.7 Favored 'General case' 0 C--N 1.277 -2.571 0 C-N-CA 119.36 -0.936 . . . . 55.119999999999997 108.599 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.465 HG23 HD12 ' C' ' 241' ' ' LEU . 34.0 mm -106.46 102.54 14.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 106.834 -1.543 . . . . 61.140000000000001 106.834 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 146.82 -164.36 28.53 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 110.856 -0.897 . . . . 10.109999999999999 110.856 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -109.54 139.66 44.28 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.159 -0.682 . . . . 72.140000000000001 109.159 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.95 118.89 36.73 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.256 -1.757 . . . . 74.120000000000005 106.256 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -105.91 122.95 47.17 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.891 -1.151 . . . . 73.439999999999998 107.891 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.44 -46.47 1.28 Allowed Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.669 -0.696 . . . . 73.549999999999997 111.682 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 74.59 29.25 61.86 Favored Glycine 0 CA--C 1.506 -0.486 0 N-CA-C 111.555 -0.618 . . . . 23.010000000000002 111.555 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . 0.475 ' HB2' HG21 ' B' ' 246' ' ' THR . 73.1 mmtt -137.25 11.41 3.03 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.528 -0.336 . . . . 72.319999999999993 110.624 -177.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -103.78 -47.05 1.31 Allowed Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 119.729 -1.224 . . . . 75.319999999999993 110.686 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.692 ' CE2' ' HB2' ' B' ' 240' ' ' GLN . 6.3 t80 -110.03 -42.11 4.29 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.996 0.427 . . . . 75.409999999999997 110.39 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.517 ' CZ2' ' HB2' ' C' ' 238' ' ' ARG . 11.2 t-105 . . . . . 0 N--CA 1.427 -1.586 0 N-CA-C 115.483 1.661 . . . . 75.150000000000006 115.483 -165.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' B' ' 261' ' ' THR . 15.8 ptt-85 . . . . . 0 N--CA 1.433 -1.316 0 CA-C-O 122.614 1.197 . . . . 70.439999999999998 114.115 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -116.25 147.41 41.51 Favored 'General case' 0 N--CA 1.399 -2.985 0 N-CA-C 105.26 -2.126 . . . . 75.25 105.26 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' C' ' 263' ' ' SER . 24.1 m -130.03 136.55 49.52 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 121.269 0.557 . . . . 62.039999999999999 110.117 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.511 ' HB2' HG21 ' C' ' 277' ' ' ILE . . . -130.41 134.37 47.08 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 109.198 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.562 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -85.95 -61.32 1.78 Allowed 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 115.266 -0.879 . . . . 71.400000000000006 109.193 -178.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -129.56 137.97 51.05 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.953 -0.699 . . . . 71.239999999999995 110.345 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.465 HD12 HG12 ' B' ' 267' ' ' VAL . 34.5 mt -135.18 119.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.879 -0.785 . . . . 70.109999999999999 108.879 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.429 ' HB3' HG12 ' C' ' 268' ' ' VAL . 30.9 ttt180 -125.56 115.92 20.94 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.998 0.428 . . . . 72.129999999999995 110.078 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 38.9 p -112.61 127.5 56.11 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.452 -0.944 . . . . 74.129999999999995 108.452 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -131.55 139.43 49.23 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.437 -0.505 . . . . 71.010000000000005 110.691 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.459 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 38.2 mt-10 62.81 92.16 0.06 Allowed 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 124.926 1.391 . . . . 45.399999999999999 114.133 170.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.459 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 2.8 mpt_? 63.55 12.04 6.14 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.859 1.264 . . . . 55.32 111.21 175.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -77.97 149.01 34.18 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.204 0.526 . . . . 62.509999999999998 111.64 -174.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.517 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.0 OUTLIER -133.65 134.96 43.8 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.943 -0.572 . . . . 72.329999999999998 111.511 176.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.6 p -132.97 137.86 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 115.276 -0.875 . . . . 70.319999999999993 111.534 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -106.03 129.79 54.07 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 114.127 -1.397 . . . . 63.539999999999999 107.863 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.465 HD12 HG23 ' B' ' 277' ' ' ILE . 3.2 tm? -125.15 116.32 21.85 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.069 -1.826 . . . . 71.129999999999995 106.069 173.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.653 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 126.98 -148.18 17.21 Favored Glycine 0 C--N 1.284 -2.348 0 N-CA-C 108.278 -1.929 . . . . 65.409999999999997 108.278 -176.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -126.96 150.16 49.51 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 118.336 1.068 . . . . 72.409999999999997 110.621 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.78 126.56 74.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.614 -1.254 . . . . 73.340000000000003 107.614 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 65.4 t -122.52 118.59 55.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 120.439 -0.504 . . . . 63.43 109.98 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 9.4 m -95.27 159.42 15.02 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 108.114 -1.069 . . . . 71.409999999999997 108.114 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -64.05 -33.76 76.48 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.354 0.597 . . . . 55.329999999999998 110.776 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.14 -47.76 74.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.405 -1.271 . . . . 71.409999999999997 111.464 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.515 0 CA-C-O 120.941 0.4 . . . . 54.229999999999997 111.367 177.155 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 22.0 m . . . . . 0 N--CA 1.415 -2.195 0 N-CA-C 109.584 -0.524 . . . . 75.319999999999993 109.584 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -112.51 124.48 52.61 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.064 -1.828 . . . . 70.409999999999997 106.064 173.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' C' ' 227' ' ' SER . 10.7 p -130.37 144.79 51.6 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 113.735 1.013 . . . . 71.209999999999994 113.735 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 10.0 p -128.51 149.58 33.43 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.494 -0.775 . . . . 64.450000000000003 110.296 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -81.03 -68.28 0.7 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.626 0.25 . . . . 74.099999999999994 111.284 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 61.8 m -138.59 127.6 23.94 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 120.367 -0.533 . . . . 75.120000000000005 110.646 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.1 m -118.68 134.6 61.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.466 -0.568 . . . . 63.439999999999998 109.466 172.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . 0.429 HG12 ' HB3' ' C' ' 232' ' ' ARG . 13.6 m -127.1 135.53 63.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-N 115.634 -0.712 . . . . 53.119999999999997 110.485 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.15 132.35 9.08 Favored Glycine 0 CA--C 1.47 -2.739 0 N-CA-C 109.089 -1.604 . . . . 44.299999999999997 109.089 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -134.4 115.21 13.75 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.603 -0.888 . . . . 75.120000000000005 108.603 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.39 91.61 0.19 Allowed Glycine 0 C--O 1.242 0.653 0 C-N-CA 121.139 -0.553 . . . . 71.150000000000006 113.427 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 56.5 29.65 15.77 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.638 1.175 . . . . 72.519999999999996 112.158 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 23.2 m -82.8 145.24 29.62 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 119.561 -0.856 . . . . 63.200000000000003 111.547 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' C' ' 274' ' ' ARG . 6.5 mtm180 -118.72 127.65 53.76 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 107.908 -1.145 . . . . 71.409999999999997 107.908 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 4.0 p -138.25 128.5 35.06 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-N 115.592 -0.731 . . . . 64.0 109.292 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.7 tt -116.62 115.3 25.45 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.485 -0.931 . . . . 72.420000000000002 108.485 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' C' ' 228' ' ' ALA . 43.1 mm -105.9 102.97 14.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 106.509 -1.663 . . . . 73.120000000000005 106.509 178.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 141.42 -163.2 26.84 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 111.028 -0.829 . . . . 53.399999999999999 111.028 -174.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -114.08 135.87 53.55 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.818 -0.808 . . . . 75.239999999999995 108.818 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.69 118.68 36.31 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.169 -1.789 . . . . 75.310000000000002 106.169 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -105.26 123.39 47.76 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 109.097 -0.705 . . . . 75.239999999999995 109.097 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.19 -43.65 1.66 Allowed Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 109.957 -1.257 . . . . 64.430000000000007 109.957 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 80.1 21.68 64.84 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.359 -0.697 . . . . 70.409999999999997 111.359 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' C' ' 287' ' ' TRP . 33.3 mttm -145.68 20.5 1.49 Allowed 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 113.987 1.106 . . . . 61.119999999999997 113.987 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -94.58 -45.5 3.18 Favored Glycine 0 N--CA 1.427 -1.922 0 N-CA-C 107.794 -2.123 . . . . 64.420000000000002 107.794 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.53 -50.91 3.11 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.578 -1.267 . . . . 74.25 107.578 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.574 ' O ' ' HA ' ' C' ' 284' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.308 -1.204 0 CA-C-N 115.268 -0.878 . . . . 71.450000000000003 112.097 -169.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 . . . . . 0 N--CA 1.426 -1.674 0 CA-C-O 121.695 0.759 . . . . 75.310000000000002 112.053 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -110.28 134.96 51.74 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.301 -1.318 . . . . 62.229999999999997 108.677 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.6 m -126.19 136.71 53.17 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 109.326 -0.62 . . . . 74.099999999999994 109.326 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.18 132.19 27.83 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.453 -1.684 . . . . 70.129999999999995 106.453 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.17 -56.85 2.5 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.873 -0.731 . . . . 71.109999999999999 111.656 -174.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.81 139.57 52.57 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.129 -0.693 . . . . 64.019999999999996 109.129 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.2 mm -131.92 118.72 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.884 -0.784 . . . . 73.209999999999994 108.884 -174.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -120.56 127.01 51.75 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.846 -0.428 . . . . 72.439999999999998 109.846 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 45.1 p -133.46 128.64 35.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.684 -0.487 . . . . 65.230000000000004 109.684 -176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.424 ' HB2' ' HD3' ' A' ' 270' ' ' LYS . 42.7 mt-10 -142.8 139.71 31.07 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 121.059 -0.256 . . . . 74.319999999999993 110.773 176.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.606 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 38.7 mt-10 64.18 95.64 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 114.748 1.388 . . . . 50.140000000000001 114.748 170.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.606 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.1 mpp_? 60.31 26.85 16.37 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.674 1.19 . . . . 74.340000000000003 110.435 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -92.35 125.95 37.23 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 115.252 -0.886 . . . . 75.140000000000001 110.614 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.539 ' HD3' ' HG2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -128.05 134.94 49.25 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.621 -0.881 . . . . 70.299999999999997 108.621 176.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.657 HG12 ' HB ' ' A' ' 275' ' ' VAL . 33.1 m -134.32 150.12 30.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 116.116 -0.493 . . . . 72.040000000000006 110.711 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.638 HE21 ' HG ' ' A' ' 276' ' ' LEU . 0.9 OUTLIER -123.14 125.34 44.96 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.336 -1.357 . . . . 71.219999999999999 107.336 178.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -116.12 117.75 30.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.65 -1.241 . . . . 75.230000000000004 107.65 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.452 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 126.59 -159.57 20.86 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 111.337 -0.705 . . . . 73.140000000000001 111.337 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' A' ' 279' ' ' ASN . 39.3 t30 -107.0 137.86 44.27 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 122.935 0.494 . . . . 72.430000000000007 110.383 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 99.9 t -113.27 114.33 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.249 -0.649 . . . . 45.420000000000002 109.249 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.513 ' HA ' ' HB3' ' A' ' 281' ' ' TYR . 27.4 m -99.32 118.39 45.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 119.844 -0.742 . . . . 65.129999999999995 110.711 176.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 17.6 m -102.0 158.95 15.78 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.562 -0.533 . . . . 73.150000000000006 109.562 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.79 -35.27 80.24 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.639 0.977 . . . . 50.109999999999999 113.639 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -39.03 68.01 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.476 1.288 . . . . 62.439999999999998 114.476 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.571 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.318 -0.763 0 N-CA-C 112.217 0.451 . . . . 74.420000000000002 112.217 -177.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.408 -2.54 0 N-CA-C 106.204 -1.776 . . . . 74.349999999999994 106.204 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 17.2 m120 -104.91 130.8 53.0 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.797 -0.816 . . . . 63.200000000000003 108.797 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 59.5 m -138.96 123.43 18.34 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.53 -0.545 . . . . 54.210000000000001 109.53 174.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 12.7 p -128.19 149.18 32.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.844 -1.169 . . . . 73.109999999999999 107.844 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 32.1 tt0 -92.91 -67.6 0.85 Allowed 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 120.005 -0.678 . . . . 73.420000000000002 110.339 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 20.7 m -123.74 133.08 53.91 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.235 -0.586 . . . . 74.439999999999998 111.429 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.84 131.71 72.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 108.492 -0.929 . . . . 72.319999999999993 108.492 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 6.4 p -127.26 131.51 70.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 110.207 -0.294 . . . . 62.439999999999998 110.207 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.486 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -122.71 131.49 8.31 Favored Glycine 0 CA--C 1.485 -1.837 0 C-N-CA 120.34 -0.933 . . . . 34.409999999999997 111.347 176.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 234' ' ' GLU . 15.9 tptm -134.41 115.84 14.48 Favored 'General case' 0 N--CA 1.428 -1.531 0 O-C-N 123.679 0.282 . . . . 70.430000000000007 110.828 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.63 99.7 0.49 Allowed Glycine 0 C--O 1.245 0.801 0 C-N-CA 120.717 -0.754 . . . . 73.25 113.878 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' B' ' 236' ' ' ARG . 51.8 mm-40 60.55 24.18 13.87 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.432 1.093 . . . . 63.240000000000002 110.597 175.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 18.9 m -82.57 144.63 30.22 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.987 0.899 . . . . 74.239999999999995 112.784 -169.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . 0.539 ' HG2' ' HD3' ' A' ' 238' ' ' ARG . 82.9 mtt180 -135.31 126.21 27.57 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.124 -1.436 . . . . 75.239999999999995 107.124 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.657 ' HB ' HG12 ' A' ' 239' ' ' VAL . 46.4 t -136.19 133.67 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.989 0 N-CA-C 109.691 -0.485 . . . . 65.030000000000001 109.691 -176.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.638 ' HG ' HE21 ' A' ' 240' ' ' GLN . 6.3 tt -119.45 117.98 29.89 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.507 -1.277 . . . . 74.340000000000003 108.849 171.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.432 HG22 ' HB3' ' B' ' 241' ' ' LEU . 2.7 pt -112.54 104.38 16.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-O 121.622 0.725 . . . . 74.430000000000007 109.508 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.687 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 148.21 -133.45 4.62 Favored Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 115.843 -0.617 . . . . 63.539999999999999 111.568 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 243' ' ' ASN . 14.3 m120 -128.29 153.5 46.92 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.507 -0.923 . . . . 74.109999999999999 108.507 -176.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.17 143.45 34.25 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.945 0.878 . . . . 73.420000000000002 110.475 170.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.513 ' HB3' ' HA ' ' A' ' 245' ' ' VAL 0.252 5.3 t80 -119.45 124.63 46.98 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 105.801 -1.926 . . . . 74.319999999999993 105.801 -175.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 144.2 -52.13 0.62 Allowed Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.003 -1.094 . . . . 61.329999999999998 112.974 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.453 ' HA3' HG23 ' B' ' 246' ' ' THR . . . 119.87 -34.74 4.08 Favored Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 108.816 -1.714 . . . . 40.130000000000003 108.816 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -135.89 87.47 2.31 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.609 -1.626 . . . . 72.099999999999994 106.609 170.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -95.97 -132.81 7.26 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.812 -0.915 . . . . 45.420000000000002 110.812 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 26.0 t80 52.07 -130.1 2.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 107.819 -1.178 . . . . 75.310000000000002 107.819 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 . . . . . 0 C--N 1.299 -1.627 0 N-CA-C 107.318 -1.364 . . . . 70.25 107.318 172.693 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 . . . . . 0 CA--C 1.502 -0.891 0 N-CA-C 112.255 0.465 . . . . 73.420000000000002 112.255 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 6.9 t30 -118.58 113.39 21.18 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.654 -0.869 . . . . 74.409999999999997 108.654 169.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 46.7 m -121.26 136.61 54.94 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-O 121.725 0.774 . . . . 61.520000000000003 110.124 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.21 147.58 52.0 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.999 -1.482 . . . . 55.539999999999999 106.999 178.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 10.0 tmtt? -104.51 -67.76 0.89 Allowed 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.677 -0.809 . . . . 75.420000000000002 109.299 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' B' ' 266' ' ' THR . 33.3 t70 -128.01 138.7 52.69 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.435 -0.58 . . . . 73.400000000000006 109.435 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.48 HD11 ' HB1' ' B' ' 228' ' ' ALA . 39.9 mm -128.88 117.57 44.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.637 -0.875 . . . . 71.400000000000006 108.637 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -114.31 114.51 26.02 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.895 -0.78 . . . . 72.420000000000002 108.895 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.486 ' OG1' ' HA2' ' A' ' 269' ' ' GLY . 78.2 p -111.53 127.24 55.65 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 107.664 -1.235 . . . . 54.539999999999999 107.664 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -139.34 138.93 37.07 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 120.842 -0.343 . . . . 73.129999999999995 111.019 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.6 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 44.5 mt-10 57.99 98.4 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 125.098 1.499 . . . . 70.299999999999997 114.908 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.6 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.2 OUTLIER 60.75 26.21 16.02 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.859 -1.064 . . . . 71.219999999999999 110.198 174.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -91.35 136.03 33.4 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.121 -0.945 . . . . 62.219999999999999 111.882 -175.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 3.5 mpt_? -125.94 134.41 51.55 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.711 -1.218 . . . . 74.230000000000004 107.711 176.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.629 HG12 ' HB ' ' B' ' 275' ' ' VAL . 19.7 m -138.97 147.41 24.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.234 0.54 . . . . 61.240000000000002 110.945 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -122.06 127.93 50.78 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.66 -1.608 . . . . 74.219999999999999 106.66 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' B' ' 277' ' ' ILE . 2.3 tm? -122.5 117.67 26.49 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.892 -1.522 . . . . 53.439999999999998 106.892 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 136.92 -126.39 3.7 Favored Glycine 0 N--CA 1.428 -1.861 0 C-N-CA 120.804 -0.713 . . . . 52.340000000000003 111.761 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' B' ' 279' ' ' ASN . 43.9 t30 -142.78 134.86 27.23 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 110.286 -0.264 . . . . 73.430000000000007 110.286 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.55 HG11 ' H ' ' B' ' 286' ' ' PHE . 68.7 t -114.94 114.91 47.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 109.539 -0.541 . . . . 64.129999999999995 109.539 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.499 ' HA ' ' HB3' ' B' ' 281' ' ' TYR . 28.5 m -104.15 112.72 38.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.69 -0.804 . . . . 61.140000000000001 111.192 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.484 HG22 ' H ' ' B' ' 248' ' ' ALA . 42.0 m -81.72 158.19 24.29 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 121.047 0.451 . . . . 75.010000000000005 110.914 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.23 93.24 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.322 1.049 . . . . 63.310000000000002 112.342 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . 0.484 ' H ' HG22 ' B' ' 246' ' ' THR . . . -55.31 -44.29 75.65 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.068 -1.424 . . . . 33.299999999999997 114.065 -173.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.71 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -74.95 -25.76 59.12 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 120.9 0.381 . . . . 62.530000000000001 110.744 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 CA--C 1.515 -0.389 0 C-N-CA 125.186 1.395 . . . . 74.230000000000004 109.458 -171.155 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 16.7 m . . . . . 0 CA--C 1.541 0.614 0 CA-C-O 121.936 0.874 . . . . 64.129999999999995 111.254 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 33.9 m -124.11 108.91 12.83 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 115.039 -0.982 . . . . 71.219999999999999 108.565 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -108.49 132.59 53.66 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 109.65 -0.5 . . . . 63.409999999999997 109.65 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' C' ' 227' ' ' SER . 37.3 t -142.19 123.86 15.06 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.418 -0.586 . . . . 75.239999999999995 109.418 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.9 p -123.7 148.64 27.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.535 -0.913 . . . . 73.329999999999998 108.535 177.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 37.4 tt0 -89.21 -72.79 0.53 Allowed 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 119.576 -0.85 . . . . 73.430000000000007 110.529 175.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 25.1 m -127.81 133.97 49.44 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.917 -1.114 . . . . 73.329999999999998 112.471 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.82 135.27 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.793 -1.188 . . . . 72.530000000000001 107.793 173.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 5.3 p -127.48 125.43 65.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 121.024 0.44 . . . . 74.209999999999994 110.677 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.57 132.52 10.5 Favored Glycine 0 CA--C 1.476 -2.406 0 N-CA-C 111.137 -0.785 . . . . 53.520000000000003 111.137 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.502 ' HB3' ' HG2' ' C' ' 234' ' ' GLU . 40.6 tptt -134.12 115.83 14.7 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 109.987 -0.375 . . . . 70.230000000000004 109.987 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.97 99.74 0.06 OUTLIER Glycine 0 CA--C 1.527 0.782 0 N-CA-C 114.159 0.424 . . . . 61.32 114.159 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 63.91 26.83 14.33 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.161 0.984 . . . . 74.540000000000006 112.421 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 37.4 m -83.41 144.79 29.38 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.444 -0.902 . . . . 64.120000000000005 113.066 -171.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 4.8 mtt-85 -135.55 127.23 29.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.001 -1.111 . . . . 72.439999999999998 108.001 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.629 ' HB ' HG12 ' B' ' 239' ' ' VAL . 55.6 t -136.49 138.44 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.594 0 N-CA-C 109.165 -0.68 . . . . 75.010000000000005 109.165 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 6.1 tt -123.44 120.88 34.25 Favored 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 119.095 -1.042 . . . . 72.340000000000003 108.434 169.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.496 HG22 ' HB3' ' C' ' 241' ' ' LEU . 1.5 pt -112.43 104.28 16.79 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 C-N-CA 123.991 0.916 . . . . 74.310000000000002 109.502 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.504 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 145.45 -133.63 5.14 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.804 -0.635 . . . . 60.109999999999999 111.699 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . 0.562 ' O ' ' HA ' ' B' ' 243' ' ' ASN . 12.5 m120 -127.28 152.29 47.63 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-O 121.218 0.532 . . . . 70.5 109.978 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -137.68 150.01 47.0 Favored 'General case' 0 N--CA 1.409 -2.52 0 N-CA-C 107.962 -1.125 . . . . 72.140000000000001 107.962 170.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.499 ' HB3' ' HA ' ' B' ' 245' ' ' VAL . 11.2 t80 -125.51 124.34 41.12 Favored 'General case' 0 N--CA 1.395 -3.175 0 N-CA-C 107.623 -1.251 . . . . 61.509999999999998 107.623 -174.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.71 ' HA2' ' HB2' ' B' ' 249' ' ' ALA . . . 143.6 -48.03 0.77 Allowed Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.653 -0.784 . . . . 75.209999999999994 111.747 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . 0.446 ' HA3' HG23 ' C' ' 246' ' ' THR . . . 111.59 -23.72 17.03 Favored Glycine 0 C--O 1.206 -1.62 0 N-CA-C 108.578 -1.809 . . . . 60.409999999999997 108.578 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -141.92 81.88 1.78 Allowed 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 106.886 -1.524 . . . . 75.409999999999997 106.886 173.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -103.88 -159.93 24.61 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.492 -1.443 . . . . 64.439999999999998 109.492 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.55 ' H ' HG11 ' B' ' 244' ' ' VAL . 71.3 t80 63.3 -175.04 0.15 Allowed 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 122.912 0.485 . . . . 71.540000000000006 110.54 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 . . . . . 0 C--N 1.303 -1.44 0 O-C-N 120.528 -1.357 . . . . 74.200000000000003 112.292 -174.072 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 . . . . . 0 N--CA 1.432 -1.351 0 N-CA-C 113.707 1.003 . . . . 72.019999999999996 113.707 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -117.24 120.58 38.68 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.03 -1.441 . . . . 74.239999999999995 108.706 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' C' ' 263' ' ' SER . 42.7 m -121.17 137.08 54.84 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.706 -0.479 . . . . 74.200000000000003 109.706 177.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -133.3 144.38 49.66 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.458 -0.942 . . . . 72.420000000000002 108.458 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -58.78 1.82 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.544 -0.862 . . . . 73.230000000000004 110.883 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' C' ' 266' ' ' THR . 1.2 m-20 -127.23 139.47 52.9 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.295 0.569 . . . . 75.150000000000006 110.734 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.428 HD11 ' HB1' ' C' ' 228' ' ' ALA . 32.6 mm -128.87 118.05 46.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 106.454 -1.684 . . . . 74.0 106.454 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -118.91 115.1 23.67 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.841 -0.429 . . . . 71.329999999999998 109.841 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 80.5 p -112.19 127.4 55.93 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 108.326 -0.99 . . . . 73.230000000000004 108.326 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.502 ' HG2' ' HB3' ' B' ' 270' ' ' LYS . 43.8 mt-10 -138.9 139.34 38.02 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 121.119 -0.232 . . . . 71.510000000000005 110.41 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.559 ' HB3' ' NH1' ' C' ' 236' ' ' ARG . 49.2 mt-10 56.76 95.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 115.539 1.681 . . . . 62.200000000000003 115.539 174.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.559 ' NH1' ' HB3' ' C' ' 235' ' ' GLU . 0.5 OUTLIER 61.06 24.14 14.26 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.164 0.986 . . . . 61.030000000000001 111.712 175.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -91.8 139.57 30.54 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.958 0.885 . . . . 75.5 112.774 -175.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.618 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 8.8 mpt_? -125.65 135.45 52.16 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.17 -1.377 . . . . 72.109999999999999 108.309 177.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.497 HG23 HG13 ' B' ' 275' ' ' VAL . 30.5 m -138.13 147.34 25.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.313 0.578 . . . . 64.450000000000003 110.66 172.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -121.1 129.53 53.35 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.089 -1.819 . . . . 75.349999999999994 106.089 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.496 ' HB3' HG22 ' B' ' 277' ' ' ILE . 2.8 tm? -122.0 118.58 29.16 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 106.162 -1.792 . . . . 74.200000000000003 106.162 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 135.54 -127.77 4.42 Favored Glycine 0 N--CA 1.416 -2.7 0 C-N-CA 120.179 -1.01 . . . . 53.240000000000002 111.421 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.596 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 45.9 t30 -144.34 130.36 19.47 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.525 0.202 . . . . 63.229999999999997 110.783 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.408 HG11 ' H ' ' C' ' 286' ' ' PHE . 85.2 t -110.92 117.88 56.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 123.713 0.805 . . . . 70.129999999999995 109.258 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 18.3 m -107.82 119.26 57.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 120.147 -0.621 . . . . 71.239999999999995 110.479 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . 0.446 HG23 ' HA3' ' B' ' 283' ' ' GLY . 29.7 m -84.6 158.66 20.82 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 120.943 -0.303 . . . . 54.149999999999999 111.223 -176.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.15 -47.83 78.4 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 122.159 0.98 . . . . 55.240000000000002 110.871 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.38 -35.98 65.87 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.265 -1.789 . . . . 72.109999999999999 112.807 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . 0.666 ' HB2' ' HA2' ' C' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.31 -1.126 0 CA-C-N 116.166 -0.47 . . . . 41.420000000000002 111.967 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.435 -1.175 0 CA-C-O 120.899 0.38 . . . . 73.239999999999995 110.048 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -123.71 136.02 54.21 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 120.989 0.423 . . . . 71.230000000000004 109.862 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' C' ' 227' ' ' SER . 33.2 m -142.83 130.41 21.3 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.133 -0.692 . . . . 73.329999999999998 109.133 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.38 153.42 34.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.507 -0.553 . . . . 61.119999999999997 109.507 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -85.35 -74.76 0.39 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.477 -0.564 . . . . 75.219999999999999 109.477 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 60.4 m -138.41 134.11 33.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.687 -0.633 . . . . 72.349999999999994 110.693 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.54 136.04 57.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 108.374 -0.973 . . . . 72.519999999999996 108.374 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.18 137.16 58.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 116.514 -0.312 . . . . 70.439999999999998 110.308 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.48 133.02 7.51 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 110.933 -0.867 . . . . 71.219999999999999 110.933 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -133.91 115.03 13.95 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.847 -0.797 . . . . 73.129999999999995 108.847 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 74.47 108.75 0.08 OUTLIER Glycine 0 CA--C 1.527 0.834 0 O-C-N 123.843 0.714 . . . . 74.019999999999996 114.42 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 58.64 20.32 7.61 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 123.716 0.807 . . . . 72.519999999999996 112.282 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 24.4 m -83.76 144.2 29.48 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-O 121.233 0.539 . . . . 72.310000000000002 110.504 -173.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 0.0 OUTLIER -150.32 128.34 11.87 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.907 -0.588 . . . . 73.230000000000004 109.677 174.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 10.1 t -136.75 140.93 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 O-C-N 123.78 0.675 . . . . 60.420000000000002 109.232 -173.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.9 tt -112.03 116.67 30.93 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 107.939 -1.134 . . . . 61.219999999999999 107.939 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 3.2 mp -101.27 104.45 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 106.555 -1.646 . . . . 71.030000000000001 106.555 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . 0.482 ' C ' HD22 ' C' ' 279' ' ' ASN . . . 138.13 -128.48 4.22 Favored Glycine 0 N--CA 1.409 -3.152 0 C-N-CA 119.446 -1.359 . . . . 32.039999999999999 112.092 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . 0.596 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 1.0 OUTLIER -128.04 138.96 52.77 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.057 0.456 . . . . 73.420000000000002 111.822 -173.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -126.62 145.79 50.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.325 -1.361 . . . . 71.519999999999996 107.325 168.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -125.85 123.35 38.49 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 108.305 -0.998 . . . . 75.120000000000005 108.305 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . 0.666 ' HA2' ' HB2' ' C' ' 249' ' ' ALA . . . 134.03 9.77 1.87 Allowed Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.59 -0.732 . . . . 72.109999999999999 113.989 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 80.99 -47.93 3.66 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-N 117.92 0.86 . . . . 35.329999999999998 111.771 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -136.65 96.61 3.37 Favored 'General case' 0 N--CA 1.413 -2.302 0 N-CA-C 107.473 -1.306 . . . . 73.409999999999997 107.473 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -110.06 -159.74 17.73 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 108.666 -1.773 . . . . 44.329999999999998 108.666 173.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.408 ' H ' HG11 ' C' ' 244' ' ' VAL . 60.6 t80 73.87 169.97 0.3 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.803 0.841 . . . . 75.310000000000002 110.993 176.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 5.5 m0 . . . . . 0 C--N 1.305 -1.368 0 N-CA-C 116.81 2.152 . . . . 74.219999999999999 116.81 -167.631 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.492 -1.267 0 N-CA-C 108.43 -0.952 . . . . 75.319999999999993 108.43 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -86.34 133.89 33.77 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.479 -1.304 . . . . 71.349999999999994 107.479 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 32.9 m -133.63 141.79 47.79 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.318 0.58 . . . . 75.299999999999997 112.386 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.34 137.88 37.79 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.003 -1.851 . . . . 74.099999999999994 106.003 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.41 -48.04 10.06 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.684 -0.858 . . . . 73.230000000000004 108.684 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -140.15 140.64 36.0 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 119.76 -0.776 . . . . 71.019999999999996 111.646 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 62.6 mt -126.49 117.17 47.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 106.806 -1.553 . . . . 71.439999999999998 106.806 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -118.92 115.96 25.47 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.619 -0.833 . . . . 63.539999999999999 110.127 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.1 t -113.11 128.69 56.56 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.602 -0.726 . . . . 65.239999999999995 109.276 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.425 ' HG2' ' HG3' ' A' ' 235' ' ' GLU . 40.3 tt0 -150.23 139.81 21.58 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 108.435 -0.95 . . . . 73.540000000000006 108.435 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.425 ' HG3' ' HG2' ' A' ' 234' ' ' GLU . 43.9 mt-10 65.6 89.14 0.1 Allowed 'General case' 0 C--O 1.22 -0.48 0 O-C-N 124.409 1.068 . . . . 73.120000000000005 113.075 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 271' ' ' GLY . 36.2 mtt85 66.33 -4.82 0.65 Allowed 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 124.448 1.099 . . . . 62.210000000000001 113.136 171.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.431 ' HA ' ' H ' ' A' ' 273' ' ' SER . . . -70.61 143.44 51.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 123.352 0.661 . . . . 74.439999999999998 111.2 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -126.37 135.81 51.92 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.979 -1.119 . . . . 71.540000000000006 107.979 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.431 HG12 ' HB ' ' A' ' 275' ' ' VAL . 34.7 m -128.73 150.82 34.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 120.844 0.354 . . . . 70.329999999999998 111.666 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.409 ' HG2' ' CG2' ' A' ' 244' ' ' VAL . 7.2 tp-100 -134.05 134.55 42.5 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.137 -0.938 . . . . 75.129999999999995 108.831 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -128.14 119.28 24.97 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.583 -1.266 . . . . 74.310000000000002 107.583 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.501 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 132.35 -115.67 1.67 Allowed Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 119.991 -1.1 . . . . 63.149999999999999 112.689 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -143.51 135.86 27.05 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.301 -0.629 . . . . 53.25 109.301 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.409 ' CG2' ' HG2' ' A' ' 240' ' ' GLN . 99.0 t -116.94 120.63 65.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.46 -1.311 . . . . 73.129999999999995 107.46 175.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.73 117.19 51.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 108.996 -0.742 . . . . 64.209999999999994 108.996 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 90.5 m -77.48 159.72 29.17 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.064 -0.717 . . . . 75.019999999999996 109.064 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.38 -38.83 91.1 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.538 0.735 . . . . 64.310000000000002 112.122 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.13 -33.74 72.57 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.861 0.864 . . . . 72.120000000000005 111.551 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.542 0 CA-C-N 115.642 -0.708 . . . . 61.340000000000003 112.223 -176.638 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.1 m . . . . . 0 N--CA 1.424 -1.756 0 N-CA-C 106.701 -1.592 . . . . 75.140000000000001 106.701 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -121.15 141.43 50.83 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.213 -1.032 . . . . 73.329999999999998 108.213 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.7 p -136.23 123.4 21.71 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.056 -0.52 . . . . 74.430000000000007 111.588 -172.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 13.4 p -129.0 148.28 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 108.917 -0.772 . . . . 72.439999999999998 108.917 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 34.5 tt0 -85.89 -69.16 0.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.686 -0.487 . . . . 74.230000000000004 109.686 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 28.6 m -126.09 128.06 46.77 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.315 -0.554 . . . . 72.400000000000006 111.404 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 36.0 m -119.77 125.67 74.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.049 0 N-CA-C 109.101 -0.704 . . . . 71.109999999999999 109.101 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.14 134.9 64.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 116.078 -0.51 . . . . 55.329999999999998 112.063 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -123.96 132.27 8.31 Favored Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 111.298 -0.721 . . . . 60.439999999999998 111.298 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 26.3 mmmt -133.76 147.6 51.31 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.117 0.967 . . . . 71.209999999999994 112.175 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.439 ' O ' ' HD2' ' A' ' 236' ' ' ARG . . . 84.53 -57.82 5.01 Favored Glycine 0 CA--C 1.502 -0.732 0 CA-C-N 115.981 -0.554 . . . . 75.530000000000001 112.453 174.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 179.6 121.3 0.06 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 103.468 -2.79 . . . . 63.509999999999998 103.468 176.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 68.6 m -151.28 155.88 39.67 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.902 0.382 . . . . 52.210000000000001 110.685 -175.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' B' ' 238' ' ' ARG . 2.2 mpt_? -127.75 127.92 44.45 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.206 -1.776 . . . . 74.030000000000001 106.206 174.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.431 ' HB ' HG12 ' A' ' 239' ' ' VAL . 33.5 t -129.1 129.79 67.92 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 109.583 -0.525 . . . . 74.420000000000002 109.583 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.502 ' HB3' ' OE1' ' B' ' 240' ' ' GLN . 4.8 tt -125.32 118.94 27.04 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.197 -1.038 . . . . 63.009999999999998 108.197 172.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 43.5 mm -107.99 104.86 17.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.957 -1.127 . . . . 71.040000000000006 107.957 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 144.77 -140.04 8.91 Favored Glycine 0 N--CA 1.419 -2.464 0 C-N-CA 120.66 -0.781 . . . . 71.219999999999999 111.794 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -115.18 140.36 49.14 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 109.72 -0.474 . . . . 73.230000000000004 109.72 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.43 129.52 53.93 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.193 -2.151 . . . . 63.109999999999999 105.193 174.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 2.0 t80 -127.49 122.81 34.4 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 107.228 -1.397 . . . . 72.319999999999993 107.228 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.72 -52.95 0.63 Allowed Glycine 0 N--CA 1.412 -2.93 0 N-CA-C 108.624 -1.79 . . . . 61.25 108.624 -175.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 139.02 -57.84 0.62 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 111.17 -0.772 . . . . 64.140000000000001 111.17 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.557 ' HA ' ' NE1' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -132.18 35.2 3.72 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.948 0.88 . . . . 74.040000000000006 110.617 -176.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -57.29 -31.26 62.29 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 116.002 1.161 . . . . 70.019999999999996 116.002 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.455 ' CB ' HD12 ' A' ' 276' ' ' LEU . 71.0 t80 -114.72 0.22 13.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.908 0.861 . . . . 72.530000000000001 110.535 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.557 ' NE1' ' HA ' ' A' ' 284' ' ' LYS . 10.5 p90 . . . . . 0 C--N 1.305 -1.347 0 CA-C-O 121.888 0.852 . . . . 73.340000000000003 111.291 -177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 . . . . . 0 N--CA 1.435 -1.18 0 CA-C-O 121.019 0.438 . . . . 72.329999999999998 110.077 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -94.03 129.86 40.39 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 103.865 -2.643 . . . . 54.25 103.865 167.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 23.9 m -131.69 137.08 48.14 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.104 -1.038 . . . . 72.530000000000001 111.63 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.501 ' HB2' HG21 ' B' ' 277' ' ' ILE . . . -132.2 135.82 46.6 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.611 -1.255 . . . . 74.450000000000003 107.611 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 0.1 OUTLIER -82.77 -61.47 1.86 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.747 -0.835 . . . . 70.209999999999994 108.747 -178.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -134.24 139.46 45.78 Favored 'General case' 0 C--O 1.254 1.318 0 C-N-CA 120.036 -0.666 . . . . 75.540000000000006 109.409 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 10.9 mt -128.43 116.77 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.199 -1.408 . . . . 72.25 107.199 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.412 ' HB3' HG12 ' B' ' 268' ' ' VAL . 56.1 ttt180 -113.3 118.83 35.71 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.216 -0.447 . . . . 72.349999999999994 110.286 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.46 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 0.0 OUTLIER -110.82 128.65 55.85 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 108.713 -0.847 . . . . 75.219999999999999 108.713 175.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 33.9 tt0 -147.46 138.88 23.84 Favored 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 108.543 -0.91 . . . . 74.030000000000001 108.543 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.556 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 52.5 mt-10 65.09 94.85 0.06 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 124.675 1.235 . . . . 60.549999999999997 113.273 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.556 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 58.6 15.78 3.88 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 125.459 1.503 . . . . 70.540000000000006 112.711 171.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -92.33 149.05 21.66 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 121.526 0.679 . . . . 74.400000000000006 111.911 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -129.45 135.75 49.05 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 115.612 -0.722 . . . . 72.430000000000007 110.183 175.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.518 HG12 ' HB ' ' B' ' 275' ' ' VAL . 30.4 m -125.87 136.8 59.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 124.089 0.868 . . . . 65.239999999999995 109.987 -177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.502 ' OE1' ' HB3' ' A' ' 276' ' ' LEU . 38.8 tp60 -115.92 132.94 56.5 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.866 -1.061 . . . . 73.140000000000001 108.693 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.28 118.36 24.94 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.348 -1.353 . . . . 75.0 107.348 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 134.04 -114.12 1.28 Allowed Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 120.044 -1.074 . . . . 72.349999999999994 111.924 177.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -144.31 140.32 29.08 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.796 -0.446 . . . . 73.109999999999999 109.796 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.499 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 97.7 t -122.11 114.87 44.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.239 -1.393 . . . . 71.200000000000003 107.239 175.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' B' ' 250' ' ' LEU . 4.2 p -122.13 118.5 55.66 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-O 121.21 0.529 . . . . 65.340000000000003 109.803 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 28.7 m -71.09 158.85 35.76 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 109.05 -0.722 . . . . 72.140000000000001 109.05 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.98 -47.41 80.47 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.038 0.923 . . . . 65.349999999999994 111.291 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.77 79.17 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.896 -1.502 . . . . 64.200000000000003 111.847 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.497 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -67.88 -40.31 83.55 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.506 0.928 . . . . 72.25 113.506 -173.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.453 ' HB2' ' CG2' ' B' ' 245' ' ' VAL . 26.6 tp . . . . . 0 C--N 1.31 -1.126 0 C-N-CA 120.043 -0.663 . . . . 64.209999999999994 111.93 -173.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.435 -1.176 0 CA-C-O 121.212 0.529 . . . . 71.200000000000003 111.379 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 53.9 m -106.11 108.16 19.53 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 107.459 -1.312 . . . . 60.32 107.459 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -124.65 131.83 53.45 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.641 -1.244 . . . . 64.409999999999997 107.641 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 15.7 m -121.54 123.79 42.85 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.835 -0.62 . . . . 40.149999999999999 110.521 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 8.4 p -126.29 149.86 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 108.024 -1.102 . . . . 63.409999999999997 108.024 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 12.8 tt0 -93.95 -77.94 0.44 Allowed 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.97 -0.752 . . . . 75.420000000000002 108.97 175.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 28.8 m -113.26 127.54 56.19 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 120.25 -0.58 . . . . 62.100000000000001 110.854 -175.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.83 120.68 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-O 121.695 0.759 . . . . 61.32 109.512 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . 0.412 HG12 ' HB3' ' B' ' 232' ' ' ARG . 27.0 m -126.92 141.55 45.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.623 -0.717 . . . . 72.120000000000005 112.199 -174.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.72 132.41 7.92 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.982 -0.847 . . . . 61.420000000000002 110.982 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 25.4 mmmt -133.87 148.83 51.3 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 124.205 1.002 . . . . 52.020000000000003 112.541 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' B' ' 236' ' ' ARG . . . 85.57 -57.99 4.88 Favored Glycine 0 CA--C 1.499 -0.945 0 C-N-CA 121.362 -0.447 . . . . 71.349999999999994 112.954 174.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 176.24 114.17 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 103.279 -2.86 . . . . 72.25 103.279 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 67.1 m -146.79 160.22 42.53 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.734 0.778 . . . . 72.540000000000006 112.448 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.532 ' HD3' ' HB3' ' C' ' 238' ' ' ARG . 0.7 OUTLIER -129.48 127.58 41.14 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 105.799 -1.926 . . . . 70.099999999999994 105.799 176.354 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.518 ' HB ' HG12 ' B' ' 239' ' ' VAL . 41.5 t -132.02 126.31 56.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.658 -0.497 . . . . 71.340000000000003 109.658 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.495 HD12 ' CB ' ' B' ' 286' ' ' PHE . 4.7 tt -121.78 118.7 29.69 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.752 -1.179 . . . . 74.310000000000002 108.029 173.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.501 HG21 ' HB2' ' B' ' 228' ' ' ALA . 44.6 mm -108.18 104.23 16.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 106.952 -1.499 . . . . 75.319999999999993 106.952 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 146.36 -158.02 27.57 Favored Glycine 0 CA--C 1.476 -2.39 0 C-N-CA 120.358 -0.925 . . . . 61.130000000000003 113.204 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -96.38 138.86 33.35 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.293 -0.632 . . . . 73.030000000000001 109.293 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -121.32 126.8 50.37 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 105.801 -1.925 . . . . 73.239999999999995 105.801 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.543 ' CD1' HG13 ' C' ' 245' ' ' VAL . 1.3 t80 -123.63 123.56 40.83 Favored 'General case' 0 N--CA 1.405 -2.716 0 N-CA-C 107.304 -1.369 . . . . 60.219999999999999 107.304 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' B' ' 249' ' ' ALA . . . 142.59 -43.98 1.01 Allowed Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 108.809 -1.716 . . . . 72.129999999999995 108.809 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.24 -29.0 8.26 Favored Glycine 0 N--CA 1.423 -2.215 0 N-CA-C 111.678 -0.569 . . . . 44.219999999999999 111.678 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . 0.533 ' HA ' ' CD1' ' B' ' 287' ' ' TRP . 42.6 pttt -149.04 19.84 0.98 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.679 -0.409 . . . . 73.299999999999997 111.974 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -53.97 -43.49 71.96 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.117 -0.563 . . . . 75.319999999999993 114.226 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.495 ' CB ' HD12 ' B' ' 276' ' ' LEU . 62.1 t80 -97.69 -1.09 44.31 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.685 0.755 . . . . 73.450000000000003 111.202 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.533 ' CD1' ' HA ' ' B' ' 284' ' ' LYS . 13.6 p90 . . . . . 0 C--N 1.315 -0.893 0 CA-C-O 121.329 0.585 . . . . 75.430000000000007 110.926 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 . . . . . 0 N--CA 1.433 -1.289 0 N-CA-C 107.955 -1.128 . . . . 62.329999999999998 107.955 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -93.29 133.2 36.76 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.569 -1.271 . . . . 73.310000000000002 107.569 172.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 48.8 m -140.67 141.8 34.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.549 0.944 . . . . 64.409999999999997 113.549 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -137.37 133.03 34.38 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.222 -1.029 . . . . 52.439999999999998 108.222 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -76.67 -57.98 3.54 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.24 -0.652 . . . . 61.32 109.24 -178.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.14 140.0 41.56 Favored 'General case' 0 C--O 1.265 1.881 0 C-N-CA 120.041 -0.663 . . . . 74.400000000000006 110.84 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.442 HG23 HG23 ' C' ' 267' ' ' VAL . 11.9 mt -130.22 116.97 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 107.898 -1.149 . . . . 63.340000000000003 107.898 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.45 ' HB3' HG12 ' C' ' 268' ' ' VAL . 38.1 ttt180 -118.02 118.1 31.02 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.263 0.554 . . . . 73.329999999999998 110.625 177.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.469 ' HB ' HG13 ' C' ' 239' ' ' VAL . 0.0 OUTLIER -110.53 129.88 55.69 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 108.707 -0.849 . . . . 65.219999999999999 108.707 175.389 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 33.6 tt0 -144.13 138.56 28.28 Favored 'General case' 0 N--CA 1.415 -2.204 0 C-N-CA 120.317 -0.553 . . . . 73.109999999999999 109.515 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.571 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 51.0 mt-10 59.72 97.76 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.617 1.167 . . . . 63.439999999999998 114.018 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.571 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 0.2 OUTLIER 61.87 13.59 5.63 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.426 1.49 . . . . 73.340000000000003 112.333 172.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.38 151.46 19.38 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.443 0.64 . . . . 71.040000000000006 111.964 -174.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.532 ' HB3' ' HD3' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -132.91 135.47 45.58 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-N 115.44 -0.8 . . . . 73.319999999999993 110.823 178.191 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.475 HG12 ' HB ' ' C' ' 275' ' ' VAL . 33.1 m -127.85 138.32 55.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.228 -0.897 . . . . 71.329999999999998 110.234 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.489 ' OE1' ' HB3' ' B' ' 276' ' ' LEU . 38.4 tp60 -116.19 133.35 56.12 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.799 -1.091 . . . . 71.319999999999993 108.873 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.27 118.41 24.17 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.802 -1.555 . . . . 63.5 106.802 175.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.474 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 133.68 -117.94 1.98 Allowed Glycine 0 N--CA 1.422 -2.269 0 C-N-CA 119.918 -1.134 . . . . 75.319999999999993 111.007 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -144.67 140.01 28.36 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 123.582 0.224 . . . . 64.299999999999997 111.066 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.485 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 86.2 t -121.58 116.19 48.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 108.408 -0.96 . . . . 64.329999999999998 108.408 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.543 HG13 ' CD1' ' B' ' 281' ' ' TYR . 2.7 p -122.62 123.48 68.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 109.46 -0.571 . . . . 74.109999999999999 109.46 176.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 24.9 m -77.84 159.29 29.06 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 109.561 -0.533 . . . . 62.049999999999997 109.561 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.96 -46.53 81.18 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.308 1.052 . . . . 65.409999999999997 110.739 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.81 67.85 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.215 -1.811 . . . . 72.439999999999998 112.245 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . 0.555 ' HB2' ' HA2' ' C' ' 282' ' ' GLY . . . . . . . . 0 C--O 1.244 0.791 0 N-CA-C 113.085 0.772 . . . . 73.409999999999997 113.085 -176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 55.9 m . . . . . 0 N--CA 1.428 -1.561 0 N-CA-C 108.654 -0.869 . . . . 71.120000000000005 108.654 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -119.45 131.93 55.71 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.867 -0.606 . . . . 75.209999999999994 109.39 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 14.9 m -117.76 122.98 44.88 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.439 0.638 . . . . 52.119999999999997 110.014 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.25 129.86 65.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.163 -0.926 . . . . 73.400000000000006 111.79 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -72.49 -75.68 0.13 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.488 -0.93 . . . . 64.310000000000002 108.488 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 86.9 m -148.94 136.56 20.42 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.22 -0.925 . . . . 73.540000000000006 110.006 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.442 HG23 HG23 ' C' ' 231' ' ' ILE . 15.9 m -124.05 129.96 73.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 116.012 -0.54 . . . . 71.209999999999994 109.758 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . 0.45 HG12 ' HB3' ' C' ' 232' ' ' ARG . 31.0 m -123.66 140.02 48.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 120.926 0.393 . . . . 71.310000000000002 110.602 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.31 132.58 9.64 Favored Glycine 0 C--N 1.299 -1.495 0 N-CA-C 110.879 -0.888 . . . . 65.439999999999998 110.879 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -134.54 128.92 34.25 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 123.432 0.693 . . . . 74.25 111.624 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 64.23 56.28 18.87 Favored Glycine 0 C--N 1.318 -0.462 0 O-C-N 123.553 0.533 . . . . 75.549999999999997 113.046 175.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 71.48 102.85 0.07 Allowed 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.467 1.507 . . . . 71.310000000000002 109.601 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.1 m -139.4 148.79 43.3 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.935 -1.029 . . . . 60.509999999999998 108.771 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -121.54 126.34 48.94 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.067 -1.827 . . . . 54.32 106.067 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.475 ' HB ' HG12 ' C' ' 239' ' ' VAL . 31.0 t -138.13 128.79 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 110.042 -0.355 . . . . 65.319999999999993 110.042 -175.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.72 117.91 25.27 Favored 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 107.97 -1.122 . . . . 53.43 107.97 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.438 HG21 ' HB2' ' C' ' 228' ' ' ALA . 50.1 mm -109.34 104.43 17.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.059 -1.089 . . . . 72.239999999999995 108.059 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 146.06 -154.85 26.21 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 120.565 -0.826 . . . . 25.050000000000001 111.978 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.41 128.17 44.67 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.7 -0.482 . . . . 74.299999999999997 109.7 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -111.93 125.46 54.08 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.876 -1.527 . . . . 75.519999999999996 106.876 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -130.18 123.9 31.34 Favored 'General case' 0 N--CA 1.404 -2.765 0 CA-C-O 121.663 0.744 . . . . 64.319999999999993 109.432 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . 0.555 ' HA2' ' HB2' ' C' ' 249' ' ' ALA . . . 151.58 -46.92 0.59 Allowed Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 108.873 -1.691 . . . . 43.240000000000002 108.873 -176.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 128.4 -25.02 4.88 Favored Glycine 0 CA--C 1.481 -2.077 0 C-N-CA 120.07 -1.062 . . . . 63.130000000000003 111.255 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' C' ' 287' ' ' TRP . 56.3 pttt -151.93 -62.09 0.17 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.177 -0.511 . . . . 74.420000000000002 110.486 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . 0.437 ' H ' ' HG3' ' C' ' 284' ' ' LYS . . . 50.5 -86.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.114 0 N-CA-C 115.503 0.961 . . . . 74.129999999999995 115.503 176.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.408 ' HA ' ' NE1' ' B' ' 287' ' ' TRP . 42.6 t80 -65.79 -29.72 70.25 Favored 'General case' 0 C--O 1.255 1.379 0 C-N-CA 125.192 1.397 . . . . 73.25 110.62 -176.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.579 ' O ' ' HB2' ' C' ' 284' ' ' LYS . 20.1 p90 . . . . . 0 C--N 1.303 -1.416 0 CA-C-N 115.669 -0.696 . . . . 73.209999999999994 109.884 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 . . . . . 0 N--CA 1.434 -1.231 0 N-CA-C 108.569 -0.901 . . . . 72.120000000000005 108.569 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.467 HD22 ' HA2' ' A' ' 278' ' ' GLY . 62.9 t30 -99.01 136.9 38.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.757 -1.201 . . . . 71.109999999999999 107.757 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 43.4 m -126.59 136.87 53.1 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.854 0.835 . . . . 30.309999999999999 112.478 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 277' ' ' ILE . . . -133.72 138.93 46.08 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.208 -1.775 . . . . 73.450000000000003 106.208 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -92.75 -60.91 1.7 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.359 -0.978 . . . . 75.310000000000002 108.359 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -129.78 140.55 51.03 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.49 0.662 . . . . 73.409999999999997 110.921 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 70.7 mt -125.43 123.26 64.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.408 -1.33 . . . . 74.219999999999999 107.408 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 57.1 ttt180 -130.01 115.89 17.78 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.491 -0.484 . . . . 74.420000000000002 109.975 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.563 HG21 HG22 ' A' ' 239' ' ' VAL . 31.4 p -126.65 128.58 46.98 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.045 0.45 . . . . 55.310000000000002 110.064 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -131.8 143.31 50.12 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 109.649 -0.5 . . . . 75.299999999999997 109.649 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.52 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 41.2 mt-10 66.11 96.88 0.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.275 1.583 . . . . 73.310000000000002 115.275 172.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.52 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.1 mpt_? 60.93 11.78 3.5 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 124.961 1.304 . . . . 73.549999999999997 111.926 175.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -88.37 140.72 29.18 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 110.096 -0.335 . . . . 63.140000000000001 110.096 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.05 142.21 51.62 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.051 -0.522 . . . . 65.140000000000001 110.601 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.563 HG22 HG21 ' A' ' 233' ' ' THR . 12.6 t -122.27 149.58 25.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 O-C-N 123.396 0.435 . . . . 73.329999999999998 110.928 -170.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -138.0 120.63 16.21 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.423 -0.955 . . . . 63.009999999999998 108.423 168.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -117.64 122.55 43.88 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.106 -1.072 . . . . 72.25 108.106 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.77 -114.08 1.11 Allowed Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.008 -1.091 . . . . 62.420000000000002 112.599 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -145.48 133.99 22.01 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.883 -0.414 . . . . 73.310000000000002 109.883 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 92.3 t -107.51 115.47 48.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.947 -0.76 . . . . 64.329999999999998 108.947 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.5 112.24 39.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.75 -0.833 . . . . 62.130000000000003 108.75 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 24.6 m -91.11 159.3 16.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.516 -0.92 . . . . 73.239999999999995 108.516 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.57 -33.72 76.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.062 0.764 . . . . 64.219999999999999 113.062 -176.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.78 -39.98 94.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.087 0.773 . . . . 61.020000000000003 113.087 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.321 -0.639 0 N-CA-C 111.418 0.155 . . . . 64.510000000000005 111.418 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.405 -2.723 0 N-CA-C 108.417 -0.957 . . . . 61.0 108.417 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.437 ' HB3' ' OD1' ' A' ' 226' ' ' ASN . 45.3 t-20 -126.38 146.83 49.9 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.7 -1.963 . . . . 64.439999999999998 105.7 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 29.6 m -142.22 125.12 16.09 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 121.122 0.487 . . . . 71.129999999999995 110.501 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 14.7 p -128.18 150.51 33.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.677 -1.231 . . . . 62.119999999999997 107.677 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . 0.351 9.1 pt-20 -98.81 -50.66 4.14 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 117.794 -1.562 . . . . 74.409999999999997 113.298 174.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 61.8 m -127.19 126.97 43.76 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 117.958 -1.497 . . . . 74.510000000000005 112.439 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.75 126.83 75.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.687 -0.857 . . . . 62.399999999999999 108.687 173.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 7.9 p -127.76 133.65 67.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-O 121.005 0.431 . . . . 65.230000000000004 111.6 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -126.26 133.11 8.04 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 111.355 -0.698 . . . . 43.140000000000001 111.355 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.53 ' HB2' ' HG2' ' B' ' 234' ' ' GLU . 29.6 mmmt -130.04 116.65 18.85 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 122.587 0.355 . . . . 75.140000000000001 111.25 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.2 100.76 0.24 Allowed Glycine 0 C--N 1.308 -0.992 0 N-CA-C 115.361 0.905 . . . . 62.420000000000002 115.361 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.435 ' H ' ' HB2' ' A' ' 236' ' ' ARG . 34.9 mt-10 61.57 20.82 11.59 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.601 0.761 . . . . 74.420000000000002 112.855 169.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 19.4 m -92.79 145.18 24.6 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.464 0.65 . . . . 52.049999999999997 112.264 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . 0.457 ' O ' HG23 ' B' ' 239' ' ' VAL . 66.0 mtt180 -108.3 127.17 53.63 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.147 -2.168 . . . . 74.109999999999999 105.147 173.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 6.1 t -121.45 123.22 69.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 120.179 -0.608 . . . . 72.409999999999997 109.37 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.626 ' HG ' ' OE1' ' B' ' 240' ' ' GLN . 26.8 tp -120.24 120.3 35.72 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.028 -1.069 . . . . 74.140000000000001 111.344 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 228' ' ' ALA . 3.6 mp -113.71 104.79 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 107.627 -1.249 . . . . 61.409999999999997 107.627 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.467 ' HA2' HD22 ' A' ' 226' ' ' ASN . . . 158.28 -145.2 11.35 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.227 -0.987 . . . . 74.200000000000003 111.858 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 45.4 t-20 -120.13 146.85 45.57 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 106.047 -1.834 . . . . 62.219999999999999 106.047 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -123.22 117.45 25.35 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.163 -1.051 . . . . 75.200000000000003 108.163 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -109.71 124.41 51.17 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.8 -1.185 . . . . 73.109999999999999 107.8 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 146.18 -46.55 0.75 Allowed Glycine 0 CA--C 1.473 -2.555 0 N-CA-C 109.896 -1.282 . . . . 45.0 109.896 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.533 ' O ' ' HG2' ' A' ' 284' ' ' LYS . . . 103.36 72.57 0.92 Allowed Glycine 0 N--CA 1.417 -2.575 0 N-CA-C 109.451 -1.46 . . . . 73.310000000000002 109.451 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 283' ' ' GLY . 4.6 ptpp? 82.09 19.4 0.33 Allowed 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 127.706 2.402 . . . . 71.540000000000006 111.419 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -47.82 -38.22 15.94 Favored Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.267 1.267 . . . . 73.510000000000005 116.267 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.458 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 80.1 t80 -83.56 -3.13 57.4 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 117.378 0.589 . . . . 73.349999999999994 112.453 -175.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.458 ' CE3' ' HB3' ' A' ' 286' ' ' PHE . 32.8 p90 . . . . . 0 N--CA 1.478 0.941 0 O-C-N 121.473 -0.767 . . . . 74.299999999999997 111.592 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 . . . . . 0 N--CA 1.423 -1.813 0 CA-C-O 121.153 0.501 . . . . 52.329999999999998 110.086 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -98.08 136.7 37.94 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 104.536 -2.394 . . . . 70.430000000000007 104.536 171.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 20.1 m -131.85 136.39 47.43 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 120.109 -0.636 . . . . 70.400000000000006 111.255 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -129.2 134.84 48.18 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.689 -1.226 . . . . 54.329999999999998 107.689 175.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -82.2 -65.98 0.95 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.017 -0.734 . . . . 72.299999999999997 109.017 178.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -128.46 140.07 52.01 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-O 121.022 0.439 . . . . 73.120000000000005 109.988 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 27.7 mt -124.72 122.64 64.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.245 -1.391 . . . . 64.310000000000002 107.245 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 22.1 ttt180 -122.84 114.55 20.65 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.746 -0.835 . . . . 64.329999999999998 108.746 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.73 HG21 HG22 ' B' ' 239' ' ' VAL . 72.4 p -117.88 127.2 53.63 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.021 -1.103 . . . . 74.340000000000003 108.021 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . 0.53 ' HG2' ' HB2' ' A' ' 270' ' ' LYS . 34.0 mt-10 -137.61 139.79 40.55 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.201 -0.599 . . . . 62.399999999999999 110.322 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.497 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 46.8 mt-10 67.5 96.71 0.06 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.542 1.312 . . . . 73.099999999999994 114.542 173.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.497 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.0 OUTLIER 58.14 27.98 15.78 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.474 1.11 . . . . 73.209999999999994 110.897 175.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.425 ' CB ' ' HB ' ' B' ' 233' ' ' THR . . . -84.77 150.89 24.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.163 0.506 . . . . 74.299999999999997 110.6 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.502 ' HD3' ' HG2' ' B' ' 274' ' ' ARG . 4.4 mpt_? -125.66 134.5 51.83 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.647 -1.983 . . . . 75.400000000000006 105.647 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.73 HG22 HG21 ' B' ' 233' ' ' THR . 2.4 t -125.41 139.67 50.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 123.404 0.44 . . . . 65.109999999999999 110.02 -172.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.626 ' OE1' ' HG ' ' A' ' 276' ' ' LEU . 24.5 tp60 -138.48 114.84 10.38 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.864 0.728 . . . . 73.349999999999994 109.8 170.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.464 HD12 HG23 ' A' ' 277' ' ' ILE . 3.4 tm? -115.0 118.73 34.24 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.431 -1.322 . . . . 65.230000000000004 107.431 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 141.19 -114.06 0.9 Allowed Glycine 0 N--CA 1.422 -2.268 0 C-N-CA 120.276 -0.964 . . . . 53.439999999999998 111.07 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 55.0 t30 -145.46 149.54 34.87 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.981 -0.748 . . . . 61.549999999999997 108.981 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 98.1 t -121.61 122.66 67.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.429 -0.952 . . . . 74.200000000000003 108.429 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 48.7 t -122.19 111.84 32.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.975 -0.75 . . . . 64.209999999999994 108.975 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 23.8 m -83.15 159.28 22.08 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.195 -1.039 . . . . 75.129999999999995 108.195 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -64.6 -42.48 95.53 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 123.207 1.48 . . . . 52.229999999999997 109.749 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.68 -34.01 61.67 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 111.762 -2.472 . . . . 74.129999999999995 112.827 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.671 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -62.9 -26.81 68.97 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.678 0.791 . . . . 65.530000000000001 112.482 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 1.2 tm? . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.981 0.896 . . . . 74.319999999999993 108.867 -177.322 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.449 -0.488 0 N-CA-C 108.338 -0.986 . . . . 62.43 108.338 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -91.55 127.93 37.18 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 121.799 0.809 . . . . 73.340000000000003 110.405 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -126.82 142.23 51.6 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.946 -1.872 . . . . 74.299999999999997 105.946 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 47.4 m -139.64 133.01 30.05 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 118.313 0.506 . . . . 70.530000000000001 111.655 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.1 p -128.22 144.17 38.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 116.056 -0.52 . . . . 72.239999999999995 110.658 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 38.2 mm-40 -81.05 -63.73 1.34 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.193 0.521 . . . . 75.439999999999998 110.801 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 38.2 m -137.59 127.13 25.08 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 118.138 -1.425 . . . . 75.450000000000003 111.915 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.05 121.13 66.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.891 -1.05 . . . . 72.129999999999995 108.704 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 5.4 p -127.38 138.79 53.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.721 -0.672 . . . . 72.510000000000005 112.266 -176.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.7 133.97 8.81 Favored Glycine 0 CA--C 1.485 -1.8 0 CA-C-N 115.793 -0.64 . . . . 61.450000000000003 112.134 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.47 ' HB2' ' HG2' ' C' ' 234' ' ' GLU . 30.9 mmmt -128.96 115.95 18.6 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 123.748 0.322 . . . . 73.340000000000003 110.689 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 81.58 93.31 0.51 Allowed Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.46 -0.876 . . . . 71.430000000000007 114.626 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 64.01 17.25 10.49 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.341 1.056 . . . . 75.400000000000006 111.89 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 19.8 m -82.88 145.19 29.58 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.743 0.783 . . . . 63.25 111.383 -172.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.539 ' HB3' ' CE1' ' B' ' 286' ' ' PHE . 51.1 mtm180 -116.84 127.44 54.3 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 108.739 -0.837 . . . . 73.439999999999998 108.739 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.44 HG12 ' CG1' ' C' ' 239' ' ' VAL . 29.2 m -120.64 123.58 70.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-O 121.394 0.616 . . . . 74.519999999999996 110.547 -176.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.583 ' HG ' ' OE1' ' C' ' 240' ' ' GLN . 26.4 tp -115.06 114.78 25.81 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.989 -0.745 . . . . 54.340000000000003 108.989 173.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.521 HG23 HD12 ' C' ' 241' ' ' LEU . 3.4 mp -112.78 103.63 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.609 0 N-CA-C 106.025 -1.843 . . . . 53.219999999999999 106.025 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.434 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 161.3 -150.83 20.86 Favored Glycine 0 N--CA 1.416 -2.662 0 C-N-CA 119.798 -1.192 . . . . 72.140000000000001 112.835 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -113.77 151.81 31.47 Favored 'General case' 0 C--N 1.273 -2.753 0 N-CA-C 104.791 -2.3 . . . . 63.43 104.791 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.4 ' OE1' HG13 ' C' ' 244' ' ' VAL . 1.5 tm-20 -130.06 118.87 22.2 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.94 -1.133 . . . . 62.350000000000001 107.94 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -113.1 124.28 52.21 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.911 0.862 . . . . 75.340000000000003 110.927 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' B' ' 249' ' ' ALA . . . 138.01 -47.32 0.94 Allowed Glycine 0 N--CA 1.417 -2.619 0 CA-C-N 114.37 -1.286 . . . . 73.040000000000006 110.442 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' B' ' 284' ' ' LYS . . . 108.25 90.92 2.15 Favored Glycine 0 N--CA 1.414 -2.79 0 N-CA-C 108.363 -1.895 . . . . 72.140000000000001 108.363 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' B' ' 287' ' ' TRP . 50.0 mtmt 90.95 -59.45 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 126.408 1.883 . . . . 75.049999999999997 109.681 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 49.87 -84.27 0.01 OUTLIER Glycine 0 N--CA 1.478 1.459 0 O-C-N 124.279 0.987 . . . . 55.219999999999999 115.101 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' B' ' 274' ' ' ARG . 1.3 t80 -52.0 -45.95 64.72 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.466 1.906 . . . . 75.519999999999996 109.908 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.581 ' O ' ' HB3' ' B' ' 284' ' ' LYS . 48.9 p90 . . . . . 0 C--O 1.201 -1.484 0 N-CA-C 106.741 -1.578 . . . . 70.230000000000004 106.741 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' C' ' 261' ' ' THR . 4.9 ptp180 . . . . . 0 N--CA 1.43 -1.431 0 CA-C-O 121.085 0.469 . . . . 60.420000000000002 110.731 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -109.98 140.74 43.65 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.248 -2.131 . . . . 73.519999999999996 105.248 173.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' C' ' 263' ' ' SER . 45.0 m -139.74 137.95 35.53 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.892 -0.505 . . . . 74.439999999999998 111.399 -176.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.65 128.92 45.09 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.421 -0.955 . . . . 74.209999999999994 108.421 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.58 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 27.9 tptp -75.31 -62.17 1.65 Allowed 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.395 -0.594 . . . . 64.310000000000002 109.395 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' C' ' 266' ' ' THR . 16.5 m-20 -134.85 139.86 45.38 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.066 0.46 . . . . 73.549999999999997 110.719 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.493 HG21 HG21 ' C' ' 239' ' ' VAL . 35.6 mt -127.53 123.52 61.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 106.96 -1.496 . . . . 65.109999999999999 106.96 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.491 ' HG3' HG13 ' B' ' 268' ' ' VAL . 31.6 ttt180 -126.9 114.98 18.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.755 -0.832 . . . . 71.230000000000004 108.755 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.412 HG21 ' HB ' ' C' ' 239' ' ' VAL . 39.4 p -110.62 127.36 55.22 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.71 -1.219 . . . . 64.540000000000006 107.71 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' B' ' 270' ' ' LYS . 40.5 mt-10 -135.07 139.62 44.89 Favored 'General case' 0 N--CA 1.42 -1.943 0 C-N-CA 120.396 -0.522 . . . . 75.209999999999994 110.31 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 64.43 101.29 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 O-C-N 124.621 1.201 . . . . 71.030000000000001 114.117 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 59.6 13.88 3.63 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.669 1.188 . . . . 75.340000000000003 111.27 173.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.38 151.58 22.97 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.619 0.6 . . . . 73.430000000000007 112.619 -172.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.05 135.24 41.15 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.02 -1.474 . . . . 73.549999999999997 107.02 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.493 HG21 HG21 ' C' ' 231' ' ' ILE . 6.9 p -132.38 146.08 33.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.058 0.456 . . . . 70.349999999999994 111.437 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.583 ' OE1' ' HG ' ' B' ' 276' ' ' LEU . 23.2 tp60 -124.6 120.16 31.12 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.67 -1.15 . . . . 72.540000000000006 108.829 172.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.521 HD12 HG23 ' B' ' 277' ' ' ILE . 3.4 tm? -113.66 117.78 32.54 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.966 -1.494 . . . . 44.530000000000001 106.966 177.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 139.14 -114.36 1.01 Allowed Glycine 0 N--CA 1.424 -2.116 0 C-N-CA 119.972 -1.109 . . . . 44.219999999999999 112.02 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -145.39 143.79 30.29 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.571 -0.529 . . . . 73.239999999999995 109.571 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.4 HG13 ' OE1' ' B' ' 280' ' ' GLU . 69.5 t -117.44 118.43 58.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.432 -0.581 . . . . 74.340000000000003 109.432 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' C' ' 281' ' ' TYR . 47.9 t -121.8 111.99 33.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.452 -0.573 . . . . 74.340000000000003 109.452 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 31.4 m -78.07 159.47 28.68 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.239 -1.023 . . . . 61.030000000000001 108.239 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.671 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -63.46 -43.38 97.53 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.482 1.134 . . . . 72.420000000000002 109.48 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.29 65.6 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.891 -1.959 . . . . 74.099999999999994 112.776 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.643 0 N-CA-C 111.995 0.368 . . . . 73.409999999999997 111.995 -176.409 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 39.2 m . . . . . 0 N--CA 1.413 -2.31 0 N-CA-C 108.173 -1.047 . . . . 41.240000000000002 108.173 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -124.26 127.85 48.29 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.733 -0.84 . . . . 70.239999999999995 108.733 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' C' ' 227' ' ' SER . 41.4 m -133.43 136.22 45.08 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 110.069 -0.345 . . . . 51.299999999999997 110.069 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.22 153.5 37.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.295 -0.632 . . . . 71.420000000000002 109.295 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.58 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 35.2 mm-40 -81.13 -88.5 0.08 Allowed 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 110.197 -0.297 . . . . 75.230000000000004 110.197 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 51.4 m -121.85 131.33 53.98 Favored 'General case' 0 N--CA 1.417 -2.09 0 C-N-CA 119.581 -0.848 . . . . 54.130000000000003 111.061 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 26.2 m -117.87 132.53 67.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.33 -0.989 . . . . 71.439999999999998 108.33 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.8 p -127.38 139.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 116.206 -0.452 . . . . 70.109999999999999 110.4 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.99 133.66 9.47 Favored Glycine 0 CA--C 1.476 -2.362 0 N-CA-C 110.155 -1.178 . . . . 75.310000000000002 110.155 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -131.36 115.55 16.39 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 111.988 0.366 . . . . 74.329999999999998 111.988 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 70.05 97.39 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.859 -1.064 . . . . 73.319999999999993 114.415 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 68.09 21.66 8.64 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.782 0.833 . . . . 50.409999999999997 111.955 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.5 m -83.77 144.7 29.14 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.027 0.751 . . . . 40.520000000000003 113.027 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -110.07 128.36 55.39 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.207 -1.775 . . . . 64.530000000000001 106.207 171.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 1.5 t -128.08 123.9 61.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 119.726 -0.79 . . . . 70.120000000000005 109.199 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.41 ' CD1' ' HG3' ' C' ' 240' ' ' GLN . 30.8 tp -117.62 117.96 30.82 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.902 -0.719 . . . . 74.540000000000006 110.3 174.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.503 HG21 ' HB2' ' C' ' 228' ' ' ALA . 3.7 mp -112.48 103.47 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.893 0 N-CA-C 105.902 -1.888 . . . . 75.510000000000005 105.902 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.35 -168.24 30.27 Favored Glycine 0 CA--C 1.478 -2.223 0 C-N-CA 120.546 -0.835 . . . . 74.420000000000002 111.456 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -96.7 156.8 16.19 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.46 -0.941 . . . . 74.120000000000005 108.46 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -129.12 121.3 27.5 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.944 -1.132 . . . . 74.430000000000007 107.944 -175.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.407 ' HB2' ' HA ' ' C' ' 245' ' ' VAL . 96.6 m-85 -116.54 125.12 51.44 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.945 0.403 . . . . 72.239999999999995 110.078 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.47 -37.74 1.84 Allowed Glycine 0 N--CA 1.437 -1.3 0 N-CA-C 111.668 -0.573 . . . . 71.230000000000004 111.668 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 104.4 103.04 2.8 Favored Glycine 0 CA--C 1.48 -2.137 0 N-CA-C 107.304 -2.319 . . . . 45.119999999999997 107.304 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 75.07 -57.78 0.59 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.785 1.234 . . . . 73.129999999999995 109.169 -172.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 57.63 -86.22 0.01 OUTLIER Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.307 0.956 . . . . 61.140000000000001 113.961 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.571 ' HB3' ' CE3' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -56.67 -39.57 73.99 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.023 1.729 . . . . 73.040000000000006 110.642 -178.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.571 ' CE3' ' HB3' ' C' ' 286' ' ' PHE . 24.6 p90 . . . . . 0 C--N 1.306 -1.296 0 CA-C-O 121.067 0.46 . . . . 61.439999999999998 111.622 -171.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 109.948 -0.39 . . . . 74.549999999999997 109.948 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 48.1 t-20 -116.75 123.97 48.48 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.644 -1.614 . . . . 53.119999999999997 106.644 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.1 m -121.65 137.42 54.75 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 120.342 -0.543 . . . . 73.530000000000001 111.239 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.4 134.06 46.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.052 -0.722 . . . . 65.329999999999998 109.052 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -91.49 -46.87 7.74 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.643 -0.253 . . . . 55.329999999999998 110.836 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -136.9 139.71 41.8 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.372 -0.603 . . . . 53.520000000000003 109.372 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 66.1 mt -137.28 119.34 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.388 -1.338 . . . . 75.239999999999995 107.388 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -134.22 122.81 23.3 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.909 0.385 . . . . 74.549999999999997 110.834 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 33.4 p -129.43 128.65 43.39 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.053 -0.351 . . . . 71.409999999999997 110.053 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.423 ' HB2' ' HD3' ' A' ' 270' ' ' LYS . 45.0 mt-10 -125.67 166.16 17.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.141 0.496 . . . . 74.409999999999997 111.91 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.426 ' HB3' ' HD2' ' A' ' 236' ' ' ARG . 41.1 mt-10 64.9 -85.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.73 1.612 . . . . 72.140000000000001 113.961 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.426 ' HD2' ' HB3' ' A' ' 235' ' ' GLU . 0.6 OUTLIER -130.65 11.7 5.28 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 109.373 -0.602 . . . . 72.540000000000006 109.373 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -73.14 134.25 44.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.495 -0.775 . . . . 71.299999999999997 110.563 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.1 145.25 50.56 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.839 -0.8 . . . . 72.040000000000006 108.839 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.7 p -132.3 141.8 44.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.719 0.771 . . . . 52.240000000000002 111.438 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -105.14 128.25 53.29 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.678 -1.23 . . . . 71.129999999999995 107.678 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -122.32 117.85 27.07 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.281 -1.377 . . . . 34.229999999999997 107.281 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 113.25 -159.79 13.48 Favored Glycine 0 C--N 1.306 -1.113 0 C-N-CA 121.23 -0.51 . . . . 61.43 111.925 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -98.78 137.39 37.44 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 122.628 0.371 . . . . 73.549999999999997 110.916 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 61.7 t -114.73 116.32 52.21 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 N-CA-C 107.22 -1.4 . . . . 74.329999999999998 107.22 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.2 p -122.44 114.37 42.23 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 N-CA-C 108.46 -0.941 . . . . 42.5 108.46 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 15.0 m -84.22 157.18 21.69 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 118.406 -1.318 . . . . 64.409999999999997 110.045 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.01 -47.09 72.51 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.41 0.624 . . . . 63.450000000000003 111.552 176.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.38 -34.42 68.85 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.561 1.545 . . . . 72.140000000000001 112.649 -175.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.608 ' HB2' ' HA3' ' A' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.31 -1.121 0 C-N-CA 124.145 0.978 . . . . 72.430000000000007 111.548 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.406 -2.639 0 N-CA-C 106.044 -1.836 . . . . 60.340000000000003 106.044 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 38.3 t-20 -126.38 140.35 52.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.911 -0.716 . . . . 73.409999999999997 109.151 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.9 m -133.76 123.1 24.31 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 120.809 -0.356 . . . . 43.409999999999997 110.392 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 8.7 p -128.92 145.1 36.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 110.128 -0.323 . . . . 72.099999999999994 110.128 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.591 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 76.9 mm-40 -85.38 -79.09 0.24 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 121.0 -0.28 . . . . 74.420000000000002 110.747 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 25.9 m -116.29 127.65 54.89 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.182 0.438 . . . . 74.140000000000001 112.182 -172.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.528 HG21 HD11 ' A' ' 277' ' ' ILE . 17.4 m -120.69 132.78 69.34 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.276 0.56 . . . . 63.310000000000002 109.583 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' B' ' 232' ' ' ARG . 3.3 p -127.98 131.81 69.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 116.358 -0.383 . . . . 73.409999999999997 111.637 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.86 131.06 7.65 Favored Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 109.3 -1.52 . . . . 32.109999999999999 109.3 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 234' ' ' GLU . 18.9 tptm -134.17 140.55 46.6 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.6 -0.518 . . . . 72.310000000000002 109.6 -177.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 81.56 -136.71 16.41 Favored Glycine 0 CA--C 1.487 -1.672 0 N-CA-C 107.78 -2.128 . . . . 73.230000000000004 107.78 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -101.36 85.41 2.79 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 118.443 1.122 . . . . 73.519999999999996 109.356 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 21.6 m -104.39 144.98 30.92 Favored 'General case' 0 N--CA 1.408 -2.562 0 CA-C-N 114.923 -1.035 . . . . 71.439999999999998 108.934 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . 0.537 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 98.8 mtt180 -122.73 125.93 46.51 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 106.138 -1.801 . . . . 72.129999999999995 106.138 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 26.9 t -131.62 131.63 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 N-CA-C 108.973 -0.751 . . . . 71.129999999999995 108.973 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 5.4 tt -125.88 114.77 18.97 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 118.429 -1.308 . . . . 72.030000000000001 108.444 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.579 HG23 HD12 ' B' ' 241' ' ' LEU . 68.5 mt -111.02 104.33 16.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.098 -0.704 . . . . 64.209999999999994 109.098 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.514 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 144.27 -143.93 12.76 Favored Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 110.969 -0.852 . . . . 73.420000000000002 110.969 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -124.29 143.53 50.5 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.213 -1.032 . . . . 45.439999999999998 108.213 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.96 130.01 46.17 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.502 0.668 . . . . 71.439999999999998 109.314 174.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -113.55 121.56 44.58 Favored 'General case' 0 N--CA 1.409 -2.493 0 N-CA-C 107.383 -1.34 . . . . 72.019999999999996 107.383 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.608 ' HA3' ' HB2' ' A' ' 249' ' ' ALA . . . 62.81 24.82 66.95 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.407 -1.269 . . . . 73.010000000000005 113.903 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -86.69 -47.63 4.76 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.037 -1.225 . . . . 62.329999999999998 110.037 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.425 ' HB2' ' NZ ' ' A' ' 284' ' ' LYS . 0.1 OUTLIER 68.28 23.51 7.72 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.043 1.337 . . . . 74.299999999999997 110.03 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 287' ' ' TRP . . . 115.02 92.91 1.88 Allowed Glycine 0 N--CA 1.407 -3.249 0 C-N-CA 120.129 -1.034 . . . . 55.439999999999998 110.768 -176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -73.1 33.78 0.07 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-O 122.54 1.162 . . . . 75.239999999999995 109.398 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.537 ' CE3' ' HB3' ' A' ' 274' ' ' ARG . 2.5 m95 . . . . . 0 N--CA 1.432 -1.337 0 CA-C-N 115.407 -0.815 . . . . 72.430000000000007 111.979 -174.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 . . . . . 0 N--CA 1.424 -1.73 0 N-CA-C 109.637 -0.505 . . . . 73.430000000000007 109.637 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 39.1 t-20 -118.06 141.7 48.19 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.545 -1.28 . . . . 54.149999999999999 107.545 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 52.5 m -133.81 137.38 45.05 Favored 'General case' 0 C--N 1.275 -2.663 0 O-C-N 122.075 -0.39 . . . . 54.219999999999999 110.172 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -127.72 160.77 30.67 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.21 -1.404 . . . . 73.099999999999994 107.21 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 4.6 tmmm? -121.67 -54.63 1.95 Allowed 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 119.599 -0.841 . . . . 74.340000000000003 109.045 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -131.76 138.03 48.43 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.81 -1.552 . . . . 73.340000000000003 106.81 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 12.5 mt -133.85 120.04 34.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 106.795 -1.557 . . . . 70.109999999999999 106.795 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.631 ' NH1' ' HB2' ' B' ' 232' ' ' ARG . 0.0 OUTLIER -115.39 119.9 37.8 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 109.191 -0.67 . . . . 75.120000000000005 109.191 -176.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 38.4 p -121.88 129.16 52.36 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.613 -1.254 . . . . 62.020000000000003 107.613 175.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 27.5 tt0 -144.69 150.51 37.45 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 120.12 -0.632 . . . . 71.129999999999995 110.398 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 77.82 -79.19 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 125.798 1.639 . . . . 75.099999999999994 113.021 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -140.57 27.1 2.08 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.569 -0.9 . . . . 65.219999999999999 108.569 -172.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -86.71 143.65 27.47 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 112.9 0.704 . . . . 64.010000000000005 112.9 -173.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -124.4 136.46 54.08 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.311 -1.366 . . . . 61.530000000000001 107.311 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.5 p -134.14 136.14 53.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.996 0.903 . . . . 74.019999999999996 111.396 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.428 ' HB2' ' CE2' ' B' ' 286' ' ' PHE . 44.1 tp60 -104.57 130.99 52.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 106.884 -1.524 . . . . 64.230000000000004 106.884 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.579 HD12 HG23 ' A' ' 277' ' ' ILE . 2.7 tm? -130.27 116.28 18.14 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 106.561 -1.644 . . . . 72.430000000000007 106.561 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 123.05 -129.39 7.41 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.634 -0.793 . . . . 53.049999999999997 112.05 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' B' ' 279' ' ' ASN . 53.3 t-20 -132.53 137.38 47.13 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.17 0.485 . . . . 75.349999999999994 109.862 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 54.4 t -114.63 114.87 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.595 -1.261 . . . . 73.150000000000006 107.595 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 3.6 p -122.42 114.3 41.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 C-N-CA 119.492 -0.883 . . . . 63.130000000000003 110.165 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 42.3 m -80.34 155.0 27.42 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 117.419 -1.713 . . . . 72.510000000000005 109.92 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.56 66.03 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.254 1.026 . . . . 74.409999999999997 111.249 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.31 -35.13 67.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.195 -1.82 . . . . 64.120000000000005 112.246 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.503 ' HB2' ' HA3' ' B' ' 282' ' ' GLY . . . -60.56 -47.03 88.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.989 -0.55 . . . . 45.219999999999999 110.381 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 18.1 tp . . . . . 0 CA--C 1.517 -0.309 0 N-CA-C 105.316 -2.105 . . . . 73.230000000000004 105.316 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.428 -1.556 0 CA-C-O 121.915 0.864 . . . . 51.200000000000003 110.171 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.495 HG23 ' HB3' ' C' ' 225' ' ' ARG . 5.1 t -115.82 120.51 39.49 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 105.687 -1.968 . . . . 72.099999999999994 105.687 171.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' B' ' 226' ' ' ASN . 37.0 t-20 -126.39 138.35 53.54 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.072 -0.651 . . . . 65.420000000000002 109.268 -172.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' C' ' 227' ' ' SER . 51.9 m -142.08 129.54 21.29 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.152 0.501 . . . . 63.140000000000001 111.336 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 14.1 p -121.11 153.16 24.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.831 -0.803 . . . . 64.450000000000003 108.831 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 75.8 mm-40 -91.94 -78.34 0.41 Allowed 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 109.583 -0.525 . . . . 63.210000000000001 109.583 171.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.6 m -114.35 127.97 56.12 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.944 -0.473 . . . . 61.329999999999998 111.192 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.27 120.74 47.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 109.162 -0.681 . . . . 71.209999999999994 109.162 176.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 5.4 m -124.76 148.33 29.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 121.246 0.546 . . . . 74.219999999999999 111.301 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -137.34 132.43 5.95 Favored Glycine 0 N--CA 1.415 -2.755 0 N-CA-C 109.489 -1.444 . . . . 61.119999999999997 109.489 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -132.51 116.19 16.44 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.524 0.678 . . . . 73.010000000000005 110.057 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 104.08 -139.19 14.45 Favored Glycine 0 CA--C 1.471 -2.715 0 N-CA-C 109.213 -1.555 . . . . 73.25 109.213 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . 0.517 ' HB3' ' O ' ' C' ' 235' ' ' GLU . 11.1 tp10 -86.42 80.65 8.6 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.133 -1.432 . . . . 74.430000000000007 107.133 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 20.6 m -113.96 144.29 43.32 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.429 -1.26 . . . . 63.219999999999999 109.061 -177.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' C' ' 238' ' ' ARG . 76.3 mtt180 -134.4 127.35 31.41 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.013 -1.106 . . . . 73.420000000000002 108.013 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 10.9 t -131.2 137.77 54.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 116.101 -0.5 . . . . 73.010000000000005 109.714 -173.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 4.5 tt -126.56 113.87 17.35 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 106.872 -1.529 . . . . 74.230000000000004 106.872 173.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.536 HG23 HD12 ' C' ' 241' ' ' LEU . 58.2 mt -112.72 103.19 15.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.509 -0.923 . . . . 73.420000000000002 108.509 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' B' ' 226' ' ' ASN . . . 140.98 -146.11 17.18 Favored Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 111.141 -0.784 . . . . 70.409999999999997 111.141 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 5.5 m-20 -123.58 138.24 54.59 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.316 -0.624 . . . . 73.530000000000001 109.316 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.81 137.85 54.29 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.075 -0.713 . . . . 72.420000000000002 109.075 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 87.4 t80 -124.03 121.92 36.52 Favored 'General case' 0 C--O 1.271 2.226 0 N-CA-C 108.493 -0.929 . . . . 71.150000000000006 108.493 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' B' ' 249' ' ' ALA . . . 81.65 -1.17 86.82 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 114.311 -1.313 . . . . 72.129999999999995 113.979 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -71.33 -60.11 4.58 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.922 -0.871 . . . . 75.519999999999996 110.922 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm 74.24 21.64 2.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.283 1.433 . . . . 73.030000000000001 109.1 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.9 90.07 0.83 Allowed Glycine 0 N--CA 1.409 -3.109 0 N-CA-C 109.48 -1.448 . . . . 75.439999999999998 109.48 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' B' ' 240' ' ' GLN . 44.5 t80 -72.73 40.54 0.09 Allowed 'General case' 0 CA--C 1.573 1.857 0 C-N-CA 124.689 1.195 . . . . 73.219999999999999 110.118 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.534 ' CE3' ' HB3' ' B' ' 274' ' ' ARG . 8.0 m95 . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 108.347 -0.982 . . . . 73.400000000000006 108.347 -176.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.495 ' HB3' HG23 ' B' ' 261' ' ' THR . 26.8 ptt180 . . . . . 0 N--CA 1.42 -1.964 0 CA-C-O 120.702 0.287 . . . . 75.109999999999999 110.553 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 37.9 t-20 -117.81 136.96 53.07 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.877 -1.527 . . . . 62.149999999999999 106.877 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' B' ' 263' ' ' SER . 32.8 m -134.34 137.28 44.04 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-O 121.041 0.448 . . . . 73.299999999999997 110.622 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -125.18 150.75 46.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.52 -0.919 . . . . 72.120000000000005 108.52 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 1.0 OUTLIER -108.26 -54.21 2.53 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 109.131 -0.692 . . . . 73.030000000000001 109.131 -177.05 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . 0.416 ' CG ' HH21 ' C' ' 232' ' ' ARG . 11.8 t70 -132.8 137.62 46.85 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.495 -1.298 . . . . 63.219999999999999 107.495 176.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.424 ' HA ' HG13 ' C' ' 267' ' ' VAL . 19.1 mt -137.25 120.48 21.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.454 -2.054 . . . . 62.340000000000003 105.454 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.416 HH21 ' CG ' ' C' ' 230' ' ' ASP . 19.0 ptp180 -126.11 120.4 30.06 Favored 'General case' 0 C--N 1.274 -2.678 0 C-N-CA 119.815 -0.754 . . . . 45.109999999999999 111.42 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.436 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 33.0 p -111.0 134.76 52.35 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.892 -1.049 . . . . 55.350000000000001 108.854 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -144.93 148.03 33.39 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.561 -0.456 . . . . 65.439999999999998 110.062 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' B' ' 272' ' ' GLU . 64.7 mt-10 73.93 -74.02 0.09 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.231 1.567 . . . . 72.239999999999995 115.231 176.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.44 ' HD2' ' HB3' ' C' ' 235' ' ' GLU . 8.0 mpt_? -136.48 17.0 3.14 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.206 -0.665 . . . . 71.239999999999995 109.206 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -78.71 131.11 36.48 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.998 0.904 . . . . 72.439999999999998 113.293 -173.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.575 ' HB3' ' HB2' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -128.5 135.74 49.84 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 114.887 -1.051 . . . . 61.219999999999999 111.157 174.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.474 HG23 ' HB ' ' C' ' 275' ' ' VAL . 7.2 p -130.99 142.59 43.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.375 -0.829 . . . . 53.130000000000003 111.529 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -104.7 132.25 51.17 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 114.363 -1.29 . . . . 75.310000000000002 107.698 171.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.536 HD12 HG23 ' B' ' 277' ' ' ILE . 2.7 tm? -130.13 116.03 17.89 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 105.303 -2.11 . . . . 72.409999999999997 105.303 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 129.63 -132.4 7.06 Favored Glycine 0 C--N 1.3 -1.462 0 C-N-CA 120.147 -1.025 . . . . 63.229999999999997 111.416 -178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 44.2 t30 -137.2 135.56 37.39 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.047 0.451 . . . . 73.439999999999998 110.492 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.07 117.46 51.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.283 0 N-CA-C 107.863 -1.162 . . . . 71.099999999999994 107.863 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 2.8 p -123.56 112.83 34.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 118.691 0.678 . . . . 72.099999999999994 110.455 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.4 m -81.98 156.05 24.89 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 117.444 -1.702 . . . . 73.209999999999994 110.298 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.445 ' HB2' ' HB1' ' B' ' 249' ' ' ALA . . . -67.64 -48.79 65.71 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.744 0.783 . . . . 73.040000000000006 112.042 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.17 75.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.116 -1.402 . . . . 65.109999999999999 112.253 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.157 0 CA-C-N 115.929 -0.578 . . . . 64.340000000000003 111.561 -179.293 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 10.5 t . . . . . 0 N--CA 1.422 -1.826 0 N-CA-C 108.334 -0.987 . . . . 34.420000000000002 108.334 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 53.1 t-20 -123.7 137.1 54.77 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.876 -1.157 . . . . 54.43 107.876 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 32.2 t -142.2 125.72 16.75 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.272 -0.64 . . . . 74.310000000000002 109.272 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.15 147.0 32.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.161 -0.681 . . . . 61.439999999999998 109.161 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 27.0 mm-40 -90.03 -76.04 0.44 Allowed 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 110.18 -0.304 . . . . 72.299999999999997 110.18 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 11.2 m -114.31 127.85 56.07 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.211 -0.996 . . . . 74.530000000000001 111.707 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' C' ' 231' ' ' ILE . 1.3 p -128.52 122.46 57.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.511 0.672 . . . . 74.319999999999993 110.028 175.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.7 133.73 68.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.547 -0.751 . . . . 75.109999999999999 112.13 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.34 130.57 6.64 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 108.404 -1.878 . . . . 35.43 108.404 170.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -134.41 116.51 15.26 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.667 -1.234 . . . . 74.120000000000005 107.667 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.9 -139.81 14.7 Favored Glycine 0 C--N 1.291 -1.939 0 N-CA-C 109.685 -1.366 . . . . 73.340000000000003 109.685 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.52 91.85 2.32 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.18 -1.045 . . . . 52.450000000000003 108.18 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 23.2 m -131.37 144.67 51.4 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 121.66 0.743 . . . . 75.340000000000003 110.893 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . 0.462 ' HD3' ' HB2' ' C' ' 287' ' ' TRP . 55.2 mtt85 -136.26 127.6 28.35 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 105.723 -1.954 . . . . 74.099999999999994 105.723 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.474 ' HB ' HG23 ' C' ' 239' ' ' VAL . 6.9 t -138.19 140.1 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 109.486 -0.561 . . . . 71.25 109.486 -175.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.3 tt -128.71 111.93 13.68 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.074 -1.084 . . . . 74.239999999999995 108.074 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 58.1 mt -111.82 103.96 16.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.575 -0.898 . . . . 74.040000000000006 108.575 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.67 -136.02 7.57 Favored Glycine 0 N--CA 1.424 -2.131 0 N-CA-C 110.992 -0.843 . . . . 44.530000000000001 110.992 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 94.3 m-20 -127.88 156.34 42.74 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 110.111 -0.329 . . . . 75.040000000000006 110.111 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.88 138.25 24.18 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.013 -0.539 . . . . 72.0 110.049 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -130.12 122.33 28.05 Favored 'General case' 0 N--CA 1.415 -2.204 0 N-CA-C 107.37 -1.344 . . . . 73.299999999999997 107.37 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.57 -14.14 58.84 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.309 -0.859 . . . . 70.219999999999999 112.447 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -64.78 -58.18 10.6 Favored Glycine 0 CA--C 1.497 -1.038 0 N-CA-C 111.613 -0.595 . . . . 73.329999999999998 111.613 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . 0.534 ' NZ ' ' HB2' ' C' ' 284' ' ' LYS . 6.7 mtmp? 65.84 31.37 9.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.561 1.144 . . . . 62.329999999999998 108.344 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.19 97.15 2.38 Favored Glycine 0 N--CA 1.417 -2.567 0 N-CA-C 108.493 -1.843 . . . . 43.350000000000001 108.493 -172.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -76.22 41.64 0.24 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.262 1.03 . . . . 74.239999999999995 110.844 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.462 ' HB2' ' HD3' ' C' ' 274' ' ' ARG . 1.3 p90 . . . . . 0 N--CA 1.414 -2.272 0 CA-C-O 122.318 1.056 . . . . 72.510000000000005 113.254 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.616 ' HG2' HH11 ' A' ' 225' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.134 0 N-CA-C 109.839 -0.43 . . . . 74.310000000000002 109.839 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -106.62 123.89 48.8 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.945 -1.131 . . . . 72.25 107.945 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 12.2 m -123.91 136.83 54.59 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 116.109 -0.496 . . . . 62.140000000000001 110.393 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.31 138.16 44.76 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.68 -1.23 . . . . 62.130000000000003 107.68 175.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -93.43 -53.86 3.9 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.676 -0.49 . . . . 62.539999999999999 109.676 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.83 139.23 52.77 Favored 'General case' 0 C--O 1.252 1.191 0 N-CA-C 109.835 -0.432 . . . . 74.310000000000002 109.835 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 28.4 mm -128.08 116.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 106.279 -1.749 . . . . 63.409999999999997 106.279 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 31.5 ttp-105 -134.43 115.87 14.49 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.606 0.717 . . . . 73.140000000000001 111.489 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.64 ' HB ' ' CB ' ' A' ' 237' ' ' ALA . 4.8 p -129.1 140.47 51.55 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.493 -0.776 . . . . 51.130000000000003 111.227 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -121.04 143.16 49.2 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.542 0.687 . . . . 70.230000000000004 112.573 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 68.79 -100.66 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.394 1.627 . . . . 55.420000000000002 115.394 171.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.622 ' HD2' ' OE2' ' A' ' 272' ' ' GLU . 16.8 mtm180 -99.08 23.39 9.1 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.476 1.131 . . . . 73.310000000000002 110.128 -171.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.64 ' CB ' ' HB ' ' A' ' 233' ' ' THR . . . -84.13 156.17 22.25 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.591 -1.64 . . . . 73.040000000000006 111.835 -176.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . 0.474 ' HD3' ' HG2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -146.18 137.85 24.86 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.502 -0.772 . . . . 62.439999999999998 110.202 174.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.53 HG12 ' HB ' ' A' ' 275' ' ' VAL . 29.7 m -132.21 142.49 42.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.394 0.616 . . . . 61.340000000000003 111.892 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.463 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 56.5 tp60 -123.48 135.38 54.03 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.535 -0.757 . . . . 43.530000000000001 109.003 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -123.19 118.17 27.01 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.735 -1.58 . . . . 75.439999999999998 106.735 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.424 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 126.8 -113.0 1.67 Allowed Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 119.756 -1.211 . . . . 62.030000000000001 114.572 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -143.98 131.92 21.57 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 110.114 -0.328 . . . . 73.420000000000002 110.114 -172.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.539 HG11 ' H ' ' A' ' 286' ' ' PHE . 48.9 t -122.14 123.63 69.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.324 -0.621 . . . . 65.219999999999999 109.324 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.406 ' HA ' ' HB2' ' A' ' 281' ' ' TYR . 12.3 m -113.59 114.62 47.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.176 0.513 . . . . 75.230000000000004 110.364 174.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 24.4 m -96.97 159.76 14.73 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.842 -0.799 . . . . 52.119999999999997 108.842 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.47 75.73 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 123.249 0.62 . . . . 70.129999999999995 111.567 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.25 -42.84 78.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.06 -0.973 . . . . 50.409999999999997 111.985 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.435 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.431 0 CA-C-N 116.368 -0.378 . . . . 71.329999999999998 110.545 -178.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 52.9 m . . . . . 0 N--CA 1.433 -1.323 0 N-CA-C 107.529 -1.285 . . . . 74.319999999999993 107.529 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 37.2 t-20 -127.11 138.32 53.16 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.197 -0.668 . . . . 65.400000000000006 109.197 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.5 m -128.62 123.14 32.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.737 -0.468 . . . . 75.25 109.737 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.92 150.12 34.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 N-CA-C 110.455 -0.202 . . . . 72.420000000000002 110.455 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.694 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 3.7 tp10 -85.46 -74.91 0.39 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.096 0.559 . . . . 74.319999999999993 110.097 178.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 32.2 m -128.59 134.71 48.68 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 122.146 -0.346 . . . . 71.019999999999996 111.234 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.59 127.07 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.659 -1.237 . . . . 74.239999999999995 107.659 172.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 10.1 p -127.23 134.84 65.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 116.439 -0.346 . . . . 73.349999999999994 110.897 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.92 132.75 7.32 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.669 -0.776 . . . . 41.140000000000001 111.999 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -132.09 116.64 17.3 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.748 -0.464 . . . . 74.219999999999999 109.748 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 109.93 -131.56 10.53 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.882 -0.887 . . . . 61.149999999999999 110.882 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.622 ' OE2' ' HD2' ' A' ' 236' ' ' ARG . 10.0 mp0 -92.5 32.3 1.23 Allowed 'General case' 0 C--O 1.252 1.22 0 C-N-CA 125.133 1.373 . . . . 51.299999999999997 110.087 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 16.7 m -81.77 145.22 30.57 Favored 'General case' 0 C--O 1.287 3.077 0 CA-C-O 122.927 1.346 . . . . 54.200000000000003 112.708 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . 0.474 ' HG2' ' HD3' ' A' ' 238' ' ' ARG . 72.1 mtm-85 -127.08 127.79 45.23 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.697 -1.592 . . . . 74.219999999999999 109.27 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.53 ' HB ' HG12 ' A' ' 239' ' ' VAL . 48.9 t -127.81 132.29 69.01 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 CA-C-N 115.957 -0.565 . . . . 52.020000000000003 109.947 -175.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.8 tt -125.01 128.41 48.52 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 118.151 -1.42 . . . . 65.540000000000006 109.677 173.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.445 HG23 HD12 ' B' ' 241' ' ' LEU . 35.0 mm -112.56 105.62 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.657 -0.868 . . . . 63.119999999999997 108.657 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 138.78 -134.02 6.56 Favored Glycine 0 C--N 1.31 -0.883 0 C-N-CA 120.648 -0.787 . . . . 61.43 113.297 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' B' ' 243' ' ' ASN . 15.1 m120 -115.87 128.27 55.67 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 122.574 0.35 . . . . 71.340000000000003 110.816 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.06 118.67 34.05 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.657 -1.609 . . . . 73.010000000000005 106.657 176.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.406 ' HB2' ' HA ' ' A' ' 245' ' ' VAL . 22.4 m-85 -106.38 123.33 47.89 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.369 -1.345 . . . . 74.329999999999998 107.369 176.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.56 -50.66 0.79 Allowed Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.391 -1.083 . . . . 70.299999999999997 110.391 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.64 53.3 Favored Glycine 0 C--N 1.308 -1.02 0 N-CA-C 110.747 -0.941 . . . . 34.420000000000002 110.747 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' B' ' 287' ' ' TRP . 17.8 ptpt -179.85 27.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.286 1.034 . . . . 74.099999999999994 110.562 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -85.61 -120.72 1.08 Allowed Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 119.944 -1.122 . . . . 54.109999999999999 111.642 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.539 ' H ' HG11 ' A' ' 244' ' ' VAL . 86.8 t80 62.53 -89.07 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.106 0.562 . . . . 73.0 111.362 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 . . . . . 0 CA--C 1.508 -0.672 0 C-N-CA 127.35 2.26 . . . . 61.119999999999997 107.206 178.715 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.493 -1.218 0 N-CA-C 107.132 -1.433 . . . . 73.420000000000002 107.132 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.537 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 29.6 m-80 -103.87 130.18 51.44 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 107.991 -1.115 . . . . 50.350000000000001 107.991 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 28.6 m -128.61 137.04 51.48 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-O 121.197 0.523 . . . . 71.140000000000001 110.615 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.498 ' HB1' HD11 ' B' ' 231' ' ' ILE . . . -131.59 155.55 47.33 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.791 -1.188 . . . . 75.530000000000001 107.791 177.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.694 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 0.1 OUTLIER -109.0 -61.72 1.58 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 119.51 -0.876 . . . . 71.409999999999997 108.854 -178.435 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -126.63 137.8 53.35 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.84 -0.8 . . . . 75.420000000000002 108.84 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.498 HD11 ' HB1' ' B' ' 228' ' ' ALA . 18.5 mm -131.66 117.55 35.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 106.874 -1.528 . . . . 72.340000000000003 106.874 -178.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.444 ' HG3' HG23 ' B' ' 268' ' ' VAL . 7.0 ptm180 -130.38 118.81 21.78 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.345 0.593 . . . . 72.439999999999998 111.492 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 34.5 p -110.72 128.14 55.61 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.352 -0.84 . . . . 61.229999999999997 109.31 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -125.01 142.38 51.52 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.035 0.445 . . . . 73.319999999999993 111.04 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.461 ' HB3' ' HD3' ' B' ' 236' ' ' ARG . 45.0 mt-10 74.76 -102.37 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.388 0 C-N-CA 125.011 1.324 . . . . 72.030000000000001 113.084 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.565 ' HD3' ' N ' ' B' ' 236' ' ' ARG . 0.7 OUTLIER -110.37 25.49 11.73 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.723 0.773 . . . . 64.319999999999993 109.448 -175.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -82.99 142.45 31.36 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 122.568 1.175 . . . . 55.32 112.759 -175.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -131.65 135.86 47.25 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.542 -1.208 . . . . 63.340000000000003 109.506 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.832 HG12 ' HB ' ' B' ' 275' ' ' VAL . 2.6 m -125.31 141.27 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 CA-C-O 121.869 0.843 . . . . 71.530000000000001 111.538 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.492 ' HB3' ' HG ' ' B' ' 276' ' ' LEU . 5.9 tp-100 -116.41 128.38 55.45 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 114.074 -1.421 . . . . 65.329999999999998 107.643 174.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.445 HD12 HG23 ' A' ' 277' ' ' ILE . 3.0 tm? -120.38 117.31 27.41 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.927 -1.509 . . . . 72.439999999999998 106.927 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.417 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 125.92 -112.23 1.61 Allowed Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.554 -1.308 . . . . 73.140000000000001 113.143 176.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.466 ' HB3' ' ND2' ' A' ' 279' ' ' ASN . 25.7 t-20 -144.97 138.36 26.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 111.556 0.206 . . . . 72.349999999999994 111.556 -174.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.515 HG11 ' H ' ' B' ' 286' ' ' PHE . 45.2 t -119.9 133.7 65.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.605 -0.887 . . . . 51.420000000000002 108.605 175.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 19.3 t -122.28 112.11 33.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 108.943 -0.762 . . . . 63.310000000000002 108.943 177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 23.5 m -95.49 158.95 15.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.97 -1.122 . . . . 62.329999999999998 107.97 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.435 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -64.39 -39.7 94.37 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.792 0.806 . . . . 74.400000000000006 110.553 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.89 -34.47 65.57 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.425 -1.716 . . . . 53.409999999999997 114.157 -175.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.439 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -68.03 -33.27 74.27 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.313 0.486 . . . . 63.25 112.313 -176.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 N--CA 1.488 1.45 0 C-N-CA 124.182 0.993 . . . . 75.010000000000005 111.135 -175.626 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' C' ' 243' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.396 -3.142 0 N-CA-C 113.665 0.987 . . . . 63.210000000000001 113.665 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 63.9 m -100.74 105.95 17.33 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 104.139 -2.541 . . . . 65.409999999999997 104.139 167.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.534 HD21 HD22 ' C' ' 241' ' ' LEU . 54.7 t30 -128.44 142.02 51.22 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.097 -0.956 . . . . 73.209999999999994 109.886 -171.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 39.6 m -137.2 128.07 27.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.807 0.337 . . . . 53.140000000000001 110.948 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.2 p -128.39 153.72 38.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.795 -0.817 . . . . 74.409999999999997 108.795 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 38.4 tt0 -96.2 -76.35 0.51 Allowed 'General case' 0 N--CA 1.418 -2.029 0 C-N-CA 120.156 -0.617 . . . . 64.310000000000002 111.452 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -116.37 128.43 55.52 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.765 -0.774 . . . . 72.019999999999996 112.635 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 11.8 m -118.45 129.08 75.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.197 0 N-CA-C 107.793 -1.188 . . . . 62.039999999999999 107.793 171.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . 0.444 HG23 ' HG3' ' B' ' 232' ' ' ARG . 4.1 p -126.83 128.25 70.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.978 -0.555 . . . . 63.210000000000001 111.126 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . 0.407 ' HA2' ' OG1' ' C' ' 233' ' ' THR . . . -116.06 132.01 9.95 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.361 -1.096 . . . . 21.420000000000002 110.361 175.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -131.99 116.4 17.06 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.491 -0.559 . . . . 72.219999999999999 109.491 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 100.56 -137.66 13.39 Favored Glycine 0 C--N 1.309 -0.92 0 N-CA-C 111.139 -0.784 . . . . 71.239999999999995 111.139 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 2.4 mp0 -77.22 40.43 0.27 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.993 1.317 . . . . 55.140000000000001 110.177 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 39.0 m -82.92 144.66 29.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.979 0.895 . . . . 73.310000000000002 112.503 -169.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 32.5 mtt180 -130.75 127.21 38.3 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.58 -1.637 . . . . 73.530000000000001 106.58 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.832 ' HB ' HG12 ' B' ' 239' ' ' VAL . 89.4 t -135.06 130.34 51.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.377 -0.601 . . . . 70.140000000000001 109.377 -176.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 7.0 tt -122.09 125.41 46.14 Favored 'General case' 0 C--N 1.277 -2.553 0 C-N-CA 117.7 -1.6 . . . . 73.319999999999993 110.144 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.43 HG23 HD12 ' C' ' 241' ' ' LEU . 29.1 mm -110.51 103.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.043 -1.465 . . . . 71.349999999999994 107.043 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 139.76 -147.65 19.35 Favored Glycine 0 C--N 1.308 -0.976 0 C-N-CA 120.197 -1.002 . . . . 62.43 113.694 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 0.9 OUTLIER -106.64 129.8 54.49 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.957 -0.386 . . . . 55.25 109.957 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.94 118.69 36.17 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.511 -1.663 . . . . 71.109999999999999 106.511 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -107.62 123.15 48.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.694 -0.854 . . . . 75.349999999999994 108.694 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 139.46 -50.17 0.79 Allowed Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 109.79 -1.324 . . . . 50.43 109.79 -176.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 94.53 17.05 40.48 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.738 -0.945 . . . . 62.210000000000001 110.738 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt 174.05 27.77 0.0 OUTLIER 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.784 1.234 . . . . 70.120000000000005 109.726 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.22 -113.36 0.23 Allowed Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.011 -0.836 . . . . 75.420000000000002 111.011 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.515 ' H ' HG11 ' B' ' 244' ' ' VAL . 92.7 t80 60.61 -83.53 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.39 0.676 . . . . 73.329999999999998 111.646 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.508 ' HE1' ' HB3' ' A' ' 286' ' ' PHE . 3.5 m-90 . . . . . 0 C--O 1.241 0.613 0 C-N-CA 126.477 1.911 . . . . 74.230000000000004 108.672 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.581 ' N ' ' HG1' ' C' ' 261' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.287 0 N-CA-C 108.756 -0.831 . . . . 72.409999999999997 108.756 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 40.8 m-80 -110.25 132.63 54.0 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 108.028 -1.101 . . . . 62.100000000000001 108.028 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 17.2 m -129.38 136.72 50.33 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 116.318 -0.401 . . . . 73.400000000000006 110.019 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.527 ' HB1' HD11 ' C' ' 231' ' ' ILE . . . -137.4 147.08 45.18 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.565 -0.902 . . . . 63.240000000000002 108.565 178.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -100.86 -64.65 1.03 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.936 -0.394 . . . . 71.040000000000006 109.936 -177.158 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.59 138.03 52.75 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 108.928 -0.767 . . . . 70.129999999999995 108.928 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.527 HD11 ' HB1' ' C' ' 228' ' ' ALA . 10.9 mm -132.0 117.46 33.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 106.552 -1.648 . . . . 74.150000000000006 106.552 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -126.03 122.12 34.96 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.585 -0.846 . . . . 74.409999999999997 112.413 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.431 ' CG2' HG13 ' C' ' 239' ' ' VAL . 17.3 p -110.47 126.99 54.92 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.051 -0.977 . . . . 70.230000000000004 109.19 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -128.93 142.77 50.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.036 0.446 . . . . 65.140000000000001 111.087 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 51.9 mt-10 78.75 -90.01 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 125.571 1.548 . . . . 72.400000000000006 113.971 173.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.474 ' HD3' ' OE2' ' C' ' 272' ' ' GLU . 0.0 OUTLIER -126.25 28.67 5.98 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.043 -1.095 . . . . 73.439999999999998 108.043 -177.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -82.58 146.42 29.17 Favored 'General case' 0 C--O 1.265 1.882 0 CA-C-O 122.794 1.283 . . . . 63.009999999999998 113.844 -174.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.1 OUTLIER -131.84 135.53 46.78 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.23 -1.35 . . . . 72.049999999999997 109.541 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.694 HG12 ' HB ' ' C' ' 275' ' ' VAL . 25.8 m -134.91 141.74 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 CA-C-O 121.936 0.874 . . . . 72.310000000000002 111.94 176.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.455 HE22 HD22 ' B' ' 276' ' ' LEU . 48.7 tp60 -110.83 133.19 53.57 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 113.985 -1.461 . . . . 73.140000000000001 108.304 176.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.534 HD22 HD21 ' B' ' 262' ' ' ASN . 3.1 tm? -125.26 117.01 22.87 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 106.249 -1.76 . . . . 55.109999999999999 106.249 177.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.409 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 125.88 -115.14 2.26 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 119.407 -1.378 . . . . 51.240000000000002 113.624 176.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 12.9 t-20 -144.34 137.54 27.22 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 110.008 -0.367 . . . . 64.439999999999998 110.008 -173.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.544 HG11 ' H ' ' C' ' 286' ' ' PHE . 60.1 t -124.26 124.84 69.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.377 -0.601 . . . . 74.140000000000001 109.377 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 32.4 t -116.21 111.85 37.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.853 -0.795 . . . . 54.43 108.853 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.8 m -94.93 159.68 14.92 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.226 -1.028 . . . . 63.340000000000003 108.226 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -64.45 -39.96 94.82 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.685 0.755 . . . . 74.319999999999993 110.418 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -33.23 61.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.608 -1.633 . . . . 75.340000000000003 112.155 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 116.15 -0.477 . . . . 34.310000000000002 112.132 -177.856 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.581 ' HG1' ' N ' ' C' ' 225' ' ' ARG . 7.7 t . . . . . 0 N--CA 1.412 -2.371 0 N-CA-C 104.771 -2.307 . . . . 72.319999999999993 104.771 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 49.6 t30 -125.82 139.24 53.66 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.086 -0.506 . . . . 64.310000000000002 111.095 -168.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 13.1 t -129.38 123.5 31.87 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.438 -0.949 . . . . 54.509999999999998 108.438 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.01 153.92 34.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.165 -1.05 . . . . 73.120000000000005 108.165 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -97.56 -79.87 0.46 Allowed 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 120.028 -0.669 . . . . 72.409999999999997 111.403 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 29.2 m -120.07 127.73 52.82 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.145 -0.622 . . . . 71.239999999999995 111.812 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.9 m -118.7 127.3 75.66 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-O 121.621 0.724 . . . . 73.319999999999993 109.292 174.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.05 120.22 63.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.406 -0.815 . . . . 55.119999999999997 109.23 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.83 131.67 9.93 Favored Glycine 0 N--CA 1.416 -2.682 0 C-N-CA 119.635 -1.269 . . . . 53.149999999999999 111.114 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -133.33 133.84 43.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.491 -0.929 . . . . 55.539999999999999 108.491 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.77 -132.84 11.43 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.264 -0.969 . . . . 61.409999999999997 111.469 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . 0.474 ' OE2' ' HD3' ' C' ' 236' ' ' ARG . 4.5 mp0 -91.37 52.83 2.16 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.945 -1.131 . . . . 74.129999999999995 107.945 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 21.7 t -83.71 145.63 28.64 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 115.141 -0.936 . . . . 62.32 110.974 -174.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 17.2 mtm180 -141.12 127.5 19.87 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.785 -1.191 . . . . 73.439999999999998 107.785 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.694 ' HB ' HG12 ' C' ' 239' ' ' VAL . 13.6 t -137.2 138.95 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.14 -1.059 . . . . 63.32 108.14 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 8.8 tt -123.99 114.75 20.19 Favored 'General case' 0 N--CA 1.404 -2.768 0 C-N-CA 118.875 -1.13 . . . . 73.019999999999996 109.916 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 47.5 mm -102.51 103.04 14.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 106.674 -1.602 . . . . 74.040000000000006 106.674 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 145.54 -145.67 15.09 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.014 -1.089 . . . . 71.109999999999999 113.232 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.46 131.83 55.89 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 122.868 0.467 . . . . 64.030000000000001 109.764 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.64 118.54 32.39 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.702 -1.592 . . . . 64.150000000000006 106.702 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.29 123.34 49.92 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.63 -0.878 . . . . 72.120000000000005 108.63 176.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.98 -45.06 0.96 Allowed Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 110.632 -0.987 . . . . 62.210000000000001 110.632 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 94.28 4.36 62.75 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.61 -0.996 . . . . 55.119999999999997 110.61 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -170.71 28.75 0.02 OUTLIER 'General case' 0 C--O 1.247 0.948 0 C-N-CA 123.756 0.822 . . . . 64.340000000000003 109.671 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.37 -124.45 0.44 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.766 -0.933 . . . . 63.119999999999997 110.766 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.544 ' H ' HG11 ' C' ' 244' ' ' VAL . 88.1 t80 65.91 -78.67 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.351 0.66 . . . . 63.539999999999999 111.187 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.31 -1.124 0 C-N-CA 124.574 1.15 . . . . 75.200000000000003 109.045 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 . . . . . 0 N--CA 1.442 -0.87 0 CA-C-O 120.904 0.383 . . . . 64.25 110.041 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -112.53 130.87 55.86 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.295 -1.372 . . . . 75.0 107.295 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.7 m -135.62 136.77 41.28 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.146 0.498 . . . . 32.420000000000002 111.044 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 277' ' ' ILE . . . -116.2 131.17 57.02 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.334 -0.988 . . . . 62.310000000000002 108.334 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 4.1 tmmm? -81.39 -62.08 1.76 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.701 -0.481 . . . . 75.209999999999994 109.701 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -130.17 140.25 50.77 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.57 0.224 . . . . 75.219999999999999 111.401 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 48.7 mt -131.84 119.47 41.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.857 -0.794 . . . . 72.019999999999996 108.857 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.421 ' HB3' HG23 ' A' ' 268' ' ' VAL . 2.5 mpt_? -112.04 126.1 54.8 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.835 -0.431 . . . . 71.010000000000005 109.835 176.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.48 128.2 30.97 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 120.979 0.419 . . . . 52.329999999999998 110.395 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.25 159.73 39.15 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.416 -0.811 . . . . 73.030000000000001 109.956 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.494 ' HB2' ' H ' ' A' ' 271' ' ' GLY . 28.2 mm-40 63.3 72.2 0.49 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.551 0.741 . . . . 70.129999999999995 112.634 177.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.31 22.71 8.04 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.177 0.991 . . . . 73.200000000000003 113.031 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.41 145.76 28.82 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.107 0.48 . . . . 65.129999999999995 111.077 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -127.63 134.94 49.64 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.787 -0.642 . . . . 74.319999999999993 110.382 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 77.8 t -123.44 132.32 71.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.566 -0.743 . . . . 74.25 110.493 -174.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.524 ' HG3' HD13 ' A' ' 276' ' ' LEU . 55.5 tp60 -118.23 114.81 23.58 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.252 -1.018 . . . . 74.329999999999998 108.252 174.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -115.69 121.97 44.12 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.275 -1.379 . . . . 73.329999999999998 107.275 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.49 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 136.48 -119.74 2.04 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 119.946 -1.121 . . . . 61.240000000000002 112.525 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -144.18 129.04 18.4 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 110.09 -0.337 . . . . 70.519999999999996 110.09 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.0 t -112.57 120.98 64.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.452 -0.573 . . . . 72.530000000000001 109.452 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 25.8 m -117.99 112.17 37.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.594 0.711 . . . . 61.43 109.665 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 17.1 m -77.8 159.65 28.87 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.755 -0.657 . . . . 73.420000000000002 109.665 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.14 90.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.206 0.527 . . . . 73.510000000000005 110.654 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.64 -33.33 63.95 Favored 'General case' 0 C--O 1.211 -0.973 0 C-N-CA 124.891 1.276 . . . . 73.329999999999998 112.325 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.308 -1.231 0 CA-C-N 115.366 -0.834 . . . . 73.430000000000007 112.865 -176.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.433 -1.292 0 N-CA-C 108.118 -1.067 . . . . 71.409999999999997 108.118 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' B' ' 226' ' ' ASN . 15.4 m120 -120.87 140.4 51.84 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.999 0.428 . . . . 54.32 110.162 -176.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 42.6 m -142.13 123.8 15.06 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.846 -0.427 . . . . 71.310000000000002 109.846 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.3 p -122.53 138.48 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 109.971 -0.381 . . . . 64.340000000000003 109.971 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 65.1 mm-40 -81.17 -68.67 0.67 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.406 -0.361 . . . . 71.099999999999994 111.387 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 99.1 m -125.56 128.33 47.78 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.432 -0.507 . . . . 75.319999999999993 112.296 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.415 ' HB ' HD12 ' B' ' 231' ' ' ILE . 3.3 p -125.02 123.77 66.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.685 -0.857 . . . . 72.299999999999997 108.685 173.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 232' ' ' ARG . 7.3 p -127.07 139.54 51.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.888 0.375 . . . . 75.200000000000003 111.077 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.76 132.34 8.13 Favored Glycine 0 N--CA 1.423 -2.18 0 C-N-CA 121.019 -0.61 . . . . 71.5 111.756 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -133.23 116.46 16.24 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.431 -0.581 . . . . 73.450000000000003 109.431 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.494 ' H ' ' HB2' ' A' ' 235' ' ' GLU . . . 80.59 73.78 1.15 Allowed Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.386 -0.911 . . . . 74.200000000000003 113.322 173.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 56.35 53.65 8.53 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 113.788 1.033 . . . . 75.450000000000003 113.788 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 50.3 m -88.09 144.4 26.52 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 107.352 -1.351 . . . . 75.129999999999995 107.352 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 2.3 mpt_? -128.1 125.31 38.97 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 105.479 -2.045 . . . . 72.230000000000004 105.479 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.481 HG12 HG22 ' B' ' 239' ' ' VAL . 4.4 m -130.54 140.19 49.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 C-N-CA 119.936 -0.706 . . . . 72.530000000000001 110.122 -174.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.524 HD13 ' HG3' ' A' ' 240' ' ' GLN . 11.1 tp -125.11 118.64 26.58 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.649 0.738 . . . . 74.420000000000002 109.62 175.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.534 HG23 HD12 ' B' ' 241' ' ' LEU . 14.4 mt -113.18 104.43 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.936 0 CA-C-N 113.942 -1.481 . . . . 64.409999999999997 107.229 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.516 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 151.8 -129.08 2.71 Favored Glycine 0 N--CA 1.423 -2.206 0 C-N-CA 120.278 -0.963 . . . . 51.210000000000001 112.658 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -123.92 141.76 51.75 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.181 -0.674 . . . . 74.049999999999997 109.181 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.491 ' HB2' HE22 ' B' ' 240' ' ' GLN . 5.6 tm-20 -130.72 123.05 28.39 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.257 -1.016 . . . . 72.430000000000007 108.257 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.482 ' HD1' ' O ' ' B' ' 245' ' ' VAL . 7.4 t80 -116.01 124.01 49.43 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 107.96 -1.126 . . . . 72.219999999999999 107.96 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.592 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 144.68 -64.34 0.46 Allowed Glycine 0 N--CA 1.424 -2.139 0 CA-C-N 115.323 -0.853 . . . . 74.019999999999996 111.434 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 124.51 25.1 1.65 Allowed Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 120.44 -0.886 . . . . 42.539999999999999 113.018 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -176.91 -5.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.159 0.8 . . . . 73.120000000000005 113.159 174.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.28 -132.26 38.23 Favored Glycine 0 CA--C 1.505 -0.588 0 N-CA-C 115.157 0.823 . . . . 63.109999999999999 115.157 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -98.77 -3.25 36.06 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.4 -0.593 . . . . 74.310000000000002 109.4 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.505 ' CZ2' ' HB3' ' A' ' 276' ' ' LEU . 10.9 m-90 . . . . . 0 CA--C 1.49 -1.34 0 CA-C-N 115.711 -0.677 . . . . 73.439999999999998 110.506 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.413 ' HB2' ' OG1' ' B' ' 261' ' ' THR . 97.5 mtt180 . . . . . 0 CA--C 1.489 -1.4 0 N-CA-C 108.673 -0.862 . . . . 52.240000000000002 108.673 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.473 ' HB3' ' ND2' ' A' ' 262' ' ' ASN . 25.1 t-20 -116.46 115.95 26.76 Favored 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 108.01 -1.107 . . . . 62.5 108.01 175.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 16.3 m -121.25 136.8 54.91 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-O 121.377 0.608 . . . . 71.120000000000005 110.799 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -124.66 124.09 41.45 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.649 -1.16 . . . . 71.439999999999998 108.357 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 0.3 OUTLIER -81.04 -57.5 3.5 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.658 -0.497 . . . . 74.400000000000006 109.658 -178.412 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -136.36 138.4 41.58 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.126 -0.63 . . . . 63.119999999999997 110.568 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.415 HD12 ' HB ' ' A' ' 267' ' ' VAL . 18.5 mt -130.36 119.19 45.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.419 -1.326 . . . . 53.420000000000002 107.419 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 69.8 mtt180 -117.16 115.53 25.51 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.733 -0.84 . . . . 64.219999999999999 108.733 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 69.4 p -112.84 127.29 56.14 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.303 -0.999 . . . . 63.119999999999997 108.303 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -134.55 139.25 45.27 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 120.07 -0.652 . . . . 73.129999999999995 109.398 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.463 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 44.8 mt-10 59.82 93.62 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 115.717 1.747 . . . . 75.310000000000002 115.717 170.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.463 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 2.8 mpt_? 62.75 20.12 11.9 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.1 -0.955 . . . . 72.109999999999999 110.954 172.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -84.1 141.83 30.83 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.935 -0.575 . . . . 43.350000000000001 110.48 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 7.9 mpt_? -124.69 133.93 53.04 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.788 -1.56 . . . . 62.310000000000002 106.788 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.55 HG12 HG22 ' B' ' 275' ' ' VAL . 23.4 m -135.84 147.56 28.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.559 -0.856 . . . . 62.109999999999999 111.467 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.606 ' CG ' HD13 ' B' ' 276' ' ' LEU . 5.5 tp-100 -124.01 120.33 32.12 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.226 -1.352 . . . . 75.120000000000005 108.425 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.534 HD12 HG23 ' A' ' 277' ' ' ILE . 2.9 tm? -118.09 117.71 29.93 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.133 -1.803 . . . . 75.120000000000005 106.133 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.524 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 139.82 -121.39 2.02 Favored Glycine 0 N--CA 1.412 -2.909 0 C-N-CA 119.398 -1.382 . . . . 61.43 112.902 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.558 HD21 HG13 ' B' ' 245' ' ' VAL . 8.2 t30 -143.27 130.35 20.71 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.083 0.468 . . . . 72.140000000000001 111.528 -174.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 98.5 t -112.58 126.7 70.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.382 -0.826 . . . . 73.040000000000006 109.254 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.558 HG13 HD21 ' B' ' 243' ' ' ASN . 4.1 m -122.03 113.7 39.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 108.134 -1.061 . . . . 73.140000000000001 108.134 173.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.474 HG21 ' HD3' ' B' ' 284' ' ' LYS . 17.3 m -77.43 160.7 28.53 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.708 -0.849 . . . . 74.319999999999993 108.708 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -61.74 -46.26 90.4 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 122.406 1.098 . . . . 51.43 109.807 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.39 -34.29 68.71 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 112.843 -1.98 . . . . 74.129999999999995 112.991 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.61 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -59.86 -26.86 66.18 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.224 0.61 . . . . 74.140000000000001 112.563 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 C--N 1.318 -0.793 0 CA-C-O 122.286 1.041 . . . . 73.319999999999993 112.248 -179.064 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.238 0.471 0 N-CA-C 109.432 -0.581 . . . . 74.329999999999998 109.432 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.563 ' CG2' ' HG2' ' C' ' 225' ' ' ARG . 9.0 t -107.18 132.47 53.01 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.537 0.684 . . . . 74.150000000000006 109.373 177.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.544 ' ND2' ' HB3' ' C' ' 226' ' ' ASN . 15.3 m120 -123.23 137.61 54.84 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.458 -0.792 . . . . 70.030000000000001 108.95 -177.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.3 m -139.24 123.62 18.2 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.667 -0.494 . . . . 74.299999999999997 109.667 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 9.2 p -117.77 141.14 38.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 120.866 0.365 . . . . 75.040000000000006 110.559 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 21.8 mm-40 -81.7 -69.03 0.64 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.595 -0.73 . . . . 62.530000000000001 110.745 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 29.2 m -133.1 127.44 33.99 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.796 -0.762 . . . . 52.310000000000002 112.183 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 3.6 p -123.51 124.18 69.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.972 -0.751 . . . . 74.25 108.972 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 8.5 p -127.32 136.97 59.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.131 0.491 . . . . 70.540000000000006 111.766 -176.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.99 133.07 10.6 Favored Glycine 0 CA--C 1.471 -2.686 0 CA-C-N 115.514 -0.766 . . . . 73.109999999999999 111.283 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -133.19 115.13 14.65 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 109.358 -0.608 . . . . 75.019999999999996 109.358 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.16 95.28 0.03 OUTLIER Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.924 -0.58 . . . . 75.040000000000006 114.532 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 63.36 31.54 15.13 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.502 0.556 . . . . 64.329999999999998 112.502 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.9 m -84.99 145.06 27.91 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.352 -0.386 . . . . 72.540000000000006 110.638 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 9.7 mpt_? -132.28 126.41 33.32 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.268 -1.382 . . . . 75.140000000000001 107.268 172.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.55 HG22 HG12 ' B' ' 239' ' ' VAL . 1.1 m -132.65 140.61 47.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 118.958 -1.097 . . . . 71.109999999999999 110.362 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.606 HD13 ' CG ' ' B' ' 240' ' ' GLN . 8.1 tp -122.86 117.17 24.98 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.024 0.916 . . . . 53.5 110.036 173.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.69 HG22 ' HB3' ' C' ' 241' ' ' LEU . 1.3 pt -112.13 103.89 16.17 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.026 0 CA-C-N 113.79 -1.55 . . . . 73.120000000000005 107.279 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 154.22 -147.18 16.09 Favored Glycine 0 N--CA 1.417 -2.598 0 CA-C-N 115.219 -0.9 . . . . 62.020000000000003 112.823 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -104.9 138.28 41.39 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.064 -1.088 . . . . 63.229999999999997 108.064 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -127.41 118.2 23.63 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.796 -1.557 . . . . 73.430000000000007 106.796 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.458 ' HB3' HG12 ' B' ' 245' ' ' VAL . 20.5 t80 -115.6 123.73 49.16 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 108.565 -0.902 . . . . 74.030000000000001 108.565 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.07 -55.32 0.68 Allowed Glycine 0 N--CA 1.416 -2.679 0 N-CA-C 109.328 -1.509 . . . . 74.230000000000004 109.328 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 102.2 44.02 1.94 Allowed Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.576 -1.009 . . . . 54.219999999999999 110.576 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . 0.474 ' HD3' HG21 ' B' ' 246' ' ' THR . 11.8 ptmm? -174.9 -18.14 0.01 OUTLIER 'General case' 0 C--O 1.253 1.278 0 O-C-N 123.713 0.302 . . . . 74.010000000000005 111.522 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 54.02 -141.99 32.23 Favored Glycine 0 CA--C 1.5 -0.898 0 CA-C-N 115.574 -0.739 . . . . 72.319999999999993 114.251 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -96.39 4.57 52.11 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.172 -0.677 . . . . 54.299999999999997 109.172 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.455 ' CH2' ' HB3' ' B' ' 276' ' ' LEU . 8.5 m-90 . . . . . 0 N--CA 1.433 -1.29 0 CA-C-N 115.441 -0.8 . . . . 73.230000000000004 112.023 -174.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.563 ' HG2' ' CG2' ' B' ' 261' ' ' THR . 82.8 mtm180 . . . . . 0 N--CA 1.436 -1.152 0 CA-C-O 121.015 0.436 . . . . 73.349999999999994 110.163 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.544 ' HB3' ' ND2' ' B' ' 262' ' ' ASN . 25.9 t-20 -116.4 123.25 47.1 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.525 -0.917 . . . . 75.239999999999995 108.525 178.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' C' ' 263' ' ' SER . 46.7 t -121.94 137.52 54.76 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.854 -0.612 . . . . 73.030000000000001 109.955 -175.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -126.08 124.38 40.48 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.488 -0.93 . . . . 70.209999999999994 108.488 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -83.74 -64.84 1.09 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.554 -0.535 . . . . 73.319999999999993 109.554 -177.201 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -127.49 138.12 52.85 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 109.617 -0.512 . . . . 70.120000000000005 109.617 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.531 HG23 HG13 ' C' ' 267' ' ' VAL . 13.7 mt -133.48 117.44 27.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.15 -1.796 . . . . 64.409999999999997 106.15 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 17.0 ptp180 -124.88 115.65 20.96 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.634 0.731 . . . . 75.409999999999997 110.052 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 49.2 p -110.64 128.34 55.65 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.949 -0.76 . . . . 71.209999999999994 108.949 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -132.33 139.45 48.16 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.23 -0.655 . . . . 52.310000000000002 109.23 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.501 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 44.3 mt-10 59.07 93.05 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.283 1.586 . . . . 70.439999999999998 115.283 171.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.501 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 1.3 mpt_? 61.35 17.17 8.07 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.164 0.985 . . . . 60.32 111.772 175.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -80.15 136.59 36.54 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.082 0.468 . . . . 64.230000000000004 110.525 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.6 OUTLIER -124.95 133.07 53.17 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.385 -1.339 . . . . 72.0 107.385 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.529 HG12 HG22 ' C' ' 275' ' ' VAL . 19.2 m -136.52 149.69 27.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.563 -0.855 . . . . 74.019999999999996 111.772 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.59 ' HG3' HD13 ' C' ' 276' ' ' LEU . 47.7 tp60 -126.07 120.74 31.0 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 114.043 -1.435 . . . . 70.030000000000001 109.079 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.69 ' HB3' HG22 ' B' ' 277' ' ' ILE . 2.1 tm? -120.99 118.55 30.13 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.744 -1.576 . . . . 65.239999999999995 106.744 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.463 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 139.66 -122.91 2.35 Favored Glycine 0 N--CA 1.417 -2.63 0 C-N-CA 119.619 -1.277 . . . . 60.130000000000003 111.91 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -137.76 129.47 28.39 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 110.274 -0.269 . . . . 44.399999999999999 110.274 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.454 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 86.0 t -112.56 123.21 68.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.0 -0.741 . . . . 73.230000000000004 109.0 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 1.6 p -122.67 111.93 32.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 N-CA-C 108.236 -1.024 . . . . 63.409999999999997 108.236 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 20.0 m -70.59 160.53 32.34 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 116.163 -0.472 . . . . 54.229999999999997 109.894 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.61 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -59.28 -46.29 88.93 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.172 0.987 . . . . 50.420000000000002 110.14 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.49 73.48 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 113.633 -1.622 . . . . 72.230000000000004 112.567 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' C' ' 281' ' ' TYR . . . . . . . . 0 N--CA 1.44 -0.963 0 CA-C-N 115.441 -0.799 . . . . 54.140000000000001 111.537 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.433 -1.286 0 N-CA-C 108.578 -0.897 . . . . 54.240000000000002 108.578 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -109.9 123.25 49.28 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.265 -0.643 . . . . 73.310000000000002 109.265 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' C' ' 227' ' ' SER . 13.0 p -125.37 127.64 46.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 110.185 -0.302 . . . . 53.219999999999999 110.185 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.05 137.04 46.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.573 -0.528 . . . . 61.509999999999998 109.573 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 62.3 mm-40 -80.5 -64.61 1.15 Allowed 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 123.043 0.215 . . . . 51.310000000000002 110.759 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 19.0 m -131.98 127.36 36.12 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 119.644 -0.822 . . . . 75.530000000000001 110.299 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.531 HG13 HG23 ' C' ' 231' ' ' ILE . 2.6 p -126.44 122.89 62.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.927 -0.768 . . . . 74.329999999999998 108.927 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 6.0 p -124.0 142.78 39.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.885 -0.598 . . . . 60.240000000000002 110.762 -175.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.92 132.16 9.27 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 110.315 -1.114 . . . . 65.230000000000004 110.315 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -134.28 115.74 14.46 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 109.009 -0.737 . . . . 71.319999999999993 109.009 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.68 94.19 0.04 OUTLIER Glycine 0 CA--C 1.523 0.542 0 O-C-N 123.506 0.504 . . . . 42.539999999999999 114.249 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . 0.491 ' CD ' HH12 ' C' ' 238' ' ' ARG . 43.6 mm-40 62.2 25.64 15.35 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.506 0.928 . . . . 62.43 113.506 176.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 25.0 m -82.28 144.42 30.63 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.679 -0.808 . . . . 64.099999999999994 110.303 -176.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . 0.628 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 63.3 mtt180 -135.86 126.11 26.45 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 105.831 -1.914 . . . . 71.140000000000001 105.831 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.529 HG22 HG12 ' C' ' 239' ' ' VAL . 1.5 m -137.88 142.0 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 119.573 -0.851 . . . . 52.229999999999997 111.496 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.59 HD13 ' HG3' ' C' ' 240' ' ' GLN . 7.5 tp -122.46 112.59 18.24 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.037 0.922 . . . . 63.240000000000002 110.798 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.422 HD11 HD13 ' C' ' 231' ' ' ILE . 1.9 pt -108.67 104.98 17.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-N 114.054 -1.43 . . . . 72.129999999999995 108.544 175.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 149.97 -149.44 21.35 Favored Glycine 0 N--CA 1.419 -2.454 0 CA-C-N 115.408 -0.815 . . . . 54.32 111.533 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -98.1 145.67 26.32 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.499 -0.926 . . . . 75.310000000000002 108.499 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.488 ' HB2' HD21 ' C' ' 276' ' ' LEU . 2.9 tm-20 -137.12 117.91 14.09 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.857 -1.535 . . . . 54.439999999999998 106.857 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.509 ' CD2' ' HB1' ' C' ' 249' ' ' ALA . 42.9 t80 -118.47 124.57 47.92 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 108.882 -0.785 . . . . 61.100000000000001 108.882 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 140.49 -52.95 0.68 Allowed Glycine 0 N--CA 1.416 -2.66 0 N-CA-C 109.371 -1.492 . . . . 73.540000000000006 109.371 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 115.27 -11.31 19.7 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.664 -0.779 . . . . 73.299999999999997 111.787 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -125.12 -5.33 7.33 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 112.581 0.586 . . . . 60.43 112.581 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.33 -121.96 19.25 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 115.777 -0.647 . . . . 72.230000000000004 113.178 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -125.47 13.16 8.15 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.296 -1.001 . . . . 75.340000000000003 108.296 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' C' ' 276' ' ' LEU . 18.0 m-90 . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 114.452 1.279 . . . . 72.340000000000003 114.452 -171.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 . . . . . 0 N--CA 1.436 -1.148 0 N-CA-C 109.355 -0.609 . . . . 72.329999999999998 109.355 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -116.55 137.96 51.77 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.423 -1.695 . . . . 43.409999999999997 106.423 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 7.9 p -128.4 137.43 51.86 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 113.474 0.916 . . . . 63.149999999999999 113.474 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.77 150.44 51.08 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.523 -1.288 . . . . 71.010000000000005 107.523 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -103.3 -50.95 3.34 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.763 -0.829 . . . . 70.129999999999995 108.763 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.441 ' HB2' HG23 ' A' ' 266' ' ' THR . 18.2 m-20 -127.36 140.71 52.0 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 109.577 -0.527 . . . . 65.239999999999995 109.577 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 55.0 mt -136.64 117.09 17.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 105.817 -1.92 . . . . 75.409999999999997 105.817 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.407 ' HB3' HG12 ' A' ' 268' ' ' VAL . 36.7 ttt180 -128.5 128.91 45.24 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.702 -0.481 . . . . 71.510000000000005 109.702 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 36.2 p -121.53 137.5 54.7 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 116.535 -0.302 . . . . 72.319999999999993 110.752 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -131.11 157.22 43.7 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 120.55 -0.46 . . . . 71.040000000000006 110.878 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 63.82 -85.77 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.942 1.297 . . . . 63.109999999999999 113.504 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.76 20.31 4.21 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 121.683 0.754 . . . . 53.210000000000001 109.331 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.523 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -69.86 130.98 43.72 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.792 -0.64 . . . . 75.540000000000006 109.989 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -125.42 135.15 52.07 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 108.075 -1.083 . . . . 74.340000000000003 108.075 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.557 HG22 ' CG2' ' A' ' 275' ' ' VAL . 96.2 t -132.42 145.37 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 121.037 0.446 . . . . 65.420000000000002 110.504 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.455 ' CG ' HD13 ' A' ' 276' ' ' LEU . 6.4 tp-100 -120.21 122.77 41.67 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.204 -1.406 . . . . 71.540000000000006 107.204 172.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.82 119.31 38.15 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.075 -1.083 . . . . 72.219999999999999 108.075 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.642 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 125.55 -132.92 8.15 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 111.305 -0.718 . . . . 52.32 111.305 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -125.1 143.82 50.73 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 117.198 0.499 . . . . 41.32 110.654 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.414 ' CG2' ' HG2' ' A' ' 240' ' ' GLN . 95.7 t -110.74 116.7 53.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.645 -1.243 . . . . 71.530000000000001 107.645 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.4 t -113.94 111.79 37.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 107.914 -1.143 . . . . 73.109999999999999 107.914 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.9 m -101.05 160.62 14.23 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 109.339 -0.615 . . . . 74.109999999999999 109.339 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.11 -32.76 66.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.89 1.276 . . . . 61.409999999999997 111.609 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.32 -48.19 74.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.685 0.794 . . . . 63.32 113.047 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.57 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.294 -0.632 . . . . 63.32 109.294 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 10.0 t . . . . . 0 N--CA 1.423 -1.786 0 N-CA-C 108.662 -0.866 . . . . 72.319999999999993 108.662 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.56 ' OD1' ' HB3' ' B' ' 226' ' ' ASN . 3.8 t30 -126.54 133.0 51.22 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.018 -0.734 . . . . 74.420000000000002 109.018 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' B' ' 227' ' ' SER . 19.6 m -117.93 123.5 45.94 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.587 0.555 . . . . 65.120000000000005 109.706 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 10.2 p -126.92 143.42 40.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.248 -0.649 . . . . 63.310000000000002 109.248 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.594 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 36.8 tt0 -83.6 -82.61 0.15 Allowed 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 120.677 -0.409 . . . . 72.120000000000005 111.004 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 230' ' ' ASP . 81.0 m -115.45 126.69 54.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.663 -0.648 . . . . 71.120000000000005 111.897 -174.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 11.5 t -118.68 120.95 65.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 107.278 -1.379 . . . . 72.150000000000006 107.278 177.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.425 HG23 ' HG3' ' B' ' 232' ' ' ARG . 20.9 m -123.83 136.52 59.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 120.216 -0.594 . . . . 72.140000000000001 111.102 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.408 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -117.48 133.17 10.38 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.92 -0.582 . . . . 75.310000000000002 111.943 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -129.6 147.2 51.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.158 -1.052 . . . . 61.520000000000003 108.158 -177.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.27 -133.39 42.45 Favored Glycine 0 C--O 1.239 0.436 0 C-N-CA 120.972 -0.632 . . . . 75.140000000000001 112.226 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -90.69 83.56 5.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.769 -0.826 . . . . 74.0 108.769 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 75.3 m -104.62 144.07 32.21 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.555 -0.858 . . . . 73.230000000000004 110.693 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 28.0 mmm-85 -133.39 123.05 24.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.05 -2.204 . . . . 73.439999999999998 105.05 171.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.58 HG12 ' HB ' ' B' ' 239' ' ' VAL . 30.6 m -140.0 140.58 35.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.239 0.542 . . . . 61.539999999999999 111.627 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.594 ' HB3' ' CH2' ' A' ' 287' ' ' TRP . 9.4 tp -122.37 124.58 44.0 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 115.663 -0.699 . . . . 64.310000000000002 109.687 175.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.728 HG23 HD12 ' B' ' 241' ' ' LEU . 71.6 mt -110.72 103.45 15.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 107.642 -1.244 . . . . 74.420000000000002 107.642 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 145.52 -135.77 6.13 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.283 -0.871 . . . . 70.329999999999998 111.504 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 46.1 t-20 -129.59 137.64 50.83 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 122.17 -0.606 . . . . 72.329999999999998 109.509 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 285' ' ' GLY . 34.4 tt0 -111.17 127.28 55.54 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.396 -0.964 . . . . 65.019999999999996 108.396 177.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 99.7 m-85 -113.73 124.52 52.47 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.681 -0.859 . . . . 73.310000000000002 108.681 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.57 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 138.99 -87.09 0.21 Allowed Glycine 0 CA--C 1.467 -2.916 0 C-N-CA 120.397 -0.906 . . . . 74.310000000000002 112.211 177.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 141.9 96.94 0.27 Allowed Glycine 0 N--CA 1.406 -3.314 0 N-CA-C 108.555 -1.818 . . . . 72.420000000000002 108.555 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp 80.24 45.25 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 O-C-N 125.106 1.121 . . . . 72.120000000000005 110.296 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.464 ' H ' ' CD ' ' A' ' 280' ' ' GLU . . . -78.17 -54.87 4.24 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 115.431 -0.804 . . . . 54.140000000000001 111.683 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -89.62 -33.83 16.53 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.146 0.498 . . . . 73.010000000000005 110.708 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.594 ' CH2' ' HB3' ' A' ' 276' ' ' LEU . 29.6 m-90 . . . . . 0 C--N 1.303 -1.452 0 CA-C-N 116.334 -0.393 . . . . 55.329999999999998 110.466 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.632 ' HA ' ' O ' ' A' ' 261' ' ' THR . 40.6 ptt180 . . . . . 0 N--CA 1.423 -1.81 0 CA-C-O 121.059 0.457 . . . . 75.209999999999994 110.543 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.56 ' HB3' ' OD1' ' A' ' 262' ' ' ASN . 51.0 t-20 -116.18 148.43 40.38 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 105.285 -2.117 . . . . 74.140000000000001 105.285 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 263' ' ' SER . 3.2 p -139.01 136.78 35.69 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 121.515 0.674 . . . . 73.5 111.829 -175.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -132.13 144.25 50.57 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.726 -1.125 . . . . 54.229999999999997 108.571 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 5.9 tmtm? -96.74 -61.32 1.43 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.948 -0.76 . . . . 62.310000000000002 108.948 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -127.18 139.38 52.98 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 121.807 -0.558 . . . . 61.399999999999999 110.089 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.437 HG21 HG11 ' B' ' 239' ' ' VAL . 6.9 mt -134.96 120.65 31.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.713 -1.588 . . . . 72.140000000000001 106.713 175.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.425 ' HG3' HG23 ' A' ' 268' ' ' VAL . 78.8 ttt-85 -123.36 120.44 33.03 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.408 -0.59 . . . . 74.530000000000001 109.408 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 81.0 p -109.99 128.87 55.66 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.139 -1.059 . . . . 64.519999999999996 108.139 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -137.25 157.17 47.24 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.598 -0.519 . . . . 73.129999999999995 109.598 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.593 ' HB3' ' HD2' ' B' ' 236' ' ' ARG . 6.2 mp0 63.09 -89.09 0.03 OUTLIER 'General case' 0 C--O 1.21 -1.01 0 C-N-CA 124.425 1.09 . . . . 71.409999999999997 113.496 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.593 ' HD2' ' HB3' ' B' ' 235' ' ' GLU . 0.0 OUTLIER -137.2 59.27 1.69 Allowed 'General case' 0 C--O 1.245 0.843 0 N-CA-C 107.701 -1.222 . . . . 73.439999999999998 107.701 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.66 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -99.61 135.19 41.4 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-O 122.353 1.073 . . . . 74.439999999999998 110.399 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 6.1 mpt_? -124.28 133.21 53.54 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 105.691 -1.966 . . . . 73.519999999999996 105.691 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.58 ' HB ' HG12 ' A' ' 275' ' ' VAL . 69.7 t -142.48 133.08 24.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.847 0.832 . . . . 63.420000000000002 111.239 -175.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.584 ' CG ' HD13 ' B' ' 276' ' ' LEU . 44.0 tp60 -105.23 132.51 51.35 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.678 -1.23 . . . . 75.530000000000001 107.678 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.728 HD12 HG23 ' A' ' 277' ' ' ILE . 3.4 tm? -121.85 117.01 25.46 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 106.354 -1.721 . . . . 51.240000000000002 106.354 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.695 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 117.84 -130.05 8.58 Favored Glycine 0 C--O 1.206 -1.632 0 N-CA-C 111.189 -0.764 . . . . 72.209999999999994 111.189 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 5.8 m-20 -124.41 148.4 47.61 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 122.0 -0.706 . . . . 62.340000000000003 112.255 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.551 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 98.5 t -118.3 114.69 45.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.647 -1.242 . . . . 32.299999999999997 107.647 175.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 58.9 t -117.86 111.98 36.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 108.698 -0.853 . . . . 74.430000000000007 108.698 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.492 ' OG1' ' HA3' ' B' ' 282' ' ' GLY . 13.6 p -93.69 161.98 14.12 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 119.895 -0.722 . . . . 54.130000000000003 109.57 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -59.25 -32.54 70.09 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.475 1.131 . . . . 43.439999999999998 109.636 176.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.57 -35.16 65.46 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 112.655 -2.066 . . . . 53.140000000000001 113.5 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -62.31 -26.42 68.41 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.069 0.461 . . . . 71.530000000000001 110.406 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 N--CA 1.433 -1.314 0 CA-C-O 121.807 0.813 . . . . 72.030000000000001 109.022 177.866 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 CA--C 1.559 1.314 0 N-CA-C 108.805 -0.813 . . . . 60.530000000000001 108.805 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 9.0 t -91.99 132.86 36.22 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.082 0.468 . . . . 73.109999999999999 109.78 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 39.9 t-20 -126.56 146.66 50.05 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.695 -0.854 . . . . 74.329999999999998 108.695 -178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 49.3 m -135.65 123.48 22.56 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.023 0.439 . . . . 63.539999999999999 110.207 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.7 p -123.38 150.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.183 -0.673 . . . . 71.340000000000003 109.183 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 39.3 tt0 -93.5 -69.27 0.76 Allowed 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.539 -0.864 . . . . 72.420000000000002 110.409 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 15.6 m -119.53 127.63 53.2 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.104 -1.039 . . . . 65.099999999999994 112.301 -176.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 25.7 t -119.08 120.59 64.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.652 -1.24 . . . . 73.439999999999998 107.652 174.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.83 131.59 69.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 112.248 0.462 . . . . 72.25 112.248 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . 0.409 ' HA2' ' OG1' ' C' ' 233' ' ' THR . . . -109.66 133.89 11.89 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.608 -0.724 . . . . 62.409999999999997 111.886 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.428 ' HB3' ' HG2' ' C' ' 234' ' ' GLU . 16.3 tppt? -131.8 130.23 41.52 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 124.826 1.25 . . . . 71.310000000000002 109.546 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.28 -133.47 14.06 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 110.551 -1.019 . . . . 43.240000000000002 110.551 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 77.1 mm-40 -87.25 97.9 11.03 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 107.849 -1.167 . . . . 74.519999999999996 107.849 176.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 66.1 m -117.86 143.42 46.32 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 119.342 -0.943 . . . . 55.0 110.417 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 18.9 mmm-85 -133.99 123.83 25.26 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 104.259 -2.497 . . . . 65.530000000000001 104.259 172.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.3 t -139.22 140.73 37.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.515 -0.921 . . . . 75.219999999999999 108.515 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.723 ' HB3' ' CH2' ' B' ' 287' ' ' TRP . 3.0 tp -126.79 122.06 33.71 Favored 'General case' 0 C--N 1.26 -3.299 0 N-CA-C 109.651 -0.5 . . . . 72.5 109.651 173.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.493 HG23 HD12 ' C' ' 241' ' ' LEU . 3.2 mp -107.01 103.72 15.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 106.386 -1.709 . . . . 73.239999999999995 106.386 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.695 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 152.48 -140.9 8.01 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 121.061 -0.59 . . . . 25.109999999999999 112.245 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -128.86 135.29 48.89 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.621 -0.881 . . . . 55.450000000000003 108.621 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.426 ' HB2' HD21 ' B' ' 276' ' ' LEU . 41.5 tt0 -111.77 133.69 53.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.814 0.34 . . . . 61.240000000000002 110.225 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -121.87 125.65 46.91 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 115.885 -0.598 . . . . 72.239999999999995 110.988 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.492 ' HA3' ' OG1' ' B' ' 246' ' ' THR . . . 133.37 -99.55 0.37 Allowed Glycine 0 CA--C 1.48 -2.156 0 C-N-CA 120.559 -0.829 . . . . 71.549999999999997 112.725 174.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 178.34 112.32 0.33 Allowed Glycine 0 C--N 1.277 -2.706 0 N-CA-C 108.106 -1.997 . . . . 60.240000000000002 108.106 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? 78.01 -50.88 0.5 Allowed 'General case' 0 C--O 1.197 -1.677 0 C-N-CA 124.217 1.007 . . . . 71.019999999999996 112.537 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' B' ' 246' ' ' THR . . . 46.5 -102.31 0.04 OUTLIER Glycine 0 C--O 1.244 0.779 0 O-C-N 124.439 1.087 . . . . 12.210000000000001 114.983 175.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -70.75 -28.42 64.68 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 123.959 0.904 . . . . 75.430000000000007 111.382 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.723 ' CH2' ' HB3' ' B' ' 276' ' ' LEU . 22.8 m-90 . . . . . 0 C--N 1.309 -1.152 0 O-C-N 122.052 -0.405 . . . . 74.540000000000006 111.645 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.577 ' HA ' ' O ' ' B' ' 261' ' ' THR . 56.4 ttp180 . . . . . 0 N--CA 1.437 -1.08 0 CA-C-O 120.904 0.383 . . . . 73.019999999999996 110.304 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 23.2 t-20 -106.95 142.76 36.06 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.72 -1.956 . . . . 62.030000000000001 105.72 175.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 9.1 p -139.98 137.31 34.6 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.216 -0.994 . . . . 74.310000000000002 113.101 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -127.45 142.02 51.52 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.101 -0.954 . . . . 60.43 109.435 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 49.0 tptt -87.81 -66.61 0.89 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.964 -0.562 . . . . 70.409999999999997 110.537 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -133.68 138.93 46.13 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.959 -0.756 . . . . 71.400000000000006 108.959 -175.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.413 HG23 ' HB ' ' C' ' 267' ' ' VAL . 10.7 mt -135.38 120.52 28.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.721 -1.214 . . . . 62.310000000000002 107.721 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 77.7 ttt180 -122.85 121.64 36.73 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 109.351 -0.611 . . . . 74.450000000000003 109.351 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 68.5 p -110.46 127.92 55.36 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.466 -0.939 . . . . 30.510000000000002 108.466 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' B' ' 270' ' ' LYS . 34.5 mt-10 -130.13 152.27 49.75 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 119.99 -0.684 . . . . 50.329999999999998 112.0 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 48.8 mt-10 69.8 -77.81 0.05 Allowed 'General case' 0 C--O 1.194 -1.84 0 CA-C-N 113.84 -1.527 . . . . 71.409999999999997 113.854 172.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.1 56.8 1.47 Allowed 'General case' 0 C--O 1.245 0.819 0 N-CA-C 107.134 -1.432 . . . . 74.140000000000001 107.134 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -104.12 135.11 46.23 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 122.492 1.139 . . . . 65.530000000000001 111.292 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 4.8 mpt_? -124.86 133.16 53.19 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 106.071 -1.825 . . . . 75.109999999999999 106.071 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.492 HG22 ' HB ' ' C' ' 275' ' ' VAL . 94.9 t -141.52 134.68 30.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.418 0.628 . . . . 74.209999999999994 110.766 -176.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.566 ' CG ' HD13 ' C' ' 276' ' ' LEU . 5.1 tp-100 -105.3 129.5 53.63 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.646 -1.242 . . . . 72.439999999999998 107.646 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.493 HD12 HG23 ' B' ' 277' ' ' ILE . 3.4 tm? -122.42 116.01 23.24 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.048 -1.834 . . . . 72.400000000000006 106.048 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.447 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 130.0 -111.07 1.11 Allowed Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 119.668 -1.253 . . . . 64.439999999999998 112.859 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.01 148.91 34.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.738 -0.467 . . . . 72.519999999999996 109.738 -174.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.515 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 91.6 t -126.94 114.94 39.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.852 -0.795 . . . . 75.120000000000005 108.852 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.87 111.77 37.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.859 -0.793 . . . . 74.340000000000003 108.859 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.3 m -85.56 160.97 19.52 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.548 -0.908 . . . . 60.5 108.548 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -63.09 -34.24 77.17 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 122.444 1.116 . . . . 63.119999999999997 109.294 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.92 -35.62 66.81 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 113.14 -1.846 . . . . 72.109999999999999 111.671 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.814 0 CA-C-N 116.383 -0.371 . . . . 54.009999999999998 111.387 -178.108 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.419 -1.994 0 N-CA-C 108.369 -0.975 . . . . 73.099999999999994 108.369 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -113.52 128.07 56.31 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.317 -0.856 . . . . 65.329999999999998 109.58 -176.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.2 m -117.61 123.25 45.73 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.033 -0.728 . . . . 75.319999999999993 109.033 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -117.67 148.74 20.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.178 -1.045 . . . . 74.329999999999998 108.178 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 43.0 tt0 -90.44 -84.66 0.23 Allowed 'General case' 0 N--CA 1.415 -2.184 0 C-N-CA 120.355 -0.538 . . . . 54.409999999999997 110.269 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 20.0 m -110.59 130.31 55.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.774 -0.77 . . . . 74.150000000000006 110.477 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.413 ' HB ' HG23 ' C' ' 231' ' ' ILE . 40.6 t -117.85 120.77 65.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.72 -1.215 . . . . 74.219999999999999 107.72 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.1 p -127.61 131.96 69.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 120.411 -0.515 . . . . 73.109999999999999 110.987 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.14 133.61 11.7 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 108.912 -1.675 . . . . 71.310000000000002 108.912 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -132.33 132.95 43.45 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.716 -0.846 . . . . 73.219999999999999 108.716 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.5 -125.23 10.21 Favored Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 120.428 -0.891 . . . . 41.409999999999997 111.346 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -91.84 97.55 11.05 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.521 -1.288 . . . . 74.319999999999993 107.521 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 33.4 m -127.61 145.07 51.0 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 113.45 0.907 . . . . 43.509999999999998 113.45 -175.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 34.5 mmm-85 -133.46 124.79 27.69 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 104.919 -2.252 . . . . 70.420000000000002 104.919 173.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.492 ' HB ' HG22 ' C' ' 239' ' ' VAL . 4.2 t -139.4 140.55 37.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 118.634 0.652 . . . . 61.32 109.729 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.685 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 5.1 tp -126.94 119.73 27.42 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-O 121.374 0.606 . . . . 72.209999999999994 109.397 172.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.405 HD12 HD13 ' C' ' 231' ' ' ILE . 54.9 mt -108.45 103.4 15.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 105.719 -1.956 . . . . 75.120000000000005 105.719 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 146.24 -146.71 17.05 Favored Glycine 0 N--CA 1.427 -1.944 0 C-N-CA 120.721 -0.752 . . . . 54.039999999999999 111.352 -175.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -121.72 140.33 52.45 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.577 -0.897 . . . . 62.049999999999997 108.577 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.527 ' HB2' HD21 ' C' ' 276' ' ' LEU . 36.0 tt0 -118.63 118.35 31.41 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.973 -0.751 . . . . 74.329999999999998 108.973 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -107.72 125.82 51.85 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 109.92 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 131.28 -129.25 5.66 Favored Glycine 0 N--CA 1.427 -1.935 0 C-N-CA 120.749 -0.738 . . . . 52.229999999999997 112.332 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -157.02 111.58 0.49 Allowed Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.52 -1.432 . . . . 62.450000000000003 109.52 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 63.56 38.14 9.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.957 0.903 . . . . 62.030000000000001 109.785 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -60.93 -68.15 1.8 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.355 -0.839 . . . . 65.420000000000002 113.53 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -89.72 -46.17 8.8 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.661 -0.496 . . . . 74.530000000000001 109.661 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.685 ' CH2' ' HB3' ' C' ' 276' ' ' LEU . 24.4 m-90 . . . . . 0 CA--C 1.493 -1.215 0 CA-C-N 116.101 -0.5 . . . . 71.109999999999999 109.892 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.879 0 CA-C-O 121.227 0.536 . . . . 74.299999999999997 110.877 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -80.84 131.86 35.42 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.017 -1.846 . . . . 73.049999999999997 106.017 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 10.6 m -120.98 137.88 54.42 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 120.061 -0.656 . . . . 73.109999999999999 111.484 -171.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.76 118.46 19.07 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.584 -1.636 . . . . 64.409999999999997 106.584 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.523 ' HE2' ' O ' ' A' ' 265' ' ' GLU . 5.7 tmmm? -86.36 -38.58 17.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.832 -0.433 . . . . 73.019999999999996 109.832 -176.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -143.82 138.77 28.93 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.142 -0.688 . . . . 61.409999999999997 109.142 174.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 60.7 mt -130.77 126.7 60.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 105.149 -2.167 . . . . 74.349999999999994 105.149 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.413 ' HE ' ' HB2' ' A' ' 232' ' ' ARG . 10.1 ttm180 -134.44 116.21 14.89 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.954 -0.758 . . . . 61.200000000000003 108.954 -177.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 31.3 p -123.42 127.74 48.86 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 110.121 -0.325 . . . . 74.230000000000004 110.121 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -144.65 145.97 32.02 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 120.86 0.362 . . . . 74.409999999999997 111.304 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 63.49 86.68 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.968 1.307 . . . . 75.439999999999998 113.989 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.51 26.43 16.06 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.014 -0.994 . . . . 74.219999999999999 111.865 177.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.49 144.64 27.16 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.825 -0.625 . . . . 63.109999999999999 109.855 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -127.24 135.49 50.69 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.932 -0.766 . . . . 74.420000000000002 108.932 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 3.3 p -132.98 145.21 34.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.952 0.882 . . . . 72.049999999999997 112.738 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -124.84 130.42 52.35 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.062 -1.458 . . . . 64.120000000000005 107.062 170.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -128.43 118.56 23.33 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.533 -1.284 . . . . 54.350000000000001 107.533 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.19 -116.79 1.8 Allowed Glycine 0 N--CA 1.427 -1.945 0 C-N-CA 119.603 -1.284 . . . . 31.539999999999999 114.123 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . 0.426 ' OD1' HG13 ' A' ' 245' ' ' VAL . 15.6 t-20 -144.48 128.69 17.73 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 122.968 0.507 . . . . 75.049999999999997 110.178 -175.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 50.2 t -108.77 114.01 45.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.376 -0.602 . . . . 75.230000000000004 109.376 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . 0.43 HG12 ' HD2' ' A' ' 281' ' ' TYR . 15.7 m -103.33 121.82 55.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.885 -0.783 . . . . 71.209999999999994 108.885 175.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.587 ' OG1' ' HA3' ' A' ' 282' ' ' GLY . 24.0 p -92.64 160.63 14.92 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.591 -1.244 . . . . 51.520000000000003 111.18 176.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.27 -34.5 78.26 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 123.78 0.832 . . . . 71.140000000000001 112.564 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -70.14 -35.37 74.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.079 0.466 . . . . 65.219999999999999 111.959 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.612 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.311 -1.09 0 CA-C-N 115.704 -0.68 . . . . 64.109999999999999 111.201 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 8.0 m . . . . . 0 N--CA 1.424 -1.76 0 N-CA-C 109.285 -0.635 . . . . 63.32 109.285 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -120.26 133.61 55.44 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.046 -1.094 . . . . 73.219999999999999 108.046 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 18.2 m -142.31 130.4 22.0 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.974 -0.454 . . . . 50.119999999999997 112.218 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -114.1 133.35 60.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 109.529 -0.545 . . . . 73.230000000000004 109.529 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.523 ' O ' ' HE2' ' A' ' 229' ' ' LYS . 71.5 mm-40 -78.4 -50.87 10.94 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 116.331 -0.395 . . . . 72.430000000000007 110.09 177.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 90.5 m -145.92 127.24 14.88 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.34 -0.85 . . . . 62.149999999999999 111.275 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.0 p -120.81 120.39 62.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.566 -0.743 . . . . 74.420000000000002 109.053 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.7 130.48 72.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.58 -0.737 . . . . 72.239999999999995 109.447 -175.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.42 131.92 8.56 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.293 -1.123 . . . . 72.519999999999996 110.293 174.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 22.8 tptt -134.01 116.7 15.83 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 110.057 -0.349 . . . . 73.549999999999997 110.057 -177.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.33 90.47 0.21 Allowed Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.33 -0.938 . . . . 70.200000000000003 113.303 174.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.498 ' HB3' ' NH1' ' A' ' 274' ' ' ARG . 19.5 mt-10 58.58 37.89 25.34 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.598 0.962 . . . . 72.219999999999999 113.598 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 15.5 m -88.43 143.7 26.83 Favored 'General case' 0 C--N 1.274 -2.682 0 C-N-CA 118.639 -1.224 . . . . 72.420000000000002 109.386 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . 0.498 ' NH1' ' HB3' ' A' ' 272' ' ' GLU . 9.2 mpt_? -116.6 127.03 54.11 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.369 -1.715 . . . . 71.439999999999998 106.369 174.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.551 HG12 ' CG1' ' B' ' 239' ' ' VAL . 17.2 m -126.41 123.42 63.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-O 121.458 0.647 . . . . 72.209999999999994 109.952 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 5.4 tt -113.57 111.77 22.43 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.744 -1.576 . . . . 55.210000000000001 106.744 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.623 HG23 HD12 ' B' ' 241' ' ' LEU . 60.0 mt -112.36 107.33 22.7 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 CA-C-O 121.612 0.72 . . . . 63.340000000000003 110.122 -177.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 137.61 -135.27 7.47 Favored Glycine 0 N--CA 1.426 -1.993 0 CA-C-N 115.533 -0.758 . . . . 61.219999999999999 112.139 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 3.1 m120 -104.09 134.34 47.51 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 112.06 0.392 . . . . 73.319999999999993 112.06 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -113.2 117.92 33.25 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 103.401 -2.814 . . . . 74.010000000000005 103.401 167.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 16.0 t80 -130.13 123.61 30.76 Favored 'General case' 0 C--O 1.264 1.818 0 CA-C-O 122.54 1.162 . . . . 73.120000000000005 113.514 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.612 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 129.98 -77.27 0.4 Allowed Glycine 0 N--CA 1.415 -2.734 0 CA-C-N 113.475 -1.693 . . . . 42.539999999999999 114.938 175.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -61.27 -81.74 0.08 OUTLIER Glycine 0 C--N 1.317 -0.508 0 N-CA-C 115.708 1.043 . . . . 72.430000000000007 115.708 -170.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -178.67 -35.95 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.122 -1.807 . . . . 73.019999999999996 106.122 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' B' ' 287' ' ' TRP . . . -158.35 -167.41 19.16 Favored Glycine 0 N--CA 1.401 -3.652 0 CA-C-N 113.73 -1.577 . . . . 74.239999999999995 109.541 176.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.416 ' HE1' ' CZ2' ' B' ' 287' ' ' TRP . 41.7 p90 -104.25 -169.66 1.66 Allowed 'General case' 0 C--N 1.294 -1.825 0 O-C-N 124.105 0.532 . . . . 72.129999999999995 110.468 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 27.8 p90 . . . . . 0 C--N 1.313 -0.985 0 C-N-CA 124.455 1.102 . . . . 70.109999999999999 113.02 179.177 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 261' ' ' THR . 14.7 ttt180 . . . . . 0 N--CA 1.437 -1.082 0 CA-C-O 120.793 0.33 . . . . 71.409999999999997 111.707 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -85.92 126.34 34.02 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.213 -2.143 . . . . 40.439999999999998 105.213 171.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' B' ' 263' ' ' SER . 18.7 m -121.25 136.61 54.94 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.789 -0.765 . . . . 74.010000000000005 111.746 -174.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.62 119.19 26.43 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.474 -1.306 . . . . 74.409999999999997 107.474 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.582 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 33.5 ttmt -75.74 -61.73 1.82 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.059 -0.719 . . . . 73.209999999999994 109.059 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -128.32 137.7 52.05 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 109.373 -0.602 . . . . 74.230000000000004 109.373 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.451 ' HA ' HG13 ' B' ' 267' ' ' VAL . 40.0 mt -128.6 128.16 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.791 0 N-CA-C 104.956 -2.238 . . . . 44.039999999999999 104.956 174.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.513 ' HB3' HG12 ' B' ' 268' ' ' VAL . 16.0 ttm180 -132.25 114.09 14.03 Favored 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 108.537 -0.912 . . . . 73.030000000000001 108.537 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 45.7 p -110.04 127.89 55.1 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.243 -1.762 . . . . 72.230000000000004 106.243 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' B' ' 270' ' ' LYS . 48.4 mt-10 -143.31 140.5 30.61 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.007 -0.738 . . . . 74.040000000000006 109.007 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 60.89 97.66 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 O-C-N 124.032 0.833 . . . . 61.450000000000003 113.212 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.535 ' HB2' ' H ' ' B' ' 272' ' ' GLU . 2.0 mpt_? 60.37 22.61 12.15 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.031 0.533 . . . . 61.399999999999999 111.533 173.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.58 140.53 33.63 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.189 0.519 . . . . 54.25 110.895 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.94 134.76 46.01 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.685 -0.688 . . . . 74.549999999999997 109.498 178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.582 HG23 ' HB ' ' B' ' 275' ' ' VAL . 7.2 p -137.53 150.01 25.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.271 0.558 . . . . 31.309999999999999 110.204 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.485 HE22 ' N ' ' B' ' 243' ' ' ASN . 22.5 tm0? -122.63 128.13 50.26 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 105.663 -1.977 . . . . 54.140000000000001 105.663 170.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.623 HD12 HG23 ' A' ' 277' ' ' ILE . 3.3 tm? -118.33 117.91 30.37 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.16 -2.163 . . . . 74.540000000000006 105.16 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.437 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 143.19 -125.56 2.6 Favored Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 118.695 -1.717 . . . . 43.439999999999998 112.852 -178.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.533 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 2.8 t-20 -144.44 128.22 17.28 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 110.292 -0.262 . . . . 74.019999999999996 110.292 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.418 HG21 ' HZ3' ' B' ' 287' ' ' TRP . 30.0 t -99.54 128.0 51.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.105 -1.442 . . . . 74.340000000000003 107.105 177.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 10.5 t -122.51 116.07 47.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 107.381 -1.34 . . . . 74.230000000000004 107.381 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.9 p -85.02 158.07 20.57 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 117.1 -1.84 . . . . 72.25 111.065 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -66.57 -47.1 73.85 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.61 1.195 . . . . 71.310000000000002 110.035 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.81 -33.49 61.6 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.243 -2.253 . . . . 51.219999999999999 113.795 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.532 ' HB2' ' HA3' ' B' ' 282' ' ' GLY . . . -58.7 -42.84 89.54 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.078 0.551 . . . . 53.240000000000002 111.171 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 N--CA 1.484 1.244 0 C-N-CA 124.807 1.243 . . . . 72.340000000000003 112.549 -179.103 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.399 -2.996 0 N-CA-C 103.618 -2.734 . . . . 63.32 103.618 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 13.9 m -94.47 108.44 20.38 Favored 'General case' 0 N--CA 1.417 -2.114 0 C-N-CA 119.208 -0.997 . . . . 74.099999999999994 109.446 -175.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -104.19 128.54 51.92 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.147 -1.057 . . . . 72.010000000000005 108.147 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' B' ' 227' ' ' SER . 38.6 t -142.78 136.09 28.51 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-O 121.074 0.464 . . . . 73.109999999999999 111.747 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 9.4 p -116.39 137.25 50.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.982 -0.554 . . . . 74.510000000000005 110.076 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.582 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 31.7 mm-40 -78.02 -57.44 3.79 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.866 -0.79 . . . . 75.200000000000003 108.866 176.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 88.0 m -146.96 126.98 13.65 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.661 0.743 . . . . 73.010000000000005 111.387 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' B' ' 231' ' ' ILE . 1.3 p -121.91 120.51 61.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.271 -0.877 . . . . 73.430000000000007 109.603 176.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' B' ' 232' ' ' ARG . 34.2 m -121.06 145.59 27.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 116.044 -0.526 . . . . 73.219999999999999 110.194 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -143.82 132.79 5.06 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 120.097 -1.049 . . . . 43.520000000000003 112.4 176.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' B' ' 234' ' ' GLU . 65.0 mttm -133.92 131.01 38.56 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.724 0.81 . . . . 73.319999999999993 112.319 176.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.03 86.57 0.59 Allowed Glycine 0 C--N 1.296 -1.679 0 N-CA-C 114.476 0.551 . . . . 54.219999999999999 114.476 172.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . 0.535 ' H ' ' HB2' ' B' ' 236' ' ' ARG . 65.3 mm-40 65.95 27.65 10.76 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 112.193 0.442 . . . . 74.439999999999998 112.193 173.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 12.9 m -83.54 143.15 30.37 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.29 0.567 . . . . 74.109999999999999 110.149 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.539 ' HB2' ' HG3' ' C' ' 238' ' ' ARG . 10.9 mpt_? -123.47 127.63 48.66 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.521 -1.659 . . . . 64.5 106.521 174.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.582 ' HB ' HG23 ' B' ' 239' ' ' VAL . 5.9 t -127.41 133.9 66.91 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 108.45 -0.945 . . . . 65.439999999999998 108.45 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.522 HD22 HE21 ' C' ' 240' ' ' GLN . 4.4 tt -121.99 112.82 18.75 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.011 -1.477 . . . . 73.129999999999995 107.011 171.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.675 HG23 HD12 ' C' ' 241' ' ' LEU . 39.4 mt -112.83 107.0 21.87 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 109.131 -0.692 . . . . 62.520000000000003 109.131 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 149.95 -137.58 6.28 Favored Glycine 0 N--CA 1.405 -3.38 0 C-N-CA 119.948 -1.12 . . . . 41.229999999999997 112.188 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 27.7 t-20 -119.03 133.18 55.97 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.998 -0.601 . . . . 44.420000000000002 110.133 -178.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -109.89 118.64 37.01 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 104.603 -2.369 . . . . 74.239999999999995 104.603 177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -120.05 123.43 43.39 Favored 'General case' 0 C--O 1.274 2.369 0 CA-C-O 122.535 1.16 . . . . 73.5 110.379 -172.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' B' ' 249' ' ' ALA . . . 111.91 -55.66 0.5 Allowed Glycine 0 N--CA 1.398 -3.9 0 CA-C-N 114.064 -1.425 . . . . 53.130000000000003 115.385 172.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.43 -97.91 0.03 OUTLIER Glycine 0 C--N 1.313 -0.737 0 N-CA-C 115.655 1.022 . . . . 72.299999999999997 115.655 -171.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 42.8 tptt 173.92 -42.06 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 103.94 -2.615 . . . . 72.319999999999993 103.94 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -147.09 161.68 28.49 Favored Glycine 1 N--CA 1.387 -4.591 0 N-CA-C 106.215 -2.754 . . . . 62.240000000000002 106.215 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -83.4 -153.63 0.14 Allowed 'General case' 0 C--N 1.278 -2.509 0 O-C-N 124.358 0.681 . . . . 75.150000000000006 110.56 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.5 ' HE1' ' HB3' ' B' ' 274' ' ' ARG . 34.4 p90 . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 125.756 1.623 . . . . 65.140000000000001 113.629 177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' B' ' 261' ' ' THR . 47.5 ttt180 . . . . . 0 N--CA 1.436 -1.156 0 CA-C-O 120.822 0.344 . . . . 71.329999999999998 111.301 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -93.23 124.93 37.56 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 104.962 -2.236 . . . . 75.120000000000005 104.962 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' B' ' 263' ' ' SER . 8.1 m -121.69 136.22 54.95 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.976 -0.689 . . . . 71.120000000000005 110.856 -174.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.38 119.02 30.92 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.829 -1.545 . . . . 70.430000000000007 106.829 174.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.543 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.8 OUTLIER -82.17 -54.72 5.04 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 116.301 -0.409 . . . . 74.140000000000001 109.958 -174.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -131.46 137.41 48.58 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.462 -1.31 . . . . 71.200000000000003 107.462 173.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.433 ' HA ' HG13 ' C' ' 267' ' ' VAL . 30.8 mt -130.73 128.79 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 104.983 -2.228 . . . . 73.319999999999993 104.983 174.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.491 ' HB3' HG12 ' C' ' 268' ' ' VAL . 10.7 ttm180 -133.05 113.85 13.26 Favored 'General case' 0 N--CA 1.401 -2.896 0 N-CA-C 108.758 -0.831 . . . . 72.319999999999993 108.758 -176.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.44 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 40.9 p -110.79 126.22 54.39 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.856 -1.164 . . . . 63.530000000000001 107.856 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 48.4 mt-10 -145.14 142.24 29.45 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 110.271 -0.27 . . . . 75.340000000000003 110.271 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 64.49 89.59 0.09 Allowed 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.437 1.085 . . . . 61.350000000000001 113.113 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.459 ' HB2' ' H ' ' C' ' 272' ' ' GLU . 4.8 mpt_? 64.75 15.99 10.13 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.993 -1.003 . . . . 71.430000000000007 112.026 174.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.47 140.97 28.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.289 0.566 . . . . 64.219999999999999 112.481 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.539 ' HG3' ' HB2' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -128.47 135.75 49.89 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.021 -0.733 . . . . 70.519999999999996 109.021 178.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' C' ' 275' ' ' VAL . 7.1 p -138.85 147.53 24.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.452 0.644 . . . . 72.530000000000001 111.469 -177.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.522 HE21 HD22 ' B' ' 276' ' ' LEU . 13.3 tm0? -117.35 132.54 56.57 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 104.506 -2.405 . . . . 74.120000000000005 104.506 172.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.675 HD12 HG23 ' B' ' 277' ' ' ILE . 3.4 tm? -129.68 117.79 20.88 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 106.319 -1.734 . . . . 72.120000000000005 106.319 177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.31 -117.65 1.66 Allowed Glycine 0 N--CA 1.426 -1.999 0 C-N-CA 119.912 -1.137 . . . . 64.049999999999997 112.474 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.6 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 18.1 t-20 -144.4 134.33 23.91 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.798 0.333 . . . . 65.430000000000007 111.435 -176.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.31 123.61 68.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.49 -0.93 . . . . 74.310000000000002 108.49 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.456 HG13 ' OD1' ' C' ' 243' ' ' ASN . 31.5 m -121.43 117.2 51.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-O 121.625 0.726 . . . . 72.109999999999999 109.143 177.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . 0.526 ' OG1' ' HA3' ' C' ' 282' ' ' GLY . 12.4 p -83.76 158.55 21.7 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 117.871 -1.532 . . . . 63.130000000000003 109.969 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.93 89.73 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.934 1.35 . . . . 71.109999999999999 108.632 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.19 62.36 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 112.374 -2.193 . . . . 34.100000000000001 112.826 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.549 0 N-CA-C 112.908 0.707 . . . . 74.329999999999998 112.908 -177.322 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.427 -1.614 0 CA-C-O 120.666 0.27 . . . . 72.409999999999997 110.706 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -97.89 138.81 34.68 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.213 -1.402 . . . . 73.129999999999995 107.213 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 45.6 m -142.58 136.12 28.91 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.639 -0.663 . . . . 54.030000000000001 111.11 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.96 130.56 74.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.101 -0.703 . . . . 64.329999999999998 109.101 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 5.5 mm-40 -75.09 -47.14 30.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.051 0.453 . . . . 65.540000000000006 110.904 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 69.8 m -150.41 127.88 11.47 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 122.005 -0.434 . . . . 74.109999999999999 110.623 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' C' ' 231' ' ' ILE . 1.1 p -126.1 119.8 55.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.983 -0.747 . . . . 75.109999999999999 108.983 174.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' C' ' 232' ' ' ARG . 25.8 m -121.04 144.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.262 -0.644 . . . . 75.340000000000003 109.262 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.33 132.42 6.65 Favored Glycine 0 CA--C 1.473 -2.558 0 N-CA-C 110.705 -0.958 . . . . 52.530000000000001 110.705 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.59 128.83 36.0 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 109.499 -0.556 . . . . 75.310000000000002 109.499 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.6 75.49 1.15 Allowed Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.357 -0.925 . . . . 44.450000000000003 113.718 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . 0.459 ' H ' ' HB2' ' C' ' 236' ' ' ARG . 53.1 mt-10 60.52 40.81 16.53 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.389 0.676 . . . . 61.219999999999999 112.269 175.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.4 m -81.98 143.81 31.33 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 119.221 -0.992 . . . . 73.0 109.482 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . 0.445 ' HB3' ' HE1' ' C' ' 287' ' ' TRP . 1.3 mpp_? -120.2 127.0 52.04 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.545 -1.65 . . . . 73.129999999999995 106.545 173.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' C' ' 239' ' ' VAL . 3.0 t -135.54 140.18 45.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 109.315 -0.624 . . . . 62.509999999999998 109.315 -175.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.534 HD12 ' CZ3' ' C' ' 287' ' ' TRP . 4.0 tt -128.17 115.6 18.64 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.145 -1.798 . . . . 64.400000000000006 106.145 170.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.416 HD12 HD13 ' C' ' 231' ' ' ILE . 56.7 mt -112.73 104.31 16.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.047 -1.464 . . . . 74.540000000000006 107.047 176.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.12 -139.5 6.72 Favored Glycine 0 N--CA 1.403 -3.507 0 C-N-CA 119.89 -1.147 . . . . 71.109999999999999 111.476 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . 0.456 ' HB3' HD22 ' C' ' 243' ' ' ASN . 28.5 t-20 -122.87 130.29 52.69 Favored 'General case' 0 C--N 1.279 -2.466 0 O-C-N 123.807 0.357 . . . . 64.519999999999996 110.237 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.88 117.9 34.64 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.618 -1.623 . . . . 75.040000000000006 106.618 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -124.77 123.94 41.06 Favored 'General case' 0 C--O 1.272 2.245 0 CA-C-O 122.394 1.092 . . . . 72.319999999999993 111.794 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . 0.526 ' HA3' ' OG1' ' C' ' 246' ' ' THR . . . 128.2 -53.91 0.79 Allowed Glycine 0 N--CA 1.419 -2.459 0 CA-C-N 114.193 -1.367 . . . . 63.409999999999997 113.515 178.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -80.48 -97.62 0.35 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.493 -0.86 . . . . 74.519999999999996 114.104 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 52.5 tttp 170.43 -34.11 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 104.877 -2.268 . . . . 74.109999999999999 104.877 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -143.05 156.31 26.4 Favored Glycine 0 N--CA 1.404 -3.442 0 N-CA-C 106.479 -2.649 . . . . 52.039999999999999 106.479 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -89.08 -166.09 1.51 Allowed 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 117.258 0.529 . . . . 70.340000000000003 109.719 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.534 ' CZ3' HD12 ' C' ' 276' ' ' LEU . 43.4 p90 . . . . . 0 C--O 1.248 1.01 0 C-N-CA 123.409 0.684 . . . . 64.409999999999997 110.756 178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 225' ' ' ARG . 24.5 mmt180 . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 121.616 0.722 . . . . 72.409999999999997 111.318 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.484 ' HB2' ' OD1' ' A' ' 262' ' ' ASN . 23.4 p-10 -116.88 156.0 28.09 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 125.23 1.412 . . . . 71.120000000000005 111.675 -173.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 263' ' ' SER . 23.4 m -116.99 136.53 52.87 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 108.813 -0.81 . . . . 63.030000000000001 108.813 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.7 135.34 43.98 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.267 -0.879 . . . . 70.409999999999997 110.285 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 1.9 tmtp? -87.84 -63.93 1.23 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.723 -0.671 . . . . 63.130000000000003 110.367 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -131.03 139.03 49.89 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.166 -0.334 . . . . 61.509999999999998 110.52 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.6 mt -137.8 128.15 36.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.029 -1.471 . . . . 73.319999999999993 107.029 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.467 ' HB2' HG12 ' A' ' 268' ' ' VAL . 65.0 mtt180 -134.41 115.14 13.67 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.437 -0.505 . . . . 71.430000000000007 109.706 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.505 HG21 ' HB ' ' A' ' 239' ' ' VAL . 28.9 p -118.95 128.31 54.29 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.415 -0.514 . . . . 74.349999999999994 109.868 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.3 153.29 46.42 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.904 -0.406 . . . . 55.32 109.904 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 63.46 83.44 0.16 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.603 1.161 . . . . 71.5 113.036 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 236' ' ' ARG . 6.1 mpt_? 58.83 22.79 10.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.913 1.285 . . . . 73.109999999999999 112.436 176.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.6 142.03 27.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 122.173 -0.329 . . . . 34.149999999999999 110.445 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.75 137.16 53.8 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.825 -0.435 . . . . 72.040000000000006 109.825 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.505 ' HB ' HG21 ' A' ' 233' ' ' THR . 3.1 p -129.16 142.59 43.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.453 0.644 . . . . 44.439999999999998 111.777 -176.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -125.99 125.38 42.6 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 108.496 -0.928 . . . . 72.439999999999998 108.496 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.422 ' HA ' HG13 ' A' ' 277' ' ' ILE . 59.7 tp -115.88 123.87 49.22 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.454 -0.943 . . . . 74.239999999999995 108.454 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.564 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 121.09 -123.54 5.57 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.382 -0.913 . . . . 71.299999999999997 112.166 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . 0.616 ' ND2' HD22 ' A' ' 279' ' ' ASN . 2.1 t-20 -141.76 128.57 20.51 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 122.196 -0.591 . . . . 61.43 111.524 -174.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 51.3 t -104.11 122.45 56.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.201 -1.407 . . . . 73.430000000000007 107.201 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.7 t -118.17 116.26 50.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.401 -0.592 . . . . 60.439999999999998 109.401 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.3 t -114.34 162.1 17.05 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 119.977 -0.689 . . . . 71.5 109.393 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.37 -32.0 62.24 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 114.862 1.43 . . . . 75.430000000000007 114.862 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.41 -37.54 65.19 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.823 1.416 . . . . 71.340000000000003 114.823 -173.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.919 0 N-CA-C 112.542 0.571 . . . . 62.219999999999999 112.542 179.814 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 N--CA 1.435 -1.211 0 N-CA-C 107.543 -1.28 . . . . 73.109999999999999 107.543 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 25.0 t-20 -86.45 121.45 29.01 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 119.847 -0.741 . . . . 73.349999999999994 109.378 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 227' ' ' SER . 50.8 m -142.32 132.77 25.09 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.554 -0.748 . . . . 72.540000000000006 111.079 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.4 p -126.82 138.22 55.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.603 -0.272 . . . . 73.340000000000003 111.6 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 55.3 mm-40 -78.11 -66.48 0.84 Allowed 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 116.031 -0.532 . . . . 74.230000000000004 110.825 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 30.1 m -133.63 126.97 32.01 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.23 -0.588 . . . . 73.519999999999996 110.41 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.72 121.68 55.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.637 -0.711 . . . . 75.099999999999994 109.601 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 232' ' ' ARG . 15.9 m -126.05 146.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-O 121.112 0.482 . . . . 74.430000000000007 111.568 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -130.02 131.26 6.54 Favored Glycine 0 N--CA 1.425 -2.073 0 N-CA-C 109.096 -1.601 . . . . 61.119999999999997 109.096 174.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.498 ' HB2' ' HG2' ' B' ' 234' ' ' GLU . 29.8 mmmt -133.25 116.14 15.82 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 120.565 0.221 . . . . 44.32 110.946 -176.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 83.68 84.05 0.91 Allowed Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 119.314 -1.422 . . . . 42.420000000000002 113.657 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 60.2 27.27 16.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.88 0.872 . . . . 73.530000000000001 111.74 171.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 17.4 m -84.11 145.49 28.4 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.281 0.563 . . . . 63.439999999999998 110.85 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -113.2 127.44 56.18 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.989 -1.856 . . . . 74.099999999999994 105.989 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 1.2 p -133.66 123.1 44.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-O 121.379 0.609 . . . . 70.129999999999995 111.418 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.529 HD23 ' CH2' ' A' ' 287' ' ' TRP . 18.3 tp -117.03 119.37 35.06 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.489 -0.93 . . . . 73.209999999999994 108.489 174.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.51 HG22 ' HB3' ' B' ' 241' ' ' LEU . 2.7 pt -113.67 104.91 17.73 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.146 0 CA-C-N 114.194 -1.367 . . . . 62.409999999999997 109.505 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 149.09 -122.78 1.51 Allowed Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.941 -0.572 . . . . 71.239999999999995 113.036 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.616 HD22 ' ND2' ' A' ' 243' ' ' ASN . 9.8 t30 -129.75 135.31 48.31 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 122.232 -0.569 . . . . 62.240000000000002 111.673 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.493 ' HG2' ' NE1' ' A' ' 287' ' ' TRP . 7.2 tp10 -111.75 118.27 35.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 105.854 -1.906 . . . . 75.530000000000001 105.854 174.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -117.8 123.13 45.2 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 105.721 -1.955 . . . . 75.430000000000007 105.721 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 121.82 -48.51 0.94 Allowed Glycine 0 C--N 1.284 -2.335 0 N-CA-C 108.192 -1.963 . . . . 50.409999999999997 108.192 -172.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 99.52 16.39 29.41 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 120.809 -0.71 . . . . 73.239999999999995 112.112 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.454 ' HB3' ' NZ ' ' A' ' 284' ' ' LYS . 0.1 OUTLIER 176.82 66.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.849 0.859 . . . . 63.520000000000003 112.728 178.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -109.72 -51.22 0.66 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 109.633 -1.387 . . . . 70.109999999999999 109.633 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -96.73 -5.82 37.76 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.243 0.544 . . . . 71.150000000000006 110.591 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.603 ' CH2' ' HB2' ' B' ' 240' ' ' GLN . 2.5 m95 . . . . . 0 CA--C 1.493 -1.222 0 N-CA-C 114.526 1.306 . . . . 75.299999999999997 114.526 -174.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 . . . . . 0 C--O 1.211 -0.969 0 CA-C-O 121.995 0.902 . . . . 75.200000000000003 111.564 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.612 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 21.2 p-10 -118.23 155.34 30.71 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 125.328 1.451 . . . . 75.209999999999994 114.27 -174.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' B' ' 263' ' ' SER . 20.7 m -117.38 135.93 53.52 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 122.362 1.077 . . . . 72.120000000000005 108.149 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -134.06 139.21 45.83 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.004 -0.998 . . . . 62.450000000000003 109.695 -174.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 37.2 ttmt -86.58 -65.53 1.0 Allowed 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.832 -0.622 . . . . 71.239999999999995 110.747 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -126.24 137.83 53.56 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.148 -1.021 . . . . 73.239999999999995 110.489 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 44.9 mt -135.39 121.74 32.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.425 -1.324 . . . . 71.310000000000002 107.425 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 58.4 mtt180 -128.17 114.85 17.52 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.804 -0.813 . . . . 75.430000000000007 108.804 177.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 45.3 p -116.37 126.59 53.69 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.778 -1.564 . . . . 71.129999999999995 106.778 175.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . 0.561 ' HB2' ' HE3' ' B' ' 270' ' ' LYS . 32.7 mt-10 -141.67 151.91 43.44 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.88 -0.785 . . . . 63.399999999999999 108.88 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 61.38 80.38 0.22 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.536 1.134 . . . . 71.340000000000003 112.466 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.523 ' HD3' ' N ' ' B' ' 236' ' ' ARG . 0.0 OUTLIER 62.78 25.16 14.95 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.821 0.674 . . . . 72.040000000000006 112.821 173.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -84.86 150.66 24.84 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.323 0.583 . . . . 65.129999999999995 110.802 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -125.54 135.14 51.94 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.122 -1.436 . . . . 72.420000000000002 107.122 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.464 ' HB ' HG21 ' B' ' 233' ' ' THR . 5.8 p -136.76 141.95 39.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.304 0.573 . . . . 73.209999999999994 111.635 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.603 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 4.4 tp60 -122.26 125.87 46.95 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-N 114.306 -1.315 . . . . 74.140000000000001 107.867 171.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.577 ' HG ' HD21 ' A' ' 262' ' ' ASN . 52.5 tp -117.3 118.54 32.55 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 107.934 -1.135 . . . . 72.329999999999998 107.934 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.567 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 128.33 -117.12 2.46 Favored Glycine 0 N--CA 1.421 -2.347 0 C-N-CA 120.389 -0.91 . . . . 70.409999999999997 111.644 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.63 HD22 ' N ' ' B' ' 244' ' ' VAL . 0.2 OUTLIER -144.57 136.41 25.87 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 120.022 -0.671 . . . . 74.319999999999993 110.243 -176.213 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.63 ' N ' HD22 ' B' ' 243' ' ' ASN . 48.1 t -108.54 120.28 59.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.258 -1.386 . . . . 33.200000000000003 107.258 174.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.16 115.23 46.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 120.894 -0.323 . . . . 72.439999999999998 110.598 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.439 HG22 ' HA3' ' B' ' 282' ' ' GLY . 14.9 t -113.93 162.25 16.63 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.626 -0.879 . . . . 73.109999999999999 108.626 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.03 -32.19 70.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.657 1.183 . . . . 62.509999999999998 114.017 -173.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.91 -41.07 67.26 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 114.417 1.266 . . . . 53.109999999999999 114.417 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.464 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -74.27 -25.98 59.94 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 114.273 1.212 . . . . 70.150000000000006 114.273 -175.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 41.6 tp . . . . . 0 C--N 1.323 -0.561 0 CA-C-O 121.312 0.577 . . . . 50.009999999999998 111.896 -173.893 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' C' ' 225' ' ' ARG . 18.0 p . . . . . 0 N--CA 1.397 -3.079 0 N-CA-C 109.249 -0.649 . . . . 72.099999999999994 109.249 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 8.2 t -127.75 141.65 51.53 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.798 -1.186 . . . . 55.210000000000001 107.798 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.663 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 25.7 t-20 -87.06 119.13 26.95 Favored 'General case' 0 CA--C 1.479 -1.768 0 N-CA-C 107.846 -1.168 . . . . 65.140000000000001 107.846 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' B' ' 227' ' ' SER . 49.7 m -142.56 128.03 18.98 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.394 -0.821 . . . . 73.219999999999999 110.889 -177.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.4 p -125.82 141.42 45.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.277 -0.569 . . . . 62.229999999999997 112.462 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 16.6 mm-40 -79.33 -59.3 2.82 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.568 -0.742 . . . . 72.109999999999999 110.938 177.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 97.0 m -143.6 127.37 17.18 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.023 -0.671 . . . . 72.25 112.694 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.519 HG12 HD12 ' C' ' 231' ' ' ILE . 24.0 m -121.07 127.81 75.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 109.056 -0.72 . . . . 72.019999999999996 109.056 172.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 5.5 p -128.64 135.37 62.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-N 116.16 -0.473 . . . . 62.100000000000001 111.877 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.7 132.58 7.99 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 110.494 -1.043 . . . . 43.009999999999998 110.494 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.561 ' HE3' ' HB2' ' B' ' 234' ' ' GLU . 13.9 mmmm -132.84 117.71 18.08 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 122.451 0.3 . . . . 74.420000000000002 111.648 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.87 87.32 0.9 Allowed Glycine 0 C--N 1.307 -1.069 0 C-N-CA 120.379 -0.915 . . . . 74.140000000000001 113.171 173.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 55.16 30.35 14.31 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.953 0.901 . . . . 55.399999999999999 111.899 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.8 m -83.06 145.08 29.48 Favored 'General case' 0 N--CA 1.422 -1.863 0 C-N-CA 120.489 -0.484 . . . . 65.219999999999999 110.355 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -116.84 127.62 54.47 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.088 -1.819 . . . . 73.409999999999997 106.088 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 1.5 p -133.03 123.14 47.57 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 121.517 0.675 . . . . 71.209999999999994 111.252 178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.54 ' HG ' ' OE1' ' C' ' 240' ' ' GLN . 8.0 tp -113.85 119.86 38.77 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.18 -1.045 . . . . 73.019999999999996 108.18 174.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.517 HG23 HD23 ' C' ' 241' ' ' LEU . 2.0 mt -112.14 103.56 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.887 0 N-CA-C 105.192 -2.151 . . . . 75.310000000000002 105.192 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 147.85 -126.96 2.48 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 119.136 -1.507 . . . . 24.25 114.635 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -128.91 135.42 49.02 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.159 0.504 . . . . 65.5 111.04 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.431 ' HG2' ' NE1' ' B' ' 287' ' ' TRP . 13.9 tp10 -113.45 118.5 34.7 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.776 -1.564 . . . . 74.430000000000007 106.776 177.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.443 ' CD2' ' HB3' ' B' ' 249' ' ' ALA . 4.6 t80 -115.25 122.75 46.94 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 106.144 -1.799 . . . . 62.109999999999999 106.144 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' B' ' 249' ' ' ALA . . . 114.72 -51.37 0.72 Allowed Glycine 0 C--N 1.288 -2.094 0 N-CA-C 108.226 -1.95 . . . . 71.439999999999998 108.226 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 89.97 15.17 58.2 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 111.204 -0.758 . . . . 63.100000000000001 111.204 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 41.4 mmtm -145.75 19.92 1.47 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.157 0.503 . . . . 75.430000000000007 109.992 -178.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . 0.406 ' HA3' HG11 ' B' ' 244' ' ' VAL . . . -81.93 -79.81 0.95 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.393 -0.908 . . . . 60.530000000000001 113.116 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.447 ' HB2' HG21 ' B' ' 244' ' ' VAL . 86.9 t80 -76.95 -13.36 59.98 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.812 0.671 . . . . 72.310000000000002 112.812 -176.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.609 ' CH2' ' HB2' ' C' ' 240' ' ' GLN . 6.4 m95 . . . . . 0 C--N 1.305 -1.345 0 CA-C-O 121.107 0.48 . . . . 64.120000000000005 112.177 -173.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' B' ' 260' ' ' THR . 24.9 mmt180 . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 122.079 0.942 . . . . 73.310000000000002 111.99 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.663 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 28.3 p-10 -117.49 155.67 29.32 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 113.419 -1.719 . . . . 72.420000000000002 114.242 -171.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' C' ' 263' ' ' SER . 23.9 t -117.75 136.37 53.42 Favored 'General case' 0 N--CA 1.409 -2.487 0 N-CA-C 107.671 -1.233 . . . . 73.010000000000005 107.671 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.43 137.92 52.07 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.872 -1.058 . . . . 74.430000000000007 108.842 -175.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 5.2 tmmm? -90.83 -62.0 1.55 Allowed 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 120.062 -0.655 . . . . 73.230000000000004 110.527 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -127.56 137.09 52.5 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 108.392 -0.966 . . . . 55.049999999999997 108.392 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.519 HD12 HG12 ' B' ' 267' ' ' VAL . 17.4 mt -137.82 123.59 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.145 -1.057 . . . . 73.25 108.145 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 81.5 mtt180 -128.32 115.1 17.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.418 -0.586 . . . . 74.040000000000006 109.418 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.469 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 33.1 p -112.31 126.87 55.72 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.342 -1.355 . . . . 74.129999999999995 107.342 175.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.526 ' HG2' ' HB2' ' B' ' 270' ' ' LYS . 43.1 mt-10 -138.87 145.78 40.38 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 120.328 -0.549 . . . . 73.030000000000001 110.508 -178.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 65.52 84.26 0.16 Allowed 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.637 1.175 . . . . 73.439999999999998 112.506 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? 61.3 23.31 13.56 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.345 1.058 . . . . 73.299999999999997 111.752 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -87.18 151.2 23.39 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.031 0.443 . . . . 71.549999999999997 111.423 -176.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -125.53 135.24 52.06 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.686 -1.227 . . . . 62.219999999999999 107.686 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 2.5 p -130.83 136.31 58.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.459 0.647 . . . . 72.439999999999998 110.929 176.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.609 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 3.9 tp60 -114.56 121.35 43.2 Favored 'General case' 0 N--CA 1.4 -2.967 0 CA-C-N 114.247 -1.342 . . . . 53.229999999999997 107.479 170.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.635 ' HG ' HD21 ' B' ' 262' ' ' ASN . 64.7 tp -115.53 118.16 32.36 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 108.32 -0.992 . . . . 72.209999999999994 108.32 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.549 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 129.5 -115.08 1.84 Allowed Glycine 0 N--CA 1.416 -2.657 0 C-N-CA 120.347 -0.93 . . . . 33.450000000000003 112.47 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.479 ' ND2' HG23 ' C' ' 245' ' ' VAL . 5.9 t30 -144.94 136.28 25.16 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 122.651 -0.323 . . . . 75.230000000000004 110.934 -173.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.453 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 61.0 t -114.79 125.85 72.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.195 0 N-CA-C 108.244 -1.021 . . . . 73.140000000000001 108.244 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.479 HG23 ' ND2' ' C' ' 243' ' ' ASN . 85.5 t -122.06 118.58 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 118.104 0.411 . . . . 72.310000000000002 110.294 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . 0.41 HG22 ' HA3' ' C' ' 282' ' ' GLY . 14.8 t -114.07 162.28 16.67 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 108.242 -1.021 . . . . 74.319999999999993 108.242 170.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.68 -31.86 73.16 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 114.229 1.196 . . . . 55.509999999999998 114.229 -172.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.41 -34.29 57.2 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.749 1.388 . . . . 63.530000000000001 114.749 -169.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . 0.514 ' HB2' ' HA2' ' C' ' 282' ' ' GLY . . . . . . . . 0 C--N 1.321 -0.667 0 C-N-CA 120.194 -0.602 . . . . 34.030000000000001 112.128 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 108.588 -0.893 . . . . 15.35 108.588 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -87.99 120.38 29.28 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.297 0.57 . . . . 64.310000000000002 110.177 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' C' ' 227' ' ' SER . 46.8 m -139.6 132.77 29.74 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.601 -0.727 . . . . 74.25 109.047 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 12.3 p -123.91 139.52 50.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.964 0.411 . . . . 64.310000000000002 111.129 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 9.1 mm-40 -75.88 -64.12 1.16 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.913 -0.585 . . . . 75.230000000000004 111.794 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 87.4 m -144.85 127.91 16.56 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 122.058 -0.402 . . . . 72.420000000000002 109.966 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.402 HG11 HD13 ' C' ' 277' ' ' ILE . 0.9 OUTLIER -126.86 123.67 63.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 115.323 -0.853 . . . . 70.129999999999995 109.638 178.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 26.5 m -124.65 146.61 29.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.179 -0.464 . . . . 65.25 110.337 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -130.85 132.52 6.9 Favored Glycine 0 CA--C 1.481 -2.062 0 N-CA-C 109.348 -1.501 . . . . 70.450000000000003 109.348 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -132.78 116.55 16.7 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.735 0.268 . . . . 72.209999999999994 111.592 -175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.95 84.42 0.85 Allowed Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.022 -1.085 . . . . 73.209999999999994 113.868 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 59.19 29.07 18.56 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.267 1.027 . . . . 74.140000000000001 111.629 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 15.8 m -82.87 145.55 29.38 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.102 -0.499 . . . . 75.319999999999993 111.102 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -113.43 128.4 56.44 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.06 -1.83 . . . . 64.150000000000006 106.06 174.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 6.6 p -137.95 123.57 25.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.533 0.682 . . . . 74.340000000000003 111.317 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.572 HD13 ' CG ' ' C' ' 240' ' ' GLN . 5.3 tp -113.88 112.17 22.9 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.866 -0.79 . . . . 61.039999999999999 108.866 175.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.402 HD13 HG11 ' C' ' 267' ' ' VAL . 5.4 mt -103.9 103.71 15.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 105.256 -2.127 . . . . 73.400000000000006 105.256 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 143.51 -144.83 14.18 Favored Glycine 0 N--CA 1.421 -2.314 0 C-N-CA 119.869 -1.158 . . . . 74.0 112.809 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -110.18 139.81 44.94 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.114 0.483 . . . . 71.200000000000003 110.342 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.583 ' HG2' ' NE1' ' C' ' 287' ' ' TRP . 12.9 tp10 -118.06 117.46 29.26 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 105.933 -1.877 . . . . 72.540000000000006 105.933 175.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . 0.42 ' HB3' ' HA ' ' C' ' 245' ' ' VAL . 6.5 t80 -111.51 123.39 50.13 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.01 -1.848 . . . . 74.409999999999997 106.01 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . 0.514 ' HA2' ' HB2' ' C' ' 249' ' ' ALA . . . 109.58 -51.29 0.71 Allowed Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 109.548 -1.421 . . . . 44.420000000000002 109.548 -173.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 86.13 24.35 41.13 Favored Glycine 0 CA--C 1.496 -1.156 0 C-N-CA 120.94 -0.648 . . . . 62.210000000000001 111.634 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -148.53 13.89 0.95 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 122.979 0.512 . . . . 64.340000000000003 110.247 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.43 -79.63 0.81 Allowed Glycine 0 N--CA 1.422 -2.263 0 C-N-CA 120.096 -1.049 . . . . 21.420000000000002 112.82 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -80.23 -19.78 46.11 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.126 0.787 . . . . 74.129999999999995 113.126 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.583 ' NE1' ' HG2' ' C' ' 280' ' ' GLU . 9.2 m95 . . . . . 0 C--N 1.307 -1.282 0 N-CA-C 114.261 1.208 . . . . 71.439999999999998 114.261 -171.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 . . . . . 0 CA--C 1.49 -1.348 0 CA-C-O 121.123 0.487 . . . . 73.239999999999995 111.504 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -115.62 114.35 24.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.038 -1.467 . . . . 61.229999999999997 107.038 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 10.1 p -129.07 137.64 51.39 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.457 0.646 . . . . 74.349999999999994 112.385 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 231' ' ' ILE . . . -133.22 129.51 37.82 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.073 -1.084 . . . . 64.329999999999998 108.073 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -82.31 -55.84 4.27 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.798 -0.445 . . . . 74.430000000000007 109.798 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 266' ' ' THR . 26.3 t0 -138.55 139.46 38.69 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 119.95 -0.7 . . . . 73.340000000000003 111.985 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.484 HD11 ' HB1' ' A' ' 228' ' ' ALA . 30.8 mm -128.33 127.79 67.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 106.889 -1.523 . . . . 73.299999999999997 106.889 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 31.0 ttt180 -134.14 115.42 14.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.283 -0.567 . . . . 72.109999999999999 110.079 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 40.8 p -110.66 127.59 55.35 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.335 -0.987 . . . . 54.310000000000002 108.335 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -128.08 148.96 50.58 Favored 'General case' 0 CA--C 1.482 -1.67 0 C-N-CA 120.089 -0.644 . . . . 52.229999999999997 109.865 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.589 ' C ' ' HD2' ' A' ' 236' ' ' ARG . 44.4 mt-10 59.27 91.24 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 O-C-N 125.12 1.512 . . . . 64.230000000000004 114.029 173.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.589 ' HD2' ' C ' ' A' ' 235' ' ' GLU . 0.1 OUTLIER 61.33 2.23 0.61 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.345 1.458 . . . . 71.310000000000002 113.401 174.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -69.92 149.58 47.66 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.398 0.679 . . . . 44.140000000000001 112.156 -175.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.34 139.01 54.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.701 -0.681 . . . . 51.399999999999999 109.805 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 6.0 p -124.85 141.93 43.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 116.052 -0.522 . . . . 60.25 110.018 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -123.26 117.7 25.9 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.739 -0.664 . . . . 63.420000000000002 109.361 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 277' ' ' ILE . 2.9 tm? -111.63 118.76 36.56 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.64 -1.615 . . . . 73.040000000000006 106.64 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.468 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 136.66 -140.2 11.28 Favored Glycine 0 N--CA 1.422 -2.278 0 C-N-CA 119.707 -1.235 . . . . 54.299999999999997 112.061 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -124.52 133.73 53.23 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 120.972 0.415 . . . . 62.030000000000001 111.411 -173.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.7 t -119.01 121.02 65.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.387 -1.338 . . . . 54.340000000000003 107.387 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.28 129.65 74.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.262 0.553 . . . . 54.119999999999997 112.366 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 5.3 m -109.79 160.53 16.26 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.808 -1.182 . . . . 75.209999999999994 107.808 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.99 76.8 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 122.918 0.487 . . . . 73.409999999999997 111.941 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.18 -34.08 63.54 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.926 1.29 . . . . 63.450000000000003 113.741 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 281' ' ' TYR . . . . . . . . 0 C--N 1.32 -0.713 0 N-CA-C 113.106 0.78 . . . . 71.409999999999997 113.106 -175.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.435 -1.197 0 N-CA-C 108.874 -0.787 . . . . 75.129999999999995 108.874 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.547 HD21 HD22 ' B' ' 241' ' ' LEU . 64.9 t30 -106.29 121.63 44.61 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.801 -0.814 . . . . 74.450000000000003 108.801 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' B' ' 227' ' ' SER . 46.9 m -137.86 123.97 20.34 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.878 0.37 . . . . 73.340000000000003 111.726 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' B' ' 228' ' ' ALA . 11.2 p -119.76 135.27 60.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.855 0.36 . . . . 74.219999999999999 111.102 176.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -69.36 -65.05 0.76 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.883 -0.599 . . . . 73.299999999999997 111.469 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 29.5 m -144.58 132.76 21.68 Favored 'General case' 0 C--O 1.25 1.117 0 C-N-CA 120.184 -0.607 . . . . 74.209999999999994 112.501 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.415 HG12 ' HB ' ' B' ' 231' ' ' ILE . 27.4 m -118.03 129.56 74.21 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 107.932 -1.136 . . . . 74.329999999999998 107.932 172.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 7.8 p -127.59 130.86 70.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-O 121.186 0.517 . . . . 72.340000000000003 111.677 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.06 133.32 11.53 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 109.719 -1.352 . . . . 74.510000000000005 109.719 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -132.56 144.69 50.58 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 117.121 0.46 . . . . 74.400000000000006 111.131 -175.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.65 -65.76 3.89 Favored Glycine 0 C--O 1.244 0.755 0 N-CA-C 110.768 -0.933 . . . . 63.439999999999998 110.768 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -176.96 125.86 0.15 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.999 -2.223 . . . . 73.019999999999996 104.999 172.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 25.0 m -149.94 160.13 43.84 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.531 -0.544 . . . . 64.140000000000001 109.531 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 54.3 mtm180 -122.72 127.36 49.12 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.142 -1.059 . . . . 73.349999999999994 108.142 172.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 1.4 p -128.18 129.17 69.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 116.154 -0.475 . . . . 63.100000000000001 109.942 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 4.1 tt -121.0 121.24 37.54 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.854 -1.165 . . . . 74.040000000000006 107.854 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.584 HG22 ' HB3' ' B' ' 241' ' ' LEU . 3.2 pt -113.03 104.59 17.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 C-N-CA 124.063 0.945 . . . . 63.310000000000002 109.107 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 155.18 -122.84 1.26 Allowed Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.554 -0.832 . . . . 74.239999999999995 113.156 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 42.4 m-80 -128.3 148.96 50.68 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.62 0.247 . . . . 65.319999999999993 110.585 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.0 OUTLIER -136.6 121.6 18.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.172 -2.159 . . . . 54.140000000000001 105.172 173.587 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.469 ' HB3' ' CB ' ' A' ' 249' ' ' ALA . 57.0 m-85 -107.81 123.59 48.8 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 109.37 -0.604 . . . . 71.030000000000001 109.37 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.442 ' N ' ' HB2' ' A' ' 249' ' ' ALA . . . 104.91 -43.73 1.61 Allowed Glycine 0 N--CA 1.42 -2.387 0 CA-C-N 115.178 -0.919 . . . . 70.329999999999998 111.209 -177.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 76.29 14.42 82.36 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.916 -0.874 . . . . 73.439999999999998 110.916 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -126.43 13.6 7.63 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.899 0.857 . . . . 75.319999999999993 109.377 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -101.48 -55.44 0.9 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.156 -1.021 . . . . 73.519999999999996 110.92 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.473 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 31.1 t80 -93.04 -18.04 23.13 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.904 -0.406 . . . . 74.319999999999993 109.904 -177.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.639 ' CH2' ' HB2' ' B' ' 240' ' ' GLN . 12.6 m-90 . . . . . 0 C--O 1.242 0.707 0 N-CA-C 115.893 1.812 . . . . 64.010000000000005 115.893 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 . . . . . 0 CA--C 1.488 -1.433 0 CA-C-O 121.265 0.555 . . . . 75.010000000000005 111.281 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.486 ' OD1' ' HA2' ' C' ' 242' ' ' GLY . 63.3 t30 -113.5 114.62 26.79 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 106.181 -1.785 . . . . 51.140000000000001 106.181 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' B' ' 263' ' ' SER . 20.1 m -125.4 137.06 54.0 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.513 0.673 . . . . 74.420000000000002 111.351 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.423 ' HB1' HD11 ' B' ' 231' ' ' ILE . . . -128.33 132.85 48.61 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.236 -0.893 . . . . 75.319999999999993 108.74 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.554 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -88.72 -68.12 0.79 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.976 -0.379 . . . . 74.219999999999999 109.976 -177.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.91 138.6 53.33 Favored 'General case' 0 CA--C 1.481 -1.673 0 C-N-CA 119.355 -0.938 . . . . 71.409999999999997 111.327 177.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.423 HD11 ' HB1' ' B' ' 228' ' ' ALA . 29.4 mm -130.91 118.4 41.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.576 -1.268 . . . . 64.519999999999996 107.576 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -118.77 117.76 29.76 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.483 -0.562 . . . . 43.420000000000002 109.483 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 49.7 p -109.5 127.2 54.26 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.903 -1.517 . . . . 75.219999999999999 106.903 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.28 155.75 46.61 Favored 'General case' 0 CA--C 1.471 -2.083 0 N-CA-C 108.759 -0.83 . . . . 73.25 108.759 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.572 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 83.8 mt-10 55.16 84.49 0.07 Allowed 'General case' 0 C--N 1.311 -1.065 0 O-C-N 125.016 1.447 . . . . 65.230000000000004 114.055 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.572 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 60.91 6.93 1.31 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.07 1.348 . . . . 74.409999999999997 113.151 173.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -69.9 148.43 49.0 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.201 0.524 . . . . 64.319999999999993 112.138 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 1.0 OUTLIER -127.87 136.09 50.92 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 108.806 -0.812 . . . . 73.340000000000003 108.806 179.216 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.437 ' HB ' HG13 ' B' ' 275' ' ' VAL . 5.4 p -127.65 142.23 44.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 116.335 -0.393 . . . . 61.5 110.853 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.639 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 5.8 tp-100 -112.89 134.62 54.31 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.918 -1.512 . . . . 71.120000000000005 106.918 173.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.584 ' HB3' HG22 ' A' ' 277' ' ' ILE . 2.8 tm? -129.28 117.44 20.69 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 105.953 -1.869 . . . . 73.319999999999993 105.953 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.466 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 137.67 -115.29 1.19 Allowed Glycine 0 N--CA 1.404 -3.489 0 C-N-CA 119.006 -1.568 . . . . 72.209999999999994 113.292 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 6.4 t30 -145.35 129.15 17.28 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 113.275 0.843 . . . . 50.219999999999999 113.275 -171.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 280' ' ' GLU . 99.2 t -119.64 125.56 74.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.339 -0.986 . . . . 63.149999999999999 108.339 176.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.449 ' HB ' ' CD2' ' A' ' 281' ' ' TYR . 57.7 t -122.29 129.66 75.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 120.843 -0.343 . . . . 75.230000000000004 111.285 -177.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.557 HG21 ' HB3' ' B' ' 284' ' ' LYS . 2.2 m -104.48 161.41 14.12 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.439 -0.948 . . . . 72.109999999999999 108.439 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.33 -32.57 74.02 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.756 0.788 . . . . 73.519999999999996 110.486 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.18 -36.06 65.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.026 -1.443 . . . . 73.099999999999994 113.805 -176.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.495 ' HB2' ' N ' ' B' ' 282' ' ' GLY . . . -74.67 -38.74 62.34 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 121.201 -0.2 . . . . 73.540000000000006 110.886 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 60.2 tp . . . . . 0 CA--C 1.547 0.86 0 C-N-CA 124.732 1.213 . . . . 71.200000000000003 112.002 -177.763 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.255 0 CA-C-O 121.182 0.515 . . . . 73.420000000000002 111.9 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.535 ' HB ' ' HG2' ' C' ' 225' ' ' ARG . 4.7 m -116.23 108.24 15.87 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.18 -1.415 . . . . 73.310000000000002 107.18 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.572 HD21 HD22 ' C' ' 241' ' ' LEU . 64.2 t30 -108.7 126.17 52.7 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.215 -1.032 . . . . 71.319999999999993 108.215 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' C' ' 227' ' ' SER . 31.9 m -142.42 123.75 14.74 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.237 0.542 . . . . 61.43 111.813 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' C' ' 228' ' ' ALA . 14.5 p -110.31 140.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.459 -0.571 . . . . 70.239999999999995 109.459 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 3.4 tm-20 -80.45 -69.26 0.61 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.423 -0.954 . . . . 71.150000000000006 108.423 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 90.7 m -137.3 128.85 28.45 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 121.629 -0.669 . . . . 72.329999999999998 112.683 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 48.9 t -118.49 128.83 75.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.08 -1.082 . . . . 52.210000000000001 108.08 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 8.6 p -127.4 134.44 65.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.131 0.491 . . . . 72.010000000000005 111.295 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.09 133.25 11.18 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.723 -1.351 . . . . 65.129999999999995 109.723 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -133.18 147.22 52.04 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 117.059 0.43 . . . . 75.200000000000003 111.349 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.58 -63.96 4.04 Favored Glycine 0 CA--C 1.498 -1.014 0 N-CA-C 110.812 -0.915 . . . . 73.25 110.812 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -178.99 126.72 0.1 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 103.624 -2.732 . . . . 72.319999999999993 103.624 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 45.7 m -147.61 161.29 41.45 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 120.949 0.404 . . . . 73.030000000000001 110.809 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.706 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 14.7 mtp180 -127.7 127.33 43.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.436 -1.32 . . . . 71.310000000000002 107.436 174.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' B' ' 239' ' ' VAL . 0.7 OUTLIER -134.8 137.31 51.13 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.109 0 N-CA-C 109.716 -0.476 . . . . 44.520000000000003 109.716 179.196 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.456 HD12 ' CG ' ' B' ' 286' ' ' PHE . 5.4 tt -124.15 124.23 42.04 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.059 -1.459 . . . . 61.009999999999998 107.059 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.464 HG23 HD12 ' C' ' 241' ' ' LEU . 6.7 mt -113.0 103.81 16.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 106.334 -1.728 . . . . 71.340000000000003 106.334 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 152.0 -141.31 8.41 Favored Glycine 0 CA--C 1.474 -2.53 0 C-N-CA 119.164 -1.493 . . . . 71.430000000000007 113.751 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 45.3 m-80 -111.57 136.93 50.09 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.109 -0.545 . . . . 71.5 109.625 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.506 ' HB2' ' NE2' ' C' ' 240' ' ' GLN . 0.1 OUTLIER -125.67 118.39 25.53 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 104.931 -2.248 . . . . 71.450000000000003 104.931 175.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -105.58 124.07 48.95 Favored 'General case' 0 N--CA 1.401 -2.885 0 CA-C-O 121.564 0.697 . . . . 54.439999999999998 110.239 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.495 ' N ' ' HB2' ' B' ' 249' ' ' ALA . . . 108.14 -45.55 1.29 Allowed Glycine 0 N--CA 1.416 -2.638 0 CA-C-N 114.991 -1.004 . . . . 62.009999999999998 110.971 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 70.79 26.26 74.33 Favored Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 109.845 -1.302 . . . . 75.400000000000006 109.845 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . 0.557 ' HB3' HG21 ' B' ' 246' ' ' THR . 24.8 tptp -136.73 14.21 3.15 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.423 -0.954 . . . . 74.349999999999994 108.423 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -112.23 -59.11 0.44 Allowed Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.569 -0.741 . . . . 61.350000000000001 111.429 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.456 ' CG ' HD12 ' B' ' 276' ' ' LEU . 19.0 t80 -90.41 -20.66 22.53 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.185 -1.043 . . . . 63.299999999999997 108.185 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.507 ' HE1' ' HB2' ' C' ' 238' ' ' ARG . 14.3 m-90 . . . . . 0 C--N 1.296 -1.727 0 CA-C-N 115.002 -0.999 . . . . 73.209999999999994 108.79 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.535 ' HG2' ' HB ' ' B' ' 261' ' ' THR . 70.5 mtt180 . . . . . 0 CA--C 1.493 -1.224 0 N-CA-C 112.691 0.626 . . . . 70.409999999999997 112.691 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -116.57 116.92 28.51 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.367 -1.345 . . . . 74.239999999999995 107.367 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' B' ' 263' ' ' SER . 15.7 p -128.72 139.39 52.24 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 121.569 0.699 . . . . 53.439999999999998 111.423 -176.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.5 ' HB1' HD11 ' C' ' 231' ' ' ILE . . . -126.91 129.49 48.29 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.015 -0.993 . . . . 52.420000000000002 108.469 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 13.8 tmtt? -87.48 -60.35 2.0 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.288 0.368 . . . . 74.439999999999998 111.614 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.32 138.04 53.54 Favored 'General case' 0 CA--C 1.484 -1.565 0 O-C-N 121.741 -0.599 . . . . 72.319999999999993 110.074 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.5 HD11 ' HB1' ' C' ' 228' ' ' ALA . 41.5 mm -133.13 119.12 35.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.777 -1.194 . . . . 72.409999999999997 107.777 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 44.9 ttt180 -122.65 115.22 21.73 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 109.479 -0.563 . . . . 71.439999999999998 109.479 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 42.5 p -110.61 127.39 55.23 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.725 -1.583 . . . . 63.340000000000003 106.725 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -141.58 153.62 44.93 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 120.143 -0.623 . . . . 74.530000000000001 110.107 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.511 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 43.4 mt-10 61.31 85.41 0.12 Allowed 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.889 1.368 . . . . 71.319999999999993 113.156 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.511 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 1.4 mpt_? 59.18 5.17 0.53 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.813 1.645 . . . . 72.340000000000003 113.393 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -69.6 147.5 50.61 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.461 0.648 . . . . 41.100000000000001 112.073 -174.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.706 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 1.5 mpt_? -126.98 135.02 50.29 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.273 -0.876 . . . . 75.030000000000001 108.959 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.2 p -128.32 139.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.066 0.46 . . . . 72.209999999999994 111.326 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.506 ' NE2' ' HB2' ' B' ' 280' ' ' GLU . 5.4 tp-100 -110.47 120.02 41.07 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.053 -0.976 . . . . 61.399999999999999 108.815 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.572 HD22 HD21 ' B' ' 262' ' ' ASN . 3.1 tm? -115.16 116.52 28.5 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 105.339 -2.097 . . . . 73.209999999999994 105.339 172.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.486 ' HA2' ' OD1' ' B' ' 226' ' ' ASN . . . 142.45 -121.88 1.86 Allowed Glycine 0 N--CA 1.41 -3.073 0 C-N-CA 118.56 -1.781 . . . . 42.200000000000003 113.174 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 35.8 t30 -144.63 128.48 17.36 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 123.621 0.248 . . . . 74.439999999999998 111.608 -171.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' B' ' 280' ' ' GLU . 92.0 t -118.52 122.98 70.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.221 -1.029 . . . . 64.400000000000006 108.221 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.94 128.85 75.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 120.533 -0.467 . . . . 73.439999999999998 110.454 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . 0.432 HG21 ' HB3' ' C' ' 284' ' ' LYS . 2.6 m -99.33 161.05 13.84 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.196 -1.038 . . . . 65.409999999999997 108.196 174.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.3 -32.29 69.91 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.832 0.853 . . . . 74.109999999999999 110.959 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.48 -35.49 63.11 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.21 -1.359 . . . . 64.140000000000001 112.522 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.573 0 CA-C-O 121.012 0.434 . . . . 53.520000000000003 111.686 -178.331 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.411 -2.388 0 N-CA-C 104.706 -2.331 . . . . 64.019999999999996 104.706 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -113.86 123.95 51.03 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.228 -1.027 . . . . 74.209999999999994 108.228 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 34.8 m -134.86 122.81 22.54 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.789 -0.819 . . . . 51.210000000000001 108.789 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' C' ' 228' ' ' ALA . 12.1 p -108.94 144.27 17.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.012 -0.736 . . . . 72.219999999999999 109.012 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -78.79 -77.17 0.17 Allowed 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 108.625 -0.88 . . . . 64.209999999999994 108.625 -176.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 85.8 m -132.82 134.12 44.25 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.133 -0.354 . . . . 65.310000000000002 110.357 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 25.6 t -118.43 129.17 75.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.245 -1.391 . . . . 65.0 107.245 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.4 p -127.79 132.35 68.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 120.919 -0.313 . . . . 42.409999999999997 111.159 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.16 132.86 11.24 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 108.869 -1.692 . . . . 74.230000000000004 108.869 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -133.86 145.55 49.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.978 0.389 . . . . 62.520000000000003 110.569 -174.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.41 -65.83 3.92 Favored Glycine 0 CA--C 1.5 -0.865 0 N-CA-C 110.631 -0.988 . . . . 63.229999999999997 110.631 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 179.89 118.94 0.06 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 126.614 1.966 . . . . 72.140000000000001 105.738 174.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 35.7 m -141.02 154.14 45.86 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.311 0.485 . . . . 70.340000000000003 112.311 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -118.89 126.76 52.52 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.366 -1.346 . . . . 74.340000000000003 107.366 171.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 2.1 p -139.08 138.51 41.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 123.044 0.215 . . . . 74.510000000000005 110.776 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.9 tt -128.6 122.63 31.39 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.385 -0.598 . . . . 62.219999999999999 109.385 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.506 HD12 HD23 ' C' ' 241' ' ' LEU . 1.3 pt -113.4 104.47 17.04 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 C-N-CA 123.915 0.886 . . . . 74.430000000000007 109.772 173.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.9 -140.43 7.9 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 119.655 -1.26 . . . . 51.229999999999997 113.123 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -100.15 139.75 35.37 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.623 -0.788 . . . . 74.200000000000003 109.521 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -142.08 118.46 10.86 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 103.324 -2.843 . . . . 74.239999999999995 103.324 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -116.84 124.99 50.87 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.329 0.585 . . . . 75.340000000000003 111.508 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 116.44 -41.52 2.1 Favored Glycine 0 N--CA 1.407 -3.277 0 CA-C-N 114.596 -1.184 . . . . 61.399999999999999 110.612 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 67.07 30.08 75.38 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 109.361 -1.496 . . . . 74.430000000000007 109.361 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . 0.432 ' HB3' HG21 ' C' ' 246' ' ' THR . 52.9 tptt -141.92 17.39 2.13 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 108.461 -0.941 . . . . 74.040000000000006 108.461 -174.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -114.32 -72.85 0.57 Allowed Glycine 0 N--CA 1.424 -2.11 0 C-N-CA 120.218 -0.991 . . . . 73.310000000000002 110.725 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -79.64 -25.91 41.24 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.049 0.452 . . . . 72.109999999999999 110.049 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 . . . . . 0 C--N 1.302 -1.495 0 N-CA-C 108.6 -0.889 . . . . 73.239999999999995 108.6 178.295 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 . . . . . 0 N--CA 1.439 -0.989 0 N-CA-C 109.614 -0.513 . . . . 52.030000000000001 109.614 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.403 ' ND2' ' HA2' ' A' ' 278' ' ' GLY . 44.9 t-20 -117.82 114.83 23.85 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 106.147 -1.797 . . . . 74.299999999999997 106.147 168.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 33.6 m -120.59 137.01 54.64 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.388 0.613 . . . . 54.310000000000002 111.149 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.77 130.31 51.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.851 -1.166 . . . . 64.310000000000002 107.851 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 39.4 ttmt -79.04 -63.97 1.29 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.816 -0.354 . . . . 74.140000000000001 111.911 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -126.51 139.25 53.37 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 118.914 -1.114 . . . . 75.140000000000001 110.261 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.3 mt -130.75 119.57 45.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.634 -0.876 . . . . 72.329999999999998 108.634 -175.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 87.2 mtt180 -125.08 115.05 19.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.755 -1.202 . . . . 71.409999999999997 107.755 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.474 HG21 HG22 ' A' ' 239' ' ' VAL . 40.4 p -128.24 128.66 45.1 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 120.567 -0.453 . . . . 72.340000000000003 109.838 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -126.6 166.07 18.0 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 119.751 -0.78 . . . . 73.0 112.608 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 71.42 -88.09 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.603 -1.635 . . . . 54.130000000000003 114.311 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.494 ' HD3' ' OE2' ' A' ' 272' ' ' GLU . 0.0 OUTLIER -135.48 26.66 3.43 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.162 -1.051 . . . . 70.329999999999998 108.162 -176.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -69.04 149.45 48.74 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.598 -0.728 . . . . 64.439999999999998 111.245 -174.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.83 134.9 53.52 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 105.932 -1.877 . . . . 70.510000000000005 105.932 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.474 HG22 HG21 ' A' ' 233' ' ' THR . 9.8 t -135.17 139.0 47.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.981 0.419 . . . . 53.399999999999999 110.659 -170.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.479 ' HB3' HD13 ' A' ' 276' ' ' LEU . 6.3 tp-100 -131.2 135.28 47.26 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.595 -1.261 . . . . 71.200000000000003 107.595 172.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.1 tt -130.42 120.2 23.85 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.947 -1.501 . . . . 64.120000000000005 106.947 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.608 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 128.93 -113.91 1.65 Allowed Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.7 -0.762 . . . . 61.340000000000003 111.386 177.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -144.39 144.33 31.37 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.613 -0.345 . . . . 71.140000000000001 110.087 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.441 ' CG2' ' HG2' ' A' ' 240' ' ' GLN . 83.6 t -118.75 118.3 57.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.811 -1.181 . . . . 63.439999999999998 107.811 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.57 112.8 35.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 N-CA-C 109.135 -0.691 . . . . 55.549999999999997 109.135 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.474 HG22 ' HA3' ' A' ' 282' ' ' GLY . 8.9 t -94.92 161.0 14.33 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.034 -1.066 . . . . 74.299999999999997 109.863 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.45 -33.61 75.94 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.42 0.688 . . . . 33.200000000000003 111.778 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.83 65.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.399 -0.819 . . . . 75.340000000000003 111.579 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.703 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.028 -0.533 . . . . 73.430000000000007 111.706 -178.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 25.8 p . . . . . 0 N--CA 1.434 -1.246 0 N-CA-C 108.554 -0.906 . . . . 54.009999999999998 108.554 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 7.9 t30 -117.99 138.46 52.18 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.419 -0.912 . . . . 75.25 111.065 -176.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 39.8 m -138.59 123.33 18.69 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.147 -0.479 . . . . 55.130000000000003 109.935 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 10.7 p -128.89 145.59 35.5 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-N 116.259 -0.428 . . . . 74.140000000000001 110.939 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 12.0 mm-40 -84.66 -75.68 0.34 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.429 -0.351 . . . . 62.240000000000002 110.945 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.7 p -118.36 127.91 54.14 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.659 0.614 . . . . 64.219999999999999 112.659 -175.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 277' ' ' ILE . 26.7 m -124.87 127.11 72.33 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 109.396 -0.594 . . . . 74.219999999999999 109.396 174.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 7.3 p -127.14 132.18 70.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 121.205 0.526 . . . . 63.100000000000001 111.863 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.541 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -113.66 131.67 10.11 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 109.919 -1.272 . . . . 75.420000000000002 109.919 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -132.12 116.42 17.01 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 111.99 0.367 . . . . 74.530000000000001 111.99 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 92.96 -123.39 7.32 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 120.747 -0.74 . . . . 65.430000000000007 112.386 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.494 ' OE2' ' HD3' ' A' ' 236' ' ' ARG . 40.9 mm-40 -92.39 35.48 1.01 Allowed 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.333 1.053 . . . . 63.439999999999998 109.335 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 50.1 m -81.68 144.36 31.22 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.069 0.938 . . . . 51.32 111.04 -174.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -130.5 126.73 37.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 104.809 -2.293 . . . . 71.409999999999997 104.809 176.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.94 134.0 41.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 121.565 0.697 . . . . 73.25 111.509 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.479 HD13 ' HB3' ' A' ' 240' ' ' GLN . 11.0 tp -120.23 121.64 39.17 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.228 -0.896 . . . . 74.099999999999994 110.671 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 267' ' ' VAL . 81.6 mt -104.39 104.27 16.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 114.107 -1.406 . . . . 75.099999999999994 108.073 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 140.22 -153.86 23.66 Favored Glycine 0 N--CA 1.427 -1.918 0 C-N-CA 120.181 -1.009 . . . . 45.219999999999999 113.866 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -91.96 128.48 37.82 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.828 0.851 . . . . 74.420000000000002 110.295 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -111.1 118.69 36.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.838 -2.282 . . . . 71.439999999999998 104.838 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -120.02 122.23 40.67 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.473 -1.306 . . . . 64.150000000000006 107.473 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.474 ' HA3' HG22 ' A' ' 246' ' ' THR . . . 125.24 -41.38 1.7 Allowed Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.351 -1.295 . . . . 71.340000000000003 110.744 -175.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 125.05 -57.96 0.67 Allowed Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 110.46 -1.056 . . . . 64.219999999999999 110.46 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -145.08 80.6 1.62 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.084 0.945 . . . . 72.430000000000007 112.517 177.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -100.86 -40.35 2.91 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 114.748 -1.115 . . . . 52.329999999999998 110.467 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -69.81 -36.53 75.71 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.17 0.51 . . . . 70.510000000000005 110.477 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.44 ' CZ2' ' HE1' ' B' ' 286' ' ' PHE . 27.8 m-90 . . . . . 0 C--N 1.295 -1.763 0 N-CA-C 108.481 -0.933 . . . . 74.329999999999998 108.481 175.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 261' ' ' THR . 36.1 ttt180 . . . . . 0 N--CA 1.428 -1.532 0 CA-C-O 120.85 0.357 . . . . 73.019999999999996 110.893 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.487 HD22 ' HA2' ' B' ' 278' ' ' GLY . 38.3 t-20 -117.17 127.79 54.47 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.615 -1.624 . . . . 63.43 106.615 169.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 58.0 m -129.98 137.25 50.21 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-O 121.625 0.726 . . . . 73.109999999999999 111.078 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -125.63 137.42 53.88 Favored 'General case' 0 N--CA 1.404 -2.756 0 CA-C-N 114.146 -1.388 . . . . 74.010000000000005 107.56 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 3.5 ttmp? -84.28 -70.77 0.55 Allowed 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.309 -0.956 . . . . 70.5 110.467 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -127.25 137.71 52.93 Favored 'General case' 0 N--CA 1.428 -1.557 0 C-N-CA 119.684 -0.807 . . . . 63.530000000000001 109.736 -174.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 6.3 mt -134.16 117.97 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.207 -1.034 . . . . 64.430000000000007 108.207 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -113.42 119.31 37.18 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.018 -1.104 . . . . 74.010000000000005 108.018 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.551 HG22 HG21 ' B' ' 239' ' ' VAL . 22.2 p -116.72 126.95 53.9 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 106.05 -1.833 . . . . 73.329999999999998 106.05 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' B' ' 270' ' ' LYS . 52.1 mt-10 -134.22 153.93 51.56 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.476 0.655 . . . . 71.439999999999998 112.366 -176.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.522 ' HB3' ' HD3' ' B' ' 236' ' ' ARG . 45.0 mt-10 71.88 -83.64 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 113.642 -1.617 . . . . 73.409999999999997 114.016 171.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.522 ' HD3' ' HB3' ' B' ' 235' ' ' GLU . 0.4 OUTLIER -136.61 42.28 2.51 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 107.964 -1.124 . . . . 73.239999999999995 107.964 -178.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -82.81 139.56 33.45 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.886 -1.052 . . . . 73.519999999999996 111.773 -177.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 5.8 mpt_? -123.74 132.52 53.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 103.751 -2.685 . . . . 72.129999999999995 103.751 173.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.551 HG21 HG22 ' B' ' 233' ' ' THR . 86.7 t -142.93 132.62 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-O 121.604 0.716 . . . . 61.149999999999999 112.006 -172.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.562 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 55.1 tp60 -112.43 132.02 55.26 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 106.901 -1.518 . . . . 74.230000000000004 106.901 173.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.475 HD12 HG23 ' A' ' 277' ' ' ILE . 1.7 tm? -130.04 117.44 20.03 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.856 -1.164 . . . . 75.219999999999999 107.856 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.59 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 129.08 -114.1 1.68 Allowed Glycine 0 C--N 1.309 -0.935 0 N-CA-C 110.817 -0.913 . . . . 74.540000000000006 110.817 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -145.38 153.66 41.45 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 122.048 -0.678 . . . . 71.25 110.467 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.562 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 61.7 t -129.53 120.26 50.2 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 108.566 -0.902 . . . . 74.200000000000003 108.566 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.14 112.37 33.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 109.528 -0.545 . . . . 74.340000000000003 109.528 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.543 HG22 ' HA3' ' B' ' 282' ' ' GLY . 6.7 t -86.82 161.31 18.41 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.577 -0.849 . . . . 54.32 111.382 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.703 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.4 -33.62 75.94 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 122.434 1.111 . . . . 53.299999999999997 109.727 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.64 78.53 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 112.708 -2.042 . . . . 72.219999999999999 113.104 -177.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -60.12 -46.66 88.87 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.186 0.595 . . . . 61.149999999999999 112.031 -174.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.286 -2.183 0 N-CA-C 101.45 -3.537 . . . . 75.349999999999994 101.45 -176.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.421 -1.914 0 CA-C-O 121.473 0.654 . . . . 65.329999999999998 112.764 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 61.8 m -91.19 108.85 20.15 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 106.653 -1.61 . . . . 74.129999999999995 106.653 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.519 HD21 HD11 ' C' ' 241' ' ' LEU . 7.5 t30 -106.25 145.67 31.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.199 0.523 . . . . 72.400000000000006 112.123 -171.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.9 m -138.57 123.86 19.29 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.218 -0.66 . . . . 72.120000000000005 109.218 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 15.0 p -127.37 143.84 39.3 Favored 'Isoleucine or valine' 0 C--O 1.249 1.027 0 N-CA-C 109.802 -0.444 . . . . 54.119999999999997 109.802 178.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 48.7 mm-40 -90.48 -71.71 0.61 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.559 -0.291 . . . . 64.239999999999995 110.437 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 26.9 m -121.66 127.06 50.39 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.086 -0.646 . . . . 73.400000000000006 110.816 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.87 123.54 56.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 116.086 -0.506 . . . . 71.319999999999993 110.163 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.17 133.92 67.12 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 CA-C-O 121.491 0.662 . . . . 71.200000000000003 112.425 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . 0.524 ' HA2' ' OG1' ' C' ' 233' ' ' THR . . . -111.23 131.64 10.44 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 110.415 -1.074 . . . . 63.25 110.415 175.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.416 ' HD2' ' HB2' ' B' ' 234' ' ' GLU . 29.1 mmmt -132.89 116.71 16.82 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 123.665 0.786 . . . . 75.019999999999996 111.761 -176.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.42 -133.81 11.75 Favored Glycine 0 C--N 1.299 -1.486 0 N-CA-C 110.711 -0.955 . . . . 54.520000000000003 110.711 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 77.8 mm-40 -85.31 48.14 1.53 Allowed 'General case' 0 C--O 1.258 1.527 0 C-N-CA 123.3 0.64 . . . . 73.010000000000005 109.939 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 74.7 m -82.09 144.68 30.63 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 122.386 1.089 . . . . 44.520000000000003 111.826 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 7.5 mtm180 -135.66 124.72 24.34 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 106.559 -1.645 . . . . 74.219999999999999 106.559 172.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' C' ' 239' ' ' VAL . 7.4 p -140.5 138.17 36.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-O 121.216 0.532 . . . . 55.43 111.303 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.561 HD13 ' CG ' ' B' ' 240' ' ' GLN . 4.5 tp -119.43 115.82 24.86 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.463 -0.79 . . . . 64.129999999999995 109.881 175.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.463 HG23 HD12 ' C' ' 241' ' ' LEU . 3.9 mp -98.9 103.37 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 N-CA-C 106.332 -1.729 . . . . 71.430000000000007 106.332 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.59 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 147.74 -157.21 27.28 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 119.563 -1.304 . . . . 52.450000000000003 114.436 178.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -96.44 124.64 40.5 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 124.084 0.954 . . . . 62.200000000000003 109.964 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -111.1 118.98 37.47 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.891 -1.892 . . . . 72.109999999999999 105.891 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.409 ' CD1' HG13 ' C' ' 245' ' ' VAL . 0.9 OUTLIER -119.4 122.52 41.96 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 107.129 -1.434 . . . . 64.319999999999993 107.129 178.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.543 ' HA3' HG22 ' B' ' 246' ' ' THR . . . 130.16 -38.44 1.97 Allowed Glycine 0 N--CA 1.417 -2.61 0 CA-C-N 114.612 -1.177 . . . . 71.319999999999993 111.332 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 116.95 -52.21 0.69 Allowed Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.02 -1.232 . . . . 72.010000000000005 110.02 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . 0.647 ' HD2' ' O ' ' B' ' 284' ' ' LYS . 0.1 OUTLIER -148.5 72.77 1.21 Allowed 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 122.403 1.097 . . . . 73.530000000000001 111.315 -178.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -90.17 -51.86 2.68 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.115 -1.194 . . . . 63.520000000000003 110.115 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.44 ' HE1' ' CZ2' ' A' ' 287' ' ' TRP . 56.3 t80 -65.52 -35.22 80.22 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.416 0.627 . . . . 75.420000000000002 110.561 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.567 ' O ' ' HB2' ' B' ' 284' ' ' LYS . 29.0 m-90 . . . . . 0 C--N 1.309 -1.176 0 N-CA-C 108.151 -1.055 . . . . 74.430000000000007 108.151 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 . . . . . 0 N--CA 1.42 -1.973 0 CA-C-O 121.224 0.535 . . . . 74.430000000000007 109.69 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.484 HD22 ' HA2' ' C' ' 278' ' ' GLY . 37.3 t-20 -117.75 128.69 55.13 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 105.906 -1.887 . . . . 52.329999999999998 105.906 170.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.1 m -128.77 136.51 50.63 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-O 121.457 0.646 . . . . 63.130000000000003 110.264 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.92 127.47 41.82 Favored 'General case' 0 N--CA 1.417 -2.103 0 N-CA-C 107.92 -1.141 . . . . 74.450000000000003 107.92 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 37.7 ttmt -80.26 -60.68 2.23 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.996 -0.682 . . . . 70.120000000000005 112.097 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -126.21 137.49 53.55 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.076 -1.083 . . . . 74.109999999999999 108.076 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 24.8 mt -136.19 117.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.202 -1.036 . . . . 74.109999999999999 108.202 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 92.5 mtt180 -120.11 119.45 33.34 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.19 -1.041 . . . . 73.549999999999997 108.19 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.566 HG22 HG21 ' C' ' 239' ' ' VAL . 28.9 p -119.75 127.83 53.19 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.462 -1.681 . . . . 64.299999999999997 106.462 -177.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.425 ' HB2' ' HD2' ' C' ' 270' ' ' LYS . 54.2 mt-10 -133.58 155.31 49.86 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.454 0.645 . . . . 61.310000000000002 112.075 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.518 ' HB3' ' HD3' ' C' ' 236' ' ' ARG . 46.6 mt-10 72.26 -86.54 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.199 0 CA-C-N 113.896 -1.502 . . . . 71.030000000000001 114.693 170.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.518 ' HD3' ' HB3' ' C' ' 235' ' ' GLU . 0.3 OUTLIER -131.11 31.32 4.44 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.654 -0.869 . . . . 71.209999999999994 108.654 -177.487 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -75.11 138.39 42.04 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 122.333 1.063 . . . . 71.540000000000006 113.547 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 4.3 mpt_? -123.91 133.37 53.75 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 103.765 -2.68 . . . . 72.519999999999996 103.765 172.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.566 HG21 HG22 ' C' ' 233' ' ' THR . 85.8 t -141.16 132.31 27.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.252 0.549 . . . . 70.120000000000005 111.218 -174.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.603 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 51.8 tp60 -111.68 128.71 56.15 Favored 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 107.05 -1.463 . . . . 64.540000000000006 107.05 174.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.519 HD11 HD21 ' B' ' 262' ' ' ASN . 1.7 tm? -128.62 117.54 21.4 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.411 -0.959 . . . . 62.310000000000002 108.411 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.545 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 131.4 -111.68 1.11 Allowed Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 110.333 -1.107 . . . . 73.450000000000003 110.333 -177.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -145.71 155.19 42.81 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 122.109 -0.642 . . . . 64.200000000000003 110.371 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.603 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 58.8 t -131.22 122.02 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 108.635 -0.876 . . . . 75.129999999999995 108.635 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.409 HG13 ' CD1' ' B' ' 281' ' ' TYR . 2.7 p -122.18 112.01 32.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.54 -0.911 . . . . 54.539999999999999 108.54 173.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . 0.485 HG22 ' HA3' ' C' ' 282' ' ' GLY . 5.0 t -81.39 162.38 23.39 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.225 0.824 . . . . 72.219999999999999 113.225 -174.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.54 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -60.36 -35.17 75.05 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 124.693 1.197 . . . . 73.329999999999998 109.678 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.49 -34.77 69.41 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.345 -1.298 . . . . 62.200000000000003 111.584 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.58 0 CA-C-N 116.129 -0.487 . . . . 51.039999999999999 110.85 -179.612 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.416 -2.143 0 N-CA-C 108.704 -0.85 . . . . 73.25 108.704 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -111.86 141.44 45.48 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.576 -0.738 . . . . 64.420000000000002 111.497 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 22.0 m -134.74 124.09 24.67 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.073 -1.084 . . . . 75.230000000000004 108.073 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.23 143.8 39.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.863 0.363 . . . . 71.510000000000005 110.613 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 53.9 mm-40 -80.42 -65.43 1.01 Allowed 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 115.955 -0.566 . . . . 61.119999999999997 111.459 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 59.2 m -140.8 130.79 24.61 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.107 -0.637 . . . . 62.25 110.906 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.0 m -123.51 133.88 67.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.852 -0.613 . . . . 73.129999999999995 109.393 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 8.3 p -128.02 140.23 49.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 116.181 -0.463 . . . . 45.329999999999998 109.945 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.03 132.87 9.61 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.988 -1.245 . . . . 73.5 109.988 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.425 ' HD2' ' HB2' ' C' ' 234' ' ' GLU . 29.8 mmmt -131.36 141.19 49.85 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.25 0.62 . . . . 72.310000000000002 110.177 -177.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 70.64 -132.02 22.05 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.883 -0.675 . . . . 64.439999999999998 112.166 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -85.94 49.35 1.76 Allowed 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 123.582 0.753 . . . . 74.349999999999994 110.502 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 67.9 m -83.22 145.07 29.36 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.602 0.964 . . . . 72.239999999999995 113.602 -174.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 41.7 mtt180 -138.68 125.68 21.23 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 103.586 -2.746 . . . . 71.420000000000002 103.586 172.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.481 ' CG1' HG22 ' C' ' 239' ' ' VAL . 4.6 p -140.28 137.78 37.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 C-N-CA 120.297 -0.561 . . . . 63.340000000000003 111.827 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.419 HD13 ' CG ' ' C' ' 240' ' ' GLN . 13.0 tp -113.15 112.43 23.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.644 0.735 . . . . 73.340000000000003 109.74 175.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 30.7 mt -101.21 103.29 14.66 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 104.996 -2.224 . . . . 63.439999999999998 104.996 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 144.26 -159.63 27.73 Favored Glycine 0 N--CA 1.42 -2.384 0 C-N-CA 118.916 -1.611 . . . . 53.039999999999999 113.863 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -92.6 129.41 38.54 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.793 -0.703 . . . . 74.400000000000006 109.848 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -111.99 122.35 47.51 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 105.435 -2.061 . . . . 71.349999999999994 105.435 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.75 124.26 40.62 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 108.517 -0.92 . . . . 65.400000000000006 108.517 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . 0.485 ' HA3' HG22 ' C' ' 246' ' ' THR . . . 122.42 -34.65 3.73 Favored Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.628 -0.715 . . . . 51.130000000000003 112.087 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 122.88 -62.63 0.55 Allowed Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.886 -0.673 . . . . 72.519999999999996 111.645 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . 0.622 ' HD2' ' O ' ' C' ' 284' ' ' LYS 0.255 0.1 OUTLIER -136.0 70.02 1.42 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.855 0.836 . . . . 74.450000000000003 112.171 178.525 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.29 -64.06 1.96 Allowed Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.66 -1.257 . . . . 70.430000000000007 110.749 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -65.03 -24.32 67.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.637 0.732 . . . . 54.219999999999999 110.911 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 . . . . . 0 C--N 1.307 -1.248 0 CA-C-N 115.804 -0.634 . . . . 75.040000000000006 110.354 179.041 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 23.6 ptt85 . . . . . 0 N--CA 1.434 -1.255 0 CA-C-O 121.135 0.493 . . . . 71.510000000000005 111.984 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.445 HD22 ' HA2' ' A' ' 278' ' ' GLY . 34.5 t30 -99.3 114.25 27.0 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.201 -1.777 . . . . 60.119999999999997 106.201 173.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.4 m -126.15 136.66 53.13 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.667 -0.813 . . . . 75.120000000000005 111.756 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -120.71 119.41 32.7 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.171 -1.418 . . . . 64.349999999999994 107.171 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -75.8 -58.2 3.42 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 123.803 0.69 . . . . 74.329999999999998 110.165 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -126.57 140.48 52.4 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.137 0.494 . . . . 73.140000000000001 111.345 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.0 mt -134.16 124.95 47.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.162 -1.051 . . . . 65.129999999999995 108.162 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -128.76 122.74 31.27 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.613 -0.514 . . . . 72.239999999999995 109.613 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 20.2 p -112.31 128.23 56.22 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.269 -1.382 . . . . 75.129999999999995 107.269 171.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -147.37 146.4 29.62 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.815 -1.18 . . . . 73.129999999999995 107.815 -175.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 60.14 72.96 0.5 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.248 0.619 . . . . 65.540000000000006 112.634 -175.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 65.28 22.87 12.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.054 0.541 . . . . 65.450000000000003 112.264 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.41 134.97 36.36 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.274 -0.421 . . . . 73.310000000000002 109.893 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.93 139.99 53.0 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.126 -0.488 . . . . 71.420000000000002 111.636 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 p -124.18 138.49 53.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.545 -0.752 . . . . 64.140000000000001 111.513 -176.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.576 ' HB3' HD22 ' A' ' 276' ' ' LEU . 6.4 tp-100 -111.15 118.64 36.53 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.688 -1.227 . . . . 63.32 107.688 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.87 118.87 36.7 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.257 -1.016 . . . . 63.020000000000003 108.257 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.572 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 134.89 -136.72 8.73 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.437 -0.887 . . . . 61.399999999999999 111.843 177.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -130.12 128.58 42.11 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.568 -0.901 . . . . 73.510000000000005 108.568 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.4 115.38 43.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.025 -1.102 . . . . 71.230000000000004 108.025 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 45.5 t -113.87 114.39 46.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.701 -0.851 . . . . 63.409999999999997 108.701 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.497 ' HB ' ' HA3' ' A' ' 282' ' ' GLY . 10.7 m -105.06 161.15 14.48 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.895 -1.15 . . . . 62.219999999999999 107.895 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.73 72.34 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.991 0.916 . . . . 75.140000000000001 113.087 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.59 -34.49 64.88 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.899 1.444 . . . . 51.200000000000003 114.899 -174.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 C--N 1.321 -0.644 0 N-CA-C 113.801 1.038 . . . . 53.299999999999997 113.801 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 N--CA 1.415 -2.189 0 CA-C-O 121.814 0.816 . . . . 71.049999999999997 108.863 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -124.69 138.37 54.3 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.372 -1.344 . . . . 73.430000000000007 107.372 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.6 m -137.63 123.83 20.48 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.935 -0.706 . . . . 74.129999999999995 111.953 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 11.7 p -122.46 137.76 54.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 115.864 -0.607 . . . . 62.25 109.721 175.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 3.7 tp10 -79.0 -65.34 1.01 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.055 -0.52 . . . . 72.230000000000004 109.937 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 30.8 m -136.97 129.78 30.53 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 121.77 -0.581 . . . . 74.420000000000002 111.973 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.445 HG12 HD12 ' B' ' 231' ' ' ILE . 35.3 m -117.79 126.45 74.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 N-CA-C 108.368 -0.975 . . . . 74.140000000000001 108.368 174.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.93 126.68 66.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 121.38 0.61 . . . . 74.420000000000002 111.518 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.57 132.49 11.0 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 109.937 -1.265 . . . . 54.32 109.937 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . 0.644 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 30.5 mmmt -133.13 116.43 16.29 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.514 0.726 . . . . 73.530000000000001 110.284 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.43 86.29 0.9 Allowed Glycine 0 C--N 1.296 -1.67 0 C-N-CA 119.483 -1.342 . . . . 64.340000000000003 113.734 174.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 55.23 31.01 15.65 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.635 1.174 . . . . 71.239999999999995 111.618 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 23.6 m -83.04 149.18 27.1 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.485 0.66 . . . . 32.350000000000001 112.169 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -119.49 128.15 53.71 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.69 -0.856 . . . . 73.209999999999994 108.69 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 24.7 t -122.54 129.99 74.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.999 -0.741 . . . . 74.099999999999994 108.999 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.576 HD22 ' HB3' ' A' ' 240' ' ' GLN . 0.9 OUTLIER -119.78 117.36 27.99 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.556 -1.646 . . . . 73.230000000000004 106.556 173.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.496 HD13 ' HB3' ' B' ' 241' ' ' LEU . 42.7 mm -112.89 104.89 17.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.411 -0.959 . . . . 74.140000000000001 108.411 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 144.31 -127.7 3.05 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 119.746 -1.216 . . . . 71.209999999999994 113.007 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -128.36 150.76 49.95 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 120.711 0.291 . . . . 65.010000000000005 110.404 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -129.15 123.62 32.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.803 -1.925 . . . . 74.340000000000003 105.803 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -120.45 123.54 43.23 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.016 -1.475 . . . . 74.200000000000003 107.016 174.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.497 ' HA3' ' HB ' ' A' ' 246' ' ' THR . . . 145.36 -82.49 0.2 Allowed Glycine 0 N--CA 1.412 -2.923 0 C-N-CA 118.905 -1.617 . . . . 72.439999999999998 112.692 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -142.02 16.97 2.56 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.71 -1.233 . . . . 73.030000000000001 113.317 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.505 ' HD3' ' HA ' ' B' ' 286' ' ' PHE . 62.7 mttm 71.57 -38.28 0.42 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.887 1.675 . . . . 71.239999999999995 113.843 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.537 ' HA2' ' CD1' ' B' ' 287' ' ' TRP . . . -72.0 -28.84 67.84 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 117.391 1.717 . . . . 61.509999999999998 117.391 -170.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 276' ' ' LEU 0.325 51.9 p90 53.33 -78.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.468 1.107 . . . . 63.43 113.917 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.3 m0 . . . . . 0 C--N 1.319 -0.76 0 O-C-N 121.677 -0.639 . . . . 73.019999999999996 110.051 177.695 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 . . . . . 0 CA--C 1.504 -0.81 0 N-CA-C 113.561 0.949 . . . . 72.430000000000007 113.561 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -101.04 114.38 28.27 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 104.408 -2.442 . . . . 63.530000000000001 104.408 167.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 55.6 m -130.2 136.01 48.77 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 118.875 -1.13 . . . . 75.409999999999997 112.885 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -120.53 126.0 49.26 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.559 -1.655 . . . . 60.240000000000002 107.443 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 13.2 tmtt? -86.29 -59.34 2.31 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 116.137 -0.483 . . . . 74.540000000000006 110.747 -176.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -126.24 138.26 53.61 Favored 'General case' 0 C--O 1.25 1.12 0 C-N-CA 119.524 -0.87 . . . . 63.229999999999997 109.352 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.449 HG21 HG21 ' B' ' 239' ' ' VAL . 28.1 mt -130.54 121.59 51.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.803 -1.184 . . . . 74.120000000000005 107.803 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 29.3 ttt180 -127.03 118.45 24.47 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-O 121.049 0.452 . . . . 75.230000000000004 109.987 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 24.9 p -109.57 127.55 54.57 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.635 -1.987 . . . . 74.409999999999997 105.635 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 33.5 tt0 -139.81 138.54 35.9 Favored 'General case' 0 N--CA 1.406 -2.674 0 C-N-CA 119.977 -0.689 . . . . 65.439999999999998 109.564 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.559 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 46.8 mt-10 60.69 91.39 0.06 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.961 1.097 . . . . 75.519999999999996 113.961 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.559 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 61.35 23.79 13.98 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.999 0.92 . . . . 74.409999999999997 110.598 175.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -94.57 144.52 25.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.84 -0.618 . . . . 65.040000000000006 110.973 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -125.16 142.27 51.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.549 -1.278 . . . . 72.340000000000003 107.549 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.449 HG21 HG21 ' B' ' 231' ' ' ILE . 7.5 p -130.75 131.98 64.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 121.479 0.657 . . . . 73.209999999999994 110.699 174.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.549 ' HG3' HD13 ' B' ' 276' ' ' LEU . 5.8 tp-100 -108.15 120.71 43.11 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 105.807 -1.923 . . . . 74.430000000000007 105.807 173.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.496 ' HB3' HD13 ' A' ' 277' ' ' ILE . 3.1 tm? -125.86 117.68 23.88 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.332 -0.988 . . . . 61.240000000000002 108.332 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.27 -122.49 2.55 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.768 -0.73 . . . . 72.439999999999998 111.423 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -144.32 128.1 17.28 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.094 -0.706 . . . . 71.510000000000005 109.094 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 73.8 t -102.91 117.99 49.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.473 -0.936 . . . . 70.209999999999994 108.473 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.16 112.72 35.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.426 0.631 . . . . 73.540000000000006 109.565 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.2 m -105.49 161.66 14.15 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.555 -0.906 . . . . 54.310000000000002 108.555 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 249' ' ' ALA . . . -56.8 -33.33 66.59 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.848 0.859 . . . . 64.230000000000004 111.919 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.04 -34.14 59.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.453 -1.249 . . . . 73.319999999999993 113.14 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -68.43 -25.45 65.03 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 122.773 0.429 . . . . 74.430000000000007 112.092 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 tt . . . . . 0 C--O 1.238 0.486 0 N-CA-C 108.594 -0.891 . . . . 65.109999999999999 108.594 -178.124 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.411 -2.405 0 N-CA-C 107.688 -1.227 . . . . 63.399999999999999 107.688 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 91.1 m -91.25 107.87 19.49 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 107.884 -1.154 . . . . 53.310000000000002 107.884 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -120.9 131.31 54.31 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.388 -1.278 . . . . 61.240000000000002 107.559 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 51.5 m -138.86 126.49 21.96 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 120.937 0.399 . . . . 73.120000000000005 110.897 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.3 138.0 53.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.798 -0.761 . . . . 74.109999999999999 110.349 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.613 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 19.8 tp10 -79.24 -59.29 2.83 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.9 -0.591 . . . . 73.109999999999999 109.686 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 39.7 m -145.4 128.11 16.22 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.62 -0.675 . . . . 54.450000000000003 111.924 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.404 HG12 ' HB ' ' C' ' 231' ' ' ILE . 35.7 m -117.54 128.22 74.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.18 -1.044 . . . . 71.140000000000001 108.18 173.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 6.5 p -128.02 129.77 69.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-N 116.062 -0.517 . . . . 61.329999999999998 112.139 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.6 132.98 11.35 Favored Glycine 0 CA--C 1.475 -2.412 0 N-CA-C 110.037 -1.225 . . . . 73.120000000000005 110.037 176.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.591 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 27.3 mmmt -133.9 115.99 15.09 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 123.184 0.594 . . . . 74.340000000000003 111.621 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 77.54 92.29 0.27 Allowed Glycine 0 C--N 1.299 -1.5 0 C-N-CA 119.872 -1.156 . . . . 72.140000000000001 113.588 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' B' ' 236' ' ' ARG . 16.0 mp0 61.59 24.82 14.86 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.886 0.875 . . . . 71.219999999999999 111.638 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 41.6 m -83.04 152.39 25.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.476 0.917 . . . . 74.120000000000005 113.476 -171.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.452 ' HB3' ' CE3' ' B' ' 287' ' ' TRP . 94.9 mtt180 -128.34 127.96 43.66 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.467 -0.938 . . . . 75.510000000000005 108.467 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 47.2 t -126.28 128.17 71.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 122.41 0.284 . . . . 72.049999999999997 110.304 -175.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.549 HD13 ' HG3' ' B' ' 240' ' ' GLN . 5.8 tp -122.43 114.62 20.97 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.569 -0.852 . . . . 64.310000000000002 110.597 169.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.614 HG23 HD12 ' C' ' 241' ' ' LEU . 40.1 mm -108.01 104.55 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 N-CA-C 106.997 -1.483 . . . . 74.519999999999996 106.997 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.84 -148.95 20.75 Favored Glycine 0 CA--C 1.476 -2.389 0 C-N-CA 119.267 -1.444 . . . . 25.329999999999998 112.98 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 18.4 m120 -112.38 136.59 51.67 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.089 -0.708 . . . . 63.530000000000001 109.089 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.88 118.81 36.54 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.167 -1.79 . . . . 71.109999999999999 106.167 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.476 ' CE2' ' HB ' ' C' ' 245' ' ' VAL . 77.7 m-85 -118.98 124.01 45.95 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.012 0.911 . . . . 65.120000000000005 109.921 175.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 139.29 -64.92 0.54 Allowed Glycine 0 N--CA 1.412 -2.928 0 C-N-CA 119.745 -1.217 . . . . 75.409999999999997 113.5 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -169.73 37.01 0.19 Allowed Glycine 0 C--O 1.21 -1.381 0 C-N-CA 117.371 -2.347 . . . . 74.519999999999996 115.367 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt 70.87 -66.37 0.3 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.637 1.175 . . . . 61.539999999999999 113.188 170.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -81.7 89.84 1.43 Allowed Glycine 0 CA--C 1.494 -1.265 0 CA-C-N 115.458 -0.792 . . . . 33.32 114.033 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.505 ' HA ' ' HD3' ' A' ' 284' ' ' LYS . 6.6 p90 -60.49 -66.45 0.53 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.815 0.846 . . . . 52.210000000000001 112.437 176.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.537 ' CD1' ' HA2' ' A' ' 285' ' ' GLY . 5.0 m-90 . . . . . 0 C--N 1.305 -1.358 0 N-CA-C 107.739 -1.208 . . . . 72.409999999999997 107.739 176.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 . . . . . 0 N--CA 1.422 -1.853 0 CA-C-O 121.276 0.56 . . . . 71.310000000000002 111.146 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -101.17 116.32 32.55 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.674 -1.972 . . . . 63.329999999999998 105.674 173.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 50.0 m -131.58 136.98 48.23 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.542 -0.863 . . . . 73.510000000000005 111.887 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.12 130.93 52.03 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.8 -1.091 . . . . 74.439999999999998 108.308 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.629 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.1 OUTLIER -80.27 -67.83 0.73 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.613 -0.884 . . . . 60.219999999999999 108.613 -178.364 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -125.54 139.19 53.82 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 119.869 -0.732 . . . . 74.239999999999995 109.258 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.417 HG23 HG23 ' C' ' 267' ' ' VAL . 20.3 mt -133.42 118.76 32.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.242 -1.392 . . . . 62.299999999999997 107.242 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -120.0 124.52 46.13 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.601 -0.44 . . . . 74.400000000000006 110.222 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 27.8 p -109.58 126.52 53.68 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 104.599 -2.371 . . . . 75.409999999999997 104.599 173.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 32.6 tt0 -140.86 138.81 34.22 Favored 'General case' 0 N--CA 1.415 -2.193 0 C-N-CA 119.804 -0.758 . . . . 63.420000000000002 109.132 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.531 ' C ' ' HD3' ' C' ' 236' ' ' ARG . 56.4 mt-10 62.91 85.74 0.13 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.303 1.002 . . . . 74.519999999999996 112.939 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.579 ' HD3' ' N ' ' C' ' 236' ' ' ARG . 0.1 OUTLIER 64.9 21.82 12.39 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.882 0.873 . . . . 75.25 111.473 174.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -91.68 147.48 22.97 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.294 0.569 . . . . 54.049999999999997 111.447 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.418 ' HG3' ' HB2' ' B' ' 274' ' ' ARG . 5.2 mpt_? -125.1 144.41 50.43 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.863 -1.162 . . . . 73.329999999999998 107.863 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.41 HG21 HG21 ' C' ' 231' ' ' ILE . 5.7 p -133.85 135.52 55.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.351 0.596 . . . . 64.209999999999994 111.377 175.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -110.41 117.81 34.59 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 106.913 -1.514 . . . . 72.0 106.913 172.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.614 HD12 HG23 ' B' ' 277' ' ' ILE . 3.2 tm? -121.88 117.69 27.11 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.947 -1.501 . . . . 74.030000000000001 106.947 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.65 -128.38 4.1 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.551 -0.833 . . . . 70.439999999999998 111.024 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 51.5 t-20 -140.14 128.83 23.08 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.426 -0.953 . . . . 71.219999999999999 108.426 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.23 115.12 44.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.637 -1.246 . . . . 71.420000000000002 107.637 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . 0.476 ' HB ' ' CE2' ' B' ' 281' ' ' TYR . 43.4 t -120.51 112.57 36.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.949 -0.76 . . . . 63.32 108.949 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.1 m -101.57 160.91 14.04 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.069 -0.715 . . . . 65.200000000000003 109.069 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -58.91 -31.77 68.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.957 1.303 . . . . 74.109999999999999 110.519 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.31 59.24 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.043 -1.89 . . . . 60.310000000000002 113.616 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.456 0 C-N-CA 120.426 -0.51 . . . . 70.239999999999995 111.412 -176.579 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.42 -1.959 0 CA-C-O 121.561 0.696 . . . . 73.510000000000005 109.259 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -121.24 137.21 54.79 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.803 -1.184 . . . . 75.5 107.803 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 18.1 t -135.95 123.3 21.92 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 108.929 -0.767 . . . . 70.209999999999994 108.929 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.02 131.34 72.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.26 -0.882 . . . . 72.349999999999994 109.119 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.629 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 17.2 tp10 -88.36 -54.76 4.03 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.534 -0.543 . . . . 70.519999999999996 109.534 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 55.0 m -150.22 127.44 11.31 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.349 -0.845 . . . . 50.340000000000003 110.842 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.417 HG23 HG23 ' C' ' 231' ' ' ILE . 5.1 m -121.21 128.42 75.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.706 -0.849 . . . . 45.32 108.706 171.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.09 135.53 63.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 116.34 -0.391 . . . . 74.549999999999997 110.352 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.53 133.49 11.4 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 109.866 -1.294 . . . . 51.240000000000002 109.866 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -132.31 116.24 16.64 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.801 -0.444 . . . . 74.430000000000007 109.801 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.32 93.16 0.56 Allowed Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.345 -0.931 . . . . 64.099999999999994 113.309 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 55.38 28.4 11.42 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.696 1.198 . . . . 75.219999999999999 111.653 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 46.3 m -82.37 154.89 25.01 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.953 1.094 . . . . 61.409999999999997 113.953 -169.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -122.85 128.26 50.14 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.871 -1.059 . . . . 71.140000000000001 108.254 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 11.0 t -125.64 130.53 72.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.073 -0.714 . . . . 74.519999999999996 109.073 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -123.55 110.59 15.23 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.284 -1.376 . . . . 75.150000000000006 107.284 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 40.8 mm -113.53 103.95 16.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.072 -1.455 . . . . 62.140000000000001 107.072 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.05 -152.65 24.53 Favored Glycine 0 CA--C 1.471 -2.676 0 C-N-CA 120.034 -1.079 . . . . 54.310000000000002 111.216 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.56 141.15 48.44 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 109.213 -0.662 . . . . 73.239999999999995 109.213 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.69 118.37 34.84 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.143 -1.428 . . . . 74.299999999999997 107.143 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -119.08 124.29 46.55 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.76 0.791 . . . . 71.439999999999998 110.828 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.51 -52.92 0.74 Allowed Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 120.072 -1.061 . . . . 22.420000000000002 113.151 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -151.59 -4.16 0.18 Allowed Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 117.434 -2.317 . . . . 64.409999999999997 115.207 -173.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm 78.47 -40.65 0.28 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.832 1.253 . . . . 71.430000000000007 109.616 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -86.03 110.38 3.47 Favored Glycine 0 N--CA 1.41 -3.067 0 N-CA-C 109.823 -1.311 . . . . 61.299999999999997 109.823 174.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -79.97 -85.84 0.08 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 112.88 0.696 . . . . 61.25 112.88 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 7.9 m0 . . . . . 0 C--N 1.316 -0.857 0 O-C-N 120.91 -1.119 . . . . 74.040000000000006 111.486 -176.851 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 . . . . . 0 C--O 1.244 0.767 0 CA-C-O 120.826 0.346 . . . . 72.310000000000002 110.475 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -113.83 127.83 56.16 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.606 -1.257 . . . . 74.140000000000001 107.606 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 28.0 m -123.41 137.66 54.76 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.93 -0.396 . . . . 71.450000000000003 109.93 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.62 125.38 28.63 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.25 -0.432 . . . . 70.540000000000006 110.284 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 12.9 tmtt? -76.3 -62.72 1.52 Allowed 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.723 0.639 . . . . 73.409999999999997 109.749 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -133.72 139.14 46.21 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-O 121.319 0.581 . . . . 53.200000000000003 112.543 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 34.5 mm -123.39 117.12 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 106.774 -1.565 . . . . 71.140000000000001 106.774 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -118.75 115.89 25.41 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.328 0.585 . . . . 71.230000000000004 110.201 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.4 128.27 50.73 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.597 -0.89 . . . . 74.140000000000001 108.597 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -137.1 164.1 29.24 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.258 0.349 . . . . 73.430000000000007 110.607 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 236' ' ' ARG . 34.7 mt-10 66.99 -88.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.777 1.231 . . . . 64.5 113.443 174.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.435 ' HD2' ' HB3' ' A' ' 235' ' ' GLU . 0.2 OUTLIER -138.18 27.25 2.62 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 108.174 -1.047 . . . . 71.409999999999997 108.174 -177.494 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -75.13 149.19 39.13 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.166 -0.925 . . . . 61.509999999999998 110.107 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -125.57 135.06 51.82 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 104.861 -2.274 . . . . 75.099999999999994 104.861 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.14 148.47 30.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.7 0.762 . . . . 71.209999999999994 111.924 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.461 ' CG ' ' HG ' ' A' ' 276' ' ' LEU . 49.9 tp60 -126.87 128.58 46.72 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.96 -1.018 . . . . 72.219999999999999 108.878 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -126.48 118.72 25.51 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.66 -1.607 . . . . 53.119999999999997 106.66 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.499 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 135.86 -135.17 7.64 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.197 -1.001 . . . . 61.43 112.409 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -128.82 128.43 43.9 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 122.687 -0.302 . . . . 74.239999999999995 110.272 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 91.3 t -118.29 127.17 75.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.718 -0.845 . . . . 74.209999999999994 108.718 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.11 112.76 39.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.563 -0.902 . . . . 71.409999999999997 108.563 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 50.6 m -81.14 160.08 24.49 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.554 -1.276 . . . . 72.0 107.554 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.49 84.33 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.543 0.571 . . . . 74.450000000000003 112.543 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.54 -34.89 65.11 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 114.32 1.23 . . . . 73.120000000000005 114.32 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 113.75 1.019 . . . . 62.210000000000001 113.75 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 36.2 p . . . . . 0 N--CA 1.42 -1.946 0 N-CA-C 106.539 -1.652 . . . . 71.340000000000003 106.539 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 0.2 OUTLIER -126.52 122.21 34.51 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.102 -0.703 . . . . 72.329999999999998 109.102 -174.529 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.409 ' N ' HD22 ' A' ' 262' ' ' ASN . 35.3 m -122.92 123.15 40.29 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.697 -0.483 . . . . 74.420000000000002 109.697 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.1 p -115.74 140.52 37.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.01 0.433 . . . . 65.209999999999994 110.629 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.597 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 22.7 tp10 -82.78 -69.2 0.64 Allowed 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.165 -0.925 . . . . 71.540000000000006 110.548 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 13.5 m -133.73 129.22 36.4 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 121.535 -0.728 . . . . 62.310000000000002 111.814 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 24.0 m -118.1 127.28 75.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.814 -1.18 . . . . 72.209999999999994 107.814 170.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.72 127.07 73.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-O 121.116 0.484 . . . . 74.439999999999998 111.533 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.84 133.57 11.53 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.623 -0.717 . . . . 64.510000000000005 111.762 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -125.06 144.17 50.54 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 124.179 0.992 . . . . 61.310000000000002 109.28 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 65.21 -132.06 35.99 Favored Glycine 0 C--N 1.305 -1.149 0 C-N-CA 121.212 -0.518 . . . . 63.409999999999997 112.931 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' B' ' 235' ' ' GLU . 8.7 mm-40 -92.79 53.65 2.07 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 125.201 1.4 . . . . 75.099999999999994 111.413 -177.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 73.5 m -83.1 150.03 26.53 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.166 0.508 . . . . 72.340000000000003 112.113 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -128.61 127.47 42.32 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.183 -1.414 . . . . 64.409999999999997 107.183 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.463 HG13 HG23 ' B' ' 239' ' ' VAL . 16.4 t -132.71 130.09 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 109.094 -0.706 . . . . 73.120000000000005 109.094 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.461 ' HG ' ' CG ' ' A' ' 240' ' ' GLN . 5.8 tt -118.31 121.55 40.67 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.879 -1.156 . . . . 72.409999999999997 107.879 174.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.448 HG23 HD12 ' B' ' 241' ' ' LEU . 3.5 mp -112.23 104.36 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.982 0 N-CA-C 107.303 -1.369 . . . . 55.140000000000001 107.303 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 151.54 -145.27 12.88 Favored Glycine 0 N--CA 1.421 -2.309 0 N-CA-C 111.064 -0.814 . . . . 25.530000000000001 111.064 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' B' ' 243' ' ' ASN . 95.7 m-20 -114.3 140.2 48.81 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 116.735 0.267 . . . . 72.409999999999997 110.594 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.8 OUTLIER -128.16 129.54 46.68 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.796 -1.557 . . . . 73.209999999999994 106.796 178.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -119.4 124.62 47.0 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 109.349 -0.612 . . . . 71.519999999999996 109.349 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . 0.417 ' CA ' ' HB2' ' A' ' 249' ' ' ALA . . . 136.42 -50.65 0.83 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 111.254 -0.739 . . . . 72.239999999999995 111.254 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 98.12 39.21 3.84 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 109.546 -1.422 . . . . 73.049999999999997 109.546 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -141.04 -56.37 0.5 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.318 -0.553 . . . . 75.129999999999995 109.641 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . 0.612 ' HA3' ' CZ3' ' A' ' 287' ' ' TRP . . . 72.21 -159.53 53.74 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.494 -0.776 . . . . 65.030000000000001 114.907 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -105.24 -0.18 26.62 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.351 -0.425 . . . . 71.209999999999994 109.92 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . 0.612 ' CZ3' ' HA3' ' A' ' 285' ' ' GLY . 24.2 m-90 . . . . . 0 C--O 1.237 0.431 0 CA-C-N 115.54 -0.755 . . . . 63.549999999999997 111.944 -174.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 261' ' ' THR . 13.9 ptt180 . . . . . 0 N--CA 1.433 -1.321 0 CA-C-O 121.589 0.709 . . . . 75.109999999999999 111.527 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 48.0 t-20 -116.85 127.63 54.48 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.342 -1.725 . . . . 72.420000000000002 106.342 172.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 19.5 m -125.75 136.37 53.09 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 109.11 -0.7 . . . . 74.25 109.11 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.502 ' HB1' HD11 ' B' ' 231' ' ' ILE . . . -131.39 127.66 37.97 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.808 -0.633 . . . . 62.420000000000002 110.447 -175.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.597 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 12.1 tmtt? -81.73 -68.12 0.72 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.686 -0.688 . . . . 44.420000000000002 109.656 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -127.38 137.48 52.77 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 119.374 -0.93 . . . . 71.230000000000004 110.961 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.502 HD11 ' HB1' ' B' ' 228' ' ' ALA . 35.9 mm -129.77 117.13 40.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 106.544 -1.65 . . . . 72.230000000000004 106.544 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . 0.585 ' HD3' ' OE2' ' B' ' 234' ' ' GLU . 18.2 ttm180 -118.47 124.31 47.29 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 120.696 0.284 . . . . 71.109999999999999 110.59 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 73.1 p -115.46 128.23 55.87 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.252 -1.018 . . . . 72.420000000000002 108.252 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . 0.585 ' OE2' ' HD3' ' B' ' 232' ' ' ARG . 59.3 mt-10 -127.01 156.24 41.94 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.132 0.491 . . . . 74.340000000000003 111.043 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' B' ' 236' ' ' ARG . 49.3 mt-10 66.68 -86.85 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.443 0 N-CA-C 114.38 1.252 . . . . 75.329999999999998 114.38 172.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . 0.462 ' HD2' ' HB3' ' B' ' 235' ' ' GLU . 0.8 OUTLIER -135.59 31.84 3.08 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.31 -0.996 . . . . 60.119999999999997 108.31 -178.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -76.56 141.91 40.99 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.106 -0.952 . . . . 74.5 111.745 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 7.1 mpt_? -125.12 133.86 52.68 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.895 -1.52 . . . . 70.549999999999997 106.895 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.573 HG12 ' HB ' ' B' ' 275' ' ' VAL . 21.7 m -140.97 151.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.419 0.628 . . . . 54.229999999999997 112.331 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.502 ' CG ' ' HG ' ' B' ' 276' ' ' LEU . 38.3 tp60 -119.43 137.31 53.85 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.019 -1.446 . . . . 71.340000000000003 108.728 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.448 HD12 HG23 ' A' ' 277' ' ' ILE . 2.7 tm? -129.39 117.96 21.43 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.212 -1.773 . . . . 75.420000000000002 106.212 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.564 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 131.33 -131.8 6.53 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.504 -0.855 . . . . 40.219999999999999 112.886 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.515 ' HB3' ' OD1' ' A' ' 279' ' ' ASN . 23.8 t-20 -125.38 136.3 53.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 122.491 -0.417 . . . . 70.150000000000006 110.912 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 280' ' ' GLU . 93.8 t -126.77 128.36 70.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.366 -0.975 . . . . 74.209999999999994 108.366 175.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 61.9 t -120.38 112.83 38.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.182 -1.044 . . . . 72.549999999999997 108.182 174.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.45 HG21 ' HB3' ' B' ' 284' ' ' LYS . 28.4 m -76.68 160.74 29.11 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 106.776 -1.564 . . . . 73.430000000000007 106.776 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.08 -33.87 76.38 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.109 0.956 . . . . 51.329999999999998 110.74 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.5 -34.4 64.58 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.404 -1.725 . . . . 71.5 114.117 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' B' ' 250' ' ' LEU . . . -59.83 -26.09 65.52 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.562 0.949 . . . . 73.349999999999994 113.562 -174.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' B' ' 249' ' ' ALA . 53.6 tp . . . . . 0 C--O 1.246 0.895 0 O-C-N 124.473 1.108 . . . . 70.420000000000002 110.781 -174.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . 0.401 HG21 ' HB2' ' C' ' 243' ' ' ASN . 2.4 m . . . . . 0 N--CA 1.436 -1.148 0 CA-C-O 121.055 0.455 . . . . 75.519999999999996 110.831 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -126.77 108.75 11.32 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.356 -1.72 . . . . 54.109999999999999 106.356 166.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 0.2 OUTLIER -124.42 128.25 48.75 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.279 -1.008 . . . . 61.299999999999997 108.279 -172.475 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 33.1 m -129.27 123.66 32.47 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.889 -0.411 . . . . 73.430000000000007 109.889 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.51 141.22 28.77 Favored 'Isoleucine or valine' 0 C--O 1.25 1.121 0 CA-C-N 115.977 -0.556 . . . . 70.25 109.749 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 20.7 tp10 -83.37 -58.04 3.0 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.582 -0.735 . . . . 74.040000000000006 110.315 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' C' ' 230' ' ' ASP . 80.4 m -149.75 133.16 16.55 Favored 'General case' 0 C--N 1.31 -1.125 0 O-C-N 121.372 -0.83 . . . . 61.119999999999997 112.428 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 12.2 m -118.5 134.68 61.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.767 -1.197 . . . . 74.329999999999998 107.767 171.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 m -125.88 122.82 62.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.033 0.444 . . . . 75.230000000000004 110.629 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.99 132.86 11.26 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.466 -0.873 . . . . 74.150000000000006 111.893 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' C' ' 234' ' ' GLU . 29.3 mmmt -126.39 147.12 49.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 124.213 1.005 . . . . 72.230000000000004 109.236 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.41 -136.25 34.23 Favored Glycine 0 C--O 1.228 -0.259 0 C-N-CA 120.009 -1.091 . . . . 62.140000000000001 110.516 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -97.35 69.55 2.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.866 0.841 . . . . 72.25 111.277 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 72.3 m -85.67 146.46 26.83 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.12 -0.945 . . . . 74.140000000000001 111.366 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 8.8 mpt_? -127.49 127.11 43.47 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.706 -1.59 . . . . 74.519999999999996 106.706 169.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.573 ' HB ' HG12 ' B' ' 239' ' ' VAL . 21.7 t -134.16 139.13 48.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 108.282 -1.007 . . . . 52.43 108.282 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . 0.502 ' HG ' ' CG ' ' B' ' 240' ' ' GLN . 6.5 tt -123.56 125.44 44.87 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 106.706 -1.59 . . . . 65.219999999999999 106.706 173.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.411 HG23 HD12 ' C' ' 241' ' ' LEU . 4.0 mp -112.57 104.06 16.44 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 105.903 -1.888 . . . . 73.439999999999998 105.903 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 153.35 -149.24 20.74 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.164 -1.017 . . . . 60.210000000000001 113.26 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -110.04 133.56 53.07 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.019 -0.734 . . . . 64.219999999999999 109.019 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' C' ' 244' ' ' VAL . 2.2 tm-20 -126.65 128.08 46.2 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 106.507 -1.664 . . . . 70.420000000000002 106.507 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -118.58 125.06 49.0 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 109.143 -0.688 . . . . 64.349999999999994 109.143 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.02 -43.29 1.24 Allowed Glycine 0 N--CA 1.417 -2.621 0 N-CA-C 110.498 -1.041 . . . . 43.210000000000001 110.498 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.39 36.14 9.0 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.319 -1.512 . . . . 73.109999999999999 109.319 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . 0.45 ' HB3' HG21 ' B' ' 246' ' ' THR . 49.4 tptt -142.56 -62.27 0.43 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.873 -0.417 . . . . 71.319999999999993 109.873 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . 0.438 ' HA3' ' CZ3' ' B' ' 287' ' ' TRP . . . 68.95 -159.67 52.66 Favored Glycine 0 N--CA 1.44 -1.079 0 O-C-N 123.408 0.443 . . . . 63.149999999999999 113.821 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -102.26 -6.8 22.72 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 121.086 -0.246 . . . . 75.430000000000007 111.223 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . 0.477 ' HB3' ' HG2' ' C' ' 238' ' ' ARG . 26.6 m-90 . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 121.907 0.86 . . . . 74.430000000000007 110.169 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 . . . . . 0 N--CA 1.439 -1.015 0 CA-C-O 121.301 0.572 . . . . 71.349999999999994 111.753 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 26.5 t-20 -117.28 127.0 53.64 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.743 -1.206 . . . . 72.349999999999994 107.743 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' C' ' 263' ' ' SER . 19.5 m -126.37 137.22 53.43 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 108.785 -0.82 . . . . 74.5 108.785 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.41 ' HB1' HD11 ' C' ' 231' ' ' ILE . . . -136.29 132.39 35.66 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.887 -0.325 . . . . 64.150000000000006 110.639 -176.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.613 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.0 OUTLIER -80.14 -76.34 0.23 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.274 -0.639 . . . . 75.510000000000005 109.274 178.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' B' ' 266' ' ' THR . 2.1 p-10 -129.09 140.51 51.54 Favored 'General case' 0 C--O 1.264 1.848 0 C-N-CA 118.062 -1.455 . . . . 70.230000000000004 112.216 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.41 HD11 ' HB1' ' C' ' 228' ' ' ALA . 28.0 mm -119.27 117.07 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 113.055 -1.884 . . . . 63.299999999999997 106.26 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . 0.47 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 17.9 ttm180 -111.75 123.67 50.73 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.907 -0.405 . . . . 73.430000000000007 109.907 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 72.0 p -116.96 128.37 55.13 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.003 -1.11 . . . . 71.239999999999995 108.003 175.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.47 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 49.2 mt-10 -127.31 160.74 30.42 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 120.586 -0.446 . . . . 73.319999999999993 111.361 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 63.43 -82.02 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.908 0 C-N-CA 124.94 1.296 . . . . 71.540000000000006 114.343 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.45 ' O ' ' HD2' ' C' ' 238' ' ' ARG . 0.2 OUTLIER -139.44 25.95 2.39 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.595 -0.891 . . . . 71.430000000000007 108.595 -178.433 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.53 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -71.23 141.83 50.59 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.826 0.822 . . . . 74.439999999999998 112.106 -177.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 9.1 mpt_? -124.55 133.43 53.3 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 106.454 -1.684 . . . . 75.030000000000001 106.454 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.503 HG23 HG13 ' B' ' 275' ' ' VAL . 21.2 m -142.94 150.18 18.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.707 0.765 . . . . 65.409999999999997 112.397 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.415 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 5.2 tp60 -112.33 137.42 50.5 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.248 -1.342 . . . . 73.200000000000003 109.062 176.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' C' ' 277' ' ' ILE . 2.8 tm? -128.13 117.53 21.78 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.278 -2.119 . . . . 72.450000000000003 105.278 172.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.485 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 130.93 -133.07 7.11 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.191 -1.004 . . . . 43.219999999999999 112.721 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.401 ' HB2' HG21 ' B' ' 260' ' ' THR . 40.8 t30 -128.99 138.56 52.02 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 122.233 -0.569 . . . . 73.109999999999999 110.716 -176.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' B' ' 280' ' ' GLU . 96.7 t -126.09 118.48 51.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.213 -0.662 . . . . 63.140000000000001 109.213 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.12 112.72 41.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.347 -0.983 . . . . 71.0 108.347 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 19.4 m -79.52 160.38 26.53 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.054 -1.461 . . . . 54.43 107.054 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.86 -33.07 72.52 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.1 0.952 . . . . 75.319999999999993 110.644 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.48 -33.33 63.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.236 -1.802 . . . . 75.340000000000003 113.848 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 114.536 1.31 . . . . 64.430000000000007 114.536 -172.534 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.411 -2.376 0 N-CA-C 105.236 -2.135 . . . . 64.120000000000005 105.236 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -126.72 139.0 53.47 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.497 -0.774 . . . . 63.329999999999998 110.922 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' C' ' 227' ' ' SER . 42.3 m -139.89 123.56 17.33 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 107.863 -1.162 . . . . 74.299999999999997 107.863 176.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.6 p -109.87 152.88 11.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.819 -0.352 . . . . 65.129999999999995 110.104 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 10.1 tp10 -88.25 -69.72 0.68 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.154 -0.475 . . . . 61.140000000000001 109.989 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 90.5 m -140.46 130.73 25.08 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.897 -0.409 . . . . 73.340000000000003 109.897 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.21 133.6 67.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.804 -0.813 . . . . 74.340000000000003 108.804 171.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 29.7 m -121.5 129.05 75.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.166 0.508 . . . . 64.510000000000005 111.154 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.54 133.47 11.5 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.433 -1.067 . . . . 53.32 110.433 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . 0.427 ' HD2' ' HB2' ' C' ' 234' ' ' GLU . 28.4 mmmt -132.07 131.52 42.48 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.124 0.569 . . . . 52.240000000000002 109.852 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 68.56 -133.02 27.51 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.782 -0.645 . . . . 43.420000000000002 112.263 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -79.35 47.39 0.8 Allowed 'General case' 0 C--N 1.305 -1.37 0 C-N-CA 125.063 1.345 . . . . 71.420000000000002 113.127 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 50.7 m -83.4 145.44 29.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.555 0.693 . . . . 74.519999999999996 112.853 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 10.2 mpt_? -130.6 127.04 38.2 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 106.537 -1.653 . . . . 62.310000000000002 106.537 170.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.439 ' HB ' HG12 ' C' ' 239' ' ' VAL . 10.0 t -137.83 140.73 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 108.771 -0.826 . . . . 61.049999999999997 108.771 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . 0.456 ' HB3' ' CZ2' ' C' ' 287' ' ' TRP . 6.8 tt -123.32 114.14 19.8 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.815 -1.18 . . . . 72.310000000000002 107.815 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 3.4 mp -104.57 104.19 16.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 105.532 -2.025 . . . . 64.420000000000002 105.532 176.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 159.26 -139.67 6.36 Favored Glycine 0 N--CA 1.41 -3.059 0 C-N-CA 119.4 -1.381 . . . . 73.230000000000004 112.402 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -127.79 142.97 51.15 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.165 -1.42 . . . . 73.209999999999994 107.165 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -141.93 132.62 25.56 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.218 -0.66 . . . . 60.310000000000002 109.218 -174.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.48 133.58 55.05 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.221 0.534 . . . . 74.129999999999995 111.023 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 122.86 -36.39 3.12 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 110.002 -1.239 . . . . 73.239999999999995 110.002 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 86.28 32.87 15.53 Favored Glycine 0 N--CA 1.419 -2.436 0 N-CA-C 111.422 -0.671 . . . . 54.219999999999999 111.422 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -131.92 -54.78 0.99 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.837 -0.801 . . . . 74.299999999999997 108.837 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . 0.414 ' HA3' ' CE3' ' C' ' 287' ' ' TRP . . . 69.21 -172.28 38.07 Favored Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 115.244 -0.889 . . . . 75.549999999999997 112.45 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -91.2 -5.73 54.47 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 110.429 -0.212 . . . . 73.409999999999997 110.429 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . 0.456 ' CZ2' ' HB3' ' C' ' 276' ' ' LEU . 27.6 m-90 . . . . . 0 N--CA 1.477 0.883 0 CA-C-O 121.55 0.69 . . . . 75.150000000000006 110.518 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.484 ' HG2' ' OG1' ' A' ' 261' ' ' THR . 14.0 ptt180 . . . . . 0 N--CA 1.445 -0.682 0 N-CA-C 109.19 -0.671 . . . . 74.319999999999993 109.19 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ASN . . . . . 0.401 HD21 HG22 ' A' ' 277' ' ' ILE . 24.2 t-20 -116.19 114.72 24.83 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.063 -0.717 . . . . 63.5 109.063 178.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 26.9 m -134.83 137.91 43.74 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.453 0.538 . . . . 62.119999999999997 112.453 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.9 135.33 45.51 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.418 -1.327 . . . . 70.530000000000001 107.418 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -55.25 3.36 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.578 -0.849 . . . . 74.420000000000002 110.493 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -139.63 139.05 36.62 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 122.279 -0.263 . . . . 61.130000000000003 110.491 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ILE . . . . . 0.483 HG21 HG21 ' A' ' 239' ' ' VAL . 30.0 mt -137.82 125.8 31.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 108.822 -0.807 . . . . 62.229999999999997 108.822 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ARG . . . . . 0.494 ' HB3' HG12 ' A' ' 268' ' ' VAL . 35.2 ttt180 -126.05 122.34 35.55 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.151 -1.055 . . . . 72.329999999999998 108.151 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' THR . . . . . 0.509 ' OG1' ' HB1' ' A' ' 237' ' ' ALA . 14.3 t -135.27 130.78 35.69 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 120.014 -0.674 . . . . 41.310000000000002 109.396 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -135.2 140.75 45.56 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 112.177 0.436 . . . . 71.420000000000002 112.177 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 66.68 106.53 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.02 1.328 . . . . 54.329999999999998 113.361 174.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 272' ' ' GLU . 47.6 mtt85 57.46 35.01 25.41 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.807 1.289 . . . . 74.549999999999997 107.564 176.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.509 ' HB1' ' OG1' ' A' ' 233' ' ' THR . . . -83.7 128.71 34.73 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 112.81 -1.996 . . . . 70.450000000000003 112.633 -170.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -129.86 135.06 47.94 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 106.878 -1.527 . . . . 72.409999999999997 106.878 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.483 HG21 HG21 ' A' ' 231' ' ' ILE . 6.7 p -143.68 140.1 25.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.646 -0.501 . . . . 74.519999999999996 109.646 175.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . 0.55 ' HB2' ' CD1' ' A' ' 286' ' ' PHE . 11.7 tm0? -125.82 136.99 53.74 Favored 'General case' 0 N--CA 1.405 -2.68 0 N-CA-C 106.431 -1.692 . . . . 70.109999999999999 106.431 177.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 tt -128.73 117.22 20.76 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 105.704 -1.962 . . . . 74.430000000000007 105.704 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.513 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 135.26 -119.23 2.06 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.367 -0.92 . . . . 53.119999999999997 113.338 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -144.43 139.53 28.42 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.032 -1.099 . . . . 73.549999999999997 108.032 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.435 ' HB ' ' HG2' ' A' ' 280' ' ' GLU . 22.5 t -125.79 121.44 59.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 109.465 -0.568 . . . . 42.549999999999997 109.465 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.76 112.64 34.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.996 -1.113 . . . . 52.219999999999999 107.996 170.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 281' ' ' TYR . 6.4 t -89.35 160.55 16.79 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.7 -1.2 . . . . 73.409999999999997 109.588 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.67 74.38 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 123.156 0.582 . . . . 74.230000000000004 110.15 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -35.5 66.82 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.167 -0.924 . . . . 53.43 112.138 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . . . . . . 0 N--CA 1.466 0.343 0 CA-C-N 116.543 -0.299 . . . . 73.109999999999999 110.614 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' A' ' 225' ' ' ARG . 10.8 t . . . . . 0 N--CA 1.397 -3.082 0 N-CA-C 105.138 -2.171 . . . . 70.319999999999993 105.138 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' ASN . . . . . 0.588 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 23.2 t-20 -122.1 127.07 49.71 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.564 -0.744 . . . . 63.32 111.786 -168.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.3 t -135.68 123.75 22.91 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 109.046 -0.724 . . . . 63.119999999999997 109.046 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.5 p -126.55 147.42 31.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 109.044 -0.725 . . . . 63.229999999999997 109.044 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -96.91 -75.86 0.53 Allowed 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 119.612 -0.835 . . . . 62.119999999999997 111.208 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 63.3 m -117.33 127.27 53.89 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.336 0.588 . . . . 62.450000000000003 110.831 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.449 HG11 HD11 ' A' ' 277' ' ' ILE . 1.4 p -134.0 123.99 45.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.876 -0.602 . . . . 70.409999999999997 110.903 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 232' ' ' ARG . 21.6 m -124.4 138.27 54.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.536 -0.756 . . . . 61.140000000000001 111.517 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.2 131.38 7.68 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 109.508 -1.437 . . . . 70.5 109.508 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.31 116.18 14.95 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 122.66 0.384 . . . . 60.119999999999997 110.976 -174.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.47 74.12 1.06 Allowed Glycine 0 N--CA 1.465 0.614 0 C-N-CA 120.079 -1.058 . . . . 50.420000000000002 112.868 172.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' GLU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 236' ' ' ARG . 35.4 tt0 58.37 77.01 0.31 Allowed 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 125.753 1.621 . . . . 54.140000000000001 110.465 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 25.7 m -121.91 143.76 49.26 Favored 'General case' 0 N--CA 1.39 -3.426 0 CA-C-N 114.977 -1.01 . . . . 70.5 109.049 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -122.51 126.15 47.23 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.001 -1.481 . . . . 70.430000000000007 107.001 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 53.2 t -124.13 126.23 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.018 0 O-C-N 123.878 0.736 . . . . 73.239999999999995 109.389 -174.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' LEU . . . . . 0.491 HD23 ' HG2' ' B' ' 240' ' ' GLN . 17.7 tp -122.31 121.47 36.81 Favored 'General case' 0 C--N 1.267 -3.008 0 C-N-CA 118.758 -1.177 . . . . 70.430000000000007 110.749 174.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' ILE . . . . . 0.449 HD11 HG11 ' A' ' 267' ' ' VAL . 74.6 mt -109.75 103.93 16.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.489 -0.93 . . . . 75.200000000000003 108.489 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLY . . . . . 0.519 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 139.64 -141.04 11.29 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.614 -0.803 . . . . 54.020000000000003 112.717 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 44.8 t-20 -123.69 140.08 53.35 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.363 -0.977 . . . . 55.520000000000003 108.363 -176.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.435 ' HG2' ' HB ' ' A' ' 244' ' ' VAL . 0.0 OUTLIER -123.72 119.91 31.16 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.487 -0.931 . . . . 70.530000000000001 108.487 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' TYR . . . . . 0.483 ' O ' HG22 ' A' ' 246' ' ' THR . 22.1 m-85 -103.72 121.78 43.71 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.037 -1.838 . . . . 62.329999999999998 106.037 174.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 110.98 -51.7 0.68 Allowed Glycine 0 N--CA 1.423 -2.193 0 N-CA-C 110.077 -1.209 . . . . 61.420000000000002 110.077 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.525 ' C ' ' HD2' ' A' ' 284' ' ' LYS . . . 84.04 3.45 89.06 Favored Glycine 0 C--O 1.223 -0.567 0 CA-C-O 121.241 0.356 . . . . 62.509999999999998 112.269 177.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.525 ' HD2' ' C ' ' A' ' 283' ' ' GLY . 3.6 mptp? -135.52 18.12 3.35 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.148 0.499 . . . . 75.409999999999997 110.27 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -90.51 -39.72 5.87 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.615 -0.994 . . . . 55.340000000000003 110.615 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 240' ' ' GLN . 29.1 t80 -79.95 -37.49 34.35 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 112.134 0.42 . . . . 73.200000000000003 112.134 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 113.675 0.991 . . . . 74.129999999999995 113.675 -175.859 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 225' ' ' ARG . . . . . 0.422 ' HA ' ' CG2' ' A' ' 261' ' ' THR . 13.8 ptt180 . . . . . 0 N--CA 1.439 -0.986 0 N-CA-C 109.762 -0.458 . . . . 73.439999999999998 109.762 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 226' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 27.4 t-20 -116.55 114.65 24.45 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.08 -0.711 . . . . 64.239999999999995 109.08 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 11.1 p -139.48 137.62 35.7 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 112.644 0.609 . . . . 74.510000000000005 112.644 -177.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -126.53 137.24 53.34 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.819 -1.082 . . . . 73.109999999999999 108.49 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -87.19 -66.67 0.89 Allowed 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.154 -0.619 . . . . 73.540000000000006 110.418 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -127.0 138.61 53.28 Favored 'General case' 0 C--O 1.264 1.822 0 CA-C-O 121.401 0.619 . . . . 63.25 109.561 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 231' ' ' ILE . . . . . 0.49 HG21 HG21 ' B' ' 239' ' ' VAL . 8.7 mt -131.48 117.39 35.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.495 -1.298 . . . . 75.209999999999994 107.495 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -116.46 115.65 26.2 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 110.01 -0.367 . . . . 72.540000000000006 110.01 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 233' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 22.3 p -114.31 127.54 55.91 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.167 -1.42 . . . . 62.409999999999997 107.167 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -143.31 138.66 29.68 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 109.434 -0.58 . . . . 43.149999999999999 109.434 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 235' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' B' ' 271' ' ' GLY . 33.2 tt0 62.59 91.32 0.07 Allowed 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 124.778 1.299 . . . . 64.420000000000002 112.569 171.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 65.59 34.85 7.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.22 -0.659 . . . . 64.540000000000006 109.22 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 237' ' ' ALA . . . . . 0.619 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -101.54 149.26 24.28 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 122.696 1.236 . . . . 73.420000000000002 113.744 -172.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 238' ' ' ARG . . . . . 0.459 ' HD2' ' C ' ' B' ' 237' ' ' ALA . 3.7 mpt_? -134.35 136.37 43.37 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.12 -1.437 . . . . 62.149999999999999 107.12 175.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 239' ' ' VAL . . . . . 0.49 HG21 HG21 ' B' ' 231' ' ' ILE . 12.1 p -137.17 137.83 46.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-O 121.696 0.76 . . . . 62.020000000000003 109.882 176.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.634 ' HB2' ' CD1' ' B' ' 286' ' ' PHE . 16.5 tm0? -118.29 132.49 56.29 Favored 'General case' 0 N--CA 1.39 -3.469 0 N-CA-C 105.068 -2.197 . . . . 62.409999999999997 105.068 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 241' ' ' LEU . . . . . 0.489 ' CD1' HD21 ' A' ' 262' ' ' ASN . 0.8 OUTLIER -130.32 116.3 18.13 Favored 'General case' 0 C--N 1.263 -3.195 0 N-CA-C 106.957 -1.497 . . . . 74.450000000000003 106.957 178.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 242' ' ' GLY . . . . . 0.522 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 130.91 -114.15 1.53 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 115.882 -0.599 . . . . 73.099999999999994 112.165 -176.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 243' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 6.8 t30 -144.74 145.75 31.85 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.379 0.59 . . . . 74.099999999999994 110.635 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . 0.461 ' CG2' ' HG3' ' B' ' 240' ' ' GLN . 69.0 t -132.69 126.71 54.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 N-CA-C 109.571 -0.529 . . . . 71.140000000000001 109.571 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 245' ' ' VAL . . . . . 0.5 ' HA ' ' HB2' ' B' ' 281' ' ' TYR . 2.7 p -123.86 111.74 30.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.967 -1.123 . . . . 75.209999999999994 107.967 169.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . 0.461 HG22 ' HA3' ' B' ' 282' ' ' GLY . 8.8 t -83.12 160.77 21.8 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.069 -1.052 . . . . 75.200000000000003 111.459 -176.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 247' ' ' ALA . . . . . 0.53 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.71 -36.12 82.81 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 122.386 1.089 . . . . 54.119999999999997 109.699 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.3 -35.55 73.97 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 113.243 -1.799 . . . . 75.150000000000006 111.6 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 249' ' ' ALA . . . . . 0.46 ' HA ' ' CB ' ' C' ' 247' ' ' ALA . . . -74.7 -26.84 60.1 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.387 -0.37 . . . . 45.409999999999997 110.863 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 52.8 tp . . . . . 0 N--CA 1.439 -0.994 0 CA-C-O 122.062 0.934 . . . . 73.109999999999999 111.976 -175.564 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.417 -2.088 0 CA-C-O 121.321 0.582 . . . . 51.32 112.2 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 261' ' ' THR . . . . . 0.553 HG23 ' HA ' ' C' ' 225' ' ' ARG . 5.1 t -104.7 108.13 19.43 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 105.798 -1.927 . . . . 63.420000000000002 105.798 167.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 262' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 25.1 t-20 -116.09 131.18 57.01 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.328 -0.851 . . . . 63.210000000000001 110.902 -172.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -140.97 123.2 15.71 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.163 0.506 . . . . 62.409999999999997 110.529 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 264' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 11.7 p -124.95 152.11 31.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.662 -0.866 . . . . 71.040000000000006 108.662 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 265' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 28.8 tt0 -103.2 -56.77 2.16 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 119.273 -0.971 . . . . 73.430000000000007 112.045 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' C' ' 230' ' ' ASP . 29.5 m -135.86 127.13 28.27 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.029 -1.068 . . . . 73.319999999999993 111.35 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 267' ' ' VAL . . . . . 0.42 ' CG2' HG23 ' B' ' 231' ' ' ILE . 21.6 m -123.62 134.3 66.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.138 -0.689 . . . . 70.310000000000002 109.138 171.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 29.3 m -127.69 134.6 65.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.99 -0.55 . . . . 74.120000000000005 110.514 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.57 131.58 5.57 Favored Glycine 0 CA--C 1.476 -2.405 0 C-N-CA 119.254 -1.451 . . . . 50.399999999999999 112.621 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 270' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 62.9 tttp -135.57 144.9 46.45 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.278 0.634 . . . . 72.120000000000005 110.864 176.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 271' ' ' GLY . . . . . 0.418 ' H ' ' HB3' ' B' ' 235' ' ' GLU . . . 81.02 52.73 4.19 Favored Glycine 0 CA--C 1.486 -1.78 0 C-N-CA 120.877 -0.677 . . . . 62.030000000000001 112.238 173.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 65.11 89.18 0.1 Allowed 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.548 1.139 . . . . 75.230000000000004 109.835 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 273' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 21.0 m -121.75 144.12 48.98 Favored 'General case' 0 N--CA 1.405 -2.695 0 C-N-CA 119.652 -0.819 . . . . 62.130000000000003 110.162 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 29.0 mmt-85 -117.22 126.8 53.35 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 104.48 -2.415 . . . . 75.140000000000001 104.48 171.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 275' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 62.0 t -132.63 123.94 50.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 108.772 -0.825 . . . . 70.129999999999995 108.772 -178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 8.7 tt -120.48 128.39 53.1 Favored 'General case' 0 C--N 1.268 -2.946 0 C-N-CA 117.595 -1.642 . . . . 74.409999999999997 110.693 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 277' ' ' ILE . . . . . 0.483 HG23 HD12 ' C' ' 241' ' ' LEU . 50.7 mt -112.58 102.63 14.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 106.467 -1.679 . . . . 75.319999999999993 106.467 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 278' ' ' GLY . . . . . 0.591 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 144.09 -136.02 6.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.69 -1.243 . . . . 73.349999999999994 114.245 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 279' ' ' ASN . . . . . 0.495 ' ND2' ' HB3' ' C' ' 243' ' ' ASN . 9.0 t-20 -127.3 141.42 51.72 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.88 -1.156 . . . . 75.109999999999999 107.88 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.01 120.07 22.95 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.818 -0.808 . . . . 63.329999999999998 108.818 -177.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 281' ' ' TYR . . . . . 0.5 ' HB2' ' HA ' ' B' ' 245' ' ' VAL . 97.2 m-85 -103.31 122.38 44.68 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 106.713 -1.588 . . . . 74.129999999999995 106.713 174.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 282' ' ' GLY . . . . . 0.461 ' HA3' HG22 ' B' ' 246' ' ' THR . . . 110.71 -51.73 0.68 Allowed Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.828 -0.909 . . . . 63.219999999999999 110.828 -176.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 283' ' ' GLY . . . . . 0.446 ' C ' ' HD2' ' B' ' 284' ' ' LYS . . . 88.41 -8.4 78.93 Favored Glycine 0 C--N 1.314 -0.656 0 N-CA-C 111.618 -0.593 . . . . 54.240000000000002 111.618 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 284' ' ' LYS . . . . . 0.446 ' HD2' ' C ' ' B' ' 283' ' ' GLY . 4.0 mptp? -124.97 17.53 8.53 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 120.913 0.387 . . . . 74.439999999999998 110.681 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -81.49 -60.03 2.28 Favored Glycine 0 N--CA 1.418 -2.507 0 N-CA-C 109.098 -1.601 . . . . 71.140000000000001 109.098 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 286' ' ' PHE . . . . . 0.634 ' CD1' ' HB2' ' B' ' 240' ' ' GLN . 28.1 t80 -67.4 -39.4 85.55 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 124.393 0.702 . . . . 65.129999999999995 112.228 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 9.9 m-90 . . . . . 0 C--N 1.307 -1.27 0 N-CA-C 114.143 1.164 . . . . 72.099999999999994 114.143 -176.279 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 225' ' ' ARG . . . . . 0.553 ' HA ' HG23 ' B' ' 261' ' ' THR . 14.5 ptt-85 . . . . . 0 CA--C 1.492 -1.275 0 N-CA-C 110.106 -0.331 . . . . 72.409999999999997 110.106 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 226' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 26.6 t-20 -116.81 114.22 23.64 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.451 -1.314 . . . . 62.020000000000003 107.451 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 227' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' C' ' 263' ' ' SER . 12.9 t -135.16 137.64 42.93 Favored 'General case' 0 N--CA 1.411 -2.408 0 CA-C-O 121.226 0.536 . . . . 70.040000000000006 109.931 -175.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . 0.664 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -132.44 135.01 45.78 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.24 -1.392 . . . . 72.409999999999997 107.24 177.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 229' ' ' LYS . . . . . 0.408 ' HD2' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -85.75 -57.12 3.17 Favored 'General case' 0 C--N 1.287 -2.145 0 C-N-CA 119.793 -0.763 . . . . 64.25 109.828 -178.163 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 230' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' C' ' 266' ' ' THR . 30.8 t70 -139.36 138.96 37.05 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.992 0.425 . . . . 75.109999999999999 110.651 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 231' ' ' ILE . . . . . 0.467 HG23 ' CG2' ' C' ' 267' ' ' VAL . 6.0 mt -137.28 117.64 16.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.18 -1.044 . . . . 73.450000000000003 108.18 -176.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -111.81 117.17 32.09 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.084 0.469 . . . . 71.319999999999993 111.233 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 233' ' ' THR . . . . . 0.463 ' HB ' ' CB ' ' C' ' 237' ' ' ALA . 15.7 p -110.53 128.32 55.58 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.56 -0.745 . . . . 63.200000000000003 109.569 176.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 234' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 28.6 tt0 -143.21 137.01 28.68 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.244 -1.021 . . . . 64.319999999999993 108.244 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 235' ' ' GLU . . . . . 0.432 ' HB2' ' H ' ' C' ' 271' ' ' GLY . 53.9 mt-10 57.81 106.18 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.14 1.533 . . . . 72.200000000000003 115.14 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 236' ' ' ARG . . . . . 0.559 ' HB2' ' HA ' ' C' ' 272' ' ' GLU . 5.5 mpt_? 59.34 33.07 22.31 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.242 -0.651 . . . . 53.43 109.242 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 237' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -96.38 138.14 34.42 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 113.755 1.02 . . . . 74.329999999999998 113.755 -168.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 238' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 5.0 mpt_? -133.45 134.73 43.93 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.022 -1.103 . . . . 71.140000000000001 108.022 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 239' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' C' ' 275' ' ' VAL . 17.3 m -138.01 145.81 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 CA-C-O 122.065 0.936 . . . . 72.030000000000001 111.02 171.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 240' ' ' GLN . . . . . 0.524 ' HB2' ' CD1' ' C' ' 286' ' ' PHE . 0.3 OUTLIER -126.06 122.86 37.02 Favored 'General case' 0 C--N 1.26 -3.284 0 N-CA-C 104.425 -2.435 . . . . 73.230000000000004 104.425 176.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 241' ' ' LEU . . . . . 0.483 HD12 HG23 ' B' ' 277' ' ' ILE . 0.8 OUTLIER -121.77 115.4 22.6 Favored 'General case' 0 C--N 1.26 -3.319 0 N-CA-C 106.992 -1.485 . . . . 55.340000000000003 106.992 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 242' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 131.14 -121.71 3.26 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 115.527 -0.76 . . . . 72.150000000000006 111.477 -174.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 243' ' ' ASN . . . . . 0.495 ' HB3' ' ND2' ' B' ' 279' ' ' ASN . 48.9 t-20 -145.1 141.34 28.73 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.035 0.917 . . . . 53.240000000000002 110.648 -177.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 244' ' ' VAL . . . . . 0.456 HG23 ' NE2' ' C' ' 240' ' ' GLN . 80.9 t -131.36 131.45 63.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 C-N-CA 123.334 0.654 . . . . 72.239999999999995 110.623 178.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 6.1 p -122.42 116.77 50.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.426 -1.694 . . . . 63.450000000000003 106.426 168.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 15.0 t -77.21 160.58 28.82 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.467 -1.293 . . . . 54.340000000000003 111.581 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 247' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.4 -39.17 93.33 Favored 'General case' 0 CA--C 1.492 -1.25 0 CA-C-N 115.715 -0.675 . . . . 75.109999999999999 109.525 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.67 -33.4 60.72 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.517 -1.674 . . . . 71.340000000000003 112.102 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.654 0 CA-C-N 116.382 -0.372 . . . . 72.349999999999994 111.268 179.286 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 261' ' ' THR . . . . . 0.542 ' HG1' ' N ' ' C' ' 225' ' ' ARG . 13.9 t . . . . . 0 N--CA 1.409 -2.502 0 N-CA-C 105.192 -2.151 . . . . 72.420000000000002 105.192 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -123.59 137.53 54.73 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.241 -0.89 . . . . 54.149999999999999 111.36 -166.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 263' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' C' ' 227' ' ' SER . 49.0 m -142.59 123.9 14.71 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.013 -0.736 . . . . 64.450000000000003 109.013 175.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.5 p -128.64 151.85 35.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.736 -0.468 . . . . 73.420000000000002 109.736 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.49 -80.21 0.19 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 109.421 -0.585 . . . . 71.239999999999995 109.421 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 266' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 8.1 t -139.22 129.29 25.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.751 -0.593 . . . . 75.420000000000002 109.995 -177.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 267' ' ' VAL . . . . . 0.467 ' CG2' HG23 ' C' ' 231' ' ' ILE . 27.0 m -120.78 135.3 61.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 116.254 -0.43 . . . . 72.340000000000003 110.033 177.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.25 140.98 45.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 116.357 -0.383 . . . . 72.310000000000002 110.604 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.43 131.53 6.11 Favored Glycine 0 CA--C 1.474 -2.483 0 N-CA-C 110.342 -1.103 . . . . 72.409999999999997 110.342 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -135.06 119.88 18.41 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.998 -1.112 . . . . 74.030000000000001 107.998 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 271' ' ' GLY . . . . . 0.432 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 80.95 76.95 1.02 Allowed Glycine 0 N--CA 1.465 0.608 0 C-N-CA 120.829 -0.7 . . . . 62.030000000000001 113.178 175.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 272' ' ' GLU . . . . . 0.559 ' HA ' ' HB2' ' C' ' 236' ' ' ARG . 45.8 mt-10 63.03 82.38 0.18 Allowed 'General case' 0 CA--C 1.48 -1.718 0 C-N-CA 124.689 1.196 . . . . 71.239999999999995 110.478 -178.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 273' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 51.7 m -125.48 143.71 50.87 Favored 'General case' 0 N--CA 1.399 -3.021 0 C-N-CA 119.036 -1.066 . . . . 64.230000000000004 109.9 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 274' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 79.0 mtt85 -136.61 126.05 25.07 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 104.148 -2.538 . . . . 74.519999999999996 104.148 174.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 275' ' ' VAL . . . . . 0.579 ' HB ' HG12 ' C' ' 239' ' ' VAL . 8.1 t -138.1 134.41 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 N-CA-C 108.012 -1.107 . . . . 54.210000000000001 108.012 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 8.9 tt -119.74 115.51 24.05 Favored 'General case' 0 N--CA 1.384 -3.767 0 C-N-CA 118.846 -1.141 . . . . 64.510000000000005 108.991 174.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.0 mp -93.59 102.43 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 104.52 -2.4 . . . . 73.200000000000003 104.52 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 278' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 139.21 -147.01 18.87 Favored Glycine 0 CA--C 1.49 -1.482 0 C-N-CA 119.317 -1.42 . . . . 72.319999999999993 113.888 -177.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -118.56 149.37 41.46 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.563 -1.273 . . . . 73.150000000000006 107.563 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 280' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' C' ' 244' ' ' VAL . 15.6 tm-20 -146.36 121.11 9.87 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.839 -1.911 . . . . 72.030000000000001 105.839 -176.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -104.12 125.05 50.13 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.58 -0.896 . . . . 75.239999999999995 108.58 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 119.46 -47.32 1.04 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 111.298 -0.721 . . . . 70.200000000000003 111.298 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 283' ' ' GLY . . . . . 0.508 ' C ' ' HD2' ' C' ' 284' ' ' LYS . . . 94.86 -9.71 70.58 Favored Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 111.022 -0.831 . . . . 53.409999999999997 111.022 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 284' ' ' LYS . . . . . 0.508 ' HD2' ' C ' ' C' ' 283' ' ' GLY . 13.4 mptt -126.92 6.35 6.61 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.766 -0.717 . . . . 73.140000000000001 112.69 -172.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -73.14 -57.96 4.94 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 119.802 -1.189 . . . . 50.310000000000002 112.182 -176.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 286' ' ' PHE . . . . . 0.524 ' CD1' ' HB2' ' C' ' 240' ' ' GLN . 23.0 t80 -75.67 -31.23 59.69 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.633 1.345 . . . . 74.439999999999998 114.633 -174.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 . . . . . 0 C--N 1.308 -1.218 0 N-CA-C 115.405 1.632 . . . . 64.510000000000005 115.405 -172.915 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.47 ' SD ' ' HG3' ' A' ' 218' ' ' LYS . 1.9 tmt? . . . . . 0 CA--C 1.518 -0.27 0 N-CA-C 107.031 -1.47 . . . . 75.129999999999995 107.031 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.47 ' HG3' ' SD ' ' A' ' 217' ' ' MET . 99.1 mttt -139.31 91.55 2.51 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.451 -1.314 . . . . 72.219999999999999 107.451 170.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.8 pt -122.88 136.5 59.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.756 0.789 . . . . 60.439999999999998 112.495 -174.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -121.21 -25.85 5.19 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 114.592 -1.185 . . . . 75.439999999999998 108.347 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -93.88 120.56 34.3 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.013 -1.106 . . . . 53.299999999999997 108.013 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 86.4 mt -83.61 138.64 18.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-O 121.685 0.755 . . . . 73.230000000000004 111.222 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 97.7 t -99.5 119.49 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.833 0 CA-C-N 114.963 -1.017 . . . . 63.109999999999999 108.369 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.462 ' HA2' ' HB ' ' A' ' 261' ' ' THR . . . 149.39 82.77 0.04 OUTLIER Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 109.637 -1.385 . . . . 72.230000000000004 109.637 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -106.4 139.59 40.64 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.21 0.448 . . . . 73.439999999999998 112.21 -174.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.536 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 9.2 t30 -104.39 120.56 41.49 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.055 -1.461 . . . . 75.439999999999998 107.055 167.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 42.5 m -121.59 146.18 47.23 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 120.838 0.352 . . . . 74.140000000000001 111.359 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 264' ' ' VAL . . . -138.66 144.58 39.72 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.548 -1.279 . . . . 72.420000000000002 107.548 175.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -97.71 -60.01 1.65 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.127 0.489 . . . . 72.420000000000002 110.176 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -130.95 139.45 50.05 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.892 -0.594 . . . . 74.120000000000005 110.812 -175.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 25.6 mt -136.15 131.82 49.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 108.002 -1.11 . . . . 53.340000000000003 108.002 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 31.2 ttm180 -129.09 116.52 19.4 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 108.666 -0.865 . . . . 65.219999999999999 108.666 175.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.449 HG21 ' HB ' ' A' ' 239' ' ' VAL . 12.4 p -119.57 127.42 52.96 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 109.171 -0.677 . . . . 43.409999999999997 109.171 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.41 ' HB2' ' HG3' ' A' ' 270' ' ' LYS . 43.9 mt-10 -135.86 144.24 45.51 Favored 'General case' 0 C--O 1.252 1.201 0 CA-C-N 116.592 -0.276 . . . . 72.129999999999995 111.063 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.551 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 41.6 mt-10 62.34 88.88 0.09 Allowed 'General case' 0 C--O 1.215 -0.715 0 O-C-N 124.908 1.38 . . . . 71.310000000000002 113.181 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.551 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.0 OUTLIER 59.45 21.72 10.17 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.868 0.867 . . . . 72.109999999999999 112.131 174.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -91.08 142.13 28.08 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.725 -0.472 . . . . 52.43 109.725 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -125.03 137.17 54.23 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.592 -0.521 . . . . 71.219999999999999 109.592 -178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 4.3 p -129.98 132.77 65.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 123.996 0.81 . . . . 73.25 111.285 -176.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.511 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 57.9 tp60 -111.95 117.0 31.51 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 107.885 -1.154 . . . . 71.430000000000007 107.885 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.73 118.5 35.77 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.767 -0.827 . . . . 65.140000000000001 108.767 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.522 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 132.87 -114.23 1.38 Allowed Glycine 0 N--CA 1.439 -1.167 0 C-N-CA 120.679 -0.772 . . . . 73.120000000000005 113.203 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -145.4 139.19 26.76 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.452 -0.944 . . . . 73.340000000000003 108.452 -177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.445 HG11 ' HA3' ' A' ' 285' ' ' GLY . 27.0 t -123.57 114.56 42.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 107.965 -1.124 . . . . 64.329999999999998 107.965 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 80.4 t -111.13 119.79 60.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 109.367 -0.605 . . . . 70.349999999999994 109.367 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 28.5 m -88.44 158.01 18.49 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 106.211 -1.774 . . . . 64.439999999999998 106.211 172.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.42 87.58 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.392 0.515 . . . . 52.450000000000003 112.392 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -61.08 -42.66 98.91 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.145 1.165 . . . . 72.530000000000001 114.145 -175.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -70.44 -45.51 65.67 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 120.877 0.37 . . . . 53.109999999999999 110.883 -175.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 4.5 pp -168.06 147.1 4.63 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 106.383 -1.71 . . . . 71.010000000000005 106.383 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -93.81 -63.53 1.19 Allowed 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.837 -0.745 . . . . 64.030000000000001 111.239 -173.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -133.14 50.35 0.88 Allowed Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 111.25 -0.74 . . . . 65.120000000000005 111.25 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 106.71 -109.78 3.16 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 120.642 -0.789 . . . . 62.219999999999999 113.384 176.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 254' ' ' ILE . 41.3 mm 70.85 82.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 124.637 1.175 . . . . 75.129999999999995 108.883 -172.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 63.92 179.06 0.17 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-N 113.723 -1.58 . . . . 72.120000000000005 109.581 -175.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.513 ' O ' ' HD2' ' B' ' 255' ' ' ARG . 22.8 pt -97.51 92.45 2.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.234 0 N-CA-C 107.038 -1.467 . . . . 74.299999999999997 107.038 168.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 8.3 t -64.92 -42.25 94.87 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.181 -0.918 . . . . 61.0 108.856 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.46 140.16 27.37 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.68 -1.146 . . . . 74.329999999999998 110.05 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -155.19 39.33 0.41 Allowed 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 125.571 1.548 . . . . 42.240000000000002 107.747 174.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 26.6 p -66.81 135.54 54.08 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.309 0.576 . . . . 74.230000000000004 110.749 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.462 ' HB ' ' HA2' ' A' ' 224' ' ' GLY . 6.0 t -92.87 127.13 38.26 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-O 121.566 0.698 . . . . 44.049999999999997 111.767 -174.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 7.9 t30 -126.57 143.13 51.31 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.238 -1.023 . . . . 65.319999999999993 108.238 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.6 m -138.36 125.6 21.63 Favored 'General case' 0 C--N 1.29 -1.984 0 O-C-N 121.718 -0.614 . . . . 42.539999999999999 109.721 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.648 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.6 p -126.89 145.94 33.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 109.244 -0.65 . . . . 63.240000000000002 109.244 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 59.9 mt-10 -87.14 -79.11 0.28 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 119.755 -0.778 . . . . 73.420000000000002 110.364 176.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 8.2 t -116.65 132.02 56.8 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.641 0.734 . . . . 62.149999999999999 111.46 -174.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 1.5 p -133.88 124.77 47.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.151 -0.931 . . . . 62.520000000000003 110.405 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 4.0 p -127.25 129.06 70.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 116.056 -0.52 . . . . 74.030000000000001 111.421 -179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.09 131.06 8.04 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 109.469 -1.453 . . . . 61.329999999999998 109.469 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.41 ' HG3' ' HB2' ' A' ' 234' ' ' GLU . 45.4 tttm -134.19 120.67 20.34 Favored 'General case' 0 N--CA 1.428 -1.55 0 C-N-CA 120.142 -0.623 . . . . 52.240000000000002 111.583 -175.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.56 83.77 1.61 Allowed Glycine 0 C--N 1.306 -1.124 0 C-N-CA 120.33 -0.938 . . . . 53.420000000000002 112.974 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 55.19 28.26 10.84 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.68 1.592 . . . . 73.310000000000002 112.424 173.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 17.7 m -82.67 151.51 26.24 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.893 0.701 . . . . 72.129999999999995 112.893 -170.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -113.09 127.71 56.28 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 115.361 -0.836 . . . . 71.049999999999997 108.931 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.4 p -137.03 123.54 28.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 121.362 0.601 . . . . 73.0 110.572 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.511 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.1 tt -117.3 124.27 48.58 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.654 -1.239 . . . . 73.049999999999997 107.654 175.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.686 HG23 HD12 ' B' ' 241' ' ' LEU . 72.4 mt -113.17 103.7 15.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 N-CA-C 108.14 -1.059 . . . . 70.109999999999999 108.14 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 141.65 -151.13 22.5 Favored Glycine 0 N--CA 1.425 -2.068 0 N-CA-C 111.433 -0.667 . . . . 60.420000000000002 111.433 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -111.76 131.88 55.02 Favored 'General case' 0 C--N 1.294 -1.817 0 O-C-N 122.216 -0.579 . . . . 74.120000000000005 109.775 -176.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 8.1 tp10 -113.97 118.57 34.53 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 124.401 1.08 . . . . 71.049999999999997 108.153 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -108.74 124.56 50.77 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 108.075 -1.083 . . . . 72.420000000000002 108.075 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.13 -52.71 0.64 Allowed Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 111.323 -0.711 . . . . 60.420000000000002 111.323 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 88.13 18.37 55.87 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.335 -1.106 . . . . 61.020000000000003 110.335 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 284' ' ' LYS . 11.5 mmpt? -122.35 -2.35 9.03 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.598 -0.519 . . . . 72.140000000000001 109.598 -177.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.445 ' HA3' HG11 ' A' ' 244' ' ' VAL . . . -78.56 -75.69 0.97 Allowed Glycine 0 N--CA 1.425 -2.051 0 C-N-CA 120.269 -0.967 . . . . 32.310000000000002 113.507 -174.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.432 ' CB ' HD12 ' A' ' 276' ' ' LEU . 59.6 t80 -79.59 -35.02 40.29 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 120.797 -0.361 . . . . 63.140000000000001 111.634 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 30.0 p90 -127.55 -175.72 3.54 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.857 -0.794 . . . . 72.239999999999995 108.857 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -144.18 -177.85 5.66 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 103.512 -2.773 . . . . 71.150000000000006 103.512 171.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.485 ' HB3' ' OD2' ' B' ' 288' ' ' ASP . 21.6 m120 -78.58 153.86 30.81 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 118.405 0.548 . . . . 71.140000000000001 109.991 -175.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -120.01 -168.61 1.64 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.639 0.978 . . . . 62.200000000000003 113.639 -169.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -118.97 103.7 9.83 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 105.717 -1.957 . . . . 62.340000000000003 105.717 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . 0.536 ' CE1' ' HD2' ' C' ' 238' ' ' ARG . 54.3 t-80 -121.3 142.72 49.68 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.559 -0.904 . . . . 63.539999999999999 108.559 -178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -78.98 109.55 13.38 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.059 -1.089 . . . . 62.109999999999999 108.059 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . 0.284 29.3 m80 77.47 133.67 0.06 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 125.474 1.51 . . . . 72.420000000000002 112.841 -174.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . 0.449 ' C ' HH21 ' C' ' 238' ' ' ARG . 13.0 t-160 . . . . . 0 C--N 1.293 -1.848 0 CA-C-N 113.376 -1.738 . . . . 45.140000000000001 108.431 -175.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . 0.412 ' HA ' ' OD1' ' C' ' 220' ' ' ASP . 25.4 ttt . . . . . 0 C--O 1.243 0.756 0 N-CA-C 108.584 -0.895 . . . . 63.450000000000003 108.584 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt 81.53 87.15 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.91 1.684 . . . . 73.310000000000002 110.034 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . 0.488 HG12 ' H ' ' B' ' 221' ' ' ALA . 13.1 tt -134.51 141.38 43.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.093 -0.958 . . . . 74.439999999999998 108.972 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . 0.539 ' CB ' ' HG2' ' C' ' 218' ' ' LYS . 6.9 p-10 -128.1 11.96 6.57 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.544 0.687 . . . . 74.140000000000001 110.433 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.488 ' H ' HG12 ' B' ' 219' ' ' ILE . . . -98.53 -159.93 0.77 Allowed 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.027 -0.988 . . . . 75.420000000000002 110.731 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' B' ' 257' ' ' SER . 75.5 mt -83.82 133.33 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.898 -0.592 . . . . 71.299999999999997 110.764 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 2.9 p -135.78 137.81 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.031 0 CA-C-N 115.316 -0.856 . . . . 74.209999999999994 108.72 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 135.27 99.09 0.59 Allowed Glycine 0 N--CA 1.44 -1.048 0 N-CA-C 109.573 -1.411 . . . . 61.32 109.573 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -113.52 145.39 41.3 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.267 0.556 . . . . 71.129999999999995 112.238 -175.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 9.1 t30 -110.54 133.73 53.03 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 105.484 -2.043 . . . . 71.209999999999994 105.484 171.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 50.8 m -133.89 149.57 51.32 Favored 'General case' 0 C--N 1.281 -2.404 0 O-C-N 121.197 -0.939 . . . . 74.519999999999996 111.769 -176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.648 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -135.99 146.29 47.05 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 107.929 -1.137 . . . . 70.120000000000005 107.929 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 3.5 tmtm? -101.88 -57.93 1.98 Allowed 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 108.917 -0.771 . . . . 45.020000000000003 108.917 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -135.26 139.21 44.25 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.255 -0.43 . . . . 74.120000000000005 109.998 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.436 HD13 HD12 ' B' ' 277' ' ' ILE . 21.8 mt -135.9 127.62 44.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 108.254 -1.017 . . . . 73.549999999999997 108.254 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 38.1 ttm180 -125.95 115.61 20.2 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.636 -0.876 . . . . 73.010000000000005 108.636 175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.418 HG21 ' CG1' ' B' ' 239' ' ' VAL . 81.7 p -110.75 126.49 54.64 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.173 -1.417 . . . . 64.430000000000007 107.173 176.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -133.29 138.86 46.6 Favored 'General case' 0 CA--C 1.493 -1.239 0 C-N-CA 120.34 -0.544 . . . . 73.340000000000003 109.753 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.588 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 43.1 mt-10 64.37 97.93 0.04 OUTLIER 'General case' 0 C--O 1.241 0.633 0 N-CA-C 114.758 1.392 . . . . 74.030000000000001 114.758 171.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.588 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.0 OUTLIER 57.71 29.25 17.04 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.57 0.748 . . . . 71.239999999999995 109.95 174.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -95.55 140.14 30.81 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-O 122.022 0.915 . . . . 75.349999999999994 110.984 -175.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.407 ' HD2' ' N ' ' B' ' 238' ' ' ARG . 0.5 OUTLIER -125.81 134.27 51.74 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 105.863 -1.903 . . . . 74.019999999999996 105.863 177.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.6 p -134.06 134.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 CA-C-O 121.895 0.855 . . . . 42.0 111.097 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.548 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 35.4 tp60 -110.64 121.0 44.25 Favored 'General case' 0 N--CA 1.402 -2.841 0 CA-C-N 114.16 -1.382 . . . . 73.219999999999999 107.271 172.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.686 HD12 HG23 ' A' ' 277' ' ' ILE . 2.9 tm? -117.24 118.76 33.19 Favored 'General case' 0 C--N 1.268 -2.963 0 N-CA-C 107.072 -1.455 . . . . 70.140000000000001 107.072 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.523 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 127.6 -109.51 1.06 Allowed Glycine 0 N--CA 1.432 -1.572 0 C-N-CA 120.472 -0.871 . . . . 62.130000000000003 112.42 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.586 ' OD1' HG23 ' B' ' 245' ' ' VAL . 24.1 t-20 -144.4 146.58 32.59 Favored 'General case' 0 C--N 1.296 -1.76 0 O-C-N 122.286 -0.538 . . . . 71.439999999999998 110.699 -176.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.548 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 25.0 t -133.06 120.42 40.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.175 -1.046 . . . . 74.209999999999994 108.175 172.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.586 HG23 ' OD1' ' B' ' 243' ' ' ASN . 88.6 t -115.57 119.37 61.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.65 -0.5 . . . . 70.209999999999994 109.65 176.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 24.8 m -79.02 157.44 28.08 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 106.003 -1.851 . . . . 74.019999999999996 106.003 174.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -65.11 -46.36 81.36 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.99 0.9 . . . . 61.509999999999998 112.201 -176.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.29 74.33 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 113.831 -1.531 . . . . 72.049999999999997 113.576 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.711 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -70.48 -46.43 63.77 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.543 0.942 . . . . 71.430000000000007 113.543 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 44.2 tp -161.0 124.57 3.36 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.967 -0.693 . . . . 42.130000000000003 110.518 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -135.92 93.64 2.96 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.83 -0.623 . . . . 71.230000000000004 109.437 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 63.42 -138.94 43.39 Favored Glycine 0 C--O 1.243 0.699 0 CA-C-N 115.585 -0.734 . . . . 74.230000000000004 114.111 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 69.36 -166.16 48.69 Favored Glycine 0 C--O 1.244 0.762 0 CA-C-N 115.338 -0.431 . . . . 63.530000000000001 112.957 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 3.0 mp -91.29 74.74 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 106.277 -1.749 . . . . 74.450000000000003 106.277 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.513 ' HD2' ' O ' ' A' ' 256' ' ' ILE . 0.0 OUTLIER -94.0 -176.61 4.06 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 114.118 -1.401 . . . . 74.430000000000007 111.017 -175.341 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . 0.438 HG22 ' O ' ' C' ' 253' ' ' GLY . 22.0 pt -55.77 147.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 124.815 1.246 . . . . 74.109999999999999 111.669 176.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . 0.47 ' O ' ' HA ' ' B' ' 222' ' ' ILE . 68.7 m -141.79 21.39 2.15 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.603 -1.258 . . . . 74.430000000000007 107.603 174.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.424 ' OD1' ' HB2' ' C' ' 217' ' ' MET . 5.5 m-20 -144.16 133.31 22.95 Favored 'General case' 0 CA--C 1.487 -1.455 0 N-CA-C 105.026 -2.213 . . . . 62.049999999999997 105.026 -176.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . 0.471 ' NE2' HD11 ' C' ' 256' ' ' ILE . 23.1 mm-40 -143.26 167.15 22.82 Favored 'General case' 0 C--N 1.309 -1.193 0 O-C-N 123.344 0.403 . . . . 63.32 111.264 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 24.6 p -76.23 139.08 41.01 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.348 -0.842 . . . . 74.140000000000001 110.507 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 7.4 t -94.33 127.69 40.37 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-O 121.429 0.633 . . . . 34.539999999999999 110.857 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.513 ' HB3' ' OD1' ' B' ' 226' ' ' ASN . 54.5 t30 -126.66 143.56 51.19 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.127 -1.064 . . . . 74.510000000000005 108.127 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' C' ' 227' ' ' SER . 24.3 m -141.97 126.31 17.63 Favored 'General case' 0 C--N 1.288 -2.096 0 O-C-N 122.019 -0.426 . . . . 71.120000000000005 110.074 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.7 p -120.16 152.28 22.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 109.09 -0.708 . . . . 73.519999999999996 109.09 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.467 ' HA ' ' CB ' ' B' ' 229' ' ' LYS . 27.8 mt-10 -92.8 -86.42 0.25 Allowed 'General case' 0 N--CA 1.404 -2.768 0 C-N-CA 119.455 -0.898 . . . . 64.200000000000003 111.151 173.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 11.3 t -109.42 130.13 55.51 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.604 -0.839 . . . . 71.140000000000001 111.745 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.5 p -132.29 124.48 52.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 115.114 -0.948 . . . . 75.140000000000001 110.54 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 7.7 p -127.1 134.52 65.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 116.078 -0.51 . . . . 70.120000000000005 111.718 -178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.78 132.28 10.32 Favored Glycine 0 CA--C 1.479 -2.208 0 N-CA-C 110.062 -1.215 . . . . 41.439999999999998 110.062 176.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -133.59 116.66 16.15 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-O 120.778 0.323 . . . . 73.329999999999998 111.281 -175.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.69 86.31 0.57 Allowed Glycine 0 C--O 1.25 1.123 0 C-N-CA 120.583 -0.818 . . . . 73.010000000000005 114.094 173.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 61.59 31.08 18.86 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.284 1.034 . . . . 73.019999999999996 111.961 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 24.5 m -83.25 145.64 29.01 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.575 0.702 . . . . 74.299999999999997 112.12 -175.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.461 ' NH2' ' HA ' ' B' ' 287' ' ' TRP . 39.6 mtp180 -115.14 125.93 54.03 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.236 -2.135 . . . . 75.030000000000001 105.236 173.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 1.6 p -135.84 127.09 44.17 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-O 120.958 0.408 . . . . 64.409999999999997 110.498 -178.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.501 HD12 ' HB3' ' B' ' 286' ' ' PHE . 5.5 tt -120.15 121.76 39.5 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.361 -1.348 . . . . 74.200000000000003 107.361 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.638 HG23 HD12 ' C' ' 241' ' ' LEU . 36.7 mt -113.06 103.72 15.88 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 N-CA-C 106.767 -1.568 . . . . 53.520000000000003 106.767 178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 145.11 -147.54 18.76 Favored Glycine 0 N--CA 1.416 -2.637 0 C-N-CA 120.917 -0.658 . . . . 73.409999999999997 111.783 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -115.01 128.71 56.43 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 120.937 -0.305 . . . . 74.319999999999993 111.392 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.542 ' HG2' ' CZ2' ' B' ' 287' ' ' TRP . 9.7 tp10 -112.46 121.47 44.92 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 107.921 -1.14 . . . . 75.340000000000003 107.921 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.463 ' CD2' ' HB ' ' C' ' 245' ' ' VAL . 86.7 m-85 -111.53 124.03 51.45 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.378 -0.971 . . . . 73.230000000000004 108.378 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.29 -61.59 0.31 Allowed Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 111.014 -0.834 . . . . 74.319999999999993 111.014 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . 0.407 ' C ' ' HD2' ' B' ' 284' ' ' LYS . . . 94.53 26.02 14.44 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.314 -0.715 . . . . 74.450000000000003 111.314 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . 0.407 ' HD2' ' C ' ' B' ' 283' ' ' GLY . 3.2 mptp? -134.09 2.57 3.35 Favored 'General case' 0 CA--C 1.501 -0.934 0 N-CA-C 110.39 -0.226 . . . . 72.420000000000002 110.39 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . 0.495 ' HA3' HG11 ' B' ' 244' ' ' VAL . . . -78.53 -66.76 1.69 Allowed Glycine 0 N--CA 1.417 -2.633 0 C-N-CA 119.952 -1.118 . . . . 74.319999999999993 112.371 -176.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.501 ' HB3' HD12 ' B' ' 276' ' ' LEU . 75.9 t80 -87.67 -37.84 16.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 112.914 0.709 . . . . 63.539999999999999 112.914 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.542 ' CZ2' ' HG2' ' B' ' 280' ' ' GLU . 20.8 p90 -109.2 152.91 24.53 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 112.86 0.689 . . . . 70.120000000000005 112.86 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . 0.485 ' OD2' ' HB3' ' A' ' 289' ' ' ASN . 5.2 p-10 -168.53 172.59 8.06 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.579 -1.192 . . . . 71.209999999999994 108.012 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -89.56 -67.3 0.85 Allowed 'General case' 0 C--N 1.31 -1.121 0 O-C-N 123.846 0.716 . . . . 64.420000000000002 111.589 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . 0.551 ' O ' ' HB3' ' C' ' 295' ' ' HIS . 14.5 t-80 -161.25 112.71 1.79 Allowed 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.656 -0.498 . . . . 72.319999999999993 109.656 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -129.69 -168.91 2.02 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 120.629 0.252 . . . . 71.0 111.516 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -87.55 83.82 7.2 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-N 116.568 -0.287 . . . . 73.0 111.177 -177.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . 0.417 ' HB3' ' O ' ' A' ' 289' ' ' ASN . 7.3 p80 -80.47 103.84 10.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.024 -1.102 . . . . 54.140000000000001 108.024 174.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -101.67 -10.26 20.17 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.476 -0.784 . . . . 65.109999999999999 112.366 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 40.0 m80 . . . . . 0 C--O 1.259 1.561 0 N-CA-C 107.562 -1.273 . . . . 71.109999999999999 107.562 173.466 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . 0.569 ' HG3' ' H ' ' C' ' 218' ' ' LYS . 8.1 tpt . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.279 -1.378 . . . . 75.030000000000001 107.279 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . 0.569 ' H ' ' HG3' ' C' ' 217' ' ' MET . 87.3 mttt -84.81 15.23 4.05 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 113.764 1.024 . . . . 71.040000000000006 113.764 -175.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 3.4 mp -83.17 122.74 37.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.856 -1.535 . . . . 75.120000000000005 106.856 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' B' ' 217' ' ' MET . 36.9 t70 -77.53 100.49 6.09 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.263 -0.426 . . . . 70.510000000000005 110.83 -176.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 78.84 132.29 0.05 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.929 1.691 . . . . 53.509999999999998 113.051 177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 0.413 HG23 ' HA ' ' C' ' 257' ' ' SER . 45.1 mt -96.71 128.89 47.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.563 -0.744 . . . . 72.219999999999999 109.246 178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 12.1 p -108.22 127.61 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.07 0 CA-C-N 115.733 -0.667 . . . . 75.019999999999996 109.229 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 135.2 89.64 0.31 Allowed Glycine 0 N--CA 1.434 -1.439 0 N-CA-C 109.447 -1.461 . . . . 75.129999999999995 109.447 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' C' ' 261' ' ' THR . 14.9 ptt180 -115.25 147.98 39.71 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.464 0.65 . . . . 73.530000000000001 111.102 -176.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 7.4 t30 -108.85 141.55 40.73 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.017 -2.216 . . . . 55.030000000000001 105.017 169.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' B' ' 263' ' ' SER . 54.0 m -139.8 139.48 36.41 Favored 'General case' 0 C--N 1.278 -2.542 0 O-C-N 121.818 -0.551 . . . . 62.109999999999999 110.889 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -127.45 143.19 51.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.782 -1.192 . . . . 62.140000000000001 107.782 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.489 ' HB2' ' HA ' ' C' ' 265' ' ' GLU . 9.3 tmtt? -102.77 -53.1 2.93 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 109.588 -0.523 . . . . 63.329999999999998 109.588 -174.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -135.21 137.96 43.14 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.248 -0.649 . . . . 64.200000000000003 109.248 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 33.5 mt -136.67 130.31 46.28 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.01 -1.107 . . . . 75.420000000000002 108.01 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -133.6 119.1 19.0 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.43 -0.952 . . . . 73.099999999999994 108.43 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 45.0 p -110.49 126.41 54.33 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 107.19 -1.411 . . . . 73.140000000000001 107.19 174.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -127.91 139.22 52.73 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 110.05 -0.352 . . . . 63.240000000000002 110.05 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.571 ' C ' ' HD3' ' C' ' 236' ' ' ARG . 62.5 mt-10 63.13 93.43 0.05 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.664 1.227 . . . . 74.140000000000001 114.218 170.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.571 ' HD3' ' C ' ' C' ' 235' ' ' GLU . 0.7 OUTLIER 56.37 26.91 11.22 Favored 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 123.889 0.875 . . . . 73.549999999999997 111.387 172.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -87.5 148.46 24.91 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.751 -0.659 . . . . 62.520000000000003 110.576 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.536 ' HD2' ' CE1' ' A' ' 292' ' ' HIS . 1.2 mpp_? -124.66 134.22 52.96 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 107.17 -1.418 . . . . 72.140000000000001 107.17 177.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 4.7 p -135.96 135.14 50.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.622 0.725 . . . . 71.239999999999995 111.188 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.501 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 36.4 tp60 -114.37 115.17 26.91 Favored 'General case' 0 N--CA 1.405 -2.69 0 CA-C-N 114.28 -1.327 . . . . 70.530000000000001 108.152 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.638 HD12 HG23 ' B' ' 277' ' ' ILE . 3.0 tm? -111.85 117.79 33.76 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 105.596 -2.002 . . . . 73.319999999999993 105.596 176.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.546 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 138.65 -130.62 4.99 Favored Glycine 0 CA--C 1.485 -1.837 0 C-N-CA 119.577 -1.297 . . . . 53.539999999999999 111.724 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -141.06 131.26 24.88 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 120.956 0.408 . . . . 70.340000000000003 109.911 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.501 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 21.4 t -114.52 129.87 69.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.668 -0.864 . . . . 73.310000000000002 108.668 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.463 ' HB ' ' CD2' ' B' ' 281' ' ' TYR . 95.8 t -122.11 118.53 55.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 109.195 -0.668 . . . . 64.219999999999999 109.195 177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 21.4 m -79.43 159.42 27.05 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.949 -1.871 . . . . 74.109999999999999 105.949 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.711 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -62.63 -47.63 82.92 Favored 'General case' 0 C--O 1.215 -0.754 0 CA-C-O 122.08 0.943 . . . . 64.230000000000004 110.772 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.88 -34.76 65.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 113.718 -1.583 . . . . 53.140000000000001 112.806 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -74.15 -45.31 49.57 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 113.74 1.015 . . . . 72.510000000000005 113.74 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 91.6 mt -150.11 107.71 3.66 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 112.671 0.619 . . . . 73.010000000000005 112.671 -174.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -108.93 -69.24 0.87 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.226 -1.027 . . . . 62.439999999999998 108.226 169.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -96.72 36.58 3.81 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.353 -0.84 . . . . 74.420000000000002 113.688 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . 0.438 ' O ' HG22 ' B' ' 256' ' ' ILE . . . -83.12 64.18 4.36 Favored Glycine 0 C--N 1.316 -0.564 0 N-CA-C 111.058 -0.817 . . . . 63.149999999999999 111.058 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 6.3 tp -80.41 66.58 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 113.367 0.877 . . . . 65.5 113.367 -175.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 154.94 108.91 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 127.605 2.362 . . . . 73.109999999999999 109.309 169.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . 0.471 HD11 ' NE2' ' B' ' 259' ' ' GLN . 9.8 pt -147.24 98.7 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.796 -1.187 . . . . 73.439999999999998 107.796 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . 0.413 ' HA ' HG23 ' C' ' 222' ' ' ILE . 15.2 m -130.63 15.2 5.41 Favored 'General case' 0 C--O 1.254 1.294 0 C-N-CA 119.953 -0.699 . . . . 71.430000000000007 112.679 -171.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -147.25 94.49 2.4 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.169 0.985 . . . . 51.100000000000001 109.236 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 14.1 mp0 -125.72 -178.05 4.13 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.827 -1.078 . . . . 62.240000000000002 111.719 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 5.6 m -77.07 138.98 39.87 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 123.768 0.827 . . . . 64.510000000000005 110.794 -176.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 15.4 t -108.86 116.23 31.6 Favored 'General case' 0 CA--C 1.56 1.342 0 CA-C-O 121.889 0.852 . . . . 63.439999999999998 110.169 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 9.0 t30 -127.77 126.7 42.25 Favored 'General case' 0 C--N 1.312 -1.061 0 O-C-N 121.808 -0.558 . . . . 62.119999999999997 111.661 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 68.4 m -121.43 134.39 55.09 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 122.126 -0.359 . . . . 33.240000000000002 110.731 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.4 p -128.32 150.55 34.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 108.166 -1.05 . . . . 53.219999999999999 108.166 178.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' C' ' 229' ' ' LYS . 49.1 mt-10 -91.11 -88.49 0.18 Allowed 'General case' 0 N--CA 1.419 -1.978 0 C-N-CA 119.374 -0.931 . . . . 71.5 111.045 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 5.8 t -107.78 132.65 53.17 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.652 -0.819 . . . . 72.25 111.914 -176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.02 131.34 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 CA-C-N 115.162 -0.926 . . . . 73.400000000000006 109.119 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.79 135.76 62.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.972 0 CA-C-N 116.104 -0.498 . . . . 74.209999999999994 110.652 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -116.72 132.04 9.86 Favored Glycine 0 CA--C 1.474 -2.511 0 N-CA-C 109.086 -1.605 . . . . 73.510000000000005 109.086 174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -134.03 116.27 15.3 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 110.227 -0.286 . . . . 72.239999999999995 110.227 -176.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.57 83.48 0.73 Allowed Glycine 0 C--N 1.305 -1.143 0 C-N-CA 120.513 -0.851 . . . . 75.129999999999995 114.217 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 60.44 33.88 20.59 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.409 1.084 . . . . 75.030000000000001 112.319 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 10.7 m -83.72 145.18 28.88 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 112.925 0.713 . . . . 52.240000000000002 112.925 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -105.87 128.13 53.56 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.486 -1.301 . . . . 74.439999999999998 107.486 168.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 7.5 p -139.22 127.59 27.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 120.974 0.416 . . . . 73.340000000000003 111.226 175.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.516 HD12 ' CB ' ' C' ' 286' ' ' PHE . 7.2 tt -117.19 120.35 38.02 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.41 -0.959 . . . . 74.310000000000002 108.41 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 28.2 mt -113.26 103.6 15.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 106.991 -1.485 . . . . 72.120000000000005 106.991 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 144.85 -146.04 16.02 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.764 -0.935 . . . . 44.399999999999999 110.764 -177.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -115.45 133.25 56.21 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 110.1 -0.333 . . . . 74.140000000000001 110.1 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.416 ' HG2' ' CZ2' ' C' ' 287' ' ' TRP . 10.5 tp10 -113.35 118.21 33.93 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.869 -1.159 . . . . 75.409999999999997 107.869 177.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -108.86 124.94 51.42 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.325 0.583 . . . . 73.120000000000005 109.861 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 106.08 -38.59 3.23 Favored Glycine 0 N--CA 1.417 -2.602 0 CA-C-N 115.089 -0.96 . . . . 63.100000000000001 110.957 -177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 72.76 35.06 58.92 Favored Glycine 0 CA--C 1.489 -1.569 0 N-CA-C 109.507 -1.437 . . . . 53.350000000000001 109.507 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -146.88 -7.3 0.49 Allowed 'General case' 0 N--CA 1.423 -1.801 0 CA-C-N 114.851 -0.675 . . . . 71.519999999999996 109.906 -173.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . 0.457 ' HA3' HG11 ' C' ' 244' ' ' VAL . . . -76.45 -70.15 1.31 Allowed Glycine 0 N--CA 1.427 -1.934 0 C-N-CA 120.789 -0.719 . . . . 72.150000000000006 112.843 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.516 ' CB ' HD12 ' C' ' 276' ' ' LEU . 70.9 t80 -77.07 -51.16 11.53 Favored 'General case' 0 CA--C 1.49 -1.355 0 C-N-CA 120.411 -0.516 . . . . 75.319999999999993 110.097 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.416 ' CZ2' ' HG2' ' C' ' 280' ' ' GLU 0.317 28.5 p90 -87.46 65.77 8.78 Favored 'General case' 0 N--CA 1.412 -2.348 0 C-N-CA 118.504 -1.278 . . . . 75.549999999999997 112.2 177.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.61 118.42 15.51 Favored 'General case' 0 N--CA 1.425 -1.712 0 N-CA-C 105.556 -2.016 . . . . 74.420000000000002 105.556 172.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -67.52 177.43 1.96 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.252 -0.885 . . . . 73.219999999999999 110.224 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -70.71 87.79 0.69 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 109.303 -0.628 . . . . 74.209999999999994 109.303 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -103.22 -28.69 11.74 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.908 -0.587 . . . . 72.040000000000006 110.215 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 61.8 m-70 -114.37 86.59 2.46 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.214 -0.448 . . . . 72.420000000000002 111.179 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -88.25 -14.43 38.44 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.61 0.719 . . . . 51.310000000000002 109.88 176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . 0.421 ' H ' ' CD2' ' C' ' 294' ' ' HIS . 6.0 p80 -81.01 0.28 36.41 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.021 -0.99 . . . . 70.329999999999998 112.052 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . 0.551 ' HB3' ' O ' ' B' ' 290' ' ' HIS . 33.6 m-70 . . . . . 0 C--N 1.304 -1.374 0 CA-C-N 116.537 -0.301 . . . . 72.120000000000005 111.424 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 26.6 ttt . . . . . 0 C--O 1.235 0.297 0 N-CA-C 109.867 -0.42 . . . . 72.409999999999997 109.867 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -147.58 83.56 1.54 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.518 -0.31 . . . . 60.140000000000001 111.066 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 13.7 tt -106.74 -9.05 10.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 107.351 -1.352 . . . . 64.239999999999995 107.351 172.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.49 111.66 4.24 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 113.639 -1.619 . . . . 73.239999999999995 108.738 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -158.29 165.17 35.46 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.54 -0.911 . . . . 45.549999999999997 108.54 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.475 HD13 HD22 ' A' ' 243' ' ' ASN . 7.1 tt -83.48 118.03 30.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.886 -0.783 . . . . 72.019999999999996 108.886 177.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.5 m -131.96 145.32 35.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 115.574 -0.739 . . . . 74.400000000000006 110.745 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 149.75 114.52 0.71 Allowed Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 111.547 -0.621 . . . . 72.030000000000001 111.547 175.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 261' ' ' THR . 37.4 ttm180 -89.63 123.49 33.72 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.921 0.36 . . . . 73.430000000000007 110.235 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 34.1 t-20 -116.88 149.23 40.43 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.527 -0.916 . . . . 73.540000000000006 108.527 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.3 m -137.09 137.52 39.39 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.97 -0.752 . . . . 71.140000000000001 108.97 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 277' ' ' ILE . . . -137.17 132.06 33.42 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 110.109 -0.33 . . . . 53.240000000000002 110.109 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 5.2 tmmm? -90.87 -55.06 3.7 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.122 -0.49 . . . . 74.299999999999997 110.971 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -131.59 139.4 49.17 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.972 -0.381 . . . . 71.099999999999994 109.972 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 68.0 mt -137.29 121.03 22.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 108.546 -0.909 . . . . 74.239999999999995 108.546 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 60.5 mtm180 -131.27 129.21 41.25 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.325 0.583 . . . . 72.349999999999994 112.011 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.44 HG21 ' HB ' ' A' ' 239' ' ' VAL . 27.2 p -132.32 128.49 37.85 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 115.415 -0.811 . . . . 74.5 109.029 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -121.48 147.99 45.04 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 111.841 0.311 . . . . 72.530000000000001 111.841 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 67.07 -87.23 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.729 1.212 . . . . 73.310000000000002 113.859 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 25.0 mtm-85 -116.31 3.02 13.33 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 123.191 0.596 . . . . 72.129999999999995 110.487 -175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -69.64 136.71 51.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 115.308 -0.86 . . . . 75.450000000000003 111.33 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -125.45 135.38 52.28 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.36 -0.978 . . . . 74.200000000000003 108.36 -177.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.9 p -129.68 146.03 34.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.573 0.701 . . . . 62.329999999999998 110.809 -178.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.53 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 6.1 tp-100 -123.72 130.01 51.98 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 107.929 -1.137 . . . . 75.329999999999998 107.929 174.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -123.32 118.68 28.08 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.469 -0.937 . . . . 74.040000000000006 108.469 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.528 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 130.27 -114.12 1.58 Allowed Glycine 0 N--CA 1.433 -1.566 0 CA-C-N 115.825 -0.625 . . . . 75.219999999999999 111.618 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.475 HD22 HD13 ' A' ' 222' ' ' ILE . 28.8 p-10 -145.19 138.75 26.75 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 122.437 -0.449 . . . . 60.149999999999999 111.375 -178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 85.5 t -122.45 114.08 41.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.806 -1.553 . . . . 73.25 106.806 174.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.457 ' HA ' ' HB2' ' A' ' 281' ' ' TYR . 7.3 p -122.78 114.35 41.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 C-N-CA 120.334 -0.546 . . . . 72.239999999999995 110.607 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 22.8 m -79.92 158.9 26.54 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 107.826 -1.176 . . . . 74.230000000000004 107.826 177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.97 -41.49 95.41 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.054 0.455 . . . . 34.229999999999997 111.368 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -35.9 67.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.408 -1.269 . . . . 70.099999999999994 113.895 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.482 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -64.95 -26.28 68.23 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 122.766 0.426 . . . . 54.130000000000003 112.126 -176.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 61.9 tp 81.04 114.53 0.06 Allowed 'General case' 0 C--O 1.223 -0.295 0 C-N-CA 125.039 1.336 . . . . 72.0 112.09 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -132.23 150.8 52.07 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.257 -0.883 . . . . 64.549999999999997 109.179 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.91 44.87 1.17 Allowed Glycine 0 N--CA 1.437 -1.272 0 N-CA-C 111.45 -0.66 . . . . 75.530000000000001 111.45 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.15 -162.11 21.76 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 121.159 -0.544 . . . . 71.140000000000001 112.398 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 42.1 mm -118.13 130.99 72.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.191 -1.04 . . . . 52.240000000000002 108.191 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -105.53 -83.92 0.51 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.975 0.417 . . . . 73.219999999999999 111.006 175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.6 tt -159.38 135.47 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 107.053 -1.462 . . . . 74.439999999999998 107.053 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.454 ' HB3' ' N ' ' A' ' 225' ' ' ARG . 48.3 m -80.14 84.15 5.9 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.755 0.788 . . . . 70.519999999999996 109.887 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -126.12 156.41 40.11 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.299 -1.319 . . . . 73.420000000000002 108.878 -175.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.446 HE22 ' HB3' ' C' ' 217' ' ' MET . 78.0 mm-40 72.19 -49.79 0.69 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.594 1.558 . . . . 71.0 112.771 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.528 ' HA ' ' O ' ' B' ' 224' ' ' GLY . 36.5 m -90.24 117.64 29.14 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 107.534 -1.284 . . . . 74.400000000000006 107.534 170.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.555 ' HB ' ' HD2' ' B' ' 225' ' ' ARG . 29.3 m -138.46 123.06 18.57 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.177 -1.046 . . . . 72.430000000000007 108.177 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.546 ' O ' ' HA ' ' A' ' 226' ' ' ASN . 38.9 t-20 -126.15 136.77 53.27 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 107.14 -1.43 . . . . 54.240000000000002 107.14 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 38.6 m -138.15 134.53 34.69 Favored 'General case' 0 C--N 1.285 -2.21 0 O-C-N 122.077 -0.389 . . . . 75.129999999999995 110.289 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 13.1 p -128.43 141.88 45.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.211 0.529 . . . . 75.010000000000005 111.118 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.608 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 6.4 mm-40 -78.58 -72.18 0.39 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.652 -0.703 . . . . 54.149999999999999 110.961 175.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -128.8 127.84 42.76 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.854 -0.738 . . . . 62.310000000000002 112.713 -175.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.425 HG12 HD12 ' B' ' 231' ' ' ILE . 35.5 m -119.97 126.9 75.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.865 0 CA-C-N 115.975 -0.557 . . . . 54.420000000000002 110.07 175.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.55 136.88 59.53 Favored 'Isoleucine or valine' 0 C--O 1.257 1.473 0 CA-C-O 121.358 0.599 . . . . 73.310000000000002 112.115 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.09 131.34 8.38 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.725 -1.35 . . . . 72.120000000000005 109.725 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -124.24 117.57 24.88 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.412 0.625 . . . . 75.129999999999995 111.536 -174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 90.24 -118.87 5.41 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.106 -1.198 . . . . 74.329999999999998 110.106 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -102.63 90.66 3.9 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.449 -1.315 . . . . 62.109999999999999 107.449 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 31.5 m -130.7 145.35 51.91 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.607 -1.179 . . . . 71.120000000000005 108.643 -177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . 0.529 ' HB2' ' HG3' ' B' ' 238' ' ' ARG . 94.0 mtt180 -130.45 127.51 39.39 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.445 -1.302 . . . . 74.120000000000005 108.225 177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.5 p -132.76 130.38 59.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.961 0.886 . . . . 64.349999999999994 111.327 -173.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.6 tt -117.51 126.13 52.06 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 107.972 -1.122 . . . . 72.450000000000003 107.972 176.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.454 HG21 ' HB2' ' A' ' 228' ' ' ALA . 34.6 mm -112.68 103.51 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 107.075 -1.454 . . . . 61.420000000000002 107.075 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.625 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 150.44 -141.17 8.5 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 119.881 -1.152 . . . . 72.140000000000001 112.85 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -113.02 134.14 54.65 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 107.798 -1.186 . . . . 74.450000000000003 107.798 -177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.4 OUTLIER -129.74 120.36 24.97 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.966 0.889 . . . . 71.430000000000007 109.104 176.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.457 ' HB2' ' HA ' ' A' ' 245' ' ' VAL . 2.8 m-85 -113.97 124.65 52.67 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.858 -1.064 . . . . 73.010000000000005 108.951 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 129.72 -42.6 1.4 Allowed Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 120.841 -0.695 . . . . 74.0 112.407 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' B' ' 286' ' ' PHE . . . 100.61 -15.95 58.12 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.81 -0.916 . . . . 54.509999999999998 110.81 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.07 83.96 2.01 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.002 -0.74 . . . . 70.129999999999995 109.002 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -84.88 -121.75 1.02 Allowed Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.653 -0.703 . . . . 73.430000000000007 112.312 176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -87.98 15.89 6.69 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.104 0.478 . . . . 75.010000000000005 110.223 -176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.428 ' CH2' ' HB2' ' A' ' 276' ' ' LEU . 78.0 m95 -65.96 -16.52 63.95 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 114.686 1.365 . . . . 74.420000000000002 114.686 -170.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.503 ' HB3' ' NH1' ' A' ' 274' ' ' ARG . 1.3 t70 70.73 132.18 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.006 0.816 . . . . 75.230000000000004 112.361 -177.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -130.91 34.88 4.02 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.13 -1.063 . . . . 71.230000000000004 108.13 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 36.4 t60 -82.56 -22.39 34.92 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.883 -1.155 . . . . 73.439999999999998 107.883 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -89.5 107.81 19.29 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 114.74 -1.118 . . . . 73.450000000000003 108.716 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -110.63 117.53 33.74 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 110.009 -0.367 . . . . 74.239999999999995 110.009 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -84.09 85.8 7.29 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.673 -0.811 . . . . 71.299999999999997 109.356 173.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -76.72 -69.98 0.48 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 114.739 -1.119 . . . . 74.340000000000003 108.57 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 30.6 m170 . . . . . 0 C--N 1.313 -1.015 0 N-CA-C 106.39 -1.708 . . . . 72.209999999999994 106.39 176.462 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 27.0 ptm . . . . . 0 CA--C 1.514 -0.425 0 N-CA-C 109.4 -0.593 . . . . 72.099999999999994 109.4 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -84.31 102.39 12.66 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.661 -1.237 . . . . 72.319999999999993 107.661 174.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 10.6 tt -123.19 -65.63 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 113.712 1.004 . . . . 62.450000000000003 113.712 -176.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . 0.537 ' HA ' ' HA3' ' B' ' 253' ' ' GLY . 33.3 t70 -108.29 133.07 53.03 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.303 0.482 . . . . 62.409999999999997 112.303 -171.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -175.32 -169.99 0.41 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.643 1.177 . . . . 65.030000000000001 108.517 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . 0.551 HG13 ' CZ ' ' B' ' 281' ' ' TYR . 8.4 tt -105.83 130.73 56.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 108.661 -0.866 . . . . 72.129999999999995 108.661 176.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 19.1 m -124.82 159.96 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 112.282 0.475 . . . . 61.310000000000002 112.282 -175.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 260' ' ' THR . . . 145.83 127.87 1.93 Allowed Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 111.86 -0.496 . . . . 44.340000000000003 111.86 176.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.555 ' HD2' ' HB ' ' A' ' 261' ' ' THR . 8.1 tpt180 -106.64 117.6 34.48 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.524 -1.287 . . . . 74.409999999999997 107.524 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.594 HD21 HG22 ' B' ' 277' ' ' ILE . 7.3 t30 -120.95 144.56 48.41 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 120.747 0.308 . . . . 55.130000000000003 111.79 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' B' ' 263' ' ' SER . 50.5 m -136.33 136.96 40.14 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.179 -0.674 . . . . 70.420000000000002 109.179 173.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.03 142.94 49.07 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.537 -0.542 . . . . 61.009999999999998 109.537 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.608 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 2.3 tmmm? -100.69 -64.1 1.07 Allowed 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 120.393 -0.523 . . . . 73.299999999999997 110.267 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -127.85 138.33 52.66 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 108.959 -0.756 . . . . 73.430000000000007 108.959 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.425 HD12 HG12 ' A' ' 267' ' ' VAL . 16.9 mt -135.57 119.91 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.095 -0.705 . . . . 73.010000000000005 109.095 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -123.23 115.71 22.18 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.873 0.368 . . . . 73.299999999999997 110.651 -178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 52.6 p -111.69 127.66 55.84 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.625 -1.25 . . . . 73.099999999999994 107.625 175.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -130.18 149.68 51.77 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.457 -0.497 . . . . 73.450000000000003 111.028 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . 0.251 33.5 mt-10 75.87 -74.16 0.08 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 115.733 1.753 . . . . 64.129999999999995 115.733 170.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.26 24.72 2.3 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 108.334 -0.987 . . . . 75.209999999999994 108.334 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.486 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -84.91 142.93 29.34 Favored 'General case' 0 C--O 1.275 2.444 0 CA-C-O 122.954 1.359 . . . . 75.340000000000003 113.895 -172.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.529 ' HG3' ' HB2' ' A' ' 274' ' ' ARG . 3.7 mpt_? -125.93 135.21 51.61 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.487 -1.233 . . . . 62.039999999999999 110.845 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.515 HG13 HG23 ' A' ' 275' ' ' VAL . 14.1 p -134.29 143.4 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.201 1.001 . . . . 74.099999999999994 110.51 -178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.56 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 4.8 tp-100 -121.12 125.17 46.56 Favored 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 114.108 -1.405 . . . . 64.200000000000003 107.857 175.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.407 HD12 HG23 ' A' ' 277' ' ' ILE . 3.2 tm? -119.16 117.04 27.6 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 106.176 -1.787 . . . . 61.200000000000003 106.176 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 139.05 -121.33 2.08 Favored Glycine 0 C--N 1.287 -2.147 0 N-CA-C 110.487 -1.045 . . . . 61.200000000000003 110.487 -178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -145.34 139.1 26.79 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.932 0.366 . . . . 71.120000000000005 110.853 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.56 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 44.8 t -122.41 122.61 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 107.989 -1.115 . . . . 73.409999999999997 107.989 175.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.516 HG21 ' O ' ' B' ' 250' ' ' LEU . 7.0 p -123.67 125.67 71.68 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 C-N-CA 120.052 -0.659 . . . . 75.109999999999999 110.89 175.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 2.1 m -81.88 160.82 23.36 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 107.393 -1.336 . . . . 63.049999999999997 107.393 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -61.97 -35.94 79.97 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 120.986 0.422 . . . . 74.519999999999996 111.636 -177.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.33 -52.28 64.0 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.698 -1.137 . . . . 72.030000000000001 112.566 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . . . . . . . . . . . -75.16 -46.42 34.38 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.707 -0.397 . . . . 20.41 110.414 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.516 ' O ' HG21 ' B' ' 245' ' ' VAL . 52.1 tp 65.53 -79.97 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.916 1.286 . . . . 70.049999999999997 113.138 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -143.72 167.78 21.46 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.869 -0.789 . . . . 74.040000000000006 108.869 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -156.16 67.32 0.3 Allowed Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.54 -1.024 . . . . 70.420000000000002 110.54 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' B' ' 220' ' ' ASP . . . -117.13 149.79 18.63 Favored Glycine 0 N--CA 1.424 -2.113 0 C-N-CA 119.206 -1.473 . . . . 54.030000000000001 114.433 -178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 10.7 pt -168.93 -156.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 N-CA-C 101.97 -3.345 . . . . 63.43 101.97 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -138.55 144.12 39.76 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 120.24 1.382 . . . . 75.209999999999994 110.163 169.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 6.9 tp -127.01 -56.54 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 O-C-N 123.756 0.66 . . . . 73.329999999999998 110.858 176.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 58.1 m -169.06 -61.28 0.02 OUTLIER 'General case' 0 C--O 1.242 0.666 0 C-N-CA 122.918 0.487 . . . . 55.149999999999999 111.559 -176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -152.39 -172.03 4.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 106.365 -1.717 . . . . 73.439999999999998 106.365 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -115.6 177.5 4.64 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 119.196 0.907 . . . . 61.409999999999997 112.376 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.483 ' OG1' HG12 ' C' ' 222' ' ' ILE . 86.1 m -82.25 131.55 35.23 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-N 115.116 -0.947 . . . . 73.219999999999999 108.92 175.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.566 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 29.1 m -126.58 112.88 16.03 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.92 -0.77 . . . . 70.510000000000005 108.92 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -121.05 138.18 54.3 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.936 -1.135 . . . . 60.450000000000003 107.936 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' C' ' 227' ' ' SER . 43.6 m -138.6 138.88 38.31 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-O 120.739 0.304 . . . . 54.039999999999999 110.219 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' C' ' 228' ' ' ALA . 12.5 p -128.51 150.33 34.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-O 120.87 0.367 . . . . 52.310000000000002 110.527 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 44.0 mm-40 -86.01 -76.21 0.35 Allowed 'General case' 0 N--CA 1.423 -1.817 0 CA-C-N 115.834 -0.621 . . . . 71.109999999999999 110.691 174.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 27.8 m -128.81 127.87 42.8 Favored 'General case' 0 C--O 1.249 1.034 0 C-N-CA 119.931 -0.707 . . . . 63.229999999999997 112.454 -176.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.412 HG12 ' HB ' ' C' ' 231' ' ' ILE . 35.1 m -118.46 129.31 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.696 -0.684 . . . . 62.509999999999998 109.265 175.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 8.8 p -127.58 128.87 70.11 Favored 'Isoleucine or valine' 0 C--O 1.266 1.922 0 CA-C-O 121.716 0.769 . . . . 70.340000000000003 112.237 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.91 132.82 10.93 Favored Glycine 0 N--CA 1.428 -1.896 0 N-CA-C 110.46 -1.056 . . . . 61.109999999999999 110.46 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -124.09 121.29 34.77 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 122.472 0.309 . . . . 72.439999999999998 111.127 -174.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.24 -130.0 9.42 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 109.65 -1.38 . . . . 44.109999999999999 109.65 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.93 98.4 11.35 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.653 -1.98 . . . . 52.240000000000002 105.653 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.4 t -130.03 143.03 50.57 Favored 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 114.989 -1.005 . . . . 72.349999999999994 108.764 -175.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.549 ' HB2' ' HG3' ' C' ' 238' ' ' ARG . 76.3 mtt180 -131.3 127.05 36.91 Favored 'General case' 0 CA--C 1.489 -1.386 0 C-N-CA 118.565 -1.254 . . . . 73.329999999999998 108.376 175.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.0 p -135.9 132.09 50.34 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 115.094 -0.957 . . . . 73.219999999999999 110.918 -175.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.521 ' HB3' ' OE1' ' C' ' 240' ' ' GLN . 5.9 tt -119.96 125.41 48.34 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 107.546 -1.279 . . . . 63.310000000000002 107.546 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.594 HG22 HD21 ' B' ' 226' ' ' ASN . 30.0 mm -112.54 103.56 15.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.662 0 N-CA-C 106.772 -1.566 . . . . 74.140000000000001 106.772 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.567 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 147.21 -143.77 11.73 Favored Glycine 0 N--CA 1.427 -1.951 0 C-N-CA 120.422 -0.894 . . . . 51.549999999999997 113.829 -177.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -108.76 132.25 54.15 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.721 -0.844 . . . . 53.0 108.721 -175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' C' ' 244' ' ' VAL . 0.0 OUTLIER -127.8 122.49 32.85 Favored 'General case' 0 C--O 1.265 1.88 0 CA-C-O 122.324 1.059 . . . . 73.299999999999997 108.593 177.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.551 ' CZ ' HG13 ' B' ' 222' ' ' ILE . 2.3 m-85 -120.52 124.11 44.57 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 114.407 -1.27 . . . . 71.299999999999997 107.7 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 128.94 -40.05 1.76 Allowed Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.333 -0.937 . . . . 31.399999999999999 111.524 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' C' ' 286' ' ' PHE . . . 97.01 -16.54 60.77 Favored Glycine 0 N--CA 1.438 -1.207 0 N-CA-C 110.576 -1.01 . . . . 61.329999999999998 110.576 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.29 77.56 1.68 Allowed 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.208 -0.496 . . . . 73.099999999999994 110.577 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -76.3 -128.86 0.3 Allowed Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 115.013 -0.994 . . . . 43.119999999999997 112.007 174.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 283' ' ' GLY . 5.0 p90 -81.99 13.55 3.29 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.484 0.659 . . . . 71.209999999999994 111.391 -175.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.465 ' CH2' ' HB2' ' B' ' 276' ' ' LEU . 39.9 m95 -74.1 -57.18 4.13 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.037 -0.528 . . . . 71.430000000000007 109.647 -177.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 35.1 t70 56.18 101.0 0.01 OUTLIER 'General case' 0 C--O 1.254 1.336 0 C-N-CA 126.091 1.756 . . . . 63.32 114.339 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -63.96 149.62 46.87 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.745 -0.661 . . . . 64.230000000000004 109.716 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -153.59 30.35 0.47 Allowed 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.279 1.038 . . . . 75.430000000000007 108.963 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . 0.493 ' HB3' ' CE1' ' B' ' 293' ' ' HIS . 46.9 m-70 -80.27 93.34 5.88 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.325 -1.307 . . . . 72.310000000000002 110.461 -177.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -80.55 -24.88 38.96 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.975 -0.557 . . . . 75.439999999999998 110.038 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . 0.493 ' CE1' ' HB3' ' B' ' 291' ' ' HIS . 29.9 m170 53.81 58.62 4.93 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 115.171 1.545 . . . . 62.420000000000002 115.171 176.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -150.24 144.99 25.95 Favored 'General case' 0 CA--C 1.492 -1.27 0 C-N-CA 123.222 0.609 . . . . 73.140000000000001 109.497 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 C--N 1.3 -1.58 0 N-CA-C 107.977 -1.12 . . . . 74.319999999999993 107.977 177.214 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . 0.618 ' SD ' ' HG3' ' C' ' 218' ' ' LYS . 1.4 tmt? . . . . . 0 C--O 1.241 0.658 0 N-CA-C 107.431 -1.322 . . . . 73.040000000000006 107.431 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . 0.618 ' HG3' ' SD ' ' C' ' 217' ' ' MET . 68.7 mttm -138.03 111.04 7.76 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 104.438 -2.43 . . . . 62.329999999999998 104.438 169.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 69.9 mt 89.75 97.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 O-C-N 125.683 1.865 . . . . 64.150000000000006 106.378 -162.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -167.61 161.7 13.75 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 124.48 1.112 . . . . 72.25 109.888 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -162.85 -45.9 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.995 -1.113 . . . . 72.530000000000001 107.995 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 0.521 HG13 ' CE1' ' C' ' 281' ' ' TYR . 12.6 tt -89.38 115.98 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-N 114.101 -1.409 . . . . 72.450000000000003 109.741 178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 35.2 m -112.42 156.21 13.51 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.916 -0.584 . . . . 72.140000000000001 109.981 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' B' ' 260' ' ' THR . . . 149.55 154.23 6.32 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.418 -1.073 . . . . 54.340000000000003 110.418 178.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' C' ' 261' ' ' THR . 28.4 ttt180 -138.56 119.48 14.31 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.023 -0.732 . . . . 74.099999999999994 109.023 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.568 HD21 HG22 ' C' ' 277' ' ' ILE . 7.2 t30 -118.78 148.97 42.26 Favored 'General case' 0 C--N 1.278 -2.534 0 CA-C-N 116.182 -0.463 . . . . 65.129999999999995 110.475 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.624 ' O ' ' HA ' ' C' ' 263' ' ' SER . 31.9 m -136.68 136.53 39.15 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.195 -1.039 . . . . 63.200000000000003 108.195 172.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.472 ' HB3' HG23 ' B' ' 264' ' ' VAL . . . -130.7 138.23 49.91 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.469 -0.567 . . . . 75.430000000000007 109.469 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 2.9 tmmm? -93.38 -64.22 1.12 Allowed 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.556 -0.458 . . . . 74.120000000000005 110.943 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' C' ' 266' ' ' THR . 28.4 t70 -127.37 137.79 52.85 Favored 'General case' 0 C--O 1.253 1.243 0 C-N-CA 120.1 -0.64 . . . . 63.539999999999999 109.682 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.412 ' HB ' HG12 ' B' ' 267' ' ' VAL . 31.3 mt -133.95 118.94 30.48 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 108.889 -0.782 . . . . 62.539999999999999 108.889 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -118.99 122.38 42.07 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.792 -0.448 . . . . 73.200000000000003 109.792 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 31.7 p -122.24 127.9 50.49 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.865 -0.791 . . . . 75.530000000000001 108.865 176.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -129.35 150.28 50.78 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 120.985 0.421 . . . . 53.5 111.596 -177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 74.42 -73.05 0.1 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 115.951 1.834 . . . . 71.510000000000005 115.951 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -139.53 29.81 2.15 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 107.498 -1.297 . . . . 70.439999999999998 107.498 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -91.3 137.6 32.24 Favored 'General case' 0 C--O 1.277 2.524 0 CA-C-O 122.571 1.177 . . . . 51.210000000000001 113.102 -173.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.549 ' HG3' ' HB2' ' B' ' 274' ' ' ARG . 2.9 mpt_? -125.7 134.71 51.72 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 113.891 -1.504 . . . . 72.140000000000001 109.426 176.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.523 HG23 HG13 ' C' ' 275' ' ' VAL . 8.5 p -133.42 139.4 49.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.832 0.825 . . . . 75.430000000000007 110.887 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.611 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 49.0 tp60 -114.85 118.89 34.79 Favored 'General case' 0 N--CA 1.401 -2.91 0 CA-C-N 114.228 -1.351 . . . . 64.140000000000001 108.425 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.437 HD12 HG23 ' B' ' 277' ' ' ILE . 3.2 tm? -111.74 118.77 36.52 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 105.416 -2.068 . . . . 72.209999999999994 105.416 175.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 135.97 -120.0 2.15 Favored Glycine 0 C--N 1.28 -2.583 0 N-CA-C 109.898 -1.281 . . . . 72.400000000000006 109.898 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 7.8 p30 -144.75 144.25 31.09 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 116.542 0.171 . . . . 55.100000000000001 111.156 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.611 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 48.9 t -124.08 114.64 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.595 0 N-CA-C 107.075 -1.454 . . . . 70.510000000000005 107.075 172.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' C' ' 281' ' ' TYR . 7.1 p -123.87 129.17 74.47 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.715 0 C-N-CA 119.298 -0.961 . . . . 70.239999999999995 111.098 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.5 m -88.91 159.2 17.79 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 107.219 -1.4 . . . . 73.400000000000006 107.219 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.79 94.37 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.726 0.774 . . . . 61.509999999999998 110.702 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.98 -34.27 63.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.111 -1.404 . . . . 64.209999999999994 112.464 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . 0.419 ' HB2' ' HA2' ' C' ' 282' ' ' GLY . . . -68.42 -31.53 70.93 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 113.297 0.851 . . . . 73.420000000000002 113.297 -175.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 89.4 mt -88.53 70.26 8.93 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 122.044 0.926 . . . . 64.010000000000005 113.042 -172.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -144.18 -51.41 0.31 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.941 -1.481 . . . . 71.319999999999993 107.098 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -100.63 176.73 27.7 Favored Glycine 0 N--CA 1.433 -1.519 0 N-CA-C 110.375 -1.09 . . . . 72.530000000000001 110.375 175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 98.52 93.87 2.0 Favored Glycine 0 C--N 1.306 -1.107 0 N-CA-C 109.589 -1.404 . . . . 73.230000000000004 109.589 -176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 62.3 mt -87.12 -41.3 14.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 120.486 0.184 . . . . 64.109999999999999 110.868 -174.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 67.74 174.87 0.26 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.769 0.828 . . . . 64.409999999999997 110.597 -174.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 3.5 mp -108.32 -54.11 5.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.403 -1.332 . . . . 72.140000000000001 107.403 176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 23.1 t 172.42 -32.69 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 105.367 -2.086 . . . . 73.349999999999994 105.367 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -34.86 106.67 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 113.212 -1.813 . . . . 70.140000000000001 114.724 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -87.59 96.51 10.44 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 105.523 -2.028 . . . . 64.010000000000005 105.523 168.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 5.3 m -63.35 121.37 13.59 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 114.616 -1.174 . . . . 75.299999999999997 108.903 -175.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 21.8 m -107.34 108.56 20.0 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 109.275 -0.639 . . . . 73.140000000000001 109.275 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -111.04 141.12 44.95 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.207 -1.034 . . . . 53.520000000000003 108.207 -178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' C' ' 227' ' ' SER . 21.7 m -140.01 140.25 36.19 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 122.035 -0.416 . . . . 53.229999999999997 110.163 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.459 HG21 HG13 ' C' ' 267' ' ' VAL . 7.2 p -129.18 142.87 42.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 C-N-CA 121.195 -0.202 . . . . 71.0 111.086 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.478 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 9.7 mm-40 -80.91 -52.73 7.14 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 111.798 0.295 . . . . 73.230000000000004 111.798 177.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 37.5 m -150.18 133.05 16.03 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.162 -0.615 . . . . 71.530000000000001 111.063 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.459 HG13 HG21 ' C' ' 264' ' ' VAL . 17.1 m -126.05 135.08 64.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 109.178 -0.675 . . . . 62.32 109.178 171.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.08 129.15 71.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 109.746 -0.464 . . . . 72.129999999999995 109.746 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.65 132.8 11.25 Favored Glycine 0 N--CA 1.428 -1.884 0 N-CA-C 108.37 -1.892 . . . . 74.120000000000005 108.37 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -128.24 117.05 20.82 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 120.925 0.393 . . . . 71.319999999999993 110.094 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.85 -136.23 17.2 Favored Glycine 0 N--CA 1.425 -2.099 0 N-CA-C 109.811 -1.316 . . . . 50.119999999999997 109.811 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -80.3 96.52 6.66 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.342 -1.355 . . . . 74.040000000000006 107.342 176.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 51.0 m -134.99 145.04 47.72 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 115.254 -0.884 . . . . 62.119999999999997 109.502 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -135.21 126.59 28.46 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 107.05 -1.463 . . . . 73.109999999999999 107.05 175.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.523 HG13 HG23 ' C' ' 239' ' ' VAL . 6.2 p -139.33 139.65 38.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 CA-C-N 115.874 -0.603 . . . . 75.209999999999994 110.301 -176.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 7.0 tt -123.2 122.35 38.19 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 107.71 -1.218 . . . . 65.439999999999998 107.71 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.568 HG22 HD21 ' C' ' 226' ' ' ASN . 42.8 mm -110.65 103.79 16.04 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.843 0 N-CA-C 106.791 -1.559 . . . . 62.140000000000001 106.791 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 146.06 -133.67 5.05 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 119.918 -1.134 . . . . 71.409999999999997 113.548 -177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 17.9 m120 -115.07 134.07 55.49 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 120.816 0.341 . . . . 72.140000000000001 110.201 -177.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.64 119.58 19.58 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.61 -1.256 . . . . 75.540000000000006 107.61 177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.521 ' CE1' HG13 ' C' ' 222' ' ' ILE . 3.4 m-85 -119.17 124.91 47.95 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.488 -0.931 . . . . 74.109999999999999 108.488 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' C' ' 249' ' ' ALA . . . 136.2 -36.91 1.95 Allowed Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.195 -0.762 . . . . 43.140000000000001 111.195 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 100.03 -27.29 20.98 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.264 -1.134 . . . . 72.140000000000001 110.264 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -132.84 87.34 2.4 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.845 -1.169 . . . . 74.219999999999999 107.845 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -84.44 -130.31 2.0 Allowed Glycine 0 C--N 1.308 -0.991 0 C-N-CA 120.944 -0.646 . . . . 71.239999999999995 112.291 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.557 ' HA ' ' O ' ' B' ' 283' ' ' GLY . 1.4 p90 -73.67 18.32 0.13 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.336 0.589 . . . . 64.340000000000003 112.007 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 53.3 m95 -79.04 32.36 0.21 Allowed 'General case' 0 C--O 1.244 0.768 0 O-C-N 121.407 -0.808 . . . . 73.430000000000007 110.304 -175.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' C' ' 286' ' ' PHE . 39.2 t70 -61.63 117.48 5.83 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.791 1.236 . . . . 74.310000000000002 111.127 -175.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 177.16 -34.49 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 105.024 -2.213 . . . . 74.450000000000003 105.024 -176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -78.4 127.62 32.46 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 105.989 -1.856 . . . . 72.510000000000005 105.989 170.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 35.5 m80 59.15 61.07 2.18 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 124.188 0.93 . . . . 64.420000000000002 110.456 -172.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 13.2 p-80 -80.88 119.62 23.66 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.378 0.609 . . . . 73.140000000000001 110.431 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -122.05 107.72 12.53 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.414 -0.812 . . . . 64.120000000000005 109.925 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -143.89 -69.77 0.31 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.872 -1.529 . . . . 71.140000000000001 106.872 176.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 126.929 2.092 . . . . 75.25 114.325 173.738 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.585 ' HA ' ' OD2' ' B' ' 220' ' ' ASP . 24.3 ptm . . . . . 0 CA--C 1.517 -0.322 0 CA-C-O 121.644 0.735 . . . . 74.099999999999994 111.263 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -89.25 -63.14 1.33 Allowed 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 109.108 -0.701 . . . . 73.299999999999997 109.108 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.8 mt 53.63 84.37 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 1.0 0 O-C-N 124.275 0.985 . . . . 62.409999999999997 112.248 175.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -102.76 113.84 27.58 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 120.824 0.345 . . . . 65.409999999999997 110.773 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -86.11 67.26 9.92 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.687 0.756 . . . . 71.219999999999999 110.32 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 60.8 mt -116.19 133.34 63.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 108.12 -1.067 . . . . 45.219999999999999 108.12 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.9 119.06 48.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 120.291 -0.563 . . . . 71.420000000000002 111.82 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 45.68 67.91 1.15 Allowed Glycine 0 N--CA 1.469 0.852 0 N-CA-C 116.164 1.226 . . . . 54.229999999999997 116.164 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -109.83 134.16 52.35 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.069 -1.052 . . . . 70.25 110.637 176.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.498 ' ND2' ' HA2' ' A' ' 278' ' ' GLY . 8.7 p30 -104.3 141.0 37.07 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.132 -1.433 . . . . 71.140000000000001 107.132 172.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.6 m -121.52 137.1 54.87 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 109.982 -0.377 . . . . 74.329999999999998 109.982 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.74 119.65 32.35 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.075 -1.454 . . . . 43.009999999999998 107.075 176.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -88.69 -41.31 12.67 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 116.206 -0.452 . . . . 63.009999999999998 110.807 -175.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -140.71 138.99 34.63 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.915 0.388 . . . . 65.140000000000001 110.352 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.6 mt -131.41 121.85 49.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 N-CA-C 107.673 -1.232 . . . . 64.230000000000004 107.673 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 60.4 ttt180 -132.58 115.1 15.03 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 121.493 0.663 . . . . 73.349999999999994 109.369 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 22.6 p -125.88 128.77 48.11 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.988 -1.116 . . . . 73.329999999999998 107.988 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -125.47 162.14 25.54 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.679 -0.808 . . . . 71.420000000000002 111.469 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 65.27 -84.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.122 1.369 . . . . 61.409999999999997 113.979 175.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -140.2 26.14 2.22 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.126 -0.943 . . . . 73.150000000000006 109.011 -168.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -79.67 151.62 30.41 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 114.832 -1.076 . . . . 75.209999999999994 109.763 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -124.11 135.43 53.52 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.241 -1.763 . . . . 73.230000000000004 106.241 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.5 p -135.87 139.59 45.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.038 0.447 . . . . 53.409999999999997 110.175 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.455 ' HB3' HD13 ' A' ' 276' ' ' LEU . 8.4 tp-100 -129.89 130.85 45.69 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.438 -0.949 . . . . 60.240000000000002 108.438 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.41 ' HA ' HG13 ' A' ' 277' ' ' ILE . 2.7 tm? -120.81 120.57 35.96 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.751 -1.203 . . . . 65.040000000000006 107.751 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.539 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 137.17 -140.09 11.09 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 120.22 -0.991 . . . . 61.210000000000001 112.127 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -123.85 128.32 49.32 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.906 -0.775 . . . . 73.310000000000002 108.906 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 71.5 t -109.4 118.71 57.31 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 107.897 -1.149 . . . . 53.030000000000001 107.897 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 61.9 t -111.39 112.75 41.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.835 -0.802 . . . . 72.120000000000005 108.835 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.409 ' OG1' ' HA3' ' A' ' 285' ' ' GLY . 29.6 m -101.53 159.6 15.15 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 108.128 -1.064 . . . . 73.430000000000007 108.128 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.59 74.32 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.637 0.977 . . . . 72.439999999999998 113.637 -175.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.02 -49.46 71.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 113.377 0.88 . . . . 63.140000000000001 113.377 -172.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.609 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -76.2 -48.31 20.88 Favored 'General case' 0 CA--C 1.502 -0.874 0 N-CA-C 113.686 0.995 . . . . 53.119999999999997 113.686 -176.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 77.6 mt -151.98 105.63 3.11 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.767 -0.457 . . . . 61.32 109.767 -169.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -104.24 -19.28 14.17 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.256 -1.016 . . . . 75.340000000000003 108.256 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -86.91 -34.8 10.57 Favored Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.045 -0.98 . . . . 70.040000000000006 113.226 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -173.69 134.22 2.81 Favored Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.613 -0.803 . . . . 31.210000000000001 111.237 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 2.0 mp -76.16 -38.37 34.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.831 0.824 . . . . 52.109999999999999 108.877 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 69.03 -88.61 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 125.212 1.405 . . . . 75.450000000000003 113.527 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 15.0 pt -138.45 167.99 20.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.405 0.621 . . . . 75.109999999999999 112.316 -170.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 14.2 t -101.57 -163.8 1.04 Allowed 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.603 -1.258 . . . . 73.150000000000006 107.603 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -108.56 173.23 6.41 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 116.346 -0.388 . . . . 74.109999999999999 110.325 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -17.56 27.52 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 113.008 0.744 . . . . 72.219999999999999 113.008 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' B' ' 224' ' ' GLY . 94.7 m -69.54 123.47 21.39 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 121.611 0.72 . . . . 45.009999999999998 112.239 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.2 t -101.05 116.51 33.01 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 115.086 -0.961 . . . . 71.030000000000001 108.465 175.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -95.57 144.16 26.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.721 -0.672 . . . . 73.209999999999994 109.195 -176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' B' ' 227' ' ' SER . 20.3 m -140.42 123.24 16.41 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.484 -0.562 . . . . 51.229999999999997 109.484 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.9 p -128.51 140.14 50.01 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-O 120.418 0.152 . . . . 75.340000000000003 110.985 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.65 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 62.6 mm-40 -77.73 -78.4 0.14 Allowed 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 116.384 -0.371 . . . . 71.040000000000006 110.273 176.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 6.1 t -124.42 130.82 53.17 Favored 'General case' 0 C--O 1.261 1.672 0 N-CA-C 112.986 0.735 . . . . 74.019999999999996 112.986 -174.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.768 HG12 HD12 ' B' ' 231' ' ' ILE . 17.0 m -118.09 125.35 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 115.109 -0.951 . . . . 61.32 109.167 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 5.1 p -127.4 125.91 66.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-O 121.17 0.509 . . . . 74.299999999999997 111.99 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.85 133.03 11.07 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 115.561 -0.745 . . . . 54.210000000000001 111.498 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -123.66 141.51 51.95 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.27 0.628 . . . . 71.239999999999995 110.437 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.41 -127.58 29.35 Favored Glycine 0 C--N 1.313 -0.737 0 C-N-CA 120.919 -0.658 . . . . 44.509999999999998 111.938 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.431 ' HB3' ' NH1' ' A' ' 274' ' ' ARG . 60.9 mm-40 -93.35 57.55 2.67 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.817 0.847 . . . . 73.099999999999994 110.407 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 70.7 m -88.74 145.09 25.83 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 120.115 -0.634 . . . . 51.219999999999999 111.969 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . 0.431 ' NH1' ' HB3' ' A' ' 272' ' ' GLU . 10.4 mpt_? -121.47 127.69 51.34 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.193 -1.41 . . . . 75.519999999999996 107.193 173.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.1 p -136.0 123.57 34.94 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 CA-C-O 121.536 0.684 . . . . 74.299999999999997 110.852 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 240' ' ' GLN . 13.3 tp -121.97 124.3 43.7 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-O 121.542 0.687 . . . . 62.329999999999998 110.256 175.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.562 HG22 ' HB3' ' B' ' 241' ' ' LEU . 2.9 pt -112.7 104.55 17.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 114.402 -1.272 . . . . 73.420000000000002 110.056 179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 146.0 -148.91 20.95 Favored Glycine 0 N--CA 1.431 -1.691 0 CA-C-N 115.53 -0.759 . . . . 71.329999999999998 111.731 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 7.0 m-20 -101.94 149.58 24.07 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 122.752 -0.263 . . . . 74.129999999999995 110.709 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.1 125.94 24.09 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.776 -1.935 . . . . 62.020000000000003 105.776 175.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -109.29 122.81 48.15 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.493 -1.299 . . . . 64.519999999999996 107.493 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 134.11 -53.03 0.8 Allowed Glycine 0 C--N 1.283 -2.373 0 N-CA-C 108.939 -1.664 . . . . 60.32 108.939 -176.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 103.32 -7.67 51.67 Favored Glycine 0 N--CA 1.435 -1.384 0 N-CA-C 109.931 -1.268 . . . . 73.099999999999994 109.931 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -160.07 53.23 0.34 Allowed 'General case' 0 C--O 1.253 1.252 0 CA-C-N 114.755 -0.722 . . . . 74.019999999999996 111.15 -175.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.409 ' HA3' ' OG1' ' A' ' 246' ' ' THR . . . -95.22 -57.87 1.19 Allowed Glycine 0 CA--C 1.524 0.606 0 CA-C-N 115.57 -0.741 . . . . 62.240000000000002 113.99 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -78.66 -2.03 37.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.363 1.078 . . . . 64.239999999999995 110.788 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.447 ' CZ2' ' HD1' ' B' ' 286' ' ' PHE . 36.9 p90 -151.61 175.31 12.48 Favored 'General case' 0 C--N 1.292 -1.935 0 N-CA-C 105.162 -2.162 . . . . 61.229999999999997 105.162 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -121.65 -62.66 1.39 Allowed 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 105.12 -2.178 . . . . 75.140000000000001 105.12 171.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 167.47 -177.17 0.02 OUTLIER 'General case' 0 C--N 1.287 -2.13 1 N-CA-C 99.748 -4.167 . . . . 65.200000000000003 99.748 170.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -135.55 107.87 7.3 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 123.168 2.713 . . . . 73.530000000000001 116.466 -173.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 60.29 23.53 12.97 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 115.531 1.678 . . . . 63.439999999999998 115.531 169.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . 0.51 ' CD2' HH12 ' B' ' 274' ' ' ARG . 89.1 m-70 -94.79 85.47 4.44 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 121.549 -0.719 . . . . 71.400000000000006 109.47 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 19.3 p80 -81.1 -9.27 59.84 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.046 -0.524 . . . . 65.140000000000001 112.057 -177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -154.45 -61.88 0.13 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.068 -0.715 . . . . 73.510000000000005 109.068 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.481 0 N-CA-C 108.426 -0.953 . . . . 71.140000000000001 108.426 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 C--O 1.223 -0.302 0 CA-C-O 120.82 0.343 . . . . 73.409999999999997 111.0 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -150.59 131.76 14.45 Favored 'General case' 0 C--O 1.209 -1.055 0 N-CA-C 109.223 -0.658 . . . . 54.399999999999999 109.223 -176.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . 0.518 ' H ' HD13 ' B' ' 219' ' ' ILE . 0.1 OUTLIER -99.82 168.44 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.52 -0.548 . . . . 64.430000000000007 109.52 174.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . 0.585 ' OD2' ' HA ' ' A' ' 217' ' ' MET . 7.6 p-10 -73.24 147.19 44.87 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 113.245 0.832 . . . . 63.399999999999999 113.245 -171.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 72.03 35.38 1.31 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.331 1.452 . . . . 44.020000000000003 113.983 174.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 59.3 mt -100.94 132.49 46.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 108.39 -0.967 . . . . 73.329999999999998 108.39 173.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.475 ' HA ' ' HG3' ' B' ' 259' ' ' GLN . 7.4 p -107.24 124.55 63.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-O 119.752 -0.166 . . . . 51.310000000000002 111.119 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 260' ' ' THR . . . 48.79 87.82 0.01 OUTLIER Glycine 0 C--N 1.354 1.533 0 O-C-N 124.504 1.127 . . . . 54.020000000000003 114.29 174.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.06 134.4 42.32 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.215 -0.994 . . . . 64.230000000000004 111.326 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' B' ' 262' ' ' ASN . 20.1 p-10 -116.67 140.29 49.57 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.381 -0.97 . . . . 54.030000000000001 108.381 174.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 263' ' ' SER . 18.2 m -121.48 136.5 54.95 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 109.526 -0.546 . . . . 64.400000000000006 109.526 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -120.8 131.53 54.51 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 106.989 -1.486 . . . . 74.219999999999999 106.989 175.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.65 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 1.4 tmtp? -93.31 -62.3 1.4 Allowed 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 109.121 -0.696 . . . . 71.510000000000005 109.121 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -127.95 137.36 52.23 Favored 'General case' 0 C--N 1.3 -1.543 0 N-CA-C 109.575 -0.528 . . . . 63.100000000000001 109.575 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.768 HD12 HG12 ' A' ' 267' ' ' VAL . 18.7 mt -133.8 122.36 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 108.523 -0.917 . . . . 74.25 108.523 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 38.9 ttp180 -123.54 115.68 21.92 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.904 -0.776 . . . . 73.310000000000002 108.904 178.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 70.6 p -109.24 127.75 54.5 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 105.831 -1.915 . . . . 74.129999999999995 105.831 177.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -125.55 161.67 26.65 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 120.207 -0.597 . . . . 72.519999999999996 111.48 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 67.52 -80.41 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.251 -1.34 . . . . 71.450000000000003 113.41 172.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.06 18.3 2.28 Favored 'General case' 0 C--O 1.195 -1.783 0 N-CA-C 108.248 -1.019 . . . . 74.540000000000006 108.248 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.52 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -68.69 149.17 49.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.903 0.859 . . . . 74.409999999999997 113.016 -172.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -125.54 135.35 52.16 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.149 -0.932 . . . . 74.219999999999999 108.628 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 8.4 p -132.38 138.7 51.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.665 0.745 . . . . 54.32 110.763 178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.541 ' CG ' HD13 ' B' ' 276' ' ' LEU . 52.5 tp60 -117.5 125.83 51.55 Favored 'General case' 0 N--CA 1.401 -2.887 0 CA-C-N 114.495 -1.229 . . . . 64.450000000000003 108.398 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.562 ' HB3' HG22 ' A' ' 277' ' ' ILE . 2.4 tm? -118.15 119.14 33.82 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 105.9 -1.889 . . . . 54.439999999999998 105.9 175.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.668 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 136.12 -147.01 19.0 Favored Glycine 0 C--N 1.278 -2.646 0 C-N-CA 119.721 -1.228 . . . . 41.149999999999999 110.875 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 86.2 m-20 -124.93 129.13 49.75 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 121.157 0.503 . . . . 64.129999999999995 110.017 -174.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 93.7 t -111.04 129.26 66.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 108.758 -0.83 . . . . 73.239999999999995 108.758 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 61.1 t -118.4 111.79 35.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.229 -1.026 . . . . 64.209999999999994 108.229 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.404 ' OG1' ' HA3' ' B' ' 285' ' ' GLY . 28.2 m -96.67 161.1 14.03 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.785 -0.821 . . . . 63.240000000000002 108.785 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.609 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.69 -33.95 76.77 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.273 0.629 . . . . 73.530000000000001 112.331 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.53 -37.16 67.58 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 115.222 1.564 . . . . 55.549999999999997 115.222 -173.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.441 ' HB2' ' N ' ' B' ' 282' ' ' GLY . . . -74.78 -37.79 62.32 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.148 0.796 . . . . 72.299999999999997 113.148 -175.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.8 mp 54.51 89.34 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 108.864 -0.791 . . . . 73.519999999999996 108.864 -167.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . 0.428 ' HB2' HG21 ' B' ' 254' ' ' ILE . 35.6 p-80 -60.97 118.5 6.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.132 -0.94 . . . . 73.430000000000007 113.465 -168.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -123.05 -70.61 0.24 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.172 -0.922 . . . . 73.150000000000006 111.167 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -82.46 72.38 2.82 Favored Glycine 0 C--O 1.218 -0.881 0 N-CA-C 111.256 -0.738 . . . . 53.130000000000003 111.256 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' B' ' 251' ' ' HIS . 12.2 tt -129.04 80.28 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 122.19 0.995 . . . . 71.439999999999998 111.83 -176.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -179.61 -50.19 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 124.986 1.314 . . . . 75.329999999999998 108.002 175.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 4.5 tp -122.61 87.96 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.142 0.972 . . . . 72.5 108.699 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . 0.547 ' HA ' ' O ' ' C' ' 252' ' ' GLY . 29.8 t -160.22 113.04 2.08 Favored 'General case' 0 N--CA 1.42 -1.955 0 N-CA-C 106.454 -1.684 . . . . 73.129999999999995 106.454 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 18.2 t70 69.48 166.82 0.28 Allowed 'General case' 0 N--CA 1.484 1.244 0 O-C-N 124.336 1.022 . . . . 73.349999999999994 112.039 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . 0.475 ' HG3' ' HA ' ' B' ' 223' ' ' VAL . 43.6 tt0 -161.24 29.21 0.14 Allowed 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 108.842 -0.799 . . . . 72.319999999999993 108.842 178.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 67.3 m -64.92 137.21 57.61 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.562 -0.744 . . . . 70.239999999999995 110.459 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 63.4 m -105.28 108.5 20.05 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.982 -0.747 . . . . 74.439999999999998 108.982 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' B' ' 226' ' ' ASN . 15.8 m120 -100.98 138.61 37.8 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.109 -0.7 . . . . 62.329999999999998 109.109 -178.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' C' ' 227' ' ' SER . 4.1 p -143.28 123.94 14.11 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 122.259 -0.276 . . . . 65.5 110.899 178.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 7.1 p -124.88 142.3 42.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 110.263 -0.273 . . . . 63.219999999999999 110.263 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 43.2 mm-40 -82.47 -78.81 0.2 Allowed 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 123.202 0.314 . . . . 65.140000000000001 110.282 175.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 10.2 t -120.86 130.43 53.93 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.992 -1.083 . . . . 65.310000000000002 112.54 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.533 HG21 HG21 ' B' ' 275' ' ' VAL . 1.5 p -125.05 124.8 68.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.711 -1.131 . . . . 64.230000000000004 110.182 177.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 14.8 p -127.01 140.57 48.71 Favored 'Isoleucine or valine' 0 C--O 1.267 2.013 0 CA-C-O 121.782 0.801 . . . . 75.099999999999994 111.395 -178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.78 133.08 9.53 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 110.609 -0.996 . . . . 74.010000000000005 110.609 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -127.59 116.51 20.45 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 123.154 0.582 . . . . 65.230000000000004 110.515 -177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 93.62 -131.03 10.57 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.126 -1.035 . . . . 71.140000000000001 110.87 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 67.5 mm-40 -91.85 52.1 1.95 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.324 0.583 . . . . 72.420000000000002 109.511 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 33.3 m -82.9 145.59 29.33 Favored 'General case' 0 C--N 1.289 -2.023 0 CA-C-O 121.499 0.666 . . . . 72.109999999999999 111.558 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.51 HH12 ' CD2' ' A' ' 292' ' ' HIS . 16.8 mtm180 -132.4 126.35 32.94 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 114.754 -1.112 . . . . 74.349999999999994 108.724 176.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.533 HG21 HG21 ' B' ' 267' ' ' VAL . 0.8 OUTLIER -135.92 127.07 43.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.245 -0.889 . . . . 75.209999999999994 111.076 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.541 HD13 ' CG ' ' B' ' 240' ' ' GLN . 11.9 tp -122.43 121.87 37.64 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.154 0.978 . . . . 74.129999999999995 110.523 175.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.788 HG22 ' HB3' ' C' ' 241' ' ' LEU . 4.6 pt -112.62 104.33 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-N 114.175 -1.375 . . . . 74.150000000000006 109.131 176.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.668 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 160.7 -148.83 17.44 Favored Glycine 0 N--CA 1.42 -2.418 0 C-N-CA 120.887 -0.673 . . . . 53.130000000000003 111.691 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 54.7 t30 -120.63 130.01 53.97 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 108.161 -1.052 . . . . 71.129999999999995 108.161 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.406 ' HG3' ' CH2' ' B' ' 287' ' ' TRP . 0.3 OUTLIER -117.96 130.52 56.26 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.038 -1.097 . . . . 74.540000000000006 108.038 -174.68 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -108.32 122.93 47.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.304 0.574 . . . . 74.109999999999999 109.991 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.441 ' N ' ' HB2' ' B' ' 249' ' ' ALA . . . 129.05 -53.23 0.81 Allowed Glycine 0 N--CA 1.421 -2.31 0 N-CA-C 109.378 -1.489 . . . . 64.230000000000004 109.378 -176.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 105.95 -7.77 41.75 Favored Glycine 0 N--CA 1.434 -1.459 0 C-N-CA 120.742 -0.742 . . . . 54.130000000000003 111.84 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . 0.555 ' HA ' ' NE1' ' B' ' 287' ' ' TRP . 11.0 ptmm? -155.95 36.73 0.35 Allowed 'General case' 0 C--O 1.251 1.183 0 N-CA-C 111.774 0.287 . . . . 75.340000000000003 111.774 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . 0.404 ' HA3' ' OG1' ' B' ' 246' ' ' THR . . . -74.43 -76.03 0.75 Allowed Glycine 0 C--N 1.315 -0.621 0 C-N-CA 120.252 -0.975 . . . . 70.319999999999993 112.809 178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.447 ' HD1' ' CZ2' ' A' ' 287' ' ' TRP . 75.3 t80 -56.36 -26.48 52.95 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.987 0.898 . . . . 75.030000000000001 111.419 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.555 ' NE1' ' HA ' ' B' ' 284' ' ' LYS . 26.8 p90 -115.18 71.85 0.78 Allowed 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.383 -0.826 . . . . 73.450000000000003 109.426 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.35 -35.46 67.67 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.862 -0.608 . . . . 74.010000000000005 110.936 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 t30 61.75 34.06 17.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.9 0.88 . . . . 55.43 110.103 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . 0.438 ' HA ' ' HB3' ' B' ' 293' ' ' HIS . 31.5 t-80 71.26 85.99 0.12 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.184 -1.371 . . . . 74.230000000000004 113.114 177.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -145.6 -51.42 0.25 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.617 -1.174 . . . . 55.299999999999997 108.123 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -103.24 -29.61 11.17 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.167 -1.049 . . . . 73.120000000000005 108.167 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . 0.438 ' HB3' ' HA ' ' B' ' 290' ' ' HIS . 8.9 t60 -43.41 132.51 4.55 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 125.728 1.611 . . . . 72.049999999999997 114.326 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -149.0 100.65 3.09 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 114.292 -1.322 . . . . 74.329999999999998 109.35 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 78.0 t60 . . . . . 0 C--O 1.264 1.854 0 C-N-CA 125.486 1.515 . . . . 62.439999999999998 113.95 175.025 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 45.8 ttm . . . . . 0 CA--C 1.502 -0.873 0 N-CA-C 109.142 -0.688 . . . . 60.310000000000002 109.142 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -157.45 114.37 2.99 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.84 -1.17 . . . . 74.129999999999995 107.84 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.49 96.87 4.79 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.123 -1.806 . . . . 75.319999999999993 106.123 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -86.73 -166.14 1.48 Allowed 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.15 -1.386 . . . . 61.450000000000003 110.963 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 70.14 79.66 0.18 Allowed 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 124.427 1.091 . . . . 74.349999999999994 109.23 -174.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 52.0 mt -116.1 138.26 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 CA-C-N 114.771 -1.104 . . . . 71.230000000000004 108.7 -175.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 7.4 p -100.74 119.87 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.73 0 CA-C-N 116.414 -0.357 . . . . 62.32 110.892 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 51.06 67.42 1.96 Allowed Glycine 0 CA--C 1.5 -0.854 0 CA-C-N 114.794 -1.094 . . . . 72.120000000000005 114.438 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' B' ' 261' ' ' THR . 1.5 ptp180 -95.88 138.03 34.11 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 118.203 -1.399 . . . . 74.019999999999996 112.814 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -116.46 115.02 25.03 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 106.695 -1.594 . . . . 72.129999999999995 106.695 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' B' ' 263' ' ' SER . 8.3 p -121.13 136.6 54.95 Favored 'General case' 0 N--CA 1.408 -2.53 0 CA-C-O 122.025 0.917 . . . . 74.530000000000001 112.402 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -121.2 135.83 55.08 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-N 114.358 -1.292 . . . . 74.019999999999996 107.639 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.578 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 1.1 tmtp? -93.62 -55.7 3.17 Favored 'General case' 0 C--N 1.274 -2.691 0 N-CA-C 109.486 -0.561 . . . . 74.140000000000001 109.486 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -131.45 138.52 49.07 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.773 0.321 . . . . 75.420000000000002 110.403 177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.438 HD12 ' HB ' ' B' ' 267' ' ' VAL . 28.3 mt -131.35 117.83 37.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 107.95 -1.13 . . . . 61.020000000000003 107.95 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 11.4 ttp180 -122.94 114.92 21.09 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.612 -0.514 . . . . 73.420000000000002 109.612 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.506 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 40.7 p -113.18 127.8 56.29 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.094 -1.076 . . . . 62.109999999999999 108.094 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -128.18 165.79 19.77 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 119.913 -0.715 . . . . 74.239999999999995 110.714 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.517 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 43.9 mt-10 68.52 -84.7 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.196 0 CA-C-N 114.791 -1.095 . . . . 63.049999999999997 112.836 175.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.507 ' O ' ' HD2' ' C' ' 238' ' ' ARG . 0.3 OUTLIER -141.25 21.5 2.24 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 108.155 -1.054 . . . . 73.129999999999995 108.155 178.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.506 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -68.42 148.32 50.81 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.623 0.725 . . . . 73.430000000000007 112.174 -173.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' C' ' 236' ' ' ARG . 3.4 mpt_? -124.27 135.18 53.21 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 107.318 -1.364 . . . . 75.109999999999999 107.318 -179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . . . . . . . . . 5.6 p -133.2 141.16 45.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 121.318 0.58 . . . . 71.129999999999995 111.183 177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -122.82 123.3 40.7 Favored 'General case' 0 N--CA 1.408 -2.539 0 CA-C-N 114.545 -1.207 . . . . 51.240000000000002 108.808 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.788 ' HB3' HG22 ' B' ' 277' ' ' ILE . 2.1 tm? -120.48 119.16 32.2 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.586 -1.264 . . . . 55.520000000000003 107.586 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.54 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 134.7 -125.43 3.77 Favored Glycine 0 N--CA 1.411 -3.005 0 N-CA-C 110.158 -1.177 . . . . 51.409999999999997 110.158 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 92.7 m-20 -130.22 150.59 51.41 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 120.909 0.385 . . . . 55.109999999999999 110.49 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 83.1 t -128.8 118.38 46.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.449 -1.315 . . . . 62.240000000000002 107.449 175.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 47.5 t -114.56 112.3 39.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.784 -0.821 . . . . 74.230000000000004 108.784 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 15.4 m -100.37 160.91 13.96 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 115.561 -0.745 . . . . 62.520000000000003 109.503 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.06 -32.21 72.71 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-O 121.773 0.796 . . . . 55.210000000000001 110.508 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.97 -42.13 72.02 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 114.062 -1.427 . . . . 52.32 112.367 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . 0.474 ' HB2' ' N ' ' C' ' 282' ' ' GLY . . . -75.34 -40.31 58.43 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 121.009 0.433 . . . . 70.329999999999998 110.014 176.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 67.4 tp 72.72 -61.49 0.5 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.646 1.578 . . . . 65.439999999999998 113.114 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -130.01 129.13 43.32 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.255 0.55 . . . . 63.310000000000002 111.354 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' B' ' 257' ' ' SER . . . -118.92 39.38 2.56 Favored Glycine 0 C--N 1.299 -1.481 0 N-CA-C 107.891 -2.084 . . . . 64.219999999999999 107.891 172.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -74.93 81.95 0.88 Allowed Glycine 0 CA--C 1.496 -1.152 0 CA-C-N 114.216 -0.992 . . . . 72.109999999999999 113.35 -174.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 11.1 tt -168.29 137.8 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.934 -1.136 . . . . 75.310000000000002 107.934 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -79.58 96.06 6.05 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 108.676 -0.861 . . . . 74.319999999999993 108.676 174.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 18.1 pt -59.87 117.85 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 N-CA-C 107.881 -1.155 . . . . 72.5 107.881 174.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 13.0 m -106.31 -31.26 8.69 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 116.185 -0.461 . . . . 73.239999999999995 111.735 -173.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -126.85 99.35 5.71 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.236 -1.024 . . . . 63.219999999999999 108.236 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -118.81 174.55 6.22 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.058 -0.519 . . . . 63.229999999999997 110.663 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 18.6 m -84.85 134.86 34.27 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.633 -0.877 . . . . 75.140000000000001 108.633 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 9.9 t -91.36 131.05 37.1 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 107.182 -1.414 . . . . 75.340000000000003 107.182 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -119.57 135.83 54.62 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.778 -0.453 . . . . 71.439999999999998 109.778 -176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 20.8 m -142.47 125.38 16.13 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.194 -0.669 . . . . 64.5 109.194 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.1 p -128.16 143.59 40.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 110.195 -0.298 . . . . 53.149999999999999 110.195 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.578 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 64.2 mm-40 -76.44 -69.74 0.49 Allowed 'General case' 0 N--CA 1.438 -1.048 0 CA-C-N 116.531 -0.304 . . . . 65.010000000000005 110.762 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 8.8 t -136.95 133.91 36.16 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 119.004 -1.078 . . . . 64.150000000000006 112.061 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.98 133.49 65.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 108.503 -0.925 . . . . 62.140000000000001 108.503 173.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 11.6 p -127.32 138.99 53.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-N 116.387 -0.369 . . . . 65.310000000000002 110.256 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -118.92 132.98 9.95 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 110.685 -0.966 . . . . 64.219999999999999 110.685 176.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -132.85 129.74 38.85 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 123.66 0.784 . . . . 74.409999999999997 109.951 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.85 -122.32 9.09 Favored Glycine 0 C--N 1.304 -1.198 0 C-N-CA 121.051 -0.595 . . . . 33.100000000000001 112.043 -176.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -96.79 51.89 1.16 Allowed 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 123.511 0.724 . . . . 53.119999999999997 110.463 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 56.3 m -83.67 144.36 29.45 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.778 0.799 . . . . 72.329999999999998 112.179 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . 0.463 ' HB3' ' CE2' ' C' ' 286' ' ' PHE . 7.6 mpt_? -127.64 127.72 44.27 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.369 -2.085 . . . . 73.030000000000001 105.369 172.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 3.4 p -138.53 124.03 23.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.099 0.476 . . . . 75.420000000000002 111.309 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 20.1 tp -113.41 120.12 39.96 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.728 0.775 . . . . 74.120000000000005 110.479 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.444 HG13 ' HA ' ' C' ' 241' ' ' LEU . 3.9 pt -112.51 103.98 16.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 N-CA-C 107.769 -1.197 . . . . 74.439999999999998 107.769 174.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 152.1 -161.14 29.23 Favored Glycine 0 N--CA 1.424 -2.133 0 C-N-CA 120.073 -1.06 . . . . 73.319999999999993 111.812 -176.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -109.0 136.07 49.14 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.319 -0.623 . . . . 73.319999999999993 109.319 -176.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.95 144.64 45.32 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.204 -1.406 . . . . 74.439999999999998 107.204 -175.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -124.06 122.9 39.12 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.33 -0.618 . . . . 73.230000000000004 109.33 176.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . 0.474 ' N ' ' HB2' ' C' ' 249' ' ' ALA . . . 127.14 -48.33 0.97 Allowed Glycine 0 N--CA 1.42 -2.373 0 N-CA-C 108.738 -1.745 . . . . 54.340000000000003 108.738 -174.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' C' ' 293' ' ' HIS . . . 103.04 -8.01 53.26 Favored Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.907 -0.877 . . . . 54.329999999999998 110.907 177.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . 0.576 ' HA ' ' NE1' ' C' ' 287' ' ' TRP . 17.3 ptmt -154.46 36.2 0.42 Allowed 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.25 0.62 . . . . 71.340000000000003 110.761 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -70.23 -78.0 0.42 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 120.359 -0.924 . . . . 73.239999999999995 112.423 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.539 ' HD1' ' CZ2' ' B' ' 287' ' ' TRP . 67.5 t80 -53.79 -19.64 4.59 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.583 1.153 . . . . 74.129999999999995 112.658 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.576 ' NE1' ' HA ' ' C' ' 284' ' ' LYS . 23.8 p90 -125.92 97.2 5.02 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.527 0.68 . . . . 72.319999999999993 111.679 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -97.93 19.7 13.43 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 123.518 1.628 . . . . 62.229999999999997 107.921 174.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -153.6 -176.75 5.96 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 102.788 -3.042 . . . . 54.039999999999999 102.788 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 68.49 -173.99 0.19 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.305 0.957 . . . . 74.420000000000002 110.26 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 -128.26 138.06 52.27 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.655 -0.498 . . . . 70.239999999999995 109.655 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -179.5 -36.18 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 O-C-N 124.145 0.903 . . . . 71.319999999999993 108.616 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . 0.442 ' HB3' ' O ' ' C' ' 283' ' ' GLY . 9.3 p80 -69.29 101.79 1.58 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.551 0.691 . . . . 74.340000000000003 111.317 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -146.76 111.28 5.21 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 105.522 -2.029 . . . . 75.319999999999993 105.522 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 8.9 p80 . . . . . 0 C--N 1.295 -1.794 0 CA-C-O 117.977 -1.011 . . . . 75.219999999999999 112.825 -172.945 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.894 0 N-CA-C 109.152 -0.684 . . . . 72.230000000000004 109.152 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.441 ' HB2' ' H ' ' A' ' 219' ' ' ILE . 2.3 mptp? -156.12 -84.79 0.05 Allowed 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 105.002 -2.222 . . . . 63.420000000000002 105.002 171.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.441 ' H ' ' HB2' ' A' ' 218' ' ' LYS . 46.8 mm -141.19 97.04 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 101.783 -3.414 . . . . 73.310000000000002 101.783 173.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -113.58 -22.21 10.41 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.719 -0.673 . . . . 75.099999999999994 111.672 -168.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . 57.15 61.73 2.46 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.018 0.927 . . . . 51.130000000000003 111.475 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 49.7 mm -116.92 138.71 46.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.301 -0.863 . . . . 74.420000000000002 110.213 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.5 m -115.79 148.85 18.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.805 -0.442 . . . . 54.039999999999999 109.805 177.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -99.12 109.88 3.87 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 109.837 -1.305 . . . . 51.530000000000001 109.837 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -103.83 135.02 46.15 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.175 0.512 . . . . 54.009999999999998 110.868 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.43 HD22 ' HA2' ' A' ' 278' ' ' GLY . 53.6 t30 -92.71 126.18 37.67 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.929 -1.508 . . . . 64.129999999999995 106.929 174.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 14.1 m -121.84 136.81 54.94 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.216 0.531 . . . . 73.219999999999999 110.23 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.81 124.06 16.63 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.897 -1.149 . . . . 62.509999999999998 107.897 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 265' ' ' GLU . 4.8 mmmm -76.76 -64.29 1.16 Allowed 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 114.431 1.271 . . . . 73.409999999999997 114.431 -176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -127.74 140.08 52.28 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.058 -1.057 . . . . 73.519999999999996 110.999 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 30.1 mm -121.15 118.21 55.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 N-CA-C 108.902 -0.777 . . . . 75.329999999999998 108.902 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 80.2 mtt180 -124.76 116.74 22.79 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 120.921 0.391 . . . . 64.420000000000002 111.046 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 27.3 p -120.44 126.76 51.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.135 -0.691 . . . . 72.099999999999994 109.135 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 270' ' ' LYS . 47.4 mt-10 -139.94 139.47 36.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 109.596 -0.52 . . . . 53.420000000000002 109.596 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 51.71 97.05 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.824 1.25 . . . . 74.319999999999993 114.229 174.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? 64.59 20.94 12.31 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.373 1.069 . . . . 75.519999999999996 110.985 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.1 129.4 45.36 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.368 0.604 . . . . 71.420000000000002 110.292 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.85 140.15 52.2 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.455 -0.793 . . . . 71.019999999999996 109.343 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 5.9 p -129.35 146.72 33.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 121.001 0.429 . . . . 55.340000000000003 111.165 -174.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -119.15 124.1 45.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.089 -1.449 . . . . 75.519999999999996 107.089 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -118.58 122.76 43.39 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.686 -0.487 . . . . 74.310000000000002 109.686 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.481 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 120.45 -156.85 15.92 Favored Glycine 0 N--CA 1.434 -1.454 0 C-N-CA 120.906 -0.664 . . . . 74.409999999999997 112.453 175.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -102.23 132.87 47.9 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.104 -0.702 . . . . 72.430000000000007 109.104 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.638 HG11 ' HA3' ' A' ' 285' ' ' GLY . 15.7 t -116.33 122.11 69.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.76 -0.83 . . . . 73.519999999999996 108.76 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 48.5 t -113.11 112.69 41.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.19 -1.041 . . . . 74.239999999999995 108.19 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.43 HG21 ' HB3' ' A' ' 284' ' ' LYS . 54.3 m -89.44 160.73 16.64 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 116.243 -0.435 . . . . 60.130000000000003 109.972 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.14 -37.2 86.26 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.33 0.652 . . . . 64.430000000000007 110.9 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.36 -35.04 64.81 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.238 1.015 . . . . 54.130000000000003 113.589 -178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -73.99 -36.75 64.56 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.79 0.663 . . . . 55.210000000000001 112.79 -175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 64.71 -172.2 0.18 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.227 0.611 . . . . 61.420000000000002 109.773 -171.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -82.9 82.8 8.02 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 122.227 1.013 . . . . 50.119999999999997 111.867 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -105.95 25.32 24.24 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 114.76 -1.109 . . . . 60.539999999999999 111.807 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -70.01 -14.85 71.28 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 111.87 -0.492 . . . . 35.229999999999997 111.87 -177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 28.6 pt -61.22 -29.59 46.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 123.289 0.636 . . . . 74.310000000000002 111.241 176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.15 79.74 5.71 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 108.545 -0.909 . . . . 70.109999999999999 108.545 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 13.2 tt -102.22 111.93 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 CA-C-O 122.281 1.038 . . . . 73.120000000000005 109.972 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 46.5 m -134.08 25.99 3.9 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 107.596 -1.261 . . . . 61.229999999999997 107.596 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -113.45 122.78 48.35 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 113.542 -1.663 . . . . 73.329999999999998 111.19 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -139.17 22.2 2.59 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.302 -1.74 . . . . 65.219999999999999 106.302 174.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 4.1 m -76.52 121.59 23.36 Favored 'General case' 0 N--CA 1.422 -1.856 0 CA-C-N 114.306 -1.315 . . . . 64.549999999999997 110.438 -173.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.5 m -99.61 108.15 20.46 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.455 -1.313 . . . . 75.140000000000001 107.455 175.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -96.07 142.77 27.88 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.323 -0.991 . . . . 61.219999999999999 108.323 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.5 m -139.72 123.63 17.61 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.724 -0.391 . . . . 71.230000000000004 111.21 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 12.3 p -128.85 144.9 36.68 Favored 'Isoleucine or valine' 0 C--O 1.253 1.243 0 N-CA-C 109.685 -0.487 . . . . 72.439999999999998 109.685 173.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.525 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 4.2 tp10 -84.34 -75.85 0.33 Allowed 'General case' 0 C--O 1.212 -0.9 0 N-CA-C 109.572 -0.529 . . . . 73.120000000000005 109.572 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 14.6 m -123.28 134.5 54.07 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.227 -0.921 . . . . 71.140000000000001 111.3 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 32.5 m -119.3 124.33 72.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 107.972 -1.121 . . . . 74.109999999999999 107.972 171.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 10.4 p -127.6 139.53 51.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 110.221 -0.288 . . . . 64.540000000000006 110.221 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.591 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -134.19 131.48 5.98 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 119.969 -1.11 . . . . 72.430000000000007 111.94 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 234' ' ' GLU . 27.5 ttmt -135.77 144.87 46.03 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 112.867 0.692 . . . . 73.340000000000003 112.867 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.72 -54.37 1.43 Allowed Glycine 0 CA--C 1.5 -0.906 0 N-CA-C 111.827 -0.509 . . . . 64.239999999999995 111.827 173.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.635 ' HB3' ' H ' ' B' ' 236' ' ' ARG . 23.1 tt0 -176.76 102.98 0.06 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 105.485 -2.043 . . . . 61.310000000000002 105.485 174.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 59.8 m -135.05 145.18 47.75 Favored 'General case' 0 C--N 1.281 -2.41 0 C-N-CA 119.923 -0.711 . . . . 74.310000000000002 110.795 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -126.7 126.22 43.14 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 104.713 -2.329 . . . . 75.310000000000002 104.713 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 1.6 p -135.75 123.99 37.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 CA-C-O 121.06 0.457 . . . . 72.129999999999995 110.763 -176.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 6.7 tt -111.52 121.21 44.56 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.963 -1.125 . . . . 73.420000000000002 107.963 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.508 HG23 HD12 ' B' ' 241' ' ' LEU . 43.5 mm -112.1 104.31 16.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 107.967 -1.123 . . . . 72.420000000000002 107.967 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.512 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 149.99 -128.87 2.81 Favored Glycine 0 N--CA 1.427 -1.936 0 C-N-CA 119.241 -1.457 . . . . 30.039999999999999 113.627 177.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -128.71 128.88 44.93 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.205 -1.035 . . . . 62.109999999999999 108.205 -175.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -112.93 118.7 35.59 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.741 -0.837 . . . . 75.239999999999995 108.741 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 90.2 m-85 -114.79 123.85 50.27 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.969 -0.752 . . . . 74.340000000000003 108.969 178.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.447 ' CA ' ' HB2' ' A' ' 249' ' ' ALA . . . 105.94 -47.12 1.09 Allowed Glycine 0 C--N 1.297 -1.611 0 N-CA-C 110.905 -0.878 . . . . 61.119999999999997 110.905 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.536 ' HA2' ' H ' ' B' ' 286' ' ' PHE . . . 89.98 47.28 3.94 Favored Glycine 0 N--CA 1.427 -1.919 0 C-N-CA 120.931 -0.652 . . . . 72.310000000000002 113.155 175.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.43 ' HB3' HG21 ' A' ' 246' ' ' THR . 0.9 OUTLIER -174.78 30.87 0.01 OUTLIER 'General case' 0 C--O 1.247 0.933 0 CA-C-O 122.151 0.977 . . . . 51.350000000000001 109.372 -177.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.638 ' HA3' HG11 ' A' ' 244' ' ' VAL . . . -86.73 128.08 8.73 Favored Glycine 0 N--CA 1.411 -3.007 0 C-N-CA 120.351 -0.928 . . . . 73.230000000000004 112.161 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 27.0 t80 73.86 -51.69 0.69 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.917 1.287 . . . . 62.350000000000001 112.396 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -145.54 -175.65 4.81 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 112.988 0.736 . . . . 73.200000000000003 112.988 -172.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.536 ' OD1' ' HA ' ' B' ' 287' ' ' TRP . 41.1 t0 171.97 155.18 0.08 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.369 2.267 . . . . 70.329999999999998 107.726 171.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -168.97 66.39 0.06 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.0 -1.482 . . . . 73.549999999999997 107.0 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -96.88 92.77 6.28 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-O 122.415 1.102 . . . . 65.129999999999995 111.523 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -122.86 133.19 54.43 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 104.969 -2.234 . . . . 74.510000000000005 104.969 174.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -71.76 -32.77 68.05 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.085 -1.046 . . . . 64.109999999999999 110.144 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 21.0 m170 -111.62 116.89 31.56 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 106.783 -1.562 . . . . 73.209999999999994 106.783 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -102.9 -57.0 2.12 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.203 0.525 . . . . 63.549999999999997 109.979 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 8.4 p80 . . . . . 0 N--CA 1.428 -1.563 0 N-CA-C 108.259 -1.015 . . . . 74.109999999999999 108.259 178.782 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 108.973 -0.751 . . . . 71.239999999999995 108.973 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt 73.43 -74.6 0.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.848 1.259 . . . . 75.420000000000002 108.69 -173.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 43.8 pt -116.56 144.0 25.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 104.289 -2.486 . . . . 75.140000000000001 104.289 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -101.27 80.82 2.14 Favored 'General case' 0 C--N 1.263 -3.186 0 C-N-CA 117.746 -1.581 . . . . 62.140000000000001 108.286 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -81.23 15.16 2.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.694 -1.594 . . . . 61.32 111.614 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 51.0 mm -83.85 115.12 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 105.648 -1.982 . . . . 63.420000000000002 105.648 175.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.417 ' HA ' ' OE1' ' B' ' 259' ' ' GLN . 26.9 m -123.35 152.72 28.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 116.212 -0.449 . . . . 60.200000000000003 110.497 -177.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -86.26 121.38 5.71 Favored Glycine 0 N--CA 1.423 -2.219 0 N-CA-C 110.754 -0.938 . . . . 73.530000000000001 110.754 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -102.69 147.73 26.46 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.306 0.574 . . . . 75.430000000000007 109.798 176.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -112.67 130.52 56.02 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 105.191 -2.152 . . . . 74.519999999999996 105.191 171.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 14.5 m -132.53 135.81 46.22 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 118.356 -1.338 . . . . 62.420000000000002 110.977 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.92 134.5 42.71 Favored 'General case' 0 N--CA 1.415 -2.18 0 N-CA-C 107.178 -1.416 . . . . 71.409999999999997 107.178 175.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' B' ' 265' ' ' GLU . 24.6 mmtp -80.17 -71.23 0.47 Allowed 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 120.659 -0.416 . . . . 75.209999999999994 112.058 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -127.11 138.59 53.21 Favored 'General case' 0 N--CA 1.414 -2.274 0 C-N-CA 118.555 -1.258 . . . . 72.310000000000002 109.597 -173.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 31.1 mm -123.41 116.98 50.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.791 -1.189 . . . . 72.450000000000003 107.791 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -117.4 115.23 24.8 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 120.299 -0.561 . . . . 75.310000000000002 109.52 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.591 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 40.8 p -110.8 126.43 54.62 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.206 -1.405 . . . . 73.099999999999994 107.206 176.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 51.0 mt-10 -143.43 138.83 29.6 Favored 'General case' 0 CA--C 1.479 -1.751 0 N-CA-C 109.811 -0.44 . . . . 73.349999999999994 109.811 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.481 ' HB2' ' H ' ' B' ' 271' ' ' GLY . 41.1 mt-10 56.49 98.22 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.868 0 O-C-N 125.292 1.62 . . . . 73.530000000000001 113.041 174.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.635 ' H ' ' HB3' ' A' ' 272' ' ' GLU . 1.1 mpt_? 60.89 35.66 19.19 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.857 0.863 . . . . 75.319999999999993 109.718 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.57 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -103.76 138.88 39.75 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.586 0.707 . . . . 72.209999999999994 111.106 -175.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 1.4 mpt_? -133.84 136.35 44.36 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.978 -1.119 . . . . 71.230000000000004 107.978 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 5.7 p -137.37 137.66 45.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-O 121.578 0.704 . . . . 64.530000000000001 112.059 -178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.423 ' HB3' ' HG ' ' B' ' 276' ' ' LEU . 47.4 tp60 -110.64 117.65 34.06 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.113 -1.44 . . . . 71.150000000000006 107.113 175.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.508 HD12 HG23 ' A' ' 277' ' ' ILE . 3.0 tm? -119.33 127.4 53.15 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.085 -0.709 . . . . 72.319999999999993 109.085 -178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 122.7 -121.3 4.59 Favored Glycine 0 CA--C 1.473 -2.542 0 N-CA-C 109.636 -1.385 . . . . 62.420000000000002 109.636 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 33.8 p30 -144.1 154.77 43.55 Favored 'General case' 0 C--N 1.285 -2.239 0 C-N-CA 119.739 -0.784 . . . . 52.039999999999999 111.41 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.701 HG11 ' HA3' ' B' ' 285' ' ' GLY . 65.6 t -123.49 130.37 74.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 CA-C-N 115.176 -0.92 . . . . 71.329999999999998 109.69 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 57.8 t -122.66 111.58 30.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.643 -1.243 . . . . 74.400000000000006 107.643 171.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.47 ' HB ' ' HA3' ' B' ' 282' ' ' GLY . 16.8 m -88.02 160.72 17.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.548 -0.908 . . . . 72.510000000000005 108.548 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.4 -43.85 96.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 122.056 0.932 . . . . 74.510000000000005 110.532 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.51 -35.63 65.83 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 113.65 -1.614 . . . . 74.439999999999998 112.282 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.451 ' HB2' ' CA ' ' B' ' 282' ' ' GLY . . . -63.52 -25.54 68.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.07 0.767 . . . . 71.439999999999998 113.07 -174.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 tt -57.41 110.36 0.85 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.269 0.557 . . . . 75.340000000000003 110.215 -177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -150.07 167.78 25.78 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.785 -0.821 . . . . 73.530000000000001 108.785 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -71.21 91.71 0.46 Allowed Glycine 0 N--CA 1.442 -0.957 0 O-C-N 124.178 0.924 . . . . 63.409999999999997 112.256 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -174.22 64.64 0.11 Allowed Glycine 0 N--CA 1.428 -1.873 0 C-N-CA 120.797 -0.716 . . . . 64.430000000000007 111.936 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 49.9 mm -74.11 114.75 14.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 108.826 -0.805 . . . . 65.120000000000005 108.826 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 72.69 103.83 0.07 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.536 1.147 . . . . 73.340000000000003 110.558 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 38.7 pt -113.96 158.47 14.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 107.878 -1.156 . . . . 73.019999999999996 107.878 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 70.5 m -93.01 76.88 4.71 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 114.347 1.24 . . . . 71.010000000000005 114.347 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -143.11 103.99 4.23 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 106.569 -1.641 . . . . 75.530000000000001 106.569 168.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . 0.417 ' OE1' ' HA ' ' B' ' 223' ' ' VAL . 29.2 mt-30 -130.01 44.1 3.02 Favored 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.262 -1.384 . . . . 74.099999999999994 107.262 175.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 68.8 m -63.88 121.32 13.77 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 113.232 -1.804 . . . . 72.040000000000006 108.324 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 62.8 m -90.29 112.96 24.7 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.665 -0.865 . . . . 63.109999999999999 108.665 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -96.47 128.62 43.56 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-N 114.891 -1.05 . . . . 60.130000000000003 109.899 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 14.5 m -121.49 121.13 36.83 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 108.194 -1.039 . . . . 74.5 108.194 175.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.8 p -129.61 145.82 35.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 108.302 -0.999 . . . . 64.200000000000003 108.302 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 20.5 tt0 -93.0 -75.44 0.49 Allowed 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 119.03 -1.068 . . . . 74.409999999999997 112.033 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 32.8 m -124.95 134.54 52.59 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 118.806 -1.158 . . . . 73.019999999999996 111.478 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.47 HG12 ' HB ' ' C' ' 231' ' ' ILE . 10.0 m -118.4 134.33 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 108.018 -1.104 . . . . 71.129999999999995 108.018 173.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 85.1 t -123.97 128.49 74.17 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 115.636 -0.711 . . . . 72.400000000000006 110.036 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.22 131.69 9.89 Favored Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 110.293 -1.123 . . . . 71.439999999999998 110.293 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.495 ' HB3' ' HG2' ' C' ' 234' ' ' GLU . 2.2 tpmt? -135.53 137.85 42.47 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 122.943 0.497 . . . . 75.140000000000001 111.073 -178.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . 0.481 ' H ' ' HB2' ' B' ' 235' ' ' GLU . . . 86.29 -52.74 4.54 Favored Glycine 0 N--CA 1.474 1.194 0 N-CA-C 114.746 0.658 . . . . 43.43 114.746 169.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . 0.721 ' HB3' ' H ' ' C' ' 236' ' ' ARG . 1.6 tm-20 -177.4 105.28 0.05 Allowed 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 103.156 -2.905 . . . . 71.209999999999994 103.156 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . 0.603 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 44.4 m -145.24 144.95 31.09 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-O 121.07 0.462 . . . . 55.329999999999998 110.764 -174.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 60.4 mtt180 -135.68 127.28 28.89 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 106.373 -1.714 . . . . 73.040000000000006 106.373 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.2 p -132.68 129.61 58.64 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.824 0 O-C-N 123.695 0.622 . . . . 74.209999999999994 110.364 -175.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.423 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 6.6 tt -110.59 115.75 30.14 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.976 -1.12 . . . . 75.109999999999999 107.976 177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.468 HG23 HD12 ' C' ' 241' ' ' LEU . 37.2 mm -106.9 103.82 16.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.031 -1.1 . . . . 71.030000000000001 108.031 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 144.04 -140.39 9.39 Favored Glycine 0 N--CA 1.424 -2.167 0 C-N-CA 119.53 -1.319 . . . . 63.32 113.285 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . 0.405 ' HB3' ' CE2' ' B' ' 281' ' ' TYR . 1.7 m-20 -111.76 129.48 56.11 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.55 -0.537 . . . . 72.530000000000001 109.55 -175.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -114.5 118.28 33.33 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.345 -0.983 . . . . 74.349999999999994 108.345 175.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.405 ' CE2' ' HB3' ' B' ' 279' ' ' ASN . 97.8 m-85 -117.22 124.52 49.27 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 109.227 -0.657 . . . . 74.439999999999998 109.227 177.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.47 ' HA3' ' HB ' ' B' ' 246' ' ' THR . . . 103.99 -46.86 1.14 Allowed Glycine 0 N--CA 1.42 -2.379 0 N-CA-C 110.139 -1.185 . . . . 71.150000000000006 110.139 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . 0.555 ' O ' ' HE2' ' B' ' 284' ' ' LYS . . . 95.5 37.31 5.09 Favored Glycine 0 N--CA 1.411 -3.016 0 C-N-CA 120.899 -0.667 . . . . 74.349999999999994 112.748 176.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . 0.555 ' HE2' ' O ' ' B' ' 283' ' ' GLY . 9.9 tppt? -161.64 35.24 0.13 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 119.21 -0.996 . . . . 74.25 112.34 -175.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . 0.701 ' HA3' HG11 ' B' ' 244' ' ' VAL . . . -89.61 144.78 17.99 Favored Glycine 0 CA--C 1.488 -1.595 0 C-N-CA 119.28 -1.438 . . . . 72.25 113.572 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.536 ' H ' ' HA2' ' A' ' 283' ' ' GLY . 0.2 OUTLIER 68.78 -71.31 0.12 Allowed 'General case' 0 C--O 1.245 0.854 0 C-N-CA 124.872 1.269 . . . . 74.0 110.18 178.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.536 ' HA ' ' OD1' ' A' ' 288' ' ' ASP . 0.0 OUTLIER -99.96 142.19 31.77 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.047 -0.979 . . . . 70.310000000000002 112.973 -173.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . 0.274 30.0 t70 88.27 169.55 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 126.835 2.054 . . . . 61.329999999999998 110.662 177.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 74.78 27.32 1.26 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 104.621 -2.363 . . . . 51.140000000000001 104.621 -165.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -85.27 -26.9 26.36 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 112.574 -2.103 . . . . 63.299999999999997 107.078 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -80.93 66.23 6.37 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 107.067 -1.456 . . . . 74.200000000000003 107.067 172.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -147.1 91.25 1.97 Allowed 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 103.057 -2.942 . . . . 73.120000000000005 103.057 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -80.81 71.83 7.75 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 122.041 0.924 . . . . 74.200000000000003 113.129 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -121.13 78.31 1.39 Allowed 'General case' 0 N--CA 1.427 -1.62 0 N-CA-C 106.838 -1.541 . . . . 64.439999999999998 106.838 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 . . . . . 0 C--N 1.298 -1.659 0 N-CA-C 107.588 -1.264 . . . . 52.32 107.588 -178.878 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 CA--C 1.51 -0.587 0 N-CA-C 110.067 -0.345 . . . . 74.329999999999998 110.067 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -143.45 97.93 3.16 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 109.068 -0.715 . . . . 72.540000000000006 109.068 -175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.29 160.17 10.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.702 -0.481 . . . . 63.32 109.702 179.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.77 146.96 30.72 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.222 -1.029 . . . . 75.439999999999998 108.222 172.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -150.28 22.18 0.84 Allowed 'General case' 0 N--CA 1.427 -1.604 0 O-C-N 123.351 0.407 . . . . 73.319999999999993 110.881 -175.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 49.2 mm -83.4 113.02 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 118.346 -1.341 . . . . 72.540000000000006 109.407 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 29.1 m -140.08 165.26 21.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 114.817 -1.083 . . . . 74.129999999999995 109.09 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -91.99 130.89 10.52 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 109.325 -1.51 . . . . 64.540000000000006 109.325 173.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -120.71 140.97 50.88 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 120.424 -0.511 . . . . 73.129999999999995 109.802 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -114.93 124.55 51.97 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.933 -1.506 . . . . 72.209999999999994 106.933 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 23.6 m -121.93 136.68 54.94 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 121.185 0.517 . . . . 60.450000000000003 110.35 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -139.51 129.72 25.29 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 107.878 -1.156 . . . . 74.25 107.878 178.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.657 ' HB2' ' O ' ' C' ' 265' ' ' GLU . 17.5 mmtp -78.46 -71.46 0.43 Allowed 'General case' 0 C--N 1.291 -1.947 0 CA-C-O 121.266 0.555 . . . . 74.209999999999994 112.361 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' C' ' 266' ' ' THR . 10.1 t0 -127.69 138.92 52.96 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.203 -0.908 . . . . 70.430000000000007 108.833 -170.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.47 ' HB ' HG12 ' B' ' 267' ' ' VAL . 23.5 mm -129.34 117.83 44.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.564 -1.272 . . . . 71.420000000000002 107.564 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 78.5 mtt180 -122.08 115.56 22.69 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.201 0.524 . . . . 71.239999999999995 109.612 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 20.0 p -110.21 126.46 54.15 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 106.843 -1.54 . . . . 74.019999999999996 106.843 177.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' B' ' 270' ' ' LYS . 48.0 mt-10 -137.59 138.38 39.48 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 108.74 -0.837 . . . . 74.209999999999994 108.74 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 50.65 92.01 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 114.661 1.356 . . . . 72.450000000000003 114.661 172.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.721 ' H ' ' HB3' ' B' ' 272' ' ' GLU . 3.5 mpt_? 66.85 34.59 5.36 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 125.23 1.412 . . . . 71.129999999999995 109.952 177.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.603 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -104.44 128.85 52.42 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-N 115.23 -0.895 . . . . 51.439999999999998 110.661 -178.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.0 OUTLIER -124.98 135.3 52.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 108.504 -0.924 . . . . 73.019999999999996 108.504 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.6 p -139.65 142.68 32.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.862 0.839 . . . . 64.400000000000006 112.212 -176.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.407 ' HB3' ' HG ' ' C' ' 276' ' ' LEU . 48.2 tp60 -110.92 130.19 55.66 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.152 -1.425 . . . . 64.549999999999997 107.152 175.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.468 HD12 HG23 ' B' ' 277' ' ' ILE . 2.8 tm? -130.13 128.79 42.52 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.008 -0.738 . . . . 64.430000000000007 109.008 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 122.25 -121.9 4.87 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 109.919 -1.273 . . . . 72.450000000000003 109.919 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 45.8 p30 -139.39 153.28 47.6 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 120.508 -0.477 . . . . 73.329999999999998 111.087 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.793 HG11 ' HA3' ' C' ' 285' ' ' GLY . 63.8 t -127.58 124.23 63.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.663 -0.699 . . . . 53.119999999999997 109.61 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 59.2 t -122.15 110.76 28.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.429 -1.322 . . . . 63.240000000000002 107.429 172.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . 0.417 ' HB ' ' HA3' ' C' ' 282' ' ' GLY . 37.7 m -87.78 161.92 17.31 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 109.154 -0.684 . . . . 72.400000000000006 109.154 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.93 -39.18 74.0 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.509 0.723 . . . . 72.140000000000001 110.83 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.41 -34.5 64.44 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 113.642 -1.617 . . . . 75.239999999999995 113.381 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -59.73 -34.78 73.38 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.255 0.465 . . . . 74.140000000000001 112.255 -175.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 56.5 tp 47.92 78.46 0.08 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.392 1.077 . . . . 54.299999999999997 112.538 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 73.6 t60 70.92 -52.3 0.68 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.898 1.279 . . . . 74.120000000000005 112.838 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.01 -72.56 1.84 Allowed Glycine 0 C--N 1.308 -1.023 0 C-N-CA 121.309 -0.472 . . . . 52.450000000000003 111.973 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -174.94 146.52 8.49 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.961 -0.856 . . . . 50.229999999999997 110.961 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 9.1 tp -100.44 -23.75 4.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.748 0.785 . . . . 52.049999999999997 110.149 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -133.25 -37.26 0.97 Allowed 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.765 -0.584 . . . . 74.140000000000001 111.323 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 16.1 tt -86.87 90.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 CA-C-O 122.559 1.171 . . . . 53.229999999999997 110.723 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 25.5 t -135.4 141.94 45.56 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 105.584 -2.006 . . . . 64.019999999999996 105.584 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.17 -62.08 1.56 Allowed 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 112.271 0.471 . . . . 72.420000000000002 112.271 -176.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 48.16 60.3 3.69 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 124.316 1.01 . . . . 74.430000000000007 111.069 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 29.1 m -77.99 140.07 39.17 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.681 -1.145 . . . . 72.420000000000002 108.656 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 85.0 m -89.11 117.25 27.97 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.976 0.894 . . . . 70.219999999999999 109.516 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -119.9 144.12 47.59 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.058 -1.428 . . . . 71.129999999999995 109.135 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -142.08 131.16 23.24 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 110.182 -0.303 . . . . 74.040000000000006 110.182 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 12.2 p -128.98 145.43 35.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.451 -0.944 . . . . 75.209999999999994 108.451 176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' C' ' 229' ' ' LYS . 7.0 tp10 -79.76 -81.49 0.12 Allowed 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 109.135 -0.691 . . . . 53.409999999999997 109.135 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 90.0 m -131.72 137.01 48.06 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.397 -0.815 . . . . 73.120000000000005 110.825 -177.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.6 m -121.06 130.71 74.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.962 -0.755 . . . . 63.32 108.962 174.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.4 p -127.56 137.38 57.87 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 116.635 -0.257 . . . . 71.299999999999997 110.473 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.93 132.88 9.65 Favored Glycine 0 CA--C 1.483 -1.934 0 N-CA-C 110.352 -1.099 . . . . 70.219999999999999 110.352 177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 47.4 tptt -134.6 147.73 50.28 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 109.145 -0.687 . . . . 65.25 109.145 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.26 -60.86 4.7 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 112.293 -0.323 . . . . 71.019999999999996 112.293 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . 0.533 ' HA ' ' HB2' ' C' ' 236' ' ' ARG . 36.4 tt0 -173.18 130.79 0.48 Allowed 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.914 -2.254 . . . . 72.239999999999995 104.914 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 17.8 t -156.11 148.08 23.18 Favored 'General case' 0 N--CA 1.413 -2.324 0 C-N-CA 120.074 -0.65 . . . . 54.439999999999998 109.926 -176.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 46.2 mtm180 -138.12 125.43 21.76 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 106.212 -1.773 . . . . 74.140000000000001 106.212 172.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 5.1 p -139.57 135.44 39.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 123.548 0.53 . . . . 62.509999999999998 110.693 -176.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' C' ' 240' ' ' GLN . 7.0 tt -115.93 111.58 20.61 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.912 -0.773 . . . . 72.129999999999995 108.912 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 47.7 mm -102.28 104.21 16.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.871 -1.159 . . . . 73.209999999999994 107.871 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 147.84 -144.39 12.34 Favored Glycine 0 CA--C 1.471 -2.705 0 N-CA-C 109.009 -1.636 . . . . 55.140000000000001 109.009 -178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -127.96 150.61 49.82 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 120.869 0.366 . . . . 73.200000000000003 110.405 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.531 ' HG2' ' ND2' ' C' ' 289' ' ' ASN . 6.2 tp10 -126.64 118.14 24.19 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.618 -0.719 . . . . 74.420000000000002 109.801 -175.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -109.18 124.12 50.32 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.913 -0.773 . . . . 73.450000000000003 108.913 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . 0.417 ' HA3' ' HB ' ' C' ' 246' ' ' THR . . . 102.94 -53.17 0.76 Allowed Glycine 0 N--CA 1.434 -1.497 0 N-CA-C 110.502 -1.039 . . . . 62.32 110.502 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' C' ' 289' ' ' ASN . . . 95.14 54.64 1.46 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.416 -0.897 . . . . 21.550000000000001 113.207 176.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 35.6 tptt -164.2 21.65 0.07 Allowed 'General case' 0 C--O 1.238 0.47 0 C-N-CA 119.903 -0.719 . . . . 64.200000000000003 110.947 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . 0.793 ' HA3' HG11 ' C' ' 244' ' ' VAL . . . -74.92 138.75 24.14 Favored Glycine 0 N--CA 1.43 -1.711 0 N-CA-C 115.011 0.764 . . . . 65.340000000000003 115.011 -174.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.413 ' H ' ' HA2' ' B' ' 283' ' ' GLY . 0.1 OUTLIER 67.43 -79.37 0.04 OUTLIER 'General case' 0 C--O 1.252 1.196 0 C-N-CA 124.786 1.234 . . . . 73.310000000000002 110.934 174.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 17.7 p90 -93.51 -69.93 0.73 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 121.078 -0.249 . . . . 73.219999999999999 111.273 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' C' ' 289' ' ' ASN . 6.7 t70 -175.54 -168.86 0.33 Allowed 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 104.055 -2.572 . . . . 70.400000000000006 104.055 -174.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . 0.531 ' ND2' ' HG2' ' C' ' 280' ' ' GLU . 33.1 t-20 177.16 -58.73 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.786 0.721 . . . . 72.239999999999995 109.506 178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -143.47 155.24 44.31 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 116.552 -0.295 . . . . 73.349999999999994 110.853 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 33.4 t60 66.45 104.78 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.233 1.413 . . . . 73.310000000000002 112.385 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -70.64 122.15 19.25 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 113.138 0.792 . . . . 74.310000000000002 113.138 -177.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 49.7 m80 60.53 105.41 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 116.456 2.021 . . . . 74.409999999999997 116.456 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -168.76 132.99 1.5 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.116 -1.809 . . . . 64.439999999999998 106.116 175.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 . . . . . 0 C--O 1.246 0.889 0 C-N-CA 123.993 0.917 . . . . 73.019999999999996 109.58 177.276 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 59.7 mtm . . . . . 0 CA--C 1.494 -1.195 0 N-CA-C 110.17 -0.307 . . . . 62.43 110.17 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -162.22 161.88 28.02 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 105.832 -1.914 . . . . 72.540000000000006 105.832 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 23.3 pt -74.58 106.08 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.813 0 N-CA-C 107.297 -1.372 . . . . 72.109999999999999 107.297 168.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -72.31 169.91 15.26 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.207 -0.906 . . . . 52.32 109.77 -175.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -72.68 -33.71 66.7 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.715 -0.846 . . . . 64.150000000000006 108.715 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.24 117.58 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 CA-C-N 114.812 -1.086 . . . . 73.530000000000001 108.088 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.427 HG11 HG13 ' B' ' 222' ' ' ILE . 45.9 t -100.82 118.67 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 108.332 -0.988 . . . . 75.319999999999993 108.332 177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 146.99 63.1 0.01 OUTLIER Glycine 0 C--N 1.287 -2.146 0 N-CA-C 107.016 -2.434 . . . . 53.5 107.016 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 23.1 ptt-85 -134.43 146.7 50.07 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 107.919 -1.141 . . . . 73.349999999999994 107.919 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.561 ' OD1' ' HA2' ' B' ' 242' ' ' GLY . 41.4 m-80 -109.96 135.32 50.99 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 108.094 -1.076 . . . . 74.239999999999995 108.094 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.9 m -121.55 136.5 54.95 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.578 0.704 . . . . 62.409999999999997 110.874 -176.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.68 127.99 47.12 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 107.137 -1.431 . . . . 53.109999999999999 107.137 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -78.88 -60.42 2.39 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.913 -0.773 . . . . 74.129999999999995 108.913 -177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -137.5 139.3 40.46 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.538 0.685 . . . . 75.430000000000007 110.831 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 67.3 mt -128.78 122.47 57.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 108.257 -1.016 . . . . 33.200000000000003 108.257 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -130.69 115.01 16.1 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-O 121.721 0.772 . . . . 73.400000000000006 111.329 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.643 HG21 HG13 ' A' ' 239' ' ' VAL . 6.8 p -111.99 137.06 50.52 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 115.226 -0.897 . . . . 74.409999999999997 109.75 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.404 ' OE2' ' HE3' ' A' ' 270' ' ' LYS . 40.5 tt0 -133.97 147.17 51.0 Favored 'General case' 0 N--CA 1.406 -2.661 0 CA-C-N 116.066 -0.516 . . . . 64.109999999999999 110.989 -174.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.429 ' HG2' ' HE ' ' A' ' 236' ' ' ARG . 32.3 tt0 73.38 -79.0 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.589 1.156 . . . . 71.150000000000006 112.727 170.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.429 ' HE ' ' HG2' ' A' ' 235' ' ' GLU . 75.1 mtm180 -136.16 15.81 3.25 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.09 0.947 . . . . 74.510000000000005 109.077 -177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.08 133.37 34.23 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.65 -1.159 . . . . 64.530000000000001 109.791 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -132.11 144.02 50.42 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.621 0.724 . . . . 74.120000000000005 112.006 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.934 HG12 ' HB ' ' A' ' 275' ' ' VAL . 15.4 m -123.69 150.4 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 CA-C-N 114.832 -1.076 . . . . 70.230000000000004 111.804 -178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -116.85 120.83 39.7 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-N 114.259 -1.337 . . . . 74.129999999999995 108.148 175.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -111.26 118.2 35.26 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.049 -1.834 . . . . 74.209999999999994 106.049 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 130.02 -155.71 21.13 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 119.828 -1.177 . . . . 33.0 112.892 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -110.83 128.58 55.82 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.136 0.574 . . . . 71.109999999999999 110.658 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.421 ' CG1' ' HA3' ' A' ' 285' ' ' GLY . 48.6 t -116.34 115.05 47.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 108.369 -0.974 . . . . 74.409999999999997 108.369 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' A' ' 281' ' ' TYR . 7.3 p -114.42 124.82 71.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.277 0.56 . . . . 53.43 112.46 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 23.8 p -117.24 166.59 12.09 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 116.001 -0.545 . . . . 71.209999999999994 111.366 175.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.96 -32.74 74.13 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 123.536 0.734 . . . . 71.239999999999995 112.757 -176.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.37 66.29 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.634 0.975 . . . . 64.209999999999994 113.634 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.645 ' HB2' ' N ' ' A' ' 282' ' ' GLY . . . -75.52 -26.36 58.0 Favored 'General case' 0 CA--C 1.503 -0.854 0 N-CA-C 112.536 0.569 . . . . 73.319999999999993 112.536 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 6.9 mp 65.34 -170.48 0.19 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.795 -1.187 . . . . 64.310000000000002 107.795 -168.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 51.2 m-70 -112.19 11.35 20.27 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.237 -0.914 . . . . 74.409999999999997 110.292 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -73.11 -24.74 75.1 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.391 -0.822 . . . . 71.430000000000007 112.381 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -79.81 -12.3 83.67 Favored Glycine 0 C--O 1.25 1.119 0 N-CA-C 111.385 -0.686 . . . . 61.439999999999998 111.385 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 55.6 mt -82.97 76.15 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 122.667 1.223 . . . . 75.340000000000003 109.12 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -155.32 -34.94 0.09 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 112.618 -2.083 . . . . 72.310000000000002 107.377 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.483 HD12 ' CD2' ' B' ' 281' ' ' TYR . 6.5 pt -94.79 -54.64 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 115.082 -0.963 . . . . 73.140000000000001 109.316 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 14.9 m 55.97 -157.8 0.24 Allowed 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.773 0.829 . . . . 62.43 111.786 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.422 ' HA ' ' OD1' ' B' ' 243' ' ' ASN . 3.6 m-20 -68.97 122.2 18.18 Favored 'General case' 0 CA--C 1.497 -1.061 0 N-CA-C 109.493 -0.558 . . . . 62.409999999999997 109.493 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -135.46 -51.67 0.75 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.663 -0.698 . . . . 70.25 110.073 -177.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 40.9 m -67.9 126.06 28.24 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.398 -0.964 . . . . 64.040000000000006 108.398 175.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 10.6 t -92.91 133.94 35.6 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-O 121.292 0.568 . . . . 73.150000000000006 109.617 -178.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -126.33 142.2 51.62 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.12 -0.696 . . . . 73.530000000000001 109.12 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.637 ' HG ' ' N ' ' B' ' 217' ' ' MET . 22.7 t -127.69 130.71 49.34 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 108.721 -0.844 . . . . 74.230000000000004 108.721 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.02 139.73 51.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 109.967 -0.383 . . . . 73.349999999999994 109.967 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 15.3 mt-10 -79.1 -70.64 0.49 Allowed 'General case' 0 N--CA 1.428 -1.575 0 C-N-CA 119.823 -0.751 . . . . 71.439999999999998 111.525 176.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 13.6 m -119.44 126.86 52.33 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 119.889 -0.724 . . . . 40.340000000000003 111.949 -174.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.39 122.26 67.73 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 N-CA-C 109.118 -0.697 . . . . 51.539999999999999 109.118 171.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.56 146.67 29.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.643 0.735 . . . . 62.240000000000002 112.593 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -127.73 133.28 7.78 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 115.14 -0.936 . . . . 34.32 111.002 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.404 ' HE3' ' OE2' ' A' ' 234' ' ' GLU . 0.2 OUTLIER -130.27 116.0 17.75 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.074 -1.084 . . . . 54.43 108.074 -179.322 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 102.16 -136.84 13.02 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.147 -1.581 . . . . 75.25 109.147 -178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -99.24 53.22 0.96 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.942 0.877 . . . . 73.019999999999996 109.701 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 7.1 m -83.02 148.22 27.69 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.167 -0.924 . . . . 61.5 111.209 -174.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 45.8 mtm180 -130.02 128.19 41.48 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.287 -0.415 . . . . 75.310000000000002 109.946 175.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.934 ' HB ' HG12 ' A' ' 239' ' ' VAL . 17.9 t -130.46 140.42 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.621 0 N-CA-C 108.095 -1.076 . . . . 55.340000000000003 108.095 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 286' ' ' PHE . 5.5 tt -126.17 121.1 31.83 Favored 'General case' 0 C--N 1.275 -2.655 0 C-N-CA 118.913 -1.115 . . . . 74.019999999999996 108.426 176.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.406 ' HA ' ' HB3' ' B' ' 241' ' ' LEU . 3.5 mp -107.92 104.61 17.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 N-CA-C 106.316 -1.735 . . . . 62.329999999999998 106.316 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 147.13 -134.77 5.37 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.435 -1.066 . . . . 62.109999999999999 110.435 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.587 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 45.2 t-20 -130.15 134.58 47.42 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 117.103 0.451 . . . . 62.200000000000003 111.396 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 287' ' ' TRP . 10.3 tp10 -111.23 122.85 48.93 Favored 'General case' 0 C--O 1.269 2.084 0 N-CA-C 106.746 -1.576 . . . . 74.219999999999999 106.746 174.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.506 ' HB2' ' HA ' ' A' ' 245' ' ' VAL . 12.0 m-85 -109.24 122.81 48.14 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 105.751 -1.944 . . . . 73.140000000000001 105.751 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.645 ' N ' ' HB2' ' A' ' 249' ' ' ALA . . . 103.86 -51.85 0.79 Allowed Glycine 0 C--N 1.297 -1.617 0 C-N-CA 120.445 -0.883 . . . . 74.140000000000001 112.999 177.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.41 30.54 18.88 Favored Glycine 0 CA--C 1.498 -0.986 0 N-CA-C 109.9 -1.28 . . . . 60.520000000000003 109.9 -178.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 50.7 mmtt -129.81 -8.98 4.47 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.465 -0.867 . . . . 73.209999999999994 111.456 -177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.421 ' HA3' ' CG1' ' A' ' 244' ' ' VAL . . . -86.61 -80.27 1.19 Allowed Glycine 0 CA--C 1.487 -1.661 0 C-N-CA 119.386 -1.388 . . . . 72.25 112.415 -175.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.477 ' HB3' HD12 ' A' ' 276' ' ' LEU . 75.6 t80 -99.98 -22.74 15.14 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.504 -1.295 . . . . 75.450000000000003 107.504 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.576 ' HA ' ' CE3' ' A' ' 287' ' ' TRP . 0.2 OUTLIER -91.7 174.61 7.26 Favored 'General case' 0 N--CA 1.41 -2.469 0 N-CA-C 115.741 1.756 . . . . 74.230000000000004 115.741 178.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -164.17 163.83 22.85 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 111.599 -2.546 . . . . 71.040000000000006 105.394 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.76 42.91 3.22 Favored 'General case' 0 C--N 1.271 -2.809 0 N-CA-C 106.861 -1.533 . . . . 73.310000000000002 106.861 171.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -86.71 171.54 10.86 Favored 'General case' 0 C--O 1.251 1.149 0 CA-C-N 112.614 -2.084 . . . . 72.040000000000006 108.82 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 79.87 85.52 0.05 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.44 1.496 . . . . 65.439999999999998 111.862 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -149.53 145.11 26.68 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 124.677 1.191 . . . . 63.509999999999998 107.878 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -129.78 -30.62 2.03 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.241 -1.022 . . . . 55.509999999999998 108.241 172.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.432 ' H ' ' CD ' ' C' ' 272' ' ' GLU . 2.1 t-80 67.24 24.75 9.07 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.038 1.735 . . . . 70.349999999999994 110.536 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 . . . . . 0 N--CA 1.435 -1.192 0 N-CA-C 106.671 -1.603 . . . . 74.329999999999998 106.671 178.538 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . 0.637 ' N ' ' HG ' ' A' ' 263' ' ' SER . 1.5 mpt? . . . . . 0 CA--C 1.502 -0.894 0 N-CA-C 107.572 -1.27 . . . . 70.129999999999995 107.572 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.401 ' CD ' ' HB2' ' A' ' 263' ' ' SER . 1.7 mmmp? -113.21 107.5 15.99 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.661 -0.866 . . . . 73.140000000000001 108.661 177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 62.7 mt -95.46 83.01 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 N-CA-C 106.9 -1.518 . . . . 63.219999999999999 106.9 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -138.25 172.95 12.15 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.596 -1.184 . . . . 73.409999999999997 107.887 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -92.08 6.28 47.07 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.612 0.72 . . . . 72.219999999999999 110.386 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . 0.427 HG13 HG11 ' A' ' 223' ' ' VAL . 0.0 OUTLIER -99.29 121.02 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-N 115.739 -0.664 . . . . 71.540000000000006 109.272 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 43.6 t -101.89 126.17 55.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 106.711 -1.589 . . . . 61.340000000000003 106.711 174.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 140.96 60.38 0.03 OUTLIER Glycine 0 C--N 1.294 -1.799 0 N-CA-C 106.305 -2.718 . . . . 64.420000000000002 106.305 -174.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 261' ' ' THR . 30.3 ptt85 -140.11 139.95 35.93 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-N 114.007 -1.096 . . . . 70.230000000000004 110.859 -170.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.496 ' OD1' ' HA2' ' C' ' 242' ' ' GLY . 51.1 m-80 -108.18 148.52 29.78 Favored 'General case' 0 C--N 1.282 -2.338 0 N-CA-C 107.919 -1.141 . . . . 72.230000000000004 107.919 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 263' ' ' SER . 31.2 m -135.95 137.44 41.3 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.572 0.701 . . . . 70.430000000000007 111.163 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -124.51 129.85 51.37 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 114.631 -1.168 . . . . 74.120000000000005 108.449 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 5.3 tmtt? -78.55 -66.49 0.85 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.384 -0.826 . . . . 72.400000000000006 108.816 -177.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -134.82 139.05 44.78 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 116.524 -0.307 . . . . 51.399999999999999 110.347 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 10.8 mt -132.23 117.72 33.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 108.241 -1.022 . . . . 65.530000000000001 108.241 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.455 ' HB3' HG12 ' B' ' 268' ' ' VAL . 25.8 ttt180 -113.64 122.46 47.25 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.938 -0.574 . . . . 65.010000000000005 110.735 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 76.0 p -110.7 132.16 54.44 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.945 -1.131 . . . . 75.450000000000003 107.945 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -133.72 150.83 51.51 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 120.353 -0.539 . . . . 73.439999999999998 109.778 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.413 ' HB3' ' HD2' ' B' ' 236' ' ' ARG . 42.4 mt-10 70.13 -95.19 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 124.556 1.142 . . . . 73.209999999999994 113.455 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' B' ' 272' ' ' GLU . 0.0 OUTLIER -129.04 31.13 4.95 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.425 -1.324 . . . . 75.209999999999994 107.425 -179.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -76.24 137.25 39.84 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.29 -0.868 . . . . 74.329999999999998 110.701 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.549 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 1.7 mpp_? -125.34 134.35 52.24 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.031 -0.986 . . . . 65.400000000000006 108.514 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.549 HG12 ' HB ' ' B' ' 275' ' ' VAL . 19.6 m -135.58 140.83 43.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.8 0.809 . . . . 52.409999999999997 111.265 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.441 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 38.8 tp60 -105.15 135.79 45.84 Favored 'General case' 0 C--N 1.27 -2.876 0 CA-C-N 114.211 -1.359 . . . . 60.030000000000001 108.463 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.406 ' HB3' ' HA ' ' A' ' 277' ' ' ILE . 1.5 tm? -125.97 117.02 22.39 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 104.911 -2.255 . . . . 63.200000000000003 104.911 175.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.574 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 125.19 -146.12 16.0 Favored Glycine 0 N--CA 1.42 -2.407 0 C-N-CA 119.549 -1.31 . . . . 44.43 111.844 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 0.7 OUTLIER -113.81 146.17 40.34 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.442 -0.577 . . . . 74.430000000000007 109.442 -176.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.441 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 59.2 t -126.78 122.48 60.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.015 -1.476 . . . . 71.310000000000002 107.015 175.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.53 126.0 72.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 C-N-CA 118.369 -1.333 . . . . 75.319999999999993 113.49 -176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 24.4 p -120.28 163.13 18.27 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 115.947 -0.569 . . . . 75.340000000000003 112.034 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.64 -31.82 58.06 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.723 1.209 . . . . 31.140000000000001 112.201 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.7 -41.36 70.17 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.885 0.698 . . . . 75.430000000000007 112.885 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.48 ' HB2' ' N ' ' B' ' 282' ' ' GLY . . . -75.01 -44.37 48.44 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.484 -0.486 . . . . 34.229999999999997 109.988 177.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 63.8 tp 64.76 -72.49 0.06 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.131 1.372 . . . . 52.539999999999999 110.36 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -130.34 77.55 1.79 Allowed 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 107.147 -1.427 . . . . 73.310000000000002 107.147 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . 0.472 ' H ' HD13 ' A' ' 256' ' ' ILE . . . -85.31 73.59 2.58 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 114.57 -1.195 . . . . 73.510000000000005 111.198 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . 0.403 ' N ' HD21 ' C' ' 250' ' ' LEU . . . 137.62 -151.79 21.37 Favored Glycine 0 N--CA 1.42 -2.4 0 N-CA-C 109.93 -1.268 . . . . 11.539999999999999 109.93 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 64.4 mt -139.78 -66.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 105.85 -1.908 . . . . 41.409999999999997 105.85 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -147.84 -157.23 0.79 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 104.625 -2.361 . . . . 74.140000000000001 104.625 174.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 11.2 tt -71.28 89.26 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 122.469 1.128 . . . . 72.450000000000003 111.118 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 14.0 m -101.72 6.88 42.03 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.534 -1.212 . . . . 74.340000000000003 109.967 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -125.1 157.67 35.74 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.039 -0.528 . . . . 72.409999999999997 111.173 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.21 28.66 0.58 Allowed 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 124.307 1.043 . . . . 55.399999999999999 110.178 175.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 58.2 m -79.01 135.44 36.9 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 109.136 -0.69 . . . . 75.340000000000003 109.136 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 10.2 t -123.53 134.54 53.85 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 121.558 0.694 . . . . 75.099999999999994 110.182 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -125.16 138.15 54.15 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.582 -0.896 . . . . 71.530000000000001 108.582 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' C' ' 227' ' ' SER . 41.8 m -130.33 132.51 45.88 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.691 -0.485 . . . . 74.099999999999994 109.691 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' B' ' 229' ' ' LYS . 7.3 p -125.68 142.35 42.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 116.123 -0.489 . . . . 70.329999999999998 110.923 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.552 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 10.4 mm-40 -82.68 -69.02 0.66 Allowed 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 123.793 0.683 . . . . 75.109999999999999 109.703 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.5 m -126.06 127.21 45.48 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 119.572 -0.851 . . . . 73.510000000000005 112.252 -176.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.46 HG11 HG11 ' B' ' 275' ' ' VAL . 48.0 t -118.66 120.76 65.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.359 -1.348 . . . . 53.409999999999997 107.359 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' B' ' 232' ' ' ARG . 27.4 m -125.6 137.46 57.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.69 0.757 . . . . 70.409999999999997 112.152 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.71 133.65 11.01 Favored Glycine 0 N--CA 1.436 -1.317 0 N-CA-C 110.279 -1.128 . . . . 71.430000000000007 110.279 176.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -132.08 115.88 16.34 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.359 0.599 . . . . 75.040000000000006 109.566 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.75 -132.28 10.95 Favored Glycine 0 N--CA 1.433 -1.561 0 C-N-CA 119.996 -1.097 . . . . 15.44 111.178 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . 0.415 ' HG3' HH11 ' B' ' 236' ' ' ARG . 21.5 mt-10 -96.14 48.28 1.1 Allowed 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 123.746 0.818 . . . . 72.329999999999998 110.437 -177.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 15.5 m -81.46 150.27 28.39 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.156 -0.929 . . . . 72.329999999999998 112.93 -171.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.608 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 49.2 mtm180 -133.26 128.09 35.09 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.887 -0.597 . . . . 75.140000000000001 110.016 173.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.641 HG13 HG23 ' C' ' 239' ' ' VAL . 22.0 t -131.83 138.69 52.19 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.778 0 N-CA-C 108.366 -0.976 . . . . 61.310000000000002 108.366 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.414 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 5.9 tt -120.99 116.32 24.86 Favored 'General case' 0 C--N 1.277 -2.561 0 C-N-CA 118.849 -1.14 . . . . 63.439999999999998 108.148 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.479 ' HA ' ' HB3' ' C' ' 241' ' ' LEU . 4.0 mp -106.31 103.5 15.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 N-CA-C 106.313 -1.736 . . . . 72.099999999999994 106.313 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 149.67 -135.02 5.13 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.729 -0.748 . . . . 74.420000000000002 112.501 -176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 48.5 t-20 -128.72 130.0 46.53 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.201 -0.666 . . . . 63.340000000000003 109.201 -178.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -111.35 118.67 36.47 Favored 'General case' 0 C--O 1.268 2.034 0 N-CA-C 106.992 -1.484 . . . . 73.230000000000004 106.992 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.483 ' CD2' HD12 ' A' ' 256' ' ' ILE . 69.8 m-85 -105.04 122.31 45.6 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 106.919 -1.511 . . . . 72.409999999999997 106.919 177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.48 ' N ' ' HB2' ' B' ' 249' ' ' ALA . . . 101.09 -52.29 0.91 Allowed Glycine 0 C--N 1.297 -1.638 0 C-N-CA 120.37 -0.919 . . . . 74.439999999999998 112.524 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.58 32.75 12.58 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.962 -1.113 . . . . 62.340000000000003 111.39 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -136.68 2.09 2.63 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.569 0.581 . . . . 65.219999999999999 112.569 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . 0.435 ' HA3' ' CG1' ' B' ' 244' ' ' VAL . . . -86.15 -77.86 1.21 Allowed Glycine 0 CA--C 1.487 -1.707 0 C-N-CA 118.712 -1.708 . . . . 40.420000000000002 110.739 -177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -97.01 -21.29 17.5 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.545 -1.28 . . . . 73.530000000000001 107.545 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.547 ' HA ' ' CE3' ' B' ' 287' ' ' TRP . 0.0 OUTLIER -93.6 173.31 7.76 Favored 'General case' 0 N--CA 1.418 -2.05 0 CA-C-N 114.309 -1.314 . . . . 72.239999999999995 114.374 177.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -140.87 149.38 41.88 Favored 'General case' 0 N--CA 1.407 -2.605 0 N-CA-C 103.952 -2.61 . . . . 74.230000000000004 103.952 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -80.14 -15.52 56.9 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.453 -0.499 . . . . 62.299999999999997 112.044 -174.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . 0.594 ' CE1' ' HA ' ' C' ' 291' ' ' HIS . 10.3 t60 -173.73 -54.54 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.934 -1.135 . . . . 72.030000000000001 107.934 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -159.66 145.98 16.17 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 106.198 -1.779 . . . . 73.239999999999995 106.198 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -154.2 130.05 10.14 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.466 -1.309 . . . . 70.219999999999999 107.466 177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -82.96 94.39 7.73 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.935 0.874 . . . . 74.310000000000002 110.464 178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -101.25 72.56 1.45 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.256 -1.386 . . . . 74.239999999999995 107.256 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 . . . . . 0 C--N 1.3 -1.571 0 N-CA-C 108.273 -1.01 . . . . 63.5 108.273 -176.026 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . 0.547 ' HG2' ' H ' ' C' ' 218' ' ' LYS . 17.6 ttt . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 106.157 -1.794 . . . . 55.229999999999997 106.157 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . 0.547 ' H ' ' HG2' ' C' ' 217' ' ' MET . 0.0 OUTLIER 68.56 130.95 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 119.456 1.026 . . . . 74.200000000000003 111.569 -174.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 10.8 tt -90.27 132.46 34.84 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 CA-C-O 121.497 0.665 . . . . 75.209999999999994 112.594 -176.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -142.4 -174.86 4.25 Favored 'General case' 0 C--O 1.247 0.953 0 N-CA-C 104.518 -2.401 . . . . 70.129999999999995 104.518 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -79.91 96.82 6.49 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 105.428 -2.064 . . . . 45.409999999999997 105.428 168.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.96 114.96 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-O 122.003 0.906 . . . . 61.310000000000002 111.8 -171.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.4 t -100.99 119.34 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 107.305 -1.368 . . . . 71.040000000000006 107.305 175.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 145.54 56.23 0.02 OUTLIER Glycine 0 C--N 1.289 -2.06 0 N-CA-C 107.504 -2.238 . . . . 52.210000000000001 107.504 -177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -122.99 144.48 49.22 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-N 114.639 -0.781 . . . . 75.310000000000002 109.715 -174.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -102.22 142.18 33.88 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 106.64 -1.615 . . . . 75.420000000000002 106.64 176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' B' ' 263' ' ' SER . 55.5 m -136.98 137.91 39.99 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.382 0.611 . . . . 71.450000000000003 111.19 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.19 130.23 50.55 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.417 -0.81 . . . . 71.230000000000004 109.262 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -84.07 -61.58 1.78 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.578 -0.527 . . . . 74.049999999999997 109.578 -177.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -129.14 138.18 51.63 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 122.152 -0.342 . . . . 70.540000000000006 110.538 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 18.4 mt -136.04 117.32 19.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 107.614 -1.254 . . . . 74.540000000000006 107.614 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -119.4 126.0 50.33 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.481 0.658 . . . . 63.329999999999998 110.82 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 24.5 p -110.17 135.44 50.95 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.431 -0.951 . . . . 62.450000000000003 108.431 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -134.89 149.83 50.35 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.757 -0.831 . . . . 63.530000000000001 108.757 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.518 ' HB3' ' HD3' ' C' ' 236' ' ' ARG . 36.6 mt-10 64.58 -99.02 0.07 Allowed 'General case' 0 C--O 1.203 -1.372 0 C-N-CA 124.556 1.142 . . . . 62.240000000000002 113.698 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.518 ' HD3' ' HB3' ' C' ' 235' ' ' GLU . 0.2 OUTLIER -122.62 35.52 4.86 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 108.221 -1.029 . . . . 74.510000000000005 108.221 -177.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -81.3 134.38 35.58 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-N 114.563 -1.198 . . . . 72.519999999999996 110.659 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 2.0 mpp_? -125.33 133.88 52.43 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-N 114.616 -1.174 . . . . 63.119999999999997 107.942 176.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.641 HG23 HG13 ' B' ' 275' ' ' VAL . 29.4 m -134.67 141.26 43.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-O 121.649 0.738 . . . . 73.030000000000001 110.922 177.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.422 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 45.1 tp60 -104.79 136.05 45.03 Favored 'General case' 0 C--N 1.273 -2.736 0 CA-C-N 114.648 -1.16 . . . . 75.519999999999996 108.495 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.479 ' HB3' ' HA ' ' B' ' 277' ' ' ILE . 1.6 tm? -126.42 116.96 21.97 Favored 'General case' 0 N--CA 1.402 -2.848 0 N-CA-C 104.864 -2.273 . . . . 74.109999999999999 104.864 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.501 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 121.66 -131.42 8.52 Favored Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 119.618 -1.277 . . . . 75.540000000000006 113.31 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.626 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 13.1 m120 -122.23 139.7 53.46 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.884 -0.413 . . . . 63.009999999999998 109.884 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.422 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 48.4 t -126.34 117.46 48.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 N-CA-C 106.545 -1.65 . . . . 74.209999999999994 106.545 172.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.03 127.85 74.87 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.797 -1.161 . . . . 71.439999999999998 113.104 -175.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 20.2 p -114.0 162.63 16.18 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 116.093 -0.503 . . . . 63.130000000000003 111.185 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.33 -32.04 69.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.445 0.698 . . . . 63.509999999999998 110.836 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.32 -33.61 59.26 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.505 1.122 . . . . 72.430000000000007 112.533 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -63.57 -26.7 68.81 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 112.244 0.461 . . . . 64.439999999999998 112.244 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . 0.403 HD21 ' N ' ' B' ' 253' ' ' GLY . 3.0 mm? -75.42 79.94 2.47 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.285 1.041 . . . . 73.129999999999995 110.082 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 24.7 t60 -167.81 -39.8 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 105.984 -1.858 . . . . 75.099999999999994 105.984 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 174.52 156.64 14.28 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 110.775 -0.93 . . . . 64.019999999999996 110.775 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 116.38 -2.36 20.45 Favored Glycine 0 C--N 1.31 -0.911 0 C-N-CA 120.529 -0.843 . . . . 73.299999999999997 112.617 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 30.0 pt -114.81 130.34 69.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-O 120.801 0.334 . . . . 54.32 110.437 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . 0.45 ' HG3' HD12 ' C' ' 256' ' ' ILE . 14.5 tpp180 -148.76 -73.66 0.18 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.341 -0.985 . . . . 74.109999999999999 108.341 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . 0.45 HD12 ' HG3' ' C' ' 255' ' ' ARG . 2.5 mp -135.83 -66.35 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 N-CA-C 106.855 -1.535 . . . . 71.129999999999995 106.855 176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 14.4 t 166.9 -160.11 0.01 OUTLIER 'General case' 0 C--O 1.258 1.539 0 N-CA-C 102.267 -3.235 . . . . 74.530000000000001 102.267 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -134.2 141.31 47.0 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 108.234 -1.024 . . . . 72.409999999999997 108.234 176.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -74.8 18.18 0.18 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.466 0.913 . . . . 74.150000000000006 113.466 -174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 89.1 m -83.73 122.0 28.05 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 109.281 -0.637 . . . . 65.5 109.281 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 8.6 t -109.03 119.95 41.07 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-O 121.592 0.71 . . . . 53.439999999999998 109.34 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -114.68 125.63 53.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.749 -0.66 . . . . 71.219999999999999 109.513 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' C' ' 227' ' ' SER . 28.5 t -117.78 135.37 54.1 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 108.179 -1.045 . . . . 62.219999999999999 108.179 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.0 141.44 42.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 116.402 -0.363 . . . . 73.230000000000004 110.333 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -78.42 -66.45 0.85 Allowed 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 122.493 0.317 . . . . 73.340000000000003 111.047 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 25.8 m -129.03 132.37 47.48 Favored 'General case' 0 N--CA 1.422 -1.834 0 C-N-CA 120.523 -0.471 . . . . 72.239999999999995 111.441 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.75 123.95 72.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 107.074 -1.454 . . . . 65.030000000000001 107.074 174.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 20.1 m -124.99 143.59 38.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.3 0.571 . . . . 70.109999999999999 112.338 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -123.2 133.78 9.16 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 110.331 -1.108 . . . . 64.530000000000001 110.331 175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -133.84 125.09 27.66 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 123.643 0.777 . . . . 60.509999999999998 109.708 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.24 -136.99 21.32 Favored Glycine 0 CA--C 1.506 -0.512 0 N-CA-C 110.108 -1.197 . . . . 45.210000000000001 110.108 -177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . 0.432 ' CD ' ' H ' ' A' ' 294' ' ' HIS . 10.2 mp0 -81.26 98.12 7.97 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.528 -0.916 . . . . 74.099999999999994 108.528 173.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 50.5 m -120.35 149.94 41.53 Favored 'General case' 0 C--N 1.278 -2.5 0 C-N-CA 120.121 -0.632 . . . . 70.349999999999994 110.845 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 75.6 mtm180 -140.1 127.49 21.36 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.022 -1.103 . . . . 70.140000000000001 108.022 174.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.416 ' HB ' HG12 ' C' ' 239' ' ' VAL . 7.8 t -135.29 140.06 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.678 0 N-CA-C 107.561 -1.274 . . . . 64.129999999999995 107.561 176.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 7.0 tt -120.65 111.74 18.01 Favored 'General case' 0 N--CA 1.403 -2.789 0 C-N-CA 118.894 -1.122 . . . . 63.509999999999998 108.871 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.66 103.18 14.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 105.272 -2.122 . . . . 74.140000000000001 105.272 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 149.11 -140.32 8.09 Favored Glycine 0 CA--C 1.492 -1.401 0 C-N-CA 120.286 -0.959 . . . . 64.150000000000006 111.852 -175.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -128.45 133.89 48.63 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.417 -0.586 . . . . 72.310000000000002 109.417 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' C' ' 287' ' ' TRP . 10.2 tp10 -111.75 118.72 36.37 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.351 -1.351 . . . . 74.319999999999993 107.351 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -105.31 123.58 48.1 Favored 'General case' 0 C--O 1.253 1.282 0 N-CA-C 107.713 -1.218 . . . . 73.430000000000007 107.713 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.35 -42.03 2.04 Favored Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 110.958 -0.857 . . . . 73.099999999999994 110.958 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 73.06 43.4 40.36 Favored Glycine 0 CA--C 1.482 -1.996 0 N-CA-C 109.219 -1.552 . . . . 53.439999999999998 109.219 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -151.46 6.23 0.47 Allowed 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 115.236 -0.482 . . . . 72.010000000000005 110.027 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -92.01 -80.6 1.43 Allowed Glycine 0 CA--C 1.491 -1.442 0 C-N-CA 119.943 -1.122 . . . . 21.210000000000001 110.693 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -95.42 -27.7 15.29 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.136 -1.061 . . . . 74.510000000000005 108.136 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.529 ' HA ' ' CE3' ' C' ' 287' ' ' TRP . 0.0 OUTLIER -88.57 153.74 20.89 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 114.61 -1.177 . . . . 74.010000000000005 112.984 177.146 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -170.0 174.1 5.69 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 106.799 -1.556 . . . . 72.329999999999998 106.799 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -152.25 56.45 0.83 Allowed 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 104.839 -2.282 . . . . 73.319999999999993 104.839 170.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 9.6 t-160 -127.1 47.85 2.29 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 113.259 -1.792 . . . . 73.400000000000006 106.409 -176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . 0.594 ' HA ' ' CE1' ' B' ' 290' ' ' HIS . 69.8 m80 -62.19 118.66 7.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 113.56 -1.655 . . . . 60.140000000000001 110.886 -176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -97.51 88.04 4.27 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 122.028 0.918 . . . . 74.319999999999993 111.769 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -94.46 93.08 7.44 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.018 -0.537 . . . . 73.310000000000002 110.915 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -73.88 104.21 4.68 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.74 -0.664 . . . . 74.030000000000001 109.507 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 . . . . . 0 C--N 1.3 -1.56 0 CA-C-O 118.157 -0.925 . . . . 74.349999999999994 109.729 -178.702 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 111.88 0.326 . . . . 65.549999999999997 111.88 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.41 ' HD3' HG23 ' A' ' 219' ' ' ILE . 7.8 tmtm? -106.61 -70.96 0.77 Allowed 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 108.094 -1.076 . . . . 75.439999999999998 108.094 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.41 HG23 ' HD3' ' A' ' 218' ' ' LYS . 2.5 pp -127.28 11.36 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 CA-C-O 122.08 0.943 . . . . 73.329999999999998 110.449 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.76 170.43 9.45 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 114.383 -1.281 . . . . 75.540000000000006 109.818 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.24 92.62 0.08 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 114.498 1.296 . . . . 72.140000000000001 114.498 -172.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 7.0 tp -117.05 132.28 67.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 106.026 -1.842 . . . . 71.219999999999999 106.026 170.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 6.0 m -139.24 161.98 27.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 N-CA-C 111.886 0.328 . . . . 44.219999999999999 111.886 -174.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -77.33 -161.94 15.44 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.579 -0.737 . . . . 72.120000000000005 113.314 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 17.0 ptt85 -131.44 125.99 33.94 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.776 0.798 . . . . 74.099999999999994 112.588 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -98.41 147.55 24.6 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 105.714 -1.958 . . . . 65.150000000000006 105.714 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.5 m -121.8 136.37 54.93 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 121.531 0.681 . . . . 73.420000000000002 111.28 -176.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.4 129.17 37.0 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.481 -1.303 . . . . 63.149999999999999 107.481 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -89.08 -43.93 10.72 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.292 -0.633 . . . . 74.120000000000005 109.292 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -139.86 138.93 36.13 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 120.693 0.283 . . . . 74.409999999999997 110.267 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 56.2 mt -137.09 123.48 28.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 106.497 -1.668 . . . . 70.430000000000007 106.497 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 60.4 ttt-85 -128.88 115.27 17.61 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.201 -1.037 . . . . 70.219999999999999 108.201 -177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 30.9 p -120.5 128.41 53.11 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.982 -0.448 . . . . 44.299999999999997 110.789 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -127.78 140.34 52.11 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 110.083 -0.34 . . . . 72.439999999999998 110.083 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.422 ' C ' ' HD2' ' A' ' 236' ' ' ARG . 40.1 mt-10 59.87 105.01 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 115.529 1.677 . . . . 53.439999999999998 115.529 169.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.43 ' O ' ' HA ' ' A' ' 272' ' ' GLU . 1.2 mpt_? 53.0 24.15 3.28 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 125.071 1.348 . . . . 72.319999999999993 111.526 176.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.97 151.67 23.07 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 120.981 0.42 . . . . 64.099999999999994 110.553 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.32 135.55 38.99 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.649 -0.705 . . . . 73.450000000000003 109.241 178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 3.2 p -133.11 140.17 47.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.863 -0.608 . . . . 70.340000000000003 110.526 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -116.32 124.42 50.08 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.63 -1.248 . . . . 75.340000000000003 107.63 174.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.2 tt -119.07 117.47 28.83 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 105.527 -2.027 . . . . 70.209999999999994 105.527 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.592 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 131.32 -162.28 23.65 Favored Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 109.662 -1.375 . . . . 44.25 109.662 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -117.43 134.74 54.49 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 109.172 -0.677 . . . . 71.409999999999997 109.172 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 30.8 t -107.0 121.61 60.05 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.29 -1.004 . . . . 74.439999999999998 108.29 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 56.2 t -113.58 114.95 48.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.502 -0.925 . . . . 72.230000000000004 108.502 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.437 HG21 ' HB2' ' A' ' 284' ' ' LYS . 12.3 m -96.96 160.37 14.39 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.259 -1.015 . . . . 74.349999999999994 108.259 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.02 -33.19 75.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.176 0.59 . . . . 74.219999999999999 111.067 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.38 66.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.353 1.061 . . . . 72.430000000000007 113.399 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -75.16 -26.09 58.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.854 0.359 . . . . 61.329999999999998 110.954 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 9.5 mp 74.53 176.68 0.23 Allowed 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 125.203 1.401 . . . . 72.420000000000002 110.219 -172.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -127.35 93.07 3.63 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.931 0.872 . . . . 51.219999999999999 109.891 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -160.48 160.28 31.65 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 110.488 -1.045 . . . . 64.140000000000001 110.488 -178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' B' ' 219' ' ' ILE . . . -154.52 -165.26 13.71 Favored Glycine 0 N--CA 1.426 -2.019 0 N-CA-C 110.044 -1.222 . . . . 34.109999999999999 110.044 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 47.2 mm -119.02 -55.61 3.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 120.886 0.374 . . . . 53.439999999999998 110.58 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -150.67 168.16 25.16 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.754 -0.462 . . . . 73.140000000000001 109.754 -175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.82 160.43 4.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 112.853 0.686 . . . . 63.32 112.853 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.535 ' HG ' ' N ' ' B' ' 217' ' ' MET . 17.2 p -154.23 -175.19 5.27 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.577 -0.897 . . . . 73.230000000000004 108.577 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 259' ' ' GLN . 12.5 t70 -95.13 -158.89 0.68 Allowed 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 108.673 -0.862 . . . . 70.530000000000001 108.673 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.416 ' H ' ' CG ' ' A' ' 258' ' ' ASP . 79.6 mt-30 -97.38 118.13 33.15 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.267 0.556 . . . . 75.230000000000004 111.337 -177.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' B' ' 222' ' ' ILE . 84.3 m -64.38 133.01 51.75 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.954 -1.021 . . . . 73.409999999999997 108.861 174.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 26.9 m -134.6 132.16 38.71 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 110.135 -0.32 . . . . 74.109999999999999 110.135 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -126.25 150.2 48.57 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 104.953 -2.239 . . . . 72.530000000000001 104.953 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 26.7 m -134.93 123.77 23.91 Favored 'General case' 0 C--O 1.263 1.797 0 N-CA-C 114.494 1.294 . . . . 74.140000000000001 114.494 -172.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.9 p -121.76 134.5 64.87 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 CA-C-N 115.108 -0.951 . . . . 72.349999999999994 110.616 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -77.35 -73.19 0.31 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.611 -0.722 . . . . 73.209999999999994 110.804 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 32.3 m -126.12 126.82 44.79 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 120.882 -0.327 . . . . 53.020000000000003 110.227 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.458 HG11 HD11 ' A' ' 277' ' ' ILE . 3.4 p -129.64 120.85 51.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 CA-C-O 121.848 0.832 . . . . 64.349999999999994 110.874 176.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 44.7 t -118.71 135.28 59.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.073 -0.967 . . . . 42.32 110.892 -175.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.472 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -121.37 131.12 8.45 Favored Glycine 0 N--CA 1.428 -1.88 0 N-CA-C 108.411 -1.875 . . . . 71.120000000000005 108.411 172.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.493 ' HB3' ' HG2' ' B' ' 234' ' ' GLU . 7.1 tmtm? -134.91 115.02 13.12 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 109.437 -0.579 . . . . 72.319999999999993 109.437 -175.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.37 82.71 0.68 Allowed Glycine 0 C--O 1.216 -0.977 0 C-N-CA 120.672 -0.775 . . . . 64.400000000000006 114.309 174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 236' ' ' ARG . 41.5 mt-10 63.62 24.32 13.91 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.438 1.095 . . . . 64.510000000000005 112.414 177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 48.8 m -82.46 145.12 30.0 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-O 121.715 0.769 . . . . 75.439999999999998 111.491 -176.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -109.09 127.86 54.5 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 106.42 -1.696 . . . . 75.439999999999998 106.42 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 2.4 p -129.23 123.55 58.48 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.665 0 N-CA-C 108.94 -0.763 . . . . 74.010000000000005 108.94 175.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.432 HD13 HE22 ' B' ' 240' ' ' GLN . 4.5 tt -113.53 120.21 40.2 Favored 'General case' 0 C--N 1.28 -2.413 0 N-CA-C 107.88 -1.155 . . . . 64.400000000000006 107.88 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.458 HD11 HG11 ' A' ' 267' ' ' VAL . 41.7 mm -112.45 103.49 15.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 107.716 -1.216 . . . . 73.310000000000002 107.716 177.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.645 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 147.15 -145.06 13.38 Favored Glycine 0 C--N 1.301 -1.381 0 N-CA-C 110.452 -1.059 . . . . 34.399999999999999 110.452 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -127.53 143.3 51.2 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.628 -0.879 . . . . 74.329999999999998 108.628 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.75 120.23 37.94 Favored 'General case' 0 C--O 1.259 1.605 0 N-CA-C 106.849 -1.537 . . . . 73.239999999999995 106.849 176.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -107.12 123.11 47.77 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 106.854 -1.536 . . . . 75.450000000000003 106.854 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 98.96 -48.08 1.33 Allowed Glycine 0 C--N 1.295 -1.701 0 C-N-CA 120.54 -0.838 . . . . 72.530000000000001 111.356 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 82.93 15.04 73.72 Favored Glycine 0 C--O 1.225 -0.45 0 C-N-CA 120.829 -0.7 . . . . 63.219999999999999 113.036 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.437 ' HB2' HG21 ' A' ' 246' ' ' THR . 32.1 mmtp -127.47 5.91 6.27 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.264 -0.551 . . . . 74.349999999999994 111.755 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -85.71 -54.79 2.69 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 110.173 -1.171 . . . . 72.329999999999998 110.173 -178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -111.86 -30.68 7.2 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.143 -0.529 . . . . 72.340000000000003 109.674 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.481 ' CH2' ' HB2' ' B' ' 238' ' ' ARG 0.283 11.3 t-105 -68.03 120.75 14.78 Favored 'General case' 0 N--CA 1.413 -2.285 0 C-N-CA 118.441 -1.304 . . . . 74.010000000000005 113.684 -173.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -111.14 111.17 22.06 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 112.872 -1.967 . . . . 71.010000000000005 108.619 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -171.29 87.66 0.1 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.587 -1.264 . . . . 72.420000000000002 107.587 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -96.23 69.64 2.71 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.599 -0.728 . . . . 73.530000000000001 112.138 -172.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 69.47 144.43 0.05 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.464 1.105 . . . . 72.109999999999999 112.288 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -142.04 -61.67 0.45 Allowed 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 115.993 -0.549 . . . . 75.040000000000006 110.081 -176.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -145.31 -79.97 0.17 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.918 -0.313 . . . . 62.109999999999999 110.905 -176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.54 ' CD2' ' HA ' ' B' ' 291' ' ' HIS . 23.6 t-80 -160.36 -51.74 0.05 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.782 -1.192 . . . . 74.519999999999996 107.782 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . 0.52 ' CE1' ' HB3' ' C' ' 288' ' ' ASP . 42.4 p-80 . . . . . 0 CA--C 1.496 -1.106 0 N-CA-C 104.584 -2.376 . . . . 70.420000000000002 104.584 172.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . 0.535 ' N ' ' HG ' ' A' ' 257' ' ' SER . 80.9 mtp . . . . . 0 C--O 1.238 0.463 0 CA-C-O 119.51 -0.281 . . . . 75.299999999999997 111.483 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -147.05 -70.95 0.23 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.57 0.623 . . . . 71.239999999999995 110.097 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . 0.406 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 38.8 pt -98.05 -21.44 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-O 121.525 0.678 . . . . 70.319999999999993 109.865 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -73.71 143.47 46.15 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.665 -1.152 . . . . 74.129999999999995 108.682 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -73.39 123.68 24.31 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 115.244 -0.889 . . . . 71.219999999999999 110.467 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . 0.537 ' H ' HG21 ' B' ' 254' ' ' ILE . 6.1 tp -82.92 114.74 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 105.471 -2.048 . . . . 74.340000000000003 105.471 173.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 10.5 m -136.17 164.49 31.55 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 115.093 -0.958 . . . . 71.340000000000003 110.806 -174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . 0.546 ' HA3' ' HB ' ' B' ' 260' ' ' THR . . . -67.93 176.14 26.12 Favored Glycine 0 N--CA 1.425 -2.057 0 N-CA-C 117.069 1.587 . . . . 65.340000000000003 117.069 -173.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.66 ' O ' ' HA ' ' B' ' 261' ' ' THR . 8.7 ptm180 -105.24 121.09 43.12 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 112.757 -1.721 . . . . 75.030000000000001 110.621 -176.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -103.69 149.11 25.27 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 104.576 -2.379 . . . . 71.409999999999997 104.576 175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 23.9 m -125.75 134.74 51.65 Favored 'General case' 0 N--CA 1.411 -2.386 0 C-N-CA 119.252 -0.979 . . . . 74.439999999999998 110.497 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.428 ' HB2' HG21 ' B' ' 277' ' ' ILE . . . -131.24 121.74 25.3 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.156 -1.384 . . . . 75.349999999999994 110.331 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -76.1 -67.14 0.71 Allowed 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 115.156 -0.929 . . . . 72.319999999999993 112.164 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -127.16 137.07 52.87 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 118.327 -1.349 . . . . 74.230000000000004 108.752 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.475 HG21 HG21 ' B' ' 239' ' ' VAL . 43.3 mt -131.93 117.68 34.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 107.35 -1.352 . . . . 64.439999999999998 107.35 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -126.09 115.15 19.38 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 109.226 -0.657 . . . . 61.240000000000002 109.226 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.472 ' OG1' ' HA2' ' A' ' 269' ' ' GLY . 71.2 p -112.66 127.24 56.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.844 -1.169 . . . . 55.130000000000003 107.844 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . 0.528 ' HB2' ' HD2' ' B' ' 270' ' ' LYS . 52.2 mt-10 -131.44 139.89 49.49 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 122.072 -0.392 . . . . 72.420000000000002 111.1 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.542 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 28.9 mt-10 60.56 93.62 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.146 0 O-C-N 124.711 1.257 . . . . 73.310000000000002 114.037 171.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.542 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 1.4 mpt_? 63.0 15.6 8.56 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 125.036 1.335 . . . . 73.239999999999995 111.06 175.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -78.15 156.57 29.82 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.197 0.522 . . . . 75.340000000000003 111.071 -176.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.481 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -139.75 135.15 32.8 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 109.362 -0.607 . . . . 60.009999999999998 109.362 177.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.4 p -133.32 142.45 41.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 121.632 0.73 . . . . 72.319999999999993 111.381 -178.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.692 ' HB2' ' CE2' ' B' ' 286' ' ' PHE . 5.8 tp-100 -109.35 131.99 54.55 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.382 -1.34 . . . . 65.129999999999995 107.382 173.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.409 ' HB3' HD13 ' A' ' 277' ' ' ILE . 3.3 tm? -129.72 115.58 17.53 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 104.801 -2.296 . . . . 75.040000000000006 104.801 171.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.645 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 135.96 -136.32 8.36 Favored Glycine 0 N--CA 1.417 -2.578 0 N-CA-C 109.057 -1.617 . . . . 61.240000000000002 109.057 -175.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -142.3 148.71 38.47 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 117.575 0.688 . . . . 74.239999999999995 109.682 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 17.2 t -114.8 124.11 71.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 107.538 -1.282 . . . . 72.219999999999999 107.538 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.15 113.37 38.45 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 C-N-CA 120.178 -0.609 . . . . 73.200000000000003 109.494 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.475 HG21 ' HB2' ' B' ' 284' ' ' LYS . 7.4 m -95.09 159.5 14.99 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.353 -1.351 . . . . 70.200000000000003 107.353 176.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.497 ' HB1' ' CE1' ' B' ' 251' ' ' HIS . . . -64.15 -32.13 73.58 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 121.941 0.876 . . . . 72.430000000000007 110.241 177.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.89 -44.47 74.13 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 113.383 -1.735 . . . . 71.019999999999996 113.366 -175.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -75.74 -47.7 24.92 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.273 -0.571 . . . . 71.030000000000001 111.16 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 94.1 mt -165.94 149.5 7.74 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.929 0.892 . . . . 71.140000000000001 109.296 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . 0.497 ' CE1' ' HB1' ' B' ' 247' ' ' ALA . 86.4 m-70 -102.32 84.84 2.53 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 105.358 -2.09 . . . . 75.430000000000007 105.358 168.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.26 -84.88 0.93 Allowed Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 108.603 -1.799 . . . . 51.240000000000002 108.603 -172.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . 0.464 ' CA ' ' HA ' ' C' ' 217' ' ' MET . . . 51.67 49.9 45.04 Favored Glycine 0 C--N 1.336 0.559 0 N-CA-C 114.64 0.616 . . . . 53.520000000000003 114.64 175.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . 0.537 HG21 ' H ' ' B' ' 222' ' ' ILE . 17.5 pt -102.56 141.45 18.61 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 113.503 0.927 . . . . 63.530000000000001 113.503 -173.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.458 ' HB3' ' OD1' ' C' ' 220' ' ' ASP . 37.7 ttt180 -110.81 -20.82 12.34 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 124.731 1.212 . . . . 74.420000000000002 109.444 178.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . 0.481 14.4 tt 71.84 68.84 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.957 0 C-N-CA 128.338 2.655 . . . . 62.539999999999999 113.336 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . 0.62 ' O ' ' HB ' ' C' ' 222' ' ' ILE . 1.6 m -124.3 98.71 5.88 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.025 -1.843 . . . . 41.439999999999998 106.025 173.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -149.06 137.18 20.77 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 114.969 1.47 . . . . 75.549999999999997 114.969 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -164.54 23.58 0.06 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.839 -1.911 . . . . 73.420000000000002 105.839 172.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.546 ' HB ' ' HA3' ' B' ' 224' ' ' GLY . 3.7 m -70.93 125.21 26.23 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.904 -1.044 . . . . 72.510000000000005 108.44 -175.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' B' ' 225' ' ' ARG . 25.3 m -132.96 135.18 45.36 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.639 -1.615 . . . . 62.039999999999999 106.639 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -126.67 146.05 50.34 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.192 -1.781 . . . . 72.530000000000001 106.192 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' C' ' 227' ' ' SER . 40.5 m -125.6 123.51 39.18 Favored 'General case' 0 C--O 1.256 1.434 0 C-N-CA 118.536 -1.266 . . . . 72.409999999999997 114.043 -170.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.439 HG21 HG13 ' B' ' 267' ' ' VAL . 11.3 p -128.63 137.31 57.67 Favored 'Isoleucine or valine' 0 C--O 1.25 1.091 0 C-N-CA 120.088 -0.645 . . . . 75.239999999999995 111.212 172.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.562 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 10.4 tp10 -86.34 -63.36 1.33 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.025 -0.534 . . . . 73.439999999999998 110.01 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 25.1 m -137.15 127.56 26.58 Favored 'General case' 0 C--N 1.316 -0.877 0 O-C-N 121.346 -0.847 . . . . 70.040000000000006 112.408 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.465 HG12 HD12 ' C' ' 231' ' ' ILE . 30.4 m -118.56 128.41 75.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 CA-C-N 115.882 -0.599 . . . . 63.109999999999999 109.815 173.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.41 130.63 74.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.61 -0.723 . . . . 65.219999999999999 109.98 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.44 132.95 9.28 Favored Glycine 0 CA--C 1.49 -1.488 0 N-CA-C 110.585 -1.006 . . . . 70.519999999999996 110.585 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.528 ' HD2' ' HB2' ' B' ' 234' ' ' GLU . 31.2 mmmt -132.91 115.64 15.49 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 123.218 0.607 . . . . 70.140000000000001 111.108 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.61 80.67 0.61 Allowed Glycine 0 C--N 1.304 -1.196 0 C-N-CA 120.445 -0.883 . . . . 43.340000000000003 114.589 172.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 63.7 28.64 14.97 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.159 0.984 . . . . 54.219999999999999 112.509 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 50.1 m -81.97 145.19 30.41 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.351 0.596 . . . . 73.239999999999995 111.175 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.436 ' HD3' ' HB3' ' C' ' 238' ' ' ARG . 6.1 mpt_? -109.5 128.72 55.38 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 106.849 -1.537 . . . . 64.319999999999993 106.849 174.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.4 p -130.96 123.06 53.32 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 N-CA-C 108.17 -1.048 . . . . 74.400000000000006 108.17 172.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 6.1 tt -114.08 116.79 29.7 Favored 'General case' 0 C--N 1.277 -2.571 0 C-N-CA 119.36 -0.936 . . . . 55.119999999999997 108.599 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.465 HG23 HD12 ' C' ' 241' ' ' LEU . 34.0 mm -106.46 102.54 14.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 106.834 -1.543 . . . . 61.140000000000001 106.834 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 146.82 -164.36 28.53 Favored Glycine 0 CA--C 1.49 -1.506 0 N-CA-C 110.856 -0.897 . . . . 10.109999999999999 110.856 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -109.54 139.66 44.28 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.159 -0.682 . . . . 72.140000000000001 109.159 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.95 118.89 36.73 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.256 -1.757 . . . . 74.120000000000005 106.256 178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -105.91 122.95 47.17 Favored 'General case' 0 N--CA 1.416 -2.146 0 N-CA-C 107.891 -1.151 . . . . 73.439999999999998 107.891 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.44 -46.47 1.28 Allowed Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.669 -0.696 . . . . 73.549999999999997 111.682 -177.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 74.59 29.25 61.86 Favored Glycine 0 CA--C 1.506 -0.486 0 N-CA-C 111.555 -0.618 . . . . 23.010000000000002 111.555 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . 0.475 ' HB2' HG21 ' B' ' 246' ' ' THR . 73.1 mmtt -137.25 11.41 3.03 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.528 -0.336 . . . . 72.319999999999993 110.624 -177.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -103.78 -47.05 1.31 Allowed Glycine 0 N--CA 1.431 -1.658 0 C-N-CA 119.729 -1.224 . . . . 75.319999999999993 110.686 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.692 ' CE2' ' HB2' ' B' ' 240' ' ' GLN . 6.3 t80 -110.03 -42.11 4.29 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.996 0.427 . . . . 75.409999999999997 110.39 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.517 ' CZ2' ' HB2' ' C' ' 238' ' ' ARG . 11.2 t-105 -70.93 148.85 47.3 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 115.483 1.661 . . . . 75.150000000000006 115.483 -165.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.55 22.59 0.08 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.683 1.593 . . . . 62.32 111.222 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . 0.424 ' H ' ' C ' ' B' ' 287' ' ' TRP . 22.4 t30 -80.21 88.98 5.45 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 122.536 1.16 . . . . 74.230000000000004 110.233 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -133.3 71.38 1.47 Allowed 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 114.039 -1.437 . . . . 74.310000000000002 108.908 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . 0.54 ' HA ' ' CD2' ' A' ' 294' ' ' HIS . 20.5 p80 -76.35 133.46 39.96 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 113.917 -1.492 . . . . 72.319999999999993 110.772 -176.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . 0.412 ' H ' ' CD2' ' A' ' 294' ' ' HIS . 9.4 t-80 -87.28 84.76 7.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.419 -0.81 . . . . 72.340000000000003 109.499 -177.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -168.04 33.07 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 104.662 -2.347 . . . . 75.409999999999997 104.662 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . 0.403 ' HA ' ' CD2' ' C' ' 292' ' ' HIS . 9.2 p80 -90.16 75.77 6.98 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.19 -1.368 . . . . 75.230000000000004 113.822 -173.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 . . . . . 0 C--N 1.312 -1.033 0 CA-C-N 113.506 -1.679 . . . . 71.319999999999993 107.2 177.109 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . 0.464 ' HA ' ' CA ' ' B' ' 253' ' ' GLY . 65.7 mtt . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 111.585 0.217 . . . . 72.209999999999994 111.585 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . 0.47 ' HG3' HD12 ' C' ' 219' ' ' ILE . 22.1 pttp -77.15 -12.37 59.94 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.966 0.888 . . . . 75.010000000000005 109.857 174.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.47 HD12 ' HG3' ' C' ' 218' ' ' LYS . 3.1 mp -127.02 137.98 56.24 Favored 'Isoleucine or valine' 0 C--O 1.256 1.439 0 N-CA-C 105.438 -2.06 . . . . 63.350000000000001 105.438 169.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . 0.458 ' OD1' ' HB3' ' B' ' 255' ' ' ARG . 28.8 p-10 -114.38 -167.88 1.28 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.649 -0.871 . . . . 45.140000000000001 108.649 176.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.8 111.44 14.21 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 113.939 1.088 . . . . 64.310000000000002 113.939 -173.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 0.62 ' HB ' ' O ' ' B' ' 257' ' ' SER . 0.0 OUTLIER -115.95 133.34 62.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 104.572 -2.381 . . . . 63.450000000000003 104.572 171.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . 0.47 ' N ' HD13 ' C' ' 222' ' ' ILE . 4.8 t -127.06 164.18 28.28 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 C-N-CA 120.659 -0.417 . . . . 62.43 110.519 -172.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -74.62 -168.75 21.2 Favored Glycine 0 C--O 1.245 0.806 0 N-CA-C 111.303 -0.719 . . . . 75.519999999999996 111.303 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' B' ' 261' ' ' THR . 15.8 ptt-85 -121.92 147.52 45.92 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 118.7 -1.2 . . . . 70.439999999999998 114.115 -173.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -116.25 147.41 41.51 Favored 'General case' 0 N--CA 1.399 -2.985 0 N-CA-C 105.26 -2.126 . . . . 75.25 105.26 171.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' C' ' 263' ' ' SER . 24.1 m -130.03 136.55 49.52 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 121.269 0.557 . . . . 62.039999999999999 110.117 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.511 ' HB2' HG21 ' C' ' 277' ' ' ILE . . . -130.41 134.37 47.08 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 115.387 -0.824 . . . . 74.420000000000002 109.198 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.562 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -85.95 -61.32 1.78 Allowed 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 115.266 -0.879 . . . . 71.400000000000006 109.193 -178.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -129.56 137.97 51.05 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.953 -0.699 . . . . 71.239999999999995 110.345 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.465 HD12 HG12 ' B' ' 267' ' ' VAL . 34.5 mt -135.18 119.92 27.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 108.879 -0.785 . . . . 70.109999999999999 108.879 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.429 ' HB3' HG12 ' C' ' 268' ' ' VAL . 30.9 ttt180 -125.56 115.92 20.94 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.998 0.428 . . . . 72.129999999999995 110.078 178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 38.9 p -112.61 127.5 56.11 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.452 -0.944 . . . . 74.129999999999995 108.452 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -131.55 139.43 49.23 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.437 -0.505 . . . . 71.010000000000005 110.691 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.459 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 38.2 mt-10 62.81 92.16 0.06 Allowed 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 124.926 1.391 . . . . 45.399999999999999 114.133 170.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.459 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 2.8 mpt_? 63.55 12.04 6.14 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.859 1.264 . . . . 55.32 111.21 175.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -77.97 149.01 34.18 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.204 0.526 . . . . 62.509999999999998 111.64 -174.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.517 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 0.0 OUTLIER -133.65 134.96 43.8 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.943 -0.572 . . . . 72.329999999999998 111.511 176.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.6 p -132.97 137.86 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-N 115.276 -0.875 . . . . 70.319999999999993 111.534 -178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 47.5 tp60 -106.03 129.79 54.07 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 114.127 -1.397 . . . . 63.539999999999999 107.863 175.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.465 HD12 HG23 ' B' ' 277' ' ' ILE . 3.2 tm? -125.15 116.32 21.85 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 106.069 -1.826 . . . . 71.129999999999995 106.069 173.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.653 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 126.98 -148.18 17.21 Favored Glycine 0 C--N 1.284 -2.348 0 N-CA-C 108.278 -1.929 . . . . 65.409999999999997 108.278 -176.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -126.96 150.16 49.51 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 118.336 1.068 . . . . 72.409999999999997 110.621 -178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 38.2 t -116.78 126.56 74.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.614 -1.254 . . . . 73.340000000000003 107.614 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 65.4 t -122.52 118.59 55.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 C-N-CA 120.439 -0.504 . . . . 63.43 109.98 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 9.4 m -95.27 159.42 15.02 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 108.114 -1.069 . . . . 71.409999999999997 108.114 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -64.05 -33.76 76.48 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.354 0.597 . . . . 55.329999999999998 110.776 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.14 -47.76 74.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.405 -1.271 . . . . 71.409999999999997 111.464 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.32 -42.51 44.9 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.941 0.4 . . . . 54.229999999999997 111.367 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 52.5 tp 76.7 -61.67 0.43 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.619 1.567 . . . . 75.209999999999994 113.248 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -155.03 170.34 22.0 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.379 0.536 . . . . 74.0 111.459 -177.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 179.83 100.33 0.14 Allowed Glycine 0 CA--C 1.527 0.811 0 O-C-N 123.435 0.459 . . . . 72.0 112.312 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.07 33.55 2.16 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.286 -0.483 . . . . 54.240000000000002 112.816 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . 0.513 ' HA ' ' CG2' ' C' ' 222' ' ' ILE . 44.1 pt -75.44 0.77 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 N-CA-C 113.845 1.054 . . . . 74.140000000000001 113.845 -174.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -85.75 -2.3 58.08 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.782 -0.821 . . . . 74.400000000000006 108.782 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . 0.59 ' HA ' HD12 ' C' ' 222' ' ' ILE . 1.9 mp 77.7 91.1 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 CA-C-O 122.611 1.196 . . . . 73.239999999999995 108.575 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 22.9 m -99.36 29.73 3.85 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 113.984 -1.462 . . . . 73.340000000000003 110.831 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -75.81 72.26 2.7 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 122.205 1.002 . . . . 35.329999999999998 111.07 176.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -164.77 -19.25 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 128.618 2.767 . . . . 73.019999999999996 107.837 174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 22.2 m -64.35 121.34 14.09 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 104.527 -2.397 . . . . 72.450000000000003 104.527 171.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 22.0 m -133.52 112.44 11.52 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 109.584 -0.524 . . . . 75.319999999999993 109.584 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -112.51 124.48 52.61 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.064 -1.828 . . . . 70.409999999999997 106.064 173.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' C' ' 227' ' ' SER . 10.7 p -130.37 144.79 51.6 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 113.735 1.013 . . . . 71.209999999999994 113.735 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 10.0 p -128.51 149.58 33.43 Favored 'Isoleucine or valine' 0 C--O 1.248 0.99 0 CA-C-N 115.494 -0.775 . . . . 64.450000000000003 110.296 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -81.03 -68.28 0.7 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 120.626 0.25 . . . . 74.099999999999994 111.284 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 61.8 m -138.59 127.6 23.94 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 120.367 -0.533 . . . . 75.120000000000005 110.646 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.1 m -118.68 134.6 61.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.466 -0.568 . . . . 63.439999999999998 109.466 172.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . 0.429 HG12 ' HB3' ' C' ' 232' ' ' ARG . 13.6 m -127.1 135.53 63.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 CA-C-N 115.634 -0.712 . . . . 53.119999999999997 110.485 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.15 132.35 9.08 Favored Glycine 0 CA--C 1.47 -2.739 0 N-CA-C 109.089 -1.604 . . . . 44.299999999999997 109.089 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -134.4 115.21 13.75 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.603 -0.888 . . . . 75.120000000000005 108.603 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.39 91.61 0.19 Allowed Glycine 0 C--O 1.242 0.653 0 C-N-CA 121.139 -0.553 . . . . 71.150000000000006 113.427 176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 56.5 29.65 15.77 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.638 1.175 . . . . 72.519999999999996 112.158 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 23.2 m -82.8 145.24 29.62 Favored 'General case' 0 N--CA 1.427 -1.614 0 C-N-CA 119.561 -0.856 . . . . 63.200000000000003 111.547 -175.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' C' ' 274' ' ' ARG . 6.5 mtm180 -118.72 127.65 53.76 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 107.908 -1.145 . . . . 71.409999999999997 107.908 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 4.0 p -138.25 128.5 35.06 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 CA-C-N 115.592 -0.731 . . . . 64.0 109.292 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.7 tt -116.62 115.3 25.45 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.485 -0.931 . . . . 72.420000000000002 108.485 -177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.511 HG21 ' HB2' ' C' ' 228' ' ' ALA . 43.1 mm -105.9 102.97 14.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 106.509 -1.663 . . . . 73.120000000000005 106.509 178.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . 0.653 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 141.42 -163.2 26.84 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 111.028 -0.829 . . . . 53.399999999999999 111.028 -174.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -114.08 135.87 53.55 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.818 -0.808 . . . . 75.239999999999995 108.818 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.69 118.68 36.31 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 106.169 -1.789 . . . . 75.310000000000002 106.169 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -105.26 123.39 47.76 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 109.097 -0.705 . . . . 75.239999999999995 109.097 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 108.19 -43.65 1.66 Allowed Glycine 0 N--CA 1.421 -2.364 0 N-CA-C 109.957 -1.257 . . . . 64.430000000000007 109.957 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 80.1 21.68 64.84 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 111.359 -0.697 . . . . 70.409999999999997 111.359 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' C' ' 287' ' ' TRP . 33.3 mttm -145.68 20.5 1.49 Allowed 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 113.987 1.106 . . . . 61.119999999999997 113.987 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -94.58 -45.5 3.18 Favored Glycine 0 N--CA 1.427 -1.922 0 N-CA-C 107.794 -2.123 . . . . 64.420000000000002 107.794 174.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.53 -50.91 3.11 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.578 -1.267 . . . . 74.25 107.578 175.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.574 ' O ' ' HA ' ' C' ' 284' ' ' LYS . 0.8 OUTLIER -88.23 161.91 16.95 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.268 -0.878 . . . . 71.450000000000003 112.097 -169.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . 0.52 ' HB3' ' CE1' ' A' ' 295' ' ' HIS . 17.4 t70 -122.68 105.54 10.17 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.549 0.69 . . . . 74.329999999999998 112.222 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -92.82 149.34 21.35 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 105.802 -1.925 . . . . 71.030000000000001 105.802 167.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -68.44 98.46 0.85 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.771 0.796 . . . . 75.409999999999997 111.365 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -171.86 169.86 5.65 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 104.224 -2.51 . . . . 71.129999999999995 104.224 -176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . 0.403 ' CD2' ' HA ' ' B' ' 294' ' ' HIS . 13.4 t-80 -94.86 149.88 20.78 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 119.37 0.986 . . . . 72.5 110.569 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . 0.486 ' HB2' ' HD3' ' C' ' 284' ' ' LYS . 11.7 t-160 -166.26 76.26 0.21 Allowed 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.987 0.915 . . . . 64.549999999999997 110.274 173.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 56.5 -171.75 0.08 Allowed 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.066 1.136 . . . . 75.25 114.066 176.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 5.8 p80 . . . . . 0 N--CA 1.427 -1.62 0 CA-C-N 114.621 -1.172 . . . . 75.230000000000004 110.013 177.785 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 66.3 mtm . . . . . 0 C--O 1.233 0.234 0 CA-C-O 120.675 0.274 . . . . 63.399999999999999 110.875 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -132.7 -42.4 0.92 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.96 -0.385 . . . . 64.430000000000007 109.96 173.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 2.0 mp -102.66 127.69 56.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 120.836 0.35 . . . . 74.340000000000003 110.152 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -136.09 102.46 5.03 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 107.975 -1.12 . . . . 73.010000000000005 107.975 175.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -134.41 135.7 42.77 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.706 -0.85 . . . . 71.120000000000005 108.706 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 63.1 mt -113.95 114.67 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 108.116 -1.068 . . . . 62.140000000000001 108.116 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.51 124.71 29.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.743 -0.662 . . . . 74.129999999999995 110.163 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -113.82 58.86 0.41 Allowed Glycine 0 C--N 1.294 -1.783 0 N-CA-C 107.458 -2.257 . . . . 61.109999999999999 107.458 175.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -100.59 132.17 46.12 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.695 0.759 . . . . 75.310000000000002 112.053 -172.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -110.28 134.96 51.74 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.301 -1.318 . . . . 62.229999999999997 108.677 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 16.6 m -126.19 136.71 53.17 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 109.326 -0.62 . . . . 74.099999999999994 109.326 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -140.18 132.19 27.83 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 106.453 -1.684 . . . . 70.129999999999995 106.453 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -96.17 -56.85 2.5 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 119.873 -0.731 . . . . 71.109999999999999 111.656 -174.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.81 139.57 52.57 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 109.129 -0.693 . . . . 64.019999999999996 109.129 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.2 mm -131.92 118.72 38.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.884 -0.784 . . . . 73.209999999999994 108.884 -174.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -120.56 127.01 51.75 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.846 -0.428 . . . . 72.439999999999998 109.846 176.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 45.1 p -133.46 128.64 35.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.684 -0.487 . . . . 65.230000000000004 109.684 -176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.424 ' HB2' ' HD3' ' A' ' 270' ' ' LYS . 42.7 mt-10 -142.8 139.71 31.07 Favored 'General case' 0 C--N 1.309 -1.186 0 C-N-CA 121.059 -0.256 . . . . 74.319999999999993 110.773 176.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.606 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 38.7 mt-10 64.18 95.64 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 114.748 1.388 . . . . 50.140000000000001 114.748 170.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.606 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.1 mpp_? 60.31 26.85 16.37 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.674 1.19 . . . . 74.340000000000003 110.435 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -92.35 125.95 37.23 Favored 'General case' 0 N--CA 1.418 -2.058 0 CA-C-N 115.252 -0.886 . . . . 75.140000000000001 110.614 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.539 ' HD3' ' HG2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -128.05 134.94 49.25 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.621 -0.881 . . . . 70.299999999999997 108.621 176.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.657 HG12 ' HB ' ' A' ' 275' ' ' VAL . 33.1 m -134.32 150.12 30.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 116.116 -0.493 . . . . 72.040000000000006 110.711 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.638 HE21 ' HG ' ' A' ' 276' ' ' LEU . 0.9 OUTLIER -123.14 125.34 44.96 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.336 -1.357 . . . . 71.219999999999999 107.336 178.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -116.12 117.75 30.95 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.65 -1.241 . . . . 75.230000000000004 107.65 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.452 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 126.59 -159.57 20.86 Favored Glycine 0 N--CA 1.433 -1.506 0 N-CA-C 111.337 -0.705 . . . . 73.140000000000001 111.337 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' A' ' 279' ' ' ASN . 39.3 t30 -107.0 137.86 44.27 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 122.935 0.494 . . . . 72.430000000000007 110.383 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 99.9 t -113.27 114.33 46.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.249 -0.649 . . . . 45.420000000000002 109.249 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.513 ' HA ' ' HB3' ' A' ' 281' ' ' TYR . 27.4 m -99.32 118.39 45.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 119.844 -0.742 . . . . 65.129999999999995 110.711 176.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 17.6 m -102.0 158.95 15.78 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.562 -0.533 . . . . 73.150000000000006 109.562 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.79 -35.27 80.24 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.639 0.977 . . . . 50.109999999999999 113.639 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -39.03 68.01 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.476 1.288 . . . . 62.439999999999998 114.476 -173.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.571 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . -74.6 -23.72 58.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 112.217 0.451 . . . . 74.420000000000002 112.217 -177.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.41 ' HB3' ' H ' ' A' ' 251' ' ' HIS . 6.7 mp 72.91 -162.26 0.1 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.066 0.947 . . . . 72.340000000000003 108.509 -172.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.41 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 72.5 m80 69.38 177.81 0.26 Allowed 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.743 0.817 . . . . 72.239999999999995 111.142 177.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -167.0 41.51 0.25 Allowed Glycine 0 CA--C 1.483 -1.965 0 C-N-CA 120.268 -0.968 . . . . 53.130000000000003 111.127 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -168.14 161.25 35.0 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 109.949 -1.26 . . . . 43.530000000000001 109.949 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 33.0 pt -96.33 113.89 31.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.61 0.719 . . . . 74.0 109.933 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.408 ' HB3' ' CD2' ' B' ' 251' ' ' HIS . 14.6 ttm180 -95.36 179.85 5.03 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.277 -1.749 . . . . 75.019999999999996 106.277 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 42.6 mm -76.66 92.86 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 119.568 1.076 . . . . 70.120000000000005 111.933 -174.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 47.7 m -139.27 -45.06 0.46 Allowed 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.256 -0.884 . . . . 64.430000000000007 110.706 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -80.08 89.09 5.38 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.668 0.747 . . . . 75.219999999999999 112.265 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -103.05 9.09 38.71 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 106.984 -1.487 . . . . 73.329999999999998 106.984 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 6.1 m -75.6 122.88 24.58 Favored 'General case' 0 N--CA 1.401 -2.923 0 CA-C-N 112.984 -1.916 . . . . 43.539999999999999 111.127 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 m -107.56 108.6 19.97 Favored 'General case' 0 N--CA 1.408 -2.54 0 N-CA-C 106.204 -1.776 . . . . 74.349999999999994 106.204 174.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 17.2 m120 -104.91 130.8 53.0 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.797 -0.816 . . . . 63.200000000000003 108.797 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 59.5 m -138.96 123.43 18.34 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.53 -0.545 . . . . 54.210000000000001 109.53 174.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 12.7 p -128.19 149.18 32.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 107.844 -1.169 . . . . 73.109999999999999 107.844 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 32.1 tt0 -92.91 -67.6 0.85 Allowed 'General case' 0 N--CA 1.42 -1.934 0 C-N-CA 120.005 -0.678 . . . . 73.420000000000002 110.339 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 20.7 m -123.74 133.08 53.91 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 120.235 -0.586 . . . . 74.439999999999998 111.429 -173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.84 131.71 72.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 N-CA-C 108.492 -0.929 . . . . 72.319999999999993 108.492 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 6.4 p -127.26 131.51 70.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 110.207 -0.294 . . . . 62.439999999999998 110.207 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.486 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -122.71 131.49 8.31 Favored Glycine 0 CA--C 1.485 -1.837 0 C-N-CA 120.34 -0.933 . . . . 34.409999999999997 111.347 176.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 234' ' ' GLU . 15.9 tptm -134.41 115.84 14.48 Favored 'General case' 0 N--CA 1.428 -1.531 0 O-C-N 123.679 0.282 . . . . 70.430000000000007 110.828 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.63 99.7 0.49 Allowed Glycine 0 C--O 1.245 0.801 0 C-N-CA 120.717 -0.754 . . . . 73.25 113.878 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' B' ' 236' ' ' ARG . 51.8 mm-40 60.55 24.18 13.87 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.432 1.093 . . . . 63.240000000000002 110.597 175.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.588 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 18.9 m -82.57 144.63 30.22 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.987 0.899 . . . . 74.239999999999995 112.784 -169.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . 0.539 ' HG2' ' HD3' ' A' ' 238' ' ' ARG . 82.9 mtt180 -135.31 126.21 27.57 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.124 -1.436 . . . . 75.239999999999995 107.124 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.657 ' HB ' HG12 ' A' ' 239' ' ' VAL . 46.4 t -136.19 133.67 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.989 0 N-CA-C 109.691 -0.485 . . . . 65.030000000000001 109.691 -176.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.638 ' HG ' HE21 ' A' ' 240' ' ' GLN . 6.3 tt -119.45 117.98 29.89 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 118.507 -1.277 . . . . 74.340000000000003 108.849 171.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.432 HG22 ' HB3' ' B' ' 241' ' ' LEU . 2.7 pt -112.54 104.38 16.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.178 0 CA-C-O 121.622 0.725 . . . . 74.430000000000007 109.508 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.687 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 148.21 -133.45 4.62 Favored Glycine 0 N--CA 1.426 -2.022 0 CA-C-N 115.843 -0.617 . . . . 63.539999999999999 111.568 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 243' ' ' ASN . 14.3 m120 -128.29 153.5 46.92 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.507 -0.923 . . . . 74.109999999999999 108.507 -176.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -141.17 143.45 34.25 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.945 0.878 . . . . 73.420000000000002 110.475 170.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.513 ' HB3' ' HA ' ' A' ' 245' ' ' VAL 0.252 5.3 t80 -119.45 124.63 46.98 Favored 'General case' 0 C--N 1.275 -2.665 0 N-CA-C 105.801 -1.926 . . . . 74.319999999999993 105.801 -175.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 144.2 -52.13 0.62 Allowed Glycine 0 C--N 1.308 -0.988 0 C-N-CA 120.003 -1.094 . . . . 61.329999999999998 112.974 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.453 ' HA3' HG23 ' B' ' 246' ' ' THR . . . 119.87 -34.74 4.08 Favored Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 108.816 -1.714 . . . . 40.130000000000003 108.816 -175.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -135.89 87.47 2.31 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 106.609 -1.626 . . . . 72.099999999999994 106.609 170.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -95.97 -132.81 7.26 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 110.812 -0.915 . . . . 45.420000000000002 110.812 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 26.0 t80 52.07 -130.1 2.24 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 107.819 -1.178 . . . . 75.310000000000002 107.819 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -124.22 14.8 9.05 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.318 -1.364 . . . . 70.25 107.318 172.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.533 ' C ' HD22 ' A' ' 289' ' ' ASN . 23.1 t70 51.21 -163.64 0.06 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.231 -1.35 . . . . 72.430000000000007 108.35 -172.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.533 HD22 ' C ' ' A' ' 288' ' ' ASP . 0.9 OUTLIER -124.94 -2.42 7.74 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 120.727 -1.233 . . . . 74.239999999999995 109.428 178.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 75.62 84.79 0.09 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 126.065 1.746 . . . . 72.030000000000001 108.969 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 67.0 t60 63.79 82.34 0.18 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.632 -1.622 . . . . 65.329999999999998 109.562 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -78.85 79.21 5.27 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.879 -1.055 . . . . 73.409999999999997 109.891 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -157.45 141.64 16.21 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.677 -0.86 . . . . 61.240000000000002 108.677 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.576 ' H ' ' CD2' ' B' ' 291' ' ' HIS . 30.8 t-80 74.01 1.44 3.9 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.249 1.82 . . . . 75.230000000000004 112.117 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . 0.433 ' C ' HH22 ' B' ' 238' ' ' ARG . 48.8 p-80 . . . . . 0 C--N 1.303 -1.428 0 N-CA-C 106.792 -1.559 . . . . 74.310000000000002 106.792 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 13.8 tpt . . . . . 0 CA--C 1.507 -0.681 0 CA-C-O 120.898 0.38 . . . . 74.019999999999996 110.788 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -96.2 140.66 30.58 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.454 -0.943 . . . . 31.140000000000001 108.454 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . 0.463 HG13 ' O ' ' C' ' 219' ' ' ILE . 18.3 pt -93.65 -164.43 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 112.796 0.665 . . . . 61.340000000000003 112.796 -174.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -141.53 127.09 18.93 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.822 -0.807 . . . . 61.439999999999998 108.822 -173.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 178.57 136.63 0.09 Allowed 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.743 0.652 . . . . 53.130000000000003 111.77 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 63.5 mt -94.6 114.9 32.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 106.096 -1.816 . . . . 75.319999999999993 106.096 171.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 17.1 m -139.22 136.07 41.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 120.976 0.417 . . . . 74.230000000000004 111.944 -175.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -105.42 84.13 0.4 Allowed Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 107.948 -2.061 . . . . 55.509999999999998 107.948 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -90.06 121.1 31.82 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 112.255 0.465 . . . . 73.420000000000002 112.255 -174.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 6.9 t30 -118.58 113.39 21.18 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.654 -0.869 . . . . 74.409999999999997 108.654 169.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 46.7 m -121.26 136.61 54.94 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-O 121.725 0.774 . . . . 61.520000000000003 110.124 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -133.21 147.58 52.0 Favored 'General case' 0 C--N 1.286 -2.184 0 N-CA-C 106.999 -1.482 . . . . 55.539999999999999 106.999 178.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 10.0 tmtt? -104.51 -67.76 0.89 Allowed 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.677 -0.809 . . . . 75.420000000000002 109.299 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' B' ' 266' ' ' THR . 33.3 t70 -128.01 138.7 52.69 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.435 -0.58 . . . . 73.400000000000006 109.435 -177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.48 HD11 ' HB1' ' B' ' 228' ' ' ALA . 39.9 mm -128.88 117.57 44.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 108.637 -0.875 . . . . 71.400000000000006 108.637 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -114.31 114.51 26.02 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.895 -0.78 . . . . 72.420000000000002 108.895 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.486 ' OG1' ' HA2' ' A' ' 269' ' ' GLY . 78.2 p -111.53 127.24 55.65 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 107.664 -1.235 . . . . 54.539999999999999 107.664 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -139.34 138.93 37.07 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 120.842 -0.343 . . . . 73.129999999999995 111.019 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.6 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 44.5 mt-10 57.99 98.4 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 125.098 1.499 . . . . 70.299999999999997 114.908 171.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.6 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.2 OUTLIER 60.75 26.21 16.02 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 114.859 -1.064 . . . . 71.219999999999999 110.198 174.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -91.35 136.03 33.4 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.121 -0.945 . . . . 62.219999999999999 111.882 -175.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 3.5 mpt_? -125.94 134.41 51.55 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.711 -1.218 . . . . 74.230000000000004 107.711 176.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.629 HG12 ' HB ' ' B' ' 275' ' ' VAL . 19.7 m -138.97 147.41 24.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.234 0.54 . . . . 61.240000000000002 110.945 176.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -122.06 127.93 50.78 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 106.66 -1.608 . . . . 74.219999999999999 106.66 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' B' ' 277' ' ' ILE . 2.3 tm? -122.5 117.67 26.49 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 106.892 -1.522 . . . . 53.439999999999998 106.892 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.687 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 136.92 -126.39 3.7 Favored Glycine 0 N--CA 1.428 -1.861 0 C-N-CA 120.804 -0.713 . . . . 52.340000000000003 111.761 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' B' ' 279' ' ' ASN . 43.9 t30 -142.78 134.86 27.23 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 110.286 -0.264 . . . . 73.430000000000007 110.286 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.55 HG11 ' H ' ' B' ' 286' ' ' PHE . 68.7 t -114.94 114.91 47.91 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.866 0 N-CA-C 109.539 -0.541 . . . . 64.129999999999995 109.539 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.499 ' HA ' ' HB3' ' B' ' 281' ' ' TYR . 28.5 m -104.15 112.72 38.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 119.69 -0.804 . . . . 61.140000000000001 111.192 176.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.484 HG22 ' H ' ' B' ' 248' ' ' ALA . 42.0 m -81.72 158.19 24.29 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-O 121.047 0.451 . . . . 75.010000000000005 110.914 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.23 93.24 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.322 1.049 . . . . 63.310000000000002 112.342 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . 0.484 ' H ' HG22 ' B' ' 246' ' ' THR . . . -55.31 -44.29 75.65 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.068 -1.424 . . . . 33.299999999999997 114.065 -173.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.71 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -74.95 -25.76 59.12 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-O 120.9 0.381 . . . . 62.530000000000001 110.744 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 8.8 mp 75.85 157.8 0.19 Allowed 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 125.186 1.395 . . . . 74.230000000000004 109.458 -171.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . 0.408 ' CD2' ' HB3' ' A' ' 255' ' ' ARG . 76.9 t60 -83.86 91.54 7.58 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.4 -0.963 . . . . 73.439999999999998 108.4 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -92.14 111.69 4.08 Favored Glycine 0 N--CA 1.429 -1.809 0 CA-C-N 115.038 -0.983 . . . . 75.340000000000003 112.374 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -80.06 62.19 4.26 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.995 -0.842 . . . . 62.439999999999998 110.995 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 9.2 tp -98.34 -15.37 7.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.121 -0.539 . . . . 72.010000000000005 109.981 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 49.2 ttp180 69.73 135.08 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.486 1.114 . . . . 74.340000000000003 113.123 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 50.1 mm -71.72 113.94 9.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 105.259 -2.126 . . . . 71.510000000000005 105.259 172.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 15.1 m -113.92 25.25 11.33 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.295 -0.562 . . . . 63.119999999999997 112.266 -171.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.515 ' OD2' ' HD2' ' C' ' 255' ' ' ARG . 4.5 p30 -111.17 -164.63 0.93 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.083 -0.508 . . . . 72.439999999999998 110.552 178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -124.66 33.59 5.19 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 116.18 -0.464 . . . . 71.519999999999996 110.475 -175.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' C' ' 224' ' ' GLY . 16.7 m -64.51 120.97 13.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.936 0.874 . . . . 64.129999999999995 111.254 -177.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 33.9 m -124.11 108.91 12.83 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 115.039 -0.982 . . . . 71.219999999999999 108.565 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -108.49 132.59 53.66 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 109.65 -0.5 . . . . 63.409999999999997 109.65 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' C' ' 227' ' ' SER . 37.3 t -142.19 123.86 15.06 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 109.418 -0.586 . . . . 75.239999999999995 109.418 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.9 p -123.7 148.64 27.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.535 -0.913 . . . . 73.329999999999998 108.535 177.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 37.4 tt0 -89.21 -72.79 0.53 Allowed 'General case' 0 N--CA 1.423 -1.817 0 C-N-CA 119.576 -0.85 . . . . 73.430000000000007 110.529 175.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' B' ' 230' ' ' ASP . 25.1 m -127.81 133.97 49.44 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.917 -1.114 . . . . 73.329999999999998 112.471 -176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.82 135.27 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.793 -1.188 . . . . 72.530000000000001 107.793 173.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 5.3 p -127.48 125.43 65.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-O 121.024 0.44 . . . . 74.209999999999994 110.677 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.57 132.52 10.5 Favored Glycine 0 CA--C 1.476 -2.406 0 N-CA-C 111.137 -0.785 . . . . 53.520000000000003 111.137 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.502 ' HB3' ' HG2' ' C' ' 234' ' ' GLU . 40.6 tptt -134.12 115.83 14.7 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 109.987 -0.375 . . . . 70.230000000000004 109.987 -178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 71.97 99.74 0.06 OUTLIER Glycine 0 CA--C 1.527 0.782 0 N-CA-C 114.159 0.424 . . . . 61.32 114.159 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 63.91 26.83 14.33 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.161 0.984 . . . . 74.540000000000006 112.421 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . 0.534 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 37.4 m -83.41 144.79 29.38 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 119.444 -0.902 . . . . 64.120000000000005 113.066 -171.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 4.8 mtt-85 -135.55 127.23 29.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.001 -1.111 . . . . 72.439999999999998 108.001 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.629 ' HB ' HG12 ' B' ' 239' ' ' VAL . 55.6 t -136.49 138.44 46.63 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.594 0 N-CA-C 109.165 -0.68 . . . . 75.010000000000005 109.165 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 6.1 tt -123.44 120.88 34.25 Favored 'General case' 0 C--N 1.276 -2.627 0 C-N-CA 119.095 -1.042 . . . . 72.340000000000003 108.434 169.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.496 HG22 ' HB3' ' C' ' 241' ' ' LEU . 1.5 pt -112.43 104.28 16.79 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 C-N-CA 123.991 0.916 . . . . 74.310000000000002 109.502 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.504 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 145.45 -133.63 5.14 Favored Glycine 0 N--CA 1.419 -2.464 0 CA-C-N 115.804 -0.635 . . . . 60.109999999999999 111.699 -178.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . 0.562 ' O ' ' HA ' ' B' ' 243' ' ' ASN . 12.5 m120 -127.28 152.29 47.63 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-O 121.218 0.532 . . . . 70.5 109.978 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -137.68 150.01 47.0 Favored 'General case' 0 N--CA 1.409 -2.52 0 N-CA-C 107.962 -1.125 . . . . 72.140000000000001 107.962 170.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.499 ' HB3' ' HA ' ' B' ' 245' ' ' VAL . 11.2 t80 -125.51 124.34 41.12 Favored 'General case' 0 N--CA 1.395 -3.175 0 N-CA-C 107.623 -1.251 . . . . 61.509999999999998 107.623 -174.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.71 ' HA2' ' HB2' ' B' ' 249' ' ' ALA . . . 143.6 -48.03 0.77 Allowed Glycine 0 N--CA 1.429 -1.812 0 C-N-CA 120.653 -0.784 . . . . 75.209999999999994 111.747 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . 0.446 ' HA3' HG23 ' C' ' 246' ' ' THR . . . 111.59 -23.72 17.03 Favored Glycine 0 C--O 1.206 -1.62 0 N-CA-C 108.578 -1.809 . . . . 60.409999999999997 108.578 -175.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . 0.555 ' HE2' ' CD2' ' C' ' 290' ' ' HIS . 62.4 mttm -141.92 81.88 1.78 Allowed 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 106.886 -1.524 . . . . 75.409999999999997 106.886 173.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -103.88 -159.93 24.61 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 109.492 -1.443 . . . . 64.439999999999998 109.492 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.55 ' H ' HG11 ' B' ' 244' ' ' VAL . 71.3 t80 63.3 -175.04 0.15 Allowed 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 122.912 0.485 . . . . 71.540000000000006 110.54 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -96.5 -16.77 20.95 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.528 -1.357 . . . . 74.200000000000003 112.292 -174.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -95.34 6.89 47.79 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.379 0.609 . . . . 72.439999999999998 112.227 -172.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -70.89 -4.32 23.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.933 . . . . 71.519999999999996 112.014 -179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -102.53 5.79 39.57 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.325 1.06 . . . . 64.239999999999995 108.709 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . 0.576 ' CD2' ' H ' ' A' ' 294' ' ' HIS . 17.9 t-160 -124.37 26.61 7.29 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 122.221 1.01 . . . . 63.32 109.333 -176.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . 0.426 ' HB2' ' HA ' ' C' ' 288' ' ' ASP . 9.2 p80 -75.98 164.78 25.83 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-N 114.99 -1.004 . . . . 72.230000000000004 110.458 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -111.72 -39.02 4.7 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 111.926 0.343 . . . . 72.329999999999998 111.926 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -89.47 127.55 35.86 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.123 -1.066 . . . . 74.209999999999994 108.123 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 . . . . . 0 C--N 1.288 -2.101 0 N-CA-C 108.149 -1.056 . . . . 73.239999999999995 108.149 178.108 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.245 0 N-CA-C 109.779 -0.452 . . . . 72.310000000000002 109.779 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -77.67 128.96 34.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.908 0.385 . . . . 70.200000000000003 110.936 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.463 ' O ' HG13 ' B' ' 219' ' ' ILE . 21.7 pt -141.29 -174.01 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 106.405 -1.702 . . . . 63.43 106.405 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -119.62 -170.96 2.04 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.812 -1.181 . . . . 51.439999999999998 107.812 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.93 -20.03 31.29 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.524 -0.917 . . . . 72.109999999999999 108.524 177.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 56.8 mt -107.21 126.75 63.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 105.811 -1.922 . . . . 23.34 105.811 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.89 120.62 52.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 113.559 0.948 . . . . 73.099999999999994 113.559 -174.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' B' ' 260' ' ' THR . . . -104.34 82.75 0.37 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 107.356 -2.298 . . . . 65.230000000000004 107.356 173.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -118.47 133.45 55.86 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 113.707 1.003 . . . . 72.019999999999996 113.707 -169.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -117.24 120.58 38.68 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 114.03 -1.441 . . . . 74.239999999999995 108.706 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' C' ' 263' ' ' SER . 42.7 m -121.17 137.08 54.84 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 109.706 -0.479 . . . . 74.200000000000003 109.706 177.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -133.3 144.38 49.66 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.458 -0.942 . . . . 72.420000000000002 108.458 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -58.78 1.82 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 119.544 -0.862 . . . . 73.230000000000004 110.883 -175.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' C' ' 266' ' ' THR . 1.2 m-20 -127.23 139.47 52.9 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.295 0.569 . . . . 75.150000000000006 110.734 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.428 HD11 ' HB1' ' C' ' 228' ' ' ALA . 32.6 mm -128.87 118.05 46.0 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 106.454 -1.684 . . . . 74.0 106.454 178.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -118.91 115.1 23.67 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.841 -0.429 . . . . 71.329999999999998 109.841 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . . . . . . . . . 80.5 p -112.19 127.4 55.93 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 108.326 -0.99 . . . . 73.230000000000004 108.326 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.502 ' HG2' ' HB3' ' B' ' 270' ' ' LYS . 43.8 mt-10 -138.9 139.34 38.02 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 121.119 -0.232 . . . . 71.510000000000005 110.41 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.559 ' HB3' ' NH1' ' C' ' 236' ' ' ARG . 49.2 mt-10 56.76 95.7 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 115.539 1.681 . . . . 62.200000000000003 115.539 174.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.559 ' NH1' ' HB3' ' C' ' 235' ' ' GLU . 0.5 OUTLIER 61.06 24.14 14.26 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.164 0.986 . . . . 61.030000000000001 111.712 175.08 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -91.8 139.57 30.54 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.958 0.885 . . . . 75.5 112.774 -175.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.618 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 8.8 mpt_? -125.65 135.45 52.16 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.17 -1.377 . . . . 72.109999999999999 108.309 177.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.497 HG23 HG13 ' B' ' 275' ' ' VAL . 30.5 m -138.13 147.34 25.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 121.313 0.578 . . . . 64.450000000000003 110.66 172.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -121.1 129.53 53.35 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.089 -1.819 . . . . 75.349999999999994 106.089 178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.496 ' HB3' HG22 ' B' ' 277' ' ' ILE . 2.8 tm? -122.0 118.58 29.16 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 106.162 -1.792 . . . . 74.200000000000003 106.162 177.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 135.54 -127.77 4.42 Favored Glycine 0 N--CA 1.416 -2.7 0 C-N-CA 120.179 -1.01 . . . . 53.240000000000002 111.421 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.596 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 45.9 t30 -144.34 130.36 19.47 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 120.525 0.202 . . . . 63.229999999999997 110.783 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.408 HG11 ' H ' ' C' ' 286' ' ' PHE . 85.2 t -110.92 117.88 56.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 123.713 0.805 . . . . 70.129999999999995 109.258 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 18.3 m -107.82 119.26 57.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 120.147 -0.621 . . . . 71.239999999999995 110.479 176.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . 0.446 HG23 ' HA3' ' B' ' 283' ' ' GLY . 29.7 m -84.6 158.66 20.82 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 120.943 -0.303 . . . . 54.149999999999999 111.223 -176.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.412 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.15 -47.83 78.4 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 122.159 0.98 . . . . 55.240000000000002 110.871 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.38 -35.98 65.87 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.265 -1.789 . . . . 72.109999999999999 112.807 -178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . 0.666 ' HB2' ' HA2' ' C' ' 282' ' ' GLY . . . -74.11 -29.91 62.07 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.166 -0.47 . . . . 41.420000000000002 111.967 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.22 98.24 7.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 122.272 1.034 . . . . 62.399999999999999 110.912 -174.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -98.32 -50.62 4.26 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.018 -1.447 . . . . 73.120000000000005 107.655 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -175.58 45.24 0.12 Allowed Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.689 -0.767 . . . . 55.210000000000001 112.778 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 164.19 136.33 1.98 Allowed Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.058 -1.068 . . . . 71.430000000000007 112.482 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 46.0 mm -106.87 89.2 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.896 -1.15 . . . . 63.549999999999997 107.896 175.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . 0.515 ' HD2' ' OD2' ' B' ' 258' ' ' ASP . 86.0 mtt180 58.77 -168.08 0.14 Allowed 'General case' 0 C--O 1.239 0.544 0 O-C-N 124.2 0.938 . . . . 71.140000000000001 113.259 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 12.8 tt -151.91 -38.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 114.994 -1.003 . . . . 64.420000000000002 109.5 174.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 26.9 t -162.48 121.37 2.23 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 109.888 -0.412 . . . . 72.519999999999996 109.888 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -125.95 138.3 53.76 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.032 -1.099 . . . . 74.129999999999995 108.032 177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -130.93 36.19 3.89 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.352 1.072 . . . . 72.340000000000003 109.975 -175.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 10.3 m -82.88 138.49 33.88 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.614 -0.721 . . . . 71.129999999999995 109.704 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 38.4 m -126.86 111.55 14.29 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.651 -0.656 . . . . 73.239999999999995 110.048 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -123.71 136.02 54.21 Favored 'General case' 0 CA--C 1.493 -1.22 0 CA-C-O 120.989 0.423 . . . . 71.230000000000004 109.862 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' C' ' 227' ' ' SER . 33.2 m -142.83 130.41 21.3 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 109.133 -0.692 . . . . 73.329999999999998 109.133 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.38 153.42 34.88 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 109.507 -0.553 . . . . 61.119999999999997 109.507 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -85.35 -74.76 0.39 Allowed 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.477 -0.564 . . . . 75.219999999999999 109.477 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 60.4 m -138.41 134.11 33.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.687 -0.633 . . . . 72.349999999999994 110.693 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.54 136.04 57.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 N-CA-C 108.374 -0.973 . . . . 72.519999999999996 108.374 174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.18 137.16 58.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 116.514 -0.312 . . . . 70.439999999999998 110.308 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.48 133.02 7.51 Favored Glycine 0 CA--C 1.477 -2.335 0 N-CA-C 110.933 -0.867 . . . . 71.219999999999999 110.933 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -133.91 115.03 13.95 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.847 -0.797 . . . . 73.129999999999995 108.847 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 74.47 108.75 0.08 OUTLIER Glycine 0 CA--C 1.527 0.834 0 O-C-N 123.843 0.714 . . . . 74.019999999999996 114.42 175.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 58.64 20.32 7.61 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 123.716 0.807 . . . . 72.519999999999996 112.282 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 24.4 m -83.76 144.2 29.48 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-O 121.233 0.539 . . . . 72.310000000000002 110.504 -173.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 0.0 OUTLIER -150.32 128.34 11.87 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.907 -0.588 . . . . 73.230000000000004 109.677 174.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 10.1 t -136.75 140.93 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.225 0 O-C-N 123.78 0.675 . . . . 60.420000000000002 109.232 -173.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.9 tt -112.03 116.67 30.93 Favored 'General case' 0 N--CA 1.407 -2.587 0 N-CA-C 107.939 -1.134 . . . . 61.219999999999999 107.939 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 3.2 mp -101.27 104.45 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.889 0 N-CA-C 106.555 -1.646 . . . . 71.030000000000001 106.555 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . 0.482 ' C ' HD22 ' C' ' 279' ' ' ASN . . . 138.13 -128.48 4.22 Favored Glycine 0 N--CA 1.409 -3.152 0 C-N-CA 119.446 -1.359 . . . . 32.039999999999999 112.092 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . 0.596 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 1.0 OUTLIER -128.04 138.96 52.77 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.057 0.456 . . . . 73.420000000000002 111.822 -173.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -126.62 145.79 50.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.325 -1.361 . . . . 71.519999999999996 107.325 168.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -125.85 123.35 38.49 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 108.305 -0.998 . . . . 75.120000000000005 108.305 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . 0.666 ' HA2' ' HB2' ' C' ' 249' ' ' ALA . . . 134.03 9.77 1.87 Allowed Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 115.59 -0.732 . . . . 72.109999999999999 113.989 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 80.99 -47.93 3.66 Favored Glycine 0 CA--C 1.506 -0.479 0 CA-C-N 117.92 0.86 . . . . 35.329999999999998 111.771 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . 0.517 ' HD3' ' OD1' ' C' ' 289' ' ' ASN . 96.0 mttt -136.65 96.61 3.37 Favored 'General case' 0 N--CA 1.413 -2.302 0 N-CA-C 107.473 -1.306 . . . . 73.409999999999997 107.473 174.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -110.06 -159.74 17.73 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 108.666 -1.773 . . . . 44.329999999999998 108.666 173.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.408 ' H ' HG11 ' C' ' 244' ' ' VAL . 60.6 t80 73.87 169.97 0.3 Allowed 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 123.803 0.841 . . . . 75.310000000000002 110.993 176.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -71.01 -27.54 63.77 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 116.81 2.152 . . . . 74.219999999999999 116.81 -167.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' B' ' 292' ' ' HIS . 27.0 t0 -78.11 -78.53 0.14 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 119.824 -0.75 . . . . 74.209999999999994 112.277 -171.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . 0.517 ' OD1' ' HD3' ' C' ' 284' ' ' LYS . 17.3 t-20 -120.13 130.87 54.82 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.361 -0.607 . . . . 74.450000000000003 109.361 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . 0.555 ' CD2' ' HE2' ' B' ' 284' ' ' LYS . 0.3 OUTLIER -133.57 -171.0 2.6 Favored 'General case' 0 C--O 1.25 1.1 0 C-N-CA 120.798 -0.361 . . . . 73.219999999999999 110.782 -174.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 80.32 105.26 0.07 Allowed 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.006 1.323 . . . . 71.030000000000001 112.567 175.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -170.05 172.9 6.22 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 105.665 -1.976 . . . . 75.140000000000001 105.665 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -123.36 98.87 6.05 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.531 -0.914 . . . . 70.349999999999994 108.531 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 52.2 t60 -177.61 -179.96 0.86 Allowed 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 104.402 -2.444 . . . . 62.409999999999997 104.402 -176.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 56.4 m170 . . . . . 0 C--N 1.304 -1.403 0 N-CA-C 108.335 -0.987 . . . . 72.150000000000006 108.335 174.473 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.66 ' HB3' ' HB2' ' B' ' 258' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.49 0 N-CA-C 109.617 -0.512 . . . . 73.209999999999994 109.617 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -138.49 148.68 44.59 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 105.362 -2.088 . . . . 75.329999999999998 105.362 171.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.5 pt -92.77 147.94 5.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.424 -0.511 . . . . 74.450000000000003 111.827 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 221' ' ' ALA . 10.5 t70 64.31 -169.64 0.2 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 125.546 1.538 . . . . 74.349999999999994 111.812 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.489 ' H ' ' CG ' ' A' ' 220' ' ' ASP . . . 70.79 163.14 0.25 Allowed 'General case' 0 C--N 1.356 0.873 0 C-N-CA 125.805 1.642 . . . . 72.519999999999996 108.549 -170.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 3.1 mp -83.9 112.32 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 C-N-CA 116.495 -2.082 . . . . 72.329999999999998 107.523 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 24.2 m -140.11 165.54 21.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 N-CA-C 107.743 -1.206 . . . . 71.219999999999999 107.743 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 96.06 34.78 5.78 Favored Glycine 0 C--N 1.289 -2.028 0 C-N-CA 119.16 -1.495 . . . . 50.219999999999999 112.225 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.15 154.52 44.92 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 108.43 -0.952 . . . . 75.319999999999993 108.43 175.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -86.34 133.89 33.77 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 107.479 -1.304 . . . . 71.349999999999994 107.479 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 32.9 m -133.63 141.79 47.79 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 121.318 0.58 . . . . 75.299999999999997 112.386 -176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -138.34 137.88 37.79 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.003 -1.851 . . . . 74.099999999999994 106.003 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.41 -48.04 10.06 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.684 -0.858 . . . . 73.230000000000004 108.684 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -140.15 140.64 36.0 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 119.76 -0.776 . . . . 71.019999999999996 111.646 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 62.6 mt -126.49 117.17 47.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 106.806 -1.553 . . . . 71.439999999999998 106.806 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 69.2 ttt-85 -118.92 115.96 25.47 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.619 -0.833 . . . . 63.539999999999999 110.127 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.1 t -113.11 128.69 56.56 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.602 -0.726 . . . . 65.239999999999995 109.276 178.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.425 ' HG2' ' HG3' ' A' ' 235' ' ' GLU . 40.3 tt0 -150.23 139.81 21.58 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 108.435 -0.95 . . . . 73.540000000000006 108.435 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.425 ' HG3' ' HG2' ' A' ' 234' ' ' GLU . 43.9 mt-10 65.6 89.14 0.1 Allowed 'General case' 0 C--O 1.22 -0.48 0 O-C-N 124.409 1.068 . . . . 73.120000000000005 113.075 177.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.439 ' HD2' ' O ' ' A' ' 271' ' ' GLY . 36.2 mtt85 66.33 -4.82 0.65 Allowed 'General case' 0 N--CA 1.503 2.185 0 C-N-CA 124.448 1.099 . . . . 62.210000000000001 113.136 171.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.431 ' HA ' ' H ' ' A' ' 273' ' ' SER . . . -70.61 143.44 51.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 123.352 0.661 . . . . 74.439999999999998 111.2 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -126.37 135.81 51.92 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 107.979 -1.119 . . . . 71.540000000000006 107.979 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.431 HG12 ' HB ' ' A' ' 275' ' ' VAL . 34.7 m -128.73 150.82 34.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 120.844 0.354 . . . . 70.329999999999998 111.666 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.409 ' HG2' ' CG2' ' A' ' 244' ' ' VAL . 7.2 tp-100 -134.05 134.55 42.5 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.137 -0.938 . . . . 75.129999999999995 108.831 176.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -128.14 119.28 24.97 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.583 -1.266 . . . . 74.310000000000002 107.583 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.501 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 132.35 -115.67 1.67 Allowed Glycine 0 N--CA 1.436 -1.365 0 C-N-CA 119.991 -1.1 . . . . 63.149999999999999 112.689 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -143.51 135.86 27.05 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.301 -0.629 . . . . 53.25 109.301 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.409 ' CG2' ' HG2' ' A' ' 240' ' ' GLN . 99.0 t -116.94 120.63 65.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 107.46 -1.311 . . . . 73.129999999999995 107.46 175.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 7.3 p -122.73 117.19 51.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 108.996 -0.742 . . . . 64.209999999999994 108.996 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 90.5 m -77.48 159.72 29.17 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.064 -0.717 . . . . 75.019999999999996 109.064 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.38 -38.83 91.1 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.538 0.735 . . . . 64.310000000000002 112.122 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -60.13 -33.74 72.57 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 123.861 0.864 . . . . 72.120000000000005 111.551 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.56 -26.86 64.69 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.642 -0.708 . . . . 61.340000000000003 112.223 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -67.09 122.73 18.42 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.869 -0.419 . . . . 74.010000000000005 109.869 178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 6.4 t60 69.98 86.82 0.12 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.828 1.251 . . . . 62.549999999999997 108.275 -171.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -162.33 103.13 0.21 Allowed Glycine 0 N--CA 1.42 -2.376 0 N-CA-C 108.779 -1.729 . . . . 75.140000000000001 108.779 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 84.75 172.37 49.05 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.503 -0.856 . . . . 72.439999999999998 111.644 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 13.8 tt -109.57 -20.75 6.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.065 0.459 . . . . 74.540000000000006 111.29 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.455 ' HB2' ' HA2' ' B' ' 252' ' ' GLY . 99.5 mtt180 -129.63 147.58 51.43 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 113.024 0.75 . . . . 74.5 113.024 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 8.0 tt -108.07 91.3 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 107.144 -1.428 . . . . 64.140000000000001 107.144 172.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 16.1 m -80.48 -44.75 18.66 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.705 -1.134 . . . . 53.25 113.824 -172.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.408 ' OD2' HG23 ' A' ' 260' ' ' THR . 16.3 t70 -86.04 127.19 34.61 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 119.873 -0.731 . . . . 52.329999999999998 111.486 -175.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -135.31 66.57 1.52 Allowed 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.831 -1.174 . . . . 65.450000000000003 107.831 174.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.408 HG23 ' OD2' ' A' ' 258' ' ' ASP . 0.8 OUTLIER -64.68 138.42 58.38 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 114.367 1.247 . . . . 71.329999999999998 114.367 -177.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 39.1 m -101.75 115.68 31.07 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 106.701 -1.592 . . . . 75.140000000000001 106.701 172.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -121.15 141.43 50.83 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.213 -1.032 . . . . 73.329999999999998 108.213 -177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.7 p -136.23 123.4 21.71 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.056 -0.52 . . . . 74.430000000000007 111.588 -172.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 13.4 p -129.0 148.28 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.37 0 N-CA-C 108.917 -0.772 . . . . 72.439999999999998 108.917 175.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 34.5 tt0 -85.89 -69.16 0.68 Allowed 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.686 -0.487 . . . . 74.230000000000004 109.686 176.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 28.6 m -126.09 128.06 46.77 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.315 -0.554 . . . . 72.400000000000006 111.404 -173.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 36.0 m -119.77 125.67 74.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.049 0 N-CA-C 109.101 -0.704 . . . . 71.109999999999999 109.101 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 20.6 m -127.14 134.9 64.99 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 116.078 -0.51 . . . . 55.329999999999998 112.063 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -123.96 132.27 8.31 Favored Glycine 0 N--CA 1.437 -1.284 0 N-CA-C 111.298 -0.721 . . . . 60.439999999999998 111.298 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 26.3 mmmt -133.76 147.6 51.31 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 124.117 0.967 . . . . 71.209999999999994 112.175 -178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.439 ' O ' ' HD2' ' A' ' 236' ' ' ARG . . . 84.53 -57.82 5.01 Favored Glycine 0 CA--C 1.502 -0.732 0 CA-C-N 115.981 -0.554 . . . . 75.530000000000001 112.453 174.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.493 ' HG3' ' CE1' ' A' ' 292' ' ' HIS . 0.7 OUTLIER 179.6 121.3 0.06 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 103.468 -2.79 . . . . 63.509999999999998 103.468 176.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 68.6 m -151.28 155.88 39.67 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-O 120.902 0.382 . . . . 52.210000000000001 110.685 -175.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . 0.478 ' HB2' ' HB3' ' B' ' 238' ' ' ARG . 2.2 mpt_? -127.75 127.92 44.45 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 106.206 -1.776 . . . . 74.030000000000001 106.206 174.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.431 ' HB ' HG12 ' A' ' 239' ' ' VAL . 33.5 t -129.1 129.79 67.92 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 109.583 -0.525 . . . . 74.420000000000002 109.583 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.502 ' HB3' ' OE1' ' B' ' 240' ' ' GLN . 4.8 tt -125.32 118.94 27.04 Favored 'General case' 0 C--N 1.287 -2.135 0 N-CA-C 108.197 -1.038 . . . . 63.009999999999998 108.197 172.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 43.5 mm -107.99 104.86 17.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.957 -1.127 . . . . 71.040000000000006 107.957 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 144.77 -140.04 8.91 Favored Glycine 0 N--CA 1.419 -2.464 0 C-N-CA 120.66 -0.781 . . . . 71.219999999999999 111.794 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -115.18 140.36 49.14 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 109.72 -0.474 . . . . 73.230000000000004 109.72 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.43 129.52 53.93 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.193 -2.151 . . . . 63.109999999999999 105.193 174.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 2.0 t80 -127.49 122.81 34.4 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 107.228 -1.397 . . . . 72.319999999999993 107.228 178.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 142.72 -52.95 0.63 Allowed Glycine 0 N--CA 1.412 -2.93 0 N-CA-C 108.624 -1.79 . . . . 61.25 108.624 -175.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 139.02 -57.84 0.62 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 111.17 -0.772 . . . . 64.140000000000001 111.17 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.557 ' HA ' ' NE1' ' A' ' 287' ' ' TRP . 0.0 OUTLIER -132.18 35.2 3.72 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.948 0.88 . . . . 74.040000000000006 110.617 -176.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -57.29 -31.26 62.29 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 116.002 1.161 . . . . 70.019999999999996 116.002 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.455 ' CB ' HD12 ' A' ' 276' ' ' LEU . 71.0 t80 -114.72 0.22 13.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.908 0.861 . . . . 72.530000000000001 110.535 -178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.557 ' NE1' ' HA ' ' A' ' 284' ' ' LYS . 10.5 p90 -137.66 87.41 2.26 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.888 0.852 . . . . 73.340000000000003 111.291 -177.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -86.86 -45.57 10.74 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.415 -0.811 . . . . 75.109999999999999 109.698 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -156.62 165.15 37.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.591 -0.731 . . . . 74.030000000000001 111.474 -175.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -103.68 74.55 1.25 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 121.861 0.839 . . . . 62.350000000000001 110.9 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -68.57 80.41 0.27 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.667 -1.151 . . . . 72.340000000000003 110.175 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . 0.493 ' CE1' ' HG3' ' A' ' 272' ' ' GLU . 3.6 m170 169.51 84.92 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 127.961 2.504 . . . . 74.200000000000003 109.91 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -94.75 -22.09 18.31 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.98 -1.119 . . . . 73.549999999999997 107.98 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 64.78 22.11 12.49 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 125.366 1.466 . . . . 73.329999999999998 112.155 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 16.7 t60 . . . . . 0 C--N 1.313 -0.979 0 N-CA-C 107.353 -1.351 . . . . 65.409999999999997 107.353 176.271 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 110.093 -0.336 . . . . 71.409999999999997 110.093 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -72.93 104.54 4.1 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 123.294 0.638 . . . . 73.510000000000005 110.978 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . 0.606 ' H ' HD13 ' B' ' 219' ' ' ILE . 0.2 OUTLIER -89.16 -17.16 8.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 116.295 -0.412 . . . . 73.349999999999994 110.593 176.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 2.2 t0 75.28 -173.99 0.12 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.719 1.608 . . . . 60.009999999999998 110.832 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -114.89 19.9 15.52 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.765 0.654 . . . . 72.140000000000001 112.765 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 2.1 mp -84.06 125.14 40.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 109.195 -0.669 . . . . 62.310000000000002 109.195 177.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 217' ' ' MET . 27.7 m -100.03 163.82 2.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-N 116.306 -0.406 . . . . 72.150000000000006 110.277 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 98.47 43.43 2.73 Favored Glycine 0 CA--C 1.49 -1.524 0 N-CA-C 110.253 -1.139 . . . . 31.43 110.253 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -142.13 154.23 44.72 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 121.019 0.438 . . . . 72.329999999999998 110.077 -175.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -94.03 129.86 40.39 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 103.865 -2.643 . . . . 54.25 103.865 167.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 23.9 m -131.69 137.08 48.14 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.104 -1.038 . . . . 72.530000000000001 111.63 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.501 ' HB2' HG21 ' B' ' 277' ' ' ILE . . . -132.2 135.82 46.6 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.611 -1.255 . . . . 74.450000000000003 107.611 175.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 0.1 OUTLIER -82.77 -61.47 1.86 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.747 -0.835 . . . . 70.209999999999994 108.747 -178.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -134.24 139.46 45.78 Favored 'General case' 0 C--O 1.254 1.318 0 C-N-CA 120.036 -0.666 . . . . 75.540000000000006 109.409 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 10.9 mt -128.43 116.77 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 N-CA-C 107.199 -1.408 . . . . 72.25 107.199 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.412 ' HB3' HG12 ' B' ' 268' ' ' VAL . 56.1 ttt180 -113.3 118.83 35.71 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.216 -0.447 . . . . 72.349999999999994 110.286 178.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.46 ' O ' ' HA2' ' A' ' 269' ' ' GLY . 0.0 OUTLIER -110.82 128.65 55.85 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 108.713 -0.847 . . . . 75.219999999999999 108.713 175.025 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 33.9 tt0 -147.46 138.88 23.84 Favored 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 108.543 -0.91 . . . . 74.030000000000001 108.543 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.556 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 52.5 mt-10 65.09 94.85 0.06 Allowed 'General case' 0 C--N 1.32 -0.678 0 O-C-N 124.675 1.235 . . . . 60.549999999999997 113.273 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.556 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 58.6 15.78 3.88 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 125.459 1.503 . . . . 70.540000000000006 112.711 171.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -92.33 149.05 21.66 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 121.526 0.679 . . . . 74.400000000000006 111.911 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.478 ' HB3' ' HB2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -129.45 135.75 49.05 Favored 'General case' 0 CA--C 1.487 -1.448 0 CA-C-N 115.612 -0.722 . . . . 72.430000000000007 110.183 175.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.518 HG12 ' HB ' ' B' ' 275' ' ' VAL . 30.4 m -125.87 136.8 59.73 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 124.089 0.868 . . . . 65.239999999999995 109.987 -177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.502 ' OE1' ' HB3' ' A' ' 276' ' ' LEU . 38.8 tp60 -115.92 132.94 56.5 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 114.866 -1.061 . . . . 73.140000000000001 108.693 176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -126.28 118.36 24.94 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 107.348 -1.353 . . . . 75.0 107.348 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 134.04 -114.12 1.28 Allowed Glycine 0 N--CA 1.415 -2.759 0 C-N-CA 120.044 -1.074 . . . . 72.349999999999994 111.924 177.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -144.31 140.32 29.08 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.796 -0.446 . . . . 73.109999999999999 109.796 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.499 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 97.7 t -122.11 114.87 44.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.239 -1.393 . . . . 71.200000000000003 107.239 175.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.453 ' CG2' ' HB2' ' B' ' 250' ' ' LEU . 4.2 p -122.13 118.5 55.66 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-O 121.21 0.529 . . . . 65.340000000000003 109.803 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 28.7 m -71.09 158.85 35.76 Favored 'General case' 0 CA--C 1.56 1.334 0 N-CA-C 109.05 -0.722 . . . . 72.140000000000001 109.05 -178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.98 -47.41 80.47 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.038 0.923 . . . . 65.349999999999994 111.291 -177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.87 -34.77 79.17 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.896 -1.502 . . . . 64.200000000000003 111.847 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.497 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -67.88 -40.31 83.55 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.506 0.928 . . . . 72.25 113.506 -173.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.453 ' HB2' ' CG2' ' B' ' 245' ' ' VAL . 26.6 tp -83.7 75.4 10.07 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.043 -0.663 . . . . 64.209999999999994 111.93 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -84.8 -54.5 4.64 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.42 -0.809 . . . . 74.510000000000005 110.373 176.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 255' ' ' ARG . . . 176.47 -160.1 27.46 Favored Glycine 0 N--CA 1.417 -2.627 0 C-N-CA 120.314 -0.946 . . . . 64.219999999999999 111.788 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 138.94 -147.21 19.06 Favored Glycine 0 N--CA 1.423 -2.193 0 N-CA-C 109.358 -1.497 . . . . 64.209999999999994 109.358 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 49.9 mm -117.27 136.02 55.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 107.627 -1.249 . . . . 75.439999999999998 107.627 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -60.62 125.21 22.83 Favored 'General case' 0 C--O 1.245 0.854 0 O-C-N 123.527 0.517 . . . . 72.310000000000002 109.683 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 2.5 pp -111.39 154.24 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.006 0 CA-C-O 121.045 0.45 . . . . 73.510000000000005 110.549 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 13.0 m -128.44 13.96 6.57 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.404 -1.332 . . . . 61.420000000000002 107.404 174.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.66 ' HB2' ' HB3' ' A' ' 217' ' ' MET . 15.6 t70 -173.27 130.78 0.47 Allowed 'General case' 0 CA--C 1.493 -1.225 0 CA-C-N 114.081 -1.418 . . . . 73.400000000000006 108.14 -175.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . 0.289 1.1 pt20 -144.03 -97.44 0.11 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 123.624 0.578 . . . . 61.229999999999997 111.193 173.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.408 ' HA ' ' OD2' ' C' ' 258' ' ' ASP . 16.2 p -94.3 131.84 39.5 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 118.757 0.708 . . . . 71.200000000000003 111.379 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 53.9 m -106.11 108.16 19.53 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 107.459 -1.312 . . . . 60.32 107.459 176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -124.65 131.83 53.45 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.641 -1.244 . . . . 64.409999999999997 107.641 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 15.7 m -121.54 123.79 42.85 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.835 -0.62 . . . . 40.149999999999999 110.521 -174.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 8.4 p -126.29 149.86 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 108.024 -1.102 . . . . 63.409999999999997 108.024 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 12.8 tt0 -93.95 -77.94 0.44 Allowed 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.97 -0.752 . . . . 75.420000000000002 108.97 175.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 28.8 m -113.26 127.54 56.19 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 120.25 -0.58 . . . . 62.100000000000001 110.854 -175.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 p -128.83 120.68 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-O 121.695 0.759 . . . . 61.32 109.512 176.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . 0.412 HG12 ' HB3' ' B' ' 232' ' ' ARG . 27.0 m -126.92 141.55 45.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.623 -0.717 . . . . 72.120000000000005 112.199 -174.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.72 132.41 7.92 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 110.982 -0.847 . . . . 61.420000000000002 110.982 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.534 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 25.4 mmmt -133.87 148.83 51.3 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 124.205 1.002 . . . . 52.020000000000003 112.541 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' B' ' 236' ' ' ARG . . . 85.57 -57.99 4.88 Favored Glycine 0 CA--C 1.499 -0.945 0 C-N-CA 121.362 -0.447 . . . . 71.349999999999994 112.954 174.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 176.24 114.17 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 103.279 -2.86 . . . . 72.25 103.279 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 67.1 m -146.79 160.22 42.53 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.734 0.778 . . . . 72.540000000000006 112.448 -175.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.532 ' HD3' ' HB3' ' C' ' 238' ' ' ARG . 0.7 OUTLIER -129.48 127.58 41.14 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 105.799 -1.926 . . . . 70.099999999999994 105.799 176.354 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.518 ' HB ' HG12 ' B' ' 239' ' ' VAL . 41.5 t -132.02 126.31 56.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 109.658 -0.497 . . . . 71.340000000000003 109.658 -176.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.495 HD12 ' CB ' ' B' ' 286' ' ' PHE . 4.7 tt -121.78 118.7 29.69 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.752 -1.179 . . . . 74.310000000000002 108.029 173.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.501 HG21 ' HB2' ' B' ' 228' ' ' ALA . 44.6 mm -108.18 104.23 16.74 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 106.952 -1.499 . . . . 75.319999999999993 106.952 176.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 146.36 -158.02 27.57 Favored Glycine 0 CA--C 1.476 -2.39 0 C-N-CA 120.358 -0.925 . . . . 61.130000000000003 113.204 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -96.38 138.86 33.35 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 109.293 -0.632 . . . . 73.030000000000001 109.293 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -121.32 126.8 50.37 Favored 'General case' 0 N--CA 1.405 -2.714 0 N-CA-C 105.801 -1.925 . . . . 73.239999999999995 105.801 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.543 ' CD1' HG13 ' C' ' 245' ' ' VAL . 1.3 t80 -123.63 123.56 40.83 Favored 'General case' 0 N--CA 1.405 -2.716 0 N-CA-C 107.304 -1.369 . . . . 60.219999999999999 107.304 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' B' ' 249' ' ' ALA . . . 142.59 -43.98 1.01 Allowed Glycine 0 N--CA 1.414 -2.816 0 N-CA-C 108.809 -1.716 . . . . 72.129999999999995 108.809 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.24 -29.0 8.26 Favored Glycine 0 N--CA 1.423 -2.215 0 N-CA-C 111.678 -0.569 . . . . 44.219999999999999 111.678 177.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . 0.533 ' HA ' ' CD1' ' B' ' 287' ' ' TRP . 42.6 pttt -149.04 19.84 0.98 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.679 -0.409 . . . . 73.299999999999997 111.974 -175.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -53.97 -43.49 71.96 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.117 -0.563 . . . . 75.319999999999993 114.226 -172.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.495 ' CB ' HD12 ' B' ' 276' ' ' LEU . 62.1 t80 -97.69 -1.09 44.31 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.685 0.755 . . . . 73.450000000000003 111.202 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.533 ' CD1' ' HA ' ' B' ' 284' ' ' LYS . 13.6 p90 -145.74 95.09 2.59 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.329 0.585 . . . . 75.430000000000007 110.926 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . 0.473 ' OD2' ' HA ' ' B' ' 291' ' ' HIS . 37.4 t70 -77.51 81.95 3.95 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 122.004 0.907 . . . . 74.140000000000001 110.096 -177.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -80.14 -53.59 6.54 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.464 -1.244 . . . . 72.329999999999998 108.773 -178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -82.18 101.64 10.59 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 103.409 -2.811 . . . . 74.299999999999997 103.409 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . 0.473 ' HA ' ' OD2' ' B' ' 288' ' ' ASP . 51.9 t-80 -53.29 127.26 23.96 Favored 'General case' 0 C--O 1.248 0.982 0 O-C-N 124.154 0.909 . . . . 75.340000000000003 112.278 -169.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -60.45 152.58 25.29 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.197 -0.91 . . . . 73.540000000000006 111.47 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 61.5 m-70 -94.65 -86.38 0.28 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.637 -1.616 . . . . 71.430000000000007 106.637 174.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -146.1 -177.6 5.69 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 105.965 -1.865 . . . . 74.310000000000002 105.965 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 . . . . . 0 C--N 1.294 -1.841 0 C-N-CA 120.538 -0.465 . . . . 72.420000000000002 109.822 178.44 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . 0.439 ' SD ' ' N ' ' C' ' 218' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.517 -0.316 0 N-CA-C 105.715 -1.957 . . . . 72.25 105.715 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . 0.439 ' N ' ' SD ' ' C' ' 217' ' ' MET . 7.1 tmtm? -78.7 -40.99 32.23 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.924 -1.51 . . . . 53.229999999999997 106.924 177.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 15.8 tt -144.8 136.34 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 108.927 -0.768 . . . . 51.520000000000003 108.927 177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -150.31 141.2 22.85 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 122.846 0.458 . . . . 70.540000000000006 110.438 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 60.79 88.47 0.08 Allowed 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.602 1.161 . . . . 63.0 112.858 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 0.554 ' HB ' HH21 ' C' ' 225' ' ' ARG . 3.5 mp -106.67 114.49 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 N-CA-C 107.563 -1.273 . . . . 41.399999999999999 107.563 177.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.92 165.34 9.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-N 115.102 -0.954 . . . . 73.140000000000001 109.938 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.13 51.84 4.03 Favored Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 109.674 -1.37 . . . . 61.350000000000001 109.674 -176.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.554 HH21 ' HB ' ' C' ' 222' ' ' ILE . 8.5 ptp180 -143.3 154.44 43.78 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 107.955 -1.128 . . . . 62.329999999999998 107.955 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -93.29 133.2 36.76 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 107.569 -1.271 . . . . 73.310000000000002 107.569 172.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 48.8 m -140.67 141.8 34.98 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 113.549 0.944 . . . . 64.409999999999997 113.549 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -137.37 133.03 34.38 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.222 -1.029 . . . . 52.439999999999998 108.222 176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.458 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -76.67 -57.98 3.54 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.24 -0.652 . . . . 61.32 109.24 -178.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.14 140.0 41.56 Favored 'General case' 0 C--O 1.265 1.881 0 C-N-CA 120.041 -0.663 . . . . 74.400000000000006 110.84 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.442 HG23 HG23 ' C' ' 267' ' ' VAL . 11.9 mt -130.22 116.97 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 107.898 -1.149 . . . . 63.340000000000003 107.898 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.45 ' HB3' HG12 ' C' ' 268' ' ' VAL . 38.1 ttt180 -118.02 118.1 31.02 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.263 0.554 . . . . 73.329999999999998 110.625 177.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.469 ' HB ' HG13 ' C' ' 239' ' ' VAL . 0.0 OUTLIER -110.53 129.88 55.69 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 108.707 -0.849 . . . . 65.219999999999999 108.707 175.389 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 33.6 tt0 -144.13 138.56 28.28 Favored 'General case' 0 N--CA 1.415 -2.204 0 C-N-CA 120.317 -0.553 . . . . 73.109999999999999 109.515 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.571 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 51.0 mt-10 59.72 97.76 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.617 1.167 . . . . 63.439999999999998 114.018 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.571 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 0.2 OUTLIER 61.87 13.59 5.63 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 125.426 1.49 . . . . 73.340000000000003 112.333 172.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.38 151.46 19.38 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.443 0.64 . . . . 71.040000000000006 111.964 -174.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.532 ' HB3' ' HD3' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -132.91 135.47 45.58 Favored 'General case' 0 CA--C 1.486 -1.498 0 CA-C-N 115.44 -0.8 . . . . 73.319999999999993 110.823 178.191 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.475 HG12 ' HB ' ' C' ' 275' ' ' VAL . 33.1 m -127.85 138.32 55.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 CA-C-N 115.228 -0.897 . . . . 71.329999999999998 110.234 -177.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.489 ' OE1' ' HB3' ' B' ' 276' ' ' LEU . 38.4 tp60 -116.19 133.35 56.12 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.799 -1.091 . . . . 71.319999999999993 108.873 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -127.27 118.41 24.17 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 106.802 -1.555 . . . . 63.5 106.802 175.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.474 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 133.68 -117.94 1.98 Allowed Glycine 0 N--CA 1.422 -2.269 0 C-N-CA 119.918 -1.134 . . . . 75.319999999999993 111.007 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -144.67 140.01 28.36 Favored 'General case' 0 C--N 1.292 -1.906 0 O-C-N 123.582 0.224 . . . . 64.299999999999997 111.066 -177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.485 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 86.2 t -121.58 116.19 48.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 108.408 -0.96 . . . . 64.329999999999998 108.408 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.543 HG13 ' CD1' ' B' ' 281' ' ' TYR . 2.7 p -122.62 123.48 68.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 N-CA-C 109.46 -0.571 . . . . 74.109999999999999 109.46 176.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 24.9 m -77.84 159.29 29.06 Favored 'General case' 0 CA--C 1.563 1.455 0 N-CA-C 109.561 -0.533 . . . . 62.049999999999997 109.561 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.47 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.96 -46.53 81.18 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.308 1.052 . . . . 65.409999999999997 110.739 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.19 -33.81 67.85 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.215 -1.811 . . . . 72.439999999999998 112.245 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . 0.555 ' HB2' ' HA2' ' C' ' 282' ' ' GLY . . . -69.14 -26.6 64.96 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 113.085 0.772 . . . . 73.409999999999997 113.085 -176.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 9.5 mp 69.82 110.48 0.05 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.401 1.08 . . . . 75.230000000000004 112.236 -176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -61.27 -52.38 64.96 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 108.779 -0.823 . . . . 75.319999999999993 108.779 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 69.28 -126.84 20.19 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 115.081 -0.963 . . . . 73.150000000000006 111.014 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.45 170.87 15.84 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 120.624 -0.798 . . . . 64.349999999999994 112.066 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 6.1 tt -64.29 124.57 19.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 C-N-CA 123.537 0.735 . . . . 63.149999999999999 111.484 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 60.6 ttp85 -147.43 83.64 1.55 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 108.824 -0.806 . . . . 75.420000000000002 108.824 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 48.8 mm 69.25 -51.63 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 125.27 1.428 . . . . 63.119999999999997 113.213 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 11.1 m 69.22 -73.28 0.09 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 126.204 1.802 . . . . 71.519999999999996 111.863 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . 0.408 ' OD2' ' HA ' ' B' ' 260' ' ' THR . 12.0 m-20 -85.99 75.37 9.97 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 121.734 0.778 . . . . 74.430000000000007 109.409 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -90.48 -20.73 22.38 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.591 -0.731 . . . . 60.350000000000001 109.755 177.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 3.1 p -100.83 121.2 41.29 Favored 'General case' 0 N--CA 1.406 -2.626 0 N-CA-C 108.043 -1.095 . . . . 62.539999999999999 108.043 174.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 55.9 m -105.01 108.48 20.02 Favored 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 108.654 -0.869 . . . . 71.120000000000005 108.654 178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -119.45 131.93 55.71 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.867 -0.606 . . . . 75.209999999999994 109.39 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 14.9 m -117.76 122.98 44.88 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.439 0.638 . . . . 52.119999999999997 110.014 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 17.8 t -111.25 129.86 65.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.163 -0.926 . . . . 73.400000000000006 111.79 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -72.49 -75.68 0.13 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.488 -0.93 . . . . 64.310000000000002 108.488 173.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 86.9 m -148.94 136.56 20.42 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 121.22 -0.925 . . . . 73.540000000000006 110.006 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.442 HG23 HG23 ' C' ' 231' ' ' ILE . 15.9 m -124.05 129.96 73.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-N 116.012 -0.54 . . . . 71.209999999999994 109.758 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . 0.45 HG12 ' HB3' ' C' ' 232' ' ' ARG . 31.0 m -123.66 140.02 48.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 120.926 0.393 . . . . 71.310000000000002 110.602 -178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.31 132.58 9.64 Favored Glycine 0 C--N 1.299 -1.495 0 N-CA-C 110.879 -0.888 . . . . 65.439999999999998 110.879 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -134.54 128.92 34.25 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 123.432 0.693 . . . . 74.25 111.624 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 64.23 56.28 18.87 Favored Glycine 0 C--N 1.318 -0.462 0 O-C-N 123.553 0.533 . . . . 75.549999999999997 113.046 175.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 71.48 102.85 0.07 Allowed 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 125.467 1.507 . . . . 71.310000000000002 109.601 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 37.1 m -139.4 148.79 43.3 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.935 -1.029 . . . . 60.509999999999998 108.771 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -121.54 126.34 48.94 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.067 -1.827 . . . . 54.32 106.067 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.475 ' HB ' HG12 ' C' ' 239' ' ' VAL . 31.0 t -138.13 128.79 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.325 0 N-CA-C 110.042 -0.355 . . . . 65.319999999999993 110.042 -175.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 6.3 tt -124.72 117.91 25.27 Favored 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 107.97 -1.122 . . . . 53.43 107.97 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.438 HG21 ' HB2' ' C' ' 228' ' ' ALA . 50.1 mm -109.34 104.43 17.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.059 -1.089 . . . . 72.239999999999995 108.059 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 146.06 -154.85 26.21 Favored Glycine 0 CA--C 1.479 -2.179 0 C-N-CA 120.565 -0.826 . . . . 25.050000000000001 111.978 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -98.41 128.17 44.67 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.7 -0.482 . . . . 74.299999999999997 109.7 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -111.93 125.46 54.08 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.876 -1.527 . . . . 75.519999999999996 106.876 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -130.18 123.9 31.34 Favored 'General case' 0 N--CA 1.404 -2.765 0 CA-C-O 121.663 0.744 . . . . 64.319999999999993 109.432 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . 0.555 ' HA2' ' HB2' ' C' ' 249' ' ' ALA . . . 151.58 -46.92 0.59 Allowed Glycine 0 N--CA 1.419 -2.498 0 N-CA-C 108.873 -1.691 . . . . 43.240000000000002 108.873 -176.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 128.4 -25.02 4.88 Favored Glycine 0 CA--C 1.481 -2.077 0 C-N-CA 120.07 -1.062 . . . . 63.130000000000003 111.255 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' C' ' 287' ' ' TRP . 56.3 pttt -151.93 -62.09 0.17 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.177 -0.511 . . . . 74.420000000000002 110.486 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . 0.437 ' H ' ' HG3' ' C' ' 284' ' ' LYS . . . 50.5 -86.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.114 0 N-CA-C 115.503 0.961 . . . . 74.129999999999995 115.503 176.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.408 ' HA ' ' NE1' ' B' ' 287' ' ' TRP . 42.6 t80 -65.79 -29.72 70.25 Favored 'General case' 0 C--O 1.255 1.379 0 C-N-CA 125.192 1.397 . . . . 73.25 110.62 -176.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.579 ' O ' ' HB2' ' C' ' 284' ' ' LYS . 20.1 p90 -125.25 151.57 45.75 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.669 -0.696 . . . . 73.209999999999994 109.884 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -97.67 126.67 43.12 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.668 -0.864 . . . . 73.420000000000002 108.668 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -156.28 -152.65 0.39 Allowed 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 103.339 -2.837 . . . . 72.140000000000001 103.339 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -55.99 143.5 32.05 Favored 'General case' 0 C--O 1.244 0.77 0 CA-C-N 119.323 0.965 . . . . 72.430000000000007 110.413 175.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -58.53 -82.85 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 114.807 1.41 . . . . 74.150000000000006 114.807 -172.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 60.15 97.91 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 O-C-N 124.127 0.892 . . . . 71.299999999999997 109.865 -175.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -99.12 -43.63 6.58 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 113.176 0.806 . . . . 73.329999999999998 113.176 -171.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 7.8 m170 75.5 149.31 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.122 0.969 . . . . 74.430000000000007 111.982 -171.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 80.9 t60 . . . . . 0 C--O 1.256 1.443 0 C-N-CA 124.869 1.267 . . . . 74.109999999999999 111.21 179.475 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 21.7 mmt . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 108.949 -0.76 . . . . 61.240000000000002 108.949 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? 50.89 64.21 1.92 Allowed 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.723 1.209 . . . . 61.409999999999997 113.352 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 21.4 pt -75.62 138.97 19.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.863 -0.608 . . . . 74.040000000000006 110.421 177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -98.44 -25.27 14.85 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.674 -0.694 . . . . 72.439999999999998 110.282 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -90.73 77.1 6.35 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 116.012 -0.54 . . . . 74.430000000000007 109.696 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 67.3 mt -99.39 132.56 44.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 115.648 -0.706 . . . . 50.119999999999997 109.315 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 10.3 p -139.21 164.29 25.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 106.16 -1.793 . . . . 75.209999999999994 106.16 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -75.37 77.86 1.18 Allowed Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 120.856 -0.687 . . . . 73.239999999999995 111.645 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -122.0 151.69 40.55 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.569 -0.901 . . . . 72.120000000000005 108.569 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.467 HD22 ' HA2' ' A' ' 278' ' ' GLY . 62.9 t30 -99.01 136.9 38.31 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.757 -1.201 . . . . 71.109999999999999 107.757 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 43.4 m -126.59 136.87 53.1 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 121.854 0.835 . . . . 30.309999999999999 112.478 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 277' ' ' ILE . . . -133.72 138.93 46.08 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.208 -1.775 . . . . 73.450000000000003 106.208 174.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -92.75 -60.91 1.7 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.359 -0.978 . . . . 75.310000000000002 108.359 -177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -129.78 140.55 51.03 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 121.49 0.662 . . . . 73.409999999999997 110.921 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 70.7 mt -125.43 123.26 64.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.408 -1.33 . . . . 74.219999999999999 107.408 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.537 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 57.1 ttt180 -130.01 115.89 17.78 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.491 -0.484 . . . . 74.420000000000002 109.975 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.563 HG21 HG22 ' A' ' 239' ' ' VAL . 31.4 p -126.65 128.58 46.98 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-O 121.045 0.45 . . . . 55.310000000000002 110.064 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -131.8 143.31 50.12 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 109.649 -0.5 . . . . 75.299999999999997 109.649 -178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.52 ' HB3' ' NH1' ' A' ' 236' ' ' ARG . 41.2 mt-10 66.11 96.88 0.05 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 115.275 1.583 . . . . 73.310000000000002 115.275 172.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.52 ' NH1' ' HB3' ' A' ' 235' ' ' GLU . 1.1 mpt_? 60.93 11.78 3.5 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 124.961 1.304 . . . . 73.549999999999997 111.926 175.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -88.37 140.72 29.18 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 110.096 -0.335 . . . . 63.140000000000001 110.096 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.05 142.21 51.62 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.051 -0.522 . . . . 65.140000000000001 110.601 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.563 HG22 HG21 ' A' ' 233' ' ' THR . 12.6 t -122.27 149.58 25.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 O-C-N 123.396 0.435 . . . . 73.329999999999998 110.928 -170.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -138.0 120.63 16.21 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.423 -0.955 . . . . 63.009999999999998 108.423 168.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -117.64 122.55 43.88 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.106 -1.072 . . . . 72.25 108.106 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.77 -114.08 1.11 Allowed Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.008 -1.091 . . . . 62.420000000000002 112.599 176.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -145.48 133.99 22.01 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.883 -0.414 . . . . 73.310000000000002 109.883 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 92.3 t -107.51 115.47 48.81 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.947 -0.76 . . . . 64.329999999999998 108.947 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.5 112.24 39.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.75 -0.833 . . . . 62.130000000000003 108.75 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 24.6 m -91.11 159.3 16.17 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.516 -0.92 . . . . 73.239999999999995 108.516 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.57 -33.72 76.21 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 113.062 0.764 . . . . 64.219999999999999 113.062 -176.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.78 -39.98 94.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.087 0.773 . . . . 61.020000000000003 113.087 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.66 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -74.95 -35.95 62.11 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 111.418 0.155 . . . . 64.510000000000005 111.418 -177.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 7.0 mp 68.43 -80.75 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.306 1.042 . . . . 74.019999999999996 109.465 -171.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -174.28 174.53 2.83 Favored 'General case' 0 CA--C 1.505 -0.762 0 C-N-CA 126.305 1.842 . . . . 73.219999999999999 108.358 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -148.07 132.74 4.34 Favored Glycine 0 N--CA 1.438 -1.198 0 C-N-CA 120.677 -0.773 . . . . 61.219999999999999 111.381 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -170.91 -174.65 38.93 Favored Glycine 0 N--CA 1.437 -1.259 0 N-CA-C 111.027 -0.829 . . . . 61.030000000000001 111.027 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 6.6 tt -167.52 -53.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 C-N-CA 123.894 0.878 . . . . 64.209999999999994 109.01 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.552 ' O ' ' HB ' ' A' ' 256' ' ' ILE . 37.8 ttm180 -165.67 102.36 0.69 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 103.088 -2.93 . . . . 73.450000000000003 103.088 176.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.552 ' HB ' ' O ' ' A' ' 255' ' ' ARG . 29.9 mm 78.11 137.25 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 124.395 1.059 . . . . 65.340000000000003 108.65 -170.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 19.2 m -90.98 -175.59 4.37 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.288 -0.634 . . . . 63.329999999999998 109.288 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -59.5 136.83 58.1 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.891 0.376 . . . . 74.340000000000003 111.141 176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -128.18 30.55 5.2 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 116.121 -0.49 . . . . 75.329999999999998 110.85 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 58.2 m -65.37 121.25 14.4 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 120.401 -0.52 . . . . 71.200000000000003 109.693 177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -105.88 126.15 51.83 Favored 'General case' 0 N--CA 1.405 -2.723 0 N-CA-C 108.417 -0.957 . . . . 61.0 108.417 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.437 ' HB3' ' OD1' ' A' ' 226' ' ' ASN . 45.3 t-20 -126.38 146.83 49.9 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.7 -1.963 . . . . 64.439999999999998 105.7 -179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 29.6 m -142.22 125.12 16.09 Favored 'General case' 0 C--N 1.277 -2.553 0 CA-C-O 121.122 0.487 . . . . 71.129999999999995 110.501 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 14.7 p -128.18 150.51 33.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.677 -1.231 . . . . 62.119999999999997 107.677 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . 0.351 9.1 pt-20 -98.81 -50.66 4.14 Favored 'General case' 0 N--CA 1.416 -2.142 0 C-N-CA 117.794 -1.562 . . . . 74.409999999999997 113.298 174.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 61.8 m -127.19 126.97 43.76 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 117.958 -1.497 . . . . 74.510000000000005 112.439 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.75 126.83 75.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.687 -0.857 . . . . 62.399999999999999 108.687 173.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 7.9 p -127.76 133.65 67.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-O 121.005 0.431 . . . . 65.230000000000004 111.6 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -126.26 133.11 8.04 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 111.355 -0.698 . . . . 43.140000000000001 111.355 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.53 ' HB2' ' HG2' ' B' ' 234' ' ' GLU . 29.6 mmmt -130.04 116.65 18.85 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 122.587 0.355 . . . . 75.140000000000001 111.25 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 79.2 100.76 0.24 Allowed Glycine 0 C--N 1.308 -0.992 0 N-CA-C 115.361 0.905 . . . . 62.420000000000002 115.361 171.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.435 ' H ' ' HB2' ' A' ' 236' ' ' ARG . 34.9 mt-10 61.57 20.82 11.59 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.601 0.761 . . . . 74.420000000000002 112.855 169.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 19.4 m -92.79 145.18 24.6 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.464 0.65 . . . . 52.049999999999997 112.264 -174.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . 0.457 ' O ' HG23 ' B' ' 239' ' ' VAL . 66.0 mtt180 -108.3 127.17 53.63 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 105.147 -2.168 . . . . 74.109999999999999 105.147 173.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 6.1 t -121.45 123.22 69.16 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 120.179 -0.608 . . . . 72.409999999999997 109.37 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.626 ' HG ' ' OE1' ' B' ' 240' ' ' GLN . 26.8 tp -120.24 120.3 35.72 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 119.028 -1.069 . . . . 74.140000000000001 111.344 177.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 228' ' ' ALA . 3.6 mp -113.71 104.79 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.748 0 N-CA-C 107.627 -1.249 . . . . 61.409999999999997 107.627 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.467 ' HA2' HD22 ' A' ' 226' ' ' ASN . . . 158.28 -145.2 11.35 Favored Glycine 0 N--CA 1.426 -2.01 0 C-N-CA 120.227 -0.987 . . . . 74.200000000000003 111.858 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 45.4 t-20 -120.13 146.85 45.57 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 106.047 -1.834 . . . . 62.219999999999999 106.047 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -123.22 117.45 25.35 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.163 -1.051 . . . . 75.200000000000003 108.163 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -109.71 124.41 51.17 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.8 -1.185 . . . . 73.109999999999999 107.8 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 146.18 -46.55 0.75 Allowed Glycine 0 CA--C 1.473 -2.555 0 N-CA-C 109.896 -1.282 . . . . 45.0 109.896 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.533 ' O ' ' HG2' ' A' ' 284' ' ' LYS . . . 103.36 72.57 0.92 Allowed Glycine 0 N--CA 1.417 -2.575 0 N-CA-C 109.451 -1.46 . . . . 73.310000000000002 109.451 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 283' ' ' GLY . 4.6 ptpp? 82.09 19.4 0.33 Allowed 'General case' 0 C--O 1.212 -0.901 0 C-N-CA 127.706 2.402 . . . . 71.540000000000006 111.419 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -47.82 -38.22 15.94 Favored Glycine 0 CA--C 1.54 1.624 0 N-CA-C 116.267 1.267 . . . . 73.510000000000005 116.267 -173.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.458 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 80.1 t80 -83.56 -3.13 57.4 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 117.378 0.589 . . . . 73.349999999999994 112.453 -175.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.458 ' CE3' ' HB3' ' A' ' 286' ' ' PHE . 32.8 p90 -151.59 -170.23 3.59 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 121.473 -0.767 . . . . 74.299999999999997 111.592 -177.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -146.01 -71.67 0.25 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.618 0.767 . . . . 73.329999999999998 110.514 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.406 ' HB3' ' CZ ' ' B' ' 274' ' ' ARG . 2.8 t-20 52.97 63.46 2.23 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.829 1.252 . . . . 62.539999999999999 112.158 -174.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.51 ' HB2' ' ND2' ' B' ' 289' ' ' ASN . 56.4 t-80 -147.01 -38.5 0.21 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.415 -1.266 . . . . 75.400000000000006 109.2 172.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -60.49 21.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.033 1.864 . . . . 71.230000000000004 116.033 -174.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -153.41 -52.98 0.1 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 123.526 0.73 . . . . 75.310000000000002 109.452 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -171.13 128.05 0.71 Allowed 'General case' 0 C--O 1.242 0.704 0 C-N-CA 122.869 0.467 . . . . 74.120000000000005 110.027 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.438 ' CD2' HH21 ' B' ' 274' ' ' ARG . 43.6 t-80 -161.0 172.58 16.64 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.204 -1.406 . . . . 73.030000000000001 107.204 174.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . 0.418 ' HB3' HH22 ' C' ' 238' ' ' ARG . 56.3 t-80 . . . . . 0 N--CA 1.432 -1.339 0 N-CA-C 107.497 -1.297 . . . . 74.120000000000005 107.497 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 11.7 tpt . . . . . 0 CA--C 1.531 0.213 0 N-CA-C 109.705 -0.48 . . . . 53.310000000000002 109.705 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.408 ' HD2' ' HB2' ' C' ' 220' ' ' ASP . 62.2 mttp -136.28 149.44 48.46 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 108.804 -0.813 . . . . 74.099999999999994 108.804 176.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 46.3 pt -82.55 167.78 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-O 121.289 0.566 . . . . 52.310000000000002 111.702 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -85.74 106.66 17.16 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.007 -1.109 . . . . 63.43 108.007 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -119.29 31.23 6.71 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.823 -1.547 . . . . 60.32 106.823 175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 64.6 mt -105.91 115.47 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 CA-C-N 114.507 -1.224 . . . . 70.519999999999996 110.937 -173.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 11.8 p -105.86 164.91 4.08 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 N-CA-C 106.402 -1.703 . . . . 71.040000000000006 106.402 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' B' ' 259' ' ' GLN . . . -73.57 73.78 1.14 Allowed Glycine 0 CA--C 1.503 -0.702 0 C-N-CA 121.011 -0.614 . . . . 64.099999999999994 111.982 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -108.11 145.0 34.72 Favored 'General case' 0 N--CA 1.423 -1.813 0 CA-C-N 115.025 -0.588 . . . . 52.329999999999998 110.086 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -98.08 136.7 37.94 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 104.536 -2.394 . . . . 70.430000000000007 104.536 171.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 20.1 m -131.85 136.39 47.43 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 120.109 -0.636 . . . . 70.400000000000006 111.255 -177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -129.2 134.84 48.18 Favored 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 107.689 -1.226 . . . . 54.329999999999998 107.689 175.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.434 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -82.2 -65.98 0.95 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.017 -0.734 . . . . 72.299999999999997 109.017 178.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -128.46 140.07 52.01 Favored 'General case' 0 C--O 1.255 1.35 0 CA-C-O 121.022 0.439 . . . . 73.120000000000005 109.988 178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 27.7 mt -124.72 122.64 64.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 107.245 -1.391 . . . . 64.310000000000002 107.245 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.552 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 22.1 ttt180 -122.84 114.55 20.65 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.746 -0.835 . . . . 64.329999999999998 108.746 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.73 HG21 HG22 ' B' ' 239' ' ' VAL . 72.4 p -117.88 127.2 53.63 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.021 -1.103 . . . . 74.340000000000003 108.021 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . 0.53 ' HG2' ' HB2' ' A' ' 270' ' ' LYS . 34.0 mt-10 -137.61 139.79 40.55 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.201 -0.599 . . . . 62.399999999999999 110.322 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.497 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 46.8 mt-10 67.5 96.71 0.06 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 114.542 1.312 . . . . 73.099999999999994 114.542 173.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.497 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.0 OUTLIER 58.14 27.98 15.78 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.474 1.11 . . . . 73.209999999999994 110.897 175.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.425 ' CB ' ' HB ' ' B' ' 233' ' ' THR . . . -84.77 150.89 24.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.163 0.506 . . . . 74.299999999999997 110.6 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.502 ' HD3' ' HG2' ' B' ' 274' ' ' ARG . 4.4 mpt_? -125.66 134.5 51.83 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.647 -1.983 . . . . 75.400000000000006 105.647 174.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.73 HG22 HG21 ' B' ' 233' ' ' THR . 2.4 t -125.41 139.67 50.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 123.404 0.44 . . . . 65.109999999999999 110.02 -172.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.626 ' OE1' ' HG ' ' A' ' 276' ' ' LEU . 24.5 tp60 -138.48 114.84 10.38 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 123.864 0.728 . . . . 73.349999999999994 109.8 170.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.464 HD12 HG23 ' A' ' 277' ' ' ILE . 3.4 tm? -115.0 118.73 34.24 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.431 -1.322 . . . . 65.230000000000004 107.431 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 141.19 -114.06 0.9 Allowed Glycine 0 N--CA 1.422 -2.268 0 C-N-CA 120.276 -0.964 . . . . 53.439999999999998 111.07 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 55.0 t30 -145.46 149.54 34.87 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.981 -0.748 . . . . 61.549999999999997 108.981 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 98.1 t -121.61 122.66 67.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 108.429 -0.952 . . . . 74.200000000000003 108.429 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 48.7 t -122.19 111.84 32.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 108.975 -0.75 . . . . 64.209999999999994 108.975 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 23.8 m -83.15 159.28 22.08 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.195 -1.039 . . . . 75.129999999999995 108.195 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -64.6 -42.48 95.53 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 123.207 1.48 . . . . 52.229999999999997 109.749 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.68 -34.01 61.67 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 111.762 -2.472 . . . . 74.129999999999995 112.827 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.671 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -62.9 -26.81 68.97 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.678 0.791 . . . . 65.530000000000001 112.482 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -79.65 76.13 6.3 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.981 0.896 . . . . 74.319999999999993 108.867 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -103.55 -44.69 5.04 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.179 -1.373 . . . . 73.349999999999994 108.109 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 152.68 -172.75 31.77 Favored Glycine 0 N--CA 1.42 -2.376 0 N-CA-C 107.226 -2.35 . . . . 65.319999999999993 107.226 -178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 80.41 -49.97 3.93 Favored Glycine 0 C--N 1.304 -1.21 0 CA-C-N 118.119 0.959 . . . . 74.319999999999993 113.161 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 2.8 mp -75.74 109.45 9.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.151 -0.685 . . . . 60.149999999999999 109.151 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -116.62 -14.74 10.85 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.263 -1.014 . . . . 65.109999999999999 108.263 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 12.4 pt -155.53 177.75 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.153 0 N-CA-C 105.887 -1.894 . . . . 70.109999999999999 105.887 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 23.9 t -96.64 146.4 24.88 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 108.154 -1.054 . . . . 53.130000000000003 108.154 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -74.04 119.08 17.77 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.423 0.63 . . . . 64.230000000000004 109.431 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . 0.488 ' HB3' ' HA3' ' B' ' 224' ' ' GLY . 88.9 mt-30 -83.5 57.31 3.97 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 114.289 1.218 . . . . 51.43 114.289 -173.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.512 ' OG1' ' HA ' ' C' ' 257' ' ' SER . 55.1 m -87.03 123.17 31.82 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.338 -0.986 . . . . 62.43 108.338 172.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -91.55 127.93 37.18 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-O 121.799 0.809 . . . . 73.340000000000003 110.405 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -126.82 142.23 51.6 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.946 -1.872 . . . . 74.299999999999997 105.946 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 47.4 m -139.64 133.01 30.05 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 118.313 0.506 . . . . 70.530000000000001 111.655 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.1 p -128.22 144.17 38.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 CA-C-N 116.056 -0.52 . . . . 72.239999999999995 110.658 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.564 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 38.2 mm-40 -81.05 -63.73 1.34 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.193 0.521 . . . . 75.439999999999998 110.801 175.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 38.2 m -137.59 127.13 25.08 Favored 'General case' 0 C--N 1.293 -1.848 0 C-N-CA 118.138 -1.425 . . . . 75.450000000000003 111.915 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 2.4 p -119.05 121.13 66.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 114.891 -1.05 . . . . 72.129999999999995 108.704 176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 5.4 p -127.38 138.79 53.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 115.721 -0.672 . . . . 72.510000000000005 112.266 -176.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.7 133.97 8.81 Favored Glycine 0 CA--C 1.485 -1.8 0 CA-C-N 115.793 -0.64 . . . . 61.450000000000003 112.134 179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.47 ' HB2' ' HG2' ' C' ' 234' ' ' GLU . 30.9 mmmt -128.96 115.95 18.6 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 123.748 0.322 . . . . 73.340000000000003 110.689 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 81.58 93.31 0.51 Allowed Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.46 -0.876 . . . . 71.430000000000007 114.626 172.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 64.01 17.25 10.49 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.341 1.056 . . . . 75.400000000000006 111.89 170.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 19.8 m -82.88 145.19 29.58 Favored 'General case' 0 N--CA 1.419 -1.995 0 CA-C-O 121.743 0.783 . . . . 63.25 111.383 -172.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.539 ' HB3' ' CE1' ' B' ' 286' ' ' PHE . 51.1 mtm180 -116.84 127.44 54.3 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 108.739 -0.837 . . . . 73.439999999999998 108.739 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.44 HG12 ' CG1' ' C' ' 239' ' ' VAL . 29.2 m -120.64 123.58 70.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-O 121.394 0.616 . . . . 74.519999999999996 110.547 -176.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.583 ' HG ' ' OE1' ' C' ' 240' ' ' GLN . 26.4 tp -115.06 114.78 25.81 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 108.989 -0.745 . . . . 54.340000000000003 108.989 173.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.521 HG23 HD12 ' C' ' 241' ' ' LEU . 3.4 mp -112.78 103.63 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.609 0 N-CA-C 106.025 -1.843 . . . . 53.219999999999999 106.025 176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.434 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 161.3 -150.83 20.86 Favored Glycine 0 N--CA 1.416 -2.662 0 C-N-CA 119.798 -1.192 . . . . 72.140000000000001 112.835 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -113.77 151.81 31.47 Favored 'General case' 0 C--N 1.273 -2.753 0 N-CA-C 104.791 -2.3 . . . . 63.43 104.791 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.4 ' OE1' HG13 ' C' ' 244' ' ' VAL . 1.5 tm-20 -130.06 118.87 22.2 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.94 -1.133 . . . . 62.350000000000001 107.94 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -113.1 124.28 52.21 Favored 'General case' 0 C--O 1.257 1.453 0 CA-C-O 121.911 0.862 . . . . 75.340000000000003 110.927 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' B' ' 249' ' ' ALA . . . 138.01 -47.32 0.94 Allowed Glycine 0 N--CA 1.417 -2.619 0 CA-C-N 114.37 -1.286 . . . . 73.040000000000006 110.442 178.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' B' ' 284' ' ' LYS . . . 108.25 90.92 2.15 Favored Glycine 0 N--CA 1.414 -2.79 0 N-CA-C 108.363 -1.895 . . . . 72.140000000000001 108.363 -176.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' B' ' 287' ' ' TRP . 50.0 mtmt 90.95 -59.45 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.63 0 C-N-CA 126.408 1.883 . . . . 75.049999999999997 109.681 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 49.87 -84.27 0.01 OUTLIER Glycine 0 N--CA 1.478 1.459 0 O-C-N 124.279 0.987 . . . . 55.219999999999999 115.101 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' B' ' 274' ' ' ARG . 1.3 t80 -52.0 -45.95 64.72 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.466 1.906 . . . . 75.519999999999996 109.908 178.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.581 ' O ' ' HB3' ' B' ' 284' ' ' LYS . 48.9 p90 -116.93 152.38 34.67 Favored 'General case' 0 C--O 1.201 -1.484 0 N-CA-C 106.741 -1.578 . . . . 70.230000000000004 106.741 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 11.5 t70 169.87 -78.34 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 106.802 -1.555 . . . . 73.109999999999999 106.802 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . 0.566 ' HA ' ' HB2' ' B' ' 292' ' ' HIS . 15.0 m120 62.56 19.96 11.63 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 114.116 -1.402 . . . . 50.229999999999997 112.417 173.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -87.96 109.39 19.78 Favored 'General case' 0 C--O 1.248 1.016 0 N-CA-C 108.01 -1.107 . . . . 73.510000000000005 108.01 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.61 22.34 13.26 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.336 1.055 . . . . 74.430000000000007 110.066 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . 0.566 ' HB2' ' HA ' ' B' ' 289' ' ' ASN . 17.0 m80 -111.19 117.04 32.14 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 114.899 -1.046 . . . . 72.150000000000006 109.331 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 72.26 -63.26 0.44 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.243 1.417 . . . . 71.349999999999994 111.588 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 6.9 m170 55.49 100.18 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 115.918 1.821 . . . . 52.399999999999999 115.918 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 . . . . . 0 C--N 1.296 -1.746 0 N-CA-C 105.587 -2.005 . . . . 72.040000000000006 105.587 176.492 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.516 -0.356 0 N-CA-C 109.353 -0.61 . . . . 74.420000000000002 109.353 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.23 167.24 11.15 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 113.188 0.81 . . . . 54.240000000000002 113.188 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.45 174.12 4.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 114.885 -1.052 . . . . 72.450000000000003 111.704 -178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . 0.408 ' HB2' ' HD2' ' B' ' 218' ' ' LYS . 12.3 t70 -93.04 -65.87 0.97 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.378 -0.971 . . . . 63.219999999999999 108.378 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -77.06 127.84 33.4 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 107.859 -1.163 . . . . 71.219999999999999 107.859 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 78.6 mt -82.73 115.55 25.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-O 121.579 0.704 . . . . 71.109999999999999 111.324 -174.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 12.2 p -104.74 164.03 4.0 Favored 'Isoleucine or valine' 0 C--O 1.257 1.481 0 N-CA-C 106.699 -1.593 . . . . 70.400000000000006 106.699 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -74.34 76.56 1.1 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.95 -0.643 . . . . 74.25 111.649 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' C' ' 261' ' ' THR . 4.9 ptp180 -111.68 154.22 25.27 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.085 0.469 . . . . 60.420000000000002 110.731 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -109.98 140.74 43.65 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.248 -2.131 . . . . 73.519999999999996 105.248 173.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' C' ' 263' ' ' SER . 45.0 m -139.74 137.95 35.53 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.892 -0.505 . . . . 74.439999999999998 111.399 -176.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.65 128.92 45.09 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.421 -0.955 . . . . 74.209999999999994 108.421 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.58 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 27.9 tptp -75.31 -62.17 1.65 Allowed 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 109.395 -0.594 . . . . 64.310000000000002 109.395 178.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' C' ' 266' ' ' THR . 16.5 m-20 -134.85 139.86 45.38 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.066 0.46 . . . . 73.549999999999997 110.719 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.493 HG21 HG21 ' C' ' 239' ' ' VAL . 35.6 mt -127.53 123.52 61.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 106.96 -1.496 . . . . 65.109999999999999 106.96 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.491 ' HG3' HG13 ' B' ' 268' ' ' VAL . 31.6 ttt180 -126.9 114.98 18.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.755 -0.832 . . . . 71.230000000000004 108.755 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.412 HG21 ' HB ' ' C' ' 239' ' ' VAL . 39.4 p -110.62 127.36 55.22 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.71 -1.219 . . . . 64.540000000000006 107.71 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.47 ' HG2' ' HB2' ' B' ' 270' ' ' LYS . 40.5 mt-10 -135.07 139.62 44.89 Favored 'General case' 0 N--CA 1.42 -1.943 0 C-N-CA 120.396 -0.522 . . . . 75.209999999999994 110.31 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 64.43 101.29 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 O-C-N 124.621 1.201 . . . . 71.030000000000001 114.117 173.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 59.6 13.88 3.63 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.669 1.188 . . . . 75.340000000000003 111.27 173.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -87.38 151.58 22.97 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 112.619 0.6 . . . . 73.430000000000007 112.619 -172.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.418 HH22 ' HB3' ' A' ' 295' ' ' HIS . 0.1 OUTLIER -135.05 135.24 41.15 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.02 -1.474 . . . . 73.549999999999997 107.02 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.493 HG21 HG21 ' C' ' 231' ' ' ILE . 6.9 p -132.38 146.08 33.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.058 0.456 . . . . 70.349999999999994 111.437 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.583 ' OE1' ' HG ' ' B' ' 276' ' ' LEU . 23.2 tp60 -124.6 120.16 31.12 Favored 'General case' 0 N--CA 1.421 -1.898 0 CA-C-N 114.67 -1.15 . . . . 72.540000000000006 108.829 172.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.521 HD12 HG23 ' B' ' 277' ' ' ILE . 3.4 tm? -113.66 117.78 32.54 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.966 -1.494 . . . . 44.530000000000001 106.966 177.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 139.14 -114.36 1.01 Allowed Glycine 0 N--CA 1.424 -2.116 0 C-N-CA 119.972 -1.109 . . . . 44.219999999999999 112.02 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -145.39 143.79 30.29 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.571 -0.529 . . . . 73.239999999999995 109.571 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.4 HG13 ' OE1' ' B' ' 280' ' ' GLU . 69.5 t -117.44 118.43 58.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.432 -0.581 . . . . 74.340000000000003 109.432 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' C' ' 281' ' ' TYR . 47.9 t -121.8 111.99 33.2 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 109.452 -0.573 . . . . 74.340000000000003 109.452 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 31.4 m -78.07 159.47 28.68 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.239 -1.023 . . . . 61.030000000000001 108.239 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.671 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -63.46 -43.38 97.53 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.482 1.134 . . . . 72.420000000000002 109.48 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -34.29 65.6 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 112.891 -1.959 . . . . 74.099999999999994 112.776 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.14 -37.21 80.83 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 111.995 0.368 . . . . 73.409999999999997 111.995 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 79.2 mt 69.39 -163.96 0.18 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 124.35 1.031 . . . . 63.049999999999997 110.677 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . 0.428 ' CD2' ' H ' ' C' ' 253' ' ' GLY . 83.6 t60 -152.65 -54.65 0.12 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.937 0.398 . . . . 65.299999999999997 110.056 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 107.08 -17.51 37.78 Favored Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 120.742 -0.742 . . . . 45.039999999999999 112.602 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . 0.428 ' H ' ' CD2' ' C' ' 251' ' ' HIS . . . 89.93 21.17 40.28 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 110.795 -0.922 . . . . 50.109999999999999 110.795 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 10.1 tt -139.88 136.82 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 108.22 -1.03 . . . . 75.129999999999995 108.22 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -59.8 115.45 3.38 Favored 'General case' 0 C--O 1.248 1.001 0 O-C-N 123.697 0.623 . . . . 71.340000000000003 110.154 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 62.5 mt -90.14 -56.79 4.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 107.48 -1.304 . . . . 72.519999999999996 107.48 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . 0.512 ' HA ' ' OG1' ' B' ' 260' ' ' THR . 14.9 m 65.82 146.08 0.03 OUTLIER 'General case' 0 C--O 1.243 0.742 0 C-N-CA 125.867 1.667 . . . . 65.239999999999995 114.088 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . 0.457 ' OD1' ' HB ' ' C' ' 260' ' ' THR . 10.9 t0 -51.22 -50.61 58.78 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 108.024 -1.102 . . . . 70.219999999999999 108.024 176.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 76.12 -24.19 0.23 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.721 1.608 . . . . 72.010000000000005 111.852 177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . 0.457 ' HB ' ' OD1' ' C' ' 258' ' ' ASP . 88.2 m -85.11 133.73 34.21 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 108.687 -0.857 . . . . 24.420000000000002 108.687 176.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 39.2 m -92.33 108.69 20.14 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 108.173 -1.047 . . . . 41.240000000000002 108.173 177.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -124.26 127.85 48.29 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.733 -0.84 . . . . 70.239999999999995 108.733 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' C' ' 227' ' ' SER . 41.4 m -133.43 136.22 45.08 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 110.069 -0.345 . . . . 51.299999999999997 110.069 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 10.9 p -128.22 153.5 37.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.295 -0.632 . . . . 71.420000000000002 109.295 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.58 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 35.2 mm-40 -81.13 -88.5 0.08 Allowed 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 110.197 -0.297 . . . . 75.230000000000004 110.197 176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 51.4 m -121.85 131.33 53.98 Favored 'General case' 0 N--CA 1.417 -2.09 0 C-N-CA 119.581 -0.848 . . . . 54.130000000000003 111.061 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 26.2 m -117.87 132.53 67.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.33 -0.989 . . . . 71.439999999999998 108.33 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.8 p -127.38 139.61 51.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 116.206 -0.452 . . . . 70.109999999999999 110.4 -177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -121.99 133.66 9.47 Favored Glycine 0 CA--C 1.476 -2.362 0 N-CA-C 110.155 -1.178 . . . . 75.310000000000002 110.155 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -131.36 115.55 16.39 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 111.988 0.366 . . . . 74.329999999999998 111.988 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 70.05 97.39 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.859 -1.064 . . . . 73.319999999999993 114.415 173.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 68.09 21.66 8.64 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.782 0.833 . . . . 50.409999999999997 111.955 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.5 m -83.77 144.7 29.14 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.027 0.751 . . . . 40.520000000000003 113.027 -175.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 55.1 mtt180 -110.07 128.36 55.39 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.207 -1.775 . . . . 64.530000000000001 106.207 171.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 1.5 t -128.08 123.9 61.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 119.726 -0.79 . . . . 70.120000000000005 109.199 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.41 ' CD1' ' HG3' ' C' ' 240' ' ' GLN . 30.8 tp -117.62 117.96 30.82 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 119.902 -0.719 . . . . 74.540000000000006 110.3 174.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.503 HG21 ' HB2' ' C' ' 228' ' ' ALA . 3.7 mp -112.48 103.47 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.893 0 N-CA-C 105.902 -1.888 . . . . 75.510000000000005 105.902 174.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.35 -168.24 30.27 Favored Glycine 0 CA--C 1.478 -2.223 0 C-N-CA 120.546 -0.835 . . . . 74.420000000000002 111.456 -176.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -96.7 156.8 16.19 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.46 -0.941 . . . . 74.120000000000005 108.46 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.481 ' HB3' ' ND1' ' C' ' 294' ' ' HIS . 2.9 tm-20 -129.12 121.3 27.5 Favored 'General case' 0 N--CA 1.41 -2.445 0 N-CA-C 107.944 -1.132 . . . . 74.430000000000007 107.944 -175.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.407 ' HB2' ' HA ' ' C' ' 245' ' ' VAL . 96.6 m-85 -116.54 125.12 51.44 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.945 0.403 . . . . 72.239999999999995 110.078 176.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 136.47 -37.74 1.84 Allowed Glycine 0 N--CA 1.437 -1.3 0 N-CA-C 111.668 -0.573 . . . . 71.230000000000004 111.668 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 104.4 103.04 2.8 Favored Glycine 0 CA--C 1.48 -2.137 0 N-CA-C 107.304 -2.319 . . . . 45.119999999999997 107.304 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . 0.491 ' HD3' ' HA ' ' C' ' 288' ' ' ASP . 94.8 mttt 75.07 -57.78 0.59 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.785 1.234 . . . . 73.129999999999995 109.169 -172.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 57.63 -86.22 0.01 OUTLIER Glycine 0 C--N 1.34 0.782 0 C-N-CA 124.307 0.956 . . . . 61.140000000000001 113.961 176.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.571 ' HB3' ' CE3' ' C' ' 287' ' ' TRP . 0.2 OUTLIER -56.67 -39.57 73.99 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.023 1.729 . . . . 73.040000000000006 110.642 -178.635 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.571 ' CE3' ' HB3' ' C' ' 286' ' ' PHE . 24.6 p90 -129.99 -171.66 2.58 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.067 0.46 . . . . 61.439999999999998 111.622 -171.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . 0.491 ' HA ' ' HD3' ' C' ' 284' ' ' LYS . 21.0 t70 -131.11 -36.27 1.33 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.981 -1.009 . . . . 63.329999999999998 109.692 169.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' C' ' 290' ' ' HIS . 26.5 t-20 -81.91 72.95 8.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.876 -0.602 . . . . 73.120000000000005 111.25 -177.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . 0.548 ' HB3' ' CD1' ' C' ' 287' ' ' TRP . 9.2 t60 163.9 116.7 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.887 2.075 . . . . 73.140000000000001 105.936 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -99.52 95.28 6.89 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 113.406 0.891 . . . . 72.010000000000005 113.406 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -152.37 135.66 15.87 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.75 -1.113 . . . . 61.420000000000002 110.512 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -124.24 133.68 53.45 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 107.745 -1.205 . . . . 73.140000000000001 107.745 173.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . 0.481 ' ND1' ' HB3' ' C' ' 280' ' ' GLU . 76.8 m80 -95.85 -46.61 6.49 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 112.935 0.717 . . . . 65.25 112.935 -173.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 . . . . . 0 C--N 1.303 -1.414 0 CA-C-O 118.528 -0.748 . . . . 51.32 109.509 -177.616 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 CA--C 1.51 -0.593 0 CA-C-O 121.591 0.71 . . . . 52.329999999999998 109.41 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -164.01 77.12 0.37 Allowed 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.841 -1.072 . . . . 70.409999999999997 110.272 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 64.3 mt -78.61 88.22 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 122.129 0.966 . . . . 72.329999999999998 108.534 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -151.97 -36.08 0.12 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.48 -1.691 . . . . 73.319999999999993 107.594 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.04 146.93 10.27 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 114.553 -1.203 . . . . 31.129999999999999 110.748 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.9 mp -83.35 124.31 39.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.138 -0.69 . . . . 64.120000000000005 109.138 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.533 HG21 HG21 ' B' ' 222' ' ' ILE . 14.9 p -100.1 148.91 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 109.501 -0.555 . . . . 71.010000000000005 109.501 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 103.6 15.07 23.81 Favored Glycine 0 N--CA 1.435 -1.4 0 N-CA-C 109.149 -1.58 . . . . 52.439999999999998 109.149 -174.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -90.01 141.89 28.23 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 114.685 -0.757 . . . . 74.549999999999997 109.948 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 262' ' ' ASN . 48.1 t-20 -116.75 123.97 48.48 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.644 -1.614 . . . . 53.119999999999997 106.644 176.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.1 m -121.65 137.42 54.75 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 120.342 -0.543 . . . . 73.530000000000001 111.239 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -130.4 134.06 46.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.052 -0.722 . . . . 65.329999999999998 109.052 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -91.49 -46.87 7.74 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 116.643 -0.253 . . . . 55.329999999999998 110.836 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -136.9 139.71 41.8 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.372 -0.603 . . . . 53.520000000000003 109.372 179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 66.1 mt -137.28 119.34 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 107.388 -1.338 . . . . 75.239999999999995 107.388 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -134.22 122.81 23.3 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.909 0.385 . . . . 74.549999999999997 110.834 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 33.4 p -129.43 128.65 43.39 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 110.053 -0.351 . . . . 71.409999999999997 110.053 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.423 ' HB2' ' HD3' ' A' ' 270' ' ' LYS . 45.0 mt-10 -125.67 166.16 17.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.141 0.496 . . . . 74.409999999999997 111.91 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.426 ' HB3' ' HD2' ' A' ' 236' ' ' ARG . 41.1 mt-10 64.9 -85.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.73 1.612 . . . . 72.140000000000001 113.961 176.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.426 ' HD2' ' HB3' ' A' ' 235' ' ' GLU . 0.6 OUTLIER -130.65 11.7 5.28 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 109.373 -0.602 . . . . 72.540000000000006 109.373 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -73.14 134.25 44.38 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 115.495 -0.775 . . . . 71.299999999999997 110.563 -178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.1 145.25 50.56 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.839 -0.8 . . . . 72.040000000000006 108.839 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 7.7 p -132.3 141.8 44.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 121.719 0.771 . . . . 52.240000000000002 111.438 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -105.14 128.25 53.29 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 107.678 -1.23 . . . . 71.129999999999995 107.678 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -122.32 117.85 27.07 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.281 -1.377 . . . . 34.229999999999997 107.281 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 113.25 -159.79 13.48 Favored Glycine 0 C--N 1.306 -1.113 0 C-N-CA 121.23 -0.51 . . . . 61.43 111.925 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -98.78 137.39 37.44 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 122.628 0.371 . . . . 73.549999999999997 110.916 -176.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 61.7 t -114.73 116.32 52.21 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.002 0 N-CA-C 107.22 -1.4 . . . . 74.329999999999998 107.22 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 6.2 p -122.44 114.37 42.23 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.666 0 N-CA-C 108.46 -0.941 . . . . 42.5 108.46 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 15.0 m -84.22 157.18 21.69 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 118.406 -1.318 . . . . 64.409999999999997 110.045 -175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -67.01 -47.09 72.51 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.41 0.624 . . . . 63.450000000000003 111.552 176.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.38 -34.42 68.85 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.561 1.545 . . . . 72.140000000000001 112.649 -175.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.608 ' HB2' ' HA3' ' A' ' 282' ' ' GLY . . . -59.42 -26.52 65.24 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 124.145 0.978 . . . . 72.430000000000007 111.548 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 33.9 tp 67.07 73.61 0.34 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.662 1.185 . . . . 63.200000000000003 111.456 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -82.69 103.16 11.99 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.7 -1.222 . . . . 72.430000000000007 107.7 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -131.42 73.72 0.46 Allowed Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 110.475 -1.05 . . . . 62.109999999999999 110.475 -178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 174.05 -174.42 46.33 Favored Glycine 0 N--CA 1.422 -2.279 0 N-CA-C 110.341 -1.104 . . . . 71.340000000000003 110.341 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 3.4 mp -90.23 124.78 43.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.289 -1.004 . . . . 71.129999999999995 108.289 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.67 84.87 5.44 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.995 -1.113 . . . . 51.009999999999998 107.995 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 15.1 tt -114.87 -13.14 11.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.791 -1.559 . . . . 72.430000000000007 106.791 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 16.3 m -68.66 148.36 50.53 Favored 'General case' 0 C--O 1.256 1.396 0 CA-C-N 113.993 -1.458 . . . . 73.209999999999994 108.138 175.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 27.6 t70 70.45 120.55 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.689 1.196 . . . . 64.140000000000001 110.655 -174.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -129.14 23.95 5.6 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 108.659 -0.867 . . . . 63.240000000000002 108.659 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' B' ' 224' ' ' GLY . 23.6 m -74.57 124.21 26.23 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 114.925 -1.034 . . . . 73.519999999999996 110.102 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 7.9 t -110.83 130.45 55.57 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 106.044 -1.836 . . . . 60.340000000000003 106.044 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 38.3 t-20 -126.38 140.35 52.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.911 -0.716 . . . . 73.409999999999997 109.151 -174.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 17.9 m -133.76 123.1 24.31 Favored 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 120.809 -0.356 . . . . 43.409999999999997 110.392 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 8.7 p -128.92 145.1 36.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 110.128 -0.323 . . . . 72.099999999999994 110.128 177.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.591 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 76.9 mm-40 -85.38 -79.09 0.24 Allowed 'General case' 0 N--CA 1.434 -1.274 0 C-N-CA 121.0 -0.28 . . . . 74.420000000000002 110.747 176.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 25.9 m -116.29 127.65 54.89 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.182 0.438 . . . . 74.140000000000001 112.182 -172.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.528 HG21 HD11 ' A' ' 277' ' ' ILE . 17.4 m -120.69 132.78 69.34 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 121.276 0.56 . . . . 63.310000000000002 109.583 174.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' B' ' 232' ' ' ARG . 3.3 p -127.98 131.81 69.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 CA-C-N 116.358 -0.383 . . . . 73.409999999999997 111.637 178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.86 131.06 7.65 Favored Glycine 0 N--CA 1.424 -2.147 0 N-CA-C 109.3 -1.52 . . . . 32.109999999999999 109.3 172.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 234' ' ' GLU . 18.9 tptm -134.17 140.55 46.6 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 109.6 -0.518 . . . . 72.310000000000002 109.6 -177.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 81.56 -136.71 16.41 Favored Glycine 0 CA--C 1.487 -1.672 0 N-CA-C 107.78 -2.128 . . . . 73.230000000000004 107.78 -174.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -101.36 85.41 2.79 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 118.443 1.122 . . . . 73.519999999999996 109.356 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 237' ' ' ALA . 21.6 m -104.39 144.98 30.92 Favored 'General case' 0 N--CA 1.408 -2.562 0 CA-C-N 114.923 -1.035 . . . . 71.439999999999998 108.934 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . 0.537 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 98.8 mtt180 -122.73 125.93 46.51 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 106.138 -1.801 . . . . 72.129999999999995 106.138 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 26.9 t -131.62 131.63 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 N-CA-C 108.973 -0.751 . . . . 71.129999999999995 108.973 -173.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 5.4 tt -125.88 114.77 18.97 Favored 'General case' 0 C--N 1.279 -2.481 0 C-N-CA 118.429 -1.308 . . . . 72.030000000000001 108.444 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.579 HG23 HD12 ' B' ' 241' ' ' LEU . 68.5 mt -111.02 104.33 16.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.098 -0.704 . . . . 64.209999999999994 109.098 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.514 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 144.27 -143.93 12.76 Favored Glycine 0 N--CA 1.424 -2.107 0 N-CA-C 110.969 -0.852 . . . . 73.420000000000002 110.969 178.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -124.29 143.53 50.5 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.213 -1.032 . . . . 45.439999999999998 108.213 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.96 130.01 46.17 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.502 0.668 . . . . 71.439999999999998 109.314 174.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -113.55 121.56 44.58 Favored 'General case' 0 N--CA 1.409 -2.493 0 N-CA-C 107.383 -1.34 . . . . 72.019999999999996 107.383 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.608 ' HA3' ' HB2' ' A' ' 249' ' ' ALA . . . 62.81 24.82 66.95 Favored Glycine 0 N--CA 1.436 -1.316 0 CA-C-N 114.407 -1.269 . . . . 73.010000000000005 113.903 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -86.69 -47.63 4.76 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.037 -1.225 . . . . 62.329999999999998 110.037 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.425 ' HB2' ' NZ ' ' A' ' 284' ' ' LYS . 0.1 OUTLIER 68.28 23.51 7.72 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.043 1.337 . . . . 74.299999999999997 110.03 179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 287' ' ' TRP . . . 115.02 92.91 1.88 Allowed Glycine 0 N--CA 1.407 -3.249 0 C-N-CA 120.129 -1.034 . . . . 55.439999999999998 110.768 -176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -73.1 33.78 0.07 Allowed 'General case' 0 CA--C 1.569 1.706 0 CA-C-O 122.54 1.162 . . . . 75.239999999999995 109.398 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.537 ' CE3' ' HB3' ' A' ' 274' ' ' ARG . 2.5 m95 -97.03 -49.76 4.88 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.407 -0.815 . . . . 72.430000000000007 111.979 -174.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -113.57 -97.26 0.44 Allowed 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 118.645 -1.222 . . . . 62.329999999999998 113.203 -169.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -149.29 178.27 8.92 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.201 -1.407 . . . . 75.310000000000002 107.201 -176.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -100.47 56.58 0.91 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 122.24 1.019 . . . . 75.329999999999998 110.907 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -112.35 -46.0 3.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.529 -1.214 . . . . 74.319999999999993 108.199 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 64.03 37.87 8.94 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 122.271 1.034 . . . . 74.430000000000007 112.143 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 44.7 t-80 -79.5 152.98 29.9 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.025 -1.443 . . . . 63.219999999999999 107.383 175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.514 ' CE1' ' HA ' ' B' ' 290' ' ' HIS . 10.1 t60 -47.15 111.06 0.36 Allowed 'General case' 0 C--O 1.245 0.829 0 CA-C-O 121.601 0.715 . . . . 72.310000000000002 112.405 177.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 65.9 t-80 . . . . . 0 N--CA 1.417 -2.08 0 N-CA-C 103.945 -2.613 . . . . 74.030000000000001 103.945 176.406 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 CA--C 1.506 -0.719 0 CA-C-O 121.412 0.625 . . . . 74.329999999999998 111.238 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -144.66 49.45 1.31 Allowed 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.917 -1.142 . . . . 70.040000000000006 107.917 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 47.1 mm -71.71 84.44 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.708 0 CA-C-N 114.379 -1.282 . . . . 70.010000000000005 108.92 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -91.62 -28.78 17.28 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 114.246 -1.343 . . . . 52.43 110.12 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -70.78 137.73 49.83 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.075 -0.966 . . . . 71.530000000000001 109.757 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . 0.533 HG21 HG21 ' A' ' 223' ' ' VAL . 3.5 mp -83.51 139.27 17.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.333 -0.988 . . . . 70.140000000000001 108.333 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 13.6 p -98.27 153.93 3.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.693 -1.225 . . . . 63.329999999999998 107.693 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 260' ' ' THR . . . 93.31 48.92 2.71 Favored Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 107.629 -2.189 . . . . 75.25 107.629 -171.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -134.14 141.49 47.13 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.792 -0.704 . . . . 73.430000000000007 109.637 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 39.1 t-20 -118.06 141.7 48.19 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.545 -1.28 . . . . 54.149999999999999 107.545 176.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 52.5 m -133.81 137.38 45.05 Favored 'General case' 0 C--N 1.275 -2.663 0 O-C-N 122.075 -0.39 . . . . 54.219999999999999 110.172 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -127.72 160.77 30.67 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.21 -1.404 . . . . 73.099999999999994 107.21 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.591 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 4.6 tmmm? -121.67 -54.63 1.95 Allowed 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 119.599 -0.841 . . . . 74.340000000000003 109.045 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -131.76 138.03 48.43 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 106.81 -1.552 . . . . 73.340000000000003 106.81 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 12.5 mt -133.85 120.04 34.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 N-CA-C 106.795 -1.557 . . . . 70.109999999999999 106.795 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.631 ' NH1' ' HB2' ' B' ' 232' ' ' ARG . 0.0 OUTLIER -115.39 119.9 37.8 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 109.191 -0.67 . . . . 75.120000000000005 109.191 -176.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 38.4 p -121.88 129.16 52.36 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.613 -1.254 . . . . 62.020000000000003 107.613 175.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 27.5 tt0 -144.69 150.51 37.45 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 120.12 -0.632 . . . . 71.129999999999995 110.398 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 77.82 -79.19 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 125.798 1.639 . . . . 75.099999999999994 113.021 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -140.57 27.1 2.08 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.569 -0.9 . . . . 65.219999999999999 108.569 -172.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -86.71 143.65 27.47 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 112.9 0.704 . . . . 64.010000000000005 112.9 -173.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.0 mpt_? -124.4 136.46 54.08 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.311 -1.366 . . . . 61.530000000000001 107.311 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' B' ' 275' ' ' VAL . 7.5 p -134.14 136.14 53.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-O 121.996 0.903 . . . . 74.019999999999996 111.396 175.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.428 ' HB2' ' CE2' ' B' ' 286' ' ' PHE . 44.1 tp60 -104.57 130.99 52.49 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 106.884 -1.524 . . . . 64.230000000000004 106.884 174.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.579 HD12 HG23 ' A' ' 277' ' ' ILE . 2.7 tm? -130.27 116.28 18.14 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 106.561 -1.644 . . . . 72.430000000000007 106.561 177.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 278' ' ' GLY . . . 123.05 -129.39 7.41 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 120.634 -0.793 . . . . 53.049999999999997 112.05 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' B' ' 279' ' ' ASN . 53.3 t-20 -132.53 137.38 47.13 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.17 0.485 . . . . 75.349999999999994 109.862 -177.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 54.4 t -114.63 114.87 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.595 -1.261 . . . . 73.150000000000006 107.595 175.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 3.6 p -122.42 114.3 41.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 C-N-CA 119.492 -0.883 . . . . 63.130000000000003 110.165 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 42.3 m -80.34 155.0 27.42 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 117.419 -1.713 . . . . 72.510000000000005 109.92 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.72 -47.56 66.03 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 122.254 1.026 . . . . 74.409999999999997 111.249 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.31 -35.13 67.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 113.195 -1.82 . . . . 64.120000000000005 112.246 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.503 ' HB2' ' HA3' ' B' ' 282' ' ' GLY . . . -60.56 -47.03 88.0 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.989 -0.55 . . . . 45.219999999999999 110.381 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' B' ' 249' ' ' ALA . 18.1 tp 165.8 161.34 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 105.316 -2.105 . . . . 73.230000000000004 105.316 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -76.63 83.03 3.28 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 118.397 0.544 . . . . 75.109999999999999 111.394 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.96 13.34 83.25 Favored Glycine 0 CA--C 1.51 -0.228 0 N-CA-C 111.551 -0.62 . . . . 63.25 111.551 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 70.66 -160.96 53.81 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 110.813 -0.915 . . . . 52.130000000000003 110.813 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 70.7 mt -89.52 -34.92 7.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 108.763 -0.829 . . . . 72.030000000000001 108.763 175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -159.97 -46.27 0.05 Allowed 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 124.281 1.032 . . . . 73.450000000000003 109.612 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 60.3 mt 62.76 81.7 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-O 122.38 1.086 . . . . 64.439999999999998 110.112 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 23.7 m -156.13 134.7 11.67 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.943 -1.503 . . . . 41.439999999999998 106.943 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -145.24 -171.83 3.74 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.785 -1.191 . . . . 73.120000000000005 107.785 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -106.34 9.3 31.93 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 120.168 -0.613 . . . . 70.120000000000005 111.64 -173.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 12.0 m -77.78 120.78 23.17 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-O 121.915 0.864 . . . . 51.200000000000003 110.171 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.495 HG23 ' HB3' ' C' ' 225' ' ' ARG . 5.1 t -115.82 120.51 39.49 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 105.687 -1.968 . . . . 72.099999999999994 105.687 171.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' B' ' 226' ' ' ASN . 37.0 t-20 -126.39 138.35 53.54 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.072 -0.651 . . . . 65.420000000000002 109.268 -172.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' C' ' 227' ' ' SER . 51.9 m -142.08 129.54 21.29 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.152 0.501 . . . . 63.140000000000001 111.336 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 14.1 p -121.11 153.16 24.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.831 -0.803 . . . . 64.450000000000003 108.831 178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 75.8 mm-40 -91.94 -78.34 0.41 Allowed 'General case' 0 N--CA 1.414 -2.256 0 N-CA-C 109.583 -0.525 . . . . 63.210000000000001 109.583 171.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 19.6 m -114.35 127.97 56.12 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.944 -0.473 . . . . 61.329999999999998 111.192 -175.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.27 120.74 47.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 109.162 -0.681 . . . . 71.209999999999994 109.162 176.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 5.4 m -124.76 148.33 29.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-O 121.246 0.546 . . . . 74.219999999999999 111.301 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -137.34 132.43 5.95 Favored Glycine 0 N--CA 1.415 -2.755 0 N-CA-C 109.489 -1.444 . . . . 61.119999999999997 109.489 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -132.51 116.19 16.44 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.524 0.678 . . . . 73.010000000000005 110.057 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 104.08 -139.19 14.45 Favored Glycine 0 CA--C 1.471 -2.715 0 N-CA-C 109.213 -1.555 . . . . 73.25 109.213 -179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . 0.517 ' HB3' ' O ' ' C' ' 235' ' ' GLU . 11.1 tp10 -86.42 80.65 8.6 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.133 -1.432 . . . . 74.430000000000007 107.133 175.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 20.6 m -113.96 144.29 43.32 Favored 'General case' 0 N--CA 1.421 -1.916 0 CA-C-N 114.429 -1.26 . . . . 63.219999999999999 109.061 -177.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' C' ' 238' ' ' ARG . 76.3 mtt180 -134.4 127.35 31.41 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.013 -1.106 . . . . 73.420000000000002 108.013 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 10.9 t -131.2 137.77 54.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 116.101 -0.5 . . . . 73.010000000000005 109.714 -173.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 4.5 tt -126.56 113.87 17.35 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 106.872 -1.529 . . . . 74.230000000000004 106.872 173.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.536 HG23 HD12 ' C' ' 241' ' ' LEU . 58.2 mt -112.72 103.19 15.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.509 -0.923 . . . . 73.420000000000002 108.509 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' B' ' 226' ' ' ASN . . . 140.98 -146.11 17.18 Favored Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 111.141 -0.784 . . . . 70.409999999999997 111.141 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 5.5 m-20 -123.58 138.24 54.59 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.316 -0.624 . . . . 73.530000000000001 109.316 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.81 137.85 54.29 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.075 -0.713 . . . . 72.420000000000002 109.075 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.564 ' HA ' ' O ' ' C' ' 245' ' ' VAL . 87.4 t80 -124.03 121.92 36.52 Favored 'General case' 0 C--O 1.271 2.226 0 N-CA-C 108.493 -0.929 . . . . 71.150000000000006 108.493 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' B' ' 249' ' ' ALA . . . 81.65 -1.17 86.82 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 114.311 -1.313 . . . . 72.129999999999995 113.979 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -71.33 -60.11 4.58 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 110.922 -0.871 . . . . 75.519999999999996 110.922 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 30.5 mtmm 74.24 21.64 2.41 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.283 1.433 . . . . 73.030000000000001 109.1 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 124.9 90.07 0.83 Allowed Glycine 0 N--CA 1.409 -3.109 0 N-CA-C 109.48 -1.448 . . . . 75.439999999999998 109.48 -175.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.428 ' CE2' ' HB2' ' B' ' 240' ' ' GLN . 44.5 t80 -72.73 40.54 0.09 Allowed 'General case' 0 CA--C 1.573 1.857 0 C-N-CA 124.689 1.195 . . . . 73.219999999999999 110.118 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.534 ' CE3' ' HB3' ' B' ' 274' ' ' ARG . 8.0 m95 -117.3 123.45 46.58 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 108.347 -0.982 . . . . 73.400000000000006 108.347 -176.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -70.44 115.83 10.07 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.725 -1.583 . . . . 65.430000000000007 106.725 172.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . 0.439 ' O ' ' HB2' ' B' ' 292' ' ' HIS . 5.6 p30 -155.76 -172.67 4.22 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.363 -0.535 . . . . 64.230000000000004 111.114 -171.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . 0.514 ' HA ' ' CE1' ' A' ' 294' ' ' HIS . 62.6 m-70 -57.49 -37.23 72.59 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.86 0.864 . . . . 52.520000000000003 112.447 -178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -88.06 44.96 1.23 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.041 -0.726 . . . . 71.430000000000007 109.041 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' B' ' 289' ' ' ASN . 1.9 t60 -78.49 87.4 4.48 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 107.566 -1.272 . . . . 74.340000000000003 107.566 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -85.21 88.78 7.51 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.883 1.068 . . . . 72.420000000000002 113.883 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -96.36 -30.52 13.35 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 105.857 -1.905 . . . . 74.219999999999999 105.857 167.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 79.9 t60 . . . . . 0 N--CA 1.427 -1.594 0 N-CA-C 104.284 -2.487 . . . . 73.420000000000002 104.284 174.584 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 55.6 ttp . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 108.06 -1.089 . . . . 62.210000000000001 108.06 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -104.03 148.99 25.59 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.794 -1.187 . . . . 61.509999999999998 107.794 171.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 14.6 tt -57.73 130.27 20.59 Favored 'Isoleucine or valine' 0 C--O 1.253 1.27 0 CA-C-O 122.15 0.976 . . . . 74.230000000000004 112.084 -176.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -108.17 154.47 21.68 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 113.982 -1.463 . . . . 74.409999999999997 108.453 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.23 16.49 4.11 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.043 0.449 . . . . 53.009999999999998 110.473 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 3.1 mp -105.55 140.62 23.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 123.143 0.577 . . . . 74.230000000000004 109.579 -175.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 13.1 p -98.66 136.83 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 108.328 -0.99 . . . . 61.409999999999997 108.328 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 109.97 48.29 0.78 Allowed Glycine 0 C--N 1.307 -1.073 0 N-CA-C 108.1 -2.0 . . . . 52.109999999999999 108.1 -172.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.495 ' HB3' HG23 ' B' ' 261' ' ' THR . 26.8 ptt180 -131.36 143.15 50.28 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.671 -0.765 . . . . 75.109999999999999 110.553 -173.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 37.9 t-20 -117.81 136.96 53.07 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 106.877 -1.527 . . . . 62.149999999999999 106.877 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' B' ' 263' ' ' SER . 32.8 m -134.34 137.28 44.04 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-O 121.041 0.448 . . . . 73.299999999999997 110.622 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -125.18 150.75 46.65 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.52 -0.919 . . . . 72.120000000000005 108.52 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 1.0 OUTLIER -108.26 -54.21 2.53 Favored 'General case' 0 C--N 1.283 -2.317 0 N-CA-C 109.131 -0.692 . . . . 73.030000000000001 109.131 -177.05 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . 0.416 ' CG ' HH21 ' C' ' 232' ' ' ARG . 11.8 t70 -132.8 137.62 46.85 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.495 -1.298 . . . . 63.219999999999999 107.495 176.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.424 ' HA ' HG13 ' C' ' 267' ' ' VAL . 19.1 mt -137.25 120.48 21.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 105.454 -2.054 . . . . 62.340000000000003 105.454 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.416 HH21 ' CG ' ' C' ' 230' ' ' ASP . 19.0 ptp180 -126.11 120.4 30.06 Favored 'General case' 0 C--N 1.274 -2.678 0 C-N-CA 119.815 -0.754 . . . . 45.109999999999999 111.42 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.436 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 33.0 p -111.0 134.76 52.35 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.892 -1.049 . . . . 55.350000000000001 108.854 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -144.93 148.03 33.39 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.561 -0.456 . . . . 65.439999999999998 110.062 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' B' ' 272' ' ' GLU . 64.7 mt-10 73.93 -74.02 0.09 Allowed 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 115.231 1.567 . . . . 72.239999999999995 115.231 176.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.44 ' HD2' ' HB3' ' C' ' 235' ' ' GLU . 8.0 mpt_? -136.48 17.0 3.14 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 109.206 -0.665 . . . . 71.239999999999995 109.206 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -78.71 131.11 36.48 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.998 0.904 . . . . 72.439999999999998 113.293 -173.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.575 ' HB3' ' HB2' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -128.5 135.74 49.84 Favored 'General case' 0 CA--C 1.497 -1.096 0 CA-C-N 114.887 -1.051 . . . . 61.219999999999999 111.157 174.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.474 HG23 ' HB ' ' C' ' 275' ' ' VAL . 7.2 p -130.99 142.59 43.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.375 -0.829 . . . . 53.130000000000003 111.529 -175.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -104.7 132.25 51.17 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 114.363 -1.29 . . . . 75.310000000000002 107.698 171.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.536 HD12 HG23 ' B' ' 277' ' ' ILE . 2.7 tm? -130.13 116.03 17.89 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 105.303 -2.11 . . . . 72.409999999999997 105.303 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 129.63 -132.4 7.06 Favored Glycine 0 C--N 1.3 -1.462 0 C-N-CA 120.147 -1.025 . . . . 63.229999999999997 111.416 -178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' C' ' 279' ' ' ASN . 44.2 t30 -137.2 135.56 37.39 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.047 0.451 . . . . 73.439999999999998 110.492 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 42.3 t -106.07 117.46 51.86 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.283 0 N-CA-C 107.863 -1.162 . . . . 71.099999999999994 107.863 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' B' ' 281' ' ' TYR . 2.8 p -123.56 112.83 34.81 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 CA-C-N 118.691 0.678 . . . . 72.099999999999994 110.455 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 11.4 m -81.98 156.05 24.89 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 117.444 -1.702 . . . . 73.209999999999994 110.298 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.445 ' HB2' ' HB1' ' B' ' 249' ' ' ALA . . . -67.64 -48.79 65.71 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.744 0.783 . . . . 73.040000000000006 112.042 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.84 -38.17 75.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.116 -1.402 . . . . 65.109999999999999 112.253 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -74.93 -27.95 60.4 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.929 -0.578 . . . . 64.340000000000003 111.561 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -77.59 93.94 4.28 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-O 121.6 0.714 . . . . 70.329999999999998 109.62 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -168.28 98.05 0.43 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.423 -1.262 . . . . 72.140000000000001 107.889 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 158.67 -49.43 0.41 Allowed Glycine 0 C--N 1.293 -1.832 0 N-CA-C 109.99 -1.244 . . . . 43.350000000000001 109.99 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 179.42 145.87 6.5 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 110.845 -0.902 . . . . 71.349999999999994 110.845 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 40.4 pt -94.61 -171.74 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 108.6 -0.889 . . . . 55.109999999999999 108.6 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 66.89 87.57 0.12 Allowed 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 123.313 0.645 . . . . 61.549999999999997 110.385 -176.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 46.4 mm -85.48 88.7 2.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 107.228 -1.397 . . . . 61.450000000000003 107.228 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 21.5 m -89.88 89.57 7.8 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.334 -0.848 . . . . 65.219999999999999 110.673 -178.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -106.96 139.69 40.96 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.819 -1.178 . . . . 72.140000000000001 107.819 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.55 28.93 8.19 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.151 0.797 . . . . 72.129999999999995 113.151 -178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 30.6 m -87.59 121.73 30.4 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.347 -0.612 . . . . 71.409999999999997 109.347 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' C' ' 225' ' ' ARG . 10.5 t -99.91 122.78 43.36 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 108.334 -0.987 . . . . 34.420000000000002 108.334 174.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 53.1 t-20 -123.7 137.1 54.77 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.876 -1.157 . . . . 54.43 107.876 -176.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 32.2 t -142.2 125.72 16.75 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.272 -0.64 . . . . 74.310000000000002 109.272 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.4 p -128.15 147.0 32.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 109.161 -0.681 . . . . 61.439999999999998 109.161 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 27.0 mm-40 -90.03 -76.04 0.44 Allowed 'General case' 0 N--CA 1.417 -2.076 0 N-CA-C 110.18 -0.304 . . . . 72.299999999999997 110.18 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 11.2 m -114.31 127.85 56.07 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.211 -0.996 . . . . 74.530000000000001 111.707 -175.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.424 HG13 ' HA ' ' C' ' 231' ' ' ILE . 1.3 p -128.52 122.46 57.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.511 0.672 . . . . 74.319999999999993 110.028 175.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 2.5 p -123.7 133.73 68.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.547 -0.751 . . . . 75.109999999999999 112.13 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.34 130.57 6.64 Favored Glycine 0 N--CA 1.429 -1.79 0 N-CA-C 108.404 -1.878 . . . . 35.43 108.404 170.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -134.41 116.51 15.26 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.667 -1.234 . . . . 74.120000000000005 107.667 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 96.9 -139.81 14.7 Favored Glycine 0 C--N 1.291 -1.939 0 N-CA-C 109.685 -1.366 . . . . 73.340000000000003 109.685 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -74.52 91.85 2.32 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.18 -1.045 . . . . 52.450000000000003 108.18 176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . 0.432 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 23.2 m -131.37 144.67 51.4 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 121.66 0.743 . . . . 75.340000000000003 110.893 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . 0.462 ' HD3' ' HB2' ' C' ' 287' ' ' TRP . 55.2 mtt85 -136.26 127.6 28.35 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 105.723 -1.954 . . . . 74.099999999999994 105.723 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.474 ' HB ' HG23 ' C' ' 239' ' ' VAL . 6.9 t -138.19 140.1 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.829 0 N-CA-C 109.486 -0.561 . . . . 71.25 109.486 -175.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.3 tt -128.71 111.93 13.68 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.074 -1.084 . . . . 74.239999999999995 108.074 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 58.1 mt -111.82 103.96 16.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.575 -0.898 . . . . 74.040000000000006 108.575 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 139.67 -136.02 7.57 Favored Glycine 0 N--CA 1.424 -2.131 0 N-CA-C 110.992 -0.843 . . . . 44.530000000000001 110.992 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' C' ' 243' ' ' ASN . 94.3 m-20 -127.88 156.34 42.74 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 110.111 -0.329 . . . . 75.040000000000006 110.111 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.88 138.25 24.18 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.013 -0.539 . . . . 72.0 110.049 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -130.12 122.33 28.05 Favored 'General case' 0 N--CA 1.415 -2.204 0 N-CA-C 107.37 -1.344 . . . . 73.299999999999997 107.37 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.57 -14.14 58.84 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.309 -0.859 . . . . 70.219999999999999 112.447 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -64.78 -58.18 10.6 Favored Glycine 0 CA--C 1.497 -1.038 0 N-CA-C 111.613 -0.595 . . . . 73.329999999999998 111.613 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . 0.534 ' NZ ' ' HB2' ' C' ' 284' ' ' LYS . 6.7 mtmp? 65.84 31.37 9.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.561 1.144 . . . . 62.329999999999998 108.344 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 111.19 97.15 2.38 Favored Glycine 0 N--CA 1.417 -2.567 0 N-CA-C 108.493 -1.843 . . . . 43.350000000000001 108.493 -172.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -76.22 41.64 0.24 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.262 1.03 . . . . 74.239999999999995 110.844 -176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.462 ' HB2' ' HD3' ' C' ' 274' ' ' ARG . 1.3 p90 -148.93 156.39 42.22 Favored 'General case' 0 N--CA 1.414 -2.272 0 CA-C-O 122.318 1.056 . . . . 72.510000000000005 113.254 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.36 24.41 0.19 Allowed 'General case' 0 C--N 1.285 -2.2 0 C-N-CA 127.072 2.149 . . . . 71.420000000000002 112.371 -176.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -135.78 5.59 3.13 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.986 -0.686 . . . . 63.509999999999998 110.857 -176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -147.99 108.4 4.12 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 119.914 -0.714 . . . . 74.239999999999995 111.359 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -146.04 97.65 2.98 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.191 -1.411 . . . . 53.399999999999999 107.191 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -109.36 -61.91 1.56 Allowed 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 115.304 -0.862 . . . . 74.430000000000007 110.282 -176.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -174.43 179.26 1.82 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 103.801 -2.666 . . . . 73.129999999999995 103.801 -172.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -79.33 88.17 4.97 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 104.758 -2.312 . . . . 74.439999999999998 104.758 171.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 . . . . . 0 C--O 1.249 1.048 0 O-C-N 124.886 1.366 . . . . 73.409999999999997 107.811 -169.364 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 C--O 1.244 0.79 0 N-CA-C 109.143 -0.688 . . . . 63.32 109.143 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp 64.3 -92.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 114.611 1.337 . . . . 52.299999999999997 114.611 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.517 ' H ' HG12 ' B' ' 222' ' ' ILE . 41.8 mt 57.92 28.84 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.382 0 N-CA-C 106.524 -1.658 . . . . 64.400000000000006 106.524 -168.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -95.3 -39.92 9.8 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 113.988 -1.46 . . . . 71.540000000000006 109.968 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -70.59 158.94 35.28 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.695 -1.224 . . . . 61.420000000000002 107.695 175.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 64.2 mt -83.05 114.92 24.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 122.167 0.984 . . . . 53.340000000000003 111.097 -170.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 22.4 m -114.88 164.28 11.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-N 114.575 -1.193 . . . . 74.319999999999993 108.018 174.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.421 ' HA3' ' HB3' ' A' ' 259' ' ' GLN . . . 114.73 52.28 0.43 Allowed Glycine 0 C--N 1.288 -2.099 0 C-N-CA 119.941 -1.123 . . . . 62.219999999999999 110.493 -174.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.616 ' HG2' HH11 ' A' ' 225' ' ' ARG . 0.0 OUTLIER -114.93 121.73 44.08 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.839 -0.43 . . . . 74.310000000000002 109.839 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -106.62 123.89 48.8 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.945 -1.131 . . . . 72.25 107.945 176.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 12.2 m -123.91 136.83 54.59 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 116.109 -0.496 . . . . 62.140000000000001 110.393 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -134.31 138.16 44.76 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.68 -1.23 . . . . 62.130000000000003 107.68 175.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -93.43 -53.86 3.9 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.676 -0.49 . . . . 62.539999999999999 109.676 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.83 139.23 52.77 Favored 'General case' 0 C--O 1.252 1.191 0 N-CA-C 109.835 -0.432 . . . . 74.310000000000002 109.835 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 28.4 mm -128.08 116.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 106.279 -1.749 . . . . 63.409999999999997 106.279 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.522 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 31.5 ttp-105 -134.43 115.87 14.49 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.606 0.717 . . . . 73.140000000000001 111.489 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.64 ' HB ' ' CB ' ' A' ' 237' ' ' ALA . 4.8 p -129.1 140.47 51.55 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.493 -0.776 . . . . 51.130000000000003 111.227 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -121.04 143.16 49.2 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.542 0.687 . . . . 70.230000000000004 112.573 -175.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 68.79 -100.66 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.394 1.627 . . . . 55.420000000000002 115.394 171.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.622 ' HD2' ' OE2' ' A' ' 272' ' ' GLU . 16.8 mtm180 -99.08 23.39 9.1 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.476 1.131 . . . . 73.310000000000002 110.128 -171.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.64 ' CB ' ' HB ' ' A' ' 233' ' ' THR . . . -84.13 156.17 22.25 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 113.591 -1.64 . . . . 73.040000000000006 111.835 -176.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . 0.474 ' HD3' ' HG2' ' A' ' 274' ' ' ARG . 0.0 OUTLIER -146.18 137.85 24.86 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.502 -0.772 . . . . 62.439999999999998 110.202 174.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.53 HG12 ' HB ' ' A' ' 275' ' ' VAL . 29.7 m -132.21 142.49 42.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.394 0.616 . . . . 61.340000000000003 111.892 -176.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.463 ' HB3' ' HG ' ' A' ' 276' ' ' LEU . 56.5 tp60 -123.48 135.38 54.03 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.535 -0.757 . . . . 43.530000000000001 109.003 173.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -123.19 118.17 27.01 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.735 -1.58 . . . . 75.439999999999998 106.735 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.424 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 126.8 -113.0 1.67 Allowed Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 119.756 -1.211 . . . . 62.030000000000001 114.572 175.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -143.98 131.92 21.57 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 110.114 -0.328 . . . . 73.420000000000002 110.114 -172.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.539 HG11 ' H ' ' A' ' 286' ' ' PHE . 48.9 t -122.14 123.63 69.34 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.324 -0.621 . . . . 65.219999999999999 109.324 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.406 ' HA ' ' HB2' ' A' ' 281' ' ' TYR . 12.3 m -113.59 114.62 47.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-O 121.176 0.513 . . . . 75.230000000000004 110.364 174.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 24.4 m -96.97 159.76 14.73 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.842 -0.799 . . . . 52.119999999999997 108.842 177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.8 -33.47 75.73 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 123.249 0.62 . . . . 70.129999999999995 111.567 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -56.25 -42.84 78.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.06 -0.973 . . . . 50.409999999999997 111.985 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.435 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -74.38 -45.56 46.06 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 116.368 -0.378 . . . . 71.329999999999998 110.545 -178.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 59.6 tp 48.34 -95.04 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.19 1.396 . . . . 74.109999999999999 112.622 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -131.49 78.29 1.82 Allowed 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 109.212 -0.662 . . . . 75.219999999999999 109.212 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -99.02 -55.48 1.05 Allowed Glycine 0 C--N 1.298 -1.565 0 N-CA-C 108.247 -1.941 . . . . 42.409999999999997 108.247 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -162.89 121.96 1.06 Allowed Glycine 0 N--CA 1.424 -2.117 0 N-CA-C 108.428 -1.869 . . . . 54.399999999999999 108.428 176.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 22.7 pt -128.67 108.06 16.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-N 117.273 0.537 . . . . 53.140000000000001 110.902 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 60.34 54.68 3.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 122.917 1.341 . . . . 74.219999999999999 110.644 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 69.7 mt -124.16 -52.29 2.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 114.154 -1.385 . . . . 73.040000000000006 109.322 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' B' ' 253' ' ' GLY . 8.6 t -135.22 -4.92 2.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 122.552 1.168 . . . . 53.329999999999998 109.374 -178.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -88.31 19.5 3.75 Favored 'General case' 0 C--N 1.281 -2.377 0 C-N-CA 125.979 1.712 . . . . 61.439999999999998 112.914 -174.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.421 ' HB3' ' HA3' ' A' ' 224' ' ' GLY . 36.5 mt-30 -101.18 86.25 2.98 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.727 0.775 . . . . 54.409999999999997 110.847 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 87.2 m -91.14 138.36 31.66 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.594 -1.185 . . . . 55.020000000000003 109.926 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 52.9 m -102.85 108.12 19.22 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.529 -1.285 . . . . 74.319999999999993 107.529 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 37.2 t-20 -127.11 138.32 53.16 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.197 -0.668 . . . . 65.400000000000006 109.197 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.5 m -128.62 123.14 32.54 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.737 -0.468 . . . . 75.25 109.737 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.92 150.12 34.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.763 0 N-CA-C 110.455 -0.202 . . . . 72.420000000000002 110.455 177.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.694 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 3.7 tp10 -85.46 -74.91 0.39 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.096 0.559 . . . . 74.319999999999993 110.097 178.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 32.2 m -128.59 134.71 48.68 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 122.146 -0.346 . . . . 71.019999999999996 111.234 -175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 17.0 m -118.59 127.07 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 N-CA-C 107.659 -1.237 . . . . 74.239999999999995 107.659 172.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 10.1 p -127.23 134.84 65.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 CA-C-N 116.439 -0.346 . . . . 73.349999999999994 110.897 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -128.92 132.75 7.32 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.669 -0.776 . . . . 41.140000000000001 111.999 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -132.09 116.64 17.3 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 109.748 -0.464 . . . . 74.219999999999999 109.748 -176.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 109.93 -131.56 10.53 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.882 -0.887 . . . . 61.149999999999999 110.882 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.622 ' OE2' ' HD2' ' A' ' 236' ' ' ARG . 10.0 mp0 -92.5 32.3 1.23 Allowed 'General case' 0 C--O 1.252 1.22 0 C-N-CA 125.133 1.373 . . . . 51.299999999999997 110.087 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 16.7 m -81.77 145.22 30.57 Favored 'General case' 0 C--O 1.287 3.077 0 CA-C-O 122.927 1.346 . . . . 54.200000000000003 112.708 -170.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . 0.474 ' HG2' ' HD3' ' A' ' 238' ' ' ARG . 72.1 mtm-85 -127.08 127.79 45.23 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.697 -1.592 . . . . 74.219999999999999 109.27 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.53 ' HB ' HG12 ' A' ' 239' ' ' VAL . 48.9 t -127.81 132.29 69.01 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.529 0 CA-C-N 115.957 -0.565 . . . . 52.020000000000003 109.947 -175.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' A' ' 240' ' ' GLN . 6.8 tt -125.01 128.41 48.52 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 118.151 -1.42 . . . . 65.540000000000006 109.677 173.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.445 HG23 HD12 ' B' ' 241' ' ' LEU . 35.0 mm -112.56 105.62 19.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.657 -0.868 . . . . 63.119999999999997 108.657 178.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 138.78 -134.02 6.56 Favored Glycine 0 C--N 1.31 -0.883 0 C-N-CA 120.648 -0.787 . . . . 61.43 113.297 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' B' ' 243' ' ' ASN . 15.1 m120 -115.87 128.27 55.67 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 122.574 0.35 . . . . 71.340000000000003 110.816 -178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.06 118.67 34.05 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.657 -1.609 . . . . 73.010000000000005 106.657 176.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.406 ' HB2' ' HA ' ' A' ' 245' ' ' VAL . 22.4 m-85 -106.38 123.33 47.89 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.369 -1.345 . . . . 74.329999999999998 107.369 176.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.56 -50.66 0.79 Allowed Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.391 -1.083 . . . . 70.299999999999997 110.391 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 92.09 15.64 53.3 Favored Glycine 0 C--N 1.308 -1.02 0 N-CA-C 110.747 -0.941 . . . . 34.420000000000002 110.747 178.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' B' ' 287' ' ' TRP . 17.8 ptpt -179.85 27.06 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.286 1.034 . . . . 74.099999999999994 110.562 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -85.61 -120.72 1.08 Allowed Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 119.944 -1.122 . . . . 54.109999999999999 111.642 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.539 ' H ' HG11 ' A' ' 244' ' ' VAL . 86.8 t80 62.53 -89.07 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.106 0.562 . . . . 73.0 111.362 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 4.1 m-90 -166.89 15.84 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 127.35 2.26 . . . . 61.119999999999997 107.206 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -85.2 104.71 15.32 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 104.707 -2.331 . . . . 71.129999999999995 104.707 -176.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -62.16 135.22 57.4 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.805 -0.634 . . . . 71.140000000000001 112.183 -171.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -52.11 113.25 0.96 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.054 -0.975 . . . . 74.439999999999998 111.327 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.478 ' H ' ' CD2' ' A' ' 293' ' ' HIS . 58.6 m-70 78.72 6.32 2.34 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.284 1.433 . . . . 73.129999999999995 113.709 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -96.74 7.31 46.88 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.274 -1.38 . . . . 72.420000000000002 107.274 174.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . 0.478 ' CD2' ' H ' ' A' ' 291' ' ' HIS . 13.3 m-70 -80.28 14.56 1.89 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.287 -1.324 . . . . 75.340000000000003 109.601 -178.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -77.13 62.65 2.26 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.868 1.432 . . . . 75.310000000000002 114.868 -170.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 . . . . . 0 C--N 1.301 -1.537 0 N-CA-C 106.394 -1.706 . . . . 74.450000000000003 106.394 172.175 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 54.1 ttm . . . . . 0 CA--C 1.508 -0.654 0 N-CA-C 109.578 -0.527 . . . . 72.209999999999994 109.578 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.492 ' H ' ' HB2' ' C' ' 218' ' ' LYS . 86.6 tttt 75.51 -72.26 0.11 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.429 1.091 . . . . 72.420000000000002 109.799 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 14.8 tt -167.63 13.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 107.52 -1.289 . . . . 73.140000000000001 107.52 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -140.03 150.4 44.35 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 115.561 -0.745 . . . . 72.439999999999998 109.102 -173.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -96.84 -12.23 23.82 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 112.501 0.556 . . . . 51.310000000000002 112.501 -175.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . 0.517 HG12 ' H ' ' A' ' 219' ' ' ILE . 58.6 mt -90.76 116.09 31.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-O 120.68 0.276 . . . . 54.43 110.372 -174.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.482 HG11 HG21 ' C' ' 222' ' ' ILE . 31.0 m -106.22 146.47 12.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-O 120.815 0.341 . . . . 72.319999999999993 110.639 176.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' B' ' 258' ' ' ASP . . . 134.3 81.43 0.16 Allowed Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 109.719 -1.352 . . . . 55.020000000000003 109.719 -175.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.417 ' HD2' ' H ' ' B' ' 224' ' ' GLY . 0.2 OUTLIER -142.72 129.5 20.46 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 107.132 -1.433 . . . . 73.420000000000002 107.132 178.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.537 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 29.6 m-80 -103.87 130.18 51.44 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 107.991 -1.115 . . . . 50.350000000000001 107.991 175.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 28.6 m -128.61 137.04 51.48 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-O 121.197 0.523 . . . . 71.140000000000001 110.615 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.498 ' HB1' HD11 ' B' ' 231' ' ' ILE . . . -131.59 155.55 47.33 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 107.791 -1.188 . . . . 75.530000000000001 107.791 177.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.694 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 0.1 OUTLIER -109.0 -61.72 1.58 Allowed 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 119.51 -0.876 . . . . 71.409999999999997 108.854 -178.435 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -126.63 137.8 53.35 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.84 -0.8 . . . . 75.420000000000002 108.84 -177.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.498 HD11 ' HB1' ' B' ' 228' ' ' ALA . 18.5 mm -131.66 117.55 35.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 N-CA-C 106.874 -1.528 . . . . 72.340000000000003 106.874 -178.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.444 ' HG3' HG23 ' B' ' 268' ' ' VAL . 7.0 ptm180 -130.38 118.81 21.78 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 121.345 0.593 . . . . 72.439999999999998 111.492 -178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 34.5 p -110.72 128.14 55.61 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.352 -0.84 . . . . 61.229999999999997 109.31 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -125.01 142.38 51.52 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.035 0.445 . . . . 73.319999999999993 111.04 176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.461 ' HB3' ' HD3' ' B' ' 236' ' ' ARG . 45.0 mt-10 74.76 -102.37 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.388 0 C-N-CA 125.011 1.324 . . . . 72.030000000000001 113.084 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.565 ' HD3' ' N ' ' B' ' 236' ' ' ARG . 0.7 OUTLIER -110.37 25.49 11.73 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.723 0.773 . . . . 64.319999999999993 109.448 -175.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -82.99 142.45 31.36 Favored 'General case' 0 N--CA 1.424 -1.735 0 CA-C-O 122.568 1.175 . . . . 55.32 112.759 -175.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -131.65 135.86 47.25 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.542 -1.208 . . . . 63.340000000000003 109.506 177.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.832 HG12 ' HB ' ' B' ' 275' ' ' VAL . 2.6 m -125.31 141.27 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.869 0 CA-C-O 121.869 0.843 . . . . 71.530000000000001 111.538 177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.492 ' HB3' ' HG ' ' B' ' 276' ' ' LEU . 5.9 tp-100 -116.41 128.38 55.45 Favored 'General case' 0 C--N 1.268 -2.971 0 CA-C-N 114.074 -1.421 . . . . 65.329999999999998 107.643 174.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.445 HD12 HG23 ' A' ' 277' ' ' ILE . 3.0 tm? -120.38 117.31 27.41 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.927 -1.509 . . . . 72.439999999999998 106.927 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.417 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 125.92 -112.23 1.61 Allowed Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.554 -1.308 . . . . 73.140000000000001 113.143 176.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.466 ' HB3' ' ND2' ' A' ' 279' ' ' ASN . 25.7 t-20 -144.97 138.36 26.77 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 111.556 0.206 . . . . 72.349999999999994 111.556 -174.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.515 HG11 ' H ' ' B' ' 286' ' ' PHE . 45.2 t -119.9 133.7 65.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.605 -0.887 . . . . 51.420000000000002 108.605 175.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 19.3 t -122.28 112.11 33.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 108.943 -0.762 . . . . 63.310000000000002 108.943 177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 23.5 m -95.49 158.95 15.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.97 -1.122 . . . . 62.329999999999998 107.97 175.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.435 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -64.39 -39.7 94.37 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.792 0.806 . . . . 74.400000000000006 110.553 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.89 -34.47 65.57 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.425 -1.716 . . . . 53.409999999999997 114.157 -175.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.439 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -68.03 -33.27 74.27 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.313 0.486 . . . . 63.25 112.313 -176.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 90.8 mt 68.23 165.05 0.24 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.182 0.993 . . . . 75.010000000000005 111.135 -175.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -86.61 66.74 9.62 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 122.669 1.224 . . . . 72.439999999999998 110.783 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . 0.416 ' O ' ' HA3' ' C' ' 252' ' ' GLY . . . -91.11 -15.85 55.12 Favored Glycine 0 N--CA 1.436 -1.336 0 N-CA-C 109.499 -1.44 . . . . 71.439999999999998 109.499 176.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 257' ' ' SER . . . -85.76 119.49 5.11 Favored Glycine 0 N--CA 1.419 -2.471 0 CA-C-N 114.857 -0.672 . . . . 64.439999999999998 111.702 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 10.0 tt -125.73 -36.9 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-O 121.171 0.51 . . . . 63.219999999999999 110.523 176.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -112.76 -14.49 13.1 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 121.929 -0.482 . . . . 64.120000000000005 110.696 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . 0.479 HG13 ' NE2' ' B' ' 259' ' ' GLN . 17.0 tt -78.95 3.28 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 CA-C-O 121.383 0.611 . . . . 73.519999999999996 111.119 -174.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.8 m -58.01 98.3 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.301 1.44 . . . . 65.129999999999995 111.454 -178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.516 ' O ' ' HA3' ' B' ' 224' ' ' GLY . 34.5 t0 37.54 85.3 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 126.871 2.068 . . . . 73.409999999999997 113.488 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . 0.479 ' NE2' HG13 ' B' ' 256' ' ' ILE . 42.0 mt-30 -87.25 -36.18 18.08 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 114.278 -1.328 . . . . 74.530000000000001 109.414 -178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' C' ' 243' ' ' ASN . 0.1 OUTLIER -65.02 120.65 13.02 Favored 'General case' 0 N--CA 1.396 -3.142 0 CA-C-N 113.33 -1.759 . . . . 63.210000000000001 113.665 -172.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 63.9 m -100.74 105.95 17.33 Favored 'General case' 0 N--CA 1.402 -2.854 0 N-CA-C 104.139 -2.541 . . . . 65.409999999999997 104.139 167.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.534 HD21 HD22 ' C' ' 241' ' ' LEU . 54.7 t30 -128.44 142.02 51.22 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.097 -0.956 . . . . 73.209999999999994 109.886 -171.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 39.6 m -137.2 128.07 27.34 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.807 0.337 . . . . 53.140000000000001 110.948 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.2 p -128.39 153.72 38.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 108.795 -0.817 . . . . 74.409999999999997 108.795 177.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 38.4 tt0 -96.2 -76.35 0.51 Allowed 'General case' 0 N--CA 1.418 -2.029 0 C-N-CA 120.156 -0.617 . . . . 64.310000000000002 111.452 175.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 87.0 m -116.37 128.43 55.52 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.765 -0.774 . . . . 72.019999999999996 112.635 -175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 11.8 m -118.45 129.08 75.26 Favored 'Isoleucine or valine' 0 C--O 1.252 1.197 0 N-CA-C 107.793 -1.188 . . . . 62.039999999999999 107.793 171.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . 0.444 HG23 ' HG3' ' B' ' 232' ' ' ARG . 4.1 p -126.83 128.25 70.69 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 CA-C-N 115.978 -0.555 . . . . 63.210000000000001 111.126 -179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . 0.407 ' HA2' ' OG1' ' C' ' 233' ' ' THR . . . -116.06 132.01 9.95 Favored Glycine 0 N--CA 1.425 -2.055 0 N-CA-C 110.361 -1.096 . . . . 21.420000000000002 110.361 175.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -131.99 116.4 17.06 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.491 -0.559 . . . . 72.219999999999999 109.491 -178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 100.56 -137.66 13.39 Favored Glycine 0 C--N 1.309 -0.92 0 N-CA-C 111.139 -0.784 . . . . 71.239999999999995 111.139 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 2.4 mp0 -77.22 40.43 0.27 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.993 1.317 . . . . 55.140000000000001 110.177 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 39.0 m -82.92 144.66 29.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.979 0.895 . . . . 73.310000000000002 112.503 -169.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 32.5 mtt180 -130.75 127.21 38.3 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 106.58 -1.637 . . . . 73.530000000000001 106.58 177.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.832 ' HB ' HG12 ' B' ' 239' ' ' VAL . 89.4 t -135.06 130.34 51.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 109.377 -0.601 . . . . 70.140000000000001 109.377 -176.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' B' ' 240' ' ' GLN . 7.0 tt -122.09 125.41 46.14 Favored 'General case' 0 C--N 1.277 -2.553 0 C-N-CA 117.7 -1.6 . . . . 73.319999999999993 110.144 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.43 HG23 HD12 ' C' ' 241' ' ' LEU . 29.1 mm -110.51 103.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.043 -1.465 . . . . 71.349999999999994 107.043 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 139.76 -147.65 19.35 Favored Glycine 0 C--N 1.308 -0.976 0 C-N-CA 120.197 -1.002 . . . . 62.43 113.694 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 0.9 OUTLIER -106.64 129.8 54.49 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.957 -0.386 . . . . 55.25 109.957 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.94 118.69 36.17 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.511 -1.663 . . . . 71.109999999999999 106.511 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -107.62 123.15 48.05 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.694 -0.854 . . . . 75.349999999999994 108.694 174.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 139.46 -50.17 0.79 Allowed Glycine 0 N--CA 1.425 -2.064 0 N-CA-C 109.79 -1.324 . . . . 50.43 109.79 -176.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 94.53 17.05 40.48 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.738 -0.945 . . . . 62.210000000000001 110.738 178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt 174.05 27.77 0.0 OUTLIER 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.784 1.234 . . . . 70.120000000000005 109.726 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.22 -113.36 0.23 Allowed Glycine 0 N--CA 1.438 -1.23 0 N-CA-C 111.011 -0.836 . . . . 75.420000000000002 111.011 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.515 ' H ' HG11 ' B' ' 244' ' ' VAL . 92.7 t80 60.61 -83.53 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.39 0.676 . . . . 73.329999999999998 111.646 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.508 ' HE1' ' HB3' ' A' ' 286' ' ' PHE . 3.5 m-90 -162.63 48.86 0.17 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 126.477 1.911 . . . . 74.230000000000004 108.672 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 9.0 t70 67.2 -166.38 0.21 Allowed 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 114.562 -1.199 . . . . 71.129999999999995 109.392 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -153.33 127.37 9.01 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 121.505 -0.747 . . . . 53.200000000000003 112.138 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -121.57 178.6 4.76 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 109.003 -0.74 . . . . 72.340000000000003 109.003 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -100.18 -75.64 0.57 Allowed 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 114.174 1.176 . . . . 73.200000000000003 114.174 -173.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -135.73 129.35 32.49 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.803 -0.359 . . . . 62.219999999999999 110.999 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -144.14 165.87 26.61 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 105.704 -1.961 . . . . 73.120000000000005 105.704 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . 0.439 ' CD2' HH21 ' C' ' 236' ' ' ARG . 27.2 t-80 -165.88 151.24 8.75 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.075 -0.713 . . . . 75.409999999999997 109.075 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . 0.414 ' HB3' ' CZ ' ' B' ' 236' ' ' ARG . 73.2 t60 . . . . . 0 C--N 1.299 -1.618 0 N-CA-C 107.807 -1.182 . . . . 74.230000000000004 107.807 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 CA--C 1.508 -0.637 0 N-CA-C 110.063 -0.347 . . . . 52.229999999999997 110.063 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . 0.492 ' HB2' ' H ' ' B' ' 218' ' ' LYS . 53.3 tptt -126.47 114.94 18.82 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.692 -0.484 . . . . 63.219999999999999 109.692 -172.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.581 ' H ' HD13 ' C' ' 219' ' ' ILE . 0.2 OUTLIER -96.56 68.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-O 122.221 1.01 . . . . 73.109999999999999 110.295 178.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -155.11 144.49 21.17 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 114.25 -1.341 . . . . 72.319999999999993 108.831 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 68.77 -72.21 0.1 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.411 1.484 . . . . 61.229999999999997 114.076 173.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 0.482 HG21 HG11 ' B' ' 223' ' ' VAL . 66.9 mt -83.91 114.66 24.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-O 121.364 0.602 . . . . 75.420000000000002 110.324 -175.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' C' ' 258' ' ' ASP . 26.8 m -112.05 143.05 22.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.522 -0.918 . . . . 75.030000000000001 108.522 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' C' ' 260' ' ' THR . . . 137.64 52.39 0.06 OUTLIER Glycine 0 C--N 1.297 -1.602 0 C-N-CA 119.798 -1.192 . . . . 52.210000000000001 111.513 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.24 138.58 52.24 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.756 -0.831 . . . . 72.409999999999997 108.756 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' C' ' 262' ' ' ASN . 40.8 m-80 -110.25 132.63 54.0 Favored 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 108.028 -1.101 . . . . 62.100000000000001 108.028 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 17.2 m -129.38 136.72 50.33 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-N 116.318 -0.401 . . . . 73.400000000000006 110.019 -177.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.527 ' HB1' HD11 ' C' ' 231' ' ' ILE . . . -137.4 147.08 45.18 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 108.565 -0.902 . . . . 63.240000000000002 108.565 178.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -100.86 -64.65 1.03 Allowed 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.936 -0.394 . . . . 71.040000000000006 109.936 -177.158 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.59 138.03 52.75 Favored 'General case' 0 C--O 1.25 1.103 0 N-CA-C 108.928 -0.767 . . . . 70.129999999999995 108.928 -176.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.527 HD11 ' HB1' ' C' ' 228' ' ' ALA . 10.9 mm -132.0 117.46 33.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 106.552 -1.648 . . . . 74.150000000000006 106.552 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -126.03 122.12 34.96 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.585 -0.846 . . . . 74.409999999999997 112.413 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.431 ' CG2' HG13 ' C' ' 239' ' ' VAL . 17.3 p -110.47 126.99 54.92 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.051 -0.977 . . . . 70.230000000000004 109.19 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -128.93 142.77 50.83 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.036 0.446 . . . . 65.140000000000001 111.087 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 51.9 mt-10 78.75 -90.01 0.02 OUTLIER 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 125.571 1.548 . . . . 72.400000000000006 113.971 173.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.474 ' HD3' ' OE2' ' C' ' 272' ' ' GLU . 0.0 OUTLIER -126.25 28.67 5.98 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.043 -1.095 . . . . 73.439999999999998 108.043 -177.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -82.58 146.42 29.17 Favored 'General case' 0 C--O 1.265 1.882 0 CA-C-O 122.794 1.283 . . . . 63.009999999999998 113.844 -174.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.1 OUTLIER -131.84 135.53 46.78 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 114.23 -1.35 . . . . 72.049999999999997 109.541 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.694 HG12 ' HB ' ' C' ' 275' ' ' VAL . 25.8 m -134.91 141.74 42.21 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 CA-C-O 121.936 0.874 . . . . 72.310000000000002 111.94 176.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.455 HE22 HD22 ' B' ' 276' ' ' LEU . 48.7 tp60 -110.83 133.19 53.57 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 113.985 -1.461 . . . . 73.140000000000001 108.304 176.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.534 HD22 HD21 ' B' ' 262' ' ' ASN . 3.1 tm? -125.26 117.01 22.87 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 106.249 -1.76 . . . . 55.109999999999999 106.249 177.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.409 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 125.88 -115.14 2.26 Favored Glycine 0 N--CA 1.433 -1.523 0 C-N-CA 119.407 -1.378 . . . . 51.240000000000002 113.624 176.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 12.9 t-20 -144.34 137.54 27.22 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 110.008 -0.367 . . . . 64.439999999999998 110.008 -173.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.544 HG11 ' H ' ' C' ' 286' ' ' PHE . 60.1 t -124.26 124.84 69.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 109.377 -0.601 . . . . 74.140000000000001 109.377 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 32.4 t -116.21 111.85 37.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.853 -0.795 . . . . 54.43 108.853 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 23.8 m -94.93 159.68 14.92 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.226 -1.028 . . . . 63.340000000000003 108.226 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.439 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -64.45 -39.96 94.82 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.685 0.755 . . . . 74.319999999999993 110.418 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -33.23 61.16 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 113.608 -1.633 . . . . 75.340000000000003 112.155 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -70.77 -45.96 63.79 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.15 -0.477 . . . . 34.310000000000002 112.132 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . 0.25 1.2 pt? 49.4 28.17 2.28 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.745 1.387 . . . . 72.349999999999994 114.745 -175.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -80.45 28.87 0.31 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.762 -0.586 . . . . 72.519999999999996 110.085 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' B' ' 252' ' ' GLY . . . -75.5 -27.06 64.12 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 114.55 0.58 . . . . 42.32 114.55 -172.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -97.68 22.64 39.76 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 121.242 -0.504 . . . . 73.219999999999999 113.05 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 9.0 tp -149.93 158.82 5.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.357 -0.979 . . . . 75.450000000000003 108.357 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -119.04 141.29 48.85 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.4 0.619 . . . . 74.010000000000005 111.734 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 6.7 tt -136.79 68.05 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 106.567 -1.642 . . . . 55.030000000000001 106.567 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . 0.477 ' HB2' ' HB3' ' B' ' 259' ' ' GLN . 47.4 t -103.56 15.49 28.81 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 112.695 -2.048 . . . . 63.32 107.275 -178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . 0.457 ' OD2' ' HG3' ' C' ' 259' ' ' GLN . 8.1 p-10 -128.5 -177.22 4.08 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 113.754 -1.566 . . . . 71.219999999999999 107.573 -176.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . 0.457 ' HG3' ' OD2' ' C' ' 258' ' ' ASP . 96.7 mt-30 72.37 -65.96 0.33 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.15 0.98 . . . . 70.540000000000006 111.999 -179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . 0.507 ' O ' ' HA2' ' C' ' 224' ' ' GLY . 23.6 m -86.84 118.36 26.18 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.855 -0.738 . . . . 75.340000000000003 110.358 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 7.7 t -136.05 108.28 7.27 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 104.771 -2.307 . . . . 72.319999999999993 104.771 172.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' C' ' 226' ' ' ASN . 49.6 t30 -125.82 139.24 53.66 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.086 -0.506 . . . . 64.310000000000002 111.095 -168.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 13.1 t -129.38 123.5 31.87 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 108.438 -0.949 . . . . 54.509999999999998 108.438 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.01 153.92 34.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 108.165 -1.05 . . . . 73.120000000000005 108.165 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -97.56 -79.87 0.46 Allowed 'General case' 0 N--CA 1.416 -2.161 0 C-N-CA 120.028 -0.669 . . . . 72.409999999999997 111.403 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 29.2 m -120.07 127.73 52.82 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.145 -0.622 . . . . 71.239999999999995 111.812 -173.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.9 m -118.7 127.3 75.66 Favored 'Isoleucine or valine' 0 C--O 1.248 0.994 0 CA-C-O 121.621 0.724 . . . . 73.319999999999993 109.292 174.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 60.5 t -118.05 120.22 63.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.406 -0.815 . . . . 55.119999999999997 109.23 -175.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -114.83 131.67 9.93 Favored Glycine 0 N--CA 1.416 -2.682 0 C-N-CA 119.635 -1.269 . . . . 53.149999999999999 111.114 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -133.33 133.84 43.03 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.491 -0.929 . . . . 55.539999999999999 108.491 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 87.77 -132.84 11.43 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.264 -0.969 . . . . 61.409999999999997 111.469 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . 0.474 ' OE2' ' HD3' ' C' ' 236' ' ' ARG . 4.5 mp0 -91.37 52.83 2.16 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.945 -1.131 . . . . 74.129999999999995 107.945 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 21.7 t -83.71 145.63 28.64 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 115.141 -0.936 . . . . 62.32 110.974 -174.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 17.2 mtm180 -141.12 127.5 19.87 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.785 -1.191 . . . . 73.439999999999998 107.785 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.694 ' HB ' HG12 ' C' ' 239' ' ' VAL . 13.6 t -137.2 138.95 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.28 0 N-CA-C 108.14 -1.059 . . . . 63.32 108.14 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 8.8 tt -123.99 114.75 20.19 Favored 'General case' 0 N--CA 1.404 -2.768 0 C-N-CA 118.875 -1.13 . . . . 73.019999999999996 109.916 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 47.5 mm -102.51 103.04 14.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 N-CA-C 106.674 -1.602 . . . . 74.040000000000006 106.674 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 145.54 -145.67 15.09 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.014 -1.089 . . . . 71.109999999999999 113.232 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -113.46 131.83 55.89 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 122.868 0.467 . . . . 64.030000000000001 109.764 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.64 118.54 32.39 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 106.702 -1.592 . . . . 64.150000000000006 106.702 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -113.29 123.34 49.92 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.63 -0.878 . . . . 72.120000000000005 108.63 176.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 141.98 -45.06 0.96 Allowed Glycine 0 N--CA 1.429 -1.821 0 N-CA-C 110.632 -0.987 . . . . 62.210000000000001 110.632 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 94.28 4.36 62.75 Favored Glycine 0 CA--C 1.501 -0.811 0 N-CA-C 110.61 -0.996 . . . . 55.119999999999997 110.61 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -170.71 28.75 0.02 OUTLIER 'General case' 0 C--O 1.247 0.948 0 C-N-CA 123.756 0.822 . . . . 64.340000000000003 109.671 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.37 -124.45 0.44 Allowed Glycine 0 N--CA 1.438 -1.213 0 N-CA-C 110.766 -0.933 . . . . 63.119999999999997 110.766 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.544 ' H ' HG11 ' C' ' 244' ' ' VAL . 88.1 t80 65.91 -78.67 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.351 0.66 . . . . 63.539999999999999 111.187 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -157.34 23.24 0.3 Allowed 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.574 1.15 . . . . 75.200000000000003 109.045 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 10.4 t70 61.57 -150.6 0.39 Allowed 'General case' 0 C--O 1.254 1.298 0 N-CA-C 105.096 -2.187 . . . . 72.519999999999996 105.096 -173.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 6.5 m120 68.41 149.82 0.07 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.644 1.177 . . . . 64.299999999999997 111.719 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 69.08 148.7 0.07 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.985 0.897 . . . . 74.340000000000003 112.407 173.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -79.1 96.77 5.92 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.145 -1.428 . . . . 75.319999999999993 107.145 172.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -58.98 119.07 6.56 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.986 -1.461 . . . . 53.119999999999997 111.213 -170.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -87.55 128.68 35.25 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.043 -1.465 . . . . 75.439999999999998 107.043 176.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -78.94 139.78 38.19 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-O 121.81 0.815 . . . . 74.230000000000004 112.27 -175.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 . . . . . 0 C--N 1.288 -2.083 0 N-CA-C 106.858 -1.534 . . . . 52.409999999999997 106.858 175.163 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 16.0 tmm? . . . . . 0 C--O 1.24 0.567 0 N-CA-C 107.963 -1.125 . . . . 55.240000000000002 107.963 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -73.61 95.67 2.34 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 123.398 0.679 . . . . 73.109999999999999 111.883 -175.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 43.4 pt -87.69 149.17 4.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.812 -0.631 . . . . 75.099999999999994 109.516 176.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -92.27 80.27 5.0 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 122.097 0.951 . . . . 65.439999999999998 110.62 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -144.54 81.95 1.67 Allowed 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.03 -1.441 . . . . 73.319999999999993 107.617 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.497 HG21 HG21 ' B' ' 223' ' ' VAL . 3.3 mp -111.81 124.62 68.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.312 -0.858 . . . . 73.049999999999997 110.355 -177.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.8 m -107.25 164.99 4.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 107.367 -1.345 . . . . 72.219999999999999 107.367 173.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -65.73 87.49 0.1 Allowed Glycine 0 C--N 1.316 -0.578 0 C-N-CA 121.132 -0.556 . . . . 43.219999999999999 111.999 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -94.63 123.62 38.18 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.904 0.383 . . . . 64.25 110.041 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -112.53 130.87 55.86 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.295 -1.372 . . . . 75.0 107.295 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.7 m -135.62 136.77 41.28 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-O 121.146 0.498 . . . . 32.420000000000002 111.044 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 277' ' ' ILE . . . -116.2 131.17 57.02 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.334 -0.988 . . . . 62.310000000000002 108.334 177.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 4.1 tmmm? -81.39 -62.08 1.76 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.701 -0.481 . . . . 75.209999999999994 109.701 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -130.17 140.25 50.77 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 120.57 0.224 . . . . 75.219999999999999 111.401 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 48.7 mt -131.84 119.47 41.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 108.857 -0.794 . . . . 72.019999999999996 108.857 -177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.421 ' HB3' HG23 ' A' ' 268' ' ' VAL . 2.5 mpt_? -112.04 126.1 54.8 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.835 -0.431 . . . . 71.010000000000005 109.835 176.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.48 128.2 30.97 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 120.979 0.419 . . . . 52.329999999999998 110.395 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -156.25 159.73 39.15 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 115.416 -0.811 . . . . 73.030000000000001 109.956 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.494 ' HB2' ' H ' ' A' ' 271' ' ' GLY . 28.2 mm-40 63.3 72.2 0.49 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.551 0.741 . . . . 70.129999999999995 112.634 177.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.31 22.71 8.04 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.177 0.991 . . . . 73.200000000000003 113.031 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.41 145.76 28.82 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.107 0.48 . . . . 65.129999999999995 111.077 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -127.63 134.94 49.64 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.787 -0.642 . . . . 74.319999999999993 110.382 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 77.8 t -123.44 132.32 71.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.566 -0.743 . . . . 74.25 110.493 -174.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.524 ' HG3' HD13 ' A' ' 276' ' ' LEU . 55.5 tp60 -118.23 114.81 23.58 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.252 -1.018 . . . . 74.329999999999998 108.252 174.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -115.69 121.97 44.12 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.275 -1.379 . . . . 73.329999999999998 107.275 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.49 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 136.48 -119.74 2.04 Favored Glycine 0 N--CA 1.436 -1.307 0 C-N-CA 119.946 -1.121 . . . . 61.240000000000002 112.525 177.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -144.18 129.04 18.4 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 110.09 -0.337 . . . . 70.519999999999996 110.09 -177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.0 t -112.57 120.98 64.01 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 109.452 -0.573 . . . . 72.530000000000001 109.452 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 25.8 m -117.99 112.17 37.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.594 0.711 . . . . 61.43 109.665 175.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 17.1 m -77.8 159.65 28.87 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.755 -0.657 . . . . 73.420000000000002 109.665 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.14 90.84 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.206 0.527 . . . . 73.510000000000005 110.654 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.64 -33.33 63.95 Favored 'General case' 0 C--O 1.211 -0.973 0 C-N-CA 124.891 1.276 . . . . 73.329999999999998 112.325 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -67.24 -32.48 73.55 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.366 -0.834 . . . . 73.430000000000007 112.865 -176.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 mm? 60.85 99.8 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 O-C-N 123.855 0.722 . . . . 64.200000000000003 109.747 -170.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -72.59 86.46 1.19 Allowed 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 113.213 0.82 . . . . 70.439999999999998 113.213 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -156.89 81.31 0.16 Allowed Glycine 0 N--CA 1.431 -1.688 0 N-CA-C 109.124 -1.591 . . . . 74.239999999999995 109.124 176.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -71.03 154.89 52.46 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 112.493 -0.243 . . . . 44.229999999999997 112.493 -177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 62.6 mt -113.47 94.73 3.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 109.388 -0.597 . . . . 72.230000000000004 109.388 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 51.3 94.78 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.6 1.333 . . . . 74.340000000000003 114.6 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 49.9 mt -84.04 83.81 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 106.861 -1.533 . . . . 51.450000000000003 106.861 174.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 39.8 m -85.82 -53.91 4.84 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.037 -0.983 . . . . 73.319999999999993 112.808 -173.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.431 ' CG ' HH22 ' C' ' 255' ' ' ARG . 8.5 t70 -130.0 101.01 5.65 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.207 -1.034 . . . . 40.409999999999997 108.207 -174.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.13 161.1 18.86 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.633 -0.712 . . . . 55.420000000000002 109.912 -174.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 51.9 m -87.08 138.44 31.49 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 124.646 1.178 . . . . 73.200000000000003 110.995 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -97.0 136.2 37.91 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 108.118 -1.067 . . . . 71.409999999999997 108.118 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' B' ' 226' ' ' ASN . 15.4 m120 -120.87 140.4 51.84 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.999 0.428 . . . . 54.32 110.162 -176.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 42.6 m -142.13 123.8 15.06 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.846 -0.427 . . . . 71.310000000000002 109.846 178.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.3 p -122.53 138.48 52.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 109.971 -0.381 . . . . 64.340000000000003 109.971 177.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 65.1 mm-40 -81.17 -68.67 0.67 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.406 -0.361 . . . . 71.099999999999994 111.387 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 99.1 m -125.56 128.33 47.78 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 120.432 -0.507 . . . . 75.319999999999993 112.296 -177.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.415 ' HB ' HD12 ' B' ' 231' ' ' ILE . 3.3 p -125.02 123.77 66.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.685 -0.857 . . . . 72.299999999999997 108.685 173.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.421 HG23 ' HB3' ' A' ' 232' ' ' ARG . 7.3 p -127.07 139.54 51.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 120.888 0.375 . . . . 75.200000000000003 111.077 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -124.76 132.34 8.13 Favored Glycine 0 N--CA 1.423 -2.18 0 C-N-CA 121.019 -0.61 . . . . 71.5 111.756 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 44.8 tptt -133.23 116.46 16.24 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 109.431 -0.581 . . . . 73.450000000000003 109.431 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.494 ' H ' ' HB2' ' A' ' 235' ' ' GLU . . . 80.59 73.78 1.15 Allowed Glycine 0 C--N 1.316 -0.583 0 C-N-CA 120.386 -0.911 . . . . 74.200000000000003 113.322 173.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 56.35 53.65 8.53 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 113.788 1.033 . . . . 75.450000000000003 113.788 -178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 50.3 m -88.09 144.4 26.52 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 107.352 -1.351 . . . . 75.129999999999995 107.352 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 2.3 mpt_? -128.1 125.31 38.97 Favored 'General case' 0 N--CA 1.414 -2.265 0 N-CA-C 105.479 -2.045 . . . . 72.230000000000004 105.479 173.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.481 HG12 HG22 ' B' ' 239' ' ' VAL . 4.4 m -130.54 140.19 49.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 C-N-CA 119.936 -0.706 . . . . 72.530000000000001 110.122 -174.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.524 HD13 ' HG3' ' A' ' 240' ' ' GLN . 11.1 tp -125.11 118.64 26.58 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.649 0.738 . . . . 74.420000000000002 109.62 175.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.534 HG23 HD12 ' B' ' 241' ' ' LEU . 14.4 mt -113.18 104.43 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.936 0 CA-C-N 113.942 -1.481 . . . . 64.409999999999997 107.229 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.516 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 151.8 -129.08 2.71 Favored Glycine 0 N--CA 1.423 -2.206 0 C-N-CA 120.278 -0.963 . . . . 51.210000000000001 112.658 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -123.92 141.76 51.75 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.181 -0.674 . . . . 74.049999999999997 109.181 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.491 ' HB2' HE22 ' B' ' 240' ' ' GLN . 5.6 tm-20 -130.72 123.05 28.39 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.257 -1.016 . . . . 72.430000000000007 108.257 178.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.482 ' HD1' ' O ' ' B' ' 245' ' ' VAL . 7.4 t80 -116.01 124.01 49.43 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 107.96 -1.126 . . . . 72.219999999999999 107.96 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.592 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 144.68 -64.34 0.46 Allowed Glycine 0 N--CA 1.424 -2.139 0 CA-C-N 115.323 -0.853 . . . . 74.019999999999996 111.434 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 124.51 25.1 1.65 Allowed Glycine 0 N--CA 1.435 -1.414 0 C-N-CA 120.44 -0.886 . . . . 42.539999999999999 113.018 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.403 ' HG3' ' HA ' ' A' ' 288' ' ' ASP . 0.2 OUTLIER -176.91 -5.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.159 0.8 . . . . 73.120000000000005 113.159 174.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 52.28 -132.26 38.23 Favored Glycine 0 CA--C 1.505 -0.588 0 N-CA-C 115.157 0.823 . . . . 63.109999999999999 115.157 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -98.77 -3.25 36.06 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.4 -0.593 . . . . 74.310000000000002 109.4 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.505 ' CZ2' ' HB3' ' A' ' 276' ' ' LEU . 10.9 m-90 -80.55 -48.02 13.36 Favored 'General case' 0 CA--C 1.49 -1.34 0 CA-C-N 115.711 -0.677 . . . . 73.439999999999998 110.506 -176.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.403 ' HA ' ' HG3' ' A' ' 284' ' ' LYS . 30.5 t70 62.6 92.94 0.05 Allowed 'General case' 0 CA--C 1.508 -0.636 0 O-C-N 125.589 1.805 . . . . 54.020000000000003 108.112 -169.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -100.86 119.85 39.28 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.224 -0.898 . . . . 73.019999999999996 111.908 -171.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -77.85 114.62 16.88 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 107.974 -1.121 . . . . 75.530000000000001 107.974 173.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -76.61 122.4 24.58 Favored 'General case' 0 N--CA 1.419 -2.005 0 N-CA-C 106.553 -1.647 . . . . 75.420000000000002 106.553 176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -63.24 106.24 0.85 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.626 0.727 . . . . 64.329999999999998 109.472 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -53.04 -54.65 32.28 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 113.76 -1.564 . . . . 75.109999999999999 113.362 -172.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -154.78 163.72 39.85 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.355 -0.609 . . . . 72.25 109.355 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 . . . . . 0 C--N 1.307 -1.246 0 N-CA-C 108.102 -1.073 . . . . 65.430000000000007 108.102 -177.195 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.519 -0.223 0 N-CA-C 107.382 -1.34 . . . . 73.230000000000004 107.382 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -125.58 56.75 1.36 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.753 -0.832 . . . . 73.109999999999999 108.753 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 82.6 mt -76.48 115.69 18.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 114.945 -1.025 . . . . 61.43 110.203 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . 0.475 ' O ' HD12 ' B' ' 222' ' ' ILE . 12.9 t70 -85.39 104.33 15.1 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 105.604 -1.999 . . . . 70.230000000000004 105.604 176.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.54 113.7 3.47 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 123.465 0.478 . . . . 72.0 111.121 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . 0.475 HD12 ' O ' ' B' ' 220' ' ' ASP . 3.5 mp -82.92 114.82 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 108.602 -0.888 . . . . 74.510000000000005 108.602 178.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.504 ' O ' ' HG3' ' B' ' 225' ' ' ARG . 26.9 m -106.52 166.62 3.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 107.004 -1.48 . . . . 74.120000000000005 107.004 176.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . 0.417 ' N ' ' HB3' ' B' ' 259' ' ' GLN . . . -54.36 115.45 5.27 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.228 -1.149 . . . . 70.030000000000001 110.228 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' B' ' 223' ' ' VAL . 97.5 mtt180 -116.75 122.42 44.42 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.673 -0.862 . . . . 52.240000000000002 108.673 -177.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.473 ' HB3' ' ND2' ' A' ' 262' ' ' ASN . 25.1 t-20 -116.46 115.95 26.76 Favored 'General case' 0 C--N 1.272 -2.787 0 N-CA-C 108.01 -1.107 . . . . 62.5 108.01 175.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 16.3 m -121.25 136.8 54.91 Favored 'General case' 0 N--CA 1.422 -1.826 0 CA-C-O 121.377 0.608 . . . . 71.120000000000005 110.799 -178.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -124.66 124.09 41.45 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.649 -1.16 . . . . 71.439999999999998 108.357 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 0.3 OUTLIER -81.04 -57.5 3.5 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.658 -0.497 . . . . 74.400000000000006 109.658 -178.412 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -136.36 138.4 41.58 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 120.126 -0.63 . . . . 63.119999999999997 110.568 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.415 HD12 ' HB ' ' A' ' 267' ' ' VAL . 18.5 mt -130.36 119.19 45.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.419 -1.326 . . . . 53.420000000000002 107.419 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 69.8 mtt180 -117.16 115.53 25.51 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 108.733 -0.84 . . . . 64.219999999999999 108.733 178.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 69.4 p -112.84 127.29 56.14 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.303 -0.999 . . . . 63.119999999999997 108.303 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -134.55 139.25 45.27 Favored 'General case' 0 N--CA 1.424 -1.753 0 C-N-CA 120.07 -0.652 . . . . 73.129999999999995 109.398 176.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.463 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 44.8 mt-10 59.82 93.62 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 115.717 1.747 . . . . 75.310000000000002 115.717 170.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.463 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 2.8 mpt_? 62.75 20.12 11.9 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.1 -0.955 . . . . 72.109999999999999 110.954 172.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -84.1 141.83 30.83 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.935 -0.575 . . . . 43.350000000000001 110.48 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 7.9 mpt_? -124.69 133.93 53.04 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 106.788 -1.56 . . . . 62.310000000000002 106.788 175.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.55 HG12 HG22 ' B' ' 275' ' ' VAL . 23.4 m -135.84 147.56 28.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.559 -0.856 . . . . 62.109999999999999 111.467 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.606 ' CG ' HD13 ' B' ' 276' ' ' LEU . 5.5 tp-100 -124.01 120.33 32.12 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.226 -1.352 . . . . 75.120000000000005 108.425 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.534 HD12 HG23 ' A' ' 277' ' ' ILE . 2.9 tm? -118.09 117.71 29.93 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.133 -1.803 . . . . 75.120000000000005 106.133 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.524 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 139.82 -121.39 2.02 Favored Glycine 0 N--CA 1.412 -2.909 0 C-N-CA 119.398 -1.382 . . . . 61.43 112.902 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.558 HD21 HG13 ' B' ' 245' ' ' VAL . 8.2 t30 -143.27 130.35 20.71 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-O 121.083 0.468 . . . . 72.140000000000001 111.528 -174.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 98.5 t -112.58 126.7 70.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.382 -0.826 . . . . 73.040000000000006 109.254 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.558 HG13 HD21 ' B' ' 243' ' ' ASN . 4.1 m -122.03 113.7 39.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 108.134 -1.061 . . . . 73.140000000000001 108.134 173.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.474 HG21 ' HD3' ' B' ' 284' ' ' LYS . 17.3 m -77.43 160.7 28.53 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.708 -0.849 . . . . 74.319999999999993 108.708 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -61.74 -46.26 90.4 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 122.406 1.098 . . . . 51.43 109.807 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.39 -34.29 68.71 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 112.843 -1.98 . . . . 74.129999999999995 112.991 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.61 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -59.86 -26.86 66.18 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 123.224 0.61 . . . . 74.140000000000001 112.563 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 9.3 mp -75.7 80.96 2.66 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.286 1.041 . . . . 73.319999999999993 112.248 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -122.89 6.82 9.31 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.237 -1.764 . . . . 63.520000000000003 106.237 174.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -163.48 -153.77 7.43 Favored Glycine 0 N--CA 1.428 -1.847 0 N-CA-C 109.155 -1.578 . . . . 62.32 109.155 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -98.61 158.04 20.33 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.757 -0.735 . . . . 73.549999999999997 111.542 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 64.3 mt -82.74 91.86 2.49 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 122.203 1.002 . . . . 73.329999999999998 110.029 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -155.19 144.69 21.22 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.653 -1.158 . . . . 73.349999999999994 107.958 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 30.5 pt -88.44 163.83 2.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 120.584 -0.446 . . . . 71.230000000000004 110.864 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.3 p -67.58 -69.9 0.29 Allowed 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 122.545 0.338 . . . . 62.299999999999997 110.631 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -129.22 159.48 35.95 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.768 -1.197 . . . . 74.299999999999997 107.768 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . 0.417 ' HB3' ' N ' ' B' ' 224' ' ' GLY . 25.2 mt-30 -94.17 90.86 6.52 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.193 0.521 . . . . 71.140000000000001 110.605 -172.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 29.8 m -90.49 139.13 30.98 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.419 -0.81 . . . . 74.329999999999998 109.432 178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.563 ' CG2' ' HG2' ' C' ' 225' ' ' ARG . 9.0 t -107.18 132.47 53.01 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.537 0.684 . . . . 74.150000000000006 109.373 177.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.544 ' ND2' ' HB3' ' C' ' 226' ' ' ASN . 15.3 m120 -123.23 137.61 54.84 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.458 -0.792 . . . . 70.030000000000001 108.95 -177.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.3 m -139.24 123.62 18.2 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.667 -0.494 . . . . 74.299999999999997 109.667 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 9.2 p -117.77 141.14 38.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 CA-C-O 120.866 0.365 . . . . 75.040000000000006 110.559 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 21.8 mm-40 -81.7 -69.03 0.64 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.595 -0.73 . . . . 62.530000000000001 110.745 177.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 29.2 m -133.1 127.44 33.99 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 119.796 -0.762 . . . . 52.310000000000002 112.183 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 3.6 p -123.51 124.18 69.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.972 -0.751 . . . . 74.25 108.972 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 8.5 p -127.32 136.97 59.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.131 0.491 . . . . 70.540000000000006 111.766 -176.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -115.99 133.07 10.6 Favored Glycine 0 CA--C 1.471 -2.686 0 CA-C-N 115.514 -0.766 . . . . 73.109999999999999 111.283 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -133.19 115.13 14.65 Favored 'General case' 0 N--CA 1.408 -2.57 0 N-CA-C 109.358 -0.608 . . . . 75.019999999999996 109.358 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.16 95.28 0.03 OUTLIER Glycine 0 CA--C 1.527 0.808 0 CA-C-N 115.924 -0.58 . . . . 75.040000000000006 114.532 174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 63.36 31.54 15.13 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.502 0.556 . . . . 64.329999999999998 112.502 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.9 m -84.99 145.06 27.91 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 116.352 -0.386 . . . . 72.540000000000006 110.638 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 9.7 mpt_? -132.28 126.41 33.32 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.268 -1.382 . . . . 75.140000000000001 107.268 172.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.55 HG22 HG12 ' B' ' 239' ' ' VAL . 1.1 m -132.65 140.61 47.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 118.958 -1.097 . . . . 71.109999999999999 110.362 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.606 HD13 ' CG ' ' B' ' 240' ' ' GLN . 8.1 tp -122.86 117.17 24.98 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.024 0.916 . . . . 53.5 110.036 173.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.69 HG22 ' HB3' ' C' ' 241' ' ' LEU . 1.3 pt -112.13 103.89 16.17 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.026 0 CA-C-N 113.79 -1.55 . . . . 73.120000000000005 107.279 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 154.22 -147.18 16.09 Favored Glycine 0 N--CA 1.417 -2.598 0 CA-C-N 115.219 -0.9 . . . . 62.020000000000003 112.823 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -104.9 138.28 41.39 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.064 -1.088 . . . . 63.229999999999997 108.064 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -127.41 118.2 23.63 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.796 -1.557 . . . . 73.430000000000007 106.796 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.458 ' HB3' HG12 ' B' ' 245' ' ' VAL . 20.5 t80 -115.6 123.73 49.16 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 108.565 -0.902 . . . . 74.030000000000001 108.565 178.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 138.07 -55.32 0.68 Allowed Glycine 0 N--CA 1.416 -2.679 0 N-CA-C 109.328 -1.509 . . . . 74.230000000000004 109.328 -176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 102.2 44.02 1.94 Allowed Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.576 -1.009 . . . . 54.219999999999999 110.576 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . 0.474 ' HD3' HG21 ' B' ' 246' ' ' THR . 11.8 ptmm? -174.9 -18.14 0.01 OUTLIER 'General case' 0 C--O 1.253 1.278 0 O-C-N 123.713 0.302 . . . . 74.010000000000005 111.522 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . 54.02 -141.99 32.23 Favored Glycine 0 CA--C 1.5 -0.898 0 CA-C-N 115.574 -0.739 . . . . 72.319999999999993 114.251 177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -96.39 4.57 52.11 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.172 -0.677 . . . . 54.299999999999997 109.172 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.455 ' CH2' ' HB3' ' B' ' 276' ' ' LEU . 8.5 m-90 -83.32 -45.92 13.21 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.441 -0.8 . . . . 73.230000000000004 112.023 -174.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' B' ' 284' ' ' LYS . 35.3 t70 -89.27 103.45 16.08 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 113.726 1.01 . . . . 72.5 113.726 -173.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -168.34 174.38 7.05 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 103.698 -2.704 . . . . 74.430000000000007 103.698 173.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -115.32 -73.76 0.64 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 119.8 1.182 . . . . 72.299999999999997 112.588 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -151.97 131.16 12.74 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.281 -0.968 . . . . 74.010000000000005 112.345 -174.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 22.4 t60 68.72 -74.02 0.08 Allowed 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.79 1.636 . . . . 72.319999999999993 111.751 171.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -156.55 -54.28 0.08 Allowed 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 106.71 -1.589 . . . . 75.439999999999998 106.71 -176.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -147.1 83.57 1.57 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.658 -1.156 . . . . 72.409999999999997 108.757 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 34.1 t60 . . . . . 0 N--CA 1.479 1.02 0 C-N-CA 124.826 1.25 . . . . 72.519999999999996 112.645 175.308 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 89.0 mtp . . . . . 0 CA--C 1.502 -0.889 0 N-CA-C 107.808 -1.182 . . . . 73.299999999999997 107.808 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -133.33 154.73 50.46 Favored 'General case' 0 N--CA 1.436 -1.166 0 C-N-CA 119.825 -0.75 . . . . 73.409999999999997 110.031 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 10.1 tt -154.29 96.27 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-O 121.728 0.775 . . . . 73.510000000000005 110.351 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -95.32 166.26 11.97 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.446 -0.946 . . . . 64.239999999999995 108.446 175.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 73.53 146.37 0.08 Allowed 'General case' 0 C--O 1.243 0.735 0 O-C-N 124.639 1.212 . . . . 54.030000000000001 110.44 -172.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 2.3 mp -94.61 115.82 34.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-O 121.723 0.773 . . . . 42.009999999999998 109.914 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . 0.506 ' O ' ' HG3' ' C' ' 225' ' ' ARG . 30.5 m -117.28 166.41 11.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 107.076 -1.453 . . . . 73.230000000000004 107.076 177.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -58.24 116.59 8.63 Favored Glycine 0 C--O 1.245 0.799 0 N-CA-C 110.625 -0.99 . . . . 43.219999999999999 110.625 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.563 ' HG2' ' CG2' ' B' ' 261' ' ' THR . 82.8 mtm180 -122.76 121.9 37.41 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 121.015 0.436 . . . . 73.349999999999994 110.163 -176.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.544 ' HB3' ' ND2' ' B' ' 262' ' ' ASN . 25.9 t-20 -116.4 123.25 47.1 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.525 -0.917 . . . . 75.239999999999995 108.525 178.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' C' ' 263' ' ' SER . 46.7 t -121.94 137.52 54.76 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.854 -0.612 . . . . 73.030000000000001 109.955 -175.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -126.08 124.38 40.48 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.488 -0.93 . . . . 70.209999999999994 108.488 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.532 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -83.74 -64.84 1.09 Allowed 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 109.554 -0.535 . . . . 73.319999999999993 109.554 -177.201 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -127.49 138.12 52.85 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 109.617 -0.512 . . . . 70.120000000000005 109.617 178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.531 HG23 HG13 ' C' ' 267' ' ' VAL . 13.7 mt -133.48 117.44 27.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 106.15 -1.796 . . . . 64.409999999999997 106.15 176.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 17.0 ptp180 -124.88 115.65 20.96 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-O 121.634 0.731 . . . . 75.409999999999997 110.052 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 49.2 p -110.64 128.34 55.65 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.949 -0.76 . . . . 71.209999999999994 108.949 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -132.33 139.45 48.16 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 109.23 -0.655 . . . . 52.310000000000002 109.23 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.501 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 44.3 mt-10 59.07 93.05 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 115.283 1.586 . . . . 70.439999999999998 115.283 171.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.501 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 1.3 mpt_? 61.35 17.17 8.07 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.164 0.985 . . . . 60.32 111.772 175.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -80.15 136.59 36.54 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.082 0.468 . . . . 64.230000000000004 110.525 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 0.6 OUTLIER -124.95 133.07 53.17 Favored 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 107.385 -1.339 . . . . 72.0 107.385 175.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.529 HG12 HG22 ' C' ' 275' ' ' VAL . 19.2 m -136.52 149.69 27.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.563 -0.855 . . . . 74.019999999999996 111.772 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.59 ' HG3' HD13 ' C' ' 276' ' ' LEU . 47.7 tp60 -126.07 120.74 31.0 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 114.043 -1.435 . . . . 70.030000000000001 109.079 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.69 ' HB3' HG22 ' B' ' 277' ' ' ILE . 2.1 tm? -120.99 118.55 30.13 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.744 -1.576 . . . . 65.239999999999995 106.744 175.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.463 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 139.66 -122.91 2.35 Favored Glycine 0 N--CA 1.417 -2.63 0 C-N-CA 119.619 -1.277 . . . . 60.130000000000003 111.91 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -137.76 129.47 28.39 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 110.274 -0.269 . . . . 44.399999999999999 110.274 -175.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.454 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 86.0 t -112.56 123.21 68.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 109.0 -0.741 . . . . 73.230000000000004 109.0 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 1.6 p -122.67 111.93 32.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 N-CA-C 108.236 -1.024 . . . . 63.409999999999997 108.236 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 20.0 m -70.59 160.53 32.34 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 116.163 -0.472 . . . . 54.229999999999997 109.894 -177.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.61 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -59.28 -46.29 88.93 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.172 0.987 . . . . 50.420000000000002 110.14 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.09 -35.49 73.48 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 113.633 -1.622 . . . . 72.230000000000004 112.567 176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' C' ' 281' ' ' TYR . . . -64.0 -45.3 89.61 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.441 -0.799 . . . . 54.140000000000001 111.537 -175.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -83.87 70.57 10.43 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 122.825 1.298 . . . . 71.549999999999997 107.887 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -99.53 -21.99 15.68 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.061 -1.427 . . . . 62.009999999999998 107.377 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -150.22 169.11 30.23 Favored Glycine 0 N--CA 1.421 -2.323 0 N-CA-C 109.355 -1.498 . . . . 53.439999999999998 109.355 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -86.66 69.25 3.14 Favored Glycine 0 C--N 1.302 -1.34 0 C-N-CA 120.88 -0.676 . . . . 54.450000000000003 111.868 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 2.9 mp -90.28 126.48 43.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.497 -0.927 . . . . 71.219999999999999 108.497 177.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . 0.431 HH22 ' CG ' ' A' ' 258' ' ' ASP . 19.1 ttm180 -131.26 86.31 2.35 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.564 0.697 . . . . 73.439999999999998 111.671 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 16.2 pt -159.12 167.77 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 106.309 -1.738 . . . . 62.439999999999998 106.309 176.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 55.9 p -162.73 177.01 9.71 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.582 -0.896 . . . . 55.229999999999997 108.582 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -96.6 94.24 7.22 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 106.413 -1.699 . . . . 55.25 106.413 173.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . 0.256 15.8 pm0 -75.42 73.75 2.48 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 122.209 1.005 . . . . 75.340000000000003 113.544 -174.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 99.5 m -102.81 139.27 38.6 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 114.126 -1.397 . . . . 71.219999999999999 108.931 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 7.1 t -91.4 110.04 21.34 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.578 -0.897 . . . . 54.240000000000002 108.578 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -109.9 123.25 49.28 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.265 -0.643 . . . . 73.310000000000002 109.265 -176.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' C' ' 227' ' ' SER . 13.0 p -125.37 127.64 46.91 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 110.185 -0.302 . . . . 53.219999999999999 110.185 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.05 137.04 46.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.573 -0.528 . . . . 61.509999999999998 109.573 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 62.3 mm-40 -80.5 -64.61 1.15 Allowed 'General case' 0 N--CA 1.441 -0.902 0 O-C-N 123.043 0.215 . . . . 51.310000000000002 110.759 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 19.0 m -131.98 127.36 36.12 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 119.644 -0.822 . . . . 75.530000000000001 110.299 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.531 HG13 HG23 ' C' ' 231' ' ' ILE . 2.6 p -126.44 122.89 62.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.927 -0.768 . . . . 74.329999999999998 108.927 174.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 6.0 p -124.0 142.78 39.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.885 -0.598 . . . . 60.240000000000002 110.762 -175.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -119.92 132.16 9.27 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 110.315 -1.114 . . . . 65.230000000000004 110.315 175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -134.28 115.74 14.46 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 109.009 -0.737 . . . . 71.319999999999993 109.009 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.68 94.19 0.04 OUTLIER Glycine 0 CA--C 1.523 0.542 0 O-C-N 123.506 0.504 . . . . 42.539999999999999 114.249 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . 0.491 ' CD ' HH12 ' C' ' 238' ' ' ARG . 43.6 mm-40 62.2 25.64 15.35 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.506 0.928 . . . . 62.43 113.506 176.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 25.0 m -82.28 144.42 30.63 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.679 -0.808 . . . . 64.099999999999994 110.303 -176.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . 0.628 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 63.3 mtt180 -135.86 126.11 26.45 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 105.831 -1.914 . . . . 71.140000000000001 105.831 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.529 HG22 HG12 ' C' ' 239' ' ' VAL . 1.5 m -137.88 142.0 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 119.573 -0.851 . . . . 52.229999999999997 111.496 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.59 HD13 ' HG3' ' C' ' 240' ' ' GLN . 7.5 tp -122.46 112.59 18.24 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.037 0.922 . . . . 63.240000000000002 110.798 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.422 HD11 HD13 ' C' ' 231' ' ' ILE . 1.9 pt -108.67 104.98 17.94 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.408 0 CA-C-N 114.054 -1.43 . . . . 72.129999999999995 108.544 175.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 149.97 -149.44 21.35 Favored Glycine 0 N--CA 1.419 -2.454 0 CA-C-N 115.408 -0.815 . . . . 54.32 111.533 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -98.1 145.67 26.32 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.499 -0.926 . . . . 75.310000000000002 108.499 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.488 ' HB2' HD21 ' C' ' 276' ' ' LEU . 2.9 tm-20 -137.12 117.91 14.09 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.857 -1.535 . . . . 54.439999999999998 106.857 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.509 ' CD2' ' HB1' ' C' ' 249' ' ' ALA . 42.9 t80 -118.47 124.57 47.92 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 108.882 -0.785 . . . . 61.100000000000001 108.882 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 140.49 -52.95 0.68 Allowed Glycine 0 N--CA 1.416 -2.66 0 N-CA-C 109.371 -1.492 . . . . 73.540000000000006 109.371 -177.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 115.27 -11.31 19.7 Favored Glycine 0 N--CA 1.432 -1.624 0 C-N-CA 120.664 -0.779 . . . . 73.299999999999997 111.787 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -125.12 -5.33 7.33 Favored 'General case' 0 C--O 1.248 0.995 0 N-CA-C 112.581 0.586 . . . . 60.43 112.581 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . 53.33 -121.96 19.25 Favored Glycine 0 CA--C 1.496 -1.124 0 CA-C-N 115.777 -0.647 . . . . 72.230000000000004 113.178 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -125.47 13.16 8.15 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.296 -1.001 . . . . 75.340000000000003 108.296 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' C' ' 276' ' ' LEU . 18.0 m-90 -77.6 -57.04 4.03 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 114.452 1.279 . . . . 72.340000000000003 114.452 -171.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -165.88 -167.55 1.11 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.548 -0.908 . . . . 71.040000000000006 108.548 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 72.78 105.94 0.07 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 126.217 1.807 . . . . 73.540000000000006 111.559 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 62.4 m170 75.79 -57.85 0.56 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.288 1.435 . . . . 74.400000000000006 113.096 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . 0.372 5.1 p80 50.61 -73.32 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 126.637 1.975 . . . . 71.25 114.168 -174.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -87.85 80.91 7.7 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.33 -0.856 . . . . 74.049999999999997 110.765 175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -162.37 151.93 15.92 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.908 -2.256 . . . . 71.340000000000003 104.908 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -84.2 23.92 1.01 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 120.874 0.369 . . . . 72.319999999999993 111.27 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 . . . . . 0 N--CA 1.438 -1.059 0 CA-C-O 118.007 -0.997 . . . . 72.239999999999995 108.532 -177.134 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.373 0 N-CA-C 112.763 0.653 . . . . 73.239999999999995 112.763 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -103.57 90.88 3.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.754 -0.832 . . . . 73.239999999999995 108.754 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.1 pt -130.48 150.56 34.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 116.224 -0.444 . . . . 71.239999999999995 111.242 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -112.59 89.45 3.08 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 103.65 -2.722 . . . . 74.519999999999996 103.65 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -85.97 16.02 4.51 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 114.985 1.476 . . . . 72.230000000000004 114.985 -165.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 222' ' ' ILE . 0.1 OUTLIER -90.0 114.34 27.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 C-N-CA 118.496 -1.282 . . . . 75.5 109.454 173.804 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.415 HG23 ' HG2' ' A' ' 225' ' ' ARG . 12.3 m -134.54 144.9 33.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-N 114.313 -1.312 . . . . 75.140000000000001 108.406 -177.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -82.57 51.33 4.51 Favored Glycine 0 C--N 1.308 -1.014 0 C-N-CA 121.141 -0.552 . . . . 52.340000000000003 113.532 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.415 ' HG2' HG23 ' A' ' 223' ' ' VAL . 33.9 ptt180 -120.86 140.25 52.03 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.355 -0.609 . . . . 72.329999999999998 109.355 178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -116.55 137.96 51.77 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.423 -1.695 . . . . 43.409999999999997 106.423 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 7.9 p -128.4 137.43 51.86 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 113.474 0.916 . . . . 63.149999999999999 113.474 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -129.77 150.44 51.08 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 107.523 -1.288 . . . . 71.010000000000005 107.523 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -103.3 -50.95 3.34 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.763 -0.829 . . . . 70.129999999999995 108.763 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.441 ' HB2' HG23 ' A' ' 266' ' ' THR . 18.2 m-20 -127.36 140.71 52.0 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 109.577 -0.527 . . . . 65.239999999999995 109.577 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 55.0 mt -136.64 117.09 17.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 105.817 -1.92 . . . . 75.409999999999997 105.817 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.407 ' HB3' HG12 ' A' ' 268' ' ' VAL . 36.7 ttt180 -128.5 128.91 45.24 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.702 -0.481 . . . . 71.510000000000005 109.702 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.523 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 36.2 p -121.53 137.5 54.7 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 116.535 -0.302 . . . . 72.319999999999993 110.752 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -131.11 157.22 43.7 Favored 'General case' 0 N--CA 1.426 -1.672 0 C-N-CA 120.55 -0.46 . . . . 71.040000000000006 110.878 174.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 63.82 -85.77 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.942 1.297 . . . . 63.109999999999999 113.504 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -132.76 20.31 4.21 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 121.683 0.754 . . . . 53.210000000000001 109.331 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.523 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -69.86 130.98 43.72 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.792 -0.64 . . . . 75.540000000000006 109.989 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 37.5 mtt85 -125.42 135.15 52.07 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 108.075 -1.083 . . . . 74.340000000000003 108.075 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.557 HG22 ' CG2' ' A' ' 275' ' ' VAL . 96.2 t -132.42 145.37 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 CA-C-O 121.037 0.446 . . . . 65.420000000000002 110.504 -175.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.455 ' CG ' HD13 ' A' ' 276' ' ' LEU . 6.4 tp-100 -120.21 122.77 41.67 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.204 -1.406 . . . . 71.540000000000006 107.204 172.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -111.82 119.31 38.15 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.075 -1.083 . . . . 72.219999999999999 108.075 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.642 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 125.55 -132.92 8.15 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 111.305 -0.718 . . . . 52.32 111.305 178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -125.1 143.82 50.73 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 117.198 0.499 . . . . 41.32 110.654 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.414 ' CG2' ' HG2' ' A' ' 240' ' ' GLN . 95.7 t -110.74 116.7 53.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.645 -1.243 . . . . 71.530000000000001 107.645 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.4 t -113.94 111.79 37.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 107.914 -1.143 . . . . 73.109999999999999 107.914 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 7.9 m -101.05 160.62 14.23 Favored 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 109.339 -0.615 . . . . 74.109999999999999 109.339 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -57.11 -32.76 66.66 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.89 1.276 . . . . 61.409999999999997 111.609 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.32 -48.19 74.53 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.685 0.794 . . . . 63.32 113.047 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.57 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . -74.17 -26.71 60.45 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.294 -0.632 . . . . 63.32 109.294 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.577 ' HG ' ' CD2' ' A' ' 251' ' ' HIS . 55.4 tp 76.61 -62.17 0.42 Allowed 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 126.102 1.761 . . . . 64.140000000000001 110.583 -175.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.577 ' CD2' ' HG ' ' A' ' 250' ' ' LEU . 97.3 m-70 -129.52 140.59 51.2 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.367 -0.975 . . . . 75.430000000000007 108.367 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -85.24 70.62 3.07 Favored Glycine 0 N--CA 1.428 -1.891 0 C-N-CA 120.8 -0.714 . . . . 43.350000000000001 112.678 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 111.37 166.56 18.45 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 121.251 -0.5 . . . . 72.530000000000001 112.426 177.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 38.7 pt -130.3 -166.39 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 107.647 -1.242 . . . . 71.200000000000003 107.647 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -49.66 110.62 0.4 Allowed 'General case' 0 C--O 1.24 0.557 0 O-C-N 124.091 0.87 . . . . 73.319999999999993 111.025 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 50.6 mm 66.51 84.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 124.684 1.194 . . . . 74.239999999999995 110.055 -176.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 18.5 t -85.97 162.56 18.47 Favored 'General case' 0 C--O 1.256 1.434 0 CA-C-N 114.594 -1.185 . . . . 75.409999999999997 109.102 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -97.0 112.79 24.39 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.99 -1.115 . . . . 71.010000000000005 107.99 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -114.51 111.32 21.21 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.412 -0.813 . . . . 54.32 109.355 -177.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 20.9 m -101.31 137.23 39.93 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.292 -1.373 . . . . 54.140000000000001 107.292 175.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 10.0 t -98.74 136.86 38.18 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.662 -0.866 . . . . 72.319999999999993 108.662 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.56 ' OD1' ' HB3' ' B' ' 226' ' ' ASN . 3.8 t30 -126.54 133.0 51.22 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.018 -0.734 . . . . 74.420000000000002 109.018 -179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' B' ' 227' ' ' SER . 19.6 m -117.93 123.5 45.94 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.587 0.555 . . . . 65.120000000000005 109.706 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 10.2 p -126.92 143.42 40.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 109.248 -0.649 . . . . 63.310000000000002 109.248 176.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.594 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 36.8 tt0 -83.6 -82.61 0.15 Allowed 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 120.677 -0.409 . . . . 72.120000000000005 111.004 178.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 230' ' ' ASP . 81.0 m -115.45 126.69 54.65 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.663 -0.648 . . . . 71.120000000000005 111.897 -174.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 11.5 t -118.68 120.95 65.74 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 107.278 -1.379 . . . . 72.150000000000006 107.278 177.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.425 HG23 ' HG3' ' B' ' 232' ' ' ARG . 20.9 m -123.83 136.52 59.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 120.216 -0.594 . . . . 72.140000000000001 111.102 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.408 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -117.48 133.17 10.38 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.92 -0.582 . . . . 75.310000000000002 111.943 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -129.6 147.2 51.37 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.158 -1.052 . . . . 61.520000000000003 108.158 -177.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 63.27 -133.39 42.45 Favored Glycine 0 C--O 1.239 0.436 0 C-N-CA 120.972 -0.632 . . . . 75.140000000000001 112.226 -177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -90.69 83.56 5.79 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.769 -0.826 . . . . 74.0 108.769 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 75.3 m -104.62 144.07 32.21 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.555 -0.858 . . . . 73.230000000000004 110.693 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 28.0 mmm-85 -133.39 123.05 24.67 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 105.05 -2.204 . . . . 73.439999999999998 105.05 171.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.58 HG12 ' HB ' ' B' ' 239' ' ' VAL . 30.6 m -140.0 140.58 35.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.239 0.542 . . . . 61.539999999999999 111.627 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.594 ' HB3' ' CH2' ' A' ' 287' ' ' TRP . 9.4 tp -122.37 124.58 44.0 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 115.663 -0.699 . . . . 64.310000000000002 109.687 175.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.728 HG23 HD12 ' B' ' 241' ' ' LEU . 71.6 mt -110.72 103.45 15.49 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 107.642 -1.244 . . . . 74.420000000000002 107.642 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.642 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 145.52 -135.77 6.13 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.283 -0.871 . . . . 70.329999999999998 111.504 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 46.1 t-20 -129.59 137.64 50.83 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 122.17 -0.606 . . . . 72.329999999999998 109.509 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 285' ' ' GLY . 34.4 tt0 -111.17 127.28 55.54 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.396 -0.964 . . . . 65.019999999999996 108.396 177.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 99.7 m-85 -113.73 124.52 52.47 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.681 -0.859 . . . . 73.310000000000002 108.681 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.57 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 138.99 -87.09 0.21 Allowed Glycine 0 CA--C 1.467 -2.916 0 C-N-CA 120.397 -0.906 . . . . 74.310000000000002 112.211 177.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 141.9 96.94 0.27 Allowed Glycine 0 N--CA 1.406 -3.314 0 N-CA-C 108.555 -1.818 . . . . 72.420000000000002 108.555 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.477 ' HE3' ' HB3' ' B' ' 288' ' ' ASP . 35.4 mmtp 80.24 45.25 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 O-C-N 125.106 1.121 . . . . 72.120000000000005 110.296 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.464 ' H ' ' CD ' ' A' ' 280' ' ' GLU . . . -78.17 -54.87 4.24 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 115.431 -0.804 . . . . 54.140000000000001 111.683 -178.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -89.62 -33.83 16.53 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.146 0.498 . . . . 73.010000000000005 110.708 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.594 ' CH2' ' HB3' ' A' ' 276' ' ' LEU . 29.6 m-90 -102.19 117.62 35.17 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.334 -0.393 . . . . 55.329999999999998 110.466 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -97.86 158.06 15.73 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 108.926 -0.768 . . . . 74.349999999999994 108.926 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.551 HD22 ' HB2' ' A' ' 292' ' ' HIS . 56.8 t30 71.05 173.49 0.31 Allowed 'General case' 0 CA--C 1.558 1.265 0 O-C-N 124.404 1.065 . . . . 64.310000000000002 110.925 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -79.78 -40.47 28.6 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.303 -0.873 . . . . 64.219999999999999 111.202 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -140.83 -68.48 0.4 Allowed 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 120.035 -0.666 . . . . 64.129999999999995 110.517 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . 0.551 ' HB2' HD22 ' A' ' 289' ' ' ASN . 7.8 t60 79.47 93.19 0.05 Allowed 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 125.885 1.674 . . . . 63.409999999999997 108.963 -177.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 76.74 140.05 0.07 Allowed 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 124.537 1.135 . . . . 74.319999999999993 108.598 -178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -157.81 81.48 0.87 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.607 0.718 . . . . 51.299999999999997 111.935 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 . . . . . 0 C--O 1.258 1.532 0 CA-C-O 117.653 -1.165 . . . . 74.519999999999996 112.437 -178.939 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 20.1 ptp . . . . . 0 N--CA 1.467 0.405 0 N-CA-C 112.8 0.667 . . . . 61.549999999999997 112.8 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -141.9 94.03 2.62 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 118.604 0.638 . . . . 64.239999999999995 110.903 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 2.5 mp -134.25 -70.57 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.454 0.645 . . . . 75.109999999999999 109.463 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -156.53 173.97 16.13 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 106.511 -1.663 . . . . 70.409999999999997 106.511 -176.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -142.55 -172.55 3.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.103 -0.703 . . . . 73.120000000000005 109.103 -177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . 0.638 ' H ' HD13 ' B' ' 222' ' ' ILE . 0.2 OUTLIER -82.67 115.45 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 CA-C-O 122.161 0.981 . . . . 74.209999999999994 109.21 177.065 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.422 HG23 ' HG2' ' B' ' 225' ' ' ARG . 27.1 m -100.84 135.27 37.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-N 114.248 -1.342 . . . . 74.510000000000005 110.229 -177.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . -83.44 73.65 2.64 Favored Glycine 0 N--CA 1.428 -1.866 0 C-N-CA 120.611 -0.804 . . . . 62.329999999999998 113.047 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.632 ' HA ' ' O ' ' A' ' 261' ' ' THR . 40.6 ptt180 -138.17 142.74 40.06 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-O 121.059 0.457 . . . . 75.209999999999994 110.543 178.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.56 ' HB3' ' OD1' ' A' ' 262' ' ' ASN . 51.0 t-20 -116.18 148.43 40.38 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 105.285 -2.117 . . . . 74.140000000000001 105.285 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 263' ' ' SER . 3.2 p -139.01 136.78 35.69 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 121.515 0.674 . . . . 73.5 111.829 -175.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -132.13 144.25 50.57 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.726 -1.125 . . . . 54.229999999999997 108.571 177.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 5.9 tmtm? -96.74 -61.32 1.43 Allowed 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.948 -0.76 . . . . 62.310000000000002 108.948 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -127.18 139.38 52.98 Favored 'General case' 0 CA--C 1.497 -1.087 0 O-C-N 121.807 -0.558 . . . . 61.399999999999999 110.089 177.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.437 HG21 HG11 ' B' ' 239' ' ' VAL . 6.9 mt -134.96 120.65 31.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 N-CA-C 106.713 -1.588 . . . . 72.140000000000001 106.713 175.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.425 ' HG3' HG23 ' A' ' 268' ' ' VAL . 78.8 ttt-85 -123.36 120.44 33.03 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 109.408 -0.59 . . . . 74.530000000000001 109.408 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 81.0 p -109.99 128.87 55.66 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.139 -1.059 . . . . 64.519999999999996 108.139 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -137.25 157.17 47.24 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.598 -0.519 . . . . 73.129999999999995 109.598 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.593 ' HB3' ' HD2' ' B' ' 236' ' ' ARG . 6.2 mp0 63.09 -89.09 0.03 OUTLIER 'General case' 0 C--O 1.21 -1.01 0 C-N-CA 124.425 1.09 . . . . 71.409999999999997 113.496 -176.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.593 ' HD2' ' HB3' ' B' ' 235' ' ' GLU . 0.0 OUTLIER -137.2 59.27 1.69 Allowed 'General case' 0 C--O 1.245 0.843 0 N-CA-C 107.701 -1.222 . . . . 73.439999999999998 107.701 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.66 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -99.61 135.19 41.4 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-O 122.353 1.073 . . . . 74.439999999999998 110.399 -179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 6.1 mpt_? -124.28 133.21 53.54 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 105.691 -1.966 . . . . 73.519999999999996 105.691 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.58 ' HB ' HG12 ' A' ' 275' ' ' VAL . 69.7 t -142.48 133.08 24.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.847 0.832 . . . . 63.420000000000002 111.239 -175.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.584 ' CG ' HD13 ' B' ' 276' ' ' LEU . 44.0 tp60 -105.23 132.51 51.35 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.678 -1.23 . . . . 75.530000000000001 107.678 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.728 HD12 HG23 ' A' ' 277' ' ' ILE . 3.4 tm? -121.85 117.01 25.46 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 106.354 -1.721 . . . . 51.240000000000002 106.354 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.695 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 117.84 -130.05 8.58 Favored Glycine 0 C--O 1.206 -1.632 0 N-CA-C 111.189 -0.764 . . . . 72.209999999999994 111.189 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 5.8 m-20 -124.41 148.4 47.61 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 122.0 -0.706 . . . . 62.340000000000003 112.255 -175.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.551 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 98.5 t -118.3 114.69 45.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 107.647 -1.242 . . . . 32.299999999999997 107.647 175.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 58.9 t -117.86 111.98 36.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 108.698 -0.853 . . . . 74.430000000000007 108.698 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.492 ' OG1' ' HA3' ' B' ' 282' ' ' GLY . 13.6 p -93.69 161.98 14.12 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 119.895 -0.722 . . . . 54.130000000000003 109.57 178.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -59.25 -32.54 70.09 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 122.475 1.131 . . . . 43.439999999999998 109.636 176.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.57 -35.16 65.46 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 112.655 -2.066 . . . . 53.140000000000001 113.5 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -62.31 -26.42 68.41 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.069 0.461 . . . . 71.530000000000001 110.406 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.8 mp -86.08 75.52 9.92 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 121.807 0.813 . . . . 72.030000000000001 109.022 177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -92.85 -44.41 8.49 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.459 -1.312 . . . . 64.299999999999997 107.459 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -125.11 21.29 6.53 Favored Glycine 0 C--N 1.311 -0.858 0 N-CA-C 108.94 -1.664 . . . . 51.399999999999999 108.94 173.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 102.82 147.78 19.44 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 110.273 -1.131 . . . . 51.119999999999997 110.273 -177.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.5 139.17 18.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.975 -0.75 . . . . 63.329999999999998 108.975 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -136.3 154.89 50.74 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.152 -1.796 . . . . 65.239999999999995 106.152 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 30.1 pt -70.32 134.76 29.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-O 121.593 0.711 . . . . 72.299999999999997 111.828 -178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 71.9 p -98.44 -163.3 1.03 Allowed 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.903 -1.044 . . . . 75.040000000000006 111.031 -175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -97.8 119.54 36.59 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.1 -1.444 . . . . 73.340000000000003 107.1 174.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 20.5 mp0 -98.44 82.76 2.92 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 120.296 -0.561 . . . . 74.540000000000006 110.8 -176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 7.2 m -64.76 135.5 55.9 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 108.805 -0.813 . . . . 60.530000000000001 108.805 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 9.0 t -91.99 132.86 36.22 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.082 0.468 . . . . 73.109999999999999 109.78 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 39.9 t-20 -126.56 146.66 50.05 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.695 -0.854 . . . . 74.329999999999998 108.695 -178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 49.3 m -135.65 123.48 22.56 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.023 0.439 . . . . 63.539999999999999 110.207 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 13.7 p -123.38 150.15 27.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.183 -0.673 . . . . 71.340000000000003 109.183 177.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 39.3 tt0 -93.5 -69.27 0.76 Allowed 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.539 -0.864 . . . . 72.420000000000002 110.409 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 15.6 m -119.53 127.63 53.2 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 119.104 -1.039 . . . . 65.099999999999994 112.301 -176.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 25.7 t -119.08 120.59 64.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 107.652 -1.24 . . . . 73.439999999999998 107.652 174.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.83 131.59 69.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 112.248 0.462 . . . . 72.25 112.248 177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . 0.409 ' HA2' ' OG1' ' C' ' 233' ' ' THR . . . -109.66 133.89 11.89 Favored Glycine 0 N--CA 1.434 -1.482 0 CA-C-N 115.608 -0.724 . . . . 62.409999999999997 111.886 179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.428 ' HB3' ' HG2' ' C' ' 234' ' ' GLU . 16.3 tppt? -131.8 130.23 41.52 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 124.826 1.25 . . . . 71.310000000000002 109.546 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.28 -133.47 14.06 Favored Glycine 0 CA--C 1.505 -0.572 0 N-CA-C 110.551 -1.019 . . . . 43.240000000000002 110.551 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 77.1 mm-40 -87.25 97.9 11.03 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 107.849 -1.167 . . . . 74.519999999999996 107.849 176.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 66.1 m -117.86 143.42 46.32 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 119.342 -0.943 . . . . 55.0 110.417 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 18.9 mmm-85 -133.99 123.83 25.26 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 104.259 -2.497 . . . . 65.530000000000001 104.259 172.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 2.3 t -139.22 140.73 37.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 108.515 -0.921 . . . . 75.219999999999999 108.515 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.723 ' HB3' ' CH2' ' B' ' 287' ' ' TRP . 3.0 tp -126.79 122.06 33.71 Favored 'General case' 0 C--N 1.26 -3.299 0 N-CA-C 109.651 -0.5 . . . . 72.5 109.651 173.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.493 HG23 HD12 ' C' ' 241' ' ' LEU . 3.2 mp -107.01 103.72 15.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 106.386 -1.709 . . . . 73.239999999999995 106.386 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.695 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 152.48 -140.9 8.01 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 121.061 -0.59 . . . . 25.109999999999999 112.245 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -128.86 135.29 48.89 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.621 -0.881 . . . . 55.450000000000003 108.621 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.426 ' HB2' HD21 ' B' ' 276' ' ' LEU . 41.5 tt0 -111.77 133.69 53.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.814 0.34 . . . . 61.240000000000002 110.225 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -121.87 125.65 46.91 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 115.885 -0.598 . . . . 72.239999999999995 110.988 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.492 ' HA3' ' OG1' ' B' ' 246' ' ' THR . . . 133.37 -99.55 0.37 Allowed Glycine 0 CA--C 1.48 -2.156 0 C-N-CA 120.559 -0.829 . . . . 71.549999999999997 112.725 174.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 178.34 112.32 0.33 Allowed Glycine 0 C--N 1.277 -2.706 0 N-CA-C 108.106 -1.997 . . . . 60.240000000000002 108.106 -179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . 0.528 ' HB3' ' HA ' ' B' ' 288' ' ' ASP . 1.1 mptm? 78.01 -50.88 0.5 Allowed 'General case' 0 C--O 1.197 -1.677 0 C-N-CA 124.217 1.007 . . . . 71.019999999999996 112.537 -178.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' B' ' 246' ' ' THR . . . 46.5 -102.31 0.04 OUTLIER Glycine 0 C--O 1.244 0.779 0 O-C-N 124.439 1.087 . . . . 12.210000000000001 114.983 175.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -70.75 -28.42 64.68 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 123.959 0.904 . . . . 75.430000000000007 111.382 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.723 ' CH2' ' HB3' ' B' ' 276' ' ' LEU . 22.8 m-90 -105.82 23.44 13.92 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 122.052 -0.405 . . . . 74.540000000000006 111.645 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . 0.528 ' HA ' ' HB3' ' B' ' 284' ' ' LYS . 30.0 t70 -65.95 101.18 0.64 Allowed 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 119.738 -0.785 . . . . 74.120000000000005 110.123 174.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -117.21 97.74 6.07 Favored 'General case' 0 N--CA 1.412 -2.372 0 CA-C-N 114.594 -1.185 . . . . 72.040000000000006 109.07 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -124.21 127.22 47.39 Favored 'General case' 0 C--N 1.283 -2.29 0 N-CA-C 107.121 -1.437 . . . . 72.530000000000001 107.121 173.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -69.67 80.27 0.43 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 114.873 1.434 . . . . 71.209999999999994 114.873 -173.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -89.1 -16.48 31.4 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.133 0.968 . . . . 75.230000000000004 108.502 170.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 61.4 m-70 -126.56 -170.64 2.24 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 105.236 -2.135 . . . . 74.519999999999996 105.236 171.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -136.93 27.78 2.93 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.672 -1.233 . . . . 71.019999999999996 107.672 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 69.3 t60 . . . . . 0 C--N 1.307 -1.249 0 N-CA-C 108.298 -1.001 . . . . 73.420000000000002 108.298 -176.853 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 110.472 -0.196 . . . . 63.25 110.472 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt 56.18 81.36 0.13 Allowed 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.825 1.25 . . . . 55.140000000000001 113.252 176.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 41.6 pt -141.36 147.97 21.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.299 -0.63 . . . . 54.229999999999997 109.299 175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -141.67 167.81 21.27 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 106.931 -1.507 . . . . 61.350000000000001 106.931 175.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 61.39 -154.5 0.36 Allowed 'General case' 0 C--O 1.243 0.747 0 O-C-N 124.345 1.028 . . . . 71.200000000000003 109.279 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 0.596 ' H ' HD13 ' C' ' 222' ' ' ILE . 0.2 OUTLIER -116.11 138.05 47.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 121.265 0.555 . . . . 70.5 110.901 -178.779 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 28.8 m -121.7 148.59 25.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.615 -0.883 . . . . 55.25 108.615 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . 0.454 ' HA2' ' HB2' ' C' ' 259' ' ' GLN . . . -81.36 63.89 4.26 Favored Glycine 0 CA--C 1.495 -1.169 0 C-N-CA 121.228 -0.51 . . . . 54.340000000000003 111.89 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.577 ' HA ' ' O ' ' B' ' 261' ' ' THR . 56.4 ttp180 -126.07 122.69 36.51 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 120.904 0.383 . . . . 73.019999999999996 110.304 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 23.2 t-20 -106.95 142.76 36.06 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 105.72 -1.956 . . . . 62.030000000000001 105.72 175.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 9.1 p -139.98 137.31 34.6 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 119.216 -0.994 . . . . 74.310000000000002 113.101 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -127.45 142.02 51.52 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.101 -0.954 . . . . 60.43 109.435 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 49.0 tptt -87.81 -66.61 0.89 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.964 -0.562 . . . . 70.409999999999997 110.537 178.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -133.68 138.93 46.13 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.959 -0.756 . . . . 71.400000000000006 108.959 -175.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.413 HG23 ' HB ' ' C' ' 267' ' ' VAL . 10.7 mt -135.38 120.52 28.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 107.721 -1.214 . . . . 62.310000000000002 107.721 -179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 77.7 ttt180 -122.85 121.64 36.73 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 109.351 -0.611 . . . . 74.450000000000003 109.351 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 68.5 p -110.46 127.92 55.36 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.466 -0.939 . . . . 30.510000000000002 108.466 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' B' ' 270' ' ' LYS . 34.5 mt-10 -130.13 152.27 49.75 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 119.99 -0.684 . . . . 50.329999999999998 112.0 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' B' ' 272' ' ' GLU . 48.8 mt-10 69.8 -77.81 0.05 Allowed 'General case' 0 C--O 1.194 -1.84 0 CA-C-N 113.84 -1.527 . . . . 71.409999999999997 113.854 172.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.1 56.8 1.47 Allowed 'General case' 0 C--O 1.245 0.819 0 N-CA-C 107.134 -1.432 . . . . 74.140000000000001 107.134 178.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.598 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -104.12 135.11 46.23 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-O 122.492 1.139 . . . . 65.530000000000001 111.292 -176.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 4.8 mpt_? -124.86 133.16 53.19 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 106.071 -1.825 . . . . 75.109999999999999 106.071 177.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.492 HG22 ' HB ' ' C' ' 275' ' ' VAL . 94.9 t -141.52 134.68 30.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.418 0.628 . . . . 74.209999999999994 110.766 -176.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.566 ' CG ' HD13 ' C' ' 276' ' ' LEU . 5.1 tp-100 -105.3 129.5 53.63 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.646 -1.242 . . . . 72.439999999999998 107.646 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.493 HD12 HG23 ' B' ' 277' ' ' ILE . 3.4 tm? -122.42 116.01 23.24 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 106.048 -1.834 . . . . 72.400000000000006 106.048 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.447 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 130.0 -111.07 1.11 Allowed Glycine 0 N--CA 1.422 -2.255 0 C-N-CA 119.668 -1.253 . . . . 64.439999999999998 112.859 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -145.01 148.91 34.26 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.738 -0.467 . . . . 72.519999999999996 109.738 -174.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.515 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 91.6 t -126.94 114.94 39.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 108.852 -0.795 . . . . 75.120000000000005 108.852 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 59.6 t -114.87 111.77 37.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.859 -0.793 . . . . 74.340000000000003 108.859 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.3 m -85.56 160.97 19.52 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.548 -0.908 . . . . 60.5 108.548 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.524 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -63.09 -34.24 77.17 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 122.444 1.116 . . . . 63.119999999999997 109.294 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.92 -35.62 66.81 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 113.14 -1.846 . . . . 72.109999999999999 111.671 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.0 -26.19 62.13 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 116.383 -0.371 . . . . 54.009999999999998 111.387 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 90.2 mt -76.54 62.4 1.9 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.628 0.728 . . . . 72.200000000000003 112.012 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -96.21 -46.81 6.3 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.114 -1.81 . . . . 73.200000000000003 106.114 173.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -113.47 -142.99 8.41 Favored Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 110.558 -1.017 . . . . 65.25 110.558 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -170.27 102.43 0.18 Allowed Glycine 0 C--N 1.299 -1.479 0 N-CA-C 110.084 -1.207 . . . . 65.439999999999998 110.084 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 34.4 pt -122.94 164.09 20.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 112.165 0.431 . . . . 63.509999999999998 112.165 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -150.12 107.14 3.57 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 105.923 -1.88 . . . . 74.420000000000002 105.923 173.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 25.4 pt -124.61 149.28 28.94 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-O 121.563 0.696 . . . . 64.129999999999995 112.484 -173.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 22.8 t -95.42 -16.19 22.47 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.399 -0.963 . . . . 55.200000000000003 108.399 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . 0.443 ' HA ' ' CG1' ' C' ' 222' ' ' ILE . 12.0 t70 -78.89 80.01 5.26 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 122.299 1.047 . . . . 72.540000000000006 108.672 177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . 0.454 ' HB2' ' HA2' ' C' ' 224' ' ' GLY . 18.3 mm-40 -122.69 172.79 8.16 Favored 'General case' 0 C--N 1.276 -2.626 0 CA-C-N 114.32 -1.309 . . . . 70.150000000000006 107.614 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 10.4 m -101.24 121.85 42.61 Favored 'General case' 0 N--CA 1.405 -2.676 0 N-CA-C 107.408 -1.33 . . . . 62.310000000000002 107.408 177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 8.8 t -91.21 110.2 21.48 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 119.206 -0.998 . . . . 73.099999999999994 108.369 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -113.52 128.07 56.31 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.317 -0.856 . . . . 65.329999999999998 109.58 -176.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 50.2 m -117.61 123.25 45.73 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 109.033 -0.728 . . . . 75.319999999999993 109.033 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 13.5 p -117.67 148.74 20.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.178 -1.045 . . . . 74.329999999999998 108.178 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 43.0 tt0 -90.44 -84.66 0.23 Allowed 'General case' 0 N--CA 1.415 -2.184 0 C-N-CA 120.355 -0.538 . . . . 54.409999999999997 110.269 -179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 20.0 m -110.59 130.31 55.6 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 119.774 -0.77 . . . . 74.150000000000006 110.477 -177.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.413 ' HB ' HG23 ' C' ' 231' ' ' ILE . 40.6 t -117.85 120.77 65.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 107.72 -1.215 . . . . 74.219999999999999 107.72 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.1 p -127.61 131.96 69.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 C-N-CA 120.411 -0.515 . . . . 73.109999999999999 110.987 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.14 133.61 11.7 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 108.912 -1.675 . . . . 71.310000000000002 108.912 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -132.33 132.95 43.45 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.716 -0.846 . . . . 73.219999999999999 108.716 -175.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 72.5 -125.23 10.21 Favored Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 120.428 -0.891 . . . . 41.409999999999997 111.346 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -91.84 97.55 11.05 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.521 -1.288 . . . . 74.319999999999993 107.521 -178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 33.4 m -127.61 145.07 51.0 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 113.45 0.907 . . . . 43.509999999999998 113.45 -175.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 34.5 mmm-85 -133.46 124.79 27.69 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 104.919 -2.252 . . . . 70.420000000000002 104.919 173.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.492 ' HB ' HG22 ' C' ' 239' ' ' VAL . 4.2 t -139.4 140.55 37.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 118.634 0.652 . . . . 61.32 109.729 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.685 ' HB3' ' CH2' ' C' ' 287' ' ' TRP . 5.1 tp -126.94 119.73 27.42 Favored 'General case' 0 C--N 1.279 -2.462 0 CA-C-O 121.374 0.606 . . . . 72.209999999999994 109.397 172.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.405 HD12 HD13 ' C' ' 231' ' ' ILE . 54.9 mt -108.45 103.4 15.43 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.261 0 N-CA-C 105.719 -1.956 . . . . 75.120000000000005 105.719 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 146.24 -146.71 17.05 Favored Glycine 0 N--CA 1.427 -1.944 0 C-N-CA 120.721 -0.752 . . . . 54.039999999999999 111.352 -175.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -121.72 140.33 52.45 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.577 -0.897 . . . . 62.049999999999997 108.577 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.527 ' HB2' HD21 ' C' ' 276' ' ' LEU . 36.0 tt0 -118.63 118.35 31.41 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.973 -0.751 . . . . 74.329999999999998 108.973 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -107.72 125.82 51.85 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 109.92 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 131.28 -129.25 5.66 Favored Glycine 0 N--CA 1.427 -1.935 0 C-N-CA 120.749 -0.738 . . . . 52.229999999999997 112.332 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -157.02 111.58 0.49 Allowed Glycine 0 N--CA 1.413 -2.87 0 N-CA-C 109.52 -1.432 . . . . 62.450000000000003 109.52 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm 63.56 38.14 9.89 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.957 0.903 . . . . 62.030000000000001 109.785 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -60.93 -68.15 1.8 Allowed Glycine 0 C--N 1.332 0.329 0 CA-C-N 115.355 -0.839 . . . . 65.420000000000002 113.53 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -89.72 -46.17 8.8 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.661 -0.496 . . . . 74.530000000000001 109.661 -179.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.685 ' CH2' ' HB3' ' C' ' 276' ' ' LEU . 24.4 m-90 -94.22 105.25 17.24 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 116.101 -0.5 . . . . 71.109999999999999 109.892 177.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -99.91 102.63 14.08 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.37 1.081 . . . . 64.230000000000004 112.163 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -97.23 138.88 34.03 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 104.107 -2.553 . . . . 64.25 104.107 172.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -62.86 99.04 0.14 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.536 1.16 . . . . 65.540000000000006 111.736 -176.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -138.13 -49.66 0.56 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 106.242 -1.762 . . . . 73.400000000000006 106.242 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 34.0 t60 54.92 67.37 1.03 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.471 -1.24 . . . . 52.219999999999999 111.077 176.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -143.82 -176.85 5.14 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.587 -0.894 . . . . 62.329999999999998 108.587 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -77.96 -7.33 56.66 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.72 0.772 . . . . 73.209999999999994 109.325 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 . . . . . 0 N--CA 1.423 -1.808 0 CA-C-N 115.291 -0.868 . . . . 61.409999999999997 110.46 179.874 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.24 0.584 0 CA-C-O 120.681 0.277 . . . . 65.209999999999994 110.308 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.433 ' HD2' ' H ' ' A' ' 218' ' ' LYS . 8.3 mptt -82.15 99.62 9.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 106.322 -1.732 . . . . 74.200000000000003 106.322 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.427 ' O ' HD12 ' A' ' 219' ' ' ILE 0.274 2.6 pp -78.68 124.85 37.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 113.31 0.855 . . . . 72.209999999999994 113.31 -174.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -142.77 169.48 17.49 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.647 -1.612 . . . . 75.200000000000003 106.647 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -102.84 -0.56 31.12 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 122.949 0.5 . . . . 43.140000000000001 111.301 -177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.6 tt -81.72 115.7 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.55 -0.907 . . . . 71.230000000000004 108.55 178.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 26.9 m -116.02 149.17 18.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.561 -0.745 . . . . 54.020000000000003 111.613 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 53.84 57.71 15.19 Favored Glycine 0 CA--C 1.507 -0.422 0 O-C-N 124.817 1.323 . . . . 63.240000000000002 113.486 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.74 124.47 43.61 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.618 -0.833 . . . . 74.299999999999997 110.877 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -80.84 131.86 35.42 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.017 -1.846 . . . . 73.049999999999997 106.017 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 10.6 m -120.98 137.88 54.42 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 120.061 -0.656 . . . . 73.109999999999999 111.484 -171.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.76 118.46 19.07 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.584 -1.636 . . . . 64.409999999999997 106.584 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.523 ' HE2' ' O ' ' A' ' 265' ' ' GLU . 5.7 tmmm? -86.36 -38.58 17.29 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 109.832 -0.433 . . . . 73.019999999999996 109.832 -176.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -143.82 138.77 28.93 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 109.142 -0.688 . . . . 61.409999999999997 109.142 174.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 60.7 mt -130.77 126.7 60.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 105.149 -2.167 . . . . 74.349999999999994 105.149 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.413 ' HE ' ' HB2' ' A' ' 232' ' ' ARG . 10.1 ttm180 -134.44 116.21 14.89 Favored 'General case' 0 C--N 1.281 -2.398 0 N-CA-C 108.954 -0.758 . . . . 61.200000000000003 108.954 -177.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 31.3 p -123.42 127.74 48.86 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 110.121 -0.325 . . . . 74.230000000000004 110.121 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -144.65 145.97 32.02 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 120.86 0.362 . . . . 74.409999999999997 111.304 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 63.49 86.68 0.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.968 1.307 . . . . 75.439999999999998 113.989 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.51 26.43 16.06 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.014 -0.994 . . . . 74.219999999999999 111.865 177.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -86.49 144.64 27.16 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.825 -0.625 . . . . 63.109999999999999 109.855 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 60.3 mtt180 -127.24 135.49 50.69 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.932 -0.766 . . . . 74.420000000000002 108.932 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 3.3 p -132.98 145.21 34.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.952 0.882 . . . . 72.049999999999997 112.738 -175.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -124.84 130.42 52.35 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 107.062 -1.458 . . . . 64.120000000000005 107.062 170.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -128.43 118.56 23.33 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.533 -1.284 . . . . 54.350000000000001 107.533 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 133.19 -116.79 1.8 Allowed Glycine 0 N--CA 1.427 -1.945 0 C-N-CA 119.603 -1.284 . . . . 31.539999999999999 114.123 176.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.426 ' OD1' HG13 ' A' ' 245' ' ' VAL . 15.6 t-20 -144.48 128.69 17.73 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 122.968 0.507 . . . . 75.049999999999997 110.178 -175.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 50.2 t -108.77 114.01 45.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 109.376 -0.602 . . . . 75.230000000000004 109.376 177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . 0.43 HG12 ' HD2' ' A' ' 281' ' ' TYR . 15.7 m -103.33 121.82 55.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.885 -0.783 . . . . 71.209999999999994 108.885 175.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.587 ' OG1' ' HA3' ' A' ' 282' ' ' GLY . 24.0 p -92.64 160.63 14.92 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.591 -1.244 . . . . 51.520000000000003 111.18 176.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.27 -34.5 78.26 Favored 'General case' 0 C--O 1.209 -1.063 0 C-N-CA 123.78 0.832 . . . . 71.140000000000001 112.564 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -70.14 -35.37 74.0 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.079 0.466 . . . . 65.219999999999999 111.959 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.612 ' HB2' ' HA2' ' A' ' 282' ' ' GLY . . . -73.84 -39.15 64.21 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.704 -0.68 . . . . 64.109999999999999 111.201 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 5.0 mp 54.3 -98.27 0.08 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.18 1.392 . . . . 71.299999999999997 111.427 -173.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -145.34 29.62 1.15 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.725 -1.213 . . . . 73.310000000000002 107.725 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -67.66 -27.21 73.6 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.708 -1.133 . . . . 74.329999999999998 111.633 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -78.77 73.56 2.26 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.578 -1.409 . . . . 73.439999999999998 109.578 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 13.6 tt -75.67 -33.99 27.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 C-N-CA 124.273 1.029 . . . . 62.420000000000002 112.86 -173.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 255' ' ' ARG . 9.7 mmt85 -117.28 89.81 3.2 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.938 0.875 . . . . 73.109999999999999 112.37 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 9.3 tp -137.76 28.63 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 CA-C-O 123.339 1.542 . . . . 43.340000000000003 107.365 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 13.2 m -98.83 36.17 1.72 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.259 -1.337 . . . . 74.109999999999999 110.038 -177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.559 ' HA ' ' O ' ' B' ' 254' ' ' ILE . 5.7 t70 -79.14 -178.33 6.1 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.288 -0.634 . . . . 65.450000000000003 109.288 -174.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -101.43 23.56 10.89 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.835 -0.541 . . . . 64.530000000000001 111.091 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 1.2 m -65.16 120.76 13.29 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.954 -0.758 . . . . 74.120000000000005 108.954 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 8.0 m -118.55 122.88 43.7 Favored 'General case' 0 N--CA 1.424 -1.76 0 C-N-CA 119.55 -0.86 . . . . 63.32 109.285 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -120.26 133.61 55.44 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.046 -1.094 . . . . 73.219999999999999 108.046 -177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 18.2 m -142.31 130.4 22.0 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.974 -0.454 . . . . 50.119999999999997 112.218 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -114.1 133.35 60.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 109.529 -0.545 . . . . 73.230000000000004 109.529 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.523 ' O ' ' HE2' ' A' ' 229' ' ' LYS . 71.5 mm-40 -78.4 -50.87 10.94 Favored 'General case' 0 N--CA 1.426 -1.668 0 CA-C-N 116.331 -0.395 . . . . 72.430000000000007 110.09 177.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 90.5 m -145.92 127.24 14.88 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.34 -0.85 . . . . 62.149999999999999 111.275 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 3.0 p -120.81 120.39 62.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.566 -0.743 . . . . 74.420000000000002 109.053 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.0 t -117.7 130.48 72.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.58 -0.737 . . . . 72.239999999999995 109.447 -175.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -122.42 131.92 8.56 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.293 -1.123 . . . . 72.519999999999996 110.293 174.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 22.8 tptt -134.01 116.7 15.83 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 110.057 -0.349 . . . . 73.549999999999997 110.057 -177.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 75.33 90.47 0.21 Allowed Glycine 0 C--N 1.308 -1.025 0 C-N-CA 120.33 -0.938 . . . . 70.200000000000003 113.303 174.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.498 ' HB3' ' NH1' ' A' ' 274' ' ' ARG . 19.5 mt-10 58.58 37.89 25.34 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 113.598 0.962 . . . . 72.219999999999999 113.598 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 15.5 m -88.43 143.7 26.83 Favored 'General case' 0 C--N 1.274 -2.682 0 C-N-CA 118.639 -1.224 . . . . 72.420000000000002 109.386 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . 0.498 ' NH1' ' HB3' ' A' ' 272' ' ' GLU . 9.2 mpt_? -116.6 127.03 54.11 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.369 -1.715 . . . . 71.439999999999998 106.369 174.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.551 HG12 ' CG1' ' B' ' 239' ' ' VAL . 17.2 m -126.41 123.42 63.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 CA-C-O 121.458 0.647 . . . . 72.209999999999994 109.952 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 5.4 tt -113.57 111.77 22.43 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.744 -1.576 . . . . 55.210000000000001 106.744 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.623 HG23 HD12 ' B' ' 241' ' ' LEU . 60.0 mt -112.36 107.33 22.7 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 CA-C-O 121.612 0.72 . . . . 63.340000000000003 110.122 -177.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . 137.61 -135.27 7.47 Favored Glycine 0 N--CA 1.426 -1.993 0 CA-C-N 115.533 -0.758 . . . . 61.219999999999999 112.139 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 3.1 m120 -104.09 134.34 47.51 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 112.06 0.392 . . . . 73.319999999999993 112.06 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -113.2 117.92 33.25 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 103.401 -2.814 . . . . 74.010000000000005 103.401 167.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.562 ' HA ' ' O ' ' B' ' 245' ' ' VAL . 16.0 t80 -130.13 123.61 30.76 Favored 'General case' 0 C--O 1.264 1.818 0 CA-C-O 122.54 1.162 . . . . 73.120000000000005 113.514 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.612 ' HA2' ' HB2' ' A' ' 249' ' ' ALA . . . 129.98 -77.27 0.4 Allowed Glycine 0 N--CA 1.415 -2.734 0 CA-C-N 113.475 -1.693 . . . . 42.539999999999999 114.938 175.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -61.27 -81.74 0.08 OUTLIER Glycine 0 C--N 1.317 -0.508 0 N-CA-C 115.708 1.043 . . . . 72.430000000000007 115.708 -170.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -178.67 -35.95 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.122 -1.807 . . . . 73.019999999999996 106.122 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' B' ' 287' ' ' TRP . . . -158.35 -167.41 19.16 Favored Glycine 0 N--CA 1.401 -3.652 0 CA-C-N 113.73 -1.577 . . . . 74.239999999999995 109.541 176.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.416 ' HE1' ' CZ2' ' B' ' 287' ' ' TRP . 41.7 p90 -104.25 -169.66 1.66 Allowed 'General case' 0 C--N 1.294 -1.825 0 O-C-N 124.105 0.532 . . . . 72.129999999999995 110.468 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 27.8 p90 -53.02 104.2 0.09 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 124.455 1.102 . . . . 70.109999999999999 113.02 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -140.01 152.88 46.61 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.622 -1.622 . . . . 34.409999999999997 106.622 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -72.79 -29.91 63.66 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 123.143 0.277 . . . . 73.340000000000003 110.287 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.454 ' NE2' ' HA ' ' B' ' 289' ' ' ASN . 42.1 t-80 58.46 75.43 0.39 Allowed 'General case' 0 C--O 1.237 0.447 0 C-N-CA 125.003 1.321 . . . . 71.239999999999995 108.665 -175.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -82.12 155.2 25.15 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.868 -1.06 . . . . 74.120000000000005 110.16 -175.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -77.19 105.6 8.39 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.339 -0.846 . . . . 75.439999999999998 109.688 -176.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -124.54 102.6 7.71 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 109.253 -0.647 . . . . 72.319999999999993 109.253 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -171.66 17.72 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.41 0.893 . . . . 75.409999999999997 113.41 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 . . . . . 0 C--O 1.261 1.685 0 N-CA-C 107.979 -1.119 . . . . 74.420000000000002 107.979 175.641 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.469 0.495 0 CA-C-O 120.742 0.306 . . . . 73.319999999999993 111.083 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -124.81 134.46 52.75 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 122.331 0.252 . . . . 65.019999999999996 110.359 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 7.2 tp -128.36 -40.39 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.603 -0.888 . . . . 73.230000000000004 108.603 174.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 219' ' ' ILE . 16.5 t70 57.23 -92.73 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.845 1.258 . . . . 72.010000000000005 111.542 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -180.0 -36.89 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.242 -1.762 . . . . 73.019999999999996 106.242 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . 0.502 HD11 ' HD2' ' B' ' 225' ' ' ARG . 17.7 tt -107.32 113.05 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 CA-C-O 122.204 1.002 . . . . 51.329999999999998 111.085 176.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.476 ' CG2' HH12 ' C' ' 255' ' ' ARG . 1.9 m -140.93 119.62 10.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 114.568 -1.196 . . . . 71.450000000000003 110.075 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.15 72.18 1.29 Allowed Glycine 0 C--N 1.308 -0.994 0 N-CA-C 109.674 -1.37 . . . . 75.409999999999997 109.674 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 261' ' ' THR . 14.7 ttt180 -108.94 121.81 45.91 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.128 -0.536 . . . . 71.409999999999997 111.707 -175.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -85.92 126.34 34.02 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 105.213 -2.143 . . . . 40.439999999999998 105.213 171.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . 0.444 ' O ' ' HA ' ' B' ' 263' ' ' SER . 18.7 m -121.25 136.61 54.94 Favored 'General case' 0 C--N 1.291 -1.947 0 C-N-CA 119.789 -0.765 . . . . 74.010000000000005 111.746 -174.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.62 119.19 26.43 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.474 -1.306 . . . . 74.409999999999997 107.474 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.582 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 33.5 ttmt -75.74 -61.73 1.82 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.059 -0.719 . . . . 73.209999999999994 109.059 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -128.32 137.7 52.05 Favored 'General case' 0 C--O 1.253 1.248 0 N-CA-C 109.373 -0.602 . . . . 74.230000000000004 109.373 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.451 ' HA ' HG13 ' B' ' 267' ' ' VAL . 40.0 mt -128.6 128.16 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.791 0 N-CA-C 104.956 -2.238 . . . . 44.039999999999999 104.956 174.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.513 ' HB3' HG12 ' B' ' 268' ' ' VAL . 16.0 ttm180 -132.25 114.09 14.03 Favored 'General case' 0 N--CA 1.397 -3.083 0 N-CA-C 108.537 -0.912 . . . . 73.030000000000001 108.537 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 45.7 p -110.04 127.89 55.1 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 106.243 -1.762 . . . . 72.230000000000004 106.243 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' B' ' 270' ' ' LYS . 48.4 mt-10 -143.31 140.5 30.61 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 109.007 -0.738 . . . . 74.040000000000006 109.007 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 60.89 97.66 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.781 0 O-C-N 124.032 0.833 . . . . 61.450000000000003 113.212 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.535 ' HB2' ' H ' ' B' ' 272' ' ' GLU . 2.0 mpt_? 60.37 22.61 12.15 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.031 0.533 . . . . 61.399999999999999 111.533 173.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . . . . . . . . . . . -99.58 140.53 33.63 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.189 0.519 . . . . 54.25 110.895 -175.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.94 134.76 46.01 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.685 -0.688 . . . . 74.549999999999997 109.498 178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.582 HG23 ' HB ' ' B' ' 275' ' ' VAL . 7.2 p -137.53 150.01 25.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.271 0.558 . . . . 31.309999999999999 110.204 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.485 HE22 ' N ' ' B' ' 243' ' ' ASN . 22.5 tm0? -122.63 128.13 50.26 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 105.663 -1.977 . . . . 54.140000000000001 105.663 170.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.623 HD12 HG23 ' A' ' 277' ' ' ILE . 3.3 tm? -118.33 117.91 30.37 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.16 -2.163 . . . . 74.540000000000006 105.16 178.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.437 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 143.19 -125.56 2.6 Favored Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 118.695 -1.717 . . . . 43.439999999999998 112.852 -178.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.533 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 2.8 t-20 -144.44 128.22 17.28 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 110.292 -0.262 . . . . 74.019999999999996 110.292 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.418 HG21 ' HZ3' ' B' ' 287' ' ' TRP . 30.0 t -99.54 128.0 51.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.105 -1.442 . . . . 74.340000000000003 107.105 177.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 281' ' ' TYR . 10.5 t -122.51 116.07 47.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 N-CA-C 107.381 -1.34 . . . . 74.230000000000004 107.381 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.9 p -85.02 158.07 20.57 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 117.1 -1.84 . . . . 72.25 111.065 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -66.57 -47.1 73.85 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.61 1.195 . . . . 71.310000000000002 110.035 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.81 -33.49 61.6 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 112.243 -2.253 . . . . 51.219999999999999 113.795 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.532 ' HB2' ' HA3' ' B' ' 282' ' ' GLY . . . -58.7 -42.84 89.54 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.078 0.551 . . . . 53.240000000000002 111.171 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 90.7 mt 65.68 -69.05 0.11 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.807 1.243 . . . . 72.340000000000003 112.549 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -154.18 166.67 32.38 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.067 -0.515 . . . . 71.310000000000002 110.12 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 171.83 -63.37 0.15 Allowed Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 109.771 -1.331 . . . . 71.450000000000003 109.771 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -95.15 147.61 18.67 Favored Glycine 0 C--N 1.303 -1.284 0 CA-C-N 115.362 -0.419 . . . . 73.200000000000003 112.063 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 258' ' ' ASP . 54.1 mt -138.8 -45.66 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 N-CA-C 107.396 -1.335 . . . . 45.43 107.396 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.96 62.4 0.35 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 122.358 1.075 . . . . 73.340000000000003 108.323 169.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 10.5 tp -128.18 5.77 3.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.22 -0.9 . . . . 73.430000000000007 112.233 -174.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 24.6 m -65.9 98.41 0.41 Allowed 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 107.848 -1.167 . . . . 71.340000000000003 107.848 173.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -61.28 146.73 46.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.187 -0.461 . . . . 42.43 110.634 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -76.29 71.77 3.01 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.83 0.824 . . . . 70.120000000000005 112.025 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 15.4 m -101.29 120.64 40.56 Favored 'General case' 0 N--CA 1.399 -2.996 0 N-CA-C 103.618 -2.734 . . . . 63.32 103.618 170.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' C' ' 225' ' ' ARG . 13.9 m -94.47 108.44 20.38 Favored 'General case' 0 N--CA 1.417 -2.114 0 C-N-CA 119.208 -0.997 . . . . 74.099999999999994 109.446 -175.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -104.19 128.54 51.92 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.147 -1.057 . . . . 72.010000000000005 108.147 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' B' ' 227' ' ' SER . 38.6 t -142.78 136.09 28.51 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-O 121.074 0.464 . . . . 73.109999999999999 111.747 -175.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 9.4 p -116.39 137.25 50.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.982 -0.554 . . . . 74.510000000000005 110.076 174.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.582 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 31.7 mm-40 -78.02 -57.44 3.79 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.866 -0.79 . . . . 75.200000000000003 108.866 176.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 88.0 m -146.96 126.98 13.65 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.661 0.743 . . . . 73.010000000000005 111.387 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' B' ' 231' ' ' ILE . 1.3 p -121.91 120.51 61.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 115.271 -0.877 . . . . 73.430000000000007 109.603 176.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' B' ' 232' ' ' ARG . 34.2 m -121.06 145.59 27.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 116.044 -0.526 . . . . 73.219999999999999 110.194 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -143.82 132.79 5.06 Favored Glycine 0 N--CA 1.429 -1.829 0 C-N-CA 120.097 -1.049 . . . . 43.520000000000003 112.4 176.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' B' ' 234' ' ' GLU . 65.0 mttm -133.92 131.01 38.56 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 123.724 0.81 . . . . 73.319999999999993 112.319 176.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 80.03 86.57 0.59 Allowed Glycine 0 C--N 1.296 -1.679 0 N-CA-C 114.476 0.551 . . . . 54.219999999999999 114.476 172.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . 0.535 ' H ' ' HB2' ' B' ' 236' ' ' ARG . 65.3 mm-40 65.95 27.65 10.76 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 112.193 0.442 . . . . 74.439999999999998 112.193 173.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 12.9 m -83.54 143.15 30.37 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-O 121.29 0.567 . . . . 74.109999999999999 110.149 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.539 ' HB2' ' HG3' ' C' ' 238' ' ' ARG . 10.9 mpt_? -123.47 127.63 48.66 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.521 -1.659 . . . . 64.5 106.521 174.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.582 ' HB ' HG23 ' B' ' 239' ' ' VAL . 5.9 t -127.41 133.9 66.91 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 108.45 -0.945 . . . . 65.439999999999998 108.45 -177.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.522 HD22 HE21 ' C' ' 240' ' ' GLN . 4.4 tt -121.99 112.82 18.75 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.011 -1.477 . . . . 73.129999999999995 107.011 171.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.675 HG23 HD12 ' C' ' 241' ' ' LEU . 39.4 mt -112.83 107.0 21.87 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 109.131 -0.692 . . . . 62.520000000000003 109.131 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 149.95 -137.58 6.28 Favored Glycine 0 N--CA 1.405 -3.38 0 C-N-CA 119.948 -1.12 . . . . 41.229999999999997 112.188 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 27.7 t-20 -119.03 133.18 55.97 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.998 -0.601 . . . . 44.420000000000002 110.133 -178.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -109.89 118.64 37.01 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 104.603 -2.369 . . . . 74.239999999999995 104.603 177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -120.05 123.43 43.39 Favored 'General case' 0 C--O 1.274 2.369 0 CA-C-O 122.535 1.16 . . . . 73.5 110.379 -172.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' B' ' 249' ' ' ALA . . . 111.91 -55.66 0.5 Allowed Glycine 0 N--CA 1.398 -3.9 0 CA-C-N 114.064 -1.425 . . . . 53.130000000000003 115.385 172.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -67.43 -97.91 0.03 OUTLIER Glycine 0 C--N 1.313 -0.737 0 N-CA-C 115.655 1.022 . . . . 72.299999999999997 115.655 -171.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 42.8 tptt 173.92 -42.06 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 103.94 -2.615 . . . . 72.319999999999993 103.94 -174.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -147.09 161.68 28.49 Favored Glycine 1 N--CA 1.387 -4.591 0 N-CA-C 106.215 -2.754 . . . . 62.240000000000002 106.215 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -83.4 -153.63 0.14 Allowed 'General case' 0 C--N 1.278 -2.509 0 O-C-N 124.358 0.681 . . . . 75.150000000000006 110.56 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.5 ' HE1' ' HB3' ' B' ' 274' ' ' ARG . 34.4 p90 -64.66 43.5 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.756 1.623 . . . . 65.140000000000001 113.629 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -76.34 170.18 16.83 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.031 -1.1 . . . . 62.340000000000003 108.031 177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . 0.454 ' HA ' ' NE2' ' A' ' 290' ' ' HIS . 16.0 m120 -86.24 26.95 0.97 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 114.616 1.339 . . . . 73.439999999999998 114.616 -165.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 32.6 m170 62.99 80.42 0.23 Allowed 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 124.653 1.181 . . . . 71.439999999999998 113.431 176.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 52.6 m-70 -111.0 -32.42 6.81 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 106.074 -1.824 . . . . 64.349999999999994 106.074 171.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 59.46 -88.9 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.965 1.706 . . . . 74.230000000000004 112.525 171.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -115.53 40.09 2.82 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.384 0.612 . . . . 72.120000000000005 109.576 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 51.0 t60 -76.04 82.86 2.9 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.723 -1.214 . . . . 70.299999999999997 107.723 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 . . . . . 0 C--N 1.295 -1.793 0 CA-C-N 114.885 -1.052 . . . . 72.310000000000002 108.55 -174.063 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 46.7 ttm . . . . . 0 C--O 1.218 -0.562 0 N-CA-C 109.765 -0.457 . . . . 73.040000000000006 109.765 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -145.48 113.13 6.33 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.413 -0.958 . . . . 71.219999999999999 108.413 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 65.1 mt -148.36 144.01 18.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 106.842 -1.54 . . . . 72.129999999999995 106.842 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -86.35 -56.62 3.35 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.243 0.474 . . . . 53.240000000000002 109.99 176.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -141.18 137.19 32.49 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.09 -1.078 . . . . 43.530000000000001 108.09 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 13.9 tt -116.81 118.86 60.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-O 121.102 0.477 . . . . 71.439999999999998 111.91 -177.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 22.0 m -134.11 151.52 32.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.935 -0.765 . . . . 65.349999999999994 108.935 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 57.26 65.81 3.3 Favored Glycine 0 C--N 1.335 0.526 0 O-C-N 124.095 0.872 . . . . 62.509999999999998 112.071 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' B' ' 261' ' ' THR . 47.5 ttt180 -97.72 121.48 39.68 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 120.513 -0.475 . . . . 71.329999999999998 111.301 -177.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -93.23 124.93 37.56 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 104.962 -2.236 . . . . 75.120000000000005 104.962 170.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' B' ' 263' ' ' SER . 8.1 m -121.69 136.22 54.95 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.976 -0.689 . . . . 71.120000000000005 110.856 -174.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -121.38 119.02 30.92 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 106.829 -1.545 . . . . 70.430000000000007 106.829 174.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.543 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.8 OUTLIER -82.17 -54.72 5.04 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 116.301 -0.409 . . . . 74.140000000000001 109.958 -174.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -131.46 137.41 48.58 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.462 -1.31 . . . . 71.200000000000003 107.462 173.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.433 ' HA ' HG13 ' C' ' 267' ' ' VAL . 30.8 mt -130.73 128.79 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.76 0 N-CA-C 104.983 -2.228 . . . . 73.319999999999993 104.983 174.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.491 ' HB3' HG12 ' C' ' 268' ' ' VAL . 10.7 ttm180 -133.05 113.85 13.26 Favored 'General case' 0 N--CA 1.401 -2.896 0 N-CA-C 108.758 -0.831 . . . . 72.319999999999993 108.758 -176.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.44 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 40.9 p -110.79 126.22 54.39 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 107.856 -1.164 . . . . 63.530000000000001 107.856 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.457 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 48.4 mt-10 -145.14 142.24 29.45 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 110.271 -0.27 . . . . 75.340000000000003 110.271 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 64.49 89.59 0.09 Allowed 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.437 1.085 . . . . 61.350000000000001 113.113 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.459 ' HB2' ' H ' ' C' ' 272' ' ' GLU . 4.8 mpt_? 64.75 15.99 10.13 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 114.993 -1.003 . . . . 71.430000000000007 112.026 174.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . . . . . . . . . . . -88.47 140.97 28.92 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.289 0.566 . . . . 64.219999999999999 112.481 -174.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.539 ' HG3' ' HB2' ' B' ' 274' ' ' ARG . 0.0 OUTLIER -128.47 135.75 49.89 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.021 -0.733 . . . . 70.519999999999996 109.021 178.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.514 HG23 ' HB ' ' C' ' 275' ' ' VAL . 7.1 p -138.85 147.53 24.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.452 0.644 . . . . 72.530000000000001 111.469 -177.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.522 HE21 HD22 ' B' ' 276' ' ' LEU . 13.3 tm0? -117.35 132.54 56.57 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 104.506 -2.405 . . . . 74.120000000000005 104.506 172.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.675 HD12 HG23 ' B' ' 277' ' ' ILE . 3.4 tm? -129.68 117.79 20.88 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 106.319 -1.734 . . . . 72.120000000000005 106.319 177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 136.31 -117.65 1.66 Allowed Glycine 0 N--CA 1.426 -1.999 0 C-N-CA 119.912 -1.137 . . . . 64.049999999999997 112.474 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.6 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 18.1 t-20 -144.4 134.33 23.91 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 120.798 0.333 . . . . 65.430000000000007 111.435 -176.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 60.2 t -112.31 123.61 68.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.49 -0.93 . . . . 74.310000000000002 108.49 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.456 HG13 ' OD1' ' C' ' 243' ' ' ASN . 31.5 m -121.43 117.2 51.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-O 121.625 0.726 . . . . 72.109999999999999 109.143 177.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . 0.526 ' OG1' ' HA3' ' C' ' 282' ' ' GLY . 12.4 p -83.76 158.55 21.7 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 117.871 -1.532 . . . . 63.130000000000003 109.969 178.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -66.45 -40.93 89.73 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.934 1.35 . . . . 71.109999999999999 108.632 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.19 62.36 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 112.374 -2.193 . . . . 34.100000000000001 112.826 177.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -59.4 -35.0 73.15 Favored 'General case' 0 C--O 1.258 1.549 0 N-CA-C 112.908 0.707 . . . . 74.329999999999998 112.908 -177.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 96.5 mt 64.53 -178.92 0.17 Allowed 'General case' 0 C--O 1.247 0.964 0 O-C-N 124.235 0.959 . . . . 73.25 110.842 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -104.3 140.5 37.78 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 120.54 -0.464 . . . . 74.329999999999998 110.206 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -87.39 -162.2 37.5 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 111.314 -0.714 . . . . 63.340000000000003 111.314 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -100.45 83.69 0.55 Allowed Glycine 0 N--CA 1.428 -1.898 0 C-N-CA 121.019 -0.61 . . . . 72.310000000000002 111.991 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 66.2 mt 72.04 148.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 C-N-CA 123.871 0.868 . . . . 74.319999999999993 111.145 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . 0.476 HH12 ' CG2' ' B' ' 223' ' ' VAL . 59.5 mtp180 -66.74 149.74 50.09 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.89 0.876 . . . . 75.140000000000001 109.703 -175.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 29.5 pt -121.23 -37.73 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 113.837 1.051 . . . . 71.030000000000001 113.837 -173.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 87.2 p 68.91 130.53 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 127.121 2.168 . . . . 74.099999999999994 113.018 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -97.69 148.87 22.89 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.026 -1.472 . . . . 74.150000000000006 107.026 177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -109.26 5.21 23.51 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.032 0.753 . . . . 73.450000000000003 113.032 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 37.8 p -82.26 131.55 35.23 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 119.855 -0.738 . . . . 75.349999999999994 111.383 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . 0.457 HG22 ' H ' ' C' ' 225' ' ' ARG . 11.2 p -102.46 108.74 20.16 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 115.861 -0.609 . . . . 72.409999999999997 110.706 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . 0.428 HD21 ' HB3' ' C' ' 295' ' ' HIS . 3.1 t-20 -97.89 138.81 34.68 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.213 -1.402 . . . . 73.129999999999995 107.213 177.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 45.6 m -142.58 136.12 28.91 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.639 -0.663 . . . . 54.030000000000001 111.11 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.96 130.56 74.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 109.101 -0.703 . . . . 64.329999999999998 109.101 176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 5.5 mm-40 -75.09 -47.14 30.21 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.051 0.453 . . . . 65.540000000000006 110.904 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 69.8 m -150.41 127.88 11.47 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 122.005 -0.434 . . . . 74.109999999999999 110.623 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' C' ' 231' ' ' ILE . 1.1 p -126.1 119.8 55.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.983 -0.747 . . . . 75.109999999999999 108.983 174.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' C' ' 232' ' ' ARG . 25.8 m -121.04 144.97 28.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 109.262 -0.644 . . . . 75.340000000000003 109.262 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -132.33 132.42 6.65 Favored Glycine 0 CA--C 1.473 -2.558 0 N-CA-C 110.705 -0.958 . . . . 52.530000000000001 110.705 176.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -133.59 128.83 36.0 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 109.499 -0.556 . . . . 75.310000000000002 109.499 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.6 75.49 1.15 Allowed Glycine 0 C--N 1.305 -1.156 0 C-N-CA 120.357 -0.925 . . . . 44.450000000000003 113.718 172.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . 0.459 ' H ' ' HB2' ' C' ' 236' ' ' ARG . 53.1 mt-10 60.52 40.81 16.53 Favored 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 123.389 0.676 . . . . 61.219999999999999 112.269 175.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 16.4 m -81.98 143.81 31.33 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 119.221 -0.992 . . . . 73.0 109.482 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . 0.445 ' HB3' ' HE1' ' C' ' 287' ' ' TRP . 1.3 mpp_? -120.2 127.0 52.04 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 106.545 -1.65 . . . . 73.129999999999995 106.545 173.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.514 ' HB ' HG23 ' C' ' 239' ' ' VAL . 3.0 t -135.54 140.18 45.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 109.315 -0.624 . . . . 62.509999999999998 109.315 -175.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.534 HD12 ' CZ3' ' C' ' 287' ' ' TRP . 4.0 tt -128.17 115.6 18.64 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.145 -1.798 . . . . 64.400000000000006 106.145 170.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.416 HD12 HD13 ' C' ' 231' ' ' ILE . 56.7 mt -112.73 104.31 16.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 107.047 -1.464 . . . . 74.540000000000006 107.047 176.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 155.12 -139.5 6.72 Favored Glycine 0 N--CA 1.403 -3.507 0 C-N-CA 119.89 -1.147 . . . . 71.109999999999999 111.476 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . 0.456 ' HB3' HD22 ' C' ' 243' ' ' ASN . 28.5 t-20 -122.87 130.29 52.69 Favored 'General case' 0 C--N 1.279 -2.466 0 O-C-N 123.807 0.357 . . . . 64.519999999999996 110.237 -177.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -110.88 117.9 34.64 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 106.618 -1.623 . . . . 75.040000000000006 106.618 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -124.77 123.94 41.06 Favored 'General case' 0 C--O 1.272 2.245 0 CA-C-O 122.394 1.092 . . . . 72.319999999999993 111.794 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . 0.526 ' HA3' ' OG1' ' C' ' 246' ' ' THR . . . 128.2 -53.91 0.79 Allowed Glycine 0 N--CA 1.419 -2.459 0 CA-C-N 114.193 -1.367 . . . . 63.409999999999997 113.515 178.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -80.48 -97.62 0.35 Allowed Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 120.493 -0.86 . . . . 74.519999999999996 114.104 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 52.5 tttp 170.43 -34.11 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 104.877 -2.268 . . . . 74.109999999999999 104.877 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -143.05 156.31 26.4 Favored Glycine 0 N--CA 1.404 -3.442 0 N-CA-C 106.479 -2.649 . . . . 52.039999999999999 106.479 174.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -89.08 -166.09 1.51 Allowed 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 117.258 0.529 . . . . 70.340000000000003 109.719 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.534 ' CZ3' HD12 ' C' ' 276' ' ' LEU . 43.4 p90 -53.97 144.9 17.8 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 123.409 0.684 . . . . 64.409999999999997 110.756 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' C' ' 287' ' ' TRP . 2.4 m-20 75.01 -81.35 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.508 0.723 . . . . 74.209999999999994 111.527 -176.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -161.77 159.67 27.39 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.489 -0.93 . . . . 72.219999999999999 108.489 -173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -78.53 94.89 5.05 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.229 -1.026 . . . . 75.230000000000004 108.229 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -86.32 -57.67 2.92 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.606 -0.725 . . . . 74.239999999999995 109.831 178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -143.63 165.26 28.12 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.16 -0.681 . . . . 74.519999999999996 109.16 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -162.09 -69.89 0.05 Allowed 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.928 -1.138 . . . . 75.129999999999995 107.928 177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 32.7 m-70 -131.1 145.87 52.15 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 108.587 -0.894 . . . . 63.219999999999999 108.587 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . 0.428 ' HB3' HD21 ' C' ' 262' ' ' ASN . 59.5 t-80 . . . . . 0 C--N 1.285 -2.206 0 N-CA-C 106.462 -1.681 . . . . 73.510000000000005 106.462 175.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 83.0 mtp . . . . . 0 CA--C 1.5 -0.945 0 N-CA-C 108.11 -1.07 . . . . 52.329999999999998 108.11 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -130.76 -65.38 0.79 Allowed 'General case' 0 C--N 1.316 -0.89 0 O-C-N 123.234 0.334 . . . . 72.310000000000002 110.638 176.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 62.9 mt 68.84 104.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.616 0 C-N-CA 124.06 0.944 . . . . 73.549999999999997 111.937 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 7.0 t70 66.97 -156.7 0.23 Allowed 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.22 -1.355 . . . . 74.019999999999996 108.407 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -125.41 30.34 5.81 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.935 -0.765 . . . . 74.510000000000005 108.935 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 50.2 mm -83.56 121.71 36.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.639 -0.71 . . . . 70.510000000000005 110.627 -176.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.95 119.59 57.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.1 0.476 . . . . 62.509999999999998 111.239 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 52.07 52.48 35.4 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 114.487 -1.233 . . . . 51.310000000000002 115.738 174.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 225' ' ' ARG . 24.5 mmt180 -100.57 134.3 43.74 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.616 0.722 . . . . 72.409999999999997 111.318 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.484 ' HB2' ' OD1' ' A' ' 262' ' ' ASN . 23.4 p-10 -116.88 156.0 28.09 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 125.23 1.412 . . . . 71.120000000000005 111.675 -173.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 263' ' ' SER . 23.4 m -116.99 136.53 52.87 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 108.813 -0.81 . . . . 63.030000000000001 108.813 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.7 135.34 43.98 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.267 -0.879 . . . . 70.409999999999997 110.285 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.497 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 1.9 tmtp? -87.84 -63.93 1.23 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.723 -0.671 . . . . 63.130000000000003 110.367 -178.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -131.03 139.03 49.89 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 122.166 -0.334 . . . . 61.509999999999998 110.52 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 24.6 mt -137.8 128.15 36.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 107.029 -1.471 . . . . 73.319999999999993 107.029 -177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.467 ' HB2' HG12 ' A' ' 268' ' ' VAL . 65.0 mtt180 -134.41 115.14 13.67 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 120.437 -0.505 . . . . 71.430000000000007 109.706 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.505 HG21 ' HB ' ' A' ' 239' ' ' VAL . 28.9 p -118.95 128.31 54.29 Favored 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 120.415 -0.514 . . . . 74.349999999999994 109.868 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -140.3 153.29 46.42 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.904 -0.406 . . . . 55.32 109.904 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 63.46 83.44 0.16 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.603 1.161 . . . . 71.5 113.036 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 236' ' ' ARG . 6.1 mpt_? 58.83 22.79 10.55 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.913 1.285 . . . . 73.109999999999999 112.436 176.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -92.6 142.03 27.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 122.173 -0.329 . . . . 34.149999999999999 110.445 -177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.75 137.16 53.8 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.825 -0.435 . . . . 72.040000000000006 109.825 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.505 ' HB ' HG21 ' A' ' 233' ' ' THR . 3.1 p -129.16 142.59 43.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.453 0.644 . . . . 44.439999999999998 111.777 -176.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -125.99 125.38 42.6 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 108.496 -0.928 . . . . 72.439999999999998 108.496 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.422 ' HA ' HG13 ' A' ' 277' ' ' ILE . 59.7 tp -115.88 123.87 49.22 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.454 -0.943 . . . . 74.239999999999995 108.454 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.564 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 121.09 -123.54 5.57 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 120.382 -0.913 . . . . 71.299999999999997 112.166 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . 0.616 ' ND2' HD22 ' A' ' 279' ' ' ASN . 2.1 t-20 -141.76 128.57 20.51 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 122.196 -0.591 . . . . 61.43 111.524 -174.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 51.3 t -104.11 122.45 56.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 107.201 -1.407 . . . . 73.430000000000007 107.201 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 40.7 t -118.17 116.26 50.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.401 -0.592 . . . . 60.439999999999998 109.401 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 14.3 t -114.34 162.1 17.05 Favored 'General case' 0 N--CA 1.421 -1.918 0 C-N-CA 119.977 -0.689 . . . . 71.5 109.393 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.37 -32.0 62.24 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 114.862 1.43 . . . . 75.430000000000007 114.862 -174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.41 -37.54 65.19 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.823 1.416 . . . . 71.340000000000003 114.823 -173.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . . . . . . . . . . . -76.11 -25.93 55.9 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 112.542 0.571 . . . . 62.219999999999999 112.542 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 2.9 mm? 69.26 -94.22 0.03 OUTLIER 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.232 1.013 . . . . 75.099999999999994 109.131 -170.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 171.33 139.04 0.03 OUTLIER 'General case' 0 C--O 1.247 0.967 0 C-N-CA 124.638 1.175 . . . . 72.230000000000004 108.674 176.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -159.28 171.74 35.83 Favored Glycine 0 N--CA 1.427 -1.933 0 N-CA-C 110.77 -0.932 . . . . 64.340000000000003 110.77 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -70.91 124.0 11.33 Favored Glycine 0 CA--C 1.498 -0.985 0 N-CA-C 109.705 -1.358 . . . . 72.140000000000001 109.705 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 8.8 tp -134.59 118.33 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 121.773 0.797 . . . . 64.340000000000003 112.719 -172.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.43 149.74 33.3 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.26 -0.882 . . . . 73.140000000000001 109.837 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.471 ' HB ' HG23 ' B' ' 223' ' ' VAL . 4.0 mm -156.27 -36.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 112.515 0.561 . . . . 72.129999999999995 112.515 -178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 25.2 t -151.54 96.0 2.2 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.063 -1.458 . . . . 45.32 107.063 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.42 ' HB3' ' HA ' ' B' ' 220' ' ' ASP . 11.0 m-20 -84.41 -1.07 54.99 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.745 -1.116 . . . . 75.150000000000006 113.722 -166.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -104.59 -21.93 13.34 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.587 0.708 . . . . 73.299999999999997 110.289 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' B' ' 225' ' ' ARG . 29.6 p -91.72 138.55 31.47 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 113.943 1.09 . . . . 74.310000000000002 113.943 -169.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.4 t -120.19 143.28 48.33 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.543 -1.28 . . . . 73.109999999999999 107.543 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 25.0 t-20 -86.45 121.45 29.01 Favored 'General case' 0 CA--C 1.489 -1.399 0 C-N-CA 119.847 -0.741 . . . . 73.349999999999994 109.378 -178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 227' ' ' SER . 50.8 m -142.32 132.77 25.09 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.554 -0.748 . . . . 72.540000000000006 111.079 -178.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.4 p -126.82 138.22 55.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 116.603 -0.272 . . . . 73.340000000000003 111.6 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 55.3 mm-40 -78.11 -66.48 0.84 Allowed 'General case' 0 C--O 1.212 -0.891 0 CA-C-N 116.031 -0.532 . . . . 74.230000000000004 110.825 176.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 30.1 m -133.63 126.97 32.01 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.23 -0.588 . . . . 73.519999999999996 110.41 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 1.4 p -128.72 121.68 55.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 115.637 -0.711 . . . . 75.099999999999994 109.601 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 232' ' ' ARG . 15.9 m -126.05 146.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-O 121.112 0.482 . . . . 74.430000000000007 111.568 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' B' ' 233' ' ' THR . . . -130.02 131.26 6.54 Favored Glycine 0 N--CA 1.425 -2.073 0 N-CA-C 109.096 -1.601 . . . . 61.119999999999997 109.096 174.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.498 ' HB2' ' HG2' ' B' ' 234' ' ' GLU . 29.8 mmmt -133.25 116.14 15.82 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 120.565 0.221 . . . . 44.32 110.946 -176.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 83.68 84.05 0.91 Allowed Glycine 0 N--CA 1.427 -1.963 0 C-N-CA 119.314 -1.422 . . . . 42.420000000000002 113.657 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 60.2 27.27 16.75 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.88 0.872 . . . . 73.530000000000001 111.74 171.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 17.4 m -84.11 145.49 28.4 Favored 'General case' 0 N--CA 1.418 -2.026 0 CA-C-O 121.281 0.563 . . . . 63.439999999999998 110.85 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -113.2 127.44 56.18 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.989 -1.856 . . . . 74.099999999999994 105.989 174.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 1.2 p -133.66 123.1 44.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-O 121.379 0.609 . . . . 70.129999999999995 111.418 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.529 HD23 ' CH2' ' A' ' 287' ' ' TRP . 18.3 tp -117.03 119.37 35.06 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.489 -0.93 . . . . 73.209999999999994 108.489 174.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.51 HG22 ' HB3' ' B' ' 241' ' ' LEU . 2.7 pt -113.67 104.91 17.73 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.146 0 CA-C-N 114.194 -1.367 . . . . 62.409999999999997 109.505 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 149.09 -122.78 1.51 Allowed Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.941 -0.572 . . . . 71.239999999999995 113.036 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.616 HD22 ' ND2' ' A' ' 243' ' ' ASN . 9.8 t30 -129.75 135.31 48.31 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 122.232 -0.569 . . . . 62.240000000000002 111.673 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.493 ' HG2' ' NE1' ' A' ' 287' ' ' TRP . 7.2 tp10 -111.75 118.27 35.13 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 105.854 -1.906 . . . . 75.530000000000001 105.854 174.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -117.8 123.13 45.2 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 105.721 -1.955 . . . . 75.430000000000007 105.721 -177.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 121.82 -48.51 0.94 Allowed Glycine 0 C--N 1.284 -2.335 0 N-CA-C 108.192 -1.963 . . . . 50.409999999999997 108.192 -172.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 99.52 16.39 29.41 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 120.809 -0.71 . . . . 73.239999999999995 112.112 175.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.454 ' HB3' ' NZ ' ' A' ' 284' ' ' LYS . 0.1 OUTLIER 176.82 66.38 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.849 0.859 . . . . 63.520000000000003 112.728 178.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -109.72 -51.22 0.66 Allowed Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 109.633 -1.387 . . . . 70.109999999999999 109.633 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -96.73 -5.82 37.76 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.243 0.544 . . . . 71.150000000000006 110.591 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.603 ' CH2' ' HB2' ' B' ' 240' ' ' GLN . 2.5 m95 -69.06 152.16 45.55 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 114.526 1.306 . . . . 75.299999999999997 114.526 -174.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -138.14 140.72 40.0 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 113.611 -1.631 . . . . 64.409999999999997 107.342 -174.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -140.09 155.14 47.15 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 110.164 -0.31 . . . . 50.43 110.164 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -147.72 3.6 0.74 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 122.705 0.402 . . . . 75.129999999999995 110.289 178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -106.25 149.76 26.56 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.963 0.411 . . . . 74.120000000000005 111.591 -172.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -143.2 167.94 20.95 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.395 -1.335 . . . . 74.329999999999998 107.395 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -146.61 -42.2 0.19 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.224 0.535 . . . . 74.519999999999996 110.806 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -107.81 -53.02 2.68 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.459 -0.941 . . . . 54.210000000000001 108.459 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 34.4 m170 . . . . . 0 C--N 1.304 -1.378 0 N-CA-C 107.199 -1.408 . . . . 60.439999999999998 107.199 176.498 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 N-CA-C 109.649 -0.5 . . . . 50.439999999999998 109.649 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 40.6 tttm 75.0 124.45 0.04 OUTLIER 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 124.921 1.289 . . . . 70.239999999999995 111.713 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 52.0 mt -129.69 -74.85 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 105.799 -1.926 . . . . 64.310000000000002 105.799 174.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . 0.42 ' HA ' ' HB3' ' A' ' 258' ' ' ASP . 25.1 m-20 66.88 -173.71 0.19 Allowed 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 113.83 -1.532 . . . . 63.340000000000003 108.65 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 64.29 27.19 13.79 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.966 0.906 . . . . 75.549999999999997 111.339 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 59.4 mt -94.82 138.48 20.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.756 0.789 . . . . 75.519999999999996 109.903 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.471 HG23 ' HB ' ' A' ' 256' ' ' ILE . 14.1 p -101.0 119.32 48.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 121.244 -0.91 . . . . 72.209999999999994 112.143 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 31.78 83.85 0.01 OUTLIER Glycine 0 N--CA 1.48 1.608 0 C-N-CA 126.164 1.84 . . . . 31.420000000000002 117.472 171.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.558 ' O ' ' HB ' ' A' ' 260' ' ' THR . 17.6 mmt180 -118.35 138.77 52.19 Favored 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 118.025 0.912 . . . . 75.200000000000003 111.564 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.612 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 21.2 p-10 -118.23 155.34 30.71 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 125.328 1.451 . . . . 75.209999999999994 114.27 -174.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' B' ' 263' ' ' SER . 20.7 m -117.38 135.93 53.52 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 122.362 1.077 . . . . 72.120000000000005 108.149 175.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -134.06 139.21 45.83 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.004 -0.998 . . . . 62.450000000000003 109.695 -174.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.548 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 37.2 ttmt -86.58 -65.53 1.0 Allowed 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 115.832 -0.622 . . . . 71.239999999999995 110.747 176.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -126.24 137.83 53.56 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 119.148 -1.021 . . . . 73.239999999999995 110.489 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 44.9 mt -135.39 121.74 32.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.425 -1.324 . . . . 71.310000000000002 107.425 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 58.4 mtt180 -128.17 114.85 17.52 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.804 -0.813 . . . . 75.430000000000007 108.804 177.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.489 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 45.3 p -116.37 126.59 53.69 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.778 -1.564 . . . . 71.129999999999995 106.778 175.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . 0.561 ' HB2' ' HE3' ' B' ' 270' ' ' LYS . 32.7 mt-10 -141.67 151.91 43.44 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.88 -0.785 . . . . 63.399999999999999 108.88 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 61.38 80.38 0.22 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 124.536 1.134 . . . . 71.340000000000003 112.466 177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.523 ' HD3' ' N ' ' B' ' 236' ' ' ARG . 0.0 OUTLIER 62.78 25.16 14.95 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 112.821 0.674 . . . . 72.040000000000006 112.821 173.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -84.86 150.66 24.84 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 121.323 0.583 . . . . 65.129999999999995 110.802 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -125.54 135.14 51.94 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.122 -1.436 . . . . 72.420000000000002 107.122 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.464 ' HB ' HG21 ' B' ' 233' ' ' THR . 5.8 p -136.76 141.95 39.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-O 121.304 0.573 . . . . 73.209999999999994 111.635 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.603 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 4.4 tp60 -122.26 125.87 46.95 Favored 'General case' 0 N--CA 1.409 -2.488 0 CA-C-N 114.306 -1.315 . . . . 74.140000000000001 107.867 171.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.577 ' HG ' HD21 ' A' ' 262' ' ' ASN . 52.5 tp -117.3 118.54 32.55 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 107.934 -1.135 . . . . 72.329999999999998 107.934 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.567 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 128.33 -117.12 2.46 Favored Glycine 0 N--CA 1.421 -2.347 0 C-N-CA 120.389 -0.91 . . . . 70.409999999999997 111.644 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.63 HD22 ' N ' ' B' ' 244' ' ' VAL . 0.2 OUTLIER -144.57 136.41 25.87 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 120.022 -0.671 . . . . 74.319999999999993 110.243 -176.213 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.63 ' N ' HD22 ' B' ' 243' ' ' ASN . 48.1 t -108.54 120.28 59.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 N-CA-C 107.258 -1.386 . . . . 33.200000000000003 107.258 174.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 42.7 t -121.16 115.23 46.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 120.894 -0.323 . . . . 72.439999999999998 110.598 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.439 HG22 ' HA3' ' B' ' 282' ' ' GLY . 14.9 t -113.93 162.25 16.63 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 108.626 -0.879 . . . . 73.109999999999999 108.626 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.03 -32.19 70.66 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.657 1.183 . . . . 62.509999999999998 114.017 -173.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.91 -41.07 67.26 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 114.417 1.266 . . . . 53.109999999999999 114.417 -169.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.464 ' HB2' ' HA2' ' B' ' 282' ' ' GLY . . . -74.27 -25.98 59.94 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 114.273 1.212 . . . . 70.150000000000006 114.273 -175.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 41.6 tp -65.19 91.83 0.11 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.312 0.577 . . . . 50.009999999999998 111.896 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -161.75 -38.81 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 126.57 1.948 . . . . 65.140000000000001 108.965 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -156.9 -160.06 9.86 Favored Glycine 0 N--CA 1.433 -1.531 0 N-CA-C 110.496 -1.042 . . . . 71.129999999999995 110.496 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 128.48 67.92 0.13 Allowed Glycine 0 N--CA 1.435 -1.426 0 N-CA-C 111.212 -0.755 . . . . 73.239999999999995 111.212 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 46.9 mm -73.44 126.17 33.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 109.971 -0.381 . . . . 74.120000000000005 109.971 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -113.49 116.16 29.15 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.576 -0.738 . . . . 75.219999999999999 112.337 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 71.3 mt -145.26 135.08 18.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 106.895 -1.52 . . . . 62.049999999999997 106.895 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 20.6 t -178.14 -169.11 0.18 Allowed 'General case' 0 C--O 1.247 0.953 0 N-CA-C 107.459 -1.311 . . . . 62.25 107.459 174.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -93.11 -159.66 0.7 Allowed 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 106.473 -1.677 . . . . 63.509999999999998 106.473 177.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -84.09 75.15 10.19 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.382 -0.97 . . . . 74.129999999999995 108.382 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.584 ' O ' HG21 ' C' ' 222' ' ' ILE . 18.0 p -96.49 131.51 43.01 Favored 'General case' 0 N--CA 1.397 -3.079 0 CA-C-N 115.579 -0.737 . . . . 72.099999999999994 109.249 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 8.2 t -127.75 141.65 51.53 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 107.798 -1.186 . . . . 55.210000000000001 107.798 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.663 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 25.7 t-20 -87.06 119.13 26.95 Favored 'General case' 0 CA--C 1.479 -1.768 0 N-CA-C 107.846 -1.168 . . . . 65.140000000000001 107.846 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' B' ' 227' ' ' SER . 49.7 m -142.56 128.03 18.98 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.394 -0.821 . . . . 73.219999999999999 110.889 -177.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 12.4 p -125.82 141.42 45.61 Favored 'Isoleucine or valine' 0 C--O 1.244 0.813 0 C-N-CA 120.277 -0.569 . . . . 62.229999999999997 112.462 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' C' ' 229' ' ' LYS . 16.6 mm-40 -79.33 -59.3 2.82 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.568 -0.742 . . . . 72.109999999999999 110.938 177.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 97.0 m -143.6 127.37 17.18 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.023 -0.671 . . . . 72.25 112.694 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.519 HG12 HD12 ' C' ' 231' ' ' ILE . 24.0 m -121.07 127.81 75.96 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 109.056 -0.72 . . . . 72.019999999999996 109.056 172.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 5.5 p -128.64 135.37 62.54 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-N 116.16 -0.473 . . . . 62.100000000000001 111.877 177.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' C' ' 233' ' ' THR . . . -125.7 132.58 7.99 Favored Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 110.494 -1.043 . . . . 43.009999999999998 110.494 177.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.561 ' HE3' ' HB2' ' B' ' 234' ' ' GLU . 13.9 mmmm -132.84 117.71 18.08 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 122.451 0.3 . . . . 74.420000000000002 111.648 -177.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.87 87.32 0.9 Allowed Glycine 0 C--N 1.307 -1.069 0 C-N-CA 120.379 -0.915 . . . . 74.140000000000001 113.171 173.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 55.16 30.35 14.31 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.953 0.901 . . . . 55.399999999999999 111.899 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 23.8 m -83.06 145.08 29.48 Favored 'General case' 0 N--CA 1.422 -1.863 0 C-N-CA 120.489 -0.484 . . . . 65.219999999999999 110.355 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -116.84 127.62 54.47 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.088 -1.819 . . . . 73.409999999999997 106.088 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 1.5 p -133.03 123.14 47.57 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 CA-C-O 121.517 0.675 . . . . 71.209999999999994 111.252 178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.54 ' HG ' ' OE1' ' C' ' 240' ' ' GLN . 8.0 tp -113.85 119.86 38.77 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.18 -1.045 . . . . 73.019999999999996 108.18 174.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.517 HG23 HD23 ' C' ' 241' ' ' LEU . 2.0 mt -112.14 103.56 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.887 0 N-CA-C 105.192 -2.151 . . . . 75.310000000000002 105.192 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 147.85 -126.96 2.48 Favored Glycine 0 N--CA 1.427 -1.947 0 C-N-CA 119.136 -1.507 . . . . 24.25 114.635 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -128.91 135.42 49.02 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.159 0.504 . . . . 65.5 111.04 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.431 ' HG2' ' NE1' ' B' ' 287' ' ' TRP . 13.9 tp10 -113.45 118.5 34.7 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 106.776 -1.564 . . . . 74.430000000000007 106.776 177.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.443 ' CD2' ' HB3' ' B' ' 249' ' ' ALA . 4.6 t80 -115.25 122.75 46.94 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 106.144 -1.799 . . . . 62.109999999999999 106.144 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' B' ' 249' ' ' ALA . . . 114.72 -51.37 0.72 Allowed Glycine 0 C--N 1.288 -2.094 0 N-CA-C 108.226 -1.95 . . . . 71.439999999999998 108.226 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 89.97 15.17 58.2 Favored Glycine 0 N--CA 1.423 -2.189 0 N-CA-C 111.204 -0.758 . . . . 63.100000000000001 111.204 177.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . 0.486 ' HE3' ' O ' ' B' ' 290' ' ' HIS . 41.4 mmtm -145.75 19.92 1.47 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.157 0.503 . . . . 75.430000000000007 109.992 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . 0.406 ' HA3' HG11 ' B' ' 244' ' ' VAL . . . -81.93 -79.81 0.95 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.393 -0.908 . . . . 60.530000000000001 113.116 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.447 ' HB2' HG21 ' B' ' 244' ' ' VAL . 86.9 t80 -76.95 -13.36 59.98 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 112.812 0.671 . . . . 72.310000000000002 112.812 -176.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.609 ' CH2' ' HB2' ' C' ' 240' ' ' GLN . 6.4 m95 -74.0 135.34 43.12 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.107 0.48 . . . . 64.120000000000005 112.177 -173.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -86.94 -0.25 56.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.234 1.016 . . . . 50.409999999999997 108.7 174.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -82.41 151.31 26.67 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 106.959 -1.497 . . . . 74.349999999999994 106.959 172.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . 0.508 ' NE2' ' HA ' ' B' ' 294' ' ' HIS . 2.5 p80 -104.55 -160.78 0.78 Allowed 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.681 -0.489 . . . . 74.230000000000004 109.681 -174.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -65.65 169.6 6.1 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 122.468 0.307 . . . . 73.439999999999998 111.309 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . 0.444 ' NE2' ' HA ' ' C' ' 289' ' ' ASN . 65.3 t-80 -83.67 64.99 8.27 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-O 122.558 1.171 . . . . 70.439999999999998 108.347 -176.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -143.95 35.7 1.26 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 113.302 -1.772 . . . . 75.329999999999998 106.917 -177.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . 0.508 ' HA ' ' NE2' ' B' ' 290' ' ' HIS . 8.3 p-80 -47.54 -47.65 27.99 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 114.357 -1.292 . . . . 75.319999999999993 113.227 -176.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 3.3 t60 . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 107.259 -1.386 . . . . 73.010000000000005 107.259 177.484 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 121.161 0.505 . . . . 64.329999999999998 110.529 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -101.97 -33.29 9.8 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.718 -1.216 . . . . 60.149999999999999 107.718 172.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 49.3 mm -102.59 109.25 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 105.137 -2.172 . . . . 74.140000000000001 105.137 169.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -115.16 27.94 9.04 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.32 0.581 . . . . 64.219999999999999 109.852 -177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -72.57 101.3 2.97 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.167 -0.924 . . . . 71.420000000000002 108.985 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 0.584 HG21 ' O ' ' B' ' 260' ' ' THR . 66.5 mt -116.25 139.19 44.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 CA-C-N 115.135 -0.939 . . . . 74.230000000000004 108.532 -177.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.06 122.4 68.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 120.885 -0.326 . . . . 62.109999999999999 111.508 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 44.06 74.18 0.22 Allowed Glycine 0 N--CA 1.469 0.885 0 O-C-N 125.15 1.531 . . . . 52.140000000000001 116.684 172.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' B' ' 260' ' ' THR . 24.9 mmt180 -115.92 131.54 56.91 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 122.079 0.942 . . . . 73.310000000000002 111.99 177.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.663 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 28.3 p-10 -117.49 155.67 29.32 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 113.419 -1.719 . . . . 72.420000000000002 114.242 -171.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' C' ' 263' ' ' SER . 23.9 t -117.75 136.37 53.42 Favored 'General case' 0 N--CA 1.409 -2.487 0 N-CA-C 107.671 -1.233 . . . . 73.010000000000005 107.671 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.43 137.92 52.07 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.872 -1.058 . . . . 74.430000000000007 108.842 -175.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 5.2 tmmm? -90.83 -62.0 1.55 Allowed 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 120.062 -0.655 . . . . 73.230000000000004 110.527 -178.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -127.56 137.09 52.5 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 108.392 -0.966 . . . . 55.049999999999997 108.392 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.519 HD12 HG12 ' B' ' 267' ' ' VAL . 17.4 mt -137.82 123.59 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.661 0 N-CA-C 108.145 -1.057 . . . . 73.25 108.145 177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 81.5 mtt180 -128.32 115.1 17.75 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.418 -0.586 . . . . 74.040000000000006 109.418 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.469 ' O ' ' HA2' ' B' ' 269' ' ' GLY . 33.1 p -112.31 126.87 55.72 Favored 'General case' 0 C--N 1.281 -2.373 0 N-CA-C 107.342 -1.355 . . . . 74.129999999999995 107.342 175.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.526 ' HG2' ' HB2' ' B' ' 270' ' ' LYS . 43.1 mt-10 -138.87 145.78 40.38 Favored 'General case' 0 N--CA 1.42 -1.933 0 C-N-CA 120.328 -0.549 . . . . 73.030000000000001 110.508 -178.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 65.52 84.26 0.16 Allowed 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.637 1.175 . . . . 73.439999999999998 112.506 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? 61.3 23.31 13.56 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.345 1.058 . . . . 73.299999999999997 111.752 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -87.18 151.2 23.39 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.031 0.443 . . . . 71.549999999999997 111.423 -176.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -125.53 135.24 52.06 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.686 -1.227 . . . . 62.219999999999999 107.686 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 2.5 p -130.83 136.31 58.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.459 0.647 . . . . 72.439999999999998 110.929 176.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.609 ' HB2' ' CH2' ' B' ' 287' ' ' TRP . 3.9 tp60 -114.56 121.35 43.2 Favored 'General case' 0 N--CA 1.4 -2.967 0 CA-C-N 114.247 -1.342 . . . . 53.229999999999997 107.479 170.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.635 ' HG ' HD21 ' B' ' 262' ' ' ASN . 64.7 tp -115.53 118.16 32.36 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 108.32 -0.992 . . . . 72.209999999999994 108.32 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.549 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 129.5 -115.08 1.84 Allowed Glycine 0 N--CA 1.416 -2.657 0 C-N-CA 120.347 -0.93 . . . . 33.450000000000003 112.47 177.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.479 ' ND2' HG23 ' C' ' 245' ' ' VAL . 5.9 t30 -144.94 136.28 25.16 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 122.651 -0.323 . . . . 75.230000000000004 110.934 -173.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.453 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 61.0 t -114.79 125.85 72.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.195 0 N-CA-C 108.244 -1.021 . . . . 73.140000000000001 108.244 177.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.479 HG23 ' ND2' ' C' ' 243' ' ' ASN . 85.5 t -122.06 118.58 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.995 0 CA-C-N 118.104 0.411 . . . . 72.310000000000002 110.294 177.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . 0.41 HG22 ' HA3' ' C' ' 282' ' ' GLY . 14.8 t -114.07 162.28 16.67 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 108.242 -1.021 . . . . 74.319999999999993 108.242 170.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.68 -31.86 73.16 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 114.229 1.196 . . . . 55.509999999999998 114.229 -172.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.41 -34.29 57.2 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.749 1.388 . . . . 63.530000000000001 114.749 -169.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . 0.514 ' HB2' ' HA2' ' C' ' 282' ' ' GLY . . . -73.26 -43.34 61.27 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.194 -0.602 . . . . 34.030000000000001 112.128 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 64.52 -65.89 0.13 Allowed 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 124.231 1.013 . . . . 64.430000000000007 109.065 -168.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -136.62 114.54 11.34 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 126.319 1.848 . . . . 74.439999999999998 106.246 173.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -87.78 -124.89 2.1 Favored Glycine 0 C--N 1.304 -1.245 0 C-N-CA 120.551 -0.833 . . . . 35.539999999999999 113.156 -173.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -134.49 66.96 0.56 Allowed Glycine 0 N--CA 1.419 -2.454 0 N-CA-C 110.113 -1.195 . . . . 75.430000000000007 110.113 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 7.5 tp -75.53 124.27 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-O 121.558 0.694 . . . . 74.430000000000007 109.532 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -93.73 -173.67 3.23 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.644 -1.243 . . . . 74.129999999999995 107.644 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 12.8 tt -73.87 130.84 35.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-O 121.109 0.48 . . . . 74.329999999999998 110.185 177.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 25.1 m -128.79 101.38 6.09 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 107.682 -1.229 . . . . 62.409999999999997 107.682 175.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -133.7 -52.1 0.86 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.527 0.679 . . . . 74.239999999999995 110.164 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -111.92 -21.06 11.78 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.789 -0.641 . . . . 72.430000000000007 110.481 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 7.4 m -84.52 121.64 27.87 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.756 -0.461 . . . . 72.530000000000001 109.756 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 10.9 t -134.34 142.68 47.32 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.588 -0.893 . . . . 15.35 108.588 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -87.99 120.38 29.28 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.297 0.57 . . . . 64.310000000000002 110.177 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' C' ' 227' ' ' SER . 46.8 m -139.6 132.77 29.74 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.601 -0.727 . . . . 74.25 109.047 177.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 12.3 p -123.91 139.52 50.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.964 0.411 . . . . 64.310000000000002 111.129 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 9.1 mm-40 -75.88 -64.12 1.16 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.913 -0.585 . . . . 75.230000000000004 111.794 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 87.4 m -144.85 127.91 16.56 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 122.058 -0.402 . . . . 72.420000000000002 109.966 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.402 HG11 HD13 ' C' ' 277' ' ' ILE . 0.9 OUTLIER -126.86 123.67 63.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 115.323 -0.853 . . . . 70.129999999999995 109.638 178.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 26.5 m -124.65 146.61 29.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 116.179 -0.464 . . . . 65.25 110.337 -177.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -130.85 132.52 6.9 Favored Glycine 0 CA--C 1.481 -2.062 0 N-CA-C 109.348 -1.501 . . . . 70.450000000000003 109.348 175.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -132.78 116.55 16.7 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.735 0.268 . . . . 72.209999999999994 111.592 -175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.95 84.42 0.85 Allowed Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.022 -1.085 . . . . 73.209999999999994 113.868 173.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 59.19 29.07 18.56 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.267 1.027 . . . . 74.140000000000001 111.629 172.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 15.8 m -82.87 145.55 29.38 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.102 -0.499 . . . . 75.319999999999993 111.102 -174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -113.43 128.4 56.44 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.06 -1.83 . . . . 64.150000000000006 106.06 174.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 6.6 p -137.95 123.57 25.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-O 121.533 0.682 . . . . 74.340000000000003 111.317 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.572 HD13 ' CG ' ' C' ' 240' ' ' GLN . 5.3 tp -113.88 112.17 22.9 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.866 -0.79 . . . . 61.039999999999999 108.866 175.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.402 HD13 HG11 ' C' ' 267' ' ' VAL . 5.4 mt -103.9 103.71 15.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 N-CA-C 105.256 -2.127 . . . . 73.400000000000006 105.256 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 143.51 -144.83 14.18 Favored Glycine 0 N--CA 1.421 -2.314 0 C-N-CA 119.869 -1.158 . . . . 74.0 112.809 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -110.18 139.81 44.94 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.114 0.483 . . . . 71.200000000000003 110.342 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.583 ' HG2' ' NE1' ' C' ' 287' ' ' TRP . 12.9 tp10 -118.06 117.46 29.26 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 105.933 -1.877 . . . . 72.540000000000006 105.933 175.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . 0.42 ' HB3' ' HA ' ' C' ' 245' ' ' VAL . 6.5 t80 -111.51 123.39 50.13 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 106.01 -1.848 . . . . 74.409999999999997 106.01 -178.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . 0.514 ' HA2' ' HB2' ' C' ' 249' ' ' ALA . . . 109.58 -51.29 0.71 Allowed Glycine 0 N--CA 1.428 -1.844 0 N-CA-C 109.548 -1.421 . . . . 44.420000000000002 109.548 -173.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 86.13 24.35 41.13 Favored Glycine 0 CA--C 1.496 -1.156 0 C-N-CA 120.94 -0.648 . . . . 62.210000000000001 111.634 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -148.53 13.89 0.95 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 122.979 0.512 . . . . 64.340000000000003 110.247 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.43 -79.63 0.81 Allowed Glycine 0 N--CA 1.422 -2.263 0 C-N-CA 120.096 -1.049 . . . . 21.420000000000002 112.82 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -80.23 -19.78 46.11 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 113.126 0.787 . . . . 74.129999999999995 113.126 -175.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.583 ' NE1' ' HG2' ' C' ' 280' ' ' GLU . 9.2 m95 -73.87 139.83 45.29 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 114.261 1.208 . . . . 71.439999999999998 114.261 -171.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.25 -44.86 71.1 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.446 -0.946 . . . . 60.439999999999998 108.446 170.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . 0.444 ' HA ' ' NE2' ' B' ' 292' ' ' HIS . 54.2 t-20 -145.57 133.99 21.91 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.784 -1.191 . . . . 62.409999999999997 107.784 -176.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -153.9 101.23 2.42 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 123.036 0.21 . . . . 63.25 110.594 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 50.8 t60 71.06 -22.75 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 125.105 1.362 . . . . 72.129999999999995 114.411 171.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . 0.313 14.5 m80 81.88 99.21 0.05 Allowed 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 114.69 1.367 . . . . 75.340000000000003 114.69 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -160.07 142.56 13.35 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 104.377 -2.453 . . . . 74.310000000000002 104.377 173.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -82.27 134.86 35.3 Favored 'General case' 0 C--N 1.287 -2.122 0 CA-C-O 121.609 0.719 . . . . 75.409999999999997 112.047 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 73.8 t60 . . . . . 0 C--N 1.296 -1.72 0 N-CA-C 106.931 -1.507 . . . . 70.310000000000002 106.931 -179.85 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 107.985 -1.117 . . . . 63.009999999999998 107.985 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -126.83 12.26 7.28 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.11 0.481 . . . . 73.150000000000006 109.751 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 8.5 tp -117.91 150.58 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 115.238 -0.892 . . . . 72.439999999999998 109.935 -176.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -121.44 -165.66 1.27 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 106.675 -1.602 . . . . 73.519999999999996 106.675 175.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -84.96 81.62 8.82 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 119.222 0.919 . . . . 52.420000000000002 112.424 -176.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.456 ' O ' ' HB3' ' A' ' 259' ' ' GLN . 47.1 mm -116.12 114.41 46.05 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 N-CA-C 107.387 -1.338 . . . . 71.329999999999998 107.387 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 15.4 m -138.08 119.21 16.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 117.747 0.249 . . . . 74.019999999999996 110.353 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 45.46 53.78 7.94 Favored Glycine 0 C--N 1.337 0.629 0 O-C-N 124.332 1.02 . . . . 62.299999999999997 113.166 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -89.93 124.87 35.09 Favored 'General case' 0 CA--C 1.49 -1.348 0 C-N-CA 119.792 -0.763 . . . . 73.239999999999995 111.504 -176.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -115.62 114.35 24.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.038 -1.467 . . . . 61.229999999999997 107.038 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 10.1 p -129.07 137.64 51.39 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.457 0.646 . . . . 74.349999999999994 112.385 -175.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 231' ' ' ILE . . . -133.22 129.51 37.82 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.073 -1.084 . . . . 64.329999999999998 108.073 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -82.31 -55.84 4.27 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.798 -0.445 . . . . 74.430000000000007 109.798 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 266' ' ' THR . 26.3 t0 -138.55 139.46 38.69 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 119.95 -0.7 . . . . 73.340000000000003 111.985 -178.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.484 HD11 ' HB1' ' A' ' 228' ' ' ALA . 30.8 mm -128.33 127.79 67.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 106.889 -1.523 . . . . 73.299999999999997 106.889 -176.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 31.0 ttt180 -134.14 115.42 14.22 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 120.283 -0.567 . . . . 72.109999999999999 110.079 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.444 ' HB ' ' HB3' ' A' ' 237' ' ' ALA . 40.8 p -110.66 127.59 55.35 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.335 -0.987 . . . . 54.310000000000002 108.335 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -128.08 148.96 50.58 Favored 'General case' 0 CA--C 1.482 -1.67 0 C-N-CA 120.089 -0.644 . . . . 52.229999999999997 109.865 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.589 ' C ' ' HD2' ' A' ' 236' ' ' ARG . 44.4 mt-10 59.27 91.24 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.116 0 O-C-N 125.12 1.512 . . . . 64.230000000000004 114.029 173.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.589 ' HD2' ' C ' ' A' ' 235' ' ' GLU . 0.1 OUTLIER 61.33 2.23 0.61 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.345 1.458 . . . . 71.310000000000002 113.401 174.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 233' ' ' THR . . . -69.92 149.58 47.66 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 123.398 0.679 . . . . 44.140000000000001 112.156 -175.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.34 139.01 54.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.701 -0.681 . . . . 51.399999999999999 109.805 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 275' ' ' VAL . 6.0 p -124.85 141.93 43.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 116.052 -0.522 . . . . 60.25 110.018 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -123.26 117.7 25.9 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 115.739 -0.664 . . . . 63.420000000000002 109.361 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . 0.476 ' HA ' ' O ' ' A' ' 277' ' ' ILE . 2.9 tm? -111.63 118.76 36.56 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.64 -1.615 . . . . 73.040000000000006 106.64 177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.468 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 136.66 -140.2 11.28 Favored Glycine 0 N--CA 1.422 -2.278 0 C-N-CA 119.707 -1.235 . . . . 54.299999999999997 112.061 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -124.52 133.73 53.23 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 120.972 0.415 . . . . 62.030000000000001 111.411 -173.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 75.7 t -119.01 121.02 65.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.387 -1.338 . . . . 54.340000000000003 107.387 176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 16.1 m -119.28 129.65 74.97 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.262 0.553 . . . . 54.119999999999997 112.366 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 5.3 m -109.79 160.53 16.26 Favored 'General case' 0 N--CA 1.427 -1.611 0 N-CA-C 107.808 -1.182 . . . . 75.209999999999994 107.808 175.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.5 -33.99 76.8 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 122.918 0.487 . . . . 73.409999999999997 111.941 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.18 -34.08 63.54 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.926 1.29 . . . . 63.450000000000003 113.741 -178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 281' ' ' TYR . . . -66.54 -38.95 88.26 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.106 0.78 . . . . 71.409999999999997 113.106 -175.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 61.5 tp 72.26 -35.29 0.32 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.459 0.703 . . . . 72.430000000000007 112.706 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.41 ' H ' ' C ' ' A' ' 249' ' ' ALA . 80.5 m80 79.78 113.69 0.07 Allowed 'General case' 0 C--O 1.247 0.933 0 C-N-CA 125.887 1.675 . . . . 75.030000000000001 110.617 -177.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -89.67 134.17 12.22 Favored Glycine 0 N--CA 1.431 -1.663 0 CA-C-N 115.043 -0.981 . . . . 73.129999999999995 112.288 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -143.14 122.93 1.99 Allowed Glycine 0 N--CA 1.425 -2.072 0 C-N-CA 121.069 -0.586 . . . . 74.349999999999994 111.977 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 10.1 tt -175.49 -48.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 124.589 1.155 . . . . 72.230000000000004 108.366 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 63.7 mtm180 -138.64 164.64 28.99 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.174 -1.417 . . . . 72.239999999999995 107.174 175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 257' ' ' SER . 13.2 tt -79.89 156.34 4.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 O-C-N 123.703 0.627 . . . . 65.430000000000007 109.806 -176.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.403 ' O ' HG12 ' A' ' 256' ' ' ILE . 28.8 m -79.19 147.31 32.68 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 105.635 -1.987 . . . . 75.120000000000005 105.635 170.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.467 ' N ' ' HA3' ' B' ' 253' ' ' GLY . 1.0 OUTLIER -66.55 171.09 5.36 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 113.058 0.762 . . . . 63.439999999999998 113.058 -169.304 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.464 HE21 HD11 ' B' ' 256' ' ' ILE . 12.7 mt-30 -87.47 84.1 7.2 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.091 0.948 . . . . 75.430000000000007 110.892 -170.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 16.7 p -97.42 139.66 33.03 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 113.816 -1.538 . . . . 72.409999999999997 111.751 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 5.9 m -115.28 108.78 17.02 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.874 -0.787 . . . . 75.129999999999995 108.874 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.547 HD21 HD22 ' B' ' 241' ' ' LEU . 64.9 t30 -106.29 121.63 44.61 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.801 -0.814 . . . . 74.450000000000003 108.801 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' B' ' 227' ' ' SER . 46.9 m -137.86 123.97 20.34 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 120.878 0.37 . . . . 73.340000000000003 111.726 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' B' ' 228' ' ' ALA . 11.2 p -119.76 135.27 60.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.855 0.36 . . . . 74.219999999999999 111.102 176.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -69.36 -65.05 0.76 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.883 -0.599 . . . . 73.299999999999997 111.469 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 230' ' ' ASP . 29.5 m -144.58 132.76 21.68 Favored 'General case' 0 C--O 1.25 1.117 0 C-N-CA 120.184 -0.607 . . . . 74.209999999999994 112.501 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.415 HG12 ' HB ' ' B' ' 231' ' ' ILE . 27.4 m -118.03 129.56 74.21 Favored 'Isoleucine or valine' 0 C--O 1.247 0.973 0 N-CA-C 107.932 -1.136 . . . . 74.329999999999998 107.932 172.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 7.8 p -127.59 130.86 70.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.846 0 CA-C-O 121.186 0.517 . . . . 72.340000000000003 111.677 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.06 133.32 11.53 Favored Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 109.719 -1.352 . . . . 74.510000000000005 109.719 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -132.56 144.69 50.58 Favored 'General case' 0 C--O 1.251 1.142 0 CA-C-N 117.121 0.46 . . . . 74.400000000000006 111.131 -175.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.65 -65.76 3.89 Favored Glycine 0 C--O 1.244 0.755 0 N-CA-C 110.768 -0.933 . . . . 63.439999999999998 110.768 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -176.96 125.86 0.15 Allowed 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.999 -2.223 . . . . 73.019999999999996 104.999 172.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 25.0 m -149.94 160.13 43.84 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 109.531 -0.544 . . . . 64.140000000000001 109.531 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' B' ' 238' ' ' ARG . 54.3 mtm180 -122.72 127.36 49.12 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 108.142 -1.059 . . . . 73.349999999999994 108.142 172.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 1.4 p -128.18 129.17 69.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 116.154 -0.475 . . . . 63.100000000000001 109.942 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . . . . . . . . . 4.1 tt -121.0 121.24 37.54 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.854 -1.165 . . . . 74.040000000000006 107.854 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.584 HG22 ' HB3' ' B' ' 241' ' ' LEU . 3.2 pt -113.03 104.59 17.26 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 C-N-CA 124.063 0.945 . . . . 63.310000000000002 109.107 175.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 155.18 -122.84 1.26 Allowed Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.554 -0.832 . . . . 74.239999999999995 113.156 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 42.4 m-80 -128.3 148.96 50.68 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.62 0.247 . . . . 65.319999999999993 110.585 -178.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.0 OUTLIER -136.6 121.6 18.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 105.172 -2.159 . . . . 54.140000000000001 105.172 173.587 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.469 ' HB3' ' CB ' ' A' ' 249' ' ' ALA . 57.0 m-85 -107.81 123.59 48.8 Favored 'General case' 0 C--N 1.271 -2.821 0 N-CA-C 109.37 -0.604 . . . . 71.030000000000001 109.37 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.442 ' N ' ' HB2' ' A' ' 249' ' ' ALA . . . 104.91 -43.73 1.61 Allowed Glycine 0 N--CA 1.42 -2.387 0 CA-C-N 115.178 -0.919 . . . . 70.329999999999998 111.209 -177.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 76.29 14.42 82.36 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.916 -0.874 . . . . 73.439999999999998 110.916 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -126.43 13.6 7.63 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.899 0.857 . . . . 75.319999999999993 109.377 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -101.48 -55.44 0.9 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.156 -1.021 . . . . 73.519999999999996 110.92 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.473 ' HB3' ' CE3' ' A' ' 287' ' ' TRP . 31.1 t80 -93.04 -18.04 23.13 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.904 -0.406 . . . . 74.319999999999993 109.904 -177.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.639 ' CH2' ' HB2' ' B' ' 240' ' ' GLN . 12.6 m-90 -115.12 157.84 23.02 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 115.893 1.812 . . . . 64.010000000000005 115.893 -176.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 289' ' ' ASN . 8.2 p-10 -73.75 -72.45 0.27 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 126.282 1.833 . . . . 73.439999999999998 112.439 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.465 ' H ' ' CG ' ' A' ' 288' ' ' ASP 0.398 6.9 m-20 103.33 80.43 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 117.515 2.413 . . . . 72.519999999999996 117.515 171.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 46.4 m80 71.41 148.04 0.08 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 116.716 2.117 . . . . 73.25 116.716 169.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -166.8 33.46 0.04 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 103.927 -2.62 . . . . 74.319999999999993 103.927 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -86.89 145.5 26.54 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.231 -1.35 . . . . 70.219999999999999 113.003 -169.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -120.94 117.37 27.14 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 106.687 -1.597 . . . . 72.010000000000005 106.687 178.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -89.14 140.74 29.15 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.025 0.44 . . . . 65.510000000000005 110.253 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--N 1.299 -1.625 0 N-CA-C 107.324 -1.362 . . . . 73.340000000000003 107.324 177.986 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 CA--C 1.512 -0.487 0 N-CA-C 108.353 -0.98 . . . . 30.41 108.353 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -89.85 -58.89 2.36 Favored 'General case' 0 CA--C 1.506 -0.745 0 N-CA-C 106.898 -1.519 . . . . 73.209999999999994 106.898 174.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 33.9 pt -138.1 157.43 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-N 115.086 -0.961 . . . . 73.209999999999994 109.512 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -173.95 -56.38 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 106.152 -1.796 . . . . 61.509999999999998 106.152 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 68.18 164.38 0.23 Allowed 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 113.805 -1.543 . . . . 65.340000000000003 112.703 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . 0.424 HG21 ' OG1' ' B' ' 261' ' ' THR . 42.2 mm -98.52 113.77 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.192 0 N-CA-C 106.55 -1.648 . . . . 71.019999999999996 106.55 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 23.9 m -132.5 118.32 34.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 109.451 -0.574 . . . . 72.239999999999995 109.451 177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 43.39 50.97 6.59 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 114.522 -1.217 . . . . 63.329999999999998 112.937 -178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -89.3 121.74 31.87 Favored 'General case' 0 CA--C 1.488 -1.433 0 C-N-CA 119.729 -0.788 . . . . 75.010000000000005 111.281 -176.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.486 ' OD1' ' HA2' ' C' ' 242' ' ' GLY . 63.3 t30 -113.5 114.62 26.79 Favored 'General case' 0 N--CA 1.416 -2.161 0 N-CA-C 106.181 -1.785 . . . . 51.140000000000001 106.181 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' B' ' 263' ' ' SER . 20.1 m -125.4 137.06 54.0 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.513 0.673 . . . . 74.420000000000002 111.351 -178.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.423 ' HB1' HD11 ' B' ' 231' ' ' ILE . . . -128.33 132.85 48.61 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.236 -0.893 . . . . 75.319999999999993 108.74 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.554 ' HB3' ' O ' ' B' ' 265' ' ' GLU . 0.3 OUTLIER -88.72 -68.12 0.79 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.976 -0.379 . . . . 74.219999999999999 109.976 -177.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -126.91 138.6 53.33 Favored 'General case' 0 CA--C 1.481 -1.673 0 C-N-CA 119.355 -0.938 . . . . 71.409999999999997 111.327 177.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.423 HD11 ' HB1' ' B' ' 228' ' ' ALA . 29.4 mm -130.91 118.4 41.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.576 -1.268 . . . . 64.519999999999996 107.576 178.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -118.77 117.76 29.76 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.483 -0.562 . . . . 43.420000000000002 109.483 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 49.7 p -109.5 127.2 54.26 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 106.903 -1.517 . . . . 75.219999999999999 106.903 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -131.28 155.75 46.61 Favored 'General case' 0 CA--C 1.471 -2.083 0 N-CA-C 108.759 -0.83 . . . . 73.25 108.759 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.572 ' C ' ' HD2' ' B' ' 236' ' ' ARG . 83.8 mt-10 55.16 84.49 0.07 Allowed 'General case' 0 C--N 1.311 -1.065 0 O-C-N 125.016 1.447 . . . . 65.230000000000004 114.055 173.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.572 ' HD2' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 60.91 6.93 1.31 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.07 1.348 . . . . 74.409999999999997 113.151 173.437 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.421 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -69.9 148.43 49.0 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 121.201 0.524 . . . . 64.319999999999993 112.138 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 274' ' ' ARG . 1.0 OUTLIER -127.87 136.09 50.92 Favored 'General case' 0 C--O 1.248 1.018 0 N-CA-C 108.806 -0.812 . . . . 73.340000000000003 108.806 179.216 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.437 ' HB ' HG13 ' B' ' 275' ' ' VAL . 5.4 p -127.65 142.23 44.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 116.335 -0.393 . . . . 61.5 110.853 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.639 ' HB2' ' CH2' ' A' ' 287' ' ' TRP . 5.8 tp-100 -112.89 134.62 54.31 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 106.918 -1.512 . . . . 71.120000000000005 106.918 173.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.584 ' HB3' HG22 ' A' ' 277' ' ' ILE . 2.8 tm? -129.28 117.44 20.69 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 105.953 -1.869 . . . . 73.319999999999993 105.953 174.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.466 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 137.67 -115.29 1.19 Allowed Glycine 0 N--CA 1.404 -3.489 0 C-N-CA 119.006 -1.568 . . . . 72.209999999999994 113.292 179.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 6.4 t30 -145.35 129.15 17.28 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 113.275 0.843 . . . . 50.219999999999999 113.275 -171.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 280' ' ' GLU . 99.2 t -119.64 125.56 74.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.339 -0.986 . . . . 63.149999999999999 108.339 176.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.449 ' HB ' ' CD2' ' A' ' 281' ' ' TYR . 57.7 t -122.29 129.66 75.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 120.843 -0.343 . . . . 75.230000000000004 111.285 -177.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.557 HG21 ' HB3' ' B' ' 284' ' ' LYS . 2.2 m -104.48 161.41 14.12 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 108.439 -0.948 . . . . 72.109999999999999 108.439 175.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.33 -32.57 74.02 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.756 0.788 . . . . 73.519999999999996 110.486 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.18 -36.06 65.47 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.026 -1.443 . . . . 73.099999999999994 113.805 -176.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.495 ' HB2' ' N ' ' B' ' 282' ' ' GLY . . . -74.67 -38.74 62.34 Favored 'General case' 0 CA--C 1.507 -0.69 0 C-N-CA 121.201 -0.2 . . . . 73.540000000000006 110.886 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 60.2 tp 73.34 -37.25 0.37 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.732 1.213 . . . . 71.200000000000003 112.002 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -169.01 179.06 4.21 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 106.517 -1.66 . . . . 74.25 106.517 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' B' ' 281' ' ' TYR . . . -166.43 56.68 0.24 Allowed Glycine 0 N--CA 1.429 -1.81 0 C-N-CA 118.437 -1.84 . . . . 74.310000000000002 113.146 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . 0.467 ' HA3' ' N ' ' A' ' 258' ' ' ASP . . . 170.74 179.15 41.86 Favored Glycine 0 N--CA 1.419 -2.436 0 C-N-CA 119.746 -1.216 . . . . 71.129999999999995 112.26 177.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . 0.571 HD12 ' H ' ' B' ' 255' ' ' ARG . 0.8 OUTLIER -147.43 -61.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 124.429 0.723 . . . . 72.450000000000003 111.492 179.089 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . 0.571 ' H ' HD12 ' B' ' 254' ' ' ILE . 10.6 ptm180 177.44 81.9 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.852 1.661 . . . . 74.310000000000002 109.648 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . 0.464 HD11 HE21 ' A' ' 259' ' ' GLN . 48.1 mm 73.32 89.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 C-N-CA 124.317 1.047 . . . . 55.130000000000003 110.332 178.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 40.3 t -54.43 -73.71 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.754 -1.112 . . . . 43.219999999999999 109.438 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -155.5 -179.79 8.43 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 107.973 -1.121 . . . . 72.349999999999994 107.973 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -114.03 78.56 1.16 Allowed 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.593 0.711 . . . . 74.450000000000003 111.009 -176.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.24 139.73 36.51 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.646 -1.161 . . . . 73.420000000000002 111.9 177.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.535 ' HB ' ' HG2' ' C' ' 225' ' ' ARG . 4.7 m -116.23 108.24 15.87 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 107.18 -1.415 . . . . 73.310000000000002 107.18 177.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.572 HD21 HD22 ' C' ' 241' ' ' LEU . 64.2 t30 -108.7 126.17 52.7 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.215 -1.032 . . . . 71.319999999999993 108.215 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' C' ' 227' ' ' SER . 31.9 m -142.42 123.75 14.74 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.237 0.542 . . . . 61.43 111.813 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' C' ' 228' ' ' ALA . 14.5 p -110.31 140.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.459 -0.571 . . . . 70.239999999999995 109.459 176.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 3.4 tm-20 -80.45 -69.26 0.61 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.423 -0.954 . . . . 71.150000000000006 108.423 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 90.7 m -137.3 128.85 28.45 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 121.629 -0.669 . . . . 72.329999999999998 112.683 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 48.9 t -118.49 128.83 75.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.08 -1.082 . . . . 52.210000000000001 108.08 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 8.6 p -127.4 134.44 65.76 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.131 0.491 . . . . 72.010000000000005 111.295 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -113.09 133.25 11.18 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.723 -1.351 . . . . 65.129999999999995 109.723 176.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -133.18 147.22 52.04 Favored 'General case' 0 C--O 1.25 1.082 0 CA-C-N 117.059 0.43 . . . . 75.200000000000003 111.349 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 86.58 -63.96 4.04 Favored Glycine 0 CA--C 1.498 -1.014 0 N-CA-C 110.812 -0.915 . . . . 73.25 110.812 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -178.99 126.72 0.1 Allowed 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 103.624 -2.732 . . . . 72.319999999999993 103.624 172.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 45.7 m -147.61 161.29 41.45 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 120.949 0.404 . . . . 73.030000000000001 110.809 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.706 ' O ' ' HA ' ' C' ' 238' ' ' ARG . 14.7 mtp180 -127.7 127.33 43.51 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.436 -1.32 . . . . 71.310000000000002 107.436 174.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' B' ' 239' ' ' VAL . 0.7 OUTLIER -134.8 137.31 51.13 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.109 0 N-CA-C 109.716 -0.476 . . . . 44.520000000000003 109.716 179.196 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.456 HD12 ' CG ' ' B' ' 286' ' ' PHE . 5.4 tt -124.15 124.23 42.04 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.059 -1.459 . . . . 61.009999999999998 107.059 178.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.464 HG23 HD12 ' C' ' 241' ' ' LEU . 6.7 mt -113.0 103.81 16.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 N-CA-C 106.334 -1.728 . . . . 71.340000000000003 106.334 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 152.0 -141.31 8.41 Favored Glycine 0 CA--C 1.474 -2.53 0 C-N-CA 119.164 -1.493 . . . . 71.430000000000007 113.751 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 45.3 m-80 -111.57 136.93 50.09 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.109 -0.545 . . . . 71.5 109.625 -177.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.506 ' HB2' ' NE2' ' C' ' 240' ' ' GLN . 0.1 OUTLIER -125.67 118.39 25.53 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 104.931 -2.248 . . . . 71.450000000000003 104.931 175.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.409 ' CE1' ' HA3' ' B' ' 252' ' ' GLY . 87.1 m-85 -105.58 124.07 48.95 Favored 'General case' 0 N--CA 1.401 -2.885 0 CA-C-O 121.564 0.697 . . . . 54.439999999999998 110.239 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.495 ' N ' ' HB2' ' B' ' 249' ' ' ALA . . . 108.14 -45.55 1.29 Allowed Glycine 0 N--CA 1.416 -2.638 0 CA-C-N 114.991 -1.004 . . . . 62.009999999999998 110.971 -178.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 70.79 26.26 74.33 Favored Glycine 0 CA--C 1.499 -0.94 0 N-CA-C 109.845 -1.302 . . . . 75.400000000000006 109.845 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . 0.557 ' HB3' HG21 ' B' ' 246' ' ' THR . 24.8 tptp -136.73 14.21 3.15 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 108.423 -0.954 . . . . 74.349999999999994 108.423 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -112.23 -59.11 0.44 Allowed Glycine 0 N--CA 1.435 -1.391 0 CA-C-N 115.569 -0.741 . . . . 61.350000000000001 111.429 -178.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.456 ' CG ' HD12 ' B' ' 276' ' ' LEU . 19.0 t80 -90.41 -20.66 22.53 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.185 -1.043 . . . . 63.299999999999997 108.185 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.507 ' HE1' ' HB2' ' C' ' 238' ' ' ARG . 14.3 m-90 -132.33 -166.68 1.77 Allowed 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.002 -0.999 . . . . 73.209999999999994 108.79 176.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -146.85 145.07 29.74 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.156 -1.053 . . . . 74.150000000000006 108.156 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -71.03 -26.94 63.32 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 123.96 0.788 . . . . 71.319999999999993 110.563 -178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -123.27 -173.44 2.72 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.325 -0.991 . . . . 74.310000000000002 108.325 -176.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -66.51 124.1 21.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.063 -1.458 . . . . 75.450000000000003 107.063 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 17.0 t60 -103.89 110.05 22.03 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.373 0.606 . . . . 63.109999999999999 111.696 -174.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 20.7 t-160 -163.26 96.95 0.89 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 106.469 -1.678 . . . . 75.010000000000005 106.469 171.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -86.84 138.69 31.36 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.43 -0.952 . . . . 71.219999999999999 108.43 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 . . . . . 0 C--N 1.293 -1.882 0 N-CA-C 107.895 -1.15 . . . . 74.219999999999999 107.895 -178.981 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 CA--C 1.505 -0.783 0 N-CA-C 109.633 -0.506 . . . . 75.239999999999995 109.633 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -70.83 105.94 3.41 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.523 -0.547 . . . . 74.340000000000003 109.523 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 12.9 pt -85.76 80.92 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-O 121.583 0.706 . . . . 71.329999999999998 110.24 174.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -93.36 92.79 7.83 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-N 115.534 -0.757 . . . . 70.420000000000002 109.766 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 67.91 164.23 0.22 Allowed 'General case' 0 C--O 1.241 0.65 0 O-C-N 125.125 1.515 . . . . 72.230000000000004 113.402 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 34.8 mm -88.94 131.83 35.29 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.969 0 N-CA-C 106.713 -1.588 . . . . 71.099999999999994 106.713 174.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 29.8 m -100.55 118.22 46.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 C-N-CA 119.282 -0.967 . . . . 62.100000000000001 112.911 -175.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 39.73 55.08 2.78 Favored Glycine 0 C--N 1.336 0.533 0 CA-C-N 113.642 -1.617 . . . . 74.530000000000001 115.646 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.535 ' HG2' ' HB ' ' B' ' 261' ' ' THR . 70.5 mtt180 -92.23 121.07 33.4 Favored 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 118.62 -1.232 . . . . 70.409999999999997 112.691 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -116.57 116.92 28.51 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.367 -1.345 . . . . 74.239999999999995 107.367 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' B' ' 263' ' ' SER . 15.7 p -128.72 139.39 52.24 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-O 121.569 0.699 . . . . 53.439999999999998 111.423 -176.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.5 ' HB1' HD11 ' C' ' 231' ' ' ILE . . . -126.91 129.49 48.29 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.015 -0.993 . . . . 52.420000000000002 108.469 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.459 ' O ' ' HB3' ' B' ' 265' ' ' GLU . 13.8 tmtt? -87.48 -60.35 2.0 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.288 0.368 . . . . 74.439999999999998 111.614 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.32 138.04 53.54 Favored 'General case' 0 CA--C 1.484 -1.565 0 O-C-N 121.741 -0.599 . . . . 72.319999999999993 110.074 175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.5 HD11 ' HB1' ' C' ' 228' ' ' ALA . 41.5 mm -133.13 119.12 35.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 107.777 -1.194 . . . . 72.409999999999997 107.777 177.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 44.9 ttt180 -122.65 115.22 21.73 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 109.479 -0.563 . . . . 71.439999999999998 109.479 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 42.5 p -110.61 127.39 55.23 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 106.725 -1.583 . . . . 63.340000000000003 106.725 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -141.58 153.62 44.93 Favored 'General case' 0 N--CA 1.418 -2.038 0 C-N-CA 120.143 -0.623 . . . . 74.530000000000001 110.107 175.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.511 ' C ' ' HD2' ' C' ' 236' ' ' ARG . 43.4 mt-10 61.31 85.41 0.12 Allowed 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.889 1.368 . . . . 71.319999999999993 113.156 -178.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.511 ' HD2' ' C ' ' C' ' 235' ' ' GLU . 1.4 mpt_? 59.18 5.17 0.53 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.813 1.645 . . . . 72.340000000000003 113.393 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -69.6 147.5 50.61 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 121.461 0.648 . . . . 41.100000000000001 112.073 -174.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.706 ' HA ' ' O ' ' B' ' 274' ' ' ARG . 1.5 mpt_? -126.98 135.02 50.29 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.273 -0.876 . . . . 75.030000000000001 108.959 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' C' ' 275' ' ' VAL . 7.2 p -128.32 139.52 51.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.066 0.46 . . . . 72.209999999999994 111.326 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.506 ' NE2' ' HB2' ' B' ' 280' ' ' GLU . 5.4 tp-100 -110.47 120.02 41.07 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.053 -0.976 . . . . 61.399999999999999 108.815 175.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.572 HD22 HD21 ' B' ' 262' ' ' ASN . 3.1 tm? -115.16 116.52 28.5 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 105.339 -2.097 . . . . 73.209999999999994 105.339 172.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.486 ' HA2' ' OD1' ' B' ' 226' ' ' ASN . . . 142.45 -121.88 1.86 Allowed Glycine 0 N--CA 1.41 -3.073 0 C-N-CA 118.56 -1.781 . . . . 42.200000000000003 113.174 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 35.8 t30 -144.63 128.48 17.36 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 123.621 0.248 . . . . 74.439999999999998 111.608 -171.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' B' ' 280' ' ' GLU . 92.0 t -118.52 122.98 70.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.221 -1.029 . . . . 64.400000000000006 108.221 175.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.94 128.85 75.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 120.533 -0.467 . . . . 73.439999999999998 110.454 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . 0.432 HG21 ' HB3' ' C' ' 284' ' ' LYS . 2.6 m -99.33 161.05 13.84 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.196 -1.038 . . . . 65.409999999999997 108.196 174.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.3 -32.29 69.91 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.832 0.853 . . . . 74.109999999999999 110.959 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.48 -35.49 63.11 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.21 -1.359 . . . . 64.140000000000001 112.522 -177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -72.95 -26.45 61.38 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.012 0.434 . . . . 53.520000000000003 111.686 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.96 28.0 0.62 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.047 0.758 . . . . 71.120000000000005 113.047 -174.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -66.04 -24.63 66.78 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.811 0.815 . . . . 73.340000000000003 109.767 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -168.48 -48.91 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 109.178 -1.569 . . . . 43.049999999999997 109.178 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 148.27 172.58 18.35 Favored Glycine 0 N--CA 1.429 -1.833 0 N-CA-C 109.426 -1.47 . . . . 73.010000000000005 109.426 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 10.2 tt -147.3 114.07 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.576 -0.528 . . . . 60.0 109.576 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -115.59 16.12 16.54 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.288 -0.415 . . . . 65.310000000000002 110.881 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 50.2 mm -61.59 99.29 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.158 -0.682 . . . . 53.439999999999998 109.158 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 14.7 m -102.63 173.85 6.15 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.493 -0.776 . . . . 71.349999999999994 109.436 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -158.11 159.82 36.65 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.233 -1.025 . . . . 63.009999999999998 108.233 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -71.29 71.04 0.61 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 122.52 1.153 . . . . 70.239999999999995 109.361 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 2.8 p -102.31 123.13 45.58 Favored 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 115.685 1.735 . . . . 72.319999999999993 115.685 -171.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 32.0 m -133.54 107.09 7.8 Favored 'General case' 0 N--CA 1.411 -2.388 0 N-CA-C 104.706 -2.331 . . . . 64.019999999999996 104.706 167.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -113.86 123.95 51.03 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.228 -1.027 . . . . 74.209999999999994 108.228 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 34.8 m -134.86 122.81 22.54 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.789 -0.819 . . . . 51.210000000000001 108.789 178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' C' ' 228' ' ' ALA . 12.1 p -108.94 144.27 17.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 109.012 -0.736 . . . . 72.219999999999999 109.012 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -78.79 -77.17 0.17 Allowed 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 108.625 -0.88 . . . . 64.209999999999994 108.625 -176.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 85.8 m -132.82 134.12 44.25 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.133 -0.354 . . . . 65.310000000000002 110.357 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 25.6 t -118.43 129.17 75.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.245 -1.391 . . . . 65.0 107.245 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 7.4 p -127.79 132.35 68.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 120.919 -0.313 . . . . 42.409999999999997 111.159 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.16 132.86 11.24 Favored Glycine 0 CA--C 1.491 -1.439 0 N-CA-C 108.869 -1.692 . . . . 74.230000000000004 108.869 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -133.86 145.55 49.77 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 116.978 0.389 . . . . 62.520000000000003 110.569 -174.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 85.41 -65.83 3.92 Favored Glycine 0 CA--C 1.5 -0.865 0 N-CA-C 110.631 -0.988 . . . . 63.229999999999997 110.631 177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 179.89 118.94 0.06 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 126.614 1.966 . . . . 72.140000000000001 105.738 174.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 35.7 m -141.02 154.14 45.86 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.311 0.485 . . . . 70.340000000000003 112.311 -174.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -118.89 126.76 52.52 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 107.366 -1.346 . . . . 74.340000000000003 107.366 171.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' C' ' 239' ' ' VAL . 2.1 p -139.08 138.51 41.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 123.044 0.215 . . . . 74.510000000000005 110.776 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 5.9 tt -128.6 122.63 31.39 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.385 -0.598 . . . . 62.219999999999999 109.385 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.506 HD12 HD23 ' C' ' 241' ' ' LEU . 1.3 pt -113.4 104.47 17.04 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 C-N-CA 123.915 0.886 . . . . 74.430000000000007 109.772 173.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.9 -140.43 7.9 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 119.655 -1.26 . . . . 51.229999999999997 113.123 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -100.15 139.75 35.37 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.623 -0.788 . . . . 74.200000000000003 109.521 -176.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -142.08 118.46 10.86 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 103.324 -2.843 . . . . 74.239999999999995 103.324 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -116.84 124.99 50.87 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.329 0.585 . . . . 75.340000000000003 111.508 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 116.44 -41.52 2.1 Favored Glycine 0 N--CA 1.407 -3.277 0 CA-C-N 114.596 -1.184 . . . . 61.399999999999999 110.612 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 67.07 30.08 75.38 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 109.361 -1.496 . . . . 74.430000000000007 109.361 -176.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . 0.432 ' HB3' HG21 ' C' ' 246' ' ' THR . 52.9 tptt -141.92 17.39 2.13 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 108.461 -0.941 . . . . 74.040000000000006 108.461 -174.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -114.32 -72.85 0.57 Allowed Glycine 0 N--CA 1.424 -2.11 0 C-N-CA 120.218 -0.991 . . . . 73.310000000000002 110.725 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -79.64 -25.91 41.24 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.049 0.452 . . . . 72.109999999999999 110.049 -177.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -137.41 167.41 21.68 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.6 -0.889 . . . . 73.239999999999995 108.6 178.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -112.55 114.48 27.16 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 105.964 -1.865 . . . . 71.450000000000003 105.964 171.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -76.2 5.17 7.28 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 113.625 0.972 . . . . 63.200000000000003 113.625 -175.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -117.39 -70.12 0.81 Allowed 'General case' 0 C--N 1.307 -1.282 0 O-C-N 122.496 -0.127 . . . . 73.140000000000001 111.021 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -178.81 137.82 0.15 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.122 -1.066 . . . . 73.530000000000001 108.122 -172.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -63.31 116.99 5.99 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.411 0.624 . . . . 70.219999999999999 110.643 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . 0.416 ' CG ' ' H ' ' C' ' 294' ' ' HIS . 7.4 p80 -80.16 -92.1 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.675 -0.693 . . . . 73.530000000000001 112.482 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . 0.416 ' H ' ' CG ' ' C' ' 293' ' ' HIS . 4.9 p80 -177.22 152.91 0.91 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 107.597 -1.26 . . . . 55.439999999999998 107.597 178.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 47.0 t-80 . . . . . 0 C--N 1.296 -1.731 0 CA-C-O 118.545 -0.741 . . . . 72.040000000000006 109.675 -176.439 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 CA--C 1.499 -0.986 0 N-CA-C 110.083 -0.34 . . . . 62.240000000000002 110.083 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -139.7 78.01 1.64 Allowed 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.361 -0.978 . . . . 60.5 108.361 175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.3 mp -104.35 -64.48 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.108 -1.442 . . . . 75.549999999999997 107.108 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 55.3 82.65 0.1 Allowed 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 124.712 1.205 . . . . 63.350000000000001 112.998 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -143.23 -178.81 6.04 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.407 -1.331 . . . . 32.140000000000001 107.407 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 7.9 tp -83.03 130.2 36.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 109.512 -0.551 . . . . 75.439999999999998 109.512 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.0 m -99.58 161.96 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 109.16 -0.682 . . . . 74.209999999999994 109.16 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.481 ' H ' HG22 ' A' ' 261' ' ' THR . . . 78.77 28.95 53.74 Favored Glycine 0 N--CA 1.429 -1.795 0 N-CA-C 109.734 -1.346 . . . . 50.039999999999999 109.734 -170.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -113.7 138.5 50.14 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 109.614 -0.513 . . . . 52.030000000000001 109.614 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.403 ' ND2' ' HA2' ' A' ' 278' ' ' GLY . 44.9 t-20 -117.82 114.83 23.85 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 106.147 -1.797 . . . . 74.299999999999997 106.147 168.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 33.6 m -120.59 137.01 54.64 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.388 0.613 . . . . 54.310000000000002 111.149 -174.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -125.77 130.31 51.19 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 107.851 -1.166 . . . . 64.310000000000002 107.851 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 39.4 ttmt -79.04 -63.97 1.29 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.816 -0.354 . . . . 74.140000000000001 111.911 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -126.51 139.25 53.37 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 118.914 -1.114 . . . . 75.140000000000001 110.261 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.3 mt -130.75 119.57 45.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.634 -0.876 . . . . 72.329999999999998 108.634 -175.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 268' ' ' VAL . 87.2 mtt180 -125.08 115.05 19.88 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.755 -1.202 . . . . 71.409999999999997 107.755 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.474 HG21 HG22 ' A' ' 239' ' ' VAL . 40.4 p -128.24 128.66 45.1 Favored 'General case' 0 C--N 1.287 -2.115 0 C-N-CA 120.567 -0.453 . . . . 72.340000000000003 109.838 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -126.6 166.07 18.0 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 119.751 -0.78 . . . . 73.0 112.608 -175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 71.42 -88.09 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 113.603 -1.635 . . . . 54.130000000000003 114.311 172.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.494 ' HD3' ' OE2' ' A' ' 272' ' ' GLU . 0.0 OUTLIER -135.48 26.66 3.43 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 108.162 -1.051 . . . . 70.329999999999998 108.162 -176.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 273' ' ' SER . . . -69.04 149.45 48.74 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.598 -0.728 . . . . 64.439999999999998 111.245 -174.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.83 134.9 53.52 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 105.932 -1.877 . . . . 70.510000000000005 105.932 177.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.474 HG22 HG21 ' A' ' 233' ' ' THR . 9.8 t -135.17 139.0 47.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-O 120.981 0.419 . . . . 53.399999999999999 110.659 -170.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.479 ' HB3' HD13 ' A' ' 276' ' ' LEU . 6.3 tp-100 -131.2 135.28 47.26 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.595 -1.261 . . . . 71.200000000000003 107.595 172.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.1 tt -130.42 120.2 23.85 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.947 -1.501 . . . . 64.120000000000005 106.947 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.608 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 128.93 -113.91 1.65 Allowed Glycine 0 N--CA 1.428 -1.88 0 C-N-CA 120.7 -0.762 . . . . 61.340000000000003 111.386 177.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -144.39 144.33 31.37 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 122.613 -0.345 . . . . 71.140000000000001 110.087 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.441 ' CG2' ' HG2' ' A' ' 240' ' ' GLN . 83.6 t -118.75 118.3 57.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 107.811 -1.181 . . . . 63.439999999999998 107.811 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 4.2 p -122.57 112.8 35.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 N-CA-C 109.135 -0.691 . . . . 55.549999999999997 109.135 177.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.474 HG22 ' HA3' ' A' ' 282' ' ' GLY . 8.9 t -94.92 161.0 14.33 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.034 -1.066 . . . . 74.299999999999997 109.863 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.45 -33.61 75.94 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.42 0.688 . . . . 33.200000000000003 111.778 -176.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.92 -34.83 65.96 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.399 -0.819 . . . . 75.340000000000003 111.579 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.703 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -66.72 -29.27 69.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.028 -0.533 . . . . 73.430000000000007 111.706 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -81.93 82.81 7.43 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 113.578 0.955 . . . . 73.230000000000004 113.578 -174.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -116.88 1.59 12.7 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.521 -1.218 . . . . 43.350000000000001 108.304 171.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 161.69 -172.13 37.8 Favored Glycine 0 N--CA 1.419 -2.446 0 N-CA-C 107.633 -2.187 . . . . 73.209999999999994 107.633 -177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 112.45 74.46 0.69 Allowed Glycine 0 N--CA 1.428 -1.868 0 C-N-CA 120.141 -1.028 . . . . 52.210000000000001 112.011 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 7.9 tp -74.64 -47.76 37.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-O 120.658 0.266 . . . . 71.030000000000001 111.226 -178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.437 ' O ' ' HA3' ' B' ' 253' ' ' GLY . 37.0 ttm180 -90.34 83.82 5.98 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-O 121.28 0.562 . . . . 64.230000000000004 109.527 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 12.6 tt -89.8 117.94 34.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 108.606 -0.887 . . . . 72.040000000000006 108.606 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 50.1 m -147.85 153.96 39.81 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.533 -0.758 . . . . 74.049999999999997 108.968 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -88.2 100.17 12.77 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 106.915 -1.513 . . . . 61.409999999999997 106.915 176.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -77.78 -22.6 49.9 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.325 -0.398 . . . . 44.409999999999997 111.641 -177.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 10.3 m -101.12 121.71 42.31 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 115.962 -0.563 . . . . 72.439999999999998 109.939 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 224' ' ' GLY . 25.8 p -93.88 117.14 29.7 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.554 -0.906 . . . . 54.009999999999998 108.554 174.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 7.9 t30 -117.99 138.46 52.18 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.419 -0.912 . . . . 75.25 111.065 -176.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 39.8 m -138.59 123.33 18.69 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 116.147 -0.479 . . . . 55.130000000000003 109.935 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 10.7 p -128.89 145.59 35.5 Favored 'Isoleucine or valine' 0 C--O 1.248 1.007 0 CA-C-N 116.259 -0.428 . . . . 74.140000000000001 110.939 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' B' ' 229' ' ' LYS . 12.0 mm-40 -84.66 -75.68 0.34 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.429 -0.351 . . . . 62.240000000000002 110.945 179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 2.7 p -118.36 127.91 54.14 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.659 0.614 . . . . 64.219999999999999 112.659 -175.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 277' ' ' ILE . 26.7 m -124.87 127.11 72.33 Favored 'Isoleucine or valine' 0 C--O 1.249 1.062 0 N-CA-C 109.396 -0.594 . . . . 74.219999999999999 109.396 174.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 232' ' ' ARG . 7.3 p -127.14 132.18 70.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 CA-C-O 121.205 0.526 . . . . 63.100000000000001 111.863 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.541 ' HA2' ' OG1' ' B' ' 233' ' ' THR . . . -113.66 131.67 10.11 Favored Glycine 0 N--CA 1.429 -1.83 0 N-CA-C 109.919 -1.272 . . . . 75.420000000000002 109.919 177.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -132.12 116.42 17.01 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 111.99 0.367 . . . . 74.530000000000001 111.99 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 92.96 -123.39 7.32 Favored Glycine 0 C--N 1.31 -0.873 0 C-N-CA 120.747 -0.74 . . . . 65.430000000000007 112.386 177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.494 ' OE2' ' HD3' ' A' ' 236' ' ' ARG . 40.9 mm-40 -92.39 35.48 1.01 Allowed 'General case' 0 C--O 1.242 0.696 0 C-N-CA 124.333 1.053 . . . . 63.439999999999998 109.335 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 50.1 m -81.68 144.36 31.22 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.069 0.938 . . . . 51.32 111.04 -174.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 66.9 mtt180 -130.5 126.73 37.59 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 104.809 -2.293 . . . . 71.409999999999997 104.809 176.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 8.8 p -138.94 134.0 41.65 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-O 121.565 0.697 . . . . 73.25 111.509 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.479 HD13 ' HB3' ' A' ' 240' ' ' GLN . 11.0 tp -120.23 121.64 39.17 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.228 -0.896 . . . . 74.099999999999994 110.671 176.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 267' ' ' VAL . 81.6 mt -104.39 104.27 16.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 114.107 -1.406 . . . . 75.099999999999994 108.073 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 140.22 -153.86 23.66 Favored Glycine 0 N--CA 1.427 -1.918 0 C-N-CA 120.181 -1.009 . . . . 45.219999999999999 113.866 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -91.96 128.48 37.82 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.828 0.851 . . . . 74.420000000000002 110.295 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -111.1 118.69 36.68 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 104.838 -2.282 . . . . 71.439999999999998 104.838 176.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.496 ' OH ' ' HA3' ' B' ' 252' ' ' GLY . 1.7 t80 -120.02 122.23 40.67 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 107.473 -1.306 . . . . 64.150000000000006 107.473 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.474 ' HA3' HG22 ' A' ' 246' ' ' THR . . . 125.24 -41.38 1.7 Allowed Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 114.351 -1.295 . . . . 71.340000000000003 110.744 -175.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 125.05 -57.96 0.67 Allowed Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 110.46 -1.056 . . . . 64.219999999999999 110.46 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . 0.286 0.0 OUTLIER -145.08 80.6 1.62 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.084 0.945 . . . . 72.430000000000007 112.517 177.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -100.86 -40.35 2.91 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 114.748 -1.115 . . . . 52.329999999999998 110.467 175.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -69.81 -36.53 75.71 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.17 0.51 . . . . 70.510000000000005 110.477 177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.44 ' CZ2' ' HE1' ' B' ' 286' ' ' PHE . 27.8 m-90 -92.45 131.17 37.83 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.481 -0.933 . . . . 74.329999999999998 108.481 175.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -50.93 -39.62 55.23 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.455 1.097 . . . . 73.530000000000001 110.692 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 6.7 t30 173.09 176.33 0.1 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 102.397 -3.186 . . . . 74.219999999999999 102.397 174.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.456 ' CE1' ' HD3' ' B' ' 274' ' ' ARG . 63.5 t60 -129.57 120.35 25.17 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 107.411 -1.329 . . . . 75.549999999999997 107.411 174.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -65.17 138.21 58.12 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 109.44 -0.578 . . . . 53.340000000000003 109.44 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . 0.441 ' CD2' ' H ' ' A' ' 292' ' ' HIS . 4.9 p80 -69.85 80.52 0.46 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.462 1.125 . . . . 55.399999999999999 113.604 -176.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -86.84 80.85 8.35 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.291 -1.744 . . . . 74.319999999999993 106.291 174.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -139.48 171.37 14.35 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.735 -1.121 . . . . 65.230000000000004 111.039 -173.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 70.2 t60 . . . . . 0 C--N 1.324 -0.527 0 C-N-CA 126.147 1.779 . . . . 70.299999999999997 106.55 175.785 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.505 -0.779 0 N-CA-C 107.553 -1.277 . . . . 73.430000000000007 107.553 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -70.17 -39.18 75.45 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.46 -0.496 . . . . 60.229999999999997 109.943 177.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . 0.461 HG22 ' H ' ' C' ' 223' ' ' VAL . 41.5 pt -68.76 134.18 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 115.539 -0.755 . . . . 55.439999999999998 110.078 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -148.34 -167.69 2.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.193 -1.41 . . . . 73.140000000000001 107.193 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . 65.71 -178.78 0.19 Allowed 'General case' 0 C--O 1.252 1.213 0 C-N-CA 124.358 1.063 . . . . 53.130000000000003 111.782 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 6.2 tp -86.7 131.97 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 N-CA-C 107.893 -1.151 . . . . 55.450000000000003 107.893 173.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.34 147.63 7.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.051 -1.092 . . . . 62.299999999999997 108.051 -177.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 85.0 36.82 10.68 Favored Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 107.554 -2.219 . . . . 52.030000000000001 107.554 -172.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 261' ' ' THR . 36.1 ttt180 -123.45 128.7 50.19 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 113.63 -1.285 . . . . 73.019999999999996 110.893 -173.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.487 HD22 ' HA2' ' B' ' 278' ' ' GLY . 38.3 t-20 -117.17 127.79 54.47 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.615 -1.624 . . . . 63.43 106.615 169.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 58.0 m -129.98 137.25 50.21 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-O 121.625 0.726 . . . . 73.109999999999999 111.078 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -125.63 137.42 53.88 Favored 'General case' 0 N--CA 1.404 -2.756 0 CA-C-N 114.146 -1.388 . . . . 74.010000000000005 107.56 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 265' ' ' GLU . 3.5 ttmp? -84.28 -70.77 0.55 Allowed 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.309 -0.956 . . . . 70.5 110.467 176.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -127.25 137.71 52.93 Favored 'General case' 0 N--CA 1.428 -1.557 0 C-N-CA 119.684 -0.807 . . . . 63.530000000000001 109.736 -174.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . . . . . . . . . 6.3 mt -134.16 117.97 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 N-CA-C 108.207 -1.034 . . . . 64.430000000000007 108.207 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -113.42 119.31 37.18 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.018 -1.104 . . . . 74.010000000000005 108.018 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.551 HG22 HG21 ' B' ' 239' ' ' VAL . 22.2 p -116.72 126.95 53.9 Favored 'General case' 0 N--CA 1.415 -2.19 0 N-CA-C 106.05 -1.833 . . . . 73.329999999999998 106.05 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' B' ' 270' ' ' LYS . 52.1 mt-10 -134.22 153.93 51.56 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.476 0.655 . . . . 71.439999999999998 112.366 -176.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.522 ' HB3' ' HD3' ' B' ' 236' ' ' ARG . 45.0 mt-10 71.88 -83.64 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 113.642 -1.617 . . . . 73.409999999999997 114.016 171.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.522 ' HD3' ' HB3' ' B' ' 235' ' ' GLU . 0.4 OUTLIER -136.61 42.28 2.51 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 107.964 -1.124 . . . . 73.239999999999995 107.964 -178.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -82.81 139.56 33.45 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.886 -1.052 . . . . 73.519999999999996 111.773 -177.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 5.8 mpt_? -123.74 132.52 53.83 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 103.751 -2.685 . . . . 72.129999999999995 103.751 173.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.551 HG21 HG22 ' B' ' 233' ' ' THR . 86.7 t -142.93 132.62 21.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-O 121.604 0.716 . . . . 61.149999999999999 112.006 -172.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.562 ' HG2' ' CG2' ' B' ' 244' ' ' VAL . 55.1 tp60 -112.43 132.02 55.26 Favored 'General case' 0 N--CA 1.412 -2.353 0 N-CA-C 106.901 -1.518 . . . . 74.230000000000004 106.901 173.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.475 HD12 HG23 ' A' ' 277' ' ' ILE . 1.7 tm? -130.04 117.44 20.03 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 107.856 -1.164 . . . . 75.219999999999999 107.856 -178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.59 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 129.08 -114.1 1.68 Allowed Glycine 0 C--N 1.309 -0.935 0 N-CA-C 110.817 -0.913 . . . . 74.540000000000006 110.817 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -145.38 153.66 41.45 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 122.048 -0.678 . . . . 71.25 110.467 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.562 ' CG2' ' HG2' ' B' ' 240' ' ' GLN . 61.7 t -129.53 120.26 50.2 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 108.566 -0.902 . . . . 74.200000000000003 108.566 177.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 2.8 p -123.14 112.37 33.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 N-CA-C 109.528 -0.545 . . . . 74.340000000000003 109.528 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.543 HG22 ' HA3' ' B' ' 282' ' ' GLY . 6.7 t -86.82 161.31 18.41 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.577 -0.849 . . . . 54.32 111.382 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.703 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.4 -33.62 75.94 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 122.434 1.111 . . . . 53.299999999999997 109.727 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.64 78.53 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 112.708 -2.042 . . . . 72.219999999999999 113.104 -177.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -60.12 -46.66 88.87 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.186 0.595 . . . . 61.149999999999999 112.031 -174.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.51 157.75 1.31 Allowed 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 101.45 -3.537 . . . . 75.349999999999994 101.45 -176.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -79.33 70.42 5.74 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 119.611 1.096 . . . . 44.409999999999997 113.164 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . 0.496 ' HA3' ' OH ' ' A' ' 281' ' ' TYR . . . 62.09 -144.63 49.17 Favored Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.085 -1.416 . . . . 72.219999999999999 115.539 174.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 255' ' ' ARG . . . -74.01 60.78 2.19 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 114.514 -0.843 . . . . 65.209999999999994 114.849 -175.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 33.1 pt -126.23 3.78 4.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 106.861 -1.533 . . . . 63.420000000000002 106.861 170.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -160.03 138.81 10.6 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 104.124 -2.547 . . . . 73.0 104.124 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 39.0 pt -127.81 140.73 48.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 118.814 0.734 . . . . 75.209999999999994 110.151 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.9 t -149.06 119.65 7.46 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 120.402 -0.519 . . . . 64.239999999999995 110.396 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -152.06 146.09 25.28 Favored 'General case' 0 C--O 1.253 1.257 0 N-CA-C 103.03 -2.952 . . . . 74.420000000000002 103.03 174.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . 0.418 ' HA ' HG12 ' C' ' 256' ' ' ILE . 55.7 mt-30 -146.61 -63.96 0.3 Allowed 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 113.649 0.981 . . . . 71.239999999999995 113.649 -172.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 31.5 m -83.48 127.11 33.45 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.243 -0.889 . . . . 65.329999999999998 112.764 -169.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 61.8 m -91.19 108.85 20.15 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 106.653 -1.61 . . . . 74.129999999999995 106.653 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.519 HD21 HD11 ' C' ' 241' ' ' LEU . 7.5 t30 -106.25 145.67 31.31 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.199 0.523 . . . . 72.400000000000006 112.123 -171.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 19.9 m -138.57 123.86 19.29 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.218 -0.66 . . . . 72.120000000000005 109.218 176.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 15.0 p -127.37 143.84 39.3 Favored 'Isoleucine or valine' 0 C--O 1.249 1.027 0 N-CA-C 109.802 -0.444 . . . . 54.119999999999997 109.802 178.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' B' ' 229' ' ' LYS . 48.7 mm-40 -90.48 -71.71 0.61 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 116.559 -0.291 . . . . 64.239999999999995 110.437 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 26.9 m -121.66 127.06 50.39 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.086 -0.646 . . . . 73.400000000000006 110.816 -177.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.87 123.54 56.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 116.086 -0.506 . . . . 71.319999999999993 110.163 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.17 133.92 67.12 Favored 'Isoleucine or valine' 0 C--O 1.251 1.147 0 CA-C-O 121.491 0.662 . . . . 71.200000000000003 112.425 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . 0.524 ' HA2' ' OG1' ' C' ' 233' ' ' THR . . . -111.23 131.64 10.44 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 110.415 -1.074 . . . . 63.25 110.415 175.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.416 ' HD2' ' HB2' ' B' ' 234' ' ' GLU . 29.1 mmmt -132.89 116.71 16.82 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 123.665 0.786 . . . . 75.019999999999996 111.761 -176.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 94.42 -133.81 11.75 Favored Glycine 0 C--N 1.299 -1.486 0 N-CA-C 110.711 -0.955 . . . . 54.520000000000003 110.711 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' C' ' 235' ' ' GLU . 77.8 mm-40 -85.31 48.14 1.53 Allowed 'General case' 0 C--O 1.258 1.527 0 C-N-CA 123.3 0.64 . . . . 73.010000000000005 109.939 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . 0.465 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 74.7 m -82.09 144.68 30.63 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 122.386 1.089 . . . . 44.520000000000003 111.826 -175.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 7.5 mtm180 -135.66 124.72 24.34 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 106.559 -1.645 . . . . 74.219999999999999 106.559 172.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' C' ' 239' ' ' VAL . 7.4 p -140.5 138.17 36.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.073 0 CA-C-O 121.216 0.532 . . . . 55.43 111.303 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.561 HD13 ' CG ' ' B' ' 240' ' ' GLN . 4.5 tp -119.43 115.82 24.86 Favored 'General case' 0 C--N 1.28 -2.434 0 CA-C-N 115.463 -0.79 . . . . 64.129999999999995 109.881 175.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.463 HG23 HD12 ' C' ' 241' ' ' LEU . 3.9 mp -98.9 103.37 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.047 0 N-CA-C 106.332 -1.729 . . . . 71.430000000000007 106.332 177.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.59 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 147.74 -157.21 27.28 Favored Glycine 0 N--CA 1.426 -1.995 0 C-N-CA 119.563 -1.304 . . . . 52.450000000000003 114.436 178.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 21.5 t30 -96.44 124.64 40.5 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 124.084 0.954 . . . . 62.200000000000003 109.964 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -111.1 118.98 37.47 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.891 -1.892 . . . . 72.109999999999999 105.891 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.409 ' CD1' HG13 ' C' ' 245' ' ' VAL . 0.9 OUTLIER -119.4 122.52 41.96 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 107.129 -1.434 . . . . 64.319999999999993 107.129 178.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.543 ' HA3' HG22 ' B' ' 246' ' ' THR . . . 130.16 -38.44 1.97 Allowed Glycine 0 N--CA 1.417 -2.61 0 CA-C-N 114.612 -1.177 . . . . 71.319999999999993 111.332 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 116.95 -52.21 0.69 Allowed Glycine 0 N--CA 1.422 -2.267 0 N-CA-C 110.02 -1.232 . . . . 72.010000000000005 110.02 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . 0.647 ' HD2' ' O ' ' B' ' 284' ' ' LYS . 0.1 OUTLIER -148.5 72.77 1.21 Allowed 'General case' 0 N--CA 1.421 -1.895 0 CA-C-O 122.403 1.097 . . . . 73.530000000000001 111.315 -178.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -90.17 -51.86 2.68 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 110.115 -1.194 . . . . 63.520000000000003 110.115 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.44 ' HE1' ' CZ2' ' A' ' 287' ' ' TRP . 56.3 t80 -65.52 -35.22 80.22 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.416 0.627 . . . . 75.420000000000002 110.561 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.567 ' O ' ' HB2' ' B' ' 284' ' ' LYS . 29.0 m-90 -110.36 88.4 2.76 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.151 -1.055 . . . . 74.430000000000007 108.151 175.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -77.48 86.35 3.84 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.911 -1.116 . . . . 75.120000000000005 111.857 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . 0.499 ' H ' ' HD3' ' B' ' 284' ' ' LYS . 45.1 t-20 -72.4 93.88 1.58 Allowed 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.078 -1.453 . . . . 72.430000000000007 107.078 175.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -156.16 163.01 40.13 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 106.582 -1.636 . . . . 73.010000000000005 106.582 -176.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -85.41 90.43 7.94 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.449 0.642 . . . . 74.400000000000006 110.553 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -92.1 -42.68 9.8 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.977 -1.01 . . . . 73.439999999999998 111.454 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 57.39 103.86 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.675 1.19 . . . . 61.210000000000001 112.151 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -129.59 135.38 48.5 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 109.009 -0.737 . . . . 63.109999999999999 109.009 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 40.5 m80 . . . . . 0 C--N 1.308 -1.2 0 CA-C-O 118.325 -0.845 . . . . 71.340000000000003 108.956 179.888 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 CA--C 1.511 -0.543 0 CA-C-O 120.71 0.291 . . . . 74.129999999999995 110.57 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -105.73 -11.0 16.45 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.023 -0.732 . . . . 74.120000000000005 109.023 175.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 11.5 tt -71.75 155.34 7.39 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 CA-C-N 114.94 -1.027 . . . . 53.210000000000001 108.422 176.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . 0.563 ' HA ' ' NH2' ' C' ' 225' ' ' ARG . 21.3 t70 -99.88 -61.26 1.39 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.206 -0.665 . . . . 70.420000000000002 109.206 -179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 65.55 -71.63 0.08 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.562 1.545 . . . . 71.010000000000005 113.923 175.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . 0.483 HG23 ' HD3' ' C' ' 225' ' ' ARG . 6.3 tp -83.69 130.19 36.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.174 0.512 . . . . 61.530000000000001 110.207 -175.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . 0.461 ' H ' HG22 ' B' ' 219' ' ' ILE . 49.1 t -99.81 140.23 19.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 106.955 -1.498 . . . . 63.200000000000003 106.955 -178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 91.02 28.21 16.18 Favored Glycine 0 N--CA 1.431 -1.637 0 N-CA-C 109.743 -1.343 . . . . 54.43 109.743 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.563 ' NH2' ' HA ' ' C' ' 220' ' ' ASP . 17.8 ptt180 -112.35 144.01 42.49 Favored 'General case' 0 N--CA 1.42 -1.973 0 CA-C-N 115.108 -0.546 . . . . 74.430000000000007 109.69 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.484 HD22 ' HA2' ' C' ' 278' ' ' GLY . 37.3 t-20 -117.75 128.69 55.13 Favored 'General case' 0 C--N 1.275 -2.633 0 N-CA-C 105.906 -1.887 . . . . 52.329999999999998 105.906 170.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 44.1 m -128.77 136.51 50.63 Favored 'General case' 0 C--N 1.274 -2.679 0 CA-C-O 121.457 0.646 . . . . 63.130000000000003 110.264 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -128.92 127.47 41.82 Favored 'General case' 0 N--CA 1.417 -2.103 0 N-CA-C 107.92 -1.141 . . . . 74.450000000000003 107.92 -178.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' B' ' 265' ' ' GLU . 37.7 ttmt -80.26 -60.68 2.23 Favored 'General case' 0 C--N 1.284 -2.263 0 C-N-CA 119.996 -0.682 . . . . 70.120000000000005 112.097 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -126.21 137.49 53.55 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.076 -1.083 . . . . 74.109999999999999 108.076 -174.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . . . . . . . . . 24.8 mt -136.19 117.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.202 -1.036 . . . . 74.109999999999999 108.202 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' C' ' 268' ' ' VAL . 92.5 mtt180 -120.11 119.45 33.34 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.19 -1.041 . . . . 73.549999999999997 108.19 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.566 HG22 HG21 ' C' ' 239' ' ' VAL . 28.9 p -119.75 127.83 53.19 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.462 -1.681 . . . . 64.299999999999997 106.462 -177.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.425 ' HB2' ' HD2' ' C' ' 270' ' ' LYS . 54.2 mt-10 -133.58 155.31 49.86 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.454 0.645 . . . . 61.310000000000002 112.075 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.518 ' HB3' ' HD3' ' C' ' 236' ' ' ARG . 46.6 mt-10 72.26 -86.54 0.03 OUTLIER 'General case' 0 C--O 1.206 -1.199 0 CA-C-N 113.896 -1.502 . . . . 71.030000000000001 114.693 170.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.518 ' HD3' ' HB3' ' C' ' 235' ' ' GLU . 0.3 OUTLIER -131.11 31.32 4.44 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.654 -0.869 . . . . 71.209999999999994 108.654 -177.487 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' C' ' 273' ' ' SER . . . -75.11 138.39 42.04 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 122.333 1.063 . . . . 71.540000000000006 113.547 -176.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 4.3 mpt_? -123.91 133.37 53.75 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 103.765 -2.68 . . . . 72.519999999999996 103.765 172.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.566 HG21 HG22 ' C' ' 233' ' ' THR . 85.8 t -141.16 132.31 27.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.252 0.549 . . . . 70.120000000000005 111.218 -174.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.603 ' HG2' ' CG2' ' C' ' 244' ' ' VAL . 51.8 tp60 -111.68 128.71 56.15 Favored 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 107.05 -1.463 . . . . 64.540000000000006 107.05 174.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.519 HD11 HD21 ' B' ' 262' ' ' ASN . 1.7 tm? -128.62 117.54 21.4 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.411 -0.959 . . . . 62.310000000000002 108.411 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.545 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 131.4 -111.68 1.11 Allowed Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 110.333 -1.107 . . . . 73.450000000000003 110.333 -177.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -145.71 155.19 42.81 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 122.109 -0.642 . . . . 64.200000000000003 110.371 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.603 ' CG2' ' HG2' ' C' ' 240' ' ' GLN . 58.8 t -131.22 122.02 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.774 0 N-CA-C 108.635 -0.876 . . . . 75.129999999999995 108.635 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.409 HG13 ' CD1' ' B' ' 281' ' ' TYR . 2.7 p -122.18 112.01 32.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.54 -0.911 . . . . 54.539999999999999 108.54 173.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . 0.485 HG22 ' HA3' ' C' ' 282' ' ' GLY . 5.0 t -81.39 162.38 23.39 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.225 0.824 . . . . 72.219999999999999 113.225 -174.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.54 ' HB2' ' HA ' ' B' ' 249' ' ' ALA . . . -60.36 -35.17 75.05 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 124.693 1.197 . . . . 73.329999999999998 109.678 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -57.49 -34.77 69.41 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.345 -1.298 . . . . 62.200000000000003 111.584 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -69.59 -36.48 76.27 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.129 -0.487 . . . . 51.039999999999999 110.85 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 97.4 mt 55.97 27.97 11.99 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.585 0.754 . . . . 75.140000000000001 111.302 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -102.74 145.99 28.9 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 116.114 -0.494 . . . . 74.010000000000005 110.946 -175.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -171.07 60.05 0.17 Allowed Glycine 0 N--CA 1.423 -2.181 0 N-CA-C 109.685 -1.366 . . . . 72.010000000000005 109.685 175.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.77 27.46 6.82 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.528 -0.844 . . . . 72.340000000000003 112.085 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 45.7 mm 43.77 81.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 C-N-CA 125.112 1.365 . . . . 73.409999999999997 113.231 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.82 89.39 3.85 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.398 -0.814 . . . . 73.040000000000006 111.218 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' B' ' 259' ' ' GLN . 25.4 mt -123.13 13.55 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 107.823 -1.177 . . . . 64.349999999999994 107.823 178.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 5.9 m -62.55 -42.34 99.48 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.92 -1.036 . . . . 60.350000000000001 109.207 178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -161.25 126.35 3.61 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.993 -1.484 . . . . 71.219999999999999 106.993 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -143.39 154.3 43.57 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 106.039 -1.837 . . . . 71.439999999999998 106.039 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 26.0 m -64.57 120.24 11.98 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.404 0.621 . . . . 71.209999999999994 110.58 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 31.2 m -94.56 108.88 20.82 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 115.272 -0.876 . . . . 73.25 108.704 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -111.86 141.44 45.48 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.576 -0.738 . . . . 64.420000000000002 111.497 -174.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 22.0 m -134.74 124.09 24.67 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.073 -1.084 . . . . 75.230000000000004 108.073 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.23 143.8 39.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.863 0.363 . . . . 71.510000000000005 110.613 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 53.9 mm-40 -80.42 -65.43 1.01 Allowed 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 115.955 -0.566 . . . . 61.119999999999997 111.459 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 59.2 m -140.8 130.79 24.61 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 120.107 -0.637 . . . . 62.25 110.906 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 21.0 m -123.51 133.88 67.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.852 -0.613 . . . . 73.129999999999995 109.393 174.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' C' ' 232' ' ' ARG . 8.3 p -128.02 140.23 49.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 116.181 -0.463 . . . . 45.329999999999998 109.945 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -120.03 132.87 9.61 Favored Glycine 0 N--CA 1.432 -1.58 0 N-CA-C 109.988 -1.245 . . . . 73.5 109.988 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.425 ' HD2' ' HB2' ' C' ' 234' ' ' GLU . 29.8 mmmt -131.36 141.19 49.85 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.25 0.62 . . . . 72.310000000000002 110.177 -177.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 70.64 -132.02 22.05 Favored Glycine 0 N--CA 1.432 -1.609 0 C-N-CA 120.883 -0.675 . . . . 64.439999999999998 112.166 -178.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -85.94 49.35 1.76 Allowed 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 123.582 0.753 . . . . 74.349999999999994 110.502 -175.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 67.9 m -83.22 145.07 29.36 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.602 0.964 . . . . 72.239999999999995 113.602 -174.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 41.7 mtt180 -138.68 125.68 21.23 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 103.586 -2.746 . . . . 71.420000000000002 103.586 172.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.481 ' CG1' HG22 ' C' ' 239' ' ' VAL . 4.6 p -140.28 137.78 37.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 C-N-CA 120.297 -0.561 . . . . 63.340000000000003 111.827 -179.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.419 HD13 ' CG ' ' C' ' 240' ' ' GLN . 13.0 tp -113.15 112.43 23.79 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.644 0.735 . . . . 73.340000000000003 109.74 175.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 30.7 mt -101.21 103.29 14.66 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 104.996 -2.224 . . . . 63.439999999999998 104.996 177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 144.26 -159.63 27.73 Favored Glycine 0 N--CA 1.42 -2.384 0 C-N-CA 118.916 -1.611 . . . . 53.039999999999999 113.863 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -92.6 129.41 38.54 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.793 -0.703 . . . . 74.400000000000006 109.848 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -111.99 122.35 47.51 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 105.435 -2.061 . . . . 71.349999999999994 105.435 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -125.75 124.26 40.62 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 108.517 -0.92 . . . . 65.400000000000006 108.517 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . 0.485 ' HA3' HG22 ' C' ' 246' ' ' THR . . . 122.42 -34.65 3.73 Favored Glycine 0 N--CA 1.428 -1.85 0 CA-C-N 115.628 -0.715 . . . . 51.130000000000003 112.087 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 122.88 -62.63 0.55 Allowed Glycine 0 N--CA 1.432 -1.63 0 C-N-CA 120.886 -0.673 . . . . 72.519999999999996 111.645 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . 0.622 ' HD2' ' O ' ' C' ' 284' ' ' LYS 0.255 0.1 OUTLIER -136.0 70.02 1.42 Allowed 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.855 0.836 . . . . 74.450000000000003 112.171 178.525 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -79.29 -64.06 1.96 Allowed Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 119.66 -1.257 . . . . 70.430000000000007 110.749 176.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -65.03 -24.32 67.46 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.637 0.732 . . . . 54.219999999999999 110.911 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -115.51 45.86 1.6 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.804 -0.634 . . . . 75.040000000000006 110.354 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -71.25 179.79 2.73 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 120.106 -0.638 . . . . 54.210000000000001 109.749 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -93.34 166.03 12.5 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 114.139 1.163 . . . . 72.519999999999996 114.139 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -56.76 -27.63 59.81 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.895 1.678 . . . . 72.510000000000005 114.44 -170.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -138.78 84.46 2.02 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.284 0.564 . . . . 74.319999999999993 109.556 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -77.01 133.81 39.02 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.532 -0.914 . . . . 62.130000000000003 108.532 176.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -97.09 171.12 8.67 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.746 -0.464 . . . . 75.120000000000005 109.746 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -95.78 150.6 20.22 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 120.015 -0.674 . . . . 72.239999999999995 109.448 176.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 . . . . . 0 C--N 1.297 -1.717 0 N-CA-C 107.766 -1.198 . . . . 65.450000000000003 107.766 -178.389 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 C--O 1.24 0.586 0 N-CA-C 109.8 -0.444 . . . . 74.200000000000003 109.8 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 45.8 mttp 70.12 140.44 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.212 1.19 . . . . 74.349999999999994 114.212 174.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 9.6 tt -76.94 116.18 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.61 0 N-CA-C 105.796 -1.927 . . . . 72.150000000000006 105.796 169.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -73.31 102.81 3.8 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 121.503 0.668 . . . . 72.129999999999995 112.145 -173.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -109.33 126.62 53.58 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.703 -1.135 . . . . 64.310000000000002 108.396 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 75.9 mt -101.18 126.99 54.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-O 121.146 0.498 . . . . 71.319999999999993 111.292 -175.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 39.9 t -138.15 119.28 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.764 0 N-CA-C 105.616 -1.994 . . . . 71.219999999999999 105.616 172.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -129.82 112.46 1.32 Allowed Glycine 0 C--N 1.297 -1.611 0 C-N-CA 120.17 -1.014 . . . . 70.129999999999995 111.18 -178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 23.6 ptt85 -137.97 142.24 40.49 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.135 0.493 . . . . 71.510000000000005 111.984 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.445 HD22 ' HA2' ' A' ' 278' ' ' GLY . 34.5 t30 -99.3 114.25 27.0 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.201 -1.777 . . . . 60.119999999999997 106.201 173.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.4 m -126.15 136.66 53.13 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 119.667 -0.813 . . . . 75.120000000000005 111.756 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -120.71 119.41 32.7 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.171 -1.418 . . . . 64.349999999999994 107.171 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -75.8 -58.2 3.42 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 123.803 0.69 . . . . 74.329999999999998 110.165 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -126.57 140.48 52.4 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.137 0.494 . . . . 73.140000000000001 111.345 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 63.0 mt -134.16 124.95 47.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.162 -1.051 . . . . 65.129999999999995 108.162 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -128.76 122.74 31.27 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 109.613 -0.514 . . . . 72.239999999999995 109.613 175.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 20.2 p -112.31 128.23 56.22 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.269 -1.382 . . . . 75.129999999999995 107.269 171.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -147.37 146.4 29.62 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.815 -1.18 . . . . 73.129999999999995 107.815 -175.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 60.14 72.96 0.5 Allowed 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 123.248 0.619 . . . . 65.540000000000006 112.634 -175.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . . . . . . . . . 42.0 mtm-85 65.28 22.87 12.13 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.054 0.541 . . . . 65.450000000000003 112.264 171.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.41 134.97 36.36 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.274 -0.421 . . . . 73.310000000000002 109.893 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.93 139.99 53.0 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.126 -0.488 . . . . 71.420000000000002 111.636 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.2 p -124.18 138.49 53.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.545 -0.752 . . . . 64.140000000000001 111.513 -176.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.576 ' HB3' HD22 ' A' ' 276' ' ' LEU . 6.4 tp-100 -111.15 118.64 36.53 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 107.688 -1.227 . . . . 63.32 107.688 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.87 118.87 36.7 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.257 -1.016 . . . . 63.020000000000003 108.257 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.572 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 134.89 -136.72 8.73 Favored Glycine 0 N--CA 1.427 -1.916 0 C-N-CA 120.437 -0.887 . . . . 61.399999999999999 111.843 177.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -130.12 128.58 42.11 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.568 -0.901 . . . . 73.510000000000005 108.568 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.4 115.38 43.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.025 -1.102 . . . . 71.230000000000004 108.025 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 45.5 t -113.87 114.39 46.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 108.701 -0.851 . . . . 63.409999999999997 108.701 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.497 ' HB ' ' HA3' ' A' ' 282' ' ' GLY . 10.7 m -105.06 161.15 14.48 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.895 -1.15 . . . . 62.219999999999999 107.895 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -33.73 72.34 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.991 0.916 . . . . 75.140000000000001 113.087 -176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.59 -34.49 64.88 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 114.899 1.444 . . . . 51.200000000000003 114.899 -174.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' B' ' 247' ' ' ALA . . . -73.81 -45.8 49.21 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 113.801 1.038 . . . . 53.299999999999997 113.801 -174.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.425 ' HB3' ' H ' ' A' ' 251' ' ' HIS . 3.3 mm? 58.88 -151.39 0.42 Allowed 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 108.256 -1.016 . . . . 71.120000000000005 108.256 -172.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.425 ' H ' ' HB3' ' A' ' 250' ' ' LEU . 5.8 t-80 -153.68 -161.98 1.36 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.116 -1.439 . . . . 75.049999999999997 107.116 177.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 167.58 -158.39 31.23 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 110.818 -0.913 . . . . 51.130000000000003 110.818 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -72.72 118.24 6.44 Favored Glycine 0 N--CA 1.441 -0.997 0 O-C-N 124.015 0.479 . . . . 61.240000000000002 111.956 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 43.2 mm -96.78 -55.72 5.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 122.879 -0.189 . . . . 73.540000000000006 110.675 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 65.31 -86.75 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.884 1.274 . . . . 70.239999999999995 111.777 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.415 HD12 ' O ' ' A' ' 256' ' ' ILE 0.338 2.7 pp -121.48 109.49 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.348 0 CA-C-O 122.681 1.229 . . . . 74.25 113.6 -179.731 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 49.6 m -146.84 137.28 23.68 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 106.754 -1.573 . . . . 63.130000000000003 106.754 176.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -98.22 -171.31 2.12 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 108.817 -0.809 . . . . 54.109999999999999 108.817 -173.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -125.42 103.87 8.14 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.265 -0.643 . . . . 70.150000000000006 109.265 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.408 HG21 ' OD1' ' B' ' 279' ' ' ASN . 8.3 m -64.78 125.65 25.47 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.442 -0.799 . . . . 71.109999999999999 110.284 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 13.5 t -91.89 129.04 37.93 Favored 'General case' 0 N--CA 1.415 -2.189 0 C-N-CA 119.653 -0.819 . . . . 71.049999999999997 108.863 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -124.69 138.37 54.3 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.372 -1.344 . . . . 73.430000000000007 107.372 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.6 m -137.63 123.83 20.48 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.935 -0.706 . . . . 74.129999999999995 111.953 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 11.7 p -122.46 137.76 54.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-N 115.864 -0.607 . . . . 62.25 109.721 175.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 3.7 tp10 -79.0 -65.34 1.01 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.055 -0.52 . . . . 72.230000000000004 109.937 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 30.8 m -136.97 129.78 30.53 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 121.77 -0.581 . . . . 74.420000000000002 111.973 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.445 HG12 HD12 ' B' ' 231' ' ' ILE . 35.3 m -117.79 126.45 74.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 N-CA-C 108.368 -0.975 . . . . 74.140000000000001 108.368 174.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 7.4 p -127.93 126.68 66.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 121.38 0.61 . . . . 74.420000000000002 111.518 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -110.57 132.49 11.0 Favored Glycine 0 N--CA 1.429 -1.808 0 N-CA-C 109.937 -1.265 . . . . 54.32 109.937 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . 0.644 ' O ' ' HA ' ' B' ' 234' ' ' GLU . 30.5 mmmt -133.13 116.43 16.29 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 123.514 0.726 . . . . 73.530000000000001 110.284 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 84.43 86.29 0.9 Allowed Glycine 0 C--N 1.296 -1.67 0 C-N-CA 119.483 -1.342 . . . . 64.340000000000003 113.734 174.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 55.23 31.01 15.65 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.635 1.174 . . . . 71.239999999999995 111.618 175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 23.6 m -83.04 149.18 27.1 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.485 0.66 . . . . 32.350000000000001 112.169 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -119.49 128.15 53.71 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.69 -0.856 . . . . 73.209999999999994 108.69 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . . . . . . . . . 24.7 t -122.54 129.99 74.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.999 -0.741 . . . . 74.099999999999994 108.999 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.576 HD22 ' HB3' ' A' ' 240' ' ' GLN . 0.9 OUTLIER -119.78 117.36 27.99 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.556 -1.646 . . . . 73.230000000000004 106.556 173.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.496 HD13 ' HB3' ' B' ' 241' ' ' LEU . 42.7 mm -112.89 104.89 17.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.411 -0.959 . . . . 74.140000000000001 108.411 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 144.31 -127.7 3.05 Favored Glycine 0 N--CA 1.434 -1.448 0 C-N-CA 119.746 -1.216 . . . . 71.209999999999994 113.007 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -128.36 150.76 49.95 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 120.711 0.291 . . . . 65.010000000000005 110.404 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -129.15 123.62 32.59 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.803 -1.925 . . . . 74.340000000000003 105.803 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -120.45 123.54 43.23 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.016 -1.475 . . . . 74.200000000000003 107.016 174.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.497 ' HA3' ' HB ' ' A' ' 246' ' ' THR . . . 145.36 -82.49 0.2 Allowed Glycine 0 N--CA 1.412 -2.923 0 C-N-CA 118.905 -1.617 . . . . 72.439999999999998 112.692 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -142.02 16.97 2.56 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.71 -1.233 . . . . 73.030000000000001 113.317 -174.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.505 ' HD3' ' HA ' ' B' ' 286' ' ' PHE . 62.7 mttm 71.57 -38.28 0.42 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 125.887 1.675 . . . . 71.239999999999995 113.843 175.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.537 ' HA2' ' CD1' ' B' ' 287' ' ' TRP . . . -72.0 -28.84 67.84 Favored Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 117.391 1.717 . . . . 61.509999999999998 117.391 -170.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.519 ' CZ ' ' HB2' ' A' ' 276' ' ' LEU 0.325 51.9 p90 53.33 -78.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.468 1.107 . . . . 63.43 113.917 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 15.3 m0 -95.47 -34.09 12.21 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 121.677 -0.639 . . . . 73.019999999999996 110.051 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -92.9 175.56 6.75 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.668 -1.234 . . . . 73.0 107.668 175.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . 0.467 ' O ' ' HB3' ' B' ' 289' ' ' ASN . 26.7 t-20 -176.79 -67.23 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.957 0.798 . . . . 72.420000000000002 111.419 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.3 t60 167.85 -43.22 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 104.557 -2.386 . . . . 75.230000000000004 104.557 -169.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -69.34 -58.26 4.24 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 113.313 -1.767 . . . . 75.040000000000006 107.478 175.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -89.07 124.49 34.35 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.964 -1.495 . . . . 72.329999999999998 106.964 172.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -154.49 -27.56 0.12 Allowed 'General case' 0 C--N 1.311 -1.066 0 O-C-N 123.791 0.682 . . . . 73.340000000000003 111.707 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -93.39 78.07 4.44 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.401 0.619 . . . . 64.420000000000002 111.695 -174.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 . . . . . 0 C--N 1.305 -1.326 0 N-CA-C 105.605 -1.998 . . . . 70.420000000000002 105.605 175.528 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 108.902 -0.777 . . . . 61.340000000000003 108.902 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . 0.531 ' O ' ' HD2' ' B' ' 218' ' ' LYS . 0.1 OUTLIER -87.8 132.92 33.99 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.999 -0.681 . . . . 73.230000000000004 111.425 179.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 13.5 tt -178.84 108.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 124.693 1.197 . . . . 43.520000000000003 108.409 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -135.07 132.97 38.84 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.5 1.143 . . . . 73.109999999999999 113.017 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -156.68 47.16 0.44 Allowed 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 102.765 -3.05 . . . . 63.539999999999999 102.765 176.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 75.4 mt -81.87 112.85 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.555 0 CA-C-N 113.721 -1.581 . . . . 73.239999999999995 112.678 -166.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . 0.439 HG12 ' HG3' ' B' ' 225' ' ' ARG . 46.9 t -141.32 119.79 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.28 0 N-CA-C 105.433 -2.062 . . . . 72.310000000000002 105.433 169.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' B' ' 259' ' ' GLN . . . -98.15 125.89 8.69 Favored Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 109.398 -1.481 . . . . 50.329999999999998 109.398 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.439 ' HG3' HG12 ' B' ' 223' ' ' VAL . 72.1 mtp180 -141.93 121.73 13.53 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 118.146 0.973 . . . . 72.430000000000007 113.561 -175.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -101.04 114.38 28.27 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 104.408 -2.442 . . . . 63.530000000000001 104.408 167.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 55.6 m -130.2 136.01 48.77 Favored 'General case' 0 N--CA 1.419 -1.989 0 C-N-CA 118.875 -1.13 . . . . 75.409999999999997 112.885 -178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -120.53 126.0 49.26 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.559 -1.655 . . . . 60.240000000000002 107.443 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 13.2 tmtt? -86.29 -59.34 2.31 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 116.137 -0.483 . . . . 74.540000000000006 110.747 -176.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -126.24 138.26 53.61 Favored 'General case' 0 C--O 1.25 1.12 0 C-N-CA 119.524 -0.87 . . . . 63.229999999999997 109.352 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.449 HG21 HG21 ' B' ' 239' ' ' VAL . 28.1 mt -130.54 121.59 51.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 107.803 -1.184 . . . . 74.120000000000005 107.803 177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.436 ' O ' ' HA ' ' B' ' 268' ' ' VAL . 29.3 ttt180 -127.03 118.45 24.47 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-O 121.049 0.452 . . . . 75.230000000000004 109.987 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . . . . . . . . . 24.9 p -109.57 127.55 54.57 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.635 -1.987 . . . . 74.409999999999997 105.635 174.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . 0.644 ' HA ' ' O ' ' A' ' 270' ' ' LYS . 33.5 tt0 -139.81 138.54 35.9 Favored 'General case' 0 N--CA 1.406 -2.674 0 C-N-CA 119.977 -0.689 . . . . 65.439999999999998 109.564 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.559 ' C ' ' HD3' ' B' ' 236' ' ' ARG . 46.8 mt-10 60.69 91.39 0.06 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 113.961 1.097 . . . . 75.519999999999996 113.961 177.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.559 ' HD3' ' C ' ' B' ' 235' ' ' GLU . 0.4 OUTLIER 61.35 23.79 13.98 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.999 0.92 . . . . 74.409999999999997 110.598 175.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' B' ' 273' ' ' SER . . . -94.57 144.52 25.52 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.84 -0.618 . . . . 65.040000000000006 110.973 -177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -125.16 142.27 51.6 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.549 -1.278 . . . . 72.340000000000003 107.549 178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.449 HG21 HG21 ' B' ' 231' ' ' ILE . 7.5 p -130.75 131.98 64.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 121.479 0.657 . . . . 73.209999999999994 110.699 174.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.549 ' HG3' HD13 ' B' ' 276' ' ' LEU . 5.8 tp-100 -108.15 120.71 43.11 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 105.807 -1.923 . . . . 74.430000000000007 105.807 173.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.496 ' HB3' HD13 ' A' ' 277' ' ' ILE . 3.1 tm? -125.86 117.68 23.88 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 108.332 -0.988 . . . . 61.240000000000002 108.332 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . . . . . . . . . . . 137.27 -122.49 2.55 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 120.768 -0.73 . . . . 72.439999999999998 111.423 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -144.32 128.1 17.28 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.094 -0.706 . . . . 71.510000000000005 109.094 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 73.8 t -102.91 117.99 49.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.473 -0.936 . . . . 70.209999999999994 108.473 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 44.3 t -122.16 112.72 35.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 121.426 0.631 . . . . 73.540000000000006 109.565 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.2 m -105.49 161.66 14.15 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.555 -0.906 . . . . 54.310000000000002 108.555 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 249' ' ' ALA . . . -56.8 -33.33 66.59 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.848 0.859 . . . . 64.230000000000004 111.919 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.04 -34.14 59.22 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.453 -1.249 . . . . 73.319999999999993 113.14 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' C' ' 247' ' ' ALA . . . -68.43 -25.45 65.03 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 122.773 0.429 . . . . 74.430000000000007 112.092 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.1 tt -68.7 104.07 1.9 Allowed 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.594 -0.891 . . . . 65.109999999999999 108.594 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . 0.452 ' CB ' ' HB1' ' C' ' 247' ' ' ALA . 14.4 t-80 -153.69 137.53 16.2 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.157 -1.053 . . . . 64.319999999999993 108.157 -177.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 53.01 -106.57 0.42 Allowed Glycine 0 C--O 1.243 0.703 0 O-C-N 124.293 0.995 . . . . 71.519999999999996 113.766 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -165.04 171.33 40.39 Favored Glycine 0 N--CA 1.419 -2.462 0 N-CA-C 107.867 -2.093 . . . . 74.430000000000007 107.867 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 66.9 mt 69.85 92.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 123.692 0.797 . . . . 75.310000000000002 110.757 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -154.37 151.64 29.28 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 109.181 -0.674 . . . . 71.150000000000006 109.181 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . 0.552 ' HA ' ' OH ' ' B' ' 281' ' ' TYR . 44.7 mt 59.97 79.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.674 0 C-N-CA 124.315 1.046 . . . . 73.549999999999997 112.043 176.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 72.6 m -163.07 115.6 1.56 Allowed 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.632 -1.247 . . . . 51.009999999999998 107.632 175.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -134.88 159.93 39.85 Favored 'General case' 0 C--O 1.257 1.452 0 C-N-CA 120.99 -0.284 . . . . 72.420000000000002 110.932 -173.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' B' ' 259' ' ' GLN . 45.0 tt0 -149.32 18.53 0.95 Allowed 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.063 -1.088 . . . . 74.329999999999998 108.063 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 19.9 m -75.3 121.85 22.82 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.688 -1.227 . . . . 63.399999999999999 107.688 -175.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 91.1 m -91.25 107.87 19.49 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 107.884 -1.154 . . . . 53.310000000000002 107.884 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -120.9 131.31 54.31 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 114.388 -1.278 . . . . 61.240000000000002 107.559 -176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 51.5 m -138.86 126.49 21.96 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 120.937 0.399 . . . . 73.120000000000005 110.897 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.5 p -122.3 138.0 53.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 119.798 -0.761 . . . . 74.109999999999999 110.349 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.613 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 19.8 tp10 -79.24 -59.29 2.83 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.9 -0.591 . . . . 73.109999999999999 109.686 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 39.7 m -145.4 128.11 16.22 Favored 'General case' 0 C--N 1.315 -0.895 0 O-C-N 121.62 -0.675 . . . . 54.450000000000003 111.924 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.404 HG12 ' HB ' ' C' ' 231' ' ' ILE . 35.7 m -117.54 128.22 74.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.18 -1.044 . . . . 71.140000000000001 108.18 173.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' B' ' 232' ' ' ARG . 6.5 p -128.02 129.77 69.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-N 116.062 -0.517 . . . . 61.329999999999998 112.139 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.6 132.98 11.35 Favored Glycine 0 CA--C 1.475 -2.412 0 N-CA-C 110.037 -1.225 . . . . 73.120000000000005 110.037 176.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.591 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 27.3 mmmt -133.9 115.99 15.09 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 123.184 0.594 . . . . 74.340000000000003 111.621 -178.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 77.54 92.29 0.27 Allowed Glycine 0 C--N 1.299 -1.5 0 C-N-CA 119.872 -1.156 . . . . 72.140000000000001 113.588 173.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . 0.4 ' H ' ' HB2' ' B' ' 236' ' ' ARG . 16.0 mp0 61.59 24.82 14.86 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.886 0.875 . . . . 71.219999999999999 111.638 175.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . 0.61 ' O ' ' HA ' ' B' ' 237' ' ' ALA . 41.6 m -83.04 152.39 25.4 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.476 0.917 . . . . 74.120000000000005 113.476 -171.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.452 ' HB3' ' CE3' ' B' ' 287' ' ' TRP . 94.9 mtt180 -128.34 127.96 43.66 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.467 -0.938 . . . . 75.510000000000005 108.467 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 47.2 t -126.28 128.17 71.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 122.41 0.284 . . . . 72.049999999999997 110.304 -175.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.549 HD13 ' HG3' ' B' ' 240' ' ' GLN . 5.8 tp -122.43 114.62 20.97 Favored 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 119.569 -0.852 . . . . 64.310000000000002 110.597 169.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.614 HG23 HD12 ' C' ' 241' ' ' LEU . 40.1 mm -108.01 104.55 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 N-CA-C 106.997 -1.483 . . . . 74.519999999999996 106.997 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . . . . . . . . . . . 149.84 -148.95 20.75 Favored Glycine 0 CA--C 1.476 -2.389 0 C-N-CA 119.267 -1.444 . . . . 25.329999999999998 112.98 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . 0.498 ' HA ' ' O ' ' C' ' 243' ' ' ASN . 18.4 m120 -112.38 136.59 51.67 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.089 -0.708 . . . . 63.530000000000001 109.089 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.88 118.81 36.54 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.167 -1.79 . . . . 71.109999999999999 106.167 178.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.552 ' OH ' ' HA ' ' B' ' 256' ' ' ILE . 77.7 m-85 -118.98 124.01 45.95 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.012 0.911 . . . . 65.120000000000005 109.921 175.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 139.29 -64.92 0.54 Allowed Glycine 0 N--CA 1.412 -2.928 0 C-N-CA 119.745 -1.217 . . . . 75.409999999999997 113.5 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . -169.73 37.01 0.19 Allowed Glycine 0 C--O 1.21 -1.381 0 C-N-CA 117.371 -2.347 . . . . 74.519999999999996 115.367 -172.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt 70.87 -66.37 0.3 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.637 1.175 . . . . 61.539999999999999 113.188 170.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -81.7 89.84 1.43 Allowed Glycine 0 CA--C 1.494 -1.265 0 CA-C-N 115.458 -0.792 . . . . 33.32 114.033 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.505 ' HA ' ' HD3' ' A' ' 284' ' ' LYS . 6.6 p90 -60.49 -66.45 0.53 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 123.815 0.846 . . . . 52.210000000000001 112.437 176.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.537 ' CD1' ' HA2' ' A' ' 285' ' ' GLY . 5.0 m-90 -102.56 80.29 1.91 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.739 -1.208 . . . . 72.409999999999997 107.739 176.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -150.07 -59.43 0.2 Allowed 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.745 -1.205 . . . . 73.349999999999994 107.745 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 289' ' ' ASN . 59.2 t30 38.02 79.95 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 O-C-N 125.418 1.699 . . . . 75.540000000000006 115.053 177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -118.23 25.38 10.36 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 105.175 -2.158 . . . . 73.329999999999998 105.175 171.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 27.7 m80 61.71 73.67 0.47 Allowed 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.187 -2.153 . . . . 73.510000000000005 105.187 -170.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -71.54 148.02 47.11 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.515 -1.675 . . . . 72.140000000000001 111.631 -167.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -76.77 156.56 32.28 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.722 -1.126 . . . . 75.319999999999993 110.105 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -89.41 -23.92 22.03 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.782 -1.192 . . . . 75.510000000000005 107.782 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 . . . . . 0 C--O 1.251 1.156 0 CA-C-N 113.182 -1.826 . . . . 72.219999999999999 109.142 -175.645 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 17.0 mmt . . . . . 0 CA--C 1.496 -1.105 0 CA-C-O 120.784 0.326 . . . . 70.239999999999995 111.49 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -106.67 84.93 2.08 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.575 -1.269 . . . . 72.239999999999995 107.575 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 14.3 tt -125.18 149.83 29.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 115.172 -0.922 . . . . 53.340000000000003 108.901 -175.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -81.74 93.14 6.75 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.35 0.595 . . . . 71.5 112.009 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -164.46 -100.22 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.839 -1.073 . . . . 73.310000000000002 108.439 174.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 47.0 mm -116.53 115.44 49.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 106.949 -1.5 . . . . 71.439999999999998 106.949 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.07 118.15 35.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.685 0.755 . . . . 73.430000000000007 111.095 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -121.79 120.29 4.33 Favored Glycine 0 N--CA 1.42 -2.37 0 N-CA-C 108.779 -1.729 . . . . 75.239999999999995 108.779 177.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -142.83 148.25 36.77 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-O 121.276 0.56 . . . . 71.310000000000002 111.146 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -101.17 116.32 32.55 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 105.674 -1.972 . . . . 63.329999999999998 105.674 173.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 50.0 m -131.58 136.98 48.23 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.542 -0.863 . . . . 73.510000000000005 111.887 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -126.12 130.93 52.03 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.8 -1.091 . . . . 74.439999999999998 108.308 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.629 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.1 OUTLIER -80.27 -67.83 0.73 Allowed 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 108.613 -0.884 . . . . 60.219999999999999 108.613 -178.364 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -125.54 139.19 53.82 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 119.869 -0.732 . . . . 74.239999999999995 109.258 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.417 HG23 HG23 ' C' ' 267' ' ' VAL . 20.3 mt -133.42 118.76 32.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.242 -1.392 . . . . 62.299999999999997 107.242 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -120.0 124.52 46.13 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.601 -0.44 . . . . 74.400000000000006 110.222 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 27.8 p -109.58 126.52 53.68 Favored 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 104.599 -2.371 . . . . 75.409999999999997 104.599 173.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 32.6 tt0 -140.86 138.81 34.22 Favored 'General case' 0 N--CA 1.415 -2.193 0 C-N-CA 119.804 -0.758 . . . . 63.420000000000002 109.132 -178.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.531 ' C ' ' HD3' ' C' ' 236' ' ' ARG . 56.4 mt-10 62.91 85.74 0.13 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.303 1.002 . . . . 74.519999999999996 112.939 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.579 ' HD3' ' N ' ' C' ' 236' ' ' ARG . 0.1 OUTLIER 64.9 21.82 12.39 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.882 0.873 . . . . 75.25 111.473 174.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -91.68 147.48 22.97 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.294 0.569 . . . . 54.049999999999997 111.447 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.418 ' HG3' ' HB2' ' B' ' 274' ' ' ARG . 5.2 mpt_? -125.1 144.41 50.43 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 107.863 -1.162 . . . . 73.329999999999998 107.863 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.41 HG21 HG21 ' C' ' 231' ' ' ILE . 5.7 p -133.85 135.52 55.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.351 0.596 . . . . 64.209999999999994 111.377 175.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -110.41 117.81 34.59 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 106.913 -1.514 . . . . 72.0 106.913 172.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.614 HD12 HG23 ' B' ' 277' ' ' ILE . 3.2 tm? -121.88 117.69 27.11 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.947 -1.501 . . . . 74.030000000000001 106.947 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . . . . . . . . . . . 138.65 -128.38 4.1 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.551 -0.833 . . . . 70.439999999999998 111.024 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' B' ' 279' ' ' ASN . 51.5 t-20 -140.14 128.83 23.08 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.426 -0.953 . . . . 71.219999999999999 108.426 -177.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . . . . . . . . . 58.5 t -103.23 115.12 44.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 107.637 -1.246 . . . . 71.420000000000002 107.637 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . 0.476 ' HB ' ' CE2' ' B' ' 281' ' ' TYR . 43.4 t -120.51 112.57 36.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.949 -0.76 . . . . 63.32 108.949 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 5.1 m -101.57 160.91 14.04 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.069 -0.715 . . . . 65.200000000000003 109.069 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.452 ' HB1' ' CB ' ' B' ' 251' ' ' HIS . . . -58.91 -31.77 68.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.957 1.303 . . . . 74.109999999999999 110.519 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -53.93 -34.31 59.24 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.043 -1.89 . . . . 60.310000000000002 113.616 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -68.49 -46.5 69.53 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 120.426 -0.51 . . . . 70.239999999999995 111.412 -176.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 25.3 tp 46.15 35.8 2.8 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.636 1.174 . . . . 74.230000000000004 111.318 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -86.58 121.94 29.82 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.945 -0.57 . . . . 74.109999999999999 111.615 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -82.1 63.55 4.38 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.137 -0.785 . . . . 45.340000000000003 111.137 177.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . -154.57 82.27 0.17 Allowed Glycine 0 C--N 1.293 -1.831 0 N-CA-C 108.947 -1.661 . . . . 64.349999999999994 108.947 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 20.3 pt -117.86 142.53 31.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 115.516 -0.342 . . . . 73.129999999999995 111.536 -175.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . 0.453 ' HG3' ' HB2' ' B' ' 259' ' ' GLN . 39.0 ttm180 56.92 78.71 0.21 Allowed 'General case' 0 CA--C 1.534 0.346 0 O-C-N 124.432 1.082 . . . . 74.540000000000006 112.988 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 29.6 pt -132.78 152.39 36.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 114.766 -1.106 . . . . 62.240000000000002 108.145 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 19.4 m -79.84 112.32 17.02 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 120.756 0.313 . . . . 43.229999999999997 110.654 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -81.32 155.04 26.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.759 -0.655 . . . . 62.439999999999998 110.429 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -120.12 -4.05 10.06 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.814 -0.63 . . . . 64.329999999999998 109.574 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 9.4 m -78.02 121.2 23.91 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.192 0.52 . . . . 62.450000000000003 109.772 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 14.5 t -111.78 124.55 52.59 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.561 0.696 . . . . 73.510000000000005 109.259 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -121.24 137.21 54.79 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.803 -1.184 . . . . 75.5 107.803 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . . . . . . . . . 18.1 t -135.95 123.3 21.92 Favored 'General case' 0 N--CA 1.415 -2.182 0 N-CA-C 108.929 -0.767 . . . . 70.209999999999994 108.929 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.02 131.34 72.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.26 -0.882 . . . . 72.349999999999994 109.119 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.629 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 17.2 tp10 -88.36 -54.76 4.03 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.534 -0.543 . . . . 70.519999999999996 109.534 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 55.0 m -150.22 127.44 11.31 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.349 -0.845 . . . . 50.340000000000003 110.842 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.417 HG23 HG23 ' C' ' 231' ' ' ILE . 5.1 m -121.21 128.42 75.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.706 -0.849 . . . . 45.32 108.706 171.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.09 135.53 63.32 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-N 116.34 -0.391 . . . . 74.549999999999997 110.352 -178.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -112.53 133.49 11.4 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 109.866 -1.294 . . . . 51.240000000000002 109.866 175.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt -132.31 116.24 16.64 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.801 -0.444 . . . . 74.430000000000007 109.801 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 82.32 93.16 0.56 Allowed Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.345 -0.931 . . . . 64.099999999999994 113.309 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 55.38 28.4 11.42 Favored 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 124.696 1.198 . . . . 75.219999999999999 111.653 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 46.3 m -82.37 154.89 25.01 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 113.953 1.094 . . . . 61.409999999999997 113.953 -169.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -122.85 128.26 50.14 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.871 -1.059 . . . . 71.140000000000001 108.254 -178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . . . . . . . . . 11.0 t -125.64 130.53 72.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.073 -0.714 . . . . 74.519999999999996 109.073 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -123.55 110.59 15.23 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.284 -1.376 . . . . 75.150000000000006 107.284 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 40.8 mm -113.53 103.95 16.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.072 -1.455 . . . . 62.140000000000001 107.072 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . . . . . . . . . . . 150.05 -152.65 24.53 Favored Glycine 0 CA--C 1.471 -2.676 0 C-N-CA 120.034 -1.079 . . . . 54.310000000000002 111.216 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -115.56 141.15 48.44 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 109.213 -0.662 . . . . 73.239999999999995 109.213 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.69 118.37 34.84 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.143 -1.428 . . . . 74.299999999999997 107.143 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -119.08 124.29 46.55 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.76 0.791 . . . . 71.439999999999998 110.828 176.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.51 -52.92 0.74 Allowed Glycine 0 N--CA 1.419 -2.475 0 C-N-CA 120.072 -1.061 . . . . 22.420000000000002 113.151 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . -151.59 -4.16 0.18 Allowed Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 117.434 -2.317 . . . . 64.409999999999997 115.207 -173.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm 78.47 -40.65 0.28 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.832 1.253 . . . . 71.430000000000007 109.616 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' C' ' 289' ' ' ASN . . . -86.03 110.38 3.47 Favored Glycine 0 N--CA 1.41 -3.067 0 N-CA-C 109.823 -1.311 . . . . 61.299999999999997 109.823 174.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -79.97 -85.84 0.08 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 112.88 0.696 . . . . 61.25 112.88 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -85.12 3.14 40.37 Favored 'General case' 0 C--N 1.316 -0.857 0 O-C-N 120.91 -1.119 . . . . 74.040000000000006 111.486 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 38.4 t70 179.62 145.26 0.18 Allowed 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.842 -1.91 . . . . 74.310000000000002 105.842 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . 0.605 ' HA ' ' HA3' ' C' ' 285' ' ' GLY . 33.4 t-20 -88.89 98.95 12.02 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.176 -1.01 . . . . 74.310000000000002 109.497 -178.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 23.1 m-70 -78.21 -11.09 59.9 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.27 -0.877 . . . . 74.409999999999997 110.459 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 67.9 m80 69.2 -61.36 0.43 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.568 1.547 . . . . 71.349999999999994 112.173 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -90.83 90.37 7.89 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.376 0.608 . . . . 71.129999999999995 109.452 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -135.23 149.57 49.9 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.632 -1.248 . . . . 61.0 107.632 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -83.57 85.26 7.29 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.983 -0.287 . . . . 73.329999999999998 110.919 -178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 . . . . . 0 C--O 1.25 1.102 0 N-CA-C 105.674 -1.973 . . . . 72.040000000000006 105.674 172.972 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' B' ' 221' ' ' ALA . 82.6 mtp . . . . . 0 CA--C 1.512 -0.496 0 N-CA-C 108.528 -0.916 . . . . 72.439999999999998 108.528 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.405 ' HB2' ' HE3' ' A' ' 218' ' ' LYS . 37.3 ttmt 59.6 36.03 22.63 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.174 0.99 . . . . 71.109999999999999 109.299 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 3.2 mp 60.51 71.17 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.052 -1.431 . . . . 71.450000000000003 110.741 -177.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -111.11 1.61 17.41 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.799 -1.091 . . . . 73.420000000000002 109.189 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -86.29 175.4 8.47 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.08 -0.964 . . . . 51.140000000000001 109.529 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 4.7 tp -82.32 119.17 31.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-O 121.691 0.758 . . . . 52.229999999999997 109.11 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 11.8 p -100.75 147.87 7.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.105 -0.952 . . . . 71.140000000000001 108.611 -176.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 84.21 59.04 2.1 Favored Glycine 0 N--CA 1.443 -0.894 0 N-CA-C 110.1 -1.2 . . . . 64.430000000000007 110.1 -176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -142.43 135.33 28.4 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 123.301 0.64 . . . . 72.310000000000002 110.475 -177.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -113.83 127.83 56.16 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 107.606 -1.257 . . . . 74.140000000000001 107.606 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 28.0 m -123.41 137.66 54.76 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.93 -0.396 . . . . 71.450000000000003 109.93 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -133.62 125.38 28.63 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.25 -0.432 . . . . 70.540000000000006 110.284 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 265' ' ' GLU . 12.9 tmtt? -76.3 -62.72 1.52 Allowed 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.723 0.639 . . . . 73.409999999999997 109.749 179.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -133.72 139.14 46.21 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-O 121.319 0.581 . . . . 53.200000000000003 112.543 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 34.5 mm -123.39 117.12 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 N-CA-C 106.774 -1.565 . . . . 71.140000000000001 106.774 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -118.75 115.89 25.41 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.328 0.585 . . . . 71.230000000000004 110.201 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.4 128.27 50.73 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 108.597 -0.89 . . . . 74.140000000000001 108.597 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -137.1 164.1 29.24 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.258 0.349 . . . . 73.430000000000007 110.607 -178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 236' ' ' ARG . 34.7 mt-10 66.99 -88.13 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 124.777 1.231 . . . . 64.5 113.443 174.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.435 ' HD2' ' HB3' ' A' ' 235' ' ' GLU . 0.2 OUTLIER -138.18 27.25 2.62 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 108.174 -1.047 . . . . 71.409999999999997 108.174 -177.494 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -75.13 149.19 39.13 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.166 -0.925 . . . . 61.509999999999998 110.107 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -125.57 135.06 51.82 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 104.861 -2.274 . . . . 75.099999999999994 104.861 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.14 148.47 30.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-O 121.7 0.762 . . . . 71.209999999999994 111.924 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.461 ' CG ' ' HG ' ' A' ' 276' ' ' LEU . 49.9 tp60 -126.87 128.58 46.72 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.96 -1.018 . . . . 72.219999999999999 108.878 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -126.48 118.72 25.51 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 106.66 -1.607 . . . . 53.119999999999997 106.66 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.499 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 135.86 -135.17 7.64 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.197 -1.001 . . . . 61.43 112.409 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -128.82 128.43 43.9 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 122.687 -0.302 . . . . 74.239999999999995 110.272 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 91.3 t -118.29 127.17 75.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 108.718 -0.845 . . . . 74.209999999999994 108.718 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.11 112.76 39.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 108.563 -0.902 . . . . 71.409999999999997 108.563 176.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 50.6 m -81.14 160.08 24.49 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.554 -1.276 . . . . 72.0 107.554 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.41 -36.49 84.33 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.543 0.571 . . . . 74.450000000000003 112.543 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.54 -34.89 65.11 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 114.32 1.23 . . . . 73.120000000000005 114.32 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -63.27 -46.06 88.59 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.75 1.019 . . . . 62.210000000000001 113.75 -173.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 66.4 tp 57.86 71.54 0.57 Allowed 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.352 1.072 . . . . 62.310000000000002 109.953 -171.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -86.32 155.18 20.74 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.825 -1.079 . . . . 72.049999999999997 108.691 -177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -147.35 -127.35 1.75 Allowed Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 110.611 -0.996 . . . . 65.310000000000002 110.611 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -149.64 43.05 0.77 Allowed Glycine 0 N--CA 1.432 -1.593 0 C-N-CA 120.513 -0.851 . . . . 74.310000000000002 112.445 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 6.4 pt -107.86 121.15 60.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-O 120.696 0.284 . . . . 72.409999999999997 110.24 176.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.81 -178.04 0.21 Allowed 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.57 1.148 . . . . 72.430000000000007 110.219 -172.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.3 tt -107.64 108.37 25.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.346 -1.353 . . . . 75.439999999999998 107.346 173.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.1 m -83.35 -34.8 25.54 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.12 -0.491 . . . . 62.399999999999999 111.397 -175.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -102.24 106.64 17.49 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.375 -0.93 . . . . 63.020000000000003 111.719 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -119.8 20.57 12.23 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.213 -1.358 . . . . 75.209999999999994 108.078 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . . . . . . . . . 11.0 m -81.23 124.77 29.58 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-N 115.783 -0.644 . . . . 71.030000000000001 110.957 -175.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' B' ' 225' ' ' ARG . 36.2 p -107.92 108.18 19.22 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 106.539 -1.652 . . . . 71.340000000000003 106.539 168.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 0.2 OUTLIER -126.52 122.21 34.51 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.102 -0.703 . . . . 72.329999999999998 109.102 -174.529 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.409 ' N ' HD22 ' A' ' 262' ' ' ASN . 35.3 m -122.92 123.15 40.29 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.697 -0.483 . . . . 74.420000000000002 109.697 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.1 p -115.74 140.52 37.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.01 0.433 . . . . 65.209999999999994 110.629 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.597 ' HB3' ' O ' ' B' ' 229' ' ' LYS . 22.7 tp10 -82.78 -69.2 0.64 Allowed 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.165 -0.925 . . . . 71.540000000000006 110.548 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 13.5 m -133.73 129.22 36.4 Favored 'General case' 0 C--N 1.312 -1.063 0 O-C-N 121.535 -0.728 . . . . 62.310000000000002 111.814 -177.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 24.0 m -118.1 127.28 75.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.814 -1.18 . . . . 72.209999999999994 107.814 170.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.72 127.07 73.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-O 121.116 0.484 . . . . 74.439999999999998 111.533 -178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.84 133.57 11.53 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 115.623 -0.717 . . . . 64.510000000000005 111.762 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -125.06 144.17 50.54 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 124.179 0.992 . . . . 61.310000000000002 109.28 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 65.21 -132.06 35.99 Favored Glycine 0 C--N 1.305 -1.149 0 C-N-CA 121.212 -0.518 . . . . 63.409999999999997 112.931 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' B' ' 235' ' ' GLU . 8.7 mm-40 -92.79 53.65 2.07 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 125.201 1.4 . . . . 75.099999999999994 111.413 -177.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 73.5 m -83.1 150.03 26.53 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.166 0.508 . . . . 72.340000000000003 112.113 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -128.61 127.47 42.32 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.183 -1.414 . . . . 64.409999999999997 107.183 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.463 HG13 HG23 ' B' ' 239' ' ' VAL . 16.4 t -132.71 130.09 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.203 0 N-CA-C 109.094 -0.706 . . . . 73.120000000000005 109.094 -177.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.461 ' HG ' ' CG ' ' A' ' 240' ' ' GLN . 5.8 tt -118.31 121.55 40.67 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.879 -1.156 . . . . 72.409999999999997 107.879 174.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.448 HG23 HD12 ' B' ' 241' ' ' LEU . 3.5 mp -112.23 104.36 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.982 0 N-CA-C 107.303 -1.369 . . . . 55.140000000000001 107.303 177.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 242' ' ' GLY . . . 151.54 -145.27 12.88 Favored Glycine 0 N--CA 1.421 -2.309 0 N-CA-C 111.064 -0.814 . . . . 25.530000000000001 111.064 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.515 ' OD1' ' HB3' ' B' ' 243' ' ' ASN . 95.7 m-20 -114.3 140.2 48.81 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 116.735 0.267 . . . . 72.409999999999997 110.594 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' B' ' 244' ' ' VAL . 0.8 OUTLIER -128.16 129.54 46.68 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.796 -1.557 . . . . 73.209999999999994 106.796 178.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -119.4 124.62 47.0 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 109.349 -0.612 . . . . 71.519999999999996 109.349 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . 0.417 ' CA ' ' HB2' ' A' ' 249' ' ' ALA . . . 136.42 -50.65 0.83 Allowed Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 111.254 -0.739 . . . . 72.239999999999995 111.254 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 98.12 39.21 3.84 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 109.546 -1.422 . . . . 73.049999999999997 109.546 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -141.04 -56.37 0.5 Allowed 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.318 -0.553 . . . . 75.129999999999995 109.641 -177.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.612 ' HA3' ' CZ3' ' A' ' 287' ' ' TRP . . . 72.21 -159.53 53.74 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.494 -0.776 . . . . 65.030000000000001 114.907 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -105.24 -0.18 26.62 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.351 -0.425 . . . . 71.209999999999994 109.92 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . 0.612 ' CZ3' ' HA3' ' A' ' 285' ' ' GLY . 24.2 m-90 -58.9 -27.18 64.99 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.54 -0.755 . . . . 63.549999999999997 111.944 -174.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -167.2 140.94 3.66 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.288 -1.005 . . . . 73.439999999999998 108.288 174.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -109.04 24.34 13.26 Favored 'General case' 0 CA--C 1.557 1.228 0 CA-C-O 121.641 0.734 . . . . 62.329999999999998 110.405 -175.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -125.05 163.9 21.36 Favored 'General case' 0 C--O 1.252 1.194 0 O-C-N 121.026 -1.046 . . . . 63.450000000000003 109.976 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -81.77 87.68 6.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 104.682 -2.34 . . . . 74.420000000000002 104.682 165.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . 0.443 ' CD2' ' H ' ' A' ' 292' ' ' HIS . 2.7 p80 -94.41 -82.18 0.37 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 114.59 1.33 . . . . 71.030000000000001 114.59 -169.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . 0.427 ' H ' ' CG ' ' A' ' 292' ' ' HIS . 75.9 m-70 -133.69 87.67 2.4 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.603 0.716 . . . . 74.040000000000006 112.783 -175.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -122.62 76.06 1.31 Allowed 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 104.407 -2.442 . . . . 73.409999999999997 104.407 171.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 107.835 -1.172 . . . . 50.130000000000003 107.835 -171.127 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 67.7 mtm . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 111.665 0.246 . . . . 74.239999999999995 111.665 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -81.52 16.41 1.72 Allowed 'General case' 0 N--CA 1.473 0.716 0 O-C-N 121.824 -0.547 . . . . 61.340000000000003 111.474 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 11.5 tt -163.22 137.82 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.919 0 C-N-CA 124.018 0.927 . . . . 73.099999999999994 108.852 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.42 117.23 19.38 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.952 -1.499 . . . . 40.140000000000001 106.952 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.422 ' HA ' ' SD ' ' A' ' 217' ' ' MET . . . -162.66 -171.75 2.85 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.373 -0.973 . . . . 74.349999999999994 108.373 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 7.0 tp -83.84 129.35 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 108.462 -0.94 . . . . 73.219999999999999 108.462 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 5.5 p -124.41 151.85 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.239 0 N-CA-C 107.08 -1.452 . . . . 72.120000000000005 107.08 -178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 92.86 39.01 5.33 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 108.866 -1.693 . . . . 72.420000000000002 108.866 -173.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.408 ' HA ' ' O ' ' A' ' 261' ' ' THR . 13.9 ptt180 -124.38 141.34 52.16 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 121.589 0.709 . . . . 75.109999999999999 111.527 -176.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 48.0 t-20 -116.85 127.63 54.48 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 106.342 -1.725 . . . . 72.420000000000002 106.342 172.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 19.5 m -125.75 136.37 53.09 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 109.11 -0.7 . . . . 74.25 109.11 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.502 ' HB1' HD11 ' B' ' 231' ' ' ILE . . . -131.39 127.66 37.97 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.808 -0.633 . . . . 62.420000000000002 110.447 -175.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.597 ' O ' ' HB3' ' A' ' 265' ' ' GLU . 12.1 tmtt? -81.73 -68.12 0.72 Allowed 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.686 -0.688 . . . . 44.420000000000002 109.656 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -127.38 137.48 52.77 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 119.374 -0.93 . . . . 71.230000000000004 110.961 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.502 HD11 ' HB1' ' B' ' 228' ' ' ALA . 35.9 mm -129.77 117.13 40.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 106.544 -1.65 . . . . 72.230000000000004 106.544 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . 0.585 ' HD3' ' OE2' ' B' ' 234' ' ' GLU . 18.2 ttm180 -118.47 124.31 47.29 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 120.696 0.284 . . . . 71.109999999999999 110.59 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 73.1 p -115.46 128.23 55.87 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.252 -1.018 . . . . 72.420000000000002 108.252 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . 0.585 ' OE2' ' HD3' ' B' ' 232' ' ' ARG . 59.3 mt-10 -127.01 156.24 41.94 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.132 0.491 . . . . 74.340000000000003 111.043 178.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' B' ' 236' ' ' ARG . 49.3 mt-10 66.68 -86.85 0.03 OUTLIER 'General case' 0 C--O 1.202 -1.443 0 N-CA-C 114.38 1.252 . . . . 75.329999999999998 114.38 172.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . 0.462 ' HD2' ' HB3' ' B' ' 235' ' ' GLU . 0.8 OUTLIER -135.59 31.84 3.08 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.31 -0.996 . . . . 60.119999999999997 108.31 -178.297 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' B' ' 233' ' ' THR . . . -76.56 141.91 40.99 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.106 -0.952 . . . . 74.5 111.745 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' B' ' 274' ' ' ARG . 7.1 mpt_? -125.12 133.86 52.68 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.895 -1.52 . . . . 70.549999999999997 106.895 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.573 HG12 ' HB ' ' B' ' 275' ' ' VAL . 21.7 m -140.97 151.41 20.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.419 0.628 . . . . 54.229999999999997 112.331 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.502 ' CG ' ' HG ' ' B' ' 276' ' ' LEU . 38.3 tp60 -119.43 137.31 53.85 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.019 -1.446 . . . . 71.340000000000003 108.728 177.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.448 HD12 HG23 ' A' ' 277' ' ' ILE . 2.7 tm? -129.39 117.96 21.43 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.212 -1.773 . . . . 75.420000000000002 106.212 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.564 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 131.33 -131.8 6.53 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.504 -0.855 . . . . 40.219999999999999 112.886 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.515 ' HB3' ' OD1' ' A' ' 279' ' ' ASN . 23.8 t-20 -125.38 136.3 53.3 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 122.491 -0.417 . . . . 70.150000000000006 110.912 -177.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 280' ' ' GLU . 93.8 t -126.77 128.36 70.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.366 -0.975 . . . . 74.209999999999994 108.366 175.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . . . . . . . . . 61.9 t -120.38 112.83 38.06 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 108.182 -1.044 . . . . 72.549999999999997 108.182 174.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.45 HG21 ' HB3' ' B' ' 284' ' ' LYS . 28.4 m -76.68 160.74 29.11 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 106.776 -1.564 . . . . 73.430000000000007 106.776 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.08 -33.87 76.38 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 122.109 0.956 . . . . 51.329999999999998 110.74 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.5 -34.4 64.58 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.404 -1.725 . . . . 71.5 114.117 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.441 ' O ' ' HB3' ' B' ' 250' ' ' LEU . . . -59.83 -26.09 65.52 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.562 0.949 . . . . 73.349999999999994 113.562 -174.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' B' ' 249' ' ' ALA . 53.6 tp 78.92 86.76 0.06 Allowed 'General case' 0 C--O 1.246 0.895 0 O-C-N 124.473 1.108 . . . . 70.420000000000002 110.781 -174.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -59.96 114.45 2.83 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.408 -1.269 . . . . 53.32 110.346 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . 82.44 17.39 68.88 Favored Glycine 0 N--CA 1.435 -1.37 0 CA-C-N 115.563 -0.744 . . . . 53.240000000000002 113.586 176.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -69.88 -48.91 38.37 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.5 -0.857 . . . . 62.140000000000001 112.02 177.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . . . . . . . . . 10.4 tp -165.91 160.99 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 105.957 -1.868 . . . . 55.140000000000001 105.957 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -87.28 136.55 32.89 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 118.695 0.68 . . . . 64.409999999999997 109.615 176.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 3.2 mp -129.17 79.06 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.135 -1.432 . . . . 61.509999999999998 107.135 172.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 4.7 p -92.21 102.94 15.46 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.534 -0.757 . . . . 52.409999999999997 110.849 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -90.04 165.58 13.94 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.627 -0.715 . . . . 72.430000000000007 109.933 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . 0.514 ' HG3' HD11 ' C' ' 254' ' ' ILE . 97.9 mt-30 -100.99 40.56 1.26 Allowed 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 122.907 0.483 . . . . 75.230000000000004 109.977 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . 0.401 HG21 ' HB2' ' C' ' 243' ' ' ASN . 2.4 m -64.78 121.53 14.78 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.62 -0.718 . . . . 75.519999999999996 110.831 -178.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 8.9 t -126.77 108.75 11.32 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 106.356 -1.72 . . . . 54.109999999999999 106.356 166.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 0.2 OUTLIER -124.42 128.25 48.75 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.279 -1.008 . . . . 61.299999999999997 108.279 -172.475 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 33.1 m -129.27 123.66 32.47 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.889 -0.411 . . . . 73.430000000000007 109.889 178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.51 141.22 28.77 Favored 'Isoleucine or valine' 0 C--O 1.25 1.121 0 CA-C-N 115.977 -0.556 . . . . 70.25 109.749 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' C' ' 229' ' ' LYS . 20.7 tp10 -83.37 -58.04 3.0 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.582 -0.735 . . . . 74.040000000000006 110.315 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' C' ' 230' ' ' ASP . 80.4 m -149.75 133.16 16.55 Favored 'General case' 0 C--N 1.31 -1.125 0 O-C-N 121.372 -0.83 . . . . 61.119999999999997 112.428 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 12.2 m -118.5 134.68 61.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.767 -1.197 . . . . 74.329999999999998 107.767 171.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 21.8 m -125.88 122.82 62.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.033 0.444 . . . . 75.230000000000004 110.629 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -109.99 132.86 11.26 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 120.466 -0.873 . . . . 74.150000000000006 111.893 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' C' ' 234' ' ' GLU . 29.3 mmmt -126.39 147.12 49.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 124.213 1.005 . . . . 72.230000000000004 109.236 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 66.41 -136.25 34.23 Favored Glycine 0 C--O 1.228 -0.259 0 C-N-CA 120.009 -1.091 . . . . 62.140000000000001 110.516 -178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -97.35 69.55 2.26 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.866 0.841 . . . . 72.25 111.277 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . . . . . . . . . 72.3 m -85.67 146.46 26.83 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.12 -0.945 . . . . 74.140000000000001 111.366 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' B' ' 238' ' ' ARG . 8.8 mpt_? -127.49 127.11 43.47 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 106.706 -1.59 . . . . 74.519999999999996 106.706 169.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.573 ' HB ' HG12 ' B' ' 239' ' ' VAL . 21.7 t -134.16 139.13 48.86 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 108.282 -1.007 . . . . 52.43 108.282 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . 0.502 ' HG ' ' CG ' ' B' ' 240' ' ' GLN . 6.5 tt -123.56 125.44 44.87 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 106.706 -1.59 . . . . 65.219999999999999 106.706 173.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.411 HG23 HD12 ' C' ' 241' ' ' LEU . 4.0 mp -112.57 104.06 16.44 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 105.903 -1.888 . . . . 73.439999999999998 105.903 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' B' ' 242' ' ' GLY . . . 153.35 -149.24 20.74 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.164 -1.017 . . . . 60.210000000000001 113.26 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -110.04 133.56 53.07 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.019 -0.734 . . . . 64.219999999999999 109.019 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' C' ' 244' ' ' VAL . 2.2 tm-20 -126.65 128.08 46.2 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 106.507 -1.664 . . . . 70.420000000000002 106.507 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -118.58 125.06 49.0 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 109.143 -0.688 . . . . 64.349999999999994 109.143 178.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . . . . . . . . . . . 137.02 -43.29 1.24 Allowed Glycine 0 N--CA 1.417 -2.621 0 N-CA-C 110.498 -1.041 . . . . 43.210000000000001 110.498 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . . . . . . . . . . . 87.39 36.14 9.0 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.319 -1.512 . . . . 73.109999999999999 109.319 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' B' ' 289' ' ' ASN . 49.4 tptt -142.56 -62.27 0.43 Allowed 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.873 -0.417 . . . . 71.319999999999993 109.873 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . 0.438 ' HA3' ' CZ3' ' B' ' 287' ' ' TRP . . . 68.95 -159.67 52.66 Favored Glycine 0 N--CA 1.44 -1.079 0 O-C-N 123.408 0.443 . . . . 63.149999999999999 113.821 175.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -102.26 -6.8 22.72 Favored 'General case' 0 C--O 1.244 0.773 0 C-N-CA 121.086 -0.246 . . . . 75.430000000000007 111.223 -175.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . 0.477 ' HB3' ' HG2' ' C' ' 238' ' ' ARG . 26.6 m-90 -57.88 -64.97 0.72 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.907 0.86 . . . . 74.430000000000007 110.169 -175.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -118.65 79.74 1.43 Allowed 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 101.947 -3.353 . . . . 72.209999999999994 101.947 173.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . 0.487 ' O ' ' HE3' ' B' ' 284' ' ' LYS 0.279 18.0 p30 -49.47 -76.21 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 118.731 2.863 . . . . 75.519999999999996 118.731 -164.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -155.5 151.13 27.33 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 118.234 -1.386 . . . . 64.340000000000003 112.925 -171.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -67.67 158.89 31.17 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.97 -1.863 . . . . 65.209999999999994 105.97 170.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -68.14 86.27 0.26 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 122.405 1.098 . . . . 75.510000000000005 113.248 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -93.75 109.99 21.64 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 105.331 -2.1 . . . . 72.450000000000003 105.331 178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -82.4 68.85 9.0 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.384 1.088 . . . . 62.329999999999998 111.821 -176.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 N--CA 1.422 -1.836 0 N-CA-C 104.349 -2.463 . . . . 75.439999999999998 104.349 -179.867 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 56.9 ttp . . . . . 0 CA--C 1.517 -0.323 0 N-CA-C 109.888 -0.412 . . . . 74.239999999999995 109.888 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt 77.9 -30.71 0.16 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.861 1.264 . . . . 65.430000000000007 113.553 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 39.3 mm -61.51 -39.74 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 106.201 -1.778 . . . . 62.030000000000001 106.201 169.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.05 -73.19 0.15 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 112.905 -1.952 . . . . 74.409999999999997 109.479 170.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . 65.09 -71.92 0.07 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.962 1.705 . . . . 74.510000000000005 113.224 176.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 7.7 tp -84.59 115.75 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-O 121.803 0.811 . . . . 74.099999999999994 110.889 -176.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 10.3 p -115.92 142.39 29.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.766 -1.198 . . . . 61.200000000000003 107.766 177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . 95.96 44.78 3.01 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 109.51 -1.436 . . . . 54.240000000000002 109.51 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -128.98 145.71 51.17 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 120.097 -0.641 . . . . 71.349999999999994 111.753 -175.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 26.5 t-20 -117.28 127.0 53.64 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.743 -1.206 . . . . 72.349999999999994 107.743 173.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' C' ' 263' ' ' SER . 19.5 m -126.37 137.22 53.43 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 108.785 -0.82 . . . . 74.5 108.785 177.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.41 ' HB1' HD11 ' C' ' 231' ' ' ILE . . . -136.29 132.39 35.66 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.887 -0.325 . . . . 64.150000000000006 110.639 -176.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.613 ' HB3' ' O ' ' C' ' 265' ' ' GLU . 0.0 OUTLIER -80.14 -76.34 0.23 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.274 -0.639 . . . . 75.510000000000005 109.274 178.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' B' ' 266' ' ' THR . 2.1 p-10 -129.09 140.51 51.54 Favored 'General case' 0 C--O 1.264 1.848 0 C-N-CA 118.062 -1.455 . . . . 70.230000000000004 112.216 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.41 HD11 ' HB1' ' C' ' 228' ' ' ALA . 28.0 mm -119.27 117.07 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.945 0 CA-C-N 113.055 -1.884 . . . . 63.299999999999997 106.26 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . 0.47 ' HD3' ' OE2' ' C' ' 234' ' ' GLU . 17.9 ttm180 -111.75 123.67 50.73 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.907 -0.405 . . . . 73.430000000000007 109.907 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.53 ' HB ' ' HB3' ' C' ' 237' ' ' ALA . 72.0 p -116.96 128.37 55.13 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.003 -1.11 . . . . 71.239999999999995 108.003 175.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.47 ' OE2' ' HD3' ' C' ' 232' ' ' ARG . 49.2 mt-10 -127.31 160.74 30.42 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 120.586 -0.446 . . . . 73.319999999999993 111.361 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 63.43 -82.02 0.03 OUTLIER 'General case' 0 C--O 1.212 -0.908 0 C-N-CA 124.94 1.296 . . . . 71.540000000000006 114.343 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.45 ' O ' ' HD2' ' C' ' 238' ' ' ARG . 0.2 OUTLIER -139.44 25.95 2.39 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.595 -0.891 . . . . 71.430000000000007 108.595 -178.433 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.53 ' HB3' ' HB ' ' C' ' 233' ' ' THR . . . -71.23 141.83 50.59 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.826 0.822 . . . . 74.439999999999998 112.106 -177.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 9.1 mpt_? -124.55 133.43 53.3 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 106.454 -1.684 . . . . 75.030000000000001 106.454 175.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.503 HG23 HG13 ' B' ' 275' ' ' VAL . 21.2 m -142.94 150.18 18.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.707 0.765 . . . . 65.409999999999997 112.397 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.415 ' HB2' ' CZ2' ' B' ' 287' ' ' TRP . 5.2 tp60 -112.33 137.42 50.5 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.248 -1.342 . . . . 73.200000000000003 109.062 176.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' C' ' 277' ' ' ILE . 2.8 tm? -128.13 117.53 21.78 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 105.278 -2.119 . . . . 72.450000000000003 105.278 172.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.485 ' O ' ' HA3' ' C' ' 278' ' ' GLY . . . 130.93 -133.07 7.11 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.191 -1.004 . . . . 43.219999999999999 112.721 -178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.401 ' HB2' HG21 ' B' ' 260' ' ' THR . 40.8 t30 -128.99 138.56 52.02 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 122.233 -0.569 . . . . 73.109999999999999 110.716 -176.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.533 ' HA ' ' O ' ' B' ' 280' ' ' GLU . 96.7 t -126.09 118.48 51.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 109.213 -0.662 . . . . 63.140000000000001 109.213 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.12 112.72 41.7 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 108.347 -0.983 . . . . 71.0 108.347 175.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 19.4 m -79.52 160.38 26.53 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.054 -1.461 . . . . 54.43 107.054 177.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.86 -33.07 72.52 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.1 0.952 . . . . 75.319999999999993 110.644 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.48 -33.33 63.6 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.236 -1.802 . . . . 75.340000000000003 113.848 -178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -62.62 -46.72 86.95 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.536 1.31 . . . . 64.430000000000007 114.536 -172.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 54.44 -86.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.835 0.854 . . . . 71.349999999999994 112.158 -173.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . 0.437 ' CD2' ' HA ' ' C' ' 254' ' ' ILE . 3.7 t60 67.96 -54.85 0.5 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.456 1.902 . . . . 63.149999999999999 112.696 176.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . 91.56 65.64 1.15 Allowed Glycine 0 CA--C 1.501 -0.809 0 N-CA-C 109.873 -1.291 . . . . 75.439999999999998 109.873 -177.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 79.03 -140.27 22.92 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 107.24 -2.344 . . . . 53.5 107.24 -171.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . 0.514 HD11 ' HG3' ' B' ' 259' ' ' GLN . 41.6 pt -138.27 133.7 43.58 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-N 117.799 0.799 . . . . 63.329999999999998 109.606 172.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -81.11 -27.27 35.65 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.66 -1.607 . . . . 72.430000000000007 106.66 173.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 13.2 tt 176.9 145.4 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 105.105 -2.183 . . . . 71.319999999999993 105.105 174.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 6.7 m -74.82 -68.93 0.5 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.053 -1.462 . . . . 75.120000000000005 107.053 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . . . . . . . . . 31.0 t70 168.17 161.74 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 103.57 -2.752 . . . . 71.299999999999997 103.57 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -88.18 39.72 0.91 Allowed 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 118.683 0.674 . . . . 75.299999999999997 110.103 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 18.4 m -70.57 121.9 18.71 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.194 -0.912 . . . . 74.030000000000001 111.031 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 10.3 t -129.03 107.87 9.94 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 105.236 -2.135 . . . . 64.120000000000005 105.236 168.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -126.72 139.0 53.47 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.497 -0.774 . . . . 63.329999999999998 110.922 -173.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' C' ' 227' ' ' SER . 42.3 m -139.89 123.56 17.33 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 107.863 -1.162 . . . . 74.299999999999997 107.863 176.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 9.6 p -109.87 152.88 11.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 120.819 -0.352 . . . . 65.129999999999995 110.104 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' C' ' 229' ' ' LYS . 10.1 tp10 -88.25 -69.72 0.68 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.154 -0.475 . . . . 61.140000000000001 109.989 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . . . . . . . . . 90.5 m -140.46 130.73 25.08 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.897 -0.409 . . . . 73.340000000000003 109.897 -176.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.21 133.6 67.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 108.804 -0.813 . . . . 74.340000000000003 108.804 171.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 29.7 m -121.5 129.05 75.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 121.166 0.508 . . . . 64.510000000000005 111.154 -177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -111.54 133.47 11.5 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.433 -1.067 . . . . 53.32 110.433 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . 0.427 ' HD2' ' HB2' ' C' ' 234' ' ' GLU . 28.4 mmmt -132.07 131.52 42.48 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 123.124 0.569 . . . . 52.240000000000002 109.852 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . . . . . . . . . . . 68.56 -133.02 27.51 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 115.782 -0.645 . . . . 43.420000000000002 112.263 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -79.35 47.39 0.8 Allowed 'General case' 0 C--N 1.305 -1.37 0 C-N-CA 125.063 1.345 . . . . 71.420000000000002 113.127 -176.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . . . . . . . . . 50.7 m -83.4 145.44 29.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.555 0.693 . . . . 74.519999999999996 112.853 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 10.2 mpt_? -130.6 127.04 38.2 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 106.537 -1.653 . . . . 62.310000000000002 106.537 170.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.439 ' HB ' HG12 ' C' ' 239' ' ' VAL . 10.0 t -137.83 140.73 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 108.771 -0.826 . . . . 61.049999999999997 108.771 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . 0.456 ' HB3' ' CZ2' ' C' ' 287' ' ' TRP . 6.8 tt -123.32 114.14 19.8 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.815 -1.18 . . . . 72.310000000000002 107.815 175.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' C' ' 241' ' ' LEU . 3.4 mp -104.57 104.19 16.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 105.532 -2.025 . . . . 64.420000000000002 105.532 176.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 159.26 -139.67 6.36 Favored Glycine 0 N--CA 1.41 -3.059 0 C-N-CA 119.4 -1.381 . . . . 73.230000000000004 112.402 -178.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -127.79 142.97 51.15 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 107.165 -1.42 . . . . 73.209999999999994 107.165 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -141.93 132.62 25.56 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.218 -0.66 . . . . 60.310000000000002 109.218 -174.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -121.48 133.58 55.05 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.221 0.534 . . . . 74.129999999999995 111.023 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 122.86 -36.39 3.12 Favored Glycine 0 CA--C 1.483 -1.927 0 N-CA-C 110.002 -1.239 . . . . 73.239999999999995 110.002 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . . . . . . . . . . . 86.28 32.87 15.53 Favored Glycine 0 N--CA 1.419 -2.436 0 N-CA-C 111.422 -0.671 . . . . 54.219999999999999 111.422 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -131.92 -54.78 0.99 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.837 -0.801 . . . . 74.299999999999997 108.837 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . 0.414 ' HA3' ' CE3' ' C' ' 287' ' ' TRP . . . 69.21 -172.28 38.07 Favored Glycine 0 N--CA 1.431 -1.637 0 CA-C-N 115.244 -0.889 . . . . 75.549999999999997 112.45 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -91.2 -5.73 54.47 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 110.429 -0.212 . . . . 73.409999999999997 110.429 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . 0.456 ' CZ2' ' HB3' ' C' ' 276' ' ' LEU . 27.6 m-90 -51.75 -50.13 61.25 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.55 0.69 . . . . 75.150000000000006 110.518 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -143.89 112.28 6.42 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.563 -1.198 . . . . 75.25 108.844 179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . 0.439 ' HB3' ' HD3' ' B' ' 284' ' ' LYS . 48.0 t-20 -135.46 86.45 2.24 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 107.462 -1.31 . . . . 70.230000000000004 107.462 173.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -136.11 129.92 32.55 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.815 -1.539 . . . . 74.409999999999997 106.912 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -83.45 -34.83 25.35 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.816 -0.354 . . . . 75.319999999999993 110.801 178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . . . . . . . . . 33.7 m170 67.87 27.82 7.2 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.095 0.958 . . . . 74.099999999999994 110.453 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -94.57 98.85 11.12 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 114.625 -1.171 . . . . 62.450000000000003 108.145 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -75.8 125.73 29.64 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.171 -0.922 . . . . 71.510000000000005 109.788 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 . . . . . 0 C--O 1.24 0.58 0 O-C-N 124.396 1.06 . . . . 45.109999999999999 111.651 174.416 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 121.328 0.585 . . . . 52.329999999999998 109.96 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -133.6 131.1 39.25 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 108.605 -0.887 . . . . 74.329999999999998 108.605 -175.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.518 ' HB ' ' CB ' ' B' ' 221' ' ' ALA . 2.5 mp -107.15 74.11 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 105.545 -2.02 . . . . 74.239999999999995 105.545 170.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -123.42 85.37 2.41 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 112.95 -1.932 . . . . 51.509999999999998 108.286 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -161.46 -178.45 6.63 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 105.413 -2.069 . . . . 73.310000000000002 105.413 -176.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 2.4 mp -83.15 114.81 24.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 N-CA-C 108.346 -0.983 . . . . 64.329999999999998 108.346 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 10.0 p -117.0 122.41 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.934 0 N-CA-C 108.904 -0.776 . . . . 64.120000000000005 108.904 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 169.76 55.12 0.04 OUTLIER Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 110.048 -1.221 . . . . 51.200000000000003 110.048 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.484 ' HG2' ' OG1' ' A' ' 261' ' ' THR . 14.0 ptt180 -92.24 139.34 30.71 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.19 -0.671 . . . . 74.319999999999993 109.19 -177.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ASN . . . . . 0.401 HD21 HG22 ' A' ' 277' ' ' ILE . 24.2 t-20 -116.19 114.72 24.83 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.063 -0.717 . . . . 63.5 109.063 178.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 26.9 m -134.83 137.91 43.74 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.453 0.538 . . . . 62.119999999999997 112.453 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -132.9 135.33 45.51 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.418 -1.327 . . . . 70.530000000000001 107.418 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -55.25 3.36 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.578 -0.849 . . . . 74.420000000000002 110.493 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -139.63 139.05 36.62 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 122.279 -0.263 . . . . 61.130000000000003 110.491 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.483 HG21 HG21 ' A' ' 239' ' ' VAL . 30.0 mt -137.82 125.8 31.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 108.822 -0.807 . . . . 62.229999999999997 108.822 -177.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ARG . . . . . 0.494 ' HB3' HG12 ' A' ' 268' ' ' VAL . 35.2 ttt180 -126.05 122.34 35.55 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 108.151 -1.055 . . . . 72.329999999999998 108.151 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.509 ' OG1' ' HB1' ' A' ' 237' ' ' ALA . 14.3 t -135.27 130.78 35.69 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 120.014 -0.674 . . . . 41.310000000000002 109.396 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -135.2 140.75 45.56 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 112.177 0.436 . . . . 71.420000000000002 112.177 -176.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 66.68 106.53 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.02 1.328 . . . . 54.329999999999998 113.361 174.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 272' ' ' GLU . 47.6 mtt85 57.46 35.01 25.41 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 122.807 1.289 . . . . 74.549999999999997 107.564 176.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.509 ' HB1' ' OG1' ' A' ' 233' ' ' THR . . . -83.7 128.71 34.73 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-N 112.81 -1.996 . . . . 70.450000000000003 112.633 -170.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -129.86 135.06 47.94 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 106.878 -1.527 . . . . 72.409999999999997 106.878 174.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.483 HG21 HG21 ' A' ' 231' ' ' ILE . 6.7 p -143.68 140.1 25.74 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.646 -0.501 . . . . 74.519999999999996 109.646 175.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . 0.55 ' HB2' ' CD1' ' A' ' 286' ' ' PHE . 11.7 tm0? -125.82 136.99 53.74 Favored 'General case' 0 N--CA 1.405 -2.68 0 N-CA-C 106.431 -1.692 . . . . 70.109999999999999 106.431 177.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 3.9 tt -128.73 117.22 20.76 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 105.704 -1.962 . . . . 74.430000000000007 105.704 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.513 ' O ' ' HA3' ' A' ' 278' ' ' GLY . . . 135.26 -119.23 2.06 Favored Glycine 0 N--CA 1.434 -1.498 0 C-N-CA 120.367 -0.92 . . . . 53.119999999999997 113.338 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -144.43 139.53 28.42 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.032 -1.099 . . . . 73.549999999999997 108.032 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.435 ' HB ' ' HG2' ' A' ' 280' ' ' GLU . 22.5 t -125.79 121.44 59.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 109.465 -0.568 . . . . 42.549999999999997 109.465 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.76 112.64 34.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 N-CA-C 107.996 -1.113 . . . . 52.219999999999999 107.996 170.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 281' ' ' TYR . 6.4 t -89.35 160.55 16.79 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 118.7 -1.2 . . . . 73.409999999999997 109.588 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.67 74.38 Favored 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 123.156 0.582 . . . . 74.230000000000004 110.15 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -55.98 -35.5 66.82 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.167 -0.924 . . . . 53.43 112.138 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ALA . . . . . 0.53 ' HA ' ' HB2' ' B' ' 247' ' ' ALA . . . -70.71 -37.49 73.55 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.543 -0.299 . . . . 73.109999999999999 110.614 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 24.0 tp 65.65 33.31 8.51 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.447 1.099 . . . . 61.039999999999999 110.011 -178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 32.6 m80 69.19 119.41 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.363 1.465 . . . . 73.409999999999997 113.579 -177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.446 ' O ' HG13 ' B' ' 254' ' ' ILE . . . -79.83 70.95 2.8 Favored Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 109.563 -1.415 . . . . 74.409999999999997 109.563 175.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 135.36 -141.32 12.52 Favored Glycine 0 N--CA 1.425 -2.056 0 N-CA-C 108.962 -1.655 . . . . 45.439999999999998 108.962 -176.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ILE . . . . . . . . . . . . . 33.3 pt -91.11 -32.07 5.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 121.905 0.86 . . . . 72.329999999999998 109.231 175.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -146.46 -156.73 0.74 Allowed 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 103.572 -2.751 . . . . 75.230000000000004 103.572 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 35.0 pt -75.62 148.85 7.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 106.306 -1.738 . . . . 64.219999999999999 106.306 170.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 10.8 p -93.7 -68.59 0.79 Allowed 'General case' 0 C--N 1.282 -2.34 0 C-N-CA 119.688 -0.805 . . . . 72.439999999999998 109.72 -178.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . 0.383 4.2 m-20 59.67 170.61 0.08 Allowed 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 117.111 2.263 . . . . 32.32 117.111 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.456 ' NE2' ' HA3' ' B' ' 224' ' ' GLY . 0.4 OUTLIER 167.31 -21.51 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.105 -2.183 . . . . 71.120000000000005 105.105 -169.197 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' THR . . . . . 0.409 ' H ' ' H ' ' A' ' 259' ' ' GLN . 0.4 OUTLIER -63.16 119.71 10.08 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 113.558 -1.656 . . . . 65.540000000000006 110.36 -174.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.484 ' OG1' ' HG2' ' A' ' 225' ' ' ARG . 10.8 t -112.65 115.33 28.41 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 105.138 -2.171 . . . . 70.319999999999993 105.138 172.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' ASN . . . . . 0.588 ' HA ' ' O ' ' B' ' 226' ' ' ASN . 23.2 t-20 -122.1 127.07 49.71 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.564 -0.744 . . . . 63.32 111.786 -168.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 5.3 t -135.68 123.75 22.91 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 109.046 -0.724 . . . . 63.119999999999997 109.046 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.561 ' HA ' ' O ' ' B' ' 228' ' ' ALA . 7.5 p -126.55 147.42 31.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 109.044 -0.725 . . . . 63.229999999999997 109.044 177.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -96.91 -75.86 0.53 Allowed 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 119.612 -0.835 . . . . 62.119999999999997 111.208 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 63.3 m -117.33 127.27 53.89 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.336 0.588 . . . . 62.450000000000003 110.831 -177.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.449 HG11 HD11 ' A' ' 277' ' ' ILE . 1.4 p -134.0 123.99 45.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.876 -0.602 . . . . 70.409999999999997 110.903 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 232' ' ' ARG . 21.6 m -124.4 138.27 54.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-N 115.536 -0.756 . . . . 61.140000000000001 111.517 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -125.2 131.38 7.68 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 109.508 -1.437 . . . . 70.5 109.508 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.31 116.18 14.95 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 122.66 0.384 . . . . 60.119999999999997 110.976 -174.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 78.47 74.12 1.06 Allowed Glycine 0 N--CA 1.465 0.614 0 C-N-CA 120.079 -1.058 . . . . 50.420000000000002 112.868 172.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 236' ' ' ARG . 35.4 tt0 58.37 77.01 0.31 Allowed 'General case' 0 CA--C 1.492 -1.268 0 C-N-CA 125.753 1.621 . . . . 54.140000000000001 110.465 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' B' ' 237' ' ' ALA . 25.7 m -121.91 143.76 49.26 Favored 'General case' 0 N--CA 1.39 -3.426 0 CA-C-N 114.977 -1.01 . . . . 70.5 109.049 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -122.51 126.15 47.23 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.001 -1.481 . . . . 70.430000000000007 107.001 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 239' ' ' VAL . 53.2 t -124.13 126.23 71.96 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.018 0 O-C-N 123.878 0.736 . . . . 73.239999999999995 109.389 -174.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' LEU . . . . . 0.491 HD23 ' HG2' ' B' ' 240' ' ' GLN . 17.7 tp -122.31 121.47 36.81 Favored 'General case' 0 C--N 1.267 -3.008 0 C-N-CA 118.758 -1.177 . . . . 70.430000000000007 110.749 174.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.449 HD11 HG11 ' A' ' 267' ' ' VAL . 74.6 mt -109.75 103.93 16.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 108.489 -0.93 . . . . 75.200000000000003 108.489 178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . 0.519 ' O ' ' HA3' ' B' ' 242' ' ' GLY . . . 139.64 -141.04 11.29 Favored Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 120.614 -0.803 . . . . 54.020000000000003 112.717 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' B' ' 243' ' ' ASN . 44.8 t-20 -123.69 140.08 53.35 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.363 -0.977 . . . . 55.520000000000003 108.363 -176.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.435 ' HG2' ' HB ' ' A' ' 244' ' ' VAL . 0.0 OUTLIER -123.72 119.91 31.16 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.487 -0.931 . . . . 70.530000000000001 108.487 179.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' TYR . . . . . 0.483 ' O ' HG22 ' A' ' 246' ' ' THR . 22.1 m-85 -103.72 121.78 43.71 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.037 -1.838 . . . . 62.329999999999998 106.037 174.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 110.98 -51.7 0.68 Allowed Glycine 0 N--CA 1.423 -2.193 0 N-CA-C 110.077 -1.209 . . . . 61.420000000000002 110.077 -174.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.525 ' C ' ' HD2' ' A' ' 284' ' ' LYS . . . 84.04 3.45 89.06 Favored Glycine 0 C--O 1.223 -0.567 0 CA-C-O 121.241 0.356 . . . . 62.509999999999998 112.269 177.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.525 ' HD2' ' C ' ' A' ' 283' ' ' GLY . 3.6 mptp? -135.52 18.12 3.35 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.148 0.499 . . . . 75.409999999999997 110.27 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -90.51 -39.72 5.87 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 110.615 -0.994 . . . . 55.340000000000003 110.615 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 240' ' ' GLN . 29.1 t80 -79.95 -37.49 34.35 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 112.134 0.42 . . . . 73.200000000000003 112.134 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -73.24 123.14 23.11 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 113.675 0.991 . . . . 74.129999999999995 113.675 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.54 136.01 36.2 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.722 -1.126 . . . . 64.540000000000006 109.199 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -82.76 72.37 9.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.686 1.365 . . . . 72.230000000000004 114.686 -171.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 173.37 111.34 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 126.074 1.749 . . . . 71.040000000000006 106.857 170.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' HIS . . . . . 0.503 ' HB2' ' NH2' ' B' ' 238' ' ' ARG . 0.4 OUTLIER -138.0 160.81 38.36 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.459 -0.791 . . . . 73.439999999999998 109.826 -175.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -125.2 104.44 8.51 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 121.552 0.692 . . . . 62.509999999999998 110.753 178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -126.27 135.36 51.46 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 107.079 -1.452 . . . . 65.219999999999999 107.079 174.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' HIS . . . . . 0.497 ' CE1' ' HB3' ' C' ' 294' ' ' HIS . 57.1 t-80 -151.41 135.04 16.29 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.15 -1.426 . . . . 71.400000000000006 107.15 -165.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' HIS . . . . . 0.474 ' HB2' ' HG3' ' C' ' 236' ' ' ARG . 1.2 p-80 . . . . . 0 CA--C 1.551 1.0 0 N-CA-C 113.545 0.943 . . . . 71.319999999999993 113.545 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 119.416 -0.326 . . . . 62.439999999999998 110.123 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.23 106.7 0.77 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.799 0.809 . . . . 54.439999999999998 109.387 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' ILE . . . . . . . . . . . . . 2.3 pp -101.94 174.61 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 113.857 1.058 . . . . 73.239999999999995 113.857 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -129.65 121.69 27.53 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 103.97 -2.604 . . . . 74.430000000000007 103.97 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . 0.518 ' CB ' ' HB ' ' A' ' 219' ' ' ILE . . . -154.25 157.71 39.15 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.633 -0.827 . . . . 73.519999999999996 112.3 -169.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' ILE . . . . . . . . . . . . . 2.4 mp -83.95 115.81 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 105.111 -2.181 . . . . 71.510000000000005 105.111 167.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 8.7 p -100.67 122.87 53.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.057 0.456 . . . . 63.109999999999999 111.489 -174.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . 0.456 ' HA3' ' NE2' ' A' ' 259' ' ' GLN . . . 174.63 57.45 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 115.487 -0.778 . . . . 54.25 111.242 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' ARG . . . . . 0.422 ' HA ' ' CG2' ' A' ' 261' ' ' THR . 13.8 ptt180 -100.0 128.09 46.13 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 120.208 -0.597 . . . . 73.439999999999998 109.762 -178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 262' ' ' ASN . 27.4 t-20 -116.55 114.65 24.45 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.08 -0.711 . . . . 64.239999999999995 109.08 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 11.1 p -139.48 137.62 35.7 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 112.644 0.609 . . . . 74.510000000000005 112.644 -177.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 264' ' ' VAL . . . -126.53 137.24 53.34 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-N 114.819 -1.082 . . . . 73.109999999999999 108.49 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -87.19 -66.67 0.89 Allowed 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.154 -0.619 . . . . 73.540000000000006 110.418 -179.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -127.0 138.61 53.28 Favored 'General case' 0 C--O 1.264 1.822 0 CA-C-O 121.401 0.619 . . . . 63.25 109.561 177.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' ILE . . . . . 0.49 HG21 HG21 ' B' ' 239' ' ' VAL . 8.7 mt -131.48 117.39 35.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 107.495 -1.298 . . . . 75.209999999999994 107.495 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -116.46 115.65 26.2 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 110.01 -0.367 . . . . 72.540000000000006 110.01 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' B' ' 237' ' ' ALA . 22.3 p -114.31 127.54 55.91 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.167 -1.42 . . . . 62.409999999999997 107.167 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -143.31 138.66 29.68 Favored 'General case' 0 N--CA 1.409 -2.505 0 N-CA-C 109.434 -0.58 . . . . 43.149999999999999 109.434 -177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 235' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' B' ' 271' ' ' GLY . 33.2 tt0 62.59 91.32 0.07 Allowed 'General case' 0 N--CA 1.434 -1.243 0 O-C-N 124.778 1.299 . . . . 64.420000000000002 112.569 171.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 236' ' ' ARG . . . . . . . . . . . . . 36.6 mtt180 65.59 34.85 7.49 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.22 -0.659 . . . . 64.540000000000006 109.22 174.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 237' ' ' ALA . . . . . 0.619 ' O ' ' HA ' ' A' ' 273' ' ' SER . . . -101.54 149.26 24.28 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 122.696 1.236 . . . . 73.420000000000002 113.744 -172.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 238' ' ' ARG . . . . . 0.503 ' NH2' ' HB2' ' A' ' 291' ' ' HIS . 3.7 mpt_? -134.35 136.37 43.37 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.12 -1.437 . . . . 62.149999999999999 107.12 175.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.49 HG21 HG21 ' B' ' 231' ' ' ILE . 12.1 p -137.17 137.83 46.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-O 121.696 0.76 . . . . 62.020000000000003 109.882 176.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.634 ' HB2' ' CD1' ' B' ' 286' ' ' PHE . 16.5 tm0? -118.29 132.49 56.29 Favored 'General case' 0 N--CA 1.39 -3.469 0 N-CA-C 105.068 -2.197 . . . . 62.409999999999997 105.068 174.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.489 ' CD1' HD21 ' A' ' 262' ' ' ASN . 0.8 OUTLIER -130.32 116.3 18.13 Favored 'General case' 0 C--N 1.263 -3.195 0 N-CA-C 106.957 -1.497 . . . . 74.450000000000003 106.957 178.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 242' ' ' GLY . . . . . 0.522 ' O ' ' HA3' ' B' ' 278' ' ' GLY . . . 130.91 -114.15 1.53 Allowed Glycine 0 CA--C 1.537 1.417 0 CA-C-N 115.882 -0.599 . . . . 73.099999999999994 112.165 -176.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 243' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 279' ' ' ASN . 6.8 t30 -144.74 145.75 31.85 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.379 0.59 . . . . 74.099999999999994 110.635 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . 0.461 ' CG2' ' HG3' ' B' ' 240' ' ' GLN . 69.0 t -132.69 126.71 54.98 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 N-CA-C 109.571 -0.529 . . . . 71.140000000000001 109.571 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 245' ' ' VAL . . . . . 0.5 ' HA ' ' HB2' ' B' ' 281' ' ' TYR . 2.7 p -123.86 111.74 30.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 107.967 -1.123 . . . . 75.209999999999994 107.967 169.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . 0.461 HG22 ' HA3' ' B' ' 282' ' ' GLY . 8.8 t -83.12 160.77 21.8 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.069 -1.052 . . . . 75.200000000000003 111.459 -176.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 247' ' ' ALA . . . . . 0.53 ' HB2' ' HA ' ' A' ' 249' ' ' ALA . . . -63.71 -36.12 82.81 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 122.386 1.089 . . . . 54.119999999999997 109.699 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 248' ' ' ALA . . . . . . . . . . . . . . . -59.3 -35.55 73.97 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 113.243 -1.799 . . . . 75.150000000000006 111.6 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 249' ' ' ALA . . . . . 0.46 ' HA ' ' CB ' ' C' ' 247' ' ' ALA . . . -74.7 -26.84 60.1 Favored 'General case' 0 CA--C 1.509 -0.611 0 CA-C-N 116.387 -0.37 . . . . 45.409999999999997 110.863 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 52.8 tp -74.62 75.95 2.01 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 122.062 0.934 . . . . 73.109999999999999 111.976 -175.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 251' ' ' HIS . . . . . 0.427 ' CG ' HD22 ' C' ' 250' ' ' LEU . 21.0 t60 -100.21 -36.27 9.36 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 105.457 -2.053 . . . . 64.310000000000002 105.457 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 252' ' ' GLY . . . . . . . . . . . . . . . -170.24 157.52 28.9 Favored Glycine 0 N--CA 1.418 -2.531 0 N-CA-C 107.339 -2.305 . . . . 45.409999999999997 107.339 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . 104.74 -176.07 22.79 Favored Glycine 0 C--N 1.294 -1.759 0 C-N-CA 120.584 -0.817 . . . . 33.240000000000002 111.545 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 254' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 252' ' ' GLY . 9.2 tt -164.15 -41.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 CA-C-O 121.145 0.498 . . . . 53.109999999999999 110.853 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 255' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -167.25 113.05 0.75 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.612 -1.996 . . . . 74.430000000000007 105.612 179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 256' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.58 -54.96 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 119.51 -0.876 . . . . 71.030000000000001 112.562 -174.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 11.4 p -84.95 28.7 0.68 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 122.805 0.442 . . . . 71.129999999999995 111.028 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -131.0 102.78 6.18 Favored 'General case' 0 N--CA 1.417 -2.104 0 N-CA-C 114.065 1.135 . . . . 60.329999999999998 114.065 -176.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 259' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -137.87 23.35 2.85 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 102.97 -2.974 . . . . 74.400000000000006 102.97 170.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 260' ' ' THR . . . . . . . . . . . . . 2.4 m -76.79 120.58 22.14 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 113.415 -1.72 . . . . 51.32 112.2 -167.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . 0.553 HG23 ' HA ' ' C' ' 225' ' ' ARG . 5.1 t -104.7 108.13 19.43 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 105.798 -1.927 . . . . 63.420000000000002 105.798 167.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 262' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' C' ' 226' ' ' ASN . 25.1 t-20 -116.09 131.18 57.01 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.328 -0.851 . . . . 63.210000000000001 110.902 -172.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 263' ' ' SER . . . . . . . . . . . . . 50.0 m -140.97 123.2 15.71 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.163 0.506 . . . . 62.409999999999997 110.529 177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 264' ' ' VAL . . . . . 0.664 ' HA ' ' O ' ' C' ' 228' ' ' ALA . 11.7 p -124.95 152.11 31.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.662 -0.866 . . . . 71.040000000000006 108.662 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 265' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' B' ' 229' ' ' LYS . 28.8 tt0 -103.2 -56.77 2.16 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 119.273 -0.971 . . . . 73.430000000000007 112.045 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' C' ' 230' ' ' ASP . 29.5 m -135.86 127.13 28.27 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.029 -1.068 . . . . 73.319999999999993 111.35 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . 0.42 ' CG2' HG23 ' B' ' 231' ' ' ILE . 21.6 m -123.62 134.3 66.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.138 -0.689 . . . . 70.310000000000002 109.138 171.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 268' ' ' VAL . . . . . . . . . . . . . 29.3 m -127.69 134.6 65.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.99 -0.55 . . . . 74.120000000000005 110.514 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 269' ' ' GLY . . . . . . . . . . . . . . . -137.57 131.58 5.57 Favored Glycine 0 CA--C 1.476 -2.405 0 C-N-CA 119.254 -1.451 . . . . 50.399999999999999 112.621 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 270' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' C' ' 234' ' ' GLU . 62.9 tttp -135.57 144.9 46.45 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 124.278 0.634 . . . . 72.120000000000005 110.864 176.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . 0.418 ' H ' ' HB3' ' B' ' 235' ' ' GLU . . . 81.02 52.73 4.19 Favored Glycine 0 CA--C 1.486 -1.78 0 C-N-CA 120.877 -0.677 . . . . 62.030000000000001 112.238 173.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 65.11 89.18 0.1 Allowed 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.548 1.139 . . . . 75.230000000000004 109.835 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 273' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' C' ' 237' ' ' ALA . 21.0 m -121.75 144.12 48.98 Favored 'General case' 0 N--CA 1.405 -2.695 0 C-N-CA 119.652 -0.819 . . . . 62.130000000000003 110.162 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 29.0 mmt-85 -117.22 126.8 53.35 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 104.48 -2.415 . . . . 75.140000000000001 104.48 171.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 275' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' B' ' 239' ' ' VAL . 62.0 t -132.63 123.94 50.24 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 N-CA-C 108.772 -0.825 . . . . 70.129999999999995 108.772 -178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 276' ' ' LEU . . . . . . . . . . . . . 8.7 tt -120.48 128.39 53.1 Favored 'General case' 0 C--N 1.268 -2.946 0 C-N-CA 117.595 -1.642 . . . . 74.409999999999997 110.693 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 277' ' ' ILE . . . . . 0.483 HG23 HD12 ' C' ' 241' ' ' LEU . 50.7 mt -112.58 102.63 14.22 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 106.467 -1.679 . . . . 75.319999999999993 106.467 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 278' ' ' GLY . . . . . 0.591 ' O ' ' HA3' ' C' ' 242' ' ' GLY . . . 144.09 -136.02 6.57 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 119.69 -1.243 . . . . 73.349999999999994 114.245 -178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 279' ' ' ASN . . . . . 0.495 ' ND2' ' HB3' ' C' ' 243' ' ' ASN . 9.0 t-20 -127.3 141.42 51.72 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 107.88 -1.156 . . . . 75.109999999999999 107.88 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 280' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.01 120.07 22.95 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.818 -0.808 . . . . 63.329999999999998 108.818 -177.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 281' ' ' TYR . . . . . 0.5 ' HB2' ' HA ' ' B' ' 245' ' ' VAL . 97.2 m-85 -103.31 122.38 44.68 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 106.713 -1.588 . . . . 74.129999999999995 106.713 174.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 282' ' ' GLY . . . . . 0.461 ' HA3' HG22 ' B' ' 246' ' ' THR . . . 110.71 -51.73 0.68 Allowed Glycine 0 N--CA 1.419 -2.479 0 N-CA-C 110.828 -0.909 . . . . 63.219999999999999 110.828 -176.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 283' ' ' GLY . . . . . 0.446 ' C ' ' HD2' ' B' ' 284' ' ' LYS . . . 88.41 -8.4 78.93 Favored Glycine 0 C--N 1.314 -0.656 0 N-CA-C 111.618 -0.593 . . . . 54.240000000000002 111.618 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . 0.446 ' HD2' ' C ' ' B' ' 283' ' ' GLY . 4.0 mptp? -124.97 17.53 8.53 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 120.913 0.387 . . . . 74.439999999999998 110.681 -176.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 285' ' ' GLY . . . . . . . . . . . . . . . -81.49 -60.03 2.28 Favored Glycine 0 N--CA 1.418 -2.507 0 N-CA-C 109.098 -1.601 . . . . 71.140000000000001 109.098 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 286' ' ' PHE . . . . . 0.634 ' CD1' ' HB2' ' B' ' 240' ' ' GLN . 28.1 t80 -67.4 -39.4 85.55 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 124.393 0.702 . . . . 65.129999999999995 112.228 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 287' ' ' TRP . . . . . . . . . . . . . 9.9 m-90 -68.36 102.52 1.42 Allowed 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 114.143 1.164 . . . . 72.099999999999994 114.143 -176.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -85.93 106.84 17.41 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.845 -1.525 . . . . 54.439999999999998 109.426 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 289' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -144.18 84.93 1.78 Allowed 'General case' 0 C--N 1.309 -1.195 0 O-C-N 121.525 -0.734 . . . . 74.209999999999994 110.281 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -144.65 72.04 1.32 Allowed 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 107.774 -1.195 . . . . 75.319999999999993 107.774 176.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 291' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -66.91 110.59 3.39 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.517 -0.765 . . . . 74.219999999999999 109.648 -176.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 292' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -75.3 -73.89 0.23 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.82 -0.627 . . . . 70.129999999999995 109.831 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 293' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -164.85 168.89 17.26 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 106.383 -1.71 . . . . 74.299999999999997 106.383 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 294' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -95.65 -81.78 0.4 Allowed 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.404 -1.332 . . . . 73.420000000000002 107.404 176.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 295' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 . . . . . 0 CA--C 1.502 -0.902 0 C-N-CA 124.541 1.136 . . . . 74.120000000000005 108.535 175.537 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 217' ' ' MET . . . . . . . . . . . . . 56.0 ttp . . . . . 0 C--O 1.241 0.64 0 CA-C-O 121.783 0.801 . . . . 74.329999999999998 110.111 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 218' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -147.5 -56.82 0.24 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 107.55 -1.278 . . . . 74.129999999999995 107.55 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 12.5 pt -99.02 77.43 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.707 0 CA-C-O 122.297 1.046 . . . . 75.319999999999993 109.286 175.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 220' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -91.19 154.63 19.17 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.505 -1.225 . . . . 73.450000000000003 108.392 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -51.83 -67.07 0.28 Allowed 'General case' 0 N--CA 1.477 0.88 0 O-C-N 123.87 0.731 . . . . 62.530000000000001 111.374 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 222' ' ' ILE . . . . . . . . . . . . . 3.0 mp -103.81 115.38 45.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 105.38 -2.082 . . . . 75.310000000000002 105.38 172.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 12.2 p -113.32 119.72 61.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 C-N-CA 119.733 -0.787 . . . . 25.440000000000001 110.494 -177.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 224' ' ' GLY . . . . . . . . . . . . . . . -174.77 55.9 0.13 Allowed Glycine 0 C--N 1.297 -1.587 0 N-CA-C 109.174 -1.571 . . . . 73.049999999999997 109.174 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 225' ' ' ARG . . . . . 0.553 ' HA ' HG23 ' B' ' 261' ' ' THR . 14.5 ptt-85 -98.1 132.56 43.53 Favored 'General case' 0 CA--C 1.492 -1.275 0 C-N-CA 120.737 -0.385 . . . . 72.409999999999997 110.106 -176.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 226' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' B' ' 262' ' ' ASN . 26.6 t-20 -116.81 114.22 23.64 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.451 -1.314 . . . . 62.020000000000003 107.451 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' C' ' 263' ' ' SER . 12.9 t -135.16 137.64 42.93 Favored 'General case' 0 N--CA 1.411 -2.408 0 CA-C-O 121.226 0.536 . . . . 70.040000000000006 109.931 -175.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . 0.664 ' O ' ' HA ' ' B' ' 264' ' ' VAL . . . -132.44 135.01 45.78 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.24 -1.392 . . . . 72.409999999999997 107.24 177.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 229' ' ' LYS . . . . . 0.408 ' HD2' ' HB3' ' B' ' 265' ' ' GLU . 0.0 OUTLIER -85.75 -57.12 3.17 Favored 'General case' 0 C--N 1.287 -2.145 0 C-N-CA 119.793 -0.763 . . . . 64.25 109.828 -178.163 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 230' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' C' ' 266' ' ' THR . 30.8 t70 -139.36 138.96 37.05 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.992 0.425 . . . . 75.109999999999999 110.651 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 231' ' ' ILE . . . . . 0.467 HG23 ' CG2' ' C' ' 267' ' ' VAL . 6.0 mt -137.28 117.64 16.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.18 -1.044 . . . . 73.450000000000003 108.18 -176.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 232' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -111.81 117.17 32.09 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.084 0.469 . . . . 71.319999999999993 111.233 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 233' ' ' THR . . . . . 0.463 ' HB ' ' CB ' ' C' ' 237' ' ' ALA . 15.7 p -110.53 128.32 55.58 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 115.56 -0.745 . . . . 63.200000000000003 109.569 176.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 234' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' B' ' 270' ' ' LYS . 28.6 tt0 -143.21 137.01 28.68 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.244 -1.021 . . . . 64.319999999999993 108.244 178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 235' ' ' GLU . . . . . 0.432 ' HB2' ' H ' ' C' ' 271' ' ' GLY . 53.9 mt-10 57.81 106.18 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 115.14 1.533 . . . . 72.200000000000003 115.14 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 236' ' ' ARG . . . . . 0.559 ' HB2' ' HA ' ' C' ' 272' ' ' GLU . 5.5 mpt_? 59.34 33.07 22.31 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 109.242 -0.651 . . . . 53.43 109.242 174.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 237' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' B' ' 273' ' ' SER . . . -96.38 138.14 34.42 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 113.755 1.02 . . . . 74.329999999999998 113.755 -168.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 238' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' C' ' 274' ' ' ARG . 5.0 mpt_? -133.45 134.73 43.93 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.022 -1.103 . . . . 71.140000000000001 108.022 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 239' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' C' ' 275' ' ' VAL . 17.3 m -138.01 145.81 28.14 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.013 0 CA-C-O 122.065 0.936 . . . . 72.030000000000001 111.02 171.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 240' ' ' GLN . . . . . 0.524 ' HB2' ' CD1' ' C' ' 286' ' ' PHE . 0.3 OUTLIER -126.06 122.86 37.02 Favored 'General case' 0 C--N 1.26 -3.284 0 N-CA-C 104.425 -2.435 . . . . 73.230000000000004 104.425 176.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.483 HD12 HG23 ' B' ' 277' ' ' ILE . 0.8 OUTLIER -121.77 115.4 22.6 Favored 'General case' 0 C--N 1.26 -3.319 0 N-CA-C 106.992 -1.485 . . . . 55.340000000000003 106.992 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 242' ' ' GLY . . . . . 0.591 ' HA3' ' O ' ' B' ' 278' ' ' GLY . . . 131.14 -121.71 3.26 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-N 115.527 -0.76 . . . . 72.150000000000006 111.477 -174.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 243' ' ' ASN . . . . . 0.495 ' HB3' ' ND2' ' B' ' 279' ' ' ASN . 48.9 t-20 -145.1 141.34 28.73 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 118.035 0.917 . . . . 53.240000000000002 110.648 -177.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 244' ' ' VAL . . . . . 0.456 HG23 ' NE2' ' C' ' 240' ' ' GLN . 80.9 t -131.36 131.45 63.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 C-N-CA 123.334 0.654 . . . . 72.239999999999995 110.623 178.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 245' ' ' VAL . . . . . . . . . . . . . 6.1 p -122.42 116.77 50.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 106.426 -1.694 . . . . 63.450000000000003 106.426 168.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 246' ' ' THR . . . . . . . . . . . . . 15.0 t -77.21 160.58 28.82 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 118.467 -1.293 . . . . 54.340000000000003 111.581 -174.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 247' ' ' ALA . . . . . 0.46 ' CB ' ' HA ' ' B' ' 249' ' ' ALA . . . -64.4 -39.17 93.33 Favored 'General case' 0 CA--C 1.492 -1.25 0 CA-C-N 115.715 -0.675 . . . . 75.109999999999999 109.525 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 248' ' ' ALA . . . . . . . . . . . . . . . -54.67 -33.4 60.72 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.517 -1.674 . . . . 71.340000000000003 112.102 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 249' ' ' ALA . . . . . . . . . . . . . . . -65.39 -26.72 68.12 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.382 -0.372 . . . . 72.349999999999994 111.268 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 250' ' ' LEU . . . . . 0.427 HD22 ' CG ' ' B' ' 251' ' ' HIS . 84.9 mt 47.98 75.72 0.13 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.647 1.179 . . . . 73.530000000000001 111.048 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 251' ' ' HIS . . . . . 0.404 ' NE2' ' HB2' ' C' ' 255' ' ' ARG . 24.0 t-80 -85.47 136.52 33.4 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 119.517 -0.873 . . . . 73.140000000000001 111.676 -172.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.14 119.44 1.91 Allowed Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 109.855 -1.298 . . . . 64.540000000000006 109.855 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 253' ' ' GLY . . . . . . . . . . . . . . . 97.15 -158.92 21.24 Favored Glycine 0 C--N 1.307 -1.056 0 N-CA-C 109.931 -1.267 . . . . 51.149999999999999 109.931 -177.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 254' ' ' ILE . . . . . . . . . . . . . 35.4 pt -124.48 110.03 24.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 117.675 0.737 . . . . 52.329999999999998 110.769 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 255' ' ' ARG . . . . . 0.404 ' HB2' ' NE2' ' C' ' 251' ' ' HIS . 57.5 mtm180 -131.34 92.51 3.2 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.792 -0.447 . . . . 73.519999999999996 109.792 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 256' ' ' ILE . . . . . . . . . . . . . 3.0 mp -94.97 78.79 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 106.272 -1.751 . . . . 74.209999999999994 106.272 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 257' ' ' SER . . . . . . . . . . . . . 12.5 p -58.74 -61.53 2.55 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.273 -1.33 . . . . 70.420000000000002 111.723 -175.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 258' ' ' ASP . . . . . 0.438 ' HB3' HD21 ' C' ' 279' ' ' ASN . 13.9 t70 -94.41 116.72 29.13 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.613 -0.884 . . . . 73.25 108.613 178.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 259' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -81.77 89.27 6.28 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.535 -1.283 . . . . 71.140000000000001 107.535 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 260' ' ' THR . . . . . . . . . . . . . 5.0 m -86.52 121.84 29.62 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 113.158 0.799 . . . . 74.430000000000007 113.158 -171.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 261' ' ' THR . . . . . . . . . . . . . 13.9 t -133.34 109.33 9.29 Favored 'General case' 0 N--CA 1.409 -2.502 0 N-CA-C 105.192 -2.151 . . . . 72.420000000000002 105.192 168.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 262' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -123.59 137.53 54.73 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.241 -0.89 . . . . 54.149999999999999 111.36 -166.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 263' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' C' ' 227' ' ' SER . 49.0 m -142.59 123.9 14.71 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 109.013 -0.736 . . . . 64.450000000000003 109.013 175.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 264' ' ' VAL . . . . . . . . . . . . . 8.5 p -128.64 151.85 35.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.736 -0.468 . . . . 73.420000000000002 109.736 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 265' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.49 -80.21 0.19 Allowed 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 109.421 -0.585 . . . . 71.239999999999995 109.421 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 266' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' C' ' 230' ' ' ASP . 8.1 t -139.22 129.29 25.17 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.751 -0.593 . . . . 75.420000000000002 109.995 -177.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . 0.467 ' CG2' HG23 ' C' ' 231' ' ' ILE . 27.0 m -120.78 135.3 61.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 116.254 -0.43 . . . . 72.340000000000003 110.033 177.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 268' ' ' VAL . . . . . . . . . . . . . 34.2 m -123.25 140.98 45.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 116.357 -0.383 . . . . 72.310000000000002 110.604 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 269' ' ' GLY . . . . . . . . . . . . . . . -133.43 131.53 6.11 Favored Glycine 0 CA--C 1.474 -2.483 0 N-CA-C 110.342 -1.103 . . . . 72.409999999999997 110.342 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 270' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -135.06 119.88 18.41 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 107.998 -1.112 . . . . 74.030000000000001 107.998 -178.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 271' ' ' GLY . . . . . 0.432 ' H ' ' HB2' ' C' ' 235' ' ' GLU . . . 80.95 76.95 1.02 Allowed Glycine 0 N--CA 1.465 0.608 0 C-N-CA 120.829 -0.7 . . . . 62.030000000000001 113.178 175.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 272' ' ' GLU . . . . . 0.559 ' HA ' ' HB2' ' C' ' 236' ' ' ARG . 45.8 mt-10 63.03 82.38 0.18 Allowed 'General case' 0 CA--C 1.48 -1.718 0 C-N-CA 124.689 1.196 . . . . 71.239999999999995 110.478 -178.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 273' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' C' ' 237' ' ' ALA . 51.7 m -125.48 143.71 50.87 Favored 'General case' 0 N--CA 1.399 -3.021 0 C-N-CA 119.036 -1.066 . . . . 64.230000000000004 109.9 177.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 274' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' C' ' 238' ' ' ARG . 79.0 mtt85 -136.61 126.05 25.07 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 104.148 -2.538 . . . . 74.519999999999996 104.148 174.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 275' ' ' VAL . . . . . 0.579 ' HB ' HG12 ' C' ' 239' ' ' VAL . 8.1 t -138.1 134.41 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.944 0 N-CA-C 108.012 -1.107 . . . . 54.210000000000001 108.012 -178.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 276' ' ' LEU . . . . . . . . . . . . . 8.9 tt -119.74 115.51 24.05 Favored 'General case' 0 N--CA 1.384 -3.767 0 C-N-CA 118.846 -1.141 . . . . 64.510000000000005 108.991 174.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 277' ' ' ILE . . . . . . . . . . . . . 3.0 mp -93.59 102.43 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.392 0 N-CA-C 104.52 -2.4 . . . . 73.200000000000003 104.52 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 278' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' C' ' 242' ' ' GLY . . . 139.21 -147.01 18.87 Favored Glycine 0 CA--C 1.49 -1.482 0 C-N-CA 119.317 -1.42 . . . . 72.319999999999993 113.888 -177.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 279' ' ' ASN . . . . . 0.438 HD21 ' HB3' ' C' ' 258' ' ' ASP . 42.9 t-20 -118.56 149.37 41.46 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.563 -1.273 . . . . 73.150000000000006 107.563 -178.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 280' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' C' ' 244' ' ' VAL . 15.6 tm-20 -146.36 121.11 9.87 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 105.839 -1.911 . . . . 72.030000000000001 105.839 -176.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 281' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -104.12 125.05 50.13 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.58 -0.896 . . . . 75.239999999999995 108.58 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 282' ' ' GLY . . . . . . . . . . . . . . . 119.46 -47.32 1.04 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 111.298 -0.721 . . . . 70.200000000000003 111.298 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 283' ' ' GLY . . . . . 0.508 ' C ' ' HD2' ' C' ' 284' ' ' LYS . . . 94.86 -9.71 70.58 Favored Glycine 0 CA--C 1.493 -1.342 0 N-CA-C 111.022 -0.831 . . . . 53.409999999999997 111.022 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 284' ' ' LYS . . . . . 0.508 ' HD2' ' C ' ' C' ' 283' ' ' GLY . 13.4 mptt -126.92 6.35 6.61 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 114.766 -0.717 . . . . 73.140000000000001 112.69 -172.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 285' ' ' GLY . . . . . . . . . . . . . . . -73.14 -57.96 4.94 Favored Glycine 0 N--CA 1.437 -1.234 0 C-N-CA 119.802 -1.189 . . . . 50.310000000000002 112.182 -176.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 286' ' ' PHE . . . . . 0.524 ' CD1' ' HB2' ' C' ' 240' ' ' GLN . 23.0 t80 -75.67 -31.23 59.69 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 114.633 1.345 . . . . 74.439999999999998 114.633 -174.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 287' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -68.45 89.3 0.35 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 115.405 1.632 . . . . 64.510000000000005 115.405 -172.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 288' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -72.35 151.42 42.7 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 124.904 1.282 . . . . 61.119999999999997 111.488 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 289' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -105.45 -86.59 0.47 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.609 0.596 . . . . 73.140000000000001 112.609 -173.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 290' ' ' HIS . . . . . 0.44 ' CE1' ' HB3' ' C' ' 292' ' ' HIS . 24.3 t-80 67.2 132.13 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.833 1.653 . . . . 74.340000000000003 111.903 -174.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 291' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -135.23 87.11 2.3 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.295 -0.412 . . . . 63.229999999999997 110.352 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 292' ' ' HIS . . . . . 0.44 ' HB3' ' CE1' ' C' ' 290' ' ' HIS . 17.9 t60 -169.94 117.37 0.57 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.729 -1.212 . . . . 74.299999999999997 107.729 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 293' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -128.25 132.36 48.74 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.816 -0.354 . . . . 62.409999999999997 111.514 -174.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 294' ' ' HIS . . . . . 0.497 ' HB3' ' CE1' ' A' ' 294' ' ' HIS . 37.3 t-80 -172.23 -6.81 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 123.359 0.664 . . . . 72.120000000000005 111.311 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 295' ' ' HIS . . . . . 0.421 ' H ' ' H ' ' C' ' 294' ' ' HIS . 67.4 m80 . . . . . 0 N--CA 1.494 1.741 0 C-N-CA 125.748 1.619 . . . . 71.25 112.707 -178.779 . . . . . . . . 1 1 . 1 stop_ save_